PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ohm, AM; Tan, AC; Heasley, LE; Reyland, ME				Ohm, A. M.; Tan, A-C; Heasley, L. E.; Reyland, M. E.			Co-dependency of PKC delta and K-Ras: inverse association with cytotoxic drug sensitivity in KRAS mutant lung cancer	ONCOGENE			English	Article							TYROSINE PHOSPHORYLATION; TUMOR-SUPPRESSOR; NUCLEAR IMPORT; SALIVARY-GLAND; BREAST-CANCER; DNA-DAMAGE; CELLS; APOPTOSIS; MUTATIONS; MIGRATION	Recent studies suggest that the presence of a KRAS mutation may be insufficient for defining a clinically homogenous molecular group, as many KRAS mutant tumors lose reliance on K-Ras for survival. Identifying pathways that support K-Ras dependency may define clinically relevant KRAS subgroups and lead to the identification of new drug targets. We have analyzed a panel of 17 KRAS mutant lung cancer cell lines classified as K-Ras-dependent or -independent for co-dependency on protein kinase C delta (PKC delta). We show that functional dependency on K-Ras and PKC delta co-segregate, and that dependency correlates with a more epithelial-like phenotype. Furthermore, we show that the pro-apoptotic and pro-tumorigenic functions of PKC delta also segregate based on K-Ras dependency, as K-Ras-independent cells are more sensitive to topoisomerase inhibitors, and depletion of PKC delta in this subgroup suppresses apoptosis through increased activation of extracellular signal-regulated kinase (ERK). In contrast, K-Ras-dependent lung cancer cells are largely insensitive to topoisomerase inhibitors, and depletion of PKC delta can increase apoptosis and decrease activation of ERK in this subgroup. We have previously shown that nuclear translocation of PKC delta is necessary and sufficient for proapoptotic signaling. Our current studies show that K-Ras-dependent cells are refractive to PKC delta-driven apoptosis. Analysis of this subgroup showed increased PKC delta expression and an increase in the nuclear: cytoplasmic ratio of PKC delta. In addition, targeting PKCd to the nucleus induces apoptosis in K-Ras-independent, but not K-Ras-dependent non-small-cell lung cancer (NSCLC) cells. Our studies provide tools for identification of the subset of patients with KRAS mutant tumors most amenable to targeting of the K-Ras pathway, and identify PKC delta as a potential target in this tumor population. These subgroups are likely to be of clinical relevance, as high PKC delta expression correlates with increased overall survival and a more epithelial tumor phenotype in patients with KRAS mutant lung adenocarcinomas.	[Ohm, A. M.; Heasley, L. E.; Reyland, M. E.] Univ Colorado, Sch Dent Med, Dept Craniofacial Biol, Anschutz Med Campus,MS 8120,POB 6511, Aurora, CO 80045 USA; [Tan, A-C] Univ Colorado, Sch Med, Div Med Oncol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Reyland, ME (corresponding author), Univ Colorado, Sch Dent Med, Dept Craniofacial Biol, Anschutz Med Campus,MS 8120,POB 6511, Aurora, CO 80045 USA.	Mary.Reyland@UCDenver.edu	Tan, Aik Choon/A-3135-2011	Tan, Aik Choon/0000-0003-2955-8369	United Against Lung Cancer research award; NIH Lung SPORE [P50 CA58187, R01DE015648]; NATIONAL CANCER INSTITUTE [P30CA046934, P50CA058187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015648] Funding Source: NIH RePORTER	United Against Lung Cancer research award; NIH Lung SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We gratefully acknowledge the intellectual contributions of Dr Ross Camidge. This work was supported by a United Against Lung Cancer research award, a pilot grant from NIH Lung SPORE Grant P50 CA58187 and R01DE015648 to MER.	Adwan TS, 2011, J BIOL CHEM, V286, P35716, DOI 10.1074/jbc.M111.255950; Allen-Petersen BL, 2014, ONCOGENE, V33, P1306, DOI 10.1038/onc.2013.59; Allen-Petersen BL, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.20; Antal CE, 2015, CELL, V160, P489, DOI 10.1016/j.cell.2015.01.001; Bailey TA, 2014, J BIOL CHEM, V289, P30443, DOI 10.1074/jbc.M114.608992; Beau-Faller M, 2009, BRIT J CANCER, V100, P985, DOI 10.1038/sj.bjc.6604925; Cai QS, 2009, J BIOL CHEM, V284, P2150, DOI 10.1074/jbc.M803235200; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; D'Costa AM, 2006, ONCOGENE, V25, P378, DOI 10.1038/sj.onc.1209065; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Garg R, 2014, ONCOGENE, V33, P5225, DOI 10.1038/onc.2013.524; Hu CT, 2013, CELL SIGNAL, V25, P1457, DOI 10.1016/j.cellsig.2013.03.011; Humphries MJ, 2008, ONCOGENE, V27, P3045, DOI 10.1038/sj.onc.1210967; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jackson D, 2005, ONCOGENE, V24, P3067, DOI 10.1038/sj.onc.1208465; Kharait S, 2006, BIOCHEM BIOPH RES CO, V343, P848, DOI 10.1016/j.bbrc.2006.03.044; Kho DH, 2009, GUT, V58, P509, DOI 10.1136/gut.2008.150938; Kolb RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050281; Koo KH, 2015, ONCOTARGET, V6, P21328, DOI 10.18632/oncotarget.4049; Lagory EL, 2010, J BIOL CHEM, V285, P1879, DOI 10.1074/jbc.M109.055392; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; Mauro LV, 2010, PANCREAS, V39, pE31, DOI 10.1097/MPA.0b013e3181bce796; McCormick F, 2015, CLIN CANCER RES, V21, P1797, DOI 10.1158/1078-0432.CCR-14-2662; Mogi A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/583929; Nguyen HM, 2012, J NEUROSCI, V32, P3474, DOI 10.1523/JNEUROSCI.4167-11.2012; Osaki S, 2000, CANCER GENE THER, V7, P300, DOI 10.1038/sj.cgt.7700096; Pagliarini R, 2015, EMBO REP, V16, P280, DOI 10.15252/embr.201439949; Park M, 2013, CLIN CANCER RES, V19, P4961, DOI 10.1158/1078-0432.CCR-13-0131; Paugh BS, 2008, FASEB J, V22, P455, DOI 10.1096/fj.07-8276com; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Reno EM, 2008, HUM PATHOL, V39, P21, DOI 10.1016/j.humpath.2007.05.023; Reyland ME, 2016, PHARMACOL THERAPEUT, V165, P1, DOI 10.1016/j.pharmthera.2016.05.001; Reyland ME, 2000, CELL DEATH DIFFER, V7, P1200, DOI 10.1038/sj.cdd.4400744; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Singh A, 2009, CELL CYCLE, V8, P2676, DOI 10.4161/cc.8.17.9336; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Symonds JM, 2016, ONCOTARGET, V7, P17905, DOI 10.18632/oncotarget.7560; Symonds JM, 2011, CANCER RES, V71, P2087, DOI 10.1158/0008-5472.CAN-10-1511; Ueda Y, 1996, J BIOL CHEM, V271, P23512, DOI 10.1074/jbc.271.38.23512; Wie SM, 2014, J BIOL CHEM, V289, P10900, DOI 10.1074/jbc.M114.551366; Wilson FH, 2015, CANCER CELL, V27, P397, DOI 10.1016/j.ccell.2015.02.005; Xia SH, 2007, J BIOL CHEM, V282, P13199, DOI 10.1074/jbc.M610225200; Xia SH, 2009, CELL SIGNAL, V21, P502, DOI 10.1016/j.cellsig.2008.12.002; Yoshida K, 2008, TRENDS MOL MED, V14, P305, DOI 10.1016/j.molmed.2008.05.003; Young A, 2013, CANCER DISCOV, V3, P112, DOI 10.1158/2159-8290.CD-12-0231; Zhu T, 2010, ONCOGENE, V29, P1050, DOI 10.1038/onc.2009.344	49	10	11	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 27	2017	36	30					4370	4378		10.1038/onc.2017.27	http://dx.doi.org/10.1038/onc.2017.27			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FB8AH	28368426	Green Accepted			2022-12-26	WOS:000406360600013
J	Hesse, J; Leberling, S; Boden, E; Friebe, D; Schmidt, T; Ding, ZP; Dieterich, P; Deussen, A; Roderigo, C; Rose, CR; Floss, DM; Scheller, J; Schrader, J				Hesse, Julia; Leberling, Stella; Boden, Elisabeth; Friebe, Daniela; Schmidt, Timo; Ding, Zhaoping; Dieterich, Peter; Deussen, Andreas; Roderigo, Claudia; Rose, Christine R.; Floss, Doreen M.; Scheller, Juergen; Schrader, Juergen			CD73-derived adenosine and tenascin-C control cytokine production by epicardium-derived cells formed after myocardial infarction	FASEB JOURNAL			English	Article						A(2B) receptor; IL-6; inflammasome; mesenchymal cells; P2X(7) receptor	EXTRACELLULAR-MATRIX; PROGENITOR CELLS; RECEPTORS; INJURY; HEART; ATP; INFLAMMATION; ACTIVATION; FIBROBLASTS; METABOLISM	Epicardium-derived cells (EPDCs) play a fundamental role in embryonic cardiac development and are reactivated in the adult heart in response to myocardial infarction (MI). In this study, EPDCs from post-MI rat hearts highly expressed the ectoenzyme CD73 and secreted the profibrotic matricellular protein tenascin-C (TNC). CD73 on EPDCs extensively generated adenosine from both extracellular ATP and NAD. This in turn stimulated the release of additional nucleotides from a Brefeldin A-sensitive intracellular pool via adenosine-A2BR signaling, forming a positive-feedback loop. A2BR activation, in addition, strongly promoted the release of major regulatory cytokines, such as IL-6, IL-11, and VEGF. TNC was found to stimulate EPDC migration and, together with ATPP2X7R signaling, to activate inflammasomes in EPDCs via TLR4. Our results demonstrate that EPDCs are an important source of various proinflammatory factors in the post-MI heart controlled by purinergic and TNC signaling. Hesse, J., Leberling, S., Boden, E., Friebe, D., Schmidt, T., Ding, Z., Dieterich, P., Deussen, A., Roderigo, C., Rose, C. R., Floss, D. M., Scheller, J., Schrader, J. CD73-derived adenosine and tenascin-C control cytokine production by epicardium-derived cells formed after myocardial infarction.	[Hesse, Julia; Leberling, Stella; Boden, Elisabeth; Friebe, Daniela; Schmidt, Timo; Ding, Zhaoping; Schrader, Juergen] Heinrich Heine Univ Dusseldorf, Dept Mol Cardiol, Univ Str 1, D-40225 Dusseldorf, Germany; [Dieterich, Peter; Deussen, Andreas] Heinrich Heine Univ Dusseldorf, Inst Neurobiol, Dusseldorf, Germany; [Floss, Doreen M.; Scheller, Juergen] Heinrich Heine Univ Dusseldorf, Inst Biochem & Mol Biol 2, Dusseldorf, Germany; [Roderigo, Claudia; Rose, Christine R.] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Physiol, Dresden, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Schrader, J (corresponding author), Heinrich Heine Univ Dusseldorf, Dept Mol Cardiol, Univ Str 1, D-40225 Dusseldorf, Germany.	schrader@uni-duesseldorf.de	Dieterich, Peter/G-8495-2016; Scheller, Jürgen/K-5290-2015	Dieterich, Peter/0000-0002-3564-0193; 	German Research Foundation [SFB 1116]	German Research Foundation(German Research Foundation (DFG))	The authors thank Bodo Steckel (Heinrich Heine University Dusseldorf, Dusseldorf) for his technical support with the HPLC measurements. This study was supported by the German Research Foundation (SFB 1116; to D.F. and J.S.). The authors declare no conflicts of interest.	Aherne CM, 2011, BBA-BIOMEMBRANES, V1808, P1329, DOI 10.1016/j.bbamem.2010.05.016; Akopova I, 2012, PURINERG SIGNAL, V8, P59, DOI 10.1007/s11302-011-9259-2; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Bollini S, 2014, STEM CELLS DEV, V23, P1719, DOI 10.1089/scd.2014.0019; Boros D, 2016, PERFUSION-UK, V31, P103, DOI 10.1177/0267659115586579; Braitsch CM, 2013, J DEV BIOL, V1, P92, DOI 10.3390/jdb1020092; Burnstock G, 2015, PURINERG SIGNAL, V11, P1, DOI 10.1007/s11302-014-9436-1; Carmona R, 2010, J CELL MOL MED, V14, P2066, DOI 10.1111/j.1582-4934.2010.01088.x; Di Virgilio F, 2013, PHARMACOL REV, V65, P872, DOI 10.1124/pr.112.006171; Ding ZP, 2016, STEM CELL TRANSL MED, V5, P639, DOI 10.5966/sctm.2015-0159; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Erb Laurie, 2012, Wiley Interdiscip Rev Membr Transp Signal, V1, P789; Fang M, 2016, J MOL CELL CARDIOL, V91, P23, DOI 10.1016/j.yjmcc.2015.12.019; Feng W, 2010, BRIT J PHARMACOL, V159, P1598, DOI 10.1111/j.1476-5381.2009.00558.x; FEOKTISTOV I, 1994, MOL PHARMACOL, V45, P1160; Feranchak AP, 2010, J BIOL CHEM, V285, P8138, DOI 10.1074/jbc.M109.065482; Feroz F, 2008, MON NOT R ASTRON SOC, V384, P449, DOI 10.1111/j.1365-2966.2007.12353.x; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Fontes JA, 2015, CYTOKINE, V74, P62, DOI 10.1016/j.cyto.2014.12.024; Goding JW, 2003, BBA-MOL BASIS DIS, V1638, P1, DOI 10.1016/S0925-4439(03)00058-9; Gorini S, 2013, AM J BLOOD RES, V3, P14; Haanes KA, 2014, PURINERG SIGNAL, V10, P431, DOI 10.1007/s11302-014-9406-7; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Huang MY, 2015, HEART FAIL REV, V20, P25, DOI 10.1007/s10741-014-9431-1; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Imanaka-Yoshida K, 2001, LAB INVEST, V81, P1015, DOI 10.1038/labinvest.3780313; Imanaka-Yoshida K, 2012, CIRC J, V76, P2513, DOI 10.1253/circj.CJ-12-1033; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Kleveland O, 2016, EUR HEART J, V37, P2406, DOI 10.1093/eurheartj/ehw171; Krebs C, 2005, J IMMUNOL, V174, P3298, DOI 10.4049/jimmunol.174.6.3298; KROLL K, 1992, CIRC RES, V71, P590, DOI 10.1161/01.RES.71.3.590; Liu Y, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0415-z; Lohman AW, 2012, CARDIOVASC RES, V95, P269, DOI 10.1093/cvr/cvs187; Machino-Ohtsuka T, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001052; Mercer SE, 2013, DEV BIOL, V382, P457, DOI 10.1016/j.ydbio.2013.08.002; Mezzaroma E, 2011, P NATL ACAD SCI USA, V108, P19725, DOI 10.1073/pnas.1108586108; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Mirabet M, 1999, J CELL SCI, V112, P491; Mitrophanov AY, 2008, BIOESSAYS, V30, P542, DOI 10.1002/bies.20769; Nishioka T, 2010, AM J PHYSIOL-HEART C, V298, pH1072, DOI 10.1152/ajpheart.00255.2009; Obana M, 2010, CIRCULATION, V121, P684, DOI 10.1161/CIRCULATIONAHA.109.893677; Pangrsic T, 2007, J BIOL CHEM, V282, P28749, DOI 10.1074/jbc.M700290200; Pomerening JR, 2009, FEBS LETT, V583, P3388, DOI 10.1016/j.febslet.2009.10.001; Ruiz-Villalba A, 2015, J AM COLL CARDIOL, V65, P2057, DOI 10.1016/j.jacc.2015.03.520; Sadej R, 2012, ACTA BIOCHIM POL, V59, P647; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Skilling J, 2006, BAYESIAN ANAL, V1, P833, DOI 10.1214/06-BA127; Smart N, 2013, VASC PHARMACOL, V58, P164, DOI 10.1016/j.vph.2012.08.001; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; SMOLENSKI RT, 1990, J CHROMATOGR-BIOMED, V527, P414, DOI 10.1016/S0378-4347(00)82125-8; Tamaoki M, 2005, AM J PATHOL, V167, P71, DOI 10.1016/S0002-9440(10)62954-9; van Wijk B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044692; VonDerLinden W, 2014, BAYESIAN PROBABILITY THEORY: APPLICATIONS IN THE PHYSICAL SCIENCES, P1; Willems IEMG, 1996, J PATHOL, V179, P321; Yegutkin GG, 2014, CRIT REV BIOCHEM MOL, V49, P473, DOI 10.3109/10409238.2014.953627; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529; Zuo PY, 2008, J BIOL CHEM, V283, P26805, DOI 10.1074/jbc.M801516200	61	24	26	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3040	3053		10.1096/fj.201601307R	http://dx.doi.org/10.1096/fj.201601307R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28363952				2022-12-26	WOS:000405931000028
J	Gustafsson, MO; Mohammad, DK; Ylosmaki, E; Choi, H; Shrestha, S; Wang, Q; Nore, BF; Saksela, K; Smith, CIE				Gustafsson, Manuela O.; Mohammad', Dara K.; Ylosmaki, Erkko; Choi, Hyunseok; Shrestha, Subhash; Wang, Qing; Nore, Beston F.; Saksela, Kalle; Smith, C. I. Edvard			ANKRD54 preferentially selects Bruton's Tyrosine Kinase (BTK) from a Human Src-Homology 3 (SH3) domain library	PLOS ONE			English	Article							ANKYRIN REPEAT; TEC FAMILY; LIGAND-BINDING; PROTEIN; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION; ACTIVATION; CONSENSUS	Bruton's Tyrosine Kinase (BTK) is a cytoplasmic protein tyrosine kinase with a fundamental role in B-lymphocyte development and activation. The nucleocytoplasmic shuttling of BTK is specifically modulated by the Ankyrin Repeat Domain 54 (ANKRD54) protein and the interaction is known to be exclusively SH3-dependent. To identify the spectrum of the ANKRD54 SH3-interactome, we applied phage-display screening of a library containing all the 296 human SH3 domains. The BTK-SH3 domain was the prime interactor. Quantitative western blotting analysis demonstrated the accuracy of the screening procedure. Revealing the spectrum and specificity of ANKRD54-interactome is a critical step toward functional analysis in cells and tissues.	[Gustafsson, Manuela O.; Mohammad', Dara K.; Wang, Qing; Nore, Beston F.; Smith, C. I. Edvard] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Clin Res Ctr, Se Stockholm, Sweden; [Mohammad', Dara K.] Salahaddin Univ Erbil, Dept Biol, Coll Sci, Erbil, Kurdistan Regio, Iraq; [Ylosmaki, Erkko; Choi, Hyunseok; Shrestha, Subhash; Saksela, Kalle] Univ Helsinki, Dept Virol, Helsinki, Finland; [Ylosmaki, Erkko; Choi, Hyunseok; Shrestha, Subhash; Saksela, Kalle] Helsinki Univ Hosp, Helsinki, Finland; [Nore, Beston F.] Univ Sulaimani, Sch Med, Dept Biochem, Fac Med Sci, Sulaimani, Iraq; [Nore, Beston F.] KISSSR, Dept Hlth, Sulaimani, Kurdistan, Iraq	Karolinska Institutet; Karolinska University Hospital; Salahaddin University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Sulimanyah	Gustafsson, MO; Smith, CIE (corresponding author), Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Lab Med, Clin Res Ctr, Se Stockholm, Sweden.	manuela.gustafsson@ki.se; edward.smith@ki.se	Nore, Beston F./N-9288-2016	Nore, Beston F./0000-0003-3865-2920; gustafsson, manuela/0000-0002-0268-9476; Mohammad, Dara K./0000-0001-9201-0991; Saksela, Kalle/0000-0003-0827-122X; SMITH, C. I. Edvard/0000-0003-1907-3392	Sodertorn University-College, Sweden; MoHE in the Kurdistan-Regional Government, Iraq; Swedish Cancer Society; Ministry of Higher Education and Scientific Research in Kurdistan-Regional Government-Erbil; CRDF Global (USA)	Sodertorn University-College, Sweden; MoHE in the Kurdistan-Regional Government, Iraq; Swedish Cancer Society(Swedish Cancer Society); Ministry of Higher Education and Scientific Research in Kurdistan-Regional Government-Erbil; CRDF Global (USA)	MOG holds a Ph.D. scholarship from Sodertorn University-College, Sweden. DKM maintains a postdoctoral-fellowship from MoHE in the Kurdistan-Regional Government, Iraq. The project was supported by a grant from the Swedish Cancer Society.; MOG holds a Ph.D. scholarship from Sodertorn University-College, Sweden. DKM thanks the Ministry of Higher Education and Scientific Research in Kurdistan-Regional Government-Erbil, Iraq for their support. BFN receives a research fund from CRDF Global (USA). The project was supported by a grant from the Swedish Cancer Society.	Allgood AG, 2011, J MOL BIOL, V414, P243, DOI 10.1016/j.jmb.2011.09.050; Asbach B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038540; Bartelt RR, 2015, BBA-MOL CELL RES, V1853, P2560, DOI 10.1016/j.bbamcr.2015.06.002; Berry DM, 2002, CURR BIOL, V12, P1336, DOI 10.1016/S0960-9822(02)01038-2; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Gustafsson MO, 2012, MOL CELL BIOL, V32, P2440, DOI 10.1128/MCB.06620-11; Hansson H, 1998, SOLUTION STRUCTURE S, V2960, P2912; Hendriks RW, 2014, NAT REV CANCER, V14, P219, DOI 10.1038/nrc3702; Karkkainen S, 2006, EMBO REP, V7, P186, DOI 10.1038/sj.embor.7400596; Kay BK, 2012, FEBS LETT, V586, P2606, DOI 10.1016/j.febslet.2012.05.025; Kleino I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121301; Kurosaki T, 2009, IMMUNOL REV, V228, P132, DOI 10.1111/j.1600-065X.2008.00748.x; Lindvall JM, 2005, IMMUNOL REV, V203, P200, DOI 10.1111/j.0105-2896.2005.00225.x; Mohamed AJ, 2009, IMMUNOL REV, V228, P58, DOI 10.1111/j.1600-065X.2008.00741.x; Mohammad DK, 2013, MOL CELL BIOL, V33, P3214, DOI 10.1128/MCB.00247-13; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Mosavi LK, 2002, P NATL ACAD SCI USA, V99, P16029, DOI 10.1073/pnas.252537899; MUSACCHIO A, 1994, PROG BIOPHYS MOL BIO, V61, P283, DOI 10.1016/0079-6107(94)90003-5; Nore BF, 2003, BBA-PROTEINS PROTEOM, V1645, P123, DOI 10.1016/S1570-9639(02)00524-1; Nore BF, 2000, EUR J IMMUNOL, V30, P145, DOI 10.1002/1521-4141(200001)30:1<145::AID-IMMU145>3.0.CO;2-0; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; Parra RG, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004659; Rawlings DJ, 1996, SCIENCE, V271, P822, DOI 10.1126/science.271.5250.822; Reiss DJ, 2004, BIOINFORMATICS, V20, P274, DOI 10.1093/bioinformatics/bth922; Saksela K, 2012, FEBS LETT, V586, P2609, DOI 10.1016/j.febslet.2012.04.042; Samuels AL, 2009, BLOOD, V113, P3845, DOI 10.1182/blood-2008-04-153452; Schwarten M, 2013, BIOCHEMISTRY-US, V52, P6160, DOI 10.1021/bi400363v; SEDGWICK SG, 1999, ANK REP DIV INT, V4, P311; SMITH CIE, 1994, J IMMUNOL, V152, P557; Smith CIE, 2001, BIOESSAYS, V23, P436, DOI 10.1002/bies.1062; Takesono A, 2002, J CELL SCI, V115, P3039; Truhlar SME, 2008, J MOL BIOL, V380, P67, DOI 10.1016/j.jmb.2008.02.053; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Wilkie A., 1993, J MED GENET, V30, P444, DOI DOI 10.1136/jmg.30.5.444-b; YU HT, 1992, SCIENCE, V258, P1665, DOI 10.1126/science.1280858	36	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174909	10.1371/journal.pone.0174909	http://dx.doi.org/10.1371/journal.pone.0174909			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369144	Green Published, gold, Green Submitted			2022-12-26	WOS:000399351000061
J	Hornung, J; Kogler, L; Wolpert, S; Freiherr, J; Derntl, B				Hornung, Jonas; Kogler, Lydia; Wolpert, Stephan; Freiherr, Jessica; Derntl, Birgit			The human body odor compound androstadienone leads to anger-dependent effects in an emotional Stroop but not dot-probe task using human faces	PLOS ONE			English	Article							ATTENTIONAL BIAS; HUMAN PHEROMONE; TIME-COURSE; SELECTIVE ATTENTION; FACIAL EXPRESSIONS; ANGRY FACES; THREAT; WOMEN; MEN; ANXIETY	The androgen derivative androstadienone is a substance found in human sweat and thus is a putative human chemosignal. Androstadienone has been studied with respect to effects on mood states, attractiveness ratings, physiological and neural activation. With the current experiment, we aimed to explore in which way androstadienone affects attention to social cues (human faces). Moreover, we wanted to test whether effects depend on specific emotions, the participants' sex and individual sensitivity to smell androstadienone. To do so, we investigated 56 healthy individuals (thereof 29 females taking oral contraceptives) with two attention tasks on two consecutive days (once under androstadienone, once under placebo exposure in pseudorandomized order). With an emotional dot-probe task we measured visuo-spatial cueing while an emotional Stroop task allowed us to investigate interference control. Our results suggest that androstadienone acts in a sex, task and emotion-specific manner as a reduction in interference processes in the emotional Stroop task was only apparent for angry faces in men under androstadienone exposure. More specifically, men showed a smaller difference in reaction times for congruent compared to incongruent trials. At the same time also women were slightly affected by smelling androstadienone as they classified angry faces more often correctly under androstadienone. For the emotional dot-probe task no modulation by androstadienone was observed. Furthermore, in both attention paradigms individual sensitivity to androstadienone was neither correlated with reaction times nor error rates in men and women. To conclude, exposure to androstadienone seems to potentiate the relevance of angry faces in both men and women in connection with interference control, while processes of visuo-spatial cueing remain unaffected.	[Hornung, Jonas; Kogler, Lydia; Derntl, Birgit] Univ Tubingen, Sch Med, Dept Psychiat & Psychotherapy, Tubingen, Germany; [Wolpert, Stephan] Univ Tubingen, Sch Med, Dept Otolaryngol Head & Neck Surg, Tubingen, Germany; [Freiherr, Jessica] Univ Klinikum RWTH Aachen, Diag & Intervent Neuroradiol, Aachen, Germany; [Freiherr, Jessica] Fraunhofer Inst Proc Engn & Packaging IVV, Freising Weihenstephan, Germany; [Derntl, Birgit] Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, Tubingen, Germany; [Derntl, Birgit] Univ Tubingen, Lead Grad Sch, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; RWTH Aachen University; RWTH Aachen University Hospital; Fraunhofer Gesellschaft; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Hornung, J (corresponding author), Univ Tubingen, Sch Med, Dept Psychiat & Psychotherapy, Tubingen, Germany.	jonas.harnung@med.uni-tuebingen.de	Freiherr, Jessica/N-9695-2015; Freiherr, Jessica/U-6826-2019	Freiherr, Jessica/0000-0001-9052-4497; Kogler, Lydia/0000-0002-9493-2321; Derntl, Birgit/0000-0003-0133-4486; Hornung, Jonas/0000-0003-4468-0258	Medical Faculty of the University of Tubingen [fORTUNE 2319-0-0]	Medical Faculty of the University of Tubingen	The Medical Faculty of the University of Tubingen (fORTUNE 2319-0-0) provided BD with the funding for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2003, SCIENCE, V300, P1536, DOI 10.1126/science.1082244; Albrecht J, 2011, CHEM SENSES, V36, P19, DOI 10.1093/chemse/bjq087; [Anonymous], 1992, WST WORTSCHATZTEST; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Bensafi A, 2004, BEHAV BRAIN RES, V152, P11, DOI 10.1016/j.bbr.2003.09.009; BIAGGIO MK, 1989, PSYCHOL REP, V64, P23, DOI 10.2466/pr0.1989.64.1.23; Burke SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040993; Chechko N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038155; Chung KC, 2016, PSYCHONEUROENDOCRINO, V68, P126, DOI 10.1016/j.psyneuen.2016.02.026; Chung KC, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00044; Davis FC, 2011, EMOTION, V11, P647, DOI 10.1037/a0021625; de Groot JHB, 2012, PSYCHOL SCI, V23, P1417, DOI 10.1177/0956797612445317; de Valk JM, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01240; Deng YL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158666; Derntl B, 2008, HORM BEHAV, V53, P90, DOI 10.1016/j.yhbeh.2007.09.006; Donges US, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041745; Ebner NC, 2010, BEHAV RES METHODS, V42, P351, DOI 10.3758/BRM.42.1.351; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; Ferdenzi C, 2016, PSYCHONEUROENDOCRINO, V66, P166, DOI 10.1016/j.psyneuen.2016.01.016; Freiherr J, 2012, J NEUROSCI METH, V205, P10, DOI 10.1016/j.jneumeth.2011.12.004; Frey MCM, 2012, PERCEPT MOTOR SKILL, V114, P807, DOI 10.2466/07.16.22.28.PMS.114.3.807-825; Gelstein S, 2011, SCIENCE, V331, P226, DOI 10.1126/science.1198331; Gohier B, 2013, EUR PSYCHIAT, V28, P74, DOI 10.1016/j.eurpsy.2011.06.007; GOWER DB, 1994, J STEROID BIOCHEM, V48, P409, DOI 10.1016/0960-0760(94)90082-5; Grillon C, 2011, PSYCHOPHYSIOLOGY, V48, P1745, DOI 10.1111/j.1469-8986.2011.01268.x; Grosser BI, 2000, PSYCHONEUROENDOCRINO, V25, P289, DOI 10.1016/S0306-4530(99)00056-6; Guapo VG, 2009, PSYCHONEUROENDOCRINO, V34, P1087, DOI 10.1016/j.psyneuen.2009.02.007; Hautzinger M, 2006, BDI 2 BECK DEPRESSIO; Hummer TA, 2017, PSYCHONEUROENDOCRINO, V75, P15, DOI 10.1016/j.psyneuen.2016.09.023; Hummer TA, 2009, HORM BEHAV, V55, P548, DOI 10.1016/j.yhbeh.2009.01.002; Jacob S, 2001, PHYSIOL BEHAV, V74, P15, DOI 10.1016/S0031-9384(01)00537-6; Jacob S, 2000, HORM BEHAV, V37, P57, DOI 10.1006/hbeh.1999.1559; Koster EHW, 2004, BEHAV RES THER, V42, P1183, DOI 10.1016/j.brat.2003.08.001; Koster EHW, 2007, EXP PSYCHOL, V54, P161, DOI 10.1027/1618-3169.54.2.161; Lundstrom JN, 2005, BIOL PSYCHOL, V70, P197, DOI 10.1016/j.biopsycho.2005.01.008; Lundstrom JN, 2003, CHEM SENSES, V28, P643, DOI 10.1093/chemse/bjg057; Lundstrom JN, 2003, HORM BEHAV, V44, P395, DOI 10.1016/j.yhbeh.2003.06.004; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mogg K, 1997, BEHAV RES THER, V35, P297, DOI 10.1016/S0005-7967(96)00109-X; Mogg K, 2004, COGNITION EMOTION, V18, P689, DOI 10.1080/02699930341000158; Moosbrugger H, 2011, FRANKFURTER AUFMERKS, V2; Mutic S, 2016, CHEM SENSES, V41, P35, DOI 10.1093/chemse/bjv058; NIXON A, 1988, J STEROID BIOCHEM, V29, P505, DOI 10.1016/0022-4731(88)90185-9; Parma V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030645; Peterson, 1989, ATTENTION SYSTEM HUM; Petrova K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076335; Pfabigan DM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01477; Pintzinger NM, 2016, J BEHAV THER EXP PSY, V52, P29, DOI 10.1016/j.jbtep.2016.02.003; POSNER MI, 1971, PSYCHOL REV, V78, P391, DOI 10.1037/h0031333; Price RB, 2015, PSYCHOL ASSESSMENT, V27, P365, DOI 10.1037/pas0000036; Reitan RM, 1992, TRAIL MAKING TEST MA; Salemink E, 2007, BEHAV RES THER, V45, P607, DOI 10.1016/j.brat.2006.04.004; Saxton TK, 2008, HORM BEHAV, V54, P597, DOI 10.1016/j.yhbeh.2008.06.001; Stevens S, 2011, J BEHAV THER EXP PSY, V42, P219, DOI 10.1016/j.jbtep.2010.11.001; Taylor GJ, 1990, CANADIAN J PSYCHIAT; Tran US, 2013, J RES PERS, V47, P390, DOI 10.1016/j.jrp.2013.03.007; Villemure C, 2007, EUR J PAIN, V11, P181, DOI 10.1016/j.ejpain.2006.02.005; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Weissman DH, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00587; White LK, 2016, NEUROIMAGE, V136, P84, DOI 10.1016/j.neuroimage.2016.04.058; Wittchen HU, 1997, SKID; Wyatt TD, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2994	64	12	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							0175055	10.1371/journal.pone.0175055	http://dx.doi.org/10.1371/journal.pone.0175055			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2IH	28369152	gold, Green Published, Green Submitted			2022-12-26	WOS:000399351000073
J	Furuno, K; Lee, K; Itoh, Y; Suzuki, K; Yonemitsu, K; Kuwata, R; Shimoda, H; Watarai, M; Maeda, K; Takano, A				Furuno, Kiwa; Lee, Kyunglee; Itoh, Yukie; Suzuki, Kazuo; Yonemitsu, Kenzo; Kuwata, Ryusei; Shimoda, Hiroshi; Watarai, Masahisa; Maeda, Ken; Takano, Ai			Epidemiological study of relapsing fever borreliae detected in Haemaphysalis ticks and wild animals in the western part of Japan	PLOS ONE			English	Article							AMBLYOMMA-AMERICANUM ACARI; DEER CERVUS-NIPPON; LONE STAR TICKS; IXODES-SCAPULARIS; GROUP SPIROCHETE; HARD TICK; ODOCOILEUS-VIRGINIANUS; EHRLICHIA-CHAFFEENSIS; PUTATIVE AGENT; LYME-DISEASE	The genus Borrelia comprises arthropod-borne bacteria, which are infectious agents in vertebrates. They are mainly transmitted by ixodid or argasid ticks. In Hokkaido, Japan, Borrelia spp. were found in deer and Haemaphysalis ticks between 2011 and 2013; however, the study was limited to a particular area. Therefore, in the present study, we conducted large-scale surveillance of ticks and wild animals in the western part of the main island of Japan. We collected 6,407 host-seeking ticks from two regions and 1,598 larvae obtained from 32 engorged female ticks and examined them to elucidate transovarial transmission. In addition, we examined whole blood samples from 190 wild boars and 276 sika deer, as well as sera from 120 wild raccoons. We detected Borrelia spp. in Haemaphysalis flava, Haemaphysalis megaspinosa, Haemaphysalis kitaokai, Haemaphysalis longicornis, and Haemaphysalis formosensis. In addition, we isolated a strain from H. megaspinosa using BarbourStoenner- Kelly medium. The minimum infection rate of ticks was less than 5%. Transovarial transmission was observed in H. kitaokai. Phylogenetic analysis of the isolated strain and DNA fragments amplified from ticks identified at least four bacterial genotypes, which corresponded to the tick species detected. Bacteria were detected in 8.4%, 15%, and 0.8% of wild boars, sika deer, and raccoons, respectively. In this study, we found seasonal differences in the prevalence of bacterial genotypes in sika deer during the winter and summer. The tick activity season corresponds to the season with a high prevalence of animals. The present study suggests that a particular bacterial genotype detected in this study are defined by a particular tick species in which they are present.	[Furuno, Kiwa; Itoh, Yukie; Yonemitsu, Kenzo; Kuwata, Ryusei; Shimoda, Hiroshi; Watarai, Masahisa; Maeda, Ken; Takano, Ai] Yamaguchi Univ, Joint Fac Vet Med, Dept Vet Med, Yamaguchi, Yamaguchi, Japan; [Lee, Kyunglee] Natl Inst Fisheries Sci, Cetacean Res Inst, Ulsan, South Korea; [Suzuki, Kazuo] Hikiiwa Pk Ctr, Wakayama, Japan; [Watarai, Masahisa; Takano, Ai] Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi, Yamaguchi, Japan	Yamaguchi University; National Institute of Fisheries Science; Yamaguchi University	Takano, A (corresponding author), Yamaguchi Univ, Joint Fac Vet Med, Dept Vet Med, Yamaguchi, Yamaguchi, Japan.; Takano, A (corresponding author), Yamaguchi Univ, United Grad Sch Vet Sci, Yamaguchi, Yamaguchi, Japan.	a-takano@yamaguchi-u.ac.jp		TAKANO, Ai/0000-0002-5919-3738	Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED; Program to Disseminate Tenure Tracking System, MEXT, Japan; JSPS KAKENHI [15H05262]; Ministry of Education, Science, Sports and Culture of Japan; Grants-in-Aid for Scientific Research [17K15685] Funding Source: KAKEN	Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Program to Disseminate Tenure Tracking System, MEXT, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Research Program on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED (http://www. amed.go.jp/en/), and Program to Disseminate Tenure Tracking System, MEXT, Japan (http:// www.jst.go.jp/tenure/index.html) and JSPS KAKENHI (https://www.jsps.go.jp/english/index. html), Grant Number 15H05262. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr Hiroki Kawabata (National Institute of Infectious Diseases) for providing technical information about the detection of Borrelia sp. in wild animals. We thank K. R. Taylor (Washington State University, Department of Veterinary Microbiology and Pathology) for his critical comments on this manuscript. We would like to thank the hunters, officers, and members of the Laboratory of Veterinary Microbiology for collecting samples from wild animal. We also acknowledge the technical expertise of the DNA Core facility at the Center for Gene Research, Yamaguchi University, which was supported by a grant-in-aid from the Ministry of Education, Science, Sports and Culture of Japan.	Bacon RM, 2004, J CLIN MICROBIOL, V42, P2326, DOI 10.1128/JCM.42.5.2326-2328.2004; Barbour AG, 2005, TICK-BORNE DISEASES OF HUMANS, P268; Barbour AG, 1996, J INFECT DIS, V173, P403, DOI 10.1093/infdis/173.2.403; Barbour AG, 2009, AM J TROP MED HYG, V81, P1120, DOI 10.4269/ajtmh.2009.09-0208; Boden K, 2016, EMERG INFECT DIS, V22, P1617, DOI 10.3201/eid2209.152034; Castellaw AH, 2010, J MED ENTOMOL, V47, P473, DOI 10.1603/ME09263; Castellaw AH, 2011, VECTOR-BORNE ZOONOT, V11, P439, DOI 10.1089/vbz.2009.0221; Chowdri HR, 2013, ANN INTERN MED, V159, P21, DOI 10.7326/0003-4819-159-1-201307020-00005; Cutler S, 2012, TICKS TICK-BORNE DIS, V3, P14, DOI 10.1016/j.ttbdis.2011.08.004; Fraenkel CJ, 2002, J CLIN MICROBIOL, V40, P3308, DOI 10.1128/JCM.40.9.3308-3312.2002; Franke J, 2013, TICKS TICK-BORNE DIS, V4, P11, DOI 10.1016/j.ttbdis.2012.06.007; FUKUNAGA M, 1995, INT J SYST BACTERIOL, V45, P804, DOI 10.1099/00207713-45-4-804; Hovius JWR, 2013, LANCET, V382, P658, DOI 10.1016/S0140-6736(13)61644-X; Inokuma H, 2002, J VET MED SCI, V64, P615, DOI 10.1292/jvms.64.615; Jordan BE, 2009, J MED ENTOMOL, V46, P131, DOI 10.1603/033.046.0117; Killmaster LF, 2014, J MED ENTOMOL, V51, P868, DOI 10.1603/ME13225; Kutsuna S, 2013, AM J TROP MED HYG, V89, P460, DOI 10.4269/ajtmh.13-0187; Lee K, 2014, TICKS TICK-BORNE DIS, V5, P841, DOI 10.1016/j.ttbdis.2014.06.006; Maegli A, 2016, TICKS TICK-BORNE DIS, V7, P154, DOI 10.1016/j.ttbdis.2015.10.008; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; Margos G, 2013, INT J SYST EVOL MICR, V63, P4284, DOI 10.1099/ijs.0.052001-0; Margos G, 2009, APPL ENVIRON MICROB, V75, P5410, DOI 10.1128/AEM.00116-09; Mccoy BN, 2014, TICKS TICK-BORNE DIS, V5, P401, DOI 10.1016/j.ttbdis.2014.01.007; Mixson TR, 2006, J MED ENTOMOL, V43, P1261, DOI 10.1603/0022-2585(2006)43[1261:POEBAR]2.0.CO;2; Moore VA, 2003, J CLIN MICROBIOL, V41, P424, DOI 10.1128/JCM.41.1.424-427.2003; Motoi Y, 2013, J VET MED SCI, V75, P263, DOI 10.1292/jvms.12-0299; Mun J, 2006, J MED ENTOMOL, V43, P120, DOI 10.1603/0022-2585(2006)043[0120:DOABMS]2.0.CO;2; Parola P, 2001, CLIN INFECT DIS, V32, P897, DOI 10.1086/319347; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; Rollend L, 2013, TICKS TICK-BORNE DIS, V4, P46, DOI 10.1016/j.ttbdis.2012.06.008; Sato K, 2014, EMERG INFECT DIS, V20, P1391, DOI 10.3201/eid2008.131761; Sayler KA, 2016, J MED ENTOMOL, V53, P949, DOI 10.1093/jme/tjw054; Schulze TL, 2006, J MED ENTOMOL, V43, P1269, DOI 10.1603/0022-2585(2006)43[1269:RAAPOS]2.0.CO;2; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; Sinski E, 2016, ADV MED SCI-POLAND, V61, P255, DOI 10.1016/j.advms.2016.03.001; SMITH RD, 1985, AM J VET RES, V46, P1396; Takano A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104532; Takano A, 2012, TICKS TICK-BORNE DIS, V3, P259, DOI 10.1016/j.ttbdis.2012.06.003; Takano A, 2010, ENVIRON MICROBIOL, V12, P134, DOI 10.1111/j.1462-2920.2009.02054.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor K. H., 2013, THESIS; TREES AJ, 1978, TROP ANIM HEALTH PRO, V10, P93, DOI 10.1007/BF02235315; Varela AS, 2004, J CLIN MICROBIOL, V42, P1163, DOI 10.1128/JCM.42.3.1163-1169.2004; Wagemakers A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-418; Wormser GP, 2005, CLIN INFECT DIS, V40, P423, DOI 10.1086/427289; Yabsley MJ, 2008, VECTOR-BORNE ZOONOT, V8, P491, DOI 10.1089/vbz.2007.0240; YAMAGUTI N, 1971, Brigham Young University Science Bulletin Biological Series, V15, P1; Yparraguirre LA, 2007, VECTOR-BORNE ZOONOT, V7, P717, DOI 10.1089/vbz.2007.0144	48	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174727	10.1371/journal.pone.0174727	http://dx.doi.org/10.1371/journal.pone.0174727			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362864	gold, Green Submitted, Green Published			2022-12-26	WOS:000399175000028
J	Hollenbach, JP; Schifano, ED; Hammel, C; Cloutier, MM				Hollenbach, Jessica P.; Schifano, Elizabeth D.; Hammel, Christopher; Cloutier, Michelle M.			Exposure to secondhand smoke and asthma severity among children in Connecticut	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; MANAGEMENT PROGRAM; PEDIATRIC ASTHMA; URBAN CHILDREN; UNITED-STATES; LUNG-FUNCTION; CARE; COMMUNITY; ANCESTRY; SYMPTOMS	Objective To determine whether secondhand smoke (SHS) exposure is associated with greater asthma severity in children with physician-diagnosed asthma living in CT, and to examine whether area of residence, race/ethnicity or poverty moderate the association. Methods A large childhood asthma database in CT (Easy Breathing) was linked by participant zip code to census data to classify participants by area of residence. Multinomial logistic regression models, adjusted for enrollment date, sex, age, race/ethnicity, area of residence, insurance type, family history of asthma, eczema, and exposure to dogs, cats, gas stove, rodents and cockroaches were used to examine the association between self-reported exposure to SHS and clinician-determined asthma severity (mild, moderate, and severe persistent vs. intermittent asthma). Results Of the 30,163 children with asthma enrolled in Easy Breathing, between 6 months and 18 years old, living in 161 different towns in CT, exposure to SHS was associated with greater asthma severity (adjusted relative risk ratio (aRRR): 1.07 [1.00, 1.15] and aRRR: 1.11 [1.02, 1.22] for mild and moderate persistent asthma, respectively). The odds of Black and Puerto Rican/Hispanic children with asthma being exposed to SHS were twice that of Caucasian children. Though the odds of SHS exposure for publicly insured children with asthma were three times greater than the odds for privately insured children (OR: 3.02 [2.84,3,21]), SHS exposure was associated with persistent asthma only among privately insured children (adjusted odds ratio (aOR): 1.23 [1.11,1.37]). Conclusion This is the first large-scale pragmatic study to demonstrate that children exposed to SHS in Connecticut have greater asthma severity, clinically determined using a systematic approach, and varies by insurance status.	[Hollenbach, Jessica P.; Cloutier, Michelle M.] Connecticut Childrens Med Ctr, Asthma Ctr, Hartford, CT 06106 USA; [Hollenbach, Jessica P.; Cloutier, Michelle M.] Univ Connecticut, Sch Med, Dept Pediat, Farmington, CT 06032 USA; [Schifano, Elizabeth D.] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA; [Hammel, Christopher] Univ Connecticut, Sch Med, Farmington, CT USA	Connecticut Children's Medical Center; University of Connecticut; University of Connecticut; University of Connecticut	Hollenbach, JP (corresponding author), Connecticut Childrens Med Ctr, Asthma Ctr, Hartford, CT 06106 USA.; Hollenbach, JP (corresponding author), Univ Connecticut, Sch Med, Dept Pediat, Farmington, CT 06032 USA.	jhollenbach@connecticutchildrens.org			Department of Public Health, State of Connecticut [2006-0051, 2008-0025, 2010-0025, 2014-0045]	Department of Public Health, State of Connecticut	This work was funded by the Department of Public Health, State of Connecticut (Contract numbers 2006-0051, 2008-0025, 2010-0025, 2014-0045) (MMC). The sponsor was not involved in the study design, data collection, analysis or interpretation, nor in the writing of the report and the decision to submit the article for publication.; This work was funded by the Department of Public Health, State of Connecticut (Contract numbers 2006-0051, 2008-0025, 2010-0025, 2014-0045). We acknowledge all of the pediatric practices and staff who have participated in the Easy Breathing program. Most especially we thank the community-based program coordinators (Ms Maria Thomas, Ms Kelly Sullivan, Ms Lynne Gunn, Ms Annmarie DeMerchant, and Ms Mary Buckley-Davis), physician champions and data entry personnel. We are also grateful for the efforts on behalf of the program by Ms Autherene Mitchell (senior database manager).	Akinbami LJ, 2013, ACAD PEDIATR, V13, P508, DOI 10.1016/j.acap.2013.07.003; Beckett WS, 1996, AM J RESP CRIT CARE, V154, P894, DOI 10.1164/ajrccm.154.4.8887582; Brehm JM, 2012, J ALLERGY CLIN IMMUN, V129, P1484, DOI 10.1016/j.jaci.2012.03.035; Bureau USC, 2010, DP 1 PROF GEN POP 20; Carlsten C, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-187; Cloutier MM, 2008, ANN ALLERG ASTHMA IM, V100, P545, DOI 10.1016/S1081-1206(10)60058-0; Cloutier MM, 2011, PEDIATRICS, V127, P11, DOI 10.1542/peds.2010-1943; Cloutier MM, 2005, J PEDIATR-US, V146, P591, DOI 10.1016/j.jpeds.2004.12.017; Cloutier MM, 2002, CHEST, V122, P1571, DOI 10.1378/chest.122.5.1571; Cowen MK, 2007, J ASTHMA, V44, P711, DOI 10.1080/02770900701595576; Gorber SC, 2009, NICOTINE TOB RES, V11, P12, DOI 10.1093/ntr/ntn010; Hall CB, 2001, J PEDIATR-US, V139, P267, DOI 10.1067/mpd.2001.116697; Halterman JS, 2004, ARCH PEDIAT ADOL MED, V158, P460, DOI 10.1001/archpedi.158.5.460; Health CDoP, 2013, CONN YOUTH TOB SURV; Homa DM, 2015, MMWR-MORBID MORTAL W, V64, P103; Howrylak JA, 2014, PEDIATRICS, V133, pE355, DOI 10.1542/peds.2013-2422; Keet CA, 2015, J ALLERGY CLIN IMMUN, V135, P655, DOI 10.1016/j.jaci.2014.11.022; Levy D, 2004, CHANGING DEMOGRAPH 2; Mannino DM, 2002, CHEST, V122, P409, DOI 10.1378/chest.122.2.409; McCarville M, 2013, ARCH DIS CHILD, V98, P510, DOI 10.1136/archdischild-2012-303109; Morkjaroenpong V, 2002, J ALLERGY CLIN IMMUN, V110, P147, DOI 10.1067/mai.2002.125832; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Ownby DR, 2015, J ALLERGY CLIN IMMUN; Pino-Yanes M, 2015, J ALLERGY CLIN IMMUN, V135, P228, DOI 10.1016/j.jaci.2014.07.053; Quinto Kenneth B, 2013, NCHS Data Brief, P1; Rabe KF, 2004, J ALLERGY CLIN IMMUN, V114, P40, DOI 10.1016/j.jaci.2004.04.042; Rose RA, 2008, SOC WORK RES, V32, P171, DOI 10.1093/swr/32.3.171; Rubin DB, 2008, MULTIPLE IMPUTATION, P202; Schifano ED, 2014, J PEDIATR-US, V165, P997, DOI 10.1016/j.jpeds.2014.07.026; Wang Z, 2015, ANN ALLERGY ASTHMA I; Winer RA, 2012, J ASTHMA, V49, P16, DOI 10.3109/02770903.2011.637594	31	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174541	10.1371/journal.pone.0174541	http://dx.doi.org/10.1371/journal.pone.0174541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362801	Green Published, Green Submitted, gold			2022-12-26	WOS:000399175000017
J	Girardi-Schappo, M; Bortolotto, GS; Stenzinger, RV; Gonsalves, JJ; Tragtenberg, MHR				Girardi-Schappo, Mauricio; Bortolotto, Germano S.; Stenzinger, Rafael V.; Gonsalves, Jheniffer J.; Tragtenberg, Marcelo H. R.			Phase diagrams and dynamics of a computationally efficient map-based neuron model	PLOS ONE			English	Article							ONE-DIMENSIONAL MAP; LARGE-SCALE MODEL; SUBTHRESHOLD OSCILLATIONS; EARLY AFTERDEPOLARIZATIONS; CARDIAC-ARRHYTHMIAS; STRANGE ATTRACTORS; SYSTEMS; BURSTS; BRAIN	We introduce a new map-based neuron model derived from the dynamical perceptron family that has the best compromise between computational efficiency, analytical tractability, reduced parameter space and many dynamical behaviors. We calculate bifurcation and phase diagrams analytically and computationally that underpins a rich repertoire of autonomous and excitable dynamical behaviors. We report the existence of a new regime of cardiac spikes corresponding to nonchaotic aperiodic behavior. We compare the features of our model to standard neuron models currently available in the literature.	[Girardi-Schappo, Mauricio] McGill Univ, Montreal Neurol Inst & Hosp, McConnell Brain Imaging Ctr, Neuroimaging Epilepsy Lab, Montreal, PQ H3A 2B4, Canada; [Bortolotto, Germano S.; Stenzinger, Rafael V.; Gonsalves, Jheniffer J.; Tragtenberg, Marcelo H. R.] Univ Fed Santa Catarina, Dept Fis, BR-88040900 Florianopolis, SC, Brazil	McGill University; Universidade Federal de Santa Catarina (UFSC)	Tragtenberg, MHR (corresponding author), Univ Fed Santa Catarina, Dept Fis, BR-88040900 Florianopolis, SC, Brazil.	marcelotragtenberg@gmail.com	Tragtenberg, Marcelo H. R./T-8865-2019; Girardi-Schappo, Mauricio/P-1906-2015; Stenzinger, Rafael Vitor/AFX-5223-2022	Girardi-Schappo, Mauricio/0000-0002-9111-4905; Stenzinger, Rafael Vitor/0000-0002-4399-6683; Bortolotto, Germano/0000-0001-9260-5629	CNPq; FAPESC	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESC(Fundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC))	M.G.S., R.V.S. and J.J.G. thank CNPq; G. S.B. thanks FAPESC.	Amir R, 2002, J NEUROSCI, V22, P1187, DOI 10.1523/JNEUROSCI.22-03-01187.2002; Brette R, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004114; CHIALVO DR, 1995, CHAOS SOLITON FRACT, V5, P461, DOI 10.1016/0960-0779(93)E0056-H; Copelli M, 2004, PHYSICA A, V342, P263, DOI 10.1016/j.physa.2004.04.087; Courbage M, 2007, CHAOS, V17, DOI 10.1063/1.2795435; de Garis H, 2010, NEUROCOMPUTING, V74, P3, DOI 10.1016/j.neucom.2010.08.004; de Souzaa SLT, 2017, PHYSICA A, V466, P224, DOI 10.1016/j.physa.2016.09.020; ECKMANN JP, 1985, REV MOD PHYS, V57, P617, DOI 10.1103/RevModPhys.57.617; Eliasmith C, 2012, SCIENCE, V338, P1202, DOI 10.1126/science.1225266; Fenton F.H., 2008, SCHOLARPEDIA, V3, P1868, DOI [10.4249/scholarpedia.1868, DOI 10.4249/SCHOLARPEDIA.1868]; FITZHUGH R, 1955, B MATH BIOL, V17, P257, DOI DOI 10.1007/BF02477753; FREDERICKSON P, 1983, J DIFFER EQUATIONS, V49, P185, DOI 10.1016/0022-0396(83)90011-6; GALLAS JAC, 1994, PHYSICA A, V202, P196, DOI 10.1016/0378-4371(94)90174-0; Girardi-Schappo M, 2013, J NEUROSCI METH, V220, P116, DOI 10.1016/j.jneumeth.2013.07.014; Girardi-Schappo M, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.024701; Hennessy J. L., 2012, COMPUTER ARCHITECTUR; Herz AVM, 2006, SCIENCE, V314, P80, DOI 10.1126/science.1127240; Ibarz B, 2011, PHYS REP, V501, P1, DOI 10.1016/j.physrep.2010.12.003; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Izhikevich EM, 2004, INT J BIFURCAT CHAOS, V14, P3847, DOI 10.1142/S0218127404011739; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Izhikevich EM, 2002, BIOSYSTEMS, V67, P95, DOI 10.1016/S0303-2647(02)00067-9; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Kinouchi O, 1996, INT J BIFURCAT CHAOS, V6, P2343, DOI 10.1142/S0218127496001508; Kugler P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151178; Kuva SM, 2001, NEUROCOMPUTING, V38, P255, DOI 10.1016/S0925-2312(01)00376-9; LUO CH, 1991, CIRC RES, V68, P1501, DOI 10.1161/01.RES.68.6.1501; Markram H, 2015, CELL, V163, P456, DOI 10.1016/j.cell.2015.09.029; McCulloch W. S., 1943, B MATH BIOPHYS, VBMB-5, P115, DOI DOI 10.1007/BF02478259; Mesbah S, 2014, CHAOS SOLITON FRACT, V65, P20, DOI 10.1016/j.chaos.2014.04.006; NAGUMO J, 1962, P IRE, V50, P2061, DOI 10.1109/JRPROC.1962.288235; Pavlov EA, 2011, PHYS LETT A, V375, P2894, DOI 10.1016/j.physleta.2011.06.014; Potjans TC, 2014, CEREB CORTEX, V24, P785, DOI 10.1093/cercor/bhs358; Quail T, 2015, P NATL ACAD SCI USA, V112, P9358, DOI 10.1073/pnas.1424320112; Rulkov NF, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041922; Rulkov NF, 2001, PHYS REV LETT, V86, P183, DOI 10.1103/PhysRevLett.86.183; Rulkov NF, 2007, ARXIV07081173V1QBIOC; Sato D, 2009, P NATL ACAD SCI USA, V106, P2983, DOI 10.1073/pnas.0809148106; Shilnikov A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.048101; Strogatz S. H., 2001, NONLINEAR DYNAMICS C; Tolkacheva EG, 2002, CHAOS, V12, P1034, DOI 10.1063/1.1515170; TRAGTENBERG MHR, 1995, PHYS REV E, V52, P2187, DOI 10.1103/PhysRevE.52.2187; Tran DX, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.258103; Weiss JN, 2010, HEART RHYTHM, V7, P1891, DOI 10.1016/j.hrthm.2010.09.017; WHITE JA, 1995, BIOPHYS J, V69, P1203, DOI 10.1016/S0006-3495(95)79995-7; Zhu ZT, 2004, EUR J NEUROSCI, V19, P1296, DOI 10.1111/j.1460-9568.2004.03240.x	46	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174621	10.1371/journal.pone.0174621	http://dx.doi.org/10.1371/journal.pone.0174621			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358843	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174800060
J	Liu, X; Wang, BJ; Xu, L; Tang, HL; Xu, GQ				Liu, Xiao; Wang, Bao-Jin; Xu, Luo; Tang, Hong-Ling; Xu, Guo-Qing			Selection of key sequence-based features for prediction of essential genes in 31 diverse bacterial species	PLOS ONE			English	Article							REGRESSION; IDENTIFICATION	Genes that are indispensable for survival are essential genes. Many features have been proposed for computational prediction of essential genes. In this paper, the least absolute shrinkage and selection operator method was used to screen key sequence-based features related to gene essentiality. To assess the effects, the selected features were used to predict the essential genes from 31 bacterial species based on a support vector machine classifier. For all 31 bacterial objects (21 Gram-negative objects and ten Gram-positive objects), the features in the three datasets were reduced from 57, 59, and 58, to 40, 37, and 38, respectively, without loss of prediction accuracy. Results showed that some features were redundant for gene essentiality, so could be eliminated from future analyses. The selected features contained more complex (or key) biological information for gene essentiality, and could be of use in related research projects, such as gene prediction, synthetic biology, and drug design.	[Liu, Xiao; Wang, Bao-Jin; Xu, Luo; Xu, Guo-Qing] Chongqing Univ, Coll Commun Engn, Chongqing, Peoples R China; [Liu, Xiao] Key Lab Chongqing Biopercept & Intelligent Inform, Chongqing, Peoples R China; [Tang, Hong-Ling] Chongqing City Management Coll, Chongqing, Peoples R China	Chongqing University	Liu, X (corresponding author), Chongqing Univ, Coll Commun Engn, Chongqing, Peoples R China.; Liu, X (corresponding author), Key Lab Chongqing Biopercept & Intelligent Inform, Chongqing, Peoples R China.	liuxiao@cqu.edu.cn			National Natural Science Foundation of China [61001157]; China Postdoctoral Science Foundation [2012M521673]; Fundamental Research Funds for the Central Universities [106112014CDJZR165503, CDJRC10160011, CDJZR12160007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant No. 61001157), the China Postdoctoral Science Foundation funded project (Grant No. 2012M521673), and the Fundamental Research Funds for the Central Universities (Project No. 106112014CDJZR165503, CDJRC10160011, CDJZR12160007).	Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chapelle O, 2007, NEURAL COMPUT, V19, P1155, DOI 10.1162/neco.2007.19.5.1155; Commichau FM, 2013, MOL BIOSYST, V9, P1068, DOI 10.1039/c3mb25595f; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Deng JY, 2011, NUCLEIC ACIDS RES, V39, P795, DOI 10.1093/nar/gkq784; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Gustafson AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-265; Harrison SC, 2007, STRUCTURE, V15, P1344, DOI 10.1016/j.str.2007.10.004; Huang T, 2013, COMPUT BIOL CHEM, V43, P46, DOI 10.1016/j.compbiolchem.2012.12.008; Hwang KB, 2013, BMB REP, V46, P41, DOI 10.5483/BMBRep.2013.46.1.159; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Joyce AR, 2006, J BACTERIOL, V188, P8259, DOI 10.1128/JB.00740-06; Juhas M, 2012, TRENDS BIOTECHNOL, V30, P601, DOI 10.1016/j.tibtech.2012.08.002; Juhas M, 2011, TRENDS CELL BIOL, V21, P562, DOI 10.1016/j.tcb.2011.07.005; Keerthi SS, 2006, J MACH LEARN RES, V7, P1493; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kubat M., 2000, P 14 INT C MACH LEAR, P179; Li ZT, 2012, THEOR APPL GENET, V125, P419, DOI 10.1007/s00122-012-1892-9; Lin W, 2014, BIOMETRIKA, V101, P785, DOI 10.1093/biomet/asu031; Liu X, 2012, INTEGR BIOL-UK, V4, P93, DOI 10.1039/c1ib00030f; Liu XR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134039; Lu Y, 2014, CURR BIOINFORM, V9, P89, DOI 10.2174/1574893608999140109113434; Luo H, 2014, NUCLEIC ACIDS RES, V42, pD574, DOI 10.1093/nar/gkt1131; Ning LW, 2014, GENET MOL RES, V13, P4564, DOI 10.4238/2014.June.17.8; Plaimas K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-56; RCore Team, 2020, R LANG ENV STAT COMP; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Saha S, 2006, GENET MOL RES, V5, P224; Seringhaus M, 2006, GENOME RES, V16, P1126, DOI 10.1101/gr.5144106; Sharp PM, 2005, NUCLEIC ACIDS RES, V33, P1141, DOI 10.1093/nar/gki242; Song K, 2014, INTEGR BIOL-UK, V6, P460, DOI 10.1039/c3ib40241j; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Viktor Mayer-Schonberger KC, 2013, BIG DATA REVOLUTION; Xu P, 2011, SCI REP-UK, V1, DOI 10.1038/srep00125; Ye YN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-769; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	36	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174638	10.1371/journal.pone.0174638	http://dx.doi.org/10.1371/journal.pone.0174638			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358836	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174800064
J	Oduro, AR; Owusu-Agyei, S; Gyapong, M; Osei, I; Adjei, A; Yawson, A; Sobe, E; Baiden, R; Adjuik, M; Binka, F				Oduro, Abraham R.; Owusu-Agyei, Seth; Gyapong, Margaret; Osei, Isaac; Adjei, Alex; Yawson, Abena; Sobe, Edward; Baiden, Rita; Adjuik, Martin; Binka, Fred			Post-licensure safety evaluation of dihydroartemisinin piperaquine in the three major ecological zones across Ghana	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; METAANALYSIS; PROFILE; HEALTH	Background Uncommon and rare adverse events (AEs), with delayed onset may not be detected before new drugs are licensed and deployed. The present study examined the post licensure safety of dihydroartemisinin-piperaquine (DHP) as an additional treatment for malaria in Ghana. The relationship between the incidence of AEs, treatment completion rate, participant characteristics and concomitant medications are reported. Methods A study conducted from September 2013 to June 2014 in Navrongo, Kintampo and Dodowa health research centres in Ghana is presented. Participants had confirmed malaria and no known allergy to study drug. Patients provided informed consent and had their symptoms and results of their clinical examinations documented. Treatment with Eurartesim (R) (20/ 160mg dihydroartemisinin and 40/320mg piperaquine by Sigma-Tau Incorporated) was given, according to the body weight of patients. First treatment doses were under observation but the second and third doses were taken at home except in a sub-study involving a nested cohort. Patients were contacted at Day 5 (+/- 2 days) either on telephone or by a home visit to document any AEs experienced. Patients were asked to report to the study team any other AEs that occurred within 28 days post-treatment. All patients in the nested cohort had electrocardiogram (ECG). Findings A total of 4563 patients, 52.1% females and 48.2% <6 years completed the study. A total of 444 patients were enrolled into the nested cohort. About 33% had temperature >= 37.5 degrees C at enrolment. Approximately 3.4% reported taking prior antimalarials, 19.4% other medications and 86% took at least one concomitant medication. Incidence of AEs was 7.6% including infections (4.6%), gastrointestinal disorders (1.0%) and local reactions at the site of venesection (0.5%). Others were respiratory disorders (0.4%) and nervous system disorders (0.3%). There were nine adverse events of special interest (AESI); itching/pruritus (7), dizziness (1), and skin lesions (1). Patients who took medications prior to enrolment had higher incidence of AEs compared with those without (9.3% vs. 6.1%; P<0.001). Statistically significant associations were found between the reported AEs and age of patients (P<0.001), their body mass index (BMI) (P<0.001) and parasite densities (P<0.001). Conclusion Dihydroartemisinin-Piperaquine was well tolerated with no serious safety concerns identified. Obesity and prior enrolment medication were among significant factors associated with increased AEs reporting.	[Oduro, Abraham R.; Osei, Isaac; Sobe, Edward] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Oduro, Abraham R.] Univ Ghana, Sch Publ Hlth, Legon, Ghana; [Oduro, Abraham R.; Owusu-Agyei, Seth; Gyapong, Margaret; Osei, Isaac; Adjei, Alex; Yawson, Abena; Sobe, Edward; Binka, Fred] INDEPTH Network, Accra, Ghana; [Owusu-Agyei, Seth; Adjei, Alex; Yawson, Abena] Kintampo Hlth Res Ctr, Kintampo, Ghana; [Gyapong, Margaret; Baiden, Rita; Adjuik, Martin] Dodowa Hlth Res Ctr, Dodowa, Ghana; [Binka, Fred] Univ Hlth & Allied Sci, Ho, Ghana	Navrongo Health Research Center; University of Ghana; INDEPTH Network; Kintampo Health Research Centre	Oduro, AR (corresponding author), Navrongo Hlth Res Ctr, Navrongo, Ghana.; Oduro, AR (corresponding author), Univ Ghana, Sch Publ Hlth, Legon, Ghana.; Oduro, AR (corresponding author), INDEPTH Network, Accra, Ghana.	Abraham.Oduro@navrongo-hrc.org		Owusu-Agyei, Seth/0000-0002-0807-1781; ODURO, ABRAHAM/0000-0002-4191-7419; Gyapong, Margaret/0000-0002-4818-3497	INDEPTH Network, Bill and Melinda Gates Foundation	INDEPTH Network, Bill and Melinda Gates Foundation	The study was sponsored by the INDEPTH Network as part of the funding for the INESS programme by the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Asante KP, 2009, J TROP MED-US, V2009, DOI 10.1155/2009/529583; Baiden R, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0664-9; Bouchaud O, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-289; Ruiz ME, 2010, CURR DRUG SAF, V5, P315, DOI 10.2174/157488610792245966; European Medicine Agency, EMACHMP4883482015; Ghana Statistical Service, 2011, MULT IND CLUST SURV; Glasser SP, 2007, J CLIN PHARMACOL, V47, P1074, DOI 10.1177/0091270007304776; Gyapong M, 2013, INT J EPIDEMIOL, V42, P1686, DOI 10.1093/ije/dyt197; Karunajeewa H, 2004, BRIT J CLIN PHARMACO, V57, P93, DOI 10.1046/j.1365-2125.2003.01962.x; Keating GM, 2012, DRUGS, V72, P937, DOI 10.2165/11203910-000000000-00000; Lee TMN, 2012, XENOBIOTICA, V42, P1088, DOI 10.3109/00498254.2012.693972; Ministry of Health Ghana, ART AM STILLS DRUG M; Mytton OT, 2007, AM J TROP MED HYG, V77, P447, DOI 10.4269/ajtmh.2007.77.447; Naing C, 2013, T ROY SOC TROP MED H, V107, P65, DOI 10.1093/trstmh/trs019; Oduro AR, 2008, ANN TROP MED PARASIT, V102, P565, DOI 10.1179/136485908X337508; Oduro AR, 2012, INT J EPIDEMIOL, V41, P968, DOI 10.1093/ije/dys111; Owusu-Agyei S, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.19033; Sinclair D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007483.pub2; STEIN CM, 1989, BRIT J CLIN PHARMACO, V27, P741, DOI 10.1111/j.1365-2125.1989.tb03435.x; Suvarna Viraj, 2010, Perspect Clin Res, V1, P57; World Health Organization, 2010, GLOB MAL PROGR GUID; World Health Organization, 2004, REV SAF CHLORPR DAPS; Zani B, 2014, COCHRANE DB SYST REV, V1	24	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174503	10.1371/journal.pone.0174503	http://dx.doi.org/10.1371/journal.pone.0174503			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358871	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000399174800045
J	Liao, XY; Feng, B; Zhang, DM; Liu, P; Zhou, XD; Li, RM; Ye, L				Liao, Xueyang; Feng, Bo; Zhang, Demao; Liu, Peng; Zhou, Xuedong; Li, Ruimin; Ye, Ling			The Sirt6 gene: Does it play a role in tooth development?	PLOS ONE			English	Article							HISTONE DEACETYLASE SIRT6; MESENCHYMAL STEM-CELLS; BONE-MARROW; OSTEOGENIC DIFFERENTIATION; PROTEIN; GROWTH; PROLIFERATION; EXPRESSION; BIOLOGY; FATE	Dental Mesenchymal Cells (DMCs) are known to play a role in tooth development as well as in the repair and regeneration of dental tissue. A large number of signaling molecules regulate the proliferation and differentiation of DMC, though the underlying mechanisms are still not fully understood. Sirtuin-6 (SIRT6), a key regulator of aging, can exert an impact on embryonic stem cell (ESC) differentiation. The experimental deletion of Sirt6 in mouse bone marrow cells has been found to have an inhibiting impact on the bone mineral density and the osteogenic differentiation of these cells. The possible role of Sirt6 in tooth development, however, has at present remained largely unexplored. In the present study, we found that SIRT6 had no effect on tooth development before birth. However, Sirt6 gene deletion in knockout mice did have two post-natal impacts: a delay in tooth eruption and sluggishness in the development of dental roots. We propose an explanation of the possible molecular basis of the changes observed in Sirt6(-/-) mice. SIRT6 is expressed in mouse odontoblasts. Sirt6 deletion enhanced the proliferation of DMCs, as well as their capacity for adipogenic differentiation. On the other hand, it inhibited their capacity for in vitro osteogenickhondrogenic differentiation. Further studies suggested that other factors may mediate the role of Sirt6 in odontogenesis. These include the nuclear factor kappa B (NF-kappa B), p38 mitogen-activated protein kinase (p38-MAPK), extracellular regulated MAP kinase (ERK) pathways and the mitochondrial energy. We demonstrated that Sirt6 plays a role in tooth root formation and confirmed that SIRT6 is necessary for DMC differentiation as well as for the development of the tooth root and for eventual tooth eruption. These results establish a new link between SIRT6 and tooth development.	[Liao, Xueyang; Feng, Bo; Zhang, Demao; Liu, Peng; Zhou, Xuedong; Li, Ruimin; Ye, Ling] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu, Peoples R China; [Li, Ruimin] NingXia Med Univ, Stomatol Hosp, Dept Endodont, Gen Hosp, Yinchuan, Peoples R China	Sichuan University; Ningxia Medical University	Li, RM; Ye, L (corresponding author), Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, State Key Lab Oral Dis, Chengdu, Peoples R China.; Li, RM (corresponding author), NingXia Med Univ, Stomatol Hosp, Dept Endodont, Gen Hosp, Yinchuan, Peoples R China.	lrm0819@nyfy.com.cn; yeling@scu.edu.cn	ye, ling/AFP-0048-2022; ZHOU, XUE/F-6129-2013	ye, ling/0000-0002-8417-7676; Zhou, Xuedong/0000-0002-9319-7302; Zhang, Demao/0000-0002-4437-3496	National Natural Science Foundation of China [81500810, 81322013]; Program of International ST Cooperation [2014DFA31990]; Foundation of Ningxia Medical University [XT2015019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of International ST Cooperation; Foundation of Ningxia Medical University	Our study was supported by the following fundings: The National Natural Science Foundation of China (81500810 and 81322013), Program of International S&T Cooperation (2014DFA31990) and Foundation of Ningxia Medical University (XT2015019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boilly B, 2000, CYTOKINE GROWTH F R, V11, P295, DOI 10.1016/S1359-6101(00)00014-9; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Cobourne MT, 2001, J DENT RES, V80, P1974, DOI 10.1177/00220345010800110501; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; Deng P, 2015, INT J ORAL SCI, V7, P197, DOI 10.1038/ijos.2015.41; Di Benedetto A, 2015, STEM CELL RES, V15, P618, DOI 10.1016/j.scr.2015.09.011; Diekwisch TGH, 2001, INT J DEV BIOL, V45, P695; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Etchegaray JP, 2015, NAT CELL BIOL, V17, P545, DOI 10.1038/ncb3147; Gertler AA, 2013, BIOGERONTOLOGY, V14, P629, DOI 10.1007/s10522-013-9478-8; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Honda MJ, 2007, INT ENDOD J, V40, P949, DOI 10.1111/j.1365-2591.2007.01301.x; Honda Masaki J, 2010, J Oral Sci, V52, P541, DOI 10.2334/josnusd.52.541; Kanfi Y, 2008, FEBS LETT, V582, P543, DOI [10.1016/j.febslet.2008.01.019, 10.1016/j.febslet.2008.06.005]; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Lappas M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/597514; Lin HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094395; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Marrelli M, 2013, INT J BIOL SCI, V9, P1070, DOI 10.7150/ijbs.6662; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Ravanti L, 2001, FASEB J, V15, P1098, DOI 10.1096/fj.00-0588fje; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sakano M, 2013, J PERIODONTAL RES, V48, P262, DOI 10.1111/jre.12003; Sarkar L, 2000, P NATL ACAD SCI USA, V97, P4520, DOI 10.1073/pnas.97.9.4520; Saygin NE, 2000, PERIODONTOL 2000, V24, P73, DOI 10.1034/j.1600-0757.2000.2240105.x; Schwer B, 2010, P NATL ACAD SCI USA, V107, P21790, DOI 10.1073/pnas.1016306107; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Sonoyama W, 2008, J ENDODONT, V34, P166, DOI 10.1016/j.joen.2007.11.021; Sun HL, 2014, J ENDODONT, V40, P393, DOI 10.1016/j.joen.2013.11.010; Sun HL, 2014, STEM CELLS, V32, P1943, DOI 10.1002/stem.1671; Wang CL, 2010, J ENDODONT, V36, P238, DOI 10.1016/j.joen.2009.09.007; Wise GE, 2009, ORTHOD CRANIOFAC RES, V12, P67, DOI 10.1111/j.1601-6343.2009.01439.x; Wise GE, 2002, CRIT REV ORAL BIOL M, V13, P323, DOI 10.1177/154411130201300403; Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039; Yang J, 2015, INT J ORAL SCI, V7, P95, DOI 10.1038/ijos.2015.7; Yao S, 2008, J DENT RES, V87, P767, DOI 10.1177/154405910808700801; Zeichner-David M, 2003, DEV DYNAM, V228, P651, DOI 10.1002/dvdy.10404; Zhang DM, 2016, INT J ORAL SCI, V8, P84, DOI 10.1038/ijos.2015.57; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	45	10	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174255	10.1371/journal.pone.0174255	http://dx.doi.org/10.1371/journal.pone.0174255			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355287	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174600041
J	De Weerdt, E; De Rijdt, T; Simoens, S; Casteels, M; Huys, I				De Weerdt, Elfi; De Rijdt, Thomas; Simoens, Steven; Casteels, Minne; Huys, Isabelle			Time spent by Belgian hospital pharmacists on supply disruptions and drug shortages: An exploratory study	PLOS ONE			English	Article							MANAGEMENT STRATEGIES; UNITED-STATES; IMPACT; CHALLENGE; CRISIS; CANCER	Introduction Supply problems of drugs are an increasing and worldwide problem, also in Belgium. Hospital pharmacists try to manage drug supply problems to minimize the impact on patient care. This study aims to quantify in a detailed manner how much time employees of 17 Belgian hospital pharmacies spend on drug supply problems. Methods During six months, employees of Belgian hospital pharmacies filled in the daily time spent on drug supply problems using a template containing all steps which can be executed to manage drug supply problems. Additionally, Belgian hospital pharmacists were asked to report the drugs which experienced drug supply problems together with the solution for this problem. Results Hospital pharmacists spent a median of 109 minutes a week on drug supply problems, with a minimum of 40 minutes per week and a maximum of 216 minutes per week. Fifty-nine percent of the total time spent on drug supply problems was executed by hospital pharmacists, 27% by pharmacy technicians; the rest was performed by logistic or administrative personnel. About one third of the total time spent was invested in gathering information on the supply problem. About two third of the supply disruptions caused drug shortages, meaning there was a need to switch to another (generic) therapeutic alternative. For most drug shortages, a Belgian generic medicine could be found. However in some cases, the alternative had to be ordered abroad or for some drug shortages, no alternative was available. Conclusion These exploratory results on time spent by hospital pharmacists on drug supply problems in Belgium highlight the economic impact of drug supply problems for hospital pharmacies. A fully reliable, daily updated list on the federal agencies websites would be a major help to hospital pharmacists.	[De Weerdt, Elfi; Simoens, Steven; Casteels, Minne; Huys, Isabelle] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Herestr, Leuven, Belgium; [De Rijdt, Thomas] Univ Hosp Leuven, Dept Pharm, UZ Herestr, Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven	De Weerdt, E (corresponding author), Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Herestr, Leuven, Belgium.	Elfi.deweerdt@kuleuven.be	Huys, Isabelle/M-8673-2016; De Weerdt, Elfi/H-7459-2018	De Weerdt, Elfi/0000-0002-8847-8812; Simoens, Steven/0000-0002-9512-2005	Research Foundation Flanders (FWO); TEVA; Research Foundation Flanders	Research Foundation Flanders (FWO)(FWO); TEVA(Teva Pharmaceutical Industries); Research Foundation Flanders(FWO)	EDW is funded by the Research Foundation-Flanders (FWO). The study is included in a project supported by Research Foundation Flanders (http://www.fwo.be/en/). The study is included in a project supported by TEVA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSM, 2014, ACC ANSM AG NAT SEC; ASHP Expert Panel on Drug Product Shortages, 2009, Am J Health Syst Pharm, V66, P1399, DOI 10.2146/ajhp090026; Caulder Celeste R, 2015, Hosp Pharm, V50, P279, DOI 10.1310/hpj5004-279; Chabner BA, 2011, NEW ENGL J MED, V365, P2147, DOI 10.1056/NEJMp1112633; Claus B, 2014, STOCKBREUKEN ZIEKENH; Crommelynck A, 2013, ORG FINANCIERING ZIE; Daouphars M, 2013, IMPACT DRUG SHORTAGE; De Weerdt E, 2015, BELGIAN EXPERIENCE D; De Weerdt E, 2015, FRONT PHARMACOL, V6, DOI [10.3329/fphar.2015.00253, 10.3389/fphar.2015.00253]; De Weerdt E, 2015, REGUL TOXICOL PHARM, V71, P251, DOI 10.1016/j.yrtph.2015.01.005; Emmerton L., 1996, INT J PHARM PRACT, V4, P75, DOI 10.1111/j.2042-7174.1996.tb00845.x; European Association of Hospital Pharmacists, 2013, MED SHORT EUR HOSP; European Association of Hospital Pharmacists, 2014, MED SHORT EUR HOSP E; European Medicines Agency European Medicines Agency-, EU MEMB STAT HEADS M; Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten, 2014, ONB MENS GEBR FAGG; Food and Drug Administration, 2011, REV FDAS APPR MED PR; Fox ER, 2014, MAYO CLIN PROC, V89, P361, DOI 10.1016/j.mayocp.2013.11.014; Gray A, 2012, B WORLD HEALTH ORGAN, V90, P158, DOI 10.2471/BLT.11.101303; Hassig TB, 2014, PHARMACOTHERAPY, V34, P72, DOI 10.1002/phar.1350; Havrilesky LJ, 2012, GYNECOL ONCOL, V125, P631, DOI 10.1016/j.ygyno.2012.03.028; IMS, 2011, ISSUES B IMP EC DOWN; Kaakeh R, 2011, AM J HEALTH-SYST PH, V68, P1811, DOI 10.2146/ajhp110210; Li E, 2015, DRUG DES DEV THER, V9, DOI 10.2147/DDDT.S75219; Metzger ML, 2012, NEW ENGL J MED, V367, P2461, DOI 10.1056/NEJMp1212468; Palm E, 2014, JPEN J PARENTER ENTE; Pauwels K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119322; Rutter PM., 1998, INT J PHARM PRACT, V6, P46, DOI DOI 10.1111/J.2042-7174.1998.TB00915.X.ACCESSED; Stein R, 2011, SHORTAGES KEY DRUGS; The Italien Medicines Agency, 2014, AIFA AG IT FARM; Ventola C Lee, 2011, P T, V36, P740; WHO, 2016, ATC DDD IND; Woodcock J, 2013, CLIN PHARMACOL THER, V93, P170, DOI 10.1038/clpt.2012.220; Yurukoglu A, 2012, MED REIMBURSEMENTS S; Zheng K, 2011, J AM MED INFORM ASSN, V18, P704, DOI 10.1136/amiajnl-2011-000083	34	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174556	10.1371/journal.pone.0174556	http://dx.doi.org/10.1371/journal.pone.0174556			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350827	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174400056
J	Hua, Y; Ma, XK; Liu, XL; Yuan, XF; Qin, H; Zhang, XP				Hua, Yang; Ma, Xiukun; Liu, Xianglong; Yuan, Xiangfei; Qin, Hai; Zhang, Xipeng			Abnormal expression of mRNA, microRNA alteration and aberrant DNA methylation patterns in rectal adenocarcinoma	PLOS ONE			English	Article							CELL-PROLIFERATION; CANCER; IDENTIFICATION; GENE; MUTATIONS; COLON; RISK; METASTASIS; PATHWAYS; PROMOTES	Aim Rectal adenocarcinoma (READ) is a malignancy cancer with the high morbidity and motility worldwide. Our study aimed to explore the potential pathogenesis of READ through integrated analysis of gene expression profiling and DNA methylation data. Methods The miRNA, mRNA expression profiling and corresponding DNA methylation data were downloaded from The Cancer Genome Atlas (TCGA) database. Differentially expressed mRNAs/miRNAs/methylated regions (DEmRNA/DEmiRNAs) were identified in READ. The negatively correlation of DEmiRNA-DEmRNAs and DNA methylation-DEmRNAs were obtained. DEmRNAs expression was validated through quantitative real-time polymerase chain reaction (qRT-PCR) and microarray expression profiling analyses. Results 1192 dysregulated DEmRNAs, 27 dysregulated DEmiRNAs and 6403 aberrant methylation CpG sites were screened in READ compared to normal controls. 1987 negative interaction pairs among 27 DEmiRNAs and 668 DEmRNAs were predicted. 446 genes with aberrant methylation were annotated. Eventually, 50 DEmRNAs (39 down- and 11 up-regulated DEmRNAs) with hypermethylation, synchronously negatively targeted by DEmiRNAs, were identified through the correlation analysis among 446 genes with aberrant methylation and 668 DEmRNAs. 50 DEmRNAs were significantly enriched in cAMP signaling pathway, circadian entrainment and glutamatergic synapse. The validation results of expression levels of DEmRNAs through qRT-PCR and microarray analyses were compatible with our study. Conclusion 7 genes of SORCS1, PDZRN4, LONRF2, CNGA3, HAND2, RSPO2 and GNAO1 with hypermethylation and negatively regulation by DEmiRNAs might contribute to the tumorigenesis of READ. Our work might provide valuable foundation for the READ in mechanism elucidation, early diagnosis and therapeutic target identification.	[Hua, Yang; Liu, Xianglong; Qin, Hai; Zhang, Xipeng] Tianjin Union Med Ctr, Dept Colorectal Surg, Tianjin, Peoples R China; [Ma, Xiukun] Tianjin Med Univ, Dept Surg, Sino Singapore Ecocity Hosp, Tianjin, Peoples R China; [Yuan, Xiangfei] Nankai Hosp, Tianjin Inst Integrat Med Acute Abdominal Dis, Tianjin, Peoples R China	Tianjin Medical University	Zhang, XP (corresponding author), Tianjin Union Med Ctr, Dept Colorectal Surg, Tianjin, Peoples R China.	xipeng_zhang@yeah.net			Tianjin Health Development Planning Commission Key Research Program [14KG108]	Tianjin Health Development Planning Commission Key Research Program	This work was supported by the Tianjin Health Development Planning Commission Key Research Program [14KG108]. The website of the funder is: [http://www.tjwsj.gov.cn/html/WSJn/portal/index.index. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini M, 2015, ONCOTARGET, V6, P32561, DOI 10.18632/oncotarget.4935; Agostini M, 2015, CANCER BIOL THER, V16, P1160, DOI 10.1080/15384047.2015.1046652; Azizian A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040568; Benard A, 2013, BRIT J CANCER, V109, P3073, DOI 10.1038/bjc.2013.654; Buell-Gutbrod R, 2015, INT J GYNECOL PATHOL, V34, P65, DOI 10.1097/PGP.0000000000000106; Chen XT, 2015, INT J OPHTHALMOL-CHI, V8, P910, DOI 10.3980/j.issn.2222-3959.2015.05.10; D'Angelo E, 2016, ONCOTARGET, V7, P28647, DOI 10.18632/oncotarget.8725; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Ferlay J, 2013, GLOBOCAN CANC INCIDE, V2012; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gong X, 2015, ONCOGENE, V34, P4692, DOI 10.1038/onc.2014.417; Goodarzi MO, 2007, DIABETES, V56, P1922, DOI 10.2337/db06-1677; Hashimoto K, 2006, GLYCOBIOLOGY, V16, p63R, DOI 10.1093/glycob/cwj010; Hrovat A, 2016, GYNECOL ENDOCRINOL, V32, P395, DOI 10.3109/09513590.2015.1126818; Hu TT, 2015, CELL BIOCHEM FUNCT, V33, P443, DOI 10.1002/cbf.3130; Ilmer M, 2015, CANCER RES, V75, P1883, DOI 10.1158/0008-5472.CAN-14-1327; Kohonen-Corish MRJ, 2014, INT J CANCER, V134, P2820, DOI 10.1002/ijc.28619; Kuniyoshi K, 2016, JPN J OPHTHALMOL, V60, P187, DOI 10.1007/s10384-016-0424-6; Liu XX, 2015, KIDNEY BLOOD PRESS R, V40, P288, DOI 10.1159/000368504; Liu Z, 2014, INT J MOL MED, V33, P589, DOI 10.3892/ijmm.2013.1598; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo JH, 2013, CANCER CAUSE CONTROL, V24, P577, DOI 10.1007/s10552-012-9996-8; Metodieva SN, 2011, TUMORI, V97, P86, DOI 10.1177/030089161109700116; Michelotti G, 2015, ONCOTARGET, V6, P34549, DOI 10.18632/oncotarget.5330; Millino C, 2017, J CELL PHYSIOL, V232, P426, DOI 10.1002/jcp.25441; Parajuli R, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-321; Pei X, 2013, BIOSCIENCE REPORTS, V33; Pelossof R, 2016, GENE CHROMOSOME CANC, V55, P311, DOI 10.1002/gcc.22329; Reiner-Benaim A, 2007, BIOMETRICAL J, V49, P107, DOI 10.1002/bimj.200510313; Riihimaki M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29765; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; van der Geest LGM, 2015, CLIN EXP METASTAS, V32, P457, DOI 10.1007/s10585-015-9719-0; Voth H, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-28; Warden CD, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt242; Wei EK, 2004, INT J CANCER, V108, P433, DOI 10.1002/ijc.11540; Wu CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4149; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu W, 2013, ADV MULTIMED, V2013, DOI 10.1155/2013/651650; Zhang S, 2016, AM J TRANSL RES, V8, P354	42	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							E0174461	10.1371/journal.pone.0174461	http://dx.doi.org/10.1371/journal.pone.0174461			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350845	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174400045
J	Koire, A; Kim, YW; Wang, J; Katsonis, P; Jin, HJ; Lichtarge, O				Koire, Amanda; Kim, Young Won; Wang, Jarey; Katsonis, Panagiotis; Jin, Haijing; Lichtarge, Olivier			Codon-level co-occurrences of germline variants and somatic mutations in cancer are rare but often lead to incorrect variant annotation and underestimated impact prediction	PLOS ONE			English	Article							GENOME; ASSOCIATION; EVOLUTION; PATTERNS	Cancer cells explore a broad mutational landscape, bringing the possibility that tumor-specific somatic mutations could fall in the same codons as germline SNVs and leverage their presence to produce substitutions with a larger impact on protein function. While multiple, temporally consecutive mutations to the same codon have in the past been detected in the germline, this phenomenon has not yet been explored in the context of germline-somatic variant co-occurrences during cancer development. We examined germline context at somatic mutation sites for 1395 patients across four cancer cohorts (breast, skin, colon, and head and neck) and found 392 codon-level co-occurrences between germline and somatic variants, including over a dozen in well-known cancer genes. We found that for the majority of these co-occurrence events, traditional somatic calling led to an inaccurate representation of the protein site and a significantly lower predicted impact on protein fitness. We conclude that these events often lead to imprecise annotation of somatic variants but do not appear to be a frequent source of driver events during cancer development.	[Koire, Amanda; Jin, Haijing; Lichtarge, Olivier] Baylor Coll Med, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Koire, Amanda] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Kim, Young Won] Baylor Coll Med, Program Integrat Mol & Biomed Sci, Houston, TX 77030 USA; [Wang, Jarey] Baylor Coll Med, Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Katsonis, Panagiotis; Lichtarge, Olivier] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Koire, A (corresponding author), Baylor Coll Med, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA.; Koire, A (corresponding author), Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA.	koire@bcm.edu	Katsonis, Panagiotis/L-6391-2019	Wang, Jarey/0000-0001-9038-4674	National Institutes of Health [GM079656-8, DE025181, GM066099]; National Science Foundation [DBI1356569]; Defense Advance Research Project Agency [N66001-15-C-4042]; Baylor Research Advocates for Student Scientists; CPRIT predoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079656, R01GM066099] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1356569] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Defense Advance Research Project Agency; Baylor Research Advocates for Student Scientists; CPRIT predoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Institutes of Health [grant numbers GM079656-8 to O.L., DE025181 to O.L., GM066099 to O.L.]; the National Science Foundation [grant number DBI1356569 to O.L.], and the Defense Advance Research Project Agency [grant number N66001-15-C-4042 to O.L]. A.K. is supported by the Baylor Research Advocates for Student Scientists and a CPRIT predoctoral fellowship.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Beals M., 1999, AMINO ACID FREQUENCY; Chen D, 2015, TRENDS GENET, V31, P41, DOI 10.1016/j.tig.2014.10.005; Chen JM, 2013, HUM MUTAT, V34, P1119, DOI 10.1002/humu.22341; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Hu H, 2014, BIOCOMPUT-PAC SYM, P51; Ishak MB, 2011, CANCER EPIDEM BIOMAR, V20, P1599, DOI 10.1158/1055-9965.EPI-11-0312; Katsonis P, 2014, GENOME RES, V24, P2050, DOI 10.1101/gr.176214.114; Katsonis P, 2014, PROTEIN SCI, V23, P1650, DOI 10.1002/pro.2552; Koire A, 2016, BIOCOMPUT-PAC SYM, P207; Krantz ID, 1998, AM J HUM GENET, V62, P1361, DOI 10.1086/301875; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10086; Malkin D., 2011, GENES CANC, V2, P475, DOI DOI 10.1177/1947601911413466; Micol JB, 2014, HAEMATOLOGICA, V99, P201, DOI 10.3324/haematol.2013.101303; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Plawski A, 2013, HERED CANCER CLIN PR, V11, DOI 10.1186/1897-4287-11-15; Rosenfeld JA, 2010, NUCLEIC ACIDS RES, V38, P6102, DOI 10.1093/nar/gkq408; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Wilkins AD, 2013, BIOINFORMATICS, V29, P2714, DOI 10.1093/bioinformatics/btt489	23	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174766	10.1371/journal.pone.0174766	http://dx.doi.org/10.1371/journal.pone.0174766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350864	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174400074
J	Ladhani, L; Pardon, G; Meeuws, H; van Wesenbeeck, L; Schmidt, K; Stuyver, L; van der Wijngaart, W				Ladhani, Laila; Pardon, Gaspard; Meeuws, Hanne; van Wesenbeeck, Liesbeth; Schmidt, Kristiane; Stuyver, Lieven; van der Wijngaart, Wouter			Sampling and detection of airborne influenza virus towards point-of-care applications	PLOS ONE			English	Article							ELECTROSTATIC PRECIPITATOR; EXHALED PARTICLES; COLLECTION; AEROSOLS	Airborne transmission of the influenza virus contributes significantly to the spread of this infectious pathogen, particularly over large distances when carried by aerosol droplets with long survival times. Efficient sampling of virus-loaded aerosol in combination with a low limit of detection of the collected virus could enable rapid and early detection of airborne influenza virus at the point-of-care setting. Here, we demonstrate a successful sampling and detection of airborne influenza virus using a system specifically developed for such applications. Our system consists of a custom-made electrostatic precipitation (ESP)-based bioaerosol sampler that is coupled with downstream quantitative polymerase chain reaction (qPCR) analysis. Aerosolized viruses are sampled directly into a miniaturized collector with liquid volume of 150 mu L, which constitutes a simple and direct interface with subsequent biological assays. This approach reduces sample dilution by at least one order of magnitude when compared to other liquid-based aerosol bio-samplers. Performance of our ESP-based sampler was evaluated using influenza virus-loaded sub-micron aerosols generated from both cultured and clinical samples. Despite the miniaturized collection volume, we demonstrate a collection efficiency of at least 10% and sensitive detection of a minimum of 3721 RNA copies. Furthermore, we show that an improved extraction protocol can allow viral recovery of down to 303 RNA copies and a maximum sampler collection efficiency of 47%. A device with such a performance would reduce sampling times dramatically, from a few hours with current sampling methods down to a couple of minutes with our ESP-based bioaerosol sampler.	[Ladhani, Laila; Pardon, Gaspard; van der Wijngaart, Wouter] KTH Royal Inst Technol, Dept Micro & Nanosyst, Stockholm, Sweden; [Meeuws, Hanne; van Wesenbeeck, Liesbeth; Schmidt, Kristiane; Stuyver, Lieven] Janssen Diagnost, Beerse, Belgium	Royal Institute of Technology	van der Wijngaart, W (corresponding author), KTH Royal Inst Technol, Dept Micro & Nanosyst, Stockholm, Sweden.	wouter@kth.se	van der Wijngaart, Wouter/O-2378-2019; Pardon, Gaspard/G-8304-2011	van der Wijngaart, Wouter/0000-0001-8248-6670; Pardon, Gaspard/0000-0001-9177-1174	European Union [115153]; European Federation of Pharmaceutical Industries and Associations (RAPP-ID project) [115153]	European Union(European Commission); European Federation of Pharmaceutical Industries and Associations (RAPP-ID project)	The funder (jointly between Innovative Medicines Initiative (IMI), http//www.imi.europa.eu/content/rapp-id, a public-private partnership between the European Union, and the European Federation of Pharmaceutical Industries and Associations (RAPP-ID project, grant agreement, no. 115153) provided support in the form of salaries for authors: L.L., G.P., H.M., L.vW., KS., L.S. and W.vW; and materials. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agranovski IE, 2005, J AEROSOL SCI, V36, P609, DOI 10.1016/j.jaerosci.2004.11.014; Almstrand AC, 2010, J APPL PHYSIOL, V108, P584, DOI 10.1152/japplphysiol.00873.2009; Almstrand AC, 2009, ANAL CHEM, V81, P662, DOI 10.1021/ac802055k; Blachere FM, 2007, INFLUENZA OTHER RESP, V1, P113, DOI 10.1111/j.1750-2659.2007.00020.x; Brooke CB, 2014, FUTURE VIROL, V9, P41, DOI 10.2217/FVL.13.118; Brown JR, 2015, J HOSP INFECT, V91, P278, DOI 10.1016/j.jhin.2015.08.004; Edwards DA, 2004, P NATL ACAD SCI USA, V101, P17383, DOI 10.1073/pnas.0408159101; Fabian P, 2009, INDOOR AIR, V19, P433, DOI 10.1111/j.1600-0668.2009.00609.x; Han T, 2010, AEROSOL SCI TECH, V44, P339, DOI 10.1080/02786821003649352; Holmgren H, 2010, J AEROSOL SCI, V41, P439, DOI 10.1016/j.jaerosci.2010.02.011; Kettleson EM, 2009, ENVIRON SCI TECHNOL, V43, P5940, DOI 10.1021/es803289w; Lemon SM, 2005, THREAT PANDEMIC INFL; Mainelis G, 2002, J AEROSOL SCI, V33, P1417, DOI 10.1016/S0021-8502(02)00091-5; Milton DK, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003205; Nauwelaers D, 2009, J CLIN VIROL, V46, P238, DOI 10.1016/j.jcv.2009.08.013; Nikitin N, 2014, ADV VIROL, V2014, P1, DOI DOI 10.1155/2014/859090); Pardon G, 2015, SENSOR ACTUAT B-CHEM, V212, P344, DOI 10.1016/j.snb.2015.02.008; Richard M, 2016, FEMS MICROBIOL REV, V40, P68, DOI 10.1093/femsre/fuv039; Tan MM, 2011, AEROSOL SCI TECH, V45, P1154, DOI 10.1080/02786826.2011.582193; Tellier R., 2009, J R SOC INTERFACE; Van Wesenbeeck L, 2014, VIROL J, V11, P105; Van Wesenbeeck L, 2013, J CLIN MICROBIOL, V51, P2977, DOI 10.1128/JCM.00911-13; Yang W, 2011, J R SOC INTERFACE, V8, P1176, DOI 10.1098/rsif.2010.0686; Zhao Y, 2014, ANN AGR ENV MED, V21, P464, DOI 10.5604/12321966.1120585	24	30	30	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174314	10.1371/journal.pone.0174314	http://dx.doi.org/10.1371/journal.pone.0174314			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350811	gold, Green Submitted, Green Published			2022-12-26	WOS:000399174400024
J	Simon, L; Nusinovici, S; Flamant, C; Cariou, B; Rouger, V; Gascoin, G; Darmaun, D; Roze, JC; Hanf, M				Simon, Laure; Nusinovici, Simon; Flamant, Cyril; Cariou, Bertrand; Rouger, Valerie; Gascoin, Geraldine; Darmaun, Dominique; Roze, Jean-Christophe; Hanf, Matthieu			Post-term growth and cognitive development at 5 years of age in preterm children: Evidence from a prospective population-based cohort	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR-DISEASE RISK; LATENT CLASS ANALYSIS; PROPENSITY SCORE; TRAJECTORIES; INFANTS; CHILDHOOD; OUTCOMES; WEIGHT; BIRTH	While the effects of growth from birth to expected term on the subsequent development of preterm children has attracted plentiful attention, less is known about the effects of post-term growth. We aimed to delineate distinct patterns of post-term growth and to determine their association with the cognitive development of preterm children. Data from a prospective population-based cohort of 3,850 surviving infants born at less than 35 weeks of gestational age were used. Growth was assessed as the Body Mass Index (BMI) Z-scores at 3, 9, 18, 24, 36, 48, and 60 months. Cognitive development at five years of age was evaluated by the Global School Adaptation score (GSA). Latent class analysis was implemented to identify distinct growth patterns and logistic regressions based on propensity matching were used to evaluate the relationship between identified growth trajectories and cognitive development. Four patterns of post-term growth were identified: a normal group with a Z-score consistently around zero during childhood (n = 2,469; 64%); a group with an early rapid rise in the BMI Z-score, but only up to 2 years of age (n = 195; 5%); a group with a slow yet steady rise in the BMI Z-score during childhood (n = 510; 13%); and a group with a negative Z-score growth until 3 years of age (n = 676; 18%). The group with a slow yet steady rise in the BMI Z-score was significantly associated with low GSA scores. Our findings indicate heterogeneous post-term growth of preterm children, with potential for association with their cognitive development.	[Simon, Laure; Flamant, Cyril; Roze, Jean-Christophe] Nantes Univ Hosp, Dept Paediat Med, Nantes, France; [Nusinovici, Simon; Roze, Jean-Christophe; Hanf, Matthieu] Nantes Univ Hosp, Clin Invest Ctr, INSERM CIC 1413, Nantes, France; [Cariou, Bertrand] Nantes Univ Hosp, Dept Endocrinol, Inst Thorax, Nantes, France; [Rouger, Valerie] Nantes Univ Hosp, Reseau Grandir Ensemble, Nantes, France; [Gascoin, Geraldine] Angers Univ Hosp, Dept Neonatal Med, Angers, France; [Darmaun, Dominique] Univ Nantes, Natl Inst Agr Res, UMR PHAN 1280, IMAD, Nantes, France; [Darmaun, Dominique] CRNH Ouest, Nantes, France; [Hanf, Matthieu] Versailles St Quentin Univ, INSERM UMR 1181, Biostat Biomath Pharmacoepidemiol & Infect Dis, Villejuif, France	Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; INRAE; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Hanf, M (corresponding author), Nantes Univ Hosp, Clin Invest Ctr, INSERM CIC 1413, Nantes, France.; Hanf, M (corresponding author), Versailles St Quentin Univ, INSERM UMR 1181, Biostat Biomath Pharmacoepidemiol & Infect Dis, Villejuif, France.	matthieu@hanf.fr	Darmaun, Dominique/X-8453-2018; Gascoin, Geraldine/ABE-4950-2020; Rozé, Jean-Christophe/AAS-1314-2021	Darmaun, Dominique/0000-0002-0366-3227; Cariou, Bertrand/0000-0002-1580-8040; Roze, Jean-Christophe/0000-0003-3367-512X; Hanf, Matthieu/0000-0001-7133-1323	Regional Health Agency of the Pays de la Loire	Regional Health Agency of the Pays de la Loire	The LIFT (Loire Infant Follow-Up Team) cohort is supported by grants from the Regional Health Agency of the Pays de la Loire.The sponsor had no role in regard to this manuscript.; The corresponding author (MH) affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained. The LIFT (Loire Infant Follow-Up Team) cohort is supported by grants from the Regional Health Agency of Pays de la Loire. The sponsor had no role in this manuscript. http://www.ars.paysdelaloire.sante.fr/Internet.paysdelaloire.0.html. Written consent was obtained for each patient before inclusion in the study, and the cohort was registered at the French data protection authority in clinical research (Commission Nationale de l'Informatique et des Libertes or CNIL, No. 851117).	Austin PC, 2014, STAT MED, V33, P1057, DOI 10.1002/sim.6004; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Boussicault G, 2013, J PEDIATR-US, V163, P460, DOI 10.1016/j.jpeds.2013.01.052; Casey PH, 2008, SEMIN PERINATOL, V32, P20, DOI 10.1053/j.semperi.2007.12.004; Cooke RWI, 2003, ARCH DIS CHILD, V88, P482, DOI 10.1136/adc.88.6.482; Dahly DL, 2012, MODERN METHODS EPIDE, P223; De Onis M, 2006, WHO CHILD GROWTH STA; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dunn KM, 2006, AM J EPIDEMIOL, V163, P754, DOI 10.1093/aje/kwj100; Euser AM, 2008, HORM RES, V70, P319, DOI 10.1159/000161862; Friedemann C, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4759; Georgieff MK, 2005, PEDIATR RES, V57, p99R, DOI 10.1203/01.PDR.0000160542.69840.0F; Gianni ML, 2012, PEDIATR RES, V72, P637, DOI 10.1038/pr.2012.128; GUIMARD P, 2001, PSYCHOL PSYCHOM, V22, P75; Guimard P, 2002, EUR REV APPL PSYCHOL, V52, P63; Haga C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051896; Kent AL, 2012, PEDIATRICS, V129, P124, DOI 10.1542/peds.2011-1578; Lapillonne A, 2013, J PEDIATR-US, V162, pS7, DOI 10.1016/j.jpeds.2012.11.048; Laptook AR, 2005, PEDIATRICS, V115, P673, DOI 10.1542/peds.2004-0667; Li CY, 2007, OBESITY, V15, P760, DOI 10.1038/oby.2007.585; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Magee CA, 2013, PEDIATR OBES, V8, P189, DOI 10.1111/j.2047-6310.2012.00112.x; McBride O, 2013, SOC PSYCH PSYCH EPID, V48, P783, DOI 10.1007/s00127-012-0613-7; Moore T, 2012, BMJ-BRIT MED J, V345, pe7961, DOI DOI 10.1136/BMJ.E7961; Morrison JL, 2010, PEDIATR NEPHROL, V25, P669, DOI 10.1007/s00467-009-1407-3; Mustillo S, 2003, PEDIATRICS, V111, P851, DOI 10.1542/peds.111.4.851; Nonnemaker JM, 2009, OBESITY, V17, P1274, DOI 10.1038/oby.2009.5; Olsen IE, 2010, PEDIATRICS, V125, pE214, DOI 10.1542/peds.2009-0913; Perumal N, 2015, J NUTR, V145, P2429, DOI 10.3945/jn.115.214064; Piyasena C, 2014, ARCH DIS CHILD-FETAL, V99, pF29, DOI [10.1136/archdischild-2014-306742, 10.1136/archdischild-2013-304101]; Pryor LE, 2011, ARCH PEDIAT ADOL MED, V165, P906, DOI 10.1001/archpediatrics.2011.153; Raikkonen K, 2009, AM J EPIDEMIOL, V170, P447, DOI 10.1093/aje/kwp132; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Roze JC, 2015, JAMA-J AM MED ASSOC, V313, P2441, DOI 10.1001/jama.2015.6734; Roze JC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000834; Silverwood RJ, 2011, AM J EPIDEMIOL, V174, P1406, DOI 10.1093/aje/kwr266; Ventura AK, 2009, OBESITY, V17, P2067, DOI 10.1038/oby.2009.123; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; Vistisen D, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001602; Ziyab AH, 2014, J EPIDEMIOL COMMUN H, V68, P934, DOI 10.1136/jech-2014-203808	40	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174645	10.1371/journal.pone.0174645	http://dx.doi.org/10.1371/journal.pone.0174645			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VE	28350831	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174400069
J	Guo, X; Koff, JL; Moffitt, AB; Cinar, M; Ramachandiran, S; Chen, Z; Switchenko, JM; Mosunjac, M; Neill, SG; Mann, KP; Bagirov, M; Du, Y; Natkunam, Y; Khoury, HJ; Rossi, MR; Harris, W; Flowers, CR; Lossos, IS; Boise, LH; Dave, SS; Kowalski, J; Bernal-Mizrachi, L				Guo, X.; Koff, J. L.; Moffitt, A. B.; Cinar, M.; Ramachandiran, S.; Chen, Z.; Switchenko, J. M.; Mosunjac, M.; Neill, S. G.; Mann, K. P.; Bagirov, M.; Du, Y.; Natkunam, Y.; Khoury, H. J.; Rossi, M. R.; Harris, W.; Flowers, C. R.; Lossos, I. S.; Boise, L. H.; Dave, S. S.; Kowalski, J.; Bernal-Mizrachi, L.			Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype	ONCOGENE			English	Article							NF-KAPPA-B; ANTI-CD20 MONOCLONAL-ANTIBODY; GENE-EXPRESSION; DNA-DAMAGE; SOMATIC MUTATIONS; MARGINAL ZONE; LYMPHOMA; ACTIVATION; COMPLEX; PROTEIN	Diffuse large B-cell lymphoma (DLBCL) has been categorized into two molecular subtypes that have prognostic significance, namely germinal center B-cell like (GCB) and activated B-cell like (ABC). Although ABC-DLBCL has been associated with NF-kappa B activation, the relationships between activation of specific NF-.B signals and DLBCL phenotype remain unclear. Application of novel gene expression classifiers identified two new DLBCL categories characterized by selective p100 (NF-kappa B2) and p105 (NF-kappa B1) signaling. Interestingly, our molecular studies showed that p105 signaling is predominantly associated with GCB subtype and histone mutations. Conversely, most tumors with p100 signaling displayed ABC phenotype and harbored ABC-associated mutations in genes such as MYD88 and PIM1. In vitro, MYD88 L265P mutation promoted p100 signaling through TAK1/IKKa and GSK3/Fbxw7a pathways, suggesting a novel role for this protein as an upstream regulator of p100. p100 signaling was engaged during activation of normal B cells, suggesting p100' s role in ABC phenotype development. Additionally, silencing p100 in ABC-DLBCL cells resulted in a GCB-like phenotype, with suppression of Blimp, IRF4 and XBP1 and upregulation of BCL6, whereas introduction of p52 or p100 into GC cells resulted in differentiation toward an ABC-like phenotype. Together, these findings identify specific roles for p100 and p105 signaling in defining DLBCL molecular subtypes and posit MYD88/p100 signaling as a regulator for B-cell activation.	[Guo, X.; Koff, J. L.; Cinar, M.; Ramachandiran, S.; Khoury, H. J.; Harris, W.; Flowers, C. R.; Boise, L. H.; Kowalski, J.; Bernal-Mizrachi, L.] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, 1365 Clifton Rd,Bldg C,3rd Floor, Atlanta, GA 30322 USA; [Moffitt, A. B.; Dave, S. S.] Duke Univ, Duke Inst Genome Sci & Policy, Dept Med, Durham, NC USA; [Chen, Z.; Switchenko, J. M.; Kowalski, J.] Emory Univ, Winship Canc Inst, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA; [Mosunjac, M.; Neill, S. G.; Mann, K. P.; Bagirov, M.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Du, Y.] Emory Univ, Dept Pharmacol, Atlanta, GA 30322 USA; [Natkunam, Y.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Rossi, M. R.] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Lossos, I. S.] Univ Miami, Sylvester Comprehens Canc Ctr, Div Hematol Oncol & Mol & Cellular Pharmacol, Miami, FL USA	Emory University; Duke University; Emory University; Emory University; Emory University; Stanford University; Emory University; University of Miami	Bernal-Mizrachi, L (corresponding author), Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, 1365 Clifton Rd,Bldg C,3rd Floor, Atlanta, GA 30322 USA.	lbernal@emory.edu	Flowers, Christopher R/F-1953-2010; Boise, Lawrence/AAD-2314-2019; Natkunam, Yasodha/L-5454-2015	Flowers, Christopher R/0000-0002-9524-3990; Natkunam, Yasodha/0000-0002-9816-1018; Moffitt, Andrea/0000-0001-5964-7851; Boise, Lawrence/0000-0001-9436-8815; Kowalski, Jeanne/0000-0003-3458-3024	NIH [R21 CA158686, K24 CA208132, CA109335, CA122105, CA127910, CA129968]; GCCDSW; Dwoskin and Rizzo Family and Fidelity; Byron Davis Research Fund	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GCCDSW; Dwoskin and Rizzo Family and Fidelity; Byron Davis Research Fund	We thank Dr Sagar Lonial and Dr Jing Chen for their critical review and helpful comments. We thank Dr Anne J Novak for providing the L265P MYD88 lentivirus. CRF was supported by NIH (R21 CA158686 and K24 CA208132) and GCCDSW. ISL by the NIH (CA109335 and CA122105) and the Dwoskin and Rizzo Family and Fidelity. JK was supported by GCCDSW. LHB received funding support from the NIH (CA127910 and CA129968) and a GCCDSW. LB-M received funding from the Byron Davis Research Fund.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Angus SP, 2012, ONCOGENE, V31, P4709, DOI 10.1038/onc.2011.622; Ansell SM, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.4; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Basak S, 2008, MOL CELL BIOL, V28, P3139, DOI 10.1128/MCB.01469-07; Bernal-Mizrachi L, 2006, P NATL ACAD SCI USA, V103, P9220, DOI 10.1073/pnas.0507809103; Bowles JA, 2006, BLOOD, V108, P2648, DOI 10.1182/blood-2006-04-020057; Braggio E, 2012, MODERN PATHOL, V25, P651, DOI 10.1038/modpathol.2011.213; Chan YW, 2009, J CELL BIOL, V185, P859, DOI 10.1083/jcb.200812167; Chang H, 2007, MOL CANCER THER, V6, P24, DOI 10.1158/1535-7163.MCT-06-0443; Chattopadhyay S, 2007, MOL BIOL CELL, V18, P4085, DOI 10.1091/mbc.E06-12-1148; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Eckfeld K, 2004, CANCER RES, V64, P8688, DOI 10.1158/0008-5472.CAN-04-2065; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Gasparini C, 2014, CELL MOL LIFE SCI, V71, P2083, DOI 10.1007/s00018-013-1545-4; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Gerondakis S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000182; Hale JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010127; Harvey D, 2011, RHEUMATOLOGY, V50, P1720, DOI 10.1093/rheumatology/ker199; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Jazirehi AR, 2005, CANCER RES, V65, P264; Joshi B, 2004, EUR J BIOCHEM, V271, P2189, DOI 10.1111/j.1432-1033.2004.04149.x; Kaser A, 2001, BIOL CHEM, V382, P1637, DOI 10.1515/BC.2001.199; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Klon AE, 2002, J MOL BIOL, V320, P677, DOI 10.1016/S0022-2836(02)00469-2; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2010, NEW ENGL J MED, V362, P1417, DOI 10.1056/NEJMra0807082; Lepin EJM, 2000, EUR J IMMUNOL, V30, P3552, DOI 10.1002/1521-4141(200012)30:12<3552::AID-IMMU3552>3.0.CO;2-L; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Lo JC, 2006, BLOOD, V107, P1048, DOI 10.1182/blood-2005-06-2452; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Marill J, 2000, MOL PHARMACOL, V58, P1341, DOI 10.1124/mol.58.6.1341; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nandi AK, 2007, BIOCHEM BIOPH RES CO, V358, P181, DOI 10.1016/j.bbrc.2007.04.125; Navarro F, 1999, EUR J IMMUNOL, V29, P277, DOI 10.1002/(SICI)1521-4141(199901)29:01<277::AID-IMMU277>3.0.CO;2-4; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Piao L, 2011, GENE CHROMOSOME CANC, V50, P13, DOI 10.1002/gcc.20828; Ramachandiran S, 2015, INT J CANCER, V136, P2341, DOI 10.1002/ijc.29301; Roman Y, 2007, BIOCHEMISTRY-US, V46, P11369, DOI 10.1021/bi7005477; Roodink I, 2008, AM J PATHOL, V173, P1873, DOI 10.2353/ajpath.2008.080136; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shaffer AL, 2012, ANNU REV IMMUNOL, V30, P565, DOI 10.1146/annurev-immunol-020711-075027; Shih VFS, 2011, CELL RES, V21, P86, DOI 10.1038/cr.2010.161; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Teras LR, 2016, CA-CANCER J CLIN, V66, P443, DOI 10.3322/caac.21357; Thompson MP, 2003, LEUKEMIA, V17, P2196, DOI 10.1038/sj.leu.2403130; Wolf A, 2006, NAT CELL BIOL, V8, P1432, DOI 10.1038/ncb1504; Wu RP, 2010, P NATL ACAD SCI USA, V107, P7479, DOI 10.1073/pnas.1002890107; Zhang BC, 2007, BLOOD, V110, P743, DOI 10.1182/blood-2006-11-058446; Zhang BC, 2015, CELL REP, V11, P715, DOI 10.1016/j.celrep.2015.03.059; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110; Zhao B, 2014, CELL REP, V8, P1595, DOI 10.1016/j.celrep.2014.07.037; Zhu DX, 2013, AM J HEMATOL, V88, P730, DOI 10.1002/ajh.23490; Zhu H, 2008, J CELL BIOL, V183, P835, DOI 10.1083/jcb.200807046	71	10	10	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 20	2017	36	29					4224	4232		10.1038/onc.2017.90	http://dx.doi.org/10.1038/onc.2017.90			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FB0LE	28368397				2022-12-26	WOS:000405835800013
J	Matsuda, M; Hirata, M				Matsuda, Miho; Hirata, Masato			Phospholipase C-related but catalytically inactive proteins regulate ovarian follicle development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INS(1,4,5)P-3 BINDING-PROTEIN; LUTEINIZING-HORMONE RECEPTOR; GRANULOSA-CELLS; GABA(A) RECEPTOR; POLYCYSTIC OVARIES; MEDICAL PROGRESS; IN-VITRO; PRIP; INSULIN; P130	Phospholipase C-related but catalytically inactive proteins PRIP-1 and -2 are inositol-1,4,5-trisphosphate binding proteins that are encoded by independent genes. Ablation of the Prip genes in mice impairs female fertility, which is manifested by fewer pregnancies, a decreased number of pups, and the decreased and increased secretion of gonadal steroids and gonadotropins, respectively. We investigated the involvement of the PRIPs in fertility, focusing on the ovaries of Prip-1 and -2 double-knock-out (DKO) mice. Multiple cystic follicles were observed in DKO ovaries, and a superovulation assay showed a markedly decreased number of ovulated oocytes. Cumulusoocyte complexes showed normal expansion, and artificial gonadotropin stimulation regulated the ovulation-related genes in a normal fashion, suggesting that the ovulation itself was probably normal. Ahistological analysis showed atresia in fewer follicles of the DKO ovaries, particularly in the secondary follicle stages. The expression of luteinizing hormone receptor (LHR) was aberrantly higher in developing follicles, and the phosphorylation of extracellular signal-regulated protein kinase, a downstream target of LH-LHR signaling, was higher in DKO granulosa cells. This suggests that the up-regulation of LH-LHR signaling is the cause of impaired follicle development. The serum estradiol level was lower, but estradiol production was unchanged in the DKO ovaries. These results suggest that PRIPs are positively involved in the development of follicles via their regulation of LH-LHR signaling and estradiol secretion. Female DKO mice had higher serum levels of insulin, testosterone, and uncarboxylatedosteocalcin, which, togetherwithreducedfertility, are reminiscent of polycystic ovary syndrome in humans.	[Matsuda, Miho] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 8128582, Japan; [Hirata, Masato] Fukuoka Dent Coll, Fukuoka 8140193, Japan	Kyushu University; Fukuoka Dental College (FDC)	Matsuda, M (corresponding author), 3-1-1 Maidashi,Higashi Ku, Fukuoka 8128582, Japan.	natural@dent.kyushu-u.ac.jp			KAKENHI Grants [24229009, 24592804]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [17H01595] Funding Source: KAKEN	KAKENHI Grants(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research, KAKENHI Grants: 24229009 (to M.H.) and 24592804 (to M.M.) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Asano S, 2014, BIOL OPEN, V3, P463, DOI 10.1242/bio.20147591; Caldwell JD, 2014, STEROIDS, V81, P13, DOI 10.1016/j.steroids.2013.11.010; Carel JC, 2008, NEW ENGL J MED, V358, P2366, DOI 10.1056/NEJMcp0800459; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chang RJ, 2013, MOL CELL ENDOCRINOL, V373, P51, DOI 10.1016/j.mce.2012.07.011; DAVOREN JB, 1986, ENDOCRINOLOGY, V119, P2155, DOI 10.1210/endo-119-5-2155; Doira N, 2001, BIOMED RES-TOKYO, V22, P157, DOI 10.2220/biomedres.22.157; Donadeu FX, 2011, ENDOCRINOLOGY, V152, P2857, DOI 10.1210/en.2010-1298; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Eppig JJ, 1998, BIOL REPROD, V59, P1445, DOI 10.1095/biolreprod59.6.1445; EPPIG JJ, 1979, NATURE, V281, P483, DOI 10.1038/281483a0; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Feng Y, 2013, AM J TRANSL RES, V5, P15; Foong SC, 2006, J CLIN ENDOCR METAB, V91, P2327, DOI 10.1210/jc.2005-2142; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Fujii M, 2010, J BIOL CHEM, V285, P4837, DOI 10.1074/jbc.M109.070045; Gao J, 2012, J BIOL CHEM, V287, P10565, DOI 10.1074/jbc.M111.294645; Harada K, 2005, J CELL PHYSIOL, V202, P422, DOI 10.1002/jcp.20136; Jakimiuk AJ, 2001, J CLIN ENDOCR METAB, V86, P1318, DOI 10.1210/jc.86.3.1318; Kanamarlapudi V, 2016, REPROD BIOMED ONLINE, V32, P635, DOI 10.1016/j.rbmo.2016.03.003; Kanematsu T, 1996, BIOCHEM J, V313, P319, DOI 10.1042/bj3130319; KANEMATSU T, 1992, J BIOL CHEM, V267, P6518; Kanematsu T, 2000, EUR J BIOCHEM, V267, P2731, DOI 10.1046/j.1432-1327.2000.01291.x; Kanematsu T, 2002, EMBO J, V21, P1004, DOI 10.1093/emboj/21.5.1004; Kanematsu T, 2007, J NEUROCHEM, V101, P898, DOI 10.1111/j.1471-4159.2006.04399.x; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; Kotani M, 2015, J CELL BIOCHEM, V116, P2814, DOI 10.1002/jcb.25228; Lan CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep14994; Makker A, 2014, J MOL ENDOCRINOL, V53, pR103, DOI 10.1530/JME-14-0220; Maman E, 2012, FERTIL STERIL, V97, P592, DOI 10.1016/j.fertnstert.2011.12.027; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Matsuda M, 2009, BIOL REPROD, V81, P681, DOI 10.1095/biolreprod.109.076760; Menon KMJ, 2004, BIOL REPROD, V70, P861, DOI 10.1095/biolreprod.103.024471; Mizokami A, 2007, J NEUROSCI, V27, P1692, DOI 10.1523/JNEUROSCI.3155-06.2007; Mizokami A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057375; Murakami A, 2017, J BIOL CHEM, V292, P7994, DOI [10.1074/jbc.M117.784777, 10.1074/jbc.M117.801936]; Orisaka M, 2013, ENDOCRINOLOGY, V154, P2870, DOI 10.1210/en.2012-2173; Oue K, 2016, J BIOL CHEM, V291, P4185, DOI 10.1074/jbc.M115.705723; Pepene CE, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-4; Schneider JE, 2004, PHYSIOL BEHAV, V81, P289, DOI 10.1016/j.physbeh.2004.02.007; Shelling AN, 2010, REPRODUCTION, V140, P633, DOI 10.1530/REP-09-0567; Sugiyama Goro, 2013, Advances in Biological Regulation, V53, P331, DOI 10.1016/j.jbior.2013.07.001; Takeuchi H, 2000, BIOCHEM J, V349, P357, DOI 10.1042/0264-6021:3490357; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; TSAFRIRI A, 1995, ADV EXP MED BIOL, V377, P121; Tsutsumi K, 2011, J BIOL CHEM, V286, P31032, DOI 10.1074/jbc.M111.235903; Uji A, 2002, LIFE SCI, V72, P443, DOI 10.1016/S0024-3205(02)02275-0; Walters KA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097808; Webber LJ, 2007, J CLIN ENDOCR METAB, V92, P1975, DOI 10.1210/jc.2006-1422; Yanagihori S, 2006, ADV ENZYME REGUL, V46, P203, DOI 10.1016/j.advenzreg.2006.01.006; YOSHIDA M, 1994, J BIOCHEM, V115, P973, DOI 10.1093/oxfordjournals.jbchem.a124447; Yoshimura K, 2001, J BIOL CHEM, V276, P17908, DOI 10.1074/jbc.M009677200; Yung Y, 2014, MOL HUM REPROD, V20, P844, DOI 10.1093/molehr/gau041; Zhang ZH, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/408012	54	1	1	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8369	8380		10.1074/jbc.M116.759928	http://dx.doi.org/10.1074/jbc.M116.759928			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28360101	hybrid, Green Published			2022-12-26	WOS:000401788600021
J	Abdelrahman, I; Elmasry, M; Olofsson, P; Steinvall, I; Fredrikson, M; Sjoberg, F				Abdelrahman, Islam; Elmasry, Moustafa; Olofsson, Pia; Steinvall, Ingrid; Fredrikson, Mats; Sjoberg, Folke			Division of overall duration of stay into operative stay and postoperative stay improves the overall estimate as a measure of quality of outcome in burn care	PLOS ONE			English	Article							LENGTH-OF-STAY; RESPIRATORY-DISTRESS-SYNDROME; INHALATION INJURY; MORTALITY; HOSPITALIZATION; MORBIDITY; VARIABLES; PREDICT	Total duration of stay adjusted for percentage of the total body surface area burned (TBSA %) is a commonly used outcome measure in burn care. However, it has been criticised as it is affected by many factors, some of which are not strictly part of burn care. A division into operative stay and postoperative stay may improve this measure. The aim was to evaluate if operative stay can serve as a more standardised measure by: comparing the variation in operative stay/TBSA% with the variation in total stay/TBSA%, and to study different factors associated with operative stay and postoperative stay. Patients and methods Surgically managed burn patients admitted between 2010-14 were included. Operative stay was defined as the time from admission until the last operation, postoperative stay as the time from the last operation until discharge. The difference in variation was analysed with F-test. A retrospective review of medical records was done to explore reasons for extended postoperative stay. Multivariable regression was used to assess factors associated with operative stay and postoperative stay. Results Operative stay/TBSA% showed less variation than total duration/TBSA% (F test = 2.38, p<0.01). The size of the burn, and the number of operations, were the independent factors that influenced operative stay (R-2 0.65). Except for the size of the burn other factors were associated with duration of postoperative stay: wound related, psychological and other medical causes, advanced medical support, and accommodation arrangements before discharge, of which the two last were the most important with an increase of (mean) 12 and 17 days (p<0.001, R-2 0.51). Conclusion Adjusted operative stay showed less variation than total hospital stay and thus can be considered a more accurate outcome measure for surgically managed burns. The size of burn and number of operations are the factors affecting this outcome measure.	[Abdelrahman, Islam; Elmasry, Moustafa] Suez Canal Univ, Dept Surg, Plast Surg Unit, Ismailia, Egypt; [Abdelrahman, Islam; Elmasry, Moustafa; Olofsson, Pia; Steinvall, Ingrid; Sjoberg, Folke] Linkoping Univ, Dept Plast Surg Hand Surg & Burns, Linkoping, Sweden; [Abdelrahman, Islam; Elmasry, Moustafa; Olofsson, Pia; Steinvall, Ingrid; Fredrikson, Mats; Sjoberg, Folke] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Sjoberg, Folke] Linkoping Univ, Dept Anaesthesiol & Intens Care, Linkoping, Sweden	Egyptian Knowledge Bank (EKB); Suez Canal University; Linkoping University; Linkoping University; Linkoping University	Steinvall, I (corresponding author), Linkoping Univ, Dept Plast Surg Hand Surg & Burns, Linkoping, Sweden.; Steinvall, I (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	ingrid.steinvall@regionostergotland.se	Steinvall, Ingrid/I-5954-2019; Abdelrahman, Islam Mohamedy/I-1341-2019	Abdelrahman, Islam Mohamedy/0000-0002-2500-728X; Steinvall, Ingrid/0000-0002-8027-9632	Burn Centre, Department of Plastic Surgery, Hand Surgery, and Burns; Linkoping University, Linkoping, Sweden	Burn Centre, Department of Plastic Surgery, Hand Surgery, and Burns; Linkoping University, Linkoping, Sweden	This work was supported by, and done at, the Burn Centre, Department of Plastic Surgery, Hand Surgery, and Burns, and the Linkoping University, Linkoping, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by, and done at, the Burn Centre, Department of Plastic Surgery, Hand Surgery, and Burns, and the Linkoping University, Linkoping, Sweden.	Andel D, 2007, J BURN CARE RES, V28, P163, DOI 10.1097/BCR.0B013E31802C9E8F; [Anonymous], J BURN CARE REHABIL; Attia A F, 2000, East Mediterr Health J, V6, P1055; Bak Z, 2009, J TRAUMA, V66, P329, DOI 10.1097/TA.0b013e318165c822; BOWSER BH, 1983, BURNS, V9, P318, DOI 10.1016/0305-4179(83)90077-3; BULL JP, 1949, ANN SURG, V130, P160, DOI 10.1097/00000658-194908000-00002; DEITCH EA, 1983, J TRAUMA, V23, P895, DOI 10.1097/00005373-198310000-00009; Elmasry M, 2016, J BURN CARE RES; Engrav LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040086; Gravante G, 2007, BURNS, V33, P312, DOI 10.1016/j.burns.2006.07.003; Hansbrough Wendy, 1995, Journal of Burn Care and Rehabilitation, V16, P531, DOI 10.1097/00004630-199509000-00012; HERNDON DN, 1989, ANN SURG, V209, P547, DOI 10.1097/00000658-198905000-00006; Ho W S, 2002, Hong Kong Med J, V8, P235; Hussain A, 2013, BURNS, V39, P1331, DOI 10.1016/j.burns.2013.04.026; Janzekovic Z, 1970, J Trauma, V10, P1103; Johnson LS, 2011, J BURN CARE RES, V32, P13, DOI 10.1097/BCR.0b013e318204b3ab; Liffner G, 2005, BURNS, V31, P263, DOI 10.1016/j.burns.2004.11.003; Meshulam-Derazon S, 2006, PLAST RECONSTR SURG, V118, P116, DOI 10.1097/01.prs.0000221111.89812.ad; National Burn Repository, 2015, ANN REPORT; Pavlovich AR, 2009, J BURN CARE RES, V30, P229, DOI 10.1097/BCR.0b013e318198e77a; Peck Michael D., 1996, Journal of Burn Care and Rehabilitation, V17, P39, DOI 10.1097/00004630-199601000-00010; Pereira C, 2004, BURNS, V30, P761, DOI 10.1016/j.burns.2004.05.012; Polit D.F., 1991, NURSING RES PRINCIPL; Saffle Jeffrey R., 1995, Journal of Burn Care and Rehabilitation, V16, P219, DOI 10.1097/00004630-199505000-00002; Sjoberg F, 2000, BURNS, V26, P553, DOI 10.1016/S0305-4179(00)00004-8; Steinvall I, 2008, BURNS, V34, P441, DOI 10.1016/j.burns.2007.10.007; Still J, 1997, BURNS, V23, P498, DOI 10.1016/S0305-4179(97)00044-2; Unal S, 2005, ANN PLAS SURG, V55, P102, DOI 10.1097/01.sap.0000164531.23770.60; Wearn C, 2015, BURNS, V41, P1161, DOI 10.1016/j.burns.2015.04.008; WONG MK, 1995, BURNS, V21, P39, DOI 10.1016/0305-4179(95)90780-4	30	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174579	10.1371/journal.pone.0174579	http://dx.doi.org/10.1371/journal.pone.0174579			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362844	gold, Green Submitted, Green Published			2022-12-26	WOS:000399175000022
J	Shi, G; Nehorai, A				Shi, Gang; Nehorai, Arye			Robustness of meta-analyses in finding gene x environment interactions	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; REGRESSION	Meta-analyses that synthesize statistical evidence across studies have become important analytical tools for genetic studies. Inspired by the success of genome-wide association studies of the genetic main effect, researchers are searching for gene x environment interactions. Confounders are routinely included in the genome-wide gene x environment interaction analysis as covariates; however, this does not control for any confounding effects on the results if covariate x environment interactions are present. We carried out simulation studies to evaluate the robustness to the covariate x environment confounder for meta-regression and joint meta-analysis, which are two commonly used meta-analysis methods for testing the gene x environment interaction or the genetic main effect and interaction jointly. Here we show that meta-regression is robust to the covariate x environment confounder while joint meta-analysis is subject to the confounding effect with inflated type I error rates. Given vast sample sizes employed in genome-wide gene x environment interaction studies, non-significant covariate x environment interactions at the study level could substantially elevate the type I error rate at the consortium level. When covariate x environment confounders are present, type I errors can be controlled in joint meta-analysis by including the covariate x environment terms in the analysis at the study level. Alternatively, meta-regression can be applied, which is robust to potential covariate x environment confounders.	[Shi, Gang] Xidian Univ, State Key Lab Integrated Serv Networks, Xian, Shaanxi, Peoples R China; [Nehorai, Arye] Washington Univ, Preston M Green Dept Elect & Syst Engn, St Louis, MO USA	Xidian University; Washington University (WUSTL)	Shi, G (corresponding author), Xidian Univ, State Key Lab Integrated Serv Networks, Xian, Shaanxi, Peoples R China.	gshi@xidian.edu.cn			Thousand Youth Talents Plan [20701160003]; State Key Laboratory of Integrated Services Networks [90108162901]	Thousand Youth Talents Plan; State Key Laboratory of Integrated Services Networks	The work of GS was supported by the Thousand Youth Talents Plan (http//www.1000plan.org/) Grant No. 20701160003 and State Key Laboratory of Integrated Services Networks (http.//isn.xidian.edu.cn/) Grant No. 90108162901. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Aschard H, 2012, HUM GENET, V131, P1591, DOI 10.1007/s00439-012-1192-0; Aschard H, 2010, HUM HERED, V70, P292, DOI 10.1159/000323318; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Burdett T, NHGRI EBI CATALOG PU; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Dudbridge F, 2014, AM J HUM GENET, V95, P301, DOI 10.1016/j.ajhg.2014.07.014; Evangelou E, 2013, NAT REV GENET, V14, P379, DOI 10.1038/nrg3472; Hancock DB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003098; Keller MC, 2014, BIOL PSYCHIAT, V75, P18, DOI 10.1016/j.biopsych.2013.09.006; Lin DY, 2010, GENET EPIDEMIOL, V34, P60, DOI 10.1002/gepi.20435; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Manning AK, 2011, GENET EPIDEMIOL, V35, P11, DOI 10.1002/gepi.20546; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Simino J, 2014, AM J HUM GENET, V95, P24, DOI 10.1016/j.ajhg.2014.05.010; VanderWeele TJ, 2013, AM J EPIDEMIOL, V178, P144, DOI 10.1093/aje/kws439; Winkler TW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005378; Xu XX, 2013, IEEE T NANOBIOSCI, V12, P354, DOI 10.1109/TNB.2013.2294331; Zeileis A., 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i10, DOI 10.18637/JSS.V011.I10]; Zheng J, 2015, APPL INFORM, V2, P10, DOI [10.1186/s40535-015-0013-7, DOI 10.1186/S40535-015-0013-7]	20	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0171446	10.1371/journal.pone.0171446	http://dx.doi.org/10.1371/journal.pone.0171446			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362796	gold, Green Published, Green Submitted			2022-12-26	WOS:000399175000002
J	Bundgaard, J; Barker, JSF				Bundgaard, Jorgen; Barker, J. S. F.			Genetic variation for resistance to high temperature stress of mature sperm - a study in Drosophila	PLOS ONE			English	Article							MALE-STERILITY; HEAT-STRESS; MELANOGASTER; BUZZATII; SPERMATOGENESIS; TOLERANCE	Genetic variation for resistance to heat stress has been found for a number of life-history components in Drosophila species. For male and female fertility (or sterility), stress resistance of the parents is confounded with stress resistance of the haploid gametes. Many genes are known to influence male fertility in Drosophila melanogaster. Some may carry temperature sensitive alleles that reduce fertility through effects on mature sperm when exposed to heat stress. In this study, sperm from each of 320 males were either not heat shocked (control) or exposed to a heat shock (36.9 degrees C for 2 hours) either in the male testes or in the female reproductive tract. We did not detect any temperature sensitive sterility alleles. These results are relevant in relation to haploid gene expression and the findings of considerable amounts of mRNA in mature sperm, potentially important for sperm function and fertilization.	[Bundgaard, Jorgen] Aarhus Univ, Dept Biosci, Sect Genet Ecol & Evolut, Ny Munkegade 116, Aarhus, Denmark; [Barker, J. S. F.] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia	Aarhus University; University of New England	Bundgaard, J (corresponding author), Aarhus Univ, Dept Biosci, Sect Genet Ecol & Evolut, Ny Munkegade 116, Aarhus, Denmark.	biojb@bios.au.dk		Barker, James/0000-0002-5232-458X; Bundgaard, Jens Rene/0000-0001-9600-1224	Faculty of Science and Technology, Aarhus University, Denmark	Faculty of Science and Technology, Aarhus University, Denmark	This study was supported by the Faculty of Science and Technology, Aarhus University, Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bijlsma R, 1999, J EVOLUTION BIOL, V12, P1125, DOI 10.1046/j.1420-9101.1999.00113.x; Bijlsma R, 2012, EVOL APPL, V5, P117, DOI 10.1111/j.1752-4571.2011.00214.x; CASTRILLON DH, 1993, GENETICS, V135, P489; COYNE JA, 1983, AM NAT, V122, P474, DOI 10.1086/284150; Das PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056535; David JR, 2005, J EVOLUTION BIOL, V18, P838, DOI 10.1111/j.1420-9101.2005.00914.x; Fischer BE, 2012, P ROY SOC B-BIOL SCI, V279, P2636, DOI 10.1098/rspb.2012.0153; Garcia-Herrero S, 2011, REPROD BIOMED ONLINE, V22, P25, DOI 10.1016/j.rbmo.2010.09.013; Gur Y, 2015, GENE DEV, V20, P411; Hennig W., 1988, SPERMATOGENESIS DROS, P239; Hoffmann AA, 2010, J EXP BIOL, V213, P870, DOI 10.1242/jeb.037630; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Jodar M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1287; Jodar M, 2012, HUM REPROD, V27, P1431, DOI 10.1093/humrep/des021; Jorgensen KT, 2006, J THERM BIOL, V31, P280, DOI 10.1016/j.jtherbio.2005.11.026; Joseph SB, 2004, TRENDS ECOL EVOL, V19, P592, DOI 10.1016/j.tree.2004.08.004; Joubert D, 2010, CLIM RES, V43, P57, DOI 10.3354/cr00883; Kawano M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044542; KREBS RA, 1994, EXS, V68, P309; LOESCHCKE V, 1994, BIOL J LINN SOC, V52, P83, DOI 10.1111/j.1095-8312.1994.tb00980.x; Onder Banu Sebnem, 2009, International Journal of Biology, V1, P45; Pedersen LD, 2011, BIOL J LINN SOC, V104, P432, DOI 10.1111/j.1095-8312.2011.01725.x; Porcelli D, 2016, J EVOL BIOL; Sisodia S, 2006, CAN J ZOOL, V84, P895, DOI 10.1139/Z06-075; SUZUKI DT, 1967, P NATL ACAD SCI USA, V57, P907, DOI 10.1073/pnas.57.4.907; Vibranovski MD, 2010, GENETICS, V186, P431, DOI 10.1534/genetics.110.118919; Vollmer JH, 2004, HEREDITY, V92, P257, DOI 10.1038/sj.hdy.6800405; Wakimoto BT, 2004, GENETICS, V167, P207, DOI 10.1534/genetics.167.1.207; ZWAAN BJ, 1991, HEREDITY, V66, P29, DOI 10.1038/hdy.1991.4	29	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0173990	10.1371/journal.pone.0173990	http://dx.doi.org/10.1371/journal.pone.0173990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358879	Green Published, gold			2022-12-26	WOS:000399174800017
J	Cheng, MH; Gao, T; Xi, FC; Cao, C; Chen, Y; Zhao, CY; Li, QR; Yu, WK				Cheng, Minhua; Gao, Tao; Xi, Fengchan; Cao, Chun; Chen, Yan; Zhao, Chenyan; Li, Qiurong; Yu, Wenkui			Dexmedetomidine ameliorates muscle wasting and attenuates the alteration of hypothalamic neuropeptides and inflammation in endotoxemic rats	PLOS ONE			English	Article							SEDATION; PATIENT; SEPSIS; PROPOFOL	Dexmedetomidine is generally used for sedaton in critically ill, it could shorten duration of mechanical ventilation, ICU stay and lower basic metabolism. However, the exact mechanism of these positive effects remains unkown. Here we investigated the hypothesis that dexmedetomidine could ameliorate muscle wasting in endotoxemic rats and whether it was related to hypothalamic neuropeptides alteration and inflammation. Fourty-eight adult male Sprague Dawley rats were intraperitoneally injected with lipopolysaccharide (LPS) (5 mg/kg) or saline, followed by 50 lag/kg dexmedetomidine or saline administration via the femoral vein catheter (infusion at 5 pg-kg(-1)-hr(-1)). Twenty-four hours after injection, hypothalamus tissues and skeletal muscle were obtained. Muscle wasting was measured by the mRNA expression of two E3 ubiquitin ligases, muscle atrophy F-box (MAFbx) and muscle ring finger 1 (MuRF-1) as well as 3-methylhistidine (3-MH) and tyrosine release. Hypothalamic inflammatory markers and neuropeptides expression were also detected in all four groups. Results showed that LPS administration led to significant increase in hypothalamic inflammation together with muscle wasting. Increased hypothalamic neuropeptides, proopiomelanocortin (POMC), cocaine and amphetamine-related transcript (CART) and neuropeptides Y (NPY) and decreased agouti-related protein (AgRP) were also observed. Meanwhile dexmedetomidine administration ameliorated muscle wasting, hypothalamic inflammation and modulated the alteration of neuropeptides, POMC, CART and AgRP, in endotoxemic rats. In conclusion, dexmedetomidine could alleviate muscle wasting in endotoxemic rats, and it could also attenuate the alteration of hypothalamic neuropeptides and reduce hypothalamic inflammation.	[Cheng, Minhua; Gao, Tao; Cao, Chun; Chen, Yan; Zhao, Chenyan; Yu, Wenkui] Nanjing Univ, Sch Med, Nanjing, Jiangsu, Peoples R China; [Gao, Tao; Xi, Fengchan; Li, Qiurong; Yu, Wenkui] Nanjing Univ, Inst Gen Surg, Jinling Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Yu, WK (corresponding author), Nanjing Univ, Sch Med, Nanjing, Jiangsu, Peoples R China.; Yu, WK (corresponding author), Nanjing Univ, Inst Gen Surg, Jinling Hosp, Sch Med, Nanjing, Jiangsu, Peoples R China.	yudrnj@nju.edu.cn			Natural Science Foundation of China [81270884]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grant 81270884 from the Natural Science Foundation of China (http://www.nsfc.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aantaa Riku, 1993, Drugs of the Future, V18, P49; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Arora S, 2006, NEUROPEPTIDES, V40, P375, DOI 10.1016/j.npep.2006.07.001; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Casaer MP, 2004, NEW ENGL J MED, V370, P1227; Casserly B, 2012, INTENS CARE MED, V38, P1946, DOI 10.1007/s00134-012-2720-z; Cheng M, 2016, WORLD J SURG; Cheung WW, 2012, AM J PHYSIOL-RENAL, V303, pF1315, DOI 10.1152/ajprenal.00341.2012; Clark MA, 1998, CRIT CARE MED, V26, P1650, DOI 10.1097/00003246-199810000-00016; DeBoer MD, 2010, NUTRITION, V26, P146, DOI 10.1016/j.nut.2009.07.003; Duan KP, 2015, CLIN ENDOCRINOL, V82, P695, DOI 10.1111/cen.12610; Fanzani A, 2012, J CACHEXIA SARCOPENI, V3, P163, DOI 10.1007/s13539-012-0074-6; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Gravel NR, 1999, CNS DRUGS, V11, P9, DOI 10.2165/00023210-199911010-00002; Guo TZ, 1996, ANESTHESIOLOGY, V84, P873, DOI 10.1097/00000542-199604000-00015; Ho KM, 2008, INTENS CARE MED, V34, P1969, DOI 10.1007/s00134-008-1186-5; Krasnow Stephanie M, 2010, Curr Opin Support Palliat Care, V4, P266, DOI 10.1097/SPC.0b013e32833e48e7; MOLDAWER LL, 1987, AM J PHYSIOL, V253, pC766, DOI 10.1152/ajpcell.1987.253.6.C766; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Oyama LM, 2010, NEUROPEPTIDES, V44, P467, DOI 10.1016/j.npep.2010.07.002; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Riker RR, 2009, CRIT CARE CLIN, V25, P527, DOI 10.1016/j.ccc.2009.05.004; Scarlett JM, 2008, ENDOCRINOLOGY, V149, P4837, DOI 10.1210/en.2007-1680; Tan JA, 2010, INTENS CARE MED, V36, P926, DOI 10.1007/s00134-010-1877-6; Taniguchi T, 2004, CRIT CARE MED, V32, P1322, DOI 10.1097/01.CCM.0000128579.84228.2A; Thaler JP, 2010, FRONT NEUROENDOCRIN, V31, P79, DOI 10.1016/j.yfrne.2009.10.002; Venn RM, 2001, BRIT J ANAESTH, V87, P684, DOI 10.1093/bja/87.5.684; Venn RM, 2000, CRIT CARE, V4, P302, DOI 10.1186/cc712; Wisse BE, 2007, ENDOCRINOLOGY, V148, P5230, DOI 10.1210/en.2007-0394; Xu L, 2013, INFLAMM RES, V62, P507, DOI 10.1007/s00011-013-0604-5; Zheng Y, 2016, J AM HEART ASS, V5; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	35	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174894	10.1371/journal.pone.0174894	http://dx.doi.org/10.1371/journal.pone.0174894			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358856	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174800100
J	Song, LM; Wang, XM; Huang, JP; Zhu, F; Jiang, X; Zhang, SG; Ban, LP				Song, Li-Mei; Wang, Xue-Min; Huang, Jian-Ping; Zhu, Fang; Jiang, Xiang; Zhang, Shan-Gan; Ban, Li-Ping			Ultrastructure and morphology of antennal sensilla of the adult diving beetle Cybister japonicus Sharp	PLOS ONE			English	Article							DYTISCUS-MARGINALIS L; COLEOPTERA-DYTISCIDAE; LOCUSTA-MIGRATORIA; FINE-STRUCTURE; WATER; THERMORECEPTORS; CHEMORECEPTORS; HYGRORECEPTORS; PREDATION; BEHAVIOR	The morphology and distribution of the antennal sensilla of adult diving beetle Cybisterjaponicus Sharp (Dytiscidae, Coleoptera), have been examined. Five types of sensilla on the antennae were identified by scanning electron microscope (SEM) and transmission electron microscope (TEM). Sensilla placodea and elongated s. placodea are the most abundant types of sensilla, distributing only on the flagellum. Both these types of sensilla carry multiple pore systems with a typical function as chemoreceptors. Three types of s. coeloconica (Type I-III) were also identified, with the characterization of the pit-in-pit style, and carrying pegs externally different from each other. Our data indicated that both type I and type II of s. coleconica contain two bipolar neurons, while the type III of s. coleconica contains three dendrites in the peg. Two sensory dendrites in the former two sensilla are tightly embedded inside the dendrite sheath, with no space left for sensilla lymph. There are no specific morphological differences in the antennal sensilla observed between males and females, except that the males have longer antennae and more sensilla than the females.	[Song, Li-Mei; Huang, Jian-Ping; Ban, Li-Ping] China Agr Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Beijing, Peoples R China; [Wang, Xue-Min] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China; [Zhu, Fang] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Jiang, Xiang] Huangpu Entry Exit Inspect & Quarantine Bur, Guangzhou, Guangdong, Peoples R China; [Zhang, Shan-Gan] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Washington State University; Chinese Academy of Sciences; Institute of Zoology, CAS	Ban, LP (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Beijing, Peoples R China.	lipingban@cau.edu.cn			Natural Science Foundation of China [31372364]; Beijing Natural Science Foundation [6132025]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the Natural Science Foundation of China (31372364) and Beijing Natural Science Foundation (6132025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altner H., 1980, International Review of Cytology, V67, P69, DOI 10.1016/S0074-7696(08)62427-4; ALTNER H, 1981, CELL TISSUE RES, V215, P289; ALTNER H, 1983, CELL TISSUE RES, V234, P279, DOI 10.1007/BF00213769; AMEISMEIER F, 1985, ZOOMORPHOLOGY, V105, P356, DOI 10.1007/BF00312279; BEHREND K, 1971, Z VERGL PHYSIOL, V75, P108, DOI 10.1007/BF00335141; Bilton David, 1994, Entomologisk Tidskrift, V115, P23; Blunck H, 1912, Z WISS ZOOL ABT A, V102, P169; Bronmark C, 2000, OIKOS, V88, P103, DOI 10.1034/j.1600-0706.2000.880112.x; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Crespo JG, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.6201; Csabai Z, 2012, NATURWISSENSCHAFTEN, V99, P751, DOI 10.1007/s00114-012-0957-6; Eyre MD, 2006, HYDROBIOLOGIA, V560, P121, DOI 10.1007/s10750-005-1223-0; Hoballah MEF, 2002, J CHEM ECOL, V28, P951, DOI 10.1023/A:1015253600083; HODGSON ES, 1953, BIOL BULL, V105, P115, DOI 10.2307/1538560; IVANOV V P, 1969, Trudy Vsesoyuznogo Entomologicheskogo Obshchestva, V53, P301; Ivanov VP, 1966, J EVOL BIOCHEM PHYS, V2, P461; Jensen J.C., 1991, CAN J ZOOL, V69, P334; JENSEN JC, 1992, CAN J ZOOL, V70, P825, DOI 10.1139/z92-117; Kehl S, 2003, ARCH HYDROBIOL, V158, P109, DOI 10.1127/0003-9136/2003/0158-0109; Keil Thomas A., 1999, P5; LEAL WS, 1993, NATURWISSENSCHAFTEN, V80, P278, DOI 10.1007/BF01135914; Lundkvist E, 2003, B ENTOMOL RES, V93, P219, DOI 10.1079/BER2003237; McIver S.B., 1985, P71; Merivee E, 2002, MICRON, V33, P429, DOI 10.1016/S0968-4328(02)00003-3; Ochieng SA, 2000, ARTHROPOD STRUCT DEV, V29, P231, DOI 10.1016/S1467-8039(01)00008-1; Ohba SY, 2010, J AM MOSQUITO CONTR, V26, P32, DOI 10.2987/09-5946.1; Ohba SY, 2009, ENVIRON ENTOMOL, V38, P856, DOI 10.1603/022.038.0339; Palma R, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.13301; SCHALLER A., 1926, ZEITSCHR WISS BIOL ABT C ZEITSCHR VERGLEICH PHYSIOL, V4, P370, DOI 10.1007/BF00340839; Shields VDC, 2001, J COMP PHYSIOL A, V186, P1135, DOI 10.1007/s003590000165; SMITH RL, 1973, CAN ENTOMOL, V105, P909, DOI 10.4039/Ent105909-6; Stange G, 1999, MICROSC RES TECHNIQ, V47, P416, DOI 10.1002/(SICI)1097-0029(19991215)47:6<416::AID-JEMT5>3.0.CO;2-X; Steinbrecht R.A., 1984, BIOL INTEGUMENT, V1, P523, DOI DOI 10.1007/978-3-642-51593-4_28; STEINBRECHT RA, 1976, TISSUE CELL, V8, P615, DOI 10.1016/0040-8166(76)90035-5; TURLINGS TCJ, 1995, P NATL ACAD SCI USA, V92, P4169, DOI 10.1073/pnas.92.10.4169; VET LEM, 1995, CHEM ECOLOGY INSECTS; Wisenden BD, 2000, PHILOS T ROY SOC B, V355, P1205, DOI 10.1098/rstb.2000.0668; YASUZUMI F, 1971, Z ZELLFORSCH MIK ANA, V117, P476, DOI 10.1007/BF00330709; Yee DA, 2014, INTRO DYTISCIDAE THE; Zacharuk R.Y., 1985, COMPREHENSIVE INSECT, P1; ZACHARUK RY, 1980, ANNU REV ENTOMOL, V25, P27, DOI 10.1146/annurev.en.25.010180.000331	41	10	12	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174643	10.1371/journal.pone.0174643	http://dx.doi.org/10.1371/journal.pone.0174643			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358865	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174800065
J	Araya-Cloutier, C; Martens, B; Schaftenaar, G; Leipoldt, F; Gruppen, H; Vincken, JP				Araya-Cloutier, Carla; Martens, Bianca; Schaftenaar, Gijs; Leipoldt, Franziska; Gruppen, Harry; Vincken, Jean-Paul			S Structural basis for non-genuine phenolic acceptor substrate specificity of Streptomyces roseochromogenes prenyltransferase CIoQ from the ABBA/PT-barrel superfamily	PLOS ONE			English	Article							MASS-SPECTROMETRY; AROMATIC PRENYLTRANSFERASES; PRENYLATED FLAVONOIDS; ISOFLAVONOIDS; MECHANISM; CLOQ; BIOSYNTHESIS; ENZYMES	Acceptor substrate specificity of Streptomyces roseochromogenes prenyltransferase SrCIoQ was investigated using different non-genuine phenolic compounds. RP-UHPLCUV-MSn was used for the tentative annotation and quantification of the prenylated products. Flavonoids, isoflavonoids and stilbenoids with different types of substitution were prenylated by SrCIoQ, although with less efficiency than the genuine substrate 4-hydroxyphenylpyruvate. The isoflavan equol, followed by the flavone 7,4'-dihydroxyflavone, were the best non genuine acceptor substrates. B-ring C-prenylation was in general preferred over A-ring Cprenylation (ratio 5:1). Docking studies of non-genuine acceptor substrates with the B-ring oriented towards the donor substrate dimethylallyl pyrophosphate, showed that the carbonyl group of the C-ring was able to make stabilizing interactions with the residue Arg160, which might determine the preference observed for B-ring prenylation. No reaction products were formed when the acceptor substrate had no phenolic hydroxyl groups. This preference can be explained by the essential hydrogen bond needed between a phenolic hydroxyl group and the residue Glu281. Acceptor substrates with an additional hydroxyl group at the C3' position (B-ring), were mainly 03'-prenylated (> 80% of the reaction products). This can be explained by the proximity of the C3' hydroxyl group to the donor substrate at the catalytic site. Flavones were preferred over isoflavones by SrCIoQ. Docking studies suggested that the orientation of the B-ring and of the phenolic hydroxyl group at position C7 (A-ring) of flavones towards the residue Tyr233 plays an important role in this observed preference. Finally, the insights obtained on acceptor substrate specificity and regioselectivity for SrCIoQ were extended to other prenyltransferases from the CloQ/NhpB family.	[Araya-Cloutier, Carla; Martens, Bianca; Gruppen, Harry; Vincken, Jean-Paul] Wageningen Univ, Food Chem Lab, Wageningen, Netherlands; [Schaftenaar, Gijs] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Sci, Nijmegen, Netherlands; [Leipoldt, Franziska] Eberhard Karls Univ Tubingen, Inst Pharmaceut, Pharmaceut Biol, Tubingen, Germany	Wageningen University & Research; Radboud University Nijmegen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Vincken, JP (corresponding author), Wageningen Univ, Food Chem Lab, Wageningen, Netherlands.	jean-paul.vincken@wur.nl	Araya-Cloutier, Carla/AAY-7281-2020; Schaftenaar, Gijs/Q-8665-2018	Araya-Cloutier, Carla/0000-0002-9304-4971; Vincken, Jean-Paul/0000-0001-8540-4327				Aisyah S, 2016, PHYTOCHEMISTRY, V122, P65, DOI 10.1016/j.phytochem.2015.12.015; Bayse CA, 2014, BIOCHEMISTRY-US, V53, P5034, DOI 10.1021/bi500531p; Bonitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027336; Cuyckens F, 2004, J MASS SPECTROM, V39, P1, DOI [10.1002/jms.585, 10.1002/jms.622]; Haagen Y, 2007, FEBS LETT, V581, P2889, DOI 10.1016/j.febslet.2007.05.031; Heide L, 2009, CURR OPIN CHEM BIOL, V13, P171, DOI 10.1016/j.cbpa.2009.02.020; Khalivulla SI, 2008, J ASIAN NAT PROD RES, V10, P953, DOI 10.1080/10286020802217630; Kosters HA, 2011, BIOMACROMOLECULES, V12, P2159, DOI 10.1021/bm2002285; Kumano T, 2008, BIOORGAN MED CHEM, V16, P8117, DOI 10.1016/j.bmc.2008.07.052; Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668; Leipoldt F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143237; Liang PH, 2002, EUR J BIOCHEM, V269, P3339, DOI 10.1046/j.1432-1033.2002.03014.x; Metzger U, 2010, J MOL BIOL, V404, P611, DOI 10.1016/j.jmb.2010.09.067; Metzger U, 2009, P NATL ACAD SCI USA, V106, P14309, DOI 10.1073/pnas.0904897106; MORANDI D, 1991, NEW PHYTOL, V117, P75, DOI 10.1111/j.1469-8137.1991.tb00946.x; ONEILL MJ, 1983, Z NATURFORSCH C, V38, P698; Ozaki T, 2009, J ANTIBIOT, V62, P385, DOI 10.1038/ja.2009.48; Palsuledesai CC, 2015, ACS CHEM BIOL, V10, P51, DOI 10.1021/cb500791f; Pojer F, 2003, P NATL ACAD SCI USA, V100, P2316, DOI 10.1073/pnas.0337708100; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Saleh O, 2009, PHYTOCHEMISTRY, V70, P1728, DOI 10.1016/j.phytochem.2009.05.009; Sasaki K, 2011, J BIOL CHEM, V286, P24125, DOI 10.1074/jbc.M111.244426; Simons R, 2012, FOOD FUNCT, V3, P810, DOI 10.1039/c2fo10290k; Simons R, 2009, RAPID COMMUN MASS SP, V23, P3083, DOI 10.1002/rcm.4215; Sobolev VS, 2006, PHYTOCHEM ANALYSIS, V17, P312, DOI 10.1002/pca.920; Stella L, 2008, RAPID COMMUN MASS SP, V22, P3867, DOI 10.1002/rcm.3811; Tello M, 2008, CELL MOL LIFE SCI, V65, P1459, DOI 10.1007/s00018-008-7579-3; van de Schans MGM, 2016, J STEROID BIOCHEM, V156, P53, DOI 10.1016/j.jsbmb.2015.11.020; van de Schans MGM, 2014, J AGR FOOD CHEM, V62, P10475, DOI 10.1021/jf503127c; Veitch NC, 2013, NAT PROD REP, V30, P988, DOI 10.1039/c3np70024k; WELLE R, 1991, PHYTOCHEMISTRY, V30, P479, DOI 10.1016/0031-9422(91)83709-T; Winkelblech J, 2015, APPL MICROBIOL BIOT, V99, P7379, DOI 10.1007/s00253-015-6811-y; Yang M, 2007, RAPID COMMUN MASS SP, V21, P3833, DOI 10.1002/rcm.3277; Yang XM, 2015, TRENDS FOOD SCI TECH, V44, P93, DOI 10.1016/j.tifs.2015.03.007; Yang Y, 2012, BIOCHEMISTRY-US, V51, P2606, DOI 10.1021/bi201800m; Yazaki K, 2009, PHYTOCHEMISTRY, V70, P1739, DOI 10.1016/j.phytochem.2009.08.023	36	8	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174665	10.1371/journal.pone.0174665	http://dx.doi.org/10.1371/journal.pone.0174665			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355308	Green Published, gold			2022-12-26	WOS:000399174600078
J	Brodschneider, R; Libor, A; Kupelwieser, V; Crailsheim, K				Brodschneider, Robert; Libor, Anika; Kupelwieser, Vera; Crailsheim, Karl			Food consumption and food exchange of caged honey bees using a radioactive labelled sugar solution	PLOS ONE			English	Article							APIS-MELLIFERA L; NEONICOTINOID INSECTICIDES; TROPHALLAXIS; TOXICITY; WORKERS; HYMENOPTERA; PESTICIDES; VARIANCE; DECLINES; APIDAE	We measured the distribution of sugar solution within groups of caged honey bees (Apis mellifera) under standard in vitro laboratory conditions using 14C polyethylene glycol as a radioactive marker to analyze ingestion by individual bees after group feeding. We studied the impact of different experimental setups by varying the number of bees, age of bees, origin of bees, duration of experiment, the amount of available diet, and the influence of the neurotoxic pesticide imidacloprid in the diet on the feeding and food sharing behavior (trophallaxis). Sugar solution was non -uniformly distributed in bees in 36 out of 135 cages. As a measure of the extent to which the sugar diet was equally distributed between caged bees, we calculated the (inner 80%) intake ratio by dividing the intake of the 90th percentile bee by the intake of the 10th percentile bee. This intake ratio ranged from 1.3 to 94.8 in 133 individual cages, further supporting a non -uniform distribution of food among caged bees. We can expect a cage with 10 or 30 bees containing one bee that ingests, on average, the 8.8 -fold of the bee in the same cage ingesting the smallest quantity of food. Inner 80% intake ratios were lower in experiments with a permanent or chronic offering of labelled sugar solution compared to temporary or acute feedings. After pooling the data of replicates to achieve a higher statistical power we compared different experimental setups. We found that uniform food distribution is best approached with 10 newly emerged bees per cage, which originate from a brood comb from a single colony. We also investigated the trophallaxis between caged honey bees which originally consumed the diet and newly added bees. Color marked bees were starved and added to the cages in a ratio of 10:5 or 20:20 after the initial set of bees consumed all the labelled sugar solution. The distribution of the labelled sugar solution by trophallaxis within 48 hours to added bees was 25% (10:5) or 45% (20:20) of the initial sugar solution. Imidacloprid at its median lethal dose (LD50) in the sugar solution reduced this post -feeding food transmission to 27% (20:20). Our results show that differences in food intake exist within caged bees that may lead to differential exposure that can influence the interpretation of toxicity tests.	[Brodschneider, Robert; Libor, Anika; Kupelwieser, Vera; Crailsheim, Karl] Graz Univ, Inst Zool, Graz, Austria	University of Graz	Brodschneider, R (corresponding author), Graz Univ, Inst Zool, Graz, Austria.	robert.brodschneider@uni-graz.at		Brodschneider, Robert/0000-0002-2535-0280	Austrian Federal Ministry of Agriculture, Forestry, Environment and Water Management [100972]	Austrian Federal Ministry of Agriculture, Forestry, Environment and Water Management	Open access publication fee was provided by the project "Zukunft Biene" (grant number: 100972) funded by the Austrian Federal Ministry of Agriculture, Forestry, Environment and Water Management.	Abbott A., 1978, PRODUCTION ECOLOGY A, P233; [Anonymous], 2002, ANGEW STAT ANWENDUNG; [Anonymous], 2011, 230 CEB; Bevk D, 2012, APIDOLOGIE, V43, P465, DOI 10.1007/s13592-011-0113-x; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Crailsheim K, 1998, APIDOLOGIE, V29, P97, DOI 10.1051/apido:19980106; CRAILSHEIM K, 1991, J COMP PHYSIOL B, V161, P55, DOI 10.1007/BF00258746; CRAILSHEIM K, 1988, J INSECT PHYSIOL, V34, P85, DOI 10.1016/0022-1910(88)90158-8; CRAILSHEIM K, 1990, ZOOL JAHRB ALLG ZOOL, V94, P303; CRAILSHEIM K, 1985, J INSECT PHYSIOL, V31, P707, DOI 10.1016/0022-1910(85)90051-4; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; Desmedt L, 2016, SCI REP-UK, V6, DOI 10.1038/srep31809; Doublet V, 2015, ENVIRON MICROBIOL, V17, P969, DOI 10.1111/1462-2920.12426; Evans JD, 2009, J APICULT RES, V48, P300, DOI 10.3896/IBRA.1.48.4.13; Fairbrother A, 2014, ENVIRON TOXICOL CHEM, V33, P719, DOI 10.1002/etc.2527; FARINA WM, 1991, ANIM BEHAV, V42, P389, DOI 10.1016/S0003-3472(05)80037-5; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Free J. B., 1957, British Journal of Animal Behaviour, V5, P41, DOI 10.1016/S0950-5601(57)80023-9; FURGALA B., 1961, BEE WORLD, V42, P249; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Hurst V, 2014, J COMP PHYSIOL A, V200, P881, DOI 10.1007/s00359-014-0932-0; Kessler SC, 2015, NATURE, V521, P74, DOI 10.1038/nature14414; KORST PJAM, 1982, INSECT SOC, V29, P209, DOI 10.1007/BF02228753; Laurino D, 2013, B INSECTOL, V66, P119; Medrzycki P, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.14; Meixner MD, 2004, INSECT SOC, V51, P43, DOI 10.1007/s00040-003-0701-5; MORITZ RFA, 1986, INSECT SOC, V33, P26, DOI 10.1007/BF02224032; MORITZ RFA, 1990, ANIM BEHAV, V40, P641, DOI 10.1016/S0003-3472(05)80693-1; MORITZ RFA, 1992, INSECT SOC, V39, P365, DOI 10.1007/BF01240621; Nauen R, 2001, PEST MANAG SCI, V57, P577, DOI 10.1002/ps.331; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; NIXON HL, 1952, PROC R SOC SER B-BIO, V140, P43, DOI 10.1098/rspb.1952.0042; OECD, 1998, 213 OECD; OEPP/EPPO, 2010, B OEPP EPPO B, V40, P323; PERSHAD SHOBHA, 1967, ANN ABEILLE [PARIS], V10, P139, DOI 10.1051/apido:19670301; Potts SG, 2010, J APICULT RES, V49, P15, DOI 10.3896/IBRA.1.49.1.02; RINDERER TE, 1976, J ECON ENTOMOL, V69, P489, DOI 10.1093/jee/69.4.489; Rondeau G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05566; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Simon-Delso N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103073; Sponsler DB, 2016, ENV TOXICOL CHEM; Suchail S, 2000, ENVIRON TOXICOL CHEM, V19, P1901, DOI [10.1897/1551-5028(2000)019&lt;1901:COITIT&gt;2.3.CO;2, 10.1002/etc.5620190726]; Suchail S, 2004, PEST MANAG SCI, V60, P291, DOI 10.1002/ps.772; Sudd JH, 1967, INTRO BEHAV ANTS; Williams G. R., 2013, J APICULT RES, VI, P1, DOI DOI 10.3896/IBRA.1.52.1.04	49	14	14	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174684	10.1371/journal.pone.0174684	http://dx.doi.org/10.1371/journal.pone.0174684			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355267	gold, Green Published			2022-12-26	WOS:000399174600080
J	Zhao, M; Huang, X; Cheng, X; Lin, X; Zhao, T; Wu, LY; Yu, XD; Wu, KW; Fan, M; Zhu, LL				Zhao, Ming; Huang, Xin; Cheng, Xiang; Lin, Xiao; Zhao, Tong; Wu, Liying; Yu, Xiaodan; Wu, Kuiwu; Fan, Ming; Zhu, Lingling			Ketogenic diet improves the spatial memory impairment caused by exposure to hypobaric hypoxia through increased acetylation of histones in rats	PLOS ONE			English	Article							BETA-HYDROXYBUTYRATE; BRAIN; NEUROPROTECTION; INVOLVEMENT; PLASTICITY; COGNITION; ALTITUDE; NEURONS; DISEASE; MODEL	Exposure to hypobaric hypoxia causes neuron cell damage, resulting in impaired cognitive function. Effective interventions to antagonize hypobaric hypoxia-induced memory impairment are in urgent need. Ketogenic diet (KD) has been successfully used to treat drug resistant epilepsy and improves cognitive behaviors in epilepsy patients and other pathophysiological animal models. In the present study, we aimed to explore the potential beneficial effects of a KD on memory impairment caused by hypobaric hypoxia and the underlying possible mechanisms. We showed that the KD recipe used was ketogenic and increased plasma levels of ketone bodies, especially beta-hydroxybutyrate. The results of the behavior tests showed that the KD did not affect general locomotor activity but obviously promoted spatial learning. Moreover, the KD significantly improved the spatial memory impairment caused by hypobaric hypoxia (simulated altitude of 6000 m, 24 h). In addition, the improving-effect of KD was mimicked by intraperitoneal injection of BHB. The western blot and immunohistochemistry results showed that KD treatment not only increased the acetylated levels of histone H3 and histone H4 compared to that of the control group but also antagonized the decrease in the acetylated histone H3 and H4 when exposed to hypobaric hypoxia. Furthermore, KD-hypoxia treatment also promoted PKA/CREB activation and BDNF protein expression compared to the effects of hypoxia alone. These results demonstrated that KD is a promising strategy to improve spatial memory impairment caused by hypobaric hypoxia, in which increased modification of histone acetylation plays an important role.	[Zhao, Ming; Huang, Xin; Cheng, Xiang; Lin, Xiao; Zhao, Tong; Wu, Liying; Yu, Xiaodan; Wu, Kuiwu; Fan, Ming; Zhu, Lingling] Beijing Inst Basic Med Sci, Dept Cognit Sci, Beijing, Peoples R China; [Fan, Ming; Zhu, Lingling] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, JS, Peoples R China; [Fan, Ming] Beijing Inst Brain Disorders, 10 Xitoutiao, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Nantong University	Fan, M; Zhu, LL (corresponding author), Beijing Inst Basic Med Sci, Dept Cognit Sci, Beijing, Peoples R China.; Fan, M; Zhu, LL (corresponding author), Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong, JS, Peoples R China.; Fan, M (corresponding author), Beijing Inst Brain Disorders, 10 Xitoutiao, Beijing, Peoples R China.	fanmingchina@126.com; linglingzhu@hotmail.com		Wu, Li-Ying/0000-0001-5277-2078; Zhu, Lingling/0000-0002-6474-5875	National Natural Science Foundation of China [81430044, 31271205, 31271211]; Beijing municipal Science and Technology Commission [Z161100000216134]; National Basic Research Program of China [2012CB518200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China, Grant#81430044, 31271205, 31271211 (http://www.nsfc.gov.cn/); the Beijing municipal Science and Technology Commission, Grant #Z161100000216134 (http://www.bjkw.gov.cn/n8785584/index.html) and the National Basic Research Program of China, Grant # 2012CB518200 (http://program.most.gov.cn/.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davidson TL, 2013, NEUROSCIENCE, V253, P110, DOI 10.1016/j.neuroscience.2013.08.044; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hallbook T, 2012, EPILEPSY RES, V100, P304, DOI 10.1016/j.eplepsyres.2011.04.017; Hawk JD, 2011, LEARN MEMORY, V18, P367, DOI 10.1101/lm.2097411; Izumi Y, 1998, J CLIN INVEST, V101, P1121, DOI 10.1172/JCI1009; Jiang Y, 2016, BRAIN RES, V1646, P451, DOI 10.1016/j.brainres.2016.06.029; Kashiwaya Y, 2013, NEUROBIOL AGING, V34, P1530, DOI 10.1016/j.neurobiolaging.2012.11.023; Kauser H, 2016, BRAIN RES, V1636, P152, DOI 10.1016/j.brainres.2016.01.053; Krasnova IN, 2013, NEUROBIOL DIS, V58, P132, DOI 10.1016/j.nbd.2013.05.009; Krikorian R, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.10.006; Li P, 2012, PHYSIOL BEHAV, V106, P439, DOI 10.1016/j.physbeh.2012.03.002; Lin C, 2013, NEUROSCIENCE, V231, P216, DOI 10.1016/j.neuroscience.2012.11.051; Maiti P, 2008, BEHAV BRAIN RES, V189, P233, DOI 10.1016/j.bbr.2008.01.007; Masuda R, 2005, J NEUROSCI RES, V80, P501, DOI 10.1002/jnr.20464; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Monti B, 2013, CURR PHARM DESIGN, V19, P5065, DOI 10.2174/1381612811319280005; Muthuraju S, 2014, MALAYS J MED SCI, V21, P41; Pagani M, 1998, CORTEX, V34, P243, DOI 10.1016/S0010-9452(08)70751-2; Postulart D, 2016, EPILEPSY BEHAVIOR E, V60, P153; Puchowicz MA, 2008, J CEREBR BLOOD F MET, V28, P1907, DOI 10.1038/jcbfm.2008.79; Samoilov M, 2016, ACTA HISTOCHEM, V118, P80, DOI 10.1016/j.acthis.2015.11.008; Samoilova M, 2010, J NEUROCHEM, V113, P826, DOI 10.1111/j.1471-4159.2010.06645.x; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Shukitt-Hale B, 1998, INT J AVIAT PSYCHOL, V8, P319, DOI 10.1207/s15327108ijap0804_1; Sleiman SF, 2016, ELIFE, V5, DOI 10.7554/eLife.15092; Tabuchi A, 2002, J BIOL CHEM, V277, P35920, DOI 10.1074/jbc.M204784200; Thaler S, 2010, GRAEF ARCH CLIN EXP, V248, P1729, DOI 10.1007/s00417-010-1425-7; Tsai YP, 2014, INT J CANCER, V134, P249, DOI 10.1002/ijc.28190; Turner PV, 2011, J AM ASSOC LAB ANIM, V50, P614; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Zhang XY, 2016, NUTR RES, V36, P349, DOI 10.1016/j.nutres.2015.12.002	34	37	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174477	10.1371/journal.pone.0174477	http://dx.doi.org/10.1371/journal.pone.0174477			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355243	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174600054
J	Ha, S; Choi, HR; Lee, YH				Ha, Shin; Choi, Hui Ran; Lee, Yo Han			Clustering of four major lifestyle risk factors among Korean adults with metabolic syndrome	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; INTERVENTION SAHELI; NATIONAL-HEALTH; DIETARY FACTORS; PREVALENCE; MANAGEMENT; PATTERNS; ASSOCIATION; ADOLESCENTS; COMMUNITY	The purpose of this study was to investigate the clustering pattern of four major lifestyle risk factors-smoking, heavy drinking, poor diet, and physical inactivity-among people with metabolic syndrome in South Korea. There were 2,469 adults with metabolic syndrome aged 30 years or older available with the 5th Korean National Health and Nutrition Examination Survey dataset. We calculated the ratio of the observed to expected (O/E) prevalence for the 16 different combinations and the prevalence odds ratios (POR) of four lifestyle risk factors. The four lifestyle risk factors tended to cluster in specific multiple combinations. Smoking and heavy drinking was clustered (POR: 1.86 for male, 4.46 for female), heavy drinking and poor diet were clustered (POR: 1.38 for male, 1.74 for female), and smoking and physical inactivity were also clustered (POR: 1.48 for male). Those who were male, younger, low-educated and living alone were much more likely to have a higher number of lifestyle risk factors. Some helpful implications can be drawn from the knowledge on clustering pattern of lifestyle risk factors for more effective intervention program targeting metabolic syndrome.	[Ha, Shin] Korea Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea; [Ha, Shin] Korea Univ, Dept Serv, Med Lib, Seoul, South Korea; [Choi, Hui Ran] Seoul Natl Univ, Grad Sch Med, Div Family Med, Seoul, South Korea; [Lee, Yo Han] Konyang Univ, Coll Med, Dept Prevent Med, Daejeon, South Korea	Korea University; Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Konyang University; Konyang University Hospital	Lee, YH (corresponding author), Konyang Univ, Coll Med, Dept Prevent Med, Daejeon, South Korea.	vionic@konyang.ac.kr	Lee, Yo Han/J-1911-2019; Stefanadis, Christodoulos/ABH-2232-2020; Ha, Shin/AAX-6873-2020; Ha, Shin/D-7723-2014	Lee, Yo Han/0000-0002-9631-9969; Stefanadis, Christodoulos/0000-0001-5974-6454; Ha, Shin/0000-0002-1454-731X				Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Anderssen SA, 1996, J INTERN MED, V240, P203, DOI 10.1046/j.1365-2796.1996.22848000.x; Atkins D, 2004, AM J PREV MED, V27, P102, DOI 10.1016/j.amepre.2004.04.016; Bassi N, 2014, AM J MED, V127, DOI 10.1016/j.amjmed.2014.06.035; Chen W, 2000, DIABETES, V49, P1042, DOI 10.2337/diabetes.49.6.1042; Choo J, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070667; Chou KL, 2008, J AGING HEALTH, V20, P788, DOI 10.1177/0898264308321082; Chung W, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3776-4; Fappa E, 2008, NUTRITION, V24, P286, DOI 10.1016/j.nut.2007.11.008; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Goldstein MG, 2004, AM J PREV MED, V27, P61, DOI 10.1016/j.amepre.2004.04.023; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Jahangiry L, 2014, J RES HEALTH SCI, V14, P303; Kandula NR, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2401-2; Kandula NR, 2013, CONTEMP CLIN TRIALS, V36, P479, DOI 10.1016/j.cct.2013.09.007; Kang Kiwon, 2010, J Prev Med Public Health, V43, P73, DOI 10.3961/jpmph.2010.43.1.73; Kim Y, 2014, EPIDEMIOLOGY HLTH, V36; Kim Y, 2013, PUBLIC HEALTH NUTR, V16, P440, DOI 10.1017/S1368980012002996; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Lee Y, 2012, GERIATR GERONTOL INT, V12, P515, DOI 10.1111/j.1447-0594.2011.00788.x; MacCallum RC, 2002, PSYCHOL METHODS, V7, P19, DOI 10.1037//1082-989X.7.1.19; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; Melka MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082368; Milligan R A, 1995, J Cardiovasc Risk, V2, P515, DOI 10.1097/00043798-199512000-00006; Mirowsky J, 2015, J HEALTH SOC BEHAV, V56, P297, DOI 10.1177/0022146515594814; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Nazzaro P, 2013, EUR J INTERN MED, V24, P183, DOI 10.1016/j.ejim.2012.08.017; Nigg CR, 2002, HEALTH EDUC RES, V17, P670, DOI 10.1093/her/17.5.670; Poortinga W, 2007, PREV MED, V44, P124, DOI 10.1016/j.ypmed.2006.10.006; Schuit AJ, 2002, PREV MED, V35, P219, DOI 10.1006/pmed.2002.1064; SINGH RB, 1993, AM J CARDIOL, V71, P1283, DOI 10.1016/0002-9149(93)90541-J; Song S, 2014, NUTR RES, V34, P383, DOI 10.1016/j.nutres.2014.03.004; Tamhane AR, 2016, STAT MED, V35, P5730, DOI 10.1002/sim.7059; Hong TK, 2012, PREV MED, V55, P409, DOI 10.1016/j.ypmed.2012.09.002; Tsai CH, 2011, ENDOCRINE, V40, P256, DOI 10.1007/s12020-011-9466-1; Watkins LL, 2003, ARCH INTERN MED, V163, P1889, DOI 10.1001/archinte.163.16.1889; Yu Y, 2015, NUTR RES PRACT, V9, P199, DOI 10.4162/nrp.2015.9.2.199	38	26	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174567	10.1371/journal.pone.0174567	http://dx.doi.org/10.1371/journal.pone.0174567			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VE	28350828	Green Submitted, gold, Green Published			2022-12-26	WOS:000399174400057
J	Molla, AA; Gelagay, AA				Molla, Abiyot Abeje; Gelagay, Abebaw Addis			Risky sexual practice and associated factors among HIV positive adults attending anti-retroviral treatment clinic at Gondar University Referral Hospital, Northwest Ethiopia	PLOS ONE			English	Article							THERAPY; BEHAVIORS	Introduction Risky sexual practice among people living with HIV/AIDS is a public health concern because of the risk of transmission of the virus to sero-discordant partner/s. There is also the risk of re-infection with new, drug resistant viral strains between sero-concordant partners. However, there is lack of information on risky sexual practices among HIV positive adults. Therefore, this study aimed to assess risky sexual practice and associated factors among adult HIV positive clients at Gondar University Referral Hospital, Northwest Ethiopia, 2015. Methods An institution based cross sectional study was conducted at Gondar University Referral Hospital from May to June 2015. A pretested structured questionnaire was used to collect the data. Using systematic random sampling technique, a total of 513 respondents were participated in this study. The data were entered into EPI info version 3.5.3 and transferred to SPSS version 20 for analysis. Descriptive, bivariate and multivariate analyses were done. A P-value <0.05 was considered to determine the statistical significance of the association between factors (independent variables) and risky sexual practice. The Odds ratio was also used to determine the presence and the degree of association between the dependent and independent variables. Results A total of 513 respondents were participated in this study. The prevalence of risky sexual practices in the past three months was 38% (95% CI: 33.3%, 42.3%). Being in the age range of 18-29 years (AOR = 2.63, 95% CI: 1.55, 4.47) and 30-39 years (AOR = 2.29, 95% CI: 1.48, 3.53), being single (AOR = 6.32, 95%CI: 2.43, 16.44),being married (AOR = 6.06,95% CI: 2.81, 13.07), having no child (AOR = 2.58, 95% CI: 1.17, 5.72), and a CD4 count of greater than 500/mm(3) were factors significantly associated with risky sexual practices. Conclusions A considerable number of HIV positive clients had risky sexual practices. It is strongly recommended that the Regional Health Bureau and health service providers working at Gondar University Hospital especially in the ART Clinic need to work hard on behavioral change communication.	[Molla, Abiyot Abeje] Univ Gondar Hosp, Gondar, Ethiopia; [Gelagay, Abebaw Addis] Univ Gondar, Dept Reprod Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar	Gelagay, AA (corresponding author), Univ Gondar, Dept Reprod Hlth, Coll Med & Hlth Sci, Gondar, Ethiopia.	abebaw.addis@gmail.com						Allen C, 2011, CULT HEALTH SEX, V13, P529, DOI 10.1080/13691058.2011.558593; Bajunirwe F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-430; Demissie K, 2015, HIV AIDS-RES PALLIAT, V7, P183, DOI 10.2147/HIV.S78300; Dessie Y, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-422; Engedashet E, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-56; Federal Democratic Republic of Ethiopia, 2014, COUNTR PROGR REP HIV; Fu TC, 2012, AIDS, V26, P2383, DOI 10.1097/QAD.0b013e32835ad438; Gerbi GB, 2009, J SUBST USE, V14, P90, DOI 10.1080/14659890802624261; Ikechebelu JI, 2009, NIGER J CLIN PRACT, V12, P416; Madiba S., 2014, WORLD J AIDS, V2014, P43584, DOI [10.4236/wja.2014.41008, DOI 10.4236/WJA.2014.41008]; Mhalu A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17342; Musinguzi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085646; Ncube N M, 2012, Ghana Med J, V46, P27; Ragnarsson A, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-20; Thanh DC, 2009, AIDS BEHAV, V13, P1151, DOI 10.1007/s10461-008-9451-8; UNAI DS, 2014, FACT SHEET GLOBAL ST; UNAI DS, 2015, AIDS NUMB WORLD AIDS; Yalew E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-308; Yaya I, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-636	19	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174267	10.1371/journal.pone.0174267	http://dx.doi.org/10.1371/journal.pone.0174267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350810	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174400021
J	Somogyi, B; Palffy, K; Balogh, KV; Botta-Dukat, Z; Voros, L				Somogyi, Boglarka; Palffy, Karoly; Balogh, Katalin V.; Botta-Dukat, Zoltan; Voros, Lajos			Unusual behaviour of phototrophic picoplankton in turbid waters	PLOS ONE			English	Article							AUTOTROPHIC PICOPLANKTON; SHALLOW LAKES; PHYTOPLANKTON SIZE; SUSPENDED CLAY; LIGHT QUALITY; BOTTOM-UP; TOP-DOWN; PICOPHYTOPLANKTON; MARINE; ECOSYSTEMS	Autotrophic picoplankton (APP) abundance and contribution to phytoplankton biomass was studied in Hungarian shallow lakes to test the effect of inorganic turbidity determining the size distribution of the phytoplankton. The studied lakes displayed wide turbidity (TSS: 4-2250 mg l(-1)) and phytoplankton biomass (chlorophyll a: 1-460 mu g l(-1)) range, as well as APP abundance (0 and 100 million cells ml(-1)) and contribution (0-100%) to total phytoplankton biomass. Inorganic turbidity had a significant effect on the abundance and contribution of APP, resulting in higher values compared to other freshwater lakes with the same phytoplankton biomass. Our analysis has provided empirical evidence for a switching point (50 mg l(-1) inorganic turbidity), above which turbidity is the key factor causing APP predominance regardless of phytoplankton biomass in shallow turbid lakes. Our results have shown that turbid shallow lakes are unique waters, where the formerly and widely accepted model (decreasing APP contribution with increasing phytoplankton biomass) is not applicable. We hypothesize that this unusual behaviour of APP in turbid waters is a result of either diminished underwater light intensity or a reduced grazing pressure due to high inorganic turbidity.	[Somogyi, Boglarka; Palffy, Karoly; Balogh, Katalin V.; Voros, Lajos] MTA Ctr Ecol Res, Balaton Limnol Inst, Dept Hydrobot, Tihany, Hungary; [Botta-Dukat, Zoltan] MTA Ctr Ecol Res, Inst Ecol & Bot, Dept Terr Ecol, Vacratot, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Hungarian Balaton Limnological Research Institute; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research	Somogyi, B (corresponding author), MTA Ctr Ecol Res, Balaton Limnol Inst, Dept Hydrobot, Tihany, Hungary.	somogyi.boglarka@okologia.mta.hu	Botta-Dukat, Zoltan/B-2911-2015	Botta-Dukat, Zoltan/0000-0002-9544-3474; Palffy, Karoly/0000-0003-2015-7972; Somogyi, Boglarka/0000-0003-0900-3315	European Social Fund [TAMOP-4.2.2.A-11/1/KONV-2012-0038]; Hungarian Scientific Research Fund [OTKA PD112449]; Bolyai Janos Research Grant (Hungarian Academy of Sciences)	European Social Fund(European Social Fund (ESF)); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Janos Research Grant (Hungarian Academy of Sciences)	This work was supported by the European Social Fund in the framework of TAMOP-4.2.2.A-11/1/KONV-2012-0038 and by the Hungarian Scientific Research Fund (OTKA PD112449). BS was supported by the Bolyai Janos Research Grant (Hungarian Academy of Sciences).	Agawin NSR, 2000, LIMNOL OCEANOGR, V45, P591, DOI 10.4319/lo.2000.45.3.0591; [Anonymous], 2014, R LANG ENV STAT COMP; Balogh K. V.-, 2009, HYDROBIOLOGIA, V632, P91, DOI DOI 10.1007/S10750-009-9830-9; Balogh K V, 2010, ACTA BIOL DEBR OECOL, V22, P75; Bell T, 2001, LIMNOL OCEANOGR, V46, P1243, DOI 10.4319/lo.2001.46.5.1243; Boenigk J, 2004, AQUAT MICROB ECOL, V34, P181, DOI 10.3354/ame034181; Boros E, 2013, HORTOBAGY TERMESZETV; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Callieri C, 2007, AQUAT ECOL, V41, P511, DOI 10.1007/s10452-007-9125-z; Callieri Cristiana, 2002, Journal of Limnology, V61, P1; Callieri Cristiana, 2008, Freshwater Reviews, V1, P1, DOI 10.1608/FRJ-1.1.1; Carrick HJ, 1997, LIMNOL OCEANOGR, V42, P1613, DOI 10.4319/lo.1997.42.7.1613; CHISHOLM SW, 1992, ENVIR SCI R, V43, P213; Craig SR, 1984, VERH INT VEREIN LIMN, V22, P351; Cronberg G., 1981, ALGOL STUD, V27, P101, DOI [10.1127/algol_stud/27/1981/101, DOI 10.1127/ALGOL_STUD/27/1981/101]; Crosbie ND, 2003, AQUAT MICROB ECOL, V33, P53, DOI 10.3354/ame033053; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Eaton AD, 1995, STAND METH CLIN CHEM; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; FOGG GE, 1995, AQUAT MICROB ECOL, V9, P33, DOI 10.3354/ame009033; Gervais F, 1997, J PLANKTON RES, V19, P771, DOI 10.1093/plankt/19.6.771; GLOVER HE, 1986, NATURE, V319, P142, DOI 10.1038/319142a0; Greisberger S, 2008, AQUAT ECOL, V42, P379, DOI 10.1007/s10452-007-9095-1; GROBBELAAR JU, 1985, J PLANKTON RES, V7, P653, DOI 10.1093/plankt/7.5.653; HART RC, 1988, FRESHWATER BIOL, V19, P123, DOI 10.1111/j.1365-2427.1988.tb00334.x; Hepperle D, 2001, INT REV HYDROBIOL, V86, P269, DOI 10.1002/1522-2632(200106)86:3<269::AID-IROH269>3.0.CO;2-7; Horn H, 2008, LIMNOLOGICA, V38, P302, DOI 10.1016/j.limno.2008.05.007; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; JACK JD, 1993, FRESHWATER BIOL, V29, P385, DOI 10.1111/j.1365-2427.1993.tb00773.x; JOHNSON PW, 1979, LIMNOL OCEANOGR, V24, P928, DOI 10.4319/lo.1979.24.5.0928; Kirk J.T.O, 1996, LIGHT PHOTOSYNTHESIS; KIRK KL, 1991, ECOLOGY, V72, P915, DOI 10.2307/1940593; Kuipers B, 2003, J SEA RES, V50, P1, DOI 10.1016/S1385-1101(03)00043-1; Loffler H., 1979, AQUAT BOT; MacIsaac EA, 1993, HDB METHODS AQUATIC, V30, P187; Malinsky-Rushansky N, 2002, J PLANKTON RES, V24, P1173, DOI 10.1093/plankt/24.11.1173; Miquelis A, 1998, HYDROBIOLOGIA, V386, P203, DOI 10.1023/A:1003540715749; MORRIS I, 1981, LIMNOL OCEANOGR, V26, P957, DOI 10.4319/lo.1981.26.5.0957; Moser M, 2009, J PLANKTON RES, V31, P349, DOI 10.1093/plankt/fbn123; Motwani NH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079230; Palffy K, 2014, EXTREMOPHILES, V18, P111, DOI 10.1007/s00792-013-0602-0; Pfandl K, 2006, AQUAT MICROB ECOL, V45, P89, DOI 10.3354/ame045089; PLATT T, 1983, NATURE, V301, P702, DOI 10.1038/301702a0; PUTT M, 1985, J PLANKTON RES, V7, P779, DOI 10.1093/plankt/7.6.779; Raven JA, 2005, VIE MILIEU, V55, P209; Raven JA, 1998, FUNCT ECOL, V12, P503, DOI 10.1046/j.1365-2435.1998.00233.x; Reynolds C. S., 1984, ECOLOGY FRESHWATER P; Schagerl M, 2003, HYDROBIOLOGIA, V506, P297, DOI 10.1023/B:HYDR.0000008562.97458.d1; Scheffer M., 1998, ECOLOGY SHALLOW LAKE; Somogyi B, 2016, J GREAT LAKES RES; Somogyi B, 2010, ANN LIMNOL-INT J LIM, V46, P9, DOI 10.1051/limn/2010001; Somogyi B, 2009, AQUAT ECOL, V43, P735, DOI 10.1007/s10452-009-9269-0; STOCKNER JG, 1991, INT REV GES HYDROBIO, V76, P483, DOI 10.1002/iroh.19910760402; STOCKNER JG, 1986, CAN J FISH AQUAT SCI, V43, P2472, DOI 10.1139/f86-307; SzelagWasielewska E, 1997, HYDROBIOLOGIA, V342, P79, DOI 10.1023/A:1017005021243; Talling JF, 1971, VERH INT VER THEOR A, V19, P214; TOTH LG, 1986, ARCH HYDROBIOL, V106, P45; Utermohl H, 1958, MITT INT VER LIMNOL, V9, P1; Voros L, 2008, ACTA ZOOL ACAD SCI H, V54, P23; VOROS L, 1991, INT REV GES HYDROBIO, V76, P617, DOI 10.1002/iroh.19910760412; WATERBURY JB, 1979, NATURE, V277, P293, DOI 10.1038/277293a0; Waterbury JB, 1986, CAN B FISH AQUAT SCI, V214, P120; WATSON S, 1988, CAN J FISH AQUAT SCI, V45, P915, DOI 10.1139/f88-112; Weisse Thomas, 1993, Advances in Microbial Ecology, V13, P327; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Zelleis A, 2008, J COMPUT GRAPH STAT, V17, P492, DOI 10.1198/106186008X319331	66	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174316	10.1371/journal.pone.0174316	http://dx.doi.org/10.1371/journal.pone.0174316			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346542	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000399174300038
J	Shin, CH; Robinson, JP; Sonnen, JA; Welker, AE; Yu, DX; VanBrocklin, MW; Holmen, SL				Shin, C. H.; Robinson, J. P.; Sonnen, J. A.; Welker, A. E.; Yu, D. X.; VanBrocklin, M. W.; Holmen, S. L.			HBEGF promotes gliomagenesis in the context of Ink4al Arf and Pten loss	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; HB-EGF; GENE-EXPRESSION; INK4A/ARF LOSS; ACTIVATION; AXL; RESISTANCE; SUBTYPES; GLIOMAS; LOOP	Heparin-binding epidermal growth factor (EGF)-like growth factor (HBEGF) is a ligand for the EGF receptor (EGFR), one of the most commonly amplified receptor tyrosine kinases (RTKs) in glioblastoma (GBM). While HBEGF has been found to be expressed in a subset of malignant gliomas, its sufficiency for glioma initiation has not been evaluated. In this study, we demonstrate that HBEGF can initiate GBM in mice in the context of Ink4a/Arf and Pten loss, and that these tumors are similar to the classical GBM subtype observed in patients. Isogenic astrocytes from these mice showed activation not only of Egfr but also the RTK Axl in response to HBEGF stimulation. Deletion of either Egfr or Axl decreased the tumorigenic properties of HBEGF-transformed cells; however, only EGFR was able to rescue the phenotype in cells lacking both RTKs indicating that Egfr is required for activation of Axl in this context. Silencing of HBEGF in vivo resulted in tumor regression and significantly increased survival, suggesting that HBEGF may be a clinically relevant target.	[Shin, C. H.; Welker, A. E.; Yu, D. X.; VanBrocklin, M. W.; Holmen, S. L.] Univ Utah, Hlth Sci Ctr, Huntsman Canc Inst, 2000 Circle Hope Dr, Salt Lake City, UT 84112 USA; [Shin, C. H.; VanBrocklin, M. W.; Holmen, S. L.] Univ Utah, Hlth Sci Ctr, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Robinson, J. P.] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Sonnen, J. A.] Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT 84112 USA; [Sonnen, J. A.] ARUP Labs, Salt Lake City, UT USA; [Yu, D. X.; VanBrocklin, M. W.; Holmen, S. L.] Univ Utah, Hlth Sci Ctr, Dept Surg, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Minnesota System; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah	Holmen, SL (corresponding author), Univ Utah, Hlth Sci Ctr, Huntsman Canc Inst, 2000 Circle Hope Dr, Salt Lake City, UT 84112 USA.	sheri.holmen@hci.utah.edu	Sonnen, Joshua/AAT-5788-2021; Sonnen, Joshua/H-3738-2016	Robinson, James/0000-0002-6585-0116; Sonnen, Joshua/0000-0001-9267-8705	HCI from the National Cancer Institute (NCI) [P30CA042014]; National Institute of Neurological Disorders and Stroke [NIH R01NS073870]; NCI [NIH F30CA203096]; NATIONAL CANCER INSTITUTE [F30CA203096, P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075155, R01NS073870] Funding Source: NIH RePORTER	HCI from the National Cancer Institute (NCI); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the members of the VanBrocklin, McMahon and Holmen labs, as well as E Holland, R DePinho and M Bosenberg for providing mouse strains, reagents and advice. We thank the Huntsman Cancer Institute (HCI) Vivarium staff for assistance. We thank Tim Parnell for his bioinformatics expertise. We acknowledge the use of the Mutation Generation and Detection Core, the DNA Synthesis Core, the DNA Sequencing Core and the Small Animal Imaging Core supported by P30CA042014 awarded to HCI from the National Cancer Institute (NCI). We also acknowledge use of the HCI Shared Resources for high-throughput genomics and bioinformatics analysis, glass wash and research histology. This work was supported by the National Institute of Neurological Disorders and Stroke (NIH R01NS073870, to SLH) and the NCI (NIH F30CA203096, to CHS).	Acquaviva J, 2011, CANCER RES, V71, P7198, DOI 10.1158/0008-5472.CAN-11-1514; Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cho JH, 2015, CELL REP, V13, P898, DOI 10.1016/j.celrep.2015.09.057; Fu SL, 1999, P NATL ACAD SCI USA, V96, P5716, DOI 10.1073/pnas.96.10.5716; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; He C, 2015, ONCOGENE, V34, P6040, DOI 10.1038/onc.2015.52; Holmen SL, 2005, CANCER RES, V65, P8250, DOI 10.1158/0008-5472.CAN-05-1173; Hu RZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063074; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kornblum HI, 1999, EUR J NEUROSCI, V11, P3236, DOI 10.1046/j.1460-9568.1999.00744.x; Li L, 2014, ONCOGENE, V33, P4253, DOI 10.1038/onc.2013.400; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu FH, 2016, CANCER CELL, V29, P669, DOI 10.1016/j.ccell.2016.03.027; Meyer AS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004155; Mishima K, 1998, ACTA NEUROPATHOL, V96, P322, DOI 10.1007/s004010050901; Ongusaha PP, 2004, CANCER RES, V64, P5283, DOI 10.1158/0008-5472.CAN-04-0925; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P1, DOI 10.1093/neuonc/nou223; Ozawa T, 2014, CANCER CELL, V26, P288, DOI 10.1016/j.ccr.2014.06.005; Puschmann TB, 2014, J NEUROCHEM, V128, P878, DOI 10.1111/jnc.12519; Ramnarain DB, 2006, CANCER RES, V66, P867, DOI 10.1158/0008-5472.CAN-05-2753; Ray KC, 2013, ONCOGENE, V33, P1; Robinson JP, 2011, ONCOGENE, V30, P1341, DOI 10.1038/onc.2010.513; Robinson JP, 2010, ONCOGENE, V29, P335, DOI 10.1038/onc.2009.333; Robinson JP, 2011, AM J CANCER RES, V1, P155; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sato S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051964; Shin Clifford H, 2015, Genes Cancer, V6, P9; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; VanBrocklin MW, 2012, NEURO-ONCOLOGY, V14, P34, DOI 10.1093/neuonc/nor184; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Yotsumoto F, 2010, INT J CANCER, V127, P2707, DOI 10.1002/ijc.25472; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	38	15	16	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 10	2017	36	32					4610	4618		10.1038/onc.2017.83	http://dx.doi.org/10.1038/onc.2017.83			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FD0RK	28368403	Green Accepted			2022-12-26	WOS:000407246200008
J	Deepak, V; Kayastha, P; McNamara, LM				Deepak, Vishwa; Kayastha, Pushpalata; McNamara, Laoise M.			Estrogen deficiency attenuates fluid flow-induced [Ca2+](i) oscillations and mechanoresponsiveness of MLO-Y4 osteocytes	FASEB JOURNAL			English	Article						E-2; mechanobiology; fluid shear stress; osteoporosis; menopause	DENTIN MATRIX PROTEIN-1; SERUM SCLEROSTIN LEVELS; STRESS IN-VITRO; BONE-CELLS; NITRIC-OXIDE; MECHANICAL STRAIN; RECEPTOR-ALPHA; POSTMENOPAUSAL WOMEN; GENE-EXPRESSION; OSTEOBLASTS	It has been proposed that estrogen regulates the mechanosensitivity of osteocytes; however, the effects of estrogen deficiency that arises during postmenopausal osteoporosis on mechanical stimulation induced calcium signaling in osteocytes remain elusive. Here, we pretreated MLO-Y4 osteocytes with 10 nM E2 for 2, 3 and 5 d, then simulated postmenopausal conditions either by estrogen withdrawal (EW) from culture medium, or by inhibiting the estrogen receptor by using fulvestrant and estrogen (FE; ICI 182,780) in vitro. We investigated [Ca2+](i) oscillations and mechanobiologic responses of osteocytes (EW and FE) that were exposed to oscillatory fluid flow (OFF; 1 Pa, 0.5 Hz). We demonstrated that estrogen treatment enhanced OFF-induced [Ca2+](i) oscillations and that this effect was abrogated both by FE and EW. Moreover, osteocytes in both estrogen-depleted groups (EW and FE) had reduced levels of NO and prostaglandin E2 release, down-regulated dentin matrix protein-1, sclerostin, osteopontin, osteocalcin, and alkaline phosphatase mRNA expression, and reduced F-actin fiber formation after OFF stimulation compared with estrogen-treated cells. We propose a link between estrogen deficiency and alterations in [Ca2+](i)-mediated mechanosensitivity of osteocytes, which ultimately alter osteocyte function and differentiation. Deepak, V., Kayastha, P., McNamara, L. M. Estrogen deficiency attenuates fluid flow induced [Ca2+](i) oscillations and mechanoresponsiveness of MLO-Y4 osteocytes.	[Deepak, Vishwa; Kayastha, Pushpalata; McNamara, Laoise M.] Natl Univ Ireland Galway, Coll Engn & Informat, Mechanobiol & Med Device Res Grp, Biomech Res Ctr,Biomed Engn, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway	McNamara, LM (corresponding author), Natl Univ Ireland Galway, Biomed Engn, Coll Engn & Informat, Galway, Ireland.	laoise.mcnamara@nuigalway.ie		Kayastha, Pushpalata/0000-0002-3452-1790	Science Foundation Ireland [RSF1352]; European Research Council [258992]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Research Council(European Research Council (ERC)European Commission)	This study was supported by grants from the Science Foundation Ireland (Grant RSF1352) and the European Research Council (Grant 258992) to L.M.M. The authors declare no conflicts of interest.	Aguirre JI, 2007, J BIOL CHEM, V282, P25501, DOI 10.1074/jbc.M702231200; Ajubi NE, 1996, BIOCHEM BIOPH RES CO, V225, P62, DOI 10.1006/bbrc.1996.1131; Ajubi NE, 1999, AM J PHYSIOL-ENDOC M, V276, pE171, DOI 10.1152/ajpendo.1999.276.1.E171; Alenghat Francis J, 2002, Sci STKE, V2002, ppe6, DOI 10.1126/stke.2002.119.pe6; Bakker AD, 2006, OSTEOPOROSIS INT, V17, P827, DOI 10.1007/s00198-006-0072-7; Bakker AD, 2005, OSTEOPOROSIS INT, V16, P983, DOI 10.1007/s00198-004-1785-0; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Balla B, 2008, CALCIFIED TISSUE INT, V82, P12, DOI 10.1007/s00223-007-9092-3; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Birmingham E, 2012, EUR CELLS MATER, V23, P13, DOI 10.22203/eCM.v023a02; Boudaoud A, 2014, NAT PROTOC, V9, P457, DOI 10.1038/nprot.2014.024; Brennan MA, 2014, HORM METAB RES, V46, P537, DOI 10.1055/s-0033-1363265; Cappariello A, 2014, ARCH BIOCHEM BIOPHYS, V558, P70, DOI 10.1016/j.abb.2014.06.017; Chen NX, 2000, AM J PHYSIOL-CELL PH, V278, pC989, DOI 10.1152/ajpcell.2000.278.5.C989; Chen NX, 2003, BONE, V33, P399, DOI 10.1016/S8756-3282(03)00159-5; Cheng BX, 2001, ENDOCRINOLOGY, V142, P3464, DOI 10.1210/en.142.8.3464; Cheng BX, 2001, J BONE MINER RES, V16, P249, DOI 10.1359/jbmr.2001.16.2.249; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Compston J., 2010, ATLAS POSTMENOPAUSAL, P33; Damien E, 2000, J BONE MINER RES, V15, P2169, DOI 10.1359/jbmr.2000.15.11.2169; Donahue SW, 2001, AM J PHYSIOL-CELL PH, V281, pC1635, DOI 10.1152/ajpcell.2001.281.5.C1635; Drake MT, 2017, BONE, V96, P8, DOI 10.1016/j.bone.2016.12.004; Etherington J, 1996, J BONE MINER RES, V11, P1333; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603; Galea Gabriel L, 2013, Bonekey Rep, V2, P413, DOI 10.1038/bonekey.2013.147; Gluhak-Heinrich J, 2003, J BONE MINER RES, V18, P807, DOI 10.1359/jbmr.2003.18.5.807; Haisenleder DJ, 2011, ENDOCRINOLOGY, V152, P4443, DOI 10.1210/en.2011-1501; Han YF, 2004, P NATL ACAD SCI USA, V101, P16689, DOI 10.1073/pnas.0407429101; Haugh MG, 2015, J MECH BEHAV BIOMED, V42, P67, DOI 10.1016/j.jmbbm.2014.11.001; Heino TJ, 2008, J ENDOCRINOL, V197, pR1, DOI 10.1677/JOE-07-0629; Iqbal J, 2005, BIOCHEM BIOPH RES CO, V328, P751, DOI 10.1016/j.bbrc.2004.12.087; Jastrzebski S, 2013, J BONE MINER RES, V28, P618, DOI 10.1002/jbmr.1773; Jessop HL, 2001, J BONE MINER RES, V16, P1045, DOI 10.1359/jbmr.2001.16.6.1045; Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013; KleinNulend J, 1995, BIOCHEM BIOPH RES CO, V217, P640, DOI 10.1006/bbrc.1995.2822; KLEINNULEND J, 1995, FASEB J, V9, P441, DOI 10.1096/fasebj.9.5.7896017; Krassas G. E., 2001, Journal of Musculoskeletal & Neuronal Interactions, V2, P143; Lara-Castillo N, 2015, BONE, V76, P58, DOI 10.1016/j.bone.2015.03.019; Lee K, 2003, NATURE, V424, P389, DOI 10.1038/424389a; Lee KCL, 2004, J ENDOCRINOL, V182, P193, DOI 10.1677/joe.0.1820193; Lee Kristen L, 2015, Cilia, V4, P7, DOI 10.1186/s13630-015-0016-y; Lu XL, 2012, BONE, V51, P466, DOI 10.1016/j.bone.2012.05.021; Lu XL, 2012, J BONE MINER RES, V27, P563, DOI 10.1002/jbmr.1474; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Mann V, 2007, BONE, V40, P674, DOI 10.1016/j.bone.2006.10.014; Marino M, 1998, BIOCHEM BIOPH RES CO, V245, P254, DOI 10.1006/bbrc.1998.8413; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; McGarry JG, 2005, BIOCHEM BIOPH RES CO, V330, P341, DOI 10.1016/j.bbrc.2005.02.175; McNamara LM, 2010, J R SOC INTERFACE, V7, P353, DOI 10.1098/rsif.2009.0282; McNamara LM, 2009, ANAT REC, V292, P355, DOI 10.1002/ar.20869; Mirza FS, 2010, J CLIN ENDOCR METAB, V95, P1991, DOI 10.1210/jc.2009-2283; Miyauchi A, 2006, J BONE MINER METAB, V24, P498, DOI 10.1007/s00774-006-0716-x; Modder UI, 2011, J BONE MINER RES, V26, P373, DOI 10.1002/jbmr.217; Osborne CK, 2004, BRIT J CANCER, V90, pS2, DOI 10.1038/sj.bjc.6601629; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Randell KM, 2002, J BONE MINER RES, V17, P528, DOI 10.1359/jbmr.2002.17.3.528; Ren J, 2012, CALCIFIED TISSUE INT, V90, P411, DOI 10.1007/s00223-012-9581-x; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Rosser J, 2012, METHODS MOL BIOL, V816, P67, DOI 10.1007/978-1-61779-415-5_6; RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012; Saxon LK, 2012, ENDOCRINOLOGY, V153, P2254, DOI 10.1210/en.2011-1977; Schaffler MB, 2012, CURR OSTEOPOROS REP, V10, P118, DOI 10.1007/s11914-012-0105-4; Shang ZZ, 2014, INT J ORAL SCI, V6, P142, DOI 10.1038/ijos.2014.2; Simon AM, 2002, J BONE MINER RES, V17, P963, DOI 10.1359/jbmr.2002.17.6.963; Sterck JGH, 1998, AM J PHYSIOL-ENDOC M, V274, pE1113, DOI 10.1152/ajpendo.1998.274.6.E1113; Szatkowski C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-156; Tan SD, 2008, BIOCHEM BIOPH RES CO, V369, P1150, DOI 10.1016/j.bbrc.2008.03.007; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; Turner CH, 1996, AM J PHYSIOL-ENDOC M, V270, pE634, DOI 10.1152/ajpendo.1996.270.4.E634; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Verbruggen SW, 2015, BIOPHYS J, V108, P1587, DOI 10.1016/j.bpj.2015.02.031; Verbruggen SW, 2014, BIOMECH MODEL MECHAN, V13, P85, DOI 10.1007/s10237-013-0487-y; Verbruggen SW, 2012, J R SOC INTERFACE, V9, P2735, DOI 10.1098/rsif.2012.0286; WAKELING AE, 1987, J ENDOCRINOL, V112, pR7, DOI 10.1677/joe.0.112R007; Wang YL, 2007, P NATL ACAD SCI USA, V104, P15941, DOI 10.1073/pnas.0707246104; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Zaman G, 2006, J BONE MINER RES, V21, P1297, DOI 10.1359/JBMR.060504	81	30	31	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3027	3039		10.1096/fj.201601280R	http://dx.doi.org/10.1096/fj.201601280R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28363954				2022-12-26	WOS:000405931000027
J	Sato, Y; Tsuyama, T; Sato, C; Karim, MF; Yoshizawa, T; Inoue, M; Yamagata, K				Sato, Yoshifumi; Tsuyama, Tomonori; Sato, Chinami; Karim, Md. Fazlul; Yoshizawa, Tatsuya; Inoue, Masahiro; Yamagata, Kazuya			Hypoxia reduces HNF4 alpha/MODY1 protein expression in pancreatic beta-cells by activating AMP-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); -cell (B-cell); hepatocyte nuclear factor 4 (HNF-4); hypoxia; transcription factor	HEPATOCYTE NUCLEAR FACTOR-4-ALPHA; INSULIN-SECRETION; OXYGEN-CONSUMPTION; ALPHA-GENE; TARGET; YOUNG; DEGRADATION; DYSFUNCTION; METABOLISM; MUTATIONS	Hypoxia plays a role in the deterioration of beta-cell function. Hepatocyte nuclear factor 4 (HNF4 alpha) has an important role in pancreatic beta-cells, and mutations of the human HNF4A gene cause a type of maturity-onset diabetes of the young (MODY1). However, it remains unclear whether hypoxia affects the expression of HNF4 alpha in beta-cells. Here, we report that hypoxia reduces HNF4 alpha protein expression in beta-cells. Hypoxia-inducible factor was not involved in the down-regulation of HNF4 alpha under hypoxic conditions. The down-regulation of HNF4 alpha was dependent on the activation of AMP-activated protein kinase (AMPK), and the reduction of HNF4 alpha protein expression by metformin, an AMPK activator, and hypoxia was inhibited by the overexpression of a kinase-dead (KD) form of AMPK alpha 2. In addition, hypoxia decreased the stability of the HNF4 alpha protein, and the down-regulation of HNF4 alpha was sensitive to proteasome inhibitors. Adenovirus-mediated overexpression of KD-AMPK alpha 2 improved insulin secretion in metformin-treated islets, hypoxic islets, and ob/ob mouse islets. These results suggest that down-regulation of HNF4 alpha could be of importance in beta-cell dysfunction by hypoxia.	[Sato, Yoshifumi; Tsuyama, Tomonori; Sato, Chinami; Karim, Md. Fazlul; Yoshizawa, Tatsuya; Yamagata, Kazuya] Kumamoto Univ, Dept Med Biochem, Fac Life Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan; [Inoue, Masahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Higashinari Ku, 1-3-3 Nakamichi, Tokyo 5378511, Japan	Kumamoto University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Yamagata, K (corresponding author), Kumamoto Univ, Dept Med Biochem, Fac Life Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	k-yamaga@kumamoto-u.ac.jp	Sato, Yoshifumi/GYQ-7230-2022	Yoshizawa, Tatsuya/0000-0002-5728-1996; Sato, Yoshifumi/0000-0003-0697-1476	Uehara Memorial Foundation; Japan Diabetes Foundation; Naito Foundation	Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Diabetes Foundation; Naito Foundation(Naito Memorial Foundation)	This work was supported by a Grant-in-Aid for Young Scientists (B) (to Y. S.), a islets (Fig. 1D). Hypoxia reduces the expression of Hnf3b/Foxa2 Grant-in-Aid for Scientific Research (B) (to K. Y.), a grant from the Uehara Memorial Foundation (to K. Y.), a grant from the Japan Diabetes Foundation (to K. Y.), and a grant from the Naito Foundation (to K. Y.).	Baskin KK, 2011, CIRC RES, V109, P1153, DOI 10.1161/CIRCRESAHA.111.252742; Bensellam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029807; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Cantley J, 2009, J CLIN INVEST, V119, P125, DOI 10.1172/JCI26934; Comellas AP, 2006, CIRC RES, V98, P1314, DOI 10.1161/01.RES.0000222418.99976.1d; da Silva Xavier Gabriela, 2003, Biochem J, V371, P761, DOI 10.1042/BJ20021812; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Gilbert M, 2008, J BIOL CHEM, V283, P24334, DOI 10.1074/jbc.M802097200; Gupta RK, 2005, J CLIN INVEST, V115, P1006, DOI 10.1172/JCI22365; Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Ihara A, 2005, BIOCHEM BIOPH RES CO, V329, P984, DOI 10.1016/j.bbrc.2005.02.072; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Leclerc I, 2001, DIABETES, V50, P1515, DOI 10.2337/diabetes.50.7.1515; Lim A, 2009, DIABETES, V58, P2813, DOI 10.2337/db09-0600; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Nammo T, 2008, GENE EXPR PATTERNS, V8, P96, DOI 10.1016/j.modgep.2007.09.006; Rousseau A, 2016, NATURE, V536, P184, DOI 10.1038/nature18943; Sato Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114868; Sato Y, 2012, J BIOL CHEM, V287, P23236, DOI 10.1074/jbc.M112.368779; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Stoner M, 2002, MOL ENDOCRINOL, V16, P2231, DOI 10.1210/me.2001-0347; Tsuboi T, 2003, J BIOL CHEM, V278, P52042, DOI 10.1074/jbc.M307800200; Viollet B, 1997, MOL CELL BIOL, V17, P4208, DOI 10.1128/MCB.17.8.4208; Wang W, 2002, MOL CELL BIOL, V22, P3425, DOI 10.1128/MCB.22.10.3425-3436.2002; Wang WJ, 2005, J ENDOCRINOL, V185, P445, DOI 10.1677/joe.1.06092; Wei JW, 2015, CELL, V161, P1576, DOI 10.1016/j.cell.2015.05.029; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Yamagata K, 2014, VITAM HORM, V95, P407, DOI 10.1016/B978-0-12-800174-5.00016-8; Yang Q, 2000, DIABETOLOGIA, V43, P520, DOI 10.1007/s001250051338; Yoshizawa T, 2014, CELL METAB, V19, P712, DOI 10.1016/j.cmet.2014.03.006; Zehetner J, 2008, GENE DEV, V22, P3135, DOI 10.1101/gad.496908; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6; Zheng X, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.66	42	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8716	8728		10.1074/jbc.M116.767574	http://dx.doi.org/10.1074/jbc.M116.767574			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28364040	Green Published, hybrid			2022-12-26	WOS:000402153900018
J	Palivec, V; Viola, CM; Kozak, M; Ganderton, TR; Krizkova, K; Turkenburg, JP; Haluskova, P; Zakova, L; Jiracek, J; Jungwirth, P; Brzozowski, AM				Palivec, Vladimir; Viola, Cristina M.; Kozak, Mateusz; Ganderton, Timothy R.; Krizkova, Kvetoslava; Turkenburg, Johan P.; Haluskova, Petra; Zakova, Lenka; Jiracek, Jiri; Jungwirth, Pavel; Brzozowski, Andrzej M.			Computational and structural evidence for neurotransmitter-mediated modulation of the oligomeric states of human insulin in storage granules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; MECHANICAL CALCULATIONS; ALLOSTERIC TRANSITION; LIGAND INTERACTIONS; ALZHEIMERS-DISEASE; PANCREATIC-ISLETS; BINDING-SITE; HEXAMER; ZINC	Human insulin is a pivotal protein hormone controlling metabolism, growth, and aging and whose malfunctioning underlies diabetes, some cancers, and neurodegeneration. Despite its central position in human physiology, the in vivo oligomeric state and conformation of insulin in its storage granules in the pancreas are not known. In contrast, many in vitro structures of hexamers of this hormone are available and fall into three conformational states: T-6, T3R3f, and R-6. As there is strong evidence for accumulation of neurotransmitters, such as serotonin and dopamine, in insulin storage granules in pancreatic beta-cells, we probed by molecular dynamics (MD) and protein crystallography (PC) if these endogenous ligands affect and stabilize insulin oligomers. Parallel studies independently converged on the observation that serotonin binds well within the insulin hexamer (site I), stabilizing it in the T3R3 conformation. Both methods indicated serotonin binding on the hexamer surface (site III) as well. MD, but not PC, indicated that dopamine was also a good site III ligand. Some of the PC studies also included arginine, which may be abundant in insulin granules upon processing of pro-insulin, and stable T3R3 hexamers loaded with both serotonin and arginine were obtained. The MD and PC results were supported further by in solution spectroscopic studies with R-state-specific chromophore. Our results indicate that the T3R3 oligomer is a plausible insulin pancreatic storage form, resulting from its complex interplay with neurotransmitters, and pro-insulin processing products. These findings may have implications for clinical insulin formulations.	[Viola, Cristina M.; Kozak, Mateusz; Ganderton, Timothy R.; Turkenburg, Johan P.; Brzozowski, Andrzej M.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Palivec, Vladimir; Krizkova, Kvetoslava; Haluskova, Petra; Zakova, Lenka; Jiracek, Jiri; Jungwirth, Pavel] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, Flemingovo Nam 2, CR-16610 Prague 6, Czech Republic; [Kozak, Mateusz] Univ Geneva, Dept Biochem, Quai Ernest Ansermet 30, CH-1205 Geneva, Switzerland	University of York - UK; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of Geneva	Brzozowski, AM (corresponding author), Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England.; Jiracek, J; Jungwirth, P (corresponding author), Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, Flemingovo Nam 2, CR-16610 Prague 6, Czech Republic.	jiracek@uochb.cas.cz; pavel.jungwirth@uochb.cas.cz; marek.brzozowski@york.ac.uk	Jungwirth, Pavel/D-9290-2011; Jiracek, Jiri/Y-6703-2019; Jiracek, Jiri/A-7124-2008; Mlčochová, Květoslava/L-6979-2017; Zakova, Lenka/Y-6234-2019; Zakova, Lenka/A-7119-2008	Jungwirth, Pavel/0000-0002-6892-3288; Jiracek, Jiri/0000-0003-3848-2773; Jiracek, Jiri/0000-0003-3848-2773; Mlčochová, Květoslava/0000-0002-6226-8067; Zakova, Lenka/0000-0001-6439-2574; Turkenburg, Johan/0000-0001-6992-6838; Kozak, Mateusz/0000-0002-1354-693X; Ganderton, Timothy Richard/0000-0002-3949-4795	Research Project of the Czech Academy of Sciences [RVO:61388963]; Medical Research Council Grant [MR/K000179/1]; Czech Science Foundation [16-01074S]; Medical Research Council [MR/K000179/1] Funding Source: researchfish; MRC [MR/K000179/1] Funding Source: UKRI	Research Project of the Czech Academy of Sciences; Medical Research Council Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Czech Science Foundation(Grant Agency of the Czech Republic); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was also supported by the Research Project of the Czech Academy of Sciences RVO:61388963 (to the Institute of Organic Chemistry and Biochemistry). This work was also supported by Medical Research Council Grant MR/K000179/1 (to A.M.B.), and Supported by Czech Science Foundation Grant 16-01074S (to P.J.). The authors declare that they have no conflicts of interest with the contents of this article.	ADAMS MJ, 1969, NATURE, V224, P491, DOI 10.1038/224491a0; Arakawa T, 2007, BIOPHYS CHEM, V127, P1, DOI 10.1016/j.bpc.2006.12.007; Arrieta-Cruz I, 2016, REV INVEST CLIN, V68, P53; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BENTLEY G, 1978, J MOL BIOL, V126, P871, DOI 10.1016/0022-2836(78)90026-8; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bloom CR, 1998, BIOCHEMISTRY-US, V37, P10937, DOI 10.1021/bi980071z; BRADER ML, 1991, BIOCHEMISTRY-US, V30, P6636, DOI 10.1021/bi00241a002; BRYANT C, 1993, BIOCHEMISTRY-US, V32, P8075, DOI 10.1021/bi00083a004; BRZOVIC PS, 1994, BIOCHEMISTRY-US, V33, P13057, DOI 10.1021/bi00248a015; Case D.A., 2022, AMBER; Chami B, 2016, METAB BRAIN DIS, V31, P497, DOI 10.1007/s11011-016-9806-1; Chang XQ, 1997, BIOCHEMISTRY-US, V36, P9409, DOI 10.1021/bi9631069; CHOI WE, 1993, BIOCHEMISTRY-US, V32, P11638, DOI 10.1021/bi00094a021; CISZAK E, 1994, BIOCHEMISTRY-US, V33, P1512, DOI 10.1021/bi00172a030; Cohen DH, 2012, ENDOCR-RELAT CANCER, V19, pF27, DOI 10.1530/ERC-11-0374; Cohen P, 2006, NAT REV MOL CELL BIO, V7, P867, DOI 10.1038/nrm2043; Conlon JM, 2001, PEPTIDES, V22, P1183, DOI 10.1016/S0196-9781(01)00423-5; CORNELL WD, 1993, J AM CHEM SOC, V115, P9620, DOI 10.1021/ja00074a030; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dunn MF, 2005, BIOMETALS, V18, P295, DOI 10.1007/s10534-005-3685-y; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FALCK B, 1963, EXPERIENTIA, V19, P139, DOI 10.1007/BF02171596; Fava E, 2012, DIABETOLOGIA, V55, P1013, DOI 10.1007/s00125-011-2438-4; FRICKER LD, 1986, NATURE, V323, P461, DOI 10.1038/323461a0; Frisch M. J., 2009, GAUSSION 09 REVISION; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; HAGEDORS H. C., 1936, Journal of the American Medical Association, V106, P177; Huang ST, 1997, BIOCHEMISTRY-US, V36, P9878, DOI 10.1021/bi9701639; HUTTON JC, 1982, BIOCHEM J, V204, P171, DOI 10.1042/bj2040171; Huus K, 2006, BIOCHEMISTRY-US, V45, P4014, DOI 10.1021/bi0524520; Ishikawa T, 2008, BIOCHEM BIOPH RES CO, V376, P32, DOI 10.1016/j.bbrc.2008.08.071; JULIUS D, 1984, CELL, V37, P1075, DOI 10.1016/0092-8674(84)90442-2; Kohagen M, 2016, J PHYS CHEM B, V120, P1454, DOI 10.1021/acs.jpcb.5b05221; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Leontyev I, 2011, PHYS CHEM CHEM PHYS, V13, P2613, DOI 10.1039/c0cp01971b; Leontyev IV, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4884276; Leontyev IV, 2012, J CHEM THEORY COMPUT, V8, P3207, DOI 10.1021/ct300011h; Lisi GP, 2014, BIOCHEMISTRY-US, V53, P3576, DOI 10.1021/bi401678n; LUNDQUIST I, 1971, DIABETOLOGIA, V7, P414, DOI 10.1007/BF01212056; Mayer JP, 2007, BIOPOLYMERS, V88, P687, DOI 10.1002/bip.20734; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Menting JG, 2014, P NATL ACAD SCI USA, V111, pE3395, DOI 10.1073/pnas.1412897111; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Norrman M, 2007, EUR J PHARM SCI, V30, P414, DOI 10.1016/j.ejps.2007.01.003; RahuelClermont S, 1997, BIOCHEMISTRY-US, V36, P5837, DOI 10.1021/bi963038q; REED AE, 1985, J CHEM PHYS, V83, P735, DOI 10.1063/1.449486; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; SEYDOUX J, 1974, EXPERIENTIA, V30, P683; SMEEKENS SP, 1991, P NATL ACAD SCI USA, V88, P340, DOI 10.1073/pnas.88.2.340; SMEEKENS SP, 1990, J BIOL CHEM, V265, P2997; Smith GD, 1998, J MOL STRUCT, V470, P71, DOI 10.1016/S0022-2860(98)00471-2; Smith GD, 1996, PROTEIN SCI, V5, P1502, DOI 10.1002/pro.5560050806; SMITH GD, 1994, P NATL ACAD SCI USA, V91, P8851, DOI 10.1073/pnas.91.19.8851; SMITH GD, 1984, P NATL ACAD SCI-BIOL, V81, P7093, DOI 10.1073/pnas.81.22.7093; Smith GD, 2003, ACTA CRYSTALLOGR D, V59, P474, DOI 10.1107/S0907444902023685; Smith GD, 2001, ACTA CRYSTALLOGR D, V57, P1091, DOI 10.1107/S0907444901007685; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Steensgaard DB, 2013, BIOCHEMISTRY-US, V52, P295, DOI 10.1021/bi3008609; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; TAYLOR SI, 1994, DIABETES, V43, P735, DOI 10.2337/diab.43.6.735; Tsuboi T, 2003, CURR BIOL, V13, P563, DOI 10.1016/S0960-9822(03)00176-3; TURNER RC, 1995, DIABETES, V44, P1, DOI 10.2337/diabetes.44.1.1; Ustione A, 2013, MOL ENDOCRINOL, V27, P1198, DOI 10.1210/me.2013-1083; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Wagner A, 2009, PROTEINS, V74, P1018, DOI 10.1002/prot.22213; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Ward Colin W, 2011, Front Endocrinol (Lausanne), V2, P76, DOI 10.3389/fendo.2011.00076; Weiss MA, 2009, VITAM HORM, V80, P33, DOI 10.1016/S0083-6729(08)00602-X; WHITTINGHAM JL, 1995, BIOCHEMISTRY-US, V34, P15553, DOI 10.1021/bi00047a022; Whittingham JL, 1998, BIOCHEMISTRY-US, V37, P11516, DOI 10.1021/bi980807s; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	85	13	13	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8342	8355		10.1074/jbc.M117.775924	http://dx.doi.org/10.1074/jbc.M117.775924			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28348075	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000401788600019
J	Hsu, MK; Lin, HY; Chen, FC				Hsu, Min-Kung; Lin, Hsuan-Yu; Chen, Feng-Chi			NMD Classifier: A reliable and systematic classification tool for nonsense-mediated decay events	PLOS ONE			English	Article							MESSENGER-RNA DECAY; EXON JUNCTION COMPLEX; CAENORHABDITIS-ELEGANS; MAMMALIAN-CELLS; GENE-EXPRESSION; SURVEILLANCE; DEGRADATION; MECHANISMS; SMG-1; YEAST	Nonsense-mediated decay (NMD) degrades mRNAs that include premature termination codons to avoid the translation and accumulation of truncated proteins. This mechanism has been found to participate in gene regulation and a wide spectrum of biological processes. However, the evolutionary and regulatory origins of NMD-targeted transcripts (NMDTs) have been less studied, partly because of the complexity in analyzing NMD events. Here we report NMD Classifier, a tool for systematic classification of NMD events for either annotated or de novo assembled transcripts. This tool is based on the assumption of minimal evolution/regulation-an event that leads to the least change is the most likely to occur. Our simulation results indicate that NMD Classifier can correctly identify an average of 99.3% of the NMD-causing transcript structural changes, particularly exon inclusions/exclusions and exon boundary alterations. Researchers can apply NMD Classifier to evolutionary and regulatory studies by comparing NMD events of different biological conditions or in different organisms.	[Hsu, Min-Kung; Chen, Feng-Chi] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Lin, Hsuan-Yu; Chen, Feng-Chi] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan Township, Miaoli, Taiwan; [Chen, Feng-Chi] China Med Univ, Sch Dent, Taichung, Taiwan	National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; China Medical University Taiwan	Chen, FC (corresponding author), Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan.; Chen, FC (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan Township, Miaoli, Taiwan.; Chen, FC (corresponding author), China Med Univ, Sch Dent, Taichung, Taiwan.	fcchen@nhri.org.tw			National Health Research Institutes ,Taiwan [105-IPHS-PPO6, 106-IPHS-PP06]; Taiwan Bioinformatics Institute Core Facility; National Center for High-speed Computing of Taiwan	National Health Research Institutes ,Taiwan(National Health Research Institutes - Taiwan); Taiwan Bioinformatics Institute Core Facility; National Center for High-speed Computing of Taiwan	FC Chen was supported by the National Health Research Institutes (105-IPHS-PPO6 and 106-IPHS-PP06), Taiwan (ow rilin org tw); The computational facilities were partly supported by the Taiwan Bioinformatics Institute Core Facility, with the assistance of the National Center for High-speed Computing of Taiwan.	Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Buhler M, 2002, EMBO REP, V3, P646, DOI 10.1093/embo-reports/kvf129; Cali BM, 1999, GENETICS, V151, P605; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Danckwardt S, 2002, BLOOD, V99, P1811, DOI 10.1182/blood.V99.5.1811; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ge Y, 2014, BIOESSAYS, V36, P236, DOI 10.1002/bies.201300156; Grimson A, 2004, MOL CELL BIOL, V24, P7483, DOI 10.1128/MCB.24.17.7483-7490.2004; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HE F, 1993, P NATL ACAD SCI USA, V90, P7034, DOI 10.1073/pnas.90.15.7034; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Jaillon O, 2008, NATURE, V451, P359, DOI 10.1038/nature06495; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lejeune F, 2002, EMBO J, V21, P3536, DOI 10.1093/emboj/cdf345; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; MAQUAT LE, 1995, RNA, V1, P453; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; McGlincy NJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-565; MORSE DE, 1969, NATURE, V224, P329, DOI 10.1038/224329a0; Page MF, 1999, MOL CELL BIOL, V19, P5943; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Rehwinkel J, 2006, TRENDS BIOCHEM SCI, V31, P639, DOI 10.1016/j.tibs.2006.09.005; Reichert VL, 2002, GENE DEV, V16, P2778, DOI 10.1101/gad.1030602; Romao L, 2000, BLOOD, V96, P2895; Savas Sevtap, 2006, Human Genomics, V2, P274; Sayani S, 2008, MOL CELL, V31, P360, DOI 10.1016/j.molcel.2008.07.005; Schweingruber C, 2013, BBA-GENE REGUL MECH, V1829, P612, DOI 10.1016/j.bbagrm.2013.02.005; Seo JS, 2012, GENOME RES, V22, P2109, DOI 10.1101/gr.145144.112; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Usuki F, 2006, MOL THER, V14, P351, DOI 10.1016/j.ymthe.2006.04.011; Usuki F, 2013, P NATL ACAD SCI USA, V110, P15037, DOI 10.1073/pnas.1300654110; Yan QH, 2015, P NATL ACAD SCI USA, V112, P3445, DOI 10.1073/pnas.1502849112; Yap K, 2013, MOL CELL NEUROSCI, V56, P420, DOI 10.1016/j.mcn.2013.01.003	36	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174798	10.1371/journal.pone.0174798	http://dx.doi.org/10.1371/journal.pone.0174798			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369084	Green Published, gold, Green Submitted			2022-12-26	WOS:000399351000045
J	Kageyama, S; Takeshita, T; Asakawa, M; Shibata, Y; Takeuchi, K; Yamanaka, W; Yamashita, Y				Kageyama, Shinya; Takeshita, Toru; Asakawa, Mikari; Shibata, Yukie; Takeuchi, Kenji; Yamanaka, Wataru; Yamashita, Yoshihisa			Relative abundance of total subgingival plaque-specific bacteria in salivary microbiota reflects the overall periodontal condition in patients with periodontitis	PLOS ONE			English	Article							WHOLE SALIVA; PATHOGENS; COMMUNITIES; SURFACES; BIOFILM; SAMPLES; ADULTS	Increasing attention is being focused on evaluating the salivary microbiota as a promising method for monitoring oral health; however, its bacterial composition greatly differs from that of dental plaque microbiota, which is a dominant etiologic factor of oral diseases. This study evaluated the relative abundance of subgingival plaque-specific bacteria in the salivary microbiota and examined a relationship between the abundance and severity of periodontal condition in patients with periodontitis. Four samples (subgingival and supragingival plaques, saliva, and tongue coating) per each subject were collected from 14 patients with a broad range of severity of periodontitis before periodontal therapy. The bacterial composition was analyzed by 16S rRNA gene amplicon sequencing using Ion PGM. Of the 66 species-level operational taxonomic units (OTUs) representing the mean relative abundance of >= 1% in any of the four niches, 12 OTUs corresponding to known periodontal pathogens, including Porphyromonas gingivalis, were characteristically predominant in the subgingival plaque and constituted 37.3 +/- 22.9% of the microbiota. The total relative abundance of these OTUs occupied only 1.6 +/- 1.2% of the salivary microbiota, but significantly correlated with the percentage of diseased sites (periodontal pocket depth >= 4 mm; r = 0.78, P < 0.001), in addition to the abundance of subgingival plaque microbiota (r = 0.61, P = 0.02). After periodontal therapy, the total relative abundance of these 12 OTUs was evaluated as well as before periodontal therapy and reductions of the abundance through periodontal therapy were strongly correlated in saliva and subgingival plaque (r = 0.81, P < 0.001). Based on these results, salivary microbiota might be a promising target for the evaluation of subgingival plaque-derived bacteria representing the present condition of periodontal health.	[Kageyama, Shinya; Takeshita, Toru; Asakawa, Mikari; Shibata, Yukie; Takeuchi, Kenji; Yamanaka, Wataru; Yamashita, Yoshihisa] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Prevent & Publ Hlth Dent, Fukuoka, Japan; [Takeshita, Toru] Kyushu Univ, Fac Dent Sci, OBT Res Ctr, Fukuoka, Japan; [Yamanaka, Wataru] YA Dent Clin, Yonago, Tottori, Japan	Kyushu University; Kyushu University	Yamashita, Y (corresponding author), Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Prevent & Publ Hlth Dent, Fukuoka, Japan.	yoshi@dent.kyushu-u.ac.jp	Takeshita, Toru/AAT-2321-2021; Takeuchi, Kenji/E-9922-2013	Kageyama, Shinya/0000-0001-9296-9385	Ministry of Education, Culture, Sports, Science and Technology of Japan; FUTOKU Foundation;  [16H05557];  [16K15856];  [26463165];  [15K15774];  [16H02692]; Grants-in-Aid for Scientific Research [16H05557] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); FUTOKU Foundation; ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Grants-in Aid for Scientific Research 16H05557 (TT), 16K15856 (TT), 26463165 (WY) 15K15774 (YY) and 16H02692 (YY) and from the Ministry of Education, Culture, Sports, Science and Technology of Japan. SK was supported by The Iwadare Scholarship Foundation, The Terayama Foundation, and The FUTOKU Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belstrom D, 2014, J CLIN PERIODONTOL, V41, P104, DOI 10.1111/jcpe.12190; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Haririan H, 2014, J PERIODONTOL, V85, P819, DOI 10.1902/jop.2013.130306; He JY, 2012, CLIN ORAL INVEST, V16, P1579, DOI 10.1007/s00784-011-0654-4; Kononen E, 2007, J CLIN MICROBIOL, V45, P2446, DOI 10.1128/JCM.02560-06; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mager DL, 2003, J CLIN PERIODONTOL, V30, P644, DOI 10.1034/j.1600-051X.2003.00376.x; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Oliveira RRDS, 2016, J DENT RES, V95, P711, DOI 10.1177/0022034516634619; Paju S, 2009, J CLIN MICROBIOL, V47, P235, DOI 10.1128/JCM.01824-08; Perez-Chaparro PJ, 2014, J DENT RES, V93, P846, DOI 10.1177/0022034514542468; Sakamoto M, 2000, MICROBIOL IMMUNOL, V44, P643, DOI 10.1111/j.1348-0421.2000.tb02545.x; Salminen Aino, 2015, Front Cell Infect Microbiol, V5, P69, DOI 10.3389/fcimb.2015.00069; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Souto R, 2008, ARCH ORAL BIOL, V53, P155, DOI 10.1016/j.archoralbio.2007.08.004; Takeshita T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22164; Umeda M, 1998, J PERIODONTOL, V69, P828, DOI 10.1902/jop.1998.69.7.828; Yamanaka W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042806; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhou YJ, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r1	23	42	43	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174782	10.1371/journal.pone.0174782	http://dx.doi.org/10.1371/journal.pone.0174782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369125	Green Published, Green Submitted, gold			2022-12-26	WOS:000399351000043
J	Rolston, A; Jennings, E; Linnane, S				Rolston, Alec; Jennings, Eleanor; Linnane, Suzanne			Water matters: An assessment of opinion on water management and community engagement in the Republic of Ireland and the United Kingdom	PLOS ONE			English	Article							NATURAL-RESOURCE MANAGEMENT; PARTICIPATION; BOTTOM	Internationally, water management is moving from the traditional top-down approach to more integrated initiatives focussing on community-led action. With inadequacies in previous engagement initiatives undertaken through the first cycle of River Basin Management Planning for the EU Water Framework Directive (WFD), the Republic of Ireland has only recently embraced this bottom-up approach. The attempted introduction of national charging for domestic water use in 2015 has resulted in significant public disquiet and protest movements against the national government. In April 2015 we undertook a survey of current opinion on water management and community engagement initiatives in the Republic of Ireland and the United Kingdom. A total of 520 survey responses identified that although freshwater bodies are important in peoples' lives, respondents were typically unaware of global initiatives such as Integrated Water Resources Management and Integrated Catchment Management. Overall, 81% of respondents did not feel included in decisions about their water environment despite an overwhelming 95% believing that local communities should have a say in how the water environment is managed. However, only 35.1% of respondents stated that they would be willing to attend local water management engagement initiatives. Rather than supporting individual gain, respondents identified social gains for the local community as avenues for increasing local involvement in water initiatives. In the Republic of Ireland, a water engagement initiative that implements the national framework local delivery model should be developed and implemented. This would 1) contribute to the second round of WFD River Basin Management Planning; 2) facilitate stronger connections between local communities and their water environment; and 3) foster bottom-up initiatives that empower communities regarding local water management issues.	[Rolston, Alec; Jennings, Eleanor; Linnane, Suzanne] Dundalk Inst Technol, Ctr Freshwater & Environm Studies, Dundalk, County Louth, Ireland	Dundalk Institute of Technology	Rolston, A (corresponding author), Dundalk Inst Technol, Ctr Freshwater & Environm Studies, Dundalk, County Louth, Ireland.	alec.rolston@dkit.ie			Environmental Protection Agency of Ireland [2014-W-DS-20]	Environmental Protection Agency of Ireland	This work was supported by Environmental Protection Agency of Ireland. Grant Number 2014-W-DS-20. www.epa.ie.	Acreman M, 2004, HYDROL EARTH SYST SC, V8, P861, DOI 10.5194/hess-8-861-2004; Andersson E., 2011, MAKING CASE PUBLIC E; [Anonymous], 2005, EC HUM WELL BEING WE; Benson D, 2013, LAND USE POLICY, V30, P748, DOI 10.1016/j.landusepol.2012.05.016; Broadmeadow S, 2004, HYDROL EARTH SYST SC, V8, P286, DOI 10.5194/hess-8-286-2004; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Cinneide M, 2010, WATER QUALITY IRELAN; Collins KB, 2010, WATER RESOUR MANAG, V24, P669, DOI 10.1007/s11269-009-9464-8; Conrad CC, 2011, ENVIRON MONIT ASSESS, V176, P273, DOI 10.1007/s10661-010-1582-5; Conrad E, 2011, ENVIRON PLANN C, V29, P761, DOI 10.1068/c10137; Cook H., 2005, Waterlines, V24, P2, DOI 10.3362/0262-8104.2005.028; Dalrymple G., 2006, VALUING WATER ENV RE; Daly D., 2014, P NAT HYDR C IR; Daniell KA, 2011, BASIN FUTURES: WATER REFORM IN THE MURRAY-DARLING BASIN, P413; Davenport MA, 2007, ENVIRON MANAGE, V39, P353, DOI 10.1007/s00267-006-0016-1; DEFRA, 2013, CATCHM BA APPR IMPR; Donzier J-F., 2015, HDB PRODUCED INT NET, P6; DSE, 2011, MY VICT WAT PERS CON; DSE, 2005, EFF ENG BUILD REL CO; Dyer J, 2014, J ENVIRON MANAGE, V137, P137, DOI 10.1016/j.jenvman.2013.11.057; Eamus D, 2006, AUST J BOT, V54, P91, DOI 10.1071/BT06029; EPA, 2015, DRINK WAT REP; EPA, 2015, DRINK WAT REP 2014; Fleming B., 2009, Waterlines, V28, P29, DOI 10.3362/1756-3488.2009.004; Forslund A., 2009, SECURING WATER ECOSY, VVolume 24; Fraser EDG, 2006, J ENVIRON MANAGE, V78, P114, DOI 10.1016/j.jenvman.2005.04.009; Groom BPK., 2000, ECOLOGICAL MANAGEMEN, V1, P117, DOI [10.1046/j.1442-8903.2000.00033.x, DOI 10.1046/J.1442-8903.2000.00033.X]; GWP. Integrated Water Resources Management, 2000, GLOB WAT PARTN TECHN; Harmonising Collaborative Planning [HarmoniCOP], 2005, LEARN TOG MAN TOG IM; Head BW, 2007, AUST J POLIT SCI, V42, P441, DOI 10.1080/10361140701513570; Hearne R, 2015, IRISH WATER WAR AUST; Heritage Council, 2004, SEEK YOUR VIEWS WAT; Hutton S.A., 2008, LIT REV; INBO, 2014, STAK ENG INCL WAT GO; Irvine K, 2009, BIOL ENVIRON, V109B, P365, DOI 10.3318/BIOE.2009.109.3.365; Jennings E, 2009, WATER RES, V43, P4316, DOI 10.1016/j.watres.2009.06.032; Johnson C., 2014, PUBLIC ENGAGEMENT NO; Lachapelle PR, 2003, SOC NATUR RESOUR, V16, P473, DOI 10.1080/08941920309151; Manyanhaire I. O., 2014, Environment and Natural Resources Research, V4, P130; McCloskey DJ., 2011, PRINC COMM ENG, V2nd, P1; McGonigle DF, 2012, ENVIRON SCI POLICY, V24, P4, DOI 10.1016/j.envsci.2012.07.016; Medema W, 2008, ECOL SOC, V13; Murray L., 2006, VAL WAT ENV INV ENV; Placht M, 2008, INT DEV ENV SUSTAINA; Powe N. A., 2004, Journal of Environmental Planning and Management, V47, P287, DOI 10.1080/0964056042000209067; Prager Katrin, 2010, Ecological Management & Restoration, V11, P187, DOI 10.1111/j.1442-8903.2010.00548.x; QDES, 2001, CHART COMM ENG; Rahaman MM, 2004, INT J WATER RESOUR D, V20, P565, DOI 10.1080/07900620412331319199; Ramachandra A, 2014, EDUC TRAIN, V56, P588, DOI 10.1108/ET-07-2014-0084; RELU, 2010, CATCHM MAN PROT WAT; Robins Lisa, 2007, International Journal of Global Environmental Issues, V7, P300, DOI 10.1504/IJGENVI.2007.016110; Rolston A., 2016, SYNTHESIS REPORT; Ryan P., 2014, THESIS; Smith JL, 2008, LOCAL ENVIRON, V13, P353, DOI 10.1080/13549830701803323; Tindale S., 2013, THESIS; UKNEA, 2014, UK NAT EC ASS SYNTH	57	11	11	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174957	10.1371/journal.pone.0174957	http://dx.doi.org/10.1371/journal.pone.0174957			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2IH	28369136	Green Published, Green Submitted, gold			2022-12-26	WOS:000399351000065
J	Cheung, SK; Scott, K				Cheung, Samantha K.; Scott, Kristin			GABA(A) receptor-expressing neurons promote consumption in Drosophila melanogaster	PLOS ONE			English	Article							GENE-EXPRESSION; TASTE CIRCUIT; IN-VIVO; BEHAVIOR; REVEALS; BRAIN; INGESTION; SIGNALS; HUNGER; SYSTEM	Feeding decisions are highly plastic and bidirectionally regulated by neurons that either promote or inhibit feeding. In Drosophila melanogaster, recent studies have identified four GABAergic interneurons that act as critical brakes to prevent incessant feeding. These GABAergic neurons may inhibit target neurons that drive consumption. Here, we tested this hypothesis by examining GABA receptors and neurons that promote consumption. We find that Resistance to dieldrin (RDL), a GABA(A) type receptor, is required for proper control of ingestion. Knockdown of Rdlin a subset of neurons causes overconsumption of tastants. Acute activation of these neurons is sufficient to drive consumption of appetitive substances and non-appetitive substances and acute silencing of these neurons decreases consumption. Taken together, these studies identify GABA(A) receptor-expressing neurons that promote Drosophila ingestive behavior and provide insight into feeding regulation.	[Cheung, Samantha K.; Scott, Kristin] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Scott, Kristin] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Scott, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Scott, K (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	kscott@berkeley.edu			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK098747]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098747] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK; Grant: R01DK098747) to KS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUCKINGHAM SD, 1994, NEUROSCI LETT, V181, P137, DOI 10.1016/0304-3940(94)90578-9; Cameron P, 2010, NATURE, V465, P91, DOI 10.1038/nature09011; Dickson BJ, VT COLLECTION UNPUB; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Edwards TN, 2010, PROG NEUROBIOL, V90, P471, DOI 10.1016/j.pneurobio.2010.01.001; Flood TF, 2013, NATURE, V499, P83, DOI 10.1038/nature12208; Gisselmann G, 2004, BRIT J PHARMACOL, V142, P409, DOI 10.1038/sj.bjp.0705818; Gohl DM, 2011, NAT METHODS, V8, P231, DOI 10.1038/NMETH.1561; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Inagaki HK, 2014, NAT METHODS, V11, P325, DOI [10.1038/nmeth.2765, 10.1038/NMETH.2765]; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Jourjine N, 2016, CELL, V166, P855, DOI 10.1016/j.cell.2016.06.046; Kain P, 2015, NEURON, V85, P819, DOI 10.1016/j.neuron.2015.01.005; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Kvon EZ, 2014, NATURE, V512, P91, DOI 10.1038/nature13395; Ledue EE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7667; Manzo A, 2012, P NATL ACAD SCI USA, V109, P6307, DOI 10.1073/pnas.1120305109; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; Marella S, 2012, NEURON, V73, P941, DOI 10.1016/j.neuron.2011.12.032; Mezler M, 2001, EUR J NEUROSCI, V13, P477, DOI 10.1046/j.1460-9568.2001.01410.x; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Pool AH, 2014, NEURON, V83, P164, DOI 10.1016/j.neuron.2014.05.006; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Yapici N, 2016, CELL, V165, P715, DOI 10.1016/j.cell.2016.02.061	29	14	14	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0175177	10.1371/journal.pone.0175177	http://dx.doi.org/10.1371/journal.pone.0175177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362856	gold, Green Submitted, Green Published			2022-12-26	WOS:000399175000075
J	Zhang, QZ; Zhao, KQ; Wu, Y; Li, XH; Yang, C; Guo, LM; Liu, CH; Qu, D; Zheng, CQ				Zhang, Qing-Zhao; Zhao, Ke-Qing; Wu, Yang; Li, Xian-Hui; Yang, Chen; Guo, Li-Min; Liu, Chun-Hong; Qu, Di; Zheng, Chun-Quan			5-aminolevulinic acid-mediated photodynamic therapy and its strain dependent combined effect with antibiotics on Staphylococcus aureus biofilm	PLOS ONE			English	Article							660 NM LASER; IN-VITRO; ANTIMICROBIAL ACTIVITY; RESISTANCE; CHITOSAN; BLUE; SUSCEPTIBILITY; CIPROFLOXACIN; ADHERENCE; BACTERIA	Staphylococcus aureus (S. aureus) is hard to be eradicated, not only due to the emergence of antibiotic resistant strains but also because of its ability to form biofilm. Antibiotics are the major approach to treating biofilm infections, but their effects are unsatisfactory. One of the potential alternative treatments for controlling biofilm infections is photodynamic therapy (PDT), which requires the administration of photosensitizer, followed by light activation. 5-aminolevulinic acid (ALA), a natural photosensitizer prodrug, presents favorable characteristics, such as easy penetration and rapid clearance. These advantages enable ALA based PDT (ALA-PDT) to be well-tolerated by patients and it can be repeatedly applied without cumulative toxicity or serious side effects. ALA-PDT has been proven to be an effective treatment for multidrug resistant pathogens; however, the study of its effect on S. aureus biofilm is limited. Here, we established our PDT system based on the utilization of ALA and a light-emitting diode, and we tested the effect of ALA-PDT on S. aureus biofilm as well as the combined effect of ALA-PDT and antibiotics on S. aureus biofilm. Our results showed that ALA-PDT has a strong antibacterial effect on S. aureus biofilm, which was confirmed by the confocal laser scanning microscope. We also found that lethal photosensitization occurred predominantly in the upper layer of the biofilm, while the residual live bacteria were located in the lower layer of the biofilm. In addition, the improved bactericidal effect was observed in the combined treatment group but in a strain-dependent manner. Our results suggest that ALA-PDT is a potential alternative approach for future clinical use to treat S. aureus biofilm-associated infections, and some patients may benefit from the combined treatment of ALA-PDT and antibiotics, but drug sensitivity testing should be performed in advance.	[Zhang, Qing-Zhao; Zhao, Ke-Qing; Yang, Chen; Guo, Li-Min; Zheng, Chun-Quan] Fudan Univ, Sch Shanghai Med, Eye & ENT Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai, Peoples R China; [Wu, Yang; Qu, Di] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Minist Educ,Key Lab Med Mol Virol, Shanghai, Peoples R China; [Wu, Yang; Qu, Di] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Minist Hlth,Key Lab Med Mol Virol, Shanghai, Peoples R China; [Wu, Yang; Qu, Di] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai, Peoples R China; [Li, Xian-Hui] Wenzhou Med Univ, Affiliated Hosp 3, Dept Otolaryngol, Wenzhou, Peoples R China; [Yang, Chen] Shanghai Jiao Tong Univ, Dept Otolaryngol, Ruijin Hosp, Sch Med, Shanghai, Peoples R China; [Liu, Chun-Hong] Fudan Univ, Eye & ENT Hosp, Dept Clin Lab, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Wenzhou Medical University; Shanghai Jiao Tong University; Fudan University	Zheng, CQ (corresponding author), Fudan Univ, Sch Shanghai Med, Eye & ENT Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai, Peoples R China.; Qu, D (corresponding author), Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Minist Educ,Key Lab Med Mol Virol, Shanghai, Peoples R China.; Qu, D (corresponding author), Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Minist Hlth,Key Lab Med Mol Virol, Shanghai, Peoples R China.; Qu, D (corresponding author), Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai, Peoples R China.	qdresearch@163.com; zhengcq96@163.com	Qu, Di/AAO-4590-2020		National Natural Science Foundation of China for Young Scholars [81300810]; Shanghai Young Doctor Training Program [20141057]; National Natural Science Foundation of China [81671982, 81271791, 81571955]	National Natural Science Foundation of China for Young Scholars(National Natural Science Foundation of China (NSFC)); Shanghai Young Doctor Training Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China for Young Scholars (No. 81300810, http://www.nsfc.gov.cn/), Shanghai Young Doctor Training Program (No. 20141057, http://www.wsjsw.gov.cn/wsj/index.html) and National Natural Science Foundation of China (81671982, 81271791 and 81571955, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000; Barra F, 2015, INT J MOL SCI, V16, P20417, DOI 10.3390/ijms160920417; Chaignon P, 2007, APPL MICROBIOL BIOT, V75, P125, DOI 10.1007/s00253-006-0790-y; Choi SS, 2014, PHOTODIAGN PHOTODYN, V11, P526, DOI 10.1016/j.pdpdt.2014.08.005; Choi S, 2015, J PHOTOCH PHOTOBIO B, V153, P7, DOI 10.1016/j.jphotobiol.2015.09.003; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Fila G, 2017, VIRULENCE, V8, P938, DOI 10.1080/21505594.2016.1250995; Harris F, 2012, MED RES REV, V32, P1292, DOI 10.1002/med.20251; Jiang L, 2013, J APPL MICROBIOL, V114, P956, DOI 10.1111/jam.12111; Konopka K, 2007, J DENT RES, V86, P694, DOI 10.1177/154405910708600803; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Li X, 2013, J SURG RES, V184, P1013, DOI 10.1016/j.jss.2013.03.094; Mai BJ, 2016, LASER SURG MED, V48, P400, DOI 10.1002/lsm.22468; Meltzer EO, 2004, J ALLERGY CLIN IMMUN, V114, pS133, DOI 10.1016/j.jaci.2004.09.011; O'Neill JF, 2002, LASER SURG MED, V31, P86, DOI 10.1002/lsm.10087; Peng Q, 1997, PHOTOCHEM PHOTOBIOL, V65, P235, DOI 10.1111/j.1751-1097.1997.tb08549.x; Rkein AM, 2014, DERMATOL CLIN, V32, P415, DOI 10.1016/j.det.2014.03.009; Ronqui MR, 2016, J PHOTOCH PHOTOBIO B, V158, P122, DOI 10.1016/j.jphotobiol.2016.02.036; Rosa LP, 2015, PHOTODIAGN PHOTODYN, V12, P276, DOI 10.1016/j.pdpdt.2015.01.001; Rosa LP, 2014, LASER MED SCI, V29, P1959, DOI 10.1007/s10103-014-1613-5; Shi H, 2016, PHOTODIAGN PHOTODYN, V15, P40, DOI 10.1016/j.pdpdt.2016.04.011; Stepanovic S, 2007, APMIS, V115, P891, DOI 10.1111/j.1600-0463.2007.apm_630.x; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Williams I, 1997, MICROBIOL-UK, V143, P2407, DOI 10.1099/00221287-143-7-2407	27	24	28	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174627	10.1371/journal.pone.0174627	http://dx.doi.org/10.1371/journal.pone.0174627			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358851	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174800062
J	Asatryan, B; Vital, C; Kellerhals, C; Medeiros-Domingo, A; Grani, C; Trachsel, LD; Schmied, CM; Saguner, AM; Eser, P; Herzig, D; Bolliger, S; Michaud, K; Wilhelm, M				Asatryan, Babken; Vital, Cristina; Kellerhals, Christoph; Medeiros-Domingo, Argelia; Grani, Christoph; Trachsel, Lukas D.; Schmied, Christian M.; Saguner, Ardan M.; Eser, Prisca; Herzig, David; Bolliger, Stephan; Michaud, Katarzyna; Wilhelm, Matthias			Sports-related sudden cardiadc deaths in the young population of Switzerlan	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; SCIENTIFIC STATEMENT; OF-CARDIOLOGY; WORKING GROUP; COLLEGE; REHABILITATION; PREVENTION; NATIONWIDE	Background In Switzerland, ECG screening was first recommended for national squad athletes in 1998. Since 2001 it has become mandatory in selected high-risk professional sports. Its impact on the rates of sports-related sudden cardiac death (SCD) is unknown. Objective We aimed to study the incidence, causes and time trends of sports-related SCD in comparison to SCD unrelated to exercise in Switzerland. Methods We reviewed all forensic reports of SCDs of the German-speaking region of Switzerland in the age group of 10 to 39 years, occurring between 1999 and 2010. Cases were classified into three categories based on whether or not deaths were associated with sports: no sports (NONE), recreational sports (REC), and competitive sports (COMP). Results Over the 12-year study period, 349 SCD cases were recorded (mean age 30 +/- 7 years, 76.5% male); 297 cases were categorized as NONE, 31 as REC, and 21 as COMP. Incidences of SCD per 100,000 person-years [mean (95% CI)] were the lowest in REC [0.43 (0.35-0.56)], followed by COMP [1.19 (0.89-1.60)] and NONE [2.46 (2.27-2.66)]. In all three categories, coronary artery disease (CAD) with or without acute myocardial infarction (MI) was the most common cause of SCD. Three professional athletes were identified in COMP category which all had SCD due to acute MI. There were no time trends, neither in overall, nor in cause-specific incidences of SCD. Conclusions The incidence of SCD in young individuals in Switzerland is low, both related and unrelated to sports. In regions, like Switzerland, where CAD is the leading cause of SCD associated with competitions, screening for cardiovascular risk factors in addition to the current PPS recommendations might be indicated to improve detection of silent CAD and further decrease the incidence of SCD.	[Asatryan, Babken; Vital, Cristina; Kellerhals, Christoph; Medeiros-Domingo, Argelia; Trachsel, Lukas D.; Eser, Prisca; Herzig, David; Wilhelm, Matthias] Univ Bern, Univ Clin Cardiol, Univ Hosp Bern, Nselspital, Bern, Switzerland; [Grani, Christoph; Schmied, Christian M.; Saguner, Ardan M.] Univ Heart Ctr, Zurich, Switzerland; [Bolliger, Stephan] Univ Zurich, Inst Forens Med, Zurich, Switzerland; [Michaud, Katarzyna] Univ Ctr Legal Med, Unit Forens Med, Lausanne, Switzerland	University of Bern; University Hospital of Bern; University of Zurich	Wilhelm, M (corresponding author), Univ Bern, Univ Clin Cardiol, Univ Hosp Bern, Nselspital, Bern, Switzerland.	matthias.wilhelm@insel.ch	Wilhelm, Matthias/AAS-9456-2020; Eser, Prisca/AAE-3758-2021; Saguner, Ardan M./AAV-3624-2020; Asatryan, Babken/K-6966-2015	Wilhelm, Matthias/0000-0003-4541-3995; Asatryan, Babken/0000-0002-0050-5717; Test, Tom/0000-0002-4998-5635; Grani, Christoph/0000-0001-6029-0597; Medeiros-Domingo, Argelia/0000-0001-5586-3418	Swiss Heart Foundation	Swiss Heart Foundation	The work was supported by an unrestricted grant from the Swiss Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basso C, 2008, VIRCHOWS ARCH, V452, P11, DOI 10.1007/s00428-007-0505-5; Bohm P, 2016, EUR J PREV CARDIOL, V23, P649, DOI 10.1177/2047487315594087; Chappex N, 2015, J FORENSIC LEG MED, V35, P62, DOI 10.1016/j.jflm.2015.07.004; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; Corrado D, 2006, JAMA-J AM MED ASSOC, V296, P1593, DOI 10.1001/jama.296.13.1593; Harmon KG, 2014, HEART, V100, P1185, DOI 10.1136/heartjnl-2014-093872.rep; Harmon KG, 2014, CIRC-ARRHYTHMIA ELEC, V7, P198, DOI 10.1161/CIRCEP.113.001376; Hofer F, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-140; Kaltman JR, 2011, CIRCULATION, V123, P1911, DOI 10.1161/CIRCULATIONAHA.110.017228; Kasanuki H, 1997, CIRCULATION, V95, P2277, DOI 10.1161/01.CIR.95.9.2277; Kim JH, 2012, NEW ENGL J MED, V366, P130, DOI 10.1056/NEJMoa1106468; Maron BJ, 2015, CIRCULATION, V132, pE267, DOI 10.1161/CIR.0000000000000238; Maron BJ, 2014, J AM COLL CARDIOL, V63, P1636, DOI 10.1016/j.jacc.2014.01.041; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Mehra R, 2007, J ELECTROCARDIOL, V40, pS118, DOI 10.1016/j.jelectrocard.2007.06.023; Myerburg RJ, 2012, CIRCULATION, V125, P1043, DOI 10.1161/CIRCULATIONAHA.111.023846; Nichols M, 2014, EUR HEART J, V35, P2950, DOI 10.1093/eurheartj/ehu299; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Quigley F, 2000, BRIT J SPORT MED, V34, P258, DOI 10.1136/bjsm.34.4.258; Risgaard B, 2014, HEART RHYTHM, V11, P1673, DOI 10.1016/j.hrthm.2014.05.026; Schmied C, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13575; Schwartz PJ, 2001, CIRCULATION, V103, P89; Solberg EE, 2016, EUR J PREV CARDIOL, V23, P657, DOI 10.1177/2047487315599891; Solberg EE, 2010, EUR J CARDIOV PREV R, V17, P337, DOI 10.1097/HJR.0b013e328332f8f7; Thompson PD, 2007, CIRCULATION, V115, P2358, DOI 10.1161/CIRCULATIONAHA.107.181485; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wilhelm M, 2011, SCHWEIZ Z SPORTSMED, V59, P96; Wilhelm M, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14129	28	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							E0174434	10.1371/journal.pone.0174434	http://dx.doi.org/10.1371/journal.pone.0174434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350812	gold, Green Published, Green Accepted			2022-12-26	WOS:000399174400043
J	Kraus, EM; Pelzl, S; Szecsenyi, J; Laux, G				Kraus, Eva Maria; Pelzl, Steffen; Szecsenyi, Joachim; Laux, Gunter			Antibiotic prescribing for acute lower respiratory tract infections (LRTI) - guideline adherence in the German primary care setting: An analysis of routine data	PLOS ONE			English	Article							PHYSICIANS	Objectives Antibiotic overprescribing in primary care has major impacts on the development of antibiotic resistance. The objective of this study is to provide insight in antibiotics prescriptions for patients suffering from cough, acute bronchitis or community acquired pneumonia in primary care. Methods Data from 2009 to 2013 of electronic health records of 12,880 patients in Germany were obtained from a research database. The prescription of antibiotics for acute lower respiratory tract infections was compared to the national S3 guideline cough from the German Society of General Practitioners and Family Medicine. Results Antibiotics were prescribed in 41% of consultations. General practitioners' decision of whether or not to prescribe an antibiotic was congruent with the guideline in 52% of consultations and the antibiotic choice congruence was 51% of antibiotic prescriptions. Hence, a congruent prescribing decision and a prescription of recommendation was found in only 25% of antibiotic prescriptions. Split by diagnosis we found that around three quarters of antibiotics prescribed for cough (73%) and acute bronchitis (78%) were not congruent to the guidelines. In contrast to that around one quarter of antibiotics prescribed for community acquired pneumonia (28%) were not congruent to the guidelines. Conclusions Our results show that there is a big gap between guideline recommendation and actual prescribing, in the decision to prescribe and the choice of antibiotic agent. This gap could be closed by periodic quality circles on antibiotic prescribing for GPs.	[Kraus, Eva Maria] Darmstadt Gen Hosp, Dept Pharm, Darmstadt, Germany; [Kraus, Eva Maria; Szecsenyi, Joachim; Laux, Gunter] Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany; [Pelzl, Steffen] SLK Kliniken Heilbronn, Dept Pharm, Heilbronn, Germany	Klinikum Darmstadt; Ruprecht Karls University Heidelberg	Kraus, EM (corresponding author), Darmstadt Gen Hosp, Dept Pharm, Darmstadt, Germany.; Kraus, EM (corresponding author), Univ Heidelberg Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany.	Eva-Maria.Kraus@med.uni-heidelberg.de	Laux, Gunter/AAL-9020-2021	Kraus, Eva Maria/0000-0001-7824-5508	Bundesministerium fur Bildung und Forschung [BMBF 01GK0601]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by Bundesministerium fur Bildung und Forschung, www.bmbf.de, Grant Number BMBF 01GK0601. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkerman AE, 2004, J ANTIMICROB CHEMOTH, V54, P1116, DOI 10.1093/jac/dkh480; Butler CC, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2242; Dekker ARJ, 2015, FAM PRACT, V32, P401, DOI 10.1093/fampra/cmv019; Gesundheit Bf, 2015, AN THER CHEM KLASS T; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Gottfried M., 2012, VDEK BASISDATEN GESU; Husten Braun V., 2008, DTSCH GESELLSCHAFT A; ISEG, 2013, BARM GEK ARZTR 2013; (KKG) AIdKfFdKiG, 2014, INT STAT KLASS KRANK; Kuehlein T, 2011, BMJ QUAL SAF, V20, P522, DOI 10.1136/bmjqs.2010.047357; Laux Gunter, 2005, Inform Prim Care, V13, P249; Livorsi D, 2016, J HOSP MED, V11, P174, DOI 10.1002/jhm.2495; Loikas D, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0351-5; McManus RJ, 2008, FAM PRACT, V25, P56, DOI 10.1093/fampra/cmm065; Murphy M, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-43; Petersen I, 2007, J ANTIMICROB CHEMOTH, V60, pI43, DOI 10.1093/jac/dkm156; SAS, P GENMOD STAT; SeBaWorld SB, WELT BLICK BERLIN 20; Smith SM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000245.pub3; van den Broek d'Obrenan J, 2014, J ANTIMICROB CHEMOTH, V69, P1701, DOI 10.1093/jac/dku005; Wood J, 2011, EUR RESPIR J, V38, P112, DOI 10.1183/09031936.00145810	21	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174584	10.1371/journal.pone.0174584	http://dx.doi.org/10.1371/journal.pone.0174584			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350820	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174400062
J	Ko, CJ; Lan, SW; Lu, YC; Cheng, TS; Lai, PF; Tsai, CH; Hsu, TW; Lin, HY; Shyu, HY; Wu, SR; Lin, HH; Hsiao, PW; Chen, CH; Huang, HP; Lee, MS				Ko, C-J; Lan, S-W; Lu, Y-C; Cheng, T-S; Lai, P-F; Tsai, C-H; Hsu, T-W; Lin, H-Y; Shyu, H-Y; Wu, S-R; Lin, H-H; Hsiao, P-W; Chen, C-H; Huang, H-P; Lee, M-S			Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis	ONCOGENE			English	Article							HEPATOCYTE GROWTH-FACTOR; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROSTAGLANDIN E-2; MATRIX DEGRADATION; COX-2 INHIBITORS; DOWN-REGULATION; TUMOR-GROWTH; EXPRESSION; CELECOXIB; INFLAMMATION	Chronic inflammation plays an important role in cancer development and progression. Cyclooxygenases-2 ( COX-2) is a key enzyme in generating prostaglandins causing inflammation, is often found to be overexpressed in prostate cancer (PCa) and is correlated with PCa cell invasion and metastasis. We aim to investigate the molecular mechanism of how COX-2 promotes PCa cell invasion and metastasis and to evaluate the effect of COX-2 inhibitors in a selected model of PCa progression. Our results showed that the expression of COX-2 and Interleukin 1 beta(IL-1 beta) was upregulated in highly invasive PCa cells and was correlated with the activated levels of membrane-anchored serine protease matriptase. The expression levels of COX-2 were increased and were correlated with matriptase levels in PCa specimens. Moreover, results showed that COX-2 overexpression or a COX-2 product Prostaglandin E2 (PGE2) caused an increase in matriptase activation and PCa cell invasion, whereas COX-2 silencing antagonized matriptase activation and cell invasion. In addition, the inhibition of COX-2-mediated matriptase activation by Celebrex and sulindac sulfide suppressed the androgen-independent and COX2-overexpressing PCa PC-3 cell invasion, tumor growth and lung metastasis in an orthotopic xenograft model. Our results indicate that COX-2/matriptase signaling contributes to the invasion, tumor growth and metastasis of COX-2-overexpressing and androgen-independent PCa cells.	[Ko, C-J; Lan, S-W; Lu, Y-C; Cheng, T-S; Lai, P-F; Hsu, T-W; Lin, H-Y; Wu, S-R; Lin, H-H; Lee, M-S] Natl Taiwan Univ, Coll Med, Dept Biochem & Mol Biol, R817,8F,1,Sect 1,Jen Ai Rd, Taipei 100, Taiwan; [Tsai, C-H; Hsiao, P-W] Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan; [Shyu, H-Y] Minist Justice, Bureau Invest, Taipei, Taiwan; [Chen, C-H] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Huang, H-P] Natl Taiwan Univ, Coll Med, Grad Inst Med Genom & Prote, Taipei, Taiwan	National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lee, MS (corresponding author), Natl Taiwan Univ, Coll Med, Dept Biochem & Mol Biol, R817,8F,1,Sect 1,Jen Ai Rd, Taipei 100, Taiwan.; Huang, HP (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Med Genom & Prote, Taipei, Taiwan.	hh691290@gmail.com; mslee2006@ntu.edu.tw	Ko, Chun-Jung/AAA-6187-2022	Ko, Chun-Jung/0000-0001-6565-7060; CHEN, CHUNG-HSIN/0000-0002-4921-5315; LEE, MING-SHYUE/0000-0002-8673-5088; HUANG, HSIANG-PO/0000-0002-3382-305X	Taiwan National Science Council [NSC 100-2628-B-002-004-MY4]; Ministry of Science and Technology [MOST 103-2321-B-002-096, MOST 104-2320-B-002-044-MY3]; National Health Research Institutes [NHRI-EX102-9909BC, NHRI-EX106-10401BI]; National Taiwan University [NTU-CESRP-104R7602C4, NTU105R89612]; National Taiwan University Hospital [NTUH106-S3387]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Research Institutes(National Health Research Institutes, Japan); National Taiwan University(National Taiwan University); National Taiwan University Hospital(National Taiwan University)	This study was supported by Taiwan National Science Council Grant NSC 100-2628-B-002-004-MY4, Ministry of Science and Technology Grants MOST 103-2321-B-002-096 and MOST 104-2320-B-002-044-MY3, National Health Research Institutes Grants NHRI-EX102-9909BC and NHRI-EX106-10401BI, and National Taiwan University Grants NTU-CESRP-104R7602C4 and NTU105R89612 to M.S. Lee, and National Taiwan University Hospital Grant NTUH106-S3387 to C.H. Chen and H.P. Huang. We thank Dr Ming-Fong Lin at the Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center for LNCaP cells, and Dr Chen-Yong Lin at the Georgetown University for his gifts of antibodies.	Abedinpour P, 2011, PROSTATE, V71, P813, DOI 10.1002/pros.21297; Amano H, 2003, J EXP MED, V197, P221, DOI 10.1084/jem.20021408; [Anonymous], 2016, Clin Adv Hematol Oncol, V14, P11; Ansari KM, 2008, MOL CANCER RES, V6, P1003, DOI 10.1158/1541-7786.MCR-07-2144; Armstrong AJ, 2012, LANCET ONCOL, V13, P443, DOI 10.1016/S1470-2045(12)70111-0; Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Bieniek J, 2014, PROSTATE, V74, P999, DOI 10.1002/pros.22815; Buchanan FG, 2003, J BIOL CHEM, V278, P35451, DOI 10.1074/jbc.M302474200; Cai Y, 2008, INT J CANCER, V123, P195, DOI 10.1002/ijc.23481; CERUTTI PA, 1991, CANCER CELL-MON REV, V3, P1; Chen CJ, 2011, AM J PHYSIOL-CELL PH, V300, pC406, DOI 10.1152/ajpcell.00403.2010; Cheng TS, 2013, CANCER PREV RES, V6, P495, DOI 10.1158/1940-6207.CAPR-12-0293-T; Cheung AS, 2012, ASIAN J ANDROL, V14, P518, DOI 10.1038/aja.2012.51; Chu TH, 2014, ONCOTARGET, V5, P1475, DOI 10.18632/oncotarget.1745; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Di Lorenzo G, 2005, PROSTATE CANCER P D, V8, P54, DOI 10.1038/sj.pcan.4500768; Galkin AV, 2004, PROSTATE, V61, P228, DOI 10.1002/pros.20094; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Gupta S, 2000, PROSTATE, V42, P73, DOI 10.1002/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G; Herrmann C, 1998, ONCOGENE, V17, P1769, DOI 10.1038/sj.onc.1202085; Igawa T, 2002, PROSTATE, V50, P222, DOI 10.1002/pros.10054; James ND, 2012, LANCET ONCOL, V13, P549, DOI 10.1016/S1470-2045(12)70088-8; Jeong Y, 2017, ASIA-PAC J CLIN ONCO, V13, P204, DOI 10.1111/ajco.12583; Kattan J, 2016, INVEST NEW DRUG, V34, P474, DOI 10.1007/s10637-016-0357-4; Kim SH, 2017, ASIAN J ANDROL, V19, P458, DOI 10.4103/1008-682X.180798; Kirschenbaum A, 2000, UROLOGY, V56, P671, DOI 10.1016/S0090-4295(00)00674-9; Kiyomiya KI, 2006, AM J PHYSIOL-CELL PH, V291, pC40, DOI 10.1152/ajpcell.00351.2005; Ko CJ, 2015, CANCER RES, V75, P2949, DOI 10.1158/0008-5472.CAN-14-3297; Kulp SK, 2004, CANCER RES, V64, P1444, DOI 10.1158/0008-5472.CAN-03-2396; Lam ET, 2012, NAT REV UROL, V9, P358, DOI [10.1038/nrurol.2012.112, 10.1038/nruro1.2012.112]; Lee LM, 2001, ANTICANCER RES, V21, P1291; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Li S, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-11; Li Z, 2013, ONCOGENE, V32, P1408, DOI 10.1038/onc.2012.161; Lim JTE, 1999, BIOCHEM PHARMACOL, V58, P1097, DOI 10.1016/S0006-2952(99)00200-2; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; Liu CH, 2001, J BIOL CHEM, V276, P18563, DOI 10.1074/jbc.M010787200; Milner JM, 2010, ARTHRITIS RHEUM-US, V62, P1955, DOI 10.1002/art.27476; Nelson William G, 2004, J Urol, V172, pS6, DOI 10.1097/01.ju.0000142058.99614.ff; ONEILL GP, 1993, FEBS LETT, V330, P156, DOI 10.1016/0014-5793(93)80263-T; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Rao PNP, 2008, J PHARM PHARM SCI, V11, P81, DOI 10.18433/J3T886; Ruan D, 2014, LIFE SCI, V116, P43, DOI 10.1016/j.lfs.2014.07.042; Ruder EH, 2011, AM J GASTROENTEROL, V106, P1340, DOI 10.1038/ajg.2011.38; Rundhaug JE, 2011, CANCER METAST REV, V30, P465, DOI 10.1007/s10555-011-9317-9; Saleem M, 2006, CANCER EPIDEM BIOMAR, V15, P217, DOI 10.1158/1055-9965.EPI-05-0737; SHI YE, 1993, CANCER RES, V53, P1409; Suzuki M, 2004, J BIOL CHEM, V279, P14899, DOI 10.1074/jbc.M313130200; Tsai CH, 2014, ONCOGENE, V33, P4643, DOI 10.1038/onc.2013.412; Uhland K, 2006, CELL MOL LIFE SCI, V63, P2968, DOI 10.1007/s00018-006-6298-x; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wang WZ, 2005, CLIN CANCER RES, V11, P3250, DOI 10.1158/1078-0432.CCR-04-2405; Wang XY, 2007, MOL CARCINOGEN, V46, P912, DOI 10.1002/mc.20320; Wu SR, 2010, AM J PATHOL, V177, P3145, DOI 10.2353/ajpath.2010.100228; Zoratti GL, 2016, ONCOTARGET, V7, P58162, DOI 10.18632/oncotarget.11262	60	30	31	2	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 10	2017	36	32					4597	4609		10.1038/onc.2017.82	http://dx.doi.org/10.1038/onc.2017.82			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FD0RK	28368394				2022-12-26	WOS:000407246200007
J	Stopa, JD; Baker, KM; Grover, SP; Flaumenhaft, R; Furie, B				Stopa, Jack D.; Baker, Katherine M.; Grover, Steven P.; Flaumenhaft, Robert; Furie, Bruce			Kinetic-based trapping by intervening sequence variants of the active sites of protein-disulfide isomerase identifies platelet protein substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; THROMBUS FORMATION; BOND FORMATION; CATHEPSIN-G; CATALYSIS; PEPTIDE; DOMAINS; FAMILY; RIBONUCLEASE; RESIDUES	Thiol isomerases such as protein-disulfide isomerase (PDI) direct disulfide rearrangements required for proper folding of nascent proteins synthesized in the endoplasmic reticulum. Identifying PDI substrates is challenging because PDI catalyzes conformational changes that cannot be easily monitored (e.g. compared with proteolytic cleavage or amino acid phosphorylation); PDI has multiple substrates; and it can catalyze either oxidation, reduction, or isomerization of substrates. Kinetic-based substrate trapping wherein the active site motif CGHC is modified to CGHA to stabilize a PDI-substrate intermediate is effective in identifying some substrates. A limitation of this approach, however, is that it captures only substrates that are reduced by PDI, whereas many substrates are oxidized by PDI. By manipulating the highly conserved-GH-residues in the CGHC active site of PDI, we created PDI variants with a slowed reaction rate toward substrates. The prolonged intermediate state allowed us to identify protein substrates that have biased affinities for either oxidation or reduction by PDI. Because extracellular PDI is critical for thrombus formation but its extracellular substrates are not known, we evaluated the ability of these bidirectional trapping PDI variants to trap proteins released from platelets and on the platelet surface. Trapped proteins were identified by mass spectroscopy. Of the trapped substrate proteins identified by mass spectroscopy, five proteins, cathepsin G, glutaredoxin-1, thioredoxin, GP1b, and fibrinogen, showed a bias for oxidation, whereas annexin V, heparanase, ERp57, kallekrein-14, serpin B6, tetranectin, and collagen VI showed a bias for reduction. These bidirectional trapping variants will enable more comprehensive identification of thiol isomerase substrates and better elucidation of their cellular functions.	Beth Israel Deaconess Med Ctr, Div Hemostasis & Thrombosis, Boston, MA 02215 USA; Harvard Med Sch, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Furie, B (corresponding author), Beth Israel Deaconess Med Ctr, Div Hemostasis & Thrombosis, Ctr Life Sci, CLS924,3 Blackfan Circle, Boston, MA 02215 USA.	bfurie@bidmc.harvard.edu		Grover, Steven/0000-0001-8709-8394	National Institutes of Health [U54HL112302, T32HL07917]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL135775, T32HL007917, R01HL136394, U54HL112302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants U54HL112302 and T32HL07917. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Bowley SR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14151; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; Cho J, 2008, J CLIN INVEST, V118, P1123, DOI 10.1172/JCI34134; CREIGHTON TE, 1993, CURR BIOL, V3, P790, DOI 10.1016/0960-9822(93)90034-L; DARBY NJ, 1994, BIOCHEMISTRY-US, V33, P7937, DOI 10.1021/bi00191a022; Darby NJ, 1995, BIOCHEMISTRY-US, V34, P16770, DOI 10.1021/bi00051a027; Darby NJ, 1996, BIOCHEMISTRY-US, V35, P10517, DOI 10.1021/bi960763s; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035; Freedman RB, 1998, CURR BIOL, V8, pR468, DOI 10.1016/S0960-9822(98)70295-7; Furie B, 2014, CIRC RES, V114, P1162, DOI 10.1161/CIRCRESAHA.114.301808; Gilbert HF, 1998, METHOD ENZYMOL, V290, P26, DOI 10.1016/S0076-6879(98)90005-2; GLEASON FK, 1992, PROTEIN SCI, V1, P609, DOI 10.1002/pro.5560010507; Holbrook LM, 2012, J THROMB HAEMOST, V10, P278, DOI 10.1111/j.1538-7836.2011.04593.x; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Hotchkiss KA, 1996, BIOCHEMISTRY-US, V35, P9761, DOI 10.1021/bi9603938; HUI KY, 1983, SCIENCE, V222, P1129, DOI 10.1126/science.6648524; JOELSON T, 1990, J BIOL CHEM, V265, P3183; Jordan PA, 2005, BLOOD, V105, P1500, DOI 10.1182/blood-2004-02-0608; Kemmink J, 1997, CURR BIOL, V7, P239, DOI 10.1016/S0960-9822(06)00119-9; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Kortemme T, 1996, BIOCHEMISTRY-US, V35, P14503, DOI 10.1021/bi9617724; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; LABOISSIERE MCA, 1995, J BIOL CHEM, V270, P28006; LAMANTIA ML, 1993, CELL, V74, P899, DOI 10.1016/0092-8674(93)90469-7; LUNDSTROM J, 1992, J BIOL CHEM, V267, P9047; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; OHBA H, 1981, J BIOCHEM, V89, P889, DOI 10.1093/oxfordjournals.jbchem.a133272; Raturi A, 2007, FREE RADICAL BIO MED, V43, P62, DOI 10.1016/j.freeradbiomed.2007.03.025; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; Walker KW, 1997, J BIOL CHEM, V272, P8845; Walker KW, 1996, BIOCHEMISTRY-US, V35, P1972, DOI 10.1021/bi952157n; WALKER KW, 1995, BIOCHEMISTRY-US, V34, P13642, DOI 10.1021/bi00041a045; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; WUNDERLICH M, 1993, J MOL BIOL, V233, P559, DOI 10.1006/jmbi.1993.1535	38	26	26	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9063	9074		10.1074/jbc.M116.771832	http://dx.doi.org/10.1074/jbc.M116.771832			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28364042	hybrid, Green Published			2022-12-26	WOS:000402538900006
J	Dadvand, P; Nieuwenhuijsen, MJ; Basagana, X; Pedrerol, MA; Dalmau-Bueno, A; Cirach, M; Rivas, L; Brunekreef, B; Querol, X; Morgan, IG; Sunyer, J				Dadvand, Payam; Nieuwenhuijsen, Mark J.; Basagana, Xavier; Pedrerol, Mar Alvarez-; Dalmau-Bueno, Albert; Cirach, Marta; Rivas, Ioar; Brunekreef, Bert; Querol, Xavier; Morgan, Ian G.; Sunyer, Jordi			Traffic-related air pollution and spectacles use in schoolchildren	PLOS ONE			English	Article							RETINAL VASCULAR CALIBER; USE REGRESSION-MODELS; RISK-FACTORS; VISUAL-ACUITY; REFRACTIVE ERRORS; ATHEROSCLEROSIS MESA; SCHOOL-CHILDREN; INCIDENT MYOPIA; DRY EYE; PREVALENCE	Purpose To investigate the association between exposure to traffic-related air pollution and use of spectacles (as a surrogate measure for myopia) in schoolchildren. Methods We analyzed the impact of exposure to NO2 and PM2.5 light absorbance at home (predicted by land-use regression models) and exposure to NO2 and black carbon (BC) at school (measured by monitoring campaigns) on the use of spectacles in a cohort of 2727 schoolchildren (7 - 10 years old) in Barcelona (2012 - 2015). We conducted cross-sectional analyses based on lifelong exposure to air pollution and prevalent cases of spectacles at baseline data collection campaign as well as longitudinal analyses based on incident cases of spectacles use and exposure to air pollution during the three-year period between the baseline and last data collection campaigns. Logistic regression models were developed to quantify the association between spectacles use and each of air pollutants adjusted for relevant covariates. Results An interquartile range increase in exposure to NO2 and PM2.5 absorbance at home was respectively associated with odds ratios (95% confidence intervals (CIs)) for spectacles use of 1.16 (1.03, 1.29) and 1.13 (0.99, 1.28) in cross-sectional analyses and 1.15 (1.00, 1.33) and 1.23 (1.03, 1.46) in longitudinal analyses. Similarly, odds ratio (95% CIs) of spectacles use associated with an interquartile range increase in exposures to NO2 and black carbon at school was respectively 1.32 (1.09, 1.59) and 1.13 (0.97, 1.32) in cross-sectional analyses and 1.12 (0.84, 1.50) and 1.27 (1.03, 1.56) in longitudinal analyses. These findings were robust to a range of sensitivity analyses that we conducted. Conclusion We observed increased risk of spectacles use associated with exposure to traffic- related air pollution. These findings require further confirmation by future studies applying more refined outcome measures such as quantified visual acuity and separating different types of refractive errors.	[Dadvand, Payam; Nieuwenhuijsen, Mark J.; Basagana, Xavier; Pedrerol, Mar Alvarez-; Dalmau-Bueno, Albert; Cirach, Marta; Rivas, Ioar; Sunyer, Jordi] Ctr Res Environm Epidemiol CREAL, ISGlobal, Barcelona, Spain; [Dadvand, Payam; Nieuwenhuijsen, Mark J.; Basagana, Xavier; Pedrerol, Mar Alvarez-; Dalmau-Bueno, Albert; Cirach, Marta; Rivas, Ioar; Sunyer, Jordi] Pompeu Fabra Univ, Barcelona, Spain; [Dadvand, Payam; Nieuwenhuijsen, Mark J.; Basagana, Xavier; Pedrerol, Mar Alvarez-; Dalmau-Bueno, Albert; Cirach, Marta; Rivas, Ioar; Sunyer, Jordi] Ciber Epidemiol & Publ Hlth CIBERESP, Madrid, Spain; [Rivas, Ioar; Querol, Xavier] CSIC, Spanish Natl Res Council, IDAEA, Inst Environm Assessment & Water Res, Barcelona, Spain; [Brunekreef, Bert] Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands; [Brunekreef, Bert] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Morgan, Ian G.] Australian Natl Univ, Coll Med Biol & Environm, ARC Ctr Excellence Vis Sci, Res Sch Biol, Canberra, ACT, Australia; [Morgan, Ian G.] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Dept Prevent Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Sunyer, Jordi] IMIM Parc Salut Mar, Barcelona, Spain	ISGlobal; Pompeu Fabra University; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Diagnostico Ambiental y Estudios del Agua (IDAEA); Utrecht University; Utrecht University; Utrecht University Medical Center; Australian National University; Sun Yat Sen University; Institut Hospital del Mar d'Investigacions Mediques (IMIM)	Dadvand, P (corresponding author), Ctr Res Environm Epidemiol CREAL, ISGlobal, Barcelona, Spain.	payam.dadvand@isglobal.org	Sunyer, Jordi/G-6909-2014; Morgan, Ian G/D-1190-2009; Nieuwenhuijsen, Mark J/C-3914-2017; Dadvand, Payam/O-8053-2018; Querol, Xavier/E-2800-2014; Dalmau Bueno, Albert/AAG-6970-2022; Dalmau Bueno, Albert/AFL-6865-2022; Basagaña, Xavier/C-3901-2017; Rivas, Ioar/J-1505-2016	Sunyer, Jordi/0000-0002-2602-4110; Morgan, Ian G/0000-0002-4548-3574; Nieuwenhuijsen, Mark J/0000-0001-9461-7981; Dadvand, Payam/0000-0002-2325-1027; Querol, Xavier/0000-0002-6549-9899; Basagaña, Xavier/0000-0002-8457-1489; Rivas, Ioar/0000-0002-4743-619X	European Research Council under the ERC Grant [268479]; Ramon y Cajal fellowship - Spanish Ministry of Economy and Competitiveness [RYC-2012-10995]	European Research Council under the ERC Grant; Ramon y Cajal fellowship - Spanish Ministry of Economy and Competitiveness	The research leading to these results has received funding from the European Research Council under the ERC Grant Agreement number 268479 - the BREATHE project. Payam Dadvand is funded by a Ramon y Cajal fellowship (RYC-2012-10995) awarded by the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to all the families and schools participating in the study for their altruism and their collaboration. The research leading to these results has received funding from the European Research Council under the ERC Grant Agreement number 268479 -the BREATHE project. Payam Dadvand is funded by a Ramon y Cajal fellowship (RYC-2012-10995) awarded by the Spanish Ministry of Economy and Competitiveness.	Adar SD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000372; Ajuntament de Barcelona, 2012, DAD BAS MOB 2011; Amato F, 2009, ATMOS ENVIRON, V43, P2770, DOI 10.1016/j.atmosenv.2009.02.039; Beelen R, 2013, ATMOS ENVIRON, V72, P10, DOI 10.1016/j.atmosenv.2013.02.037; Beuerman RW, 2010, MYOPIA ANIMAL MODELS; Borchert MS, 2011, OPHTHALMOLOGY, V118, P1966, DOI 10.1016/j.ophtha.2011.06.030; Bronzetti E, 2007, EUR J HISTOCHEM, V51, P251; Bruce N, 2000, B WORLD HEALTH ORGAN, V78, P1078; Cesaroni G, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-48; Chen TC, 2010, INVEST OPHTH VIS SCI, V51, P6140, DOI 10.1167/iovs.10-5234; Chinnery HR, 2012, AM J PATHOL, V180, P209, DOI 10.1016/j.ajpath.2011.09.041; Cumberland PM, 2007, BRIT J OPHTHALMOL, V91, P151, DOI 10.1136/bjo.2006.102277; Dadvand P, 2015, P NATL ACAD SCI USA, V112, P7937, DOI 10.1073/pnas.1503402112; Dadvand P, 2013, ENVIRON HEALTH PERSP, V121, P1365, DOI 10.1289/ehp.1206430; Dolgin E, 2015, NATURE, V519, P276, DOI 10.1038/519276a; Eeftens M, 2012, ENVIRON SCI TECHNOL, V46, P11195, DOI 10.1021/es301948k; Eeftens M, 2011, OCCUP ENVIRON MED, V68, P765, DOI 10.1136/oem.2010.061135; El-Shazly AA, 2012, OPHTHAL PHYSL OPT, V32, P304, DOI 10.1111/j.1475-1313.2012.00918.x; Fernandes M, 2014, ACTA OPHTHALMOLOGICA; Freeman EE, 2010, OPHTHAL EPIDEMIOL, V17, P301, DOI 10.3109/09286586.2010.508354; Goto E, 2002, AM J OPHTHALMOL, V133, P181, DOI 10.1016/S0002-9394(01)01365-4; Guggenheim JA, 2012, INVEST OPHTH VIS SCI, V53, P2856, DOI 10.1167/iovs.11-9091; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075260; He MG, 2015, JAMA-J AM MED ASSOC, V314, P1142, DOI 10.1001/jama.2015.10803; Herbort Carl P, 2011, J Ophthalmic Vis Res, V6, P270; Holden B, 2014, EYE, V28, P142, DOI 10.1038/eye.2013.256; Ip JM, 2008, INVEST OPHTH VIS SCI, V49, P3858, DOI 10.1167/iovs.07-1451; Katz J, 1997, INVEST OPHTH VIS SCI, V38, P334; Kolodjaschna J, 2004, AM J PHYSIOL-HEART C, V287, pH691, DOI 10.1152/ajpheart.01240.2003; Leone JF, 2010, ARCH OPHTHALMOL-CHIC, V128, P894, DOI 10.1001/archophthalmol.2010.134; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu ZG, 1999, CORNEA, V18, P403, DOI 10.1097/00003226-199907000-00002; Liu ZG, 1999, OPHTHALMOLOGY, V106, P939, DOI 10.1016/S0161-6420(99)00513-8; Lougheed T, 2014, ENVIRON HEALTH PERSP, V122, pA11, DOI 10.1289/ehp.122-A12; Louwies T, 2013, ENVIRON HEALTH PERSP, V121, P1011, DOI 10.1289/ehp.1205721; Macri A, 2014, GRAEFES ARCH CLIN EX; Martine  George, 2007, STATE WORLD POPULATI; McCluskey P, 2004, LANCET, V364, P2125, DOI 10.1016/S0140-6736(04)17554-5; Ministry of Public Works, 2012, ATL URB VULN SPAIN M; Torricelli AAM, 2011, ARQ BRAS OFTALMOL, V74, P377, DOI 10.1590/S0004-27492011000500016; Morgan I, 2005, PROG RETIN EYE RES, V24, P1, DOI 10.1016/j.preteyeres.2004.06.004; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Nguyen TT, 2008, DIABETES CARE, V31, P544, DOI 10.2337/dc07-1528; Njie-Mbye YF, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00366; Pan CW, 2012, OPHTHAL PHYSL OPT, V32, P3, DOI 10.1111/j.1475-1313.2011.00884.x; Rahi JS, 2011, OPHTHALMOLOGY, V118, P797, DOI 10.1016/j.ophtha.2010.09.025; Rivas I, 2014, ENVIRON INT, V69, P200, DOI 10.1016/j.envint.2014.04.009; Rymer J, 2005, VISUAL NEUROSCI, V22, P251, DOI 10.1017/S0952523805223015; Sacca SC, 2013, MUTAT RES-REV MUTAT, V752, P153, DOI 10.1016/j.mrrev.2013.01.001; Saw SM, 2006, INVEST OPHTH VIS SCI, V47, P1839, DOI 10.1167/iovs.05-1081; Smith JA, 2007, OCUL SURF, V5, P93; Sunyer J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001792; Tau J, 2013, INVEST OPHTH VIS SCI, V54, P4759, DOI 10.1167/iovs.12-10541; Tong L, 2002, OPTOMETRY VISION SCI, V79, P606, DOI 10.1097/00006324-200209000-00012; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wakamatsu TH, 2008, ARQ BRAS OFTALMOL, V71, P72, DOI 10.1590/S0004-27492008000700015; Williams C, 2008, BRIT J OPHTHALMOL, V92, P959, DOI 10.1136/bjo.2007.134700; WILLIAMS RN, 1982, CURR EYE RES, V2, P465, DOI 10.3109/02713688208996350; Wojciechowski R, 2011, CLIN GENET, V79, P301, DOI 10.1111/j.1399-0004.2010.01592.x; Wolfram C, 2014, BRIT J OPHTHALMOL, V98, P857, DOI 10.1136/bjophthalmol-2013-304228; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; World Health Organisation (WHO), 2021, AMBIENT OUTDOOR AIR; Xiang F, 2013, EYE, V27, P1353, DOI 10.1038/eye.2013.194	63	20	20	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0167046	10.1371/journal.pone.0167046	http://dx.doi.org/10.1371/journal.pone.0167046			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369072	Green Published, Green Submitted, gold			2022-12-26	WOS:000399351000002
J	Reid, REB; Koch, PL				Reid, Rachel E. B.; Koch, Paul L.			Isotopic ecology of coyotes from scat and road kill carcasses: A complementary approach to feeding experiments	PLOS ONE			English	Article							INCORPORATING CONCENTRATION-DEPENDENCE; STABLE-ISOTOPES; DISCRIMINATION FACTORS; DIETARY VARIABILITY; NITROGEN ISOTOPES; CARBON ISOTOPES; FECAL ANALYSIS; FECES; FRACTIONATION; DELTA-N-15	Scat is frequently used to study animal diets because it is easy to find and collect, but one concern is that gross fecal analysis (GFA) techniques exaggerate the importance of smallbodied prey to mammalian mesopredator diets. To capitalize on the benefits of scat, we suggest the analysis of scat carbon and nitrogen isotope values (delta(13) C and delta(15) N). This technique offers researchers a non-invasive method to gather short-term dietary information. We conducted three interrelated studies to validate the use of isotopic values from coyote scat: 1) we determined tissue-to-tissue apparent C and N isotope enrichment factors (e(13)* and e(15)*) for coyotes from road kill animals (n = 4); 2) we derived diet-to-scat isotope discrimination factors for coyotes; and 3) we used field collected coyote scats (n = 12) to compare estimates of coyote dietary proportions from stable isotope mixing models with estimates from two GFA techniques. Scat consistently had the lowest d13 C and d15 N values among the tissues sampled. We derived a diet-to-scat Delta C-13 value of -1.5 parts per thousand +/- 1.6 parts per thousand and Delta(15) N value of 2.3 parts per thousand +/- 1.3 parts per thousand for coyotes. Coyote scat delta(13) C and delta(15) N values adjusted for discrimination consistently plot within the isotopic mixing space created by known dietary items. In comparison with GFA results, we found that mixing model estimates of coyote dietary proportions de-emphasize the importance of small-bodied prey. Coyote scat delta(13) C and delta N-15 values therefore offer a relatively quick and non-invasive way to gain accurate dietary information.	[Reid, Rachel E. B.; Koch, Paul L.] Univ Calif Santa Cruz, Earth & Planetary Sci Dept, Santa Cruz, CA 95064 USA; [Reid, Rachel E. B.] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA	University of California System; University of California Santa Cruz; Washington University (WUSTL)	Reid, REB (corresponding author), Univ Calif Santa Cruz, Earth & Planetary Sci Dept, Santa Cruz, CA 95064 USA.; Reid, REB (corresponding author), Washington Univ, Dept Anthropol, St Louis, MO 63130 USA.	rachel.beth.brown@gmail.com		Reid, Rachel/0000-0002-2091-0701	National Science Foundation, Directorate of Biological Sciences, Doctoral Dissertation Improvement Grant [DEB-467 1311431]; Mildred E. Mathias Graduate Student Research Grant	National Science Foundation, Directorate of Biological Sciences, Doctoral Dissertation Improvement Grant; Mildred E. Mathias Graduate Student Research Grant	This research was funded by a National Science Foundation, Directorate of Biological Sciences, Doctoral Dissertation Improvement Grant (DEB-467 1311431) to PLK and REBR as well as a Mildred E. Mathias Graduate Student Research Grant (http://www.ucnrs.org/grants/mathias-grant.html) to REBR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE SH, 1991, J ARCHAEOL SCI, V18, P293, DOI 10.1016/0305-4403(91)90067-Y; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Balter V, 2006, OECOLOGIA, V147, P212, DOI 10.1007/s00442-005-0263-5; Blumenthal SA, 2012, P NATL ACAD SCI USA, V109, P21277, DOI 10.1073/pnas.1215782109; Bosley KL, CAN J FISH AQUAT SCI; Botha MS, 2005, S AFR J SCI, V101, P371; BROWN TA, 1988, RADIOCARBON, V30, P171, DOI 10.1017/S0033822200044118; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; COATES DB, 1991, J AGR SCI, V116, P287, DOI 10.1017/S0021859600077704; Codron D, 2007, J ZOOL, V273, P21, DOI 10.1111/j.1469-7998.2007.00292.x; Codron D, 2006, AM J PHYS ANTHROPOL, V129, P204, DOI 10.1002/ajpa.20253; Codron D, 2005, S AFR J WILDL RES, V35, P43; Codron D, 2011, CAN J ZOOL, V89, P453, DOI [10.1139/Z11-010, 10.1139/z11-010]; Codron D, 2009, MAMM BIOL, V74, P36, DOI 10.1016/j.mambio.2007.12.005; COFFEY R. J., 1940, American Journal of Digestive Diseases, V7, P141; Crowley BE, 2010, OECOLOGIA, V164, P611, DOI 10.1007/s00442-010-1701-6; Debelica Anica, 2009, Texas Tech University Museum Special Publications, V55, P1; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; del Rio CM, 2005, PHYSIOLOGICAL ADAPTATIONS TO FEEDING INVERTEBRATES, P141; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DOBUSH GR, 1985, CAN J ZOOL, V63, P1917, DOI 10.1139/z85-285; Fedriani JM, 2001, ECOGRAPHY, V24, P325, DOI 10.1034/j.1600-0587.2001.240310.x; Fedriani JM, 2001, ECOL LETT, V4, P477, DOI 10.1046/j.1461-0248.2001.00250.x; FLOYD TJ, 1978, J WILDLIFE MANAGE, V42, P528, DOI 10.2307/3800814; Fourqurean JW, 2003, CHEM ECOL, V19, P373, DOI 10.1080/02757540310001609370; Fuller MF, 1998, ANNU REV NUTR, V18, P385, DOI 10.1146/annurev.nutr.18.1.385; Gier HT, 1968, COYOTES IN KANSAS, P1; Godbois IA, 2005, WILDLIFE SOC B, V33, P149, DOI 10.2193/0091-7648(2005)33[149:EODOML]2.0.CO;2; Hatch KA, 2011, URSUS, V22, P133, DOI 10.2192/URSUS-D-10-00034.1; HAWTHORNE VM, 1972, CALIF FISH GAME, V58, P4; Hobson KA, 2014, ISOT ENVIRON HEALT S, P1; Hwang YT, 2007, CAN J ZOOL, V85, P388, DOI 10.1139/Z07-019; Jacob U, 2005, MAR ECOL PROG SER, V287, P251, DOI 10.3354/meps287251; Kelly BT, 1997, CAN J ZOOL, V75, P1811, DOI 10.1139/z97-810; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Klare U, 2011, MAMMAL REV, V41, P294, DOI 10.1111/j.1365-2907.2011.00183.x; Koch PL, 2007, ECOL METHOD CONCEPT, P99, DOI 10.1002/9780470691854.ch5; Koch PL, 2002, OECOLOGIA, V133, P14, DOI 10.1007/s00442-002-0977-6; Kurle CM, 2014, ISOT ENVIRON HEALT S, P1; MAYER WV, 1952, AM MIDL NAT, V48, P480, DOI 10.2307/2422262; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; McDonald JE, 2005, J MAMMAL, V86, P1022, DOI 10.1644/1545-1542(2005)86[1022:EOSAAO]2.0.CO;2; McLaren AAD, 2015, WILDLIFE SOC B, V39, P788, DOI 10.1002/wsb.599; McMahon KW, 2015, ECOL EVOL, V5, P1278, DOI 10.1002/ece3.1437; MERIWETHER D, 1980, J MAMMAL, V61, P774, DOI 10.2307/1380339; MEYERS PA, 1994, CHEM GEOL, V114, P289, DOI 10.1016/0009-2541(94)90059-0; Montanari S, 2015, RAPID COMMUN MASS SP, V29, P1062, DOI 10.1002/rcm.7194; O'Connell TC, 1999, AM J PHYS ANTHROPOL, V108, P409, DOI 10.1002/(SICI)1096-8644(199904)108:4&lt;409::AID-AJPA3&gt;3.0.CO;2-E; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Passey BH, 2005, J ARCHAEOL SCI, V32, P1459, DOI 10.1016/j.jas.2005.03.015; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; PRAHL FG, 1994, GEOCHIM COSMOCHIM AC, V58, P3035, DOI 10.1016/0016-7037(94)90177-5; Prugh LR, 2008, WILDLIFE BIOL, V14, P318, DOI 10.2981/0909-6396(2008)14[318:UOFGTD]2.0.CO;2; PUTMAN RJ, 1984, MAMMAL REV, V14, P79, DOI 10.1111/j.1365-2907.1984.tb00341.x; Reid REB, 2015, WILDLIFE BIOL, V21, P254, DOI 10.2981/wlb.00105; REYNOLDS JC, 1991, MAMMAL REV, V21, P97, DOI 10.1111/j.1365-2907.1991.tb00113.x; Robbins C. T., 1993, WILDLIFE FEEDING NUT; Robbins CT, 2010, OECOLOGIA, V162, P571, DOI 10.1007/s00442-009-1485-8; Robbins CT, 2005, OECOLOGIA, V144, P534, DOI 10.1007/s00442-005-0021-8; Robinson TF, 2005, SMALL RUMINANT RES, V58, P123, DOI 10.1016/j.smallrumres.2004.09.005; Roth JD, 2000, CAN J ZOOL, V78, P848, DOI 10.1139/cjz-78-5-848; Salvarina I, 2013, RAPID COMMUN MASS SP, V27, P1945, DOI 10.1002/rcm.6649; Santini A, 2007, MOL ECOL NOTES, V7, P955, DOI 10.1111/j.1471-8286.2007.01829.x; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; Schwarm A, 2009, J ANIM PHYSIOL AN N, V93, P596, DOI 10.1111/j.1439-0396.2008.00842.x; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Spaulding R, 2000, WILDLIFE SOC B, V28, P947; Sponheimer M, 2003, CAN J ZOOL, V81, P871, DOI 10.1139/Z03-066; Sponheimer M, 2003, J ARCHAEOL SCI, V30, P1649, DOI 10.1016/S0305-4403(03)00066-9; Sponheimer M, 2003, INT J OSTEOARCHAEOL, V13, P80, DOI 10.1002/oa.655; Sterner RW, 2002, STOICHIOMETRY HOMEOS, P1; SUTOH M, 1993, J ANIM SCI, V71, P226, DOI 10.2527/1993.711226x; SUTOH M, 1987, Radioisotopes, V36, P74, DOI 10.3769/radioisotopes.36.2_74; Team RC, 2015, R LANG ENV STAT COMP; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Tsutaya T, 2016, RAPID COMMUN MASS SP; TUMLISON R, 1983, SOUTHWEST NAT, V28, P315, DOI 10.2307/3670792; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Varo N, 2008, COMP BIOCHEM PHYS A, V149, P217, DOI 10.1016/j.cbpa.2007.12.002; WEAVER JL, 1979, J WILDLIFE MANAGE, V43, P783, DOI 10.2307/3808764; WEAVER JL, 1993, J WILDLIFE MANAGE, V57, P534, DOI 10.2307/3809278; WEDIN DA, 1995, ECOLOGY, V76, P1383, DOI 10.2307/1938142; Wittmer MHOM, 2010, BASIC APPL ECOL, V11, P83, DOI 10.1016/j.baae.2009.10.007	84	16	16	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174897	10.1371/journal.pone.0174897	http://dx.doi.org/10.1371/journal.pone.0174897			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2IH	28369133	Green Published, gold, Green Submitted			2022-12-26	WOS:000399351000059
J	Nguyen, VP; Kim, SW; Kim, H; Kim, H; Seok, KH; Jung, MJ; Ahn, YC; Kang, HW				Van Phuc Nguyen; Kim, Sung Won; Kim, Hanna; Kim, Hyejin; Seok, Kwang Hyuk; Jung, Min Jung; Ahn, Yeh-chan; Kang, Hyun Wook			Biocompatible astaxanthin as a novel marineoriented agent for dual chemo-photothermal therapy	PLOS ONE			English	Article							GOLD NANOPARTICLES; IN-VITRO; OPTICAL-PROPERTIES; INDOCYANINE GREEN; LASER TREATMENT; TARGETED DRUG; HUMAN HEALTH; ABLATION; CARCINOMA; TOXICITY	The photothermal effect of a marine-oriented xanthophyll carotenoid, astaxanthin (AXT), was characterized based on its potential absorption of visible laser light and conversion of optical light energy into heat for thermal treatment. As an antioxidant and anticancer agent, AXT extracted from marine material can be utilized for photothermal therapy due to its strong light absorption. The current study investigated the feasibility of the marine-based material AXT to increase the therapeutic efficacy of chemo-photothermal therapy (PTT) by assessing photothermal sessions in both cells and tumor tissues. A quasi-cw Q-switched 80 W532 nm laser system was utilized to induce thermal necrosis in in vitro and in vivo models. An in vitro cytotoxicity study of AXT was implemented using squamous cell carcinoma (VX2) and macrophage (246.7) cell lines. In vivo PTT experiments were performed on 17 rabbits bearing VX2 tumors on their eyes that were treated with or without intratumoral injection of AXT at a dose of 100 mu l (300 mu g/ml) followed by laser irradiation at a low irradiance of 0.11 W/cm(2). Fluorescence microscopy images revealed cellular death via apoptosis and necrosis owing to the dual chemo-photothermal effects induced by AXT. In vivo experimental results demonstrated that the AXT-assisted irradiation entailed a temperature increase by 30.4 degrees C after tumor treatment for 4 min. The relative variations in tumor volume confirmed that the tumors treated with both AXT and laser irradiation completely disappeared 14 days after treatment, but the tumors treated under other conditions gradually grew. Due to selective light absorption, AXT-assisted laser treatment could be an effective thermal therapy for various drug-resistant cancers.	[Van Phuc Nguyen; Kim, Hanna; Kim, Hyejin; Ahn, Yeh-chan; Kang, Hyun Wook] Pukyong Natl Univ, Interdisciplinary Program Biomed Mech & Elect Eng, Busan, South Korea; [Kim, Sung Won] Kosin Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Busan, South Korea; [Seok, Kwang Hyuk] Kosin Univ, Coll Med, Dept Biochem, Busan, South Korea; [Jung, Min Jung] Kosin Univ, Coll Med, Dept Pathol, Busan, South Korea; [Ahn, Yeh-chan; Kang, Hyun Wook] Pukyong Natl Univ, Dept Biomed Engn, Busan, South Korea; [Ahn, Yeh-chan; Kang, Hyun Wook] Pukyong Natl Univ, Ctr Marine Integrated Biomed Technol BK Plus 21, Busan, South Korea	Pukyong National University; Pukyong National University; Pukyong National University	Kang, HW (corresponding author), Pukyong Natl Univ, Interdisciplinary Program Biomed Mech & Elect Eng, Busan, South Korea.; Kang, HW (corresponding author), Pukyong Natl Univ, Dept Biomed Engn, Busan, South Korea.; Kang, HW (corresponding author), Pukyong Natl Univ, Ctr Marine Integrated Biomed Technol BK Plus 21, Busan, South Korea.	wkang@pukyong.ac.kr		Seok, Kwang Hyuk/0000-0003-3195-8775	Marine Biotechnology Program - Ministry of Oceans and Fisheries, Korea [20150220]	Marine Biotechnology Program - Ministry of Oceans and Fisheries, Korea	This research was supported by a grant from Marine Biotechnology Program (20150220) funded by Ministry of Oceans and Fisheries, Korea.; This research was supported by a grant from Marine Biotechnology Program (20150220) funded by Ministry of Oceans and Fisheries, Korea. We greatly thank Dr. Won Kyo Jung, Marine Bioengineering Laboratory for his technical supports.	Abe O, 2005, LANCET, V366, P2087; Ambati RR, 2014, MAR DRUGS, V12, P128, DOI 10.3390/md12010128; Anarjan N, 2011, LWT-FOOD SCI TECHNOL, V44, P1658, DOI 10.1016/j.lwt.2011.01.013; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Bharathiraja S, 2016, NANOMATERIALS-BASEL, V6, DOI 10.3390/nano6040078; Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502; BONADONNA G, 1976, NEW ENGL J MED, V294, P405, DOI 10.1056/NEJM197602192940801; BOUSSIBA S, 1991, PLANT CELL PHYSIOL, V32, P1077, DOI 10.1093/oxfordjournals.pcp.a078171; BUCHWALD M, 1968, BIOCHEMISTRY-US, V7, P834, DOI 10.1021/bi00842a042; Chen WR, 1996, CANCER LETT, V98, P169; Chew BP, 1999, ANTICANCER RES, V19, P1849; de la Zerda A, 2012, ACS NANO, V6, P4694, DOI 10.1021/nn204352r; Dickerson EB, 2008, CANCER LETT, V269, P57, DOI 10.1016/j.canlet.2008.04.026; Dowlatshahi K, 2002, AM J SURG, V184, P359, DOI 10.1016/S0002-9610(02)00942-X; El-Sayed IH, 2006, CANCER LETT, V239, P129, DOI 10.1016/j.canlet.2005.07.035; El-Sayed MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076207; FABIAN J, 1992, CHEM REV, V92, P1197, DOI 10.1021/cr00014a003; Fassett RG, 2011, MAR DRUGS, V9, P447, DOI 10.3390/md9030447; Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3; GSCHWIND M, 1995, J NEUROCHEM, V65, P292; Guerin M, 2003, TRENDS BIOTECHNOL, V21, P210, DOI 10.1016/S0167-7799(03)00078-7; Haraldsdottir KH, 2008, EJSO-EUR J SURG ONC, V34, P739, DOI 10.1016/j.ejso.2008.01.008; Higuera-Ciapara I, 2006, CRIT REV FOOD SCI, V46, P185, DOI 10.1080/10408690590957188; Huang XH, 2008, LASER MED SCI, V23, P217, DOI 10.1007/s10103-007-0470-x; Huang XH, 2010, J ADV RES, V1, P13, DOI 10.1016/j.jare.2010.02.002; Hussein G, 2006, J NAT PROD, V69, P443, DOI 10.1021/np050354+; Jain PK, 2007, PLASMONICS, V2, P107, DOI 10.1007/s11468-007-9031-1; Jing LJ, 2014, BIOMATERIALS, V35, P5814, DOI 10.1016/j.biomaterials.2014.04.005; Kim H, 2014, OPT LETT, V39, P2806, DOI 10.1364/OL.39.002806; Kim JW, 2009, NAT NANOTECHNOL, V4, P688, DOI 10.1038/nnano.2009.231; Kraatz BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012838; Kramer MW, 2011, WORLD J UROL, V29, P433, DOI 10.1007/s00345-011-0680-5; Kumar P, 2015, MAT SCI ENG C-MATER, V57, P321, DOI 10.1016/j.msec.2015.08.006; Kuo TR, 2010, J AM CHEM SOC, V132, P14163, DOI 10.1021/ja105360z; LANE CM, 1989, EYE, V3, P33, DOI 10.1038/eye.1989.5; Lemaster J.E., 2017, WILEY INTERDISCIP RE, V9; Li YB, 2010, NANOMEDICINE-UK, V5, P1161, DOI 10.2217/NNM.10.85; Lim S-a, 2011, KOREAN J HELICOBACTE, V11; LIZARD G, 1995, CYTOMETRY, V21, P275, DOI 10.1002/cyto.990210308; MAJNO G, 1995, AM J PATHOL, V146, P3; Meirow D, 2001, HUM REPROD UPDATE, V7, P535, DOI 10.1093/humupd/7.6.535; Moon HK, 2009, ACS NANO, V3, P3707, DOI 10.1021/nn900904h; Nagendraprabhu P, 2011, INVEST NEW DRUG, V29, P207, DOI 10.1007/s10637-009-9342-5; Nguyen VP, 2016, J BIOPHOTONICS; Niidome T, 2006, J CONTROL RELEASE, V114, P343, DOI 10.1016/j.jconrel.2006.06.017; O'Neal DP, 2004, CANCER LETT, V209, P171, DOI 10.1016/j.canlet.2004.02.004; Oak C, 2015, LASER SURG MED, V47, P704, DOI 10.1002/lsm.22409; Ong LC, 2016, ARCH TOXICOL, V90, P103, DOI 10.1007/s00204-014-1376-6; PALOZZA P, 1992, ARCH BIOCHEM BIOPHYS, V297, P291, DOI 10.1016/0003-9861(92)90675-M; Pashkow FJ, 2008, AM J CARDIOL, V101, p58D, DOI 10.1016/j.amjcard.2008.02.010; Peng CL, 2011, ACS NANO, V5, P5594, DOI 10.1021/nn201100m; Pietrow PK, 2001, J ENDOUROL, V15, P415, DOI 10.1089/089277901300189466; Spiller Gene A., 2003, Journal of Medicinal Food, V6, P51, DOI 10.1089/109662003765184741; Stewart JS, 2008, FOOD CHEM TOXICOL, V46, P3030, DOI 10.1016/j.fct.2008.05.038; SULTAN R A, 1990, Lasers in Medical Science, V5, P185, DOI 10.1007/BF02031380; SVAASAND L O, 1990, Lasers in Medical Science, V5, P121, DOI 10.1007/BF02031373; THOMSEN S, 1991, PHOTOCHEM PHOTOBIOL, V53, P825, DOI 10.1111/j.1751-1097.1991.tb09897.x; Yah CS, 2013, BIOMED RES-INDIA, V24, P400; Yang K, 2012, ADV MATER, V24, P5586, DOI 10.1002/adma.201202625; Yang K, 2012, BIOMATERIALS, V33, P2206, DOI 10.1016/j.biomaterials.2011.11.064; Yang K, 2010, NANO LETT, V10, P3318, DOI 10.1021/nl100996u; Yuan A, 2013, J PHARM SCI-US, V102, P6, DOI 10.1002/jps.23356; Yue CX, 2013, BIOMATERIALS, V34, P6853, DOI 10.1016/j.biomaterials.2013.05.071; Zha ZB, 2013, ADV MATER, V25, P777, DOI 10.1002/adma.201202211; Zhang JL, 2010, MOL PHARMACEUT, V7, P1159, DOI 10.1021/mp1000235; Zheng CF, 2012, BIOMATERIALS, V33, P5603, DOI 10.1016/j.biomaterials.2012.04.044; Zhou FF, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3078803	67	12	12	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174687	10.1371/journal.pone.0174687	http://dx.doi.org/10.1371/journal.pone.0174687			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369126	Green Published, Green Submitted, gold			2022-12-26	WOS:000399351000033
J	Li, NY; Liu, HX; Su, YM				Li, Ningyu; Liu, Huanxing; Su, Yumin			Numerical study on the hydrodynamics of thunniform bio-inspired swimming under self-propulsion	PLOS ONE			English	Article							FLUID-STRUCTURE INTERACTION; MACKEREL SCOMBER-JAPONICUS; IMMERSED BOUNDARY METHOD; INERTIAL FLOW REGIMES; OSCILLATING FOILS; REYNOLDS-NUMBER; CHUB MACKEREL; CAUDAL FIN; FISH PROPULSION; FLEXIBLE PLATE	Numerical simulations are employed to study the hydrodynamics of self-propelled thunniform swimming. The swimmer is modeled as a tuna-like flexible body undulating with kinematics of thunniform type. The wake evolution follows the vortex structures arranged nearly vertical to the forward direction, vortex dipole formation resulting in the propulsion motion, and finally a reverse Karman vortex street. We also carry out a systematic parametric study of various aspects of the fluid dynamics behind the freely swimming behavior, including the swimming speed, hydrodynamic forces, power requirement and wake vortices. The present results show that the fin thrust as well as swimming velocity is an increasing function of both tail undulating amplitude A(p) and oscillating amplitude of the caudal fin. theta(m). Whereas change on the propulsive performance with A(p) is associated with the strength of wake vortices and the area of suction region on the fin, the swimming performance improves with. theta(m) due to the favorable tilting of the fin that make the pressure difference force more oriented toward the thrust direction. Moreover, the energy loss in the transverse direction and the power requirement increase with A(p) but decrease with. theta(m), and this indicates that for achieving a desired swimming speed increasing. theta(m) seems more efficiently than increasing A(p). Furthermore, we have compared the current simulations with the published experimental studies on undulatory swimming. Comparisons show that our work tackles the flow regime of natural thunniform swimmers and follows the principal scaling law of undulatory locomotion reported. Finally, this study enables a detailed quantitative analysis, which is difficult to obtain by experiments, of the force production of the thunniform mode as well as its connection to the self-propelled swimming kinematics and vortex wake structure. The current findings help provide insights into the swimming performance and mechanisms of self-propelled thunniform locomotion.	[Li, Ningyu; Su, Yumin] Harbin Engn Univ, Sci & Technol Underwater Vehicle Lab, Harbin, Peoples R China; [Liu, Huanxing] Beijing Inst Specialized Machinery, Beijing, Peoples R China	Harbin Engineering University	Su, YM (corresponding author), Harbin Engn Univ, Sci & Technol Underwater Vehicle Lab, Harbin, Peoples R China.	fuwapt@163.com	Li, Ningyu/GSM-8619-2022		National Natural Science Foundation of China [51479039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work has been supported by National Natural Science Foundation of China (Grant No. 51479039). The URL of the funder's websiteis http://www.nsfc.gov.cn/. The author who received the funding is YS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar I, 2007, THEOR COMP FLUID DYN, V21, P155, DOI 10.1007/s00162-007-0045-2; Alben S, 2005, P NATL ACAD SCI USA, V102, P11163, DOI 10.1073/pnas.0505064102; Anderson J.M., 1996, THESIS; Anderson JM, 1998, J FLUID MECH, V360, P41, DOI 10.1017/S0022112097008392; ANSYS Inc, 2015, FLUENT 16 1 DOC; Barrett D.S., 1996, THESIS; Barrett DS, 1999, J FLUID MECH, V392, P183, DOI 10.1017/S0022112099005455; Ben-Gida H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080086; Borazjani I, 2010, J EXP BIOL, V213, P89, DOI 10.1242/jeb.030932; Borazjani I, 2008, J COMPUT PHYS, V227, P7587, DOI 10.1016/j.jcp.2008.04.028; Borazjani I, 2008, J EXP BIOL, V211, P1541, DOI 10.1242/jeb.015644; Borazjani I, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2071; Borazjani I, 2009, J EXP BIOL, V212, P576, DOI 10.1242/jeb.025007; BREDER C. M., 1926, ZOOLOGICA, V4, P159; Carling J, 1998, J EXP BIOL, V201, P3143; Chang XH, 2012, COMPUT FLUIDS, V68, P54, DOI 10.1016/j.compfluid.2012.08.004; Cheng Wei, 2004, RES SIMULATION CONTR; Dabiri JO, 2005, J EXP BIOL, V208, P3519, DOI 10.1242/jeb.01813; DEWAR H, 1994, J EXP BIOL, V192, P45; Donley JM, 2000, J EXP BIOL, V203, P3103; Ebrahimi M, 2015, APPL BIONICS BIOMECH, V2015, P1, DOI 10.1155/2015/325934; Fish FE, 2006, ANNU REV FLUID MECH, V38, P193, DOI 10.1146/annurev.fluid.38.050304.092201; Fish FE, 2000, PHASE RELATIONSHIPS; Gazzola M, 2012, J FLUID MECH, V698, P5, DOI 10.1017/jfm.2011.558; Gazzola M, 2014, NAT PHYS, V10, P758, DOI 10.1038/NPHYS3078; Gazzola M, 2011, J COMPUT PHYS, V230, P7093, DOI 10.1016/j.jcp.2011.04.025; Gibb AC, 1999, J EXP BIOL, V202, P2433; Graham JB, 2004, J EXP BIOL, V207, P4015, DOI 10.1242/jeb.01267; Guo J, 2009, AUTON ROBOT, V26, P241, DOI 10.1007/s10514-009-9117-z; Hanchi S, 2013, J FLUID STRUCT, V39, P275, DOI 10.1016/j.jfluidstructs.2013.02.019; Hu JX, 2014, J FLUID STRUCT, V46, P77, DOI 10.1016/j.jfluidstructs.2013.12.012; Hu WR, 2007, J HYDRODYN, V19, P395, DOI 10.1016/S1001-6058(07)60132-2; Hua RN, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4832857; Hubner B, 2002, P INT C LIGHTW STRUC; Hultmark M, 2007, EXP FLUIDS, V43, P683, DOI 10.1007/s00348-007-04I2-I; Johnson TA, 1999, J FLUID MECH, V378, P19, DOI 10.1017/S0022112098003206; Katumata Y., 2009, J BIOMECHANICAL SCI, V4, P54, DOI DOI 10.1299/JBSE.4.54; Kelly SD, 2010, THEOR COMP FLUID DYN, V24, P45, DOI 10.1007/s00162-009-0174-x; Lauder GV, 2012, INTEGR COMP BIOL, V52, P576, DOI 10.1093/icb/ics096; Lauder GV, 2000, AM ZOOL, V40, P101, DOI 10.1668/0003-1569(2000)040[0101:FOTCFD]2.0.CO;2; Lee JE, 2013, CONTR AUT SYST ICCAS; Lee J, 2013, COMPUT FLUIDS, V71, P348, DOI 10.1016/j.compfluid.2012.10.029; Lindsey CC, 1978, FISH PHYSIOL, VVII, DOI DOI 10.1016/S1546-5098(08)60163-6; Liu H, 1997, J EXP BIOL, V200, P2807; Liu H, 1996, J EXP BIOL, V199, P1245; Liu Huanxing, 2014, Journal of Huazhong University of Science and Technology (Natural Science Edition), V42, P117; Lu XY, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2357733; Magnuson J.J., 1979, FISH PHYSIOL, V7, P239, DOI DOI 10.1016/S1546-5098(08)60166-1; Muller UK, 1997, J EXP BIOL, V200, P2893; Muller UK, 2001, J EXP BIOL, V204, P2751; Namkoong K, 2005, J FLUID STRUCT, V20, P51, DOI 10.1016/j.jfluidstructs.2004.06.008; Nauen JC, 2002, J EXP BIOL, V205, P1709; Olivier M, 2016, J FLUID STRUCT, V64, P46, DOI 10.1016/j.jfluidstructs.2016.04.002; Pan DY, 2014, EUR J MECH B-FLUID, V46, P17, DOI 10.1016/j.euromechflu.2014.02.001; Park YJ, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/3/036002; Pedro G, 2003, INT J NUMER METH FL, V42, P493, DOI 10.1002/fld.525; Piperno S, 2001, COMPUT METHOD APPL M, V190, P3147, DOI 10.1016/S0045-7825(00)00386-8; Polidoro V., 2003, FLAPPING FOIL PROPUL; Read DA, 2003, J FLUID STRUCT, V17, P163, DOI 10.1016/S0889-9746(02)00115-9; Schultz WW, 2002, INTEGR COMP BIOL, V42, P1018, DOI 10.1093/icb/42.5.1018; [苏玉民 Su Yumin], 2013, [船舶力学, Journal of Ship Mechanics], V17, P468; Taylor GK, 2003, NATURE, V425, P707, DOI 10.1038/nature02000; TRIANTAFYLLOU GS, 1993, J FLUID STRUCT, V7, P205, DOI 10.1006/jfls.1993.1012; TRIANTAFYLLOU MS, 1995, SCI AM, V272, P64, DOI 10.1038/scientificamerican0395-64; Triantafyllou MS, 2000, ANNU REV FLUID MECH, V32, P33, DOI 10.1146/annurev.fluid.32.1.33; TRIANTAFYLLOU MS, 1991, PHYS FLUIDS A-FLUID, V3, P2835, DOI 10.1063/1.858173; Tytell ED, 2004, J EXP BIOL, V207, P1825, DOI 10.1242/jeb.00968; Tytell ED, 2007, EXP FLUIDS, V43, P701, DOI 10.1007/s00348-007-0343-x; Tytell ED, 2010, P NATL ACAD SCI USA, V107, P19832, DOI 10.1073/pnas.1011564107; van Rees WM, 2015, J FLUID MECH, V775, P178, DOI 10.1017/jfm.2015.283; van Rees WM, 2013, J FLUID MECH, V722, DOI 10.1017/jfm.2013.157; [王亮 Wang Liang], 2012, [力学学报, Chinese Journal of Theoretical and Applied Mechanics], V44, P179; WARDLE CS, 1989, J FISH BIOL, V35, P129, DOI 10.1111/j.1095-8649.1989.tb03399.x; WEBB PW, 1994, MECHANICS AND PHYSIOLOGY OF ANIMAL SWIMMING, P45; Wolfgang MJ, 1999, J EXP BIOL, V202, P2303; Wu TY, 2002, ADV APPL MECH, V38, P291, DOI 10.1016/S0065-2156(02)80105-3; Xia D, 2015, OCEAN ENG, V110, P1, DOI 10.1016/j.oceaneng.2015.10.008; Xiao Q, 2014, BIOINSPIR BIOMIM, V9, P15; Yan H, 2008, J BIONIC ENG, V5, P258, DOI 10.1016/S1672-6529(08)60033-5; Yang L, 2011, J BIONIC ENG, V8, P406, DOI 10.1016/S1672-6529(11)60046-2; Yang LA, 2011, CHINA OCEAN ENG, V25, P73, DOI 10.1007/s13344-011-0006-9; Yang Y, 2008, CHINESE PHYS LETT, V25, P597, DOI 10.1088/0256-307X/25/2/066; Yeh PD, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4876231; Young J, 2013, AIAA J, V51, P2727, DOI 10.2514/1.J052542; Zhang J, 2010, J FLUID MECH, V659, P43, DOI 10.1017/S0022112010002387; Zhang Q, 2001, COMPUT METHOD APPL M, V190, P6341, DOI 10.1016/S0045-7825(01)00231-6; Zhang X, 2011, J HYDRODYN, V23, P325, DOI 10.1016/S1001-6058(10)60119-9; Zhu Q, 2002, J FLUID MECH, V468, P1, DOI 10.1017/S002211200200143X; Zhu XJ, 2014, COMPUT FLUIDS, V97, P1, DOI 10.1016/j.compfluid.2014.03.031	90	35	36	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174740	10.1371/journal.pone.0174740	http://dx.doi.org/10.1371/journal.pone.0174740			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362836	gold, Green Published, Green Submitted			2022-12-26	WOS:000399175000030
J	Feng, YL; Yin, YX; Ding, J; Yuan, H; Yang, L; Xu, JJ; Hu, LQ				Feng, Ya-Ling; Yin, Yong-Xiang; Ding, Jian; Yuan, Hua; Yang, Lan; Xu, Jian-Juan; Hu, Ling-Qin			Alpha-1-antitrypsin suppresses oxidative stress in preeclampsia by inhibiting the p38MAPK signaling pathway: An in vivo and in vitro study	PLOS ONE			English	Article							ASSOCIATION; PREGNANCY; APOPTOSIS; PLACENTA; SYSTEM; P38	This present study was designed to investigate the effects of alpha-1-antitrypsin (AAT) on oxidative stress in preeclampsia (PE) by regulating p38 mitogen-activated protein kinase (p38MAPK) signaling pathway. HTR8/SVneo cells were randomly assigned into normal, hypoxia/reoxygenation (H/R), HR + AAT and HR + siRNA-AAT groups. Quantitative realtime polymerase chain reaction (qRT-PCR) and Western blotting were used to detect the mRNA and protein expressions of p-p38MAPK, AAT, signal transducer and activator of transcription 1 (STAT1) and activating transcription factor2 (ATF2). Flow cytometry, scratch test, cell counting kit-8 (CCK-8) assay and the 3-(4,5)-dimethylthiazol (-z-y1)-3,5-di-phenyltetrazolium bromide (MTT) assay were conducted to detect reactive oxygen species (ROS) and cell apoptosis, cell migration, proliferation and cytotoxicity, respectively. Mouse models in PE were established, which were divided into normal pregnancy (NP), PE and PE + AAT groups with blood pressure and urine protein measured. Chromatin immunoprecipitation (ChIP) and enzyme-linked immunosorbent assay (ELISA) were conducted to detect the activity of oxidative stress-related kinases and expressions of inflammatory cytokines and coagulation-related factors in cells and mice placenta. Immunohistochemistry, Western blotting and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay were performed to detect AAT and p38MAPK expressions, apoptosis-related protein expressions, and apoptosis rate in mice placenta. Compared with the normal group, the H/R group had decreased expression of AAT, activity of superoxide dismutase (SOD) and GSHPx, cell proliferation and migration, but increased p38MAPK, STAT1, ATF2, MDA, H2O2, inflammatory cytokines, coagulation-related factors, cell cytotoxicity, ROS, apoptotic factors and apoptosis rate. Compared with the H/R group, the HR + ATT group had increased expressions of AAT, activity of SOD and GSH-Px, cell proliferation and migration but decreased p38MAPK, STAT1, ATF2, malonyldialdehyde (MDA), H2O2, inflammatory cytokines and coagulation-related factors, cell cytotoxicity, ROS, apoptotic factors and apoptosis rate, while opposite results were observed in the HR + siRNA-ATT group. Compared	[Feng, Ya-Ling; Ding, Jian; Yuan, Hua; Yang, Lan; Xu, Jian-Juan; Hu, Ling-Qin] Nanjing Med Univ, Dept Obstet & Gynecol, Wuxi Matemal & Child Hlth Hosp, Wuxi, Peoples R China; [Yin, Yong-Xiang] Nanjing Med Univ, Dept Pathol, Affiliated Matern & Child Hlth Hosp, Wuxi, Peoples R China	Nanjing Medical University; Nanjing Medical University	Feng, YL; Hu, LQ (corresponding author), Nanjing Med Univ, Dept Obstet & Gynecol, Wuxi Matemal & Child Hlth Hosp, Wuxi, Peoples R China.	yalingf0817@163.com; lingqinxx@163.com			Jiangsu provincial science and Technology Department of the key disease standardized diagnosis and treatment project [BE2015618]; standardized diagnosis and treatment projects research program of Medical Science and Technology Development Fund of the Medical Control Center in Wuxi City [YGZXG1408]; Nature Sciences Foundation of Jiangsu Province [BK20141100]; Wuxi Maternal and Child Health-Care Hospital Dr. start fund research projects [2014BS06]; Maternal and Child Health research projecting Jiangsu province [F201422]	Jiangsu provincial science and Technology Department of the key disease standardized diagnosis and treatment project; standardized diagnosis and treatment projects research program of Medical Science and Technology Development Fund of the Medical Control Center in Wuxi City; Nature Sciences Foundation of Jiangsu Province; Wuxi Maternal and Child Health-Care Hospital Dr. start fund research projects; Maternal and Child Health research projecting Jiangsu province	This study was supported in part by a grant from Jiangsu provincial science and Technology Department of the key disease standardized diagnosis and treatment project (No. BE2015618), by a grant from standardized diagnosis and treatment projects research program of Medical Science and Technology Development Fund of the Medical Control Center in Wuxi City (No. YGZXG1408), by Nature Sciences Foundation of Jiangsu Province (No. BK20141100), by Wuxi Maternal and Child Health-Care Hospital Dr. start fund research projects (No. 2014BS06), and by Maternal and Child Health research projecting Jiangsu province (F201422). The authors are grateful to reviewers for critical comments to the manuscript.	Al-Omari M, 2011, MOL MED, V17, P865, DOI 10.2119/molmed.2011.00089; Bosco C., 2010, Cardiovascular & Hematological Agents in Medicinal Chemistry, V8, P87; Burton GJ, 2009, PLACENTA, V30, pS43, DOI 10.1016/j.placenta.2008.11.003; Catarino C, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/684384; Cindrova-Davies T, 2009, PLACENTA, V30, pS55, DOI 10.1016/j.placenta.2008.11.020; Cindrova-Davies T, 2007, AM J PATHOL, V170, P1511, DOI 10.2353/ajpath.2007.061035; CRYSTAL RG, 1990, J CLIN INVEST, V85, P1343, DOI 10.1172/JCI114578; D'Souza V, 2016, CLIN EXP HYPERTENS, V38, P225, DOI 10.3109/10641963.2015.1081226; Dordevic NZ, 2008, REPROD TOXICOL, V25, P213, DOI 10.1016/j.reprotox.2007.11.001; Du L, 2016, J HUM HYPERTENS; Ekmekci OB, 2015, ARCH GYNECOL OBSTET, V292, P53, DOI 10.1007/s00404-014-3601-1; Feng YL, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00176; Feng YL, 2015, J CARDIOVASC PHARM, V66, P96, DOI 10.1097/FJC.0000000000000250; Hung TH, 2008, PLACENTA, V29, P565, DOI 10.1016/j.placenta.2008.03.005; James JL, 2010, J PATHOL, V221, P363, DOI 10.1002/path.2719; Jonigk D, 2013, P NATL ACAD SCI USA, V110, P15007, DOI 10.1073/pnas.1309648110; Luo X, 2011, CELL TISSUE RES, V344, P551, DOI 10.1007/s00441-011-1164-z; Marcus NY, 2012, EXP BIOL MED, V237, P1163, DOI 10.1258/ebm.2012.012106; Meeme A, 2017, CARDIOVASC J AFR, V28, P23, DOI 10.5830/CVJA-2016-047; Mert I, 2012, J OBSTET GYNAECOL RE, V38, P658, DOI 10.1111/j.1447-0756.2011.01771.x; Myatt L, 1997, HUM REPROD, V12, P167, DOI 10.1093/humrep/12.1.167; Nagiah S, 2015, HUM EXP TOXICOL, V34, P838, DOI 10.1177/0960327114559992; Omatsu K, 2005, SEMIN THROMB HEMOST, V31, P314, DOI 10.1055/s-2005-872438; Rani N, 2010, J OBSTET GYNAECOL RE, V36, P1189, DOI 10.1111/j.1447-0756.2010.01303.x; Sanchez-Aranguren LC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00372; Savaj S, 2012, IRAN J KIDNEY DIS, V6, P334; Son GH, 2013, EUR J OBSTET GYN R B, V166, P139, DOI 10.1016/j.ejogrb.2012.10.011; Webster RP, 2006, MOL HUM REPROD, V12, P677, DOI 10.1093/molehr/gal071; Wu W, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002779; Zhou C, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011067; Zhou X, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.03.013; Zsila F, 2010, BIOCHEM BIOPH RES CO, V393, P242, DOI 10.1016/j.bbrc.2010.01.110	32	33	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0173711	10.1371/journal.pone.0173711	http://dx.doi.org/10.1371/journal.pone.0173711			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358847	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174800008
J	Li, YF; Morrow, J; Raby, B; Tantisira, K; Weiss, ST; Huang, W; Qiu, WL				Li, Yunfeng; Morrow, Jarrett; Raby, Benjamin; Tantisira, Kelan; Weiss, Scott T.; Huang, Wei; Qiu, Weiliang			Detecting disease-associated genomic outcomes using constrained mixture of Bayesian hierarchical models for paired data	PLOS ONE			English	Article							GENE-EXPRESSION; SELECTION	Detecting disease-associated genomic outcomes is one of the key steps in precision medicine research. Cutting-edge high-throughput technologies enable researchers to unbiasedly test if genomic outcomes are associated with disease of interest. However, these technologies also include the challenges associated with the analysis of genome-wide data. Two big challenges are (1) how to reduce the effects of technical noise; and (2) how to handle the curse of dimensionality (i.e., number of variables are way larger than the number of samples). To tackle these challenges, we propose a constrained mixture of Bayesian hierarchical models (MBHM) for detecting disease-associated genomic outcomes for data obtained from paired/matched designs. Paired/matched designs can effectively reduce effects of confounding factors. MBHM does not involve multiple testing, hence does not have the problem of the curse of dimensionality. It also could borrow information across genes so that it can be used for whole genome data with small sample sizes.	[Li, Yunfeng; Huang, Wei] Zhejiang Univ, Sch Math Sci, Hangzhou, Zhejiang, Peoples R China; [Morrow, Jarrett; Raby, Benjamin; Tantisira, Kelan; Weiss, Scott T.; Qiu, Weiliang] Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA	Zhejiang University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Qiu, WL (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA.	stwxq@channing.harvard.edu	Raby, Benjamin/AAK-3866-2021	Qiu, Weiliang/0000-0002-9155-6957; Morrow, Jarrett/0000-0002-5670-5865	NIH [R01 HL091528, R01 HL127332, U01 HL65899]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH R01 HL091528 (Scott T. Weiss), NIH R01 HL127332 (Kelan Tantisira) and U01 HL65899 (Kelan Tantisira) (littps://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avalos M, 2013, BMC BIOINFORM S6, V16, pS1; Ayari H, 2013, J BIOSCIENCES, V38, P311, DOI 10.1007/s12038-013-9310-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Chen Z, 2007, CORRELATIVE LEARNING: A BASIS FOR BRAIN AND ADAPTIVE SYSTEMS, P1; Goeman JJ, 2006, J ROY STAT SOC B, V68, P477, DOI 10.1111/j.1467-9868.2006.00551.x; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Gutierrez-Roelens I, 2011, ARTHRITIS RHEUM-US, V63, P1246, DOI 10.1002/art.30292; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Kendziorski CM, 2003, STAT MED, V22, P3899, DOI 10.1002/sim.1548; Kuriakose MA, 2004, CELL MOL LIFE SCI, V61, P1372, DOI 10.1007/s00018-004-4069-0; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Lo K, 2007, BIOINFORMATICS, V23, P328, DOI 10.1093/bioinformatics/btl612; MILLIGAN GW, 1986, MULTIVAR BEHAV RES, V21, P441, DOI 10.1207/s15327906mbr2104_5; Newton MA, 2001, J COMPUT BIOL, V8, P37, DOI 10.1089/106652701300099074; Oron AP, 2008, BIOINFORMATICS, V24, P2586, DOI 10.1093/bioinformatics/btn465; Qian J, 2014, BIOMETRICS, V70, P153, DOI 10.1111/biom.12113; Qiu WL, 2008, INT J BIOSTAT, V4, P20; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wu BL, 2005, BIOINFORMATICS, V21, P1565, DOI 10.1093/bioinformatics/bti217	21	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174602	10.1371/journal.pone.0174602	http://dx.doi.org/10.1371/journal.pone.0174602			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358896	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174800059
J	Yan, L; Zhang, QZ; Virolle, MJ; Xu, DL				Yan, Lan; Zhang, Qizhong; Virolle, Marie-Joelle; Xu, Delin			In conditions of over-expression, WblI, a WhiB-like transcriptional regulator, has a positive impact on the weak antibiotic production of Streptomyces lividans TK24	PLOS ONE			English	Article							POLYKETIDE SYNTHASE CPK; COELICOLOR A3(2); MORPHOLOGICAL-DIFFERENTIATION; GENE-CLUSTER; SECONDARY METABOLISM; OXIDATIVE STRESS; 4FE-4S CLUSTER; SIGMA-FACTOR; SPORULATION; PROTEIN	Regulators of the WhiB-like (wbl) family are playing important role in the complex regulation of metabolic and morphological differentiation in Streptomyces. In this study, we investigated the role of wblI, a member of this family, in the regulation of secondary metabolite production in Streptomyces lividans. The over-expression of wblI was correlated with an enhanced biosynthesis of undecylprodigiosin and actinorhodin and with a reduction of the biosynthesis of yCPK and of the grey spore pigment encoded by the whiE locus. Five regulatory targets of WblI were identified using in vitro formaldehyde crosslinking and confirmed by EMSA and qRT-PCR. These included the promoter regions of wblI itself, two genes of the ACT cluster (actVA3 and the intergenic region between the divergently orientated genes actII-1 and actII-2) and that of wblA, another member of the Wbl family. Quantitative RTPCR analysis indicated that the expression of actVA3 encoding a protein of unknown function as well as that of actII-1, a TetR regulator repressing the expression of actII-2, encoding the ACT transporter, were down regulated in the WblI over-expressing strain. Consistently the expression of the transporter actII-2 was up-regulated. The expression of WblA, that is known to have a negative impact on ACT biosynthesis, was strongly down regulated in the WblI over-expressing strain. These data are consistent with the positive impact that WblI over-expression has on ACT biosynthesis. The latter might result from direct activation of ACT biosynthesis and export and from repression of the expression of WblA, a likely indirect, repressor of ACT biosynthesis.	[Yan, Lan; Zhang, Qizhong; Xu, Delin] Jinan Univ, Key Lab Eutrophicat & Red Tide Prevent, Engn Res Ctr Trop & Subtrop Aquat Ecol Engn,Minis, Dept Ecol,Inst Hydrobiol,Sch Life Sci & Technol,G, Guangzhou, Guangdong, Peoples R China; [Virolle, Marie-Joelle] Univ Paris Saclay, Grp Energet Metab Streptomyces, I2BC, CEA,CNRS,Univ Paris Sud,INRA, Gif Sur Yvette, France	Chinese Academy of Sciences; Jinan University; CEA; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Xu, DL (corresponding author), Jinan Univ, Key Lab Eutrophicat & Red Tide Prevent, Engn Res Ctr Trop & Subtrop Aquat Ecol Engn,Minis, Dept Ecol,Inst Hydrobiol,Sch Life Sci & Technol,G, Guangzhou, Guangdong, Peoples R China.; Virolle, MJ (corresponding author), Univ Paris Saclay, Grp Energet Metab Streptomyces, I2BC, CEA,CNRS,Univ Paris Sud,INRA, Gif Sur Yvette, France.	marie-joelle.virolle@i2bc.paris-saclay.fr; xudelin@hotmail.com		virolle, marie-joelle/0000-0001-9509-4115	National Natural science Foundation of China [31300046]; Natural Science Foundation of Guangdong Province [S2013010013705, 2015A030313319]; PRES UniverSud Paris; Universite Paris Sud; CNRS	National Natural science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); PRES UniverSud Paris; Universite Paris Sud; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the National Natural science Foundation of China (No. 31300046) and the Natural Science Foundation of Guangdong Province (No. S2013010013705, 2015A030313319), the PRES UniverSud Paris, the Universite Paris Sud, and the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsa JA, 1999, MOL MICROBIOL, V34, P607, DOI 10.1046/j.1365-2958.1999.01630.x; Bibb MJ, 2012, MOL MICROBIOL, V84, P1033, DOI 10.1111/j.1365-2958.2012.08070.x; BIBB MJ, 1985, GENE, V38, P215, DOI 10.1016/0378-1119(85)90220-3; Burian J, 2013, NUCLEIC ACIDS RES, V41, P10062, DOI 10.1093/nar/gkt751; Bush MJ, 2016, MBIO, V7, DOI 10.1128/mBio.00523-16; Bush MJ, 2015, NAT REV MICROBIOL, V13, P749, DOI 10.1038/nrmicro3546; CABALLERO JL, 1991, MOL GEN GENET, V230, P401, DOI 10.1007/BF00280297; Casonato S, 2012, INFECT IMMUN, V80, P3132, DOI 10.1128/IAI.06328-11; Chater KF, 2008, J MICROBIOL, V46, P1, DOI 10.1007/s12275-007-0233-1; Crack JC, 2009, BIOCHEMISTRY-US, V48, P12252, DOI 10.1021/bi901498v; D'Alia D, 2011, MICROB BIOTECHNOL, V4, P239, DOI 10.1111/j.1751-7915.2010.00232.x; DAVIS NK, 1990, MOL MICROBIOL, V4, P1679, DOI 10.1111/j.1365-2958.1990.tb00545.x; den Hengst CD, 2010, MOL MICROBIOL, V78, P361, DOI 10.1111/j.1365-2958.2010.07338.x; Flardh K, 1999, MICROBIOL-SGM, V145, P2229, DOI 10.1099/00221287-145-9-2229; Flardh K, 2009, NAT REV MICROBIOL, V7, P36, DOI 10.1038/nrmicro1968; Fowler-Goldsworthy K, 2011, MICROBIOL-SGM, V157, P1312, DOI 10.1099/mic.0.047555-0; Gottelt M, 2010, MICROBIOL-SGM, V156, P2343, DOI 10.1099/mic.0.038281-0; Hackl S, 2015, ARCH PHARM, V348, P455, DOI 10.1002/ardp.201500073; Higo A, 2012, DNA RES, V19, P259, DOI 10.1093/dnares/dss010; Homerova D, 2003, FOLIA MICROBIOL, V48, P489, DOI 10.1007/BF02931330; Hopwood DA, 2007, STREPTOMYCES NATURE; Jakimowicz P, 2005, J BIOL CHEM, V280, P8309, DOI 10.1074/jbc.M412622200; Kaiser BK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00156; Kang SH, 2007, J BACTERIOL, V189, P4315, DOI 10.1128/JB.01789-06; Kelemen GH, 1998, J BACTERIOL, V180, P2515, DOI 10.1128/JB.180.9.2515-2521.1998; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kim JS, 2013, J MICROBIOL BIOTECHN, V23, P1365, DOI 10.4014/jmb.1306.06032; Kim JS, 2012, J MICROBIOL BIOTECHN, V22, P736, DOI 10.4014/jmb.1112.12032; Larsson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037516; Lee HN, 2013, APPL ENVIRON MICROB, V79, P4159, DOI 10.1128/AEM.00546-13; McCormick JR, 2012, FEMS MICROBIOL REV, V36, P206, DOI 10.1111/j.1574-6976.2011.00317.x; Molle V, 2000, J BACTERIOL, V182, P1286, DOI 10.1128/JB.182.5.1286-1295.2000; Pawlik K, 2007, ARCH MICROBIOL, V187, P87, DOI 10.1007/s00203-006-0176-7; Pawlik K, 2010, J MOL MICROB BIOTECH, V19, P147, DOI 10.1159/000321501; Persson J, 2013, FEMS MICROBIOL LETT, V341, P96, DOI 10.1111/1574-6968.12099; Ryding NJ, 1998, MOL MICROBIOL, V29, P343, DOI 10.1046/j.1365-2958.1998.00939.x; SANCHEZ J, 1985, CAN J MICROBIOL, V31, P942, DOI 10.1139/m85-177; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Smith LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040407; SOLIVERI J, 1992, J BACTERIOL, V174, P6215, DOI 10.1128/JB.174.19.6215-6220.1992; Soliveri JA, 2000, MICROBIOL-SGM, V146, P333, DOI 10.1099/00221287-146-2-333; Tschowri N, 2014, CELL, V158, P1136, DOI 10.1016/j.cell.2014.07.022; Xu DL, 2014, BIOCHEM BIOPH RES CO, V450, P513, DOI 10.1016/j.bbrc.2014.06.003; Xu DL, 2010, APPL ENVIRON MICROB, V76, P7741, DOI 10.1128/AEM.00819-10; Zheng F, 2012, CELL BIOCHEM BIOPHYS, V63, P103, DOI 10.1007/s12013-012-9348-z	46	2	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174781	10.1371/journal.pone.0174781	http://dx.doi.org/10.1371/journal.pone.0174781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358920	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174800088
J	Cankorur, VS; Duman, B; Taylor, C; Stewart, R				Cankorur, Vesile Senturk; Duman, Berker; Taylor, Clare; Stewart, Robert			Gender preference and perinatal depression in Turkey: A cohort study	PLOS ONE			English	Article							1ST POSTPARTUM YEAR; RISK-FACTORS; POSTNATAL DEPRESSION; SOCIAL SUPPORT; EASTERN TURKEY; TAMIL-NADU; WOMEN; PREVALENCE; INDIA; SYMPTOMS	Background Child gender preference is important in some cultures and has been found to modify risk for antenatal and postnatal depression. We investigated discrepancies in the child gender preference between participating women and other key family members and the extent to which these predicted perinatal depression. Methods In a large cohort study of perinatal depression in urban and rural Turkey, participants had been asked about child gender preferences: their own, and those of their husband, parents, and parents in-law. Of 730 participants recruited in their third trimester (94.6% participation), 578 (79.2%) were reassessed at a mean (SD) 4.1 (3.3) months after childbirth, and 488 (66.8%) were reassessed at 13.7 (2.9) months. Results No associations were found between any gender preference reported in the antenatal period and depression at any examination. On the other hand, we found associations of antenatal depression with differences in participant-reported gender preference and that reported for their mother-in-law (OR 1.81, 1.08-3.04). This non-agreement also predicted depression at the 4 month (OR 2.24, 1.24-4.03) and 14 month (OR 2.07, 1.05-4.04) postnatal examinations. These associations with postnatal depression persisted after adjustment for a range of covariates (ORs 3.19 (1.54-6.59) and 3.30 (1.49-7.33) respectively). Conclusions Reported disagreement in child gender preferences between a woman and her mother-in-law was a predictor of post-natal depression and may reflect wider family disharmony as an underlying factor.	[Cankorur, Vesile Senturk; Duman, Berker] Ankara Univ, Dept Psychiat, Fac Med, Ankara, Turkey; [Taylor, Clare; Stewart, Robert] Kings Coll London, Inst Psychiat, London, England; [Stewart, Robert] South London & Maudsley NHS Fdn Trust, London, England	Ankara University; University of London; King's College London; South London & Maudsley NHS Trust	Cankorur, VS (corresponding author), Ankara Univ, Dept Psychiat, Fac Med, Ankara, Turkey.	vesile.senturk@kcl.ac.uk	Duman, Berker/AAK-2637-2020; Stewart, Robert/B-1667-2010	Duman, Berker/0000-0001-9807-8989; Stewart, Robert/0000-0002-4435-6397; Taylor, Clare/0000-0002-6181-1400	Wellcome Trust [080100/Z/06/B]; National Institute for Health Research (NIHR) Biomedical Research Centre at South London; Maudsley NHS Foundation Trust and King's College London	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research (NIHR) Biomedical Research Centre at South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust and King's College London	The study was funded by a Wellcome Trust Masters Training Fellowship and a further Wellcome Trust PhD Prize Studentship awarded to the first author (grant number 080100/Z/06/B). RS is part-funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London.	Aydin N, 2005, WOMEN HEALTH, V41, P1, DOI 10.1300/J013v41n02_01; Aydin N, 2004, SOC PSYCH PSYCH EPID, V39, P483, DOI 10.1007/s00127-004-0770-4; Beck CT, 2001, NURS RES, V50, P275, DOI 10.1097/00006199-200109000-00004; BOOTH BE, 1994, BRIT MED J, V309, P1259, DOI 10.1136/bmj.309.6964.1259; Cankorur Senturk V, 2015, BMJ OPEN, V1; Chandran M, 2002, BRIT J PSYCHIAT, V181, P499, DOI 10.1192/bjp.181.6.499; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dennis CL, 2005, BMJ-BRIT MED J, V331, P15, DOI 10.1136/bmj.331.7507.15; Dhillon N, 2010, MIDWIFERY, V26, P286, DOI 10.1016/j.midw.2008.09.001; Dindar I, 2007, PUBLIC HEALTH NURS, V24, P176, DOI 10.1111/j.1525-1446.2007.00622.x; Ekuklu G, 2004, J REPROD MED, V49, P908; Engindeniz AN, 1996, BAHAR SEMPOZYUMLARI, P51; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Gayness BN, 2005, EVIDENCE REPORT TECH; Ghubash R, 1997, BRIT J PSYCHIAT, V171, P65, DOI 10.1192/bjp.171.1.65; Glasser S, 2000, J PSYCHOSOM OBST GYN, V21, P99, DOI 10.3109/01674820009075615; Inandi T, 2002, INT J EPIDEMIOL, V31, P1201, DOI 10.1093/ije/31.6.1201; Kamal HS, 1999, J OBSTET GYNAECOLOGY, V25, P43; Lancaster CA, 2010, AM J OBSTET GYNECOL, V202, P5, DOI 10.1016/j.ajog.2009.09.007; Lee DTS, 2004, BRIT J PSYCHIAT, V184, P34, DOI 10.1192/bjp.184.1.34; Murray L, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0662-5; Nielsen BB, 1997, BMJ-BRIT MED J, V314, P1521, DOI 10.1136/bmj.314.7093.1521; NORBECK JS, 1983, J HEALTH SOC BEHAV, V24, P30, DOI 10.2307/2136301; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Patel V, 2002, AM J PSYCHIAT, V159, P43, DOI 10.1176/appi.ajp.159.1.43; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Senturk V, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-48; Tezel A, 2006, PATIENT EDUC COUNS, V63, P64, DOI 10.1016/j.pec.2005.08.011; Wang SY, 2006, J PSYCHOSOM RES, V60, P303, DOI 10.1016/j.jpsychores.2005.08.012; Xie R, 2009, CAN J PSYCHIAT, V54, P856; Xie RH, 2007, SOC SCI MED, V65, P680, DOI 10.1016/j.socscimed.2007.04.003	31	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174558	10.1371/journal.pone.0174558	http://dx.doi.org/10.1371/journal.pone.0174558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VG	28355286	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174600064
J	Massardier-Galata, L; Morinay, J; Bailleul, F; Wajnberg, E; Guinet, C; Coquillard, P				Massardier-Galata, Lauriane; Morinay, Jennifer; Bailleul, Federic; Wajnberg, Eric; Guinet, Christophe; Coquillard, Patrick			Breeding success of a marine central place forager in the context of climate change: A modeling approach	PLOS ONE			English	Article							ANTARCTIC FUR SEALS; POLAR FRONTAL ZONE; ARCTOCEPHALUS-GAZELLA; MATERNAL CHARACTERISTICS; BODY-SIZE; BEHAVIOR; ENERGY; PREY; PREDATOR; SURVIVAL	In response to climate warming, a southward shift in productive frontal systems serving as the main foraging sites for many top predator species is likely to occur in Subantarctic areas. Central place foragers, such as seabirds and pinnipeds, are thus likely to cope with an increase in the distance between foraging locations and their land-based breeding colonies. Understanding how central place foragers should modify their foraging behavior in response to changes in prey accessibility appears crucial. A spatially explicit individual-based simulation model (Marine Central Place Forager Simulator (MarCPFS)), including bio-energetic components, was built to evaluate effects of possible changes in prey resources accessibility on individual performances and breeding success. The study was calibrated on a particular example: the Antarctic fur seal (Arctocephalus gazelle), which alternates between oceanic areas in which females feed and the land-based colony in which they suckle their young over a 120 days rearing period. Our model shows the importance of the distance covered to feed and prey aggregation which appeared to be key factors to which animals are highly sensitive. Memorization and learning abilities also appear to be essential breeding success traits. Females were found to be most successful for intermediate levels of prey aggregation and short distance to the resource, resulting in optimal female body length. Increased distance to resources due to climate warming should hinder pups' growth and survival while female body length should increase.	[Massardier-Galata, Lauriane; Coquillard, Patrick] Univ Cote dAzur, Nice, France; [Massardier-Galata, Lauriane; Wajnberg, Eric; Coquillard, Patrick] Univ Cote dAzur, INRA, CNRS, ISA, Valbonne, France; [Morinay, Jennifer; Bailleul, Federic; Guinet, Christophe] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS)	Massardier-Galata, L (corresponding author), Univ Cote dAzur, Nice, France.; Massardier-Galata, L (corresponding author), Univ Cote dAzur, INRA, CNRS, ISA, Valbonne, France.	lauriane.massardier@gmail.fr	Guinet, Christophe/AAR-8457-2020; Morinay, Jennifer/R-4535-2019	Morinay, Jennifer/0000-0002-7905-9691	French ANR (Agence Nationale de la Recherche); French Provence-Alpes-COte d'Azur region	French ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); French Provence-Alpes-COte d'Azur region(Region Provence-Alpes-Cote d'Azur)	This work was supported by the French ANR (Agence Nationale de la Recherche, MyctO3D-MAP, SVSE 7 2011, Y. Cherel). Ph.D. grant of the French Provence-Alpes-COte d'Azur region supported this work.	Abbott MR, 2000, DEEP-SEA RES PT II, V47, P3285, DOI 10.1016/S0967-0645(00)00069-2; Arnould JPY, 1996, J ZOOL, V239, P769, DOI 10.1111/j.1469-7998.1996.tb05477.x; Arnould JPY, 1996, PHYSIOL ZOOL, V69, P93, DOI 10.1086/physzool.69.1.30164202; Austin D, 2004, OIKOS, V105, P15, DOI 10.1111/j.0030-1299.1999.12730.x; Authier M, 2011, J EVOLUTION BIOL, V24, P607, DOI 10.1111/j.1420-9101.2010.02193.x; Bailleul F, 2005, MAR ECOL PROG SER, V293, P273, DOI 10.3354/meps293273; Bailleul F, 2010, ECOGRAPHY, V33, P709, DOI 10.1111/j.1600-0587.2009.06034.x; Beauplet G, 2006, OIKOS, V112, P430, DOI 10.1111/j.0030-1299.2006.14412.x; Beauplet G, 2005, J ANIM ECOL, V74, P1160, DOI 10.1111/j.1365-2656.2005.01016.x; Beauplet G, 2004, MAR ECOL PROG SER, V273, P211, DOI 10.3354/meps273211; Beauplet G, 2007, P R SOC B, V274, P1877, DOI 10.1098/rspb.2007.0454; Belkin IM, 1996, J GEOPHYS RES-OCEANS, V101, P3675, DOI 10.1029/95JC02750; BENHAMOU S, 1994, ANIM BEHAV, V47, P1423, DOI 10.1006/anbe.1994.1189; Benoit-Bird KJ, 2013, MAR ECOL PROG SER, V479, P283, DOI 10.3354/meps10209; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Bonadonna F, 2000, POLAR BIOL, V23, P149, DOI 10.1007/s003000050021; Bonadonna F, 2001, MAR ECOL PROG SER, V223, P287, DOI 10.3354/meps223287; Bonner W.N., 1984, Symposia of the Zoological Society of London, P253; Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Bost CA, 2009, J MARINE SYST, V783, P63; Bost CA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9220; BOYD IL, 1989, BEHAV ECOL SOCIOBIOL, V24, P377, DOI 10.1007/BF00293265; Boyd IL, 1999, BEHAV ECOL, V10, P198, DOI 10.1093/beheco/10.2.198; Boyd PW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014130; Brzek P, 2004, AUK, V121, P1187, DOI 10.1642/0004-8038(2004)121[1187:EOROGD]2.0.CO;2; Cairns DK, 2008, MAR ECOL PROG SER, V356, P239, DOI 10.3354/meps07286; Cherel Y, 1997, POLAR BIOL, V17, P87, DOI 10.1007/s003000050109; Ciannelli L, 2015, ICES J MAR SCI, V72, P285, DOI 10.1093/icesjms/fsu145; Coquillard P, 2012, ECOL MODEL, V242, P28, DOI 10.1016/j.ecolmodel.2012.05.019; COSTA DP, 1989, ECOLOGY, V70, P596, DOI 10.2307/1940211; Davies NB, INTRO BEHAV ECOLOGY, P4; Drinkwater KF, 2010, J MARINE SYST, V79, P374, DOI 10.1016/j.jmarsys.2008.12.014; Dumont B, 2001, ECOL MODEL, V141, P201, DOI 10.1016/S0304-3800(01)00274-5; Forcada J, 2014, NATURE, V511, P462, DOI 10.1038/nature13542; Gentry RL, 1986, FUR SEALS MATERNAL S, P291; Georges JY, 2000, ECOLOGY, V81, P295, DOI 10.2307/177427; Goldsworthy SD, 2004, POLAR BIOL, V27, P801, DOI 10.1007/s00300-004-0648-7; Taboada FG, 2012, CLIMATIC CHANGE, V115, P419, DOI 10.1007/s10584-012-0485-6; Grimm V, 1999, ECOL MODEL, V115, P129, DOI 10.1016/S0304-3800(98)00188-4; Grunbaum D, 1998, AM NAT, V151, P97, DOI 10.1086/286105; GUINET C, 1994, ANTARCT SCI, V6, P473, DOI 10.1017/S0954102094000714; Guinet C, 2001, MAR ECOL PROG SER, V219, P251, DOI 10.3354/meps219251; Guinet C, 2000, CAN J ZOOL, V78, P476, DOI 10.1139/cjz-78-3-476; Guinet C, 2014, MAR ECOL PROG SER, V499, P285, DOI 10.3354/meps10660; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Jaud T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047444; KREBS JR, 1977, ANIM BEHAV, V25, P30, DOI 10.1016/0003-3472(77)90064-1; Langton R, 2014, ECOL MODEL, V273, P31, DOI 10.1016/j.ecolmodel.2013.10.030; Lea MA, 2003, ICES J MAR SCI, V60, P990, DOI 10.1016/S1054-3139(03)00101-2; Lea MA, 2002, MAR ECOL PROG SER, V245, P281, DOI 10.3354/meps245281; Lea MA, 2002, POLAR BIOL, V25, P269, DOI 10.1007/s00300-001-0339-6; Lea MA, 2006, MAR ECOL PROG SER, V310, P77, DOI 10.3354/meps310077; Lehodey P, 2010, PROG OCEANOGR, V84, P69, DOI 10.1016/j.pocean.2009.09.008; Luque SP, 2007, CAN J ZOOL, V85, P1275, DOI 10.1139/Z07-092; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; Martinez C, 1999, ESTADISTICA MUESTREO; McCafferty DJ, 1998, MAR ECOL PROG SER, V166, P285, DOI 10.3354/meps166285; McKinney M.L., 1990, P75; Merkle JA, 2014, ECOL LETT, V17, P924, DOI 10.1111/ele.12294; Nabe-Nielsen J, 2013, OIKOS, V122, P1307, DOI 10.1111/j.1600-0706.2013.00069.x; Nonacs P, 2001, BEHAV ECOL, V12, P71, DOI 10.1093/oxfordjournals.beheco.a000381; Orians GH, 1977, THEORY CENTRAL PLACE, P153; Perrin N, 1998, FUNCT ECOL, V12, P500, DOI 10.1046/j.1365-2435.1998.00217.x; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; R Core Team, 2018, R LANG ENV STAT COMP; Reid K, 2005, CAN J ZOOL, V83, P604, DOI 10.1139/Z05-045; Schlather M, 2016, RANDOMFIELDS SIMULAT; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA, P256; Sibly RM, 2013, METHODS ECOL EVOL, V4, P151, DOI 10.1111/2041-210x.12002; Staniland IJ, 2007, MAR BIOL, V152, P233, DOI 10.1007/s00227-007-0698-9; Sverdrup H.U., 1953, ICES J MAR SCI, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; TRUJILLO A.P., 2008, ESSENTIALS OCEANOGRA; Turns J., 2014, POLAR REC, P1; Wilson PN, 1960, BIOL REV; Winship AJ, 2006, LOW WAKE FI, P177; [No title captured]	76	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0173797	10.1371/journal.pone.0173797	http://dx.doi.org/10.1371/journal.pone.0173797			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355282	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174600026
J	Pither, J; Botta, A; Maity, C; Ghosh, S				Pither, Jason; Botta, Amy; Maity, Chittaranjan; Ghosh, Sanjoy			Analysis using national databases reveals a positive association between dietary polyunsaturated fatty acids with TV watching and diabetes in European females	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; INSULIN-RESISTANCE; YOUNG ADULTHOOD; HIGH OMEGA-6; MEDIA USE; CHILDREN; RISK; ADOLESCENTS	In recent years, dietary polyunsaturated fatty acids (PUFA) have increased in parallel to sedentary behavior and diabetes across the world. To test any putative association between dietary PUFA and sedentary behavior or diabetes in females, we obtained country-specific, cross-sectional data on sedentary activity and diabetes prevalence from European Cardiovascular Statistics 2012. Age and gender-specific, nutritional data from each country were obtained from nutritional surveys as well. Socioeconomic (GDP), physical environment (urbanization index) and climatic confounders were accounted for each country. Upon analysis, we found a strong, positive association between sedentary lifestyle in 11-yr old girls (> = 2 hours of TV/weekday) and dietary PUFA across 21 European countries. Further, a weak association of dietary PUFA and a strong relationship of per-capita GDP was established with elevated fasting blood glucose [(> = 7.0 mmol/L; or on medication] among 25+ year old adult females across 23 countries in Europe. In summary, we present novel ecological evidence that dietary PUFA is strongly associated with sedentary behavior among pre-teen girls and weakly associated with diabetes among adult women across Europe. In the latter group, per-capita GDP was a significant predictor for diabetes as well. Therefore, we recommend that prospective randomized controlled trials (RCTs) be implemented to evaluate if ubiquitous presence of dietary PUFA and low socioeconomic status are possible confounders when intervening to treat/prevent sedentary lifestyle or diabetes in female subjects in Western nations.	[Pither, Jason; Botta, Amy; Ghosh, Sanjoy] Univ British Columbia Okanagan, IK Barber Sch Arts & Sci, Dept Biol, Kelowna, BC, Canada; [Maity, Chittaranjan] KPC Med Coll, Dept Biochem, Kolkata, W Bengal, India	University of British Columbia; University of British Columbia Okanagan	Ghosh, S (corresponding author), Univ British Columbia Okanagan, IK Barber Sch Arts & Sci, Dept Biol, Kelowna, BC, Canada.	sanjoy.ghosh@ubc.ca			MSFHR; Canadian Diabetes Association; NSERC; PEO Doctoral Award	MSFHR(Michael Smith Foundation for Health Research); Canadian Diabetes Association; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); PEO Doctoral Award	This work was supported by a salary award from the MSFHR to SG, operating grants from the Egg Farmers of Canada, Dairy Farmers of Canada and Canadian Diabetes Association to SG, NSERC to JP and a PEO Doctoral Award to AB. All authors declare no conflict of interest. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Abbatecola AM, 2009, REJUV RES, V12, P25, DOI 10.1089/rej.2008.0799; Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Alessandri JM, 2011, J NUTR BIOCHEM, V22, P820, DOI 10.1016/j.jnutbio.2010.07.005; Andersson T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104033; Assah FK, 2011, DIABETES CARE, V34, P491, DOI 10.2337/dc10-0990; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Botta A, 2016, JOURNAL OF AGRICULTU; Briend A, 2011, MATERN CHILD NUTR, V7, P141, DOI 10.1111/j.1740-8709.2011.00305.x; Brynes AE, 2000, AM J CLIN NUTR, V72, P1111; Centers for Disease Control National Center for Chronic Disease Prevention and Health Promotion, 2003, Nutr Clin Care, V6, P135; Conklin SM, 2007, PSYCHOSOM MED, V69, P932, DOI 10.1097/PSY.0b013e31815aaa42; Dinca-Panaitescu S, 2011, HEALTH POLICY, V99, P116, DOI 10.1016/j.healthpol.2010.07.018; Feinman RD, 2014, NUTRITION; Gajos JM, 2016, NEUROSCI BIOBEHAV R, V69, P147, DOI 10.1016/j.neubiorev.2016.07.017; German JB, 2004, AM J CLIN NUTR, V80, P550; Goodman A, 2012, J PHYS ACT HEALTH, V9, P1105, DOI 10.1123/jpah.9.8.1105; Gordon-Larsen P, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.6.e83; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Halton TL, 2008, AM J CLIN NUTR, V87, P339, DOI 10.1093/ajcn/87.2.339; Halton TL, 2006, NEW ENGL J MED, V355, P1991, DOI 10.1056/NEJMoa055317; Harika RK, 2013, ANN NUTR METAB, V63, P229, DOI 10.1159/000355437; Helge JW, 2001, J APPL PHYSIOL, V90, P670, DOI 10.1063/1.1380406; Hozyasz K. K., 2013, Journal of Food Research, V2, P29; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Kaveeshwar SA, 2014, AUSTRALAS MED J, V7, P45, DOI [10.4066/AMJ.2013.1979, 10.4066/AMJ.2014.1979]; Keim SA, 2013, MATERN CHILD NUTR; Kim JH, 2012, J FOOD SCI, V77, pH63, DOI 10.1111/j.1750-3841.2011.02522.x; Kolle E, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-36; Kris-Etherton PM, 1999, CIRCULATION, V100, P1253, DOI 10.1161/01.CIR.100.11.1253; Lambert J, 2004, BRIT J NUTR, V92, pS147, DOI 10.1079/BJN20041160; Madden SMM, 2009, J NUTR, V139, P528, DOI 10.3945/jn.108.100628; Marshall SJ, 2004, INT J OBESITY, V28, P1238, DOI 10.1038/sj.ijo.0802706; McNamee R, 2005, OCCUP ENVIRON MED, V62, P500, DOI 10.1136/oem.2002.001115; Micha Renata, 2014, BMJ, V348, pg2272, DOI 10.1136/bmj.g2272; Mohan V, 2007, INDIAN J MED RES, V125, P217; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Narasimhan Sowmya, 2016, Indian J Endocrinol Metab, V20, P47, DOI 10.4103/2230-8210.172248; OBARZANEK E, 1994, AM J CLIN NUTR, V60, P15, DOI 10.1093/ajcn/60.1.15; Ogden CL, 2000, JAMA-J AM MED ASSOC, V288, P1728, DOI DOI 10.1001/JAMA.288.14.1728; Paniagua JA, 2007, J AM COLL NUTR, V26, P434, DOI 10.1080/07315724.2007.10719633; PITA ML, 1985, ANN NUTR METAB, V29, P366, DOI 10.1159/000176993; Primack BA, 2009, ARCH GEN PSYCHIAT, V66, P181, DOI 10.1001/archgenpsychiatry.2008.532; RAHEJA BS, 1993, ANN NY ACAD SCI, V683, P258, DOI 10.1111/j.1749-6632.1993.tb35715.x; Rey-Lopez JP, 2008, NUTR METAB CARDIOVAS, V18, P242, DOI 10.1016/j.numecd.2007.07.008; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Santaliestra-Pasias AM, 2014, PUBLIC HEALTH NUTR, V17, P2295, DOI 10.1017/S1368980013002486; Saunders TJ, 2014, CAN J DIABETES, V38, P53, DOI 10.1016/j.jcjd.2013.08.266; Shapira N, 2007, EUR J CANCER PREV, V16, P486, DOI 10.1097/CEJ.0b013e3280145b6d; Shapira N, 2012, ISR MED ASSOC J, V14, P435; Silva S, 2015, AM J CLIN NUTR IN PR; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; Smuts CM, 2015, BRIT J NUTR, V113, P212, DOI 10.1017/S0007114514003493; Soriguer F, 2004, EUR J ENDOCRINOL, V150, P33, DOI 10.1530/eje.0.1500033; Stringhini S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5452; Tamayo T, 2014, DIABETES RES CLIN PR, V103, P206, DOI 10.1016/j.diabres.2013.11.007; Tanaka C, 2014, OBES REV, V15, P791, DOI 10.1111/obr.12195; Team RC, 2014, R LANG ENV STAT COMP; Telama R, 2000, MED SCI SPORT EXER, V32, P1617; Tofield A, 2013, EUR HEART J, V34, P77, DOI 10.1093/eurheartj/ehs400; Trang NHHD, 2013, AM J PREV MED, V44, P223, DOI 10.1016/j.amepre.2012.10.021; Tremblay MS, 2003, INT J OBESITY, V27, P1100, DOI 10.1038/sj.ijo.0802376; Waxman A, 2005, WORLD REV NUTR DIET, V95, P162, DOI 10.1159/000088302; Westerterp KR, 2010, NUTR REV, V68, P148, DOI 10.1111/j.1753-4887.2010.00270.x; Wong CK, 2015, J NUTR BIOCHEM, V26, P319, DOI 10.1016/j.jnutbio.2014.11.004; Yam D, 1996, ISRAEL J MED SCI, V32, P1134	65	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0173084	10.1371/journal.pone.0173084	http://dx.doi.org/10.1371/journal.pone.0173084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355278	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174600009
J	Ward-Caviness, CK; Neas, LM; Blach, C; Haynes, CS; LaRocque-Abramson, K; Grass, E; Dowdy, ZE; Devlin, RB; Diaz-Sanchez, D; Cascio, WE; Miranda, ML; Gregory, SG; Shah, SH; Kraus, WE; Hauser, ER				Ward-Caviness, Cavin K.; Neas, Lucas M.; Blach, Colette; Haynes, Carol S.; LaRocque-Abramson, Karen; Grass, Elizabeth; Dowdy, Z. Elaine; Devlin, Robert B.; Diaz-Sanchez, David; Cascio, Wayne E.; Miranda, Marie Lynn; Gregory, Simon G.; Shah, Svati H.; Kraus, William E.; Hauser, Elizabeth R.			A genome-wide trans-ethnic interaction study links the PIGR-FCAMR locus to coronary atherosclerosis via interactions between genetic variants and residential exposure to traffic	PLOS ONE			English	Article							AIR-POLLUTION; CARDIOVASCULAR-DISEASE; ENVIRONMENT INTERACTIONS; ULTRAFINE PARTICLES; ASSOCIATION; ROADWAY; RISK; EXPRESSION; RECEPTORS; IMMUNE	Air pollution is a worldwide contributor to cardiovascular disease mortality and morbidity. Traffic-related air pollution is a widespread environmental exposure and is associated with multiple cardiovascular outcomes such as coronary atherosclerosis, peripheral arterial disease, and myocardial infarction. Despite the recognition of the importance of both genetic and environmental exposures to the pathogenesis of cardiovascular disease, studies of how these two contributors operate jointly are rare. We performed a genome-wide interaction study (GWIS) to examine gene-traffic exposure interactions associated with coronary atherosclerosis. Using race-stratified cohorts of 538 African-Americans (AA) and 1562 European-Americans (EA) from a cardiac catheterization cohort (CATHGEN), we identify gene by-traffic exposure interactions associated with the number of significantly diseased coronary vessels as a measure of chronic atherosclerosis. We found five suggestive (P<1x10(-5)) interactions in the AA GWIS, of which two (rs1856746 and rs2791713) replicated in the EA cohort (P < 0.05). Both SNPs are in the PIGR-FCAMR locus and are eQTLs in lymphocytes. The protein products of both PIGR and FCAMR are implicated in inflammatory processes. In the EA GWIS, there were three suggestive interactions; none of these replicated in the AA GWIS. All three were intergenic; the most significant interaction was in a regulatory region associated with SAMSN1, a gene previously associated with atherosclerosis and B cell activation. In conclusion, we have uncovered several novel genes associated with coronary atherosclerosis in individuals chronically exposed to increased ambient concentrations of traffic air pollution. These genes point towards inflammatory pathways that may modify the effects of air pollution on cardiovascular disease risk.	[Ward-Caviness, Cavin K.; Blach, Colette; Haynes, Carol S.; LaRocque-Abramson, Karen; Grass, Elizabeth; Dowdy, Z. Elaine; Gregory, Simon G.; Shah, Svati H.; Kraus, William E.; Hauser, Elizabeth R.] Duke Univ, Sch Med, Duke Mol Physiol Inst, Durham, NC USA; [Ward-Caviness, Cavin K.] Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [Ward-Caviness, Cavin K.; Neas, Lucas M.; Devlin, Robert B.; Diaz-Sanchez, David; Cascio, Wayne E.] US EPA, Natl Hlth & Environm Effects Res Lab, Chapel Hill, NC USA; [Miranda, Marie Lynn] Rice Univ, Natl Ctr Geospatial Med, Houston, TX USA; [Shah, Svati H.; Kraus, William E.] Duke Univ, Sch Med, Div Cardiol, Durham, NC USA; [Hauser, Elizabeth R.] Duke Univ, Sch Med, Dept Biostat & Bioinformat, Durham, NC 27708 USA; [Hauser, Elizabeth R.] Vet Affairs Med Ctr, Cooperat Studies Program Epidemiol Ctr Durham, Durham, NC 27705 USA	Duke University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; United States Environmental Protection Agency; Rice University; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Hauser, ER (corresponding author), Duke Univ, Sch Med, Duke Mol Physiol Inst, Durham, NC USA.; Hauser, ER (corresponding author), Duke Univ, Sch Med, Dept Biostat & Bioinformat, Durham, NC 27708 USA.; Hauser, ER (corresponding author), Vet Affairs Med Ctr, Cooperat Studies Program Epidemiol Ctr Durham, Durham, NC 27705 USA.	elizabeth.hauser@duke.edu	Cascio, Wayne Eugene/GPG-0840-2022	Cascio, Wayne Eugene/0000-0003-1360-8093; Miranda, Marie Lynn/0000-0002-5670-0837; Gregory, Simon/0000-0002-7805-1743; Neas, Lucas/0000-0002-9377-8334; Hauser, Elizabeth/0000-0003-0367-9189	National Institutes of Health [HL095987, HL10621, HL36587]; Office of Research and Development, U.S. Environmental Protection Agency; Health Effects Institute [R-82811201]; National Institutes of Health [HL095987, HL10621, HL36587]; Office of Research and Development, U.S. Environmental Protection Agency; Health Effects Institute [R-82811201]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Development, U.S. Environmental Protection Agency(United States Environmental Protection Agency); Health Effects Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Development, U.S. Environmental Protection Agency(United States Environmental Protection Agency); Health Effects Institute	This work was supported by the following grants from the National Institutes of Health (nih. gov): HL095987, HL10621, and HL36587. This project was supported in part by an appointment to the Research Participation Program at the Office of Research and Development, U.S. Environmental Protection Agency (http://orise.orau.gov/epa/ applicants/current-research-opportunties.aspx). This work was supported in part by a grant from the Health Effects Institute (healtheffects.org) award number R-82811201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Ballinger SW, 2005, FREE RADICAL BIO MED, V38, P1278, DOI 10.1016/j.freeradbiomed.2005.02.014; Barratt J, 2004, PATHOGENESIS IGA NEP, P197; Beckerman BS, 2012, J TOXICOL ENV HEAL A, V75, P402, DOI 10.1080/15287394.2012.670899; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Cassandrini D, 2013, J INHERIT METAB DIS, V36, P43, DOI 10.1007/s10545-012-9487-9; Cesaroni G., 2014, BMJ, V348; Christensen R.H.B., 2010, ORDINAL REGRESSION M; Claudio J, 2001, ONCOGENE, V20, P5373, DOI 10.1038/sj.onc.1204698; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; ESRI, 2011, ARCGIS DESKT REL 10; Fu SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-369; Gan WQ, 2012, AM J EPIDEMIOL, V175, P898, DOI 10.1093/aje/kwr424; Ghosh R, 2016, ENVIRON HEALTH PERSP, V124, P193, DOI 10.1289/ehp.1408865; Hagler GSW, 2009, ATMOS ENVIRON, V43, P1229, DOI 10.1016/j.atmosenv.2008.11.024; Hoffmann B, 2007, EPIDEMIOLOGY, V18, pS75; Hoffmann B, 2007, CIRCULATION, V116, P489, DOI 10.1161/CIRCULATIONAHA.107.693622; Hoffmann B, 2009, BIOMARKERS, V14, P74, DOI 10.1080/13547500902965096; Hoffmann B, 2009, EPIDEMIOLOGY, V20, P280, DOI 10.1097/EDE.0b013e3181961ac2; HOOD L, 1985, CELL, V40, P225, DOI 10.1016/0092-8674(85)90133-3; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Kaufman JD, 2016, LANCET; Kraus WE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005553; Kraus WE, 2015, J CARDIOVASC TRANSL, V8, P449, DOI 10.1007/s12265-015-9648-y; Lanktree MB, 2009, GENOME MED, V1, DOI 10.1186/gm28; Li N, 2003, ENVIRON HEALTH PERSP, V111, P455, DOI 10.1289/ehp.6000; Li W, 2016, OBESITY; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Masud R, 2012, J CLINICAL BIOINFORM, V2; Maurano MT, 2015, NAT GENET, V47, P1393, DOI 10.1038/ng.3432; McDonald KJ, 2002, BIOCHEM BIOPH RES CO, V290, P438, DOI 10.1006/bbrc.2001.6218; McGuinn LA, 2016, ENVIRON RES, V145, P9, DOI 10.1016/j.envres.2015.10.026; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Mukerjee S, 2015, ATMOS POLLUT RES, V6, P82, DOI 10.5094/APR.2015.010; Murcray CE, 2009, AM J EPIDEMIOL, V169, P219, DOI 10.1093/aje/kwn353; NCDOT (North Carolina Department of Transportation), 2015, GIS DAT LAY STAT PRI; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Ohlmeier S, 2012, J PROTEOME RES, V11, P599, DOI 10.1021/pr2006395; Polfus LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074642; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; R Development Core Team, 2012, R LANG ENV STAT COMP; Rosenlund M, 2008, EPIDEMIOLOGY, V19, P121, DOI 10.1097/EDE.0b013e31815c1921; Shah SH, 2012, AM HEART J, V163, P844, DOI 10.1016/j.ahj.2012.02.005; Shah SH, 2010, CIRC-CARDIOVASC GENE, V3, P207, DOI 10.1161/CIRCGENETICS.109.852814; Sheffield NC, 2013, GENOME RES, V23, P777, DOI 10.1101/gr.152140.112; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Tabas I, 2011, NAT MED, V17, P791, DOI 10.1038/nm0711-791; U.S. Census Bureau, 2013, TIGER LIN SHAP TIGER; Wang Y, 2016, AM J EPIDEMIOLOGY; Ward-Caviness CK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152670; Ward-Caviness CK, 2015, ENVIRON HEALTH PERSP, V123, P1007, DOI 10.1289/ehp.1306980; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wines BD, 2006, TISSUE ANTIGENS, V68, P103, DOI 10.1111/j.1399-0039.2006.00613.x; Zanobetti A, 2011, PROG CARDIOVASC DIS, V53, P344, DOI 10.1016/j.pcad.2011.01.001; Zhu YF, 2002, J AIR WASTE MANAGE, V52, P1032, DOI 10.1080/10473289.2002.10470842; Zhu YX, 2004, J EXP MED, V200, P737, DOI 10.1084/jem.20031816; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	58	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0173880	10.1371/journal.pone.0173880	http://dx.doi.org/10.1371/journal.pone.0173880			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355232	Green Published, gold			2022-12-26	WOS:000399174600029
J	Fang, Y; Yu, NM; Wang, RL; Su, D				Fang, Yuan; Yu, Ningmei; Wang, Runlong; Su, Dong			An on-chip instrument for white blood cells classification based on a lens-less shadow imaging technique	PLOS ONE			English	Article							LEUKOCYTE; COUNTS; HEAT	Routine blood tests provide important basic information for disease diagnoses. The proportions of three subtypes of white blood cells (WBCs), which are neutrophils, monocytes, lymphocytes, is key information for disease diagnosis. However, current instruments for routine blood tests, such as blood cell analyzers, flow cytometers, and optical microscopes, are cumbersome, time consuming and expensive. To make a smaller, automatic low-cost blood cell analyzer, much research has focused on a technique called lens-less shadow imaging, which can obtain microscopic images of cells in a lens-less system. Nevertheless, the efficiency of this imaging system is not satisfactory because of two problems: low resolution and imaging diffraction phenomena. In this paper, a novel method of classifying cells with the shadow imaging technique was proposed. It could be used for the classification of the three subtypes of WBCs, and the correlation of the results of classification between the proposed system and the reference system (BC-5180, Mindray) was 0.93. However, the instrument was only 10 x 10 x 10 cm, and the cost was less than $100. Depending on the lens-free shadow imaging technology, the main hardware could be integrated on a chip scale and could be called an on-chip instrument.	[Fang, Yuan; Yu, Ningmei; Wang, Runlong; Su, Dong] Xian Univ & Technol, Sch Automat & Informat Engn, Xian, Shaanxi Provinc, Peoples R China; [Fang, Yuan] Baoji Univ Arts & Sci, Sch Elect & Elect Engn, Baoji, Shaanxi Provinc, Peoples R China	Xi'an University of Technology; Baoji University of Arts & Sciences	Yu, NM (corresponding author), Xian Univ & Technol, Sch Automat & Informat Engn, Xian, Shaanxi Provinc, Peoples R China.	yunm@xaut.edu.cn			National Natural Science foundation of China [61471296]; key discipline project in Shaanxi province of China [2014KW01-06]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC)); key discipline project in Shaanxi province of China	This work was supported by the National Natural Science foundation of China (No. 61471296, http://www.nsfc.gov.cn/) and the key discipline project in Shaanxi province of China under Grant (No. 2014KW01-06). The authors received no specific funding for this work.; This work was supported by the National Natural Science Foundation of China (No. 61471296) and the key discipline project in the Shaanxi Province of China under Grant (No. 2014KW01-06).	Camitta B. M., 2012, PEDIATRIA POLSKA, V87, P72, DOI 10.1016/S0031-3939(12)70597-8; Chung J, 2015, PLOS ONE, V10; FULWYLER MJ, 1965, SCIENCE, V150, P910, DOI 10.1126/science.150.3698.910; Ghosh P, 2016, APPL SOFT COMPUT, V46, P629, DOI 10.1016/j.asoc.2015.12.038; Hiremath P S, 2010, INT J COMPUTER APPL, V37, P59; Huang X, 2013, PLOS ONE, V9; Isikman S O, 2011, IEEE J SEL TOP QUANT, V18, P1; KRAMER MS, 1993, J CLIN EPIDEMIOL, V46, P349, DOI 10.1016/0895-4356(93)90149-U; Lee JB, 2014, NUTRIENTS, V6, P2466, DOI 10.3390/nu6062466; Lee S A, 2011, PLOS ONE, V6; Mohammed MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046860; Osma-Ruiz V, 2007, PATTERN RECOGN, V40, P1078, DOI 10.1016/j.patcog.2006.06.025; PETERSEN SE, 1979, EUR J CANCER, V15, P383, DOI 10.1016/0014-2964(79)90072-0; Putzu L, 2014, ARTIF INTELL MED, V62, P179, DOI 10.1016/j.artmed.2014.09.002; Roy M, 2014, SENSOR ACTUAT B-CHEM, V201, P321, DOI 10.1016/j.snb.2014.05.011; Severs Y, 1996, EUR J APPL PHYSIOL O, V74, P234, DOI 10.1007/BF00377446; Vroon DH, 1990, CLIN METHODS HIST PH; Yagi M, 2003, IEEE T NEURAL NETWOR, V14, P1144, DOI 10.1109/TNN.2003.819038	18	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174580	10.1371/journal.pone.0174580	http://dx.doi.org/10.1371/journal.pone.0174580			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350891	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174400060
J	Liu, QY; Liu, HM; Chen, CQ; Wang, JM; Han, Y; Long, ZF				Liu, Qingya; Liu, Huimei; Chen, Ciqiong; Wang, Jinmei; Han, Yu; Long, Zhangfu			Effects of element complexes containing Fe, Zn and Mn on artificial morel's biological characteristics and soil bacterial community structures	PLOS ONE			English	Article							WILD EDIBLE MUSHROOMS; MORCHELLA-ESCULENTA; DIVERSITY; CELLULOSOME; SEQUENCES; CONICA; CYCLE	This study described the effects of elements (including Fe, Zn, Mn and their complexes) on the following factors in artificial morel cultivation: the characteristics of mycelia and sclerotia, soil bacterial community structures, yields and contents of microelements. The results indicated that the groups containing Mn significantly promoted mycelia growth rates, and all the experimental groups resulted in higher yields than the control (P<0.01), although their mycelia and sclerotia did not show obvious differences. It was also found that Proteobacteria, Chloroflexi, Bacteroides, Firmicutes, Actinobacteria, Acidobacteria and Nitrospirae were the dominated bacterial phyla. The Zn-Fe group had an unexpectedly high proportion (75.49%) of Proteobacteria during the primordial differentiation stage, while Pseudomonas also occupied a high proportion (5.52%) in this group. These results suggested that different trace elements clearly affected morel yields and soil bacterial community structures, particularly due to the high proportions of Pseudomonas during the primordial differentiation stage.	[Liu, Qingya; Liu, Huimei; Chen, Ciqiong; Long, Zhangfu] Sichuan Univ, Coll Life Sci, Key Lab Bioresources & Ecoenvironm, Minist Educ, Chengdu, Peoples R China; [Wang, Jinmei; Han, Yu] Sichuan Tongfeng Sci & Technol Co Ltd, Chengdu, Peoples R China	Sichuan University	Long, ZF (corresponding author), Sichuan Univ, Coll Life Sci, Key Lab Bioresources & Ecoenvironm, Minist Educ, Chengdu, Peoples R China.	Lzf0028@163.com	Liu, Qing/GWC-9222-2022; liu, qingqing/HHD-0360-2022		National Science Foundation of China [J1103518]; Sichuan provience scientific support program [2016KZ0006, H130923]; Sichuan Tongfeng Sci & Technol Co. Ltd [No. 2010-01]; Tongfeng Science & Technology Co. Ltd	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan provience scientific support program; Sichuan Tongfeng Sci & Technol Co. Ltd; Tongfeng Science & Technology Co. Ltd	This work was partially supported by grants from the National Science Foundation of China (No. J1103518), Sichuan provience scientific support program (No. 2016KZ0006, H130923) and Sichuan Tongfeng Sci & Technol Co. Ltd (No. 2010-01). Tongfeng Science & Technology Co. Ltd. provied support in the form of salaries for authors JMW amd YH but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ayaz F. A., 2011, Food and Nutrition Sciences, V2, P53, DOI 10.4236/fns.2011.22007; Bond DR, 2003, APPL ENVIRON MICROB, V69, P1548, DOI 10.1128/AEM.69.3.1548-1555.2003; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chen SC, 2013, FUNGAL ECOL, V6, P110, DOI 10.1016/j.funeco.2012.08.003; Cheng Xiaoyan, 2009, Weishengwu Xuebao, V49, P718; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Falandysz J, 2013, APPL MICROBIOL BIOT, V97, P477, DOI 10.1007/s00253-012-4552-8; Gupta P, 2015, ARCH MICROBIOL, V197, P851, DOI 10.1007/s00203-015-1121-4; Haas D, 2003, ANNU REV PHYTOPATHOL, V41, P117, DOI 10.1146/annurev.phyto.41.052002.095656; Hartman WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057127; Hirsch P, 1998, SYST APPL MICROBIOL, V21, P374, DOI 10.1016/S0723-2020(98)80047-7; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Kalac P, 2000, FOOD CHEM, V69, P273, DOI 10.1016/S0308-8146(99)00264-2; Kanwal HK, 2011, CURR MICROBIOL, V62, P1245, DOI 10.1007/s00284-010-9849-1; Lakshmi KV, 2009, INT J SYST EVOL MICR, V59; Li A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-3; Li JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063275; Li Xue, 2013, African Journal of Microbiology Research, V7, P4707; Lin YT, 2014, BOT STUD, V55, DOI 10.1186/s40529-014-0050-x; Liu HG, 2012, BIOL TRACE ELEM RES, V147, P341, DOI 10.1007/s12011-012-9321-0; Liu HM, 2015, SCI HORTIC-AMSTERDAM, V189, P86, DOI 10.1016/j.scienta.2015.03.047; Long YH, 2010, INSECT SCI, V17, P265, DOI 10.1111/j.1744-7917.2010.01327.x; McFarlane Erika M., 2005, Mycologist, V19, P62, DOI 10.1017/S0269915X0500203X; Michelot D, 1998, TOXICON, V36, P1997, DOI 10.1016/S0041-0101(98)00131-7; Mladenka P, 2011, J INORG BIOCHEM, V105, P693, DOI 10.1016/j.jinorgbio.2011.02.003; Mortimer PE, 2012, FUNGAL DIVERS, V56, P31, DOI 10.1007/s13225-012-0196-3; Nasreddine L, 2002, TOXICOL LETT, V127, P29, DOI 10.1016/S0378-4274(01)00480-5; Nelson MC, 2011, BIORESOURCE TECHNOL, V102, P3730, DOI 10.1016/j.biortech.2010.11.119; Nitha B, 2007, CURR SCI INDIA, V92, P235; OWER R, 1982, MYCOLOGIA, V74, P142, DOI 10.2307/3792639; Ower R, 1986, US Patent, Patent No. 4594809; Park KM, 2015, EVID BASED COMPLEMEN; Parks CG, 1997, USDA FOR EST SERVICE; Pion M, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2242; Ponpium P, 2000, ENZYME MICROB TECH, V26, P459, DOI 10.1016/S0141-0229(99)00195-7; Qiu GM, 2005, J RARE EARTH, V23, P645; ROBBINS WJ, 1965, MYCOLOGIA, V57, P262, DOI 10.2307/3756827; Rousk J, 2015, ECOL MONOGR, V85, P457, DOI 10.1890/14-1796.1; Sanmee R, 2003, FOOD CHEM, V82, P527, DOI 10.1016/S0308-8146(02)00595-2; Sarikurkcu C, 2012, ECOL FOOD NUTR, V51, P346, DOI 10.1080/03670244.2012.674448; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Sigurbjornsdottir MA, 2014, CAN J MICROBIOL, V60, P307, DOI 10.1139/cjm-2013-0888; Smith Jane, 2007, ECOLOGY MANAGEMENT M, P161; Su CA, 2013, DARU, V21, DOI 10.1186/2008-2231-21-5; Tamaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025263; Tekeste Z, 2015, NUTRITION, V31, P1243, DOI 10.1016/j.nut.2015.04.021; Tian Mei, 2015, Huanjing Kexue, V36, P1739; VOLK TJ, 1990, MYCOL RES, V94, P399, DOI 10.1016/S0953-7562(09)80365-1; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Xu Q, 2004, J BACTERIOL, V186, P968, DOI 10.1128/JB.186.4.968-977.2004; Yang LQ, 2015, ENVIRON SCI POLLUT R, V22, P6679, DOI 10.1007/s11356-014-3862-z; Zhang XY, 2015, SCI TOTAL ENVIRON, V536, P59, DOI 10.1016/j.scitotenv.2015.07.043	53	10	11	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174618	10.1371/journal.pone.0174618	http://dx.doi.org/10.1371/journal.pone.0174618			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350840	Green Submitted, gold, Green Published			2022-12-26	WOS:000399174400067
J	Loncoman, CA; Hartley, CA; Coppo, MJC; Vaz, PK; Diaz-Mendez, A; Browning, GF; Lee, SW; Devlin, JM				Loncoman, Carlos A.; Hartley, Carol A.; Coppo, Mauricio J. C.; Vaz, Paola K.; Diaz-Mendez, Andres; Browning, Glenn F.; Lee, Sang-won; Devlin, Joanne M.			Development and application of a TaqMan single nucleotide polymorphism genotyping assay to study infectious laryngotracheitis virus recombination in the natural host	PLOS ONE			English	Article							GALLID-1 HERPESVIRUS-INFECTION; GLYCOPROTEIN-G; IN-VIVO; CHICKEN; POLYMERASE; ALPHAHERPESVIRUSES; ESTABLISHMENT; DEFICIENT; AUSTRALIA; STRAINS	To date, recombination between different strains of the avian alphaherpesvirus infectious laryngotracheitis virus (ILTV) has only been detected in field samples using full genome sequencing and sequence analysis. These previous studies have revealed that natural recombination is widespread in ILTV and have demonstrated that recombination between two attenuated ILTV vaccine strains generated highly virulent viruses that produced widespread disease within poultry flocks in Australia. In order to better understand ILTV recombination, this study developed a TaqMan single nucleotide polymorphism (SNP) genotyping assay to detect recombination between two field strains of ILTV (CSW-1 and V1-99 ILTV) under experimental conditions. Following in vivo co-inoculation of these two ILTV strains in specific pathogen free (SPF) chickens, recovered viruses were plaque purified and subjected to the SNP genotyping assay. This assay revealed ILTV recombinants in all co-inoculated chickens. In total 64/87 (74%) of the recovered viruses were recombinants and 23 different recombination patterns were detected, with some of them occurring more frequently than others. The results from this study demonstrate that the TaqMan SNP genotyping assay is a useful tool to study recombination in ILTV and also show that recombination occurs frequently during experimental co-infection with ILTV in SPF chickens. This tool, when used to assess ILTV recombination in the natural host, has the potential to greatly contribute to our understanding of alphaherpesvirus recombination.	[Loncoman, Carlos A.; Hartley, Carol A.; Coppo, Mauricio J. C.; Vaz, Paola K.; Diaz-Mendez, Andres; Browning, Glenn F.; Lee, Sang-won; Devlin, Joanne M.] Univ Melbourne, Asia Pacific Ctr Anim Hlth, Fac Vet & Agr Sci, Melbourne, Vic, Australia	University of Melbourne	Loncoman, CA (corresponding author), Univ Melbourne, Asia Pacific Ctr Anim Hlth, Fac Vet & Agr Sci, Melbourne, Vic, Australia.	cloncoman@student.unimelb.edu.au	Browning, Glenn Francis/P-4459-2014; Loncoman, Carlos/AAE-6481-2020; Vaz, Paola K./D-8713-2015	Browning, Glenn Francis/0000-0002-0903-2469; Loncoman, Carlos/0000-0002-4321-8873; Vaz, Paola K./0000-0001-6877-7383; Hartley, Carol/0000-0001-6174-7341; Diaz-Mendez, Andres/0000-0003-3004-8518; Coppo, Mauricio/0000-0002-4344-9532; Devlin, Joanne/0000-0003-0400-9670	Australian Research Council [FT140101287]; Becas Chile, CONICYT, Gobierno de Chile	Australian Research Council(Australian Research Council); Becas Chile, CONICYT, Gobierno de Chile	This work was supported by the Australian Research Council (FT140101287). Carlos Loncoman is supported by Becas Chile, CONICYT, Gobierno de Chile.; We gratefully acknowledge Mahathi Nadimpalli, Nino Ficorilli and Mesula Korsa for their help with cell culture, Jose Quinteros, June Daly, Jenece Wheeler and Cheryl Colson for their help with the in vivo studies, and Zelalem Mekuria and Alistair Legione for their help with the Geneious software. This work was supported by the Australian Research Council (FT140101287). Carlos Loncoman is supported by Becas Chile, CONICYT, Gobierno de Chile.	Agnew-Crumpton R, 2016, INFECT GENET EVOL, V43, P67, DOI 10.1016/j.meegid.2016.05.023; BAGUST TJ, 1986, AVIAN DIS, V30, P179, DOI 10.2307/1590631; BAGUST TJ, 1986, AVIAN PATHOL, V15, P581, DOI 10.1080/03079458608436317; Blacker HP, 2011, AUST VET J, V89, P89, DOI 10.1111/j.1751-0813.2010.00665.x; Coppo MJC, 2011, AVIAN PATHOL, V40, P411, DOI 10.1080/03079457.2011.588686; CRUTE JJ, 1989, J BIOL CHEM, V264, P19266; Davison AJ, 2010, VET MICROBIOL, V143, P52, DOI 10.1016/j.vetmic.2010.02.014; Devlin JM, 2006, J GEN VIROL, V87, P2839, DOI 10.1099/vir.0.82194-0; Devlin JM, 2006, ARCH VIROL, V151, P1281, DOI 10.1007/s00705-005-0721-8; Drake JW, 2005, GENETICS, V170, P969, DOI 10.1534/genetics.104.040410; FAHEY KJ, 1983, AVIAN PATHOL, V12, P505, DOI 10.1080/03079458308436195; Garcia M, 2013, DIS POULTRY, P137; Hiroshima Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120358; JAVIER RT, 1986, SCIENCE, V234, P746, DOI 10.1126/science.3022376; KAWAGUCHI T, 1987, CANCER RES, V47, P4460; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kirkpatrick NC, 2006, AVIAN PATHOL, V35, P449, DOI 10.1080/03079450601028803; Kirkpatrick NC, 2006, AVIAN DIS, V50, P28, DOI 10.1637/7414-072205R.1; Kolb AW, 2015, J VIROL, V89, P6427, DOI 10.1128/JVI.00416-15; Kolb AW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076267; Lee SW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120282; Lee SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055121; Lee SW, 2012, SCIENCE, V337, P188, DOI 10.1126/science.1217134; Loncoman CA, 2017, INFECT GENET EVOL, V49, P174, DOI 10.1016/j.meegid.2016.12.022; Mahmoudian A, 2011, AVIAN PATHOL, V40, P237, DOI 10.1080/03079457.2011.553582; Muylkens B, 2009, J VIROL, V83, P3127, DOI 10.1128/JVI.02474-08; Norberg P., 2015, J VIROL; Szpara ML, 2014, J VIROL, V88, P1209, DOI 10.1128/JVI.01987-13; Thiry E, 2005, REV MED VIROL, V15, P89, DOI 10.1002/rmv.451; Vaz PK, 2016, J GEN VIROL, V97, P747, DOI 10.1099/jgv.0.000378	30	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174590	10.1371/journal.pone.0174590	http://dx.doi.org/10.1371/journal.pone.0174590			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350819	gold, Green Published			2022-12-26	WOS:000399174400063
J	Modi, BP; Teves, ME; Pearson, LN; Parikh, HI; Chaemsaithong, P; Sheth, NU; York, TP; Romero, R; Strauss, JF				Modi, Bhavi P.; Teves, Maria E.; Pearson, Laurel N.; Parikh, Hardik I.; Chaemsaithong, Piya; Sheth, Nihar U.; York, Timothy P.; Romero, Roberto; Strauss, Jerome F., III			Rare mutations and potentially damaging missense variants in genes encoding fibrillar collagens and proteins involved in their production are candidates for risk for preterm premature rupture of membranes	PLOS ONE			English	Article							OSTEOGENESIS IMPERFECTA; ASSOCIATION; FETAL; BIRTH; ADMIXTURE; PROMOTER; DISEASE; GENETICS; POLYMORPHISM; DISCOVERY	Preterm premature rupture of membranes (PPROM) is the leading identifiable cause of preterm birth with similar to 40% of preterm births being associated with PPROM and occurs in 1% 2% of all pregnancies. We hypothesized that multiple rare variants in fetal genes involved in extracellular matrix synthesis would associate with PPROM, based on the assumption that impaired elaboration of matrix proteins would reduce fetal membrane tensile strength, predisposing to unscheduled rupture. We performed whole exome sequencing (WES) on neonatal DNA derived from pregnancies complicated by PPROM (49 cases) and healthy term deliveries (20 controls) to identify candidate mutations/variants. Genotyping for selected variants from the WES study was carried out on an additional 188 PPROM cases and 175 controls. All mothers were self-reported African Americans, and a panel of ancestry informative markers was used to control for genetic ancestry in all genetic association tests. In support of the primary hypothesis, a statistically significant genetic burden (all samples combined, SKAT-O p-value = 0.0225) of damaging/potentially damaging rare variants was identified in the genes of interest-fibrillar collagen genes, which contribute to fetal membrane strength and integrity. These findings suggest that the fetal contribution to PPROM is polygenic, and driven by an increased burden of rare variants that may also contribute to the disparities in rates of preterm birth among African Americans.	[Modi, Bhavi P.; York, Timothy P.; Strauss, Jerome F., III] Virginia Commonwealth Univ, Dept Human & Mol Genet, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Teves, Maria E.; York, Timothy P.; Strauss, Jerome F., III] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Med Coll Virginia Campus, Richmond, VA 23298 USA; [Pearson, Laurel N.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Parikh, Hardik I.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Chaemsaithong, Piya; Romero, Roberto] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, Bethesda, MD USA; [Chaemsaithong, Piya; Romero, Roberto] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, NIH, Detroit, MI USA; [Sheth, Nihar U.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Romero, Roberto] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Romero, Roberto] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Romero, Roberto] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA	Virginia Commonwealth University; Virginia Commonwealth University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Virginia Commonwealth University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Virginia Commonwealth University; University of Michigan System; University of Michigan; Michigan State University; Wayne State University	Strauss, JF (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Med Coll Virginia Campus, Richmond, VA 23298 USA.; Strauss, JF (corresponding author), Virginia Commonwealth Univ, Dept Obstet & Gynecol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	jerome.strauss@vcuhealth.org	Teves, Maria/AAJ-9523-2020; Parikh, Hardik/AAG-4963-2021; Romero, Roberto/A-5268-2019	Teves, Maria/0000-0001-7035-2202; Modi, Bhavi/0000-0003-1510-5916; Parikh, Hardik/0000-0002-5621-7343; chaemsaithong, piya/0000-0003-1750-9834; Romero, Roberto/0000-0002-4448-5121; Chaemsaithong, piya/0000-0002-5398-6868	National Institutes of Health [R01 HD073555, P60 MD002256]; Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); Federal funds from NICHD, NIH [HSN275201300006C]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD073555, ZIAHD002400] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P60MD002256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); Federal funds from NICHD, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was funded by National Institutes of Health Grants R01 HD073555 and P60 MD002256. This research was also supported, in part, by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); and, in part, with Federal funds from NICHD, NIH under Contract No. HSN275201300006C (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ms. Sonya Washington for enrolling subjects for the study at MCV Hospitals, Richmond VA. We also thank Dr. Barbara Boyan, Virginia Commonwealth University, for providing primary culture of human ear chondrocytes. This research was funded by National Institutes of Health Grants R01 HD073555 and P60 MD002256. This research was also supported, in part, by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services (NICHD/NIH); and, in part, with Federal funds from NICHD, NIH under Contract No. HSN275201300006C.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], 2021, LANG ENV STAT COMP; Anum EA, 2009, PLACENTA, V30, P207, DOI 10.1016/j.placenta.2008.12.007; Anum EA, 2009, PEDIATR RES, V65, P1, DOI 10.1203/PDR.0b013e31818912e7; Brusin Joyce Helena, 2008, Radiol Technol, V79, P535; Bryc K, 2015, AM J HUM GENET, V96, P37, DOI 10.1016/j.ajhg.2014.11.010; Capece A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108578; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Davis EC, 1998, J CELL BIOL, V140, P295, DOI 10.1083/jcb.140.2.295; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Diaz-Prado S, 2011, DIFFERENTIATION, V81, P162, DOI 10.1016/j.diff.2011.01.005; Diaz-Prado S, 2010, CELL TISSUE BANK, V11, P183, DOI 10.1007/s10561-009-9144-1; Dolan SM, 2010, PUBLIC HEALTH GENOM, V13, P514, DOI 10.1159/000294202; Ferrand PE, 2002, MOL HUM REPROD, V8, P494, DOI 10.1093/molehr/8.5.494; Fujimoto T, 2002, J BIOL CHEM, V277, P6296, DOI 10.1074/jbc.M107865200; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hampson V, 1997, BRIT J OBSTET GYNAEC, V104, P1087, DOI 10.1111/j.1471-0528.1997.tb12073.x; HANIS CL, 1986, AM J PHYS ANTHROPOL, V70, P433, DOI 10.1002/ajpa.1330700404; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Houari MB, 2015, HUM MUTAT, V23, P1; Hurst BS, 2014, OBSTET GYNECOL, V123, P506, DOI 10.1097/AOG.0000000000000123; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; KANAYAMA N, 1985, AM J OBSTET GYNECOL, V153, P899, DOI 10.1016/0002-9378(85)90703-3; KEY TC, 1978, OBSTET GYNECOL, V51, P67; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lind J, 2002, ACTA OBSTET GYN SCAN, V81, P293, DOI 10.1034/j.1600-0412.2002.810403.x; Liu YS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-1; Malfait F, 2005, AM J MED GENET C, V139C, P17, DOI 10.1002/ajmg.c.30070; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moore RM, 2006, PLACENTA, V27, P1037, DOI 10.1016/j.placenta.2006.01.002; Myking S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061781; Myking S, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-174; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Parry S, 1998, NEW ENGL J MED, V338, P663, DOI 10.1056/NEJM199803053381006; Plunkett J, 2008, ANN MED, V40, P167, DOI 10.1080/07853890701806181; Romero R, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.026; Schwarze U, 2013, HUM MOL GENET, V22, P1, DOI 10.1093/hmg/dds371; Shen Tammy T, 2008, BMC Pregnancy Childbirth, V8, P43, DOI 10.1186/1471-2393-8-43; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SKINNER SJM, 1981, OBSTET GYNECOL, V57, P487; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Strauss JF, 2013, REPROD SCI, V20, P140, DOI 10.1177/1933719111424454; Taksande A, 2008, IRAN J PEDIATR, V18, P175, DOI 10.4103/0971-3026.40306; Wang H, 2004, HUM MOL GENET, V13, P2659, DOI 10.1093/hmg/ddh287; Wang HY, 2006, P NATL ACAD SCI USA, V103, P13463, DOI 10.1073/pnas.0603676103; Weinberg CR, 2009, AM J EPIDEMIOL, V170, P1373, DOI 10.1093/aje/kwp325; Wenstrup RJ, 2004, J BIOL CHEM, V279, P53331, DOI 10.1074/jbc.M409622200; Wesche WA, 2001, J CUTAN PATHOL, V28, P211, DOI 10.1034/j.1600-0560.2001.028004211.x; Wilcox AJ, 2008, AM J EPIDEMIOL, V167, P474, DOI 10.1093/aje/kwm319; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; York TP, 2014, AM J OBSTET GYNECOL, V210, P398, DOI 10.1016/j.ajog.2013.10.001; York TP, 2013, AM J EPIDEMIOL, V178, P543, DOI 10.1093/aje/kwt005; York TP, 2009, TWIN RES HUM GENET, V12, P333, DOI 10.1375/twin.12.4.333	58	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174356	10.1371/journal.pone.0174356	http://dx.doi.org/10.1371/journal.pone.0174356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346524	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174300041
J	Qi, Q; Kang, SS; Zhang, S; Pham, C; Fu, H; Brat, DJ; Ye, K				Qi, Q.; Kang, S. S.; Zhang, S.; Pham, C.; Fu, H.; Brat, D. J.; Ye, K.			Co-amplification of phosphoinositide 3-kinase enhancer A and cyclin-dependent kinase 4 triggers glioblastoma progression	ONCOGENE			English	Article							PIKE-A; GENE; GTPASE; MDM2; CDK4; AMPLIFICATION; INHIBITION; PATHWAYS; GRADE; P53	Glioblastoma (GBM) is the most common primary brain tumor and has a dismal prognosis. Amplification of chromosome 12q13-q15 (Cyclin-dependent kinase 4 (CDK4) amplicon) is frequently observed in numerous human cancers including GBM. Phosphoinositide 3-kinase enhancer (PIKE) is a group of GTP-binding proteins that belong to the subgroup of centaurin GTPase family, encoded by CENTG1 located in CDK4 amplicon. However, the pathological significance of CDK4 amplicon in GBM formation remains incompletely understood. In the current study, we show that co-expression of PIKE-A and CDK4 in TP53/ PTEN double knockout GBM mouse model additively shortens the latency of glioma onset and survival compared to overexpression of these genes alone. Consequently, p-mTOR, p-Akt and p-ERK pathways are highly upregulated in the brain tumors, in alignment with their oncogenic activities by CDK4 and PIKE-A stably transfected in GBM cell lines. Hence, our findings support that PIKE amplification or overexpression coordinately acts with CDK4 to drive GBM tumorigenesis.	[Qi, Q.; Kang, S. S.; Zhang, S.; Brat, D. J.; Ye, K.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Room 141,Whitehead Bldg,615 Michael St, Atlanta, GA 30322 USA; [Qi, Q.; Pham, C.; Fu, H.] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Qi, Q.; Pham, C.; Fu, H.] Emory Univ, Sch Med, Emory Chem Biol Discovery Ctr, Atlanta, GA 30322 USA; [Zhang, S.] Jinan Univ, Coll Pharm, Inst Tumor Pharmacol, Guangzhou, Guangdong, Peoples R China; [Fu, H.] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Ye, K.] Tongji Univ, Sch Med, Dept Regenerat Med, Translat Ctr Stem Cell Res,Tongji Hosp, Shanghai, Peoples R China	Emory University; Emory University; Emory University; Jinan University; Emory University; Tongji University	Ye, K (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Room 141,Whitehead Bldg,615 Michael St, Atlanta, GA 30322 USA.	kye@emory.edu			Federal funds from National Cancer Institute (NCI), National Institutes of Health (NIH), under the NCI Chemical Biology Consortium [HHSN261200800001E]; NIH grant [RO1 CA186918, U01 CA168449]; SBTF Foundation; National Natural Science Foundation of China [81672781]; Winship Cancer Institute of Emory University Cancer Center [P30-CA138292]; NATIONAL CANCER INSTITUTE [P30CA138292, U01CA168449, R01CA186918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG051538] Funding Source: NIH RePORTER	Federal funds from National Cancer Institute (NCI), National Institutes of Health (NIH), under the NCI Chemical Biology Consortium; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SBTF Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Winship Cancer Institute of Emory University Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work has been funded in part with Federal funds from National Cancer Institute (NCI), National Institutes of Health (NIH), under the NCI Chemical Biology Consortium Contract HHSN261200800001E (HF; KY), NIH grant RO1 CA186918 (KY), U01 CA168449 (HF), SBTF Foundation (KY), National Natural Science Foundation of China (No. 81672781). We are thankful to Dr Suzanne J. Baker for the PTEN/P53 loxP/loxP mice and to the Winship Cancer Institute of Emory University Cancer Center Support Grant P30-CA138292.	Ahn JY, 2004, P NATL ACAD SCI USA, V101, P6993, DOI 10.1073/pnas.0400921101; Ahn JY, 2004, J BIOL CHEM, V279, P16441, DOI 10.1074/jbc.M312175200; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Feng CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090388; Grzmil M, 2010, BBA-PROTEINS PROTEOM, V1804, P476, DOI 10.1016/j.bbapap.2009.10.018; He KY, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003900; Ivanov AA, 2013, TRENDS PHARMACOL SCI, V34, P393, DOI 10.1016/j.tips.2013.04.007; KHATIB ZA, 1993, CANCER RES, V53, P5535; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; LANG FF, 1994, ONCOGENE, V9, P949; Liu R, 2008, P NATL ACAD SCI USA, V105, P7570, DOI 10.1073/pnas.0712306105; Liu X, 2007, ONCOGENE, V26, P4918, DOI 10.1038/sj.onc.1210290; Ma ZN, 2016, ONCOTARGET, V7, P66558, DOI 10.18632/oncotarget.11684; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Muranen T, 2016, CANCER RES, V76, P7168, DOI 10.1158/0008-5472.CAN-16-0155; Muthusamy V, 2006, GENE CHROMOSOME CANC, V45, P447, DOI 10.1002/gcc.20310; Network The Cancer Genome Atlas Research, 2013, Nature, V494, P506, DOI 10.1038/nature11903; Pathak P, 2016, BRAIN PATHOL; Proescholdt MA, 2012, NEURO-ONCOLOGY, V14, P1357, DOI 10.1093/neuonc/nos216; Qi Q, 2013, ONCOGENE, V32, P1030, DOI 10.1038/onc.2012.109; Reifenberger G, 1996, CANCER RES, V56, P5141; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Uras N, 2012, J OBSTET GYNAECOL, V32, P533, DOI 10.3109/01443615.2012.677875; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wikman H, 2005, GENE CHROMOSOME CANC, V42, P193, DOI 10.1002/gcc.20122; Ye KQ, 2000, CELL, V103, P919, DOI 10.1016/S0092-8674(00)00195-1; Ye KQ, 2004, J CELL SCI, V117, P155, DOI 10.1242/jcs.00924; Zhang S, 2016, CELL DEATH DIFFER, V23, P52, DOI 10.1038/cdd.2015.66; Zhu H, 2009, P NATL ACAD SCI USA, V106, P2712, DOI 10.1073/pnas.0813314106	32	12	12	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 10	2017	36	32					4562	4572		10.1038/onc.2017.67	http://dx.doi.org/10.1038/onc.2017.67			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FD0RK	28368413	Green Accepted			2022-12-26	WOS:000407246200004
J	Ueno, N; Nishimura, N; Ueno, S; Endo, S; Tatetsu, H; Hirata, S; Hata, H; Matsuoka, M; Mitsuya, H; Okuno, Y				Ueno, N.; Nishimura, N.; Ueno, S.; Endo, S.; Tatetsu, H.; Hirata, S.; Hata, H.; Matsuoka, M.; Mitsuya, H.; Okuno, Y.			PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4	ONCOGENE			English	Article							REGULATORY FACTOR FAMILY; MULTIPLE-MYELOMA; DISTAL ELEMENTS; GENE; PROTEINS; EXPRESSION; SURVIVAL; IDENTIFICATION; THALIDOMIDE; MECHANISM	We previously reported that PU.1 is downregulated in the majority of myeloma cell lines and primary myeloma cells of certain myeloma patients, and conditional expression of PU.1 in such myeloma cell lines induced cell cycle arrest and apoptosis. We found downregulation of IRF4 protein in the U266 myeloma cell line following induction of PU.1. Previous studies reported that knockdown of IRF4 in myeloma cell lines induces apoptosis, prompting us to further investigate the role of IRF4 downregulation in PU.1-induced cell cycle arrest and apoptosis in myeloma cells. PU. 1 induced downregulation of IRF4 at the protein level, cell cycle arrest and apoptosis in six myeloma cell lines. Chromatin immunoprecipitation (ChIP) revealed that PU.1 directly binds to the IRF4 promoter, whereas a reporter assay showed that PU.1 may suppress IRF4 promoter activity. Stable expression of IRF4 in myeloma cells expressing PU.1 partially rescued the cells from apoptosis induced by PU.1. As it was reported that IRF4 directly binds to the IRF7 promoter and downregulates its expression in activated B cell-like subtype of diffuse large B cell lymphoma cells, we performed ChIP assays and found that IRF4 directly binds the IRF7 promoter in myeloma cells. It is known that IRF7 positively upregulates interferon-beta (IFN beta) and induces apoptosis in many cell types. Binding of IRF4 to the IRF7 promoter decreased following PU.1 induction, accompanied by downregulation of IRF4 protein expression. Knockdown of IRF7 protected PU.1-expressing myeloma cells from apoptosis. Furthermore, IFN beta, which is a downstream target of IRF7, was upregulated in myeloma cells along with IRF7 after PU.1 induction. Finally, we evaluated the mRNA expression levels of PU.1, IRF4 and IRF7 in primary myeloma cells from patients and found that PU.1 and IRF7 were strongly downregulated in contrast to the high expression levels of IRF4. These data strongly suggest that PU.1-induced apoptosis in myeloma cells is associated with IRF4 downregulation and subsequent IRF7 upregulation.	[Ueno, N.; Nishimura, N.; Ueno, S.; Endo, S.; Tatetsu, H.; Hirata, S.; Hata, H.; Matsuoka, M.; Mitsuya, H.; Okuno, Y.] Kumamoto Univ, Grad Sch Med, Dept Hematol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan; [Ueno, N.; Nishimura, N.; Ueno, S.; Endo, S.; Tatetsu, H.; Hirata, S.; Hata, H.; Matsuoka, M.; Mitsuya, H.; Okuno, Y.] Kumamoto Univ, Grad Sch Med, Dept Rheumatol & Infect Dis, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan	Kumamoto University; Kumamoto University	Okuno, Y (corresponding author), Kumamoto Univ, Grad Sch Med, Dept Hematol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.; Okuno, Y (corresponding author), Kumamoto Univ, Grad Sch Med, Dept Rheumatol & Infect Dis, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	yokuno@gpo.kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (JSPS KAKENHI) [26461427]	Ministry of Education, Culture, Sports, Science and Technology of Japan (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (JSPS KAKENHI grant number 26461427).	Brugnoli F, 2010, EXP CELL RES, V316, P38, DOI 10.1016/j.yexcr.2009.09.004; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen Q, 2001, BLOOD, V98, P2183, DOI 10.1182/blood.V98.7.2183; Desai S, 2009, J IMMUNOL, V183, P5778, DOI 10.4049/jimmunol.0901120; DOLBEARE F, 1983, P NATL ACAD SCI-BIOL, V80, P5573, DOI 10.1073/pnas.80.18.5573; Endo S, 2016, BIOCHEM BIOPH RES CO, V469, P236, DOI 10.1016/j.bbrc.2015.11.116; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Kaufman RM, 1999, BLOOD, V94, P3178, DOI 10.1182/blood.V94.9.3178.421k23_3178_3184; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Krysinska H, 2007, MOL CELL BIOL, V27, P878, DOI 10.1128/MCB.01915-06; Kyle RA, 2008, BLOOD, V111, P2962, DOI 10.1182/blood-2007-10-078022; Lehtonen A, 2005, J IMMUNOL, V175, P6570, DOI 10.4049/jimmunol.175.10.6570; Li YL, 2001, BLOOD, V98, P2958, DOI 10.1182/blood.V98.10.2958; Lopez-Girona A, 2011, BRIT J HAEMATOL, V154, P325, DOI 10.1111/j.1365-2141.2011.08689.x; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Miyoshi H, 1997, P NATL ACAD SCI USA, V94, P10319, DOI 10.1073/pnas.94.19.10319; Moreau P, 2012, BLOOD, V120, P947, DOI 10.1182/blood-2012-04-403733; Morgan GJ, 2012, NAT REV CANCER, V12, P335, DOI 10.1038/nrc3257; NELSEN B, 1993, SCIENCE, V261, P82, DOI 10.1126/science.8316859; Nikolajczyk BS, 1999, IMMUNITY, V11, P11, DOI 10.1016/S1074-7613(00)80077-1; Ochiai K, 2013, IMMUNITY, V38, P918, DOI 10.1016/j.immuni.2013.04.009; Ocio EM, 2008, LANCET ONCOL, V9, P1157, DOI 10.1016/S1470-2045(08)70304-8; Ohguchi H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10258; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Okuno Y, 2002, BLOOD, V100, P4420, DOI 10.1182/blood-2002-03-0788; Okuno Y, 2002, P NATL ACAD SCI USA, V99, P6246, DOI 10.1073/pnas.092027799; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Palumbo A, 2008, BLOOD, V111, P3968, DOI 10.1182/blood-2007-10-117457; Palumbo A, 2014, J CLIN ONCOL, V32, P587, DOI 10.1200/JCO.2013.48.7934; Piya S, 2011, MOL CANCER RES, V9, P1356, DOI 10.1158/1541-7786.MCR-11-0185; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Savickiene J, 2011, DIFFERENTIATION, V81, P57, DOI 10.1016/j.diff.2010.08.003; Schonheit J, 2013, CELL REP, V3, P1617, DOI 10.1016/j.celrep.2013.04.007; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Takaoka A, 2008, CANCER SCI, V99, P467, DOI 10.1111/j.1349-7006.2007.00720.x; Tatetsu H, 2007, CANCER RES, V67, P5328, DOI 10.1158/0008-5472.CAN-06-4265; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Ueno S, 2009, ONCOGENE, V28, P4116, DOI 10.1038/onc.2009.263; Yang YB, 2012, CANCER CELL, V21, P723, DOI 10.1016/j.ccr.2012.05.024; Yuki H, 2013, BLOOD, V121, P962, DOI 10.1182/blood-2012-05-431429; Zhu YX, 2014, BLOOD, V124, P536, DOI 10.1182/blood-2014-02-557819	47	17	18	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 3	2017	36	31					4481	4497		10.1038/onc.2017.79	http://dx.doi.org/10.1038/onc.2017.79			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FC4JL	28368411				2022-12-26	WOS:000406806000010
J	Principe, DR; Diaz, AM; Torres, C; Mangan, RJ; DeCant, B; McKinney, R; Tsao, MS; Lowy, A; Munshi, HG; Jung, B; Grippo, PJ				Principe, D. R.; Diaz, A. M.; Torres, C.; Mangan, R. J.; DeCant, B.; McKinney, R.; Tsao, M-S; Lowy, A.; Munshi, H. G.; Jung, B.; Grippo, P. J.			TGF beta engages MEK/ERK to differentially regulate benign and malignant pancreas cell function	ONCOGENE			English	Article							ERK MAP KINASE; SIGNALING PATHWAYS; CANCER CELLS; RAS; INHIBITION; EXPRESSION; P21; PROMOTES; ARREST; TRANSCRIPTION	While TGF beta signals are anti-proliferative in benign and well-differentiated pancreatic cells, TGF beta appears to promote the progression of advanced cancers. To better understand dysregulation of the TGF beta pathway, we first generated mouse models of neoplastic disease with TGF beta receptor deficiencies. These models displayed reduced levels of pERK irrespective of KRAS mutation. Furthermore, exogenous TGF beta led to rapid and sustained TGFBR1-dependent ERK phosphorylation in benign pancreatic duct cells. Similar to results that our group has published in colon cancer cells, inhibition of ERK phosphorylation in duct cells mitigated TGF beta-induced upregulation of growth suppressive pSMAD2 and p21, prevented downregulation of the pro-growth signal CDK2 and ablated TGF beta-induced EMT. These observations suggest that ERK is a key factor in growth suppressive TGF beta signals, yet may also contribute to detrimental TGF beta signaling such as EMT. In neoplastic PanIN cells, pERK was not necessary for either TGF beta-induced pSMAD2 phosphorylation or CDK2 repression, but was required for upregulation of p21 and EMT indicating a partial divergence between TGF beta and MEK/ERK in early carcinogenesis. In cancer cells, pERK had no effect on TGF beta-induced upregulation of pSMAD2 and p21, suggesting the two pathways have completely diverged with respect to the cell cycle. Furthermore, inhibition of pERK both reduced levels of CDK2 and prevented EMT independent of exogenous TGF beta, consistent with most observations identifying pERK as a tumor promoter. Combined, these data suggest that during carcinogenesis pERK initially facilitates and later antagonizes TGF beta-mediated cell cycle arrest, yet remains critical for the pathological, EMT-inducing arm of TGF beta signaling.	[Principe, D. R.] Univ Illinois, Coll Med, Chicago, IL USA; [Diaz, A. M.; Torres, C.; Mangan, R. J.; DeCant, B.; McKinney, R.; Jung, B.; Grippo, P. J.] Univ Illinois, Dept Med, Chicago, IL USA; [Tsao, M-S] Univ Toronto, Univ Hlth Network, Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON, Canada; [Lowy, A.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Munshi, H. G.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of California System; University of California San Diego; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Principe, DR (corresponding author), Univ Illinois, Coll Med, Dept Med, 840 South Wood St,738A CSB, Chicago, IL 60612 USA.; Grippo, PJ (corresponding author), Univ Illinois, Dept Med, Div Gastroenterol & Hepatol, 840 South Wood St,738A CSB, Chicago, IL 60612 USA.	principe@illinois.edu; pgrippo@uic.edu	Tsao, Ming-Sound/M-3503-2017; Tsao, Ming Sound/AFQ-7332-2022; Torres, Carolina/M-1169-2014	Tsao, Ming Sound/0000-0002-9160-5405; Torres, Carolina/0000-0002-7908-6884	Barnum Foundation at Northwestern University; University of Illinois College of Medicine Hazel I. Craig fellowship; Zell Family Foundation at Northwestern University	Barnum Foundation at Northwestern University; University of Illinois College of Medicine Hazel I. Craig fellowship; Zell Family Foundation at Northwestern University	This work is dedicated to the memory of our friend Daniel Wang, who recently lost his long and courageous fight with cancer. We appreciate the contributions of Dr Nancy Krett for her critical evaluation of our work. The authors would also like to thank undergraduate students Carol Cavarson, Saminder Singh, Jacob Hoekstra, Danielle Calloway and Matthew J. Michalik for their hard work, as well as Dr Steven Waters (University of Illinois at Chicago) for his assistance with genotyping. This work was supported by the Barnum and Zell Family Foundations at Northwestern University to PG and the University of Illinois College of Medicine Hazel I. Craig fellowship to DP.	Bachmann J, 2013, NUTR CANCER, V65, P827, DOI 10.1080/01635581.2013.804580; Bauer J, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0456-4; Bauer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039381; Brugarolas J, 1999, P NATL ACAD SCI USA, V96, P1002, DOI 10.1073/pnas.96.3.1002; Buonato JM, 2014, CANCER RES, V74, P309, DOI 10.1158/0008-5472.CAN-12-4721; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Chow JYC, 2007, CARCINOGENESIS, V28, P2321, DOI 10.1093/carcin/bgm159; Ciccarelli C, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-41; Coleman ML, 2003, EMBO J, V22, P2036, DOI 10.1093/emboj/cdg189; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Fensterer H, 2004, GENE CHROMOSOME CANC, V39, P224, DOI 10.1002/gcc.20000; Filmus Jorge, 1993, Current Opinion in Oncology, V5, P123; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Grabliauskaite K, 2015, J PATHOL, V235, P502, DOI 10.1002/path.4440; Hashimoto K, 2001, PANCREAS, V22, P341, DOI 10.1097/00006676-200105000-00002; Ijichi H, 2004, ONCOGENE, V23, P1043, DOI 10.1038/sj.onc.1207222; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Neuzillet C, 2013, CANCER METAST REV, V32, P147, DOI 10.1007/s10555-012-9396-2; Nicolas FJ, 2003, ONCOGENE, V22, P3698, DOI 10.1038/sj.onc.1206420; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Principe D. R., 2016, ONCOTARGET; Principe DR, 2016, CANCER RES, V76, P2525, DOI 10.1158/0008-5472.CAN-15-1293; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; SCHWARZ LC, 1988, CANCER RES, V48, P6999; Shen RZ, 2013, CANCER LETT, V339, P135, DOI 10.1016/j.canlet.2013.07.010; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Torii S, 2006, CANCER SCI, V97, P697, DOI 10.1111/j.1349-7006.2006.00244.x; Trobridge P, 2009, GASTROENTEROLOGY, V136, P1680, DOI 10.1053/j.gastro.2009.01.066; Voss M, 1999, INT J ONCOL, V14, P93; Warmflash A, 2012, P NATL ACAD SCI USA, V109, pE1947, DOI 10.1073/pnas.1207607109; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Yasutome M, 2005, CLIN EXP METASTAS, V22, P461, DOI 10.1007/s10585-005-2891-x; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhou QD, 2012, J MOL MED, V90, P563, DOI 10.1007/s00109-011-0833-4	39	42	42	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 27	2017	36	30					4336	4348		10.1038/onc.2016.500	http://dx.doi.org/10.1038/onc.2016.500			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FB8AH	28368414	Green Published, hybrid			2022-12-26	WOS:000406360600010
J	Freidl, GS; Spruijt, IT; Borlee, F; Smit, LAM; van Gageldonk-Lafeber, AB; Heederik, DJJ; Yzermans, J; van Dijk, CE; Maassen, CBM; van der Hoek, W				Freidl, Gudrun S.; Spruijt, Ineke T.; Borlee, Floor; Smit, Lidwien A. M.; van Gageldonk-Lafeber, Arianne B.; Heederik, Dick J. J.; Yzermans, Joris; van Dijk, Christel E.; Maassen, Catharina B. M.; van der Hoek, Wim			Livestock-associated risk factors for pneumonia in an area of intensive animal farming in the Netherlands	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; Q-FEVER EPIDEMIC; ETIOLOGY; CHILDREN; ADULTS	Previous research conducted in 2009 found a significant positive association between pneumonia in humans and living close to goat and poultry farms. However, as this result might have been affected by a large goat-related Q fever epidemic, the aim of the current study was to re-evaluate this association, now that the Q-fever epidemic had ended. In 2014/15, 2,494 adults (aged 20-72 years) living in a livestock-dense area in the Netherlands participated in a medical examination and completed a questionnaire on respiratory health, lifestyle and other items. We retrieved additional information for 2,426/2,494 (97%) participants from electronic medical records (EMR) from general practitioners. The outcome was self reported, physician-diagnosed pneumonia or pneumonia recorded in the EMR in the previous three years. Livestock license data was used to determine exposure to livestock. We quantified associations between livestock exposures and pneumonia using odds ratios adjusted for participant characteristics and comorbidities (aOR). The three-year cumulative frequency of pneumonia was 186/2,426 (7.7%). Residents within 2,000m of a farm with at least 50 goats had an increased risk of pneumonia, which increased the closer they lived to the farm (2,000m aOR 1.9, 95% CI 1.4-2.6; 500m aOR 4.4, 95% CI 2.0-9.8). We found no significant associations between exposure to other farm animals and pneumonia. However, when conducting sensitivity analyses using pneumonia outcome based on EMR only, we found a weak but statistically significant association with presence of a poultry farm within 1,000m (aOR: 1.7, 95% CI 1.1-2.7). Living close to goat and poultry farms still constitute risk factors for pneumonia. Individuals with pneumonia were not more often seropositive for Coxiella bumetii, indicating that results are not explained by Q fever. We strongly recommend identification of pneumonia causes by the use of molecular diagnostics and investigating the role of non-infectious agents such as particulate matter or endotoxins.	[Freidl, Gudrun S.; Spruijt, Ineke T.; van Gageldonk-Lafeber, Arianne B.; Maassen, Catharina B. M.; van der Hoek, Wim] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Ctr Infect Dis Epidemiol & Surveillance, Bilthoven, Netherlands; [Freidl, Gudrun S.] European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden; [Borlee, Floor; Smit, Lidwien A. M.; Heederik, Dick J. J.] Univ Utrecht, Div Environm Epidemiol, IRAS, Utrecht, Netherlands; [Borlee, Floor; Yzermans, Joris; van Dijk, Christel E.] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; European Centre for Disease Prevention & Control; Utrecht University; Netherlands Institute for Health Services Research	Freidl, GS (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Ctr Infect Dis Epidemiol & Surveillance, Bilthoven, Netherlands.; Freidl, GS (corresponding author), European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden.	gudrun.freidl@rivm.nl	Smit, Lidwien AM/AFC-8689-2022	Smit, Lidwien AM/0000-0003-0292-0946; Heederik, Dick/0000-0002-4550-1437	Ministry of Health, Welfare and Sports; Ministry of Economic Affairs of The Netherlands; Lung Foundation Netherlands [3.2.11.022]	Ministry of Health, Welfare and Sports; Ministry of Economic Affairs of The Netherlands(Ministry of Economic Affairs, Netherlands); Lung Foundation Netherlands	The Livestock Farming and Neighbouring Residents' Health (VGO) study was funded by the Ministry of Health, Welfare and Sports and the Ministry of Economic Affairs of The Netherlands, and supported by a grant from the Lung Foundation Netherlands (Grant number: 3.2.11.022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnink A. RHJ, 2012, 9 INT LIV ENV S; Almirall J, 2015, ARCH BRONCONEUMOL, V51, P627, DOI 10.1016/j.arbres.2014.10.003; Basinas I, 2012, J ENVIRON MONITOR, V14, P604, DOI 10.1039/c1em10576k; Becker S, 2003, EXP LUNG RES, V29, P29, DOI 10.1080/01902140303762; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borlee F., 2015, EUR RESP J; Borlee F., 2016, B48 ASTHMA INSIGHTS; Dijkstra F, 2012, FEMS IMMUNOL MED MIC, V64, P3, DOI 10.1111/j.1574-695X.2011.00876.x; EFSA Panel on Animal Health Welfare, 2010, EFSA J, V8; Heederik D., 2011, MOGELIJKE EFFECTEN I; Hermans T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096607; Huijskens EGW, 2016, ZOONOSES PUBLIC HLTH, V63, P160, DOI 10.1111/zph.12218; Maassen K, 2016, VEEHOUDERIJ GEZONDHE, P136; Mushtaq N, 2011, J ALLERGY CLIN IMMUN, V127, P1236, DOI 10.1016/j.jaci.2010.11.039; Raeven VM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1641-9; Rivas-Santiago CE, 2015, INFECT IMMUN, V83, P2507, DOI 10.1128/IAI.03018-14; Roest HIJ, 2011, EPIDEMIOL INFECT, V139, P1, DOI 10.1017/S0950268810002268; Schnoor M, 2007, EPIDEMIOL INFECT, V135, P1389, DOI 10.1017/S0950268807007832; Scott JAG, 2012, CLIN INFECT DIS, V54, pS109, DOI 10.1093/cid/cir1065; Slok Edwin N E, 2015, BMC Res Notes, V8, P456, DOI 10.1186/s13104-015-1389-0; Smit LAM, 2017, PNEUMONIA, V9, DOI 10.1186/s41479-017-0027-0; Smit LAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038843; Snijders BEP, 2013, PRIM CARE RESP J, V22, P400, DOI 10.4104/pcrj.2013.00085; Spoorenberg SMC, 2016, NETH J MED, V74, P75; Teepe J, 2010, EUR RESPIR J, V35, P1113, DOI 10.1183/09031936.00101509; van der Hoek W, 2012, ADV EXP MED BIOL, V984, P329, DOI 10.1007/978-94-007-4315-1_17; van Gageldonk-Lafeber AB, 2013, NETH J MED, V71, P418; Van Os J, 2011, ALTERRA RAPPORT; Wouters I, 2011, EPIDEMIOLOGY	29	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174796	10.1371/journal.pone.0174796	http://dx.doi.org/10.1371/journal.pone.0174796			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362816	Green Published, Green Submitted, gold			2022-12-26	WOS:000399175000035
J	Hahn, NG; Rodriguez-Saona, C; Hamilton, GC				Hahn, Noel G.; Rodriguez-Saona, Cesar; Hamilton, George C.			Characterizing the spatial distribution of brown marmorated stink bug, Halyomorpha halys Stal (Hemiptera: Pentatomidae), populations in peach orchards	PLOS ONE			English	Article							DYNAMICS; AUTOCORRELATION; HETEROPTERA; PATTERNS; INSECTS; ECOLOGY; SCALES; IMPACT; PEST	Geospatial analyses were used to investigate the spatial distribution of populations of Halyomorpha halys, an important invasive agricultural pest in mid-Atlantic peach orchards. This spatial analysis will improve efficiency by allowing growers and farm managers to predict insect arrangement and target management strategies. Data on the presence of H. halys were collected from five peach orchards at four farms in New Jersey from 2012-2014 located in different land-use contexts. A point pattern analysis, using Ripley's K function, was used to describe clustering of H. halys. In addition, the clustering of damage indicative of H. halys feeding was described. With low populations early in the growing season, H. halys did not exhibit signs of clustering in the orchards at most distances. At sites with low populations throughout the season, clustering was not apparent. However, later in the season, high infestation levels led to more evident clustering of H. halys. Damage, although present throughout the entire orchard, was found at low levels. When looking at trees with greater than 10% fruit damage, damage was shown to cluster in orchards. The Moran's I statistic showed that spatial autocorrelation of H. halys was present within the orchards on the August sample dates, in relation to both populations density and levels of damage. Kriging the abundance of H. halys and the severity of damage to peaches revealed that the estimations of these are generally found in the same region of the orchards. This information on the clustering of H. halys populations will be useful to help predict presence of insects for use in management or scouting programs.	[Hahn, Noel G.; Rodriguez-Saona, Cesar; Hamilton, George C.] Rutgers State Univ, Dept Entomol, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Hahn, NG (corresponding author), Rutgers State Univ, Dept Entomol, New Brunswick, NJ 08901 USA.	nghahn@gmail.com			National Institute of Food and Agriculture; U.S. Department of Agriculture [2011-51181-30937]; USDA Sustainable agriculture research and education SARE [GNE12-038]; New Jersey Agricultural Experiment Station Multistate funds [08191, D-08-08191-02-13]	National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); USDA Sustainable agriculture research and education SARE; New Jersey Agricultural Experiment Station Multistate funds	Funded by National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number USDA NIFA SCRI #2011-51181-30937, USDA Sustainable agriculture research and education SARE GNE12-038, New Jersey Agricultural Experiment Station Multistate funds 08191 and is publication.	Alspach PA, 1999, NEW ZEAL J ECOL, V23, P39; [Anonymous], 2014, R LANG ENV STAT COMP; Arbogast RT, 2000, J ECON ENTOMOL, V93, P1531, DOI 10.1603/0022-0493-93.5.1531; Armas C, 2005, J ECOL, V93, P978, DOI 10.1111/j.1365-2745.2005.01033.x; Clevenger AP, 2003, BIOL CONSERV, V109, P15, DOI 10.1016/S0006-3207(02)00127-1; Corley JC, 2007, ENTOMOL EXP APPL, V125, P231, DOI 10.1111/j.1570-7458.2007.00623.x; ESRI, 2013, ESRO 2013 ARCGOS DES; Fortin M.-J., 2002, ENCY ENV, V4, P2051, DOI [10.1002/9780470057339.vas039, DOI 10.1002/9780470057339]; Fortin MJ, 2005, SPATIAL ANALYSIS: A GUIDE FOR ECOLOGISTS, P1; FORTIN MJ, 1989, VEGETATIO, V83, P209, DOI 10.1007/BF00031693; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; HOHN ME, 1993, ENVIRON ENTOMOL, V22, P1066, DOI 10.1093/ee/22.5.1066; JOHNSON DL, 1988, MEM ENTOMOL SOC CAN, P33; Joseph SV, 2014, J ECON ENTOMOL, V107, P1839, DOI 10.1603/EC14154; Klaas BA, 2000, ECOGRAPHY, V23, P246, DOI 10.1111/j.1600-0587.2000.tb00280.x; Koenig WD, 1999, TRENDS ECOL EVOL, V14, P22, DOI 10.1016/S0169-5347(98)01533-X; Lancaster J, 2003, J ANIM ECOL, V72, P969, DOI 10.1046/j.1365-2656.2003.00764.x; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; Leskey TC, 2015, BROWN MARM STINK BUG; LIEBHOLD AM, 1993, ANNU REV ENTOMOL, V38, P303, DOI 10.1146/annurev.en.38.010193.001511; Lynch HJ, 2008, CAN J FOREST RES, V38, P3112, DOI 10.1139/X08-143; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Mountrakis G, 2009, INT J GEOGR INF SCI, V23, P1389, DOI 10.1080/13658810802406132; New Jersey Department of Environmetal Protection, 2012, 2012 IM NJDEP 2012 L; Nielsen AL, 2009, J ECON ENTOMOL, V102, P1133, DOI 10.1603/029.102.0335; Papadopoulos NT, 2012, ENVIRON ENTOMOL, V32, P319; Rice KB, 2014, J INTEGR PEST MANAG, V5, DOI 10.1603/IPM14002; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; Robert J, 2006, P NATL ACAD SCI USA, V104, P864; Roland J, 1997, NATURE, V386, P710, DOI 10.1038/386710a0; SCHUMANN FW, 1982, J ECON ENTOMOL, V75, P748, DOI 10.1093/jee/75.4.748; Schweiger O, 2005, J APPL ECOL, V42, P1129, DOI 10.1111/j.1365-2664.2005.01085.x; Tillman PG, 2009, ENVIRON ENTOMOL, V38, P1038, DOI 10.1603/022.038.0411; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Venugopal PD, 2015, ENVIRON ENTOMOL, V44, P474, DOI 10.1093/ee/nvv061; Venugopal PD, 2015, J EC ENTOMOL; WALLNER WE, 1987, ANNU REV ENTOMOL, V32, P317, DOI 10.1146/annurev.en.32.010187.001533; WEISZ R, 1995, J ECON ENTOMOL, V88, P1650, DOI 10.1093/jee/88.6.1650; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Williams DW, 1995, J BIOGEOGR, V22, P665, DOI 10.2307/2845968	41	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0170889	10.1371/journal.pone.0170889	http://dx.doi.org/10.1371/journal.pone.0170889			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362797	Green Published, gold, Green Submitted			2022-12-26	WOS:000399175000001
J	Jiang, N; Zhou, Z; Yang, JB; Zhang, SD; Guan, KY; Tan, YH; Yu, WB				Jiang, Nan; Zhou, Zhuang; Yang, Jun-Bo; Zhang, Shu-Dong; Guan, Kai-Yun; Tan, Yun-Hong; Yu, Wen-Bin			Phylogenetic reassessment of tribe Anemoneae (Ranunculaceae): Non-monophyly of Anemone s.l. revealed by plastid datasets	PLOS ONE			English	Article							ANEMOCLEMA-GLAUCIFOLIUM; FLORAL DEVELOPMENT; RIBOSOMAL DNA; NUCLEAR; CHLOROPLAST; CLEMATIS; INCONGRUENCE; EVOLUTION; SOFTWARE; PATTERNS	Morphological and molecular evidence strongly supported the monophyly of tribe Anemoneae DC.; however, phylogenetic relationships among genera of this tribe have still not been fully resolved. In this study, we sampled 120 specimens representing 82 taxa of tribe Anemoneae. One nuclear ribosomal internal transcribed spacer (nrITS) and six plastid markers (atpB-rbcL, matK, psbA-trnQ, rpoB-trnC, rbcL and rps16) were amplified and sequenced. Both Maximum likelihood and Bayesian inference methods were used to reconstruct phylogenies for this tribe. Individual datasets supported all traditional genera as monophyletic, except Anemone and Clematis that were polyphyletic and paraphyletic, respectively, and revealed that the seven single-gene datasets can be split into two groups, i.e. nrITS + atpBrbcL and the remaining five plastid markers. The combined nrITS + atpB-rbcL dataset recovered monophyly of subtribes Anemoninae (i.e. Anemone s.I.) and Clematidinae (including Anemoclema), respectively. However, the concatenated plastid dataset showed that one group of subtribes Anemoninae (Hepatica and Anemone spp. from subgenus Anemonidium) close to the Glade Clematis s.l. + Anemoclema. Our results strongly supported a close relationship between Anemoclema and Clematis s.I., which included Archiclematis and Naravelia. Non-monophyly of Anemone s.l. using the plastid dataset indicates to revise as two genera, new Anemone s.l. (including Pulsatilla, Barneoudia, Oreithales and Knowltonia), Hepatica (corresponding to Anemone subgenus Anemonidium).	[Jiang, Nan; Tan, Yun-Hong; Yu, Wen-Bin] Chinese Acad Sci, Southeast Asia Biodivers Res Inst, Mengla, Yunnan, Peoples R China; [Jiang, Nan; Tan, Yun-Hong; Yu, Wen-Bin] Chinese Acad Sci, Ctr Integrat Conservat, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China; [Jiang, Nan; Zhou, Zhuang] Zhejiang Acad Agr Sci, Zhejiang Inst Subtrop Crops, Wenzhou, Zhejiang, Peoples R China; [Yang, Jun-Bo; Zhang, Shu-Dong] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Plant Germplasm & Genom Ctr, Kunming, Peoples R China; [Guan, Kai-Yun] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Xinjiang, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Zhejiang Academy of Agricultural Sciences; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Yu, WB (corresponding author), Chinese Acad Sci, Southeast Asia Biodivers Res Inst, Mengla, Yunnan, Peoples R China.; Yu, WB (corresponding author), Chinese Acad Sci, Ctr Integrat Conservat, Xishuangbanna Trop Bot Garden, Mengla, Yunnan, Peoples R China.	yuwenbin@xtbg.ac.cn	Yu, Wen-Bin/H-8339-2014	Yu, Wen-Bin/0000-0002-7643-2112; Zhou, Zhuang/0000-0002-3894-2576	Natural Science Foundation of China [31200158]; Natural Science Foundation of Zhejiang Province [LQ12CO2002]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This study was supported by Natural Science Foundation of China (31200158) and Natural Science Foundation of Zhejiang Province (LQ12CO2002).	[Anonymous], 1964, J INTEGR PLANT BIOL; Barniske A-M, 2009, MUTATIONAL DYNAMICS; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Candolle A.P., 1818, REGNI VEGETABILIS SY, V1; Ehrendorfer F, 1995, PLANT SYST EVOL, P283; Ehrendorfer F. R., 2001, ACTA PHYTOTAX SINICA, V39, P293; Franchet A., 1886, B SOC BOT FRANCE, V33, P358, DOI [10.1080/00378941.1886.10828470, DOI 10.1080/00378941.1886.10828470]; Grey-Wilson C., 2000, CLEMATIS THE GENUS; Guan Meng-Meng, 2013, Plant Diversity and Resources, V35, P555, DOI 10.7677/ynzwyj201312130; Hoot SB, 2012, SYST BOT, V37, P139, DOI 10.1600/036364412X616729; HOOT SB, 1991, SYST BOT, V16, P741, DOI 10.2307/2418876; HOOT SB, 1994, SYST BOT, V19, P169, DOI 10.2307/2419720; Hoot SB, 1995, PLANT SYST EVOL, P241; HOOT SB, 1994, J MOL EVOL, V38, P274; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jiang N., 2010, THESIS; Jiang N, 2012, PHYTOTAXA, V57, P56, DOI 10.11646/phytotaxa.57.1.8; JOHANSSON JT, 1993, PLANT SYST EVOL, V187, P29, DOI 10.1007/BF00994090; Johnson M., 1997, SLAKTET KLEMATIS; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kuntze O., 1885, VERHANDLUNGEN BOTANI, V26, P83; Lehtonen S, 2016, BOT J LINN SOC, V182, P825, DOI 10.1111/boj.12477; Maddison WP., 2019, CHROMASEQ MESQUITE P; Meyer KM, 2010, INT J PLANT SCI, V171, P323, DOI 10.1086/650153; Miikeda O, 2006, BOT J LINN SOC, V152, P153, DOI 10.1111/j.1095-8339.2006.00551.x; Mlinarec J, 2012, ANN BOT-LONDON, V110, P703, DOI 10.1093/aob/mcs128; Nishimoto Y, 2003, GENES GENET SYST, V78, P139, DOI 10.1266/ggs.78.139; Pelser PB, 2010, AM J BOT, V97, P856, DOI 10.3732/ajb.0900287; Pfosser M, 2011, STAPFIA, V95, P16; Prantl K., 1888, BOT JB, V9, P325; Ren Y, 2004, PLANT SYST EVOL, V247, P145, DOI 10.1007/s00606-004-0129-z; Ren Y, 2010, BOT J LINN SOC, V162, P77, DOI 10.1111/j.1095-8339.2009.01017.x; Ro KE, 1997, MOL PHYLOGENET EVOL, V8, P117, DOI 10.1006/mpev.1997.0413; Schuettpelz E, 2002, PLANT SYST EVOL, V231, P143, DOI 10.1007/s006060200016; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Takhtajan A., 2009, FLOWERING PLANTS, DOI 10.1007/978-1-4020-9609-9; Tamura M., 1997, Thai Forest Bulletin (Botany), P63; TAMURA M, 1986, Acta Phytotaxonomica et Geobotanica, V37, P106; TAMURA M, 1991, Acta Phytotaxonomica et Geobotanica, V42, P177; TAMURA M, 1987, Acta Phytotaxonomica et Geobotanica, V38, P33; TAMURA M, 1993, FAMILIES GENERA VASC, V2, P563, DOI DOI 10.1007/978-3-662-02899-5_67; TAMURA M., 1995, NATURL PFLANZ, P223; TAMURA MICHIO, 1956, ACTA PHYTOTAX ET GEOBOT, V16, P79; Tonti-Filippini J, 2017, PLANT J, P89; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; VanRaamsdonk LWD, 1997, BOT J LINN SOC, V123, P91, DOI 10.1006/bojl.1996.0075; Wang W.T., 1980, FLORA REIPUBLICAE PO, V28, P1; Wang WC, 2001, FLORAL CHINA, V6, P133; Wang W, 2009, PERSPECT PLANT ECOL, V11, P81, DOI 10.1016/j.ppees.2009.01.001; [Wang Wen-tsdai 王文采], 2002, [植物分类学报, Acta Phytotaxonomica Sinica], V40, P193; Wang WT, 2005, ACTA PHYTOTAXON SIN, V43, P431; WANG WT, 1964, ACTA PHYTOTAXON SIN, V9, P103; Wu ZY., 2003, FAMILIES GENERA ANGI; Xie L, 2011, SYST BOT, V36, P907, DOI 10.1600/036364411X604921; Yang T. Y. Aleck, 1999, Systematics and Geography of Plants, V68, P281, DOI 10.2307/3668608; Yu WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074828; Zeng LP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5956; Zhang Guo-Li, 2002, Acta Botanica Yunnanica, V24, P765; Zhang Y, 2015, PLANT SYST EVOL, V301, P1335, DOI 10.1007/s00606-014-1160-3; Zhang Y, 2015, PLANT SYST EVOL, V301, P411, DOI 10.1007/s00606-014-1082-0; Zhang YX, 2012, MOL PHYLOGENET EVOL, V63, P777, DOI 10.1016/j.ympev.2012.02.023; Ziman S. N., 2008, Journal of Japanese Botany, V83, P127	65	24	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174792	10.1371/journal.pone.0174792	http://dx.doi.org/10.1371/journal.pone.0174792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362811	Green Submitted, Green Published, gold			2022-12-26	WOS:000399175000034
J	Lin, TW; Chang, CF; Chang, YJ; Liao, YH; Yu, HM; Chen, YR				Lin, Tien-Wei; Chang, Chi-Fon; Chang, Yu-Jen; Liao, Yi-Hung; Yu, Hui-Ming; Chen, Yun-Ru			Alzheimer's amyloid-beta A2T variant and its N-terminal peptides inhibit amyloid-beta fibrillization and rescue the induced cytotoxicity	PLOS ONE			English	Article							HEREDITARY CEREBRAL-HEMORRHAGE; PROTOFIBRIL FORMATION; MOLECULAR-STRUCTURE; DISEASE MUTATIONS; TOTTORI D7N; ENGLISH H6R; FIBRILS; PROTEIN; AGGREGATION; A-BETA(1-42)	Alzheimer's disease (AD) is the most common dementia affecting tens of million people worldwide. The primary neuropathological hallmark in AD is amyloid plaques composed of amyloid-beta peptide (A beta). Several familial mutations found in A beta sequence result in early onset of AD. Previous studies showed that the mutations located at N-terminus of A beta, such as the English (H6R) and Tottori (D7N) mutations, promote fibril formation and increase cytotoxicity. However, A2T mutant located at the very N-terminus of A beta shows low-prevalence incidence of AD, whereas, another mutant A2V causes early onset of AD. To understand the molecular mechanism of the distinct effect and develop new potential therapeutic strategy, here, we examined the effect of full-length and N-terminal A2V/T variants to wild type (WT) A beta 40 by fibrillization assays and NMR studies. We found that full-length and N-terminal A2V accelerated WT fibrillization and induced large chemical shifts on the N-terminus of WT A beta, whereas, full-length and N-terminal A2T retarded the fibrillization. We further examined the inhibition effect of various N-terminal fragments (NTFs) of A2T to WT A beta. The A2T NTFs ranging from residue 1 to residue 7 to 10, but not 1 to 6 or shorter, are capable to retard WT A beta fibrillization and rescue cytotoxicity. The results suggest that in the presence of full-length or specific N-terminal A2T can retard A beta aggregation and the A2T NTFs can mitigate its toxicity. Our results provide a novel targeting site for future therapeutic development of AD.	[Lin, Tien-Wei] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei, Taiwan; [Lin, Tien-Wei; Chang, Chi-Fon; Chang, Yu-Jen; Liao, Yi-Hung; Yu, Hui-Ming; Chen, Yun-Ru] Acad Sinica, Genom Res Ctr, Taipei, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan	Chen, YR (corresponding author), Acad Sinica, Genom Res Ctr, Taipei, Taiwan.	yrchen@gate.sinica.edu.tw	Chen, Yun-Ru/C-9304-2014	Chen, Yun-Ru/0000-0002-6596-6338; Chang, Chi-Fon/0000-0002-2961-0748	Academia Sinica, Taiwan [CDA-106-L01]; Ministry of Science and Technology, Taiwan [MOST 103-2113-M-001 -015, 104-2321-B-001-071, 104-2320-B-001 -013 -MY3, 104-2745-B-001-002]	Academia Sinica, Taiwan(Academia Sinica - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Academia Sinica, Taiwan (CDA-106-L01; https://www.sinica.edu.tw) and the Ministry of Science and Technology, Taiwan (MOST 103-2113-M-001 -015, 104-2321-B-001-071, 104-2320-B-001 -013 -MY3, and 104-2745-B-001-002; https://www.most.gov.tw/en/public). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adessi C, 2003, J BIOL CHEM, V278, P13905, DOI 10.1074/jbc.M211976200; Basi GS, 2010, J BIOL CHEM, V285, P3417, DOI 10.1074/jbc.M109.045187; Benilova I, 2014, J BIOL CHEM, V289, P30977, DOI 10.1074/jbc.M114.599027; Bertini I, 2011, J AM CHEM SOC, V133, P16013, DOI 10.1021/ja2035859; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Chen WT, 2011, J BIOL CHEM, V286, P9646, DOI 10.1074/jbc.M110.177246; Chen WM, 2012, OCEAN ENG, V42, P7, DOI 10.1016/j.oceaneng.2011.12.019; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Das P, 2015, BIOPHYS J, V108, P738, DOI 10.1016/j.bpj.2014.12.013; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Endo H, 2014, BIOORG MED CHEM LETT, V24, P5621, DOI 10.1016/j.bmcl.2014.10.076; Fradinger EA, 2008, P NATL ACAD SCI USA, V105, P14175, DOI 10.1073/pnas.0807163105; Frieden C, 2007, PROTEIN SCI, V16, P2334, DOI 10.1110/ps.073164107; Funke SA, 2012, CURR PHARM DESIGN, V18, P755; Garai K, 2007, BIOCHEMISTRY-US, V46, P10655, DOI 10.1021/bi700798b; Giaccone G, 2010, ACTA NEUROPATHOL, V120, P803, DOI 10.1007/s00401-010-0747-1; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Grundman M, 2000, NEUROL CLIN, V18, P807, DOI 10.1016/S0733-8619(05)70227-9; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Huet A, 2006, BIOPHYS J, V91, P3829, DOI 10.1529/biophysj.106.090993; Jack CR, 2013, NEURON, V80, P1347, DOI 10.1016/j.neuron.2013.12.003; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kepp KP, 2012, CHEM REV, V112, P5193, DOI 10.1021/cr300009x; Khodarahmi R, 2016, INT J BIOL MACROMOLE; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Levine H, 2007, AMYLOID, V14, P185, DOI 10.1080/13506120701461020; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Liao YH, 2015, PROTEIN EXPRES PURIF, V113, P63, DOI 10.1016/j.pep.2015.05.002; Lim KH, 2006, CHEMBIOCHEM, V7, P1662, DOI 10.1002/cbic.200600270; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Messa M, 2014, J BIOL CHEM, V289, P24143, DOI 10.1074/jbc.M114.576256; Ni CL, 2011, FASEB J, V25, P1390, DOI 10.1096/fj.10-175539; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Noy D, 2008, J AM CHEM SOC, V130, P1376, DOI 10.1021/ja076282l; Ono K, 2010, J BIOL CHEM, V285, P23184, DOI 10.1074/jbc.M109.086496; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Rajasekhar K, 2016, ACS CHEM NEUROSCI, V7, P1300, DOI 10.1021/acschemneuro.6b00175; Rambaran RN, 2008, PRION, V2, P112, DOI 10.4161/pri.2.3.7488; Riek R, 2001, EUR J BIOCHEM, V268, P5930, DOI 10.1046/j.0014-2956.2001.02537.x; Rossi G, 1998, NEUROLOGY, V50, P688, DOI 10.1212/WNL.50.3.688; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sarroukh R, 2013, BBA-BIOMEMBRANES, V1828, P2328, DOI 10.1016/j.bbamem.2013.04.012; Schlenzig D, 2009, BIOCHEMISTRY-US, V48, P7072, DOI 10.1021/bi900818a; Schutz AK, 2015, ANGEW CHEM INT EDIT, V54, P331, DOI 10.1002/anie.201408598; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Sharma B, 2016, J PHYS CHEM B, V120, P9019, DOI 10.1021/acs.jpcb.6b03892; Smith DP, 2007, BIOCHEMISTRY-US, V46, P2881, DOI 10.1021/bi0620961; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Tougu V, 2009, J NEUROCHEM, V110, P1784, DOI 10.1111/j.1471-4159.2009.06269.x; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; Villemagne VL, 2017, SEMIN NUCL MED, V47, P75, DOI 10.1053/j.semnuclmed.2016.09.006; Walti MA, 2015, CHEMBIOCHEM, V16, P659, DOI 10.1002/cbic.201402595; Wakutani Y, 2004, J NEUROL NEUROSUR PS, V75, P1039, DOI 10.1136/jnnp.2003.010611; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991; Yoshiike Y, 2001, J BIOL CHEM, V276, P32293, DOI 10.1074/jbc.M010706200; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Zheng XY, 2016, J PHYS CHEM B, V120, P1615, DOI 10.1021/acs.jpcb.5b08177; Zheng XY, 2015, ACS CHEM NEUROSCI, V6, P1732, DOI 10.1021/acschemneuro.5b00171	70	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174561	10.1371/journal.pone.0174561	http://dx.doi.org/10.1371/journal.pone.0174561			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362827	Green Published, Green Submitted, gold			2022-12-26	WOS:000399175000018
J	Adane, K; Spigt, M; Johanna, L; Noortje, D; Abera, SF; Dinant, GJ				Adane, Kelemework; Spigt, Mark; Johanna, Laturnus; Noortje, Dorscheidt; Abera, Semaw Ferede; Dinant, Geert-Jan			Tuberculosis knowledge, attitudes, and practices among northern Ethiopian prisoners: Implications for TB control efforts	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS	Introduction Although awareness is an important component in tuberculosis (TB) control, we do not know how much Ethiopian prisoners know about TB. This study assessed the level of knowledge, attitudes, and practices (KAP) of prisoners about TB in eight northern Ethiopian prisons. Methods Data were collected cross-sectionally from 615 prisoners using a standardized questionnaire between March and May 2016. The outcome variables were defined considering the basic elements about TB. Results Out of 615 prisoners, only 37.7% mentioned bacteria as a cause of TB while 21.7% related TB to exposure to cold wind. Eighty-eight per cent correctly mentioned the aerial route of TB transmission and 27.3% had perceived stigma towards TB. The majority (63.7%) was not aware of the possibility of getting multi-drug-resistant strains when they would not adhere to treatment. Overall, only 24% knew the basic elements about TB, 41% had favorable attitudes, and 55% had a good practice. Prisoners who were urban residents were generally more knowledgeable than rural residents (adjusted OR = 2.16; 95% CI = 1.15-4.06). Illiterates were found to be less knowledgeable (adjusted OR = 0.17; 95% CI = 0.06-0.46), less likely to have a favorable attitude (adjusted OR = 0.31; 95% CI = 0.15-0.64), and less good practice (adjusted OR = 0.35; 95% CI = 0.18-0.69). Significant differences were also observed between the different study prisons. Conclusions Knowledge of prisoners regarding the cause of TB and consequences of non-adherence to TB treatment was low. Knowledge on the transmission, symptoms, and prevention was fairly high. Health education interventions, focused on the cause and the translation of the knowledge to appropriate practices, are needed in all the study prisons. Special attention should be given to less educated prisoners, and to prisons with a high number of prisoners and those in remote areas.	[Adane, Kelemework] Mekelle Univ, Dept Med Microbiol & Immunol, Coll Hlth Sci, Mekelle, Ethiopia; [Adane, Kelemework; Spigt, Mark; Dinant, Geert-Jan] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Family Med, Maastricht, Netherlands; [Johanna, Laturnus; Noortje, Dorscheidt] Maastricht Univ, Fac Hlth Med & Life Sci, Maastricht, Netherlands; [Abera, Semaw Ferede] Mekelle Univ, Dept Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia	Mekelle University; Maastricht University; Maastricht University; Mekelle University	Adane, K (corresponding author), Mekelle Univ, Dept Med Microbiol & Immunol, Coll Hlth Sci, Mekelle, Ethiopia.; Adane, K (corresponding author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Family Med, Maastricht, Netherlands.	ingoldmlt@gmail.com			Maastricht University through Nuffic scholarship; Mekelle University	Maastricht University through Nuffic scholarship; Mekelle University	This study was financially supported by Maastricht University through Nuffic scholarship and Mekelle University. The funder had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Abebe DS, 2011, INT J TUBERC LUNG D, V15, P668, DOI 10.5588/ijtld.10.0363; Abebe DS, 2011, INT J TUBERC LUNG D, V15, P228; Abebe G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013339; Adane K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149453; Aerts A, 2006, INT J TUBERC LUNG D, V10, P1215; Amo-Adjei J, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-38; Baillargeon J, 2004, PREV MED, V38, P607, DOI 10.1016/j.ypmed.2003.11.020; Baker L, 2003, JAMA-J AM MED ASSOC, V289, P2400, DOI 10.1001/jama.289.18.2400; Bati J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-734; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Berile, 2012, STATUS HUMAN RIGHTS; Cramm JM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-72; Editors PM, 2010, PLOS MED, V7; Esmael A, 2013, AM J TROP MED HYG, V88, P785, DOI 10.4269/ajtmh.12-0312; Ferreira Júnior Sérgio, 2013, Rev. bras. epidemiol., V16, P100, DOI 10.1590/S1415-790X2013000100010; Hoa NP, 2003, SCAND J PUBLIC HEALT, V31, P59, DOI 10.1080/14034950310015121; Legesse M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-187; Mercy Chinenye Nwankwo, 2015, IJSRP, V5; Mesfin M. M., 2005, Ethiopian Journal of Health Development, V19, P21; MORISKY DE, 1990, HEALTH EDUC QUART, V17, P253, DOI 10.1177/109019819001700303; Nguyen PH, 2009, HEALTH POLICY, V90, P8, DOI 10.1016/j.healthpol.2008.08.006; O'Grady J, 2011, TUBERCULOSIS, V91, P173, DOI 10.1016/j.tube.2010.12.002; Sacchi FPC, 2015, EMERG INFECT DIS, V21, P452, DOI 10.3201/eid2103.140896; Saifodine A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-559; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Tolossa D, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-804; Walmsley R, 2010, WORLD PRISON POPULAT, Veleventh, P15; WHO, 2016, GLOB TUB REP; WHO, 2007, STAT PAP PRIS TUB; WOODS GL, 1997, J CORRECT HEALTH CAR, V4, P61; World Health Organisation, 2008, WORLD HEAL ORGAN, P1; World Health Organization, 2014, GLOB TUB REP	32	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174692	10.1371/journal.pone.0174692	http://dx.doi.org/10.1371/journal.pone.0174692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358877	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174800073
J	Franzetti, A; Navarra, F; Tagliaferri, I; Gandolfi, I; Bestetti, G; Minora, U; Azzoni, RS; Diolaiuti, G; Smiraglia, C; Ambrosini, R				Franzetti, Andrea; Navarra, Federico; Tagliaferri, Ilario; Gandolfi, Isabella; Bestetti, Giuseppina; Minora, Umberto; Azzoni, Roberto Sergio; Diolaiuti, Guglielmina; Smiraglia, Claudio; Ambrosini, Roberto			Potential sources of bacteria colonizing the cryoconite of an Alpine glacier	PLOS ONE			English	Article							FORNI GLACIER; MICROBIAL ACTIVITY; SP NOV.; HOLES; COMMUNITIES; SEQUENCES; GRANULES; FORELAND; YEASTS; ALBEDO	We investigated the potential contribution of ice-marginal environments to the microbial communities of cryoconite holes, small depressions filled with meltwater that form on the surface of Forni Glacier (Italian Alps). Cryoconite holes are considered the most biologically active environments on glaciers. Bacteria can colonize these environments by short-range transport from ice-marginal environments or by long-range transport from distant areas. We used high throughput DNA sequencing to identify Operational Taxonomic Units (OTUs) present in cryoconite holes and three ice-marginal environments, the moraines, the glacier forefield, and a large (> 3 m high) ice-cored dirt cone occurring on the glacier surface. Bacterial communities of cryoconite holes were different from those of ice-marginal environments and hosted fewer OTUs. However, a network analysis revealed that the cryoconite holes shared more OTUs with the moraines and the dirt cone than with the glacier forefield. Ice-marginal environments may therefore act as sources of bacteria for cryoconite holes, but differences in environmental conditions limit the number of bacterial strains that may survive in them. At the same time, cryoconite holes host a few OTUs that were not found in any ice-marginal environment we sampled, thus suggesting that some bacterial populations are positively selected by the specific environmental conditions of the cryoconite holes.	[Franzetti, Andrea; Navarra, Federico; Tagliaferri, Ilario; Gandolfi, Isabella; Bestetti, Giuseppina; Ambrosini, Roberto] Univ Milano Bicocca, Dept Earth & Environm Sci DISAT, Milan, Italy; [Minora, Umberto; Azzoni, Roberto Sergio; Diolaiuti, Guglielmina; Smiraglia, Claudio] Univ Milan, A Desio Dept Earth Sci, Milan, Italy	University of Milano-Bicocca; University of Milan	Ambrosini, R (corresponding author), Univ Milano Bicocca, Dept Earth & Environm Sci DISAT, Milan, Italy.	roberto.ambrosini@unimib.it	Ambrosini, Roberto/F-3188-2012; Franzetti, Andrea/A-6666-2008	Ambrosini, Roberto/0000-0002-7148-1468; Franzetti, Andrea/0000-0003-1279-9940; MINORA, UMBERTO FILIPPO/0000-0003-2151-6500; Gandolfi, Isabella/0000-0002-0267-2412	University of Milano-Bicocca [7-19-20011002]; Sanpellegrino SPA brand Levissima; DARAS (Department of Regional Affairs, Autonomies and Sport) of the Presidency of the Council of Ministers of the Italian government through the GlacioVAR project	University of Milano-Bicocca; Sanpellegrino SPA brand Levissima; DARAS (Department of Regional Affairs, Autonomies and Sport) of the Presidency of the Council of Ministers of the Italian government through the GlacioVAR project	This work was partially funded by the University of Milano-Bicocca (grant 7-19-20011002 to RA), and by Sanpellegrino SPA brand Levissima. The publication cost has been covered by DARAS (Department of Regional Affairs, Autonomies and Sport) of the Presidency of the Council of Ministers of the Italian government through the GlacioVAR project (to G. Diolaiuti). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosini R, 2016, MICROB ECOL IN PRESS; Anesio AM, 2012, TRENDS ECOL EVOL, V27, P219, DOI 10.1016/j.tree.2011.09.012; Anesio AM, 2009, GLOBAL CHANGE BIOL, V15, P955, DOI 10.1111/j.1365-2486.2008.01758.x; Azzoni RS, 2016, CRYOSPHERE, V10, P665, DOI 10.5194/tc-10-665-2016; Benjamini Y, 2001, ANN STAT, V29, P1165; Bennett GL, 2012, EARTH SURF PROC LAND, V37, P1584, DOI 10.1002/esp.3259; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Buzzini P, 2005, ANN GLACIOL, V40, P119, DOI 10.3189/172756405781813591; Cameron KA, 2012, FEMS MICROBIOL ECOL, V82, P254, DOI 10.1111/j.1574-6941.2011.01277.x; Cameron KA, 2012, POLAR BIOL, V35, P1375, DOI 10.1007/s00300-012-1178-3; Christner BC, 2003, EXTREMOPHILES, V7, P177, DOI 10.1007/s00792-002-0309-0; De Caceres M, 2010, OIKOS, V119, P1674, DOI 10.1111/j.1600-0706.2010.18334.x; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edwards A, 2014, FEMS MICROBIOL ECOL, V89, P222, DOI 10.1111/1574-6941.12283; Edwards A, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/035003; Edwards A, 2013, POLAR RES, V32, DOI 10.3402/polar.v32i0.19468; Edwards A, 2013, FUNGAL ECOL, V6, P168, DOI 10.1016/j.funeco.2012.11.001; Foreman CM, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000358; Francesa-Alfaro A., 2016, LIGHT DEPENDENT MICR, P1; Franzetti A, 2016, ENV MICROBI IN PRESS; Fugazza D, 2015, GEOGR FIS DIN QUAT, V38, P25, DOI 10.4461/GFDQ.2015.38.03; Gobbi M, 2006, ARCT ANTARCT ALP RES, V38, P357, DOI 10.1657/1523-0430(2006)38[357:EASAAY]2.0.CO;2; Hamilton TL, 2013, ISME J, V7, P1402, DOI 10.1038/ismej.2013.31; Hartmann M, 2012, ISME J, V6, P2199, DOI 10.1038/ismej.2012.84; Hodson A, 2008, ECOL MONOGR, V78, P41, DOI 10.1890/07-0187.1; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Kaczmarek l, 2015, POLAR REC, V52, P1; LaybournParry J, 2012, Ecology of Snow and Ice Environments, P1, DOI 10.1093/acprof:oso/9780199583072.001.0001; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Legendre P., 2012, NUMERICAL ECOLOGY; Lindstrom ES, 2012, ENV MICROBIOL REP, V4, P1, DOI 10.1111/j.1758-2229.2011.00257.x; Margesin R, 2003, INT J SYST EVOL MICR, V53, P1291, DOI 10.1099/ijs.0.02436-0; Margesin R, 2002, ARCT ANTARCT ALP RES, V34, P88, DOI 10.2307/1552512; Margesin R, 2012, INT J SYST EVOL MICR, V62, P2662, DOI 10.1099/ijs.0.037556-0; Mueller Derek R., 2001, Beihefte zur Nova Hedwigia, V123, P173; Musilova M, 2016, GEOCHEM PERSPECT LET, V2, P106, DOI 10.7185/geochemlet.1611; Musilova M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00193; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Porazinska DL, 2004, ARCT ANTARCT ALP RES, V36, P84, DOI 10.1657/1523-0430(2004)036[0084:TBABOC]2.0.CO;2; R Core Team, 2021, R LANGUAGE ENV STAT; Rime T, 2016, ISME J, P1; Segawa T, 2014, ENVIRON MICROBIOL, V16, P3250, DOI 10.1111/1462-2920.12543; Senese A, 2014, CRYOSPHERE, V8, P1921, DOI 10.5194/tc-8-1921-2014; Senese A, 2012, GEOGR FIS DIN QUAT, V35, P69, DOI 10.4461/GFDQ.2012.35.7; Smiraglia C, 2015, GEOGR FIS DIN QUAT, V38, P79, DOI 10.4461/GFDQ.2015.38.08; Stibal M, 2015, ENV MICROBIOL REP, V7, P293, DOI 10.1111/1758-2229.12246; Takeuchi N, 2000, B GLACIOLOGICAL RES, V17, P51; Takeuchi N, 2010, ANN GLACIOL, V51, P9, DOI 10.3189/172756411795932010; Telling J, 2010, ANN GLACIOL, V51, P153, DOI 10.3189/172756411795932056; Turchetti B, 2008, FEMS MICROBIOL ECOL, V63, P73, DOI 10.1111/j.1574-6941.2007.00409.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang YF, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0005368, 10.1371/journal.pone.0007401]; WHARTON RA, 1985, BIOSCIENCE, V35, P499, DOI 10.2307/1309818; Zarsky JD, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/035044; Zawierucha K, 2015, J ZOOL, V295, P159, DOI 10.1111/jzo.12195; Zdanowski M. K., 2016, MICROB ECOL, V2016, P1	56	28	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174786	10.1371/journal.pone.0174786	http://dx.doi.org/10.1371/journal.pone.0174786			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358872	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174800090
J	Su, J; Yu, QL; Zhu, H; Li, XJ; Cui, HB; Du, WP; Ji, LD; Tong, MQ; Zheng, YB; Xu, HY; Zhang, JJ; Zhu, YY; Xia, YZ; Liu, T; Yao, Q; Yang, J; Chen, XM; Yu, JB				Su, Jia; Yu, Qinglin; Zhu, Hao; Li, Xiaojing; Cui, Hanbin; Du, Weiping; Ji, Lindan; Tong, Maoqing; Zheng, Yibo; Xu, Hongyu; Zhang, Jianjiang; Zhu, Yunyun; Xia, Yezi; Liu, Ting; Yao, Qi; Yang, Jun; Chen, Xiaomin; Yu, Jingbo			The risk of clopidogrel resistance is associated with ABCB1 polymorphisms but not promoter methylation in a Chinese Han population	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; PLATELET-FUNCTION; DNA METHYLATION; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; ANTIPLATELET THERAPY; REACTIVITY; IMPACT; ACTIVATION; MECHANISMS	The goal of our study was to investigate the contribution of ABCB1 expression to the risk of clopidogrel resistance (CR). Platelets functions were measured using the Verify-Now P2Y12 assay. Applying Polymerase Chain Reaction Restriction Fragment Length Polymorphism (PCR-RFLP), the single-nucleotide polymorphisms (SNPs) was tested. Using bisulphite pyrosequencing assay, we investigated the association of the ABCB1 DNA methylation levels and CR. It was shown that female, hypertension, and lower albumin levels increased the risk of CR (P<0.05). If patients did not have hypoproteinaemia or had hypertension, the SNP in rs1045642 was associated with CR (CC vs. TT: albumin >= 35, P= 0.042; hypertension, P = 0.045; C vs. T: albumin >= 35, P = 0.033; hypertension, P= 0.040). Additionally, the platelet inhibition of the CT+TT genotype in rs1128503 was larger than that of the CC genotype (P = 0.021). Multivariate logistic regression analysis showed that male, higher albumin and hsCRP decreased the risk of CR, and the stent size maybe positively correlated with CR. The SNP in rs1045642 was related to all-cause mortality (P= 0.024). We did not find any relationship between the methylation levels of the ABCB1 promoter and CR. In conclusions, our study indicated that ABCB1 polymorphisms might be useful in further evaluating the pathogenesis of CR.	[Su, Jia; Li, Xiaojing; Zheng, Yibo; Xu, Hongyu; Zhang, Jianjiang; Zhu, Yunyun; Xia, Yezi; Liu, Ting; Yao, Qi; Yang, Jun; Yu, Jingbo] Ningbo 1 Hosp, Dept Gerontol, Ningbo, Zhejiang, Peoples R China; [Yu, Qinglin] Ningbo 1 Hosp, Dept Tradit Chinese Internal Med, Ningbo, Zhejiang, Peoples R China; [Zhu, Hao] Ningbo 1 Hosp, Dept Anaesthesia, Ningbo, Zhejiang, Peoples R China; [Cui, Hanbin; Du, Weiping; Chen, Xiaomin] Ningbo 1 Hosp, Dept Cardiol, Ningbo, Zhejiang, Peoples R China; [Ji, Lindan] Ningbo Univ, Sch Med, Dept Biochem, Ningbo, Zhejiang, Peoples R China; [Tong, Maoqing] Ningbo Univ, Sch Med, Ningbo Hosp 1, Key Lab Mol Med, Ningbo, Zhejiang, Peoples R China	Ningbo University; Ningbo University	Yao, Q; Yang, J; Yu, JB (corresponding author), Ningbo 1 Hosp, Dept Gerontol, Ningbo, Zhejiang, Peoples R China.; Chen, XM (corresponding author), Ningbo 1 Hosp, Dept Cardiol, Ningbo, Zhejiang, Peoples R China.	nbyaoqi@sina.com; yangjun4499@163.com; chxmin@hotmail.com; nbyujingbo@163.com	chen, xia/GYR-3948-2022; xu, hong/GSD-8903-2022; chen, xia/GXM-5435-2022; chen, xi/GXH-3653-2022		Plan of Science and Technology on Medicine and Health in Zhejiang Province [2017KY574]	Plan of Science and Technology on Medicine and Health in Zhejiang Province	The authors received the funding of the Plan of Science and Technology on Medicine and Health in Zhejiang Province (2017KY574) for this work.	Abuhaliema Ali M, 2016, Asian Pac J Cancer Prev, V17, P261; Alexopoulos D, 2012, PLATELETS, V23, P83, DOI 10.3109/09537104.2011.600478; Anderson JL, 2013, CIRCULATION, V127, pE663, DOI 10.1161/CIR.0b013e31828478ac; Angiolillo DJ, 2005, DIABETES, V54, P2430, DOI 10.2337/diabetes.54.8.2430; Aradi D, 2014, EUR HEART J, V35, P209, DOI 10.1093/eurheartj/eht375; Beitelshees AL, 2015, PHARMACOGEN PERS MED, V8, P43, DOI 10.2147/PGPM.S52900; Blazing MA, 2014, AM HEART J, V168, P205, DOI 10.1016/j.ahj.2014.05.004; Campo G, 2010, J THROMB THROMBOLYS, V30, P319, DOI 10.1007/s11239-010-0457-5; Cayla G, 2011, JAMA-J AM MED ASSOC, V306, P1765, DOI 10.1001/jama.2011.1529; Chiu SN, 2012, HUM GENET, V131, P1295, DOI 10.1007/s00439-012-1156-4; FOJO A, 1986, SOMAT CELL MOLEC GEN, V12, P415, DOI 10.1007/BF01570737; Fontana P, 2010, J THROMB HAEMOST, V8, P2614, DOI 10.1111/j.1538-7836.2010.04063.x; Franchi F, 2015, NAT REV CARDIOL, V12, P30, DOI 10.1038/nrcardio.2014.156; Geisler T, 2008, J THROMB HAEMOST, V6, P54; Gremmel T, 2010, J THROMB HAEMOST, V8, P37, DOI 10.1111/j.1538-7836.2009.03644.x; GROS P, 1986, NATURE, V323, P728, DOI 10.1038/323728a0; Hermans MP, 2011, THER ADV CHRONIC DIS, V2, P307, DOI 10.1177/2040622311413952; Hochholzer W, 2006, J AM COLL CARDIOL, V48, P1742, DOI 10.1016/j.jacc.2006.06.065; Hochholzer W, 2010, J AM COLL CARDIOL, V55, P2427, DOI 10.1016/j.jacc.2010.02.031; Huang Z, 2016, THER CLIN RISK MANAG, V12, P217, DOI 10.2147/TCRM.S95453; Jakubowski JA, 2008, THROMB HAEMOSTASIS, V99, P409, DOI 10.1160/TH07-09-0575; Jennings LK, 2009, THROMB HAEMOSTASIS, V102, P248, DOI 10.1160/TH09-03-0192; Karazniewicz-Lada M, 2015, J CLIN PHARM THER, V40, P226, DOI 10.1111/jcpt.12236; Kim IS, 2010, J THROMB THROMBOLYS, V30, P486, DOI 10.1007/s11239-010-0484-2; Kubica A, 2014, EUR J PHARMACOL, V742, P47, DOI 10.1016/j.ejphar.2014.08.009; Legendre CR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150629; Brambila-Tapia AJL, 2013, REV INVEST CLIN, V65, P445; Malek LA, 2008, CIRC J, V72, P1165, DOI 10.1253/circj.72.1165; Marcucci R, 2009, CIRCULATION, V119, P237, DOI 10.1161/CIRCULATIONAHA.108.812636; Matetzky S, 2004, CIRCULATION, V109, P3171, DOI 10.1161/01.CIR.0000130846.46168.03; Matrisciano F, 2016, CURR NEUROPHARMACOL, V14, P41, DOI 10.2174/1570159X13666150713174242; Mikeska T, 2007, J MOL DIAGN, V9, P368, DOI 10.2353/jmoldx.2007.060167; Morita S, 2012, INT J MOL SCI, V13, P8259, DOI 10.3390/ijms13078259; Nguyen TA, 2005, J AM COLL CARDIOL, V45, P1157, DOI 10.1016/j.jacc.2005.01.034; Park MW, 2016, GENET MED, V18, P833, DOI 10.1038/gim.2015.171; Ramkaran P, 2015, GENE, V571, P28, DOI 10.1016/j.gene.2015.06.044; RAZIN A, 1984, P NATL ACAD SCI-BIOL, V81, P2275, DOI 10.1073/pnas.81.8.2275; Sangkuhl K, 2010, PHARMACOGENET GENOM, V20, P463, DOI 10.1097/FPC.0b013e3283385420; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Spiewak M, 2009, KARDIOL POL, V67, P827; Spiliopoulos S, 2015, WORLD J CARDIOL, V7, P912, DOI 10.4330/wjc.v7.i12.912; SU J, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/450814; Su J, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0114-2; Su J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046366; Tan LA, 2015, J NEUROINTERV SURG, V7, P217, DOI 10.1136/neurintsurg-2014-011111; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Teng RL, 2012, CLIN PHARMACOKINET, V51, P305, DOI 10.2165/11630960-000000000-00000; Udell JA, 2016, EUR HEART J, V37, P390, DOI 10.1093/eurheartj/ehv443; Wang YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22722; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wiviott SD, 2015, LANCET, V386, P292, DOI 10.1016/S0140-6736(15)60213-6; Yang J, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/324203; Yin G, 2016, TUMOUR BIOL; Zhang ZY, 2015, INT J CLIN EXP PATHO, V8, P15240	55	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174511	10.1371/journal.pone.0174511	http://dx.doi.org/10.1371/journal.pone.0174511			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358842	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174800047
J	Gluckman, TL; Mundy, NI				Gluckman, Thanh-Lan; Mundy, Nicholas I.			The differential expression of MC1R regulators in dorsal and ventral quail plumages during embryogenesis: Implications for plumage pattern formation	PLOS ONE			English	Article							AVIAN MELANOCORTIN SYSTEM; POSSIBLE INVOLVEMENT; PIGMENT PATTERNS; JAPANESE-QUAIL; COAT COLOR; AGOUTI; PROTEIN; MUTATION; RECEPTOR; CHICKEN	Melanin pigmentation patterns are ubiquitous in animals and function in crypsis, physical protection, thermoregulation and signalling. In vertebrates, pigmentation patterns formed over large body regions as well as within appendages (hair/feathers) may be due to the differential distribution of pigment producing cells (melanocytes) and/or regulation of the melanin synthesis pathway. We took advantage of the pigmentation patterns of Japanese quail embryos (pale ventrum and patterned feathers dorsally) to explore the role of genes and their transcripts in regulating the function of the melanocortin-1-receptor (MC1R) via 1. activation: pro-opiomelanocortin (POMC), endoproteases prohormone convertase 1 (PC1) and 2 (PC2), and 2. inhibition agouti signaling and agouti-related protein (ASIP and AGRP, respectively). Melanocytes are present in all feather follicles at both 8 and 12 days post-fertilisation (E8/E12), so differential deposition of melanocytes is not responsible for pigmentation patterns in embryonic quail. POMC transcripts expressed were a subset of those found in chicken and POMC expression within feather follicles was strong. PC1 was not expressed in feather follicles. PC2 was strongly expressed in all feather follicles at E12. ASIP transcript expression was variable and we report four novel ASIP transcripts. ASIP is strongly expressed in ventral feather follicles, but not dorsally. AGRP expression within feather follicles was weak. These results demonstrate that the pale-bellied quail phenotype probably involves inhibition of MC1R, as found previously. However, quail may require MC1R activation for eumelanogenesis in dorsal feathers which may have important implications for an understanding of colour pattern formation in vertebrates.	[Gluckman, Thanh-Lan; Mundy, Nicholas I.] Univ Cambridge, Dept Zool, Downing St, Cambridge, England; [Gluckman, Thanh-Lan] Coll France, Ctr Interdisciplinary Res Biol, Paris, France	University of Cambridge; UDICE-French Research Universities; PSL Research University Paris; College de France	Gluckman, TL (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge, England.; Gluckman, TL (corresponding author), Coll France, Ctr Interdisciplinary Res Biol, Paris, France.	thanhlan.gluckman@gmail.com			Cambridge Commonwealth, European and International scholarship; Murray Edwards College, Cambridge	Cambridge Commonwealth, European and International scholarship; Murray Edwards College, Cambridge	This research was supported by a Cambridge Commonwealth, European and International scholarship to T-LG (www.cambridgetrust.org/about/cambridge-overseas-trust), and Murray Edwards College, Cambridge to NIM (http://www.murrayedwards.cam.ac.uk).	Ainsworth SJ, 2010, J ANAT, V216, P3, DOI 10.1111/j.1469-7580.2009.01173.x; BENJANNET S, 1991, P NATL ACAD SCI USA, V88, P3564, DOI 10.1073/pnas.88.9.3564; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Boswell T, 2002, MOL BRAIN RES, V100, P31, DOI 10.1016/S0169-328X(02)00145-6; Boswell T, 2005, PEPTIDES, V26, P1733, DOI 10.1016/j.peptides.2004.11.039; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Enshell-Seijffers D, 2008, DEVELOPMENT, V135, P217, DOI 10.1242/dev.011031; Farooqi IS, 2006, DIABETES, V55, P2549, DOI 10.2337/db06-0214; Fontanesi L, 2010, GENOMICS, V95, P166, DOI 10.1016/j.ygeno.2009.11.003; Gunn TM, 2000, TCM, V10, P1; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; He L, 2003, ANN NY ACAD SCI, V994, P288, DOI 10.1111/j.1749-6632.2003.tb03192.x; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Jackson IJ, 2007, HUM MOL GENET, V16, P2341, DOI 10.1093/hmg/ddm191; Kaelin CB, 2012, SCIENCE, V337, P1536, DOI 10.1126/science.1220893; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Le Douarin NM, 1999, NEURAL CREST, V2; Lin SJ, 2013, SCIENCE, V340, P1442, DOI 10.1126/science.1230374; Ling MK, 2004, BRIT J PHARMACOL, V143, P626, DOI 10.1038/sj.bjp.0705900; Ling MK, 2003, EUR J BIOCHEM, V270, P1441, DOI 10.1046/j.1432-1033.2003.03506.x; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Manceau M, 2011, SCIENCE, V331, P1062, DOI 10.1126/science.1200684; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Nadeau N, 2008, GENETICS, V178, P777, DOI 10.1534/genetics.107.077073; Niwa T, 2002, MECH DEVELOP, V118, P139, DOI 10.1016/S0925-4773(02)00256-3; Oribe E, 2012, GEN COMP ENDOCR, V177, P231, DOI 10.1016/j.ygcen.2012.04.016; Prum RO, 2002, P ROY SOC B-BIOL SCI, V269, P781, DOI 10.1098/rspb.2001.1896; Rawles ME, 1939, P NATL ACAD SCI USA, P1; RICHARDSON MK, 1991, DEV BIOL, V143, P309, DOI 10.1016/0012-1606(91)90082-E; Roulin A, 2013, SEMIN CELL DEV BIOL, V24, P594, DOI 10.1016/j.semcdb.2013.05.005; Roulin A, 2011, OECOLOGIA, V166, P913, DOI 10.1007/s00442-011-1955-7; San-Jose LM, 2017, MOL ECOL, V26, P259, DOI 10.1111/mec.13861; Saneyasu T, 2013, J POULT SCI, V50, P364, DOI 10.2141/jpsa.0120188; Steingrimsson E, 2006, DEV DYNAM, V235, P2401, DOI 10.1002/dvdy.20840; Takeuchi S, 2003, ANN NY ACAD SCI, V994, P366, DOI 10.1111/j.1749-6632.2003.tb03201.x; Takeuchi S, 1999, BBA-MOL CELL RES, V1448, P512, DOI 10.1016/S0167-4889(98)00165-7; Takeuchi S, 2000, BBA-MOL CELL RES, V1496, P261, DOI 10.1016/S0167-4889(00)00022-7; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; VRIELING H, 1994, P NATL ACAD SCI USA, V91, P5667, DOI 10.1073/pnas.91.12.5667; Wilczynski A, 2004, J MED CHEM, V47, P2194, DOI 10.1021/jm0303608; Willer BH, 1938, P NATL ACAD SCI USA, V24, P446, DOI 10.1073/pnas.24.10.446; Yabuuchi M, 2010, J POULT SCI, P1; Yoshihara C, 2012, GEN COMP ENDOCR, V175, P495, DOI 10.1016/j.ygcen.2011.12.009; Yoshihara C, 2011, GEN COMP ENDOCR, V171, P46, DOI 10.1016/j.ygcen.2010.12.018	46	8	8	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174714					18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355309	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174600081
J	Herrador, Z; Fernandez-Martinez, A; Gomez-Barroso, D; Leon, I; Vieira, C; Muro, A; Benito, A				Herrador, Zaida; Fernandez-Martinez, Amalia; Gomez-Barroso, Diana; Leon, Inmaculada; Vieira, Carmen; Muro, Antonio; Benito, Agustin			Mediterranean spotted fever in Spain, 1997-2014: Epidemiological situation based on hospitalization records	PLOS ONE			English	Article							RICKETTSIA-CONORII INFECTION; ACUTE-RENAL-FAILURE; DISEASES; EUROPE; SOUTHERN; DOG	Introduction Mediterranean spotted fever (MSF) is a zoonotic disease caused by Rickettsia conorii. In Spain, deficiencies in the official reporting result in misreporting of this disease. This study aims to describe the clinical and temporal-spatial characteristics of MSF hospitalizations between 1997 and 2014. Materials and methods We performed a retrospective descriptive study using the Hospitalization Minimum Data Set (CMBD). All CMBD's hospital discharges with ICD-9 CM code 082.1 were analyzed. Hospitalization rates were calculated and clinical characteristics were described. Spatial distribution of cases and their temporal behavior were also assessed. Results A total of 4,735 hospitalizations with MSF diagnosis were recorded during the study period, out of which 62.2% were male, mean age of 48. Diabetes mellitus, alcohol dependence syndrome, and chronic liver disease occurred in 10.8%, 2.4% and 2.8% hospitalizations, respectively. The median annual hospitalization rate showed a decreasing trend from a maximum of 12.9 in 1997 to a minimum rate of 3.1 in 2014. Most admissions occurred during the summer, showing a significant annual seasonal behavior. Important regional differences were found. Discussion Although MSF hospitalization rates have decreased considerably, it remains a public health problem due to its severity and economic impact. Therefore, it would be desirable to improve its oversight and surveillance.	[Herrador, Zaida; Fernandez-Martinez, Amalia; Benito, Agustin] Hlth Inst Carlos III ISCIII Spanish, Natl Ctr Trop Med, Madrid, Spain; [Herrador, Zaida; Fernandez-Martinez, Amalia; Vieira, Carmen; Muro, Antonio; Benito, Agustin] Network Biomed Res Trop Dis RICET Spanish, Madrid, Spain; [Gomez-Barroso, Diana; Leon, Inmaculada] Network Biomed Res Ctr Epidemiol & Publ Hlth CIBE, Madrid, Spain; [Gomez-Barroso, Diana; Leon, Inmaculada] Hlth Inst Carlos III ISCIII Spanish, Natl Ctr Epidemiol, Madrid, Spain; [Vieira, Carmen; Muro, Antonio] Univ Salamanca, Unidad Invest Enfermedades Infecciosas & Trop E I, Inst Invest Biomed Salamanca, Ctr Invest Enfermedades Trop,Fac Farm,IBSAL,CIETU, Salamanca, Spain	Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Herrador, Z (corresponding author), Hlth Inst Carlos III ISCIII Spanish, Natl Ctr Trop Med, Madrid, Spain.; Herrador, Z (corresponding author), Network Biomed Res Trop Dis RICET Spanish, Madrid, Spain.	zherrador@isciii.es	; Gomez-Barroso, Diana/Q-5417-2018	Vieira Lista, Maria del Carmen/0000-0002-3559-9573; Gomez-Barroso, Diana/0000-0001-7388-1767; Benito, Agustin/0000-0001-8229-5540; Herrador, Zaida/0000-0002-6508-3818; Muro, Antonio/0000-0003-0244-4740; Inmaculada, Leon-Gomez/0000-0002-8565-8332	Institute de Salud Carlos III [P115/01398]; European Union (ERDF/ESF); Network Biomedical Research on Tropical Diseases - European Regional Development Fund (FEDER) from the European Comission [RD12/0018/0001]	Institute de Salud Carlos III(Instituto de Salud Carlos III); European Union (ERDF/ESF); Network Biomedical Research on Tropical Diseases - European Regional Development Fund (FEDER) from the European Comission	This study was supported by Project "P115/01398", funded by Institute de Salud Carlos III and co-funded by European Union (ERDF/ESF, "Investing in your future") and the Network Biomedical Research on Tropical Diseases (RICET in Spanish) RD12/0018/0001, supported by the European Regional Development Fund (FEDER) from the European Comission.	[Anonymous], 2007, VET MED S, P26; Anton E, 2003, EUR J CLIN MICROBIOL, V22, P126, DOI 10.1007/s10096-002-0879-x; Baltadzhiev Ivan G, 2012, Folia Med (Plovdiv), V54, P36; Bernabeu-Wittel M, 2006, EUR J CLIN MICROBIOL, V25, P375, DOI 10.1007/s10096-006-0147-6; Bernabeu-Wittel M, 2005, ENFERM INFEC MICR CL, V23, P163, DOI 10.1157/13072167; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Brouqui P, 2007, FEMS IMMUNOL MED MIC, V49, P2, DOI 10.1111/j.1574-695X.2006.00138.x; Cardesa JJ, 1984, ESP PEDIAT, V21, P133; Centers for Disease Control and Prevention (U.S.) C for M& MS (U.S, 2004, C M MS US ICD 9 CM I; Colomba C, 2014, INT J INFECT DIS, V26, P12, DOI 10.1016/j.ijid.2014.01.024; Crespo P, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1042-3; Dantas-Torres F, 2007, LANCET INFECT DIS, V7, P724, DOI 10.1016/S1473-3099(07)70261-X; De Sousa R, 2003, ANN NY ACAD SCI, V990, P285; DELGADO S, 1995, EUR J EPIDEMIOL, V11, P597, DOI 10.1007/BF01719315; ECDC: European Centre for Disease Prevention and Control, 2013, EP SIT RICK EU EFTA; Estrada-Pena A, 2010, EFSA J; Garcia-Magallon B, 2015, REV ESP SALUD PUBLIC, V89, P321, DOI 10.4321/S1135-57272015000300009; Godoy P, 2008, ATEN PRIM, V40, P371, DOI 10.1157/13124133; Instituto Nacional de Estadistica (INE), 2016, OFF POP FIG SPAN MUN; Instituto Nacional de Estadistica (INE). [ National Institute of Statistics], 2016, POP FIG DEM CENS SPA; Internacional Diabetes Federation (IDF), 2015, DIAB SPAIN; Lledo L, 2014, VECTOR-BORNE ZOONOT, V14, P383, DOI 10.1089/vbz.2013.1513; Lledo L, 2009, INT J ENV RES PUB HE, V6, P2526, DOI 10.3390/ijerph6102526; MANSUETO S, 1986, J INFECT DIS, V154, P539, DOI 10.1093/infdis/154.3.539-a; Marquez FJ, 2008, PARASITOL RES, V103, P119, DOI 10.1007/s00436-008-0938-z; Ministerio de Sanidad Servicios Sociales e Igualdad, 2012, NOT MET; Ministerio de Sanidad Servicios Sociales e Igualdad, HOSP DISCH REC NAT H; Ministerio de Sanidad Servicios Sociales e Igualdad (MSSSI), 2014, EV IND EST SAL ESP M; Ortuno A, 2009, CLIN MICROBIOL INFEC, V15, P241, DOI 10.1111/j.1469-0691.2008.02158.x; Parker NR, 2006, LANCET, V367, P679, DOI 10.1016/S0140-6736(06)68266-4; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Portillo A, 2009, CLIN MICROBIOL INFEC, V15, P307, DOI 10.1111/j.1469-0691.2008.02250.x; RAOULT D, 1982, NOUV PRESSE MED, V11, P607; Raoult D, 1997, CLIN MICROBIOL REV, V10, P694, DOI 10.1128/CMR.10.4.694; Rovery C, 2008, INFECT DIS CLIN N AM, V22, P515, DOI 10.1016/j.idc.2008.03.003; Rovery C, 2008, EMERG INFECT DIS, V14, P1360, DOI 10.3201/eid1409.071133; Saporito L, 2010, J MED MICROBIOL, V59, P990, DOI 10.1099/jmm.0.015891-0; Socolovschi C, 2009, PARASITE, V16, P259, DOI 10.1051/parasite/2009164259; Spain, 2015, CTR NAC EP I SAL CAR; UNAIDS, 2021, YOUNG PEOPL HIV	40	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174745	10.1371/journal.pone.0174745	http://dx.doi.org/10.1371/journal.pone.0174745			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355307	Green Published, gold			2022-12-26	WOS:000399174600084
J	Truong, G; Guanzon, D; Kinhal, V; Elfeky, O; Lai, A; Longo, S; Nuzhat, Z; Palma, C; Scholz-Romero, K; Menon, R; Mol, BW; Rice, GE; Salomon, C				Truong, Grace; Guanzon, Dominic; Kinhal, Vyjayanthi; Elfeky, Omar; Lai, Andrew; Longo, Sherri; Nuzhat, Zarin; Palma, Carlos; Scholz-Romero, Katherin; Menon, Ramkumar; Mol, Ben W.; Rice, Gregory E.; Salomon, Carlos			Oxygen tension regulates the miRNA profile and bioactivity of exosomes released from extravillous trophoblast cells - Liquid biopsies for monitoring complications of pregnancy	PLOS ONE			English	Article							PLACENTA-DERIVED EXOSOMES; 1ST TRIMESTER; TNF-ALPHA; MATERNAL CIRCULATION; SPIRAL ARTERIES; INVASION; MIGRATION; PROLIFERATION; TUMORIGENESIS; PREECLAMPSIA	Our understanding of how cells communicate has undergone a paradigm shift since the recent recognition of the role of exosomes in intercellular signaling. In this study, we investigated whether oxygen tension alters the exosome release and miRNA profile from extravillous trophoblast (EVT) cells, modifying their bioactivity on endothelial cells (EC). Furthermore, we have established the exosomal miRNA profile at early gestation in women who develop pre-eclampsia (PE) and spontaneous preterm birth (SPTB). HTR-8/SVneo cells were used as an EVT model. The effect of oxygen tension (i.e. 8% and 1% oxygen) on exosome release was quantified using nanocrystals (Qdot (R)) coupled to CD63 by fluorescence NTA. A real-time, live-cell imaging system (Incucyte (TM)) was used to establish the effect of exosomes on EC. Plasma samples were obtained at early gestation (< 18 weeks) and classified according to pregnancy outcomes. An Illumina TrueSeq Small RNA kit was used to construct a small RNA library from exosomal RNA obtained from EVT and plasma samples. The number of exosomes was significantly higher in EVT cultured under 1% compared to 8% oxygen. In total, 741 miRNA were identified in exosomes from EVT. Bioinformatic analysis revealed that these miRNA were associated with cell migration and cytokine production. Interestingly, exosomes isolated from EVT cultured at 8% oxygen increased EC migration, whilst exosomes cultured at 1% oxygen decreased EC migration. These changes were inversely proportional to TNF-alpha released from EC. Finally, we have identified a set of unique miRNAs in exosomes from EVT cultured at 1% oxygen and exosomes isolated from the circulation of mothers at early gestation, who later developed PE and SPTB. We suggest that aberrant exosomal signalling by placental cells is a common aetiological factor in pregnancy complications characterised by incomplete SpA remodeling and is therefore a clinically relevant biomarker of pregnancy complications.	[Truong, Grace; Guanzon, Dominic; Kinhal, Vyjayanthi; Elfeky, Omar; Lai, Andrew; Nuzhat, Zarin; Palma, Carlos; Scholz-Romero, Katherin; Rice, Gregory E.; Salomon, Carlos] Univ Queensland, Clin Res Ctr, Royal Brisbane & Womens Hosp, Exosome Biol Lab,Ctr Clin Diagnost, Brisbane, Qld, Australia; [Longo, Sherri; Rice, Gregory E.; Salomon, Carlos] Ochsner Clin Fdn, Dept Obstet & Gynecol, Maternal Fetal Med, New Orleans, LA USA; [Menon, Ramkumar] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med & Perinatal Res, Galveston, TX 77555 USA; [Mol, Ben W.] Univ Adelaide, Sch Med, Discipline Obstet & Gynaecol, Robinson Res Inst, Adelaide, SA, Australia; [Rice, Gregory E.; Salomon, Carlos] Univ Concepcion, Fac Pharm, Dept Clin Biochem & Immunol, Concepcion, Chile	Royal Brisbane & Women's Hospital; University of Queensland; Ochsner Health System; University of Texas System; University of Texas Medical Branch Galveston; Robinson Research Institute; University of Adelaide; Universidad de Concepcion	Salomon, C (corresponding author), Univ Queensland, Clin Res Ctr, Royal Brisbane & Womens Hosp, Exosome Biol Lab,Ctr Clin Diagnost, Brisbane, Qld, Australia.; Salomon, C (corresponding author), Ochsner Clin Fdn, Dept Obstet & Gynecol, Maternal Fetal Med, New Orleans, LA USA.; Salomon, C (corresponding author), Univ Concepcion, Fac Pharm, Dept Clin Biochem & Immunol, Concepcion, Chile.	c.salomongallo@uq.edu.au	Salomon, Carlos F/L-2167-2013; Palma, Carlos/ABB-6084-2020; Lai, Andrew/M-2946-2019; Lai, Andrew/S-8920-2016; RICE, GREGORY/F-2412-2010	Salomon, Carlos F/0000-0003-4474-0046; Palma, Carlos/0000-0001-6182-7501; Lai, Andrew/0000-0002-4424-8767; Lai, Andrew/0000-0002-4424-8767; RICE, GREGORY/0000-0001-7177-0246; Guanzon, Dominic/0000-0001-7913-5749	University of Queensland Fellowship; Lions Medical Research Foundation; NHMRC Principal Research Fellowship; University of Queensland Early Career Researcher (ECR); Royal Brisbane and Women's Foundation; UQ-Ochsner Seed Fund for Collaborative Research; Therapeutics Innovation Australia [IS017025]; National Collaborative Research Infrastructure Strategy; UQ ECR award; UQ-Ochsner Seed Grant	University of Queensland Fellowship; Lions Medical Research Foundation; NHMRC Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland Early Career Researcher (ECR)(University of Queensland); Royal Brisbane and Women's Foundation; UQ-Ochsner Seed Fund for Collaborative Research; Therapeutics Innovation Australia; National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science); UQ ECR award; UQ-Ochsner Seed Grant	CS was in receipt of a University of Queensland Fellowship. CS was also funded by the Lions Medical Research Foundation. GER was in receipt of a NHMRC Principal Research Fellowship. This study was supported by University of Queensland Early Career Researcher (ECR) grants to CS, Royal Brisbane and Women's Foundation, and UQ-Ochsner Seed Fund for Collaborative Research to CS and SL. The IS017025 accredited research facility was supported by grants from Therapeutics Innovation Australia and the National Collaborative Research Infrastructure Strategy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the assistance of Dr. Jamie Riches and Dr. Rachel Hancock of the Central Analytical Research Facility, Institute for Future Environments, Queensland University of Technology (QUT) for the electron microscope analyses. CS was in receipt of a University of Queensland Fellowship. GER was in receipt of an NHMRC Principal Research Fellowship. This study was supported by UQ ECR award, Royal Brisbane and Women's Foundation and UQ-Ochsner Seed Grant. The IS017025 accredited research facility was supported by grants from Therapeutics Innovation Australia and the National Collaborative Research Infrastructure Strategy. We thank Debbie Bullock (UQ Centre for Clinical Research) for assistance in editing the manuscript. We also acknowledge the assistance of Dr. Kevin Dudley, Vincent Chand and Sahana Manoli at the Genomics Laboratory, CARF, QUT for their assistance in using next generation sequencing resources.	Abou-Kheir W, 2017, PLACENTA, V50, P1, DOI 10.1016/j.placenta.2016.12.007; Adam S, 2016, PLACENTA; Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Bilban M, 2010, PLACENTA, V31, P989, DOI 10.1016/j.placenta.2010.08.011; Bulmer JN, 2012, FASEB J, V26, P2975, DOI 10.1096/fj.12-203679; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Cao LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133074; Chen Y, 2013, BIOCHEM BIOPH RES CO, V432, P116, DOI 10.1016/j.bbrc.2013.01.075; Chen Y, 2014, CELL REP, V7, P1982, DOI 10.1016/j.celrep.2014.05.007; Cheng L, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.23743; Daoud G, 2016, FASEB J, V30; DaSilva-Arnold S, 2015, PLACENTA, V36, P1412, DOI 10.1016/j.placenta.2015.10.013; Dragovic RA, 2015, NANOPARTICLE TRACKIN; ELLIS SA, 1990, J IMMUNOL, V144, P731; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Gupta S, 2002, J CLIN IMMUNOL, V22, P185, DOI 10.1023/A:1016089607548; Illsley NP, 2010, INT J DEV BIOL, V54, P409, DOI 10.1387/ijdb.082798ni; Kabir-Salmani M, 2003, ENDOCRINOLOGY, V144, P1620, DOI 10.1210/en.2002-220886; King HW, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-421; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kucharzewska P, 2013, P NATL ACAD SCI USA, V110, P7312, DOI 10.1073/pnas.1220998110; Li W, 2015, BIOCHEM BIOPH RES CO, V464, P881, DOI 10.1016/j.bbrc.2015.07.057; Li YP, 2015, CELL PROLIFERAT, V48, P643, DOI 10.1111/cpr.12223; Li Y, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-014-2826-z; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lyall F, 2001, AM J PATHOL, V158, P1713, DOI 10.1016/S0002-9440(10)64127-2; Lyall F, 2013, HYPERTENSION, V62, P1046, DOI 10.1161/HYPERTENSIONAHA.113.01892; Mackowiak Sebastian D, 2011, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1210s36; Meekins JW, 1997, PLACENTA, V18, P459, DOI 10.1016/S0143-4004(97)80048-3; Mincheva-Nilsson L, 2014, AM J REPROD IMMUNOL, V72, P440, DOI 10.1111/aji.12311; Mitchell MD, 2015, AM J OBSTET GYNECOL, V213, pS173, DOI 10.1016/j.ajog.2015.07.001; Morales-Prieto DM, 2012, PLACENTA, V33, P725, DOI 10.1016/j.placenta.2012.05.009; Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006; Rice GE, 2015, J CLIN ENDOCR METAB, V100, pE1280, DOI 10.1210/jc.2015-2270; Robson A, 2012, FASEB J, V26, P4876, DOI 10.1096/fj.12-210310; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Salomon C, 2014, FRONT PHARMACOL, P5; Salomon C, 2016, DIABETES, V65, P598, DOI 10.2337/db15-0966; Salomon C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/693157; Salomon C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098667; Salomon C, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00175; Salomon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079636; Salomon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068451; Sarker S, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-204; Schatz F, 2016, HUM REPROD UPDATE, V22, P497, DOI 10.1093/humupd/dmw004; Song LQ, 2015, BIOCHEM BIOPH RES CO, V464, P705, DOI 10.1016/j.bbrc.2015.07.004; Takao T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021990; Tang X, 2013, MOL CELL BIOCHEM, V378, P237, DOI 10.1007/s11010-013-1614-x; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Toder V, 2003, J ASSIST REPROD GEN, V20, P73, DOI 10.1023/A:1021740108284; Tranquilli AL, 2013, PREGNANCY HYPERTENS, V3, P44, DOI [10.1016/j.preghy.2012.11.001, 10.1016/j.preghy.2013.04.006]; Wang YP, 2012, FEBS J, V279, P4510, DOI 10.1111/febs.12037; Xie L, 2014, ENDOCRINOLOGY, V155, P4975, DOI 10.1210/en.2014-1501; Yan C, 2016, BIOCHEM BIOPH RES CO, V470, P68, DOI 10.1016/j.bbrc.2015.12.116; Zhang S, 2015, NUTRIENTS, V7, P360, DOI 10.3390/nu7010360; Zhang WC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11702	57	74	76	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174514	10.1371/journal.pone.0174514	http://dx.doi.org/10.1371/journal.pone.0174514			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350871	gold, Green Published			2022-12-26	WOS:000399174400052
J	Zhou, JZ; Li, SY; Wang, YP; Lei, Y; Foreman, RD; Yin, JY; Chen, JDZ				Zhou, Jingzhu; Li, Shiying; Wang, Yinping; Lei, Yong; Foreman, Robert D.; Yin, Jieyun; Chen, Jiande D. Z.			Effects and mechanisms of auricular electroacupuncture on gastric hypersensitivity in a rodent model of functional dyspepsia	PLOS ONE			English	Article							VISCERAL HYPERSENSITIVITY; ELECTRICAL-STIMULATION; RECTAL DISTENSION; AUTONOMIC FUNCTION; ACUPUNCTURE; MOTILITY; MANAGEMENT; SYMPTOMS; MIGRAINE; STRESS	Background Functional dyspepsia (FD) is a common functional gastrointestinal disease, and abdominal pain is one of the main symptoms. The aim of this study was to explore the effects and mechanisms of auricular electro-acupuncture (AEA) on gastric hypersensitivity in a rodent model of FD. Methods Ten-day-old pups were gavaged with 0.2 ml of 0.1% iodoacetamide daily for 6 days. AEA at the "stomach" point with different parameters or sham-EA was performed on 8-week-old animals. Gastric sensitivity to gastric distention was measured under different conditions. Autonomic functions were assessed from the spectral analysis of heart rate variability (HRV) derived from the electrocardiogram. Naloxone was injected intraperitoneally before AEA to explore the opioid mechanism. Gastric emptying was measured at the end of the study. Results 1) Gastric sensitivity to gastric distention was higher in the FD rats. AEA with parameters of 0.1s on, 0.4s off, 100Hz, 0.3ms and 0.4-0.5mA, but not other parameters or sham- EA, decreased gastric hypersensitivity in the FD rats. Naloxone did not block the effect of AEA. 2) Lower vagal activity and higher sympathovagal ratio were noted in the FD rats, compared with the controls. AEA increased vagal activity and improved sympathovagal imbalance. Conclusions AEA ameliorates gastric hypersensitivity in FD rats and this effect may be attributed to the improvement of sympathovagal balance.	[Zhou, Jingzhu; Li, Shiying; Lei, Yong; Yin, Jieyun; Chen, Jiande D. Z.] VA Med Ctr, Vet Res & Educ Fdn, Oklahoma City, OK 73104 USA; [Zhou, Jingzhu; Foreman, Robert D.] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK USA; [Zhou, Jingzhu; Wang, Yinping] Nanjing Med Univ, Affiliated Hosp 1, Dept Acupuncture & Moxibust, Nanjing, Jiangsu, Peoples R China; [Chen, Jiande D. Z.] Ningbo Pace Translat Med Res Ctr, Ningbo, Zhejiang, Peoples R China; [Chen, Jiande D. Z.] Johns Hopkins Univ, Ctr Neurogastroenterol, Baltimore, MD 21218 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Nanjing Medical University; Johns Hopkins University	Chen, JDZ (corresponding author), VA Med Ctr, Vet Res & Educ Fdn, Oklahoma City, OK 73104 USA.; Chen, JDZ (corresponding author), Ningbo Pace Translat Med Res Ctr, Ningbo, Zhejiang, Peoples R China.; Chen, JDZ (corresponding author), Johns Hopkins Univ, Ctr Neurogastroenterol, Baltimore, MD 21218 USA.	JiandeDZChen@gmail.com	Wang, Yin/HCI-9352-2022					Al-Chaer ED, 2000, GASTROENTEROLOGY, V119, P1276, DOI 10.1053/gast.2000.19576; Arai YCP, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/945063; Camilleri M, 2013, NAT REV GASTRO HEPAT, V10, P187, DOI 10.1038/nrgastro.2013.11; Carbone F, 2014, DIGEST DIS, V32, P222, DOI 10.1159/000357854; Ceccherelli F, 2012, ACUPUNCTURE ELECTRO, V37, P277; Chen Jian-yong, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P880; Chen J, 2008, AM J PHYSIOL-GASTR L, V295, pG614, DOI 10.1152/ajpgi.90322.2008; Dai F, 2013, AM J PHYSIOL-GASTR L, V305, pG333, DOI 10.1152/ajpgi.00224.2012; Gao XY, 2008, AUTON NEUROSCI-BASIC, V138, P50, DOI 10.1016/j.autneu.2007.10.003; Han JS, 2004, NEUROSCI LETT, V361, P258, DOI 10.1016/j.neulet.2003.12.019; HAUSKEN T, 1993, PSYCHOSOM MED, V55, P12, DOI 10.1097/00006842-199301000-00004; He BJ, 2013, PAIN MED, V14, P1608, DOI 10.1111/pme.12197; He W, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/786839; Hveem K, 1998, SCAND J GASTROENTERO, V33, P123; Jia CS, 2009, J TRADIT CHIN MED, V29, P43, DOI 10.1016/S0254-6272(09)60030-3; KAMETANI H, 1979, J PHYSIOL-LONDON, V294, P407, DOI 10.1113/jphysiol.1979.sp012937; Kienbaum P, 2001, CIRCULATION, V103, P850, DOI 10.1161/01.CIR.103.6.850; Kim SE, 2013, J NEUROGASTROENTEROL, V19, P233, DOI 10.5056/jnm.2013.19.2.233; La Marca R, 2010, CLIN SCI, V118, P537, DOI 10.1042/CS20090264; Lacy BE, 2013, ALIMENT PHARM THER, V38, P170, DOI 10.1111/apt.12355; Lacy BE, 2012, ALIMENT PHARM THER, V36, P3, DOI 10.1111/j.1365-2036.2012.05128.x; Lee KJ, 2004, BEST PRACT RES CL GA, V18, P707, DOI 10.1016/j.bpg.2004.04.007; Li H, 2013, ACUPUNCT MED, V31, P57, DOI 10.1136/acupmed-2012-010173; Lin Yuan, 2011, J ACUPUNC TUINA SCI, V9, P39; Liu JS, 2012, AM J PHYSIOL-REG I, V303, pR209, DOI 10.1152/ajpregu.00301.2010; Liu JS, 2004, DIGEST DIS SCI, V49, P729, DOI 10.1023/B:DDAS.0000030081.91006.86; Liu LS, 2008, GASTROENTEROLOGY, V134, P2070, DOI 10.1053/j.gastro.2008.02.093; Liu Yue-dong, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P887; Lorena SLS, 2002, DIGEST DIS SCI, V47, P27; Ma TT, 2012, ALIMENT PHARM THER, V35, P552, DOI 10.1111/j.1365-2036.2011.04979.x; Mahadeva S, 2006, WORLD J GASTROENTERO, V12, P2661, DOI 10.3748/wjg.v12.i17.2661; Nogier P., 1981, ACURICULOTHERAPY AUR AURICULOTHERAPY AURI; Peuker ET, 2002, CLIN ANAT, V15, P35, DOI 10.1002/ca.1089; Samsom M, 1999, GASTROENTEROLOGY, V116, P515, DOI 10.1016/S0016-5085(99)70171-X; Sator-Katzenschlager SM, 2007, EXPERT REV MED DEVIC, V4, P23, DOI 10.1586/17434440.4.1.23; Song J, 2013, NEUROGASTROENT MOTIL, V25, P807, DOI 10.1111/nmo.12183; Sun Y, 2014, NEUROGASTROENT MOTIL, V26, P176, DOI 10.1111/nmo.12248; Takahashi T, 2011, NEUROMODULATION, V14, P8, DOI 10.1111/j.1525-1403.2010.00295.x; Wang Y, 2013, EUR J PAIN, V17, P1447, DOI 10.1002/j.1532-2149.2013.00325.x; Wang Yan-Gang, 2007, Zhongguo Zhen Jiu, V27, P245; Wong TM, 2001, J BIOMED SCI, V8, P299, DOI 10.1159/000054047; Wu SJ, 2011, J RES MED SCI, V16, P39; Xu SP, 2006, DIGEST DIS SCI, V51, P2154, DOI 10.1007/s10620-006-9412-x; Yin JY, 2011, AM J PHYSIOL-REG I, V301, pR465, DOI 10.1152/ajpregu.00271.2010; Yin JY, 2010, AM J PHYSIOL-GASTR L, V298, pG563, DOI 10.1152/ajpgi.00252.2009; Zhang ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114226; Zhou YY, 2012, WORLD J GASTROENTERO, V18, P7201, DOI 10.3748/wjg.v18.i48.7201	47	21	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174568	10.1371/journal.pone.0174568	http://dx.doi.org/10.1371/journal.pone.0174568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350818	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174400058
J	Tan, HH; Xu, J; Teoh, HL; Chan, BPL; Seet, RCS; Venketasubramanian, N; Sharma, VK; Chen, CLH; Dong, Y				Tan, Hui Hui; Xu, Jing; Teoh, Hock Luen; Chan, Bernard Poon-Lap; Seet, Raymond Chee Seong; Venketasubramanian, Narayanaswarmy; Sharma, Vijay Kumar; Chen, Christopher Li-Hsian; Dong, YanHong			Decline in changing Montreal Cognitive Assessment (MoCA) scores is associated with post-stroke cognitive decline determined by a formal neuropsychological evaluation	PLOS ONE			English	Article							MINI-MENTAL-STATE; STROKE; IMPAIRMENT; SUPERIOR; DEMENTIA; VALIDITY; DISEASE	Objectives We aimed to examine changes in the Montreal Cognitive Assessment (MoCA) and MiniMental State Examination (MMSE) scores within a one-year period after stroke/transient ischemic attack (TIA) in associating cognitive decline determined by a formal neuropsychological test battery. Methods Patients with ischemic stroke/TIA received MoCA and MMSE at baseline within 14 days after stroke/TIA, at 3-6 months and 1-year follow-ups. The scores of MoCA and MMSE were considered to have declined if there were a reduction of >= 2 points in the respective scores measured across two time points. The decline in neuropsychological diagnosis transitional status was defined by a category transition from no cognitive impairment or any cognitive impairment to a more severe cognitive impairment or dementia. Results 275 patients with a mean age of 59.8 +/- 11.6 years, and education of 7.7 +/- 4.3 years completed all the assessments at baseline, 3-6 months and 1-year follow-ups. A decline in MoCA scores from 3-6 months to 1 year was associated with higher risk of decline in diagnosis transitional status (odd ratio = 3.21, p = 0.004) in the same time period whereas there was no association with a decline in MMSE scores. Conclusions The decline in MoCA scores from 3-6 months to 1 year after stroke/TIA has three times higher risk for decline in the diagnosis transitional status. The decline of MoCA scores (reduction >= 2points) is associated with the decline in neuropsychological diagnosis transitional status.	[Tan, Hui Hui; Teoh, Hock Luen; Chan, Bernard Poon-Lap; Seet, Raymond Chee Seong; Sharma, Vijay Kumar; Dong, YanHong] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Med, Div Neurol, Singapore, Singapore; [Xu, Jing] Singapore Clin Res Inst, Singapore, Singapore; [Venketasubramanian, Narayanaswarmy; Chen, Christopher Li-Hsian] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Pharmacol, Memory Ageing & Cognit Ctr, Singapore, Singapore; [Venketasubramanian, Narayanaswarmy] Raffles Hosp, Neurosci Ctr, Singapore, Singapore; [Dong, YanHong] Univ New South Wales, Ctr Healthy Brain Ageing CHeBA, Sydney, NSW, Australia; [Dong, YanHong] Univ New South Wales, Dementia Collaborat Res Ctr Assessment & Better C, Sch Psychiat, UNSW Med, Sydney, NSW, Australia	National University of Singapore; Singapore Clinical Research Institute; National University of Singapore; Raffles Hospital; University of New South Wales Sydney; University of New South Wales Sydney	Dong, Y (corresponding author), Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Med, Div Neurol, Singapore, Singapore.; Dong, Y (corresponding author), Univ New South Wales, Ctr Healthy Brain Ageing CHeBA, Sydney, NSW, Australia.; Dong, Y (corresponding author), Univ New South Wales, Dementia Collaborat Res Ctr Assessment & Better C, Sch Psychiat, UNSW Med, Sydney, NSW, Australia.	mdcdy@nus.edu.sg	Venketasubramanian, Narayanaswamy/GPP-5948-2022; Chen, Christopher/E-7023-2013; sharma, Vijay/T-5286-2019	Chen, Christopher/0000-0002-1047-9225; sharma, Vijay/0000-0002-8976-5696; Seet, Raymond/0000-0001-8946-3578; /0000-0002-4763-6984	National Medical Research Council [NMRC/CG/NUHS/2010]; NUHS National Clinician Scientist Program award	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NUHS National Clinician Scientist Program award	This study is funded by a Center Grant (NMRC/CG/NUHS/2010) from the National Medical Research Council (http://www.nmrc.gov.sg/). Y. Dong was a recipient of the NUHS National Clinician Scientist Program award during this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is funded by a Center Grant from the National Medical Research Council (NMRC/CG/NUHS/2010). Y. Dong was a recipient of the NUHS National Clinician Scientist Program award during this study. The authors thank all participants for their involvement, the research team from NUHS Memory Ageing and Cognition Centre for data collection.	Dong YH, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0570-y; Dong YH, 2012, J NEUROL NEUROSUR PS, V83, P580, DOI 10.1136/jnnp-2011-302070; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Godefroy O, 2011, STROKE, V42, P1712, DOI 10.1161/STROKEAHA.110.606277; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Hamilton RH, 2011, BRAIN LANG, V118, P40, DOI 10.1016/j.bandl.2011.02.005; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Kalmijn S, 1996, STROKE, V27, P2230, DOI 10.1161/01.STR.27.12.2230; Krishnan K, 2016, CHANGES MONTREAL COG; Narasimhalu K, 2009, NEUROLOGY, V73, P1866, DOI 10.1212/WNL.0b013e3181c3fcb7; Narasimhalu K, 2008, DEMENT GERIATR COGN, V25, P17, DOI 10.1159/000111128; Narasimhalu K, 2011, STROKE, V42, P883, DOI 10.1161/STROKEAHA.110.594671; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Salvadori E, 2013, J NEUROL, V260, P2220, DOI 10.1007/s00415-013-6962-7; Sivakumar L, 2014, STROKE, V45, P1709, DOI 10.1161/STROKEAHA.114.004726; Van Heugten CM, 2015, CLIN REHABIL, V29, P694, DOI 10.1177/0269215514553012; Yeo D, 1997, NEUROLOGICAL J S E A, V2	18	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0173291	10.1371/journal.pone.0173291	http://dx.doi.org/10.1371/journal.pone.0173291			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VD	28346532	Green Submitted, gold, Green Published			2022-12-26	WOS:000399174300004
J	Kenny, TC; Hart, P; Ragazzi, M; Sersinghe, M; Chipuk, J; Sagar, MAK; Eliceiri, KW; LaFramboise, T; Grandhi, S; Santos, J; Riar, AK; Papa, L; D'Aurello, M; Manfredi, G; Bonini, MG; Germain, D				Kenny, T. C.; Hart, P.; Ragazzi, M.; Sersinghe, M.; Chipuk, J.; Sagar, M. A. K.; Eliceiri, K. W.; LaFramboise, T.; Grandhi, S.; Santos, J.; Riar, A. K.; Papa, L.; D'Aurello, M.; Manfredi, G.; Bonini, M. G.; Germain, D.			Selected mitochondrial DNA landscapes activate the SIRT3 axis of the UPRmt to promote metastasis	ONCOGENE			English	Article							UNFOLDED PROTEIN RESPONSE; BREAST-CANCER; OXIDATIVE-PHOSPHORYLATION; EXPRESSION; MUTATIONS; AMPK; TUMORIGENICITY; DEACETYLATION; ACCUMULATION; METABOLISM	By causing mitochondrial DNA (mtDNA) mutations and oxidation of mitochondrial proteins, reactive oxygen species (ROS) leads to perturbations in mitochondrial proteostasis. Several studies have linked mtDNA mutations to metastasis of cancer cells but the nature of the mtDNA species involved remains unclear. Our data suggests that no common mtDNA mutation identifies metastatic cells; rather the metastatic potential of several ROS-generating mutations is largely determined by their mtDNA genomic landscapes, which can act either as an enhancer or repressor of metastasis. However, mtDNA landscapes of all metastatic cells are characterized by activation of the SIRT/FOXO/SOD2 axis of the mitochondrial unfolded protein response (UPRmt). The UPRmt promotes a complex transcription program ultimately increasing mitochondrial integrity and fitness in response to oxidative proteotoxic stress. Using SOD2 as a surrogate marker of the UPRmt, we found that in primary breast cancers, SOD2 is significantly increased in metastatic lesions. We propose that the ability of selected mtDNA species to activate the UPRmt is a process that is exploited by cancer cells to maintain mitochondrial fitness and facilitate metastasis.	[Kenny, T. C.; Riar, A. K.; Papa, L.; Germain, D.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Med, Div Hematol Oncol, 1 Gustave L Levy Pl Box 1079, New York, NY 10029 USA; [Hart, P.; Bonini, M. G.] Univ Illinois, Dept Med, Chicago, IL USA; [Ragazzi, M.] Arcispedale Santa Maria Nuova IRCCS, Pathol Unit, Reggio Emilia, Italy; [Sersinghe, M.; Chipuk, J.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Sagar, M. A. K.; Eliceiri, K. W.] Univ Wisconsin, Dept Biomed Engn, Lab Opt & Computat Instrumentat, Madison, WI USA; [LaFramboise, T.; Grandhi, S.] Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; [Santos, J.] Natl Inst Environm Hlth Sci, Durham, NC USA; [D'Aurello, M.; Manfredi, G.] Brain & Mind Res Inst, Weill Cornell Med, New York, NY USA	Icahn School of Medicine at Mount Sinai; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; IRCCS Arcispedale S. Maria Nuova; Icahn School of Medicine at Mount Sinai; University of Wisconsin System; University of Wisconsin Madison; Case Western Reserve University; Cornell University	Germain, D (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, Dept Med, Div Hematol Oncol, 1 Gustave L Levy Pl Box 1079, New York, NY 10029 USA.	doris.germain@mssm.edu	Eliceiri, Kevin/ABD-4516-2020; Ragazzi, Moira/J-5737-2018; Sagar, Abdul Kader/ABG-8019-2020	Eliceiri, Kevin/0000-0001-8678-670X; Ragazzi, Moira/0000-0002-8761-9265; Sagar, Abdul Kader/0000-0002-1564-0727; Hart, Peter/0000-0003-1843-9102; Riar, Amanjot Kaur/0000-0003-1357-3548; Kenny, Timothy Cole/0000-0001-8258-5716	NIH RO1 [CA1722046]; NATIONAL CANCER INSTITUTE [T32CA078207, R01CA206005, R01CA172046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008056] Funding Source: NIH RePORTER	NIH RO1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the electron microscopy facility at Mount Sinai and the sequencing core facility at Case Western. We thank Maria Gomez for her help in generating the Supplementary Tables, Elizabeth Slocum for her contribution to the analysis by electron microscopy and Yukie Takabatake for her contribution to the graphical illustration of the model in Figure 7. This work was funded by an NIH RO1 number CA1722046 to DG.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bai RK, 2007, CANCER RES, V67, P4687, DOI 10.1158/0008-5472.CAN-06-3554; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Conklin MW, 2009, CELL BIOCHEM BIOPHYS, V53, P145, DOI 10.1007/s12013-009-9046-7; Covarrubias D, 2008, J HUM GENET, V53, P924, DOI 10.1007/s10038-008-0331-x; Cruz-Bermudez A, 2015, ONCOTARGET, V6, P13628, DOI 10.18632/oncotarget.3698; D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326; Desmetz C, 2008, J PROTEOME RES, V7, P3830, DOI 10.1021/pr800130d; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Feeley KP, 2015, CANCER RES, V75, P4429, DOI 10.1158/0008-5472.CAN-15-0074; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002; Hart PC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7053; Hashizume O, 2012, P NATL ACAD SCI USA, V109, P10528, DOI 10.1073/pnas.1202367109; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hu J, 2012, CELL, V148, P651, DOI 10.1016/j.cell.2011.12.028; Imanishi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023401; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Ishikawa K, 2012, J BIOENERG BIOMEMBR, V44, P639, DOI 10.1007/s10863-012-9468-6; Jandova J, 2012, EXP CELL RES, V318, P2215, DOI 10.1016/j.yexcr.2012.06.006; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lin YF, 2016, NATURE, V533, P416, DOI 10.1038/nature17989; Lombard David B, 2011, Handb Exp Pharmacol, V206, P163, DOI 10.1007/978-3-642-21631-2_8; Martinus RD, 1996, EUR J BIOCHEM, V240, P98, DOI 10.1111/j.1432-1033.1996.0098h.x; McMahon S, 2014, CARCINOGENESIS, V35, P1046, DOI 10.1093/carcin/bgu012; Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Munch C, 2016, NATURE, V534, P710, DOI 10.1038/nature18302; Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Nunes JB, 2015, HUM MOL GENET, V24, P1977, DOI 10.1093/hmg/ddu612; Obre E, 2015, INT J BIOCHEM CELL B, V59, P167, DOI 10.1016/j.biocel.2014.12.008; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Papa L, 2014, J BIOL CHEM, V289, P5412, DOI 10.1074/jbc.C113.526475; Papa L, 2014, MOL CELL BIOL, V34, P699, DOI 10.1128/MCB.01337-13; Papa L, 2011, J CELL SCI, V124, P1396, DOI 10.1242/jcs.078220; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Ragazzi M, 2011, HUM PATHOL, V42, P166, DOI 10.1016/j.humpath.2010.07.014; Rappa F, 2016, CELL STRESS CHAPERON, V21, P927, DOI 10.1007/s12192-016-0721-5; Riggins RB, 2005, MOL CANCER THER, V4, P33; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Seo JH, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002507; Serasinghe MN, 2015, MOL CELL, V57, P521, DOI 10.1016/j.molcel.2015.01.003; Shi T, 2010, J DIGEST DIS, V11, P55, DOI 10.1111/j.1751-2980.2009.00416.x; Takibuchi G, 2013, MITOCHONDRION, V13, P881, DOI 10.1016/j.mito.2013.07.117; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Tian Y, 2016, TRENDS CELL BIOL, V26, P563, DOI 10.1016/j.tcb.2016.06.006; van Waveren C, 2006, CARCINOGENESIS, V27, P409, DOI 10.1093/carcin/bgi242; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; Yang W, 2016, CELL, V167, P985, DOI 10.1016/j.cell.2016.10.016; Yuan Y, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1349-z; Yuzefovych LV, 2016, CANCER RES, V76, P30, DOI 10.1158/0008-5472.CAN-15-0692; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	54	59	61	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 3	2017	36	31					4393	4404		10.1038/onc.2017.52	http://dx.doi.org/10.1038/onc.2017.52			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FC4JL	28368421	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000406806000002
J	Schaefer, SM; Segalada, C; Cheng, PF; Bonalli, M; Parfejevs, V; Levesque, MP; Dummer, R; Nicolis, SK; Sommer, L				Schaefer, S. M.; Segalada, C.; Cheng, P. F.; Bonalli, M.; Parfejevs, V.; Levesque, M. P.; Dummer, R.; Nicolis, S. K.; Sommer, L.			Sox2 is dispensable for primary melanoma and metastasis formation	ONCOGENE			English	Article							SQUAMOUS-CELL CARCINOMA; CANCER STEM-CELLS; INITIATING CELLS; TRANSCRIPTION FACTOR; CUTANEOUS MELANOMA; MOUSE MODEL; EXPRESSION; TUMORIGENICITY; NEUROGENESIS; MAINTENANCE	Tumor initiation and metastasis formation in many cancers have been associated with emergence of a gene expression program normally active in embryonic or organ-specific stem cells. In particular, the stem cell transcription factor Sox2 is not only expressed in a variety of tumors, but is also required for their formation. Melanoma, the most aggressive skin tumor, derives from melanocytes that during development originate from neural crest stem cells. While neural crest stem cells do not express Sox2, expression of this transcription factor has been reported in melanoma. However, the role of Sox2 in melanoma is controversial. To study the requirement of Sox2 for melanoma formation, we therefore performed CRISPR-Cas9-mediated gene inactivation in human melanoma cells. In addition, we conditionally inactivated Sox2 in a genetically engineered mouse model, in which melanoma spontaneously develops in the context of an intact stroma and immune system. Surprisingly, in both models, loss of Sox2 did neither affect melanoma initiation, nor growth, nor metastasis formation. The lack of a tumorigenic role of Sox2 in melanoma might reflect a distinct stem cell program active in neural crest stem cells and during melanoma formation.	[Schaefer, S. M.; Segalada, C.; Bonalli, M.; Parfejevs, V.; Sommer, L.] Univ Zurich, Inst Anat, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Cheng, P. F.; Levesque, M. P.; Dummer, R.] Univ Zurich Hosp, Dept Dermatol, Zurich, Switzerland; [Nicolis, S. K.] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy	University of Zurich; University of Zurich; University Zurich Hospital; University of Milano-Bicocca	Sommer, L (corresponding author), Univ Zurich, Inst Anat, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	lukas.sommer@anatom.uzh.ch	Cheng, Phil/AAN-8567-2021	Cheng, Phil/0000-0003-2940-006X; Segalada, Corina/0000-0003-4187-4145; Parfejevs, Vadims/0000-0002-1836-3999; NICOLIS, SILVIA KIRSTEN/0000-0003-0378-3808	Swiss National Science Foundation (SNF); University Research Priority Program (URPP) 'Translational Cancer Research' Biobank; Swiss Cancer League; AIRC; Telethon	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); University Research Priority Program (URPP) 'Translational Cancer Research' Biobank; Swiss Cancer League; AIRC(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon)	We thank Annika Klug for help with hematoxylin and eosin stainings and Jessica Hausel for assistance in histology. We would like to thank Daniel Zingg for his help with statistical analysis. Further, we acknowledge the advice by the Cancer Biology PhD program of the University of Zurich. This work was supported by the Swiss National Science Foundation (SNF), the University Research Priority Program (URPP) 'Translational Cancer Research' Biobank, and the Swiss Cancer League. Work in the Nicolis laboratory was supported by AIRC and Telethon.	Ackermann J, 2005, CANCER RES, V65, P4005, DOI 10.1158/0008-5472.CAN-04-2970; Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Basu-Roy U, 2010, CELL DEATH DIFFER, V17, P1345, DOI 10.1038/cdd.2010.57; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; BUTTNER P, 1995, CANCER-AM CANCER SOC, V75, P2499, DOI 10.1002/1097-0142(19950515)75:10<2499::AID-CNCR2820751016>3.0.CO;2-8; Buzaid AC, 1997, J CLIN ONCOL, V15, P1039, DOI 10.1200/JCO.1997.15.3.1039; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Carrasco-Garcia E, 2016, AM J CANCER RES, V6, P701; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cesarini V, ONCOGENE; Chen PL, 2013, MODERN PATHOL, V26, P44, DOI 10.1038/modpathol.2012.132; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Favaro R, 2014, CANCER RES, V74, P1833, DOI 10.1158/0008-5472.CAN-13-1942; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Ferone G, 2016, CANCER CELL, V30, P519, DOI 10.1016/j.ccell.2016.09.001; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Girouard SD, 2012, LAB INVEST, V92, P362, DOI 10.1038/labinvest.2011.188; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Kareta MS, 2015, CELL STEM CELL, V16, P39, DOI 10.1016/j.stem.2014.10.019; Kaufman CK, 2016, SCIENCE, V351, DOI 10.1126/science.aad2197; Laga AC, 2011, EXP DERMATOL, V20, P339, DOI 10.1111/j.1600-0625.2011.01247.x; Laga AC, 2010, AM J PATHOL, V176, P903, DOI 10.2353/ajpath.2010.090495; Li H, 2012, CELL STEM CELL, V11, P845, DOI 10.1016/j.stem.2012.09.014; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Miyagi S, 2008, FEBS LETT, V582, P2811, DOI 10.1016/j.febslet.2008.07.011; Santini R, 2014, ONCOGENE, V33, P4697, DOI 10.1038/onc.2014.71; Sarkar A, 2016, CELL REP, V16, P1929, DOI 10.1016/j.celrep.2016.07.034; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Shakhova O, 2013, CANCER LETT, V338, P74, DOI 10.1016/j.canlet.2012.10.009; Shakhova O, 2012, NAT CELL BIOL, V14, P882, DOI 10.1038/ncb2535; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Van Keymeulen A, 2015, NATURE, V525, P119, DOI 10.1038/nature14665; Vanner RJ, 2014, CANCER CELL, V26, P33, DOI 10.1016/j.ccr.2014.05.005; Wakamatsu Y, 2004, DEV DYNAM, V229, P74, DOI 10.1002/dvdy.10498; Weina K, 2016, PIGM CELL MELANOMA R, V29, P453, DOI 10.1111/pcmr.12483; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Zingg D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7051; Zipser MC, 2011, PIGM CELL MELANOMA R, V24, P326, DOI 10.1111/j.1755-148X.2010.00823.x	45	21	21	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 3	2017	36	31					4516	4524		10.1038/onc.2017.55	http://dx.doi.org/10.1038/onc.2017.55			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FC4JL	28368416	Green Accepted			2022-12-26	WOS:000406806000013
J	Li, CH; Zhang, JT; Baylink, DJ; Wang, XH; Goparaju, NB; Xu, Y; Wasnik, S; Cheng, YM; Berumen, EC; Qin, XZ; Lau, KHW; Tang, XL				Li, Chih-Huang; Zhang, Jintao; Baylink, David J.; Wang, Xiaohua; Goparaju, Naga Bharani; Xu, Yi; Wasnik, Samiksha; Cheng, Yanmei; Berumen, Edmundo Carreon; Qin, Xuezhong; Lau, Kin-Hing William; Tang, Xiaolei			Dendritic cells, engineered to overexpress 25-hydroxyvitamin D 1 alpha-hydroxylase and pulsed with a myelin antigen, provide myelin-specific suppression of ongoing experimental allergic encephalomyelitis	FASEB JOURNAL			English	Article						multiple sclerosis; regulatory T cells; T-reg; 1,25(OH)(2)D; foxp3	REGULATORY T-CELLS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; TRANSCRIPTION FACTOR FOXP3; MULTIPLE-SCLEROSIS; VITAMIN-D; 1,25-DIHYDROXYVITAMIN D-3; LYMPH-NODES; IN-VIVO; EXPRESSION; MIGRATION	Multiple sclerosis (MS) is caused by immune_mediated damage of myelin sheath. Current therapies aim to block such immune responses. However, this blocking is not sufficiently specific and hence compromises immunity, leading to severe side effects. In addition, blocking medications usually provide transient effects and require frequent administration, which further increases the chance to compromise immunity. In this regard, myelin specific therapy may provide the desired specificity and a long-lasting therapeutic effect by inducing myelin specific regulatory T (T-reg) cells. Tolerogenic dendritic cells (To1DCs) are one such therapy. However, ex vivo generated To1DCs may be converted into immunogenic DCs in a proinflammatory environment. In this study, we identified a potential novel myelin_specific therapy that works with immunogenic DCs, hence without the in vivo conversion concern. We showed that immunization with DCs, engineered to overexpress 25-hydroxyvitamin D l alpha-hydroxylase for de novo synthesis of a focally high 1,25-dihydroxyvitamin D concentration in the peripheral lymphoid tissues, induced T-reg cells. In addition, such engineered DCs, when pulsed with a myelin antigen, led to myelin_specific suppression of ongoing experimental allergic encephalomyelitis (an MS animal model), and the disease suppression depended on forkhead-box-protein-P3(foxp3)(+) T-reg cells. Our data support a novel concept that immunogenic DCs can be engineered for myelin_specific therapy for MS. Li, C._H., Zhang, J., Baylink, D. J., Wang, X., Goparaju, N. B., Xu, Y., Wasnik, S., Cheng, Y., Berumen, E. C., Qin, X., Lau, K._H. W., Tang, X. Dendritic cells, engineered to overexpress 25-hydroxyvitamin D la-hydroxylase and pulsed with a myelin antigen, provide myelin_specific suppression of ongoing experimental allergic encephalomyelitis.	[Li, Chih-Huang; Zhang, Jintao; Baylink, David J.; Wang, Xiaohua; Goparaju, Naga Bharani; Xu, Yi; Wasnik, Samiksha; Cheng, Yanmei; Berumen, Edmundo Carreon; Qin, Xuezhong; Lau, Kin-Hing William; Tang, Xiaolei] Loma Linda Univ, Dept Med, Div Regenerat Med, Loma Linda, CA 92354 USA; [Qin, Xuezhong; Lau, Kin-Hing William] Loma Linda Univ, Musculoskeletal Dis Ctr, Jerry L Pettis Mem Vet Affairs Med Ctr, Loma Linda, CA 92354 USA; [Li, Chih-Huang] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Emergency Med, Taoyuan, Taiwan; [Li, Chih-Huang] Chang Gung Univ, Grad Inst Clin Med Sci, Sch Med, Taoyuan, Taiwan; [Zhang, Jintao] Zhengzhou Univ, Inst Med & Pharmaceut Sci, Zhengzhou, Henan, Peoples R China; [Wang, Xiaohua] Shandong Univ, Jinan Infect Dis Hosp, Div Infect Dis, Jinan, Peoples R China; [Cheng, Yanmei] Shanghai Univ Tradit Chinese Med, Yue Yang Hosp Tradit Chinese & Western Med, Shanghai, Peoples R China	Loma Linda University; Loma Linda University; Chang Gung Memorial Hospital; Chang Gung University; Zhengzhou University; Shandong University; Shanghai University of Traditional Chinese Medicine	Tang, XL (corresponding author), Loma Linda Univ, Dept Med, Div Regenerat Med, Loma Linda, CA 92354 USA.	xitang@llu.edu	Tang, Xiaolei/AAT-7669-2021; Wasnik, Samiksha/I-1063-2019	Tang, Xiaolei/0000-0003-1492-9622; Wasnik, Samiksha/0000-0001-6097-0517; wasnik, samiksha/0000-0001-6680-996X	Research Innovation Grant from Department of Medicine at Loma Linda University [681205-2967]; Chang-Gung Memorial Hospital [CMRPG3E0041, CMRPG3C1431]; Veterans Affairs [IK6BX003782] Funding Source: NIH RePORTER	Research Innovation Grant from Department of Medicine at Loma Linda University; Chang-Gung Memorial Hospital(Chang Gung Memorial Hospital); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Dr. David Lo (University of California, Riverside, Riverside, CA, USA) for a critical reading of the manuscript and Penelope Garcia (Loma Linda University) for technical assistance. This work was supported by Research Innovation Grant 681205-2967 from the Department of Medicine at Loma Linda University (to X.T.), and was partially funded by Chang-Gung Memorial Hospital Research Grant CMRPG3E0041 and CMRPG3C1431. The authors declare no conflicts of interest.	Adorini L, 2003, J CELL BIOCHEM, V88, P227, DOI 10.1002/jcb.10340; Ben-Nun A, 2014, J AUTOIMMUN, V54, P33, DOI 10.1016/j.jaut.2014.06.004; Brockmann L, 2017, J IMMUNOL, V198, P1130, DOI 10.4049/jimmunol.1601045; Carbone F, 2014, NAT MED, V20, P69, DOI 10.1038/nm.3411; Clifford DB, 2010, LANCET NEUROL, V9, P438, DOI 10.1016/S1474-4422(10)70028-4; Creusot RJ, 2009, BLOOD, V113, P6638, DOI 10.1182/blood-2009-02-204321; Farias AS, 2013, CNS NEUROSCI THER, V19, P269, DOI 10.1111/cns.12071; Fernando V, 2014, INT J MOL SCI, V15, P1700, DOI 10.3390/ijms15021700; Ferreira GB, 2015, CELL REP, V10, P711, DOI 10.1016/j.celrep.2015.01.013; Flayer CH, 2017, ALLERGY, V72, P679, DOI 10.1111/all.13130; FRASER DR, 1970, NATURE, V228, P764, DOI 10.1038/228764a0; Grimm AJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15907; Grishkan IV, 2013, P NATL ACAD SCI USA, V110, P21101, DOI 10.1073/pnas.1306072110; Gross CC, 2012, EUR J IMMUNOL, V42, P569, DOI 10.1002/eji.201242402; Hardenberg G, 2011, SEMIN IMMUNOL, V23, P130, DOI 10.1016/j.smim.2011.01.012; Hersh CM, 2014, IMMUNOTHERAPY-UK, V6, P249, DOI 10.2217/imt.14.7; Hwang SS, 2017, ALLERGY, V72, P772, DOI 10.1111/all.13078; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Kang SW, 2012, J IMMUNOL, V188, P5276, DOI 10.4049/jimmunol.1101211; Kim HJ, 2015, SCIENCE, V350, P334, DOI 10.1126/science.aad0616; Kozovska ME, 1999, NEUROLOGY, V53, P1692, DOI 10.1212/WNL.53.8.1692; Lee HW, 2015, SCI REP-UK, V5, DOI 10.1038/srep09865; Li B, 2015, MOL THER, V23, P339, DOI 10.1038/mt.2014.201; Lim DS, 2009, EUR J IMMUNOL, V39, P1334, DOI 10.1002/eji.200838987; Linda H, 2009, NEW ENGL J MED, V361, P1081, DOI 10.1056/NEJMoa0810316; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Matarese G, 2005, P NATL ACAD SCI USA, V102, P5150, DOI 10.1073/pnas.0408995102; Mayo L, 2016, BRAIN, V139, P1939, DOI 10.1093/brain/aww113; McNally JP, 2014, J IMMUNOL, V192, P73, DOI 10.4049/jimmunol.1301891; Melcon MO, 2014, J NEUROL SCI, V344, P171, DOI 10.1016/j.jns.2014.06.051; Miller A, 1998, J NEUROIMMUNOL, V92, P113, DOI 10.1016/S0165-5728(98)00191-X; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Nashold FE, 2013, J NEUROIMMUNOL, V263, P64, DOI 10.1016/j.jneuroim.2013.07.016; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Okada N, 2001, BRIT J CANCER, V84, P1564, DOI 10.1054/bjoc.2001.1801; Palanichamy A, 2014, J IMMUNOL, V193, P580, DOI 10.4049/jimmunol.1400118; Tenorio EP, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/786078; Pennati A, 2016, J NEUROSCI, V36, P12598, DOI 10.1523/JNEUROSCI.1994-16.2016; Prietl B, 2014, EUR J NUTR, V53, P751, DOI 10.1007/s00394-013-0579-6; Raker VK, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00569; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Ritter U, 2004, J LEUKOCYTE BIOL, V76, P472, DOI 10.1189/jlb.0104037; Rosenblum MD, 2016, NAT REV IMMUNOL, V16, P90, DOI 10.1038/nri.2015.1; Schmitt EG, 2012, J IMMUNOL, V189, P5638, DOI 10.4049/jimmunol.1200936; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Shen ZH, 1997, J IMMUNOL, V158, P2723; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Spanier JA, 2015, J NEUROIMMUNOL, V286, P48, DOI 10.1016/j.jneuroim.2015.06.015; Steinman L, 2015, MULT SCLER J, V21, P1223, DOI 10.1177/1352458515581441; Szeles L, 2009, J IMMUNOL, V182, P2074, DOI 10.4049/jimmunol.0803345; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Voigylander C, 2006, J IMMUNOTHER, V29, P407, DOI 10.1097/01.cji.0000210081.60178.b4; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yeste A, 2012, P NATL ACAD SCI USA, V109, P11270, DOI 10.1073/pnas.1120611109; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	57	7	7	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2996	3006		10.1096/fj.201601243R	http://dx.doi.org/10.1096/fj.201601243R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28363955	Green Published, hybrid			2022-12-26	WOS:000405931000024
J	Martinez-Sernandez, V; Mezo, M; Gonzalez-Warleta, M; Perteguer, MJ; Garate, T; Romaris, F; Ubeira, FM				Martinez-Sernandez, Victoria; Mezo, Mercedes; Gonzalez-Warleta, Marta; Perteguer, Maria J.; Garate, Teresa; Romaris, Fernanda; Ubeira, Florencio M.			Delineating distinct heme-scavenging and -binding functions of domains in MF6p/helminth defense molecule (HDM) proteins from parasitic flatworms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell-penetrating peptide (CPP); heme; homeostasis; oligomerization; parasite; Fasciola; fluke; MF6p; FhHDM-1; MF6p; HDM; trematode	CELL-PENETRATING PEPTIDES; FASCIOLA-HEPATICA; PORPHYRIN; AGGREGATION; TRAFFICKING; HEMOGLOBIN; COMPLEX; SURFACE; GLOBIN; CATTLE	MF6p/FhHDM-1 is a small protein secreted by the parasitic flatworm (trematode) Fasciola hepatica that belongs to a broad family of heme-binding proteins (MF6p/helminth defense molecules (HDMs)). MF6p/HDMs are of interest for understanding heme homeostasis in trematodes and as potential targets for the development of new flukicides. Moreover, interest in these molecules has also increased because of their immunomodulatory properties. Here we have extended our previous findings on the mechanism of MF6p/HDM-heme interactions and mapped the protein regions required for heme binding and for other biological functions. Our data revealed that MF6p/FhHDM-1 forms high-molecular-weight complexes when associated with heme and that these complexes are reorganized by a stacking procedure to form fibril-like and granular nanostructures. Furthermore, we showed that MF6p/FhHDM-1 is a transitory heme-binding protein as protein.heme complexes can be disrupted by contact with an apoprotein (e.g. apomyoglobin) with higher affinity for heme. We also demonstrated that (i) the heme-binding region is located in the MF6p/FhHDM-1 C-terminal moiety, which also inhibits the peroxidase-like activity of heme, and (ii) MF6p/HDMs from other trematodes, such as Opisthorchis viverrini and Paragonimus westermani, also bind heme. Finally, we observed that the N-terminal, but not the C-terminal, moiety of MF6p/HDMs has a predicted structural analogy with cell-penetrating peptides and that both the entire protein and the peptide corresponding to the N-terminal moiety of MF6p/FhHDM-1 interact in vitro with cell membranes in hemin-preconditioned erythrocytes. Our findings suggest that MF6p/HDMs can transport heme in trematodes and thereby shield the parasite from the harmful effects of heme.	[Martinez-Sernandez, Victoria; Romaris, Fernanda; Ubeira, Florencio M.] Univ Santiago de Compostela, Fac Farm, Lab Parasitol, Santiago De Compostela 15782, Spain; [Mezo, Mercedes; Gonzalez-Warleta, Marta] Inst Galego Calidade Alimentaria INGACAL, Ctr Invest Agr Mabegondo, Lab Parasitol, Abegondo 15318, A Coruna, Spain; [Perteguer, Maria J.; Garate, Teresa] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid 28220, Spain	Universidade de Santiago de Compostela; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Ubeira, FM (corresponding author), Univ Santiago de Compostela, Fac Farm, Lab Parasitol, Santiago De Compostela 15782, Spain.	fm.ubeira@usc.es	PERTEGUER, MARIA J/T-1266-2018; Mezo, Mercedes/R-4703-2019; González-Warleta, Marta/R-5124-2019	PERTEGUER, MARIA J/0000-0002-7533-5134; Mezo, Mercedes/0000-0001-8819-453X; González-Warleta, Marta/0000-0003-3315-5757; Ubeira, Florencio/0000-0001-7312-2752; Romaris Martinez, Fernanda/0000-0002-0633-674X	Ministerio de Ciencia e Innovacion (Spain) [AGL2011-30563-C03]; Xunta de Galicia (Spain) [GPC2014/058]; Instituto de Salud Carlos III-Accion Estrategica de Salud Intramural [PI14CIII/00076]; European Fund for Regional Development (FEDER); Spanish Ministerio de Educacion, Cultura y Deporte (Programa de Formacion del Profesorado Universitario); Ministerio de Ciencia e Innovacion (Spain) [AGL2011-30563-C03]; Xunta de Galicia (Spain) [GPC2014/058]; Instituto de Salud Carlos III-Accion Estrategica de Salud Intramural [PI14CIII/00076]; European Fund for Regional Development (FEDER); Spanish Ministerio de Educacion, Cultura y Deporte (Programa de Formacion del Profesorado Universitario)	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia (Spain)(Xunta de Galicia); Instituto de Salud Carlos III-Accion Estrategica de Salud Intramural; European Fund for Regional Development (FEDER)(European Commission); Spanish Ministerio de Educacion, Cultura y Deporte (Programa de Formacion del Profesorado Universitario); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia (Spain)(Xunta de Galicia); Instituto de Salud Carlos III-Accion Estrategica de Salud Intramural; European Fund for Regional Development (FEDER)(European Commission); Spanish Ministerio de Educacion, Cultura y Deporte (Programa de Formacion del Profesorado Universitario)	This work was supported in part by Ministerio de Ciencia e Innovacion (Spain) Grant AGL2011-30563-C03, Xunta de Galicia (Spain) Grant GPC2014/058, Instituto de Salud Carlos III-Accion Estrategica de Salud Intramural Grant PI14CIII/00076, and the European Fund for Regional Development (FEDER).r Holds a predoctoral fellowship from the Spanish Ministerio de Educacion, Cultura y Deporte (Programa de Formacion del Profesorado Universitario).	Ashrafi K, 2014, TRAVEL MED INFECT DI, V12, P636, DOI 10.1016/j.tmaid.2014.09.006; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Burrows ND, 2013, MICROSC MICROANAL, V19, P1542, DOI 10.1017/S1431927613013354; Cao XD, 2016, J PROTEOMICS, V130, P221, DOI 10.1016/j.jprot.2015.10.001; CARR C, 1985, INFECT IMMUN, V49, P84, DOI 10.1128/IAI.49.1.84-89.1985; Chen CY, 2011, CELL, V145, P720, DOI 10.1016/j.cell.2011.04.025; Choi CYH, 1999, BIOCHEMISTRY-US, V38, P16916, DOI 10.1021/bi991665k; Culbertson DS, 2010, BIOCHEMISTRY-US, V49, P6052, DOI 10.1021/bi1006942; Flint A, 2015, J BACTERIOL, V197, P1002, DOI 10.1128/JB.02346-14; Fry HC, 2012, J AM CHEM SOC, V134, P14646, DOI 10.1021/ja304674d; FUHRHOP JH, 1993, J AM CHEM SOC, V115, P11036, DOI 10.1021/ja00076a090; GALLAGHER WA, 1967, BIOCHEM J, V105, P461, DOI 10.1042/bj1050461; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; GE Healthcare Life Science, 2000, USITC PUBL; Gioannini TL, 2002, J BIOL CHEM, V277, P47818, DOI 10.1074/jbc.M206404200; Giovannetti R., 2012, MACRONANOSPECTROSCOP, P87, DOI [10.5772/38797, DOI 10.5772/38797]; Giovannetti R, 2010, J PHOTOCH PHOTOBIO A, V211, P108, DOI 10.1016/j.jphotochem.2010.02.003; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; GREGG BA, 1989, J PHYS CHEM-US, V93, P4227, DOI 10.1021/j100347a065; Hacariz O, 2012, J PROTEOME RES, V11, P3592, DOI 10.1021/pr300015p; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100; Hofbauer S, 2015, ARCH BIOCHEM BIOPHYS, V574, P36, DOI 10.1016/j.abb.2015.01.010; Holton TA, 2013, BIOINFORMATICS, V29, P3094, DOI 10.1093/bioinformatics/btt518; HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016; KACA W, 1994, J BIOL CHEM, V269, P25078; KAWAMURAKONISHI Y, 1985, J BIOCHEM-TOKYO, V98, P1181, DOI 10.1093/oxfordjournals.jbchem.a135384; Keiser J, 2005, EMERG INFECT DIS, V11, P1507, DOI 10.3201/eid1110.050614; Lee KS, 2007, J BIOL CHEM, V282, P36525, DOI 10.1074/jbc.M705620200; Lengyel Jeffrey, 2014, Journal of Structural and Functional Genomics, V15, P117, DOI 10.1007/s10969-014-9179-9; Li BL, 2009, ANAL CHIM ACTA, V651, P234, DOI 10.1016/j.aca.2009.09.009; Liu XL, 2016, J MED CHEM, V59, P5238, DOI 10.1021/acs.jmedchem.5b02016; Maiti NC, 1998, J PHYS CHEM B, V102, P1528, DOI 10.1021/jp9723372; Martinez-Sernandez V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156530; Martinez-Sernandez V, 2014, J BIOL CHEM, V289, P1441, DOI 10.1074/jbc.M113.499517; MCGONIGLE S, 1995, PARASITOLOGY, V111, P209, DOI 10.1017/S0031182000064969; Mezo M, 2004, J PARASITOL, V90, P845, DOI 10.1645/GE-192R; Mezo M, 2003, J PARASITOL, V89, P843, DOI 10.1645/GE-74RI.1; Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002; Mulvenna J, 2010, PROTEOMICS, V10, P1063, DOI 10.1002/pmic.200900393; Oliveira MF, 2002, FEBS LETT, V512, P139, DOI 10.1016/S0014-5793(02)02243-3; PASTERNACK RF, 1983, BIOCHEMISTRY-US, V22, P1753, DOI 10.1021/bi00277a002; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Rai J, 2007, J PEPT SCI, V13, P406, DOI 10.1002/psc.862; Robinson MW, 2012, FASEB J, V26, P4614, DOI 10.1096/fj.12-213876; Robinson MW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002042; Schmidt N, 2010, FEBS LETT, V584, P1806, DOI 10.1016/j.febslet.2009.11.046; Smith LJ, 2010, PROTEINS, V78, P2349, DOI 10.1002/prot.22747; SOLAR I, 1991, BIOCHIM BIOPHYS ACTA, V1062, P51, DOI 10.1016/0005-2736(91)90334-5; SRINIVAS V, 1990, BIOCHEM INT, V21, P849; Thivierge K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002307; Travascio P, 1998, CHEM BIOL, V5, P505, DOI 10.1016/S1074-5521(98)90006-0; Verma S, 2012, J PHYS CHEM LETT, V3, P1877, DOI 10.1021/jz300639q; von Berlepsch H, 2015, J PHYS CHEM B, V119, P11900, DOI 10.1021/acs.jpcb.5b05576; Wang F, 2006, BIOCHEM PHARMACOL, V71, P799, DOI 10.1016/j.bcp.2005.12.002; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Yang F, 2010, J BIOL CHEM, V285, P39437, DOI 10.1074/jbc.M110.159913; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	59	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8667	8682		10.1074/jbc.M116.771675	http://dx.doi.org/10.1074/jbc.M116.771675			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28348084	Green Published, hybrid			2022-12-26	WOS:000402153900014
J	Darwiche, R; Mene-Saffrane, L; Gfeller, D; Asojo, OA; Schneiter, R				Darwiche, Rabih; Mene-Saffrane, Laurent; Gfeller, David; Asojo, Oluwatoyin A.; Schneiter, Roger			The pathogen-related yeast protein Pry1, a member of the CAP protein superfamily, is a fatty acid-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; VENOM ALLERGEN; DOMAIN; GENE; INHIBITOR; MECHANISM; REVEALS; EXPORT; MOTIF	Members of the CAP superfamily (cysteine-rich secretory proteins, antigen 5, and pathogenesis-related 1 proteins), also known as SCP superfamily (sperm-coating proteins), have been implicated in many physiological processes, including immune defenses, venom toxicity, and sperm maturation. Their mode of action, however, remains poorly understood. Three proteins of the CAP superfamily, Pry1, -2, and -3 (pathogen related in yeast), are encoded in the Saccharomyces cerevisiae genome. We have shown previously that Pry1 binds cholesterol in vitro and that Pry function is required for sterol secretion in yeast cells, indicating that members of this superfamily may generally bind sterols or related small hydrophobic compounds. On the other hand, tablysin-15, aCAPprotein from the horsefly Tabanus yao, has been shown to bind leukotrienes and free fatty acids in vitro. Therefore, here we assessed whether the yeast Pry1 protein binds fatty acids. Computational modeling and site-directed mutagenesis indicated that the mode of fatty acid binding is conserved between tablysin-15 and Pry1. Pry1 bound fatty acids with micromolar affinity in vitro, and its function was essential for fatty acid export in cells lacking the acyl-CoA synthetases Faa1 and Faa4. Fatty acid binding of Pry1 is independent of its capacity to bind sterols, and the two sterol-and fatty acid-binding sites are nonoverlapping. These results indicate that some CAP family members, such as Pry1, can bind different lipids, particularly sterols and fatty acids, at distinct binding sites, suggesting that the CAP domain may serve as a stable, secreted protein domain that can accommodate multiple ligand-binding sites.	[Darwiche, Rabih; Mene-Saffrane, Laurent; Schneiter, Roger] Univ Fribourg, Dept Biol, Chemin Musee 10, CH-1700 Fribourg, Switzerland; [Gfeller, David] Univ Lausanne, Ludwig Ctr Canc Res, Biopole 3, CH-1066 Epalinges, Switzerland; [Gfeller, David] SIB, CH-1015 Lausanne, Switzerland; [Asojo, Oluwatoyin A.] Baylor Coll Med, Natl Sch Trop Med, Houston, TX 77030 USA	University of Fribourg; University of Lausanne; Swiss Institute of Bioinformatics; Baylor College of Medicine	Schneiter, R (corresponding author), Univ Fribourg, Dept Biol, Chemin Musee 10, CH-1700 Fribourg, Switzerland.	roger.schneiter@unifr.ch	Asojo, Oluwatoyin/H-1324-2019; Gfeller, David/A-6493-2019; Mène-Saffrané, Laurent/A-7440-2013	Asojo, Oluwatoyin/0000-0002-4043-2700; Gfeller, David/0000-0002-3952-0930; Mène-Saffrané, Laurent/0000-0002-1763-7871; Schneiter, Roger/0000-0002-9102-8396	Swiss National Science Foundation [31003A_153416]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation, 31003A_153416. The authors declare that they have no conflict of interest with the contents of this article.	Cantacessi C, 2009, BIOTECHNOL ADV, V27, P376, DOI 10.1016/j.biotechadv.2009.02.005; Choudhary V, 2014, J LIPID RES, V55, P883, DOI 10.1194/jlr.M047126; Choudhary V, 2012, P NATL ACAD SCI USA, V109, P16882, DOI 10.1073/pnas.1209086109; Connerth M, 2010, J BIOL CHEM, V285, P26832, DOI 10.1074/jbc.M110.122085; Darwiche R., 2016, J STEROIDS HORM SCI, V7, P172; Darwiche R, 2016, SCI REP-UK, V6, DOI 10.1038/srep28838; Eberle HB, 2002, J CELL SCI, V115, P827; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Gamir J, 2017, PLANT J, V89, P502, DOI 10.1111/tpj.13398; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Gibbs GM, 2006, J BIOL CHEM, V281, P4156, DOI 10.1074/jbc.M506849200; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guo M, 2005, J BIOL CHEM, V280, P12405, DOI 10.1074/jbc.M413566200; Henriksen A, 2001, PROTEINS, V45, P438, DOI 10.1002/prot.1160; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; JOHNSON DR, 1994, J CELL BIOL, V127, P751, DOI 10.1083/jcb.127.3.751; Kelleher A, 2014, ACTA CRYSTALLOGR D, V70, P2186, DOI 10.1107/S1399004714013315; Ma DY, 2010, TOXICON, V55, P45, DOI 10.1016/j.toxicon.2009.06.038; Michinaka Y, 2003, J BIOSCI BIOENG, V95, P435, DOI 10.1016/S1389-1723(03)80041-5; MIOSGA T, 1995, YEAST, V11, P681, DOI 10.1002/yea.320110709; MURPHY EV, 1995, GENE, V159, P131, DOI 10.1016/0378-1119(95)00061-A; Omura S, 1981, Methods Enzymol, V72, P520; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Rich T, 1996, GENE, V180, P125, DOI 10.1016/S0378-1119(96)00431-3; Scharnewski M, 2008, FEBS J, V275, P2765, DOI 10.1111/j.1742-4658.2008.06417.x; Schneiter Roger, 2013, Biomol Concepts, V4, P519, DOI 10.1515/bmc-2013-0021; Serrano RL, 2004, J MOL BIOL, V339, P173, DOI 10.1016/j.jmb.2004.03.015; Thompson TC, 2010, YONSEI MED J, V51, P479, DOI 10.3349/ymj.2010.51.4.479; Tiwari R, 2007, EMBO J, V26, P5109, DOI 10.1038/sj.emboj.7601924; Van Galen J, 2010, MOL MEMBR BIOL, V27, P81, DOI 10.3109/09687680903507080; Xu XQ, 2012, J BIOL CHEM, V287, P10967, DOI 10.1074/jbc.M112.340471	32	28	28	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8304	8314		10.1074/jbc.M117.781880	http://dx.doi.org/10.1074/jbc.M117.781880			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28365570	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000401788600016
J	Baglietto, G; Gigante, G; Del Giudice, P				Baglietto, Gabriel; Gigante, Guido; Del Giudice, Paolo			Density-based clustering: A 'landscape view' of multi-channel neural data for inference and dynamic complexity analysis	PLOS ONE			English	Article							LEMPEL-ZIV COMPLEXITY; CORTICAL ACTIVITY; DECISION-MAKING; CELL ASSEMBLIES; SPIKING NEURONS; IN-VIVO; ADAPTATION; NETWORKS; STATES; SEQUENCES	Two, partially interwoven, hot topics in the analysis and statistical modeling of neural data, are the development of efficient and informative representations of the time series derived from multiple neural recordings, and the extraction of information about the connectivity structure of the underlying neural network from the recorded neural activities. In the present paper we show that state-space clustering can provide an easy and effective option for reducing the dimensionality of multiple neural time series, that it can improve inference of synaptic couplings from neural activities, and that it can also allow the construction of a compact representation of the multi-dimensional dynamics, that easily lends itself to complexity measures. We apply a variant of the 'mean-shift' algorithm to perform state-space clustering, and validate it on an Hopfield network in the glassy phase, in which metastable states are largely uncorrelated from memories embedded in the synaptic matrix. In this context, we show that the neural states identified as clusters' centroids offer a parsimonious parametrization of the synaptic matrix, which allows a significant improvement in inferring the synaptic couplings from the neural activities. Moving to the more realistic case of a multi-modular spiking network, with spike-frequency adaptation inducing history-dependent effects, we propose a procedure inspired by Boltzmann learning, but extending its domain of application, to learn inter-module synaptic couplings so that the spiking network reproduces a prescribed pattern of spatial correlations; we then illustrate, in the spiking network, how clustering is effective in extracting relevant features of the network's state-space landscape. Finally, we show that the knowledge of the cluster structure allows casting the multi-dimensional neural dynamics in the form of a symbolic dynamics of transitions between clusters; as an illustration of the potential of such reduction, we define and analyze a measure of complexity of the neural time series.	[Baglietto, Gabriel; Del Giudice, Paolo] Italian Natl Inst Nucl Res INFN, INFN Roma1, Rome, Italy; [Baglietto, Gabriel] UNLP CONICET, IFLYSIB Inst Fis Liquidos & Sistemas Biol, La Plata, Buenos Aires, Argentina; [Gigante, Guido; Del Giudice, Paolo] Italian Inst Hlth ISS, Rome, Italy; [Gigante, Guido] Mperience Srl, Rome, Italy	Istituto Nazionale di Fisica Nucleare (INFN); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Istituto Superiore di Sanita (ISS)	Baglietto, G (corresponding author), Italian Natl Inst Nucl Res INFN, INFN Roma1, Rome, Italy.; Baglietto, G (corresponding author), UNLP CONICET, IFLYSIB Inst Fis Liquidos & Sistemas Biol, La Plata, Buenos Aires, Argentina.	gabriel.baglietto@gmail.com	Del Giudice, Paolo/N-4655-2015	Del Giudice, Paolo/0000-0002-5633-8241	European Union [720270]	European Union(European Commission)	Paolo Del Giudice was supported in part by the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 720270 (HBP SGA1).	Abasolo D, 2015, J NEUROPHYSIOL, V113, P2742, DOI 10.1152/jn.00575.2014; Abdollah-nia MF, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/02/P02018; Abeles M, 2001, J NEUROSCI METH, V107, P141, DOI 10.1016/S0165-0270(01)00364-8; ABELES M, 1995, P NATL ACAD SCI USA, V92, P8616, DOI 10.1073/pnas.92.19.8616; Akrami A, 2012, BRAIN RES, V1434, P4, DOI 10.1016/j.brainres.2011.07.030; Amigo JM, 2004, NEURAL COMPUT, V16, P717, DOI 10.1162/089976604322860677; Amit Daniel J., 1992, MODELING BRAIN FUNCT; Capone C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118412; Casali AG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006294; Deco G, 2005, J COGNITIVE NEUROSCI, V17, P294, DOI 10.1162/0898929053124875; Duarte RCF, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00124; Fukunaga K, 2014, INFORM THEORY, V21, P32; Gigante G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.148101; Gigante G, 2007, MATH BIOSCI, V207, P336, DOI 10.1016/j.mbs.2006.11.010; Hertz JA, 2013, PRINCIPLES OF NEURAL CODING, P527; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Huguet G, 2014, J VISION, V14, DOI 10.1167/14.3.19; Igel C, 2003, NEUROCOMPUTING, V50, P105, DOI 10.1016/S0925-2312(01)00700-7; KASPAR F, 1987, PHYS REV A, V36, P842, DOI 10.1103/PhysRevA.36.842; La Camera G, 2004, NEURAL COMPUT, V16, P2101, DOI 10.1162/0899766041732468; Latimer KW, 2015, SCIENCE, V349, P184, DOI 10.1126/science.aaa4056; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Liu YH, 2001, J COMPUT NEUROSCI, V10, P25, DOI 10.1023/A:1008916026143; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Mattia M, 2000, NEURAL COMPUT, V12, P2305, DOI 10.1162/089976600300014953; Mattia M, 2013, J NEUROSCI, V33, P11155, DOI 10.1523/JNEUROSCI.4664-12.2013; Mattia M, 2012, COGN NEURODYNAMICS, V6, P239, DOI 10.1007/s11571-011-9179-4; Mazzucato L, 2015, J NEUROSCI, V35, P8214, DOI 10.1523/JNEUROSCI.4819-14.2015; Morcos Ari S, 2016, NATURE NEUROSCIENCE; Riedmiller M., 1992, P ISCIS 7 U; Roach JP, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.052307; Rodriguez A, 2014, SCIENCE, V344, P1492, DOI 10.1126/science.1242072; Roudi Y, 2015, CURR OPIN NEUROBIOL, V32, P38, DOI 10.1016/j.conb.2014.10.011; Roudi Y, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051915; Samaria F S, 1994, APPL COMP VIS 1994 P, P138; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Sohl-Dickstein J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.220601; Stevenson IH, 2011, NAT NEUROSCI, V14, P139, DOI 10.1038/nn.2731; Theodoni P, 2011, J NEUROSCI, V31, P234, DOI 10.1523/JNEUROSCI.2757-10.2011	40	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174918	10.1371/journal.pone.0174918	http://dx.doi.org/10.1371/journal.pone.0174918			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369106	Green Published, Green Submitted, gold			2022-12-26	WOS:000399351000062
J	Ghazwan, A; Forrest, SM; Holt, CA; Whatling, GM				Ghazwan, Aseel; Forrest, Sarah M.; Holt, Cathy A.; Whatling, Gemma M.			Can activities of daily living contribute to EMG normalization for gait analysis?	PLOS ONE			English	Article							HUMAN LOCOMOTION; ELECTROMYOGRAPHY; RELIABILITY; AMPLITUDE; WALKING	This study aims to examine alternative methods of normalization that effectively reflect muscle activity as compared to Maximal Voluntary Contraction (MVC). EMG data recorded from knee flexion-extension muscles in 10 control subjects during the stance phase of the gait cycle were examined by adopting different approaches of normalization: MVC, Mean and Peak Dynamic during gait cycles, (MDM and PDM, respectively), Peak Dynamic during activities of daily living (ADLs), (*PDM), and a combination of ADLs and MVC(**PDM). Intra-and inter-individual variability were calculated to determine reliability and similarity to MCV. **PDM showed excellent reliability across subjects in comparison to MVC, where variance ratio ranged from 0.43-0.99 for **PDM and 0.79-1.08 for MVC. Coefficient of variability showed a similar trend to Variance Ratio, ranging from 0.60-1.25 for **PDM and 1.97-3.92 for MVC. Both MVC and **PDM, and to some extent *PDM, demonstrated good-toexcellent relative amplitude's matching; i.e. root mean square difference and absolute difference were both around 0.08 for Vastus medialis to about 4 for Medial gastrocnemius. It was concluded that **PDM and *PDM were reliable, **PDM mirrored MVC and thus could be used as an alternative to MVC for subjects who are unable to provide the required effort for MVC testing. Where MVC testing is not possible, *PDM is the next preferred option.	[Ghazwan, Aseel; Forrest, Sarah M.; Holt, Cathy A.; Whatling, Gemma M.] Cardiff Univ, Cardiff Sch Engn, Cardiff, S Glam, Wales; [Ghazwan, Aseel; Forrest, Sarah M.; Holt, Cathy A.; Whatling, Gemma M.] Cardiff Univ, Arthrit Res UK Biomech & Bioengn Ctr, Cardiff, S Glam, Wales	Cardiff University; Cardiff University	Ghazwan, A (corresponding author), Cardiff Univ, Cardiff Sch Engn, Cardiff, S Glam, Wales.; Ghazwan, A (corresponding author), Cardiff Univ, Arthrit Res UK Biomech & Bioengn Ctr, Cardiff, S Glam, Wales.	GhazwanAM@cardiff.ac.uk	Whatling, Gemma M/J-2474-2012; Whatling, Gemma/V-4957-2019; Ghazwan, Aseel/ABD-6620-2020; Holt, Catherine/F-3565-2010	Whatling, Gemma/0000-0001-6912-9580; Ghazwan, Aseel/0000-0001-5794-0472; Holt, Catherine/0000-0002-0428-8078	Arthritis Research UK [18461]; EPSRC [EP/J010111/1]; Arthrex; Higher Committee for Education Development in Iraq (HCED); Engineering and Physical Sciences Research Council [EP/J010111/1] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Arthrex; Higher Committee for Education Development in Iraq (HCED); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding was received from Arthritis Research UK [18461], EPSRC [EP/J010111/1], Arthrex and the Higher Committee for Education Development in Iraq (HCED). Data collection support was from NISCHR CRC. Ethics: REC for Wales/Cardiff and Vale UHB.	Benoit DL, 2003, GAIT POSTURE, V18, P56, DOI 10.1016/S0966-6362(02)00194-7; Bolgla LA, 2007, J ELECTROMYOGR KINES, V17, P102, DOI 10.1016/j.jelekin.2005.11.007; Burden A, 1999, MED ENG PHYS, V21, P247, DOI 10.1016/S1350-4533(99)00054-5; Burden A, 2010, J ELECTROMYOGR KINES, V20, P1023, DOI 10.1016/j.jelekin.2010.07.004; Burden AM, 2003, J ELECTROMYOGR KINES, V13, P519, DOI 10.1016/S1050-6411(03)00082-8; Campenella B, 2000, ISOKINET EXERC SCI, V8, P1; Clarys JP, 2000, ERGONOMICS, V43, P1750, DOI 10.1080/001401300750004159; De Luca CJ, 1997, J APPL BIOMECH, V13, P135, DOI 10.1123/jab.13.2.135; Doorenbosch CAM, 2004, NEUROSCI LETT, V368, P78, DOI 10.1016/j.neulet.2004.06.055; DUBO HIC, 1976, ARCH PHYS MED REHAB, V57, P415; Eberhart H., 1954, HUMAN LIMBS THEIR SU, P437; Halaki M, 2012, NORMALIZATION EMG SI, P176; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; HERSHLER C, 1978, IEEE T BIO-MED ENG, V25, P413, DOI 10.1109/TBME.1978.326338; JENSEN C, 1993, EUR J APPL PHYSIOL O, V67, P266, DOI 10.1007/BF00864227; Kamen G, 2010, ESSENTIALS ELECTROMY; KNUTSON LM, 1994, J ELECTROMYOGR KINES, V4, P47, DOI 10.1016/1050-6411(94)90026-4; MCGILL SM, 1986, SPINE, V11, P666, DOI 10.1097/00007632-198609000-00004; Nishijima Y, 2010, J ELECTROMYOGR KINES, V20, P550, DOI 10.1016/j.jelekin.2009.07.006; Norcross MF, 2010, J ELECTROMYOGR KINES, V20, P420, DOI 10.1016/j.jelekin.2009.08.003; Perry J., 2010, J SPORT SCI MED, V9, P353; Shiavi R, 1998, MED BIOL ENG COMPUT, V36, P171, DOI 10.1007/BF02510739; Sousa A.S., 2012, ELECTROMYOGRAPHY NEW; Winby CR, 2009, J BIOMECH, V42, P2294, DOI 10.1016/j.jbiomech.2009.06.019; WINTER DA, 1987, ELECTROEN CLIN NEURO, V67, P402, DOI 10.1016/0013-4694(87)90003-4; YANG JF, 1984, ARCH PHYS MED REHAB, V65, P517; YANG JF, 1983, ARCH PHYS MED REHAB, V64, P417	28	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174670	10.1371/journal.pone.0174670	http://dx.doi.org/10.1371/journal.pone.0174670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369104	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000399351000032
J	Lu, YG; Aitken, RJ; Lin, MJ				Lu, Yonggang; Aitken, Robert John; Lin, Minjie			Detailed analysis of the male reproductive system in a potential bio-indicator species - The marine invertebrate Galeolaria caespitosa (Polychaeta: Serpulidae)	PLOS ONE			English	Article							SABELLA-SPALLANZANII POLYCHAETA; SPIRORBIS-SPIRORBIS L; MID-ATLANTIC RIDGE; GULF-OF-MEXICO; SPERM ULTRASTRUCTURE; LARVAL DEVELOPMENT; FERTILIZATION SUCCESS; MEDITERRANEAN SEA; SPERMATOGENESIS; ANNELIDA	For the first time, this study has systemically investigated the male reproductive system in a sessile broadcast-spawning marine invertebrate, Galeolaria caespitosa (Polychaeta: Serpulidae), which has significant potential as a bio-indicator species of coastal marine pollution. The abdomen of G. caespitosa was divided by intersegmental septa into over 80 trunk segments. Each segment served as a germinal chamber with a C-shaped gonadal arrangement consisting of several distinct compartments: a seminiferous epithelium (SE) compartment located in the centre of the chamber, with each of its two ends connecting to a nurse cell (NC) compartment and then an efferent duct (ED) compartment. The SE compartment contained a multilayered seminiferous epithelium where spermatogenesis was initiated. Spermatids were released in pairs into the lumen of the SE compartment and then transported to the NC compartment where they underwent spermiogenesis with the support of secretory vesicles released by the nurse cells. Spermatozoa were stored in the ED compartment and subsequently released into the seawater through the vas deferens. Unlike vertebrates where germ cells differentiated in close proximity to the nurse cell population (i.e. Sertoli cells), the spermatogenic cells of G. caespitosa exhibited no direct contact with supporting cells at any spermatogenic stage. This finding suggested that the spermatogenesis in G. caespitosa was more dependent on intrinsic developmental programming than most species. Notwithstanding such differences, there were clear parallels between the male reproductive system of G. caespitosa and mammals, in terms of the structure and function. The independence of spermatogenic cells from supporting cells in G. caespitosa raised the possibility of inducing spermiogenesis in vitro, which would provide a useful tool to dissect the mechanisms underlying this complex cell differentiation process in invertebrates and other higher order animals.	[Lu, Yonggang; Aitken, Robert John; Lin, Minjie] Univ Newcastle, Prior Res Ctr Reprod Sci, Sch Environm & Life Sci, Fac Sci, Callaghan, NSW, Australia	University of Newcastle	Aitken, RJ (corresponding author), Univ Newcastle, Prior Res Ctr Reprod Sci, Sch Environm & Life Sci, Fac Sci, Callaghan, NSW, Australia.	John.Aitken@newcastle.edu.au	Lu, Yonggang/HHN-6203-2022; Aitken, Robert John/AAY-8238-2020	Lu, Yonggang/0000-0003-0198-8906; Aitken, Robert John/0000-0002-9152-156X	School of Environmental and Life, the University of Newcastle, Australia	School of Environmental and Life, the University of Newcastle, Australia	Special project grant (2013-2015) to ML by School of Environmental and Life, the University of Newcastle, Australia. http://www.newcastle.edu.au/about-uon/governance-and-leadership/faculties-and-schools/faculty-of-science-and-information-technology/school-of-environmental-and-life-sciences The funder had no role in this study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS JC, 1962, P LINN SOC N S W, V87, P185; [Anonymous], 1982, GAMETE RES, V6, P29; Blake EA, 2005, INVERTEBR BIOL, V124, P254, DOI 10.1111/j.1744-7410.2005.00022.x; Bloom W., 1975, TXB HISTOLOGY, P805; Bochert R, 1996, ACTA ZOOL-STOCKHOLM, V77, P191, DOI 10.1111/j.1463-6395.1996.tb01263.x; Bolton TF, 1997, MAR ECOL PROG SER, V159, P209, DOI 10.3354/meps159209; Bremner J, 2008, J EXP MAR BIOL ECOL, V366, P37, DOI 10.1016/j.jembe.2008.07.007; Buhrmann C, 1996, OPHELIA, V45, P81; Cotter E, 2003, MAR BIOL, V142, P905, DOI 10.1007/s00227-002-0987-2; Currie DR, 2000, MAR BIOL, V136, P645, DOI 10.1007/s002270050724; DALY JM, 1977, J MAR BIOL ASSOC UK, V57, P219, DOI 10.1017/S0025315400021366; Dean H.K., 2008, REV BIOL TROP, V56, P11, DOI [10.15517/rbt.v56i4.27162, DOI 10.15517/RBT.V56I4.27162]; ECKELBARGER KJ, 1984, J ULTRA MOL STRUCT R, V89, P146, DOI 10.1016/S0022-5320(84)80011-8; Eckelbarger KJ, 2005, J MAR BIOL ASSOC UK, V85, P1425, DOI 10.1017/S0025315405012609; ECKELBARGER KJ, 1987, MAR BIOL, V95, P415, DOI 10.1007/BF00409572; Eckelbarger KJ, 2002, BIOL BULL-US, V203, P134, DOI 10.2307/1543382; Eckelbarger KJ, 2001, MAR BIOL, V138, P761, DOI 10.1007/s002270000510; Edgar GJ., 2008, AUSTR MARINE LIFE PL, P193; Falkenberg LJ, 2016, MAR ENVIRON RES, V114, P51, DOI 10.1016/j.marenvres.2015.12.005; Gherardi M, 2011, ITAL J ZOOL, V78, P174, DOI 10.1080/11250003.2010.529468; Giangrande A, 2000, MAR BIOL, V136, P847, DOI 10.1007/s002279900251; Giangrande Adriana, 1997, Oceanography and Marine Biology an Annual Review, V35, P323; Halt MN, 2009, INVERTEBR SYST, V23, P205, DOI 10.1071/IS09003; Hilario A, 2005, BIOL BULL-US, V208, P20, DOI 10.2307/3593097; Hollows CF, 2007, MAR ECOL PROG SER, V333, P51, DOI 10.3354/meps333051; Hutchings P, 1998, BIODIVERS CONSERV, V7, P1133, DOI 10.1023/A:1008871430178; JAMIESON BGM, 1989, BIOL REV, V64, P93, DOI 10.1111/j.1469-185X.1989.tb00673.x; Jones R, 1992, OXF REV REPROD BIOL, V15, P233; Kennedy AD, 1999, ENVIRON MONIT ASSESS, V54, P47, DOI 10.1023/A:1005854731889; Kupriyanova EK, 2005, INVERTEBR REPROD DEV, V48, P7, DOI 10.1080/07924259.2005.9652166; Licciano M, 2002, INVERTEBR BIOL, V121, P55; LUCHT J, 1989, HELGOLANDER MEERESUN, V43, P19, DOI 10.1007/BF02365547; MARSDEN JR, 1981, AUST J MAR FRESH RES, V32, P667; Melville F, 2006, MAR POLLUT BULL, V52, P1260, DOI 10.1016/j.marpolbul.2006.02.021; PICARD A, 1980, INT J INVER REP DEV, V2, P73; Purschke G, 2005, ZOOMORPHOLOGY, V124, P137, DOI 10.1007/s00435-005-0001-x; Purschke G, 2002, ZOOMORPHOLOGY, V121, P125, DOI 10.1007/s004350100050; Radashevsky VI, 2011, INVERTEBR REPROD DEV, V55, P168, DOI 10.1080/07924259.2011.553410; Reunov AA, 2010, ACTA ZOOL-STOCKHOLM, V91, P447, DOI 10.1111/j.1463-6395.2009.00435.x; RICE SA, 1989, BIOL BULL, V176, P123, DOI 10.2307/1541579; RICE SA, 1981, ZOOMORPHOLOGY, V97, P1, DOI 10.1007/BF00310099; Ross KE, 2001, ARCH ENVIRON CON TOX, V40, P489; Rouse GW, 1999, HYDROBIOLOGIA, V402, P215, DOI 10.1023/A:1003700827759; ROUSE GW, 1992, MAR BIOL, V113, P655, DOI 10.1007/BF00349709; Rouse GW, 1998, INVERTEBRATE ZOOLOGY, P196; Schlegel P, 2014, MAR POLLUT BULL, V78, P213, DOI 10.1016/j.marpolbul.2013.10.040; Styan CA, 2008, EVOLUTION, V62, P3041, DOI 10.1111/j.1558-5646.2008.00521.x; Van Dover CL, 1999, MAR ECOL PROG SER, V181, P201, DOI 10.3354/meps181201; Vortsepneva EV, 2006, SCI MAR, V70, P343, DOI 10.3989/scimar.2006.70s3343; Waring JS, 2006, J ENVIRON MONITOR, V8, P1149, DOI 10.1039/b612509n; WILSON WH, 1991, B MAR SCI, V48, P500	51	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174907	10.1371/journal.pone.0174907	http://dx.doi.org/10.1371/journal.pone.0174907			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369153	Green Published, gold, Green Submitted			2022-12-26	WOS:000399351000060
J	Ma, JT; Ren, YP; Zhang, L; Kong, XP; Wang, T; Shi, YY; Bu, RF				Ma, Juntao; Ren, Yipeng; Zhang, Lei; Kong, Xiangpan; Wang, Tong; Shi, Yueyi; Bu, Rongfa			Knocking- down of CREPT prohibits the progression of oral squamous cell carcinoma and suppresses cyclin D1 and c-Myc expression	PLOS ONE			English	Article							PROMOTES TUMOR-GROWTH; POOR-PROGNOSIS; CANCER; TRANSCRIPTION; GENE; DEGRADATION; TARGET	Background As a regulator essential for many cell cycle-related proteins, the robust expression of Cell cycle-Related and Expression-elevated Protein in Tumor (CREPT) implicates a poor diagnosis of endoderm and mesoderm-derived tumors. Whether CREPT plays the same role in the tumorigenesis derived from ectodermal tissues remains elusive. Methods To explore the role of CREPT in ectoderm-derived tumors, cells from 7oral squamous cell carcinoma (OSCC) lines and 84clinical OSCC samples were exploited in this study. Quantitative PCR, Western blot assay and immunohistochemistry were applied in the evaluation of CREPT, cyclin D1 and c-Myc expression. Knocking-down of CREPT was performed by lentivirus delivering specific shRNA of CREPT. The effects of CREPT on OSCC were examined by cell proliferation, colony formation, apoptosis, cell migration and xenograft implantation experiments. Results Compared with human normal oral keratinocytes, OSCC cell lines showed a significantly elevated expression of CREPT in both mRNA and protein levels. Consistently, samples from OSCC patients also exhibited a noticeably stronger CREPT expression than the non-cancerous samples. In contrast, knocking down of CREPT in OSCC cell lines significantly reduced proliferation, colony formation and migration as well as the expression of cyclin D1 and c-Myc, but promoted apoptosis. Statistical analysis also suggested that CREPT expression was significantly correlated with the T and N classification of OSCC. Furthermore, CAL27 mouse xenograft model confirmed that down-regulation of CREPT prohibited cyclin D1 and c-Myc expression, through which decreased the in vivo tumor growth, but increased the survival ratio of hosts. Conclusion In OSCC cell lines, up-regulated CREPT expression enhanced cell proliferation, migration and cell cycle as well as promoted cyclin D1 and c-Myc expression as it did in endoderm and mesoderm-origin tumors. Our study strongly suggests that CREPT could be used as a marker for the OSCC prognosis and might work as a potential target in future OSCC therapy.	[Ma, Juntao; Ren, Yipeng; Zhang, Lei; Shi, Yueyi; Bu, Rongfa] Chinese Peoples Liberat Army Gen Hosp, Dept Stomatol, Beijing, Peoples R China; [Ma, Juntao] Dalian Med Univ, Dept Stomatol, Affiliated Hosp 1, Dalian, Peoples R China; [Kong, Xiangpan] Capital Med Univ, Beijing Stomatol Hosp, Dept Oral & Maxillofacial Head & Neck Surg, Beijing, Peoples R China; [Wang, Tong] Nankai Univ, Sch Med, Tianjin, Peoples R China	Chinese People's Liberation Army General Hospital; Dalian Medical University; Capital Medical University; Nankai University	Bu, RF (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Stomatol, Beijing, Peoples R China.	rongfabu@aliyun.com			Natural Sciences Funds of China [81071781]; Fund of Technology Innovation Cultivation of PLA General Hospital [15KMM11]	Natural Sciences Funds of China(National Natural Science Foundation of China (NSFC)); Fund of Technology Innovation Cultivation of PLA General Hospital	This study was supported by Natural Sciences Funds of China (81071781) for RB and the Fund of Technology Innovation Cultivation of PLA General Hospital (15KMM11) for YS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya N, 2009, J ORAL PATHOL MED, V38, P759, DOI 10.1111/j.1600-0714.2009.00781.x; Bretones G, 2011, J BIOL CHEM, V286, P9815, DOI 10.1074/jbc.M110.165977; den Hollander J, 2010, BLOOD, V116, P1498, DOI 10.1182/blood-2009-11-251074; Endo Y, 2004, INT J CANCER, V110, P225, DOI 10.1002/ijc.20118; Esposito V, 2005, J CLIN PATHOL, V58, P734, DOI 10.1136/jcp.2004.023531; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Huang SF, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-40; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jian SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066133; Kong X. P., 2014, MOL CELLULAR BIOCH; Liu T, 2016, AM J TRANSL RES, V8, P2097; Liu ZH, 2015, INT J BIOCHEM CELL B, V60, P139, DOI 10.1016/j.biocel.2014.12.022; Lu DD, 2012, CANCER CELL, V21, P92, DOI 10.1016/j.ccr.2011.12.016; Markopoulos AK, 2012, OPEN DENT J, V6, P126, DOI 10.2174/1874210601206010126; Mithani SK, 2007, ORAL DIS, V13, P126, DOI 10.1111/j.1601-0825.2006.01349.x; Morales JC, 2014, NUCLEIC ACIDS RES, V42, P4996, DOI 10.1093/nar/gku160; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Ni ZY, 2011, TRANSCR-AUSTIN, V2, P237, DOI 10.4161/trns.2.5.17803; Ohnishi Y, 2014, ONCOL LETT, V7, P1123, DOI 10.3892/ol.2014.1880; Ozawa N, 2004, ENDOCRINOLOGY, V145, P4244, DOI 10.1210/en.2003-0402; Saito T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137923; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Scully C, 2009, ORAL ONCOL, V45, P301, DOI 10.1016/j.oraloncology.2009.01.004; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; She YG, 2014, INT J CLIN EXP PATHO, V7, P6596; Wang Y, 2014, ONCOL REP, V31, P1389, DOI 10.3892/or.2014.2990; Zhang YQ, 2014, J BIOL CHEM, V289, P22589, DOI 10.1074/jbc.M114.560979; Zheng GX, 2016, BIOCHEM BIOPH RES CO, V480, P436, DOI 10.1016/j.bbrc.2016.10.067	28	24	25	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174309	10.1371/journal.pone.0174309	http://dx.doi.org/10.1371/journal.pone.0174309			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369091	Green Published, gold, Green Submitted			2022-12-26	WOS:000399351000014
J	Yan, TL; Ke, YN; Chen, Y; Xu, CF; Yu, CH; Li, YM				Yan, Tianlian; Ke, Yini; Chen, Yi; Xu, Chengfu; Yu, Chaohui; Li, Youming			Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19-9, globulin, eosinophils and hemoglobin	PLOS ONE			English	Article							PRIMARY SCLEROSING CHOLANGITIS; SERUM IGG4; PROGNOSTIC-SIGNIFICANCE; IGG4-RELATED DISEASE; HEMOLYTIC-ANEMIA; NONCODING RNAS; PANCREATICODUODENECTOMY; MALIGNANCY; GUIDELINES; DISORDERS	Autoimmune pancreatitis (AIP) is a special type of chronic pancreatitis, which may be misdiagnosed as pancreatic carcinoma. This study aims to verify new biomarkers for AIP and propose a serological pattern to differentiate AIP from pancreatic adenocarcinoma with routinely performed tests. In this study, data of serum samples were collected and compared between 25 patients with AIP and 100 patients with pancreatic carcinoma. Receiver operating characteristic analysis and logistic regression was performed to evaluate the diagnostic effect of serum parameters in differentiating AIP from pancreatic carcinoma alone or in combination. Among several serum markers observed in the two groups, carbohydrate antigen 19-9 (Ca19-9), globulin, eosinophils and hemoglobin were selected as the independent markers. Serum levels of Globulin, Eosinophil percentage in AIP group were significantly higher than in pancreatic cancer group (P<0.05), while hemoglobin and tumor marker CA19-9 levels were lower (P < 0.05). The combination of these markers identified patients with AIP with 92% sensitivity and 79% specificity, which indicated relatively high diagnostic value. Elevated serum eosinophils, globulin, together with decreased hemoglobin level can be used as a pre-operative indicator for AIP and can help to initiate diagnosis of AIP in time.	[Yan, Tianlian; Ke, Yini; Chen, Yi; Xu, Chengfu; Yu, Chaohui; Li, Youming] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Li, YM (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Gastroenterol, Hangzhou, Zhejiang, Peoples R China.	zlym@zju.edu.cn	Xu, Cheng/GXH-4815-2022	Xu, Cheng/0000-0003-1000-733X; Ma, Han/0000-0001-9985-3035				Akamatsu M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158669; Al-Saif F, 2006, PANCREAS, V33, P316; BAE G, 1977, BRIT J HAEMATOL, V37, P137; Buijs J, 2014, UROLOGY, V83, P521, DOI 10.1016/j.urology.2013.10.052; Frampton AE, 2015, EUR J CANCER, V51, P1389, DOI 10.1016/j.ejca.2015.04.006; Ghazale A, 2007, AM J GASTROENTEROL, V102, P1646, DOI 10.1111/j.1572-0241.2007.01264.x; Goldwire FW, 2008, WORLD J GASTROENTERO, V14, P6748, DOI 10.3748/wjg.14.6748; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Hardacre JM, 2003, ANN SURG, V237, P853, DOI 10.1097/00000658-200306000-00014; Hart PA, 2013, GUT, V62, P1771, DOI 10.1136/gutjnl-2012-303617; Johansen JS, 2016, INT J CANCER, V139, P2312, DOI 10.1002/ijc.30291; Kamisawa T, 2008, EUR J GASTROEN HEPAT, V20, P1167, DOI 10.1097/MEG.0b013e3283069dc2; Kim TY, 2011, CLIN NEPHROL, V76, P440, DOI 10.5414/CN107117; Kitara DL, 2011, AFR HEALTH SCI, V11, P449; Masamune A, 2016, GUT, V88; Masutani H, 2014, WORLD J GASTROENTERO, V20, P8740, DOI 10.3748/wjg.v20.i26.8740; Ngwa T, 2015, PANCREAS, V44, P557, DOI 10.1097/MPA.0000000000000297; O'Reilly Derek A, 2014, World J Gastrointest Pathophysiol, V5, P71, DOI 10.4291/wjgp.v5.i2.71; Okazaki K, 2000, GASTROENTEROLOGY, V118, P573, DOI 10.1016/S0016-5085(00)70264-2; Okazaki K, 2006, J GASTROENTEROL, V41, P626, DOI 10.1007/s00535-006-1868-0; Okazaki K, 2014, GUT LIVER, V8, P462, DOI 10.5009/gnl14107; Okazaki K, 2012, PANCREAS, V41, P1341, DOI 10.1097/MPA.0b013e3182706ed5; Okazaki K, 2011, J GASTROENTEROL, V46, P277, DOI 10.1007/s00535-011-0386-x; Okazaki K, 2009, PANCREAS, V38, P849, DOI 10.1097/MPA.0b013e3181b9ee1c; Pineau BC, 1997, CAN J GASTROENTEROL, V11, P45, DOI 10.1155/1997/948191; Previdi MC, 2017, FUTURE ONCOL, V13, P443, DOI 10.2217/fon-2016-0253; Psarras K, 2011, HEPATOB PANCREAT DIS, V10, P465, DOI 10.1016/S1499-3872(11)60080-5; Sah RP, 2011, CURR OPIN RHEUMATOL, V23, P108, DOI 10.1097/BOR.0b013e3283413469; Sah RP, 2010, AM J GASTROENTEROL, V105, P2485, DOI 10.1038/ajg.2010.236; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Shiokawa M, 2013, AM J GASTROENTEROL, V108, P610, DOI 10.1038/ajg.2012.465; Taucher V, 2016, CELL ONCOL, V39, P295, DOI 10.1007/s13402-016-0275-7; Uchida K, 2016, CLIN J GASTROENTEROL, V9, P7, DOI 10.1007/s12328-016-0628-9; Uehara T, 2014, PATHOL INT, V64, P51, DOI 10.1111/pin.12136; van Heerde MJ, 2012, DIGEST DIS SCI, V57, P2458, DOI 10.1007/s10620-012-2191-7; van Heerde MJ, 2014, DIGEST DIS SCI, V59, P1322, DOI 10.1007/s10620-013-3004-3; Vasaitis L, 2016, EUR J INTERN MED, V27, P1, DOI 10.1016/j.ejim.2015.09.022; Wang Q, 2009, PANCREAS, V38, P149, DOI 10.1097/MPA.0b013e31818d8ecc; Wu LL, 2013, DIGESTION, V88, P128, DOI 10.1159/000353597; Wu WC, 2013, J DIGEST DIS, V14, P500, DOI 10.1111/1751-2980.12075; Yadav D, 2003, CLIN GASTROENTEROL H, V1, P129, DOI 10.1053/cgh.2003.50016; Yamanishi H, 2011, PANCREAS, V40, P840, DOI 10.1097/MPA.0b013e3182143b10; YOSHIDA K, 1995, DIGEST DIS SCI, V40, P1561, DOI 10.1007/BF02285209; Zhang LZ, 2011, PANCREAS, V40, P1172, DOI 10.1097/MPA.0b013e318233bec5	44	9	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174735	10.1371/journal.pone.0174735	http://dx.doi.org/10.1371/journal.pone.0174735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369140	Green Published, gold, Green Submitted			2022-12-26	WOS:000399351000040
J	Oh, M; Rhee, S; Moon, JH; Chae, H; Lee, S; Kang, J; Kim, S				Oh, Minsik; Rhee, Sungmin; Moon, Ji Hwan; Chae, Heejoon; Lee, Sunwon; Kang, Jaewoo; Kim, Sun			Literature-based condition-specific miRNA-mRNA target prediction	PLOS ONE			English	Article							FOCAL-ADHESION KINASE; BREAST-CANCER; INTEGRATIVE ANALYSIS; MICRORNA; EXPRESSION; APOPTOSIS; GENES; CELLS	miRNAs are small non-coding RNAs that regulate gene expression by binding to the 3'-UTR of genes. Many recent studies have reported that miRNAs play important biological roles by regulating specific mRNAs or genes. Many sequence-based target prediction algorithms have been developed to predict miRNA targets. However, these methods are not designed for condition-specific target predictions and produce many false positives; thus, expression based target prediction algorithms have been developed for condition-specific target predictions. A typical strategy to utilize expression data is to leverage the negative control roles of miRNAs on genes. To control false positives, a stringent cutoff value is typically set, but in this case, these methods tend to reject many true target relationships, i.e., false negatives. To overcome these limitations, additional information should be utilized. The literature is probably the best resource that we can utilize. Recent literature mining systems compile millions of articles with experiments designed for specific biological questions, and the systems provide a function to search for specific information. To utilize the literature information, we used a literature mining system, BEST, that automatically extracts information from the literature in PubMed and that allows the user to perform searches of the literature with any English words. By integrating omics data analysis methods and BEST, we developed Context-MMIA,a miRNA-mRNA target prediction method that combines expression data analysis results and the literature information extracted based on the user-specified context. In the pathway enrichment analysis using genes included in the top 200 miRNA-targets, Context-MMIA outperformed the four existing target prediction methods that we tested. In another test on whether prediction methods can re-produce experimentally validated target relationships, Context-MMIA outperformed the four existing target prediction methods. In summary, Context-MMIA allows the user to specify a context of the experimental data to predict miRNA targets, and we believe that Context-MMIA is very useful for predicting condition-specific miRNA targets.	[Oh, Minsik; Rhee, Sungmin; Kim, Sun] Seoul Natl Univ, Dept Comp Sci & Engn, Seoul, South Korea; [Moon, Ji Hwan; Kim, Sun] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Chae, Heejoon] Sookmyung Womens Univ, Div Comp Sci, Seoul, South Korea; [Lee, Sunwon; Kang, Jaewoo] Korea Univ, Dept Comp Sci & Engn, Seoul, South Korea; [Kim, Sun] Seoul Natl Univ, Bioinformat Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Sookmyung Women's University; Korea University; Seoul National University (SNU)	Kim, S (corresponding author), Seoul Natl Univ, Dept Comp Sci & Engn, Seoul, South Korea.; Kim, S (corresponding author), Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea.; Kim, S (corresponding author), Seoul Natl Univ, Bioinformat Inst, Seoul, South Korea.	sunkim.bioinfo@snu.ac.kr		Rhee, Sung-Min/0000-0002-7087-4219	National Research Foundation of Korea [2012M3A9D1054622, 2014M3C9A3063541, 2012M3C4A7033341]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by grant numbers 2012M3A9D1054622, 2014M3C9A3063541, and 2012M3C4A7033341, National Research Foundation of Korea (URL:http://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi-sso-return2=none). The authors who received the funding are: Minsik, Sungmin, Ji Hwan, Heejoon, Sunwon, Jaewoo, Sun. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ben-Moshe NB, 2012, NUCLEIC ACIDS RES, V40, P10614, DOI 10.1093/nar/gks841; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bisognin A, 2012, NUCLEIC ACIDS RES, V40, pW13, DOI 10.1093/nar/gks460; Chae H, 2014, BIOINFORMATICS; Cho JH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-8; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Esquivel-Velazquez M, 2015, J INTERF CYTOK RES, V35, P1, DOI 10.1089/jir.2014.0026; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Flamini MI, 2009, MOL HUM REPROD, V15, P675, DOI 10.1093/molehr/gap045; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gasco M, 2002, BREAST CANCER RES, V4, P70, DOI 10.1186/bcr426; Goggins W, 2004, INT J CANCER, V111, P792, DOI 10.1002/ijc.20322; Haidari M, 2013, LIFE SCI, V93, P994, DOI 10.1016/j.lfs.2013.10.027; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; King JA, 2004, BREAST CANCER RES, V6, pR478, DOI 10.1186/bcr815; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lark AL, 2005, MODERN PATHOL, V18, P1289, DOI 10.1038/modpathol.3800424; Lee J, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1335-8; Lee S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164680; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lipponen P, 1999, ENDOCR-RELAT CANCER, V6, P13, DOI 10.1677/erc.0.0060013; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Luo DH, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-203; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mehlen P, 2011, NAT REV CANCER, V11, P188, DOI 10.1038/nrc3005; Moses H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003277; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Nam S, 2009, NUCLEIC ACIDS RES, V37, pW356, DOI 10.1093/nar/gkp294; Norfo R, 2014, BLOOD, V124, pE21, DOI 10.1182/blood-2013-12-544197; Piccirilli M, 2005, TUMORI J, V91, P256, DOI 10.1177/030089160509100309; Reedijk M, 2012, ADV EXP MED BIOL, V727, P241, DOI 10.1007/978-1-4614-0899-4_18; Rhee S, 2015, METHODS, V83, P80, DOI 10.1016/j.ymeth.2015.04.003; Saadatmand S, 2013, BRIT J SURG, V100, P252, DOI 10.1002/bjs.8980; Santen RJ, 2002, J STEROID BIOCHEM, V80, P239, DOI 10.1016/S0960-0760(01)00189-3; Schramm G, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-39; Sheng-Da Hsu, 2010, NUCLEIC ACIDS RES; Sigoillot FD, 2004, INT J CANCER, V109, P491, DOI 10.1002/ijc.11717; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Iterson M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt525; Yu K, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S17-S6	49	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174999	10.1371/journal.pone.0174999	http://dx.doi.org/10.1371/journal.pone.0174999			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362846	Green Published, Green Submitted, gold			2022-12-26	WOS:000399175000059
J	Soffer, N; Woolston, J; Li, MR; Das, C; Sulakvelidze, A				Soffer, Nitzan; Woolston, Joelle; Li, Manrong; Das, Chythanya; Sulakvelidze, Alexander			Bacteriophage preparation lytic for Shigella significantly reduces Shigella sonnei contamination in various foods	PLOS ONE			English	Article							UNITED-STATES; OPERATIONS; INFECTION; OUTBREAK; SPP.	ShigaShield (TM) is a phage preparation composed of five lytic bacteriophages that specifically target pathogenic Shigella species found in contaminated waters and foods. In this study, we examined the efficacy of various doses (9x10(5)-9x10(7) PFU/g) of ShigaShield (TM) in removing experimentally added Shigella on deli meat, smoked salmon, pre-cooked chicken, lettuce, melon and yogurt. The highest dose (2x10(7) or 9x10(7) PFU/g) of ShigaShield (TM) applied to each food type resulted in at least 1 log (90%) reduction of Shigella in all the food types. There was significant (P<0.01) reduction in the Shigella levels in all phage treated foods compared to controls, except for the lowest phage dose (9x10(5) PFU/g) on melon where reduction was only ca. 45% (0.25 log). The genomes of each component phage in the cocktail were fully sequenced and analyzed, and they were found not to contain any "undesirable genes" including those listed in the US Code for Federal Regulations (40 CFR Ch1). Our data suggest that ShigaShieldTM (and similar phage preparations with potent lytic activity against Shigella spp.) may offer a safe and effective approach for reducing the levels of Shigella in various foods that may be contaminated with the bacterium.	[Soffer, Nitzan; Woolston, Joelle; Li, Manrong; Das, Chythanya; Sulakvelidze, Alexander] Intralytix Inc, Baltimore, MD 21201 USA		Soffer, N (corresponding author), Intralytix Inc, Baltimore, MD 21201 USA.	nsoffer@intralytix.com			Small Business Innovation Research (SBIR) [W911NF-11-C-0074]; United States Army [W911QY09-C-0079]	Small Business Innovation Research (SBIR)(United States Department of Agriculture (USDA)); United States Army(United States Department of DefenseUnited States Army)	Our studies were supported, in part, by a Small Business Innovation Research (SBIR) award W911NF-11-C-0074 and Contract No. W911QY09-C-0079 from the United States Army (to A.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2015, INT J FOOD MICROBIOL, V194, P78, DOI 10.1016/j.ijfoodmicro.2014.11.013; Bardhan P, 2010, EMERG INFECT DIS, V16, P1718, DOI 10.3201/eid1611.090934; Bowen A, 2016, EMERG INFECT DIS, V22, P1613, DOI 10.3201/eid2209.160624; CDC, 2013, CURRENT; Centers for Disease Control and Prevention (CDC), SHIG SHIG; DEMAIO J, 1993, MIL MED, V158, P161, DOI 10.1093/milmed/158.3.161; DUPONT HL, 1989, J INFECT DIS, V159, P1126, DOI 10.1093/infdis/159.6.1126; Ganim S., 2016, CNN, P1; Goodridge Lawrence D, 2011, Bacteriophage, V1, P130; GREER GG, 1988, J FOOD SCI, V53, P1226, DOI 10.1111/j.1365-2621.1988.tb13570.x; Gupta A, 2004, CLIN INFECT DIS, V38, P1372, DOI 10.1086/386326; Hyams KC, 2017, IMPACT INFECT DIS HL, V20, p1497 ~ 504; KAPPERUD G, 1995, J CLIN MICROBIOL, V33, P609, DOI 10.1128/JCM.33.3.609-614.1995; Kimura AC, 2004, EMERG INFECT DIS, V10, P1147, DOI 10.3201/eid1006.030599; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Mai Volker, 2015, Bacteriophage, V5, pe1088124, DOI 10.1080/21597081.2015.1088124; Mani S, 2016, VACCINE, V34, P2887, DOI 10.1016/j.vaccine.2016.02.075; MULCZYK M, 1974, ACTA MICROBIOL HUNG, V21, P115; Nygren BL, 2013, EPIDEMIOL INFECT, V141, P233, DOI 10.1017/S0950268812000222; Perera MN, 2015, FOOD MICROBIOL, V52, P42, DOI 10.1016/j.fm.2015.06.006; QUIN NE, 1982, MIL MED, V147, P728, DOI 10.1093/milmed/147.9.728; Riddle MS, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-9; Rohwer F, 2009, ENVIRON MICROBIOL, V11, P2771, DOI 10.1111/j.1462-2920.2009.02101.x; Woolston J., 2015, ELS, P1; Worley-Morse TO, 2014, ENVIRON SCI-PROC IMP, V16, P81, DOI 10.1039/c3em00427a; Zhang H, 2013, POULTRY SCI, V92, P211, DOI 10.3382/ps.2011-02037	26	54	56	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0175256	10.1371/journal.pone.0175256	http://dx.doi.org/10.1371/journal.pone.0175256			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362863	Green Published, Green Submitted, gold			2022-12-26	WOS:000399175000077
J	Won, MH; Dawid, IB				Won, Minho; Dawid, Igor B.			PCR artifact in testing for homologous recombination in genomic editing in zebrafish	PLOS ONE			English	Article							CRISPR/CAS9 SYSTEM; DNA; EFFICIENT; TALEN; PRECISE; EXPRESSION; IMMUNITY; DESIGN; LIGASE	We report a PCR-induced artifact in testing for homologous recombination in zebrafish. We attempted to replace the Inx2a gene with a donor cassette, mediated by a TALEN induced double stranded cut. The donor construct was flanked with homology arms of about 1 kb at the 5' and 3' ends. Injected embryos (G0) were raised and outcrossed to wild type fish. A fraction of the progeny appeared to have undergone the desired homologous recombination, as tested by PCR using primer pairs extending from genomic DNA outside the homology region to a site within the donor cassette. However, Southern blots revealed that no recombination had taken place. We conclude that recombination happened during PCR in vitro between the donor integrated elsewhere in the genome and the Inx2a locus. We conclude that PCR alone may be insufficient to verify homologous recombination in genome editing experiments in zebrafish.	[Won, Minho; Dawid, Igor B.] NICHHD, Sect Dev Biol, DDB, NIH, Bethesda, MD 20892 USA; [Won, Minho] Chungnam Natl Univ, Dept Pharmacol, Coll Med, Daejeon, South Korea	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Chungnam National University	Dawid, IB (corresponding author), NICHHD, Sect Dev Biol, DDB, NIH, Bethesda, MD 20892 USA.	idawid@nih.gov		Won, Minho/0000-0002-5873-5216	intramural research program of the Eugene Kennedy Shriver National Institute for Child Health and Human Development [008809]	intramural research program of the Eugene Kennedy Shriver National Institute for Child Health and Human Development	This work was funded by the intramural research program of the Eugene Kennedy Shriver National Institute for Child Health and Human Development, under program number ZIA HD 008809. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, manuscripts emanating from the intramural research program are subject to a clearance procedure, and this manuscript has been cleared.	Auer TO, 2014, METHODS, V69, P142, DOI 10.1016/j.ymeth.2014.03.027; Cade L, 2012, NUCLEIC ACIDS RES, V40, P8001, DOI 10.1093/nar/gks518; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Esengil H, 2007, NAT CHEM BIOL, V3, P154, DOI 10.1038/nchembio858; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gupta A, 2013, GENOME RES, V23, P1008, DOI 10.1101/gr.154070.112; He F, 2007, CANCER RES, V67, P634, DOI 10.1158/0008-5472.CAN-06-1860; Hisano Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08841; Horstick EJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv035; Hoshijima K, 2016, DEV CELL, V36, P654, DOI 10.1016/j.devcel.2016.02.015; Hruscha A, 2013, DEVELOPMENT, V140, P4982, DOI 10.1242/dev.099085; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Irion U, 2014, DEVELOPMENT, V141, P4827, DOI 10.1242/dev.115584; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Liu Y, 2014, METHODS, V69, P58, DOI 10.1016/j.ymeth.2014.02.011; Meeker ND, 2007, BIOTECHNIQUES, V43, P610, DOI 10.2144/000112619; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Qi YP, 2013, GENOME RES, V23, P547, DOI 10.1101/gr.145557.112; Shin J, 2014, DEVELOPMENT, V141, P3807, DOI 10.1242/dev.108019; Southern E, 2015, METHODS MOL BIOL, V1312, P1, DOI 10.1007/978-1-4939-2694-7_1; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Won MH, 2015, P NATL ACAD SCI USA, V112, P12426, DOI 10.1073/pnas.1517033112; Wu PY, 2009, MOL CELL BIOL, V29, P3163, DOI 10.1128/MCB.01895-08; Zhang Y, 2016, METHOD CELL BIOL, V135, P107, DOI 10.1016/bs.mcb.2016.03.005; Zu Y, 2013, NAT METHODS, V10, P329, DOI 10.1038/NMETH.2374	30	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0172802	10.1371/journal.pone.0172802	http://dx.doi.org/10.1371/journal.pone.0172802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362803	Green Published, Green Submitted, gold			2022-12-26	WOS:000399175000003
J	Silva, RPD; Machado, BAS; Barreto, GD; Costa, SS; Andrade, LN; Amaral, RG; Carvalho, AA; Padilha, FF; Barbosa, JDV; Umsza-Guez, MA				Dantas Silva, Rejane Pina; Souza Machado, Bruna Aparecida; Barreto, Gabriele de Abreu; Costa, Samantha Serra; Andrade, Luciana Nalone; Amaral, Ricardo Guimaraes; Carvalho, Adriana Andrade; Padilha, Francine Ferreira; Viana Barbosa, Josiane Dantas; Umsza-Guez, Marcelo Andres			Antioxidant, antimicrobial, antiparasitic, and cytotoxic properties of various Brazilian propolis extracts	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; IN-VITRO; ANTIBACTERIAL ACTIVITY; BIOLOGICAL-ACTIVITY; PHENOLIC-COMPOUNDS; CONSTITUENTS; SEASONALITY; FLAVONOIDS; CAPACITY; REGIONS	Propolis is known for its biological properties and its preparations have been continuously investigated in an attempt to solve the problem of their standardization, an issue that limits the use of propolis in food and pharmaceutical industries. The aim of this study was to evaluate in vitro antioxidant, antimicrobial, antiparasitic, and cytotoxic effects of extracts of red, green, and brown propolis from different regions of Brazil, obtained by ethanolic and supercritical extraction methods. We found that propolis extracts obtained by both these methods showed concentration-dependent antioxidant activity. The extracts obtained by ethanolic extraction showed higher antioxidant activity than that shown by the extracts obtained by supercritical extraction. Ethanolic extracts of red propolis exhibited up to 98% of the maximum antioxidant activity at the highest extract concentration. Red propolis extracts obtained by ethanolic and supercritical methods showed the highest levels of antimicrobial activity against several bacteria. Most extracts demonstrated antimicrobial activity against Staphylococcus aureus. None of the extracts analyzed showed activity against Escherichia coli or Candida albicans. An inhibitory effect of all tested ethanolic extracts on the growth of Trypanosoma cruzi Y strain epimastigotes was observed in the first 24 h. However, after 96 h, a persistent inhibitory effect was detected only for red propolis samples. Only ethanolic extracts of red propolis samples R01Et.B2 and R02Et.B2 showed a cytotoxic effect against all four cancer cell lines tested (HL-60, HCT-116, OVCAR-8, and SF-295), indicating that red propolis extracts have great cytotoxic potential. The biological effects of ethanolic extracts of red propolis revealed in the present study suggest that red propolis can be a potential alternative therapeutic treatment against Chagas disease and some types of cancer, although high activity of red propolis in vitro needs to be confirmed by future in vivo investigations.	[Dantas Silva, Rejane Pina; Costa, Samantha Serra] Univ Fed Bahia, Dept Pharm, Salvador, BA, Brazil; [Dantas Silva, Rejane Pina; Souza Machado, Bruna Aparecida; Barreto, Gabriele de Abreu] Natl Serv Ind Learning SENAI, Dept Biotechnol & Food, Fac Technol, SENAI,CIMATEC, Salvador, BA, Brazil; [Souza Machado, Bruna Aparecida; Viana Barbosa, Josiane Dantas] Natl Serv Ind Learning SENAI, Fac Technol, Inst Technol Hlth, SENAI,CIMATEC, Salvador, BA, Brazil; [Andrade, Luciana Nalone; Amaral, Ricardo Guimaraes] Univ Fed Sergipe, Dept Physiol, Sao Cristovao, Sergipe, Brazil; [Carvalho, Adriana Andrade] Univ Fed Sergipe, Dept Pharm, Lagarto, Sergipe, Brazil; [Padilha, Francine Ferreira] Univ Tiradentes, Inst Res & Technol, Aracaju, Sergipe, Brazil; [Umsza-Guez, Marcelo Andres] Univ Fed Bahia, Dept Biotechnol, Salvador, BA, Brazil	Universidade Federal da Bahia; Faculdade de Tecnologia Senai Cimatec; Faculdade de Tecnologia Senai Cimatec; Universidade Federal de Sergipe; Universidade Federal de Sergipe; Universidade Tiradentes; Universidade Federal da Bahia	Machado, BAS (corresponding author), Natl Serv Ind Learning SENAI, Dept Biotechnol & Food, Fac Technol, SENAI,CIMATEC, Salvador, BA, Brazil.; Machado, BAS (corresponding author), Natl Serv Ind Learning SENAI, Fac Technol, Inst Technol Hlth, SENAI,CIMATEC, Salvador, BA, Brazil.	brunamachado17@hotmail.com	Machado, Bruna Aparecida Souza/C-3130-2016; Carvalho, Adriana A/F-4831-2013; Umsza-Guez, Marcelo Andrés/AAL-1315-2020; Machado, Bruna/AAP-6877-2021; Umsza-Guez, Marcelo/AAV-8564-2020; Andrade, Luciana/P-4604-2017	Machado, Bruna Aparecida Souza/0000-0003-1655-0325; Carvalho, Adriana A/0000-0001-9739-3127; Andrade, Luciana/0000-0002-5481-4355; Barreto, Gabriele/0000-0002-0180-281X				Ahn MR, 2007, FOOD CHEM, V101, P1383, DOI 10.1016/j.foodchem.2006.03.045; Alencar SM, 2007, J ETHNOPHARMACOL, V113, P278, DOI 10.1016/j.jep.2007.06.005; Amaral RG, 2015, J PHARM PHARMACOL, V67, P1100, DOI 10.1111/jphp.12409; Ayres DC, 2007, MEM I OSWALDO CRUZ, V102, P215, DOI 10.1590/S0074-02762007005000020; Bankova V, 1996, Z NATURFORSCH C, V51, P277; Bankova V, 2005, J ETHNOPHARMACOL, V100, P114, DOI 10.1016/j.jep.2005.05.004; Bankova V, 1998, APIDOLOGIE, V29, P361, DOI 10.1051/apido:19980406; Biscaia D, 2009, J SUPERCRIT FLUID, V51, P17, DOI 10.1016/j.supflu.2009.07.011; Buriol L, 2009, QUIM NOVA, V32, P296, DOI 10.1590/S0100-40422009000200006; Carvalho AA, 2011, FOOD CHEM, V126, P1239, DOI 10.1016/j.foodchem.2010.12.035; Castaldo S, 2002, FITOTERAPIA, V73, pS1, DOI 10.1016/S0367-326X(02)00185-5; Castro ML, 2007, QUIM NOVA, V30, P1512, DOI 10.1590/S0100-40422007000700003; CASTRO SL, 1995, J ETHNOPHARMACOL, V46, P55; Catchpole O, 2015, FITOTERAPIA, V106, P167, DOI 10.1016/j.fitote.2015.09.004; Choi YM, 2006, LWT-FOOD SCI TECHNOL, V39, P756, DOI 10.1016/j.lwt.2005.05.015; Choudhari MK, 2012, J ETHNOPHARMACOL, V141, P363, DOI 10.1016/j.jep.2012.02.047; Christov R, 2005, NAT PROD RES, V19, P673, DOI 10.1080/14786410512331328159; Cottica SM, 2015, LWT-FOOD SCI TECHNOL, V60, P609, DOI 10.1016/j.lwt.2014.08.045; Cottica SM, 2011, J BRAZIL CHEM SOC, V22, P929, DOI 10.1590/S0103-50532011000500016; Dantas AP, 2006, J ETHNOPHARMACOL, V103, P187, DOI 10.1016/j.jep.2005.07.018; Daugsch A, 2008, EVID-BASED COMPL ALT, V5, P435, DOI 10.1093/ecam/nem057; Duman M, 2015, FOOD CHEM, V189, P80, DOI 10.1016/j.foodchem.2014.08.091; Duran G, 2008, PARASITOL RES, V102, P1217, DOI 10.1007/s00436-008-0896-5; Freitas SF, 2006, PHYTOMEDICINE, V13, P170, DOI 10.1016/j.phymed.2004.07.008; GHISALBERTI EL, 1979, BEE WORLD, V60, P59, DOI 10.1080/0005772X.1979.11097738; Graikou K, 2016, LWT-FOOD SCI TECHNOL, V65, P261, DOI 10.1016/j.lwt.2015.08.025; Gressler LT, 2012, RES VET SCI, V93, P1314, DOI 10.1016/j.rvsc.2012.02.007; Kalogeropoulos N, 2009, FOOD CHEM, V116, P452, DOI 10.1016/j.foodchem.2009.02.060; Kasote D, 2015, PHYTOCHEM LETT, V11, P326, DOI 10.1016/j.phytol.2014.08.017; Kim DO, 2003, J AGR FOOD CHEM, V51, P6509, DOI 10.1021/jf0343074; Koo H, 2000, CURR MICROBIOL, V41, P192, DOI 10.1007/s0028400101170; Kumazawa S, 2004, FOOD CHEM, V84, P329, DOI 10.1016/S0308-8146(03)00216-4; Lopez BGC, 2014, FOOD CHEM, V146, P174, DOI 10.1016/j.foodchem.2013.09.063; Lotti C, 2010, J AGR FOOD CHEM, V58, P2209, DOI 10.1021/jf100070w; Lu LC, 2005, INT J FOOD MICROBIOL, V102, P213, DOI 10.1016/j.ijfoodmicro.2004.12.017; MARCUCCI MC, 1995, APIDOLOGIE, V26, P83, DOI 10.1051/apido:19950202; Marcucci MC, 2001, J ETHNOPHARMACOL, V74, P105, DOI 10.1016/S0378-8741(00)00326-3; Martinez-Diaz RA, 2001, MEM I OSWALDO CRUZ, V96, P53, DOI 10.1590/S0074-02762001000100006; Melliou E, 2007, FOOD CHEM, V103, P375, DOI 10.1016/j.foodchem.2006.07.033; Miguel MG, 2010, FOOD CHEM TOXICOL, V48, P3418, DOI 10.1016/j.fct.2010.09.014; Ministe A rio da Agricultura Pecua A ria e Abastecimento, PEC AB IND GEOGR IG; Moreira L, 2008, FOOD CHEM TOXICOL, V46, P3482, DOI 10.1016/j.fct.2008.08.025; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NCCLS, 2000, M100S10M7 NCCLS, V5; Nedji N., 2014, Asian Pacific Journal of Tropical Disease, V4, P433, DOI 10.1016/S2222-1808(14)60601-0; Novak EM, 2014, J FUNCT FOODS, V11, P91, DOI 10.1016/j.jff.2014.09.008; Oses SM, 2016, FOOD CHEM, V196, P1215, DOI 10.1016/j.foodchem.2015.10.050; Packer Janaina F., 2007, Rev. bras. farmacogn., V17, P102, DOI 10.1590/S0102-695X2007000100019; Park YK, 2002, J AGR FOOD CHEM, V50, P2502, DOI 10.1021/jf011432b; Piccinelli AL, 2011, J AGR FOOD CHEM, V59, P6484, DOI 10.1021/jf201280z; Popova M, 2011, FOOD CHEM, V126, P1431, DOI 10.1016/j.foodchem.2010.11.130; Prytzyk E, 2003, J ETHNOPHARMACOL, V88, P189, DOI 10.1016/S0378-8741(03)00210-1; REZENDE GP, 2006, BRAZILIAN J ORAL SCI, V0005, P00967, DOI DOI 10.20396/BJOS.V5I16.8641876; Ristivojevic P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157097; Salomao K, 2004, LETT APPL MICROBIOL, V38, P87, DOI 10.1111/j.1472-765X.2003.01458.x; Salomao K, 2010, ANTIMICROB AGENTS CH, V54, P2023, DOI 10.1128/AAC.01241-09; Salomao K, 2011, COMPLEMENTARY ALTERN; Sawaya ACHF, 2004, ANALYST, V129, P739, DOI 10.1039/b403873h; Sforcin J. M., 2001, Journal of Venomous Animals and Toxins, V7, P1; Sforcin JM, 2000, J ETHNOPHARMACOL, V73, P243, DOI 10.1016/S0378-8741(00)00320-2; Sforcin JM, 2002, J VENOM ANIM TOXINS, P8; Sforcin JM, 2007, J ETHNOPHARMACOL, P113; Siheri W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155355; Silici S, 2005, J ETHNOPHARMACOL, V99, P69, DOI 10.1016/j.jep.2005.01.046; Silva Aleksandro Schafer da, 2009, Cienc. Rural, V39, P2550; Silva-Carvalho R, 2014, J FUNCT FOODS, V11, P160, DOI 10.1016/j.jff.2014.09.009; Simoes-Ambrosio LMC, 2010, FITOTERAPIA, V81, P1102, DOI 10.1016/j.fitote.2010.07.008; Machado BAS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145954; Machado BAS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134489; Tiveron AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165588; Tosi EA, 2007, FOOD CHEM, V104, P1025, DOI 10.1016/j.foodchem.2007.01.011; Valencia D, 2012, FOOD CHEM, V131, P645, DOI 10.1016/j.foodchem.2011.08.086; van den Berg R, 1999, FOOD CHEM, V66, P511, DOI 10.1016/S0308-8146(99)00089-8; Veiga-Santos P, 2010, PARASITOLOGY, V137, P1661, DOI 10.1017/S003118201000034X; World Health Organization (WHO), CHAG DIS AM TRYP	75	95	98	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0172585	10.1371/journal.pone.0172585	http://dx.doi.org/10.1371/journal.pone.0172585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358806	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174800004
J	Kim, Y; Kim, MH; Jeon, S; Kim, J; Kim, C; Bae, JS; Jung, CK				Kim, Yourha; Kim, Min-Hee; Jeon, Sora; Kim, Jeeyoon; Kim, Chankyung; Bae, Ja Seong; Jung, Chan Kwon			Prognostic implication of histological features associated with EHD2 expression in papillary thyroid carcinoma	PLOS ONE			English	Article							BRAF MUTATIONS; PSAMMOMA BODY; COMMON TYPE; RISK GROUP; CANCER; TUMOR; IDENTIFICATION; SUBCLASSIFICATION; CALCIFICATION; MIGRATION	Papillary thyroid carcinoma (PTC) is a heterogeneous tumor with various histological and molecular subtypes. EHD2 is involved in endocytosis and endosomal recycling. This study aimed to investigate the prognostic significance of EHD2 expression in PTC and develop a new model for predicting persistent/recurrent disease after thyroidectomy. Pathologic slides of 512 consecutive patients with PTC >= 1 cm were retrospectively reviewed. BRAF mutation analysis and immunohistochemistry for EHD2 were performed. Clinical significance of EHD2 mRNA expression was analyzed in 388 PTC patients using The Cancer Genome Atlas dataset. The presence of dyscohesive cells and psammoma bodies were found have significant association with persistent/recurrent disease (p = 0.049 and p = 0.038, respectively). The best discrimination of disease-free survival was found by dividing patients into three prognostic groups based on the following two risk factors according to the size category: psammoma bodies >= 4 and dyscohesive cells (>= 1% and >= 20% in PTCs of < 2.0 cm and >= 2.0 cm, respectively). In PTCs of >= 2.0 cm, patients with the two risk factors had a hazard ratio of 13.303 (p = 0.005) compared to those without risk factors. High expression level of EHD2 was associated with BRAFV600E (p < 0.001), presence of dyscohesive cells (p = 0.010), and absence of psammoma bodies (p = 0.001). Increased EHD2 mRNA expression level was associated with extrathyroidal extension (p < 0.001), pT3-4 (p < 0.001), lymph node metastasis (p < 0.001), higher risk of recurrence (p < 0.001), and BRAFV600E (p < 0.001). Our prognostic model is useful for predicting persistent/recurrent disease after surgery of PTC. EHD2 mRNA expression could be a novel prognostic marker for PTC patients.	[Kim, Yourha; Jeon, Sora; Kim, Jeeyoon; Kim, Chankyung; Jung, Chan Kwon] Catholic Univ Korea, Dept Hosp Pathol, Coll Med, Seoul, South Korea; [Kim, Yourha; Jeon, Sora] Catholic Univ Korea, Dept Biomed & Hlth Sci, Coll Med, Seoul, South Korea; [Kim, Min-Hee] Catholic Univ Korea, Div Endocrinol & Metab, Dept Internal Med, Coll Med, Seoul, South Korea; [Kim, Chankyung] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Bae, Ja Seong] Catholic Univ Korea, Dept Surg, Coll Med, Seoul, South Korea; [Jung, Chan Kwon] Catholic Univ Korea, Canc Res Inst, Coll Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; University of Adelaide; Catholic University of Korea; Catholic University of Korea	Jung, CK (corresponding author), Catholic Univ Korea, Dept Hosp Pathol, Coll Med, Seoul, South Korea.; Jung, CK (corresponding author), Catholic Univ Korea, Canc Res Inst, Coll Med, Seoul, South Korea.	ckjung@catholic.ac.kr	Jung, Chan Kwon/C-7578-2014	Jung, Chan Kwon/0000-0001-6843-3708	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future planning of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [2013R1A2A2A01068570, H116C2013]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future planning of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant (2013R1A2A2A01068570) of Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future planning, and a grant (H116C2013) of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Ahn HS, 2014, NEW ENGL J MED, V371, P1765, DOI 10.1056/NEJMp1409841; Bahl K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123710; Bai Y, 2008, CANCER SCI, V99, P1908, DOI 10.1111/j.1349-7006.2008.00908.x; Bai YH, 2009, CANCER LETT, V281, P188, DOI 10.1016/j.canlet.2009.02.043; Bai Y, 2009, MODERN PATHOL, V22, P887, DOI 10.1038/modpathol.2009.38; Bignotti E, 2006, GYNECOL ONCOL, V103, P405, DOI 10.1016/j.ygyno.2006.03.056; Cai BS, 2013, J BIOL CHEM, V288, P30172, DOI 10.1074/jbc.M113.488627; Cho U, 2014, J KOREAN MED SCI, V29, P1054, DOI 10.3346/jkms.2014.29.8.1054; Das DK, 2009, DIAGN CYTOPATHOL, V37, P534, DOI 10.1002/dc.21081; DeLellis R, 2004, PATHOLOGY GENETICS T; Gnemmi V, 2014, HISTOPATHOLOGY, V64, P263, DOI 10.1111/his.12246; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hiltzik D, 2006, CANCER-AM CANCER SOC, V106, P1286, DOI 10.1002/cncr.21739; Jang MH, 2015, J PATHOL TRANSL MED, V49, P112, DOI 10.4132/jptm.2015.01.31; Jung CK, 2014, J CLIN ENDOCR METAB, V99, pE276, DOI 10.1210/jc.2013-2503; Jung CK, 2010, MODERN PATHOL, V23, P1201, DOI 10.1038/modpathol.2010.116; Kakudo K, 2004, J CLIN PATHOL, V57, P1041, DOI 10.1136/jcp.2004.017889; Kang WK, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0227-0; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee SR, 2013, THYROID, V23, P1416, DOI 10.1089/thy.2012.0640; Lee YS, 2015, INT J CLIN EXP PATHO, V8, P7988; Li M, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0396-4; Liu Z., 2011, J WATER RESOURCES AR, V9, P9; Nikiforov YE, 2016, JAMA ONCOL; Shi XG, 2016, J CLIN ENDOCR METAB, V101, P263, DOI 10.1210/jc.2015-2917; Simone LC, 2014, HISTOL HISTOPATHOL, V29, P285, DOI 10.14670/HH-29.285; Smith JS, 2000, GENOMICS, V64, P44, DOI 10.1006/geno.1999.6101; Stoeber M, 2012, EMBO J, V31, P2350, DOI 10.1038/emboj.2012.98; Yang XJ, 2015, TUMOR BIOL, V36, P3717, DOI 10.1007/s13277-014-3011-9	30	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174737	10.1371/journal.pone.0174737	http://dx.doi.org/10.1371/journal.pone.0174737			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358874	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174800080
J	Wilburn, DB; Doty, KA; Chouinard, AJ; Eddy, SL; Woodley, SK; Houck, LD; Feldhoff, RC				Wilburn, Damien B.; Doty, Kari A.; Chouinard, Adam J.; Eddy, Sarah L.; Woodley, Sarah K.; Houck, Lynne D.; Feldhoff, Richard C.			Olfactory effects of a hypervariable multicomponent pheromone in the red-legged salamander, Plethodon shermani	PLOS ONE			English	Article							COURTSHIP PHEROMONE; VOMERONASAL NEURONS; FEMALE RECEPTIVITY; MATE CHOICE; SEX; FAMILY; VERTEBRATE; ACTIVATION; RECEPTORS; COMMUNICATION	Chemical communication via chemosensory signaling is an essential process for promoting and modifying reproductive behavior in many species. During courtship in plethodontid salamanders, males deliver a mixture of non-volatile proteinaceous pheromones that activate chemosensory neurons in the vomeronasal epithelium (VNE) and increase female receptivity. One component of this mixture, Plethodontid Modulating Factor (PMF), is a hypervariable pheromone expressed as more than 30 unique isoforms that differ between individual males likely driven by co-evolution with female receptors to promote gene duplication and positive selection of the PMF gene complex. Courtship trials with females receiving different PMF isoform mixtures had variable effects on female mating receptivity, with only the most complex mixtures increasing receptivity, such that we believe that sufficient isoform diversity allows males to improve their reproductive success with any female in the mating population. The aim of this study was to test the effects of isoform variability on VNE neuron activation using the agmatine uptake assay. All isoform mixtures activated a similar number of neurons (>200% over background) except for a single purified PMF isoform (+17%). These data further support the hypothesis that PMF isoforms act synergistically in order to regulate female receptivity, and different putative mechanisms are discussed.	[Wilburn, Damien B.; Doty, Kari A.; Feldhoff, Richard C.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Wilburn, Damien B.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Chouinard, Adam J.; Eddy, Sarah L.; Houck, Lynne D.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Woodley, Sarah K.] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15219 USA	University of Louisville; University of Washington; University of Washington Seattle; Oregon State University; Duquesne University	Wilburn, DB (corresponding author), Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA.; Wilburn, DB (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	dwilburn@u.washington.edu		Wilburn, Damien/0000-0002-1255-9982; Woodley, Sarah/0000-0001-7877-6392	National Science Foundation [IOS-0818649, IOS-1146899, IOS-0818554, IOS-1147271]; National Science Foundation Graduate Research Fellowship; Highlands Biological Station; Direct For Biological Sciences [1146899] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Highlands Biological Station; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was supported in part by National Science Foundation (nsf.gov) grants to RCF: IOS-0818649, IOS-1146899 and to LDH: IOS-0818554, IOS-1147271, a National Science Foundation (nsf.gov) Graduate Research Fellowship to DBW, and a Highlands Biological Station (highlandsbiological.org) Grant-in-Aid to DBW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2014, BIOCHEM SOC T, V42, P873, DOI 10.1042/BST20140051; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; ARNOLD SJ, 1976, Z TIERPSYCHOL, V42, P247; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chouinard AJ, 2013, CHEM SIGNAL, V12, P99, DOI 10.1007/978-1-4614-5927-9_8; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Feldhoff Richard C., 1999, P117; Garza-Garcia A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007123; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Houck LD, 2007, ANIM BEHAV, V73, P315, DOI 10.1016/j.anbehav.2006.07.008; Houck LD, 1998, COPEIA, P214; Houck LD, 2003, REPROD BIOL PHYLOGEN, V1, P383; Houck LD, 1994, AMPH BIOL, P351; Isogai Y, 2011, NATURE, V478, P241, DOI 10.1038/nature10437; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Kiemnec-Tyburczy KM, 2012, CHEM SENSES, V37, P335, DOI 10.1093/chemse/bjr105; Kini RM, 2010, TOXICON, V56, P855, DOI 10.1016/j.toxicon.2010.07.010; Laberge F, 2008, NEUROSCIENCE, V151, P329, DOI 10.1016/j.neuroscience.2007.11.006; Legrand S, 2004, Z NATURFORSCH C, V59, P708; Leinders-Zufall T, 2009, NAT NEUROSCI, V12, P1551, DOI 10.1038/nn.2452; Lemaster MP, 2002, J CHEM ECOL, V28, P1269, DOI 10.1023/A:1016294003641; Marc RE, 1999, J COMP NEUROL, V407, P47, DOI 10.1002/(SICI)1096-9861(19990428)407:1<47::AID-CNE4>3.0.CO;2-0; Marc RE, 1999, J COMP NEUROL, V407, P65; Michel WC, 1999, J NEUROSCI METH, V90, P143, DOI 10.1016/S0165-0270(99)00077-1; MOLLER AP, 1993, BEHAV ECOL SOCIOBIOL, V32, P167; Mudge JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r91; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Palmer CA, 2007, FEBS J, V274, P2300, DOI 10.1111/j.1742-4658.2007.05766.x; Palmer CA, 2010, J MOL EVOL, V70, P427, DOI 10.1007/s00239-010-9342-2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Powell S, 2012, NUCL ACIDS RES, V40; Roberts SA, 2012, SCIENCE, V338, P1462, DOI 10.1126/science.1225638; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; Rollmann SM, 1999, SCIENCE, V285, P1907, DOI 10.1126/science.285.5435.1907; Schubert SN, 2008, HORM BEHAV, V54, P270, DOI 10.1016/j.yhbeh.2008.03.009; Schubert SN, 2006, HORM BEHAV, V50, P469, DOI 10.1016/j.yhbeh.2006.06.014; SEVER DM, 1976, COPEIA, P830, DOI 10.2307/1443479; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Uzbay TI, 2012, NEUROSCI BIOBEHAV R, V36, P502, DOI 10.1016/j.neubiorev.2011.08.006; Vaccaro EA, 2010, ANIM BEHAV, V80, P983, DOI 10.1016/j.anbehav.2010.08.020; Wilburn DB, 2016, J PROTEOMICS, V135, P12, DOI 10.1016/j.jprot.2015.06.007; Wilburn DB, 2015, ANIM BEHAV, V100, P1, DOI 10.1016/j.anbehav.2014.10.019; Wilburn DB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096975; Wilburn DB, 2012, EVOLUTION, V66, P2227, DOI 10.1111/j.1558-5646.2011.01572.x; Wirsig-Wiechmann CR, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-26; Wirsig-Wiechmann CR, 2002, BRAIN RES, V952, P335, DOI 10.1016/S0006-8993(02)03369-3; Woodley S, 2015, HORM BEHAV, V68, P3, DOI 10.1016/j.yhbeh.2014.06.008; Woodley SK, 2007, BRAIN RES, V1138, P95, DOI 10.1016/j.brainres.2006.12.094; Woodley SK, 2010, J COMP PHYSIOL A, V196, P713, DOI 10.1007/s00359-010-0540-6; WOODLEY SK, 1994, GEN COMP ENDOCR, V96, P206, DOI 10.1006/gcen.1994.1175; Wyatt TD, 2010, J COMP PHYSIOL A, V196, P685, DOI 10.1007/s00359-010-0564-y; Yoshinaga S, 2013, J BIOL CHEM, V288, P16064, DOI 10.1074/jbc.M112.436782; ZUK M, 1992, ANIM BEHAV, V44, P999, DOI 10.1016/S0003-3472(05)80312-4	58	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174370	10.1371/journal.pone.0174370	http://dx.doi.org/10.1371/journal.pone.0174370			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358844	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174800033
J	Portal, C; Gouyer, V; Gottrand, F; Desseyn, JL				Portal, Celine; Gouyer, Valerie; Gottrand, Frederic; Desseyn, Jean-Luc			Preclinical mouse model to monitor live Muc5b-producing conjunctival goblet cell density under pharmacological treatments	PLOS ONE			English	Article							DRY EYE; EXPRESSION; GENE	Purpose Modification of mucous cell density and gel-forming mucin production are established hallmarks of mucosal diseases. Our aim was to develop and validate a mouse model to study live goblet cell density in pathological situations and under pharmacological treatments. Methods We created a reporter mouse for the gel-forming mucin gene Muc5b. Muc5b-positive goblet cells were studied in the eye conjunctiva by immunohistochemistry and probe-based confocal laser endomicroscopy (pCLE) in living mice. Dry eye syndrome (DES) model was induced by topical application of benzalkonium chloride (BAK) and recombinant interleukine (rIL) 13 was administered to reverse the goblet cell loss in the DES model. Results Almost 50% of the total of conjunctival goblet cells are Muc5b+ in unchallenged mice. The decrease density of Muc5b+ conjunctival goblet cell population in the DES model reflects the whole conjunctival goblet cell loss. Ten days of BAK in one eye followed by 4 days without any treatment induced a-18.3% decrease in conjunctival goblet cell density. A four days of rIL13 application in the DES model restored the normal goblet cell density. Conclusion Muc5b is a biological marker of DES mouse models. We bring the proof of concept that our model is unique and allows a better understanding of the mechanisms that regulate gel forming mucin production/secretion and mucous cell differentiation in the conjunctiva of living mice and can be used to test treatment compounds in mucosal disease models.	[Portal, Celine; Gouyer, Valerie; Gottrand, Frederic; Desseyn, Jean-Luc] Univ Lille, INSERM, CHU Lille, LIRIC,UMR 995, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille	Desseyn, JL (corresponding author), Univ Lille, INSERM, CHU Lille, LIRIC,UMR 995, Lille, France.	jean-lucdesseyn@inserm.fr	Desseyn, Jean-Luc/M-5070-2018; Portal, Celine/AAC-9407-2020; Gouyer, Valérie/R-4984-2018; gottrand, frederic/G-7370-2015	Desseyn, Jean-Luc/0000-0001-6876-8049; Portal, Celine/0000-0002-1862-0166; Gouyer, Valérie/0000-0002-4223-7060; gottrand, frederic/0000-0002-5290-0436	Universite Lille 2 fellowship	Universite Lille 2 fellowship	C.P. is the recipient of a Universite Lille 2 fellowship.	Chen JP, 2016, INVEST OPHTH VIS SCI, V57, P604, DOI 10.1167/iovs.15-18457; Chen Y, 2001, AM J RESP CRIT CARE, V164, P1059, DOI 10.1164/ajrccm.164.6.2012114; Colligris B, 2014, EXPERT OPIN PHARMACO, V15, P1371, DOI 10.1517/14656566.2014.914492; Colligris B, 2014, SAUDI J OPHTHALMOL, V28, P19, DOI 10.1016/j.sjopt.2013.12.003; Coursey TG, 2016, AM J PATHOL, V186, P1547, DOI 10.1016/j.ajpath.2016.02.004; Danahay H, 2015, CELL REP, V10, P239, DOI 10.1016/j.celrep.2014.12.017; Dartt DA, 2002, PROG RETIN EYE RES, V21, P555, DOI 10.1016/S1350-9462(02)00038-1; Dartt DA, 2014, CURR OPIN ALLERGY CL, V14, P464, DOI 10.1097/ACI.0000000000000098; Das B, 2010, J HISTOCHEM CYTOCHEM, V58, P141, DOI 10.1369/jhc.2009.954891; Desseyn JL, 2003, GENOMICS, V81, P433, DOI 10.1016/S0888-7543(03)00036-3; Desseyn JL, 1997, J BIOL CHEM, V272, P3168, DOI 10.1074/jbc.272.6.3168; Gipson IK, 2001, J CLIN ENDOCR METAB, V86, P594, DOI 10.1210/jc.86.2.594; Gouyer V, 2015, SCI REP-UK, V5, DOI 10.1038/srep09577; Gouyer V, 2010, HISTOCHEM CELL BIOL, V133, P517, DOI 10.1007/s00418-010-0688-8; Gupta D, 2011, INVEST OPHTH VIS SCI, V52, P4951, DOI 10.1167/iovs.10-7068; Harrop CA, 2013, EXP LUNG RES, V39, P39, DOI 10.3109/01902148.2012.748854; Henriksson JT, 2015, INVEST OPHTH VIS SCI, V56, P4186, DOI 10.1167/iovs.14-15496; Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x; Jumblatt MM, 2003, CORNEA, V22, P41, DOI 10.1097/00003226-200301000-00010; Laoukili J, 2001, J CLIN INVEST, V108, P1817, DOI 10.1172/JCI13557; Lin ZR, 2011, MOL VIS, V17, P257; Mantelli F, 2013, J CELL PHYSIOL, V228, P2253, DOI 10.1002/jcp.24398; Marko CK, 2013, AM J PATHOL, V183, P35, DOI 10.1016/j.ajpath.2013.03.017; Marko CK, 2014, INVEST OPHTH VIS SCI, V55, P291, DOI 10.1167/iovs.13-13194; Neumann H, 2010, GASTROENTEROLOGY, V139, P388, DOI 10.1053/j.gastro.2010.06.029; Portal C, 2017, SCI REP-UK, V7, DOI 10.1038/srep44591; Ridley C, 2014, J BIOL CHEM, V289, P16409, DOI 10.1074/jbc.M114.566679; Roy MG, 2014, NATURE, V505, P412, DOI 10.1038/nature12807; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Spitzer M, 2014, NAT METHODS, V11, P121, DOI 10.1038/nmeth.2811; Spurr-Michaud S, 2007, EXP EYE RES, V84, P939, DOI 10.1016/j.exer.2007.01.018; Tetaert D, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-39; Valque H, 2011, HISTOCHEM CELL BIOL, V136, P699, DOI 10.1007/s00418-011-0872-5; Yoshisue H, 2004, BIOSCI BIOTECH BIOCH, V68, P2024, DOI 10.1271/bbb.68.2024; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	35	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174764	10.1371/journal.pone.0174764	http://dx.doi.org/10.1371/journal.pone.0174764			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355261	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174600086
J	Gonzalez, R; De la Rosa, AJ; Rufini, A; Rodriguez-Hernandez, MA; Navarro-Villaran, E; Marchal, T; Pereira, S; De la Mata, M; Muller-Schilling, M; Pascasio-Acevedo, JM; Ferrer-Rios, MT; Gomez-Bravo, MA; Padillo, FJ; Muntane, J				Gonzalez, Raul; De la Rosa, Angel J.; Rufini, Alessandro; Rodriguez-Hernandez, Maria A.; Navarro-Villaran, Elena; Marchal, Trinidad; Pereira, Sheila; De la Mata, Manuel; Mueller-Schilling, Martina; Pascasio-Acevedo, Juan M.; Ferrer-Rios, Maria T.; Gomez-Bravo, Miguel A.; Padillo, Francisco J.; Muntane, Jordi			Role of p63 and p73 isoforms on the cell death in patients with hepatocellular carcinoma submitted to orthotopic liver transplantation	PLOS ONE			English	Article							P53 FAMILY; EXPRESSION; APOPTOSIS; PROTEINS; FLIP; CASPASE-8; PATHWAY; BINDING; GENE	Background & Aims Patients with hepatocellular carcinoma (HCC) submitted to orthotopic liver transplantation (OLT) have a variable 5-year survival rate limited mostly by tumor recurrence. The etiology, age, sex, alcohol, Child-Pugh, and the immunesuppressor have been associated with tumour recurrence. The expression of Delta Np73 is related to the reduced survival of patients with HCC. The study evaluated the expression of p63 and p73 isoforms and cell death receptors, and their relation to tumour recurrence and survival. The results were in vitro validated in HCC cell lines. Methods HCC sections from patients submitted to OLT were used. The in vitro study was done in differentiated hepatitis B virus (HBV)-expressing Hep3B and control HepG2 cells. The expression of cell death receptors and cFLIPS/L, caspase-8 and-3 activities, and cell proliferation were determined in control and p63 and p73 overexpressing HCC cells. Results The reduced tumor expression of cell death receptors and TAp63 and TAp73, and increased Delta Np63 and ANp73 expression were associated with tumor recurrence and reduced survival. The in vitro study demonstrated that HBV-expressing Hep3B vs HepG2 cells showed reduced expression of p63 and p73, cell death receptors and caspase activation, and increased cFLIP(L)/cFLIP(S) ratio. The overexpression of TAp63 and TAp73 exerted a more potent pro-apoptotic and anti-proliferative effects in Hep3B than HepG2-transfected cells which was related to cFLIP(L) upregulation. Conclusions The reduction of TAp63 and TAp73 isoforms, rather than alteration of Delta N isoform expression, exerted a significant functional repercussion on cell death and proliferation in HBV-expressing HepB cells.	[Gonzalez, Raul; De la Rosa, Angel J.; Rodriguez-Hernandez, Maria A.; Navarro-Villaran, Elena; Pereira, Sheila] Univ Seville, Hosp Univ Virgen del Rocio, IBiS, Inst Biomed Seville IBiS,CSIC, Seville, Spain; [Rufini, Alessandro] CRUK Leicester Canc, Dept Canc Studies, Leicester, Leics, England; [Marchal, Trinidad] Hosp Univ Reina Sofia, IMIBIC, Dept Pathol, Cordoba, Spain; [De la Mata, Manuel] Hosp Univ Reina Sofia, IMIBIC, Dept Gastroenterol, Cordoba, Spain; [De la Mata, Manuel; Pascasio-Acevedo, Juan M.; Ferrer-Rios, Maria T.; Gomez-Bravo, Miguel A.; Padillo, Francisco J.; Muntane, Jordi] CIBERehd, Madrid, Spain; [Mueller-Schilling, Martina] Univ Hosp Heidelberg, Gastroenterol & Hepatol Dept Internal Med 4, Heidelberg, Germany; [Pascasio-Acevedo, Juan M.; Ferrer-Rios, Maria T.] Univ Seville, Hosp Univ Virgen del Rocio, IBiS, Dept Gastroenterol,CSIC, Seville, Spain; [Gomez-Bravo, Miguel A.; Padillo, Francisco J.; Muntane, Jordi] Univ Seville, Hosp Univ Virgen del Rocio, IBiS, Dept Gen Surg,CSIC, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Ruprecht Karls University Heidelberg; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Muntane, J (corresponding author), CIBERehd, Madrid, Spain.; Muntane, J (corresponding author), Univ Seville, Hosp Univ Virgen del Rocio, IBiS, Dept Gen Surg,CSIC, Seville, Spain.	jmuntane-ibis@us.es	Navarro-Villarán, Elena/F-4699-2018; Padillo-Ruiz, Javier/AAF-9792-2021; Rodríguez-Hernández, Ángeles/K-9717-2015	Navarro-Villarán, Elena/0000-0003-0765-9089; Padillo-Ruiz, Javier/0000-0002-1220-0822; Rodríguez-Hernández, Ángeles/0000-0003-1846-0606; GOMEZ BRAVO, MIGUEL ANGEL/0000-0002-5155-3508	Institute de Salud Carlos III [PI13/00021]; Consejeria de Economia, Innovacion, Ciencia y Empleo [CTS-6264]; Consejeria de Salud [PI13/00025]; ERDF	Institute de Salud Carlos III(Instituto de Salud Carlos III); Consejeria de Economia, Innovacion, Ciencia y Empleo; Consejeria de Salud; ERDF(European Commission)	Institute de Salud Carlos III (PI13/00021), Consejeria de Economia, Innovacion, Ciencia y Empleo (CTS-6264) and Consejeria de Salud (PI13/00025). CIBERehd founded by Institute de Salud Carlos III and co-financed by European Development Regional Fund "A way to achieve Europe" ERDF for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini MR, 2004, ONCOGENE, V23, P6997, DOI 10.1038/sj.onc.1207925; Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Castillo J, 2009, GASTROENTEROLOGY, V137, P1805, DOI 10.1053/j.gastro.2009.07.065; Chang DW, 2002, EMBO J, V21, P3704, DOI 10.1093/emboj/cdf356; Courtois S, 2004, ONCOGENE, V23, P631, DOI 10.1038/sj.onc.1206929; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gonzalez R, 2013, ANTIOXID REDOX SIGN, V18, P491, DOI 10.1089/ars.2011.4476; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Hughes MA, 2016, MOL CELL, V61, P834, DOI 10.1016/j.molcel.2016.02.023; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Irwin MS, 2001, APOPTOSIS, V6, P17, DOI 10.1023/A:1009663809458; Kinoshita H, 2000, INT J CANCER, V88, P986, DOI 10.1002/1097-0215(20001215)88:6<986::AID-IJC23>3.0.CO;2-B; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Lee H, 2006, BIOCHEM BIOPH RES CO, V344, P166, DOI 10.1016/j.bbrc.2006.03.128; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llovet JM, 2005, SEMIN LIVER DIS, V25, P181, DOI 10.1055/s-2005-871198; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Minguez B, 2011, DIS MARKERS, V31, P181, DOI [10.1155/2011/310675, 10.3233/DMA-2011-0841]; Muller M, 2006, DRUG RESIST UPDATE, V9, P288, DOI 10.1016/j.drup.2007.01.001; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Mundt HM, 2010, BIOCHEM BIOPH RES CO, V396, P335, DOI 10.1016/j.bbrc.2010.04.093; Nakamura M, 2007, J HEPATOL, V46, P77, DOI 10.1016/j.jhep.2006.07.032; Park BJ, 2000, CANCER RES, V60, P3370; Petitjean A, 2005, ONCOGENE, V24, P512, DOI 10.1038/sj.onc.1208215; Ramalho FS, 2006, J GASTROEN HEPATOL, V21, P1276, DOI 10.1111/j.1440-1746.2006.04309.x; Rodriguez-Hernandez A, 2015, REDOX BIOL, V6, P174, DOI 10.1016/j.redox.2015.07.010; Sayan AE, 2001, ONCOGENE, V20, P5111, DOI 10.1038/sj.onc.1204669; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Seitz SJ, 2010, INT J CANCER, V126, P2049, DOI 10.1002/ijc.24861; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Stiewe T, 2004, CLIN CANCER RES, V10, P626, DOI 10.1158/1078-0432.CCR-0153-03; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Zaika AI, 2006, CELL DEATH DIFFER, V13, P935, DOI 10.1038/sj.cdd.4401897; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179	39	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174326	10.1371/journal.pone.0174326	http://dx.doi.org/10.1371/journal.pone.0174326			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350813	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174400025
J	Villa, PM; Marttinen, P; Gillberg, J; Lokki, AI; Majander, K; Orden, MR; Taipale, P; Pesonen, A; Raikkonen, K; Hamalainen, E; Kajantie, E; Laivuori, H				Villa, Pia M.; Marttinen, Pekka; Gillberg, Jussi; Lokki, A. Inkeri; Majander, Kerttu; Orden, Maija-Riitta; Taipale, Pekka; Pesonen, Anukatriina; Raikkonen, Katri; Hamalainen, Esa; Kajantie, Eero; Laivuori, Hannele			Cluster analysis to estimate the risk of preeclampsia in the high-risk Prediction and Prevention of Preeclampsia and Intrauterine Growth Restriction (PREDO) study	PLOS ONE			English	Article							PREGNANCY COMPLICATIONS; WOMEN; VALIDITY; REGISTRY; ASPIRIN	Objectives Preeclampsia is divided into early-onset (delivery before 34 weeks of gestation) and late-onset (delivery at or after 34 weeks) subtypes, which may rise from different etiopathogenic backgrounds. Early-onset disease is associated with placental dysfunction. Late-onset disease develops predominantly due to metabolic disturbances, obesity, diabetes, lipid dysfunction, and inflammation, which affect endothelial function. Our aim was to use cluster analysis to investigate clinical factors predicting the onset and severity of preeclampsia in a cohort of women with known clinical risk factors. Methods We recruited 903 pregnant women with risk factors for preeclampsia at gestational weeks 12(+0)-13(+6). Each individual outcome diagnosis was independently verified from medical records. We applied a Bayesian clustering algorithm to classify the study participants to clusters based on their particular risk factor combination. For each cluster, we computed the risk ratio of each disease outcome, relative to the risk in the general population. Results The risk of preeclampsia increased exponentially with respect to the number of risk factors. Our analysis revealed 25 number of clusters. Preeclampsia in a previous pregnancy (n = 138) increased the risk of preeclampsia 8.1 fold (95% confidence interval (CI) 5.711.2) compared to a general population of pregnant women. Having a small for gestational age infant (n = 57) in a previous pregnancy increased the risk of early-onset preeclampsia 17.5 fold (95%CI 2.160.5). Cluster of those two risk factors together (n = 21) increased the risk of severe preeclampsia to 23.8-fold (95%CI 5.160.6), intermediate onset (delivery between 34(+0)-36(+6) weeks of gestation) to 25.1-fold (95%CI 3.179.9) and preterm preeclampsia (delivery before 37(+0) weeks of gestation) to 16.4-fold (95%CI 2.052.4). Body mass index over 30 kg/m(2) (n = 228) as a sole risk factor increased the risk of preeclampsia to 2.1-fold (95%CI 1.13.6). Together with preeclampsia in an earlier pregnancy the risk increased to 11.4 (95%CI 4.520.9). Chronic hypertension (n = 60) increased the risk of preeclampsia 5.3-fold (95%CI 2.49.8), of severe preeclampsia 22.2-fold (95%CI 9.941.0), and risk of early-onset preeclampsia 16.7-fold (95%CI 2.057.6). If a woman had chronic hypertension combined with obesity, gestational diabetes and earlier preeclampsia, the risk of term preeclampsia increased 4.8-fold (95%CI 0.121.7). Women with type 1 diabetes mellitus had a high risk of all subgroups of preeclampsia. Conclusion The risk of preeclampsia increases exponentially with respect to the number of risk factors. Early-onset preeclampsia and severe preeclampsia have different risk profile from term preeclampsia.	[Villa, Pia M.; Laivuori, Hannele] Univ Helsinki, Obstet & Gynaecol, Helsinki, Finland; [Villa, Pia M.; Lokki, A. Inkeri; Hamalainen, Esa; Laivuori, Hannele] Helsinki Univ Hosp, Helsinki, Finland; [Marttinen, Pekka; Gillberg, Jussi] Aalto Univ, Helsinki Inst Informat Technol, Dept Comp Sci, Espoo, Finland; [Lokki, A. Inkeri] Univ Helsinki, Res Programs Unit, Immunobiol, Helsinki, Finland; [Lokki, A. Inkeri] Univ Helsinki, Med & Clin Genet, Helsinki, Finland; [Lokki, A. Inkeri] Univ Helsinki, Bacteriol & Immunol, Helsinki, Finland; [Majander, Kerttu] Univ Tubingen, Inst Archaeol Sci, Tubingen, Germany; [Orden, Maija-Riitta] Kuopio Univ Hosp, Obstet & Gynecol, Kuopio, Finland; [Taipale, Pekka] Suomen Terveystalo Oy, Kuopio, Finland; [Pesonen, Anukatriina; Raikkonen, Katri] Univ Helsinki, Dept Psychol & Logoped, Helsinki, Finland; [Hamalainen, Esa] Univ Helsinki, HUSLAB, Helsinki, Finland; [Kajantie, Eero] Natl Inst Hlth & Welf, Helsinki, Finland; [Kajantie, Eero] Natl Inst Hlth & Welf, Oulu, Finland; [Kajantie, Eero] Oulu Univ Hosp, MRC Oulu, PEDEGO Res Unit, Oulu, Finland; [Kajantie, Eero] Univ Oulu, Oulu, Finland; [Kajantie, Eero] Helsinki Univ Hosp, Childrens Hosp, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Helsinki, Finland; [Laivuori, Hannele] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Aalto University; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Eberhard Karls University of Tubingen; Kuopio University Hospital; University of Eastern Finland; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki	Villa, PM (corresponding author), Univ Helsinki, Obstet & Gynaecol, Helsinki, Finland.; Villa, PM (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	pia.villa@helsinki.fi	Lokki, A. Inkeri/H-4783-2019; Marttinen, Pekka E/N-6234-2015; Laivuori, Hannele/F-2953-2011	Lokki, A. Inkeri/0000-0003-4397-8415; Marttinen, Pekka E/0000-0001-7078-7927; Laivuori, Hannele/0000-0003-3212-7826; Pesonen, Anu-Katriina/0000-0002-0662-6261; Villa, Pia/0000-0002-0317-0713; Raikkonen, Katri/0000-0003-3124-3470	Academy of Finland [259272, 286607, 121196, 134957, 278941, 284859]; EVO; Finnish Medical Foundation; Jane and Aatos Erkko Foundation; Novo Nordisk Foundation; Paivikki and Sakari Sohlberg Foundation; Clinical Graduate School in Paediatrics and Obstetrics/Gynaecology in University of Helsinki; Signe and Ane Gylleberg Foundation	Academy of Finland(Academy of Finland); EVO; Finnish Medical Foundation; Jane and Aatos Erkko Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Paivikki and Sakari Sohlberg Foundation; Clinical Graduate School in Paediatrics and Obstetrics/Gynaecology in University of Helsinki; Signe and Ane Gylleberg Foundation	This work was supported by Academy of Finland (grants no. 259272, 286607 to PM, 121196, 134957, 278941 to HL, 284859 to KR and to AKP and EK), EVO (a special state subsidy for health science research) to EH, the Finnish Medical Foundation to HL, the Jane and Aatos Erkko Foundation to HL, the Novo Nordisk Foundation to EK, the Paivikki and Sakari Sohlberg Foundation to HL and PV, the Clinical Graduate School in Paediatrics and Obstetrics/Gynaecology in University of Helsinki to PV, the Signe and Ane Gylleberg Foundation to KR and EK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists, 2016, PRACT ADV LOW DOS AS; American College of Obstetricians and Gynecologists, 2014, HYP PREGN TASK FORC; Bishop Christopher M., 2006, PATTERN RECOGNITION; Bramham K, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.02.014; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Duley L, 2007, COCHRANE DB SYST REV; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Girchenko P, 2016, INT J EPIDEMIOL; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Klemmensen AK, 2007, AM J EPIDEMIOL, V166, P117, DOI 10.1093/aje/kwm139; Klungsoyr K, 2014, PAEDIATR PERINAT EP, V28, P362, DOI 10.1111/ppe.12138; Knight AK, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1068-z; Lisonkova S, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.08.019; Lowe SA, 2014, AUST NZ J OBSTET GYN; Magee LA, 2014, J OBSTET GYNAECOL CA, V36, P416, DOI 10.1016/S1701-2163(15)30588-0; Mostello D, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.11.058; Nadeau-Vallee M, 2016, REPRODUCTION, V152, pR277, DOI 10.1530/REP-16-0453; Naimy Z, 2015, BJOG-INT J OBSTET GY, V122, P859, DOI 10.1111/1471-0528.12978; National Institute of Health and Excellence, MAN HYP DIS PREGN; Nelson DB, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.010; Ness RB, 2006, AM J OBSTET GYNECOL, V195, P40, DOI 10.1016/j.ajog.2005.07.049; Ostensen M, 2013, CURR OPIN RHEUMATOL, V25, P591, DOI 10.1097/BOR.0b013e328363ebf7; Pesonen A, 2016, DEPRESSIVE ANXIETY S, V11; Pihkala J, 1989, Duodecim, V105, P1540; Rana S, 2013, HYPERTENS PREGNANCY, V32, P189, DOI 10.3109/10641955.2013.784788; Roberge S, 2012, AM J PERINAT, V29, P551, DOI 10.1055/s-0032-1310527; Roberge S, 2012, FETAL DIAGN THER, V31, P141, DOI 10.1159/000336662; Roberts JM, 2013, J REPROD IMMUNOL, V99, P1, DOI 10.1016/j.jri.2013.05.003; Staff AC, 2013, HYPERTENSION, V61, P932, DOI 10.1161/HYPERTENSIONAHA.111.00250; Villa PM, 2013, BJOG-INT J OBSTET GY, V120, P64, DOI 10.1111/j.1471-0528.2012.03493.x; Villa PM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-110; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; Wikstrom A, 2011, PREVIOUS PREECLAMPSI, V204, p148e1; World Health Organization, 2011, WHO REC PREV TREATM; Yogev Y, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.039	36	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174399	10.1371/journal.pone.0174399	http://dx.doi.org/10.1371/journal.pone.0174399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350823	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174400035
J	Cui, Y; Zeng, WJ; Yu, J; Lu, J; Hu, YN; Diao, N; Liang, B; Han, P; Shi, HS				Cui, Yue; Zeng, Wenjuan; Yu, Jie; Lu, Jing; Hu, Yuannan; Diao, Nan; Liang, Bo; Han, Ping; Shi, Heshui			Quantification of left coronary bifurcation angles and plaques by coronary computed tomography angiography for prediction of significant coronary stenosis: A preliminary study with dual-source CT	PLOS ONE			English	Article							FRACTIONAL FLOW RESERVE; INTRAVASCULAR ULTRASOUND; ARTERY BIFURCATION; SHEAR-STRESS; ATHEROSCLEROTIC PLAQUES; LESIONS; CONSENSUS; DISEASE	Purpose To evaluate the diagnostic performance of left coronary bifurcation angles and plaque characteristics for prediction of coronary stenosis by dual-source CT. Methods 106 patients suspected of coronary artery disease undergoing both coronary computed tomography angiography (CCTA) and invasive coronary angiography (CAG) within three months were included. Left coronary bifurcation angles including the angles between the left anterior descending artery and left circumflex artery (LAD-LCx), left main coronary artery and left anterior descending artery (LM-LAD), left main coronary artery and left circumflex artery (LM-LCx) were measured on CT images. CCTA plaque parameters were calculated by plaque analysis software. Coronary stenosis >= 50% by CAG was defined as significant. Results 106 patients with 318 left coronary bifurcation angles and 126 vessels were analyzed. The bifurcation angle of LAD-LCx was significantly larger in left coronary stenosis >= 50% than stenosis < 50%, and significantly wider in the non-calcified plaque group than calcified. Multivariable analyses showed the bifurcation angle of LAD-LCx was an independent predictor for significant left coronary stenosis (OR = 1.423, P = 0.002). In ROC curve analysis, LAD-LCx predicted significant left coronary stenosis with a sensitivity of 66.7%, specificity of 78.4%, positive predictive value of 85.2% and negative predictive value of 55.8%. The lipid plaque volume improved the diagnostic performance of CCTA diameter stenosis (AUC: 0.854 vs. 0.900, P = 0.045) in significant coronary stenosis. Conclusions The bifurcation angle of LAD-LCx could predict significant left coronary stenosis. Wider LAD-LCx is related to non-calcified lesions. Lipid plaque volume could improve the diagnostic performance of CCTA for coronary stenosis prediction.	[Cui, Yue; Yu, Jie; Hu, Yuannan; Diao, Nan; Liang, Bo; Han, Ping; Shi, Heshui] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Radiol, Wuhan, Peoples R China; [Zeng, Wenjuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Clin Lab, Wuhan, Peoples R China; [Lu, Jing] Xiamen Univ, Zhongshan Hosp, Dept Nucl Med, Xiamen, Fujian, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Xiamen University	Shi, HS (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Radiol, Wuhan, Peoples R China.	shiheshui2014@163.com	Yu, Jie/ABB-4105-2021; Zeng, Wen/GPS-8058-2022		National Natural Science Foundation of China [81271570]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (Grant No. 81271570).	Achenbach S, 2004, J AM COLL CARDIOL, V43, P842, DOI 10.1016/j.jacc.2003.09.053; Achenbach S, 2008, JACC-CARDIOVASC IMAG, V1, P177, DOI 10.1016/j.jcmg.2007.11.006; Chaichana T, 2011, J BIOMECH, V44, P1869, DOI 10.1016/j.jbiomech.2011.04.033; Cheng C, 2006, CIRCULATION, V113, P2744, DOI 10.1161/CIRCULATIONAHA.105.590018; Dey D, 2010, RADIOLOGY, V257, P516, DOI 10.1148/radiol.10100681; Diaz-Zamudio M, 2015, RADIOLOGY, V276, P408, DOI 10.1148/radiol.2015141648; Gaur S, 2016, EUR HEART J, V37, P1220, DOI 10.1093/eurheartj/ehv690; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Maurovich-Horvat P, 2014, NAT REV CARDIOL, V11, P390, DOI 10.1038/nrcardio.2014.60; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Murasato Y, 2007, CATHETER CARDIO INTE, V69, P248, DOI 10.1002/ccd.20916; Nadjiri J, 2016, J CARDIOVASC COMPUT, V10, P97, DOI 10.1016/j.jcct.2016.01.007; Opolski MP, 2014, EUR J RADIOL, V83, P135, DOI 10.1016/j.ejrad.2013.10.005; Papadopoulou SL, 2012, EUR HEART J-CARD IMG, V13, P635, DOI 10.1093/ehjci/jes083; Papadopoulou SL, 2011, ATHEROSCLEROSIS, V219, P163, DOI 10.1016/j.atherosclerosis.2011.07.005; Papafaklis MI, 2007, INT J CARDIOL, V115, P276, DOI 10.1016/j.ijcard.2006.04.030; Papafaklis MI, 2015, ATHEROSCLEROSIS, V240, P205, DOI 10.1016/j.atherosclerosis.2015.03.017; Pflederer T, 2006, INVEST RADIOL, V41, P793, DOI 10.1097/01.rli.0000239318.88270.9f; Salavati A, 2012, J CARDIOVASC COMPUT, V6, P78, DOI 10.1016/j.jcct.2011.10.018; Saremi F, 2015, AM J ROENTGENOL, V204, pW249, DOI 10.2214/AJR.14.13760; Stankovic G, 2013, EUROINTERVENTION, V9, P36, DOI 10.4244/EIJV9I1A7; Sun JY, 2008, AM J ROENTGENOL, V190, P748, DOI 10.2214/AJR.07.2763; Tesche C, 2016, J CARDIOVASC COMPUT, V10, P199, DOI 10.1016/j.jcct.2016.03.002	25	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174352	10.1371/journal.pone.0174352	http://dx.doi.org/10.1371/journal.pone.0174352			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346530	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174300040
J	Collins, PJ; McCully, ML; Martinez-Munoz, L; Santiago, C; Wheeldon, J; Caucheteux, S; Thelen, S; Cecchinato, V; Laufer, JM; Purvanov, V; Monneau, YR; Lortat-Jacob, H; Legler, DF; Uguccioni, M; Thelen, M; Piguet, V; Mellado, M; Moser, B				Collins, Paul J.; McCully, Michelle L.; Martinez-Munoz, Laura; Santiago, Cesar; Wheeldon, James; Caucheteux, Stephan; Thelen, Sylvia; Cecchinato, Valentina; Laufer, Julia M.; Purvanov, Vladimir; Monneau, Yoan R.; Lortat-Jacob, Hugues; Legler, Daniel F.; Uguccioni, Mariagrazia; Thelen, Marcus; Piguet, Vincent; Mellado, Mario; Moser, Bernhard			Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4	FASEB JOURNAL			English	Article						CXCR4; signal transduction; synergism; allosteric receptor modulation	CENTRAL-NERVOUS-SYSTEM; DENDRITIC CELLS; RECEPTOR 4; FACTOR-I; CONSTITUTIVE EXPRESSION; EMBRYONIC-DEVELOPMENT; SIGNAL-TRANSDUCTION; NMR-SPECTROSCOPY; B-CELL; MIGRATION	The chemokine receptor, CXC chemokine receptor 4 (CXCR4), is selective for CXC chemokine ligand 12 (CXCL12), is broadly expressed in blood and tissue cells, and is essential during embryogenesis and hematopoiesis. CXCL14 is a homeostatic chemokine with unknown receptor selectivity and preferential expression in peripheral tissues. Here, we demonstrate that CXCL14 synergized with CXCL12 in the induction of chemokine responses in primary human lymphoid cells and cell lines that express CXCR4. Combining subactive concentrations of CXCL12 with 100-300 nM CXCL14 resulted in chemotaxis responses that exceeded maximal responses that were obtained with CXCL12 alone. CXCL14 did not activate CXCR4-expressing cells (i.e., failed to trigger chemotaxis and Ca2+ mobilization, as well as signaling via ERK1/2 and the small GTPase Rac1); however, CXCL14 bound to CXCR4 with high affinity, induced redistribution of cell-surface CXCR4, and enhanced HIV-1 infection by >3-fold. We postulate that CXCL14 is a positive allosteric modulator of CXCR4 that enhances the potency of CXCR4 ligands. Our findings provide new insights that will inform the development of novel therapeutics that target CXCR4 in a range of diseases, including cancer, autoimmunity, and HIV. Collins, P. J., McCully, M. L., Martinez-Mufioz, L., Santiago, C., Wheeldon, J., Caucheteux, S., Thelen, S., Cecchinato, V., Laufer, J. M., Purvanov, V., Monneau, Y. R., Lortat-Jacob, H., Legler, D. F., Uguccioni, M., Thelen, M., Piguet, V., Mellado, M., Moser, B. Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4.	[Collins, Paul J.; McCully, Michelle L.; Wheeldon, James; Caucheteux, Stephan; Piguet, Vincent; Moser, Bernhard] Cardiff Univ, Sch Med, Div Infect & Immun, Cardiff, S Glam, Wales; [Martinez-Munoz, Laura; Santiago, Cesar; Mellado, Mario] CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain; [Thelen, Sylvia; Cecchinato, Valentina; Uguccioni, Mariagrazia; Thelen, Marcus] Univ Svizzera Italiana, Inst Res Biomed, Bellinzona, Switzerland; [Laufer, Julia M.; Purvanov, Vladimir; Legler, Daniel F.] Univ Konstanz, Biotechnol Inst Thurgau, Kreuzlingen, Switzerland; [Laufer, Julia M.; Purvanov, Vladimir; Legler, Daniel F.] Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany; [Monneau, Yoan R.; Lortat-Jacob, Hugues] Univ Grenoble Alpes, CNRS, CEA, Inst Biol Struct,Unite Mixtes Rech 5075, Grenoble, France; [Uguccioni, Mariagrazia] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Collins, Paul J.] Univ Birmingham, Birmingham, W Midlands, England	Cardiff University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Universita della Svizzera Italiana; University of Konstanz; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Milan; University of Birmingham	Moser, B (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Henry Wellcome Bldg Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	moserb@cardiff.ac.uk	Monneau, Yoan Rocky/GQQ-2938-2022; Mellado, Mario/M-9893-2014; Martínez-Muñoz, Laura/C-2719-2017; Santiago, Cesar/K-4240-2014	Monneau, Yoan Rocky/0000-0003-0773-6603; Mellado, Mario/0000-0001-6325-1630; Martínez-Muñoz, Laura/0000-0003-3098-279X; Cecchinato, Valentina/0000-0001-7415-8706; Moser, Bernhard/0000-0002-4354-4572; Piguet, Vincent/0000-0001-6079-4517; Legler, Daniel F./0000-0001-8610-4764; Uguccioni, Mariagrazia/0000-0002-9570-7011; Santiago, Cesar/0000-0002-5149-1722; Collins, Paul/0000-0003-2325-3265	Medical Research Council [MR/L018284/1]; Spanish Ministry of Economy and Competitiveness [SAF-2014-53416-R]; Networks for Cooperative Research in Health Program (RETICS) [RD 12/0009/009 RIER]; ComFuturo Program from Spanish Research Council General Foundation; Swiss National Science Foundation [SNF 31003A_169936, SNF3100A0-143718/1]; Agence Nationale de la Recherche [ANR-NT05-4-41968-Chemoglycan]; Grenoble Instruct Centre (CNRS-CEA-UJF-EMBL) [UMS 3518]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-02]; Grenoble Alliance for Structural Biology Funding (GRAL) [ANR-10-LABX-49-01]; Cardiff University Infection and Immunity Institutional Ph.D. Scholarship; Royal Society Wolfson Research Merit Award; MRC [MR/L018284/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Spanish Ministry of Economy and Competitiveness(Spanish Government); Networks for Cooperative Research in Health Program (RETICS); ComFuturo Program from Spanish Research Council General Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Grenoble Instruct Centre (CNRS-CEA-UJF-EMBL); French Infrastructure for Integrated Structural Biology (FRISBI); Grenoble Alliance for Structural Biology Funding (GRAL); Cardiff University Infection and Immunity Institutional Ph.D. Scholarship; Royal Society Wolfson Research Merit Award(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (MR/L018284/1 to B.M.), the Spanish Ministry of Economy and Competitiveness (SAF-2014-53416-R), and the Networks for Cooperative Research in Health Program (RETICS; RD 12/0009/009 RIER to M.M., L.M.-M., and C.S.). L.M.-M. is supported by the ComFuturo Program from the Spanish Research Council General Foundation, the Swiss National Science Foundation (SNF 31003A_169936 to D.F.L., and SNF3100A0-143718/1 to M.U.), the Agence Nationale de la Recherche (ANR-NT05-4-41968-Chemoglycan to H.L.-J.), with additional support from the Grenoble Instruct Centre (UMS 3518 CNRS-CEA-UJF-EMBL), the French Infrastructure for Integrated Structural Biology (FRISBI; ANR-10-INSB-05-02), and Grenoble Alliance for Structural Biology Funding (GRAL; ANR-10-LABX-49-01). P.J.C. is a recipient of a Cardiff University Infection and Immunity Institutional Ph.D. Scholarship, and B.M. is the recipient of a Royal Society Wolfson Research Merit Award.	Agace WW, 2000, CURR BIOL, V10, P325, DOI 10.1016/S0960-9822(00)00380-8; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Cao XT, 2000, J IMMUNOL, V165, P2588, DOI 10.4049/jimmunol.165.5.2588; Cecchinato V, 2016, J LEUKOCYTE BIOL, V99, P851, DOI 10.1189/jlb.1MR1015-457R; Christopoulos A, 2014, MOL PHARMACOL, V86, P463, DOI 10.1124/mol.114.094342; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; De Clercq E, 2009, BIOCHEM PHARMACOL, V77, P1655, DOI 10.1016/j.bcp.2008.12.014; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Frederick MJ, 2000, AM J PATHOL, V156, P1937, DOI 10.1016/S0002-9440(10)65067-5; Garcia-Andres C, 2010, DEV DYNAM, V239, P2769, DOI 10.1002/dvdy.22413; Gordon CT, 2011, INT J DEV BIOL, V55, P335, DOI 10.1387/ijdb.103258cg; Gouwy M, 2012, IMMUNOL LETT, V145, P10, DOI 10.1016/j.imlet.2012.04.005; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Handel TM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00282; Hara T, 2012, J BIOCHEM, V151, P469, DOI 10.1093/jb/mvs030; Hauser MA, 2016, IMMUNITY, V44, P59, DOI 10.1016/j.immuni.2015.12.010; Hevezi P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006395; Hromas R, 1999, BIOCHEM BIOPH RES CO, V255, P703, DOI 10.1006/bbrc.1999.0257; Kleist AB, 2016, BIOCHEM PHARMACOL, V114, P53, DOI 10.1016/j.bcp.2016.04.007; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Kurth I, 2001, J EXP MED, V194, P855, DOI 10.1084/jem.194.6.855; Laguri C, 2011, J AM CHEM SOC, V133, P9642, DOI 10.1021/ja201753e; Loetscher P, 2001, J LEUKOCYTE BIOL, V69, P881; Loetscher P, 1998, J BIOL CHEM, V273, P22279, DOI 10.1074/jbc.273.35.22279; Lu J, 2016, J INFLAMM-LOND, V13, DOI 10.1186/s12950-015-0109-9; Maerki C, 2009, J IMMUNOL, V182, P507, DOI 10.4049/jimmunol.182.1.507; Martinez LB, 2009, J NEUROIMMUNE PHARM, V4, P116, DOI 10.1007/s11481-008-9140-4; Martinez-Munoz L, 2014, P NATL ACAD SCI USA, V111, pE1960, DOI 10.1073/pnas.1322887111; Mazzucchelli L, 1999, J CLIN INVEST, V104, pR49, DOI 10.1172/JCI7830; McCully ML, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00033; Meuter S, 2007, MOL CELL BIOL, V27, P983, DOI 10.1128/MCB.01648-06; Meuter S, 2008, CYTOKINE, V44, P248, DOI 10.1016/j.cyto.2008.08.009; Mokhtar NM, 2010, MOL HUM REPROD, V16, P170, DOI 10.1093/molehr/gap100; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Moser B, 1997, TRENDS MICROBIOL, V5, P88, DOI 10.1016/S0966-842X(97)01019-6; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nagasawa T, 2014, J MOL MED, V92, P433, DOI 10.1007/s00109-014-1123-8; Nara N, 2007, J BIOL CHEM, V282, P30794, DOI 10.1074/jbc.M700412200; Niggli V, 2014, INT REV CEL MOL BIO, V312, P201, DOI 10.1016/B978-0-12-800178-3.00007-5; Nomiyama H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-222; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Ogilvie P, 2004, J IMMUNOL, V172, P6715, DOI 10.4049/jimmunol.172.11.6715; Ojeda AF, 2013, GENE EXPR PATTERNS, V13, P303, DOI 10.1016/j.gep.2013.05.006; Otte M, 2014, FEBS LETT, V588, P4769, DOI 10.1016/j.febslet.2014.11.009; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; Proudfoot AEI, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00183; Salogni L, 2009, BLOOD, V113, P5848, DOI 10.1182/blood-2008-12-194597; Schaerli P, 2005, IMMUNITY, V23, P331, DOI 10.1016/j.immuni.2005.08.012; Shellenberger TD, 2004, CANCER RES, V64, P8262, DOI 10.1158/0008-5472.CAN-04-2056; Shurin GV, 2005, J IMMUNOL, V174, P5490, DOI 10.4049/jimmunol.174.9.5490; Sleeman MA, 2000, INT IMMUNOL, V12, P677, DOI 10.1093/intimm/12.5.677; Stanford MM, 2003, J LEUKOCYTE BIOL, V74, P791, DOI 10.1189/jlb.1102547; Starnes T, 2006, EXP HEMATOL, V34, P1101, DOI 10.1016/j.exphem.2006.05.015; Struyf S, 2005, EUR J IMMUNOL, V35, P1583, DOI 10.1002/eji.200425753; Tan SY, 2015, IMMUNOL CELL BIOL, V93, P337, DOI 10.1038/icb.2015.16; Tanegashima K, 2013, FEBS LETT, V587, P3770, DOI 10.1016/j.febslet.2013.10.017; Tanegashima K, 2013, FEBS LETT, V587, P1731, DOI 10.1016/j.febslet.2013.04.046; Tanegashima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010321; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Thelen M, 2010, CURR OPIN PHARMACOL, V10, P38, DOI 10.1016/j.coph.2009.09.004; Tilton B, 2000, J EXP MED, V192, P313, DOI 10.1084/jem.192.3.313; Vega B, 2011, J LEUKOCYTE BIOL, V90, P399, DOI 10.1189/jlb.1010565; Venetz D, 2010, INT J CANCER, V127, P2300, DOI 10.1002/ijc.25236; Wescott MP, 2016, P NATL ACAD SCI USA, V113, P9928, DOI 10.1073/pnas.1601278113; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Wolf M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00213; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b; Zwijnenburg PJG, 2003, IMMUNOL LETT, V85, P1, DOI 10.1016/S0165-2478(02)00200-6	70	37	38	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3084	3097		10.1096/fj.201700013R	http://dx.doi.org/10.1096/fj.201700013R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28360196	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000405931000032
J	Cao, Q; Yang, YM; Zhong, XZ; Dong, XP				Cao, Qi; Yang, Yiming; Zhong, Xi Zoe; Dong, Xian-Ping			The lysosomal Ca2+ release channel TRPML1 regulates lysosome size by activating calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-PORE CHANNELS; ION-CHANNEL; STORAGE DISEASES; CALCIUM-RELEASE; MEMBRANE-FUSION; LUMINAL PH; NAADP; MUCOLIPIDOSIS; TRAFFICKING; PATHWAY	Intracellular lysosomal membrane trafficking, including fusion and fission, is crucial for cellular homeostasis and normal cell function. Both fusion and fission of lysosomal membrane are accompanied by lysosomal Ca2+ release. We recently have demonstrated that the lysosomal Ca2+ release channel P2X4 regulates lysosome fusion through a calmodulin (CaM)-dependent mechanism. However, the molecular mechanism underlying lysosome fission remains uncertain. In this study, we report that enlarged lysosomes/vacuoles induced by either vacuolin-1 or P2X4 activation are suppressed by up-regulating the lysosomal Ca2+ release channel transient receptor potential mucolipin 1 (TRPML1) but not the lysosomal Na+ release channel two-pore channel 2 (TPC2). Activation of TRPML1 facilitated the recovery of enlarged lysosomes/vacuoles. Moreover, the effects of TRPML1 on lysosome/vacuole size regulation were eliminated by Ca2+ chelation, suggesting a requirement for TRPML1-mediated Ca2+ release. We further demonstrate that the prototypical Ca2+ sensor CaM is required for the regulation of lysosome/vacuole size by TRPML1, suggesting that TRPML1 may promote lysosome fission by activating CaM. Given that lysosome fission is implicated in both lysosome biogenesis and reformation, our findings suggest that TRPML1 may function as a key lysosomal Ca2+ channel controlling both lysosome biogenesis and reformation.	[Cao, Qi; Yang, Yiming; Zhong, Xi Zoe; Dong, Xian-Ping] Dalhousie Univ, Dept Physiol & Biophys, Sir Charles Tupper Med Bldg,5850 Coll St, Halifax, NS B3H 4R2, Canada	Dalhousie University	Dong, XP (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, Sir Charles Tupper Med Bldg,5850 Coll St, Halifax, NS B3H 4R2, Canada.	xpdong@dal.ca	Yang, Yiming/X-3444-2019	Yang, Yiming/0000-0002-6716-8014; Dong, Xianping/0000-0002-4496-7104	Department of Physiology and Biophysics; Dalhousie University; Dalhousie Medical Research Foundation (DMRF) Equipment Grant; DMRF new investigator award; Canadian Institutes of Health Research Grant [MOP-119349]; Canadian Institutes of Health Research New Investigator Award [201109MSH261462-208625]; Nova Scotia Health Research Foundation (NSHRF) Establishment Grant [MED-PRO-2011-7485]; Canada Foundation for Innovation (CFI) Leaders Opportunity Fund for Research Infrastructure Grant [29291]	Department of Physiology and Biophysics; Dalhousie University; Dalhousie Medical Research Foundation (DMRF) Equipment Grant; DMRF new investigator award; Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation (NSHRF) Establishment Grant; Canada Foundation for Innovation (CFI) Leaders Opportunity Fund for Research Infrastructure Grant	This work was supported by start-up funds ( to X.-P. D.) from the Department of Physiology and Biophysics, Dalhousie University, Dalhousie Medical Research Foundation (DMRF) Equipment Grant, DMRF new investigator award, Canadian Institutes of Health Research Grant MOP-119349, Canadian Institutes of Health Research New Investigator Award 201109MSH261462-208625, Nova Scotia Health Research Foundation (NSHRF) Establishment Grant MED-PRO-2011-7485, and Canada Foundation for Innovation (CFI) Leaders Opportunity Fund for Research Infrastructure Grant 29291. The authors declare that they have no conflicts of interest with the contents of this article.	Baars TL, 2007, MOL BIOL CELL, V18, P3873, DOI 10.1091/mbc.E07-03-0205; Bakker AC, 1997, J CELL SCI, V110, P2227; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Campbell EM, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-40; Cang CL, 2014, NAT CHEM BIOL, V10, P463, DOI 10.1038/nchembio.1522; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Cao Q, 2015, J CELL BIOL, V209, P879, DOI 10.1083/jcb.201409071; Cao Q, 2015, DEV CELL, V33, P427, DOI 10.1016/j.devcel.2015.04.010; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Cheng XP, 2014, NAT MED, V20, P1187, DOI 10.1038/nm.3611; Cheng XP, 2010, FEBS LETT, V584, P2013, DOI 10.1016/j.febslet.2009.12.056; Christensen KA, 2002, J CELL SCI, V115, P599; Clarke CE, 2000, J PHYSIOL-LONDON, V523, P697, DOI 10.1111/j.1469-7793.2000.00697.x; Colombo MI, 1997, J BIOL CHEM, V272, P7707, DOI 10.1074/jbc.272.12.7707; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dayam RM, 2015, TRAFFIC, V16, P1010, DOI 10.1111/tra.12303; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Efe JA, 2005, CURR OPIN CELL BIOL, V17, P402, DOI 10.1016/j.ceb.2005.06.002; Evans EL, 2010, BIOCHEM SOC T, V38, P1458, DOI 10.1042/BST0381458; Galione A, 2015, CELL CALCIUM, V58, P27, DOI 10.1016/j.ceca.2014.09.010; Grimm C, 2010, CHEM BIOL, V17, P135, DOI 10.1016/j.chembiol.2009.12.016; Guse AH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002890; Hay JC, 2007, EMBO REP, V8, P236, DOI 10.1038/sj.embor.7400921; Huang P, 2014, J BIOL CHEM, V289, P17658, DOI 10.1074/jbc.M114.552158; Huynh C, 2005, EMBO REP, V6, P843, DOI 10.1038/sj.embor.7400495; Jha A, 2014, EMBO J, V33, P501, DOI 10.1002/embj.201387035; Kilpatrick BS, 2016, J CELL SCI, V129, P3859, DOI 10.1242/jcs.190322; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Lee JH, 2015, TISSUE ENG REGEN MED, V12, P90, DOI 10.1007/s13770-015-0102-7; Li RJ, 2016, ELIFE, V5, DOI 10.7554/eLife.19360; Li XR, 2016, NAT CELL BIOL, V18, P404, DOI 10.1038/ncb3324; Lloyd-Evans E, 2011, CELL CALCIUM, V50, P200, DOI 10.1016/j.ceca.2011.03.010; Lu YY, 2014, AUTOPHAGY, V10, P1895, DOI 10.4161/auto.32200; Luzio JP, 2007, BIOCHEM SOC T, V35, P1088, DOI 10.1042/BST0351088; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Miedel MT, 2008, J EXP MED, V205, P1477, DOI 10.1084/jem.20072194; Miller A, 2015, TRAFFIC, V16, P284, DOI 10.1111/tra.12249; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; Patel S, 2011, CELL CALCIUM, V50, P157, DOI 10.1016/j.ceca.2011.03.011; Peri F, 2008, CELL, V133, P916, DOI 10.1016/j.cell.2008.04.037; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Piper RC, 2004, TRENDS CELL BIOL, V14, P471, DOI 10.1016/j.tcb.2004.07.010; Pitt SJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004854; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Pittman JK, 2011, CELL CALCIUM, V50, P139, DOI 10.1016/j.ceca.2011.01.004; Priel A, 2004, J GEN PHYSIOL, V123, P281, DOI 10.1085/jgp.200308986; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Puertollano R, 2009, AM J PHYSIOL-RENAL, V296, pF1245, DOI 10.1152/ajprenal.90522.2008; Ruas M, 2015, EMBO J, V34, P1743, DOI 10.15252/embj.201490009; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; Shen DB, 2011, BIOESSAYS, V33, P448, DOI 10.1002/bies.201000152; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Thompson EG, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-54; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; Venkatachalam K, 2015, CELL CALCIUM, V58, P48, DOI 10.1016/j.ceca.2014.10.008; Vergarajauregui S, 2009, J BIOL CHEM, V284, P36357, DOI 10.1074/jbc.M109.047241; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Xu M, 2013, AM J PHYSIOL-CELL PH, V304, pC458, DOI 10.1152/ajpcell.00342.2012; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200; Zhang F, 2011, AM J PHYSIOL-CELL PH, V301, pC421, DOI 10.1152/ajpcell.00393.2010; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P11384, DOI 10.1073/pnas.1202194109	73	56	57	4	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8424	8435		10.1074/jbc.M116.772160	http://dx.doi.org/10.1074/jbc.M116.772160			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28360104	Green Published, hybrid			2022-12-26	WOS:000401788600026
J	Kashefiolasl, S; Brawanski, N; Platz, J; Bruder, M; Senft, C; Marquardt, G; Seifert, V; Tritt, S; Konczalla, J				Kashefiolasl, Sepide; Brawanski, Nina; Platz, Johannes; Bruder, Markus; Senft, Christian; Marquardt, Gerhard; Seifert, Volker; Tritt, Stephanie; Konczalla, Juergen			MRI-detection rate and incidence of lumbar bleeding sources in 190 patients with nonaneurysmal SAH	PLOS ONE			English	Article							SPONTANEOUS SUBARACHNOID HEMORRHAGE; DIGITAL-SUBTRACTION-ANGIOGRAPHY; PROGNOSTIC-FACTORS	Background Up to 15% of all spontaneous subarachnoid hemorrhages (SAH) have a non-aneurysmal SAH (NASAH). The evaluation of SAH patients with negative digital subtraction angiography (DSA) is sometimes a diagnostic challenge. Our goal in this study was to reassess the yield of standard MR-imaging of the complete spinal axis to rule out spinal bleeding sources in patients with NASAH. Methods We retrospectively analyzed the spinal MRI findings in 190 patients with spontaneous NASAH, containing perimesencephalic (PM) and non-perimesencephalic (NPM) SAH, diagnosed by computer tomography (CT) and/or lumbar puncture (LP), and negative 2nd DSA. Results 190 NASAH patients were included in the study, divided into PM-SAH (n = 87; 46%) and NPM-SAH (n = 103; 54%). Overall, 23 (22%) patients had a CT negative SAH, diagnosed by positive LP. MR-imaging of the spinal axis detected two patients with lumbar ependymoma (n = 2; 1,05%). Both patients complained of radicular sciatic pain. The detection rate raised up to 25%, if only patients with radicular sciatic pain received an MRI. Conclusion Routine radiological investigation of the complete spinal axis in NASAH patients is expensive and can not be recommended for standard procedure. However, patients with clinical signs of low-back/sciatic pain should be worked up for a spinal pathology.	[Kashefiolasl, Sepide; Brawanski, Nina; Platz, Johannes; Bruder, Markus; Senft, Christian; Marquardt, Gerhard; Seifert, Volker; Konczalla, Juergen] Goethe Univ, Dept Neurosurg, Frankfurt, Germany; [Tritt, Stephanie] Goethe Univ, Inst Neuroradiol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Kashefiolasl, S (corresponding author), Goethe Univ, Dept Neurosurg, Frankfurt, Germany.	Sepide.Kashefiolasi@kgu.de	Senft, Christian/F-4252-2010; Brawanski, Nina/AAL-7455-2020; Kashefiolasl, Sepide/AAI-1749-2019; Konczalla, Juergen/AAJ-8528-2021	Senft, Christian/0000-0003-1288-6913; Brawanski, Nina/0000-0003-1502-4980; Tritt, Stephanie/0000-0003-1428-8618; Konczalla, Juergen/0000-0001-9771-7806				Agid R, 2010, AM J NEURORADIOL, V31, P696, DOI 10.3174/ajnr.A1884; Bakker NA, 2014, J NEUROSURG, V120, P99, DOI 10.3171/2013.9.JNS131337; Beseoglu K, 2010, ACTA NEUROCHIR, V152, P409, DOI 10.1007/s00701-009-0518-8; Cairns CJS, 2003, ANAESTH INTENS CARE, V31, P87, DOI 10.1177/0310057X0303100117; CERVONI L, 1995, NEUROSURG REV, V18, P61, DOI 10.1007/BF00416480; Chen HC, 2008, SURG NEUROL, V70, P213, DOI 10.1016/j.surneu.2007.04.003; CUMMINGS TM, 1994, AM J ROENTGENOL, V162, P959, DOI 10.2214/ajr.162.4.8141025; Dalyai R, 2013, NEUROSURGERY, V72, P646, DOI 10.1227/NEU.0b013e3182846de8; Fassett DR, 2009, COMMUNICATION; Germans MR, 2008, J NEUROL, V255, P1910, DOI 10.1007/s00415-009-0021-4; Germans MR, 2015, NEUROLOGY, V84, P1337, DOI 10.1212/WNL.0000000000001423; Germans MR, 2014, J NEUROL, V261, P2199, DOI 10.1007/s00415-014-7480-y; Jung JY, 2006, J CLIN NEUROSCI, V13, P1011, DOI 10.1016/j.jocn.2005.09.007; Kalra VB, 2015, STROKE, V46, P401, DOI 10.1161/STROKEAHA.114.007370; Khan AA, 2013, CLIN NEUROL NEUROSUR, V115, P1470, DOI 10.1016/j.clineuro.2013.02.002; Kim Tae Jin, 2016, Korean J Neurotrauma, V12, P159, DOI 10.13004/kjnt.2016.12.2.159; Konczalla J, 2015, EUR J NEUROL, V22, P1329, DOI 10.1111/ene.12762; Konczalla J, 2016, J NEUROSURG, V124, P1731, DOI 10.3171/2015.5.JNS15161; Konczalla J, 2015, NEUROSURG REV, V38, P121, DOI 10.1007/s10143-014-0568-0; Konczalla J, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-140; Little AS, 2007, NEUROSURGERY, V61, P1139, DOI 10.1227/01.neu.0000306091.30517.e7; Nicastro N, 2013, CASE REP NEUROL MED, V2013, DOI 10.1155/2013/701820; Schievink WI, 1997, STROKE, V28, P2572; Ulrich CT, 2008, ACTA NEUROCHIR, V150, P185, DOI 10.1007/s00701-007-1407-7; van Beijnum J, 2007, J NEUROL, V254, P1044, DOI 10.1007/s00415-006-0485-4; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; WALTON JN, 1953, NEUROLOGY, V3, P517, DOI 10.1212/WNL.3.7.517; Wijdicks EFM, 1997, NEUROLOGY, V49, P634, DOI 10.1212/WNL.49.2.634	28	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174734	10.1371/journal.pone.0174734	http://dx.doi.org/10.1371/journal.pone.0174734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369075	Green Published, Green Submitted, gold			2022-12-26	WOS:000399351000039
J	Nakamura, A; Tochio, N; Fujioka, S; Ito, S; Kigawa, T; Shimada, Y; Matsuoka, M; Yoshida, S; Kinoshita, T; Asami, T; Seto, H; Nakano, T				Nakamura, Ayako; Tochio, Naoya; Fujioka, Shozo; Ito, Shinsaku; Kigawa, Takanori; Shimada, Yukihisa; Matsuoka, Makoto; Yoshida, Shigeo; Kinoshita, Toshinori; Asami, Tadao; Seto, Hideharu; Nakano, Takeshi			Molecular actions of two synthetic brassinosteroids, iso-carbaBL and 6-deoxoBL, which cause altered physiological activities between Arabidopsis and rice	PLOS ONE			English	Article							PLANT-GROWTH; RECEPTOR; BRASSINOLIDE; CASTASTERONE; CYTOCHROME-P450; ELONGATION; PERCEPTION; CYP85A2; GENES; AMBER	Brassinosteroid (BR) is an important plant hormone that is perceived by the BRASSINOS-TEROID INSENSITIVE 1 (BRI1) receptor. BRI1 is conserved among dicot and monocot species; however, the molecular mechanism underlying BR perception in monocots is not fully understood. We synthesised two BRs, iso-carbabrassinolide (iso-carbaBL) and 6-deoxoBL, which have different BR activities in Arabidopsis thaliana (Arabidopsis) and rice. Our bioassay indicated that iso-carbaBL has relatively strong BR activity in Arabidopsis, but is inactive in rice and competitively inhibits BR activity. The bioactivity of 6-deoxoBL was similar to that of BL in Arabidopsis, but was much lower in rice. Binding experiments using recombinant Arabidopsis and rice BRI1 protein fragments suggested that iso-carbaBL and 6-deoxoBL bind to both receptors. These results showed that iso-carbaBL and 6-deoxoBL act as an antagonist and agonist, respectively, of BRs in rice. A docking simulation analysis suggested that iso-carbaBL fits deeper in the binding pocket to block the binding of active BR to rice BRI1. The simulated binding energy of 6-deoxoBL with rice BRI1 is much lower than that with Arabidopsis BRI1. The possible structural characteristics of rice BRI1 were determined based on the difference in the BR activities of iso-carbaBL and 6-deoxoBL in Arabidopsis and rice.	[Nakamura, Ayako; Fujioka, Shozo; Yoshida, Shigeo; Seto, Hideharu; Nakano, Takeshi] RIKEN, Wako, Saitama, Japan; [Tochio, Naoya; Kigawa, Takanori] RIKEN, Syst & Struct Biol Ctr, Yokohama, Kanagawa, Japan; [Ito, Shinsaku; Asami, Tadao] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Shimada, Yukihisa] RIKEN, Plant Sci Ctr, Yokohama, Kanagawa, Japan; [Matsuoka, Makoto] Nagoya Univ, Biosci & Biotechnol Ctr, Chikusa Ku, Nagoya, Aichi, Japan; [Kinoshita, Toshinori] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi, Japan; [Asami, Tadao; Nakano, Takeshi] JST CREST, Kawaguchi, Saitama, Japan; [Nakamura, Ayako; Shimada, Yukihisa] Yokohama City Univ, Kihara Inst Biol Res, Totsuka Ku, 641-12 Maioka, Yokohama, Kanagawa, Japan; [Tochio, Naoya] Hiroshima Univ, Reseach Ctr Math Chromatin Live Dynam RcMcD, Higashihiroshima, Japan; [Kinoshita, Toshinori] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi, Japan; [Nakano, Takeshi] RIKEN, CSRS, Wako, Saitama, Japan	RIKEN; RIKEN; University of Tokyo; RIKEN; Nagoya University; Nagoya University; Japan Science & Technology Agency (JST); Yokohama City University; Hiroshima University; Nagoya University; RIKEN	Nakamura, A (corresponding author), RIKEN, Wako, Saitama, Japan.; Nakamura, A (corresponding author), Yokohama City Univ, Kihara Inst Biol Res, Totsuka Ku, 641-12 Maioka, Yokohama, Kanagawa, Japan.	aynakamu@yokohama-cu.ac.jp	Shimada, Yukihisa/D-8879-2016; Kinoshita, Toshinori/C-2891-2012; Nakano, Takeshi/E-9171-2013; Kigawa, Takanori/A-7679-2010	Shimada, Yukihisa/0000-0001-7497-9408; Kinoshita, Toshinori/0000-0001-7621-1259; Nakano, Takeshi/0000-0002-3188-7770; Kigawa, Takanori/0000-0003-0146-9719	Japan Society for the Promotion of Science [05J07571]; Program for Promotion of Basic Research Activities for Innovation Biosciencefor; CREST; Japan Science and Technology Agency; Platform for Dynamic Approaches to Living System from Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Basic Research Activities for Innovation Biosciencefor; CREST(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Platform for Dynamic Approaches to Living System from Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html) for AN (grant No. 05J07571), the Program for Promotion of Basic Research Activities for Innovation Biosciencefor (this program was transferred to http://www.naro.affrc.go.jp/english/brian/index.html) TN and TA (no grant No. was given), CREST (http://www.jst.go.jp/kisoken/crest/en/index.html), Japan Science and Technology Agency for TN and TA (no grant No. was given), and Platform for Dynamic Approaches to Living System from Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan for NT (no grant No. was given and this program was transferred to Japan Agency for Medical Research and Development and the grant HP has been expired).	Baron DL, 1998, PHYTOCHEMISTRY, V49, P1849, DOI 10.1016/S0031-9422(98)00367-7; Case D, 2006, AMBER 9; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Clouse SD, 1996, PLANT J, V10, P1, DOI 10.1046/j.1365-313X.1996.10010001.x; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; GROVE MD, 1979, NATURE, V281, P216, DOI 10.1038/281216a0; He JX, 2005, SCIENCE, V307, P1634, DOI 10.1126/science.1107580; Hothorn M, 2011, NATURE, V474, P467, DOI 10.1038/nature10153; Kim BK, 2008, BIOCHEM BIOPH RES CO, V374, P614, DOI 10.1016/j.bbrc.2008.07.073; Kim TW, 2005, PLANT CELL, V17, P2397, DOI 10.1105/tpc.105.033738; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Muto T, 2013, BIOORGAN MED CHEM, V21, P4413, DOI 10.1016/j.bmc.2013.04.048; Nakamura A, 2006, PLANT PHYSIOL, V140, P580, DOI 10.1104/pp.105.072330; Nomura T, 2005, J BIOL CHEM, V280, P17873, DOI 10.1074/jbc.M414592200; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; Seto H, 2002, TETRAHEDRON, V58, P9741, DOI 10.1016/S0040-4020(02)01247-4; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Sun YD, 2013, CELL RES, V23, P1326, DOI 10.1038/cr.2013.131; Suzuki M, 2015, PLANT CELL REP, V34, P1343, DOI 10.1007/s00299-015-1791-z; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Takeuchi J, 2014, NAT CHEM BIOL, V10, P477, DOI [10.1038/NCHEMBIO.1524, 10.1038/nchembio.1524]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Yamamuro C, 2000, PLANT CELL, V12, P1591, DOI 10.1105/tpc.12.9.1591; YOKOTA T, 1982, TETRAHEDRON LETT, V23, P1275, DOI 10.1016/S0040-4039(00)87081-1	30	3	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174015	10.1371/journal.pone.0174015	http://dx.doi.org/10.1371/journal.pone.0174015			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369122	Green Submitted, Green Published, gold			2022-12-26	WOS:000399351000012
J	Kolte, SW; Larcombe, SD; Jadhao, SG; Magar, SP; Warthi, G; Kurkure, NV; Glass, EJ; Shiels, BR				Kolte, Sunil W.; Larcombe, Stephen D.; Jadhao, Suresh G.; Magar, Swapnil P.; Warthi, Ganesh; Kurkure, Nitin V.; Glass, Elizabeth J.; Shiels, Brian R.			PCR diagnosis of tick-borne pathogens in Maharashtra state, India indicates fitness cost associated with carrier infections is greater for crossbreed than native cattle breeds	PLOS ONE			English	Article							LINEAR MIXED MODELS; THEILERIA-ORIENTALIS; ANAPLASMA-MARGINALE; HOST-RESISTANCE; ANNULATA; TRANSMISSION; TOLERANCE; BUFFALOS; PARASITE; BABESIA	Tick-borne pathogens (TBP) are responsible for significant economic losses to cattle production, globally. This is particularly true in countries like India where TBP constrain rearing of high yielding Bos taurus, as they show susceptibility to acute tick borne disease (TBD), most notably tropical theileriosis caused by Theileria annulata. This has led to a programme of cross breeding Bos taurus (Holstein-Friesian or Jersey) with native Bos indicus (numerous) breeds to generate cattle that are more resistant to disease. However, the cost to fitness of subclinical carrier infection in crossbreeds relative to native breeds is unknown, but could represent a significant hidden economic cost. In this study, a total of 1052 bovine blood samples, together with associated data on host type, sex and body score, were collected from apparently healthy animals in four different agro-climatic zones of Maharashtra state. Samples were screened by PCR for detection of five major TBPs: T. annulata, T. orientalis, B. bigemina, B. bovis and Anaplasma spp.. The results demonstrated that single and co-infection with TBP are common, and although differences in pathogen spp. prevalence across the climatic zones were detected, simplistic regression models predicted that host type, sex and location are all likely to impact on prevalence of TBP. In order to remove issues with autocorrelation between variables, a subset of the dataset was modelled to assess any impact of TBP infection on body score of crossbreed versus native breed cattle (breed type). The model showed significant association between infection with TBP (particularly apicomplexan parasites) and poorer body condition for crossbreed animals. These findings indicate potential cost of TBP carrier infection on crossbreed productivity. Thus, there is a case for development of strategies for targeted breeding to combine productivity traits with disease resistance, or to prevent transmission of TBP in India for economic benefit.	[Kolte, Sunil W.; Jadhao, Suresh G.; Magar, Swapnil P.; Warthi, Ganesh; Kurkure, Nitin V.] Nagpur Vet Coll, Maharashtra Anim & Fishery Sci, Nagpur, Maharashtra, India; [Larcombe, Stephen D.; Shiels, Brian R.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Glass, Elizabeth J.] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; [Glass, Elizabeth J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush, Midlothian, Scotland	Maharashtra Animal & Fishery Sciences University; Nagpur Veterinary College; University of Glasgow; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Larcombe, SD (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland.	Stephen.Larcombe@glasgow.ac.uk	Warthi, Ganesh/AAL-6221-2020; Glass, Elizabeth J/L-4612-2016	Warthi, Ganesh/0000-0002-7497-601X; Glass, Elizabeth J/0000-0002-6183-0185; Shiels, Brian/0000-0001-7595-2514	Department of Biotechnology, Ministry of Science and Technology India; Biotechnology and Biological Sciences Research Council UK [BB/J004227/1, BB/J004235/1]; BBSRC [BBS/E/D/20231760, BB/L004739/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20231760, BB/L004739/1] Funding Source: researchfish	Department of Biotechnology, Ministry of Science and Technology India; Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	SWK and NK were funded by Department of Biotechnology, Ministry of Science and Technology India, http://www.dStindia.nic.in/dia:grantBT/IN/Indo-UK/FADH/45/SWKS2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BRS and SDL were funded by the Biotechnology and Biological Sciences Research Council UK, http://www.bbsrc.ac.uk/grantBB/L004739/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EJG was also supported by the Biotechnology and Biological Sciences Research Council UK, http://www.bbsrc.ac.uk/, Institute Strategic Programme Grants (ISP3 Innate Immunity & Endemic Disease) grant: BB/J004227/1 and (ISP1 Analysis and Prediction in Complex Animal System) grant: BB/J004235/1.	Aparna M, 2011, PARASITOL INT, V60, P524, DOI 10.1016/j.parint.2011.08.002; Bishop RP, 2015, INT J PARASITOL-PAR, V4, P333, DOI 10.1016/j.ijppaw.2015.08.006; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bolker BM, 2011, GLMMS ACTION GENE BY, V1, P127; Brown C.D.G., 1990, HDB ANIMAL DIS TROPI; deCastro JJ, 1997, VET PARASITOL, V71, P77, DOI 10.1016/S0304-4017(97)00033-2; ERIKS IS, 1993, J CLIN MICROBIOL, V31, P2091, DOI 10.1128/JCM.31.8.2091-2096.1993; Gautam O. P., 1981, Advances in the Control of Theileriosis. Proceedings of an International Conference held at the International Laboratory for Research on Animal Diseases in Nairobi, 9-13th February, 1981, P262; Ghaemi P, 2012, PARASITOL RES, V110, P527, DOI 10.1007/s00436-011-2517-y; Gharbi M, 2006, VET PARASITOL, V137, P231, DOI 10.1016/j.vetpar.2006.01.015; Ghosh S, 2014, J VECTOR DIS, V51, P259; Glass EJ, 2005, INT J PARASITOL, V35, P337, DOI 10.1016/j.ijpara.2004.12.006; Glass Elizabeth J., 2012, Frontiers in Genetics, V3, P263, DOI 10.3389/fgene.2012.00263; Glass EJ, 2012, VET IMMUNOL IMMUNOP, V148, P178, DOI 10.1016/j.vetimm.2012.03.006; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Idnani J., 1938, IND J VET SCI, V9, P99; Kolte SW, 2003, INDIAN VET J, V80, P399; Kumar T, 2015, VET WORLD, V8, P768, DOI 10.14202/vetworld.2015.768-771; McFadden AMJ, 2011, NEW ZEAL VET J, V59, P79, DOI 10.1080/00480169.2011.552857; McLeod R., 1999, FINAL REPORT JOINT E; Minjauw B., 2003, RES REPORT; Muhanguzi D., 2010, International Journal of Animal and Veterinary Advances, V2, P76; MURALEEDHARAN K, 1984, INDIAN VET J, V61, P76; Muraleedharan K ZK, 1991, PREVALENCE HAEMOPROT, V20, P79; Rajput Z.I., 2005, Journal of Zhejiang University Science, V6B, P1057, DOI 10.1631/jzus.2005.B1057; Reinbold JB, 2010, AM J VET RES, V71, P1178, DOI 10.2460/ajvr.71.10.1178; Salih D. A., 2015, Journal of Veterinary Medicine and Animal Health, V7, P45; Setty D.R.L., 1972, Mysore J Agric Sci, V6, P474; Sharma A, 2013, BIOMED RES INT; Shastri U. V., 1991, Journal of Veterinary Parasitology, V5, P29; Simuunza M. C., 2009, THESIS; Simuunza M, 2011, VET PARASITOL, V175, P331, DOI 10.1016/j.vetpar.2010.09.027; Singh V, J DAIRY VET ANIM RES, V2; Sivakumar T, 2012, VET PARASITOL, V190, P263, DOI 10.1016/j.vetpar.2012.05.014	34	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174595	10.1371/journal.pone.0174595	http://dx.doi.org/10.1371/journal.pone.0174595			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358861	Green Accepted, gold, Green Submitted, Green Published			2022-12-26	WOS:000399174800058
J	Ursini, F; Arturi, F; Nicolosi, K; Ammendolia, A; D'Angelo, S; Russo, E; Naty, S; Bruno, C; De Sarro, G; Olivieri, I; Grembiale, RD				Ursini, Francesco; Arturi, Franco; Nicolosi, Kassandra; Ammendolia, Antonio; D'Angelo, Salvatore; Russo, Emilio; Naty, Saverio; Bruno, Caterina; De Sarro, Giovambattista; Olivieri, Ignazio; Grembiale, Rosa Daniela			Plantar fascia enthesopathy is highly prevalent in diabetic patients without peripheral neuropathy and correlates with retinopathy and impaired kidney function	PLOS ONE			English	Article							ACHILLES-TENDON; SCREENING INSTRUMENT; MICHIGAN NEUROPATHY; CALCANEAL SPURS; FOOT; ULTRASOUND; MELLITUS; ULCERATION; PRESSURES; THICKNESS	Background Aim of this study was to evaluate the prevalence of plantar fascia (PF) enthesopathy in Type 2 diabetes mellitus (T2DM) patients without distal peripheral neuropathy (DPN). Methods We recruited 50 T2DM patients without DPN and 50 healthy controls. DPN was excluded using the Michigan Neuropathy Screening Instrument (MNSI). All patients underwent a bilateral sonographicevaluation of the enthesealportion of the PF. Results PF thickness was significantly higher in T2DM patients (p<0.0001). T2DM patients presented a higher prevalence of entheseal thickening (p = 0.002), enthesophyte (p = 0.02) and cortical irregularity (p = 0.02). The overall sum of abnormalities was higher in T2DM patients (p<0.0001), as was the percentage of bilateral involvement (p = 0.005). In a logistic regression analysis, retinopathy predicted entheseal thickening (OR 3.5, p= 0.05) and enthesophytes (OR 5.13, p = 0.001); reduced eGFR predicted enthesophytes (OR 2.93, p = 0.04); body mass index (BMI) predicted cortical irregularity (OR 0.87, p = 0.05); mean glucose predicted enthesophyte (OR 1.01, p = 0.03); LDL cholesterol predicted cortical irregularity (OR 0.98, p = 0.02). Conclusions Our data suggest that T2DM is associated with PF enthesopathyindependently of DPN.	[Ursini, Francesco; Nicolosi, Kassandra; Russo, Emilio; Naty, Saverio; Bruno, Caterina; De Sarro, Giovambattista; Grembiale, Rosa Daniela] Univ Catanzaro Magna Graecia, Dept Hlth Sci, Catanzaro, Italy; [Arturi, Franco; Ammendolia, Antonio] Univ Catanzaro Magna Graecia, Dept Med & Surg Sci, Catanzaro, Italy; [D'Angelo, Salvatore; Olivieri, Ignazio] San Carlo Hosp Potenza, Rheumatol Dept Lucania, Potenza, Italy; [D'Angelo, Salvatore; Olivieri, Ignazio] Madonna delle Grazie Hosp Matera, Potenza, Italy	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro	Ursini, F (corresponding author), Univ Catanzaro Magna Graecia, Dept Hlth Sci, Catanzaro, Italy.	francesco.ursini@yahoo.it	D'Angelo, Salvatore/H-9010-2012; Ammendolia, Antonio/K-2155-2016; Ursini, Francesco/AAC-5725-2022; Russo, Emilio/G-5241-2010; Bruno, Caterina/K-5772-2016; Ursini, Francesco/K-5632-2016	Ammendolia, Antonio/0000-0002-2828-2455; Russo, Emilio/0000-0002-1279-8123; Bruno, Caterina/0000-0002-5995-4592; Ursini, Francesco/0000-0001-8194-8642; GREMBIALE, Rosa Daniela/0000-0002-0338-6784; D'Angelo, Salvatore/0000-0002-7442-1110				Abate M, 2014, FOOT ANKLE INT, V35, P44, DOI 10.1177/1071100713510496; Abate M, 2013, RHEUMATOLOGY, V52, P599, DOI 10.1093/rheumatology/kes395; Abate M, 2012, CLIN RHEUMATOL, V31, P1109, DOI 10.1007/s10067-012-1955-y; Al-Homood IA, 2013, CLIN RHEUMATOL, V32, P527, DOI 10.1007/s10067-012-2144-8; Armstrong DG, 1999, J BONE JOINT SURG AM, V81A, P535, DOI 10.2106/00004623-199904000-00011; Batista F, 2008, FOOT ANKLE INT, V29, P498, DOI 10.3113/FAI.2008.0498; Benitez-Aguirre Paul Z, 2012, J Diabetes Sci Technol, V6, P348; Benjamin M, 2000, ARTHRITIS RHEUM-US, V43, P576, DOI 10.1002/1529-0131(200003)43:3<576::AID-ANR14>3.0.CO;2-A; Benjamin M, 2009, ADV EXP MED BIOL, V649, P57; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bolton NRM, 2005, CLIN BIOMECH, V20, P540; Burner T, 2012, CONNECT TISSUE RES, V53, P535, DOI 10.3109/03008207.2012.710670; Cheing GLY, 2013, CLIN BIOMECH, V28, P88, DOI 10.1016/j.clinbiomech.2012.09.001; Cheung JTM, 2006, CLIN BIOMECH, V21, P194, DOI 10.1016/j.clinbiomech.2005.09.016; Chuter V, 2001, DIABETIC MED, V18, P558, DOI 10.1046/j.1464-5491.2001.00527.x; Colen LB, 2013, PLAST RECONSTR SURG, V131, p37E, DOI 10.1097/PRS.0b013e3182729e0b; Craig ME, 2008, DIABETES CARE, V31, P1201, DOI 10.2337/dc07-2168; D'Ambrogi E, 2003, DIABETES CARE, V26, P1525, DOI 10.2337/diacare.26.5.1525; Fateh HR, 2016, J DIABETES METAB DIS, V15, DOI 10.1186/s40200-016-0229-7; FELDMAN EL, 1994, DIABETES CARE, V17, P1281, DOI 10.2337/diacare.17.11.1281; Frykberg RG, 1998, DIABETES CARE, V21, P1714, DOI 10.2337/diacare.21.10.1714; Gallego PH, 2008, DIABETES CARE, V31, P1585, DOI 10.2337/dc07-2236; Gandjbakhch F, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3516; Gefen A, 2003, MED ENG PHYS, V25, P491, DOI 10.1016/S1350-4533(03)00029-8; Giacomozzi C, 2005, CLIN BIOMECH, V20, P532, DOI 10.1016/j.clinbiomech.2005.01.011; Gregg EW, 2002, DIABETES CARE, V25, P61, DOI 10.2337/diacare.25.1.61; Hernandez-Diaz C, 2012, REUMATOL CLIN, V8, P46, DOI 10.1016/j.reuma.2012.10.005; Junyent M, 2005, ARTERIOSCL THROM VAS, V25, P2203, DOI 10.1161/01.ATV.0000183888.48105.d1; Kaleagasioglu F, 2015, KNEE SURG SPORTS TRA; Kim J.-H., 2012, INT J PHOTOENERGY, V2012, P7, DOI DOI 10.1371/J0URNAL.P0NE.0051280; Kumar CGS, 2015, J DIABETES, V7, P850, DOI 10.1111/1753-0407.12254; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Menz HB, 2008, J FOOT ANKLE RES, V1, DOI 10.1186/1757-1146-1-7; Moghtaderi A, 2006, CLIN NEUROL NEUROSUR, V108, P477, DOI 10.1016/j.clineuro.2005.08.003; Morel M, 2005, SURG RADIOL ANAT, V27, P176, DOI 10.1007/s00276-004-0311-6; Moroney Paul J, 2014, Foot Ankle Spec, V7, P95, DOI 10.1177/1938640013516792; Oliva F, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-95; Papanas N, 2009, EXP CLIN ENDOCR DIAB, V117, P645, DOI 10.1055/s-0029-1224121; Petropoulos IN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123517; Reddy GK, 2004, EXP DIABESITY RES, V5, P143, DOI 10.1080/15438600490277860; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Tombini M, 2016, J ALZHEIMERS DIS, V54, P1619, DOI 10.3233/JAD-160261; Toumi H, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-87; Tsai WC, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-255; Tsouli SG, 2009, ATHEROSCLEROSIS, V205, P151, DOI 10.1016/j.atherosclerosis.2008.10.032; Ursini F, 2016, J AM PODIATR MED ASS; Ursini F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163464; Ursini F, 2016, JOINT BONE SPINE, V83, P611, DOI 10.1016/j.jbspin.2016.07.006; Ursini F, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002552; Volpato S, 2010, CURR DIABETES REV, V6, P134, DOI 10.2174/157339910791162961; Wakefield RJ, 2007, J RHEUMATOL, V34, P848; Williams GA, 2004, OPHTHALMOLOGY, V111, P1055, DOI 10.1016/j.ophtha.2004.02.004	52	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174529	10.1371/journal.pone.0174529	http://dx.doi.org/10.1371/journal.pone.0174529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358891	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174800049
J	Werfel, J; Ingber, DE; Bar-Yam, Y				Werfel, Justin; Ingber, Donald E.; Bar-Yam, Yaneer			Theory and associated phenomenology for intrinsic mortality arising from natural selection	PLOS ONE			English	Article							LIFE-SPAN; EXPERIMENTAL EVOLUTION; RENORMALIZATION-GROUP; EXTRINSIC MORTALITY; PROGRAMMED DEATH; CELL-DEATH; SENESCENCE; AGE; GENETICS; ORIGIN	Standard evolutionary theories of aging and mortality, implicitly based on assumptions of spatial averaging, hold that natural selection cannot favor shorter lifespan without direct compensating benefit to individual reproductive success. However, a number of empirical observations appear as exceptions to or are difficult to reconcile with this view, suggesting explicit lifespan control or programmed death mechanisms inconsistent with the classic understanding. Moreover, evolutionary models that take into account the spatial distributions of populations have been shown to exhibit a variety of self-limiting behaviors, maintained through environmental feedback. Here we extend recent work on spatial modeling of lifespan evolution, showing that both theory and phenomenology are consistent with programmed death. Spatial models show that self-limited lifespan robustly results in long-term benefit to a lineage; longer-lived variants may have a reproductive advantage for many generations, but shorter lifespan ultimately confers long-term reproductive advantage through environmental feedback acting on much longer time scales. Numerous model variations produce the same qualitative result, demonstrating insensitivity to detailed assumptions; the key conditions under which self-limited lifespan is favored are spatial extent and locally exhaustible resources. Factors including lower resource availability, higher consumption, and lower dispersal range are associated with evolution of shorter lifespan. A variety of empirical observations can parsimoniously be explained in terms of long-term selective advantage for intrinsic mortality. Classically anomalous empirical data on natural lifespans and intrinsic mortality, including observations of longer lifespan associated with increased predation, and evidence of programmed death in both unicellular and multicellular organisms, are consistent with specific model predictions. The generic nature of the spatial model conditions under which intrinsic mortality is favored suggests a firm theoretical basis for the idea that evolution can quite generally select for shorter lifespan directly.	[Werfel, Justin; Ingber, Donald E.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Werfel, Justin; Bar-Yam, Yaneer] New England Complex Syst Inst, Cambridge, MA 02142 USA; [Werfel, Justin; Ingber, Donald E.] Harvard Med Sch, Boston, MA 02115 USA; [Werfel, Justin; Ingber, Donald E.] Childrens Hosp, Boston, MA 02115 USA; [Ingber, Donald E.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University	Werfel, J (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.	justin.werfel@wyss.harvard.edu	Ingber, Donald E/AAC-5894-2019		New England Complex Systems Institute; U.S. Department of Defense Breast Cancer Innovator Award [BC074986]; Wyss Institute for Biologically Inspired Engineering	New England Complex Systems Institute; U.S. Department of Defense Breast Cancer Innovator Award(United States Department of Defense); Wyss Institute for Biologically Inspired Engineering	This work was supported by internal funding from the New England Complex Systems Institute (primarily 2007-2009) [necsi.edu], a U.S. Department of Defense Breast Cancer Innovator Award (BC074986 to DEI) [defense.gov], and the Wyss Institute for Biologically Inspired Engineering [wyss.harvard.edu]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameisen JC, 1996, SCIENCE, V272, P1278, DOI 10.1126/science.272.5266.1278; Ameisen JC, 2002, CELL DEATH DIFFER, V9, P367, DOI 10.1038/sj.cdd.4400950; Aravind L, 2001, SCIENCE, V291, P1279, DOI 10.1126/science.291.5507.1279; AUSTAD SN, 1993, J ZOOL, V229, P695, DOI 10.1111/j.1469-7998.1993.tb02665.x; Bar-Yam Y., 1999, ADV COMPLEX SYST, V2, P277; Bar-Yam Y, 2016, COMPLEXITY, V21, P73, DOI 10.1002/cplx.21785; Baudisch A, 2012, SCIENCE, V338, P618, DOI 10.1126/science.1226467; BOERLIJST MC, 1991, SFI STUD SCI COMPLEX, P255; Bronikowski AM, 2011, SCIENCE, V331, P1325, DOI 10.1126/science.1201571; Budovskaya YV, 2008, CELL, V134, P291, DOI 10.1016/j.cell.2008.05.044; Cailliet GM, 2001, EXP GERONTOL, V36, P739, DOI 10.1016/S0531-5565(00)00239-4; Caswell H, 2007, TRENDS ECOL EVOL, V22, P173, DOI 10.1016/j.tree.2007.01.006; Charlesworth B, 2000, GENETICS, V156, P927; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; de Aguiar MAM, 2004, J STAT PHYS, V114, P1417, DOI 10.1023/B:JOSS.0000013958.15218.47; De Grey ADNJ, 2002, ANN NY ACAD SCI, V959, P452, DOI 10.1111/j.1749-6632.2002.tb02115.x; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Duszenko M, 2006, TRENDS PARASITOL, V22, P536, DOI 10.1016/j.pt.2006.08.010; Dytham C, 2006, OIKOS, V113, P530, DOI 10.1111/j.2006.0030-1299.14395.x; Evan Gerard I., 1994, Trends in Cell Biology, V4, P191, DOI 10.1016/0962-8924(94)90134-1; Finch CE, 2001, EXP GERONTOL, V36, P591, DOI 10.1016/S0531-5565(00)00227-8; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; Finch CE, 1990, LONGEVITY SENESCENCE; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gardner A, 2015, NATURE, V524, pE3, DOI 10.1038/nature14596; Girondot M, 1998, CURRENT STUDIES HERP, P133; Goldsmith TC, 2008, J THEOR BIOL, V252, P764, DOI 10.1016/j.jtbi.2008.02.035; GOSS RJ, 1994, GERONTOLOGY, V40, P65, DOI 10.1159/000213579; GRANT RL, 1963, PERSPECT BIOL MED, V6, P443; Grosberg RK, 2007, ANNU REV ECOL EVOL S, V38, P621, DOI 10.1146/annurev.ecolsys.36.102403.114735; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Guarente L, 1998, P NATL ACAD SCI USA, V95, P11034, DOI 10.1073/pnas.95.19.11034; Guerin JC, 2004, ANN NY ACAD SCI, V1019, P518, DOI 10.1196/annals.1297.096; Haber C, 2004, J GERONTOL A-BIOL, V59, P515, DOI 10.1093/gerona/59.6.B515; Harris J, 2000, SCIENCE, V288, P59, DOI 10.1126/science.288.5463.59; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; Hayflick L, 2000, NATURE, V408, P267, DOI 10.1038/35041709; Hekimi S, 2003, SCIENCE, V299, P1351, DOI 10.1126/science.1082358; James ER, 2002, CELL DEATH DIFFER, V9, P355, DOI 10.1038/sj.cdd.4400986; Judge DS, 2000, J GERONTOL A-BIOL, V55, pB201, DOI 10.1093/gerona/55.4.B201; KARA TC, 1994, GERONTOLOGY, V40, P161, DOI 10.1159/000213585; Keeling MJ, 1995, OIKOS, V74, P414, DOI 10.2307/3545986; Keller L, 1997, NATURE, V389, P958, DOI 10.1038/40130; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Keymer JE, 2008, NATURE PRECEDINGS; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Koonin EV, 2002, CELL DEATH DIFFER, V9, P394, DOI 10.1038/sj.cdd.4400991; Kowald A, 2015, EXP GERONTOL, V71, P89, DOI 10.1016/j.exger.2015.08.006; Lahdenpera M, 2004, NATURE, V428, P178, DOI 10.1038/nature02367; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Leigh EG, 2010, J EVOLUTION BIOL, V23, P6, DOI 10.1111/j.1420-9101.2009.01876.x; Leslie Mitch, 2006, Sci Aging Knowledge Environ, V2006, pnf12, DOI 10.1126/sageke.2006.8.nf12; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Lewontin R. C., 1965, P77; LIBERTINI G, 1988, J THEOR BIOL, V132, P145, DOI 10.1016/S0022-5193(88)80153-X; Lonergan M, 2003, J GERONTOL A-BIOL, V58, P775; Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991; Love M. S., 2002, ROCKFISHES NE PACIFI; Martin GM, 2000, NATURE, V408, P263, DOI 10.1038/35041705; Martinez DE, 1998, EXP GERONTOL, V33, P217, DOI 10.1016/S0531-5565(97)00113-7; MARTINEZ DE, 1992, P NATL ACAD SCI USA, V89, P9920, DOI 10.1073/pnas.89.20.9920; Martins ACR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024328; Medawar P., 1952, UNSOLVED PROBLEM BIO; Miller RA, 2002, MILBANK Q, V80, P155, DOI 10.1111/1468-0009.00006; Mitteldorf J, 2006, EVOL ECOL RES, V8, P561; Mitteldorf J, 2009, J THEOR BIOL, V260, P186, DOI 10.1016/j.jtbi.2009.05.013; Muller WA, 1996, TRENDS GENET, V12, P91, DOI 10.1016/0168-9525(96)81419-3; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Ocampo A, 2016, CELL, V167, P1719, DOI 10.1016/j.cell.2016.11.052; OdlingSmee FJ, 1996, AM NAT, V147, P641, DOI 10.1086/285870; Okasha S., 2006, EVOLUTION LEVELS SEL, DOI [10.1093/acprof:oso/9780199267972.001.0001, DOI 10.1093/ACPROF:OSO/9780199267972.001.0001]; Olshansky SJ, 2002, SCI AM, V286, P92, DOI 10.1038/scientificamerican0602-92; Orzack SH, 2003, POPUL DEV REV, V29, P19; PATNAIK BK, 1994, GERONTOLOGY, V40, P200, DOI 10.1159/000213588; Patnaik BK, 1994, GERONTOLOGY, V40, P61; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Pletcher SD, 2007, ANNU REV ECOL EVOL S, V38, P299, DOI 10.1146/annurev.ecolsys.38.091206.095634; Rauch EM, 2004, NATURE, V431, P449, DOI 10.1038/nature02745; Rauch EM, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.228101; Rauch EM, 2003, J THEOR BIOL, V221, P655, DOI 10.1006/jtbi.2003.3127; Reznick D, 2001, EXP GERONTOL, V36, P791, DOI 10.1016/S0531-5565(00)00241-2; Reznick DN, 2004, NATURE, V431, P1095, DOI 10.1038/nature02936; Ricklefs RE, 1998, AM NAT, V152, P24, DOI 10.1086/286147; Ritch A, 2012, J ROY COLL PHYS EDIN, V42, P368, DOI 10.4997/JRCPE.2012.417; Rose MR, 2005, INTEGR COMP BIOL, V45, P486, DOI 10.1093/icb/45.3.486; Ross C. A., 1989, CROCODILES ALLIGATOR; Salathe M, 2006, ECOL LETT, V9, P941, DOI 10.1111/j.1461-0248.2006.00942.x; Sanchez A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001547; SATO K, 1994, J MATH BIOL, V32, P251, DOI 10.1007/BF00163881; Scott-Phillips TC, 2014, EVOLUTION, V68, P1231, DOI 10.1111/evo.12332; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Sober E, 1998, UNTO OTHERS; Stacey BC, 2011, ARXIV11103845; Stearns SC, 2000, P NATL ACAD SCI USA, V97, P3309, DOI 10.1073/pnas.060289597; STIVEN AE, 1962, ECOLOGY, V43, P173, DOI 10.2307/1932064; Tan TCJ, 2012, P NATL ACAD SCI USA, V109, P4209, DOI 10.1073/pnas.1118885109; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tormanen U, 1999, BRIT J CANCER, V79, P996, DOI 10.1038/sj.bjc.6690159; Travis JMJ, 2004, J GERONTOL A-BIOL, V59, P301; van Baalen Minus, 2000, P359; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Vaupel JW, 2004, THEOR POPUL BIOL, V65, P339, DOI 10.1016/j.tpb.2003.12.003; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; Wade MJ, 2010, NATURE, V463, pE8, DOI 10.1038/nature08809; Walker DW, 2000, NATURE, V405, P296, DOI 10.1038/35012693; Walker ML, 2008, BIOL REPROD, V79, P398, DOI 10.1095/biolreprod.108.068536; Weisman A., 1891, ESSAYS HEREDITY KIND, V1, P1; Werfel J, 2004, P NATL ACAD SCI USA, V101, P11019, DOI 10.1073/pnas.0305059101; Werfel J, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.238103; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; Wilson EO, 2008, BIOSCIENCE, V58, P17, DOI 10.1641/B580106; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102; WILSON KG, 1971, PHYS REV B, V4, P3174, DOI 10.1103/PhysRevB.4.3174; WODINSKY J, 1977, SCIENCE, V198, P948, DOI 10.1126/science.198.4320.948; ZWAAN B, 1995, EVOLUTION, V49, P649, DOI 10.2307/2410318	124	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0173677	10.1371/journal.pone.0173677	http://dx.doi.org/10.1371/journal.pone.0173677			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VG	28355288	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174600023
J	Sun, LX; Ren, J; He, WJ				Sun, Luxi; Ren, Jie; He, Weijie			Neural correlates of facial expression processing during a detection task: An ERP study	PLOS ONE			English	Article							BRAIN POTENTIALS; EMOTIONAL EXPRESSION; SPATIAL ATTENTION; FACE PERCEPTION; TIME-COURSE; RESPONSES; WORD; FEAR; ACTIVATION; PICTURES	Given finite attentional resources, how emotional aspects of stimuli are processed automatically is controversial. Present study examined the time-course for automatic processing of facial expression by assessing N170, and late positive potentials (LPPs) of event-related potentials (ERPs) using a modified rapid serial visual presentation (RSVP) paradigm. Observers were required to confirm a certain house image and to detect whether a face image was presented at the end of a series of pictures. There were no significant main effects on emotional type for P1 amplitudes, whereas happy and fearful expressions elicited larger N170 amplitudes than neutral expressions. Significantly different LPP amplitudes were elicited depending on the type of emotional facial expressions (fear > happy > neutral). These results indicated that threatening priority was absent but discrimination of expressive vs. neutral faces occurred in implicit emotional tasks, at approximately 250 ms post-stimulus. Moreover, the three types of expressions were discriminated during the later stages of processing. Encoding emotional information of faces can be automated to a relatively higher degree, when attentional resources are mostly allocated to superficial analyzing.	[Sun, Luxi] Chongqing Univ, Sch Econ & Business Adm, Chongqing, Peoples R China; [Ren, Jie; He, Weijie] Chongqing Univ Arts & Sci, Lab Emot & Mental Hlth, Chongqing, Peoples R China	Chongqing University; Chongqing University of Arts & Sciences	He, WJ (corresponding author), Chongqing Univ Arts & Sci, Lab Emot & Mental Hlth, Chongqing, Peoples R China.	hweijie@foxmail.com		Ren, Jie/0000-0002-8000-302X	National Natural Science Foundation of China [31600917]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	WH received the funding of National Natural Science Foundation of China (31600917) for this work, http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was supported by the National Natural Science Foundation of China (31600917)	Bar-Haim Y, 2005, BRAIN COGNITION, V59, P11, DOI 10.1016/j.bandc.2005.03.005; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Blau Vera C, 2007, Behav Brain Funct, V3, P7; Bradley MA, 2003, BEHAV NEUROSCI, V117, P369, DOI 10.1037/0735-7044.117.2.369; Brosch T, 2008, PSYCHOL SCI, V19, P362, DOI 10.1111/j.1467-9280.2008.02094.x; Campanella S, 2002, J COGNITIVE NEUROSCI, V14, P210, DOI 10.1162/089892902317236858; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Deffke I, 2007, NEUROIMAGE, V35, P1495, DOI 10.1016/j.neuroimage.2007.01.034; Donchin E., 1986, PSYCHOPHYSIOLOGY SYS; Eger E, 2003, NEUROPSYCHOLOGIA, V41, P808, DOI 10.1016/S0028-3932(02)00287-7; Eimer M, 2003, COGN AFFECT BEHAV NE, V3, P97, DOI 10.3758/CABN.3.2.97; Ekman P., 2003, EMOTIONS REVEALED, V2; Erk S, 2006, EUR J NEUROSCI, V24, P1227, DOI 10.1111/j.1460-9568.2006.04976.x; Hajcak G, 2007, BEHAV NEUROSCI, V121, P1156, DOI 10.1037/0735-7044.121.6.1156; Hajcak G, 2009, CLIN NEUROPHYSIOL, V120, P505, DOI 10.1016/j.clinph.2008.11.028; Hopf JM, 2002, J NEUROPHYSIOL, V88, P2088, DOI 10.1152/jn.2002.88.4.2088; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Kawasaki H, 2001, NAT NEUROSCI, V4, P15, DOI 10.1038/82850; Kissler J, 2009, BIOL PSYCHOL, V80, P75, DOI 10.1016/j.biopsycho.2008.03.004; Knyazev GG, 2009, NEUROSCIENCE, V164, P1588, DOI 10.1016/j.neuroscience.2009.09.057; Kranczioch C, 2003, COGNITIVE BRAIN RES, V17, P177, DOI 10.1016/S0926-6410(03)00092-2; Krombholz A, 2007, BIOL PSYCHOL, V76, P156, DOI 10.1016/j.biopsycho.2007.07.004; Lane RD, 1999, NEUROPSYCHOLOGIA, V37, P989, DOI 10.1016/S0028-3932(99)00017-2; Langeslag SJE, 2007, BIOL PSYCHOL, V76, P109, DOI 10.1016/j.biopsycho.2007.06.007; Leppanen JM, 2004, PSYCHOL RES-PSYCH FO, V69, P22, DOI 10.1007/s00426-003-0157-2; Li W, 2008, J COGNITIVE NEUROSCI, V20, P95; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Luck S. J., 2000, NEW COGNITIVE NEUROS; LUCK Steven J., INTRO EVENT RELATED; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Miltner WHR, 2005, INT J PSYCHOPHYSIOL, V57, P43, DOI 10.1016/j.ijpsycho.2005.01.012; Pessoa L, 2002, COGNITIVE BRAIN RES, V15, P31, DOI 10.1016/S0926-6410(02)00214-8; Pizzagalli DA, 2002, NEUROIMAGE, V16, P663, DOI 10.1006/nimg.2002.1126; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Pourtois G, 2006, PROG BRAIN RES, V156, P67, DOI 10.1016/S0079-6123(06)56004-2; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rellecke J, 2012, BIOL PSYCHOL, V90, P23, DOI 10.1016/j.biopsycho.2012.02.002; Rellecke J, 2011, BRAIN COGNITION, V77, P23, DOI 10.1016/j.bandc.2011.07.001; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Schutter DJLG, 2004, INT J PSYCHOPHYSIOL, V53, P29, DOI 10.1016/j.ijpsycho.2004.01.003; Smith NK, 2003, NEUROPSYCHOLOGIA, V41, P171, DOI 10.1016/S0028-3932(02)00147-1; Van Strien JW, 2010, NEUROREPORT, V21, P656, DOI 10.1097/WNR.0b013e32833ab89e; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1111/1469-8986.3720190; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Wild-Wall N, 2008, BIOL PSYCHOL, V77, P138, DOI 10.1016/j.biopsycho.2007.10.001; Williams LM, 2006, NEUROIMAGE, V31, P458, DOI 10.1016/j.neuroimage.2005.12.009; Williams LM, 2004, HUM BRAIN MAPP, V21, P64, DOI 10.1002/hbm.10154; Zhang DD, 2014, SOC COGN AFFECT NEUR, V9, P1897, DOI 10.1093/scan/nst188	54	13	13	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174016	10.1371/journal.pone.0174016	http://dx.doi.org/10.1371/journal.pone.0174016			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VE	28350800	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174400011
J	Wang, WC; Lu, ML; Chen, VCH; Ng, MH; Huang, KY; Hsieh, MH; Hsieh, MJ; McIntyre, RS; Lee, Y; Lee, CTC				Wang, Wei-Chen; Lu, Mong-Liang; Chen, Vincent Chin-Hung; Ng, Mei-Hing; Huang, Kuo-You; Hsieh, Ming-Hong; Hsieh, Meng-Jer; McIntyre, Roger S.; Lee, Yena; Lee, Charles Tzu-Chi			Asthma, corticosteroid use and schizophrenia: A nationwide populationbased study in Taiwan	PLOS ONE			English	Article							AUTOIMMUNE-DISEASES; CEREBROSPINAL-FLUID; BIPOLAR DISORDER; INTERLEUKIN-6; RISK; PATHOPHYSIOLOGY; ASSOCIATION; PREVALENCE; ILLNESS; MODEL	Objective Asthma and corticosteroid use have been implicated as possible risk factors for schizophrenia. The retrospective cohort study herein aimed to investigate the association between asthma, corticosteroid use, and schizophrenia. Method Longitudinal data (2000 to 2007) from adults with asthma (n = 50,046) and without asthma (n = 50,046) were compared on measures of schizophrenia incidence using Taiwan's National Health Insurance Research Database (NHIRD). Incidence of schizophrenia diagnosis (ICD-9 codes 295. XX) between 2000 and 2007 were compared between groups. Competing risk-adjusted Cox regression analyses were conducted, adjusting for sex, age, residence, socioeconomic status, corticosteroid use, outpatient and emergency room visit frequency, Charlson comorbidity index, and total length of hospital stays days for any disorder. Results Of the 75,069 subjects, 238 received a diagnosis of schizophrenia. The mean (SD) followup interval for all subjects was 5.8 (2.3) years. After adjusting for potential confounding factors, asthma was associated with significantly greater hazard ratio for incident schizophrenia 1.40 (95% CI = 1.05, 1.87). Additional factors associated with greater incidence of schizophrenia were rural residence, lower economic status, and poor general health. Older age (i. e. >= 65 years) was negatively associated with schizophrenia incidence. Corticosteroid use was not associated with increased risk for schizophrenia. Conclusions Asthma was associated with increased risk for schizophrenia. The results herein suggest that a convergent disturbance in the immune-inflammatory system may contribute to the pathoetiology of asthma and schizophrenia.	[Wang, Wei-Chen; Hsieh, Ming-Hong] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Lu, Mong-Liang] Taipei Med Univ, Dept Psychiat, Wan Fang Hosp, Taipei, Taiwan; [Lu, Mong-Liang] Taipei Med Univ, Sch Med, Coll Med, Taipei, Taiwan; [Chen, Vincent Chin-Hung] Chiayi Chang Gung Mem Hosp, Chang Gung Med Fdn, Dept Psychiat, Chiayi, Taiwan; [Chen, Vincent Chin-Hung] Chang Gung Univ, Sch Med, Taoyuan, Taiwan; [Ng, Mei-Hing] Tsaotun Psychiat Ctr, Dept Hlth, Nantou, Taiwan; [Huang, Kuo-You] Chung Shan Med Univ, Dept Speech Language Pathol & Audiol, Taichung, Taiwan; [Hsieh, Ming-Hong] Chung Shan Med Univ Hosp, Dept Psychiat, Taichung, Taiwan; [Hsieh, Meng-Jer] Chang Gung Univ, Dept Resp Therapy, Taoyuan, Taiwan; [Hsieh, Meng-Jer] Chiayi Chang Gung Mem Hosp, Chang Gung Med Fdn, Dept Pulm & Crit Care Med, Chiayi, Taiwan; [McIntyre, Roger S.; Lee, Yena] Univ Toronto, Univ Hlth Network, Mood Disorders Psychopharmacol Unit, Toronto, ON, Canada; [Lee, Yena] Univ Toronto, Dept Pharmacol & Psychiat, Toronto, ON, Canada; [Lee, Charles Tzu-Chi] Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan	Chung Shan Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Chang Gung Memorial Hospital; Chang Gung University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chang Gung University; Chang Gung Memorial Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; National Taiwan Normal University	Lee, CTC (corresponding author), Natl Taiwan Normal Univ, Dept Hlth Promot & Hlth Educ, Taipei, Taiwan.	Lee@ntnu.edu.tw	Lee, Yena/D-9016-2019; Students, MDPU/ABE-8402-2020; McIntyre, Roger/AAU-1000-2020; Lee, Yena/L-5505-2019	Lee, Yena/0000-0003-0629-9456; McIntyre, Roger/0000-0003-4733-2523; Lee, Yena/0000-0003-0629-9456; Lu, Mong-Liang/0000-0003-3184-6554; Wang, WeiChen/0000-0002-9568-1069; Hsieh, Meng-Jer/0000-0002-2077-0470	Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan [CMRPG6E0271]	Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan	This study was supported by grants from Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan (grant number: CMRPG6E0271). The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Alpert O, 2014, GEN HOSP PSYCHIAT, V36, DOI 10.1016/j.genhosppsych.2014.05.001; [Anonymous], CMPRSK SUBDISTRIBUTI; Bag O, 2012, GEN HOSP PSYCHIAT, V34; Brown ES, 2002, J CLIN PSYCHOPHARM, V22, P55, DOI 10.1097/00004714-200202000-00009; Cazzola M, 2012, RESP MED, V106, P249, DOI 10.1016/j.rmed.2011.07.021; Chen MH, 2014, J AM MED DIR ASS; Chen MH, 2014, J PSYCHIATR RES, V49, P25, DOI 10.1016/j.jpsychires.2013.10.015; Chen SJ, 2012, BRIT J PSYCHIAT, V200, P374, DOI 10.1192/bjp.bp.111.092098; Chen YH, 2009, SCHIZOPHR RES, V108, P191, DOI 10.1016/j.schres.2008.12.021; DHOORE W, 1993, METHOD INFORM MED, V32, P382; Drozdowicz LB, 2014, MAYO CLIN PROC, V89, P817, DOI 10.1016/j.mayocp.2014.01.010; Eaton WW, 2006, AM J PSYCHIAT, V163, P521, DOI 10.1176/appi.ajp.163.3.521; Engelhardt B, 2009, SEMIN IMMUNOPATHOL, V31, P497, DOI 10.1007/s00281-009-0177-0; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Finkelman FD, 2010, J IMMUNOL, V184, P1663, DOI 10.4049/jimmunol.0902185; Freedman R, 2003, NEW ENGL J MED, V349, P1738, DOI 10.1056/NEJMra035458; GANGULI R, 1987, ANN NY ACAD SCI, V496, P676, DOI 10.1111/j.1749-6632.1987.tb35829.x; Garver DL, 2003, NEUROPSYCHOPHARMACOL, V28, P1515, DOI 10.1038/sj.npp.1300217; HWU HG, 1989, ACTA PSYCHIAT SCAND, V79, P136, DOI 10.1111/j.1600-0447.1989.tb08581.x; Institutes NHR, 2014, INTR NAT HLTH INS RE; JUDD FK, 1983, MED J AUSTRALIA, V2, P350, DOI 10.5694/j.1326-5377.1983.tb122496.x; Khandaker GM, 2016, PSYCHOPHARMACOLOGY, V233, P1559, DOI 10.1007/s00213-015-3975-1; Khandaker GM, 2015, LANCET PSYCHIAT, V2, P258, DOI 10.1016/S2215-0366(14)00122-9; Kredentser MS, 2014, J CLIN PSYCHIAT, V75, P154, DOI 10.4088/JCP.13m08711; Leucht S, 2007, ACTA PSYCHIAT SCAND, V116, P317, DOI 10.1111/j.1600-0447.2007.01095.x; Lin A, 1998, SCHIZOPHR RES, V32, P9, DOI 10.1016/S0920-9964(98)00034-6; Lin TC, 2014, J AFFECT DISORDERS, V168, P30, DOI 10.1016/j.jad.2014.06.033; Maslan J, 2014, OTOLARYNG CLIN N AM, V47, P13, DOI 10.1016/j.otc.2013.09.010; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-43; Pedersen MS, 2012, SCHIZOPHR RES, V138, P58, DOI 10.1016/j.schres.2012.02.019; Pino O, 2014, ACTAS ESP PSIQUIATRI, V42, P185; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Ribeiro-Santos R, 2014, CURR NEUROPHARMACOL, V12, P273, DOI 10.2174/1570159X1203140511160832; Saatian B, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24333; Sasayama D, 2013, J PSYCHIATR RES, V47, P401, DOI 10.1016/j.jpsychires.2012.12.001; Yarlagadda Atmaram, 2009, Psychiatry (Edgmont), V6, P18	37	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0173063	10.1371/journal.pone.0173063	http://dx.doi.org/10.1371/journal.pone.0173063			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VE	28350822	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174400004
J	Ulrich, D; Bjelic-Radisic, V; Hollein, A; Trutnovsky, G; Tamussino, K; Aigmuller, T				Ulrich, Daniela; Bjelic-Radisic, Vesna; Hoellein, Anna; Trutnovsky, Gerda; Tamussino, Karl; Aigmueller, Thomas			Quality of life and objective outcome assessment in women with tape division after surgery for stress urinary incontinence	PLOS ONE			English	Article							FREE VAGINAL TAPE; POSTOPERATIVE VOIDING DYSFUNCTION; SLING REVISION; MOBILIZATION; QUESTIONNAIRE; VALIDATION; RETENTION; PROLAPSE; IMPACT	Background Midurethral tapes may cause long-term complications such as voiding dysfunction, groin pain, de novo urgency or mesh erosion, which necessitate a reoperation. There is a paucity of data regarding health related quality of life in patients undergoing tape removal. The aim of the study was to evaluate quality of life (QoL) and objective outcome after midurethral tape division or excision. Methods All patients who underwent a midurethral tape division for voiding difficulties, pain or therapy resistant de novo overactive bladder between 1999 and 2014 were invited for follow-up. A control group with a suburethral tape without division was established in a 1:2 ratio and matched for age, tape used and year of tape insertion. Patients completed the Kings A Health Questionnaire (KHQ), Incontinence Outcome Questionnaire, Female Sexual Function Index Questionnaire and the Patient Global Impression of Improvement score. Results Tape division or excision was performed in 32 women. Overall, 15 (60%) of 25 women who were alive were available for clinical examination and completed the questionnaires. Tape division was performed for voiding dysfunction (n = 7), overactive bladder (n = 2), mesh extrusion (n = 3) and ongoing pain (n = 3). Median time to tape division/excision was 10 months. Three women in the tape division group had undergone reoperation for stress urinary incontinence (SUI). At a median follow-up of 11 years (IQR 9-13) subjective SUI rate was 53% (8/15 women) in the tape division group and 17% (5/30) in the control group (p = 0.016), with no significant differences in objective SUI rates between groups. With regard to quality of life, the study group had significantly worse scores in the SUI related domains role limitation, physical limitation, severity measures and social limitations (KHQ) compared to the control group. Conclusions Women needing tape division or excision have lower SUI related QoL scores compared to controls mostly because of higher subjective SUI rates.	[Ulrich, Daniela; Bjelic-Radisic, Vesna; Hoellein, Anna; Trutnovsky, Gerda; Tamussino, Karl; Aigmueller, Thomas] Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria	Medical University of Graz	Trutnovsky, G (corresponding author), Med Univ Graz, Dept Obstet & Gynecol, Graz, Austria.	gerda.trutnovsky@medunigraz.at	Gold, Daniela/ABE-4818-2020	Gold, Daniela/0000-0002-7196-454X; Trutnovsky, Gerda/0000-0001-6445-2418				Aigmueller T, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.07.010; Berner MM, 2004, GEBURTSH FRAUENHEILK, V64, P293; Bjelic-Radisic V, 2005, NEUROUROL URODYNAM, V24, P63, DOI 10.1002/nau.20092; Bjelic-Radisic V, 2007, INT UROGYNECOL J, V18, P1139, DOI 10.1007/s00192-007-0302-3; Chang WC, 2010, INT UROGYNECOL J, V21, P229, DOI 10.1007/s00192-009-1016-5; de Leval J, 2003, EUR UROL, V44, P724, DOI 10.1016/j.eururo.2003.09.003; Fong EDM, 2010, BJU INT, V106, P596, DOI 10.1111/j.1464-410X.2010.09544.x; George A, 2012, FEMALE PELVIC MED RE, V18, P332, DOI 10.1097/SPV.0b013e318270adfe; Glazener CM, 2015, COCHRANE DB SYST REV, V7; Leng WW, 2004, J UROLOGY, V172, P1379, DOI 10.1097/01.ju.0000138555.70421.ca; Nguyen JN, 2005, UROLOGY, V66, P523, DOI 10.1016/j.urology.2005.03.055; Nilsson CG, 2013, INT UROGYNECOL J, V24, P1265, DOI 10.1007/s00192-013-2090-2; Ogah J, 2011, NEUROUROL URODYNAM, V30, P284, DOI 10.1002/nau.20980; Ogah J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006375.pub2; Price N, 2009, INT UROGYNECOL J, V20, P855, DOI 10.1007/s00192-009-0858-1; Rautenberg O, 2014, NEUROUROL URODYNAM, V33, P1147, DOI 10.1002/nau.22459; SHUMAKER SA, 1994, QUAL LIFE RES, V3, P291, DOI 10.1007/BF00451721; Sokol AI, 2005, AM J OBSTET GYNECOL, V192, P1537, DOI 10.1016/j.ajog.2004.10.623; Srikrishna S, 2010, INT UROGYNECOL J, V21, P523, DOI 10.1007/s00192-009-1069-5; Ulmsten U, 1996, Int Urogynecol J Pelvic Floor Dysfunct, V7, P81, DOI 10.1007/BF01902378; Ulrich D, 2016, J UROLOGY IN PRESS; Unger CA, 2016, INT UROGYNECOL J, V27, P117, DOI 10.1007/s00192-015-2769-7	22	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174628	10.1371/journal.pone.0174628	http://dx.doi.org/10.1371/journal.pone.0174628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346541	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174300064
J	Moyo, TK; Wilson, CS; Moore, DJ; Eischen, CM				Moyo, T. K.; Wilson, C. S.; Moore, D. J.; Eischen, C. M.			Myc enhances B-cell receptor signaling in precancerous B cells and confers resistance to Btk inhibition	ONCOGENE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ANTIGEN RECEPTOR; C-MYC; FOLLICULAR LYMPHOMA; TARGETING BTK; SYK; IBRUTINIB; ACTIVATION; PCI-32765; SURVIVAL	Dysregulation of the oncogenic transcription factor MYC induces B-cell transformation and is a driver for B-cell non-Hodgkin lymphoma (B-NHL). MYC overexpression in B-NHL is associated with more aggressive phenotypes and poor prognosis. Although genomic studies suggest a link between MYC overexpression and B-cell receptor (BCR) signaling molecules in B-NHL, signaling pathways essential to Myc-mediated B-cell transformation have not been fully elucidated. We utilized intracellular phospho-flow cytometry to investigate the relationship between Myc and BCR signaling in pre-malignant B cells. Utilizing the E mu-myc mouse model, where Myc is overexpressed specifically in B cells, both basal and stimulated BCR signaling were increased in precancerous B lymphocytes from E mu-myc mice compared with wild-type littermates. B cells overexpressing Myc displayed constitutively higher levels of activated CD79a, Btk, Plc gamma 2 and Erk1/2. Notably, Myc-overexpressing B cells maintained elevated BCR signaling despite treatment with ibrutinib, a Bruton's tyrosine kinase inhibitor. Furthermore, PI3K/Akt pathway signaling was also increased in E mu-myc B cells, and this increase was partially suppressed with ibrutinib. In addition, experiments with Btk-null B cells revealed off-target effects of ibrutinib on BCR signaling. Our data show that in pre-malignant B cells, Myc overexpression is sufficient to activate BCR and PI3K/Akt signaling pathways and further enhances signaling following BCR ligation. Therefore, our results indicate that precancerous B cells have already acquired enhanced survival and growth capabilities before transformation, and that elevated MYC levels confer resistance to pharmacologic inhibitors of BCR signaling, which has significant implications for B-NHL treatment.	[Moyo, T. K.] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA; [Wilson, C. S.; Moore, D. J.; Eischen, C. M.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Med Ctr, Nashville, TN 37232 USA; [Moore, D. J.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Eischen, C. M.] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Canc Biol, 233 South 10th St,Bluemle Life Sci Bldg,Room 650, Philadelphia, PA 19107 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Jefferson University	Eischen, CM (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Dept Canc Biol, 233 South 10th St,Bluemle Life Sci Bldg,Room 650, Philadelphia, PA 19107 USA.	christine.eischen@jefferson.edu	Moore, Daniel/V-6145-2019; Moore, Daniel J/A-4924-2008	Moore, Daniel/0000-0002-6889-9345; Moore, Daniel J/0000-0002-6889-9345	NIH/NCI [R21CA184352]; Hematology Helping Hands Research Award; NCI Cancer Center [P30CA68485, P30CA056036]; NATIONAL CANCER INSTITUTE [R21CA184352, P30CA068485, P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM062459] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hematology Helping Hands Research Award; NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr Peggy Kendall for providing Btk<SUP>-/-</SUP> mice and members of the Eischen laboratory and Dr Jonathan Irish for their advice. This work was supported by NIH/NCI R21CA184352 (CME), the Hematology Helping Hands Research Award (TKM) and the NCI Cancer Center support grant P30CA68485 that supports the Vanderbilt Flow Cytometry Shared Resource and the NCI Cancer Center support grant P30CA056036.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Advani RH, 2013, J CLIN ONCOL, V31, P88, DOI 10.1200/JCO.2012.42.7906; Baba Y, 2001, P NATL ACAD SCI USA, V98, P2582, DOI 10.1073/pnas.051626198; Beitz LO, 1999, J BIOL CHEM, V274, P32662, DOI 10.1074/jbc.274.46.32662; Bye AP, 2015, ARTERIOSCL THROM VAS, V35, P2326, DOI 10.1161/ATVBAHA.115.306130; Byrd JC, 2016, NEW ENGL J MED, V374, P323, DOI 10.1056/NEJMoa1509981; Byrd JC, 2013, NEW ENGL J MED, V369, P32, DOI 10.1056/NEJMoa1215637; Chen LF, 2008, BLOOD, V111, P2230, DOI 10.1182/blood-2007-07-100115; Christie L, 2008, LEUKEMIA LYMPHOMA, V49, P470, DOI 10.1080/10428190701836845; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Ding JY, 2000, J BIOL CHEM, V275, P30873, DOI 10.1074/jbc.M004813200; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Geahlen RL, 2009, BBA-MOL CELL RES, V1793, P1115, DOI 10.1016/j.bbamcr.2009.03.004; Gramling MW, 2012, CELL DEATH DIFFER, V19, P1220, DOI 10.1038/cdd.2012.1; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Huh YO, 2008, BRIT J HAEMATOL, V142, P36, DOI 10.1111/j.1365-2141.2008.07152.x; Irish JM, 2006, J IMMUNOL, V177, P1581, DOI 10.4049/jimmunol.177.3.1581; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; KUROSAKI T, 1995, J EXP MED, V182, P1815, DOI 10.1084/jem.182.6.1815; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Love C, 2012, NAT GENET, V44, P1321, DOI 10.1038/ng.2468; Manne BK, 2015, J BIOL CHEM, V290, P11557, DOI 10.1074/jbc.M114.629527; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Pan ZY, 2007, CHEMMEDCHEM, V2, P58, DOI 10.1002/cmdc.200600221; Pede V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060275; Ponader S, 2012, BLOOD, V119, P1182, DOI 10.1182/blood-2011-10-386417; Psathas JN, 2013, BLOOD, V122, P4220, DOI 10.1182/blood-2012-12-473090; Refaeli Y, 2008, PLOS BIOL, V6, P1208, DOI 10.1371/journal.pbio.0060152; Richter J, 2012, NAT GENET, V44, P1316, DOI 10.1038/ng.2469; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Satterthwaite AB, 1997, P NATL ACAD SCI USA, V94, P13152, DOI 10.1073/pnas.94.24.13152; Schmitz R, 2012, NATURE, V490, P116, DOI 10.1038/nature11378; Shaffer AL, 2012, ANNU REV IMMUNOL, V30, P565, DOI 10.1146/annurev-immunol-020711-075027; Speich HE, 2008, AM J PHYSIOL-CELL PH, V295, pC1045, DOI 10.1152/ajpcell.90644.2007; Wang ML, 2013, NEW ENGL J MED, V369, P507, DOI 10.1056/NEJMoa1306220; Woyach JA, 2012, BLOOD, V120, P1175, DOI 10.1182/blood-2012-02-362624; Xu XX, 2013, INT J CLIN EXP PATHO, V6, P788; Yeomans A, 2016, BLOOD, V127, P449, DOI 10.1182/blood-2015-07-660969; Young KH, 2008, AM J CLIN PATHOL, V129, P157, DOI 10.1309/NKK3FEX2BE5L7EKB	42	23	24	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 10	2017	36	32					4653	4661		10.1038/onc.2017.95	http://dx.doi.org/10.1038/onc.2017.95			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FD0RK	28368423	Green Accepted			2022-12-26	WOS:000407246200012
J	Cesarini, V; Guida, E; Todaro, F; Di Agostino, S; Tassinari, V; Nicolis, S; Favaro, R; Caporali, S; Lacal, PM; Botti, E; Costanzo, A; Rossi, P; Jannini, EA; Dolci, S				Cesarini, V.; Guida, E.; Todaro, F.; Di Agostino, S.; Tassinari, V.; Nicolis, S.; Favaro, R.; Caporali, S.; Lacal, P. M.; Botti, E.; Costanzo, A.; Rossi, P.; Jannini, E. A.; Dolci, S.			Sox2 is not required for melanomagenesis, melanoma growth and melanoma metastasis in vivo	ONCOGENE			English	Article							CELL LUNG-CANCER; MALIGNANT-MELANOMA; SELF-RENEWAL; MOUSE MODEL; STEM; EXPRESSION; MAINTENANCE; ONCOGENE; GENE; PROGRESSION	Melanoma is a dangerous form of skin cancer derived from the malignant transformation of melanocytes. The transcription factor SOX2 is not expressed in melanocytes, however, it has been shown to be differentially expressed between benign nevi and malignant melanomas and to be essential for melanoma stem cell maintenance and expansion in vitro and in xenograft models. By using a mouse model in which BRaf(V600E) mutation cooperates with Pten loss to induce the development of metastatic melanoma, we investigated if Sox2 is required during the process of melanomagenesis, melanoma growth and metastasis and in the acquisition of resistance to BRAF inhibitors (BRAFi) treatments. We found that deletion of Sox2 specifically in Pten null and BRafV600E-expressing melanocytes did not prevent tumor formation and did not modify the temporal kinetics of melanoma occurrence compared to Sox2 wt mice. In addition, tumor growth was similar between Sox2 wt and Sox2 deleted (del) melanomas. By querying publicly available databases, we did not find statistically significant differences in SOX2 expression levels between benign nevi and melanomas, and analysis on two melanoma patient cohorts confirmed that Sox2 levels did not significantly change between primary and metastatic melanomas. Melanoma cell lines derived from both Sox2 genotypes showed a similar sensitivity to vemurafenib treatment and the same ability to develop vemurafenib resistance in long-term cultures. Development of vemurafenib resistance was not dependent on SOX2 expression also in human melanoma cell lines in vitro. Our findings exclude an oncogenic function for Sox2 during melanoma development and do not support a role for this transcription factor in the acquisition of resistance to BRAFi treatments.	[Cesarini, V.; Guida, E.; Todaro, F.; Tassinari, V.; Rossi, P.; Dolci, S.] Univ Roma Tor Vergata, Dept Biomed & Prevent, Via Montpellier 1, I-00133 Rome, Italy; [Di Agostino, S.] Regina Elena Natl Canc Inst IFO, Oncogenom & Epigenet Unit, Rome, Italy; [Nicolis, S.; Favaro, R.] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Caporali, S.; Lacal, P. M.] Inst Dermopat Dell Immacolata IRCCS, Mol Oncol Lab, Rome, Italy; [Botti, E.; Jannini, E. A.] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Costanzo, A.] Humanitas Univ, Dept Biomed, Milan, Italy	University of Rome Tor Vergata; IRCCS Istituti Fisioterapici Ospitalieri (IFO); University of Milano-Bicocca; University of Rome Tor Vergata; Humanitas University	Dolci, S (corresponding author), Univ Roma Tor Vergata, Dept Biomed & Prevent, Via Montpellier 1, I-00133 Rome, Italy.	dolci@uniroma2.it	Di Agostino, Silvia/H-1121-2018; Di Agostino, Silvia/S-8566-2019; Tassinari, Valentina/AAW-1649-2021; Costanzo, Antonio/GZG-2433-2022; Cesarini, Valeriana VC/K-5816-2016; Lacal, Pedro M/A-1481-2013; Rossi, Pellegrino/AAA-7072-2019; Favaro, Rebecca/HHZ-8978-2022	Di Agostino, Silvia/0000-0003-3730-1125; Tassinari, Valentina/0000-0003-2167-9414; Costanzo, Antonio/0000-0001-9697-2557; Cesarini, Valeriana VC/0000-0001-9323-1796; Lacal, Pedro M/0000-0003-1166-4593; Favaro, Rebecca/0000-0002-6195-5711; ROSSI, PELLEGRINO/0000-0003-4796-327X; NICOLIS, SILVIA KIRSTEN/0000-0003-0378-3808; todaro, federica/0000-0001-6544-193X; Guida, Eugenia/0000-0002-1690-3277	Telethon; AIRC; AIRC [17585]; MIUR [2015XSNA83_006, 2015XCR88M]	Telethon(Fondazione Telethon); AIRC(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro); MIUR(Ministry of Education, Universities and Research (MIUR))	We thank G Graziani for helpful criticisms and for sharing results with us and G Rossi for histology assistance. We wish to thank Genentek (San Francisco, CA, USA) for the supply of vemurafenib and GlaxoSmithKline (Brentford, UK) for the supply of dabrafenib. SN is supported by Telethon and AIRC grants. SC is recipient of a fellowship from AIRC (Investigator Grant Project 17585). This work has been supported by MIUR Grants 2015XSNA83_006 and 2015XCR88M.	Akasaka K, 2009, J INVEST DERMATOL, V129, P1516, DOI 10.1038/jid.2008.406; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bosenberg M, 2006, GENESIS, V44, P262, DOI 10.1002/dvg.20205; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Camilo V, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-753; Campolo F, 2013, STEM CELLS, V31, P1408, DOI 10.1002/stem.1392; Chen YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071140; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Girouard SD, 2012, LAB INVEST, V92, P362, DOI 10.1038/labinvest.2011.188; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Graziani G, 2015, BIOCHEM PHARMACOL, V95, P16, DOI 10.1016/j.bcp.2015.03.004; Hutz K, 2014, CARCINOGENESIS, V35, P942, DOI 10.1093/carcin/bgt410; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Irie N, 2015, CELL, V160, P253, DOI 10.1016/j.cell.2014.12.013; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Lacal PM, 2005, INT J ONCOL, V27, P1625; Laga AC, 2011, EXP DERMATOL, V20, P339, DOI 10.1111/j.1600-0625.2011.01247.x; Laga AC, 2010, AM J PATHOL, V176, P903, DOI 10.2353/ajpath.2010.090495; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Lundberg IV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101957; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Mukhopadhyay A, 2014, CELL REP, V8, P40, DOI 10.1016/j.celrep.2014.05.036; Otsubo T, 2008, BRIT J CANCER, V98, P824, DOI 10.1038/sj.bjc.6604193; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Sanchez-Laorden B, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004815; Santini R, 2014, ONCOGENE, V33, P4697, DOI 10.1038/onc.2014.71; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Schaefer SM, ONCOGENE; Shakhova O, 2012, NAT CELL BIOL, V14, P882, DOI 10.1038/ncb2535; Shinozaki M, 2004, CLIN CANCER RES, V10, P1753, DOI 10.1158/1078-0432.CCR-1169-3; Singh S, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-73; Talantov D, 2005, CLIN CANCER RES, V11, P7234, DOI 10.1158/1078-0432.CCR-05-0683; Toschi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095303; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Wilbertz T, 2011, MODERN PATHOL, V24, P944, DOI 10.1038/modpathol.2011.49; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1	42	12	12	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 3	2017	36	31					4508	4515		10.1038/onc.2017.53	http://dx.doi.org/10.1038/onc.2017.53			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FC4JL	28368402	Green Published			2022-12-26	WOS:000406806000012
J	Gosselin-Badaroudine, P; Chahine, M				Gosselin-Badaroudine, Pascal; Chahine, Mohamed			Biophysical characterization of the Varroa destructor Na(V)1 sodium channel and its affinity for tau-fluvalinate insecticide	FASEB JOURNAL			English	Article						Xenopus oocytes; Na(v)1; voltage-gated sodium channels	ACARI; HYMENOPTERA; JACOBSONI; TOXICITY; APIDAE	The decline of the western honeybee (Apis mellifera) has been reported to be due to parasitism by Varroa destructor mites and to colony collapse disorder in which these mites may be involved. In-hive chemicals such as T-fluvalinate are being used to control V. destructor populations. This approach may lead to the chronic exposure of bees to this liposoluble chemical, which tends to accumulate in hives. We cloned a variant of the V. destructor voltage-dependent sodium (VdNav1) channel and studied its biophysical characteristics and sensitivity to r-fluvalinate using the Xenopus oocyte expression system and the 2-microelectrode voltage-clamp technique. We compared the affinity of VdNav1 for r-fluvalinate with the honeybee voltage-dependent sodium ortholog. Our results showed that the honeybee sodium channel is more sensitive to r-fluvalinate than the V. destructor channel, suggesting that care must be taken when treating hives with this chemical. Gosselin-Badaroudine, P., Chahine, M. Biophysical characterization of the Varroa destructor Nav1 sodium channel and its affinity for r-fluvalinate insecticide.	[Gosselin-Badaroudine, Pascal; Chahine, Mohamed] Inst Univ Sante Mentale Quebec, Ctr Rech, 2601 Chemin Canardiere, Quebec City, PQ G1J 2G3, Canada; [Chahine, Mohamed] Univ Laval, Dept Med, Quebec City, PQ, Canada	Laval University; Laval University	Chahine, M (corresponding author), Inst Univ Sante Mentale Quebec, Ctr Rech, 2601 Chemin Canardiere, Quebec City, PQ G1J 2G3, Canada.	mohamed.chahine@phc.ulaval.ca			Natural Sciences and Engineering Research Council of Canada [(NSERC)]; NSERC	Natural Sciences and Engineering Research Council of Canada [(NSERC)](Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by the Natural Sciences and Engineering Research Council of Canada [(NSERC) Discovery Grant]. P.G.-B. was supported by an NSERC Postgraduate Scholarship. The authors thank Valerie Pouliot and Karine Drapeau for technical assistance and Pierre Giovenazzo (all from the Universite Laval) for providing the mites used in the study.	Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; CHAHINE M, 1992, J MOL CELL CARDIOL, V24, P1231, DOI 10.1016/0022-2828(92)93090-7; Charreton M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144879; Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012; Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110; Du YZ, 2009, J BIOL CHEM, V284, P33869, DOI 10.1074/jbc.M109.045690; Frazier J, 2011, AM BEE J, V151, P779; Gosselin-Badaroudine P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12475; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; Johnson RM, 2010, INT J ACAROL, V36, P1, DOI 10.1080/01647950903468273; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Oldroyd BP, 1999, TRENDS ECOL EVOL, V14, P312, DOI 10.1016/S0169-5347(99)01613-4; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Sammataro D, 2005, INT J ACAROL, V31, P67, DOI 10.1080/01647950508684419; Santiago GP, 2000, FLA ENTOMOL, V83, P468, DOI 10.2307/3496722; Soderlund DM, 2010, PESTIC BIOCHEM PHYS, V97, P78, DOI 10.1016/j.pestbp.2009.06.010; Song WZ, 2004, J BIOL CHEM, V279, P32554, DOI 10.1074/jbc.M402392200; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Wang RW, 2003, INSECT BIOCHEM MOLEC, V33, P733, DOI 10.1016/S0965-1748(03)00068-7	22	6	6	1	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3066	3071		10.1096/fj.201601338R	http://dx.doi.org/10.1096/fj.201601338R			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28356346				2022-12-26	WOS:000405931000030
J	Gu, LL; Larson-Casey, JL; Carter, AB				Gu, Linlin; Larson-Casey, Jennifer L.; Carter, A. Brent			Macrophages utilize the mitochondrial calcium uniporter for profibrotic polarization	FASEB JOURNAL			English	Article						MCU; asbestos; reactive oxygen species; pulmonary fibrosis; ATP	PULMONARY-FIBROSIS; ALTERNATIVE ACTIVATION; GENE-EXPRESSION; LIVER-INJURY; CA2+ UPTAKE; RESPONSES; RECEPTOR; CELLS; INFLAMMATION; RECRUITMENT	Fibrosis in multiple organs, including the liver, kidney, and lung, often occurs secondary to environmental exposure. Asbestos exposure is one important environmental cause of lung fibrosis. The mechanisms that mediate fibrosis is not fully understood, although mitochondrial oxidative stress in alveolar macrophages is critical for fibrosis development. Mitochondrial Ca2+ levels can be associated with production of reactive oxygen species. Here, we show that patients with asbestosis have higher levels of mitochondrial Ca2+ compared with normal patients. The mitochondrial calcium uniporter (MCU) is a highly selective ion channel that transports Ca2+ into the mitochondrial matrix to modulate metabolism. Asbestos exposure increased mitochondrial Ca2+ influx in alveolar macrophages from wild-type, but not MCLI+/-, mice. MCU expression polarized macrophages to a profibrotic phenotype after exposure to asbestos, and the profibrotic polarization was regulated by MCU-mediated ATP production. Profibrotic polarization was abrogated when MCU was absent or its activity was blocked. Of more importance, mice that were deficient in MCU were protected from pulmonary fibrosis. Regulation of mitochondrial Ca2+ suggests that MCU may play a pivotal role in the development of fibrosis and could potentially be a therapeutic target for pulmonary fibrosis. Gu, L., Larson-Casey, J. L., Carter, A. B. Macrophages utilize the mitochondrial calcium uniporter for profibrotic polarization.	[Gu, Linlin; Larson-Casey, Jennifer L.; Carter, A. Brent] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Carter, A. Brent] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Carter, AB (corresponding author), Univ Alabama Birmingham, Dept Med, 1918 Univ Blvd,404 MCLM, Birmingham, AL 35294 USA.	bcarter1@uab.edu	Casey, Jennifer/N-8385-2019	Casey, Jennifer/0000-0001-7238-7986	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences [2R01-E5015981-10]; U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development (Biomedical Laboratory Research and Development Grant) [1BX001135-04]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [P30-DK079626]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015981] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001135] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences; U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development (Biomedical Laboratory Research and Development Grant); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (Grant 2R01-E5015981-10). This work was also supported by a Merit Review from the U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development (Biomedical Laboratory Research and Development Grant 1BX001135-04). OCR assays were supported by NIH National Institute of Diabetes and Digestive and Kidney Diseases (Grant P30-DK079626). The authors thank the Diabetes Research Center Bio-Analytical Redox Biology Core, Douglas R. Moellering, and Praveen Vayalill (both from the University of Alabama at Birmingham) for technical assistance on the Seahorse assay.	De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Gizatullina ZZ, 2003, BIOCHEM BIOPH RES CO, V304, P643, DOI 10.1016/S0006-291X(03)00654-5; Glancy B, 2013, BIOCHEMISTRY-US, V52, P2793, DOI 10.1021/bi3015983; Griffiths EJ, 2009, BBA-BIOENERGETICS, V1787, P1324, DOI 10.1016/j.bbabio.2009.01.019; Hansson MJ, 2008, FREE RADICAL BIO MED, V45, P284, DOI 10.1016/j.freeradbiomed.2008.04.021; He C, 2016, AM J RESP CELL MOL, V55, P58, DOI 10.1165/rcmb.2015-0183OC; He C, 2013, J BIOL CHEM, V288, P20745, DOI 10.1074/jbc.M112.410720; He C, 2011, J BIOL CHEM, V286, P15597, DOI 10.1074/jbc.M110.187377; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Iwata Y, 2012, J IMMUNOL, V188, P4568, DOI 10.4049/jimmunol.1102154; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kawamura K, 2009, PATHOL INT, V59, P300, DOI 10.1111/j.1440-1827.2009.02369.x; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kovac S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.390; Larson-Casey JL, 2016, IMMUNITY, V44, P582, DOI 10.1016/j.immuni.2016.01.001; Larson-Casey JL, 2014, J BIOL CHEM, V289, P36204, DOI 10.1074/jbc.M114.593285; Liu T, 2008, CIRC RES, V103, P279, DOI 10.1161/CIRCRESAHA.108.175919; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Mammucari C, 2015, CELL REP, V10, P1269, DOI 10.1016/j.celrep.2015.01.056; McGowan TA, 2002, AM J PHYSIOL-RENAL, V282, pF910, DOI 10.1152/ajprenal.00252.2001; Murthy S, 2015, FASEB J, V29, P3527, DOI 10.1096/fj.15-271304; Murthy S, 2010, J BIOL CHEM, V285, P25062, DOI 10.1074/jbc.M109.099655; Murthy S, 2009, AM J PHYSIOL-LUNG C, V297, pL846, DOI 10.1152/ajplung.90590.2008; Nesti LJ, 2007, J CELL BIOCHEM, V101, P348, DOI 10.1002/jcb.21180; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; O'Hagan KA, 2009, P NATL ACAD SCI USA, V106, P2188, DOI 10.1073/pnas.0808801106; Osborn-Heaford HL, 2015, FREE RADICAL BIO MED, V86, P47, DOI 10.1016/j.freeradbiomed.2015.04.031; Osborn-Heaford HL, 2012, J BIOL CHEM, V287, P3301, DOI 10.1074/jbc.M111.308387; Ouimet M, 2015, J CLIN INVEST, V125, P4334, DOI 10.1172/JCI81676; Patron M, 2014, MOL CELL, V53, P726, DOI 10.1016/j.molcel.2014.01.013; Patron M, 2013, J BIOL CHEM, V288, P10750, DOI 10.1074/jbc.R112.420752; Rasmussen TP, 2015, P NATL ACAD SCI USA, V112, P9129, DOI 10.1073/pnas.1504705112; Redente EF, 2014, AM J RESP CELL MOL, V50, P825, DOI 10.1165/rcmb.2013-0386OC; Rimessi A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7201; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Ryan AJ, 2014, J BIOL CHEM, V289, P33391, DOI 10.1074/jbc.M114.579870; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Shaughnessy LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2683, DOI 10.2741/2364; Stahl M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081382; Tarasov AI, 2012, CELL CALCIUM, V52, P28, DOI 10.1016/j.ceca.2012.03.003; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Wu YJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7081; Yan HY, 2015, MOL NEUROBIOL, V52, P1637, DOI 10.1007/s12035-014-8942-z	45	24	24	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3072	3083		10.1096/fj.201601371R	http://dx.doi.org/10.1096/fj.201601371R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28351840	Green Published			2022-12-26	WOS:000405931000031
J	Sanchez-Carrera, D; Bravo-Navas, S; Cabezon, E; Arechaga, I; Cabezas, M; Yanez, L; Pipaon, C				Sanchez-Carrera, Damaso; Bravo-Navas, Sara; Cabezon, Elena; Arechaga, Ignacio; Cabezas, Matilde; Yanez, Lucrecia; Pipaon, Carlos			Fludarabine resistance mediated by aminoglycoside-3'-phosphotransferase-IIa and the structurally related eukaryotic cAMP-dependent protein kinase	FASEB JOURNAL			English	Article						purine analogues; protein kinase A; DNA damage; FANC proteins	CHRONIC LYMPHOCYTIC-LEUKEMIA; NUCLEOTIDE EXCISION-REPAIR; ANTIBIOTIC-RESISTANCE; NUCLEOSIDE ANALOGS; CRYSTAL-STRUCTURES; DNA; INHIBITION; 9-BETA-D-ARABINOFURANOSYL-2-FLUOROADENINE; ENZYME; CYTOTOXICITY	While working with G418-resistant stably transfected cells, we realized the neomycin resistance (NeoR) gene, which encodes the aminoglycoside-3'-phosphotransferase-IIa [APH(3')-IIa], also confers resistance to the nucleoside analog fludarabine. Fludarabine is a cytostatic drug widely used in the treatment of hematologic and solid tumors, as well as in the conditioning of patients before transplantation of hematopoietic progenitors. We present evidence that NeoR-transfected cells do not incorporate fludarabine, thus avoiding DNA damage caused by the drug, evidenced by a lack of FANCD2 monoubiquitination and impaired apoptosis. A screening of other nucleoside analogs revealed that APH(3')-IIa only protects against ATP purine analogs. Moreover, APH(3')-IIa ATPase activity is inhibited by fludarabine monophosphate, suggesting that APH(3')-IIa blocks fludarabine incorporation into DNA by dephosphorylating its active fludarabine triphosphate form. Furthermore, overexpression of the catalytic subunit of the eukaryotic kinase PKA, which is structurally related to APHs, also provides resistance to fludarabine, anticipating its putative utility as a response marker to the drug. Our results preclude the use of Neo marker plasmids in the study of purine analogs and unveils a new resistance mechanism against these chemotherapeuticals. Sanchez-Carrera, D., Bravo-Navas, S., Cabezon, E., Arechaga, I., Cabezas, M., Yaiiez, L., Pipaon, C. Fludarabine resistance mediated by aminoglycoside-3'-phosphotransferase-IIa and the structurally related eukaryotic cAMP-dependent protein kinase.	[Sanchez-Carrera, Damaso; Bravo-Navas, Sara; Yanez, Lucrecia; Pipaon, Carlos] Hosp Univ Marques Valdecilla, Inst Invest Marques Valdecilla IDIVAL, Lab Hematol Mol, Serv Hematol & Hemoterapia, Santander, Spain; [Cabezon, Elena; Arechaga, Ignacio; Cabezas, Matilde] Univ Cantabria, CSIC, Dept Biol Mol, Santander, Spain; [Cabezon, Elena; Arechaga, Ignacio; Cabezas, Matilde] Univ Cantabria, CSIC, Inst Biomed & Biotecnol Cantabria IBBTEC, Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC)	Pipaon, C (corresponding author), Hosp Univ Marques Valdecilla, Lab Hematol Mol, Pabellon 20,Bajo Avda Valdecilla S-N, Santander 39008, Spain.	cpipaon@humv.es	Pipaon, Carlos/L-4922-2014; Cabezon, Elena/K-5874-2014; Yáñez San Segundo, Lucrecia/G-4662-2016	Pipaon, Carlos/0000-0002-3851-6710; Yáñez San Segundo, Lucrecia/0000-0001-9925-3048; Cabezon, Elena/0000-0002-6177-5016; Bravo Navas, Sara/0000-0002-7166-0191	Hematology Service of the Hospital Marques de Valdecilla; Spanish Ministerio de Economia y Competitividad [BFU2011-22874]	Hematology Service of the Hospital Marques de Valdecilla; Spanish Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by the Hematology Service of the Hospital Marques de Valdecilla and Spanish Ministerio de Economia y Competitividad (Grant BFU2011-22874 to E.C and I.A). Fibroblast cell lines were kindly provided by Dr. Jordi Surralles (Universidad de Barcelona, Barcelona, Spain). The authors thank Virgina Martinez Callejo (Hospital Marques de Valdecilla) for providing many of the nucleoside analogues, and Gerardo Carranza [Institute de Biomedicina y Biotecnologia de Cantabria (IBBTEC)] for his help. The authors declare no conflicts of interest.	Amigo-Jimenez I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099993; Chang XB, 1998, J BIOL CHEM, V273, P23844, DOI 10.1074/jbc.273.37.23844; Daigle DM, 1997, J BIOL CHEM, V272, P24755, DOI 10.1074/jbc.272.40.24755; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; GANDHI V, 1994, LEUKEMIA LYMPHOMA, V14, P3, DOI 10.3109/10428199409052689; GANDHI V, 1993, LEUKEMIA LYMPHOMA, V10, P49, DOI 10.3109/10428199309147356; Grosdidier A, 2011, J COMPUT CHEM, V32, P2149, DOI 10.1002/jcc.21797; Hao WH, 2014, J FOOD DRUG ANAL, V22, P236, DOI 10.1016/j.jfda.2013.09.008; Hon WC, 1997, CELL, V89, P887, DOI 10.1016/S0092-8674(00)80274-3; Huang P, 2000, LEUKEMIA, V14, P1405, DOI 10.1038/sj.leu.2401845; HUANG P, 1990, J BIOL CHEM, V265, P16617; Kim C, 2006, J BIOL CHEM, V281, P6964, DOI 10.1074/jbc.M513257200; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; Li L, 1997, CANCER RES, V57, P1487; Michl J, 2016, EMBO J, V35, P909, DOI 10.15252/embj.201693860; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moufarij MA, 2006, BLOOD, V108, P4187, DOI 10.1182/blood-2006-05-023259; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ricci Francesca, 2009, Ther Clin Risk Manag, V5, P187; Sanchez-Carrera D, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150039; Sandoval A, 1996, CLIN CANCER RES, V2, P1731; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; SPRIGGS D, 1986, BIOCHEM PHARMACOL, V35, P247, DOI 10.1016/0006-2952(86)90521-6; Van Den Neste E, 2005, INT J ONCOL, V27, P1113; Wright Gerard D., 1999, Frontiers in Bioscience, V4, pD9, DOI 10.2741/Wright; Yamauchi T, 2014, BMC CANCER, V14, P547; YANG SW, 1992, J BIOL CHEM, V267, P2345; Young PG, 2009, J BACTERIOL, V191, P4133, DOI 10.1128/JB.00149-09; Zecevic A, 2011, CLIN CANCER RES, V17, P4731, DOI 10.1158/1078-0432.CCR-10-2561; ZHENG JH, 1993, PROTEIN SCI, V2, P1559, DOI 10.1002/pro.5560021003	32	1	1	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3007	3017		10.1096/fj.201601245R	http://dx.doi.org/10.1096/fj.201601245R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28373209				2022-12-26	WOS:000405931000025
J	Harding, CM; Pulido, MR; Di Venanzio, G; Kinsella, RL; Webb, AI; Scott, NE; Pachon, J; Feldman, MF				Harding, Christian M.; Pulido, Marina R.; Di Venanzio, Gisela; Kinsella, Rachel L.; Webb, Andrew I.; Scott, Nichollas E.; Pachon, Jeronimo; Feldman, Mario F.			Pathogenic Acinetobacter species have a functional type I secretion system and contact-dependent inhibition systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE; BIOFILM FORMATION; VI SECRETION; SP NOV.; BAUMANNII; IDENTIFICATION; GROWTH; EFFLUX; MEMBER; OVEREXPRESSION	Pathogenic Acinetobacter species, including Acinetobacter baumannii and Acinetobacter nosocomialis, are opportunistic human pathogens of increasing relevance worldwide. Although their mechanisms of drug resistance are well studied, the virulence factors that govern Acinetobacter pathogenesis are incompletely characterized. Here we define the complete secretome of A. nosocomialis strain M2 in minimal medium and demonstrate that pathogenic Acinetobacter species produce both a functional type I secretion system (T1SS) and a contact-dependent inhibition (CDI) system. Using bioinformatics, quantitative proteomics, and mutational analyses, we show that Acinetobacter uses its T1SS for exporting two putative T1SS effectors, an Repeatsin-Toxin (RTX)-serralysin-like toxin, and the biofilm-associated protein (Bap). Moreover, we found that mutation of any component of the T1SS system abrogated type VI secretion activity under nutrient-limited conditions, indicating a previously unrecognized cross-talk between these two systems. We also demonstrate that the Acinetobacter T1SS is required for biofilm formation. Last, we show that both A. nosocomialis and A. baumannii produce functioning CDI systems that mediate growth inhibition of sister cells lacking the cognate immunity protein. The Acinetobacter CDI systems are widely distributed across pathogenic Acinetobacter species, with many A. bauman-nii isolates harboring two distinct CDI systems. Collectively, these data demonstrate the power of differential, quantitative proteomics approaches to study secreted proteins, define the role of previously uncharacterized protein export systems, and observe cross-talk between secretion systems in the pathobiology of medically relevant Acinetobacter species.	[Harding, Christian M.; Pulido, Marina R.; Di Venanzio, Gisela; Kinsella, Rachel L.; Feldman, Mario F.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Pulido, Marina R.; Pachon, Jeronimo] Univ Seville, Unit Infect Dis Microbiol & Prevent Med, Seville 41004, Spain; [Pulido, Marina R.; Pachon, Jeronimo] Univ Seville, Biomed Inst Seville, Univ Hosp Virgen Rocio, CSIC, Seville 41004, Spain; [Kinsella, Rachel L.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2R3, Canada; [Webb, Andrew I.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Webb, Andrew I.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3050, Australia; [Scott, Nichollas E.] Univ Melbourne, Doherty Inst, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia	Washington University (WUSTL); University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; University of Alberta; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne	Feldman, MF (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	mariofeldman@wustl.edu	Di Venanzio, Gisela/GYV-3910-2022; Pachon, Jeronimo/M-4337-2014; Pulido, Marina/J-3176-2018	Pachon, Jeronimo/0000-0002-8166-5308; Pulido, Marina Rosa/0000-0003-1633-4294; Scott, Nichollas/0000-0003-2556-8316	Subprograma Sara Borrell from the Instituto de Salud Carlos III, Subdireccion General de Evaluacion y Fomento de la Investigacion, Ministerio de Economia y Competitividad of Spain [CD14/00014]; Natural Sciences and Engineering Research Council of Canada (NSERC); National Health and Medical Research Council of Australia (NHMRC) Overseas (Biomedical) Fellowship [APP1037373]; NHMRC [APP1100164]; University of Melbourne Early Career Researcher Grant Scheme [603107]	Subprograma Sara Borrell from the Instituto de Salud Carlos III, Subdireccion General de Evaluacion y Fomento de la Investigacion, Ministerio de Economia y Competitividad of Spain; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Health and Medical Research Council of Australia (NHMRC) Overseas (Biomedical) Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne Early Career Researcher Grant Scheme(University of Melbourne)	Supported by the Subprograma Sara Borrell from the Instituto de Salud Carlos III, Subdireccion General de Evaluacion y Fomento de la Investigacion, Ministerio de Economia y Competitividad of Spain (CD14/00014).; Funded by Natural Sciences and Engineering Research Council of Canada (NSERC).; Supported by a National Health and Medical Research Council of Australia (NHMRC) Overseas (Biomedical) Fellowship APP1037373, NHMRC Project Grant APP1100164, and the University of Melbourne Early Career Researcher Grant Scheme (Proposal 603107).	Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Aoki SK, 2010, NATURE, V468, P439, DOI 10.1038/nature09490; Arenas J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-622; Balakrishnan L, 2001, J MOL BIOL, V313, P501, DOI 10.1006/jmbi.2001.5038; Beck CM, 2014, STRUCTURE, V22, P707, DOI 10.1016/j.str.2014.02.012; Bentancor LV, 2012, J BACTERIOL, V194, P3950, DOI 10.1128/JB.06769-11; Brossard KA, 2012, INFECT IMMUN, V80, P228, DOI 10.1128/IAI.05913-11; Carruthers MD, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00906-13; Carruthers MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059388; CDC, 2013, ANTIBIOTIC RESISTANC; Cosgaya C, 2016, INT J SYST EVOL MICR, V66, P4105, DOI 10.1099/ijsem.0.001318; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Coyne S, 2010, ANTIMICROB AGENTS CH, V54, P4389, DOI 10.1128/AAC.00155-10; Damier-Piolle L, 2008, ANTIMICROB AGENTS CH, V52, P557, DOI 10.1128/AAC.00732-07; De Gregorio E, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2136-6; Delepelaire P, 2004, BBA-MOL CELL RES, V1694, P149, DOI 10.1016/j.bbamcr.2004.05.001; Garcia EC, 2016, P NATL ACAD SCI USA, V113, P8296, DOI 10.1073/pnas.1606323113; Garcia EC, 2013, MOL MICROBIOL, V89, P1213, DOI 10.1111/mmi.12339; Garcia-Bayona L, 2017, ELIFE, V6, DOI 10.7554/eLife.24869; Giammanco A, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00310-16; Goh HMS, 2013, APPL ENVIRON MICROB, V79, P6535, DOI 10.1128/AEM.01402-13; Harding CM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005391; Harding CM, 2015, MOL MICROBIOL, V96, P1023, DOI 10.1111/mmi.12986; Harding CM, 2013, MBIO, V4, DOI 10.1128/mBio.00360-13; Hayes CS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a010025; Hinsa SM, 2003, MOL MICROBIOL, V49, P905, DOI 10.1046/j.1365-2958.2003.03615.x; Holland I. B., 2016, ECOSAL PLUS, V7; Ishihama Y, 2006, J PROTEOME RES, V5, P988, DOI 10.1021/pr050385q; Jamet A, 2015, MBIO, V6, DOI 10.1128/mBio.00285-15; Johnson TL, 2016, J BACTERIOL, V198, P711, DOI 10.1128/JB.00622-15; Kodori M, 2017, LETT APPL MICROBIOL, V64, P304, DOI 10.1111/lam.12717; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lesic B, 2009, MICROBIOL-SGM, V155, P2845, DOI 10.1099/mic.0.029082-0; Liu CC, 2014, GENOMICS, V104, P215, DOI 10.1016/j.ygeno.2014.07.011; Loehfelm TW, 2008, J BACTERIOL, V190, P1036, DOI 10.1128/JB.01416-07; Luo TL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00182; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Magnet S, 2001, ANTIMICROB AGENTS CH, V45, P3375, DOI 10.1128/AAC.45.12.3375-3380.2001; Mari-Almirall M., 2016, CLIN MICROBIOL INFEC, V23; Mercy C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147435; Nemec A, 2015, INT J SYST EVOL MICR, V65, P934, DOI 10.1099/ijs.0.000043; Parker R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011096; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Peleg AY, 2009, ANTIMICROB AGENTS CH, V53, P2605, DOI 10.1128/AAC.01533-08; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Roca I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00148; Ruhe ZC, 2013, TRENDS MICROBIOL, V21, P230, DOI 10.1016/j.tim.2013.02.003; Satchell KJF, 2011, ANNU REV MICROBIOL, V65, P71, DOI 10.1146/annurev-micro-090110-102943; Schaab C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014068; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Scott NE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M000031-MCP201; Sun GW, 2010, MOL MICROBIOL, V76, P677, DOI 10.1111/j.1365-2958.2010.07124.x; Thomas S, 2014, BBA-MOL CELL RES, V1843, P1629, DOI 10.1016/j.bbamcr.2013.09.017; Tilley D, 2014, FEMS MICROBIOL LETT, V356, P53, DOI 10.1111/1574-6968.12496; Tucker AT, 2014, MBIO, V5, DOI 10.1128/mBio.01313-14; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, P11033, DOI 10.1093/nar/gkw880; WANG RC, 1991, J MOL BIOL, V217, P441, DOI 10.1016/0022-2836(91)90748-U; Weber BS, 2015, P NATL ACAD SCI USA, V112, P9442, DOI 10.1073/pnas.1502966112; Weber BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055142; Yoon EJ, 2013, ANTIMICROB AGENTS CH, V57, P2989, DOI 10.1128/AAC.02556-12; Zhang DP, 2011, NUCLEIC ACIDS RES, V39, P4532, DOI 10.1093/nar/gkr036	62	35	37	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9075	9087		10.1074/jbc.M117.781575	http://dx.doi.org/10.1074/jbc.M117.781575			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28373284	Green Published, hybrid			2022-12-26	WOS:000402538900007
J	Lince-Deroche, N; Fetters, T; Sinanovic, E; Devjee, J; Moodley, J; Blanchard, K				Lince-Deroche, Naomi; Fetters, Tamara; Sinanovic, Edina; Devjee, Jaymala; Moodley, Jack; Blanchard, Kelly			The costs and cost effectiveness of providing first-trimester, medical and surgical safe abortion services in KwaZulu-Natal Province, South Africa	PLOS ONE			English	Article							HEALTH SYSTEM COST; POSTABORTION CARE; UNSAFE ABORTION; TERMINATION; FACILITIES	Background Despite a liberal abortion law, access to safe abortion services in South Africa is challenging for many women. Medication abortion was introduced in 2013, but its reach remains limited. We aimed to estimate the costs and cost effectiveness of providing first-trimester medication abortion and manual vacuum aspiration (MVA) services to inform planning for first-trimester service provision in South Africa and similar settings. Methods We obtained data on service provision and outcomes from an operations research study where medication abortion was introduced alongside existing MVA services in public hospitals in KwaZulu-Natal province. Clinical data were collected through interviews with first-trimester abortion clients and summaries completed by nurses performing the procedures. In parallel, we performed micro-costing at three of the study hospitals. Using a model built in Excel, we estimated the average cost per medical and surgical procedure and determined the cost per complete abortion performed. Results are presented in 2015 US dollars. Results A total of 1,129 women were eligible for a first trimester abortion at the three study sites. The majority (886, 78.5%) were eligible to choose their abortion procedure; 94.1% (n = 834) chose medication abortion. The total average cost per medication abortion was $63.91 (52.32-75.51). The total average cost per MVA was higher at $69.60 (52.62-86.57); though the cost ranges for the two procedures overlapped. Given average costs, the cost per complete medication abortion was lower than the cost per complete MVA despite three (0.4%) medication abortion women being hospitalized and two (0.3%) having ongoing pregnancies at study exit. Personnel costs were the largest component of the total average cost of both abortion methods. Conclusion This analysis supports the scale-up of medication abortion alongside existing MVA services in South Africa. Women can be offered a choice of methods, including medication abortion with MVA as a back-up, without increasing costs.	[Lince-Deroche, Naomi] Ibis Reprod Hlth, Johannesburg, South Africa; [Fetters, Tamara] Ipas, Chapel Hill, NC USA; [Sinanovic, Edina] Univ Cape Town, Sch Publ Hlth & Family Med, Hlth Econ Unit, Cape Town, South Africa; [Devjee, Jaymala] King Dinuzulu Hosp, Dept Obstet & Gynaecol, Durban, South Africa; [Moodley, Jack] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Durban, South Africa; [Blanchard, Kelly] Ibis Reprod Hlth, Cambridge, MA USA	University of Cape Town; University of Kwazulu Natal	Lince-Deroche, N (corresponding author), Ibis Reprod Hlth, Johannesburg, South Africa.	nlince-deroche@heroza.org	Sinanovic, Edina/AAR-2590-2020	Lince-Deroche, Naomi/0000-0003-3689-4205	Consortium for Research on Unsafe Abortion and its principal donor; UK Department for International Development	Consortium for Research on Unsafe Abortion and its principal donor; UK Department for International Development	This research was funded primarily by the Consortium for Research on Unsafe Abortion and its principal donor, the UK Department for International Development.	Blanchard K, 2015, CONTRACEPTION, V92, P330, DOI 10.1016/j.contraception.2015.07.001; Casciola J., 2016, S AFRICAN HEAL REV, P95; Creinin MD, 2000, CONTRACEPTION, V62, P117, DOI 10.1016/S0010-7824(00)00151-7; Department of Public Service and Administration, 2015, SAL SCAL TRANSL KEYS; Harries J, 2012, J BIOSOC SCI, V44, P197, DOI 10.1017/S0021932011000678; Harries J, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-16; Hu D, 2009, BJOG-INT J OBSTET GY, V116, P768, DOI 10.1111/j.1471-0528.2009.02142.x; Hu Delphine, 2010, Afr J Reprod Health, V14, P85; International Monetary Fund, WORLD EC OUTLOOK DAT; Jewkes RK, 2005, BJOG-INT J OBSTET GY, V112, P1236, DOI 10.1111/j.1471-0528.2005.00697.x; Johnston HB, 2007, J FAM PLAN REPROD H, V33, P250, DOI 10.1783/147118907782101751; Kawonga M, 2008, J FAM PLAN REPROD H, V34, P159, DOI 10.1783/147118908784734846; KwaZulu-Natal Department of Health, 2013, POL CHOIC TERM PREGN; Levin C, 2009, REPROD HEALTH MATTER, V17, P120, DOI 10.1016/S0968-8080(09)33432-1; National Health Laboratory Service, 2014, STAT PRIC LIST 2014; Ngo TD, 2011, B WORLD HEALTH ORGAN, V89, P360, DOI 10.2471/BLT.10.084046; Niinimaki M, 2009, OBSTET GYNECOL, V114, P795, DOI 10.1097/AOG.0b013e3181b5ccf9; Oanda, 2015, HIST EXCH RAT USD ZA; Parmar D, 2015, GLOB PUBLIC HEALTH, V27, P1; Republic of South Africa Essential Drugs Programme, 2012, STAND TREATM GUID ES; Schmidt-Traub G., 2015, INVESTMENT NEEDS ACH; Shearer JC, 2010, INT J GYNECOL OBSTET, V108, P165, DOI 10.1016/j.ijgo.2009.08.037; Singh S, 2009, ADDING IT COSTS BENE; Singh S, 2013, ADDING IT NEED COST; Slade P, BR J OBS GYNAECOL, V105, P1288; South African National Blood Service, 2016, WHATS YOUR TYP; South African National Department of Health, 2010, 2011 NAT ANT SENT HI; South African National Department of Health, 2015, UN PAT FEE SCHED UPF; Stevens GA, 2013, LANCET, V1, P16, DOI DOI 10.1016/S2214-109X(13)70001-9; United Nations Department of Economic and Social Affairs, 2015, SUST DEV KNOWL PLATF; United Nations Population Fund [UNFPA], 2009, INT C POP DEV METH R; United Nations Statistics Division, 2008, MILL DEV GOALS IND O; United States Agency for International Development (USAID), 2006, ACH MILL DEV GOALS C; Vlassoff M, 2015, HEALTH POLICY PLANN, V30, P223, DOI 10.1093/heapol/czu006; Vlassoff M, 2012, INT J GYNECOL OBSTET, V118, pS127, DOI 10.1016/S0020-7292(12)60011-3; Vlassoff M, 2009, INT PERSPECT SEX R H, V35, P114, DOI 10.1363/ipsrh.35.114.09; Weeks A, 2005, OBSTET GYNECOL, V106, P540, DOI 10.1097/01.AOG.0000173799.82687.dc; White RG, 2008, SEX TRANSM INFECT, V84, P528, DOI 10.1136/sti.2008.032011; WHO, 2009, CONSTR SCAL HLTH REL; Winikoff B, 2012, INT PERSPECT SEX R H, V38, P164, DOI 10.1363/3816412; World Health Organization, 2012, SAF AB TECHN POL GUI, V2nd ed.; Wu YM, 2000, BRIT J OBSTET GYNAEC, V107, P524	42	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174615	10.1371/journal.pone.0174615	http://dx.doi.org/10.1371/journal.pone.0174615			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369061	Green Published, gold, Green Submitted			2022-12-26	WOS:000399351000024
J	Bor, R; Farkas, K; Fabian, A; Balint, A; Milassin, A; Rutka, M; Matuz, M; Nagy, F; Szepes, Z; Molnar, T				Bor, Renata; Farkas, Klaudia; Fabian, Anna; Balint, Anita; Milassin, Agnes; Rutka, Mariann; Matuz, Maria; Nagy, Ferenc; Szepes, Zoltan; Molnar, Tamas			Clinical role, optimal timing and frequency of serum infliximab and anti-infliximab antibody level measurements in patients with inflammatory bowel disease	PLOS ONE			English	Article							CROHNS-DISEASE; PARALLEL-GROUP; DOUBLE-BLIND; METAANALYSIS; MAINTENANCE; EFFICACY; IMMUNOGENICITY; OUTCOMES; THERAPY; SAFETY	Background Serum infliximab (IFX) and antibody-to-infliximab (ATI) levels are objective parameters, that may have a great role in the therapeutic decisions during maintenance biological therapy. Research design and methods 48 inflammatory bowel disease patients receiving maintenance IFX therapy were prospectively enrolled and divided into adequate (complete remission N = 20) and inadequate responder (partial response, loss of response, dose escalation; N = 28) groups. Blood samples were collected just before (trough level, TL) and two (W2aTL) and six weeks (W6aTL) after the administration of IFX. Results Single measurement of ATI titer was insufficient for predicting therapeutic response due to transient expression of ATI, however, using the three points' measurements, significant difference has been detected between the adequate and inadequate responder group (5.0% vs 35.7%; p = 0.016). The mean value of TL was significantly higher in the adequate responder group (3.11 +/- 1.64 vs. 1.19 +/- 1.11; p<0.001) without further difference on the second and sixth week. Sensitivity and specificity for predicting the therapeutic response were 85.0% and 71.4% based on the cut-off value of TL 2.0 mu g/ml. Conclusion Simultaneous measurement of serum IFX level prior to administration of regular IFX infusion and ATI titers significantly increase the diagnostic accuracy for the therapeutic decision in patients uncertainly responding to the therapy. The measurement of W2aTL and W6aTL levels did not result in further improvement in the prediction of therapeutic response.	[Bor, Renata; Farkas, Klaudia; Fabian, Anna; Balint, Anita; Milassin, Agnes; Rutka, Mariann; Nagy, Ferenc; Szepes, Zoltan; Molnar, Tamas] Univ Szeged, Dept Med 1, Szeged, Hungary; [Matuz, Maria] Univ Szeged, Fac Pharm, Dept Clin Pharm, Szeged, Hungary	Szeged University; Szeged University	Molnar, T (corresponding author), Univ Szeged, Dept Med 1, Szeged, Hungary.	molnar.tamas@med.u-szeged.hu	matuz, maria/ABE-1900-2021; Molnár, Tamás/GMX-4334-2022	matuz, maria/0000-0002-7877-2399; Bor, Renata/0000-0001-9393-5240; Fabian, Anna/0000-0002-0824-7476	Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences [BO/00632/14/5]; New National Excellence Program of the Ministry of Human Capacities [UNKP-UNKP-16-4]; National Research, Development and Innovation Office [K119809]	Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); New National Excellence Program of the Ministry of Human Capacities; National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary)	This work was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (BO/00632/14/5), the UNKP-UNKP-16-4 New National Excellence Program of the Ministry of Human Capacities and by the research grant of the National Research, Development and Innovation Office (K119809).	Baert F, 2003, NEW ENGL J MED, V348, P601, DOI 10.1056/NEJMoa020888; Ben-Horin S, 2016, GUT, V65, P1132, DOI 10.1136/gutjnl-2015-309290; Cornillie F, 2014, GUT, V63, P1721, DOI 10.1136/gutjnl-2012-304094; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hanauer SB, 2004, CLIN GASTROENTEROL H, V2, P542, DOI 10.1016/S1542-3565(04)00238-1; Lee LYW, 2012, EUR J GASTROEN HEPAT, V24, P1078, DOI 10.1097/MEG.0b013e32835558cf; Levesque BG, 2014, ALIMENT PHARM THER, V39, P1126, DOI 10.1111/apt.12733; Molnar T, 2013, ALIMENT PHARM THER, V37, P225, DOI 10.1111/apt.12160; Moore C, 2016, J CROHNS COLITIS, V10, P619, DOI 10.1093/ecco-jcc/jjw007; Nanda KS, 2013, AM J GASTROENTEROL, V108, P40, DOI 10.1038/ajg.2012.363; O'Meara S, 2014, INFLAMM BOWEL DIS, V20, P1, DOI 10.1097/01.MIB.0000436951.80898.6d; Park W, 2015, EXPERT REV CLIN IMMU, V11, pS25, DOI 10.1586/1744666X.2015.1090311; Paul S, 2013, INFLAMM BOWEL DIS, V19, P2568, DOI 10.1097/MIB.0b013e3182a77b41; Rutgeerts P, 2004, GASTROENTEROLOGY, V126, P1593, DOI 10.1053/j.gastro.2004.02.070; Sands BE, 2004, CLIN GASTROENTEROL H, V2, P912, DOI 10.1016/S1542-3565(04)00414-8; Schnitzler F, 2009, GUT, V58, P492, DOI 10.1136/gut.2008.155812; Seow CH, 2010, GUT, V59, P49, DOI 10.1136/gut.2009.183095; Ungar B, 2016, ALIMENT PHARM THER, V43, P1293, DOI 10.1111/apt.13631; Ungar B, 2014, GUT, V63, P1258, DOI 10.1136/gutjnl-2013-305259; Weisshof R, 2016, INFLAMM BOWEL DIS, V22, P1655, DOI 10.1097/MIB.0000000000000797; Yoo DH, 2013, ANN RHEUM DIS, V72, P1613, DOI 10.1136/annrheumdis-2012-203090	21	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0172916	10.1371/journal.pone.0172916	http://dx.doi.org/10.1371/journal.pone.0172916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362851	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000399175000004
J	Pickar, A; Xu, P; Elson, A; Zengel, J; Sauder, C; Rubin, S; He, B				Pickar, Adrian; Xu, Pei; Elson, Andrew; Zengel, James; Sauder, Christian; Rubin, Steve; He, Biao			Establishing a small animal model for evaluating protective immunity against mumps virus	PLOS ONE			English	Article							VACCINE; INFECTION; PATHOGENESIS; REPLICATION; ANTIBODIES; PROTEIN; MICE; TRANSCRIPTION; PERSISTENCE; POPULATION	Although mumps vaccines have been used for several decades, protective immune correlates have not been defined. Recently, mumps outbreaks have occurred in vaccinated populations. To better understand the causes of the outbreaks and to develop means to control outbreaks in mumps vaccine immunized populations, defining protective immune correlates will be critical. Unfortunately, no small animal model for assessing mumps immunity exists. In this study, we evaluated use of type I interferon (IFN) alpha/beta receptor knockout mice (IFN-alpha/beta R-/-) for such a model. We found these mice to be susceptible to mumps virus administered intranasally and intracranially. Passive transfer of purified IgG from immunized mice protected naive mice from mumps virus infection, confirming the role of antibody in protection and demonstrating the potential for this model to evaluate mumps immunity.	[Pickar, Adrian; Xu, Pei; Elson, Andrew; Zengel, James; He, Biao] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Sauder, Christian; Rubin, Steve] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Pickar, Adrian] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Xu, Pei] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	University System of Georgia; University of Georgia; US Food & Drug Administration (FDA); Duke University; University of Chicago	He, B (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.	bhe@uga.edu		Zengel, James/0000-0003-3153-3603	National Institutes of Health [R01AI 097368]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106307, R01AI097368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported from National Institutes of Health, R01AI 097368 to BH (https://projectreporter.nih.gov/project_info_description.cfm?aid=9056969&icde=32866347&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC&pball=). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We appreciate the helpful discussion and technical assistance from all members of Dr. Biao He's laboratory. This work was supported by a grant from National Institutes of Health (R01AI 097368).	BJORVATN B, 1974, SCAND J INFECT DIS, V6, P125, DOI 10.3109/inf.1974.6.issue-2.05; Brandao J. S., 2015, J INFECT DIS, P1; BUYNAK EB, 1968, J AMER MED ASSOC, V203, P9, DOI 10.1001/jama.1968.03140010011002; CARBONE KM, 2001, FIELDS VIROLOGY, P1381; Cusi MG, 2001, ARCH VIROL, V146, P1241, DOI 10.1007/s007050170088; Davidkin I, 2008, J INFECT DIS, V197, P950, DOI 10.1086/528993; DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968; eguljev S Z, 2012, EUROSURVEILLANCE, V17, P20169; FRIEDMAN MG, 1981, J INFECT DIS, V143, P617, DOI 10.1093/infdis/143.4.617; Hassan J, 2012, J CLIN VIROL; Kaaijk P, 2008, EUROSURVEILLANCE, V13, P6; Kolokoltsova OA, 2010, J VIROL, V84, P13063, DOI 10.1128/JVI.01389-10; Marin M, 2008, VACCINE, V26, P3601, DOI 10.1016/j.vaccine.2008.04.075; MARIS EP, 1946, J EXP MED, V84, P323, DOI 10.1084/jem.84.4.323; Nelson GE, 2013, PEDIATR INFECT DIS J, V32, P374, DOI 10.1097/INF.0b013e318279f593; Pagano J S, 1967, Prog Immunobiol Stand, V3, P196; PHILIP RN, 1995, AM J EPIDEMIOL, V142, P233, DOI 10.1093/oxfordjournals.aje.a117631; Pickar A, 2014, J VIROL, V88, P4414, DOI 10.1128/JVI.03673-13; Rubin SA, 2005, J INFECT DIS, V191, P1123, DOI 10.1086/428098; Rubin S, 2015, J PATHOL, V235, P242, DOI 10.1002/path.4445; Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109; Smits G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058234; TANAKA K, 1992, VACCINE, V10, P824, DOI 10.1016/0264-410X(92)90044-K; TSURUDOME M, 1987, ARCH VIROL, V97, P167, DOI 10.1007/BF01314419; UKKONEN P, 1981, J MED VIROL, V8, P131, DOI 10.1002/jmv.1890080207; WEIBEL RE, 1968, J AMER MED ASSOC, V203, P14; Xu P, 2014, J VIROL, V88, P2600, DOI 10.1128/JVI.02778-13; Xu P, 2013, J VIROL, V87, P8158, DOI 10.1128/JVI.01028-13; Xu P, 2012, J VIROL, V86, P1768, DOI 10.1128/JVI.06019-11; Xu P, 2011, VIROLOGY, V417, P126, DOI 10.1016/j.virol.2011.05.003; YOUNG ML, 1967, PEDIATRICS, V40, P798; Zengel J, 2015, J VIROL, V89, P7338, DOI 10.1128/JVI.00686-15	32	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174444	10.1371/journal.pone.0174444	http://dx.doi.org/10.1371/journal.pone.0174444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362871	Green Published, Green Submitted, gold			2022-12-26	WOS:000399175000015
J	Fu, LY; Jia, LY; Zhang, W; Han, PP; Kang, L; Ma, YX; Yu, HR; Zhai, TQ; Chen, XY; Guo, Q				Fu, Liyuan; Jia, Liye; Zhang, Wen; Han, Peipei; Kang, Li; Ma, Yixuan; Yu, Hairui; Zhai, Tianqi; Chen, Xiaoyu; Guo, Qi			The association between sleep duration and physical performance in Chinese community dwelling elderly	PLOS ONE			English	Article							SELF-REPORTED SLEEP; LONG-SLEEP; POOR SLEEP; OLDER MEN; MORTALITY; STRENGTH; ADULTS; DECLINE; QUALITY; HEALTH	Background Physical performance is an important healthy factor in elder people. Good living habits, which include sleep, can maintain physical strength and physical performance. The aim of the present study was to conduct a cross-sectional study to determine the association between total sleep duration and physical performance. Methods Our study population comprised residents of the township central hospital in the suburban of Tianjin, China. We measured muscle strength, walk speed and balance function by grip, 4m walk test and timed up and go test (TUGT). We divided sleep duration into four groups <7h, 7-8h, >8-9h, >9h. Results A total 898 participants had completed data (392 men and 506 women, mean age 67.71 years). In man, adjusted sleep duration was associated with lower grip in > 9 h group, the mean value (95% CI) was 0.429 (0.409, 0.448), and longer TUGT time was also associated with long sleep duration, 10.46s (9.97 s, 10.95 s). In women, adjusted slower 4-m walk speed present an inverse U-shaped relation with sleep duration, by 0.93 m/s (0.86 m/s, 0.98 m/s), 0.97 m/s (0.96 m/s, 1.00 m/s), 0.97 m/s (0.95 m/s, 0.99 m/s) and 0.92 m/s (0.89 m/s, 0.96 m/s); longer TUGT time were associated with long sleep duration (> 9 h), by 11.23 s (10.70 s, 11.77 s). Conclusion In Chinese community-dwelling elderly, lower muscle strength and lower balance function were associated with long sleep duration in men. Slower walk speed and lower balance function were associated with long sleep duration in women.	[Fu, Liyuan; Zhang, Wen; Guo, Qi] Tianjin Med Univ, TEDA Int Cardiovasc Hosp, Dept Rehabil Med, Cardiovasc Clin Coll, Tianjin, Peoples R China; [Fu, Liyuan; Jia, Liye; Zhang, Wen; Han, Peipei; Kang, Li; Ma, Yixuan; Yu, Hairui; Zhai, Tianqi; Chen, Xiaoyu; Guo, Qi] Tianjin Med Univ, Dept Rehabil & Sports Med, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Guo, Q (corresponding author), Tianjin Med Univ, TEDA Int Cardiovasc Hosp, Dept Rehabil Med, Cardiovasc Clin Coll, Tianjin, Peoples R China.; Guo, Q (corresponding author), Tianjin Med Univ, Dept Rehabil & Sports Med, Tianjin, Peoples R China.	guoqijp@gmail.com			National Natural Science Foundation of China [81372118]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant numbers: National Natural Science Foundation of China (81372118); URL: http://www.nsfc.gov.cn/.	Auyeung TW, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2015.04.006; Ayas NT, 2003, DIABETES CARE, V26, P380, DOI 10.2337/diacare.26.2.380; Brasure M, 2015, AHRQ COMP EFFECTIVEN; Buxton OM, 2010, SOC SCI MED, V71, P1027, DOI 10.1016/j.socscimed.2010.05.041; Chainani V, 2016, INT J CARDIOL, V215, P487, DOI 10.1016/j.ijcard.2016.04.068; Clark BC, 2006, J APPL PHYSIOL, V101, P264, DOI 10.1152/japplphysiol.01404.2005; Cui YF, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0117-x; Dam TTL, 2008, J AM GERIATR SOC, V56, P1665, DOI 10.1111/j.1532-5415.2008.01846.x; Delmonico MJ, 2009, AM J CLIN NUTR, V90, P1579, DOI 10.3945/ajcn.2009.28047; den Ouden MEM, 2011, MATURITAS, V69, P208, DOI 10.1016/j.maturitas.2011.04.008; Evans WJ, 2010, AM J CLIN NUTR, V91, p1123S, DOI 10.3945/ajcn.2010.28608A; Fex A, 2012, J CLIN SLEEP MED, V8, P309, DOI 10.5664/jcsm.1922; Gangwisch JE, 2008, SLEEP, V31, P1087; Goldman SE, 2007, SLEEP, V30, P1317, DOI 10.1093/sleep/30.10.1317; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hale L, 2013, J SLEEP RES, V22, P305, DOI 10.1111/jsr.12020; Hamburg NM, 2007, ARTERIOSCL THROM VAS, V27, P2650, DOI 10.1161/ATVBAHA.107.153288; Hubscher M, 2010, GAIT POSTURE, V32, P383, DOI 10.1016/j.gaitpost.2010.06.018; Imaizumi H, 2015, OBESITY FACTS, V8, P234, DOI 10.1159/000436997; Iolascon G, 2015, AGING CLIN EXP RES, V27, pS23, DOI 10.1007/s40520-015-0405-5; Kakizaki M, 2013, J SLEEP RES, V22, P209, DOI 10.1111/j.1365-2869.2012.01053.x; Karakelides H, 2005, CURR TOP DEV BIOL, V68, P123, DOI 10.1016/S0070-2153(05)68005-2; Knutson KL, 2009, ARCH INTERN MED, V169, P1055, DOI 10.1001/archinternmed.2009.119; Kronholm E, 2006, J SLEEP RES, V15, P276, DOI 10.1111/j.1365-2869.2006.00543.x; Kronholm E, 2009, J SLEEP RES, V18, P436, DOI 10.1111/j.1365-2869.2009.00765.x; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; McInnes L, 2005, WORLDV EVID-BASED NU, V2, P33, DOI 10.1111/j.1524-475X.2005.04094.x; Mearns Bryony M, 2015, Nat Rev Cardiol, V12, P379, DOI 10.1038/nrcardio.2015.84; Reyes S, 2013, AGING CLIN EXP RES, V25, P175, DOI 10.1007/s40520-013-0028-7; Shin H, 2011, J AGING RES, DOI DOI 10.4061/2011/191896; Spira AP, 2012, J AM GERIATR SOC, V60, P1092, DOI 10.1111/j.1532-5415.2012.03968.x; Stenholm S, 2012, J GERONTOL A-BIOL, V67, P1068, DOI 10.1093/gerona/gls064; Stenholm S, 2011, SLEEP, V34, P1583, DOI 10.5665/sleep.1402; Stenholm S, 2010, J GERONTOL A-BIOL, V65, P649, DOI 10.1093/gerona/glq017; Stone KL, 2009, J AM GERIATR SOC, V57, P604, DOI 10.1111/j.1532-5415.2008.02171.x; Wang K, 2015, ENDOCRINE, V49, P538, DOI 10.1007/s12020-014-0493-6; Wolkove N, 2007, CAN MED ASSOC J, V176, P1299, DOI 10.1503/cmaj.060792; Yang L, 2016, SLEEP; Yeo Yohwan, 2013, J Prev Med Public Health, V46, P271, DOI 10.3961/jpmph.2013.46.5.271; Youngstedt SD, 2004, SLEEP MED REV, V8, P159, DOI 10.1016/j.smrv.2003.10.002; Zhang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115883	42	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174832	10.1371/journal.pone.0174832	http://dx.doi.org/10.1371/journal.pone.0174832			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VI	28358845	gold, Green Submitted, Green Published			2022-12-26	WOS:000399174800098
J	Metrak, M; Chachulski, L; Navruzshoev, D; Pawlikowski, P; Rojan, E; Sulwinski, M; Suska-Malawska, M				Metrak, Monika; Chachulski, Lukasz; Navruzshoev, Dovutsho; Pawlikowski, Pawel; Rojan, Elzbieta; Sulwinski, Marcin; Suska-Malawska, Malgorzata			Nature's patchwork: How water sources and soil salinity determine the distribution and structure of halophytic plant communities in arid environments of the Eastern Pamir	PLOS ONE			English	Article							SEED-GERMINATION; VEGETATION; CLASSIFICATION; CLIMATE; BIOMASS	The eastern part of the Pamir Mountains, located in Central Asia, is characterized by great climatic continentality and aridity. Wetlands developed in this hostile region are restricted to spring areas, terraces of shallow lakes or floodplains along rivers, and provide diversified ecosystem services e.g. as water reservoirs, refugia for rare species and pastures for domestic cattle. These ecosystems are particularly susceptible to climate changes, that in the Pamir Mountains result in increased temperatures, intense permafrost/glacial melt and alterations of precipitation patterns. Climatic changes affect pasture management in the mountains, causing overutilization of sites located at lower elevations. Thus, both climate and man-induced disturbances may violate the existing ecological equilibrium in high mountain wetlands of the Eastern Pamir, posing a serious risk to their biodiversity and to food security of the local population. In this context, we sought to assess how environmental drivers (with special focus on soil features and potential water sources) shape the distribution and diversity of halophytic plant communities developed in valleys in the Eastern Pamir. This task was completed by means of a vegetation survey and comprehensive analyses of habitat conditions. The lake terraces and floodplains studied were covered by a repetitive mosaic of plant communities determined by differences in soil moisture and salinity. On lower, wetter sites, this patchwork was formed by Blysmus rufus dominated salt marshes, saline small sedge meadows and saline meadows with Kobresia royleana and Primula pamirica; and on drier, elevated sites, by endemic grasslands with Hordeum brevisubulatum and Puccinellia species and patches of xerohalophytic vegetation. Continuous instability of water sources and summer droughts occurring in the Pamir Mountains may lead to significant structural and functional transformations of described wetland ecosystems. Species more tolerant to decreased soil moisture and/or increased soil salinity will expand, leading to alterations of ecosystem services provided by the Pamirs' wetlands. The described research will help to assess the current state of the wetlands and to predict directions of their future changes.	[Metrak, Monika; Pawlikowski, Pawel; Sulwinski, Marcin; Suska-Malawska, Malgorzata] Univ Warsaw, Dept Plant Ecol & Environm Protect, Fac Biol, Biol & Chem Res Ctr, Warsaw, Poland; [Chachulski, Lukasz] Warsaw Univ Life Sci, Fac Agr & Bot, Dept Bot, Warsaw, Poland; [Navruzshoev, Dovutsho] Acad Sci Republ Tajikistan, Kh Yu Yusufbekov Pamir Biol Inst, Khorog, Tajikistan; [Rojan, Elzbieta] Univ Warsaw, Fac Geog & Reg Studies, Warsaw, Poland	University of Warsaw; Warsaw University of Life Sciences; Academy of Sciences of Republic of Tajikistan; KH.YU. Yusufbekov Pamir Biological Institute; University of Warsaw	Metrak, M (corresponding author), Univ Warsaw, Dept Plant Ecol & Environm Protect, Fac Biol, Biol & Chem Res Ctr, Warsaw, Poland.	mmetrak@biol.uw.edu.pl	Suska-Malawska, Małgorzata/AAT-9188-2021	Suska-Malawska, Małgorzata/0000-0002-5400-9508; Metrak, Monika/0000-0002-6069-6041; Pawlikowski, Pawel/0000-0002-0656-5067; Rojan, Elzbieta/0000-0003-0550-1480; Chachulski, Lukasz/0000-0002-8290-0816; Sulwinski, Marcin/0000-0001-9248-4513	National Science Centre of Poland [2013/09/B/ST10/01662]	National Science Centre of Poland(National Science Centre, Poland)	This work was financially supported by the National Science Centre of Poland (https www.ncn.gov.pl/). Grant number is 2013/09/B/ST10/01662.	Achrorov F, 2006, WORKS, V1; AGAKHANJANZ O, 1995, ECOL STUD-ANAL SYNTH, V113, P63; Agakhanjanz OE, 1965, MAIN PROBLEMS PHYS G; Agakhanjanz OE, 1978, ARCTIC ALPINE RES, V10, P97; Akhmadov KM, 2006, LAND USE CHANGE AND MOUNTAIN BIODIVERSITY, P239; Albert R., 2000, ERGEBNISSE WELTWEITE, V7, P69; [Anonymous], 2010, GLACIER RESOURCES TA; BARKMAN J. J., 1964, ACTA BOT NEER, V13, P394; Bashour I.I., 2007, METHODS ANAL SOILS A; Braakter CJF, 1998, CANOCO REFERENCE MAN; Breckle SW, 2006, LAND USE CHANGE AND MOUNTAIN BIODIVERSITY, P225, DOI 10.1201/9781420002874.ch16; Breckle SW, 2002, SALINITY: ENVIRONMENT - PLANTS - MOLECULES, P53; Cantero JJ, 1998, PLANT ECOL, V137, P79, DOI 10.1023/A:1008071813231; Chytry A M., 2010, VEGETATION CZECH REP; Chytry M, 2003, J VEG SCI, V14, P563, DOI 10.1111/j.1654-1103.2003.tb02183.x; COLOVOS G, 1976, ANAL CHEM, V48, P1693, DOI 10.1021/ac50006a016; D'Odorico P, 2006, BIOSCIENCE, V601, P898; Dite D, 2006, PRESLIA, V78, P331; Estrelles E, 2015, J ARID ENVIRON, V117, P1, DOI 10.1016/j.jaridenv.2015.02.005; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; Gilbert AA, 2013, PLANT ECOL, V214, P433, DOI 10.1007/s11258-013-0180-3; GOLUB VB, 1994, FOLIA GEOBOT PHYTOTX, V29, P15, DOI 10.1007/BF02807774; GORBUNOV AP, 1978, ARCTIC ALPINE RES, V10, P283, DOI 10.2307/1550761; Gul B, 2013, ENVIRON EXP BOT, V92, P4, DOI 10.1016/j.envexpbot.2012.11.006; Hagg W, 2006, NORD HYDROL, V37, P93, DOI 10.2166/nh.2006.001; Hameed A, 2014, ENVIRON EXP BOT, V107, P32, DOI 10.1016/j.envexpbot.2014.04.005; Haritashya, 2011, ENCY SNOW ICE GLACIE, P13; Hill M.O., 1979, TWINSPAN FORTRAN PRO; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Ikonnikov SS, 1967, VEGETATION DEV AQUAT; Ikonnikov SS, 1963, WORKS, V20; IUSS Working Group WRB, 2006, WORLD SOIL RES REP; Kassam KA, 2009, HUM ECOL, V37, P677, DOI 10.1007/s10745-009-9284-8; Keddy PA, 2013, WETLAND ECOLOGY PRIN; Khan M. A., 2006, SABKHA ECOSYSTEMS, P129; Khan MA, 2003, TASK VEG SC, V38, P167; Khan MA, 2001, BIOL PLANTARUM, V44, P301, DOI 10.1023/A:1010272030538; Khromova TE, 2006, REMOTE SENS ENVIRON, V102, P24, DOI 10.1016/j.rse.2006.01.019; Kimble J. M., 2004, CRYOSOLS PERMAFROST; Konar M, 2013, ADV WATER RESOUR, V51, P317, DOI 10.1016/j.advwatres.2012.02.009; Lal Rattan, 2013, Ecohydrology & Hydrobiology, V13, P8, DOI 10.1016/j.ecohyd.2013.03.006; LAUSI D, 1979, VEGETATIO, V39, P171; Laws Lim M., 2012, LEAD J, V8, P43; Li WQ, 2008, PAK J BOT, V40, P1081; Lioubimtseva E, 2006, REV FISH SCI, V14, P29, DOI 10.1080/10641260500340603; Lioubimtseva E, 2005, J ARID ENVIRON, V62, P285, DOI 10.1016/j.jaridenv.2004.11.005; Markov KV, 1951, GEOGRAFGIZ, V24, P98; Mergili M, 2012, GEOGR ANN A, V94A, P79, DOI 10.1111/j.1468-0459.2011.00450.x; Metrak M., 2015, CREEPING ENV PROBLEM, P665, DOI [10.1007/978-3-319-12859-7_28, DOI 10.1007/978-3-319-12859-7_28]; Michel S, 2010, SURVEY MARCO POLO SH, P1; MIKHAILOVA S. G., 1970, Izvestiya Akademii Nauk Tadzhikskoi SSR. Otdel Biologicheski Nauk, V1, P7; Mucina L, 2016, APPL VEG SCI, V19, P3, DOI 10.1111/avsc.12257; Navruzshoev D, 2013, RARE BEING DANGER EX; Nelson D.W., 1996, METHODS SOIL ANAL, P961, DOI DOI 10.2136/SSSAB00KSER5.3.C34; Nowak A, 2015, PHYTOCOENOLOGIA, V45, P299, DOI 10.1127/phyto/2015/0048; Nowak A, 2015, PAK J BOT, V47, P1415; Nowak A, 2015, OPEN LIFE SCI, V10, P71, DOI 10.1515/biol-2015-0009; Omer RM, 2006, J ARID ENVIRON, V67, P641, DOI 10.1016/j.jaridenv.2006.03.008; Ostrowska A, 1991, METHODS CHEM ANAL AS; Ovczinnikov PN, 1951, T TFAN SSSR, V27; Ovczinnikov PN, 1954, IZV AN TADJITSKOI SS, V6; Pachajanov DN, 2002, NATO SCI S SS IV EAR, V13, P169; Richards L.A., 1954, AGR HDB USDA; Rodwell J. S., 2000, BRIT PLANT COMMUNITI, V5, P1; Rogel JA, 2001, GEODERMA, V99, P81; Rojan E., 2007, SLUPSKIE PRACE GEOGR, V4, P123; Rolecek J, 2009, J VEG SCI, V20, P596, DOI 10.1111/j.1654-1103.2009.01062.x; Ross D., 1995, RECOMMENDED SOIL TES, V493, P62; Seilsepour M, 2009, J AGR ENV SCI, V5, P1; Seim A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153888; Shahgedanova M., 2002, PHYS GEOGRAPHY NO EU, P284; Shanazarov AS, 2011, STRATEGY ACTION PLAN; Shirokova Y., 2000, Irrigation and Drainage Systems, V14, P199, DOI 10.1023/A:1026560204665; Squires V., 2013, HIGH ALTITUDE RANGEL, P78; Stanyukovich KV, 1949, NEW SERIES, V10; Stevanovic ZD, 2016, PHYTOCOENOLOGIA, V46, P317, DOI 10.1127/phyto/2016/0076; Stevens JC, 2006, AUST J AGR RES, V57, P1279, DOI 10.1071/AR06031; Stieshenko AP, 1955, T AN TADJITSKOI SSRR; Stieshenko AP, 1955, IZV OTD EST NAUK A N, V12; Strogonov BP, 1964, T I BOT SSR, V20, P166; Taghvaei Mansour, 2012, Journal of Ecology and Field Biology, V35, P73, DOI 10.5141/JEFB.2012.011; Tichy L, 2002, J VEG SCI, V13, P451, DOI 10.1111/j.1654-1103.2002.tb02069.x; UNGAR IA, 1967, AM MIDL NAT, V78, P98, DOI 10.2307/2423373; Unger-Shayesteh K, 2013, GLOBAL PLANET CHANGE, V110, P4, DOI 10.1016/j.gloplacha.2013.02.004; United Nations Development Programme, 2011, GLAC CENTR AS DIS RE; VANDERMAAREL E, 1979, VEGETATIO, V39, P97, DOI 10.1007/BF00052021; Vanselow KA., 2011, THESIS; Vanselow KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148930; Vanselow KA, 2012, MT RES DEV, V32, P324, DOI 10.1659/MRD-JOURNAL-D-12-00001.1; Vassijevskaja VD, 2004, CRYOSOLS: PERMAFROST-AFFECTED SOILS, P581; Velichko AA, 2011, GEOGR POL, V84, P179, DOI 10.7163/GPol.2011.S1.12; Walter H., 1973, RELATION CLIMATE ECO; Williams M.W., 2008, CENTRAL ASIA TEMPERA, DOI [10.7265/N5NK3BZ8, DOI 10.7265/N5NK3BZ8]; Zhou H, GLOBAL PLAN IN PRESS	94	16	17	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174496	10.1371/journal.pone.0174496	http://dx.doi.org/10.1371/journal.pone.0174496			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358825	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174800043
J	O'Dea, S; Annibaldi, V; Gallagher, L; Mulholland, J; Molloy, EL; Breen, CJ; Gilbert, JL; Martin, DS; Maguire, M; Curry, FR				O'Dea, Shirley; Annibaldi, Valeria; Gallagher, Louise; Mulholland, Joanne; Molloy, Emer L.; Breen, Conor J.; Gilbert, Jennifer L.; Martin, Darren S.; Maguire, Michael; Curry, Fitz-Roy			Vector-free intracellular delivery by reversible permeabilization	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDES; NONVIRAL GENE DELIVERY; IN-VITRO; MEMBRANES; PROTEINS; THERAPY; ETHANOL; VIVO	Despite advances in intracellular delivery technologies, efficient methods are still required that are vector-free, can address a wide range of cargo types and can be applied to cells that are difficult to transfect whilst maintaining cell viability. We have developed a novel vector- free method that uses reversible permeabilization to achieve rapid intracellular delivery of cargos with varying composition, properties and size. A permeabilizing delivery solution was developed that contains a low level of ethanol as the permeabilizing agent. Reversal of cell permeabilization is achieved by temporally and volumetrically controlling the contact of the target cells with this solution. Cells are seeded in conventional multi-well plates. Following removal of the supernatant, the cargo is mixed with the delivery solution and applied directly to the cells using an atomizer. After a short incubation period, permeabilization is halted by incubating the cells in a phosphate buffer saline solution that dilutes the ethanol and is non-toxic to the permeabilized cells. Normal culture medium is then added. The procedure lasts less than 5 min. With this method, proteins, mRNA, plasmid DNA and other molecules have been delivered to a variety of cell types, including primary cells, with low toxicity and cargo functionality has been confirmed in proof-of-principle studies. Co-delivery of different cargo types has also been demonstrated. Importantly, delivery occurs by diffusion directly into the cytoplasm in an endocytic-independent manner. Unlike some other vector-free methods, adherent cells are addressed in situ without the need for detachment from their substratum. The method has also been adapted to address suspension cells. This delivery method is gentle yet highly reproducible, compatible with high throughput and automated cell-based assays and has the potential to enable a broad range of research, drug discovery and clinical applications.	[O'Dea, Shirley; Annibaldi, Valeria; Gallagher, Louise; Mulholland, Joanne; Molloy, Emer L.; Breen, Conor J.; Gilbert, Jennifer L.; Martin, Darren S.; Maguire, Michael; Curry, Fitz-Roy] Avectas Ltd, Maynooth, Kildare, Ireland; [Curry, Fitz-Roy] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA	University of California System; University of California Davis	O'Dea, S (corresponding author), Avectas Ltd, Maynooth, Kildare, Ireland.	sodea@avectas.com	O'Dea, Shirley/AAM-1377-2020	O'Dea, Shirley/0000-0002-7197-4676; Breen, Conor/0000-0003-4737-7350	Avectas Ltd.	Avectas Ltd.	Avectas Ltd. provided support in the form of salaries for SOD, VA, LG, JM, EM, CB, JG, DM, MM and consultancy fees for FC. Avectas Ltd. had a role in the decision to publish the manuscript but did not have a role in the study design, data collection and analysis or preparation of the manuscript other than that declared for the authors in the 'author contributions' section.	Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Bourgeaux V, 2016, DRUG DES DEV THER, V10, P665, DOI 10.2147/DDDT.S96470; Cooper ST, 2015, PHYSIOL REV, V95, P1205, DOI 10.1152/physrev.00037.2014; Crevenna AH, 2013, J BIOL CHEM, V288, P12102, DOI 10.1074/jbc.M113.456327; Cui SH, 2014, BIOTECHNOL LETT, V36, P1, DOI 10.1007/s10529-013-1325-0; D'Astolfo DS, 2015, CELL, V161, P674, DOI 10.1016/j.cell.2015.03.028; Gurtovenko AA, 2007, J PHYS CHEM B, V111, P10453, DOI 10.1021/jp073113e; Gurtovenko AA, 2009, J PHYS CHEM B, V113, P1983, DOI 10.1021/jp808041z; Hapala I, 1997, CRIT REV BIOTECHNOL, V17, P105, DOI 10.3109/07388559709146609; Johnson RM, 2011, METHODS MOL BIOL, V683, P535, DOI 10.1007/978-1-60761-919-2_38; Koynova R, 2014, CURR PHARM BIOTECHNO, V15, P806, DOI 10.2174/1389201015666141031112443; LAMBERT H, 1990, BIOCHEM CELL BIOL, V68, P729, DOI 10.1139/o90-105; Lentz YK, 2006, J AEROSOL MED, V19, P372, DOI 10.1089/jam.2006.19.372; Li L, 2015, J BIOMED NANOTECHNOL, V11, P739, DOI 10.1166/jbn.2015.2069; Li SL, 2004, CURR GENE THER, V4, P309; Medepalli K, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/20/205101; Mellott AJ, 2013, ANN BIOMED ENG, V41, P446, DOI 10.1007/s10439-012-0678-1; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; PRAUSNITZ MR, 1993, BIOPHYS J, V65, P414, DOI 10.1016/S0006-3495(93)81081-6; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Sharei A, 2013, P NATL ACAD SCI USA, V110, P2082, DOI 10.1073/pnas.1218705110; Stewart MP, 2016, NATURE, V538, P183, DOI 10.1038/nature19764; Tapani E, 1996, ACTA RADIOL, V37, P923, DOI 10.3109/02841859609175470; van de Ven AL, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3090448; Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141	26	15	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174779	10.1371/journal.pone.0174779	http://dx.doi.org/10.1371/journal.pone.0174779			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358921	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000399174800087
J	Sun, H; Zhou, N; Wang, H; Huang, DF; Lang, ZH				Sun, He; Zhou, Ni; Wang, Hai; Huang, Dafang; Lang, Zhihong			Processing and targeting of proteins derived from polyprotein with 2A and LP4/2A as peptide linkers in a maize expression system	PLOS ONE			English	Article							COORDINATE EXPRESSION; MULTIPLE PROTEINS; GENE-EXPRESSION; GLYPHOSATE TOLERANCE; INSECT RESISTANCE; CLEAVAGE; SEQUENCES; ARABIDOPSIS; TOBACCO	In the transformation of multiple genes, gene fusion is an attractive alternative to other methods, including sexual crossing, re-transformation, and co-transformation, among others. The 2A peptide from the foot-and-mouth disease virus (FMDV) causes the co-translational "cleavage" of polyprotein and operates in a wide variety of eukaryotic cells. LP4, a linker peptide that originates from a natural polyprotein occurring in the seed of Impatiens balsa mina, can be split between the first and second amino acids in post-translational processing. LP4/2A is a hybrid linker peptide that contains the first nine amino acids of LP4 and 20 amino acids of 2A. The three linkers have been used as a suitable technique to link the expression of genes in some transgenic plants, but to date the cleavage efficiency of three linkers have not been comprehensively demonstrated in the same transformation system, especially in the staple crop. To verify the functions of 2A, LP4, and LP4/2A linker peptides in transgenic maize, six fusion protein vectors that each encoded a single open reading frame (ORF) incorporating two report genes, Green Fluorescent Protein (GFP) and P-glucuronidase (GUS), separated by 2A (or modified 2A), LP4 or LP4/2A were assembled to compare the cleavage efficiency of the three linkers in a maize transient expression system. The results demonstrated the more protein production and higher cleavage splicing efficiency with the polyprotein construct linked by the LP4/2A peptide than those of the polyprotein constructs linked by 2A or LP4 alone. Seven other fusion proteins that each encoded a single ORF incorporating two different genes GFP and Red Fluorecent Protein (RFP) with different signal peptides were assembled to study the subcellular localization of genes linked by LP4/2A. The subcellular localization experiments suggested that both types of signal peptide, co-translational and post-translational, could lead their proteins to the target localization in maize protoplast transformed by LP4/2A polyprotein construct and it implied the LP4/2A linker peptide could alleviate the inhibition of 2A processing by the carboxy-terminal region of upstream protein of 2A when translocated into the ER.	[Sun, He; Zhou, Ni; Wang, Hai; Huang, Dafang; Lang, Zhihong] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Lang, ZH (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China.	langzhihong@caas.cn		Wang, Hai/0000-0002-1722-1518	National Nature Science Foundation of China [30771383]; Genetically Modified Organisms Breeding Major Projects [2013ZX08003-001, 2014ZX08003-001]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Genetically Modified Organisms Breeding Major Projects	This work was supported by National Nature Science Foundation of China (No. 30771383) and Genetically Modified Organisms Breeding Major Projects (No. 2013ZX08003-001, No. 2014ZX08003-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buren S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051973; Chang S, 2015, APPL BIOCHEM BIOTECH, V175, P3813, DOI 10.1007/s12010-015-1549-7; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; de Felipe P, 2004, TRAFFIC, V5, P616, DOI 10.1111/j.1398-9219.2004.00205.x; de Felipe P, 2003, J BIOL CHEM, V278, P11441, DOI 10.1074/jbc.M211644200; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; de Felipe P, 2010, BIOTECHNOL J, V5, P213, DOI 10.1002/biot.200900134; Donnelly MLL, 2001, J GEN VIROL, V82, P1027, DOI 10.1099/0022-1317-82-5-1027; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; El Amrani A, 2004, PLANT PHYSIOL, V135, P16, DOI 10.1104/pp.103.032649; Francois IEJA, 2004, PLANT SCI, V166, P113, DOI 10.1016/j.plantsci.2003.09.001; Francois IEJA, 2002, PLANT PHYSIOL, V128, P1346, DOI 10.1104/pp.010794; Funston GM, 2008, J GEN VIROL, V89, P389, DOI 10.1099/vir.0.83444-0; Ha SH, 2010, PLANT BIOTECHNOL J, V8, P928, DOI 10.1111/j.1467-7652.2010.00543.x; Halpin C, 1999, PLANT J, V17, P453, DOI 10.1046/j.1365-313X.1999.00394.x; Hernandez-Garcia Carlos M, 2010, J Vis Exp, DOI 10.3791/1733; JEFFERSON RA, 1987, BIOCHEM SOC T, V15, P17, DOI 10.1042/bst0150017; Jha S, 2009, RICE, V2, P143, DOI 10.1007/s12284-009-9030-2; Kwon SJ, 2004, KOREAN J GENETIC, V26, P199; Luke GA, 2008, J GEN VIROL, V89, P1036, DOI 10.1099/vir.0.83428-0; Ma CL, 2002, MOL BREEDING, V9, P191, DOI 10.1023/A:1019760127368; Osborn MJ, 2005, MOL THER, V12, P569, DOI 10.1016/j.ymthe.2005.04.013; Park S, 2009, BIOTECHNOL LETT, V31, P911, DOI 10.1007/s10529-009-9951-2; Quilis J, 2014, PLANT BIOTECHNOL J, V12, P367, DOI 10.1111/pbi.12143; Ralley L, 2004, PLANT J, V39, P477, DOI 10.1111/j.1365-313X.2004.02151.x; Randall J, 2004, PLANT SCI, V167, P367, DOI 10.1016/j.plantsci.2004.04.005; Rasala BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094028; RYAN MD, 1991, J GEN VIROL, V72, P2727, DOI 10.1099/0022-1317-72-11-2727; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; SCHLEDZEWSKI K, 1994, TRANSGENIC RES, V3, P249, DOI 10.1007/BF02336778; Sun H, 2012, PLANT CELL REP, V31, P1877, DOI 10.1007/s00299-012-1301-5; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tailor RH, 1997, J BIOL CHEM, V272, P24480, DOI 10.1074/jbc.272.39.24480; Yang S, 2008, GENE THER, V15, P1411, DOI 10.1038/gt.2008.90	36	11	12	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174804	10.1371/journal.pone.0174804	http://dx.doi.org/10.1371/journal.pone.0174804			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358924	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174800093
J	Zhang, F; Zhao, J; Feng, AS				Zhang, Fang; Zhao, Juan; Feng, Albert S.			Vocalizations of female frogs contain nonlinear characteristics and individual signatures	PLOS ONE			English	Article							NEIGHBOR-STRANGER DISCRIMINATION; BULLFROGS RANA-CATESBEIANA; TOAD ALYTES-CISTERNASII; MAJORCAN MIDWIFE TOAD; EARED TORRENT FROGS; AFRICAN CLAWED FROG; ODORRANA-TORMOTA; CARPENTER FROG; VOCAL SIGNALS; CALLS	Anuran vocalization is sexually dimorphic, with males doing the bulk of vocalizing. Female vocalization is rare and has been observed in a handful of species, including the concave eared torrent frog (Odorrana tormota). Females O. tormota have been reported to emit moderate -level calls to attract males. In contrast to males, female's vocal signals show no evidence of nonlinear phenomena (NLP). However, with females emitting calls so infrequently that this conclusion must be considered tentative in light of the limited supporting data. The present study was undertaken to test the hypotheses that their vocalizations: 1. may not be purely linear, 2. may contain individual signatures, similar to their male counterparts. We recorded 671 calls from six captive gravid females and found that their vocalizations are as complex as male calls, with numerous calls exhibiting complex upward/downward frequency modulations, and 39% of female calls containing at least one component of the NLP, i.e., subharmonics, deterministic chaos, frequency jump, or biphonation. Furthermore, females in captivity tend to call in bouts throughout the day and night, and the call rate varies hourly with a maximum of >10 calls per minute matching the maximum call rate in males. Similar to males, female vocalizations carry individual signatures, and all sound parameters analyzed differ significantly between individuals. This represents the first report ever showing that vocalizations of female anurans: 1. contain NLP, 2. carry individual signatures. Presence of signatures in both the male and female vocalizations opens up the possibility for males (and females) to distinguish individual frogs in both sexes acoustically, and thus their sound communication ability may be more advanced than previously thought.	[Zhang, Fang; Zhao, Juan] Anhui Normal Univ, Coll Life Sci, Wuhu, Anhui, Peoples R China; [Feng, Albert S.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL USA; [Feng, Albert S.] Univ Illinois, Beckman Inst, Urbana, IL USA	Anhui Normal University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Zhang, F (corresponding author), Anhui Normal Univ, Coll Life Sci, Wuhu, Anhui, Peoples R China.	biozhf@mail.ahnu.edu.cn			National Natural Sciences Foundation (China) [31640073]; Anhui Provincial Key Laboratory of the Conservation and Exploitation of Biological Resources [591601]	National Natural Sciences Foundation (China)(National Natural Science Foundation of China (NSFC)); Anhui Provincial Key Laboratory of the Conservation and Exploitation of Biological Resources	This work was funded by grants from the National Natural Sciences Foundation (China) to F.Z (NSFC grants 31640073) and the Anhui Provincial Key Laboratory of the Conservation and Exploitation of Biological Resources (No 591601). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arch VS, 2008, BIOL LETTERS, V4, P19, DOI 10.1098/rsbl.2007.0494; Bee MA, 2001, ANIM BEHAV, V62, P1129, DOI 10.1006/anbe.2001.1851; Bee MA, 2002, P ROY SOC B-BIOL SCI, V269, P1443, DOI 10.1098/rspb.2002.2041; Bee MA, 2001, ETHOLOGY, V107, P65, DOI 10.1046/j.1439-0310.2001.00640.x; Boersma P., 2010, PRAAT DOING PHONETIC, DOI DOI 10.1007/s10072-018-3598-5; Bosch J, 2002, NATURWISSENSCHAFTEN, V89, P575, DOI 10.1007/s00114-002-0378-z; Bosch J, 2001, J HERPETOL, V35, P647, DOI 10.2307/1565904; Bush SL, 1997, J HERPETOL, V31, P251, DOI 10.2307/1565393; Bush SL, 1996, P ROY SOC B-BIOL SCI, V263, P913, DOI 10.1098/rspb.1996.0135; Cui JG, 2010, ANIM BEHAV, V80, P181, DOI 10.1016/j.anbehav.2010.05.012; Dreiner S., 2016, 12 C PHD RES MICR EL, P1; EMERSON SB, 1992, COPEIA, P1123; Emerson SB, 1999, BRAIN BEHAV EVOLUT, V53, P187, DOI 10.1159/000006594; Favaro L, 2015, SCI REP-UK, V5, DOI 10.1038/srep17255; Feng AS, 2009, ETHOLOGY, V115, P1015, DOI 10.1111/j.1439-0310.2009.01692.x; Feng AS, 2009, ETHOLOGY, V115, P851, DOI 10.1111/j.1439-0310.2009.01666.x; Feng AS, 2006, NATURE, V440, P333, DOI 10.1038/nature04416; FENG AS, 1976, J NEUROPHYSIOL, V39, P871, DOI 10.1152/jn.1976.39.4.871; Fitch WT, 2002, ANIM BEHAV, V63, P407, DOI 10.1006/anbe.2001.1912; Gasser H, 2009, ETHOLOGY, V115, P596, DOI 10.1111/j.1439-0310.2009.01639.x; GERHARDT HC, 1978, SCIENCE, V199, P992, DOI 10.1126/science.199.4332.992; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; GIVEN MF, 1987, HERPETOLOGICA, V43, P467; GIVEN MF, 1993, ANIM BEHAV, V46, P1139, DOI 10.1006/anbe.1993.1303; Herzel H., 1993, APPL MECH REV, V46, P399, DOI [10.1115/1.3120369, DOI 10.1115/1.3120369]; Jouventin P, 1999, ANIM BEHAV, V57, P1175, DOI 10.1006/anbe.1999.1086; Judge Kevin A., 2000, Herpetological Review, V31, P236; Narins PM, 2004, J ACOUST SOC AM, V115, P910, DOI 10.1121/1.1636851; Riede T, 1997, Z SAUGETIERKD, V62, P198; ROBISSON P, 1993, ETHOLOGY, V94, P279; Roy D, 1997, CURR SCI INDIA, V72, P923; Shen JX, 2008, NATURE, V453, P914, DOI 10.1038/nature06719; Shen JX, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1339; Suthers RA, 2006, J EXP BIOL, V209, P4984, DOI 10.1242/jeb.02594; TITUS K, 1984, AM MIDL NAT, V111, P1, DOI 10.2307/2425535; Tobias ML, 1998, P NATL ACAD SCI USA, V95, P1870, DOI 10.1073/pnas.95.4.1870; Volodina EV, 2006, ETHOLOGY, V112, P815, DOI 10.1111/j.1439-0310.2006.01231.x; Wang YS, 2010, J HERPETOL, V44, P475, DOI 10.1670/09-055.1; Wilden I., 1998, Bioacoustics, V9, P171; Zhang F, 2015, CURR ZOOL, V61, P996, DOI 10.1093/czoolo/61.6.996	40	25	29	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174815	10.1371/journal.pone.0174815	http://dx.doi.org/10.1371/journal.pone.0174815			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VI	28358859	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174800094
J	Capovilla, M; Robichon, A; Rassoulzadegan, M				Capovilla, Maria; Robichon, Alain; Rassoulzadegan, Minoo			A new paramutation-like example at the Delta gene of Drosophila	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; EPIGENETIC INHERITANCE; DNA METHYLATION; SMALL RNAS; TRANSVECTION; EXPRESSION; COMPLEX; MAIZE; RESOURCE; PATHWAY	The hereditary transmission of a phenotype independent from DNA sequence implies epigenetic effects. Paramutation is a heritable epigenetic phenomenon observed in plants and animals. To investigate paramutation in Drosophila, we used the P{ry (+t7.2) = PZ} Dl(05151) P-element insertion in the Drosophila melanogaster genome that causes a dominant visible phenotype: the presence of characteristic extra-veins in the fly wings. This extra-vein phenotype presents variable expressivity and incomplete penetrance. The insert is a PZ element located 680 bp upstream from the ATG of the Delta (Dl) gene, encoding the Notch ligand involved in wing vein development, and acts as a null allele. In the G2 offspring from a cross between the heterozygous transgenic stock and wild-type flies, we observed the transmission of the extra-vein phenotype to wild-type flies without the transgene, independently of gender and across many generations. This is a "paramutation-like" example in the fly: the heritable transmission of a phenotypic change not linked to a classical genetic mutation. A "paramutagenic" allele in heterozygotes transmits the phenotype of the heterozygotes to the wild-type allele ("paramutant") in a stable manner through generations. Distinct from paramutation events so far described in Drosophila, here we deal with a dominant effect on a single gene involving variable hereditary signals.	[Capovilla, Maria; Robichon, Alain] Univ Cote Azur, CNRS, Inst Sophia Agrobiotech, UMR INRA 1355 7254, Sophia Antipolis, France; [Rassoulzadegan, Minoo] Univ Cote Azur, Inserm CNRS U1091 U7277, Nice, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Capovilla, M (corresponding author), Univ Cote Azur, CNRS, Inst Sophia Agrobiotech, UMR INRA 1355 7254, 400 Route Chappes, Sophia Antipolis, France.	Maria.Capovilla@inra.fr		robichon, alain/0000-0003-1075-9646; Capovilla, Maria/0000-0002-1308-7964	ANR blanc "Gustaile" [BSV701702]; National Research Agency (ANR) through the LABEX SIGNALIFE program [ANR-11-LABX-0028-01]	ANR blanc "Gustaile"(French National Research Agency (ANR)); National Research Agency (ANR) through the LABEX SIGNALIFE program(French National Research Agency (ANR))	This work was supported by ANR blanc "Gustaile" n. BSV701702, and National Research Agency (ANR) through the LABEX SIGNALIFE program (n. ANR-11-LABX-0028-01). M.C. thanks the Italian Fondazione Telethon for endowing her with equipment used in these studies (grant n. 3021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramayo R, 1996, CELL, V86, P103, DOI 10.1016/S0092-8674(00)80081-1; Arteaga-Vazquez MA, 2010, CURR OPIN GENET DEV, V20, P156, DOI 10.1016/j.gde.2010.01.008; Attrill H, 2016, NUCLEIC ACIDS RES, V44, pD786, DOI 10.1093/nar/gkv1046; Baulcombe DC, 2006, COLD SPRING HARB SYM, V71, P13, DOI 10.1101/sqb.2006.71.052; Birney E, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006105; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; Bohacek J, 2015, NAT REV GENET, V16, P641, DOI 10.1038/nrg3964; Bohacek J, 2013, NEUROPSYCHOPHARMACOL, V38, P220, DOI 10.1038/npp.2012.110; BRINK RA, 1973, ANNU REV GENET, V7, P129, DOI 10.1146/annurev.ge.07.120173.001021; Chandler VL, 2007, CELL, V128, P641, DOI 10.1016/j.cell.2007.02.007; Chen Q, 2016, SCIENCE, V351, P397, DOI 10.1126/science.aad7977; Crozatier M, 2003, MECH DEVELOP, V120, P529, DOI 10.1016/S0925-4773(03)00041-8; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; de Vanssay A, 2012, NATURE, V490, P112, DOI 10.1038/nature11416; deCelis JF, 1997, DEVELOPMENT, V124, P1919; DIAZBENJUMEA FJ, 1994, DEVELOPMENT, V120, P569; Gabriel JM, 2015, SEMIN CELL DEV BIOL, V44, P11, DOI 10.1016/j.semcdb.2015.08.008; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; GARCIABELLIDO A, 1992, ANNU REV GENET, V26, P277, DOI 10.1146/annurev.ge.26.120192.001425; Grandjean V, 2015, SCI REP-UK, V5, DOI 10.1038/srep18193; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Guzzardo PM, 2013, CURR OPIN GENET DEV, V23, P44, DOI 10.1016/j.gde.2012.12.003; Hardcastle TJ, 2016, RNA BIOL, V13, P1060, DOI 10.1080/15476286.2016.1218591; Heil CSS, 2014, G3-GENES GENOM GENET, V4, P2095, DOI 10.1534/g3.114.012393; Herman H, 2003, NAT GENET, V34, P199, DOI 10.1038/ng1162; Hollick JB, 2016, NATURE REV GENETICS; Huppert SS, 1997, DEVELOPMENT, V124, P3283; Kamimura K, 2004, J CELL BIOL, V166, P1069, DOI 10.1083/jcb.200403077; KOOH PJ, 1993, DEVELOPMENT, V117, P493; KOPCZYNSKI CC, 1988, GENE DEV, V2, P1723, DOI 10.1101/gad.2.12b.1723; Lewis EB, 1954, AM NATURALIST; Lim JP, 2013, TRENDS GENET, V29, P176, DOI 10.1016/j.tig.2012.12.008; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Mlodzik M, 1992, METHODS NEUROSCI; MULLER HP, 1990, TRENDS GENET, V6, P300, DOI 10.1016/0168-9525(90)90236-Y; Onorati MC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005444; PARODY TR, 1993, GENETICS, V135, P527; Pilu R, 2015, SEMIN CELL DEV BIOL, V44, P2, DOI 10.1016/j.semcdb.2015.08.015; Pirrotta V, 1999, BBA-REV CANCER, V1424, pM1; Raddatz G, 2013, P NATL ACAD SCI USA, V110, P8627, DOI 10.1073/pnas.1306723110; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Rassoulzadegan M, 2002, EMBO J, V21, P440, DOI 10.1093/emboj/21.3.440; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; ROBERTSON HM, 1988, GENETICS, V118, P461; Roch F, 1998, DEVELOPMENT, V125, P1823; Rodgers AB, 2015, P NATL ACAD SCI USA, V112, P13699, DOI 10.1073/pnas.1508347112; Ronsseray S, 2015, SEMIN CELL DEV BIOL, V44, P39, DOI 10.1016/j.semcdb.2015.08.009; Sarkies P, 2014, NAT REV MOL CELL BIO, V15, P525, DOI 10.1038/nrm3840; Schaefer S, 2015, Q REV BIOL, V90, P381, DOI 10.1086/683699; Smukowski Heil CS, 2014, DETECTABLE EFFECT DN; Spradling AC, 1999, GENETICS, V153, P135; Stam M, 2009, MOL PLANT, V2, P578, DOI 10.1093/mp/ssp020; STURTEVANT MA, 1995, DEVELOPMENT, V121, P785; Takayama S, 2014, GENOME RES, V24, P821, DOI 10.1101/gr.162412.113; Thumm M, 2001, MOL GENET GENOMICS, V266, P657, DOI 10.1007/s004380100585; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Wangler MF, 2017, DIS MODEL MECH, V10, P77, DOI 10.1242/dmm.027680; Wu RF, 2016, MOL GENET GENOMICS, V291, P1013, DOI 10.1007/s00438-016-1179-y	60	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0172780	10.1371/journal.pone.0172780	http://dx.doi.org/10.1371/journal.pone.0172780			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355214	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174600005
J	Ojeh, N; Akgul, B; Tomic-Canic, M; Philpott, M; Navsaria, H				Ojeh, Nkemcho; Akguel, Baki; Tomic-Canic, Marjana; Philpott, Mike; Navsaria, Harshad			In vitro skin models to study epithelial regeneration from the hair follicle	PLOS ONE			English	Article							CULTURED AUTOLOGOUS KERATINOCYTES; ARTIFICIAL SKIN; STEM-CELLS; EQUIVALENT; MARKERS; GROWTH; DIFFERENTIATION; RECONSTRUCTION; MORPHOGENESIS; MECHANISMS	The development of dermal equivalents (DEs) for the treatment of burns has contributed toward efficient wound closure. A collagen-glycosaminoglycan DE (C-GAG) grafted with hair follicles converted a full-thickness wound to partial-thickness resulting in complete wound closure and restored hair. In this study we compared the ability of both intact pilosebaceous units (PSU) or truncated hair follicles (THF) to regenerate a multilayered epidermis in vitro when implanted into de-epidermalized dermis (DED) or C-GAG with the epidermis generated in vivo using C-CAG. Keratinocytes explanted from the outer root sheath of PSU and THF in both DED and C-GAG but only formed a multilayered epidermis with PSU in DED. PSU were more effective at forming multilayered epidermis in DED than THF. Both DED and C-GAG skin expressed proliferation (PCNA), differentiation (K1, K10), hyperproliferation (K6, K16), basal (K14), putative stem cell (p63), extracellular matrix protein (Collagen IV), mesenchymal (vimentin) and adherens junction (beta-catenin) markers. These data suggest DEs supported initial maintenance of the implanted hair follicles, in particular PSU, and provide an excellent model with which to investigate the regulation of hair follicle progenitor epithelial cells during epidermal regeneration. Although neither PSU nor THF formed multilayered epidermis in C-CAG in vitro, hair follicles implanted into engrafted C-GAG on a burns patient resulted in epithelial regeneration and expression of proliferation and differentiation markers in a similar manner to that seen in vitro. However, the failure of C-GAG to support epidermal regeneration in vitro suggests in vivo factors are essential for full epidermal regeneration using C-GAG.	[Ojeh, Nkemcho; Philpott, Mike; Navsaria, Harshad] Barts & London Queen Marys Sch Med & Dent, Blizard Inst, Ctr Cutaneous Res, London, England; [Akguel, Baki] Univ Cologne, Inst Virol, Cologne, Germany; [Tomic-Canic, Marjana] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA; [Ojeh, Nkemcho] Univ West Indies, Fac Med Sci, Cave Hill Campus, Wanstead, Barbados	University of London; Queen Mary University London; University of Cologne; University of Miami; University West Indies Mona Jamaica; University West Indies Cave Hill Campus	Ojeh, N (corresponding author), Barts & London Queen Marys Sch Med & Dent, Blizard Inst, Ctr Cutaneous Res, London, England.; Ojeh, N (corresponding author), Univ West Indies, Fac Med Sci, Cave Hill Campus, Wanstead, Barbados.	nkemcho.ojeh@cavehill.uwi.edu	Akgül, Baki/H-5629-2019	Akgül, Baki/0000-0002-6564-9412; Philpott, Michael/0000-0002-1255-4612				Ali N, 2015, BRIT J DERMATOL, V173, P391, DOI 10.1111/bjd.13886; ARASE S, 1990, Journal of Dermatology (Tokyo), V17, P667; ARGYRIS TS, 1976, AM J PATHOL, V83, P329; Auxenfans C, 2009, EUR J DERMATOL, V19, P107, DOI 10.1684/ejd.2008.0573; BOYCE ST, 1988, SURGERY, V103, P421; Boyce ST, 2002, ANN SURG, V235, P269, DOI 10.1097/00000658-200202000-00016; Casale C, 2016, BIOMATERIALS, V101, P86, DOI 10.1016/j.biomaterials.2016.05.047; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; DAGALAKIS N, 1980, J BIOMED MATER RES, V14, P511, DOI 10.1002/jbm.820140417; Fredriksson C, 2008, BURNS, V34, P212, DOI 10.1016/j.burns.2007.03.008; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Ghosh MM, 1997, ANN PLAS SURG, V39, P390, DOI 10.1097/00000637-199710000-00010; Gustafson CJ, 1999, BURNS, V25, P331, DOI 10.1016/S0305-4179(99)00004-2; Hassanein AM, 2004, BRIT J DERMATOL, V150, P511, DOI 10.1046/j.1365-2133.2004.05811.x; HECK EL, 1985, J TRAUMA, V25, P106, DOI 10.1097/00005373-198502000-00002; Heimbach DM, 2003, J BURN CARE REHABIL, V24, P42, DOI 10.1097/00004630-200301000-00009; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jones I, 2003, WOUND REPAIR REGEN, V11, P132, DOI 10.1046/j.1524-475X.2003.11209.x; KREJCI NC, 1991, J INVEST DERMATOL, V97, P843, DOI 10.1111/1523-1747.ep12491522; LANE EB, 1991, ANN NY ACAD SCI, V642, P197; LEIGH IM, 1993, BRIT J DERMATOL, V129, P110, DOI 10.1111/j.1365-2133.1993.tb03511.x; LEIGH IM, 1995, BRIT J DERMATOL, V133, P501, DOI 10.1111/j.1365-2133.1995.tb02696.x; LENOIR MC, 1988, DEV BIOL, V130, P610, DOI 10.1016/0012-1606(88)90356-9; Machesney M, 1998, AM J PATHOL, V152, P1133; Martorina F, 2017, BIOMATERIALS, V113, P217, DOI 10.1016/j.biomaterials.2016.10.051; MCKAY I, 1994, BURNS, V20, pS19, DOI 10.1016/0305-4179(94)90083-3; MESSENGER AG, 1984, BRIT J DERMATOL, V110, P685, DOI 10.1111/j.1365-2133.1984.tb04705.x; Michel M, 1999, IN VITRO CELL DEV-AN, V35, P318; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Nanney LB, 2006, J INVEST DERM SYMP P, V11, P132, DOI 10.1038/sj.jidsymp.5650002; Navsaria HA, 2004, PLAST RECONSTR SURG, V113, P978, DOI 10.1097/01.PRS.0000105632.86651.EF; NAVSARIA HA, 1994, BURNS, V20, pS57, DOI 10.1016/0305-4179(94)90092-2; NAVSARIA HA, 1995, TRENDS BIOTECHNOL, V13, P91, DOI 10.1016/S0167-7799(00)88913-1; Ojeh NO, 2001, TISSUE ENG, V7, P457, DOI 10.1089/10763270152436508; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Philpott MP, 1996, DERMATOL CLIN, V14, P595, DOI 10.1016/S0733-8635(05)70387-9; PHILPOTT MP, 1990, J CELL SCI, V97, P463; PRUNIERAS M, 1983, J INVEST DERMATOL, V81, pS28, DOI 10.1111/1523-1747.ep12540324; PURKIS PE, 1990, J CELL SCI, V97, P39; Ralston DR, 1999, BRIT J DERMATOL, V140, P605; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Spector JA, 2007, ANN PLAS SURG, V59, P63, DOI 10.1097/01.sap.0000263323.65563.e7; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Waseem A, 1999, J INVEST DERMATOL, V112, P362, DOI 10.1046/j.1523-1747.1999.00535.x; WESTGATE GE, 1993, BRIT J DERMATOL, V129, P372, DOI 10.1111/j.1365-2133.1993.tb03160.x; YANG JS, 1993, J INVEST DERMATOL, V101, P652, DOI 10.1111/1523-1747.ep12371671; YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203; YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933	49	10	11	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174389	10.1371/journal.pone.0174389	http://dx.doi.org/10.1371/journal.pone.0174389			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350869	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174400033
J	Jaworska, N; Cox, SM; Casey, KF; Boileau, I; Cherkasova, M; Larcher, K; Dagher, A; Benkelfat, C; Leyton, M				Jaworska, Natalia; Cox, Sylvia M.; Casey, Kevin F.; Boileau, Isabelle; Cherkasova, Mariya; Larcher, Kevin; Dagher, Alain; Benkelfat, Chawki; Leyton, Marco			Is there a relation between novelty seeking, striatal dopamine release and frontal cortical thickness?	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; RECEPTOR AVAILABILITY; HEALTHY-ADULTS; SURFACE-AREA; INDIVIDUAL-DIFFERENCES; PARKINSONS-DISEASE; SENSATION SEEKING; DECISION-MAKING; AMPHETAMINE; IMPULSIVITY	Background Novelty-seeking (NS) and impulsive personality traits have been proposed to reflect an interplay between fronto-cortical and limbic systems, including the limbic striatum (LS). Although neuroimaging studies have provided some evidence for this, most are comprised of small samples and many report surprisingly large effects given the challenges of trying to relate a snapshot of brain function or structure to an entity as complex as personality. The current work tested a priori hypotheses about associations between striatal dopamine (DA) release, cortical thickness (CT), and NS in a large sample of healthy adults. Methods Fifty-two healthy adults (45M/7F; age: 23.8 +/- 4.93) underwent two positron emission tomography scans with [C-11] raclopride (specific for striatal DA D2/3 receptors) with or without amphetamine (0.3 mg/kg, p.o.). Structural magnetic resonance image scans were acquired, as were Tridimensional Personality Questionnaire data. Amphetamine-induced changes in [C-11] raclopride binding potential values (Delta BPND) were examined in the limbic, sensorimotor (SMS) and associative (AST) striatum. CT measures, adjusted for whole brain volume, were extracted from the dorsolateral sensorimotor and ventromedial/limbic cortices. Results BPND values were lower in the amphetamine vs. no-drug sessions, with the largest effect in the LS. When comparing low vs. high LS Delta BPND groups (median split), higher NS2 (impulsiveness) scores were found in the high Delta BPND group. Partial correlations (age and gender as covariates) yielded a negative relation between ASTS Delta BPND and sensorimotor CT; trends for inverse associations existed between Delta BPND values in other striatal regions and frontal CT. In other words, the greater the amphetamine-induced striatal DA response, the thinner the frontal cortex. Conclusions These data expand upon previously reported associations between striatal DA release in the LS and both NS related impulsiveness and CT in the largest sample reported to date. The findings add to the plausibility of these associations while suggesting that the effects are likely weaker than has been previously proposed.	[Jaworska, Natalia; Cox, Sylvia M.; Benkelfat, Chawki; Leyton, Marco] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Jaworska, Natalia] Mental Hlth Res Inst, Ottawa, ON, Canada; [Casey, Kevin F.] Le Ctr Hosp Univ CHU St Justine, Montreal, PQ, Canada; [Boileau, Isabelle] CAMH, Toronto, ON, Canada; [Cherkasova, Mariya] Univ British Columbia, Div Neurol, Vancouver, BC, Canada; [Larcher, Kevin; Dagher, Alain] McGill Univ, MNI, Montreal, PQ, Canada	McGill University; University of Ottawa; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of British Columbia; McGill University	Leyton, M (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.	marco.leyton@mcgill.ca	Leyton, Marco/AAY-7557-2020; Cherkasova, Mariya/Q-2437-2018	Leyton, Marco/0000-0002-1243-2252; Cherkasova, Mariya/0000-0002-4750-8093				Aston JAD, 2000, NEUROIMAGE, V12, P245, DOI 10.1006/nimg.2000.0620; Aupperle RL, 2015, HUM BRAIN MAPP, V36, P449, DOI 10.1002/hbm.22639; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Boileau I, 2007, J NEUROSCI, V27, P3998, DOI 10.1523/JNEUROSCI.4370-06.2007; Boileau I, 2006, ARCH GEN PSYCHIAT, V63, P1386, DOI 10.1001/archpsyc.63.12.1386; Boileau I, 2013, ADDICTION, V108, P953, DOI 10.1111/add.12066; Boulos PK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152983; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; Casey KF, 2013, J NEUROSCI, V33, P15285, DOI 10.1523/JNEUROSCI.5029-12.2013; Cherkasova MV, 2014, NEUROPSYCHOPHARMACOL, V39, P1498, DOI 10.1038/npp.2013.349; Choi EY, 2012, J NEUROPHYSIOL, V108, P2242, DOI 10.1152/jn.00270.2012; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Cox SML, 2009, BIOL PSYCHIAT, V65, P846, DOI 10.1016/j.biopsych.2009.01.021; D'Amour-Horvat V, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00432; Depue RA, 1999, BEHAV BRAIN SCI, V22, P491; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6; Durazzo TC, 2011, ALCOHOL CLIN EXP RES, V35, P1187, DOI 10.1111/j.1530-0277.2011.01452.x; First MB, 1995, AXIS 1 DISORDERS; Fortier CB, 2011, ALCOHOL CLIN EXP RES, V35, P2193, DOI 10.1111/j.1530-0277.2011.01576.x; Gjedde A, 2010, P NATL ACAD SCI USA, V107, P3870, DOI 10.1073/pnas.0912319107; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Haber SN., 2011, NEUROBIOLOGY SENSATI, P49; Holmes AJ, 2016, J NEUROSCI, V36, P4038, DOI 10.1523/JNEUROSCI.3206-15.2016; HURD YL, 1994, NEUROSCIENCE, V63, P357, DOI 10.1016/0306-4522(94)90535-5; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Ishii T, 2016, J NEUROL, V263, P1828, DOI 10.1007/s00415-016-8206-0; Jacobus J, 2015, DEV COGN NEUROS-NETH, V16, P101, DOI 10.1016/j.dcn.2015.04.006; Jiang Y, 2015, PSYCHOL MED, V45, P3467, DOI 10.1017/S0033291715001361; Josefsson K, 2013, DEV PSYCHOPATHOL, V25, P713, DOI 10.1017/S0954579413000126; Kim JH, 2014, ACTA NEUROPSYCHIATR, V26, P35, DOI 10.1017/neu.2013.29; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Ko JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023298; Lange E., 2016, PSYCHOL MED, V47, P1; Lappin JM, 2009, J CEREBR BLOOD F MET, V29, P554, DOI 10.1038/jcbfm.2008.146; Laruelle M, 2000, J CEREBR BLOOD F MET, V20, P423, DOI 10.1097/00004647-200003000-00001; Lawrence AD, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00086; Lee B, 2009, J NEUROSCI, V29, P14734, DOI 10.1523/JNEUROSCI.3765-09.2009; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Leyton M, 2002, NEUROPSYCHOPHARMACOL, V27, P1027, DOI 10.1016/S0893-133X(02)00366-4; Leyton M, 2010, PLEASURES BRAIN, P222; Martinez D, 2003, J CEREBR BLOOD F MET, V23, P285, DOI 10.1097/01.WCB.0000048520.34839.1A; Milella MS, 2016, J PSYCHIATR NEUROSCI, V41, P322, DOI 10.1503/jpn.150207; Morris LS, 2016, CORTEX, V74, P118, DOI 10.1016/j.cortex.2015.11.004; Nordstrom AL, 1998, PSYCHIAT RES-NEUROIM, V83, P1, DOI 10.1016/S0925-4927(98)00021-3; Oberlin BG, 2015, PSYCHOPHARMACOLOGY, V232, P2207, DOI 10.1007/s00213-014-3850-5; Oswald LM, 2007, NEUROIMAGE, V36, P153, DOI 10.1016/j.neuroimage.2007.01.055; Oswald LM, 2015, NEUROIMAGE, V113, P26, DOI 10.1016/j.neuroimage.2015.03.022; Pereira JB, 2012, HUM BRAIN MAPP, V33, P2521, DOI 10.1002/hbm.21378; Reeves SJ, 2012, PSYCHIAT RES-NEUROIM, V202, P60, DOI 10.1016/j.pscychresns.2011.09.011; Riccardi P, 2006, AM J PSYCHIAT, V163, P1639, DOI 10.1176/appi.ajp.163.9.1639; Rimol LM, 2012, BIOL PSYCHIAT, V71, P552, DOI 10.1016/j.biopsych.2011.11.026; Robertson CL, 2015, J NEUROSCI, V35, P5990, DOI 10.1523/JNEUROSCI.4850-14.2015; Savage SW, 2014, OBESITY, V22, P1452, DOI 10.1002/oby.20690; Schilling C, 2013, MOL PSYCHIATR, V18, P624, DOI 10.1038/mp.2012.56; Schilling C, 2012, NEUROIMAGE, V59, P824, DOI 10.1016/j.neuroimage.2011.07.058; Schultz W, 2016, DIALOGUES CLIN NEURO, V18, P23; Shao N, 2015, NEUROSCI LETT, V587, P79, DOI 10.1016/j.neulet.2014.12.007; Smith CT, 2016, J NEUROPHYSIOL, V115, P1146, DOI 10.1152/jn.00261.2015; Storsve AB, 2014, J NEUROSCI, V34, P8488, DOI 10.1523/JNEUROSCI.0391-14.2014; Tziortzi AC, 2014, CEREB CORTEX, V24, P1165, DOI 10.1093/cercor/bhs397; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vijayakumar N, 2016, HUM BRAIN MAPP, V37, P2027, DOI 10.1002/hbm.23154; Volkow ND, 2007, J NEUROSCI, V27, P12700, DOI 10.1523/JNEUROSCI.3371-07.2007; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Yuan P, 2014, NEUROSCI BIOBEHAV R, V42, P180, DOI 10.1016/j.neubiorev.2014.02.005; Zald DH, 2008, J NEUROSCI, V28, P14372, DOI 10.1523/JNEUROSCI.2423-08.2008; Zhou Q., 2014, THESCIENTIFICWORLDJO, V2014	68	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174219	10.1371/journal.pone.0174219	http://dx.doi.org/10.1371/journal.pone.0174219			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VD	28346539	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174300031
J	Wang, LT; Chiou, SS; Chai, CY; Hsi, E; Chiang, CM; Huang, SK; Wang, SN; Yokoyama, KK; Hsu, SH				Wang, L-T; Chiou, S-S; Chai, C-Y; Hsi, E.; Chiang, C-M; Huang, S-K; Wang, S-N; Yokoyama, K. K.; Hsu, S-H			Transcription factor SPZ1 promotes TWIST-mediated epithelial-mesenchymal transition and oncogenesis in human liver cancer	ONCOGENE			English	Article							SAETHRE-CHOTZEN-SYNDROME; HEPATOCELLULAR-CARCINOMA; EXPRESSION; METASTASIS; PROTEIN; CELLS; GENE; TUMORIGENESIS; PROGRESSION; MECHANISMS	The epithelial-mesenchymal transition (EMT) is an important process in the progression of cancer. However, its occurrence and mechanism of regulation are not fully understood. We propose a regulatory pathway in which spermatogenic leucine zipper 1 (SPZ1) promotes EMT through its transactivating ability in increasing TWIST1 expression. We compared the expression of SPZ1 and TWIST1 in specimens of hepatocarcinoma cells (HCCs) and non-HCCs. Expression of SPZ1 exhibited a tumor-specific expression pattern and a high correlation with patients' survival time, tumor size, tumor number and progression stage. Moreover, forced expression and knockdown of SPZ1 in hepatoma cells showed that SPZ1 was able to regulate the cellular proliferation, invasion, and tumorigenic activity in a TWIST1-dependent manner in vitro and in vivo. These data demonstrate that SPZ1, a newly dscribed molecule, transactivates TWIST1 promoters, and that this SPZ1-TWIST axis mediates EMT signaling and exerts significant regulatory effects on tumor oncogenesis.	[Wang, L-T; Yokoyama, K. K.; Hsu, S-H] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung 807, Taiwan; [Chiou, S-S] Kaohsiung Med Univ Hosp, Dept Pediat, Fac Med, Kaohsiung, Taiwan; [Chiou, S-S] Kaohsiung Med Univ Hosp, Div Hematol Oncol, Dept Pediat, Kaohsiung, Taiwan; [Chai, C-Y] Kaohsiung Med Univ Hosp, Dept Pathol, Coll Med, Fac Med, Kaohsiung, Taiwan; [Hsi, E.] Kaohsiung Med Univ Hosp, Dept Genome Med, Coll Med, Kaohsiung, Taiwan; [Chiang, C-M] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Chiang, C-M] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Huang, S-K] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan, Taiwan; [Wang, S-N] Kaohsiung Med Univ Hosp, Div Hepatobiliary Surg, Dept Surg, Kaohsiung 807, Taiwan; [Wang, S-N] Kaohsiung Med Univ Hosp, Dept Surg, Fac Med, Kaohsiung, Taiwan; [Yokoyama, K. K.] Tokushima Bunri Univ, Dept Pharmaceut Sci, Sanuki, Japan; [Yokoyama, K. K.] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Tokyo, Japan; [Yokoyama, K. K.; Hsu, S-H] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan; [Yokoyama, K. K.] Kaohsiung Med Univ, Coll Med, Ctr Environm Med, Kaohsiung, Taiwan; [Yokoyama, K. K.] Kaohsiung Med Univ, Ctr Stem Cell Res, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Health Research Institutes - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Tokushima Bunri University; University of Tokyo; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University	Yokoyama, KK; Hsu, SH (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung 807, Taiwan.; Wang, SN (corresponding author), Kaohsiung Med Univ Hosp, Div Hepatobiliary Surg, Dept Surg, Kaohsiung 807, Taiwan.	snwang@cc.kmu.edu; kazu@kmu.edu.tw; jackhsu@kmu.edu.tw	Hsu, Shih-Hsien/D-5139-2009	Wang, Li-Ting/0000-0002-3335-8055; Hsu, Shih Hsien/0000-0003-2102-0505; Chai, Chee-Yin/0000-0003-0486-9742	Kaohsiung Medical University Hospital [KMUH 104-4R34, KMUH 105-5R28, 105-5T10]; National Science Council, Taiwan [NSC-102-2320-B-037-032-MY3, MOST 105-2314-B-037-070-MY2]; Ministry of Science and Technology [MOST-104-2314-B-037-043, MOST 104-2320-B-037-033-My2, MOST 104-2314-B-033-002, MOST-105-2314-B-037-049]; National Health Research Institutes [NHRI-Ex102-10109B1, NHRI-Ex104-10416S1]; Kaohsiung Medical University grant [KMU-TP103G00, KMU-TP103G01, KMU-TP103G03, KMU-TP103G04, KMU-TP103G05, KMU-TP103A104, KMU-DT103001, KMU-TP104A04, KMU-TPE23, KMU-DT104001, KMU-TP105PR4, KMU-TP105E00]; NIH [CA103867]; CPRIT [RP110471, RP140367]; Welch Foundation [I-1805]; NATIONAL CANCER INSTITUTE [R01CA103867] Funding Source: NIH RePORTER	Kaohsiung Medical University Hospital; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Research Institutes(National Health Research Institutes, Japan); Kaohsiung Medical University grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge supports from the Liver Disease Prevention and Treatment Research Foundation in Taiwan. This work was supported in part by research grants KMUH 104-4R34 and KMUH 105-5R28, 105-5T10 from Kaohsiung Medical University Hospital, NSC-102-2320-B-037-032-MY3, MOST 105-2314-B-037-070-MY2 from the National Science Council, Taiwan, MOST-104-2314-B-037-043; MOST 104-2320-B-037-033-My2, MOST 104-2314-B-033-002, and MOST-105-2314-B-037-049 from Ministry of Science and Technology, the National Health Research Institutes (NHRI-Ex102-10109B1; NHRI-Ex104-10416S1), Kaohsiung Medical University grant (KMU-TP103G00, G01, G03, G04, G05, KMU-TP103A104, KMU-DT103001, KMU-TP104A04, KMU-TPE23, KMU-DT104001, KMU-TP105PR4, and KMU-TP105E00), NIH (CA103867), CPRIT (RP110471 and RP140367) and Welch Foundation (I-1805).	[Anonymous], 1989, JPN J SURG, V19, P98; Barnes RM, 2009, INT J DEV BIOL, V53, P909, DOI 10.1387/ijdb.082747rb; Beck B, 2015, CELL STEM CELL, V16, P67, DOI 10.1016/j.stem.2014.12.002; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Che N, 2011, HUM PATHOL, V42, P840, DOI 10.1016/j.humpath.2010.03.010; El Ghouzzi V, 1999, EUR J HUM GENET, V7, P27, DOI 10.1038/sj.ejhg.5200240; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; Hou Y, 2012, CELL RES, V22, P259, DOI 10.1038/cr.2011.139; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; Hsu SH, 2005, CANCER RES, V65, P4041, DOI 10.1158/0008-5472.CAN-04-3658; Hsu SH, 2004, EXP CELL RES, V294, P185, DOI 10.1016/j.yexcr.2003.10.029; Hsu SH, 2001, MECH DEVELOP, V100, P177, DOI 10.1016/S0925-4773(00)00513-X; Hsu SH, 2013, CANCER RES, V73, P508, DOI 10.1158/0008-5472.CAN-12-2795; IP YT, 1992, GENE DEV, V6, P1518, DOI 10.1101/gad.6.8.1518; Kwok WK, 2007, CARCINOGENESIS, V28, P2467, DOI 10.1093/carcin/bgm185; Lei PF, 2015, ONCOL LETT, V10, P417, DOI 10.3892/ol.2015.3246; LI L, 1995, DEV BIOL, V172, P280, DOI 10.1006/dbio.1995.0023; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin A, 2010, NAT CELL BIOL, V12, P924, DOI 10.1038/ncb1010-924; Ohba K, 2014, INT J CLIN EXP PATHO, V7, P3158; PAN DJ, 1991, GENE DEV, V5, P1892, DOI 10.1101/gad.5.10.1892; Piccinin S, 2012, CANCER CELL, V22, P404, DOI 10.1016/j.ccr.2012.08.003; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yu WL, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00012; Zhou Y, 2015, INT J CLIN EXP MED, V8, P9239; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868	32	15	16	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 3	2017	36	31					4405	4414		10.1038/onc.2017.69	http://dx.doi.org/10.1038/onc.2017.69			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FC4JL	28368406	Green Published, hybrid			2022-12-26	WOS:000406806000003
J	Colleoni, B; Paternot, S; Pita, JM; Bisteau, X; Coulonval, K; Davis, RJ; Raspe, E; Roger, PP				Colleoni, B.; Paternot, S.; Pita, J. M.; Bisteau, X.; Coulonval, K.; Davis, R. J.; Raspe, E.; Roger, P. P.			JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21	ONCOGENE			English	Article							N-TERMINAL KINASE; THYROID EPITHELIAL-CELLS; CYCLIN-DEPENDENT KINASES; JUN NH2-TERMINAL KINASE; SIGNAL-TRANSDUCTION; ACTIVATING KINASE; MAMMALIAN TARGET; UBIQUITIN LIGASE; PROTEIN-KINASES; CANCER	Cyclin D-CDK4/6 are the first cyclin-dependent kinase (CDK) complexes to be activated by mitogenic/oncogenic pathways. They have a central role in the cell multiplication decision and in its deregulation in cancer cells. We identified T172 phosphorylation of CDK4 rather than cyclin D accumulation as the distinctly regulated step determining CDK4 activation. This finding challenges the view that the only identified metazoan CDK-activating kinase, cyclin H-CDK7-Mat1 (CAK), which is constitutively active, is responsible for the activating phosphorylation of all cell cycle CDKs. We previously showed that T172 phosphorylation of CDK4 is conditioned by an adjacent proline (P173), which is not present in CDK6 and CDK1/2. Although CDK7 activity was recently shown to be required for CDK4 activation, we proposed that proline-directed kinases might specifically initiate the activation of CDK4. Here, we report that JNKs, but not ERK1/2 or CAK, can be direct CDK4-activating kinases for cyclin D-CDK4 complexes that are inactivated by p21-mediated stabilization. JNKs and ERK1/2 also phosphorylated p21 at S130 and T57, which might facilitate CDK7-dependent activation of p21-bound CDK4, however, mutation of these sites did not impair the phosphorylation of CDK4 by JNKs. In two selected tumor cells, two different JNK inhibitors inhibited the phosphorylation and activation of cyclin D1-CDK4-p21 but not the activation of cyclin D3-CDK4 that is mainly associated to p27. Specific inhibition by chemical genetics in MEFs confirmed the involvement of JNK2 in cyclin D1-CDK4 activation. Therefore, JNKs could be activating kinases for cyclin D1-CDK4 bound to p21, by independently phosphorylating both CDK4 and p21.	[Colleoni, B.; Paternot, S.; Pita, J. M.; Bisteau, X.; Coulonval, K.; Raspe, E.; Roger, P. P.] Univ Libre Bruxelles, Inst Interdisciplinary Res IRIBHM, WELBIO, Brussels, Belgium; [Colleoni, B.; Paternot, S.; Pita, J. M.; Bisteau, X.; Coulonval, K.; Raspe, E.; Roger, P. P.] Univ Libre Bruxelles, U CRC, Brussels, Belgium; [Davis, R. J.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Davis, R. J.] Howard Hughes Med Inst, Worcester, MA USA	Universite Libre de Bruxelles; WELBIO; Universite Libre de Bruxelles; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute	Roger, PP (corresponding author), Univ Libre Bruxelles, IRIBHM, Campus Erasme,808 Route Lennik, B-1070 Brussels, Belgium.; Roger, PP (corresponding author), ASTAR, IMCB, 61 Biopolis Dr,Proteos 3-09, Singapore 138673, Singapore.	proger@ulb.ac.be	Bisteau, Xavier/Q-7239-2018; Bisteau, Xavier/AAH-6744-2021	Bisteau, Xavier/0000-0002-8896-5098; Davis, Roger/0000-0002-0130-1652	WELBIO (Walloon Excellence in Lifesciences and Biotechnology); Belgian Foundation against Cancer [2014-130]; FRS-FNRS [T003813F, J.0002.16]; Docteur JP Naets Fund; Fondation Rose et Jean Hoguet; Fonds David et Alice Van Buuren; Fondation Jaumotte-Demoulin; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107220] Funding Source: NIH RePORTER	WELBIO (Walloon Excellence in Lifesciences and Biotechnology)(WELBIO); Belgian Foundation against Cancer; FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); Docteur JP Naets Fund; Fondation Rose et Jean Hoguet; Fonds David et Alice Van Buuren; Fondation Jaumotte-Demoulin; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The p21 expression plasmids and MCF-7 cells were provided by Ludger Hengst (Innsbruck University) and Geert Berx (Ghent University), respectively. Amin Bredan edited the English text. We thank Professor Jacques E. Dumont (Universite Libre de Bruxelles) for continued interest and support. This study was supported by WELBIO (Walloon Excellence in Lifesciences and Biotechnology), the Belgian Foundation against Cancer (Grant 2014-130), the FRS-FNRS Grants T003813F and J.0002.16 and the Docteur JP Naets Fund (managed by the King Baudouin Foundation). BC was a fellow of the FRIA and is supported by the Fondation Rose et Jean Hoguet, the Fonds David et Alice Van Buuren and the Fondation Jaumotte-Demoulin, JMP is a fellow of the Televie and PPR is a Senior Research Associate of the FRS-FNRS.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Asghar U, 2015, NAT REV DRUG DISCOV, V14, P130, DOI 10.1038/nrd4504; Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bartek J, 1996, CURR OPIN CELL BIOL, V8, P805, DOI 10.1016/S0955-0674(96)80081-0; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bisteau X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003546; Blain SW, 1997, J BIOL CHEM, V272, P25863, DOI 10.1074/jbc.272.41.25863; Blancquaert S, 2010, MOL ENDOCRINOL, V24, P1453, DOI 10.1210/me.2010-0087; Bockstaele L, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-25; Bockstaele L, 2006, MOL CELL BIOL, V26, P5070, DOI 10.1128/MCB.02006-05; Bockstaele L, 2009, MOL CELL BIOL, V29, P4188, DOI 10.1128/MCB.01823-08; Bode AM, 2007, MOL CARCINOGEN, V46, P591, DOI 10.1002/mc.20348; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Bubici C, 2014, BRIT J PHARMACOL, V171, P24, DOI 10.1111/bph.12432; Cellurale C, 2011, MOL CELL BIOL, V31, P1565, DOI 10.1128/MCB.01122-10; Chen JJ, 1996, MOL CELL BIOL, V16, P4673; Choi YJ, 2012, CANCER CELL, V22, P438, DOI 10.1016/j.ccr.2012.09.015; Coulonval K, 2003, EXP CELL RES, V291, P135, DOI 10.1016/S0014-4827(03)00392-6; Coulonval K, 2011, MOL BIOL CELL, V22, P3971, DOI 10.1091/mbc.E11-02-0136; Cui J, 2005, J BIOL CHEM, V280, P9913, DOI 10.1074/jbc.M412165200; Cui J, 2006, CANCER RES, V66, P10024, DOI 10.1158/0008-5472.CAN-06-0136; Cui J, 2009, MOL CANCER THER, V8, P3214, DOI 10.1158/1535-7163.MCT-09-0408; Das M, 2011, GENE DEV, V25, P634, DOI 10.1101/gad.1989311; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Fallahi-Sichani M, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145877; Finegan KG, 2010, CANCER RES, V70, P5797, DOI 10.1158/0008-5472.CAN-09-3669; Fisher RP, 2005, J CELL SCI, V118, P5171, DOI 10.1242/jcs.02718; Ganuza M, 2012, EMBO J, V31, P2498, DOI 10.1038/emboj.2012.94; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Hamilton E, 2016, CANCER TREAT REV, V45, P129, DOI 10.1016/j.ctrv.2016.03.002; Hui LJ, 2008, J CLIN INVEST, V118, P3943, DOI 10.1172/JCI37156; Hwang CY, 2009, MOL CELL BIOL, V29, P3379, DOI 10.1128/MCB.01758-08; Jakel H, 2012, CELL CYCLE, V11, P1910, DOI 10.4161/cc.19957; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Jarviluoma A, 2006, MOL CELL BIOL, V26, P2430, DOI 10.1128/MCB.26.6.2430-2440.2006; Kaldis P, 1999, CELL MOL LIFE SCI, V55, P284, DOI 10.1007/s000180050290; Kaldis P, 1998, MOL BIOL CELL, V9, P2545, DOI 10.1091/mbc.9.9.2545; KATO JY, 1994, MOL CELL BIOL, V14, P2713, DOI 10.1128/MCB.14.4.2713; Khatlani TS, 2007, ONCOGENE, V26, P2658, DOI 10.1038/sj.onc.1210050; Kim GY, 2002, J BIOL CHEM, V277, P29792, DOI 10.1074/jbc.M201299200; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Larochelle S, 2006, NAT STRUCT MOL BIOL, V13, P55, DOI 10.1038/nsmb1028; Larochelle S, 2007, MOL CELL, V25, P839, DOI 10.1016/j.molcel.2007.02.003; Lin JY, 1996, MOL CELL BIOL, V16, P1786; Liu Y, 2004, J BIOL CHEM, V279, P4507, DOI 10.1074/jbc.M309995200; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; MATSUOKA M, 1994, MOL CELL BIOL, V14, P7265, DOI 10.1128/MCB.14.11.7265; Nitta RT, 2011, ONCOGENE, V30, P234, DOI 10.1038/onc.2010.414; Nitta RT, 2008, J BIOL CHEM, V283, P34935, DOI 10.1074/jbc.M804970200; Parra E, 2010, ONCOL REP, V24, P1339, DOI 10.3892/or_00000991; Patel R, 1998, J CELL SCI, V111, P2247; Paternot S, 2006, CELL CYCLE, V5, P61, DOI 10.4161/cc.5.1.2265; Paternot S, 2003, J BIOL CHEM, V278, P26533, DOI 10.1074/jbc.M302492200; Paternot S, 2006, MOL ENDOCRINOL, V20, P3279, DOI 10.1210/me.2005-0515; Paternot S, 2014, CELL CYCLE, V13, P2879, DOI 10.4161/15384101.2014.946841; Paternot S, 2010, CELL CYCLE, V9, P689, DOI 10.4161/cc.9.4.10611; Paternot S, 2009, CANCER RES, V69, P4577, DOI 10.1158/0008-5472.CAN-08-3260; Potapova O, 2000, J BIOL CHEM, V275, P24767, DOI 10.1074/jbc.M904591199; Puyol M, 2010, CANCER CELL, V18, P63, DOI 10.1016/j.ccr.2010.05.025; Ray A, 2009, MOL CELL BIOL, V29, P986, DOI 10.1128/MCB.00898-08; Rocha AS, 2008, MOL BIOL CELL, V19, P4814, DOI 10.1091/mbc.E08-06-0617; ROGER PP, 1992, J CELL BIOL, V117, P383, DOI 10.1083/jcb.117.2.383; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Schachter MM, 2013, MOL CELL, V50, P250, DOI 10.1016/j.molcel.2013.04.003; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 2016, CANCER DISCOV, V6, P353, DOI 10.1158/2159-8290.CD-15-0894; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shim J, 1996, NATURE, V381, P804, DOI 10.1038/381804a0; SOLOMON MJ, 1994, TRENDS BIOCHEM SCI, V19, P496, DOI 10.1016/0968-0004(94)90137-6; TASSAN JP, 1994, J CELL BIOL, V127, P467, DOI 10.1083/jcb.127.2.467; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tournier Cathy, 2013, Genes Cancer, V4, P397, DOI 10.1177/1947601913486349; Tsuiki H, 2003, CANCER RES, V63, P250; Turner NC, 2015, NEW ENGL J MED, V373, P209, DOI 10.1056/NEJMoa1505270; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang L, 2004, ONCOGENE, V23, P5978, DOI 10.1038/sj.onc.1207802; Welcker M, 1998, CANCER RES, V58, P5053; Wesierska-Gadek J, 2009, ACTA BIOCHIM POL, V56, P495; Wohlbold L, 2006, CELL CYCLE, V5, P546, DOI 10.4161/cc.5.5.2541; Xue Y, 2003, MOL CARCINOGEN, V36, P38, DOI 10.1002/mc.10096; Yang YM, 2003, CLIN CANCER RES, V9, P391; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zhan J, 2007, MOL CELL BIOL, V27, P3530, DOI 10.1128/MCB.00086-06; Zhang T, 2012, CHEM BIOL, V19, P140, DOI 10.1016/j.chembiol.2011.11.010; Zhu HY, 2005, J BIOL CHEM, V280, P29282, DOI 10.1074/jbc.M407352200	95	14	15	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 27	2017	36	30					4349	4361		10.1038/onc.2017.7	http://dx.doi.org/10.1038/onc.2017.7			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FB8AH	28368408	Green Published, hybrid			2022-12-26	WOS:000406360600011
J	Giraldez, S; Galindo-Moreno, M; Limon-Mortes, MC; Rivas, AC; Herrero-Ruiz, J; Mora-Santos, M; Saez, C; Japon, MA; Tortolero, M; Romero, F				Giraldez, Servando; Galindo-Moreno, Maria; Cristina Limon-Mortes, M.; Cristina Rivas, A.; Herrero-Ruiz, Joaquin; Mora-Santos, Mar; Saez, Carmen; Japon, Miguel A.; Tortolero, Maria; Romero, Francisco			G(1)/S phase progression is regulated by PLK1 degradation through the CDK1/beta TrCP axis	FASEB JOURNAL			English	Article						cell cycle; HSP90; protein degradation; ubiquitin ligase	POLO-LIKE KINASE-1; CELL-CYCLE PROGRESSION; SCF-BETA-TRCP; UBIQUITIN LIGASE; MAMMALIAN-CELLS; GENE-EXPRESSION; PROTEIN-KINASE; CHECKPOINT; CANCER; HSP90	Polo-like kinase 1 (PLK1) is a serine/threonine kinase involved in several stages of the cell cycle, including the entry and exit from mitosis, and cytokinesis. Furthermore, it has an essential role in the regulation of DNA replication. Together with cyclin A, PLK1 also promotes CDH1 phosphorylation to trigger its ubiquitination and degradation, allowing cell cycle progression. The PLK1 levels in different type of tumors are very high compared to normal tissues, which is consistent with its role in promoting proliferation. Therefore, several PLK1 inhibitors have been developed and tested for the treatment of cancer. Here, we further analyzed PLK1 degradation and found that cytoplasmic PLK1 is ubiquitinated and subsequently degraded by the SCF1mcP/proteasome. This procedure is triggered when heat shock protein (HSP) 90 is inhibited with geldanamycin, which results in misfolding of PLK1. We also identified CDK1 as the major kinase involved in this degradation. Our work shows for the first time that HSP90 inhibition arrests cell cycle progression at the Gi/S transition. This novel mechanism inhibits CDH1 degradation through CDK1-dependent PLK1 destruction by the SCF beta TrcP/proteasome. In these conditions, CDH1 substrates do not accumulate and cell cycle arrests, providing a novel pathway for regulation of the cell cycle at the G1-to-S boundary. Giraldez, S., Galindo-Moreno, M., Limon-Mortes, M. C., Rivas, A. C., Herrero-Ruiz, J., Mora Santos, M., Saez, C., Japon, M. A., Tortolero, M., Romero, F. Gi/S phase progression is regulated by PLK1 degradation through the CDK1/beta TrCP axis.	[Giraldez, Servando; Galindo-Moreno, Maria; Cristina Limon-Mortes, M.; Cristina Rivas, A.; Herrero-Ruiz, Joaquin; Mora-Santos, Mar; Tortolero, Maria; Romero, Francisco] Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain; [Saez, Carmen; Japon, Miguel A.] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBIS, Seville, Spain; [Saez, Carmen; Japon, Miguel A.] Hosp Univ Virgen del Rocio, Dept Anat Patol, Seville, Spain	University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Virgen del Rocio University Hospital	Romero, F (corresponding author), Fac Biol, Dept Microbiol, Ave Reina Mercedes 6, Seville 41012, Spain.	frport@us.es	Ruiz, Joaquin Herrero/AAP-5598-2020; Moreno, María Galindo/AAA-5574-2020; Sáez, Carmen/B-9468-2015; del Mar Mora-Santos, Maria/V-3495-2017; Sáez, CARMEN/AAH-6431-2021; Romero, Francisco/K-2101-2014; Japón, Miguel A/L-2555-2017; Tortolero, Maria/K-5744-2014; GIRALDEZ, SERVANDO/K-3927-2014	Ruiz, Joaquin Herrero/0000-0002-4120-139X; Moreno, María Galindo/0000-0003-3201-4098; Sáez, Carmen/0000-0002-8600-0508; del Mar Mora-Santos, Maria/0000-0002-8042-0886; Sáez, CARMEN/0000-0002-4657-4048; Romero, Francisco/0000-0002-9588-6881; Japón, Miguel A/0000-0002-5980-5044; Tortolero, Maria/0000-0003-1797-9940; GIRALDEZ, SERVANDO/0000-0001-9543-9347	Ministerio de Economia y Competitividad (MINECO) [SAE2014-53799]; Institute de Salud Carlos III [FIS PI13/02282]	Ministerio de Economia y Competitividad (MINECO); Institute de Salud Carlos III(Instituto de Salud Carlos III)	This work was supported, in part, by grants from the Ministerio de Economia y Competitividad (MINECO; SAE2014-53799) and the Institute de Salud Carlos III (FIS PI13/02282)	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bruinsma W, 2012, TRENDS BIOCHEM SCI, V37, P534, DOI 10.1016/j.tibs.2012.09.005; Butler LM, 2015, MOL CANCER RES, V13, P1445, DOI 10.1158/1541-7786.MCR-15-0234; de Carcer G, 2004, CANCER RES, V64, P5106, DOI 10.1158/0008-5472.CAN-03-2214; de Carcer G, 2001, EMBO J, V20, P2878, DOI 10.1093/emboj/20.11.2878; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Engelbert D, 2008, ONCOGENE, V27, P907, DOI 10.1038/sj.onc.1210703; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fukushima H, 2013, CELL REP, V4, P803, DOI 10.1016/j.celrep.2013.07.031; Giraldez S, 2014, ONCOTARGET, V5, P4370, DOI 10.18632/oncotarget.2021; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Ho A, 2002, CURR OPIN GENET DEV, V12, P47, DOI 10.1016/S0959-437X(01)00263-5; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Lee JY, 2007, MOL CELL BIOL, V27, P3187, DOI 10.1128/MCB.01461-06; Lee KS, 2005, CELL CYCLE, V4, P1346, DOI 10.4161/cc.4.10.2049; Li W, 2013, INT REV CEL MOL BIO, V303, P203, DOI 10.1016/B978-0-12-407697-6.00005-2; Limon-Mortes MC, 2008, J CELL SCI, V121, P1825, DOI 10.1242/jcs.020552; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Liu T, 2011, J BIOL CHEM, V286, P36352, DOI 10.1074/jbc.M111.250175; Liu XQ, 2015, TRANSL ONCOL, V8, P185, DOI 10.1016/j.tranon.2015.03.010; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Lyman SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017692; Machida YJ, 2007, GENE DEV, V21, P184, DOI 10.1101/gad.1495007; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Malhotra V, 2001, AM J RESP CELL MOL, V25, P92, DOI 10.1165/ajrcmb.25.1.4384; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Medema RH, 2011, CLIN CANCER RES, V17, P6459, DOI 10.1158/1078-0432.CCR-11-0541; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Nakai A, 2001, EMBO J, V20, P2885, DOI 10.1093/emboj/20.11.2885; Romero F, 1998, J BIOL CHEM, V273, P7776, DOI 10.1074/jbc.273.13.7776; Romero F, 2004, MOL CELL BIOL, V24, P2720, DOI 10.1128/MCB.24.7.2720-2733.2004; Santaguida S, 2015, NAT REV MOL CELL BIO, V16, P473, DOI 10.1038/nrm4025; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Sigl R, 2009, J CELL SCI, V122, P4208, DOI 10.1242/jcs.054197; Simizu S, 2000, NAT CELL BIOL, V2, P852, DOI 10.1038/35041102; Skaar JR, 2008, NAT CELL BIOL, V10, P755, DOI 10.1038/ncb0708-755; SLEBOS RJC, 1994, P NATL ACAD SCI USA, V91, P5320, DOI 10.1073/pnas.91.12.5320; Song B, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-3; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Srethapakdi M, 2000, CANCER RES, V60, P3940; Stancato LF, 1997, J BIOL CHEM, V272, P4013, DOI 10.1074/jbc.272.7.4013; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Sutherland C., 2011, INT J ALZHEIMERS DIS, V2011; Takai N, 2005, ONCOGENE, V24, P287, DOI 10.1038/sj.onc.1208272; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; XUE S, 1981, J CELL SCI, V51, P163	56	9	9	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2925	2936		10.1096/fj.201601108R	http://dx.doi.org/10.1096/fj.201601108R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28360195				2022-12-26	WOS:000405931000018
J	Yamamoto, J; Bergstrom, J; Davis, A; Wing, D; Schousboe, JT; Nichols, JF; Kado, DM				Yamamoto, J.; Bergstrom, J.; Davis, A.; Wing, D.; Schousboe, J. T.; Nichols, J. F.; Kado, D. M.			Trunk lean mass and its association with 4 different measures of thoracic kyphosis in older community dwelling persons	PLOS ONE			English	Article							OSTEOPOROTIC FRACTURES; HYPERKYPHOTIC POSTURE; PREDICTS MORTALITY; MUSCLE COMPOSITION; PHYSICAL FUNCTION; WOMEN; MEN; EXERCISE; STRENGTH; RISK	Background The causes of age-related hyperkyphosis (HK) include osteoporosis, but only 1/3 of those most severely affected have vertebral fractures, suggesting that there are other important, and potentially modifiable causes. We hypothesized that muscle mass and quality may be important determinants of kyphosis in older persons. Methods We recruited 72 persons >65 years to participate in a prospective study designed to evaluate kyphosis and fall risk. At the baseline visit, participants had their body composition measures completed using Dual Energy X-ray Absorptiometry (DXA). They had kyphosis measured in either the standing [S] or lying [L] position: 1) Cobb angle from DXA [L]; 2) Debrunner kyphometer [S]; 3) architect's flexicurve ruler [S]; and 4) blocks method [L]. Multivariable linear/logistic regression analyses were done to assess the association between each body composition and 4 kyphosis measures. Results Women (n = 52) were an average age of 76.8 (SD 6.7) and men 80.5 (SD 7.8) years. They reported overall good/excellent health (93%), the average body mass index was 25.3 (SD 4.6) and 35% reported a fall in the past year. Using published cut-offs, about 20-30% were determined to have HK. For the standing assessments of kyphosis only, after adjusting for age, sex, weight and hip BMD, persons with lower TLM were more likely to be hyperkyphotic. Conclusions Lower TLM is associated with HK in older persons. The results were stronger when standing measures of kyphosis were used, suggesting that the effects of muscle on thoracic kyphosis are best appreciated under spinal loading conditions.	[Yamamoto, J.] Univ Hawaii, Honolulu, HI 96822 USA; [Bergstrom, J.; Davis, A.; Wing, D.; Nichols, J. F.; Kado, D. M.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Schousboe, J. T.] Pk Nicollet Osteoporosis Ctr, Minneapolis, MN USA; [Schousboe, J. T.] Inst Res & Educ, Minneapolis, MN USA	University of Hawaii System; University of California System; University of California San Diego	Kado, DM (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	dkado@ucsd.edu		Kado, Deborah/0000-0002-2582-5573	NIA [T35 AG26757]; NIAMS [AR-06828]; Academic Senate, UCSD; Department of Family Medicine and Public Health; UCSD Stein Institute of Research on Aging; NATIONAL INSTITUTE ON AGING [T35AG026757] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Academic Senate, UCSD; Department of Family Medicine and Public Health; UCSD Stein Institute of Research on Aging; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	NIA T35 AG26757 (JY); NIAMS AR-06828 (DK); Academic Senate, UCSD (DK); Department of Family Medicine and Public Health (DK); UCSD Stein Institute of Research on Aging (DK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoli A, 2009, RADIOL MED, V114, P286, DOI 10.1007/s11547-009-0369-7; Bansal S, 2014, ARCH PHYS MED REHAB, V95, P129, DOI 10.1016/j.apmr.2013.06.022; Briggs AM, 2007, PHYS THER, V87, P595, DOI 10.2522/ptj.20060119; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Gine-Garriga M, 2014, ARCH PHYS MED REHAB, V95, P753, DOI 10.1016/j.apmr.2013.11.007; Kado DM, 2007, J GERONTOL A-BIOL, V62, P652, DOI 10.1093/gerona/62.6.652; Kado DM, 2014, J BONE MINER RES, V29, P2210, DOI 10.1002/jbmr.2251; Kado DM, 2013, J BONE MINER RES, V28, P179, DOI 10.1002/jbmr.1728; Kado DM, 2009, ANN INTERN MED, V150, P681, DOI 10.7326/0003-4819-150-10-200905190-00005; Kado DM, 2006, SPINE, V31, P463, DOI 10.1097/01.brs.0000200131.01313.a9; Kado DM, 2004, J AM GERIATR SOC, V52, P1662, DOI 10.1111/j.1532-5415.2004.52458.x; Kado DM, 1999, ARCH INTERN MED, V159, P1215, DOI 10.1001/archinte.159.11.1215; Katzman WB, 2015, PHYS THER; Katzman W, 2012, J GERONTOL A-BIOL, V67, P191, DOI 10.1093/gerona/glr160; Katzman WB, 2015, J GERONTOL A-BIOL, V70, P635, DOI 10.1093/gerona/glu213; Katzman WB, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-19; Kim H, 2013, GERIATR GERONTOL INT, V13, P458, DOI 10.1111/j.1447-0594.2012.00923.x; Laskey MA, 1996, NUTRITION, V12, P45, DOI 10.1016/0899-9007(95)00017-8; Mika A, 2005, SPINE, V30, P241, DOI 10.1097/01.brs.0000150521.10071.df; MILNE JS, 1983, AGE AGEING, V12, P225, DOI 10.1093/ageing/12.3.225; Money JE, 2015, CALCIFIED TISSUE INT; Sinaki M, 2005, OSTEOPOROSIS INT, V16, P1004, DOI 10.1007/s00198-004-1791-2; Tran TH, 2016, OSTEOPOROSIS INT, V27, P1255, DOI 10.1007/s00198-015-3368-7	23	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174710	10.1371/journal.pone.0174710	http://dx.doi.org/10.1371/journal.pone.0174710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2IH	28369088	Green Published, Green Submitted, gold			2022-12-26	WOS:000399351000034
J	Orbach, DN; Marshall, CD; Mesnick, SL; Wursig, B				Orbach, Dara N.; Marshall, Christopher D.; Mesnick, Sarah L.; Wursig, Bernd			Patterns of cetacean vaginal folds yield insights into functionality	PLOS ONE			English	Article							FEMALE REPRODUCTIVE-TRACT; SEXUAL SELECTION; GENITAL ALLOMETRY; SEA LION; SPERM; COEVOLUTION; BACULUM; SIZE; MORPHOLOGY; EVOLUTION	Complex foldings of the vaginal wall are unique to some cetaceans and artiodactyls and are of unknown function(s). The patterns of vaginal length and cumulative vaginal fold length were assessed in relation to body length and to each other in a phylogenetic context to derive insights into functionality. The reproductive tracts of 59 female cetaceans (20 species, 6 families) were dissected. Phylogenetically-controlled reduced major axis regressions were used to establish a scaling trend for the female genitalia of cetaceans. An unparalleled level of vaginal diversity within a mammalian order was found. Vaginal folds varied in number and size across species, and vaginal fold length was positively allometric with body length. Vaginal length was not a significant predictor of vaginal fold length. Functional hypotheses regarding the role of vaginal folds and the potential selection pressures that could lead to evolution of these structures are discussed. Vaginal folds may present physical barriers, which obscure the pathway of seawater and/or sperm travelling through the vagina. This study contributes broad insights to the evolution of reproductive morphology and aquatic adaptations and lays the foundation for future functional morphology analyses.	[Orbach, Dara N.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Orbach, Dara N.; Marshall, Christopher D.; Wursig, Bernd] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Marshall, Christopher D.; Wursig, Bernd] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Mesnick, Sarah L.] NOAA, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA	Dalhousie University; Texas A&M University System; Texas A&M University System; Texas A&M University College Station; National Oceanic Atmospheric Admin (NOAA) - USA	Orbach, DN (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.; Orbach, DN (corresponding author), Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA.	dnorbach@gmail.com	Marshall, Christopher/AAF-9097-2019; , Sarah/AAZ-8821-2021	, Sarah/0000-0003-0544-4666	Texas A&M University at Galveston (Department of Marine Biology; Texas Institute of Oceanography); American Museum of Natural History (Lerner Gray Memorial Fund); Natural Science and Engineering Research Council of Canada [PGSD2-420080-2012]; Texas Sea Grant	Texas A&M University at Galveston (Department of Marine Biology; Texas Institute of Oceanography); American Museum of Natural History (Lerner Gray Memorial Fund); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Texas Sea Grant	This research was supported by grants to D.N.O. from Texas A&M University at Galveston (Department of Marine Biology; Texas Institute of Oceanography), American Museum of Natural History (Lerner Gray Memorial Fund), Natural Science and Engineering Research Council of Canada (PGSD2-420080-2012), and Texas Sea Grant (Grands-In-Aid of Graduate Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-King M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001851; Anderson MJ, 2006, J ZOOL, V270, P682, DOI 10.1111/j.1469-7998.2006.00173.x; Atkinson S, 1997, Rev Reprod, V2, P175, DOI 10.1530/revreprod/2.3.175; Baker R.R., 1995, HUMAN SPERM COMPETIT; Berta A, 2015, MARINE MAMMALS: EVOLUTIONARY BIOLOGY, 3RD EDITION, P1, DOI 10.1016/C2011-0-07338-6; Biewener Andrew A., 2015, P227; Brennan PLR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000418; Brennan PLR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a017749; Brennan PLR, 2016, INTEGR COMP BIOL, V56, P669, DOI 10.1093/icb/icw018; Brown J., 2000, SCALING BIOL; Brownell R., 1986, REP INT WHALING COMM, V8, P97; Chen PX, 1984, REPROD WHALES DOLPHI, V6, P445; Clarke Robert, 1994, Investigations on Cetacea, V25, P93; Colegrove KM, 2009, ANAT REC, V292, P1801, DOI 10.1002/ar.21009; Dines JP, 2015, EVOLUTION, V69, P1560, DOI 10.1111/evo.12676; Dines JP, 2014, EVOLUTION, V68, P3296, DOI 10.1111/evo.12516; Dixson AF, 2002, FOLIA PRIMATOL, V73, P63, DOI 10.1159/000064784; DIXSON AF, 1994, ARCH SEX BEHAV, V23, P267, DOI 10.1007/BF01541563; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Eberhard W.G., 1985, SEXUAL SELECTION ANI; Fitzpatrick JL, 2012, EVOLUTION, V66, P3595, DOI 10.1111/j.1558-5646.2012.01713.x; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Geraci JR., 1993, MARINE MAMMALS ASHOR, P371; Green R.F., 1972, P247; Green RF, 1977, BREEDING DOLPHINS PR, P185; Harrison R. J., 1969, P253; HARRISON R. J., 1952, TRANS ZOOL SOC LONDON, V27, P437; Holt WV, 2000, ANIM REPROD SCI, V62, P3, DOI 10.1016/S0378-4320(00)00152-4; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; Hunter J, 1787, PHILOS T ROY SOC LON, V77, P371, DOI DOI 10.1098/RSTL.1787.0038; Kellogg R., 1938, COOP RES J, V1, P649; Kinahan AA, 2008, J ZOOL, V274, P312, DOI 10.1111/j.1469-7998.2007.00386.x; Kinahan AA, 2007, EVOL ECOL, V21, P201, DOI 10.1007/s10682-006-0022-z; LABARBERA M, 1989, ANNU REV ECOL SYST, V20, P97, DOI 10.1146/annurev.es.20.110189.000525; Laws R, 1966, LINN S ZOO SOC LOND, V15, P117; Lupold S, 2004, BIOL J LINN SOC, V83, P497, DOI 10.1111/j.1095-8312.2004.00407.x; Manjerovic MB, 2008, J ZOOL, V275, P375, DOI 10.1111/j.1469-7998.2008.00449.x; MATTNER PE, 1968, J REPROD FERTIL, V17, P253, DOI 10.1530/jrf.0.0170253; McGowen MR, 2009, MOL PHYLOGENET EVOL, V53, P891, DOI 10.1016/j.ympev.2009.08.018; Meek A, 1918, J ANAT, V52, P186; Miller EH, 2001, BIOL J LINN SOC, V72, P345, DOI 10.1006/bijl.2000.0509; MULLINS KJ, 1989, ANAT RECORD, V225, P106, DOI 10.1002/ar.1092250205; OMMANNEY F. D., 1932, DISCOVERY REPTS [GOVERNMENT DEPENDENCIES FALKLAND ISLS], V5, P363; Orbach DN, 2016, ANAT REC, V299, P520, DOI 10.1002/ar.23318; Pabst D. Ann, 1999, P15; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Plon S, 2004, THESIS; Puniamoorthy N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-275; Pycraft WP, 1932, P ZOOL SOC LOND, V102, P807; R Core Team, 2021, R LANGUAGE ENV STAT; READ AJ, 1995, MAR MAMMAL SCI, V11, P423, DOI 10.1111/j.1748-7692.1995.tb00667.x; Retief TA, 2013, MAMM BIOL, V78, P356, DOI 10.1016/j.mambio.2012.12.002; Revell LJ, 2016, PHYTOOLS PHYLOGENETI; ROBECK TR, 1994, J ZOO WILDLIFE MED, V25, P321; Rodrigues FR, 2008, ANAT REC, V291, P557, DOI 10.1002/ar.20688; Santos I. P., 2011, Animal Reproduction, V8, P73; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Schroeder J.P., 1990, P435; SCHROEDER JP, 1989, J EXP ZOOL, V249, P316, DOI 10.1002/jez.1402490310; Schulte-Hostedde AI, 2011, BIOL J LINN SOC, V104, P955, DOI 10.1111/j.1095-8312.2011.01775.x; Showalter I, 2014, BIOL J LINN SOC, V111, P183, DOI 10.1111/bij.12184; Simmons LW, 2014, AUSTRAL ENTOMOL, V53, P1, DOI 10.1111/aen.12053; SINHA AA, 1966, J WILDLIFE MANAGE, V30, P121, DOI 10.2307/3797891; Slijper E. J., 1962, P1; Slijper EJ, 1966, WHALES DOLPHINS PORP, P277, DOI [10.1525/9780520321373-017, DOI 10.1525/9780520321373-017]; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Tarpley RJ, 1999, OBSERVATIONS OVARY M; Tasikas DE, 2009, EVOL ECOL, V23, P223, DOI 10.1007/s10682-007-9216-2; TEDMAN RA, 1991, AUST J ZOOL, V39, P351, DOI 10.1071/ZO9910351; Wainwright PC, 2005, INTEGR COMP BIOL, V45, P256, DOI 10.1093/icb/45.2.256; Yassin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057158; Yurkowski DJ, 2011, J MAMMAL, V92, P803, DOI 10.1644/10-MAMM-A-082.1	74	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0175037	10.1371/journal.pone.0175037	http://dx.doi.org/10.1371/journal.pone.0175037			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362830	gold, Green Published, Green Submitted			2022-12-26	WOS:000399175000065
J	Salisch, NC; Vujadinovic, M; van der Helm, E; Spek, D; Vorthoren, L; Serroyen, J; Kuipers, H; Schuitemaker, H; Zahn, R; Custers, J; Vellinga, J				Salisch, Nadine C.; Vujadinovic, Marija; van der Helm, Esmeralda; Spek, Dirk; Vorthoren, Lars; Serroyen, Jan; Kuipers, Harmjan; Schuitemaker, Hanneke; Zahn, Roland; Custers, Jerome; Vellinga, Jort			Antigen capsid-display on human adenovirus 35 via pIX fusion is a potent vaccine platform	PLOS ONE			English	Article							MALARIA-NAIVE ADULTS; PHASE 2A TRIAL; PROTEIN-IX; IMMUNE-RESPONSE; PLASMODIUM-FALCIPARUM; PROTECTIVE IMMUNITY; BOOST IMMUNIZATION; DOUBLE-BLIND; VECTORS; IMMUNOGENICITY	Durable protection against complex pathogens is likely to require immunity that comprises both humoral and cellular responses. While heterologous prime-boost regimens based on recombinant, replication-incompetent Adenoviral vectors (AdV) and adjuvanted protein have been able to induce high levels of concomitant humoral and cellular responses, complex manufacturing and handling in the field may limit their success. To combine the benefits of genetic and protein-based vaccination within one vaccine construct and to facilitate their use, we generated Human Adenovirus 35 (HAdV35) vectors genetically encoding a model antigen based on the Plasmodium falciparum (P. falciparum) circumsporozoite (CS) protein and displaying a truncated version of the same antigen (CSshort) via protein IX on the capsid, with or without a flexible glycine-linker and/or a 45 angstrom--spacer. The four tested pIX-antigen display variants were efficiently incorporated and presented on the HAdV35 capsid irrespective of whether a transgene was encoded or not. Transgene-expression and producibility of the display-/expression vectors were not impeded by the pIX-display. In mice, the pIX-modified vectors induced strong humoral antigen-specific immunity that increased with the inclusion of the linker-/spacer molecules, exceeded the responses induced by the genetic, transgene-expressing HAdV35 vector, and surpassed recombinant protein in potency. In addition, the pIX-display/expression vectors elicited high antigen-specific cellular immune responses that matched those of the genetic HAdV35 vector expressing CS. pIX-modified display-/expression HAdV vectors may therefore be a valuable technology for the development of vaccines against complex pathogens, especially in resource-limited settings.	[Salisch, Nadine C.; Vujadinovic, Marija; van der Helm, Esmeralda; Spek, Dirk; Vorthoren, Lars; Serroyen, Jan; Kuipers, Harmjan; Schuitemaker, Hanneke; Zahn, Roland; Custers, Jerome; Vellinga, Jort] Janssen Vaccines & Prevent, Leiden, Netherlands; [Vorthoren, Lars] ProQR Therapeut NV, Leiden, Netherlands		Vellinga, J (corresponding author), Janssen Vaccines & Prevent, Leiden, Netherlands.	JVelling@its.jnj.com	Zahn, Roland/ABE-8779-2021	Pieper Pournara, Linda/0000-0002-3810-5524				ALEY SB, 1986, J EXP MED, V164, P1915, DOI 10.1084/jem.164.6.1915; Barouch DH, 2011, VACCINE, V29, P5203, DOI 10.1016/j.vaccine.2011.05.025; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Bayer W, J VIROLOGY, V84, P1967; Bayer W, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-75; Boyer JL, 2010, HUM GENE THER, V21, P891, DOI 10.1089/hum.2009.148; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Casimiro DR, 2004, J VIROL, V78, P11434, DOI 10.1128/JVI.78.20.11434-11438.2004; Diaz-Montero CM, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-62; Dmitriev IP, 2002, J VIROL, V76, P6893, DOI 10.1128/JVI.76.14.6893-6899.2002; FURCINITTI PS, 1989, EMBO J, V8, P3563, DOI 10.1002/j.1460-2075.1989.tb08528.x; Gilbert SC, 2002, VACCINE, V20, P1039, DOI 10.1016/S0264-410X(01)00450-9; Hammer SM, 2013, NEW ENGL J MED, V369, P2083, DOI 10.1056/NEJMoa1310566; Havenga M, 2006, J GEN VIROL, V87, P2135, DOI 10.1099/vir.0.81956-0; Higginbotham JN, 2002, HUM GENE THER, V13, P129, DOI 10.1089/10430340152712683; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Krause A, 2006, J VIROL, V80, P5523, DOI 10.1128/JVI.02667-05; Le Bon A, 2003, NAT IMMUNOL, V4, P1009, DOI 10.1038/ni978; Letvin NL, 2004, J VIROL, V78, P7490, DOI 10.1128/JVI.78.14.7490-7497.2004; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Matthews QL, 2006, MOL IMAGING, V5, P510, DOI 10.2310/7290.2006.00029; Matthews QL, 2011, MOL PHARMACEUT, V8, P3, DOI 10.1021/mp100214b; Meulenbroek RA, 2004, MOL THER, V9, P617, DOI 10.1016/j.ymthe.2004.01.012; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Molinier-Frenkel V, 2002, J VIROL, V76, P127, DOI 10.1128/JVI.76.1.127-135.2002; Nakai M, 2007, HUM GENE THER, V18, P925, DOI 10.1089/hum.2007.085; Olotu AI, 2010, J INFECT DIS, V201, P970, DOI 10.1086/651025; Ophorst OJAE, 2007, VACCINE, V25, P6501, DOI 10.1016/j.vaccine.2007.06.019; Ouedraogo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078679; Plassmeyer ML, 2009, J BIOL CHEM, V284, P26951, DOI 10.1074/jbc.M109.013706; Radosevic K, 2010, CLIN VACCINE IMMUNOL, V17, P1687, DOI 10.1128/CVI.00311-10; Rodriguez A, 2009, VACCINE, V27, P6226, DOI 10.1016/j.vaccine.2009.07.106; Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a; Smaill F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006843; Soler E, 2007, BIOTECHNOL ANN REV, V13, P65, DOI 10.1016/S1387-2656(07)13004-0; Stanley DA, 2014, NAT MED, V20, P1126, DOI 10.1038/nm.3702; Stewart VA, 2007, INFECT IMMUN, V75, P2283, DOI 10.1128/IAI.01879-06; Sumida SM, 2004, J VIROL, V78, P2666, DOI 10.1128/JVI.78.6.2666-2673.2004; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; Teigler JE, J VIROLOGY, V86, P9590; VANOOSTRUM J, 1985, J VIROL, V56, P439, DOI 10.1128/JVI.56.2.439-448.1985; Vellinga J, 2004, J VIROL, V78, P3470, DOI 10.1128/JVI.78.7.3470-3479.2004; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; VOGELSTEIN B, 1982, P NATL ACAD SCI-BIOL, V79, P395, DOI 10.1073/pnas.79.2.395; Zak DE, 2012, P NATL ACAD SCI USA, V109, pE3503, DOI 10.1073/pnas.1208972109	46	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174728	10.1371/journal.pone.0174728	http://dx.doi.org/10.1371/journal.pone.0174728			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362809	Green Submitted, Green Published, gold			2022-12-26	WOS:000399175000029
J	Sekhar, GN; Georgian, AR; Sanderson, L; Vizcay-Barrena, G; Brown, RC; Muresan, P; Fleck, RA; Thomas, SA				Sekhar, Gayathri N.; Georgian, Ana R.; Sanderson, Lisa; Vizcay-Barrena, Gema; Brown, Rachel C.; Muresan, Paula; Fleck, Roland A.; Thomas, Sarah A.			Organic cation transporter 1 (OCT1) is involved in pentamidine transport at the human and mouse blood-brain barrier (BBB)	PLOS ONE			English	Article							TRYPANOSOMA-BRUCEI; ENDOTHELIAL-CELLS; ADENOSINE TRANSPORTER; NUCLEOSIDE TRANSPORTERS; DIABETES-MELLITUS; DRUG-RESISTANCE; GENE-EXPRESSION; P-GLYCOPROTEIN; IN-VITRO; PROTEIN	Pentamidine is an effective trypanocidal drug used against stage 1 Human African Trypanosomiasis (HAT). At the blood-brain barrier (BBB), it accumulates inside the endothelial cells but has limited entry into the brain. This study examined transporters involved in pentamidine transport at the human and mouse BBB using hCMEC/D3 and bEnd.3 cell lines, respectively. Results revealed that both cell lines expressed the organic cation transporters (OCT1, OCT2 and OCT3), however, P-gp was only expressed in hCMEC/D3 cells. Polarised expression of OCT1 was also observed. Functional assays found that ATP depletion significantly increased [H-3]pentamidine accumulation in hCMEC/D3 cells (***p<0.001) but not in bEnd.3 cells. Incubation with unlabelled pentamidine significantly decreased accumulation in hCMEC/D3 and bEnd.3 cells after 120 minutes (***p<0.001). Treating both cell lines with haloperidol and amantadine also decreased [H-3]pentamidine accumulation significantly (***p<0.001 and "p<0.01 respectively). However, prazosin treatment decreased [H-3]pentamidine accumulation only in hCMEC/D3 cells (*p<0.05), and not bEnd.3 cells. Furthermore, the presence of OCTN, MATE, PMAT, ENT or CNT inhibitors/substrates had no significant effect on the accumulation of [3H]pentamidine in both cell lines. From the data, we conclude that pentamidine interacts with multiple transporters, is taken into brain endothelial cells by OCT1 transporter and is extruded into the blood by ATP-dependent mechanisms. These interactions along with the predominant presence of OCT1 in the luminal membrane of the BBB contribute to the limited entry of pentamidine into the brain. This information is of key importance to the development of pentamidine based combination therapies which could be used to treat CNS stage HAT by improving CNS delivery, efficacy against trypanosomes and safety profile of pentamidine.	[Sekhar, Gayathri N.; Georgian, Ana R.; Sanderson, Lisa; Brown, Rachel C.; Muresan, Paula; Thomas, Sarah A.] Kings Coll London, Inst Pharmaceut Sci, London, England; [Vizcay-Barrena, Gema; Fleck, Roland A.] Kings Coll London, Ctr Ultrastruct Imaging, London, England	University of London; King's College London; University of London; King's College London	Thomas, SA (corresponding author), Kings Coll London, Inst Pharmaceut Sci, London, England.	sarah.thomas@kcl.ac.uk	Fleck, Roland/AAL-1292-2020; Thomas, Sarah/C-6796-2009	Fleck, Roland/0000-0003-1542-6218; Muresan, Paula/0000-0003-4925-168X; Thomas, Sarah/0000-0002-0053-0154	Medical Research Council PhD studentship [MR/K500811/1]; MRC DPFS award [MR/K015451/1]; Wellcome Trust; UK Medical Research Council (MRC); UK Department for International Development (DFID) under the MRC/DFID; European Union; MRC [MR/K015451/1] Funding Source: UKRI; Medical Research Council [1252909, MR/K015451/1] Funding Source: researchfish	Medical Research Council PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC DPFS award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by the Medical Research Council PhD studentship MR/K500811/1), a MRC DPFS award (MR/K015451/1) and a multiuser equipment grant from The Wellcome Trust. The MRC DPFS award is jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement and is also part of the EDCTP2 programme supported by the European Union. The MRC DPFS grant was awarded to Dr S.A. Thomas (P1), Dr C.A. Dreiss, Dr C. Lorenz, Professor S. Persaud, Dr M. Christie (all at King's College London), Dr V. Yardley and Professor S. Croft.(both at LSHTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Ahlin G, 2008, J MED CHEM, V51, P5932, DOI 10.1021/jm8003152; Andre P, 2012, J CEREBR BLOOD F MET, V32, P1989, DOI 10.1038/jcbfm.2012.109; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Basselin M, 2002, ANTIMICROB AGENTS CH, V46, P3731, DOI 10.1128/AAC.46.12.3731-3738.2002; BOUCHARD P, 1982, DIABETES, V31, P40, DOI 10.2337/diabetes.31.1.40; Chang C, 2004, MOL PHARMACOL, V65, P558, DOI 10.1124/mol.65.3.558; Clark A, 2015, PEDIATR TRANSPLANT, V19, P326, DOI 10.1111/petr.12441; Coelho AC, 2003, MOL BIOCHEM PARASIT, V130, P83, DOI 10.1016/S0166-6851(03)00162-2; de Koning HP, 2001, INT J PARASITOL, V31, P512, DOI 10.1016/S0020-7519(01)00167-9; de Koning HP, 2001, ACTA TROP, V80, P245, DOI 10.1016/S0001-706X(01)00177-2; Dickens D, 2012, BIOCHEM PHARMACOL, V83, P805, DOI 10.1016/j.bcp.2011.12.032; Dos Santos Pereira JN, 2014, AAPS J, V16, P1247; Doua F, 1996, AM J TROP MED HYG, V55, P586, DOI 10.4269/ajtmh.1996.55.586; Duan HC, 2015, DRUG METAB DISPOS, V43, P1773, DOI 10.1124/dmd.115.064824; FAIRLAMB AH, 1980, EXP PARASITOL, V49, P366, DOI 10.1016/0014-4894(80)90072-7; Fevre EM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000333; Geier EG, 2013, CLIN PHARMACOL THER, V94, P636, DOI 10.1038/clpt.2013.175; Graf FE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002475; Grundemann D, 2005, P NATL ACAD SCI USA, V102, P5256, DOI 10.1073/pnas.0408624102; Hartz AMS, 2010, MOL INTERV, V10, P293, DOI 10.1124/mi.10.5.6; Hayeshi R, 2008, EUR J PHARM SCI, V35, P383, DOI 10.1016/j.ejps.2008.08.004; Hosoya K, 2011, CLIN EXP NEPHROL, V15, P478, DOI 10.1007/s10157-011-0460-y; Itagaki S, 2012, DRUG METAB DISPOS, V40, P1138, DOI 10.1124/dmd.111.042432; Iwaki K, 2006, J PHARM PHARMACOL, V58, P1617, DOI 10.1211/jpp.58.12.0008; JHA TK, 1984, T ROY SOC TROP MED H, V78, P252, DOI 10.1016/0035-9203(84)90289-X; Kang HJ, 2006, DRUG METAB DISPOS, V34, P1145, DOI 10.1124/dmd.105.009126; Leprohon P, 2006, EUKARYOT CELL, V5, P1713, DOI 10.1128/EC.00152-06; Li JY, 2001, J CEREBR BLOOD F MET, V21, P929, DOI 10.1097/00004647-200108000-00005; Lin CJ, 2010, J NEUROCHEM, V114, P717, DOI 10.1111/j.1471-4159.2010.06801.x; Matovu E, 2001, MICROBES INFECT, V3, P763, DOI 10.1016/S1286-4579(01)01432-0; Matsson P, 2009, PHARM RES-DORDR, V26, P1816, DOI 10.1007/s11095-009-9896-0; Ming X, 2009, DRUG METAB DISPOS, V37, P424, DOI 10.1124/dmd.108.024083; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mroczkowska JE, 1997, BIOCHEM BIOPH RES CO, V241, P127, DOI 10.1006/bbrc.1997.7779; Munday JC, 2015, MOL MICROBIOL, V96, P887, DOI 10.1111/mmi.12979; Munday JC, 2014, J ANTIMICROB CHEMOTH, V69, P651, DOI 10.1093/jac/dkt442; Park R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.258; Poller B, 2008, J NEUROCHEM, V107, P1358, DOI 10.1111/j.1471-4159.2008.05730.x; Ramirez SH, 2009, J CEREBR BLOOD F MET, V29, P1933, DOI 10.1038/jcbfm.2009.112; Redzic ZB, 2005, J NEUROCHEM, V94, P1420, DOI 10.1111/j.1471-4159.2005.03312.x; Rochfort KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101815; Sanderson L, 2009, J PHARMACOL EXP THER, V329, P967, DOI 10.1124/jpet.108.149872; Sturk LM, 2004, ACTA TROP, V91, P131, DOI 10.1016/j.actatropica.2004.03.010; Tamai I, 2000, J PHARM SCI-US, V89, P1371, DOI 10.1002/1520-6017(200011)89:11<1371::AID-JPS1>3.0.CO;2-D; Tamai I, 1997, FEBS LETT, V419, P107, DOI 10.1016/S0014-5793(97)01441-5; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Taylor CJ, 2006, J PHYSIOL-LONDON, V576, P769, DOI 10.1113/jphysiol.2006.117374; TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956; Watson CP, 2012, BRAIN RES, V1436, P111, DOI 10.1016/j.brainres.2011.11.053; Wittwer MB, 2013, J MED CHEM, V56, P781, DOI 10.1021/jm301302s; Wu K-C, 2015, J NEUROCHEM; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Youdim KA, 2004, FREE RADICAL BIO MED, V36, P592, DOI 10.1016/j.freeradbiomed.2003.11.023; Young JD, 2013, MOL ASPECTS MED, V34, P529, DOI 10.1016/j.mam.2012.05.007; Zhou MY, 2007, J BIOL CHEM, V282, P3188, DOI 10.1074/jbc.M609421200	56	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0173474	10.1371/journal.pone.0173474	http://dx.doi.org/10.1371/journal.pone.0173474			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362799	Green Published, Green Submitted, gold			2022-12-26	WOS:000399175000008
J	Zhou, P; Zeng, WJ; Zhang, X; Li, SJ				Zhou, Pei; Zeng, Weijie; Zhang, Xin; Li, Shoujun			The genetic evolution of canine parvovirus - A new perspective	PLOS ONE			English	Article							HEMORRHAGIC ENTERITIS; MODIFIED-LIVE; HOST-RANGE; VP2 GENE; DOGS; SEQUENCE; VARIANT; IMMUNIZATION; REPLACEMENT; ANTIBODIES	To trace the evolution process of CPV-2, all of the VP2 gene sequences of CPV-2 and FPV (from 1978 to 2015) from GenBank were analyzed in this study. Then, several new ideas regarding CPV-2 evolution were presented. First, the VP2 amino acid 555 and 375 positions of CPV-2 were first ruled out as a universal mutation site in CPV-2a and amino acid 101 position of FPV feature I or T instead of only I in existing rule. Second, the recently confusing nomenclature of CPV-2 variants was substituted with a optional nomenclature that would serve future CPV-2 research. Third, After check the global distribution of variants, CPV-2a is the predominant variant in Asia and CPV-2c is the predominant variant in Europe and Latin America. Fourth, a series of CPV-2-like strains were identified and deduced to evolve from modified live vaccine strains. Finally, three single VP2 mutation (F267Y, Y324I, and T440A) strains were caught concern. Furthermore, these three new VP2 mutation strains may be responsible for vaccine failure, and the strains with VP2 440A may become the novel CPV sub-variant. In conclusion, a summary of all VP2 sequences provides a new perspective regarding CPV-2 evolution and the correlative biological studies needs to be further performed.	[Zhou, Pei; Zeng, Weijie; Zhang, Xin; Li, Shoujun] South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China; [Zhou, Pei; Zeng, Weijie; Zhang, Xin; Li, Shoujun] Key Lab Comprehens Prevent & Control Severe Clin, Guangzhou, Guangdong, Peoples R China; [Zhou, Pei; Zeng, Weijie; Zhang, Xin; Li, Shoujun] Guangdong Engn & Technol Res Ctr Pets, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Li, SJ (corresponding author), South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China.; Li, SJ (corresponding author), Key Lab Comprehens Prevent & Control Severe Clin, Guangzhou, Guangdong, Peoples R China.; Li, SJ (corresponding author), Guangdong Engn & Technol Res Ctr Pets, Guangzhou, Guangdong, Peoples R China.	shoujunli@scau.edu.cn			Promote Scientific and Technological Development Program [2013B040200032]; Science and Technology Planning Project of Guangdong Province [2013B020202001]; Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases [2013A061401013]; China Scholarship Council (CSC)	Promote Scientific and Technological Development Program; Science and Technology Planning Project of Guangdong Province; Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases; China Scholarship Council (CSC)(China Scholarship Council)	This work was supported by the Promote Scientific and Technological Development Program (2013B040200032), the Science and Technology Planning Project of Guangdong Province (2013B020202001), the Guangdong Provincial Key Laboratory of Prevention and Control for Severe Clinical Animal Diseases (2013A061401013). Pei Zhou received financial support from the China Scholarship Council (CSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPEL MJG, 1979, VET REC, V105, P156, DOI 10.1136/vr.105.8.156; APPEL MJG, 1979, CORNELL VET, V69, P123; Appel MJG, 1980, US patent, Patent No. [4,193,991, 4193991]; BASS EP, 1982, J AM VET MED ASSOC, V181, P909; BINN L N, 1970, Infection and Immunity, V1, P503; BUONAVOGLIA C, 1983, ZBL VET MED B, V30, P526; Buonavoglia C, 2001, J GEN VIROL, V82, P3021, DOI 10.1099/0022-1317-82-12-3021; CARMICHAEL LE, 1981, ADV VET SCI COMP MED, V25, P1; Chinchkar SR, 2006, ARCH VIROL, V151, P1881, DOI 10.1007/s00705-006-0753-8; Decaro N, 2006, J VET MED B, V53, P468, DOI 10.1111/j.1439-0450.2006.00974.x; Decaro N, 2008, NEW MICROBIOL, V31, P125; Decaro N, 2006, J VIROL METHODS, V136, P65, DOI 10.1016/j.jviromet.2006.03.030; Decaro N, 2012, VET MICROBIOL, V159, P239, DOI 10.1016/j.vetmic.2012.03.039; Calderon MG, 2011, VIRUS RES, V157, P106, DOI 10.1016/j.virusres.2011.02.015; GENG YF, 2015, PLOS ONE, V10, DOI DOI 10.1371/journal.pone.0137288; Gupta SK, 2016, VIRUS RES, V213, P46, DOI 10.1016/j.virusres.2015.10.019; Hong C, 2007, J VET DIAGN INVEST, V19, P535, DOI 10.1177/104063870701900512; Hueffer K, 2003, J VIROL, V77, P1718, DOI 10.1128/JVI.77.3.1718-1726.2003; Ikeda Y, 2000, VIROLOGY, V278, P13, DOI 10.1006/viro.2000.0653; Kang BK, 2008, VIRUS GENES, V36, P127, DOI 10.1007/s11262-007-0189-6; Kapil S, 2007, J CLIN MICROBIOL, V45, P4044, DOI 10.1128/JCM.01300-07; KELLY WR, 1978, AUST VET J, V54, P593, DOI 10.1111/j.1751-0813.1978.tb02426.x; Martella V, 2005, CLIN DIAGN LAB IMMUN, V12, P1243, DOI 10.1128/CDLI.12.10.1243-1245.2005; Martella V, 2006, VIRUS GENES, V33, P11, DOI 10.1007/s11262-005-0034-8; Nelson CDS, 2007, VIROLOGY, V361, P283, DOI 10.1016/j.virol.2006.11.032; Ohshima T, 2008, J VET MED SCI, V70, P769, DOI 10.1292/jvms.70.769; Organtini LJ, 2015, J VIROL, V89, P1909, DOI 10.1128/JVI.02611-14; Parrish C R, 1990, Adv Virus Res, V38, P403; PARRISH CR, 1991, J VIROL, V65, P6544, DOI 10.1128/JVI.65.12.6544-6552.1991; PARRISH CR, 1988, J GEN VIROL, V69, P1111, DOI 10.1099/0022-1317-69-5-1111; PARRISH CR, 1985, SCIENCE, V230, P1046, DOI 10.1126/science.4059921; Phromnoi S, 2010, VIRUS GENES, V41, P23, DOI 10.1007/s11262-010-0475-6; REED AP, 1988, J VIROL, V62, P266, DOI 10.1128/JVI.62.1.266-276.1988; Riedl M, 2016, VET J; Saxena Lovleen, 2013, Virus Res, V173, P426, DOI 10.1016/j.virusres.2013.01.020; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Stucker KM, 2012, J VIROL, V86, P1514, DOI 10.1128/JVI.06222-11; Truyen U, 1996, VIROLOGY, V215, P186, DOI 10.1006/viro.1996.0021; Truyen U, 2006, VET MICROBIOL, V117, P9, DOI 10.1016/j.vetmic.2006.04.003; TSAO J, 1991, SCIENCE, V251, P1456, DOI 10.1126/science.2006420; Vihinen-Ranta M, 2002, J VIROL, V76, P1884, DOI 10.1128/JVI.76.4.1884-1891.2002; Wu J, 2015, J VET MED SCI, V77, P1305, DOI 10.1292/jvms.14-0665; Yoon SH, 2009, ARCH VIROL, V154, P1353, DOI 10.1007/s00705-009-0444-3; Zhang RZ, 2010, VIRUS GENES, V40, P397, DOI 10.1007/s11262-010-0466-7	44	61	62	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0175035	10.1371/journal.pone.0175035	http://dx.doi.org/10.1371/journal.pone.0175035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362831	Green Published, gold, Green Submitted			2022-12-26	WOS:000399175000064
J	Kulaw, DH; Cowan, JH; Jackson, MW				Kulaw, Dannielle H.; Cowan, James H., Jr.; Jackson, Melissa W.			Temporal and spatial comparisons of the reproductive biology of northern Gulf of Mexico (USA) red snapper (Lutjanus campechanus) collected a decade apart	PLOS ONE			English	Article							SPOTTED SEA-TROUT; SPAWNING FREQUENCY; REACTION NORMS; SARDINA-PILCHARDUS; OOCYTE GROWTH; AGE; SIZE; FECUNDITY; STOCK; MATURATION	In studies done a decade apart, we provide evidence of a recent shift toward a slower progression to sexual maturity as well as reduced egg production, especially among young, small female red snapper, in the Gulf of Mexico ( Gulf). Slower maturation rates ( among fish <= 6 years old), lower GSI values and decreased spawning frequency were observed, and were especially pronounced in the northwestern Gulf. Furthermore, an Index of Reproductive Importance showed that young fish (ages 2-7) are contributing far less to the spawning stock in recent years, while older fish (> 8 years) are contributing more, when compared to fish from the same age groups sampled in the previous decade. Coincident with these changes in reproductive output, fishing pressure has steadily declined gulf-wide, and spawning stock biomass and spawning potential ratio have increased. Thus, it is possible that the age structure of the red snapper stock is becoming less truncated, or that reproductive effort observed is due to the temporary influence of recent strong year classes produced in 2004 and 2006 as they begin to reach full reproductive potential. If the latter is true, careful documentation of the stock's reproductive dynamics during a time of population growth provides new understanding at the meta-population spatial and decadal temporal scales. In contrast, if the former is true, a truncated age structure due to overharvest can limit the productivity of the Gulf red snapper stock. In addition, we have learned that red snapper females in the northwestern Gulf collected on natural reefs and banks have much higher reproductive output than those on artificial reefs in the form of standing and toppled oil and gas platforms, thus making the need to know the relative abundance of females found on these disparate habitats an important next step toward better-understanding factors impacting the reproductive dynamics of this species.	[Kulaw, Dannielle H.; Cowan, James H., Jr.] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; [Jackson, Melissa W.] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; [Kulaw, Dannielle H.] Texas A&M Corpus Christi, Dept Life Sci, Corpus Christi, TX 78412 USA	Louisiana State University System; Louisiana State University; University of South Alabama; Texas A&M University System; Texas A&M University Corpus Christi	Kulaw, DH; Cowan, JH (corresponding author), Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA.; Jackson, MW (corresponding author), Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA.; Kulaw, DH (corresponding author), Texas A&M Corpus Christi, Dept Life Sci, Corpus Christi, TX 78412 USA.	dannielle.kulaw@tamucc.edu; jhcowan@lsu.edu; melissa_woods@hotmail.com			US Department of Commerce via NOAA Fisheries; Marine Fisheries initiative program [NA87FF0424, NA08NMF4330409]	US Department of Commerce via NOAA Fisheries; Marine Fisheries initiative program	This research was funded by the US Department of Commerce via NOAA Fisheries. The grants were awarded as part of the Marine Fisheries initiative program. Grants numbers were NA87FF0424 and NA08NMF4330409.	Allman RJ, 2002, PROCEEDINGS OF THE FIFTY-THIRD ANNUAL GULF AND CARIBBEAN FISHERIES INSTITUTE, P482; [Anonymous], 2016, FISHERIES AQUACULTUR, DOI DOI 10.5772/63026; BAGENAL TB, 1978, ASPECTS FISH FECUNDI, P75; Bradley E., 1975, Proceedings Gulf Caribb Fish lnst, V27, P77; Brown-Peterson NJ, 2011, MAR COAST FISH, V3, P52, DOI 10.1080/19425120.2011.555724; Brown-Peterson NJ, 2009, REGIONAL DIFFERENCES; BROWNPETERSON N, 1988, FISH B-NOAA, V86, P373; Brule T, 2010, T AM FISH SOC, V139, P957, DOI 10.1577/T09-125.1; Cass-Calay S. L, 2015, STOCK ASSESSMENT RED; Cass-Calay SL, 2014, SE DAT ASS REV; Chesney EJ, 1994, SIZE DEPENDENT SPAWN; Claramunt G, 2007, FISH RES, V85, P248, DOI 10.1016/j.fishres.2007.01.009; Collins L.A., 2001, GULF CARIBBEAN FISHE; Collins LA, 1996, IOCLARM C P, P48; CONOVER DO, 1990, OECOLOGIA, V83, P316, DOI 10.1007/BF00317554; Cooper WT, 2013, FISH RES, V138, P31, DOI 10.1016/j.fishres.2012.05.016; Cowan JH, 2011, FISHERIES, V36, P319, DOI 10.1080/03632415.2011.589318; COWAN JH, 1995, T AM FISH SOC, V124, P280, DOI 10.1577/1548-8659(1995)124<0280:NPFRPO>2.3.CO;2; Dieckmann U, 2007, MAR ECOL PROG SER, V335, P253, DOI 10.3354/meps335253; FAO, 2016, STAT WORLD FISH AQ 2; Fischer AJ, 2004, FISH B-NOAA, V102, P593; Fitzhugh G. R., 2004, CHARACTERIZATION RED; Fitzhugh GR, 2012, FISH B-NOAA, V110, P413; Futch RB, 1976, AGE GROWTH REPROD RE; Ganias K, 2003, MAR BIOL, V142, P1169, DOI 10.1007/s00227-003-1028-5; Ganias K, 2011, MAR COAST FISH, V3, P119, DOI 10.1080/19425120.2011.555729; Glenn HD, MARINE COAS IN PRESS; [GMFMC Council GoMFM], 2011, REG AM REEF FISH FIS, P43; Gold JR, 2007, AM FISH SOC S BETH M; Gonzalez ME, 1994, P GULF CARIBBEAN FIS, V43, P29; Goodyear CP, 1997, FISH B-NOAA, V95, P39; Heino M, 2002, ICES J MAR SCI, V59, P562, DOI 10.1006/jmsc.2002.1192; Heino M, 2002, EVOLUTION, V56, P669, DOI 10.1111/j.0014-3820.2002.tb01378.x; Hixon MA, 2014, ICES J MAR SCI, V71, P2171, DOI 10.1093/icesjms/fst200; Hood PB, 2007, AM FISH S S, V60, P267; HUNTER JR, 1979, FISH B-NOAA, V77, P641; HUNTER JR, 1992, FISH B-NOAA, V90, P101; Hunter JR, 1985, MEASUREMENT SPAWNING; Hunter JR, 1983, BATCH FECUNDITY MULT; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; Jackson MW, 2007, AM FISH S S, V60, P217; Jackson MW, 2006, J FISH BIOL, V68, P695, DOI 10.1111/j.1095-8649.2006.00951.x; Jalabert B, 2005, REPROD NUTR DEV, V45, P261, DOI 10.1051/rnd:2005019; Kulaw D. H., 2012, THESIS; Kulaw DH, 2012, HABITAT REGION SPECI; Lowerre-Barbieri S, 2015, MAR ECOL PROG SER, V526, P125, DOI 10.3354/meps11212; Lowerre-Barbieri SK, 2011, MAR COAST FISH, V3, P71, DOI 10.1080/19425120.2011.556932; Melvin GD, 2007, ICES J MAR SCI, V64, P69, DOI 10.1093/icesjms/fsl018; Murua H., 2003, Journal of Northwest Atlantic Fishery Science, V33, P23, DOI 10.2960/J.v33.a2; Nelson RS, 1988, STUDY LIFE HIST ECOL; NIELAND DL, 1993, T AM FISH SOC, V122, P318, DOI 10.1577/1548-8659(1993)122&lt;0318:RBAAVO&gt;2.3.CO;2; Nieland DL, 2002, T AM FISH SOC, V131, P245, DOI 10.1577/1548-8659(2002)131<0245:AGAROS>2.0.CO;2; Nieland DL, 2007, AM FISH SOC S BRTH M, V60; Nunes C, 2011, MAR COAST FISH, V3, P127, DOI 10.1080/19425120.2011.556911; Patterson WF, 2001, T AM FISH SOC, V130, P533, DOI 10.1577/1548-8659(2001)130<0533:MOTRSI>2.0.CO;2; Pitcher T.J., 1982, FISHERIES ECOLOGY; Porch CE, 2015, MAR COAST FISH, V7, P233, DOI 10.1080/19425120.2015.1040567; Porch CE, 2013, MODELING DEPENDENCE; Porch CE, 2007, AM FISH SOC S BETH M, V60; Porch CE, 2013, SEDAR31AW03; Render JH, 1995, LIFE HIST AGE GROWTH; RIJNSDORP AD, 1990, NETH J SEA RES, V25, P279, DOI 10.1016/0077-7579(90)90027-E; Saari CR, 2014, FISH B-NOAA, V112, P261, DOI 10.7755/FB.112.4.3; Saari CR, 2011, COMPARISON AGE GROWT; Schirripa MJ, 1999, SFD9900 SE FISH SCI; SEDAR (Southeast Data A and Review), 2009, STOCK ASS RED SNAPP; SEDAR (Southeast Data Assessment and Review)., 2005, STOCK ASS REP SEDAR; SEDAR (Southeast Data Assessment and Review), 2013, SEDAR31 GULF MEX RED; Stearns S.C., 1992, pi; Stratoudakis Y, 2006, FISH FISH, V7, P35, DOI 10.1111/j.1467-2979.2006.00206.x; Szedlmayer ST, 2000, ESTIMATION ABUNDANCE; Trippel EA, 2004, CAN J FISH AQUAT SCI, V61, P2097, DOI [10.1139/f04-125, 10.1139/F04-125]; TRIPPEL EA, 1995, BIOSCIENCE, V45, P759, DOI 10.2307/1312628; Update S, 2009, SE DAT ASS REV; WALLACE RA, 1981, AM ZOOL, V21, P325; White DB, 2004, B MAR SCI, V75, P335; WILSON CA, 1994, FISH B-NOAA, V92, P841; Wilson CA, 1994, LIFE HIST GAPS RED S; Woods MK, 2003, PROCEEDINGS OF THE FIFTY-FOURTH ANNUAL GULF AND CARIBBEAN FISHERIES INSTITUTE, P526; Woods MK, 2003, DEMOGRAPHIC DIFFEREN; Woods MK, 2003, THESIS; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Yoneda M, 2013, MAR BIOL, V160, P2733, DOI 10.1007/s00227-013-2266-9	83	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0172360	10.1371/journal.pone.0172360	http://dx.doi.org/10.1371/journal.pone.0172360			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355239	gold, Green Submitted, Green Published			2022-12-26	WOS:000399174600003
J	Lebherz-Eichinger, D; Tudor, B; Ankersmit, HJ; Reiter, T; Haas, M; Einwallner, E; Roth-Walter, F; Krenn, CG; Roth, GA				Lebherz-Eichinger, Diana; Tudor, Bianca; Ankersmit, Hendrik J.; Reiter, Thomas; Haas, Martin; Einwallner, Elisa; Roth-Walter, Franziska; Krenn, Claus G.; Roth, Georg A.			Increased trefoil factor 2 levels in patients with chronic kidney disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SERUM; EXPRESSION; PEPTIDES; COLITIS; HSP27; TFF2; RISK	In chronically damaged tissue, trefoil factor family (TFF) peptides ensure epithelial protection and restitution. In chronic kidney disease (CKD), TFF1 and TFF2 are reported to be upregulated. Especially in the early phase, CKD is associated with silently ongoing renal damage and inflammation. Moreover, many patients are diagnosed late during disease progression. We therefore sought to investigate the potential of TFF2 as biomarker for CKD. We followed 118 patients suffering from predialysis CKD and 23 healthy volunteers. TFF2 concentrations were measured using ELISA. Our results showed, that median TFF2 serum levels were significantly higher in patients with later CKD stages as compared to healthy controls (p < 0.001) or early stages (p < 0.001). In patients with mid CKD stages TFF2 serum levels were significantly higher than in healthy controls (p = 0.002). Patients with early or mid CKD stages had significantly higher TFF2 urine concentrations than later CKD stages (p < 0.001 and p = 0.009, respectively). Fractional TFF2 excretion differed significantly between early CKD stages and healthy controls (p = 0.01). ROC curve showed that TFF2 levels can predict different CKD stages (AUC > 0.75). In conclusion, urine and serum TFF2 levels of CKD patients show a different profile dependent on CKD stages. Whereas TFF2 urine levels continuously decreased with disease progression, TFF2 serum concentrations progressively increased from the early to later CKD stages, indicating changes in renal function and offering the potential to examine the course of CKD.	[Lebherz-Eichinger, Diana; Tudor, Bianca; Krenn, Claus G.; Roth, Georg A.] Med Univ Vienna, Dept Anesthesiol Gen Intens Care & Pain Med, Vienna, Austria; [Lebherz-Eichinger, Diana; Ankersmit, Hendrik J.] Med Univ Vienna, Christian Doppler Lab Cardiac & Thorac Diag & Reg, Vienna, Austria; [Lebherz-Eichinger, Diana; Tudor, Bianca; Krenn, Claus G.; Roth, Georg A.] Med Univ Vienna, RAIC Lab 13C1, Vienna, Austria; [Ankersmit, Hendrik J.] Med Univ Vienna, Dept Thorac Surg, Vienna, Austria; [Reiter, Thomas; Haas, Martin] Med Univ Vienna, Div Nephrol & Dialysis, Dept Med 3, Vienna, Austria; [Haas, Martin] Univ Hosp St Polten, Dept Cardiol, St Polten, Austria; [Einwallner, Elisa] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Roth-Walter, Franziska] Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Comparat Med, Vienna, Austria; [Roth-Walter, Franziska] Univ Vienna, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Lebherz-Eichinger, D (corresponding author), Med Univ Vienna, Dept Anesthesiol Gen Intens Care & Pain Med, Vienna, Austria.; Lebherz-Eichinger, D (corresponding author), Med Univ Vienna, Christian Doppler Lab Cardiac & Thorac Diag & Reg, Vienna, Austria.; Lebherz-Eichinger, D (corresponding author), Med Univ Vienna, RAIC Lab 13C1, Vienna, Austria.	diana.lebherz-eichinger@meduniwien.ac.at	Roth-Walter, Franziska/V-4651-2017	Roth-Walter, Franziska/0000-0001-5005-9228; Ankersmit, Hendrik Jan/0000-0002-8761-3517				Anders HJ, 2003, KIDNEY INT, V63, P401, DOI 10.1046/j.1523-1755.2003.00750.x; Astor BC, 2011, AM J NEPHROL, V34, P291, DOI 10.1159/000330699; Chutipongtanate S, 2005, J CLIN INVEST, V115, P3613, DOI 10.1172/JCI25342; Cook GA, 1999, FEBS LETT, V456, P155, DOI 10.1016/S0014-5793(99)00940-0; Coons SJ, 2009, CLIN THER, V31, P2572, DOI 10.1016/j.clinthera.2009.11.035; Du TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080271; Gronbaek H, 2006, DIGESTION, V74, P33, DOI 10.1159/000096591; Itoh H, 1996, BIOCHEM J, V318, P939, DOI 10.1042/bj3180939; Kinchen KS, 2002, ANN INTERN MED, V137, P479, DOI 10.7326/0003-4819-137-6-200209170-00007; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Lebherz-Eichinger D, 2014, TRANSL RES; Lebherz-Eichinger D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138312; Lebherz-Eichinger D, 2012, CLIN CHIM ACTA, V413, P282, DOI 10.1016/j.cca.2011.10.010; Lefebvre O, 1996, SCIENCE, V274, P259, DOI 10.1126/science.274.5285.259; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Musial K, 2013, KIDNEY INT, V83, P971, DOI 10.1038/ki.2013.33; Otto W, 2005, CELL MOL LIFE SCI, V62, P2939, DOI 10.1007/s00018-005-5482-8; Rinnert M, 2010, CELL TISSUE RES, V339, P639, DOI 10.1007/s00441-009-0913-8; Roth GA, 2011, CLIN CHIM ACTA, V412, P713, DOI 10.1016/j.cca.2010.12.030; System USRD, 2014, 2014 ANN DAT REP OV; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Tran CP, 1999, GUT, V44, P636, DOI 10.1136/gut.44.5.636; Vestergaard EM, 2004, SCAND J CLIN LAB INV, V64, P146, DOI 10.1080/00365510410001176; Xian CJ, 1999, AM J PHYSIOL-GASTR L, V277, pG785, DOI 10.1152/ajpgi.1999.277.4.G785; Zoccali C, 2006, KIDNEY INT, V70, P26, DOI 10.1038/sj.ki.5000417	25	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174551	10.1371/journal.pone.0174551	http://dx.doi.org/10.1371/journal.pone.0174551			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355260	gold, Green Submitted, Green Published			2022-12-26	WOS:000399174600063
J	Yoon, JP; Seo, A; Kim, JJ; Lee, CH; Baek, SH; Kim, SY; Jeong, ET; Oh, KS; Chung, SW				Yoon, Jong Pil; Seo, Anna; Kim, Jeong Jun; Lee, Chang-Hwa; Baek, Seung-Hun; Kim, Shin Yoon; Jeong, Eun Taek; Oh, Kyung-Soo; Chung, Seok Won			Deltoid muscle volume affects clinical outcome of reverse total shoulder arthroplasty in patients with cuff tear arthropathy or irreparable cuff tears	PLOS ONE			English	Article							ROTATOR CUFF; CONSTANT SCORE; FATTY INFILTRATION; STRENGTH; OSTEOARTHRITIS; DEGENERATION; PROSTHESIS; RUPTURE; YOUNGER; ATROPHY	We aimed to estimate the interrelation between preoperative deltoid muscle status by measuring the 3 -dimensional deltoid muscle volume and postoperative functional outcomes after reverse total shoulder arthroplasty(RTSA). Thirty-five patients who underwent RTSA participated in this study. All patients underwent preoperative magnetic resonance imaging (MRI) as well as pre- and postoperative radiography and various functional outcome evaluations at least 1 year. The primary outcome parameter was set as age- and sex -matched Constant scores. The 3 -dimensional deltoid muscle model was generated using a medical image processing software and in-house code, and the deltoid muscle volume was calculated automatically. Various clinical and radiographic factors comprising the deltoid muscle volume adjusted for body mass index(BMI) were analyzed, and their interrelation with the outcome parameters was appraised using a multivariate analysis. As a result, all practical consequences considerably improved following surgery(all p<0.01). Overall, 20 and 15 indicated a higher and a lower practical consequence than the average, respectively, which was assessed by the matched Constant scores. The deltoid muscle volume adjusted for BMI(p = 0.009), absence of a subscapularis complete tear (p = 0.040), and greater change in acromion-deltoid tuberosity distance(p = 0.013) were associated with higher matched Constant scores. Multivariate analysis indicated that the deltoid muscle volume was the single independent prognostic factor for practical consequences(p = 0.011). In conclusion, the preoperative deltoid muscle volume significantly affected the functional outcome following RTSA in patients with cuff tear arthropathy or irreparable cuff tears. Therefore, more attention should be paid to patients with severe atrophied deltoid muscle who are at a high risk for poor practical consequences subsequent to RTSA.	[Yoon, Jong Pil; Lee, Chang-Hwa; Baek, Seung-Hun; Kim, Shin Yoon] Kyungpook Natl Univ, Coll Med, Dept Orthopaed Surg, Daegu, South Korea; [Seo, Anna; Kim, Jeong Jun] Kyungpook Natl Univ, Inst Adv Convergence Technol, Daegu, South Korea; [Jeong, Eun Taek; Oh, Kyung-Soo; Chung, Seok Won] Konkuk Univ, Sch Med, Dept Orthopaed Surg, Seoul, South Korea	Kyungpook National University; Kyungpook National University; Konkuk University; Konkuk University Medical Center	Chung, SW (corresponding author), Konkuk Univ, Sch Med, Dept Orthopaed Surg, Seoul, South Korea.	smilecsw@gmail.com		Yoon, Jong Pil/0000-0001-6446-6254; Baek, Seung-Hoon/0000-0002-8909-3287	Institute for Information & Communications Technology Promotion (IITP) grant - Korean government (MSIP) [B0101-16-1081]	Institute for Information & Communications Technology Promotion (IITP) grant - Korean government (MSIP)	This work was supported by the Institute for Information & Communications Technology Promotion (IITP) grant funded by the Korean government (MSIP) (B0101-16-1081).	Ackland DC, 2010, J BONE JOINT SURG AM, V92A, P1221, DOI 10.2106/JBJS.I.00001; Angst F, 2011, ARTHRIT CARE RES, V63, pS174, DOI 10.1002/acr.20630; Bamman MM, 2000, MED SCI SPORT EXER, V32, P1307, DOI 10.1097/00005768-200007000-00019; Beck JD, 2013, J HAND SURG-AM, V38A, P965, DOI 10.1016/j.jhsa.2013.02.025; Boileau P, 2005, J SHOULDER ELB SURG, V14, p147S, DOI 10.1016/j.jse.2004.10.006; Cho JG, 2015, HEAD NECK-J SCI SPEC, V37, P619, DOI 10.1002/hed.23646; Constant CR, 2008, J SHOULDER ELB SURG, V17, P355, DOI 10.1016/j.jse.2007.06.022; De Wilde L, 2002, CLIN BIOMECH, V17, P499, DOI 10.1016/S0268-0033(02)00065-7; Ek ETH, 2013, J SHOULDER ELB SURG, V22, P1199, DOI 10.1016/j.jse.2012.11.016; Fuchs B, 1999, J SHOULDER ELB SURG, V8, P599, DOI 10.1016/S1058-2746(99)90097-6; GERBER C, 1992, CLIN ORTHOP RELAT R, P152; GOUTALLIER D, 1994, CLIN ORTHOP RELAT R, P78; GRAMMONT P, 1987, Rhumatologie, V39, P407; GRAMMONT PM, 1993, ORTHOPEDICS, V16, P65, DOI 10.3928/0147-7447-19930101-11; Greiner SH, 2010, ARCH ORTHOP TRAUM SU, V130, P177, DOI 10.1007/s00402-009-1001-y; HAMADA K, 1990, CLIN ORTHOP RELAT R, P92; 박종혁, 2014, [Clinics in Shoulder and Elbow, 대한 견주관절 학회지], V17, P152; Jobin CM, 2012, J SHOULDER ELB SURG, V21, P1269, DOI 10.1016/j.jse.2011.08.049; Kasten P, 2009, INT ORTHOP, V33, P1641, DOI 10.1007/s00264-008-0666-0; Katolik LI, 2005, J SHOULDER ELB SURG, V14, P279, DOI 10.1016/j.jse.2004.10.009; Kim Kyungil, 2014, [Clinics in Shoulder and Elbow, 대한 견주관절 학회지], V17, P145; Kukkonen J, 2013, J SHOULDER ELB SURG, V22, P1650, DOI 10.1016/j.jse.2013.05.002; Kyu Kim Young, 2015, [Clinics in Shoulder and Elbow, 대한 견주관절 학회지], V18, P248; Lindemann U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157885; Marcon M, 2015, J MAGN RESON IMAGING, V42, P515, DOI 10.1002/jmri.24777; Meakin JR, 2013, J ANAT, V222, P608, DOI 10.1111/joa.12047; Meyer DC, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-247; Mizner RL, 2005, J RHEUMATOL, V32, P1533; Muh SJ, 2013, J BONE JOINT SURG AM, V95A, P1877, DOI [10.2106/JBJS.L.10005, 10.2106/JBJS.L.00005]; Nyffeler RW, 2005, J SHOULDER ELB SURG, V14, P524, DOI 10.1016/j.jse.2004.09.010; Oh JH, 2011, AM J SPORT MED, V39, P1413, DOI 10.1177/0363546511399865; Ozaki H, 2011, J GERONTOL A-BIOL, V66, P257, DOI 10.1093/gerona/glq182; Park Yong Bok, 2014, [Clinics in Shoulder and Elbow, 대한 견주관절 학회지], V17, P68; Roche CP, 2013, BONE JOINT J, V95B, P530, DOI 10.1302/0301-620X.95B4.30442; Rosso C, 2013, KNEE SURG SPORT TR A, V21, P1369, DOI 10.1007/s00167-013-2407-1; Sathappan Sathappan S, 2007, Am J Orthop (Belle Mead NJ), V36, P534; Saul KR, 2015, J APPL BIOMECH, V31, P484, DOI 10.1123/jab.2014-0177; SCHANTZ P, 1983, ACTA PHYSIOL SCAND, V117, P219, DOI 10.1111/j.1748-1716.1983.tb07200.x; Simovitch RW, 2007, J BONE JOINT SURG AM, V89A, P934, DOI 10.2106/JBJS.F.01075; Sirveaux F, 2004, J BONE JOINT SURG BR, V86B, P388, DOI 10.1302/0301-620X.86B3.14024; Sproule DM, 2011, J CHILD NEUROL, V26, P1252, DOI 10.1177/0883073811405053; Sung-Hoon Moon, 2015, [Clinics in Shoulder and Elbow, 대한 견주관절 학회지], V18, P138; Tungtrongjit Yodpiti, 2012, J Med Assoc Thai, V95 Suppl 10, pS58; Vidt ME, 2016, ARTHROSCOPY, V32, P128, DOI 10.1016/j.arthro.2015.06.035; Whatley AN, 2011, J SHOULDER ELB SURG, V20, P114, DOI 10.1016/j.jse.2010.04.049; Zacharias A, 2016, OSTEOARTHR CARTILAGE, V24, P1727, DOI 10.1016/j.joca.2016.05.002; 태석기, 2008, [Clinics in Shoulder and Elbow, 대한 견주관절 학회지], V11, P96	47	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174361	10.1371/journal.pone.0174361	http://dx.doi.org/10.1371/journal.pone.0174361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355234	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174600045
J	Cavalieri, V; Geraci, F; Spinelli, G				Cavalieri, Vincenzo; Geraci, Fabiana; Spinelli, Giovanni			Diversification of spatiotemporal expression and copy number variation of the echinoid hbox12/pmar1/micro1 multigene family	PLOS ONE			English	Article							SEA-URCHIN EMBRYO; GENE REGULATORY NETWORK; HOMEOBOX-CONTAINING GENE; NUCLEAR BETA-CATENIN; DUPLICATE GENES; COLOR-VISION; HEMICENTROTUS-PULCHERRIMUS; TRANSCRIPTION FACTOR; CHROMATIN INSULATOR; ECTODERM CELLS	Changes occurring during evolution in the cis-regulatory landscapes of individual members of multigene families might impart diversification in their spatiotemporal expression and function. The archetypal member of the echinoid hbox12/pmar1/micro1 family is hbox12-a, a homeobox-containing gene expressed exclusively by dorsal blastomeres, where it governs the dorsal/ventral gene regulatory network during embryogenesis of the sea urchin Paracentrotus lividus. Here we describe the inventory of the hbox12/pmar1/micro1 genes in P. lividus, highlighting that gene copy number variation occurs across individual sea urchins of the same species. We show that the various hbox12/pmar1/micro1 genes group into three subfamilies according to their spatiotemporal expression, which ranges from broad transcription throughout development to transient expression in either the animal hemisphere or micromeres of the early embryo. Interestingly, the promoter regions of those genes showing comparable expression patterns are highly similar, while differing from those of the other subfamilies. Strikingly, phylogenetic analysis suggests that the hbox12/pmar1/micro1 genes are species-specific, exhibiting extensive divergence in their noncoding, but not in their coding, sequences across three distinct sea urchin species. In spite of this, two micromere-specific genes of P. lividus possess a TCF/LEF-binding motif in a similar position, and their transcription relies on Wnt/beta-catenin signaling, similar to the pmar1 and micro1 genes, which in other sea urchin species are involved in micro-mere specification. Altogether, our findings suggest that the hbox12/pmar1/micro1 gene family evolved rather rapidly, generating paralogs whose cis-regulatory sequences diverged following multiple rounds of duplication from a common ancestor.	[Cavalieri, Vincenzo; Geraci, Fabiana; Spinelli, Giovanni] Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol STEBICE, Viale Sci Edificio 16, Palermo, Italy; [Cavalieri, Vincenzo] Univ Palermo, Adv Technol Network Ctr ATeN, Viale Sci Edificio 18, Palermo, Italy	University of Palermo; University of Palermo	Cavalieri, V; Spinelli, G (corresponding author), Univ Palermo, Dept Biol Chem & Pharmaceut Sci & Technol STEBICE, Viale Sci Edificio 16, Palermo, Italy.; Cavalieri, V (corresponding author), Univ Palermo, Adv Technol Network Ctr ATeN, Viale Sci Edificio 18, Palermo, Italy.	vincenzo.cavalieri@unipa.it; giovanni.spinelli@unipa.it	Geraci, Fabiana/H-9003-2012	Geraci, Fabiana/0000-0001-9734-1765; SPINELLI, Giovanni/0000-0002-2785-2014				Assis R, 2013, P NATL ACAD SCI USA, V110, P17409, DOI 10.1073/pnas.1313759110; Baiamonte E, 2016, NUCLEIC ACID THER, V26, P318, DOI 10.1089/nat.2016.0614; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Cameron RA, 2009, NUCLEIC ACIDS RES, V37, pD750, DOI 10.1093/nar/gkn887; Castillo-Davis CI, 2004, GENOME RES, V14, P1530, DOI 10.1101/gr.2662504; Cavalieri V, 2008, DEV BIOL, V321, P455, DOI 10.1016/j.ydbio.2008.06.006; Cavalieri V, 2015, SYMMETRY-BASEL, V7, P1721, DOI 10.3390/sym7041721; Cavalieri V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143860; Cavalieri V, 2014, ELIFE, V3, DOI 10.7554/eLife.04664; Cavalieri V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003847; Cavalieri V, 2011, DEVELOPMENT, V138, P4279, DOI 10.1242/dev.066480; Cavalieri V, 2009, NUCLEIC ACIDS RES, V37, P7407, DOI 10.1093/nar/gkp859; Cavalieri Vincenzo, 2009, V518, P175, DOI 10.1007/978-1-59745-202-1_13; Cavalieri V, 2007, GENE EXPR PATTERNS, V7, P124, DOI 10.1016/j.modgep.2006.06.001; Cheng XR, 2014, DEV BIOL, V391, P147, DOI 10.1016/j.ydbio.2014.04.015; Cook DE, 2012, SCIENCE, V338, P1206, DOI 10.1126/science.1228746; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Di Bernardo M, 1999, DEVELOPMENT, V126, P2171; DIBERNARDO M, 1995, P NATL ACAD SCI USA, V92, P8180, DOI 10.1073/pnas.92.18.8180; Duboc V, 2004, DEV CELL, V6, P397, DOI 10.1016/S1534-5807(04)00056-5; Duboc V, 2010, DEVELOPMENT, V137, P223, DOI 10.1242/dev.042531; Eirin-Lopez JM, 2004, MOL BIOL EVOL, V21, P1992, DOI 10.1093/molbev/msh213; Ettensohn CA, 2003, DEVELOPMENT, V130, P2917, DOI 10.1242/dev.00511; Ettensohn CA, 2007, DEVELOPMENT, V134, P3077, DOI 10.1242/dev.009092; Ettensohn CA, 2013, GENESIS, V51, P383, DOI 10.1002/dvg.22380; Fagotto F, 1996, J CELL BIOL, V132, P1105, DOI 10.1083/jcb.132.6.1105; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Flowers VL, 2004, DEV DYNAM, V231, P727, DOI 10.1002/dvdy.20194; Force A, 1999, GENETICS, V151, P1531; Fradkin LG, 2002, P NATL ACAD SCI USA, V99, P13663, DOI 10.1073/pnas.212511099; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Garfield DA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001696; GHANEM N, 1988, HUM GENET, V79, P209, DOI 10.1007/BF00366239; GROOT PC, 1991, GENOMICS, V10, P779, DOI 10.1016/0888-7543(91)90463-O; Gu ZL, 2004, NAT GENET, V36, P577, DOI 10.1038/ng1355; Gu ZL, 2002, MOL BIOL EVOL, V19, P256, DOI 10.1093/oxfordjournals.molbev.a004079; Ha M, 2009, P NATL ACAD SCI USA, V106, P2295, DOI 10.1073/pnas.0807350106; Haillot E, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002247; Hinman VF, 2003, P NATL ACAD SCI USA, V100, P13356, DOI 10.1073/pnas.2235868100; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Jagla WM, 2002, HUM MOL GENET, V11, P23, DOI 10.1093/hmg/11.1.23; Katju V, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-73; Kitamura K, 2002, DEV GENES EVOL, V212, P1, DOI 10.1007/s00427-001-0202-3; Lee JA, 2006, ANN NEUROL, V59, P398, DOI 10.1002/ana.20732; Linzmeier RM, 2005, GENOMICS, V86, P423, DOI 10.1016/j.ygeno.2005.06.003; LITTLEWOOD DTJ, 1995, PHILOS T R SOC B, V347, P213, DOI 10.1098/rstb.1995.0023; Logan CY, 1999, DEVELOPMENT, V126, P345; Royo JL, 2011, P NATL ACAD SCI USA, V108, P14186, DOI 10.1073/pnas.1109037108; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2007, ORIGINS GENOME ARCHI; Makova KD, 2003, GENOME RES, V13, P1638, DOI 10.1101/gr.1133803; Makrinou E, 2001, GENOME RES, V11, P935, DOI 10.1101/gr.175901; Martik M.L., 2016, F1000RES, V5; Materna SC, 2013, DEV BIOL, V375, P92, DOI 10.1016/j.ydbio.2012.11.033; Materna SC, 2010, GENE EXPR PATTERNS, V10, P177, DOI 10.1016/j.gep.2010.04.002; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; McCauley BS, 2010, DEV BIOL, V340, P200, DOI 10.1016/j.ydbio.2009.11.020; Nei M, 1997, MOL BIOL EVOL, V14, P611, DOI 10.1093/oxfordjournals.molbev.a025800; Neitz J, 1996, SCIENCE, V274, P801, DOI 10.1126/science.274.5288.801; Nishimura Y, 2004, DEV GENES EVOL, V214, P525, DOI 10.1007/s00427-004-0442-0; Niu AL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-298; Ohno S., 1970, EVOLUTION GENE DUPLI; Oliveri P, 2002, DEV BIOL, V246, P209, DOI 10.1006/dbio.2002.0627; Oliveri P, 2003, DEV BIOL, V258, P32, DOI 10.1016/S0012-1606(03)00108-8; Parfitt DE, 2014, PHILOS T R SOC LON B, V369; Patel MV, 2012, J EXP ZOOL PART B, V318B, P368, DOI 10.1002/jez.b.22453; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Revilla-I-Domingo R, 2007, P NATL ACAD SCI USA, V104, P12383, DOI 10.1073/pnas.0705324104; Rottinger E, 2004, DEVELOPMENT, V131, P1075, DOI 10.1242/dev.01000; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Satou Y, 2015, P JPN ACAD B-PHYS, V91, P33, DOI 10.2183/pjab.91.33; Sitnikova T, 1998, MOL BIOL EVOL, V15, P50, DOI 10.1093/oxfordjournals.molbev.a025846; Smith AB, 2006, MOL BIOL EVOL, V23, P1832, DOI 10.1093/molbev/msl039; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Trask BJ, 1998, HUM MOL GENET, V7, P13, DOI 10.1093/hmg/7.1.13; WANG DGW, 1995, MOL MAR BIOL BIOTECH, V4, P148; Wikramanayake AH, 2004, GENESIS, V39, P194, DOI 10.1002/gene.20045; Wu SY, 2007, DEVELOPMENT, V134, P1061, DOI 10.1242/dev.02805; Yamazaki A, 2005, DEV GENES EVOL, V215, P450, DOI 10.1007/s00427-005-0006-y; Yokoyama S, 1999, GENETICS, V153, P919; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	86	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							E0174404	10.1371/journal.pone.0174404	http://dx.doi.org/10.1371/journal.pone.0174404			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350855	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174400038
J	Qu, PX; Qing, SZ; Liu, RQ; Qin, HY; Wang, WW; Qiao, F; Ge, H; Liu, J; Zhang, Y; Cui, W; Wang, YS				Qu, Pengxiang; Qing, Suzhu; Liu, Ruiqi; Qin, Hongyu; Wang, Weiwei; Qiao, Fang; Ge, Hui; Liu, Jun; Zhang, Yong; Cui, Wei; Wang, Yongsheng			Effects of embryo-derived exosomes on the development of bovine cloned embryos	PLOS ONE			English	Article							IN-VITRO CULTURE; PREIMPLANTATION EMBRYO; RAT OOCYTES; CROSS-TALK; COMPETENCE; MEDIA; STRESS; VIVO; MATURATION; PROTOCOLS	The developmental competence of in vitro cultured (IVC) embryos is markedly lower than that of their in vivo counterparts, suggesting the need for optimization of IVC protocols. Embryo culture medium is routinely replaced three days after initial culture in bovine, however, whether this protocol is superior to continuous nonrenewal culture method under current conditions remains unclear. Using bovine somatic cell nuclear transfer (SCNT) embryos as the model, our results showed that compared with routine renewal treatment, nonrenewal culture system significantly improved blastocyst formation, blastocyst quality (increased total cell number, decreased stress and apoptosis, enhanced Oct-4 expression and ratio of ICM/TE), as well as following development to term. Existence and function of SCNT embryo-derived exosomes were then investigated to reveal the cause of impaired development induced by culture medium replacement. Exosomes were successfully isolated through differential centrifugation and identified by both electron microscopy and immunostaining against exosomal membrane marker CD9. Supplementation of extracted exosomes into freshly renewed medium significantly rescued not only blastocyst formation and quality (in vitro development), but also following growth to term (in vivo development). Notably, ratio of ICM/TE and calving rate were enhanced to a similar level as that in nonrenewal group. In conclusion, our results for the first time indicate that 1: bovine SCNT embryos can secrete exosomes into chemically defined culture medium during IVC; 2: secreted exosomes are essential for SCNT blastocyst formation, blastocyst quality, and following development to term; 3: removal of exosomes induced by culture medium replacement impairs SCNT embryo development, which can be avoided by nonrenewal culture procedure or markedly recovered by exosome supplementation.	[Qu, Pengxiang; Qing, Suzhu; Liu, Ruiqi; Qin, Hongyu; Wang, Weiwei; Qiao, Fang; Ge, Hui; Liu, Jun; Zhang, Yong; Wang, Yongsheng] Northwest A&F Univ, Coll Vet Med, Key Lab Anim Biotechnol, Minist Agr, Yangling, Shaanxi, Peoples R China; [Cui, Wei; Wang, Yongsheng] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; University of Massachusetts System; University of Massachusetts Amherst	Zhang, Y; Wang, YS (corresponding author), Northwest A&F Univ, Coll Vet Med, Key Lab Anim Biotechnol, Minist Agr, Yangling, Shaanxi, Peoples R China.; Cui, W; Wang, YS (corresponding author), Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA.	zhy1956@263.net; wcui@umass.edu; wangyongsheng01@nwsuaf.edu.cn	Cui, Wei/F-2192-2016	Cui, Wei/0000-0001-7281-3471	National Natural Science Foundation of China [31472094, 31302045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China http://www.nstc.gov.cn to YW (no. 31472094) and JL (no. 31302045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beninson LA, 2015, IMMUNOL LETT, V163, P187, DOI 10.1016/j.imlet.2014.10.019; Beyhan Z, 2007, MOL REPROD DEV, V74, P18, DOI 10.1002/mrd.20618; Biggers John D, 2002, Reprod Biomed Online, V4 Suppl 1, P30; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Burnett Lindsey A, 2016, Front Biosci (Schol Ed), V8, P79; Cui W, 2016, SCI REP-UK, V6, DOI 10.1038/srep37396; Cui W, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108266; Enright BP, 2000, THERIOGENOLOGY, V54, P659, DOI 10.1016/S0093-691X(00)00381-2; Farin PW, 2006, THERIOGENOLOGY, V65, P178, DOI 10.1016/j.theriogenology.2005.09.022; Feliciano DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088810; Greening DW, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.134890; Hashimoto S, 2008, J REPROD DEVELOP, V54, P370, DOI 10.1262/jrd.20012; Jiao GZ, 2016, CELL REPROGRAM, V18, P17, DOI 10.1089/cell.2015.0055; Jiao GZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058018; Kropp J, 2015, J DAIRY SCI, V98, P6552, DOI 10.3168/jds.2015-9510; Kurosaka S, 2004, BIOL REPROD, V71, P1578, DOI 10.1095/biolreprod.104.029322; Latham KE, 2015, INT REV CEL MOL BIO, V316, P227, DOI 10.1016/bs.ircmb.2015.01.005; Li Q, 2011, BIOL REPROD, V84, P1111, DOI 10.1095/biolreprod.110.089557; Lin ML, 2014, APOPTOSIS, V19, P1637, DOI 10.1007/s10495-014-1031-y; Lin SL, 2015, FERTIL STERIL, V104, P1442, DOI 10.1016/j.fertnstert.2015.08.029; Lopera-Vasquez R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148083; Marcho C, 2015, REPRODUCTION, V150, pR109, DOI 10.1530/REP-15-0180; Michalak Marek, 2015, Clin Exp Reprod Med, V42, P1, DOI 10.5653/cerm.2015.42.1.1; Ng YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058502; PAPAIOANNOU VE, 1988, DEVELOPMENT, V102, P793; Paul S, 2014, MOL REPROD DEV, V81, P171, DOI 10.1002/mrd.22219; Pontes JHF, 2009, THERIOGENOLOGY, V71, P690, DOI 10.1016/j.theriogenology.2008.09.031; Qu PX, 2016, CELL REPROGRAM, V18, P162, DOI 10.1089/cell.2015.0079; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reed ML, 2009, FERTIL STERIL, V92, P1783, DOI 10.1016/j.fertnstert.2009.05.008; Rizos D, 2008, REPROD DOMEST ANIM, V43, P44, DOI 10.1111/j.1439-0531.2008.01230.x; Saadeldin IM, 2015, STEM CELLS CLONING, V8, P103, DOI 10.2147/SCCAA.S84991; Saadeldin IM, 2014, CELL REPROGRAM, V16, P223, DOI 10.1089/cell.2014.0003; Sfontouris IA, 2016, J ASSIST REPROD GEN, V33, P1261, DOI 10.1007/s10815-016-0774-5; Shelke GV, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24783; Shen W, 2007, REPRODUCTION, V134, P223, DOI 10.1530/REP-06-0378; Stokes PJ, 2005, DEV BIOL, V284, P62, DOI 10.1016/j.ydbio.2005.05.001; Sun QY, 2001, MOL REPROD DEV, V59, P192, DOI 10.1002/mrd.1022; Sun SC, 2013, REPROD FERT DEVELOP, V25, P617, DOI 10.1071/RD12011; Takahashi M, 2000, THERIOGENOLOGY, V54, P137, DOI 10.1016/S0093-691X(00)00332-0; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vilella F, 2015, DEVELOPMENT, V142, P3210, DOI 10.1242/dev.124289; Wang LJ, 2012, THERIOGENOLOGY, V78, P2110, DOI 10.1016/j.theriogenology.2012.03.011; Wang TY, 2014, MOL HUM REPROD, V20, P318, DOI 10.1093/molehr/gat088; Wang YS, 2011, REPROD DOMEST ANIM, V46, P404, DOI 10.1111/j.1439-0531.2010.01679.x; Wang YS, 2011, ANIM REPROD SCI, V124, P48, DOI 10.1016/j.anireprosci.2011.01.015; Wang YS, 2011, THERIOGENOLOGY, V75, P819, DOI 10.1016/j.theriogenology.2010.10.022; Wydooghe E, 2015, BIOL REV CAMB PHILOS; Xiong XR, 2014, ZYGOTE, V22, P1, DOI 10.1017/S0967199412000184	52	61	63	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174535	10.1371/journal.pone.0174535	http://dx.doi.org/10.1371/journal.pone.0174535			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350875	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174400053
J	Szymanska-Czerwinska, M; Mitura, A; Niemczuk, K; Zareba, K; Jodelko, A; Pluta, A; Scharf, S; Vitek, B; Aaziz, R; Vorimore, F; Laroucau, K; Schnee, C				Szymanska-Czerwinska, Monika; Mitura, Agata; Niemczuk, Krzysztof; Zareba, Kinga; Jodelko, Agnieszka; Pluta, Aneta; Scharf, Sabine; Vitek, Bailey; Aaziz, Rachid; Vorimore, Fabien; Laroucau, Karine; Schnee, Christiane			Dissemination and genetic diversity of chlamydial agents in Polish wildfowl: Isolation and molecular characterisation of avian Chlamydia abortus strains	PLOS ONE			English	Article							CHLAMYDOPHILA-PSITTACI; FAMILY CHLAMYDIACEAE; BIRDS; DIAGNOSIS; PCR; PREVALENCE; GALLINACEA; PROPOSAL; RISK	Wild birds are considered as a reservoir for avian chlamydiosis posing a potential infectious threat to domestic poultry and humans. Analysis of 894 cloacal or fecal swabs from free-living birds in Poland revealed an overall Chlamydiaceae prevalence of 14.8% (n = 132) with the highest prevalence noted in Anatidae (19.7%) and Corvidae (13.4%). Further testing conducted with species-specific real-time PCR showed that 65 samples (49.2%) were positive for C. psittaci whereas only one was positive for C. avium. To classify the non-identified chlamydial agents and to genotype the C. psittaci and C. avium-positive samples, specimens were subjected to ompA-PCR and sequencing (n = 83). The ompA-based NJ dendrogram revealed that only 23 out of 83 sequences were assigned to C. psittaci, in particular to four clades representing the previously described C. psittaci genotypes B, C, Mat116 and 1V. Whereas the 59 remaining sequences were assigned to two new clades named G1 and G2, each one including sequences recently obtained from chlamydiae detected in Swedish wetland birds. G1 (18 samples from Anatidae and Rallidae) grouped closely together with genotype 1V and in relative proximity to several C. abortus isolates, and G2 (41 samples from Anatidae and Corvidae) grouped closely to C. psittaci strains of the classical ABE cluster, Matt116 and M56. Finally, deep molecular analysis of four representative isolates of genotypes 1V, G1 and G2 based on 16S rRNA, IGS and partial 23S rRNA sequences as well as MLST clearly classify these isolates within the C. abortus species. Consequently, we propose an expansion of the C. abortus species to include not only the classical isolates of mammalian origin, but also avian isolates so far referred to as atypical C. psittaci or C. psittaci/C. abortus intermediates.	[Szymanska-Czerwinska, Monika; Mitura, Agata; Niemczuk, Krzysztof; Zareba, Kinga; Jodelko, Agnieszka] Natl Inst Vet Res, Dept Cattle & Sheep Dis, Pulawy, Poland; [Pluta, Aneta] Natl Inst Vet Res, Dept Biochem, Pulawy, Poland; [Scharf, Sabine; Vitek, Bailey; Schnee, Christiane] Friedrich Loeffler Inst, Inst Mol Pathogenesis, Fed Res Inst Anim Hlth, Jena, Germany; [Aaziz, Rachid; Vorimore, Fabien; Laroucau, Karine] Univ Paris Est, Bacterial Zoonoses Unit, Hlth Anim Lab, Anses, Maisons Alfort, France	National Veterinary Institute - National Research Institute; National Veterinary Institute - National Research Institute; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Szymanska-Czerwinska, M (corresponding author), Natl Inst Vet Res, Dept Cattle & Sheep Dis, Pulawy, Poland.	monika.szymanska@piwet.pulawy.pl	Szymańska-Czerwińska, Monika/ABI-7174-2020; Niemczuk, Krzysztof/AAV-7798-2021; Jodełko, Agnieszka/ABI-7256-2020; Zaręba-Marchewka, Kinga/AAX-3839-2020; Mitura, Agata/ABC-9809-2020; Aaziz, Rachid/GOE-4376-2022; Laroucau, Karine/GSO-1980-2022	Szymańska-Czerwińska, Monika/0000-0001-8974-0870; Niemczuk, Krzysztof/0000-0003-1611-9770; Jodełko, Agnieszka/0000-0002-4821-4847; Zaręba-Marchewka, Kinga/0000-0003-0657-4171; Laroucau, Karine/0000-0001-7605-8602; Schnee, Christiane/0000-0001-7643-9114	Polish Ministry of Science and Higher Education program "Iuventus Plus" [IP2014 047273]; Friedrich-Loeffler-Institut, Germany; University Paris-Est, Anses, Animal Health Laboratory, Anses, France	Polish Ministry of Science and Higher Education program "Iuventus Plus"; Friedrich-Loeffler-Institut, Germany; University Paris-Est, Anses, Animal Health Laboratory, Anses, France	The scientific work was funded under the Polish Ministry of Science and Higher Education program "Iuventus Plus" in the years 2015-2016 (project number IP2014 047273). Financing was also provided from local funds at Friedrich-Loeffler-Institut, Germany and University Paris-Est, Anses, Animal Health Laboratory, Anses, France.	Aaziz R, 2015, APPL ENVIRON MICROB, V81, P4581, DOI 10.1128/AEM.00778-15; Andersen Arthur A., 2007, P303, DOI 10.1002/9780470344668.ch15; Avian Chlamydiosis, 2012, OIE TERR MAN 2012; Beckmann KM, 2014, ECOHEALTH, V11, P544, DOI 10.1007/s10393-014-0951-x; Blomqvist Maria, 2012, Infect Ecol Epidemiol, V2, DOI 10.3402/iee.v2i0.8435; Blomqvist M, 2012, AVIAN DIS, V56, P737, DOI 10.1637/10105-022812-ResNote.1; Chahota R, 2006, MICROBIOL IMMUNOL, V50, P663, DOI 10.1111/j.1348-0421.2006.tb03839.x; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Di Francesco A, 2015, VET REC, V177, P466, DOI 10.1136/vr.103218; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Guo WN, 2016, SCI REP-UK, V6, DOI 10.1038/srep19638; Harkinezhad T, 2009, VET MICROBIOL, V135, P68, DOI 10.1016/j.vetmic.2008.09.046; Heddema ER, 2006, APPL ENVIRON MICROB, V72, P4423, DOI 10.1128/AEM.02662-05; Herrmann B, 2006, EMERG INFECT DIS, V12, P330, DOI 10.3201/eid1202.050404; Iatsentiuk S P, 2007, Genetika, V43, P1454; Krawiec M, 2015, VECTOR-BORNE ZOONOT, V15, P652, DOI 10.1089/vbz.2015.1814; Luniak M., 2004, INT URB WILDL S; Madani SA, 2013, AVIAN PATHOL, V42, P38, DOI 10.1080/03079457.2012.757288; Menard A, 2006, J MED MICROBIOL, V55, P471, DOI 10.1099/jmm.0.46335-0; Opota O, 2015, J MED MICROBIOL, V64, P1174, DOI 10.1099/jmm.0.000139; Pannekoek Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014179; Pannekoek Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-42; Pantchev A, 2009, VET J, V181, P145, DOI 10.1016/j.tvjl.2008.02.025; Pospischil A, 2009, DRUG TODAY, V45, P141; Pudjiatmoko, 1997, INT J SYST BACTERIOL, V47, P425; Sachse K, 2008, BMC MICROBIOL, P8; Sachse K, 2015, SYST APPL MICROBIOL, V38, P99, DOI 10.1016/j.syapm.2014.12.004; Sachse K, 2014, SYST APPL MICROBIOL, V37, P79, DOI 10.1016/j.syapm.2013.12.004; Sachse K, 2012, VET MICROBIOL, V157, P476, DOI 10.1016/j.vetmic.2012.01.002; Siarkou VI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019813; Takahashi T, 1997, J CLIN MICROBIOL, V35, P2908, DOI 10.1128/JCM.35.11.2908-2914.1997; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor-Brown A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3055-x; Thomas V, 2006, ENVIRON MICROBIOL, V8, P2125, DOI 10.1111/j.1462-2920.2006.01094.x; Van Loock M, 2003, INT J SYST EVOL MICR, V53, P761, DOI 10.1099/ijs.0.02329-0; Vazquez B, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-45; Vorimore F, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftu016; Vorimore F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074823; Zocevic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058741	40	39	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174599	10.1371/journal.pone.0174599	http://dx.doi.org/10.1371/journal.pone.0174599			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350846	Green Submitted, gold, Green Published			2022-12-26	WOS:000399174400064
J	Kieneker, LM; Eisenga, MF; Joosten, MM; de Boer, RA; Gansevoort, RT; Kootstra-Ros, JE; Navis, G; Bakker, SJL				Kieneker, Lyanne M.; Eisenga, Michele F.; Joosten, Michel M.; de Boer, Rudolf A.; Gansevoort, Ron T.; Kootstra-Ros, Jenny E.; Navis, Gerjan; Bakker, Stephan J. L.			Plasma potassium, diuretic use and risk of developing chronic kidney disease in a predominantly White population	PLOS ONE			English	Article							END-STAGE DISEASE; SERUM POTASSIUM; RENAL-DISEASE; BLOOD-PRESSURE; SALT SENSITIVITY; DEVELOPING HYPERTENSION; GLUCOSE-INTOLERANCE; RACIAL-DIFFERENCES; BODY POTASSIUM; CYSTATIN C	Objective Both hypokalemia and hyperkalemia are associated with disease progression in patients with chronic kidney disease (CKD). It is unclear whether similar associations are present in the general population. Our aim was to examine the association of plasma potassium with risk of developing CKD and the role of diuretics in this association in a population-based cohort. Research design and methods We studied 5,130 subjects free of CKD at baseline of the Prevention of Renal and Vascular End-Stage Disease (PREVEND) study, a prospective, population-based cohort of Dutch men and women aged 28-75 years. Hypokalemia was defined as plasma potassium <3.5 mmol/L, and hyperkalemia as plasma potassium >= 5.0 mmol/L. Risk of CKD was defined as de novo development of eGFR <60 ml/min/1.73m(2) and/or albuminuria >30 mg/24h. Results Mean baseline plasma potassium was 4.4 +/- 0.3 mmol/L. The prevalences of hypokalemia and hyperkalemia were 0.5% and 3.8%, respectively; 3.0% of the subjects used diuretics. During a median follow-up of 10.3 years (interquartile range: 6.3-11.4 years), 753 subjects developed CKD. The potassium-CKD association was modified by diuretic use (P-interaction = 0.02). Both hypokalemia without (HR, 7.74, 95% CI, 3.43-17.48) or with diuretic use (HR, 4.32, 95% CI, 1.77-10.51) were associated with an increased CKD risk as compared to plasma potassium 4.0-4.4 mmol/L without diuretic use. Plasma potassium concentrations >= 3.5 mmol/L were associated with an increased CKD risk among subjects using diuretics (Ptrend = 0.01) but not among subjects not using diuretics (P-trend = 0.74). Conclusion In this population-based cohort, hypokalemia was associated with an increased CKD risk, regardless of diuretic use. In the absence of hypokalemia, plasma potassium was not associated with an increased CKD risk, except among subjects using diuretics.	[Kieneker, Lyanne M.; Eisenga, Michele F.; Joosten, Michel M.; Gansevoort, Ron T.; Navis, Gerjan; Bakker, Stephan J. L.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [de Boer, Rudolf A.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Kootstra-Ros, Jenny E.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Kieneker, LM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands.	lyannekieneker@gmail.com	de Boer, Rudolf/ABE-9879-2020	Joosten, Michel Marinus/0000-0002-0039-6629	Dutch Kidney Foundation	Dutch Kidney Foundation	The Prevention of Renal and Vascular End-Stage Disease (PREVEND) study has been made possible by grants from the Dutch Kidney Foundation. The funder of the work had no role in the conception, execution, or analysis of the research and had no role in drafting the manuscript.	Adrogue HJ, 2007, NEW ENGL J MED, V356, P1966, DOI 10.1056/NEJMra064486; Ardiles L, 2013, AM J PHYSIOL-RENAL, V304, pF1399, DOI 10.1152/ajprenal.00604.2012; BARDEN AE, 1986, J HYPERTENS, V4, P339, DOI 10.1097/00004872-198606000-00013; Chatterjee R, 2011, AM J CLIN NUTR, V93, P1087, DOI 10.3945/ajcn.110.007286; Chen Y, 2016, MAYO CLIN PROC, V91, P1403, DOI 10.1016/j.mayocp.2016.05.018; EDDY AA, 1991, AM J PATHOL, V138, P1111; Erlinger TP, 2003, AM J KIDNEY DIS, V42, P256, DOI 10.1016/S0272-6386(03)00650-4; FLYNN MA, 1989, AM J CLIN NUTR, V50, P713, DOI 10.1093/ajcn/50.4.713; Foley RN, 2007, J AM SOC NEPHROL, V18, P2575, DOI 10.1681/ASN.2006121411; FOTHERBY MD, 1992, J HYPERTENS, V10, P1403, DOI 10.1097/00004872-199211000-00013; Fukui M, 2014, INT J CLIN PRACT, V68, P700, DOI 10.1111/ijcp.12367; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gennari FJ, 1998, NEW ENGL J MED, V339, P451, DOI 10.1056/NEJM199808133390707; GONICK HC, 1971, AM J MED SCI, V261, P281, DOI 10.1097/00000441-197105000-00007; GORDEN P, 1973, DIABETES, V22, P544, DOI 10.2337/diab.22.7.544; Goyal A, 2012, JAMA-J AM MED ASSOC, V307, P157, DOI 10.1001/jama.2011.1967; GROBBEE DE, 1987, J HYPERTENS, V5, P115, DOI 10.1097/00004872-198702000-00016; Grubb A, 2010, CLIN CHEM LAB MED, V48, P1619, DOI 10.1515/CCLM.2010.318; Gumz ML, 2015, NEW ENGL J MED, V373, P60, DOI 10.1056/NEJMra1313341; Halbesma N, 2008, KIDNEY INT, V74, P505, DOI 10.1038/ki.2008.200; Hawkins RC, 2003, CLIN CHIM ACTA, V331, P171, DOI 10.1016/S0009-8981(03)00112-8; Hayes J, 2012, NEPHRON CLIN PRACT, V120, pC8, DOI 10.1159/000329511; He FJ, 2010, HYPERTENSION, V55, P681, DOI 10.1161/HYPERTENSIONAHA.109.147488; HELDERMAN JH, 1983, DIABETES, V32, P106, DOI 10.2337/diabetes.32.2.106; Hillege HL, 2001, J INTERN MED, V249, P519, DOI 10.1046/j.1365-2796.2001.00833.x; Hollander-Rodriguez JC, 2006, AM FAM PHYSICIAN, V73, P283; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jiang R, 2006, AM J EPIDEMIOL, V163, P222, DOI 10.1093/aje/kwj033; Joosten MM, 2015, KIDNEY INT, V87, P1262, DOI 10.1038/ki.2015.33; Kieneker LM, 2016, KIDNEY INT; Kieneker LM, 2014, HYPERTENSION, V64, P769, DOI 10.1161/HYPERTENSIONAHA.114.03750; KLEINFELD M, 1993, J NATL MED ASSOC, V85, P861; KNOCHEL JP, 1984, AM J MED, V77, P18, DOI 10.1016/S0002-9343(84)80004-2; Koenig W, 2003, AM J EPIDEMIOL, V158, P357, DOI 10.1093/aje/kwg135; Korgaonkar S, 2010, CLIN J AM SOC NEPHRO, V5, P762, DOI 10.2215/CJN.05850809; Lampe JW, 1999, AM J CLIN NUTR, V70, p475S, DOI 10.1093/ajcn/70.3.475s; LIN HB, 1994, CIRCULATION, V89, P331, DOI 10.1161/01.CIR.89.1.331; Luo JC, 2016, CLIN J AM SOC NEPHRO, V11, P90, DOI 10.2215/CJN.01730215; MACGREGOR GA, 1982, LANCET, V2, P567; MCCABE RD, 1994, AM J HYPERTENS, V7, P346, DOI 10.1093/ajh/7.4.346; MCCABE RD, 1994, HYPERTENSION, V24, P77, DOI 10.1161/01.HYP.24.1.77; Nakhoul GN, 2015, AM J NEPHROL, V41, P456, DOI 10.1159/000437151; NATH KA, 1991, AM J KIDNEY DIS, V17, P654, DOI 10.1016/S0272-6386(12)80344-1; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; PRATT JH, 1989, NEW ENGL J MED, V321, P1152, DOI 10.1056/NEJM198910263211703; Ray PE, 2001, KIDNEY INT, V59, P1850, DOI 10.1046/j.1523-1755.2001.0590051850.x; Reungjui S, 2007, KIDNEY INT, V72, P1483, DOI 10.1038/sj.ki.5002564; Reungjui S, 2008, CURR OPIN NEPHROL HY, V17, P470, DOI 10.1097/MNH.0b013e328305b9a5; Riphagen IJ, 2016, J HYPERTENS, V34, P215, DOI 10.1097/HJH.0000000000000786; ROWE JW, 1980, METABOLISM, V29, P498, DOI 10.1016/0026-0495(80)90074-8; Ruster C, 2006, J AM SOC NEPHROL, V17, P2985, DOI 10.1681/ASN.2006040356; STANTON BA, 1989, AM J PHYSIOL, V257, pR989, DOI 10.1152/ajpregu.1989.257.5.R989; Suga S, 2002, KIDNEY INT, V61, P951, DOI 10.1046/j.1523-1755.2002.00208.x; Suga SI, 2001, AM J PHYSIOL-RENAL, V281, pF620, DOI 10.1152/ajprenal.2001.281.4.F620; TOLINS JP, 1987, J CLIN INVEST, V79, P1447, DOI 10.1172/JCI112973; Turban S, 2008, J AM SOC NEPHROL, V19, P1396, DOI 10.1681/ASN.2007101142; van Ballegooijen AJ, 2015, HYPERTENSION, V66, P563, DOI 10.1161/HYPERTENSIONAHA.115.05837; Visser ST, 2013, EXPERT REV PHARM OUT, V13, P285, DOI [10.1586/ERP.13.20, 10.1586/erp.13.20]; Wang HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067140; Wysowski DK, 2003, CLIN CHEM, V49, P190, DOI 10.1373/49.1.190; YOUNG DB, 1995, AM J PHYSIOL-REG I, V268, pR825, DOI 10.1152/ajpregu.1995.268.4.R825	61	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174686	10.1371/journal.pone.0174686	http://dx.doi.org/10.1371/journal.pone.0174686			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346526	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174300070
J	Kupke, T; Malsam, J; Schiebel, E				Kupke, Thomas; Malsam, Joerg; Schiebel, Elmar			A ternary membrane protein complex anchors the spindle pole body in the nuclear envelope in budding yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PORE COMPLEXES; CELL-CYCLE; COMPONENT; NDC1P; CURVATURE; MPS3; DUPLICATION; INTERACTS; INSERTION; BODIES	In budding yeast (Saccharomyces cerevisiae) the multilayered spindle pole body (SPB) is embedded in the nuclear envelope (NE) at fusion sites of the inner and outer nuclear membrane. The SPB is built from 18 different proteins, including the three integral membrane proteins Mps3, Ndc1, and Mps2. These membrane proteins play an essential role in the insertion of the new SPB into the NE. How the huge core structure of the SPB is anchored in the NE has not been investigated thoroughly until now. The present model suggests that the NE protein Mps2 interacts via Bbp1 with Spc29, one of the coiled-coil proteins forming the central plaque of the SPB. To test this model, we purified and reconstituted the Mps2-Bbp1 complex from yeast and incorporated the complex into liposomes. We also demonstrated that Mps2-Bbp1 directly interacts with Mps3 and Ndc1. We then purified Spc29 and reconstituted the ternary Mps2-Bbp1-Spc29 complex, proving that Bbp1 can simultaneously interact with Mps2 and Spc29 and in this way link the central plaque of the SPB to the nuclear envelope. Interestingly, Bbp1 induced oligomerization of Spc29, which may represent an early step in SPB duplication. Together, this analysis provides important insights into the interaction network that inserts the new SPB into the NE and indicates that the Mps2-Bbp1 complex is the central unit of the SPB membrane anchor.	[Kupke, Thomas; Schiebel, Elmar] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Allianz, Neuenheimer Feld 282, D-69120 Heidelberg, Germany; [Kupke, Thomas; Malsam, Joerg] Univ Heidelberg BZH, Biochem Zentrum, Neuenheimer Feld 328, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Schiebel, E (corresponding author), Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Allianz, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	e.schiebel@zmbh.uni-heidelberg.de		Kupke, Thomas/0000-0003-2341-1710; schiebel, Elmar/0000-0002-3683-247X	Deutsche Forschungsgemeinschaft [SFB638]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This was supported by a grant from the Deutsche Forschungsgemeinschaft (Collaborative Research Centre SFB638; to E. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Antonin W, 2005, NAT CELL BIOL, V7, P10, DOI 10.1038/ncb0105-10; Antonin W, 2009, CURR BIOL, V19, pR410, DOI 10.1016/j.cub.2009.03.053; Araki Y, 2006, MOL BIOL CELL, V17, P1959, DOI 10.1091/mbc.E05-07-0668; Araki Y, 2010, J CELL BIOL, V189, P41, DOI 10.1083/jcb.200910027; Beck R, 2008, P NATL ACAD SCI USA, V105, P11731, DOI 10.1073/pnas.0805182105; Bullitt E, 1997, CELL, V89, P1077, DOI 10.1016/S0092-8674(00)80295-0; Burns S, 2015, ELIFE, V4, DOI 10.7554/eLife.08586; BYERS B, 1975, J BACTERIOL, V124, P511, DOI 10.1128/JB.124.1.511-523.1975; Chen JJ, 2014, J CELL BIOL, V204, P523, DOI 10.1083/jcb.201307043; Chial HJ, 1998, J CELL BIOL, V143, P1789, DOI 10.1083/jcb.143.7.1789; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Elliott S, 1999, P NATL ACAD SCI USA, V96, P6205, DOI 10.1073/pnas.96.11.6205; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gardner JM, 2011, J CELL BIOL, V193, P489, DOI 10.1083/jcb.201011017; Hays FA, 2010, METHOD ENZYMOL, V470, P695, DOI 10.1016/S0076-6879(10)70029-X; Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106; Jaspersen SL, 2006, J CELL BIOL, V174, P665, DOI 10.1083/jcb.200601062; Jaspersen SL, 2012, NUCLEUS-PHILA, V3, P226, DOI 10.4161/nucl.20148; Keck JM, 2011, SCIENCE, V332, P1557, DOI 10.1126/science.1205193; Knop M, 1997, EMBO J, V16, P6985, DOI 10.1093/emboj/16.23.6985; Kupke T, 2011, EMBO J, V30, P3337, DOI 10.1038/emboj.2011.242; Lau CK, 2004, EUKARYOT CELL, V3, P447, DOI 10.1128/EC.3.2.447-458.2004; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Madrid AS, 2006, J CELL BIOL, V173, P361, DOI 10.1083/jcb.200506199; Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015; Meseroll RA, 2016, J CELL PHYSIOL, V231, P2353, DOI 10.1002/jcp.25355; Munoz-Centeno MD, 1999, MOL BIOL CELL, V10, P2393, DOI 10.1091/mbc.10.7.2393; O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017; Onischenko E, 2009, J CELL BIOL, V185, P475, DOI 10.1083/jcb.200810030; Park CJ, 2004, MOL BIOL CELL, V15, P1711, DOI 10.1091/mbc.E03-07-0461; Ruthnick D, 2016, MOL CELL BIOL, V36, P1324, DOI 10.1128/MCB.00048-16; Schaerer F, 2001, MOL BIOL CELL, V12, P2519, DOI 10.1091/mbc.12.8.2519; Schramm C, 2000, EMBO J, V19, P421, DOI 10.1093/emboj/19.3.421; Seybold C, 2013, CURR BIOL, V23, pR858, DOI 10.1016/j.cub.2013.07.024; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; WINEY M, 1993, J CELL BIOL, V122, P743, DOI 10.1083/jcb.122.4.743; Zizlsperger N, 2008, BIOCHEMISTRY-US, V47, P11858, DOI 10.1021/bi801378z; Zizlsperger N, 2010, J STRUCT BIOL, V170, P246, DOI 10.1016/j.jsb.2010.01.022	43	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8447	8458		10.1074/jbc.M117.780601	http://dx.doi.org/10.1074/jbc.M117.780601			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28356353	Green Published, hybrid			2022-12-26	WOS:000401788600028
J	Yu, JC; Yu, QH; Liu, YL; Zhang, RY; Xue, LB				Yu, Junchao; Yu, Qiuhong; Liu, Yaling; Zhang, Ruiyun; Xue, Lianbi			Hydrogen gas alleviates oxygen toxicity by reducing hydroxyl radical levels in PC12 cells	PLOS ONE			English	Article							RICH SALINE PROTECTS; ISCHEMIA/REPERFUSION INJURY; MOLECULAR-HYDROGEN; RAT MODEL; ANTIOXIDANT; INHALATION; THERAPY; SAFETY; BLOOD; WATER	Hyperbaric oxygen (HBO) therapy through breathing oxygen at the pressure of above 1 atmosphere absolute (ATA) is useful for varieties of clinical conditions, especially hypoxicischemic diseases. Because of generation of reactive oxygen species (ROS), breathing oxygen gas at high pressures can cause oxygen toxicity in the central nervous system, leading to multiple neurological dysfunction, which limits the use of HBO therapy. Studies have shown that Hydrogen gas (H-2) can diminish oxidative stress and effectively reduce active ROS associated with diseases. However, the effect of H-2 on ROS generated from HBO therapy remains unclear. In this study, we investigated the effect of H-2 on ROS during HBO therapy using PC12 cells. PC12 cells cultured in medium were exposed to oxygen gas or mixed oxygen gas and H-2 at 1 ATA or 5 ATA. Cells viability and oxidation products and ROS were determined. The data showed that H-2 promoted the cell viability and inhibited the damage in the cell and mitochondria membrane, reduced the levels of lipid peroxidation and DNA oxidation, and selectively decreased the levels of (OH)-O-center dot but not disturbing the levels of O-2, H2O2, or NO. in PC12 cells during HBO therapy. These results indicated that H-2 effectively reduced (OH)-O-center dot, protected cells against oxygen toxicity resulting from HBO therapy, and had no effect on other ROS. Our data supported that H-2 could be potentially used as an antioxidant during HBO therapy.	[Yu, Junchao; Yu, Qiuhong; Liu, Yaling; Xue, Lianbi] Capital Med Univ, Beijing Tiantan Hosp, Dept Hyperbar Oxygenat, Beijing, Peoples R China; [Zhang, Ruiyun] Civil Aviat Gen Hosp, Dept Neurol, Beijing, Peoples R China	Capital Medical University	Xue, LB (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Hyperbar Oxygenat, Beijing, Peoples R China.	Xue40@VIP.sina.com			National Natural Science Foundation of China [30972829]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 30972829). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitani H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053913; Bansal D, 2011, SAUDI J GASTROENTERO, V17, P174, DOI 10.4103/1319-3767.80379; Cardenas DP, 2015, NEUROIMAGE, V119, P382, DOI 10.1016/j.neuroimage.2015.06.082; Chen T, 2016, EXP EYE RES, V148, P65, DOI 10.1016/j.exer.2016.05.017; Eken A, 2005, CLIN BIOCHEM, V38, P1133, DOI 10.1016/j.clinbiochem.2005.09.001; Elayan IM, 2000, J NEUROPHYSIOL, V83, P2022, DOI 10.1152/jn.2000.83.4.2022; Guo SX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124897; Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165; Heyboer M, 2014, UNDERSEA HYPERBAR M, V41, P379; Ji XT, 2012, J SURG RES, V178, pE9, DOI 10.1016/j.jss.2011.12.038; Kajiyama S, 2008, NUTR RES, V28, P137, DOI 10.1016/j.nutres.2008.01.008; Kawamura T, 2013, AM J PHYSIOL-LUNG C, V304, pL646, DOI 10.1152/ajplung.00164.2012; Kikkawa YS, 2014, NEUROSCI LETT, V579, P125, DOI 10.1016/j.neulet.2014.07.025; Lee JW, 2012, J PEDIATR SURG, V47, P736, DOI 10.1016/j.jpedsurg.2011.09.035; Li GM, 2013, J SURG RES, V181, P279, DOI 10.1016/j.jss.2012.06.058; Miller ER, 2005, ANN INTERN MED, V142, P37, DOI 10.7326/0003-4819-142-1-200501040-00110; Nakao A, 2010, J CLIN BIOCHEM NUTR, V46, P140, DOI 10.3164/jcbn.09-100; NARKOWICZ CK, 1993, FREE RADICAL RES COM, V19, P71, DOI 10.3109/10715769309056501; Oharazawa H, 2010, INVEST OPHTH VIS SCI, V51, P487, DOI 10.1167/iovs.09-4089; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohta S, 2011, CURR PHARM DESIGN, V17, P2241, DOI 10.2174/138161211797052664; Ono H, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-21; Oter S, 2005, CLIN BIOCHEM, V38, P706, DOI 10.1016/j.clinbiochem.2005.04.005; Ren JD, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/930894; Saitoh Y, 2010, TOXICOL IND HEALTH, V26, P203, DOI 10.1177/0748233710362989; Tamasawa A, 2015, EUR J PHARMACOL, V762, P96, DOI 10.1016/j.ejphar.2015.04.051; Ushida T, 2016, FREE RADICAL BIO MED, V101, P524, DOI 10.1016/j.freeradbiomed.2016.10.491; Wang F, 2011, J SURG RES, V167, pE339, DOI 10.1016/j.jss.2010.11.005; Watanabe S, 2014, J RADIAT RES, V55, P1107, DOI 10.1093/jrr/rru067; Zheng XF, 2009, FREE RADICAL RES, V43, P478, DOI 10.1080/10715760902870603; Zhou LS, 2013, BRAIN RES, V1517, P150, DOI 10.1016/j.brainres.2013.04.007	31	13	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0173645	10.1371/journal.pone.0173645	http://dx.doi.org/10.1371/journal.pone.0173645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362819	Green Published, Green Submitted, gold			2022-12-26	WOS:000399175000009
J	Schaffer, S; Zachos, FE; Koblmuller, S				Schaeffer, Sylvia; Zachos, Frank E.; Koblmueller, Stephan			Opening the treasure chest: A DNA-barcoding primer set for most higher taxa of Central European birds and mammals from museum collections	PLOS ONE			English	Article							SPECIMENS; IDENTIFICATION; EXTRACTION; TAXONOMY; SAMPLES; SKIN	DNA-barcoding is a rapidly developing method for efficiently identifying samples to species level by means of short standard DNA sequences. However, reliable species assignment requires the availability of a comprehensive DNA barcode reference library, and hence numerous initiatives aim at generating such barcode databases for particular taxa or geographic regions. Historical museum collections represent a potentially invaluable source for the DNA-barcoding of many taxa. This is particularly true for birds and mammals, for which collecting fresh (voucher) material is often very difficult to (nearly) impossible due to the special animal welfare and conservation regulations that apply to vertebrates in general, and birds and mammals in particular. Moreover, even great efforts might not guarantee sufficiently complete sampling of fresh material in a short period of time. DNA extracted from historical samples is usually degraded, such that only short fragments can be amplified, rendering the recovery of the barcoding region as a single fragment impossible. Here, we present a new set of primers that allows the efficient amplification and sequencing of the entire barcoding region in most higher taxa of Central European birds and mammals in six overlapping fragments, thus greatly increasing the value of historical museum collections for generating DNA barcode reference libraries. Applying our new primer set in recently established NGS protocols promises to further increase the efficiency of barcoding old bird and mammal specimens.	[Schaeffer, Sylvia; Koblmueller, Stephan] Karl Franzens Univ Graz, Inst Zool, Univ Pl 2, Graz, Austria; [Zachos, Frank E.] Nat Hist Museum Vienna, Burgring 7, Vienna, Austria	University of Graz	Schaffer, S; Koblmuller, S (corresponding author), Karl Franzens Univ Graz, Inst Zool, Univ Pl 2, Graz, Austria.	sylvia.schaeffer@uni-graz.at; stephan.koblmueller@uni-graz.at		Koblmuller, Stephan/0000-0002-1024-3220	Austrian Federal Ministry of Science, Research and Economy; Natural History Museum Vienna	Austrian Federal Ministry of Science, Research and Economy; Natural History Museum Vienna	This study was funded by the Austrian Federal Ministry of Science, Research and Economy and the Natural History Museum Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAR W, 1988, FORENSIC SCI INT, V39, P59, DOI 10.1016/0379-0738(88)90118-1; Burrell AS, 2015, J HUM EVOL, V79, P35, DOI 10.1016/j.jhevol.2014.10.015; Clare EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022648; Coissac E, 2012, MOL ECOL, V21, P1834, DOI 10.1111/j.1365-294X.2012.05550.x; Collins RA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028381, 10.1371/journal.pone.0030581]; de Moraes-Barros N, 2007, GENET MOL BIOL, V30, P1181, DOI 10.1590/S1415-47572007000600024; Duftner N, 2005, J MOL EVOL, V60, P277, DOI 10.1007/s00239-004-0017-8; Eaton MJ, 2010, CONSERV GENET, V11, P1389, DOI 10.1007/s10592-009-9967-0; Fulton TL, 2012, METHODS MOL BIOL, V840, P1, DOI 10.1007/978-1-61779-516-9_1; Galan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048374; Gippoliti S, 2014, REND LINCEI-SCI FIS, V25, P351, DOI 10.1007/s12210-014-0304-2; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; Hall LM, 1997, BIOTECHNIQUES, V22, P928; Haring Elisabeth, 2015, Acta ZooBot Austria, V152, P149; Hausmann A, 2016, GENOME, V59, P671, DOI 10.1139/gen-2015-0197; Hausmann A, 2009, ZOOTAXA, P1; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hedmark E, 2005, INT J LEGAL MED, V119, P370, DOI 10.1007/s00414-005-0521-4; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Johnson JW, 2015, ZOOTAXA, V3985, P491, DOI 10.11646/zootaxa.3985.4.2; Kalendar R, 2014, METHODS MOL BIOL, V1116, P271, DOI 10.1007/978-1-62703-764-8_18; Krishnamurthy PK, 2012, BIODIVERS CONSERV, V21, P1901, DOI 10.1007/s10531-012-0306-2; Kvist S, 2010, MITOCHONDR DNA, V21, P198, DOI 10.3109/19401736.2010.529905; Leray M, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-34; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Meier R, 2016, CLADISTICS, V32, P100, DOI 10.1111/cla.12115; Mendoza MLZ, 2015, BRIEF BIOINFORM, V16, P745, DOI 10.1093/bib/bbv001; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Mitchell A, 2015, MOL ECOL RESOUR, V15, P1102, DOI 10.1111/1755-0998.12380; Mutanen M, 2015, MOL ECOL RESOUR, V15, P967, DOI 10.1111/1755-0998.12361; Patel S, 2010, MOL ECOL RESOUR, V10, P431, DOI 10.1111/j.1755-0998.2009.02793.x; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Prosser SWJ, 2016, MOL ECOL RESOUR, V16, P487, DOI 10.1111/1755-0998.12474; Qu HY, 2008, J GENET GENOMICS, V35, P485, DOI 10.1016/S1673-8527(08)60066-1; Randi E, 2007, HYSTRIX, V18, P157; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Richlen ML, 2005, MOL ECOL NOTES, V5, P688, DOI 10.1111/j.1471-8286.2005.01032.x; Shokralla S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09687; Strutzenberger P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049710; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Triant DA, 2007, J MAMMAL, V88, P908, DOI 10.1644/06-MAMM-A-204R1.1; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Wilson J-J, CONSERV BIO IN PRESS; Zimmermann J, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-18	48	14	18	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174449	10.1371/journal.pone.0174449	http://dx.doi.org/10.1371/journal.pone.0174449			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358863	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174800040
J	Solarte, VA; Conget, P; Vernot, JP; Rosas, JE; Rivera, ZJ; Garcia, JE; Arango-Rodriguez, ML				Solarte, victor Alfonso; Conget, Paulette; Vernot, Jean-Paul; Rosas, Jaiver Eduardo; Rivera, Zuly Jenny; Garcia, Javier Eduardo; Arango-Rodriguez, Martha Ligia			A tetrameric peptide derived from bovine lactoferricin as a potential therapeutic tool for oral squamous cell carcinoma: A preclinical model	PLOS ONE			English	Article							ENHANCED ANTITUMOR-ACTIVITY; ANTIMICROBIAL PEPTIDES; CANCER-THERAPY; APOPTOSIS; MITOCHONDRIA; OPPORTUNITY; REGRESSION; AUTOPHAGY; DEATH	Oral squamous cell carcinoma is the fifth most common epithelial cancer in the world, and its current clinical treatment has both low efficiency and poor selectivity. Cationic amphipathic peptides have been proposed as new drugs for the treatment of different types of cancer. The main goal of the present work was to determine the potential of LfcinB(20-25)4, a tetrameric peptide based on the core sequence RRWQWR of bovine lactoferricin LfcinB (20-25), for the treatment of OSCC. In brief, OSCC was induced in the buccal pouch of hamsters by applying 7,12-Dimethylbenz(a)anthracene, and tumors were treated with one of the following peptides: LfcinB(20-25)4, LfcinB(20-25), or vehicle (control). Lesions were macroscopically evaluated every two days and both histological and serum IgG assessments were conducted after 5 weeks. The size of the tumors treated with LfcinB(20-25)4 and LfcinB(20-25) was smaller than that of the control group (46.16 4.41 and 33.92 2.74 mm3 versus 88.77 10.61 mm3, respectively). Also, LfcinB(20-25)4 caused acellularity in the parenchymal tumor compared with LfcinB(20-25) and vehicle treatments. Furthermore, our results demonstrated that both LfcinB(20-25)4 and LfcinB(20-25) induced higher degree of apoptosis relative to the untreated tumors (75-86% vs 8%, respectively). Moreover, although the lowest inflammatory response was achieved when LfcinB(20-25)4 was used, this peptide appeared to induce higher levels of IgG antibodies relative to the vehicle and LfcinB(20-25). In addition the cellular damage and selectivity of the LfcinB(20-25)4 peptide was evaluated in vitro. These assays showed that LfcinB(20-25)4 triggers a selective necrotic effect in the carcinoma cell line. Cumulatively, these data indicate that LfcinB(20-25)4 could be considered as a new therapeutic agent for the treatment of OSCC.	[Solarte, victor Alfonso; Vernot, Jean-Paul] Univ Nacl Colombia, Biomed Res Inst, Cellular & Mol Physiol Grp, Fac Med, Bogota, Colombia; [Conget, Paulette] Univ Desarrollo, Ctr Regenerat Med, Sch Med Clin Alemana, Santiago, Chile; [Rosas, Jaiver Eduardo; Garcia, Javier Eduardo] Univ Nacl Colombia, Dept Pharm, Fac Sci, Bogota, Colombia; [Rivera, Zuly Jenny] Univ Nacl Colombia, Dept Chem, Fac Sci, Bogota, Colombia; [Arango-Rodriguez, Martha Ligia] Fdn Ofalmol Santander, Banco Multitejidos, Clin Carlos Ardila Lulle FOSCAL Int, Bucaramanga, Colombia; [Arango-Rodriguez, Martha Ligia] Fdn Ofalmol Santander, Ctr Terapias Avanzadas, Clin Carlos Ardila Lulle FOSCAL Int, Bucaramanga, Colombia	Universidad Nacional de Colombia; Universidad del Desarrollo; Universidad Nacional de Colombia; Universidad Nacional de Colombia	Arango-Rodriguez, ML (corresponding author), Fdn Ofalmol Santander, Banco Multitejidos, Clin Carlos Ardila Lulle FOSCAL Int, Bucaramanga, Colombia.; Arango-Rodriguez, ML (corresponding author), Fdn Ofalmol Santander, Ctr Terapias Avanzadas, Clin Carlos Ardila Lulle FOSCAL Int, Bucaramanga, Colombia.	martha.arango@foscal.com.co		Garcia Castaneda, Javier Eduardo/0000-0001-6882-4397; Rivera Monroy, Zuly Jenny/0000-0001-6915-8488; Solarte David, Victor Alfonso/0000-0002-9856-1484	COLCIENCIAS [678-2014, 511-2010]	COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This research was conducted with the financial support of COLCIENCIAS to the project "Diseno, Sintesis Quimica y Caracterizacion de Peptidos Derivados de Lactoferricina y Evaluacion de Su Actividad Anticancerigena Fase II", contract: RC no. 678-2014. Victor Alfonso Solarte David was a recipient of scholarships from COLCIENCIAS for doctorates in Colombia (Grant 511-2010).	Al-Ansari Sali, 2015, Curr Oral Health Rep, V2, P202; Barasch A, 2004, ORAL SURG ORAL MED O, V97, P307, DOI 10.1016/j.tripleo.2003.12.016; Berge G, 2010, CANCER IMMUNOL IMMUN, V59, P1285, DOI 10.1007/s00262-010-0857-6; Bidwell GL, 2012, THER DELIV, V3, P609, DOI 10.4155/TDE.12.37; Bolhassani A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-3; Camilio KA, 2014, CANCER IMMUNOL IMMUN, V63, P601, DOI 10.1007/s00262-014-1540-0; CARAFOLI E, 1986, J CARDIOVASC PHARM, V8, pS3, DOI 10.1097/00005344-198600088-00002; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Chapple DS, 2004, ANTIMICROB AGENTS CH, V48, P2190, DOI 10.1128/AAC.48.6.2190-2198.2004; Chi AC, 2015, CA-CANCER J CLIN, V65, P401, DOI 10.3322/caac.21293; Dennison SR, 2006, CURR PROTEIN PEPT SC, V7, P487, DOI 10.2174/138920306779025611; Dobrzynska I, 2005, MOL CELL BIOCHEM, V276, P113, DOI 10.1007/s11010-005-3557-3; Eike LM, 2015, ONCOTARGET, V6, P34910, DOI 10.18632/oncotarget.5308; Eliassen LT, 2006, INT J CANCER, V119, P493, DOI 10.1002/ijc.21886; Eliassen LT, 2003, J PEPT SCI, V9, P510, DOI 10.1002/psc.472; Eskelinen EL, 2011, AUTOPHAGY, V7, P935, DOI 10.4161/auto.7.9.15760; Farnaud S, 2004, FEMS MICROBIOL LETT, V238, P221, DOI 10.1016/j.femsle.2004.07.038; Faustino-Rocha A, 2013, LAB ANIMAL, V42, P217, DOI 10.1038/laban.254; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Furlong SJ, 2010, EXP MOL PATHOL, V88, P371, DOI 10.1016/j.yexmp.2010.02.001; Gifford JL, 2005, CELL MOL LIFE SCI, V62, P2588, DOI 10.1007/s00018-005-5373-z; Grollo L, 2005, IMMUNOL CELL BIOL, V83, P584; Hilchie AL, 2013, EXP MOL PATHOL, V95, P192, DOI 10.1016/j.yexmp.2013.07.006; Huang SH, 2013, MED ORAL PATOL ORAL, V18, pE233, DOI 10.4317/medoral.18772; Iwasaki T, 2009, PEPTIDES, V30, P660, DOI 10.1016/j.peptides.2008.12.019; Kondratskyi A, 2015, BBA-BIOMEMBRANES, V1848, P2532, DOI 10.1016/j.bbamem.2014.10.030; Leon-Calvijo MA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/453826; Lim LY, 2015, NANOMED-NANOTECHNOL, V11, P1445, DOI 10.1016/j.nano.2015.04.006; Mader JS, 2006, EXPERT OPIN INV DRUG, V15, P933, DOI 10.1517/13543784.15.8.933; Mader JS, 2005, MOL CANCER THER, V4, P612, DOI 10.1158/1535-7163.MCT-04-0077; Medina SH, 2009, CHEM REV, V109, P3141, DOI 10.1021/cr900174j; Montanez MI, 2015, NANOMED-NANOTECHNOL, V11, P579, DOI 10.1016/j.nano.2015.01.006; Nagini S, 2009, ANTI-CANCER AGENT ME, V9, P843, DOI 10.2174/187152009789124619; Nagini S, 2009, ORAL ONCOL, V45, pE31, DOI 10.1016/j.oraloncology.2009.01.006; Nguyen LT, 2005, J PEPT SCI, V11, P379, DOI 10.1002/psc.629; Nicotera P, 1999, BIOCHEM SOC SYMP, V66, P69, DOI 10.1042/bss0660069; Onishi J, 2008, J PEPT SCI, V14, P1032, DOI 10.1002/psc.1039; Orrenius S, 2015, BIOCHEM BIOPH RES CO, V460, P72, DOI 10.1016/j.bbrc.2015.01.137; Pan WR, 2013, J DAIRY SCI, V96, P7511, DOI 10.3168/jds.2013-7285; Patergnani S, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00173; Rapidis AD, 2009, ORAL ONCOL, V45, P299, DOI 10.1016/j.oraloncology.2009.04.001; Richardson A, 2009, BIOCHEM BIOPH RES CO, V388, P736, DOI 10.1016/j.bbrc.2009.08.083; Riedl S, 2011, CHEM PHYS LIPIDS, V164, P766, DOI 10.1016/j.chemphyslip.2011.09.004; Rivera C, 2015, INT J CLIN EXP PATHO, V8, P11884; Roy MK, 2002, J DAIRY SCI, V85, P2065, DOI 10.3168/jds.S0022-0302(02)74284-7; SALLEY JJ, 1954, J DENT RES, V33, P253, DOI 10.1177/00220345540330021201; Schibli DJ, 1999, FEBS LETT, V446, P213, DOI 10.1016/S0014-5793(99)00214-8; Shai Y, 2002, BIOPOLYMERS, V66, P236, DOI 10.1002/bip.10260; Solarte VA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/630179; Galeano CFV, 2014, J MEX CHEM SOC, V58, P386; Vogel HJ, 2002, BIOCHEM CELL BIOL, V80, P49, DOI 10.1139/o01-213; Wu DD, 2014, CANCER LETT, V351, P13, DOI 10.1016/j.canlet.2014.05.002; Yang N, 2002, J PEPT RES, V60, P187, DOI 10.1034/j.1399-3011.2002.21008.x; Zhao J, 2014, ARCH PHARM, V347, P469, DOI 10.1002/ardp.201300415	54	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174707	10.1371/journal.pone.0174707	http://dx.doi.org/10.1371/journal.pone.0174707			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358840	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174800075
J	Jorge, P; Grzywacz, D; Kamysz, W; Lourenco, A; Pereira, MO				Jorge, Paula; Grzywacz, Daria; Kamysz, Wojciech; Lourenco, Analia; Pereira, Maria Olivia			Searching for new strategies against biofilm infections: Colistin-AMP combinations against Pseudomonas aeruginosa and Staphylococcus aureus single- and double-species biofilms	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; TACHYPLESIN-I; INSIGHTS; PATHOGENESIS; POLYMYXINS; RESISTANCE; AGENTS	Antimicrobial research is being pressured to look for more effective therapeutics for the ever-growing antibiotic-resistant infections, and antimicrobial peptides (AMP) and antimicrobial combinations are promising solutions. This work evaluates colistin-AMP combinations against two major pathogens, Pseudomonas aeruginosa and Staphylococcus aureus, encompassing non- and resistant strains. Colistin (CST) combined with the AMP temporin A (TEMP-A), citropin 1.1 (CIT-1.1) and tachyplesin I linear analogue (TP-I-L) was tested against planktonic, single- and double-species biofilm cultures. Overall synergy for planktonic P. aeruginosa and synergy/additiveness for planktonic S. aureus were observed. Biofilm growth prevention was achieved with synergy and additiveness. Pre-established 24 hold biofilms were harder to eradicate, especially for S. aureus and double-species biofilms; still, some synergy and addictiveness was observed for higher concentrations, including for the biofilms of resistant strains. Different treatment times and growth media did not greatly influence AMP activity. CST revealed low toxicity compared with the other AMP but its combinations were toxic for high concentrations. Overall, combinations reduced effective AMP concentrations, mainly in prevention scenarios. Improvement of effectiveness and toxicity of therapeutic strategies will be further investigated.	[Jorge, Paula; Pereira, Maria Olivia] Univ Minho, CEB Ctr Biol Engn, LIBRO Lab Res Biofilms Rosario Oliveira, Braga, Portugal; [Grzywacz, Daria; Kamysz, Wojciech] Lipopharm Pl, Zblewo, Poland; [Kamysz, Wojciech] Med Univ Gdansk, Fac Pharm, Gdansk, Poland; [Lourenco, Analia] Univ Vigo, ESEI Escuela Super Ingn Informat, Orense, Spain; [Lourenco, Analia] Univ Minho, CEB Ctr Biol Engn, Braga, Portugal	Universidade do Minho; Fahrenheit Universities; Medical University Gdansk; Universidade de Vigo; Universidade do Minho	Jorge, P (corresponding author), Univ Minho, CEB Ctr Biol Engn, LIBRO Lab Res Biofilms Rosario Oliveira, Braga, Portugal.	paulajorge@ceb.uminho.pt	Jorge, Paula/L-6576-2018; Grzywacz, Daria/AAL-2771-2021; Lourenço, Anália/Y-9447-2019	Jorge, Paula/0000-0002-0094-7830; Grzywacz, Daria/0000-0002-1667-9295; Lourenço, Anália/0000-0001-8401-5362	Portuguese Foundation for Science and Technology (FCT) [UID/B10/04469/2013]; COMPETE [POCI-01-0145-FEDER-006684]; FCT; European Community fund FEDER, through Program COMPETE; BioTecNorte operation - European Regional Development Fund under the scope of Norte -Programa Operacional Regional do Norte [NORTE-01-0145-FEDER-000004]; University of Vigo [14V105]; DXPCTSUG-FEDER unha maneira de facer Europa [2012/273]; European Regional Development Fund under the Operational Programme Innovative Economy [WNP-POIG.01.04.00-22-052/11]; European Society of Clinical Microbiology and Infectious Diseases (ESCMID); FCT [SFRH/BD/88192/2012]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); COMPETE; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Community fund FEDER, through Program COMPETE; BioTecNorte operation - European Regional Development Fund under the scope of Norte -Programa Operacional Regional do Norte; University of Vigo; DXPCTSUG-FEDER unha maneira de facer Europa; European Regional Development Fund under the Operational Programme Innovative Economy; European Society of Clinical Microbiology and Infectious Diseases (ESCMID); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors acknowledge the Portuguese Foundation for Science and Technology (FCT) (http://www.fct.pt/), under the scope of the strategic funding of UID/B10/04469/2013 and COMPETE 2020 (POCI-01-0145-FEDER-006684). This study was also supported by FCT and the European Community fund FEDER, through Program COMPETE, and BioTecNorte operation (NORTE-01-0145-FEDER-000004) funded by the European Regional Development Fund under the scope of Norte2020 -Programa Operacional Regional do Norte. This work was also partially funded by the [14V105] Contract-Programme from the University of Vigo (https://mw.uvigo.gal/ uvigo_en/) and the Agrupamento INBIOMED (http://inbiomed.webs.uvigaes/) from DXPCTSUG-FEDER unha maneira de facer Europa (2012/273) and co-financed by the European Regional Development Fund (http://ec.europleuiregionaL policy/EN/fundingierdf/) under the Operational Programme Innovative Economy (WNP-POIG.01.04.00-22-052/11).). Lipopharm.pl (http://www.lipopharm.p1/) provided support in the form of salaries for authors DG and WK. The authors also acknowledge the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) (https://www.escmid.org/) for the Research Grant 2014 to Anglia Lourenco, and FCT for the PhD Grant of Paula Jorge (grant number SFRH/BD/88192/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves D, 2014, BIOFOULING, V30, P483, DOI 10.1080/08927014.2014.889120; Archer NK, 2011, VIRULENCE, V2, P445, DOI 10.4161/viru.2.5.17724; Baldan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089614; Bjarnsholt T, 2013, NAT REV DRUG DISCOV, V12, P791, DOI 10.1038/nrd4000; Boland MP, 2006, BBA-BIOMEMBRANES, V1758, P1178, DOI 10.1016/j.bbamem.2006.02.010; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Cirioni O, 2007, PEPTIDES, V28, P747, DOI 10.1016/j.peptides.2007.01.001; CLSI, 2009, M07A9 CLSI; Falagas ME, 2005, CLIN INFECT DIS, V40, P1333, DOI 10.1086/429323; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Giacometti A, 2005, PEPTIDES, V26, P2111, DOI 10.1016/j.peptides.2005.03.009; Hirakura Y, 2002, BBA-BIOMEMBRANES, V1562, P32, DOI 10.1016/S0005-2736(02)00358-9; Jorge P, 2016, CURR BIOINFORM, V11, P523, DOI 10.2174/1574893611666160617093955; Jorge P, 2012, BIOFOULING, V28, P1033, DOI 10.1080/08927014.2012.728210; Mangoni ML, 2009, BBA-BIOMEMBRANES, V1788, P1610, DOI 10.1016/j.bbamem.2009.04.021; Mashburn LM, 2005, J BACTERIOL, V187, P554, DOI 10.1128/JB.187.2.554-566.2005; Mogi T, 2009, CELL MOL LIFE SCI, V66, P3821, DOI 10.1007/s00018-009-0129-9; Naghmouchi K, 2013, ANTIMICROB AGENTS CH, V57, P2719, DOI 10.1128/AAC.02328-12; Nair N, 2014, INFECT IMMUN, V82, P2162, DOI 10.1128/IAI.00059-14; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; NSAI, 2009, 1099352009 NSAI ISO; Petrosillo N, 2008, CLIN MICROBIOL INFEC, V14, P816, DOI 10.1111/j.1469-0691.2008.02061.x; Pletzer D, 2016, J BACTERIOL, V198, P2572, DOI 10.1128/JB.00017-16; Plotly Technologies Inc, 2015, COLL DAT SCI; Saiman L, 2007, PAEDIATR RESPIR REV, V8, P249, DOI 10.1016/j.prrv.2007.04.006; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Velkov T, 2013, FUTURE MICROBIOL, V8, P711, DOI [10.2217/FMB.13.39, 10.2217/fmb.13.39]; Wang HZ, 2011, ANTIMICROB AGENTS CH, V55, P4469, DOI 10.1128/AAC.00126-11; White RL, 1996, ANTIMICROB AGENTS CH, V40, P1914, DOI 10.1128/AAC.40.8.1914; Wozniak Daniel J, 2014, F1000Prime Rep, V6, P26, DOI 10.12703/P6-26; Yan H, 2001, ANTIMICROB AGENTS CH, V45, P1558, DOI 10.1128/AAC.45.5.1558-1560.2001; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; YONEZAWA A, 1992, BIOCHEMISTRY-US, V31, P2998, DOI 10.1021/bi00126a022	34	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174654	10.1371/journal.pone.0174654	http://dx.doi.org/10.1371/journal.pone.0174654			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355248	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174600077
J	Zhang, F; Wu, ZC; Wang, MM; Zhang, F; Dingkuhn, M; Xu, JL; Zhou, YL; Li, ZK				Zhang, Fan; Wu, Zhi-Chao; Wang, Ming-Ming; Zhang, Fan; Dingkuhn, Michael; Xu, Jian-Long; Zhou, Yong-Li; Li, Zhi-Kang			Genome-wide association analysis identifies resistance loci for bacterial blight in a diverse collection of indica rice germplasm	PLOS ONE			English	Article							ORYZAE PV.-ORYZAE; RACE-SPECIFIC RESISTANCE; KINASE-LIKE PROTEIN; DISEASE RESISTANCE; XANTHOMONAS-ORYZAE; GENE; EVOLUTION; FAMILY; XA21; INTROGRESSION	Bacterial blight, which is caused by Xanthomonas oryzae pv. oryzae (Xoo), is one of the most devastating rice diseases worldwide. The development and use of disease -resistant cultivars have been the most effective strategy to control bacterial blight. Identifying the genes mediating bacterial blight resistance is a prerequisite for breeding cultivars with broad-spectrum and durable resistance. We herein describe a genome-wide association study involving 172 diverse Oryza sativa ssp. indica accessions to identify loci influencing the resistance to representative strains of six Xoo races. Twelve resistance loci containing 121 significantly associated signals were identified using 317,894 single nucleotide polymorphisms, which explained 13.3-59.9% of the variability in lesion length caused by Xoo races P1, P6, and P9a. Two hotspot regions (L11 and L12) were located within or nearby two cloned R genes (xa25 and Xa26) and one fine -mapped R gene (Xa4). Our results confirmed the relatively high resolution of genome-wide association studies. Moreover, we detected novel significant associations on chromosomes 2, 3, and 6-10. Haplotype analyses of xa25, the Xa26 paralog (MRKc, LOC 0s11g47290), and a Xa4 candidate gene (LOC 11g46870) revealed differences in bacterial blight resistance among indica subgroups. These differences were responsible for the observed variations in lesion lengths resulting from infections by Xoo races P1 and P9a. Our findings may be relevant for future studies involving bacterial blight resistance gene cloning, and provide insights into the genetic basis for bacterial blight resistance in indica rice, which may be useful for knowledge -based crop improvement.	[Zhang, Fan; Wu, Zhi-Chao; Wang, Ming-Ming; Zhang, Fan; Xu, Jian-Long; Zhou, Yong-Li; Li, Zhi-Kang] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China; [Wu, Zhi-Chao; Wang, Ming-Ming; Zhang, Fan] Chinese Acad Agr Sci, Grad Sch, Beijing, Peoples R China; [Dingkuhn, Michael] Int Rice Res Inst, Crop & Environm Sci Div, Los Banos, Laguna, Philippines; [Dingkuhn, Michael] Ctr Cooperat Int Rech Agron Dev CIRAD, UMR AGAP, Montpellier, France; [Xu, Jian-Long; Zhou, Yong-Li; Li, Zhi-Kang] Chinese Acad Agr Sci, Shenzhen Inst Breeding & Innovat, Shenzhen, Guangdong, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Graduate School, CAAS; CGIAR; International Rice Research Institute (IRRI); CIRAD; Universite de Montpellier; Chinese Academy of Agricultural Sciences	Xu, JL; Zhou, YL (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China.; Xu, JL; Zhou, YL (corresponding author), Chinese Acad Agr Sci, Shenzhen Inst Breeding & Innovat, Shenzhen, Guangdong, Peoples R China.	xujianlong@caas.cn; zhouylcaas@126.com	Xu, Jianlong/AAI-8310-2020	Wu, Zhichao/0000-0002-3006-043X	National Natural Science Foundation of China [U1201211, 31661143009]; National High-tech Program of China [2014AA10A603]; CAAS Innovative Team Award; Bill and Melinda Gates Foundation [0PP51587]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech Program of China(National High Technology Research and Development Program of China); CAAS Innovative Team Award; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Support was provided by: National Natural Science Foundation of China U1201211 to Zhi-Kang Li; National Natural Science Foundation of China 31661143009 to Yong-Li Zhou; National High-tech Program of China 2014AA10A603 to Yong-Li Zhou; the CAAS Innovative Team Award; and the Bill and Melinda Gates Foundation 0PP51587 to Zhi-Kang Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari TB, 1999, PHYTOPATHOLOGY, V89, P687, DOI 10.1094/PHYTO.1999.89.8.687; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Brar DS, 1997, PLANT MOL BIOL, V35, P35, DOI 10.1023/A:1005825519998; Bureau TE, 1996, P NATL ACAD SCI USA, V93, P8524, DOI 10.1073/pnas.93.16.8524; Cheema KK, 2008, GENET RES, V90, P397, DOI 10.1017/S0016672308009786; Chen S, 2011, THEOR APPL GENET, V122, P1331, DOI 10.1007/s00122-011-1534-7; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Fang ZD, 1990, ACTA PHYTOPATHOL SIN, V20, P81; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gao Dong-Ying, 2002, Acta Genetica Sinica, V29, P138; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; Han B, 2013, CURR OPIN PLANT BIOL, V16, P133, DOI 10.1016/j.pbi.2013.03.006; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Hutin M, 2015, PLANT J, V84, P694, DOI 10.1111/tpj.13042; Iyer AS, 2004, MOL PLANT MICROBE IN, V17, P1348, DOI 10.1094/MPMI.2004.17.12.1348; JOHAL GS, 1992, SCIENCE, V258, P985, DOI 10.1126/science.1359642; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Khush G. S., 1989, BACTERIAL BLIGHT RIC, P207; Lee KS, 2003, PHYTOPATHOLOGY, V93, P147, DOI 10.1094/PHYTO.2003.93.2.147; Li HJ, 2012, MOL PLANT, V5, P281, DOI 10.1093/mp/ssr079; Li ZK, 2006, P NATL ACAD SCI USA, V103, P7994, DOI 10.1073/pnas.0507492103; Liu H, 2007, J PHYTOPATHOL, V155, P129, DOI 10.1111/j.1439-0434.2007.01197.x; Liu QS, 2011, PLANT CELL ENVIRON, V34, P1958, DOI 10.1111/j.1365-3040.2011.02391.x; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; McCouch SR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10532; MEW TW, 1993, PLANT DIS, V77, P5, DOI 10.1094/PD-77-0005; MEW TW, 1987, ANNU REV PHYTOPATHOL, V25, P359, DOI 10.1146/annurev.py.25.090187.002043; NAKAI H, 1988, RICE GENETICS NEWSLE, V5, P101; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; Noda Takahito, 1996, Annals of the Phytopathological Society of Japan, V62, P549, DOI 10.3186/jjphytopath.62.549; OGAWA T, 1993, JARQ-JPN AGR RES Q, V27, P71; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; POUTEAU S, 1994, PLANT J, V5, P535, DOI 10.1046/j.1365-313X.1994.5040535.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; SAS Institute, 2008, SAS STAT US GUID; Shalev G, 1997, GENETICS, V146, P1143; Shin J-H., 2006, J STAT SOFTW, V16, P1, DOI [10.18637/jss.v016.c03, DOI 10.18637/JSS.V016.C03]; Song WY, 1998, MOL GEN GENET, V258, P449, DOI 10.1007/s004380050755; Song WY, 1997, PLANT CELL, V9, P1279, DOI 10.1105/tpc.9.8.1279; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Sun X, 2003, THEOR APPL GENET, V106, P683, DOI 10.1007/s00122-002-1117-8; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; Turner S. D., 2014, BIORXIV, DOI DOI 10.1101/005165; Wang CL, 2015, MOL PLANT, V8, P290, DOI 10.1016/j.molp.2014.10.010; Wang GL, 1998, PLANT CELL, V10, P765, DOI 10.1105/tpc.10.5.765; Wang QX, 2015, MOL PLANT, V8, P946, DOI 10.1016/j.molp.2015.02.014; WESSLER SR, 1995, CURR OPIN GENET DEV, V5, P814, DOI 10.1016/0959-437X(95)80016-X; Woodrow P, 2011, MOL BIOL REP, V38, P3787, DOI 10.1007/s11033-010-0494-3; Yoshimura S, 1998, P NATL ACAD SCI USA, V95, P1663, DOI 10.1073/pnas.95.4.1663; Zhang F, 2015, PLANT PATHOL, V64, P568, DOI 10.1111/ppa.12283; Zhang F, 2015, PLANT BREEDING, V134, P286, DOI 10.1111/pbr.12256; ZHANG Q, 1991, Scientia Agricultura Sinica, V24, P26; Zhou JH, 2015, PLANT J, V82, P632, DOI 10.1111/tpj.12838	57	20	23	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174598	10.1371/journal.pone.0174598	http://dx.doi.org/10.1371/journal.pone.0174598			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355306	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174600071
J	Dumitrescu, G; Komaromi, A; Rooyackers, O; Klaude, M; Hebert, C; Wernerman, J; Norberg, A				Dumitrescu, Gabriel; Komaromi, Andras; Rooyackers, Olav; Klaude, Maria; Hebert, Christina; Wernerman, Jan; Norberg, Ake			Repeated quantitative measurements of De Novo synthesis of albumin and fibrinogen	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; SYNTHESIS RATES; LIVER PROTEIN; AMINO-ACIDS; MUSCLE	The possibility of using two different isotopomers, for the incorporation of isotopically labeled amino acids, was explored to enable longitudinal studies of de novo synthesis of two export liver proteins, albumin and fibrinogen. The agreement of the synthesis rates between the two different labels was evaluated along with the reproducibility of repeated experiments using different time intervals. Healthy volunteers were studied in a standardized fed state. Protocol A (n = 10) involved two measurements 48 hours apart. Protocol B (n = 6) involved three measurements at baseline and five hours and then seven days after the initial measurement. De novo synthesis of albumin and fibrinogen by the incorporation of D-5-phenylalanine or D-8-phenylalanine were measured using the flooding dose technique. Albumin and fibrinogen were isolated from plasma using standard techniques. Fractional and absolute synthesis rates were calculated. Repeated measurements employing the two isotoptomers showed good agreement for albumin fractional synthesis rate after 48 hours (p = 0.92) and after 7 days (p = 0.99), with a coefficient of variation of 5.9% when using the same isotopic label. For fibrinogen, the coefficient of variation for the fractional synthesis rate employing the same isotopic label was 16.6%. Repeated measurements after 48 hours and seven days showed less agreement although there was no statistical difference (P = 0.32 and P = 0.30 respectively). Repeated measurement after five hours showed a statistical significant difference for the fractional synthesis rate of fibrinogen (p = 0.008) but not for albumin (p = 0.12). Repeated measurements of albumin de novo synthesis more than 48 hours apart show acceptable agreement using either one or two different isotopic labels. For fibrinogen the larger intra-individual scatter necessitates larger study groups to detect changes in longitudinal studies. Repeated measurements within 48 hours need to be validated further.	[Dumitrescu, Gabriel; Komaromi, Andras; Rooyackers, Olav; Wernerman, Jan; Norberg, Ake] Karolinska Univ Hosp, Dept Anesthesia & Intens Care Med, Stockholm, Sweden; [Dumitrescu, Gabriel; Rooyackers, Olav; Klaude, Maria; Hebert, Christina; Wernerman, Jan; Norberg, Ake] Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Dumitrescu, G (corresponding author), Karolinska Univ Hosp, Dept Anesthesia & Intens Care Med, Stockholm, Sweden.; Dumitrescu, G (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden.	gabriel.dumitrescu@karolinska.se			Swedish Medical Research Council [04210, 14244]; Country Council of Stockholm [502033, 511126, 80109]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Country Council of Stockholm	The study was supported by grants from the Swedish Medical Research Council (projects 04210 and 14244), the Country Council of Stockholm (projects 502033, 511126 and 80109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balagopal P, 2008, J THROMB HAEMOST, V6, P1296, DOI 10.1111/j.1538-7836.2008.03037.x; Ballmer PE, 1996, HEPATOLOGY, V24, P53, DOI 10.1002/hep.510240111; Barber MD, 2000, AM J PHYSIOL-ENDOC M, V279, pE707, DOI 10.1152/ajpendo.2000.279.3.E707; Barle H, 2006, CLIN SCI, V110, P93, DOI 10.1042/CS20050222; Barle H, 1997, HEPATOLOGY, V25, P154, DOI 10.1053/jhep.1997.v25.pm0008985282; Barle H, 2004, CLIN PHYSIOL FUNCT I, V24, P91, DOI 10.1111/j.1475-097X.2004.00535.x; Barle H, 2002, CLIN SCI, V103, P525; Barle H, 2001, INTENS CARE MED, V27, P836, DOI 10.1007/s001340100914; Barle H, 1999, AM J PHYSIOL-ENDOC M, V277, pE591, DOI 10.1152/ajpendo.1999.277.4.E591; Bunt JEH, 2007, AM J PHYSIOL-GASTR L, V292, pG1157, DOI 10.1152/ajpgi.00300.2006; Caso G, 2007, AM J CLIN NUTR, V85, P446, DOI 10.1093/ajcn/85.2.446; Caso G, 2006, J NUTR, V136, P1504, DOI 10.1093/jn/136.6.1504; Caso G, 2009, J NUTR, V139, P2032, DOI 10.3945/jn.109.107532; Dahlberg G., 1940, STAT METHODS MED BIO, P122; Dumitrescu G, 2015, THROMB RES, V136, P402, DOI 10.1016/j.thromres.2015.05.023; Essen P, 1998, CRIT CARE MED, V26, P92, DOI 10.1097/00003246-199801000-00022; Fu AZ, 1998, AM J PHYSIOL-ENDOC M, V275, pE1023, DOI 10.1152/ajpendo.1998.275.6.E1023; Giordano M, 2008, DIABETOLOGIA, V51, P21, DOI 10.1007/s00125-007-0874-y; Hunter KA, 2001, CLIN SCI, V100, P459, DOI 10.1042/CS20000228; Komaromi A, 2015, ALBUMIN KINETICS INF; McMillan DC, 1996, NUTRITION, V12, P602, DOI 10.1016/S0899-9007(96)00172-4; MCNURLAN MA, 1993, BRIT J NUTR, V69, P117, DOI 10.1079/BJN19930014; NADLER SB, 1962, SURGERY, V51, P224; Norberg A, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1283-8; Norberg A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136371; Pilgeram L, 2010, CARDIOVASC ENG, V10, P78, DOI 10.1007/s10558-010-9092-1; PILGERAM LO, 1968, THROMB DIATH HAEMOST, V20, P31, DOI 10.1055/s-0038-1651246; Preston T, 1998, J NUTR, V128, P1355, DOI 10.1093/jn/128.8.1355; Preston T, 2010, RAPID COMMUN MASS SP, V24, P549, DOI 10.1002/rcm.4402; SLATER C, 1995, J MASS SPECTROM, V30, P1325, DOI 10.1002/jms.1190300917; van den Akker CHP, 2007, AM J CLIN NUTR, V86, P1003, DOI 10.1093/ajcn/86.4.1003; Verbruggen SC, 2011, CLIN NUTR, V30, P469, DOI 10.1016/j.clnu.2011.02.001; Volpi E, 1996, DIABETES, V45, P1245, DOI 10.2337/diabetes.45.9.1245; Witte KKA, 2008, INT J CARDIOL, V129, P363, DOI 10.1016/j.ijcard.2007.07.119	34	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174611	10.1371/journal.pone.0174611	http://dx.doi.org/10.1371/journal.pone.0174611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350862	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174400066
J	Gallimidi, AB; Nussbaum, G; Hermano, E; Weizman, B; Meirovitz, A; Vlodavsky, I; Gotte, M; Elkin, M				Gallimidi, Adi Binder; Nussbaum, Gabriel; Hermano, Esther; Weizman, Barak; Meirovitz, Amichay; Vlodavsky, Israel; Goette, Martin; Elkin, Michael			Syndecan-1 deficiency promotes tumor growth in a murine model of colitis-induced colon carcinoma	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; INFLAMMATORY-BOWEL-DISEASE; CELL-SURFACE PROTEOGLYCAN; EPITHELIAL SYNDECAN-1; LINKING INFLAMMATION; ULCERATIVE-COLITIS; KAPPA-B; CANCER; EXPRESSION; STAT3	Syndecan-1 (Sdc1) is an important member of the cell surface heparan sulfate proteoglycan family, highly expressed by epithelial cells in adult organisms. Sdc1 is involved in the regulation of cell migration, cell-cell and cell-matrix interactions, growth-factor, chemokine and integrin activity, and implicated in inflammatory responses and tumorigenesis. Gastrointestinal tract represents an important anatomic site where loss of Sdc1 expression was reported both in inflammation and malignancy. However, the biological significance of Sdc1 in chronic colitis-associated tumorigenesis has not been elucidated. To the best of our knowledge, this study is the first to test the effects of Sdc1 loss on colorectal tumor development in inflammation-driven colon tumorigenesis. Utilizing a mouse model of colitis-related colon carcinoma induced by the carcinogen azoxymethane (AOM), followed by the inflammatory agent dextran sodium sulfate (DSS), we found that Sdc1 deficiency results in increased susceptibility to colitis-associated tumorigenesis. Importantly, colitis-associated tumors developed in Sdc1-defficient mice were characterized by increased local production of IL-6, activation of STAT3, as well as induction of several STAT3 target genes that act as important effectors of colonic tumorigenesis. Altogether, our results highlight a previously unknown effect of Sdc1 loss in progression of inflammation-associated cancer and suggest that decreased levels of Sdc1 may serve as an indicator of colon carcinoma progression in the setting of chronic inflammation.	[Gallimidi, Adi Binder; Hermano, Esther; Weizman, Barak; Meirovitz, Amichay; Elkin, Michael] Hadassah Hebrew Univ, Med Ctr, Sharett Oncol Inst, Jerusalem, Israel; [Nussbaum, Gabriel] Hebrew Univ Jerusalem, Inst Dent Sci, Hadassah Fac Dent Med, Jerusalem, Israel; [Vlodavsky, Israel] Technion, Canc & Vasc Biol Res Ctr, Rappaport Fac Med, Haifa, Israel; [Goette, Martin] Muenster Univ, Dept Gynecol & Obstet, Med Ctr, Munster, Germany	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Munster	Elkin, M (corresponding author), Hadassah Hebrew Univ, Med Ctr, Sharett Oncol Inst, Jerusalem, Israel.	melkin@hadassah.org.il	Gotte, M/Z-5878-2019; Götte, Martin/G-2254-2018	Gotte, M/0000-0003-2360-2496; Götte, Martin/0000-0003-2360-2496	German Israel Research Foundation (GIF) [1-1004-202.15/2008]; Israel Science Foundation [806/14]; Mizutani Foundation for Glycoscience	German Israel Research Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); Israel Science Foundation(Israel Science Foundation); Mizutani Foundation for Glycoscience	This work was supported by the German Israel Research Foundation (GIF) grant No. 1-1004-202.15/2008 (to ME, MG and IV), Israel Science Foundation (grant 806/14) and the Mizutani Foundation for Glycoscience (to ME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl MR, 2015, ONCOTARGET, V6, P28693, DOI 10.18632/oncotarget.4981; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; BEAULIEU JF, 1991, ANAT EMBRYOL, V183, P363; Beauvais DLM, 2004, J CELL BIOL, V167, P171, DOI 10.1083/jcb.200404171; Becker C, 2005, CELL CYCLE, V4, P217; Belmiro CLR, 2005, INT J COLORECTAL DIS, V20, P295, DOI 10.1007/s00384-004-0677-2; Bento AF, 2012, BIOCHEM PHARMACOL, V84, P1459, DOI 10.1016/j.bcp.2012.09.007; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bode L, 2008, J CLIN INVEST, V118, P229, DOI 10.1172/JCI32335; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Cekic C, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/850351; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Clevers H, 2006, NEW ENGL J MED, V354, P761, DOI 10.1056/NEJMcibr055457; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Danese S, 2010, ONCOGENE, V29, P3313, DOI 10.1038/onc.2010.109; Day R, 1999, DIGEST DIS SCI, V44, P2508, DOI 10.1023/A:1026647308089; Derksen PWB, 2002, BLOOD, V99, P1405, DOI 10.1182/blood.V99.4.1405; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Elenius V, 2004, J BIOL CHEM, V279, P41928, DOI 10.1074/jbc.M404506200; Floer M, 2010, AM J PATHOL, V176, P146, DOI 10.2353/ajpath.2010.080639; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Gotte M, 2002, INVEST OPHTH VIS SCI, V43, P1135; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Hashimoto Y, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-185; Hayashida K, 2008, J BIOL CHEM, V283, P19895, DOI 10.1074/jbc.M801614200; Jarnicki A, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-14; Joo EJ, 2014, OMICS, V18, P231, DOI 10.1089/omi.2013.0128; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Katoh H, 2013, CANCER CELL, V24, P631, DOI 10.1016/j.ccr.2013.10.009; Kim SY, 2015, INT J MED SCI, V12, P92, DOI 10.7150/ijms.10497; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Knelson EH, 2014, TRENDS BIOCHEM SCI, V39, P277, DOI 10.1016/j.tibs.2014.03.001; Kumar K, 2005, ROBBINS COTRANS PATH, V7, P213; Lambaerts K, 2009, CURR OPIN CELL BIOL, V21, P662, DOI 10.1016/j.ceb.2009.05.002; Lerner I, 2011, J CLIN INVEST, V121, P1709, DOI 10.1172/JCI43792; Li N, 2011, CANCER CELL, V19, P429, DOI 10.1016/j.ccr.2011.03.018; Li Y, 2010, GUT, V59, P227, DOI 10.1136/gut.2009.184176; Lundin M, 2005, ONCOLOGY-BASEL, V68, P306, DOI 10.1159/000086969; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marcon R, 2013, J IMMUNOL, V191, P4288, DOI 10.4049/jimmunol.1202743; Masouleh BK, 2009, J IMMUNOL, V182, P4985, DOI 10.4049/jimmunol.0800574; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Oshiro M, 2001, HISTOCHEM CELL BIOL, V115, P373; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; Patterson AM, 2012, INFLAMM BOWEL DIS, V18, P1112, DOI 10.1002/ibd.21879; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Ramani VC, 2011, J BIOL CHEM, V286, P6490, DOI 10.1074/jbc.M110.183277; Rops AL, 2007, KIDNEY INT, V72, P1204, DOI 10.1038/sj.ki.5002514; SIMONASSMANN P, 1989, J CELL BIOL, V109, P1837, DOI 10.1083/jcb.109.4.1837; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Stepp MA, 2015, ADV WOUND CARE, V4, P235, DOI 10.1089/wound.2014.0555; Teng YHF, 2012, MATRIX BIOL, V31, P3, DOI 10.1016/j.matbio.2011.10.001; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Vanhoutte D, 2007, CIRCULATION, V115, P475, DOI 10.1161/CIRCULATIONAHA.106.644609; Wang X, 2013, MATER RES LETT, V1, P19, DOI 10.1080/21663831.2012.686586; Wei HT, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0383-2; West NR, 2015, NAT REV IMMUNOL, V15, P615, DOI 10.1038/nri3896; Wolf MJ, 2012, CANCER CELL, V22, P91, DOI 10.1016/j.ccr.2012.05.023; Xu J, 2005, J IMMUNOL, V174, P5758, DOI 10.4049/jimmunol.174.9.5758; Yablecovitch D, 2011, J PHARMACOL EXP THER, V337, P391, DOI 10.1124/jpet.110.174276; Yuan K, 2004, BLOOD, V104, P1025, DOI 10.1182/blood-2003-09-3334; Zhang SH, 2013, INFLAMM BOWEL DIS, V19, P1025, DOI 10.1097/MIB.0b013e318280298f; Zhang XL, 2013, J IMMUNOL, V191, P4551, DOI 10.4049/jimmunol.1300931	70	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174343	10.1371/journal.pone.0174343	http://dx.doi.org/10.1371/journal.pone.0174343			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350804	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174400026
J	Nasir, NAA; Agarwal, R; Kadir, SHSA; Vasudevan, S; Tripathy, M; Iezhitsa, I; Daher, AM; Ibrahim, MI; Ismail, NM				Nasir, Nurul Alimah Abdul; Agarwal, Renu; Kadir, Siti Hamimah Sheikh Abdul; Vasudevan, Sushil; Tripathy, Minaketan; Iezhitsa, Igor; Daher, Aqil Mohammad; Ibrahim, Mohd Ikraam; Ismail, Nafeeza Mohd			Reduction of oxidative-nitrosative stress underlies anticataract effect of topically applied tocotrienol in streptozotocin-induced diabetic rats	PLOS ONE			English	Article							NF-KAPPA-B; LENS EPITHELIAL-CELLS; LONG-TERM INCIDENCE; K+-ATPASE ACTIVITY; ALDOSE REDUCTASE; NITRIC-OXIDE; ALPHA-CRYSTALLIN; PHENOLIC-COMPOUNDS; DELTA-TOCOTRIENOL; CATARACT	Cataract, a leading cause of blindness, is of special concern in diabetics as it occurs at earlier onset. Polyol accumulation and increased oxidative-nitrosative stress in cataractogenesis are associated with NF kappa B activation, iNOS expression, ATP depletion, loss of ATPase functions, calpain activation and proteolysis of soluble to insoluble proteins. Tocotrienol was previously shown to reduce lens oxidative stress and inhibit cataractogenesis in galactosefed rats. In current study, we investigated anticataract effects of topical tocotrienol and possible mechanisms involved in streptozotocin-induced diabetic rats. Diabetes was induced in Sprague Dawley rats by intraperitoneal injection of streptozotocin. Diabetic rats were treated with vehicle (DV) or tocotrienol (DT). A third group consists of normal, non-diabetic rats were treated with vehicle (NV). All treatments were given topically, bilaterally, twice daily for 8 weeks with weekly slit lamp monitoring. Subsequently, rats were euthanized and lenses were subjected to estimation of polyol accumulation, oxidative-nitrosative stress, NF kappa B activation, iNOS expression, ATP levels, ATPase activities, calpain activity and total protein levels. Cataract progression was delayed from the fifth week onwards in DT with lower mean of cataract stages compared to DV group (p< 0.01) despite persistent hyperglycemia. Reduced cataractogenesis in DT group was accompanied with lower aldose reductase activity and sorbitol level compared to DV group (p< 0.01). DT group also showed reduced NF kappa B activation, lower iNOS expression and reduced oxidative-nitrosative stress compared to DV group. Lenticular ATP and ATPase and calpain 2 activities in DT group were restored to normal. Consequently, soluble to insoluble protein ratio in DT group was higher compared to DV (p< 0.05). In conclusion, preventive effect of topical tocotrienol on development of cataract in STZ-induced diabetic rats could be attributed to reduced lens aldose reductase activity, polyol levels and oxidative-nitrosative stress. These effects of tocotrienol invlove reduced NF kappa B activation, lower iNOS expression, restoration of ATP level, ATPase activities, calpain activity and lens protein levels.	[Nasir, Nurul Alimah Abdul; Agarwal, Renu; Kadir, Siti Hamimah Sheikh Abdul; Vasudevan, Sushil; Iezhitsa, Igor; Ibrahim, Mohd Ikraam; Ismail, Nafeeza Mohd] Univ Teknol MARA Sungai Buloh Campus, Fac Med, Ctr Neurosci Res, Sungai Buloh, Selangor, Malaysia; [Tripathy, Minaketan] Univ Teknol MARA Puncak Alam Campus, Fac Pharm, Puncak Alam, Selangor, Malaysia; [Iezhitsa, Igor] Volgograd State Med Univ, Pharmacol Res Inst, Volgograd, Russia; [Daher, Aqil Mohammad] Natl Def Univ Malaysia, Fac Med & Def Hlth, Dept Community Med, Kuala Lumpur, Malaysia	Volgograd State Medical University; Universiti Pertahanan Nasional Malaysia	Nasir, NAA (corresponding author), Univ Teknol MARA Sungai Buloh Campus, Fac Med, Ctr Neurosci Res, Sungai Buloh, Selangor, Malaysia.	nurulalimah@salam.uitm.edu.my	Sheikh Abdul Kadir, Siti Hamimah/ABA-7769-2021; Abdul Nasir, Nurul Alimah/I-7950-2019; Agarwal, Renu/ABA-7780-2020; DAHER, AQIL M/A-5821-2018; Iezhitsa, Igor/B-5687-2012; Agarwal, Renu/G-5958-2012	Sheikh Abdul Kadir, Siti Hamimah/0000-0002-1671-4839; Abdul Nasir, Nurul Alimah/0000-0002-4285-7059; DAHER, AQIL M/0000-0002-3504-4340; Iezhitsa, Igor/0000-0002-2852-8486; Agarwal, Renu/0000-0002-3050-7449	Research Management Institute (RMI); Institute of Medical Molecular Biotechnology (IMMB); Laboratory Animal Care Unit (LACU), Universiti Teknologi MARA, Malaysia; Ministry of Higher Education, Government of Malaysia [600-RMI/RAGS 5/3 (39/2014)]	Research Management Institute (RMI); Institute of Medical Molecular Biotechnology (IMMB); Laboratory Animal Care Unit (LACU), Universiti Teknologi MARA, Malaysia; Ministry of Higher Education, Government of Malaysia	This work was funded by Ministry of Higher Education, Government of Malaysia, under the grant no 600-RMI/RAGS 5/3 (39/2014).; We acknowledge the administrative and facility support by Research Management Institute (RMI), Institute of Medical Molecular Biotechnology (IMMB) and Laboratory Animal Care Unit (LACU), Universiti Teknologi MARA, Malaysia. We also would like to thank our hard-working optometrists, Norhafni Razali and Iskandar Supardi for their help in clinical grading. This work was funded by Ministry of Higher Education, Government of Malaysia, under the grant no 600-RMI/RAGS 5/3 (39/2014).	ADAMS JD, 1983, J PHARMACOL EXP THER, V227, P749; Alexander G, 2003, INVEST OPHTH VIS SCI, V44, P2683, DOI 10.1167/iovs.02-0829; Andersson M, 1996, OPHTHALMIC RES, V28, P51, DOI 10.1159/000267944; Bar-Shai M, 2006, FREE RADICAL BIO MED, V40, P2112, DOI 10.1016/j.freeradbiomed.2006.02.009; BENDER CJ, 1994, MED HYPOTHESES, V43, P307, DOI 10.1016/0306-9877(94)90107-4; Boileau TWM, 2003, J BIOCHEM MOL TOXIC, V17, P108, DOI 10.1002/jbt.10067; BORCHMAN D, 1989, INVEST OPHTH VIS SCI, V30, P1633; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Chethan S, 2008, BIOORGAN MED CHEM, V16, P10085, DOI 10.1016/j.bmc.2008.10.003; DAVID LL, 1984, INVEST OPHTH VIS SCI, V25, P1275; Delamere NA, 2004, PROG RETIN EYE RES, V23, P593, DOI 10.1016/j.preteyeres.2004.06.003; Derham BK, 2003, EUR J BIOCHEM, V270, P2605, DOI 10.1046/j.1432-1033.2003.03631.x; Dudek EJ, 2001, FREE RADICAL BIO MED, V31, P651, DOI 10.1016/S0891-5849(01)00634-7; Estevez AG, 2002, ANN NY ACAD SCI, V962, P207, DOI 10.1111/j.1749-6632.2002.tb04069.x; Fariss MW, 2005, MOL INTERV, V5, P94, DOI 10.1124/mi.5.2.7; Frega N, 1998, J AM OIL CHEM SOC, V75, P1723, DOI 10.1007/s11746-998-0323-1; GARNER WH, 1983, P NATL ACAD SCI-BIOL, V80, P2044, DOI 10.1073/pnas.80.7.2044; Grauslund J, 2011, ACTA OPHTHALMOL, V89, P25, DOI [10.1111/j.1755-3768.2009.01619.x, 10.1111/j.1755-3768.2010.02105.x]; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; HUANG FL, 1994, CELL MOL BIOL RES, V40, P41; Husain K, 2011, MOL CANCER THER, V10, P2363, DOI 10.1158/1535-7163.MCT-11-0424; Inomata M, 2001, CURR EYE RES, V23, P307, DOI 10.1076/ceyr.23.4.307.5455; Jaiswal SK, 2014, J BIOCHEM MOL TOXIC, V28, P320, DOI 10.1002/jbt.21568; Jia ZY, 2011, MOL VIS, V17, P210; Jiang Q, 2015, FASEB J S, V29, P607; Kaileh M, 2010, J AM COLL NUTR, V29, p334S, DOI 10.1080/07315724.2010.10719848; KamalEldin A, 1996, LIPIDS, V31, P671, DOI 10.1007/BF02522884; Kanthan GL, 2011, ACTA OPHTHALMOL, V89, pE434, DOI 10.1111/j.1755-3768.2011.02149.x; Katori T, 1999, HORM METAB RES, V31, P5, DOI 10.1055/s-2007-978687; Khan MB, 2015, METAB BRAIN DIS, V30, P115, DOI 10.1007/s11011-014-9593-5; Kim J, 2010, GRAEF ARCH CLIN EXP, V248, P811, DOI 10.1007/s00417-010-1313-1; KINOSHIT.JH, 1974, INVEST OPHTH VISUAL, V13, P713; Kourie JI, 1998, AM J PHYSIOL-CELL PH, V275, pC1, DOI 10.1152/ajpcell.1998.275.1.C1; Kuhad A, 2009, LIFE SCI, V84, P296, DOI 10.1016/j.lfs.2008.12.014; LEE AYW, 1995, P NATL ACAD SCI USA, V92, P2780, DOI 10.1073/pnas.92.7.2780; Lee AYW, 1999, FASEB J, V13, P23, DOI 10.1096/fasebj.13.1.23; Lee IS, 2015, J NAT PROD, V78, P2249, DOI 10.1021/acs.jnatprod.5b00469; Lee SC, 2001, CLIN GENET, V59, P356, DOI 10.1034/j.1399-0004.2001.590510.x; Li L, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-94; Lorenzi M, 2007, EXP DIABETES RES, DOI 10.1155/2007/61038; LOU MF, 1988, EXP EYE RES, V46, P517, DOI 10.1016/S0014-4835(88)80009-5; lqbal J, 2012, J PHARM RES, V5, P30; Mafauzy M., 2011, MED J MALAYSIA, V66, P175; Makpol S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/785743; MITTON KP, 1993, EXP EYE RES, V56, P187, DOI 10.1006/exer.1993.1026; Moor AN, 2004, EXP EYE RES, V78, P933, DOI 10.1016/j.exer.2004.01.001; Nagai N, 2008, TOXICOLOGY, V247, P139, DOI 10.1016/j.tox.2008.02.016; Nagai N, 2007, TOXICOLOGY, V242, P7, DOI 10.1016/j.tox.2007.09.002; Nambu H, 2008, DIABETES RES CLIN PR, V82, P18, DOI 10.1016/j.diabres.2008.03.023; Nasir NAA, 2014, MOL VIS, V20, P822; Nowak G, 2012, J PHARMACOL EXP THER, V340, P330, DOI 10.1124/jpet.111.186882; Olofsson EM, 2007, FREE RADICAL BIO MED, V42, P1098, DOI 10.1016/j.freeradbiomed.2007.01.012; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Paterson CA, 1997, CURR EYE RES, V16, P333, DOI 10.1076/ceyr.16.4.333.10689; Paterson CA, 2004, EXP EYE RES, V78, P699, DOI 10.1016/j.exer.2003.09.018; Prokofyeva E, 2013, ACTA OPHTHALMOL, V91, P395, DOI 10.1111/j.1755-3768.2012.02444.x; Qureshi AA, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-239; Qureshi AA, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-143; Randazzo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018980; Reddy ABM, 2011, CHEM-BIOL INTERACT, V191, P346, DOI 10.1016/j.cbi.2011.02.028; Rhodes JD, 2009, EXP EYE RES, V88, P226, DOI 10.1016/j.exer.2008.10.025; Schloesser A, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/789710; Shi Q, 2009, MOL VIS, V15, P2129; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Suryanarayana P, 2005, INVEST OPHTH VIS SCI, V46, P2092, DOI 10.1167/iovs.04-1304; Tang DX, 2003, INVEST OPHTH VIS SCI, V44, P2059, DOI 10.1167/iovs.02-0345; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; Tiwari BS, 2002, PLANT PHYSIOL, V128, P1271, DOI 10.1104/pp.010999; VANHEYNINGEN R, 1959, NATURE, V184, P194, DOI 10.1038/184194b0; Vinson Joe A, 2006, Pathophysiology, V13, P151, DOI 10.1016/j.pathophys.2006.05.006; Wan Nazaimoon W M, 2002, Malays J Pathol, V24, P77; Wang XF, 2003, INVEST OPHTH VIS SCI, V44, P2067, DOI 10.1167/iovs.02-0841; Wang XQ, 2003, J CELL SCI, V116, P2099, DOI 10.1242/jcs.00420; Wang Y, 2015, J IMMUNOL, V195, P126, DOI 10.4049/jimmunol.1403149; Waris G, 2001, MOL CELL BIOL, V21, P7721, DOI 10.1128/MCB.21.22.7721-7730.2001; Wu SJ, 2008, MOL NUTR FOOD RES, V52, P921, DOI 10.1002/mnfr.200700418; XIE QW, 1994, J BIOL CHEM, V269, P4705; Xu WL, 2009, NUTRITION, V25, P555, DOI 10.1016/j.nut.2008.10.019; Yao J, 2009, INT J MOL MED, V24, P153, DOI 10.3892/ijmm_00000218; Yawadio R, 2007, FOOD CHEM, V101, P1616, DOI 10.1016/j.foodchem.2006.04.016; YOSHIDA H, 1984, BIOCHIM BIOPHYS ACTA, V798, P252, DOI 10.1016/0304-4165(84)90313-1; YOSHIDA H, 1985, CURR EYE RES, V4, P983, DOI 10.3109/02713689509000005; Zhang S, 2008, MOL VIS, V14, P862	83	20	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174542	10.1371/journal.pone.0174542	http://dx.doi.org/10.1371/journal.pone.0174542			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350848	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174400054
J	Sanchez, PR; Prieto, L; De Ory, SJ; Cooke, EF; Navarro, ML; Ramos, JT; Holguin, A				Sanchez, Patricia Rojas; Prieto, Luis; De Ory, Santiago Jimenez; Cooke, Elisa Fernandez; Navarro, Maria Luisa; Ramos, Jose Tomas; Holguin, Africa		Madrid Cohort HIV-1 Infected; Spanish Natl AIDS Network CoRISPe	Impact of lopinavir-ritonavir exposure in HIV-1 infected children and adolescents in Madrid, Spain during 2000-2014	PLOS ONE			English	Article							HIV-INFECTED CHILDREN; 1ST-LINE ANTIRETROVIRAL THERAPY; PROTEASE-INHIBITOR; DRUG-RESISTANCE; PEDIATRIC POPULATION; VIROLOGICAL SUCCESS; LOPINAVIR/RITONAVIR; NEVIRAPINE; MUTATIONS; LABEL	Background The most-used protease-inhibitor in children is Lopinavir-ritonavir (LPV/r), which provides durable suppression of viral load and increases CD4+T-counts. This study describes the virological outcome of the HIV-1-infected paediatric population exposed to LPV/r during 15 years in Spain. Methodology Patients from the Madrid Cohort of HIV-1- infected-children and adolescents exposed to LPV/r as different line therapy during 2000 - 2014 were selected. The baseline epidemiological-clinical features, viral suppression, changes in CD4+T-CD8+T cell counts and drug susceptibility were recorded before and during LPV/r exposure. Drug resistance mutations (DRM) were identified in viruses from samples collected until 2011. We predicted drug susceptibility to 19 antiretrovirals among those carrying DRM using the Stanford's HIVdb Algorithm. Results A total of 199 (37.3%) of the 534 patients from the cohort were exposed to LPV/r during 2000-2014 in first (group 1), second (group 2) or more line-therapies (group 3). Patients were mainly Spaniards (81.9%), perinatally infected (96.5%) with subtype-B (65.3%) and HIV-diagnosed before year 2000 (67.8%). The mean age at first LPV/r exposure was 9.7 years. After protease-inhibitor exposure, viral suppression was higher in groups 1 and 2 than in group 3. Viral suppression occurred in 87.5%, 68.6% and 64.8% patients from groups 1, 2 and 3, respectively. Among the 64 patients with available resistance data during LPV/r treatment, 27(42.3%) carried DRM to protease-inhibitor, 28 (58.3%) to reverse-transcriptase- inhibitors and 21 (43.7%) to non-reverse-transcriptase-inhibitors. Darunavir/ritonavir, atazanavir-ritonavir and tipranavir/ritonavir presented the highest susceptibility and nelfinavir the lowest. Conclusions A better lymphocyte recovering occurred when protease-inhibitor was taken as part of a first-line regimen and a higher number of patients reached viral suppression. The least compromised antiretrovirals for rescue antiretroviral regimens, according to DRM in the LPV/rexposed- paediatric cohort, were mainly the new protease inhibitors.	[Sanchez, Patricia Rojas; Holguin, Africa] Hosp RamOn y Cajal IRYCIS, Microbiol & Parasitol Dept, HIV Mol Epidemiol Lab 1, Madrid, Spain; [Sanchez, Patricia Rojas; Holguin, Africa] CIBER ESP, Madrid, Spain; [Prieto, Luis] Hosp Univ Getafe, Dept Infect Dis, Madrid, Spain; [De Ory, Santiago Jimenez] Hosp Univ Gregorio Maranon IISGM, Mol Inmunobiol Lab, Madrid, Spain; [De Ory, Santiago Jimenez] CIBER BBN, Madrid, Spain; [Cooke, Elisa Fernandez] Hosp Univ Doce Octubre, Infect Dis Dept, Madrid, Spain; [Navarro, Maria Luisa] Hosp Univ Gregorio Maranon, Paediat Dept, Infect Dis Unit, Madrid, Spain; [Ramos, Jose Tomas] Hosp Clin Univ, Infect Dis Dept, Madrid, Spain; [Ramos, Jose Tomas] Univ Complutense, Madrid, Spain	Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario de Getafe; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Hospital Universitario 12 de Octubre; General University Gregorio Maranon Hospital; Complutense University of Madrid	Holguin, A (corresponding author), Hosp RamOn y Cajal IRYCIS, Microbiol & Parasitol Dept, HIV Mol Epidemiol Lab 1, Madrid, Spain.; Holguin, A (corresponding author), CIBER ESP, Madrid, Spain.	africa.holguin@salud.madrid.org	Holguín, Africa/AAF-9001-2021; Prieto, Luis Enrique/HFZ-7903-2022	Holguín, Africa/0000-0002-1330-8050; Fernandez-Cooke, Elisa/0000-0002-5921-8261; , Patricia/0000-0001-6935-0066	Plan Nacional de I+D+I, Institute de Salud Carlos III (ISCIII) [FIS PI12/00240]; European Development Regional Fund "A way to achieve Europe" (ERDF); Institute de Salud Carlos III, Spanish Health Ministry [RD06/0006/0035]; Fundacion para la investigacion y prevencion del SIDA en Espana (FIPSE); Plan Nacional de I+D+I [RD12/0017/0035, RD12/0017/0037]; ISCIII-Subdireccion General de Evaluacion	Plan Nacional de I+D+I, Institute de Salud Carlos III (ISCIII); European Development Regional Fund "A way to achieve Europe" (ERDF); Institute de Salud Carlos III, Spanish Health Ministry; Fundacion para la investigacion y prevencion del SIDA en Espana (FIPSE); Plan Nacional de I+D+I; ISCIII-Subdireccion General de Evaluacion	This study was supported by Plan Nacional de I+D+I 2008-2011, Institute de Salud Carlos III (ISCIII), FIS PI12/00240 and cofinanced by the European Development Regional Fund "A way to achieve Europe" (ERDF). This study is included in the Subprograma de Inmigracion y Salud from CIBERESP (Spain). We want to particularly acknowledge the patients in this study for their participation and the Pediatric HIV BioBank integrated in the Spanish AIDS Research Network for providing two clinical samples used in this work. The Pediatric HIV BioBank, integrated in the Spanish AIDS Research Network, is supported by Institute de Salud Carlos III, Spanish Health Ministry (Grant no RD06/0006/0035) and Fundacion para la investigacion y prevencion del SIDA en Espana (FIPSE). CoRISPe cohort is funded by RD12/0017/0035 and RD12/0017/0037 Project, supported by Plan Nacional de I+D+I and cofinanced by the ISCIII-Subdireccion General de Evaluacion and European Development Regional Fund "A way to achieve Europe" (ERDF). We thank CoRISPE and the professionals responsible for the routine resistance testing in the participant hospitals for providing epidemiological-clinical data and pol sequences of enrolled patients when available.; We want to particularly acknowledge the patients in this study for their participation and the Paediatric HIV BioBank integrated in the Spanish AIDS Research Network for providing two clinical samples used in this work. The Paediatric HIV BioBank, integrated in the Spanish AIDS Research Network, is supported by Instituto de Salud Carlos III, Spanish Health Ministry (Grant no RD06/0006/0035) and Fundacion para la investigacion y prevencion del SIDA en Espana (FIPSE). CoRISPe cohort is funded by RD12/0017/0035 and RD12/0017/0037 Project, supported by Plan Nacional de I+D+I and cofinanced by the ISCIII-Subdireccion General de Evaluacion and European Development Regional Fund "A way to achieve Europe" (ERDF). We thank CoRISPE and the professionals responsible for the routine resistance testing in the participant hospitals for providing epidemiological-clinical data and pol sequences of enrolled patients when available.	Abbott laboratories, 2010, KAL HIGHL PRESCR INF; Aldeguer L, 2007, ENFERM INFEC MICR CL, V25, P32, DOI 10.1157/13096750; [Anonymous], US ANT DRUGS TREAT P; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Babiker A, 2011, LANCET INFECT DIS, V11, P273, DOI 10.1016/S1473-3099(10)70313-3; Bierman WFW, 2009, AIDS, V23, P279, DOI 10.1097/QAD.0b013e32831c54e5; Bongiovanni M, 2003, ANTIVIR THER, V8, P209; Chadwick EG, 2011, AIDS, V25, P643, DOI 10.1097/QAD.0b013e32834403f6; Childs T, 2015, LANCET HIV, V2, pE151, DOI 10.1016/S2352-3018(15)00021-1; Cotton MF, 2013, LANCET, V382, P1555, DOI 10.1016/S0140-6736(13)61409-9; Cvetkovic RS, 2003, DRUGS, V63, P769, DOI 10.2165/00003495-200363080-00004; de Mulder M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052155; de Mulder M, 2011, J ANTIMICROB CHEMOTH, V66, P2362, DOI 10.1093/jac/dkr305; Delaugerre C, 2004, JAIDS-J ACQ IMM DEF, V37, P1269, DOI 10.1097/01.qai.0000137408.78031.37; European Medicines Agency, 2009, EMEAHC00036820090; Fernandez-Cooke E, 2016, ANTIVIR THER, V21, P65, DOI 10.3851/IMP2973; Frange P, 2011, PEDIATR INFECT DIS J, V30, P684, DOI 10.1097/INF.0b013e31821752d6; Garcia-Merino I, 2010, AIDS RES HUM RETROV, V26, P241, DOI 10.1089/aid.2009.0122; Holguin A, 2011, PEDIATR INFECT DIS J, V30, pE82, DOI 10.1097/INF.0b013e3182117289; Huang XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08528; Jenabian MA, 2015, EXPERT REV ANTI-INFE, V13, P1213, DOI 10.1586/14787210.2015.1068117; Judd A, 2007, CLIN INFECT DIS, V45, P918, DOI 10.1086/521167; Kempf DJ, 2004, J INFECT DIS, V189, P51, DOI 10.1086/380509; Lima VD, 2008, J INFECT DIS, V198, P51, DOI 10.1086/588675; Martinez BL, 2010, HIV AIDS-RES PALLIAT, V2, P59; Meyers T, 2015, PEDIATR INFECT DIS J, V34, P175, DOI 10.1097/INF.0000000000000544; Palumbo P, 2010, NEW ENGL J MED, V363, P1510, DOI 10.1056/NEJMoa1000931; Penazzato M, 2014, COCHRANE DB SYST REV, V22; Penazzato M, 2015, CLIN INFECT DIS, V60, pS177, DOI 10.1093/cid/civ110; Ramos JT, 2009, HIV MED, V10, P536, DOI 10.1111/j.1468-1293.2009.00728.x; Sanchez PR, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.02.003; Sanchez PR, 2014, J ANTIMICROB CHEMOTH, V69, P2032, DOI 10.1093/jac/dku104; Saez-Llorens X, 2003, PEDIATR INFECT DIS J, V22, P216, DOI 10.1097/00006454-200303000-00003; Stephens D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093950; Violari A, 2012, NEW ENGL J MED, V366, P2380, DOI 10.1056/NEJMoa1113249; Welch S, 2009, HIV MED, V10, P591, DOI 10.1111/j.1468-1293.2009.00759.x; Wensing Annemarie M, 2014, Top Antivir Med, V22, P642; Yin DE, 2014, PEDIATRICS, V134, pE1104, DOI 10.1542/peds.2014-0527	38	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0173168	10.1371/journal.pone.0173168	http://dx.doi.org/10.1371/journal.pone.0173168			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350802	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174400005
J	Griva, K; Stygall, J; Wilson, MH; Martin, D; Levett, D; Mitchell, K; Mythen, M; Montgomery, HE; Grocott, MP; Aref-Adib, G; Edsell, M; Plant, T; Imray, C; Cooke, D; Harrington, J; Khosravi, M; Newman, SP				Griva, Konstadina; Stygall, Jan; Wilson, Mark H.; Martin, Daniel; Levett, Denny; Mitchell, Kay; Mythen, Monty; Montgomery, Hugh E.; Grocott, Mike P.; Aref-Adib, Golnar; Edsell, Mark; Plant, Tracie; Imray, Chris; Cooke, Debbie; Harrington, Jane; Khosravi, Maryam; Newman, Stanton P.		Caudwell Xtreme Everest Res Grp	Caudwell Xtreme Everest: A prospective study of the effects of environmental hypoxia on cognitive functioning	PLOS ONE			English	Article							ALTITUDE; PERFORMANCE; DYSFUNCTION; SURGERY	Background The neuropsychological consequences of exposure to environmental hypobaric hypoxia (EHH) remain unclear. We thus investigated them in a large group of healthy volunteers who trekked to Mount Everest base camp (5,300 m). Methods A neuropsychological (NP) test battery assessing memory, language, attention, and executive function was administered to 198 participants (age 44.5 +/- 13.7 years; 60% male). These were studied at baseline (sea level), 3,500 m (Namche Bazaar), 5,300 m (Everest Base Camp) and on return to 1,300 m (Kathmandu) (attrition rate 23.7%). A comparable control group (n = 25; age 44.5 +/- 14.1 years; 60% male) for comparison with trekkers was tested at/or near sea level over an equivalent timeframe so as to account for learning effects associated with repeat testing. The Reliable Change Index (RCI) was used to calculate changes in cognition and neuropsychological function during and after exposure to EHH relative to controls. Results Overall, attention, verbal ability and executive function declined in those exposed to EHH when the performance of the control group was taken into account (RCI.05 to -. 95) with decline persisting at descent. Memory and psychomotor function showed decline at highest ascent only (RCI -. 08 to -. 56). However, there was inter-individual variability in response: whilst NP performance declined in most, this improved in some trekkers. Cognitive decline was greater amongst older people (r =.42; p <.0001), but was otherwise not consistently associated with socio-demographic, mood, or physiological variables. Conclusions After correcting for learning effects, attention, verbal abilities and executive functioning declined with exposure to EHH. There was considerable individual variability in the response of brain function to sustained hypoxia with some participants not showing any effects of hypoxia. This might have implications for those facing sustained hypoxia as a result of any disease.	[Griva, Konstadina; Stygall, Jan; Newman, Stanton P.] City Univ London, Hlth Serv Res Grp, Coll Bldg Room A224, London, England; [Griva, Konstadina] Natl Univ Singapore, Dept Psychol, 9 Arts Link AS4-02-28, Singapore, Singapore; [Wilson, Mark H.] Imperial Coll, Traumat Brain Injury Ctr, London, England; [Wilson, Mark H.] Queen Mary Univ, Londons Air Ambulance, London, England; [Martin, Daniel; Mitchell, Kay; Mythen, Monty; Montgomery, Hugh E.; Grocott, Mike P.; Khosravi, Maryam] UCL, Inst Human Hlth & Performance, London, England; [Levett, Denny; Grocott, Mike P.] Univ Hosp Southampton, Anaesthesia & Crit Care Res Unit, Southampton, Hants, England; [Grocott, Mike P.] Univ Southampton, Fac Med, Div Clin & Expt Sci, Integrat Physiol & Crit Illness Grp, Southampton, Hants, England; [Grocott, Mike P.] Southampton NIHR Resp Biomed Res Unit, Southampton, Hants, England; [Aref-Adib, Golnar; Harrington, Jane] UCL, Div Psychiat, London, England; [Edsell, Mark] St George Hosp, London, England; [Plant, Tracie] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Imray, Chris] Warwick Med Sch, Div Translat & Syst Med, Warwick, England; [Cooke, Debbie] Univ Surrey, Fac Hlth & Med Sci, Sch Hlth Sci, Surrey, England	City University London; National University of Singapore; Imperial College London; University of London; Queen Mary University London; University of London; University College London; University of Southampton; University of Southampton; University of London; University College London; St Georges University London; University of Edinburgh; University of Warwick; University of Surrey	Newman, SP (corresponding author), City Univ London, Hlth Serv Res Grp, Coll Bldg Room A224, London, England.	Stanton.Newman.1@city.ac.uk	Grocott, Michael/C-4394-2008; Griva, Konstadina/A-6549-2018; Levett, Denny Zelda Hope/AAY-4627-2021; Levett, Denny/F-4474-2011; Levett, Denny/D-2239-2017; Mitchell, Kay/ABC-2981-2020; Mitchell, Kay/F-8974-2012; Montgomery, Hugh/L-1229-2019; Montgomery, Hugh/C-2592-2008	Grocott, Michael/0000-0002-9484-7581; Levett, Denny Zelda Hope/0000-0002-8418-1675; Levett, Denny/0000-0002-8418-1675; Levett, Denny/0000-0002-8418-1675; Mitchell, Kay/0000-0001-6393-8475; Newman, Stanton/0000-0001-6712-6079; Montgomery, Hugh/0000-0001-8797-5019; GRIVA, KONSTADINA/0000-0001-8173-5663; Cooke, Debbie/0000-0003-1944-7905; Wilson, Mark/0000-0002-2346-4911; Richardson, Alan/0000-0001-8931-2518; imray, chris/0000-0001-8451-4102; Martin, Daniel/0000-0001-6220-8235; Aref-Adib, Golnar/0000-0003-2220-5317; Murray, Andrew/0000-0002-0929-9315	United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme; Eli Lilly; London Clinic; Smiths Medical; Deltex Medical; Rolex Foundation; Association of Anaesthetists of Great Britain and Ireland; United Kingdom Intensive Care Foundation; Sir Halley Stewart Trust; National Institute for Health Research [ACF-2013-18-011] Funding Source: researchfish	United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); Eli Lilly(Eli Lilly); London Clinic; Smiths Medical; Deltex Medical; Rolex Foundation; Association of Anaesthetists of Great Britain and Ireland; United Kingdom Intensive Care Foundation; Sir Halley Stewart Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	The research was funded from a variety of sources, none of which are public: Mr John Caudwell, BOC Medical (now part of Linde Gas therapeutics), Eli Lilly Critical Care, the London Clinic, Smiths Medical, Deltex Medical and the Rolex Foundation (unrestricted grants), the Association of Anaesthetists of Great Britain and Ireland, the United Kingdom Intensive Care Foundation and the Sir Halley Stewart Trust. The Caudwell Xtreme Everest volunteers who trekked to Everest base camp also kindly donated to support the research. Some of this work was undertaken at University College London Hospital University College London Comprehensive Biomedical Research Centre, which received a proportion of funding from the United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the support of, Mr. John Caudwell, BOC Medical (now part of Linde Gas Therapeutics), Eli Lilly, the London Clinic, Smiths Medical, Deltex Medical, and the Rolex Foundation (unrestricted grants), the Association of Anaesthetists of Great Britain and Ireland, the United Kingdom Intensive Care Foundation, the Sir Halley Stewart Trust, Tonia Griva, Kevin FY Lam and all members of the Caudwell Xtreme Everest Research Group as follows: Investigators V. Ahuja, G. Aref-Adib, R. Burnham, A. Chisholm, K. Clarke, D. Coates, M. Coates, D. Cook, M. Cox, S. Dhillon, C. Dougall, P. Doyle, P. Duncan, M. Edsell, L. Edwards, L. Evans, P. Gardiner, M. P. Grocott, P. Gunning, N. Hart, J. Harrington, J. Harvey, C. Holloway, D. Howard, D. Hurlbut, C. Imray, C. Ince, M. Jonas, J. van der Kaaij, M. Khosravi, N. Kolfschoten, D. Levett, H. Luery, A. Luks, D. Martin, R. McMorrow, P. Meale, K. Mitchell, H. E. Montgomery, G. Morgan, J. Morgan, A. Murray, M. Mythen, S. P. Newman, M. O'Dwyer, J. Pate, T. Plant, M. Pun, P. Richards, A. Richardson, G. Rodway, J. Simpson, C. Stroud, M. Stroud, J. Stygal, B. Symons, P. Szawarski, A. Van Tulleken, C. Van Tulleken, A. Vercueil, L. Wandrag, M. Wilson, J. Windsor; Scientific Advisory Group B. Basnyat, C. Clarke, T. Hornbein, J. Milledge, J. West.	Abraini JH, 1998, PFLUG ARCH EUR J PHY, V436, P553, DOI 10.1007/s004240050671; AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Basnyat B, 2004, HIGH ALT MED BIOL, V5, P171, DOI 10.1089/1527029041352126; Benton AL, 1994, MULTILINGUAL APHASIA; Bjursten H, 2010, HIGH ALT MED BIOL, V11, P31, DOI 10.1089/ham.2009.1041; Casati A, 2005, ANESTH ANALG, V101, P740, DOI 10.1213/01.ane.0000166974.96219.cd; Dikmen SS, 1999, J INT NEUROPSYCH SOC, V5, P346, DOI 10.1017/S1355617799544056; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; GOODMAN LA, 1961, ANN MATH STAT, V32, P148, DOI 10.1214/aoms/1177705148; Grocott M, 2007, CRIT CARE, V11, DOI 10.1186/cc5142; Grocott MPW, 2010, HIGH ALT MED BIOL, V11, P133, DOI 10.1089/ham.2009.1093; Grocott MPW, 2009, NEW ENGL J MED, V360, P140, DOI 10.1056/NEJMoa0801581; Harris GA, 2009, WILD ENVIRON MED, V20, P261, DOI 10.1580/08-WEME-OR-261R.1; Heilbronner RL, 2010, CLIN NEUROPSYCHOL, V24, P1267, DOI 10.1080/13854046.2010.526785; Hopkins RO, 2006, CHEST, V130, P869, DOI 10.1378/chest.130.3.869; Hopkins RO, 2001, PULMONARY DISORDERS; Jansen GFA, 2007, J APPL PHYSIOL, V103, P518, DOI 10.1152/japplphysiol.01429.2006; Jung T, 2008, SOC PERSONAL PSYCHOL, V2, P302, DOI 10.1111/j.1751-9004.2007.00054.x; KRAMER AF, 1993, HUM FACTORS, V35, P329, DOI 10.1177/001872089303500208; Levett DZH, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-98; Lewis MS, 2006, ARCH CLIN NEUROPSYCH, V21, P421, DOI 10.1016/j.acn.2006.05.004; Lezak DH, 2004, NEUROPSYCHOLOGICAL A, V4; Lieberman P, 2005, AVIAT SPACE ENVIR MD, V76, pB198; Masyn K. E., 2013, OXFORD HDB QUANTITAT, V2, P551, DOI DOI 10.1093/OXFORDHB/9780199934898.013.0025; Matthews C, 1964, INSTRUCTION MANUAL A; McLachlan G., 2000, WILEY SER PROB STAT; MCLACHLAN GJ, 1987, J R STAT SOC C-APPL, V36, P318; Mitrushina MN, 1999, HDB NORMATIVE DATA N, DOI DOI 10.1016/S1474-4422(06)70630-5; Muthen L.K., 1998, MPLUS USERS GUIDE, V8th; Nagin D. S., 2005, GROUP BASED MODELING, DOI DOI 10.4159/9780674041318; Newman S, 1993, CARDIAC SURG BRAIN, P34; Newman S, 2007, ANESTHESIOLOGY, V106, P572, DOI 10.1097/00000542-200703000-00023; NOBLE J, 1993, ANAESTH INTENS CARE, V21, P180, DOI 10.1177/0310057X9302100208; Pavlicek V, 2005, AVIAT SPACE ENVIR MD, V76, P28; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; RAMASWAMY V, 1993, MARKET SCI, V12, P103, DOI 10.1287/mksc.12.1.103; Reitan R.M., 1993, HALSTEAD REITAN NEUR; Rey A, 1964, LEXAMEN CLINIQUE PSY; ROACH RC, 1993, LAKE LOUISE ACUTE MO, P272; Schou L, 2012, RESP MED, V106, P1071, DOI 10.1016/j.rmed.2012.03.013; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith A., 1973, SYMBOL DIGIT MODALIT, DOI 10.1037/t27513-000; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Trenerry MR., 1989, STROOP NEUROPSYCHOLO; Turner CE, 2015, PHYSIOL BEHAV, V142, P104, DOI 10.1016/j.physbeh.2015.02.006; van der Post J, 2002, J PSYCHOPHARMACOL, V16, P337, DOI 10.1177/026988110201600408; Virues-Ortega J, 2006, DEVELOPMENTAL SCI, V9, P400, DOI 10.1111/j.1467-7687.2006.00505.x; Virues-Ortega Javier, 2004, Neuropsychology Review, V14, P197; Wechsler D., 1939, MEASUREMENT ADULT IN; West JB, 2004, ANN INTERN MED, V141, P789, DOI 10.7326/0003-4819-141-10-200411160-00010; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6; Yan XA, 2011, EXP BRAIN RES, V208, P437, DOI 10.1007/s00221-010-2494-x	53	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174277	10.1371/journal.pone.0174277	http://dx.doi.org/10.1371/journal.pone.0174277			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VD	28346535	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000399174300036
J	Levast, B; Barblu, L; Coutu, M; Prevost, J; Brassard, N; Peres, A; Stegen, C; Madrenas, J; Kaufmann, DE; Finzi, A				Levast, Benoit; Barblu, Lucie; Coutu, Mathieu; Prevost, Jeremie; Brassard, Nathalie; Peres, Adam; Stegen, Camille; Madrenas, Joaquin; Kaufmann, Daniel E.; Finzi, Andres			HIV-1 gp120 envelope glycoprotein determinants for cytokine burst in human monocytes	PLOS ONE			English	Article							PROTEIN GP120; CD4-BOUND CONFORMATION; NEURONAL DEGENERATION; BLOOD MONOCYTES; CELL CHEMOTAXIS; DENDRITIC CELLS; INFECTION; CYTOTOXICITY; ACTIVATION; EXPRESSION	The first step of HIV infection involves the interaction of the gp120 envelope glycoprotein to its receptor CD4, mainly expressed on CD4(+) T cells. Besides its role on HIV-1 entry, the gp120 has been shown to be involved in the production of IL-1, IL-6, CCL20 and other innate response cytokines by bystander, uninfected CD4(+) T cells and monocytes. However, the gp120 determinants involved in these functions are not completely understood. Whether signalling leading to cytokine production is due to CD4 or other receptors is still unclear. Enhanced chemokine receptor binding and subsequent clustering receptors may lead to cytokine production. By using a comprehensive panel of gp120 mutants, here we show that CD4 binding is mandatory for cytokine outburst in monocytes. Our data suggest that targeting monocytes in HIV-infected patients might decrease systemic inflammation and the potential tissue injury associated with the production of inflammatory cytokines. Understanding how gp120 mediates a cytokine burst in monocytes might help develop new approaches to improve the chronic inflammation that persists in these patients despite effective suppression of viremia by antiretroviral therapy.	[Levast, Benoit; Peres, Adam; Stegen, Camille; Madrenas, Joaquin; Finzi, Andres] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Levast, Benoit; Peres, Adam; Stegen, Camille; Madrenas, Joaquin; Finzi, Andres] McGill Univ, Microbiome & Dis Tolerance Ctr, Montreal, PQ, Canada; [Barblu, Lucie; Coutu, Mathieu; Prevost, Jeremie; Brassard, Nathalie; Kaufmann, Daniel E.; Finzi, Andres] Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada; [Prevost, Jeremie; Finzi, Andres] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Madrenas, Joaquin] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Kaufmann, Daniel E.] Univ Montreal, Dept Med, Montreal, PQ, Canada	McGill University; McGill University; Universite de Montreal; Universite de Montreal; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Universite de Montreal	Madrenas, J; Finzi, A (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.; Madrenas, J; Finzi, A (corresponding author), McGill Univ, Microbiome & Dis Tolerance Ctr, Montreal, PQ, Canada.; Kaufmann, DE; Finzi, A (corresponding author), Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada.; Finzi, A (corresponding author), Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada.; Madrenas, J (corresponding author), Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA.; Kaufmann, DE (corresponding author), Univ Montreal, Dept Med, Montreal, PQ, Canada.	andres.finzi@umontreal.ca; daniel.kaufmann@umontreal.ca; joaquin.madrenas@labiomed.org	Peres, Adam G/R-5245-2017	Peres, Adam G/0000-0002-7331-1112; Prevost, Jeremie/0000-0002-5260-5154; Finzi, Andres/0000-0002-4992-5288	Canadian Institutes for Health Research [13442, 137694, 352417]; NIH [R01 HL092565]; Canada Research Chairs [950-229930, 228107]; Research Scholar Career Award of the Quebec Health Research Fund (FRQ-S) [31035]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chairs(Canada Research ChairsCGIAR); Research Scholar Career Award of the Quebec Health Research Fund (FRQ-S)	This work was supported by grants from the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca/e/193.html) held by Drs. JM (#13442), DEK (#137694) and AF (#352417); and NIH R01 HL092565 (https://www.nih.gov) to DEK. AF (#950-229930) and JM (#228107) are the recipients of Canada Research Chairs (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx). DEK is supported by a Research Scholar Career Award of the Quebec Health Research Fund (FRQ-S, #31035) (http://www.frqs.gouv.qc.ca/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badr G, 2005, J IMMUNOL, V175, P302, DOI 10.4049/jimmunol.175.1.302; Bahraoui E, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0214-z; Baran J, 2001, CLIN DIAGN LAB IMMUN, V8, P303, DOI 10.1128/CDLI.8.2.303-313.2001; Biswas P, 2003, BLOOD, V101, P4452, DOI 10.1182/blood-2002-10-3056; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Coutu M, 2015, J VIROL METHODS, V215, P37, DOI 10.1016/j.jviromet.2015.02.017; Del Corno M, 2014, J VIROL, V88, P11045, DOI 10.1128/JVI.00307-14; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Ellegard R, 2015, J IMMUNOL, V195, P1698, DOI 10.4049/jimmunol.1500618; Fantuzzi L, 2001, J IMMUNOL, V166, P5381, DOI 10.4049/jimmunol.166.9.5381; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; Florio C, 2000, AIDS, V14, P931, DOI 10.1097/00002030-200005260-00004; Fouts TR, 2015, P NATL ACAD SCI USA, V112, pE992, DOI 10.1073/pnas.1423669112; Garg A, 2014, J INFECT DIS, V209, P441, DOI 10.1093/infdis/jit469; George MD, 2014, CURR OPIN INFECT DIS, V27, P275, DOI [10.1097/QCO.0000000000000059, 10.1097/QCO.0000000000000056]; Jelicic K, 2013, NAT IMMUNOL, V14, P1256, DOI 10.1038/ni.2746; Jones G, 2005, VIROLOGY, V334, P178, DOI 10.1016/j.virol.2005.01.027; Kong LY, 1996, CELL IMMUNOL, V172, P77, DOI 10.1006/cimm.1996.0217; Korber B, 1998, SCIENCE, V280, P1868, DOI 10.1126/science.280.5371.1868; Lederman MM, 2013, ADV IMMUNOL, V119, P51, DOI 10.1016/B978-0-12-407707-2.00002-3; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; Melendez RI, 2015, J NEUROVIROLOGY; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Nazli A, 2013, J IMMUNOL, V191, P4246, DOI 10.4049/jimmunol.1301482; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Nosheny RL, 2005, NEUROTOX RES, V8, P187, DOI 10.1007/BF03033829; OH SK, 1992, J ACQ IMMUN DEF SYND, V5, P251; Patella V, 2000, J IMMUNOLOGY, V164; Richard J, 2016, EBIOMEDICINE, V3, P122, DOI 10.1016/j.ebiom.2015.12.004; Richard J, 2014, J VIROL METHODS, V208, P107, DOI 10.1016/j.jviromet.2014.08.003; Rizzuto C, 2000, AIDS RES HUM RETROV, V16, P741, DOI 10.1089/088922200308747; Ronaldson PT, 2008, J NEUROCHEM, V106, P1298, DOI 10.1111/j.1471-4159.2008.05479.x; Rychert J, 2010, AIDS RES HUM RETROV, V26, P1139, DOI 10.1089/aid.2009.0290; Santosuosso M, 2009, J INFECT DIS, V200, P1050, DOI 10.1086/605695; Shan MM, 2007, PLOS PATHOG, V3, P1637, DOI 10.1371/journal.ppat.0030169; Shutt DC, 1998, J CELL SCI, V111, P99; Simmons RP, 2013, AIDS, V27, P2505, DOI 10.1097/01.aids.0000432455.06476.bc; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veillette M, 2015, J VIROL, V89, P545, DOI 10.1128/JVI.02868-14; Walsh JG, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-35; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; Zhen A, 2014, J VIROL, V88, P9934, DOI 10.1128/JVI.00616-14	42	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174550	10.1371/journal.pone.0174550	http://dx.doi.org/10.1371/journal.pone.0174550			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346521	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174300055
J	Jain, A; Tripathi, R; Turpin, CP; Wang, C; Plattner, R				Jain, A.; Tripathi, R.; Turpin, C. P.; Wang, C.; Plattner, R.			Ab1 kinase regulation by BRAF/ERK and cooperation with Akt in melanoma	ONCOGENE			English	Article							C-ABL; METASTATIC MELANOMA; MALIGNANT-MELANOMA; MUTANT MELANOMA; FAMILY KINASES; MEK INHIBITION; RAF INHIBITORS; CANCER; RESISTANCE; INVASION	The melanoma incidence continues to increase, and the disease remains incurable for many due to its metastatic nature and high rate of therapeutic resistance. In particular, melanomas harboring BRAFV600E and PTEN mutations often are resistant to current therapies, including BRAF inhibitors (BRAFi) and immune checkpoint inhibitors. Abl kinases (Abl/Arg) are activated in melanomas and drive progression; however, their mechanism of activation has not been established. Here we elucidate a novel link between BRAF(V600E)/ERK signaling and Abl kinases. We demonstrate that BRAF(V600E)/ERK play a critical role in binding, phosphorylating and regulating Abl localization and Abl/Arg activation by Src family kinases. Importantly, Abl/Arg activation downstream of BRAFV600E has functional and biological significance, driving proliferation, invasion, as well as switch in epithelial-mesenchymal-transition transcription factor expression, which is known to be critical for melanoma cells to shift between differentiated and invasive states. Finally, we describe findings of high translational significance by demonstrating that Abl/Arg cooperate with PI3K/Akt/PTEN, a parallel pathway that is associated with intrinsic resistance to BRAFi and immunotherapy, as Abl/Arg and Akt inhibitors cooperate to prevent viability, cell cycle progression and in vivo growth of melanomas harboring mutant BRAF/PTEN. Thus, these data not only provide mechanistic insight into Abl/Arg regulation during melanoma development, but also pave the way for the development of new strategies for treating patients with melanomas harboring mutant BRAF/PTEN, which often are refractory to current therapies.	[Jain, A.; Tripathi, R.; Turpin, C. P.; Plattner, R.] Univ Kentucky, Sch Med, Dept Pharmacol & Nutr Sci, Lexington, KY 40536 USA; [Wang, C.] Univ Kentucky, Sch Med, Dept Biostat, Lexington, KY 40536 USA; [Wang, C.] Univ Kentucky, Sch Med, Markey Canc Ctr, Lexington, KY 40536 USA; [Plattner, R.] Univ Kentucky, Sch Med, Dept Toxicol & Canc Biol, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Plattner, R (corresponding author), Univ Kentucky, Sch Med, Pharmacol & Nutr Sci, 800 Rose St,Combs Res Bldg,Rm 209, Lexington, KY 40536 USA.	rplat2@uky.edu	Tripathi, Rakshamani/J-8450-2019	Tripathi, Rakshamani/0000-0001-9394-1173; Turpin, Courtney/0000-0001-6299-8062	Markey Cancer Center Flow Cytometry, Biospecimen and Tissue Procurement, and Biostatistics Shared Resources; Research Communication Office [P30CA177558]; NIH Grant [R01CA166499]; NATIONAL CANCER INSTITUTE [P30CA177558, R01CA166499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007778] Funding Source: NIH RePORTER	Markey Cancer Center Flow Cytometry, Biospecimen and Tissue Procurement, and Biostatistics Shared Resources; Research Communication Office; NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Markey Cancer Center Flow Cytometry, Biospecimen and Tissue Procurement, and Biostatistics Shared Resources and the Research Communication Office (P30CA177558). We thank Drs D'Orazio and Kyprianou for critically reading the manuscript. This work was supported by NIH Grant R01CA166499 to RP.	Aguissa-Toure AH, 2012, CELL MOL LIFE SCI, V69, P1475, DOI 10.1007/s00018-011-0878-0; ALEXANDROPOULOS K, 1995, P NATL ACAD SCI USA, V92, P3110, DOI 10.1073/pnas.92.8.3110; Tran A, 2012, EXPERT OPIN INV DRUG, V21, P861, DOI 10.1517/13543784.2012.679341; Anderson WF, 2009, CANCER, V115, P4176, DOI 10.1002/cncr.24481; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Bondzi C, 2000, ONCOGENE, V19, P5030, DOI 10.1038/sj.onc.1203862; Caramel J, 2013, CANCER CELL, V24, P466, DOI 10.1016/j.ccr.2013.08.018; Cheung M, 2008, CANCER RES, V68, P3429, DOI 10.1158/0008-5472.CAN-07-5867; Choi Y, 2009, J BIOL CHEM, V284, P29005, DOI 10.1074/jbc.M109.026633; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Denecker G, 2014, CELL DEATH DIFFER, V21, P1250, DOI 10.1038/cdd.2014.44; Fiore LS, 2014, ONCOGENE, V33, P4508, DOI 10.1038/onc.2013.399; Ganguly SS, 2012, ONCOGENE, V31, P1804, DOI 10.1038/onc.2011.361; Ganguly Sourik S, 2012, Genes Cancer, V3, P414, DOI 10.1177/1947601912458586; Girotti MR, 2015, CANCER CELL, V27, P85, DOI 10.1016/j.ccell.2014.11.006; Girotti MR, 2014, MOL ONCOL, V8, P1140, DOI 10.1016/j.molonc.2014.07.027; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Karimkhani C, 2014, AM J CLIN DERMATOL, V15, P323, DOI 10.1007/s40257-014-0083-7; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Li BJ, 2002, J BIOL CHEM, V277, P28870, DOI 10.1074/jbc.M202388200; Li R, 2011, CURR BIOL, V21, P1534, DOI 10.1016/j.cub.2011.08.023; Li X, 2008, CELL SIGNAL, V20, P2145, DOI 10.1016/j.cellsig.2008.08.006; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Menzies AM, 2012, CLIN CANCER RES, V18, P3242, DOI 10.1158/1078-0432.CCR-12-0052; Murray JC, 2014, CANCER IMMUNOL RES, V2, P1186, DOI 10.1158/2326-6066.CIR-14-0083; Nathanson KL, 2013, CLIN CANCER RES, V19, P4868, DOI 10.1158/1078-0432.CCR-13-0827; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Peng WY, 2016, CANCER DISCOV, V6, P202, DOI 10.1158/2159-8290.CD-15-0283; Plattner R, 2004, MOL CELL BIOL, V24, P2573, DOI 10.1128/mcb.24.6.2573-2583.2004; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Poynter JN, 2006, MELANOMA RES, V16, P267, DOI 10.1097/01.cmr.0000222600.73179.f3; Qiang L, 2014, AUTOPHAGY, V10, P1864, DOI 10.4161/auto.32171; Queirolo P, 2015, CANCER TREAT REV, V41, P519, DOI 10.1016/j.ctrv.2015.04.010; Redondo P, 2004, J INVEST DERMATOL, V123, P1208, DOI 10.1111/j.0022-202X.2004.23496.x; Richard G, 2016, EMBO MOL MED, V8, P1143, DOI 10.15252/emmm.201505971; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Sims JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055509; Sini P, 2004, NAT CELL BIOL, V6, P268, DOI 10.1038/ncb1096; Smith-Pearson PS, 2010, J BIOL CHEM, V285, P40201, DOI 10.1074/jbc.M110.147330; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Srinivasan D, 2009, CELL SIGNAL, V21, P1143, DOI 10.1016/j.cellsig.2009.03.003; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Vandamme N, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00352; Vultur A, 2014, ONCOGENE, V33, P1850, DOI 10.1038/onc.2013.131; Wang J, 2015, TRENDS CANCER, V1, P110, DOI 10.1016/j.trecan.2015.07.004; Weiss MB, 2014, MOL CANCER RES, V12, P1314, DOI 10.1158/1541-7786.MCR-14-0170; Wheler J, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1029-z; Wilden SM, 2016, J DTSCH DERMATOL GES, V14, P685, DOI [10.1111/ddg.13012_g, 10.1111/ddg.13012]; Xing F, 2012, ONCOGENE, V31, P446, DOI 10.1038/onc.2011.250; Zhang CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066108; Zhao FS, 2015, BIOSCI TRENDS, V9, P325, DOI 10.5582/bst.2015.01106	54	12	12	3	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 10	2017	36	32					4585	4596		10.1038/onc.2017.76	http://dx.doi.org/10.1038/onc.2017.76			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FD0RK	28368422	Green Accepted			2022-12-26	WOS:000407246200006
J	Peters, D; Radine, C; Reese, A; Budach, W; Sohn, D; Janicke, RU				Peters, Dominik; Radine, Claudia; Reese, Alina; Budach, Wilfried; Sohn, Dennis; Jaenicke, Reiner U.			The DEAD-box RNA helicase DDX41 is a novel repressor of p21(WAF1/CIP1) mRNA translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRRADIATION-INDUCED APOPTOSIS; BINDING PROTEIN; P21 EXPRESSION; TRANSCRIPTIONAL COACTIVATOR; MULTIPLE FUNCTIONS; EMERGING ROLES; CELL-CYCLE; P53; INHIBITOR; TARGET	The cyclin-dependent kinase inhibitor p21 is an important player in stress pathways exhibiting both tumor-suppressive and oncogenic functions. Thus, expression of p21 has to be tightly controlled, which is achieved by numerous mechanisms at the transcriptional, translational, and posttranslational level. Performing immunoprecipitation of bromouridine-labeled p21 mRNAs that had been incubated before with cytoplasmic extracts of untreated HCT116 colon carcinoma cells, we identified the DEAD-box RNA helicase DDX41 as a novel regulator of p21 expression. DDX41 specifically precipitates with the 3'UTR, but not with the 5'UTR, of p21 mRNA. Knockdown of DDX41 increases basal and gamma irradiation-induced p21 protein levels without affecting p21 mRNA expression. Conversely, overexpression of DDX41 strongly inhibits expression of a FLAG-p21 and a luciferase construct, but only in the presence of the p21 3'UTR. Together, these data suggest that this helicase regulates p21 expression at the translational level independent of the transcriptional activity of p53. However, knockdown of DDX41 completely fails to increase p21 protein levels in p53-deficient HCT116 cells. Moreover, posttranslational up-regulation of p21 achieved in both p53(+/+) and p53(-/-) HCT116 cells in response to pharmaceutical inhibition of the proteasome (by MG-132) or p90 ribosomal S6 kinases (by BI-D1870) is further increased by knockdown of DDX41 only in p53-proficient but not in p53-deficient cells. Although our data demonstrate that DDX41 suppresses p21 translation without disturbing the function of p53 to directly induce p21 mRNA expression, this process indirectly requires p53, perhaps in the form of another p53 target gene or as a still undefined posttranscriptional function of p53.	[Peters, Dominik; Radine, Claudia; Reese, Alina; Budach, Wilfried; Sohn, Dennis; Jaenicke, Reiner U.] Heinrich Heine Univ, Med Fac, Clin Radiat Therapy & Radiooncol, Lab Mol Radiooncol, Univ Str 1, D-40255 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Janicke, RU (corresponding author), Heinrich Heine Univ, Med Fac, Clin Radiat Therapy & Radiooncol, Lab Mol Radiooncol, Univ Str 1, D-40255 Dusseldorf, Germany.	janicke@uni-duesseldorf.de			Deutsche Forschungsgemeinschaft Grants [JA 1060/3-1, JA 1060/5-1, SO 881/5-1]	Deutsche Forschungsgemeinschaft Grants(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants JA 1060/3-1 and JA 1060/5-1 (to R.U.J.) and SO 881/5-1 (to D.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Abdelhaleem M, 2004, ANTICANCER RES, V24, P3951; Abdul-Ghani M, 2005, J CELL PHYSIOL, V204, P210, DOI 10.1002/jcp.20285; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Borgdorff V, 2010, ONCOGENE, V29, P2262, DOI 10.1038/onc.2009.497; Botlagunta M, 2008, ONCOGENE, V27, P3912, DOI 10.1038/onc.2008.33; Bourgeois CF, 2016, NAT REV MOL CELL BIO, V17, P426, DOI 10.1038/nrm.2016.50; Chao CH, 2006, CANCER RES, V66, P6579, DOI 10.1158/0008-5472.CAN-05-2415; Child ES, 2006, CELL CYCLE, V5, P1313, DOI 10.4161/cc.5.12.2863; Dardenne E, 2014, CELL REP, V7, P1900, DOI 10.1016/j.celrep.2014.05.010; Dotto GP, 2000, BBA-REV CANCER, V1471, pM43, DOI 10.1016/S0304-419X(00)00019-6; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fontoura BMA, 1997, MOL CELL BIOL, V17, P3146, DOI 10.1128/MCB.17.6.3146; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Germann S, 2012, ONCOGENE, V31, P4536, DOI 10.1038/onc.2011.618; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hermeking H, 2012, NAT REV CANCER, V12, P613, DOI 10.1038/nrc3318; Irion U, 2004, CURR BIOL, V14, P138, DOI 10.1016/j.cub.2004.01.002; Irion U, 1999, CURR BIOL, V9, P1373, DOI 10.1016/S0960-9822(00)80082-2; Janicke RU, 2007, CELL CYCLE, V6, P407; Jiang Y, 2017, PROTEIN CELL, V8, P83, DOI 10.1007/s13238-016-0303-4; Jiang YQ, 2014, J BIOL CHEM, V289, P3164, DOI 10.1074/jbc.M113.524413; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kechavarzi B, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r14; Kim MY, 2009, BMB REP, V42, P125, DOI 10.5483/BMBRep.2009.42.3.125; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Lewinsohn M, 2016, BLOOD, V127, P1017, DOI 10.1182/blood-2015-10-676098; Li J, 2007, CANCER RES, V67, P11317, DOI 10.1158/0008-5472.CAN-07-1088; Linder P, 2013, BBA-GENE REGUL MECH, V1829, P750, DOI 10.1016/j.bbagrm.2013.03.007; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Marcel V, 2015, ONCOGENE, V34, P5513, DOI 10.1038/onc.2015.25; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Neise D, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.386; Nicol SM, 2013, ONCOGENE, V32, P3461, DOI 10.1038/onc.2012.426; PAUSE A, 1993, MOL CELL BIOL, V13, P6789, DOI 10.1128/MCB.13.11.6789; Polprasert C, 2015, CANCER CELL, V27, P658, DOI 10.1016/j.ccell.2015.03.017; Riley KJL, 2007, RNA, V13, P1825, DOI 10.1261/rna.673407; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Schmucker D, 2000, MECH DEVELOP, V91, P189, DOI 10.1016/S0925-4773(99)00298-1; Scott DD, 2016, BIOCHEM CELL BIOL, V94, P419, DOI 10.1139/bcb-2016-0068; Scoumanne A, 2011, NUCLEIC ACIDS RES, V39, P213, DOI 10.1093/nar/gkq778; Shu LM, 2006, GENE DEV, V20, P2961, DOI 10.1101/gad.1463306; Sohn D, 2011, CELL DEATH DIFFER, V18, P1664, DOI 10.1038/cdd.2011.34; Sohn D, 2006, CANCER RES, V66, P11254, DOI 10.1158/0008-5472.CAN-06-1569; Sohn D, 2016, ONCOTARGET, V7, P15915, DOI 10.18632/oncotarget.7432; Tsuchiya N, 2011, CANCER RES, V71, P4628, DOI 10.1158/0008-5472.CAN-10-2475; Wang WG, 2000, MOL CELL BIOL, V20, P760, DOI 10.1128/MCB.20.3.760-769.2000; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e; Weiss RH, 2003, CANCER CELL, V4, P425, DOI 10.1016/S1535-6108(03)00308-8; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yang LQ, 2007, J BIOL CHEM, V282, P16811, DOI 10.1074/jbc.M610488200; Yano M, 2005, J BIOL CHEM, V280, P12690, DOI 10.1074/jbc.M411119200; Zaccara S, 2014, CELL DEATH DIFFER, V21, P1522, DOI 10.1038/cdd.2014.79; Zhang Jin, 2008, Curr Mol Med, V8, P845, DOI 10.2174/156652408786733748; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	58	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8331	8341		10.1074/jbc.M116.772327	http://dx.doi.org/10.1074/jbc.M116.772327			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28348086	Green Published, hybrid			2022-12-26	WOS:000401788600018
J	Boyle, MD; Soneja, S; Quiros-Alcala, L; Dalemarre, L; Sapkota, AR; Sangaramoorthy, T; Wilson, S; Milton, D; Sapkota, A				Boyle, Meleah D.; Soneja, Sutyajeet; Quiros-Alcala, Lesliam; Dalemarre, Laura; Sapkota, Amy R.; Sangaramoorthy, Thurka; Wilson, Sacoby; Milton, Donald; Sapkota, Amir			A pilot study to assess residential noise exposure near natural gas compressor stations	PLOS ONE			English	Article							ROAD TRAFFIC NOISE; TERM EXPOSURE; PUBLIC-HEALTH; EMISSIONS; SHALE	Background U.S. natural gas production increased 40% from 2000 to 2015. This growth is largely related to technological advances in horizontal drilling and high-volume hydraulic fracturing. Environmental exposures upon impacted communities are a significant public health concern. Noise associated with natural gas compressor stations has been identified as a major concern for nearby residents, though limited studies exist. Objectives We conducted a pilot study to characterize noise levels in 11 homes located in Doddridge County, West Virginia, and determined whether these levels differed based on time of day, indoors vs. outdoors, and proximity of homes to natural gas compressor stations. We also compared noise levels at increasing distances from compressor stations to available noise guidelines, and evaluated low frequency noise presence. Methods We collected indoor and outdoor 24-hour measurements (L-eq,L-24hr) in eight homes located within 750 meters (m) of the nearest compressor station and three control homes located > 1000m. We then evaluated how A-weighted decibel (dBA) exposure levels differed based on factors outlined above. Results The geometric mean (GM) for 24-hour outdoor noise levels at homes located < 300m (L-eq,L-24hr :60.3 dBA; geometric standard deviation (GSD): 1.0) from the nearest compressor station was nearly 9 dBA higher than control homes (L-eq,L-24hr: 51.6 dBA; GSD: 1.1). GM for 24 hour indoor noise for homes < 300m (L-eq,L-24hr: 53.4 dBA; GSD: 1.2) from the nearest compressor station was 11.2 dBA higher than control homes (L-eq,L-24hr: 42.2 dBA; GSD: 1.1). Indoor average daytime noise for homes <300m of the nearest compressor stations were 13.1 dBA higher than control homes, while indoor nighttime readings were 9.4 dBA higher. Conclusions Findings indicate that living near a natural gas compressor station could potentially result in high environmental noise exposures. Larger studies are needed to confirm these findings and evaluate potential health impacts and protection measures.	[Boyle, Meleah D.; Soneja, Sutyajeet; Quiros-Alcala, Lesliam; Dalemarre, Laura; Sapkota, Amy R.; Wilson, Sacoby; Milton, Donald; Sapkota, Amir] Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, College Pk, MD 20742 USA; [Sangaramoorthy, Thurka] Univ Maryland, Coll Behav & Social Sci, Dept Anthropol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Sapkota, A (corresponding author), Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, College Pk, MD 20742 USA.	amirsap@umd.edu	Sapkota, Amir/A-5968-2011; Sapkota, Amy R/A-6046-2011; Sangaramoorthy, Thurka/AAZ-2730-2021	Soneja, Sutyajeet/0000-0003-4914-2432; Sangaramoorthy, Thurka/0000-0002-8467-5907	Maryland Department of Health and Mental Hygiene [M00B4400326]	Maryland Department of Health and Mental Hygiene	This work was funded by the Maryland Department of Health and Mental Hygiene, Grant ID: M00B4400326. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funded by the Maryland Department of Health and Mental Hygiene, Grant ID: M00B4400326.	Adgate JL, 2014, ENV SCI TECHNOL; Allen RW, 2009, ENVIRON RES, V109, P334, DOI 10.1016/j.envres.2008.12.006; Allshouse W, 2016, ANN M INT SOC EXP SC, P678; [Anonymous], 2012, WHAT IS SHAL GAS WHY; Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X; Berglund B., 1999, GUIDELINES COMMUNITY; Cusick M., 2014, STATE REGULATORS TAK; Finkel ML, 2011, AM J PUBLIC HEALTH, V101, P784, DOI 10.2105/AJPH.2010.300089; Floud S, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-89; Haley M, 2016, ENV HLTH PERSPECT; Hays J, 2016, SCI TOTAL ENV, V9; Huang J, 2013, J EXPO SCI ENV EPID, V23, P559, DOI 10.1038/jes.2013.21; Kheirbek I, 2014, J URBAN HEAL B NEW Y; Leventhall H G, 2004, Noise Health, V6, P59; Maryland Department of the Environment Maryland Department of Natural Resources, 2013, MARC SHAL SAF DRIL 2; Maryland Institute for Applied Environmental Health, 2014, POT PUBL HLTH IMP NA; McCawley M., 2013, AIR NOISE LIGHT MONI; Miedema HME, 2001, ENVIRON HEALTH PERSP, V109, P409, DOI 10.2307/3454901; Munzel T, 2014, EUR HEART J, V35, P829, DOI 10.1093/eurheartj/ehu030; Murphy E, 2014, ENVIRON INT, V63, P207, DOI 10.1016/j.envint.2013.11.001; Nolt-Helms C., 2018, EPA600X18163; Passchier-Vermeer W, 2000, ENVIRON HEALTH PERSP, V108, P123, DOI 10.1289/ehp.00108s1123; Pawlaczyk-Luszczynska Malgorzata, 2005, International Journal of Occupational Medicine and Environmental Health, V18, P185; Rich A, 2014, J AIR WASTE MANAGE, V64, P61, DOI 10.1080/10962247.2013.832713; Roy AA, 2014, J AIR WASTE MANAGE, V64, P19, DOI 10.1080/10962247.2013.826151; Shonkoff S. B., 2014, ENV HLTH PERSPECT; Sorensen M, 2013, ENVIRON HEALTH PERSP, V121, P217, DOI 10.1289/ehp.1205503; Starck J, 2003, Noise Health, V5, P63; U.S. Energy Information Administration, 2016, TOT EN; U.S. Environmental Protection Agency, 2016, EPA ID NOT LEV AFF H; van Kamp I, 2013, NOISE HEALTH, V15, P153, DOI 10.4103/1463-1741.112361; WHO (WorldHealthOrganization), 2009, NIGHT NOIS GUID EUR; Witter R., 2010, HLTH IMPACT ASSESSME	33	10	12	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174310	10.1371/journal.pone.0174310	http://dx.doi.org/10.1371/journal.pone.0174310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369113	gold, Green Published, Green Submitted			2022-12-26	WOS:000399351000015
J	Saito, Y; Takahashi, O; Arioka, H; Kobayashi, D				Saito, Yuki; Takahashi, Osamu; Arioka, Hiroko; Kobayashi, Daiki			Associations between body fat variability and later onset of cardiovascular disease risk factors	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; BLOOD-PRESSURE VARIABILITY; TO-VISIT VARIABILITY; MIDDLE-AGED MEN; WEIGHT VARIABILITY; MYOCARDIAL-INFARCTION; GLYCEMIC VARIABILITY; MASS INDEX	Objective There is current debate regarding whether body weight variability is associated with cardiovascular events. Recently, high body fat percentage (BF%) has been shown to be a cardiovascular risk factor. We therefore hypothesized that BF% variability would present a stronger cardiovascular risk than body weight variability. Methods A single-center retrospective cohort study of medical check-up examinees aged 20 years or older at baseline (2005) was performed. Examinees were followed in 2007, 2009, and 2013-2014. BF% variability in 2005, 2007 and 2009 was calculated as the root-mean square error (RMSE) using a simple linear regression model. Multiple logistic regression models estimated the association between BF%-RMSE and new diagnoses of cardiovascular risk factors occurring between the 2009 and 2013-2014 visits. Results In total, 11,281 participants (mean age: 51.3 years old, 48.8% were male) were included in this study. The average BF%-RMSE of our subjects was 0.63, and the average BMI-RMSE was 0.24. The high BF%-RMSE group (76-100th percentile) had a higher incidence of hypertension and a lower incidence of diabetes mellitus than the low BF%-RMSE group (1-25th percentile). This tendency was particularly evident in male participants. BMI-RMSE was not associated with any cardiovascular risks in our study. Conclusions This study indicates that body fat variability has contrasting effects on cardiovascular risk factors, while body weight variability has no significant effects.	[Saito, Yuki; Takahashi, Osamu; Arioka, Hiroko; Kobayashi, Daiki] St Lukes Int Hosp, Dept Med, Div Gen Internal Med, Tokyo, Japan; [Takahashi, Osamu; Kobayashi, Daiki] St Lukes Life Sci Inst, Ctr Clin Epidemiol, Tokyo, Japan	St. Luke's International Hospital	Saito, Y (corresponding author), St Lukes Int Hosp, Dept Med, Div Gen Internal Med, Tokyo, Japan.	yuki.saito@keio.jp		Saito, Yuki/0000-0003-2686-9604				Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; BLAIR SN, 1993, ANN INTERN MED, V119, P749, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00024; Boey E, 2016, ATHEROSCLEROSIS, V244, P86, DOI 10.1016/j.atherosclerosis.2015.10.110; Bohm A, 2013, EUR J CLIN NUTR, V67, pS79, DOI 10.1038/ejcn.2012.168; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; De Schutter A, 2011, OCHSNER J, V11, P220; DELEON CFM, 1992, INT J EPIDEMIOL, V21, P460, DOI 10.1093/ije/21.3.460; Deurenberg-Yap M, 2002, Obes Rev, V3, P209, DOI 10.1046/j.1467-789X.2002.00069.x; Di Flaviani A, 2011, DIABETES CARE, V34, P1605, DOI 10.2337/dc11-0034; Field AE, 2004, OBES RES, V12, P267, DOI 10.1038/oby.2004.34; Floras JS, 2013, CAN J CARDIOL, V29, P557, DOI 10.1016/j.cjca.2013.02.012; Floud S, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-42; Hasler G, 2005, OBES RES, V13, P1991, DOI 10.1038/oby.2005.244; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1059, DOI 10.1136/bmj.330.7499.1059; Hirakawa Y, 2014, DIABETES CARE, V37, P2359, DOI 10.2337/dc14-0199; IRIBARREN C, 1995, NEW ENGL J MED, V333, P686, DOI 10.1056/NEJM199509143331102; Jean N, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0464-7; JEFFERY RW, 1992, AM J CLIN NUTR, V55, P641, DOI 10.1093/ajcn/55.3.641; Jo J, 2012, ADIPOCYTE, V1, P80, DOI 10.4161/adip.19705; Jo J, 2010, BIOPHYS J, V99, P3535, DOI 10.1016/j.bpj.2010.10.009; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Lee JS, 2001, INT J OBESITY, V25, P1063, DOI 10.1038/sj.ijo.0801633; Lee JS, 2010, J GERONTOL A-BIOL, V65, P78, DOI 10.1093/gerona/glp042; Levin Kate Ann, 2006, Evid Based Dent, V7, P51, DOI 10.1038/sj.ebd.6400407; LISSNER L, 1991, NEW ENGL J MED, V324, P1839, DOI 10.1056/NEJM199106273242602; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Matsushita Y, 2014, OBESITY, V22, P287, DOI 10.1002/oby.20425; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Monnier L, 2008, DIABETES CARE, V31, pS150, DOI 10.2337/dc08-s241; Muntner P, 2015, ANN INTERN MED, V163, P329, DOI 10.7326/M14-2803; Nakanishi N, 2000, INT J OBESITY, V24, P1226, DOI 10.1038/sj.ijo.0801389; Nalysnyk L, 2010, DIABETES OBES METAB, V12, P288, DOI 10.1111/j.1463-1326.2009.01160.x; Ohwaki K, 2011, EUR J CANCER, V47, P262, DOI 10.1016/j.ejca.2010.09.023; Oliveros E, 2014, PROG CARDIOVASC DIS, V56, P426, DOI 10.1016/j.pcad.2013.10.003; Omori H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100733; Padwal R, 2016, ANN INTERN MED, V164, P532, DOI 10.7326/M15-1181; Reddigan JI, 2011, AM J CARDIOL, V108, P1426, DOI 10.1016/j.amjcard.2011.07.005; Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI 10.1093/eurheartj/ehp487; Roubenoff R, 1996, AM J CLIN NUTR, V64, P459; Saarni SE, 2004, INT J OBESITY, V28, P796, DOI 10.1038/sj.ijo.0802627; Sesso HD, 2001, CIRCULATION, V104, P393, DOI 10.1161/hc2901.093115; Setoguchi S, 2008, J AM COLL CARDIOL, V51, P1247, DOI 10.1016/j.jacc.2007.10.063; Shiroma EJ, 2010, CIRCULATION, V122, P743, DOI 10.1161/CIRCULATIONAHA.109.914721; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Sun G, 2005, AM J CLIN NUTR, V81, P74; Takezawa J, 2009, OBES RES CLIN PRACT, V3, P179, DOI 10.1016/j.orcp.2009.04.003; Tamakoshi K, 2003, INT J OBESITY, V27, P1059, DOI 10.1038/sj.ijo.0802386; Wallner SJ, 2004, INT J OBESITY, V28, P1143, DOI 10.1038/sj.ijo.0802736; Yamashita K, 2012, CIRC J, V76, P2435, DOI 10.1253/circj.CJ-12-0337; Yoshiike N, 1998, INT J OBESITY, V22, P684, DOI 10.1038/sj.ijo.0800651; Yoshiike N, 2002, ASIA PAC J CLIN NUTR, V11, pS727, DOI 10.1046/j.1440-6047.11.s8.18.x; Yumi M, 2012, OBESITY, V20, P1744, DOI 10.1038/oby.2011.285	55	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0175057	10.1371/journal.pone.0175057	http://dx.doi.org/10.1371/journal.pone.0175057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369119	Green Submitted, gold, Green Published			2022-12-26	WOS:000399351000074
J	Humiecka, M; Szpila, M; Klos, P; Maleszewski, M; Szczepanska, K				Humiecka, Monika; Szpila, Marcin; Klos, Piotr; Maleszewski, Marek; Szczepanska, Katarzyna			Mouse blastomeres acquire ability to divide asymmetrically before compaction	PLOS ONE			English	Article							INNER CELL MASS; PREIMPLANTATION EMBRYO; 8-CELL BLASTOMERES; OUTER BLASTOMERES; CLEAVAGE DIVISION; MAMMALIAN EMBRYO; POLARITY; STAGE; BLASTOCYST; TROPHECTODERM	The mouse preimplantation embryo generates the precursors of trophectoderm (TE) and inner cell mass (ICM) during the 8- to 16-cell stage transition, when the apico-basal polarized blastomeres undergo divisions that give rise to cells with different fate. Asymmetric segregation of polar domain at 8-16 cell division generate two cell types, polar cells which adopt an outer position and develop in TE and apolar cells which are allocated to inner position as the precursors of ICM. It is still not know when the blastomeres of 8-cell stage start to be determined to undergo asymmetric division. Here, we analyzethe frequency of symmetric and asymmetric divisions of blastomeres isolated from 8-cell stage embryo before and after compaction. Using p-Ezrin as the polarity marker we found that size of blastomeres in 2/16 pairs cannot be used as a criterion for distinguishing symmetric and asymmetric divisions. Our results showed that at early 8- cell stage, before any visible signs of cortical polarity, a subset of blastomeres had been already predestined to divide asymmetrically. We also showed that almost all of 8- cell stage blastomeres isolated from compacted embryo divide asymmetrically, whereas in intact embryos, the frequency of asymmetric divisions is significantly lower. Therefore we conclude that in intact embryo the frequency of symmetric and asymmetric division is regulated by cell-cell interactions.	[Humiecka, Monika; Szpila, Marcin; Klos, Piotr; Maleszewski, Marek; Szczepanska, Katarzyna] Univ Warsaw, Inst Zool, Dept Embryol, Fac Biol, Warsaw, Poland	University of Warsaw	Szczepanska, K (corresponding author), Univ Warsaw, Inst Zool, Dept Embryol, Fac Biol, Warsaw, Poland.	kasiasz@biol.uw.edu.pl	Szczepańska, Katarzyna/V-6379-2018	Szczepańska, Katarzyna/0000-0002-8805-725X; Szpila, Marcin/0000-0001-8484-9762; HUMIECKA, Monika/0000-0003-4382-108X; Maleszewski, Marek/0000-0002-6699-0452				Ajduk A, 2014, DEV BIOL, V392, P133, DOI 10.1016/j.ydbio.2014.05.009; Anani S, 2014, DEVELOPMENT, V141, P2813, DOI 10.1242/dev.107276; BECK F, 1995, DEV DYNAM, V204, P219, DOI 10.1002/aja.1002040302; Chazaud C, 2016, DEVELOPMENT, V143, P1063, DOI 10.1242/dev.128314; Dard N, 2004, DEV BIOL, V271, P87, DOI 10.1016/j.ydbio.2004.03.024; Dard N, 2001, DEV BIOL, V233, P161, DOI 10.1006/dbio.2001.0192; Dard N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008171; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; ERBACH GT, 1994, BIOL REPROD, V50, P1027, DOI 10.1095/biolreprod50.5.1027; FLEMING TP, 1987, DEV BIOL, V119, P520, DOI 10.1016/0012-1606(87)90055-8; FLEMING TP, 1986, J EMBRYOL EXP MORPH, V95, P169; FULTON BP, 1978, NATURE, V273, P149, DOI 10.1038/273149a0; Goolam M, 2016, CELL, V165, P61, DOI 10.1016/j.cell.2016.01.047; HANDYSIDE AH, 1981, J REPROD IMMUNOL, V2, P339, DOI 10.1016/0165-0378(81)90004-8; Hirate Y, 2015, DEV GROWTH DIFFER, V57, P544, DOI 10.1111/dgd.12235; HOULISTON E, 1987, J CELL BIOL, V104, P1299, DOI 10.1083/jcb.104.5.1299; Humiecka M, 2016, MECH DEV; Hunt PA, 2003, CURR BIOL, V13, P546, DOI 10.1016/S0960-9822(03)00189-1; Jedrusik A, 2008, GENE DEV, V22, P2692, DOI 10.1101/gad.486108; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; JOHNSON MH, 1983, DEV BIOL, V95, P211, DOI 10.1016/0012-1606(83)90019-2; JOHNSON MH, 1981, J CELL BIOL, V91, P303, DOI 10.1083/jcb.91.1.303; Kondratiuk I, 2012, DEV BIOL, V368, P54, DOI 10.1016/j.ydbio.2012.05.013; LEVY JB, 1986, J EMBRYOL EXP MORPH, V95, P213; Louvet S, 1996, DEV BIOL, V177, P568, DOI 10.1006/dbio.1996.0186; Louvet-Vallee S, 2001, DEV BIOL, V231, P190, DOI 10.1006/dbio.2000.0147; Maitre JL, 2015, NAT CELL BIOL, V17, P849, DOI 10.1038/ncb3185; Maitre JL, 2016, NATURE; MARO B, 1984, J EMBRYOL EXP MORPH, V81, P211; McConnell J, 2005, MOL REPROD DEV, V71, P399, DOI 10.1002/mrd.20318; McDole K, 2011, DEV BIOL, V355, P239, DOI 10.1016/j.ydbio.2011.04.024; NICOLSON GL, 1975, J CELL BIOL, V66, P263, DOI 10.1083/jcb.66.2.263; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Pauken CM, 2000, DEV BIOL, V223, P411, DOI 10.1006/dbio.2000.9763; PICKERING SJ, 1988, HUM REPROD, V3, P978, DOI 10.1093/oxfordjournals.humrep.a136828; Piotrowska K, 2001, DEVELOPMENT, V128, P3739; Piotrowska K, 2001, NATURE, V409, P517, DOI 10.1038/35054069; Piotrowska-Nitsche K, 2005, DEVELOPMENT, V132, P479, DOI 10.1242/dev.01602; Plachta N, 2011, NAT CELL BIOL, V13, P117, DOI 10.1038/ncb2154; Plusa B, 2005, NATURE, V434, P391, DOI 10.1038/nature03388; Plusa B, 2005, J CELL SCI, V118, P505, DOI 10.1242/jcs.01666; Ralston A, 2008, DEV BIOL, V313, P614, DOI 10.1016/j.ydbio.2007.10.054; REEVE WJD, 1981, J EMBRYOL EXP MORPH, V62, P339; REEVE WJD, 1983, J EMBRYOL EXP MORPH, V75, P117; Samarage CR, 2015, DEV CELL, V34, P435, DOI 10.1016/j.devcel.2015.07.004; SPINDLE A, 1982, J EXP ZOOL, V219, P361, DOI 10.1002/jez.1402190311; SURANI MAH, 1984, DEV BIOL, V102, P335, DOI 10.1016/0012-1606(84)90198-2; Suwinska A, 2008, DEV BIOL, V322, P133, DOI 10.1016/j.ydbio.2008.07.019; Vinot S, 2005, DEV BIOL, V282, P307, DOI 10.1016/j.ydbio.2005.03.001; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Yamanaka Y, 2010, DEVELOPMENT, V137, P715, DOI 10.1242/dev.043471	52	9	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0175032	10.1371/journal.pone.0175032	http://dx.doi.org/10.1371/journal.pone.0175032			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362853	Green Submitted, Green Published, gold			2022-12-26	WOS:000399175000063
J	Komiyama, Y; Kurosaki, M; Nakanishi, H; Takahashi, Y; Itakura, J; Yasui, Y; Tamaki, N; Takada, H; Higuchi, M; Gotou, T; Kubota, Y; Takaura, K; Hayashi, T; Oh, W; Okada, M; Enomoto, N; Izumi, N				Komiyama, Yasuyuki; Kurosaki, Masayuki; Nakanishi, Hiroyuki; Takahashi, Yuka; Itakura, Jun; Yasui, Yutaka; Tamaki, Nobuharu; Takada, Hitomi; Higuchi, Mayu; Gotou, Tomoyuki; Kubota, Youhei; Takaura, Kenta; Hayashi, Tsuguru; Oh, Wann; Okada, Mao; Enomoto, Nobuyuki; Izumi, Namiki			Prediction of diuretic response to tolvaptan by a simple, readily available spot urine Na/K ratio	PLOS ONE			English	Article							REFRACTORY ASCITES; CIRRHOTIC ASCITES; HEART-FAILURE; ANTAGONIST; FUROSEMIDE; EFFICACY; SODIUM	Background Tolvaptan is vasopressin type 2 receptor antagonist that inhibits water reabsorption. It is used in combination with standard diuretics to treat ascites unresponsive to standard diuretic therapy or hyponatremia because of liver cirrhosis. This study evaluated the effectiveness and safety of tolvaptan in clinical practice and aimed to determine the factors related to its effectiveness. Methods Tolvaptan was administered to 88 consecutive cirrhotic patients with ascites unresponsive to standard diuretic therapy. An effective treatment response was a >= 2% reduction in body weight on day 7. The association of patient pretreatment characteristics with therapeutic effects was analyzed. Results Mean weight reduction on day 7 of tolvaptan therapy was -2.9% +/- 3.2%, and treatment was effective in 52% of patients. Multivariate analysis revealed that spot urine Na/K ratio >= 2.5 at baseline was the only factor independently related to therapeutic effect, with an odds ratio of 7.85 (95% confidence interval 2.64-23.40, p = 0.0002). Weight reduction percentage on day 7 was -4.0% +/- 2.8% in patients with spot urine Na/K >= 2.5, which was significantly greater than the 0.7% +/- 2.7% loss in those with urine Na/K < 2.5 (p < 0.05). A spot urine Na/K ratio >= 2.5 had a sensitivity of 85% and specificity of 60% for predicting effective treatment. No adverse events of treatment led to treatment discontinuation. Conclusions Baseline spot urine Na/K was predictive of an effective response to tolvaptan therapy. It is simple to perform and readily available and might serve as an indicator of optimal timing of tolvaptan administration in patients with inadequate response to conventional Na diuretic therapy.	[Komiyama, Yasuyuki; Kurosaki, Masayuki; Nakanishi, Hiroyuki; Takahashi, Yuka; Itakura, Jun; Yasui, Yutaka; Tamaki, Nobuharu; Higuchi, Mayu; Gotou, Tomoyuki; Kubota, Youhei; Takaura, Kenta; Hayashi, Tsuguru; Oh, Wann; Okada, Mao; Izumi, Namiki] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Komiyama, Yasuyuki; Takada, Hitomi; Enomoto, Nobuyuki] Univ Yamanashi, Dept Internal Med 1, Fac Med, Yamanashi, Japan	University of Yamanashi	Izumi, N (corresponding author), Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan.	izumi012@musashino.jrc.or.jp	Nakanishi, Hiroyuki/AAD-9324-2020	Nakanishi, Hiroyuki/0000-0003-3982-3314; Yasui, Yutaka/0000-0002-6117-4990; Tamaki, Nobuharu/0000-0003-4634-6616				Akiyama S, 2015, HEPATOL RES, V45, P1062, DOI 10.1111/hepr.12455; Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1053/jhep.1996.v23.ajhep0230164; BERNARDI M, 1985, Z KARDIOL, V74, P129; BOYER TD, 1983, GASTROENTEROLOGY, V84, P1051; El-Bokl MA, 2009, WORLD J GASTROENTERO, V15, P3631, DOI 10.3748/wjg.15.3631; Gheorghiade M, 2007, JAMA-J AM MED ASSOC, V297, P1332, DOI 10.1001/jama.297.12.1332; GINES P, 1987, GASTROENTEROLOGY, V93, P234, DOI 10.1016/0016-5085(87)91007-9; Gines P, 2004, NEW ENGL J MED, V350, P1646, DOI 10.1056/NEJMra035021; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Karatapanis S, 2003, GUT S6, V52; Kogiso T, 2016, HEPATOL RES, V46, pE194, DOI 10.1111/hepr.12547; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Nakanishi H, 2016, J GASTROENTEROL, V51, P620, DOI 10.1007/s00535-015-1143-3; Ohki T, 2015, WORLD J HEPATOL, V7, P1685, DOI 10.4254/wjh.v7.i12.1685; PEREZAYUSO RM, 1983, GASTROENTEROLOGY, V84, P961; Runyon BA, 2013, HEPATOLOGY, V57, P1651, DOI 10.1002/hep.26359; Sakaida I, 2014, HEPATOL RES, V44, P73, DOI 10.1111/hepr.12098; Sakaida I, 2013, J INT MED RES, V41, P835, DOI 10.1177/0300060513480089; Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181; STANLEY MM, 1989, NEW ENGL J MED, V321, P1632, DOI 10.1056/NEJM198912143212403; Stiehm AJ, 2002, HEPATOLOGY BALTIMORE, V36; Tsien CD, 2013, GUT, V62, P131, DOI 10.1136/gutjnl-2011-301255	22	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174649	10.1371/journal.pone.0174649	http://dx.doi.org/10.1371/journal.pone.0174649			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362879	Green Published, gold, Green Submitted			2022-12-26	WOS:000399175000025
J	Milanowski, M; Pomastowski, P; Railean-Plugaru, V; Rafinska, K; Ligor, T; Buszewski, B				Milanowski, Maciej; Pomastowski, Pawel; Railean-Plugaru, Viorica; Rafinska, Katarzyna; Ligor, Tomasz; Buszewski, Boguslaw			Biosorption of silver cations onto Lactococcus lactis and Lactobacillus casei isolated from dairy products	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; ACID BACTERIA; STARTER CULTURES; HEAVY-METALS; IN-VITRO; NANOPARTICLES; IDENTIFICATION; MILK; TOXICITY; REMOVAL	The current work deals with the phenomenon of silver cations uptake by two kinds of bacteria isolated from dairy products. The mechanism of sorption of silver cations by Lactococcus lactis and Lactobacillus casei bacteria was investigated. Inductively coupled plasma-mass spectrometry (ICP-MS) was used for determination of silver concentration sorbed by bacteria. Analysis of charge distribution was conducted by diffraction light scattering method. Changes in the ultrastructure of Lactococcus lactis and Lactobacillus casei cells after treatment with silver cations were investigated using transmission electron microscopy observation. Molecular spectroscopy methods, namely Fourier transform-infrared spectroscopy (FT-IR) and matrix-assisted laser desorption/ionization mass spectrometry ( MALDI MS) were employed for description of the sorption mechanism. Moreover, an analysis of volatile organic compounds (VOCs) extracted from bacterial cells was performed.	[Milanowski, Maciej; Pomastowski, Pawel; Railean-Plugaru, Viorica; Rafinska, Katarzyna; Ligor, Tomasz; Buszewski, Boguslaw] Nicolaus Copernicus Univ, Fac Chem, Dept Environm Chem & Bioanalyt, Torun, Poland; [Milanowski, Maciej; Pomastowski, Pawel; Railean-Plugaru, Viorica; Rafinska, Katarzyna; Ligor, Tomasz; Buszewski, Boguslaw] Nicolaus Copernicus Univ, Interdisciplinary Ctr Modern Technol, Torun, Poland	Nicolaus Copernicus University; Nicolaus Copernicus University	Buszewski, B (corresponding author), Nicolaus Copernicus Univ, Fac Chem, Dept Environm Chem & Bioanalyt, Torun, Poland.; Buszewski, B (corresponding author), Nicolaus Copernicus Univ, Interdisciplinary Ctr Modern Technol, Torun, Poland.	bbusz@chem.uni.torun.pl	Rafińska, Katarzyna/Y-2474-2018; Buszewski, BogusÅaw/AAT-5316-2020; Monedeiro-Milanowski, Maciej/ABE-8399-2020; Ligor, Tomasz/H-7958-2014	Rafińska, Katarzyna/0000-0002-3358-7317; Monedeiro-Milanowski, Maciej/0000-0003-3713-4099; Pomastowski, Pawel/0000-0002-1594-0623; Buszewski, Boguslaw/0000-0002-5482-7500; Ligor, Tomasz/0000-0001-5707-982X	National Science Centre, Poland [2013/08/W/N28/00701, 2014/14/A/ST4/00641, 2014/15/N/ST4/03702, 2016/21/B/ST4/02130]	National Science Centre, Poland(National Science Centre, Poland)	This work was supported by Symfonia I grant no. 2013/08/W/N28/00701, Maestro-6 no. 2014/14/A/ST4/00641 (2015-2018), Preludium grant no. 2014/15/N/ST4/03702 from the National Science Centre, Poland. The work was also financially supported by the National Science Centre, Poland in the frame of the Opus 11 project no. 2016/21/B/ST4/02130 (2016-2019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are thankful to Dr. J. Rudnicka for her technical assistance in GC/MS analyses. This work was supported by Symfonia I grant No. 2013/08/W/N28/00701, Maestro-6 No. 2014/14/A/ST4/00641 (2015-2018), Preludium grant No.: 2014/15/N/ST4/03702 from the National Science Centre, Poland. The work was also financially supported by the National Science Centre, Poland in the frame of the Opus 11 project No. 2016/21/B/ST4/02130 (2016-2019).	Abdullah S. A., 2010, Pakistan Journal of Nutrition, V9, P1203; Ahamed M, 2010, CLIN CHIM ACTA, V411, P1841, DOI 10.1016/j.cca.2010.08.016; Alemayehu D, 2014, INT J FOOD MICROBIOL, V172, P57, DOI 10.1016/j.ijfoodmicro.2013.11.024; Alvarez-Ordonez A, 2011, J MICROBIOL METH, V84, P369, DOI 10.1016/j.mimet.2011.01.009; Arnold JW, 1998, J SCI FOOD AGR, V78, P343, DOI 10.1002/(SICI)1097-0010(199811)78:3<343::AID-JSFA124>3.0.CO;2-5; Asztemborska M, 2014, NUKLEONIKA, V59, P169, DOI 10.2478/nuka-2014-0023; Beekes M, 2007, VET MICROBIOL, V123, P305, DOI 10.1016/j.vetmic.2007.04.010; Bhakta JN, 2012, J APPL MICROBIOL, V112, P1193, DOI 10.1111/j.1365-2672.2012.05284.x; Bondarenko O, 2013, ARCH TOXICOL, V87, P1181, DOI 10.1007/s00204-013-1079-4; Buszewski B, 2016, J MICROBIOL IMMUNOL; Buszewski B, 2008, J CHROMATOGR B, V868, P88, DOI 10.1016/j.jchromb.2008.04.038; Carminati D, 2014, LETT APPL MICROBIOL, V59, P299, DOI 10.1111/lam.12275; Chae YJ, 2009, AQUAT TOXICOL, V94, P320, DOI 10.1016/j.aquatox.2009.07.019; Chen J, 2015, SCI REP-UK, V5, DOI 10.1038/srep14199; Chen J, 2013, APPL ENVIRON MICROB, V79, P6140, DOI 10.1128/AEM.01953-13; Chudobova D, 2015, MICROBIOL RES, V170, P147, DOI 10.1016/j.micres.2014.08.003; Cui L, 2003, J CLIN MICROBIOL, V41, P5, DOI 10.1128/JCM.41.1.5-14.2003; Davati N, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.8(5)2015.16750; Davis R, 2010, CURRENT RES TECHNOLO, P1582; Dec M, 2014, RES MICROBIOL, V165, P190, DOI 10.1016/j.resmic.2014.02.003; Delgado S, 2013, FOOD MICROBIOL, V36, P103, DOI 10.1016/j.fm.2013.04.015; Douillard FP, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-S1-S8; Ercan O, 2015, APPL ENVIRON MICROB, V81, P320, DOI 10.1128/AEM.02484-14; Gadd GM, 2009, J CHEM TECHNOL BIOT, V84, P13, DOI 10.1002/jctb.1999; Gaglio R, 2014, INT J FOOD MICROBIOL, V177, P37, DOI 10.1016/j.ijfoodmicro.2014.02.007; Giraffa G, 2012, ENG LIFE SCI, V12, P391, DOI 10.1002/elsc.201100118; Gopal J, 2013, J MASS SPECTROM, V48, P119, DOI 10.1002/jms.3135; Halttunen T, 2007, INT J FOOD MICROBIOL, V114, P30, DOI 10.1016/j.ijfoodmicro.2006.10.040; He TT, 2014, BIOMETALS, V27, P673, DOI 10.1007/s10534-014-9756-1; Hong Y, 2015, FOOD SCI BIOTECHNOL, V24, P545, DOI 10.1007/s10068-015-0071-6; Hrynkiewicz K, 2015, ENVIRON SCI POLLUT R, V22, P3055, DOI 10.1007/s11356-014-3489-0; Khalid K., 2011, International Journal of Biosciences (IJB), V1, P1; Khan Muhammad Saleem, 2015, Journal of Biodiversity and Environmental Sciences, V6, P211; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; KIM SJ, 1985, MAR ECOL PROG SER, V26, P203, DOI 10.3354/meps026203; Klodzinska E, 2010, ELECTROPHORESIS, V31, P1590, DOI 10.1002/elps.200900559; Leroy F, 2004, TRENDS FOOD SCI TECH, V15, P67, DOI 10.1016/j.tifs.2003.09.004; Lesmana SO, 2009, BIOCHEM ENG J, V44, P19, DOI 10.1016/j.bej.2008.12.009; Lin ZY, 2005, SPECTROCHIM ACTA A, V61, P1195, DOI 10.1016/j.saa.2004.06.041; Ljungh Asa, 2006, Current Issues in Intestinal Microbiology, V7, P73; Martin R, 2007, RES MICROBIOL, V158, P31, DOI 10.1016/j.resmic.2006.11.004; Mikiciuk J, 2016, J ENVIRON SCI HEAL B, V51, P222, DOI 10.1080/03601234.2015.1120614; Mishra Ritesh, 2012, Toxicol Int, V19, P25, DOI 10.4103/0971-6580.94512; Monachese M, 2012, APPL ENVIRON MICROB, V78, P6397, DOI 10.1128/AEM.01665-12; Mosier AP, 2015, J ENVIRON MANAGE, V160, P67, DOI 10.1016/j.jenvman.2015.05.016; Mrvcic J, 2012, WORLD J MICROB BIOT, V28, P2771, DOI 10.1007/s11274-012-1094-2; Muyanja CMBK, 2003, INT J FOOD MICROBIOL, V80, P201, DOI 10.1016/S0168-1605(02)00148-4; Nambou K, 2014, INT DAIRY J, V34, P237, DOI 10.1016/j.idairyj.2013.03.012; Nejati F, 2016, INT J DAIRY TECHNOL, V69, P89, DOI 10.1111/1471-0307.12223; Papaleo MC, 2013, NEW BIOTECHNOL, V30, P824, DOI 10.1016/j.nbt.2013.03.011; Perin LM, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-36; Pfeiler EA, 2007, TRENDS MICROBIOL, V15, P546, DOI 10.1016/j.tim.2007.09.010; Pomastowski P, 2014, COLLOID SURFACE B, V120, P21, DOI 10.1016/j.colsurfb.2014.03.009; Pomastowski P., 2015, J ANAL BIOANAL TECH, VS13, DOI [10.4172/2155-9872.S13-008, DOI 10.4172/2155-9872.S13-008]; Pomastowski P, 2016, J AM CHEM SOC, V138, P7899, DOI 10.1021/jacs.6b02699; Railean-Plugaru V, 2016, J APPL MICROBIOL, V120, P1250, DOI 10.1111/jam.13093; Raynaud S, 2005, APPL ENVIRON MICROB, V71, P8016, DOI 10.1128/AEM.71.12.8016-8023.2005; Romoli R, 2011, J MASS SPECTROM, V46, P1051, DOI 10.1002/jms.1987; Sanders JW, 1999, FEMS MICROBIOL REV, V23, P483, DOI 10.1111/j.1574-6976.1999.tb00409.x; Santos MI, 2015, FOODS, V4, P283, DOI 10.3390/foods4030283; Singh AL, 2010, BIOREMEDIAT J, V14, P92, DOI 10.1080/10889861003767050; Sintubin L, 2009, APPL MICROBIOL BIOT, V84, P741, DOI 10.1007/s00253-009-2032-6; Tait E, 2014, J APPL MICROBIOL, V116, P1010, DOI 10.1111/jam.12418; Tait E, 2014, J CHROMATOGR SCI, V52, P363, DOI 10.1093/chromsci/bmt042; Taju G, 2014, COMP BIOCHEM PHYS C, V161, P41, DOI 10.1016/j.cbpc.2014.01.007; Teneva-Angelova T, 2016, ANN MICROBIOL, V66, P449, DOI 10.1007/s13213-015-1127-9; Ulanowska A, 2011, BIOMED CHROMATOGR, V25, P391, DOI 10.1002/bmc.1460; Vijayaraghavan K, 2008, BIOTECHNOL ADV, V26, P266, DOI 10.1016/j.biotechadv.2008.02.002; von Neubeck M, 2015, INT J FOOD MICROBIOL, V211, P57, DOI 10.1016/j.ijfoodmicro.2015.07.001; Wang JL, 2009, BIOTECHNOL ADV, V27, P195, DOI 10.1016/j.biotechadv.2008.11.002; Xu YY, 2015, CHEM BIODIVERS, V12, P1415, DOI 10.1002/cbdv.201400342; Zhang CH, 2014, REACT KINET MECH CAT, V113, P201, DOI 10.1007/s11144-014-0727-x; Zhang Y, 2008, BIOMED MICRODEVICES, V10, P321, DOI 10.1007/s10544-007-9139-2; Zhao YF, 2015, BIOPROC BIOSYST ENG, V38, P69, DOI 10.1007/s00449-014-1244-z	74	19	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174521	10.1371/journal.pone.0174521	http://dx.doi.org/10.1371/journal.pone.0174521			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362838	Green Submitted, Green Published, gold			2022-12-26	WOS:000399175000016
J	Correa, MG; Sacchetti, SB; Ribeiro, FV; Pimentel, SP; Casarin, RCV; Cirano, FR; Casati, MZ				Correa, Monica G.; Sacchetti, Silvana B.; Ribeiro, Fernanda Vieira; Pimentel, Suzana Peres; Viana Casarin, Renato Correa; Cirano, Fabiano Ribeiro; Casati, Marcio Z.			Periodontitis increases rheumatic factor serum levels and citrullinated proteins in gingival tissues and alter cytokine balance in arthritic rats	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; ARGININE DEIMINASE SYSTEM; PORPHYROMONAS-GINGIVALIS; ORAL BACTERIA; INFECTION; SEVERITY; MICE; EXPRESSION; IL-17; BETA	This study investigated some immunological features by experimental periodontitis (EP) and rheumatoid arthritis (RA) disease interact in destructive processes in arthritic rats. Rats were assigned to the following groups: EP +RA; RA; EP; and Negative Control. RA was induced by immunizations with type-II collagen and a local immunization with Complete Freund's adjuvant in the paw. Periodontitis was induced by ligating the right first molars. The serum level of rheumatoid factor (RF) and anti-citrullinated protein antibody (ACCPA) were measured before the induction of EP (T1) and at 28 days after (T2) by ELISA assay. ACCPA levels were also measured in the gingival tissue at T2. The specimens were processed for morphometric analysis of bone loss, and the gingival tissue surrounding the first molar was collected for the quantification of interleukin IL-1 beta, IL-4, IL-6, IL-17 and TNF-alpha using a Luminex/MAGpix assay. Paw edema was analyzed using a plethysmometer. Periodontitis increased the RF and ACCPA levels in the serum and in the gingival tissue, respectively. Besides, the level of paw swelling was increased by EP and remained in progress until the end of the experiment, when EP was associated with RA. Greater values of IL-17 were observed only when RA was present, in spite of PE. It can be concluded that periodontitis increases rheumatic factor serum levels and citrullinated proteins level in gingival tissues and alter cytokine balance in arthritic rats; at the same time, arthritis increases periodontal destruction, confirming the bidirectional interaction between diseases.	[Correa, Monica G.; Ribeiro, Fernanda Vieira; Pimentel, Suzana Peres; Viana Casarin, Renato Correa; Cirano, Fabiano Ribeiro; Casati, Marcio Z.] Univ Paulista, Sch Dent, Dent Res Div, Sao Paulo, SP, Brazil; [Sacchetti, Silvana B.] Santa Casa Sao Paulo, Pediat Rheumatol Unit, Sao Paulo, SP, Brazil	Universidade Paulista	Casati, MZ (corresponding author), Univ Paulista, Sch Dent, Dent Res Div, Sao Paulo, SP, Brazil.	mzcasati@gmail.com	Cirano, Fabiano/ABA-1897-2020; CORREA, MONICA GRAZIELI/E-8661-2013; Cirano, Fabiano R/J-2092-2014; casati, marcio zaffalon/ABA-2670-2020; Ribeiro, Fernanda/I-4030-2012	Cirano, Fabiano/0000-0002-7331-4612; CORREA, MONICA GRAZIELI/0000-0003-1895-3283; Cirano, Fabiano R/0000-0002-7331-4612; casati, marcio zaffalon/0000-0001-9234-0536; Ribeiro, Fernanda/0000-0002-2697-620X; Casarin, Renato/0000-0003-1743-5855	National Council for Scientific and Technological Development (CNPq) [442275/2014-5/303868/2013-9]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by The National Council for Scientific and Technological Development (CNPq) [Process number 442275/2014-5/303868/2013-9] (http://cnpq.br/).	Al-Katma MK, 2007, JCR-J CLIN RHEUMATOL, V13, P134, DOI 10.1097/RHU.0b013e3180690616; Barrella GE, 2012, BRAZ ORAL RES, V26, P158, DOI 10.1590/S1806-83242012000200012; Bartold PM, 2010, J CLIN PERIODONTOL, V37, P405, DOI 10.1111/j.1600-051X.2010.01552.x; BEDI GS, 1994, PREP BIOCHEM, V24, P251, DOI 10.1080/10826069408010097; BONAGURA VR, 1993, J IMMUNOL, V151, P3840; Cantley MD, 2011, J CLIN PERIODONTOL, V38, P532, DOI 10.1111/j.1600-051X.2011.01714.x; Casati MZ, 2013, J PERIODONTOL, V84, pE58, DOI 10.1902/jop.2013.120746; CASIANOCOLON A, 1988, APPL ENVIRON MICROB, V54, P1318; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chabaud M, 1998, J IMMUNOL, V161, P409; Cirano FR, 2016, BRAZ ORAL RES, V30, DOI [10.1590/1807-3107bor-2016.vol30.0128, 10.1590/1807-3107BOR-2016.vol30.0128]; de Aquino SG, 2014, J IMMUNOL, V192, P4103, DOI 10.4049/jimmunol.1301970; de Pablo P, 2008, J RHEUMATOL, V5; Duarte PM, 2010, ARCH ORAL BIOL, V55, P142, DOI 10.1016/j.archoralbio.2009.10.006; Dutzan N, 2009, J CLIN PERIODONTOL, V36, P396, DOI 10.1111/j.1600-051X.2009.01390.x; Firestein GS, 2005, JCR-J CLIN RHEUMATOL, V11, pS39, DOI 10.1097/01.rhu.0000166673.34461.33; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Garlet GP, 2008, MICROBES INFECT, V10, P489, DOI 10.1016/j.micinf.2008.01.010; Garlet GP, 2010, J CLIN PERIODONTOL, V37, P591, DOI 10.1111/j.1600-051X.2010.01586.x; Gully N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100838; Hara Y, 1996, J PERIODONTAL RES, V31, P502, DOI 10.1111/j.1600-0765.1996.tb01416.x; Havemose-Poulsen A, 2006, J PERIODONTOL, V77, P280, DOI 10.1902/jop.2006.050051; Hitchon CA, 2011, CURR OPIN RHEUMATOL, V23, P352, DOI 10.1097/BOR.0b013e3283477b7b; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Kinane DF, 2011, J CLIN PERIODONTOL, V38, P44, DOI 10.1111/j.1600-051X.2010.01682.x; Konig MF, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaj1921; Liao F, 2009, MED HYPOTHESES, V72, P732, DOI 10.1016/j.mehy.2008.12.040; LISTGARTEN MA, 1986, J CLIN PERIODONTOL, V13, P418, DOI 10.1111/j.1600-051X.1986.tb01485.x; Lohman RJ, 2012, FASEB J, V26, P2877, DOI 10.1096/fj.11-201004; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Marchesan JT, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4376; MARQUIS RE, 1987, APPL ENVIRON MICROB, V53, P198, DOI 10.1128/AEM.53.1.198-200.1987; McGraw WT, 1999, INFECT IMMUN, V67, P3248, DOI 10.1128/IAI.67.7.3248-3256.1999; Mercado F, 2000, J CLIN PERIODONTOL, V27, P267, DOI 10.1034/j.1600-051x.2000.027004267.x; Mercado FB, 2001, J PERIODONTOL, V72, P779, DOI 10.1902/jop.2001.72.6.779; Milici AJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2365; Mitani A, 2015, J PERIODONTOL, V86, P301, DOI 10.1902/jop.2014.140293; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; NIEDERMAN R, 1990, ARCH ORAL BIOL, V35, pS205, DOI 10.1016/0003-9969(90)90159-8; Okada M, 2011, J PERIODONTOL, V82, P1433, DOI 10.1902/jop.2011.110020; Orhan CE, 2013, EUR J PHARMACOL, V705, P35, DOI 10.1016/j.ejphar.2013.02.013; Ortiz P, 2009, J PERIODONTOL, V80, P535, DOI 10.1902/jop.2009.080447; PIKE R, 1994, J BIOL CHEM, V269, P406; Pimentel SP, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-224; Queiroz CM, 2012, J CLIN PERIODONTOL, V39, P608, DOI 10.1111/j.1600-051X.2012.01886.x; Ramamurthy HS, 2005, J PERIODONTOL, V76, P229, DOI 10.1902/jop.2005.76.2.229; Ribeiro J, 2005, J CLIN PERIODONTOL, V32, P412, DOI 10.1111/j.1600-051X.2005.00689.x; Rosenstein ED, 2004, INFLAMMATION, V28, P311, DOI 10.1007/s10753-004-6641-z; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Shawcross DI, 2008, HEPATOLOGY, V48, P1202, DOI 10.1002/hep.22474; Shirai H, 2006, PROTEINS, V64, P1010, DOI 10.1002/prot.20863; Singh S, 2015, PHARMACOGN RES, V7, P188, DOI 10.4103/0974-8490.150515; Sitonio MM, 2013, INFLAMM RES, V62, P107, DOI 10.1007/s00011-012-0557-0; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; The J, 1996, Oral Dis, V2, P253; Tobon GJ, 2010, J AUTOIMMUN, V35, P10, DOI 10.1016/j.jaut.2009.12.009; Umukoro Solomon, 2015, Journal of Basic and Clinical Physiology and Pharmacology, V26, P501, DOI 10.1515/jbcpp-2014-0113; Vander Cruyssen B, 2005, AUTOIMMUN REV, V4, P468, DOI 10.1016/j.autrev.2005.04.018; Vossenaar ER, 2004, ARTHRITIS RES THER, V6, P107, DOI 10.1186/ar1184; Wegner N, 2010, IMMUNOL REV, V233, P34, DOI 10.1111/j.0105-2896.2009.00850.x	61	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174442	10.1371/journal.pone.0174442	http://dx.doi.org/10.1371/journal.pone.0174442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358812	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174800039
J	Gleeson, S; Liao, YW; Dugo, C; Cave, A; Zhou, LF; Ayar, Z; Christiansen, J; Scott, T; Dawson, L; Gavin, A; Schlegel, TT; Gladding, P				Gleeson, Sarah; Liao, Yi-Wen; Dugo, Clementina; Cave, Andrew; Zhou, Lifeng; Ayar, Zina; Christiansen, Jonathan; Scott, Tony; Dawson, Liane; Gavin, Andrew; Schlegel, Todd T.; Gladding, Patrick			ECG-derived spatial QRS-T angle is associated with ICD implantation, mortality and heart failure admissions in patients with LV systolic dysfunction	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; AORTIC-VALVE STENOSIS; PROGNOSTIC VALUE; VENTRICULAR HYPERTROPHY; VARIABILITY; PRESSURE; CARDIOMYOPATHY; PREDICTION; BIOMARKERS; STATEMENT	Background Increased spatial QRS-T angle has been shown to predict appropriate implantable cardioverter defibrilIator (ICD) therapy in patients with left ventricular systolic dysfunction (LVSD). We performed a retrospective cohort study in patients with left ventricular ejection fraction (LVEF) 31-40% to assess the relationship between the spatial QRS-T angle and other advanced ECG (A-ECG) as well as echocardiographic metadata, with all-cause mortality or ICD implantation for secondary prevention. Methods 534 patients <= 75 years of age with LVEF 31-40% were identified through an echocardiography reporting database. Digital 12-lead ECGs were retrospectively matched to 295 of these patients, for whom echocardiographic and A-ECG metadata were then generated. Data mining was applied to discover novel ECG and echocardiographic markers of risk. Machine learning was used to develop a model to predict possible outcomes. Results 49 patients (17%) had events, defined as either mortality (n = 16) or ICD implantation for secondary prevention (n = 33). 72 parameters (58 A-ECG, 14 echocardiographic) were univariately different (p<0.05) in those with vs. without events. After adjustment for multiplicity, 24 A-ECG parameters and 3 echocardiographic parameters remained different (p<2x10(-3). These included the posterior-to-leftward QRS loop ratio from the derived vectorcardiographic horizontal plane (previously associated with pulmonary artery pressure, p = 2x10(-6)); spatial mean QRS-T angle (134 vs. 112 degrees, p = 1.6x10(-4)); various repolarisation vectors; and a previously described 5-parameter A-ECG score for LVSD (p = 4x10(-6)) that also correlated with echocardiographic global longitudinal strain (R-2 = - 0.51, P < 0.0001). A spatial QRS-T angle > 110 degrees had an adjusted HR of 3.4 (95% CI 1.6 to 7.4) for secondary ICD implantation or all-cause death and adjusted HR of 4.1 (95% CI 1.2 to 13.9) for future heart failure admission. There was a loss of complexity between A-ECG and echocardiographic variables with an increasing degree of disease. Conclusion Spatial QRS-T angle > 110 degrees was strongly associated with arrhythmic events and all-cause death. Deep analysis of global ECG and echocardiographic metadata revealed underlying relationships, which otherwise would not have been appreciated. Delivered at scale such techniques may prove useful in clinical decision making in the future.	[Gleeson, Sarah; Liao, Yi-Wen; Dugo, Clementina; Cave, Andrew; Christiansen, Jonathan; Scott, Tony; Dawson, Liane; Gavin, Andrew; Gladding, Patrick] North Shore Hosp, Dept Cardiol, Waitemata Dist Hlth Board, Auckland, New Zealand; [Dugo, Clementina] Azienda Osped Univ Integrata, Div Cardiol, Verona, Italy; [Zhou, Lifeng] North Shore Hosp, Dept Epidemiol & Publ Hlth, Waitemata Dist Hlth Board, Auckland, New Zealand; [Ayar, Zina] North Shore Hosp, Dept Clin Informat, Waitemata Dist Hlth Board, Auckland, New Zealand; [Schlegel, Todd T.] Karolinska Inst, Dept Clin Physiol, Stockholm, Sweden; [Schlegel, Todd T.] Nicollier Schlegel Sarl, Trelex, Switzerland; [Gladding, Patrick] North Shore Hosp, Theranost Lab, Waitemata Dist Hlth Board, Auckland, New Zealand	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Karolinska Institutet	Gladding, P (corresponding author), North Shore Hosp, Dept Cardiol, Waitemata Dist Hlth Board, Auckland, New Zealand.; Gladding, P (corresponding author), North Shore Hosp, Theranost Lab, Waitemata Dist Hlth Board, Auckland, New Zealand.	patrickg@theranosticslab.com			Theranostics Lab	Theranostics Lab	Theranostics Lab supplied funding for the data visualisations. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aro AL, 2012, EUROPACE, V14, P872, DOI 10.1093/europace/eur393; Baffy G, 2014, PHYSIOL BEHAV, V131, P49, DOI 10.1016/j.physbeh.2014.04.018; Bahlmann E, 2010, JACC-CARDIOVASC IMAG, V3, P555, DOI 10.1016/j.jcmg.2009.11.019; Batdorf BH, 2006, J ELECTROCARDIOL, V39, P266, DOI 10.1016/j.jelectrocard.2005.11.004; Baumert M, 2016, EUROPACE, V18, P925, DOI 10.1093/europace/euv405; Borazjani I, 2013, COMP MATH MATH PHYS, V2013, P11; Borleffs CJW, 2009, CIRC-ARRHYTHMIA ELEC, V2, P548, DOI 10.1161/CIRCEP.109.859108; Brown RA, 2011, J ELECTROCARDIOL, V44, P404, DOI 10.1016/j.jelectrocard.2011.01.001; Chua KC, 2016, J CARDIOVASC ELECTRO; Cortez D, 2015, J ELECTROCARDIOL, V48, P826, DOI 10.1016/j.jelectrocard.2015.07.016; de Groote P, 1998, J AM COLL CARDIOL, V32, P948, DOI 10.1016/S0735-1097(98)00337-4; Deo RC, 2015, CIRCULATION, V132, P1920, DOI 10.1161/CIRCULATIONAHA.115.001593; Dilaveris P, 2001, AM HEART J, V142, P833, DOI 10.1067/mhj.2001.118737; Dilaveris P, 2001, J HUM HYPERTENS, V15, P63, DOI 10.1038/sj.jhh.1001129; Drenos F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125876; FUJITA K, 1976, JPN CIRC J, V40, P1301, DOI 10.1253/jcj.40.1301; Gaibazzi N, 2015, JACC-CARDIOVASC IMAG, V8, P389, DOI 10.1016/j.jcmg.2014.10.014; Garcia D, 2000, CIRCULATION, V101, P765, DOI 10.1161/01.CIR.101.7.765; Ghio S, 2001, J AM COLL CARDIOL, V37, P183, DOI 10.1016/S0735-1097(00)01102-5; Gladding PA, 2013, J PERS MED, V3, P203, DOI 10.3390/jpm3030203; Haugaa KH, 2010, JACC-CARDIOVASC IMAG, V3, P247, DOI 10.1016/j.jcmg.2009.11.012; Hunter WG, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003190; Hunter Wynn G, 2016, Curr Heart Fail Rep, V13, P119, DOI 10.1007/s11897-016-0289-5; Johnson K, 2015, J CARDIOVASC DEV DIS, V2, P93, DOI 10.3390/jcdd2020093; Kamphuis VP, 2014, J ELECTROCARDIOL, V47, P175, DOI 10.1016/j.jelectrocard.2013.10.010; Kardys I, 2003, EUR HEART J, V24, P1357, DOI 10.1016/S0195-668X(03)00203-3; Kober L, 2016, N ENGL J MED; KORS JA, 1990, EUR HEART J, V11, P1083, DOI 10.1093/oxfordjournals.eurheartj.a059647; Kusumoto FM, 2014, CIRCULATION, V130, P94, DOI 10.1161/CIR.0000000000000056; La Rovere MT, 2003, CIRCULATION, V107, P565, DOI 10.1161/01.CIR.0000047275.25795.17; Lingman M, 2016, INT J CARDIOL, V218, P1, DOI 10.1016/j.ijcard.2016.05.005; Lipton JA, 2010, CORONARY ARTERY DIS, V21, P26, DOI 10.1097/MCA.0b013e328332ee32; Miotto R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26094; Nemutlu E, 2015, J CARD FAIL, V21, P460, DOI 10.1016/j.cardfail.2015.04.005; Pavri BB, 2008, CIRCULATION, V117, P3181, DOI 10.1161/CIRCULATIONAHA.107.733451; Piccirillo G, 2007, EUR HEART J, V28, P1344, DOI 10.1093/eurheartj/ehl367; Rahimtoola SH, 2010, JACC-CARDIOVASC IMAG, V3, P563, DOI 10.1016/j.jcmg.2010.02.006; Rautaharju PM, 2006, CIRCULATION, V113, P481, DOI 10.1161/CIRCULATIONAHA.105.537415; Rosenqvist M, 1998, CIRCULATION, V98, P663, DOI 10.1161/01.CIR.98.7.663; Schlegel TT, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-28; Schlegel TT, 2010, BMC CARDIOVASC DISOR, V10, P1; Shah SJ, 2015, CIRCULATION, V131, P269, DOI 10.1161/CIRCULATIONAHA.114.010637; Shah SH, 2015, CIRC-CARDIOVASC GENE, V8, P410, DOI 10.1161/CIRCGENETICS.114.000223; Shi B, J ELECTROCARDIOLOGY, V47, P52; Steinhubl SR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3487; Sweeney MO, 2005, CIRCULATION, V111, P2898, DOI 10.1161/CIRCULATIONAHA.104.526673; Tereshchenko LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051812; Tereshchenko LG, 2011, J ELECTROCARDIOL, V44, P208, DOI 10.1016/j.jelectrocard.2010.08.012; Topol EJ, 2014, CELL, V157, P241, DOI 10.1016/j.cell.2014.02.012; URSCHEL DL, 1953, AM HEART J, V45, P65, DOI 10.1016/0002-8703(53)90007-6; Voulgari C, 2010, DIABETIC MED, V27, P1420, DOI 10.1111/j.1464-5491.2010.03120.x; Voulgari C, 2010, METABOLISM, V59, P159, DOI 10.1016/j.metabol.2009.06.028; Walsh JA, 2014, CIRCULATION, V130, P573, DOI 10.1161/CIRCULATIONAHA.114.009024; Wang J, 2013, MOL BIOSYST, V9, P2618, DOI 10.1039/c3mb70227h; Yamazaki T, 2005, HEART RHYTHM, V2, P73, DOI 10.1016/j.hrthm.2004.10.040; Zhang XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139514; Zhang YH, 2015, CHIN J INTEGR MED, V10, P10, DOI DOI 10.1371/J0URNAL.P0NE.0131597	57	15	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0171069	10.1371/journal.pone.0171069	http://dx.doi.org/10.1371/journal.pone.0171069			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358801	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174800002
J	Palviainen, M; Pumpanen, J; Berninger, F; Ritala, K; Duan, B; Heinonsalo, J; Sun, H; Koster, E; Koster, K				Palviainen, Marjo; Pumpanen, Jukka; Berninger, Frank; Ritala, Kaisa; Duan, Baoli; Heinonsalo, Jussi; Sun, Hui; Koster, Egle; Koster, Kajar			Nitrogen balance along a northern boreal forest fire chronosequence	PLOS ONE			English	Article							SCOTS PINE; NORWAY SPRUCE; SOIL CARBON; JACK PINE; CONIFEROUS FOREST; FEATHER MOSSES; CLIMATE-CHANGE; BIRCH STEMS; FIXATION; DEPOSITION	Fire is a major natural disturbance factor in boreal forests, and the frequency of forest fires is predicted to increase due to climate change. Nitrogen (N) is a key determinant of carbon sequestration in boreal forests because the shortage of N limits tree growth. We studied changes in N pools and fluxes, and the overall N balance across a 155-year non stand replacing fire chronosequence in sub-arctic Pinus sylvestris forests in Finland. Two years after the fire, total ecosystem N pool was 622 kg ha(-1) of which 16% was in the vegetation, 8% in the dead biomass and 76% in the soil. 155 years after the fire, total N pool was 960 kg ha(-1), with 27% in the vegetation, 3% in the dead biomass and 69% in the soil. This implies an annual accumulation rate of 2.28 kg ha(-1) which was distributed equally between soil and biomass. The observed changes in N pools were consistent with the computed N balance +2.11 kg ha(-1) yr(-1) over the 155-year post-fire period. Nitrogen deposition was an important component of the N balance. The biological N fixation increased with succession and constituted 9% of the total N input during the 155 post-fire years. N2O fluxes were negligible (< 0.01 kg ha(-1) yr(-1)) and did not differ among post-fire age classes. The number and intensity of microbial genes involved in N cycling were lower at the site 60 years after fire compared to the youngest and the oldest sites indicating potential differences in soil N cycling processes. The results suggest that in sub-arctic pine forests, the non-stand-replacing, intermediate severity fires decrease considerably N pools in biomass but changes in soil and total ecosystem N pools are slight. Current fire-return interval does not seem to pose a great threat to ecosystem productivity and N status in these sub-arctic forests.	[Palviainen, Marjo; Berninger, Frank; Ritala, Kaisa; Koster, Egle; Koster, Kajar] Univ Helsinki, Dept Forest Sci, Helsinki, Finland; [Pumpanen, Jukka] Univ Eastern Finland, Dept Environm & Biol Sci, Kuopio, Finland; [Duan, Baoli] Inst Mt Hazards & Environm, Chengdu, Peoples R China; [Heinonsalo, Jussi; Sun, Hui] Univ Helsinki, Dept Food & Environm Sci, Helsinki, Finland; [Sun, Hui] Nanjing Forestry Univ, Collaborat Innovat Ctr Sustainable Forestry South, Coll Forestry, Nanjing, Jiangsu, Peoples R China	University of Helsinki; University of Eastern Finland; Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; University of Helsinki; Nanjing Forestry University	Palviainen, M (corresponding author), Univ Helsinki, Dept Forest Sci, Helsinki, Finland.	marjo.palviainen@helsinki.fi	Köster, Egle/AAH-8618-2021; Köster, Kajar/C-8397-2012; Pumpanen, Jukka/B-1254-2012	Köster, Kajar/0000-0003-1988-5788; Pumpanen, Jukka/0000-0003-4879-3663; Heinonsalo, Jussi/0000-0001-8516-1388; Palviainen, Marjo/0000-0001-9963-4748	Academy of Finland [286685, 294600, 307222]; Foundation for Research of Natural Resources in Finland [2016085]; Estonian Research Council grant [PUT715]	Academy of Finland(Academy of Finland); Foundation for Research of Natural Resources in Finland; Estonian Research Council grant(Estonian Research Council)	This research was supported by the Academy of Finland (project number 286685, to project leader JP; project numbers 294600, 307222 to KK). The study was also supported by The Foundation for Research of Natural Resources in Finland (2016085; to JP MP KK). KK was supported by Estonian Research Council grant (PUT715). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akselsson C, 2005, GLOBAL ECOL BIOGEOGR, V14, P85, DOI 10.1111/j.1466-822X.2004.00137.x; Alexander HD, 2012, ECOSYSTEMS, V15, P1065, DOI 10.1007/s10021-012-9567-6; Alexis MA, 2007, BIOGEOCHEMISTRY, V82, P201, DOI 10.1007/s10533-006-9063-1; Anderson-Teixeira KJ, 2008, P NATL ACAD SCI USA, V105, P228, DOI 10.1073/pnas.0710214104; [Anonymous], 1998, ENVIRON SCI POLICY, DOI DOI 10.1016/S1462-9011(98)00008-2; [Anonymous], 1974, FIRE ECOSYSTEMS; Berg B, 2004, ACTA OECOL, V26, P15, DOI 10.1016/j.actao.2004.03.003; BERGERON Y, 1991, ECOLOGY, V72, P1980, DOI 10.2307/1941553; Bladon KD, 2008, CAN J FOREST RES, V38, P2359, DOI 10.1139/X08-071; Boby LA, 2010, ECOL APPL, V20, P1633, DOI 10.1890/08-2295.1; Boerner REJ, 2008, CAN J FOREST RES, V38, P3056, DOI 10.1139/X08-144; Bond-Lamberty B, 2006, BIOGEOCHEMISTRY, V81, P1, DOI 10.1007/s10533-006-9025-7; BORMANN FH, 1977, SCIENCE, V196, P981, DOI 10.1126/science.196.4293.981; Brais S, 2000, FOREST ECOL MANAG, V137, P231, DOI 10.1016/S0378-1127(99)00331-X; Brais S, 2005, FOREST ECOL MANAG, V220, P216, DOI 10.1016/j.foreco.2005.08.013; Butterbach-Bahl K., 2011, EUROPEAN NITROGEN AS, P99, DOI 10.1017/CBO9780511976988.009; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; Davies GM, 2015, ECOL EVOL, V5, P5295, DOI 10.1002/ece3.1782; DeLuca TH, 2002, OECOLOGIA, V133, P206, DOI 10.1007/s00442-002-1025-2; DeLuca TH, 2008, SCIENCE, V320, P1181, DOI 10.1126/science.1154836; Drebs A., 2002, CLIMATOLOGICAL STAT; ENGELMARK O, 1984, CAN J BOT, V62, P893, DOI 10.1139/b84-127; FAO. Food and Agriculture Organisation, 1990, 60 FAO; Finer L., 2010, FINNISH ENV, V10, P1; Flannigan M, 2009, GLOBAL CHANGE BIOL, V15, P549, DOI 10.1111/j.1365-2486.2008.01660.x; Flechard CR, 2011, ATMOS CHEM PHYS, V11, P2703, DOI 10.5194/acp-11-2703-2011; Gauthier S, 2015, CAN J FOREST RES, V45, P553, DOI 10.1139/cjfr-2014-0125; Giesen TW, 2008, CAN J FOREST RES, V38, P2455, DOI 10.1139/X08-092; Granhall V., 1980, Ecological Bulletins, V32, P333; Gundale MJ, 2011, GLOBAL CHANGE BIOL, V17, P2743, DOI 10.1111/j.1365-2486.2011.02407.x; Harden JW, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000494; HARDY RWF, 1968, PLANT PHYSIOL, V43, P1185, DOI 10.1104/pp.43.8.1185; Helmisaari H. S., 1991, Plant roots and their environment. Proceedings of an ISRR-symposium, 21-26 August 1988, Uppsala, Sweden., P204; HELMISAARI HS, 1995, PLANT SOIL, V168, P327, DOI 10.1007/BF00029345; Hjellbrekke A.G., 2013, 22013 EMEPCCC; Hobbie SE, 2000, GLOBAL CHANGE BIOL, V6, P196, DOI 10.1046/j.1365-2486.2000.06021.x; Hogberg P, 2012, GLOBAL CHANGE BIOL, V18, P1, DOI 10.1111/j.1365-2486.2011.02553.x; Hyvonen R, 2008, BIOGEOCHEMISTRY, V89, P121, DOI 10.1007/s10533-007-9121-3; Jarvinen O, 1990, ACIDIFICATION FINLAN, P151, DOI DOI 10.1007/978-3-642-75450-0_; Johnson DW, 2005, FOREST ECOL MANAG, V220, P155, DOI 10.1016/j.foreco.2005.08.011; Johnson DW, 2001, FOREST ECOL MANAG, V140, P227, DOI 10.1016/S0378-1127(00)00282-6; Johnson DW, 2004, WATER AIR SOIL POLL, V4, P263, DOI [10.1023/B:WAFO.0000028359.17442.d1, DOI 10.1023/B:WAFO.0000028359.17442.D1]; Johnson EA, 2008, ECOL LETT, V11, P419, DOI 10.1111/j.1461-0248.2008.01173.x; Kilpelainen A, 2010, CLIMATIC CHANGE, V103, P383, DOI [10.1007/s10584-009-9788-7, 10.1007/s10584.009.9788.7]; Kim Y, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000663; Koster K, 2015, FOREST ECOL MANAG, V354, P35, DOI 10.1016/j.foreco.2015.06.039; Korhonen JFJ, 2013, BIOGEOSCIENCES, V10, P1083, DOI 10.5194/bg-10-1083-2013; Koster Egle, 2015, Geoderma Regional, V5, P181, DOI 10.1016/j.geodrs.2015.07.001; Koster K, 2014, GEODERMA, V235, P74, DOI 10.1016/j.geoderma.2014.07.001; Lagerstrom A, 2007, FUNCT ECOL, V21, P1027, DOI 10.1111/j.1365-2435.2007.01331.x; Lamontagne S, 2000, CAN J FISH AQUAT SCI, V57, P118, DOI 10.1139/f00-108; LEHTONEN I, 1978, Silva Fennica, V12, P47; Leppanen SM, 2013, ENVIRON EXP BOT, V90, P62, DOI 10.1016/j.envexpbot.2012.12.006; Levine JS, 1988, GLOBAL BIOGEOCHEM CY, V2, P445, DOI 10.1029/GB002i004p00445; Levy-Booth DJ, 2014, SOIL BIOL BIOCHEM, V75, P11, DOI 10.1016/j.soilbio.2014.03.021; Limmer C, 1996, SOIL BIOL BIOCHEM, V28, P177, DOI 10.1016/0038-0717(95)00118-2; Lovblad G., 1995, ECOL B, V44, P17; Makinen H, 2006, ECOL APPL, V16, P1865, DOI 10.1890/1051-0761(2006)016[1865:PTDOSP]2.0.CO;2; Malkonen E., 1974, Metsantutkimuslaitoksen Julkaisuja, V84; Merila P, 2014, FOREST ECOL MANAG, V311, P17, DOI 10.1016/j.foreco.2013.06.029; Millar RB, 2004, FISH RES, V70, P397, DOI 10.1016/j.fishres.2004.08.016; Nave LE, 2011, ECOL APPL, V21, P1189, DOI 10.1890/10-0660.1; Neary DG, 1999, FOREST ECOL MANAG, V122, P51, DOI 10.1016/S0378-1127(99)00032-8; Neff JC, 2005, CAN J FOREST RES, V35, P2178, DOI 10.1139/X05-154; Nieder R., 2008, P1; Niklasson M, 2000, ECOLOGY, V81, P1484, DOI 10.1890/0012-9658(2000)081[1484:NASOFL]2.0.CO;2; NOHRSTEDT HO, 1985, CAN J FOREST RES, V15, P715, DOI 10.1139/x85-116; Oksanen L, 2001, OIKOS, V94, P27, DOI 10.1034/j.1600-0706.2001.11311.x; Olsson BA, 1996, FOREST ECOL MANAG, V82, P19, DOI 10.1016/0378-1127(95)03697-0; Page-Dumroese DS, 2006, CAN J FOREST RES, V36, P2270, DOI 10.1139/X06-125; Palviainen M, 2008, CAN J FOREST RES, V38, P3047, DOI 10.1139/X08-147; Palviainen M, 2015, ECOSYSTEMS, V18, P343, DOI 10.1007/s10021-014-9832-y; Palviainen M, 2014, AMBIO, V43, P218, DOI 10.1007/s13280-013-0439-x; PERSSON HA, 1983, PLANT SOIL, V71, P87, DOI 10.1007/BF02182644; Petersen DG, 2012, ENVIRON MICROBIOL, V14, P993, DOI 10.1111/j.1462-2920.2011.02679.x; PIETIKAINEN J, 1995, SOIL BIOL BIOCHEM, V27, P101, DOI 10.1016/0038-0717(94)00125-K; Pihlatie M, 2007, TELLUS B, V59, P458, DOI 10.1111/j.1600-0889.2007.00278.x; Pihlatie MK, 2013, AGR FOREST METEOROL, V171, P124, DOI 10.1016/j.agrformet.2012.11.008; Reed SC, 2011, ANNU REV ECOL EVOL S, V42, P489, DOI 10.1146/annurev-ecolsys-102710-145034; Repola J, 2009, SILVA FENN, V43, P625, DOI 10.14214/sf.184; Ritala K., 2015, THESIS; Rousk K, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00150; Ruoho-Airola T, 2012, AMBIO, V41, P549, DOI 10.1007/s13280-012-0319-9; Schindlbacher A, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004590; Schopp W, 2003, HYDROL EARTH SYST SC, V7, P436, DOI 10.5194/hess-7-436-2003; Seedre M, 2011, J FOREST RES-JPN, V16, P168, DOI 10.1007/s10310-011-0264-7; Shorohova E, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2008083; Smithwick EAH, 2005, ECOSYSTEMS, V8, P163, DOI 10.1007/s10021-004-0097-8; Stuiver BM, 2015, FOREST ECOL MANAG, V347, P130, DOI 10.1016/j.foreco.2015.03.017; Sun H, 2015, APPL ENVIRON MICROB, V81, P7869, DOI 10.1128/AEM.02063-15; Tamminen P, 2003, COMMUN SOIL SCI PLAN, V34, P1193, DOI 10.1081/CSS-120020437; Tas N, 2014, ISME J, V8, P1904, DOI 10.1038/ismej.2014.36; Tu Qichao, 2014, Mol Ecol Resour, V14, P914, DOI 10.1111/1755-0998.12239; Ukonmaanaho L, 2008, BOREAL ENVIRON RES, V13, P67; Ullah S, 2009, CAN J FOREST RES, V39, P666, DOI 10.1139/X08-209; Viro PJ, 1969, COMM I FOR FENN, V67, P5; Vuorenmaa J, 2002, ENVIRON MONIT ASSESS, V76, P213, DOI 10.1023/A:1015584014417; Wan SQ, 2001, ECOL APPL, V11, P1349, DOI 10.1890/1051-0761(2001)011[1349:FEONPA]2.0.CO;2; Wirth C, 2002, PLANT SOIL, V242, P41, DOI 10.1023/A:1020813505203; Yanai RD, 2012, J FOREST, V110, P448, DOI 10.5849/jof.11-087; Yermakov Z, 2006, OECOLOGIA, V149, P690, DOI 10.1007/s00442-006-0474-4; Zackrisson O, 2004, ECOLOGY, V85, P3327, DOI 10.1890/04-0461; Zhang XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060781, 10.1371/journal.pone.0053931, 10.1371/journal.pone.0061922]	104	13	13	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174720	10.1371/journal.pone.0174720	http://dx.doi.org/10.1371/journal.pone.0174720			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358884	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174800077
J	Arnau, G; Bhattacharjee, R; Sheela, MN; Chair, H; Malapa, R; Lebot, V; Abraham, K; Perrier, X; Petro, D; Penet, L; Pavis, C				Arnau, Gemma; Bhattacharjee, Ranjana; Sheela, M. N.; Chair, Hana; Malapa, Roger; Lebot, Vincent; Abraham, K.; Perrier, Xavier; Petro, Dalila; Penet, Laurent; Pavis, Claudie			Understanding the genetic diversity and population structure of yam (Dioscorea alata L.) using microsatellite markers	PLOS ONE			English	Article							SEED SET; BENIN; DNA; CULTIVARS; GERMPLASM; RELATEDNESS; POLYPLOIDY; STERILITY; PATTERN; FARMERS	Yams (Dioscorea sp.) are staple food crops for millions of people in tropical and subtropical regions. Dioscorea alata, also known as greater yam, is one of the major cultivated species and most widely distributed throughout the tropics. Despite its economic and cultural importance, very little is known about its origin, diversity and genetics. As a consequence, breeding efforts for resistance to its main disease, anthracnose, have been fairly limited. The objective of this study was to contribute to the understanding of D. alata genetic diversity by genotyping 384 accessions from different geographical regions (South Pacific, Asia, Africa and the Caribbean), using 24 microsatellite markers. Diversity structuration was assessed via Principal Coordinate Analysis, UPGMA analysis and the Bayesian approach implemented in STRUCTURE. Our results revealed the existence of a wide genetic diversity and a significant structuring associated with geographic origin, ploidy levels and morpho-agronomic characteristics. Seventeen major groups of genetically close cultivars have been identified, including eleven groups of diploid cultivars, four groups of triploids and two groups of tetraploids. STRUCTURE revealed the existence of six populations in the diploid genetic pool and a few admixed cultivars. These results will be very useful for rationalizing D. alata genetic resources in breeding programs across different regions and for improving germplasm conservation methods.	[Arnau, Gemma] Ctr Cooperat Int Rech Agron Dev CIRAD, UMR Agap, Stn Roujol, Petit Bourg, Guadeloupe, France; [Bhattacharjee, Ranjana] IITA, Biosci Ctr, PMB, Ibadan, Oyo State, Nigeria; [Sheela, M. N.; Abraham, K.] CTCRI, Sreekariyam, Triruvananthapu, India; [Chair, Hana; Perrier, Xavier] CIRAD, UMR Agap, Montpellier, France; [Malapa, Roger] VARTC, Espiritu Santo, PB, Vanuatu; [Lebot, Vincent] CIRAD, UMR Agap, Port Vila, Vanuatu; [Petro, Dalila; Penet, Laurent; Pavis, Claudie] INRA, ASTRO Agrosyst Trop, Petit Bourg, Guadeloupe, France	CIRAD; CGIAR; International Institute of Tropical Agriculture (IITA); Indian Council of Agricultural Research (ICAR); ICAR - Central Tuber Crops Research Institute; CIRAD; Universite de Montpellier; CIRAD; INRAE	Arnau, G (corresponding author), Ctr Cooperat Int Rech Agron Dev CIRAD, UMR Agap, Stn Roujol, Petit Bourg, Guadeloupe, France.; Bhattacharjee, R (corresponding author), IITA, Biosci Ctr, PMB, Ibadan, Oyo State, Nigeria.	gemma.arnau@cirad.fr; R.Bhattacharjee@cgiar.org	MN, SHEELA/ABA-8592-2020; Bhattacharjee, Ranjana/AAN-1979-2020; MN, Sheela/ABB-1850-2020	MN, SHEELA/0000-0002-9053-2582; PERRIER, Xavier/0000-0002-0092-003X	INRA [AIP Bio-Ressources: Div-Yam]; FEDER Guadeloupe [projects Caramba-Valexbiotrop]	INRA [AIP Bio-Ressources: Div-Yam]; FEDER Guadeloupe [projects Caramba-Valexbiotrop]	This work was funded by grants from INRA [AIP Bio-Ressources: Div-Yam-2010] and by FEDER Guadeloupe [projects Caramba-Valexbiotrop].	Abang Mathew M., 2003, African Journal of Biotechnology, V2, P486; Abraham K, 1997, TROP AGR, V74, P272; ABRAHAM K, 1990, EUPHYTICA, V48, P45; ABRAHAM K, 1986, EUPHYTICA, V35, P337, DOI 10.1007/BF00021841; ABRAHAM K, 1991, GENETICA, V83, P93, DOI 10.1007/BF00058525; Andris M, 2010, MOL ECOL RESOUR, V10, P1106, DOI 10.1111/j.1755-0998.2010.02916.x; Ano G., 2002, PHYTOMA, V551, P36; Arnau G, 2009, APPUI DEV FILIERE IG; Arnau G, 2014, VARIETES IGNAME INTR; Arnau G, 2009, THEOR APPL GENET, V118, P1239, DOI 10.1007/s00122-009-0977-6; Asemota HN, 1996, EUPHYTICA, V92, P341, DOI 10.1007/BF00037118; AYENSU ES, 1972, ECON BOT, V26, P301, DOI 10.1007/BF02860700; Bourret D, 1973, THESIS; Chair H, 2010, CONSERV GENET, V11, P2255, DOI 10.1007/s10592-010-0110-z; Clegg M. T., 1992, Reproductive biology and plant breeding., P311; Degras, 1997, P IGN PLANT SE CUL C, P33; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Egesi C. N., 2002, African Crop Science Journal, V10, P195; Egesi C. N., 2006, Plant Genetic Resources Characterization and Utilization, V4, P181, DOI 10.1079/PGR2006121; Ellegren H, 2002, TRENDS GENET, V18, P25, DOI 10.1016/S0168-9525(01)02553-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fournet J, 1975, ANTILEES GUYANE, V1, P115; Gamiette F, 1999, GENET RESOUR CROP EV, V46, P19, DOI 10.1023/A:1008649130567; HAMON P, 1992, CAN J BOT, V70, P996, DOI 10.1139/b92-123; Jacquemoud-Collet, 2006, DARWIN SOFTWARE VERS; KIMURA M, 1983, MOL BIOL EVOL, V1, P84; Kloda JM, 2008, HEREDITY, V100, P253, DOI 10.1038/sj.hdy.6801044; Lakshmi KR, 1980, J ROOT CROPS, V6, P29; Lebot V, 1998, GENET RESOUR CROP EV, V45, P499, DOI 10.1023/A:1008603303314; Lebot V, 2009, TROPICAL ROOT TUBER, VXIX; Mahalakshmi V, 2007, GENET RESOUR CROP EV, V54, P1817, DOI 10.1007/s10722-006-9203-4; Malapa R, 2005, GENET RESOUR CROP EV, V52, P919, DOI 10.1007/s10722-003-6122-5; Malapa R., 2005, THESIS; Maledon, 2011, P 1 INT S ROOTS RHIZ; Mantel N, 1967, CANCER RES, V27, P311; MARTIN FW, 1977, TROP AGR, V54, P1; Martin FW, 1973, TROPIC AGR TRINIDAD, V50, P1; Miege J, 1952, 32 ANN B, V353-354, P144; Mignouna HD, 2002, THEOR APPL GENET, V105, P726, DOI 10.1007/s00122-002-0912-6; MUZACTUCKER I, 1993, J SCI FOOD AGR, V62, P219, DOI 10.1002/jsfa.2740620303; Nemorin A, 2013, ANN BOT-LONDON, V112, P811, DOI 10.1093/aob/mct145; Nwankiti A. O., 1984, Proceedings: sixth symposium of the International Society for Tropical Root Crops, Lima, Peru, 21-26 February, 1983, P633; Otoo E, 2015, J AGR SCI, V7, P226; Pfeiffer T, 2011, J HERED, V102, P479, DOI 10.1093/jhered/esr024; Prain D, 1939, ANN ROYAL BOT GARDEN, V14, P211; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rohlf FJ, 2000, NTSYS PC NUMERICAL T; Sartie A., 2014, African Journal of Biotechnology, V13, P2807; Sartie A, 2012, GENET RESOUR CROP EV, V59, P1753, DOI 10.1007/s10722-012-9797-7; Sastrapradja S, 1982, YAMS IGNAMES, P45; Scarcelli N, 2006, GENET RESOUR CROP EV, V53, P121, DOI 10.1007/s10722-004-1950-5; Scarcelli N, 2011, GENETICA, V139, P1055, DOI 10.1007/s10709-011-9607-8; SHARMA ARUN KUMAR, 1956, GENETICA, V28, P112, DOI 10.1007/BF01694314; Sharma K, 2008, AFR J BIOTECHNOL, V7, P1018; SINGH R. D., 1966, INDIAN PHYTOPATHOL, V19, P65; Siqueira MVBM, 2014, GENET RESOUR CROP EV, V61, P611, DOI 10.1007/s10722-013-0063-4; Siqueira MVBM, 2012, HORTIC BRAS, V30, P653, DOI 10.1590/S0102-05362012000400015; Siqueira MVBM, 2011, AM J BOT, V98, pE144, DOI 10.3732/ajb.1000513; Tamiru M, 2007, CROP SCI, V47, P1744, DOI 10.2135/cropsci2006.11.0719; Tostain Serge, 2007, Plant Genetic Resources Characterization and Utilization, V5, P71, DOI 10.1017/S1479262107672323; Vallunen JA, 2006, PROTOCOLS WORKING M1; Vandenbroucke H, 2016, GENET RESOUR CROP EV, V63, P495, DOI 10.1007/s10722-015-0267-x; Velayudhan K. C., 1989, Journal of Root Crops, V15, P79; Vernier P, 2003, OUTLOOK AGR, V32, P35, DOI 10.5367/000000003101294244; Vigouroux Y, 2002, MOL BIOL EVOL, V19, P1251, DOI 10.1093/oxfordjournals.molbev.a004186; WINCH JE, 1984, PLANT PATHOL, V33, P467, DOI 10.1111/j.1365-3059.1984.tb02870.x; Zannou A, 2009, AFR J BIOTECHNOL, V8, P26	69	28	28	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174150	10.1371/journal.pone.0174150	http://dx.doi.org/10.1371/journal.pone.0174150			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355293	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174600038
J	Hou, GX; Liu, PP; Yang, J; Wen, SJ				Hou, Guo-Xin; Liu, Panpan; Yang, Jing; Wen, Shijun			Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan-Meier plotter	PLOS ONE			English	Article							II-BETA; DNA TOPOISOMERASES; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; MICROARRAY DATA; CYCLE ARREST; COLON-CANCER; ALPHA; PROTEIN; DAMAGE	DNA topoisomerases are essential to modulate DNA topology during various cellular genetic processes. The expression and distinct prognostic value of topoisomerase isoforms in non-small-cell lung cancer (NSCLC) is not well established. In the current study, we have examined the mRNA expression of topoisomerase isoforms by using Oncomine analysis and investigated their prognostic value via the Kaplan-Meier plotter database in NSCLC patients. Our analysis indicated that the expression level of topoisomerases in lung cancer was higher compared with normal tissues. Especially, high expression of two topoisomerase isoforms, TOP2A and TOP3A, was found to be correlated to worse overall survival (OS) in all NSCLC and lung adenocarcinoma (Ade) patients, but not in lung squamous cell carcinoma (SCC) patients. In a contrast, high expression of isoforms TOP1 and TOP2B indicated better OS in all NSCLC and Ade, but not in SCC patients. Meanwhile, high expression of TOP1 MT and TOP3B was not correlated with OS in NSCLC patients. Furthermore, we also demonstrated a relationship between topoisomerase isoforms and the clinicopathological features for the NSCLC patients, such as grades, clinical stages, lymph node status, smoking status, gender, chemotherapy and radiotherapy. These results support that TOP2A and TOP3A are associated with worse prognosis in NSCLC patients. In addition, our study also shows that TOP1 and TOP2B contribute to favorable prognosis in NSCLC patients. The exact prognostic significance of TOP1 MT and TOP3B need to be further elucidated. Comprehensive evaluation of expression and prognosis of topoisomerase isoforms will be a benefit for the better understanding of heterogeneity and complexity in the molecular biology of NSCLC, paving a way for more accurate prediction of prognosis and discovery of potential drug targets for NSCLC patients.	[Hou, Guo-Xin; Liu, Panpan; Yang, Jing; Wen, Shijun] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Wen, Shijun] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Wen, SJ (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.; Wen, SJ (corresponding author), Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou, Guangdong, Peoples R China.	wenshj@sysucc.org.cn	Wen, Shijun/Q-2571-2015	Wen, Shijun/0000-0002-9347-8243; Hou, Guoxin/0000-0002-4102-4012	National Natural Science Foundation of China [81672952, 81430060]; Guangdong Science and Technology Program [2014A030313196, 20136051000034]; Guangzhou Technology Program [201504010038, 201508020250]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Program; Guangzhou Technology Program	The project is supported partly by National Natural Science Foundation of China (81672952, 81430060), Guangdong Science and Technology Program (2014A030313196, 20136051000034), and Guangzhou Technology Program (No. 201504010038 and No. 201508020250). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chhatriwala H, 2006, CANCER BIOL THER, V5, P1600, DOI 10.4161/cbt.5.12.3546; Chiappori AA, 2010, J THORAC ONCOL, V5, P484, DOI 10.1097/JTO.0b013e3181ccb27b; de Resende MF, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-36; Demel HR, 2015, AM J CANCER RES, V5, P1649; Demoulin B, 2015, TOXICOL IN VITRO, V29, P1156, DOI 10.1016/j.tiv.2015.04.015; Dingemans AMC, 2001, LUNG CANCER, V32, P117, DOI 10.1016/S0169-5002(00)00224-5; Douarre C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041094; Errington F, 1999, MOL PHARMACOL, V56, P1309, DOI 10.1124/mol.56.6.1309; Forterre P, 2007, BIOCHIMIE, V89, P427, DOI 10.1016/j.biochi.2006.12.009; Gao HL, 1999, P NATL ACAD SCI USA, V96, P12168, DOI 10.1073/pnas.96.21.12168; Giaccone G, 1995, BBA-GENE STRUCT EXPR, V1264, P337, DOI 10.1016/0167-4781(95)00171-9; GIOVANELLA BC, 1989, SCIENCE, V246, P1046, DOI 10.1126/science.2555920; GUPTA M, 1995, BBA-GENE STRUCT EXPR, V1262, P1, DOI 10.1016/0167-4781(95)00029-G; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hanagiri Takeshi, 2011, Journal of UOEH, V33, P205; Herzog CE, 1998, CANCER RES, V58, P5298; Hsieh MY, 2014, CLIN CANCER RES, V20, P1489, DOI 10.1158/1078-0432.CCR-13-1997; Huang H, 2015, INT J CLIN EXP PATHO, V8, P11537; HUSAIN I, 1994, CANCER RES, V54, P539; Jain M, 2013, ENDOCR-RELAT CANCER, V20, P361, DOI 10.1530/ERC-12-0403; Kobayashi M, 2001, BIOCHEM BIOPH RES CO, V287, P282, DOI 10.1006/bbrc.2001.5580; Krogh BO, 2002, P NATL ACAD SCI USA, V99, P1853, DOI 10.1073/pnas.032613199; Lan J, 2014, TUMOR BIOL, V35, P179, DOI 10.1007/s13277-013-1022-6; Lee YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132579; Liu DG, 2002, CANCER, V94, P2239, DOI 10.1002/cncr.10450; Low RL, 2003, EUR J BIOCHEM, V270, P4173, DOI 10.1046/j.1432-1033.2003.03814.x; Lu BH, 2016, THORAC CANCER, V7, P486, DOI 10.1111/1759-7714.12359; Lyu YL, 2006, MOL CELL BIOL, V26, P7929, DOI 10.1128/MCB.00617-06; MCLEOD HL, 1994, INT J CANCER, V59, P607, DOI 10.1002/ijc.2910590506; Mirski SEL, 2000, LAB INVEST, V80, P787, DOI 10.1038/labinvest.3780083; Mohanty S, 2008, P NATL ACAD SCI USA, V105, P5063, DOI 10.1073/pnas.0801235105; Nitiss JL, 1998, BBA-GENE STRUCT EXPR, V1400, P63, DOI 10.1016/S0167-4781(98)00128-6; Non-Small Cell Lung Cancer Collaborative G, 2010, COCHRANE DATABASE SY; Oliveira-Costa JP, 2010, HUM PATHOL, V41, P1624, DOI 10.1016/j.humpath.2010.01.027; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; Proszek J, 2014, SENSORS-BASEL, V14, P1195, DOI 10.3390/s140101195; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Romer MU, 2013, MOL ONCOL, V7, P101, DOI 10.1016/j.molonc.2012.09.001; Schoeffler AJ, 2005, BIOCHEM SOC T, V33, P1465, DOI 10.1042/BST0331465; Sereno M, 2012, INT J ONCOL, V40, P2104, DOI 10.3892/ijo.2012.1378; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Skarlos DV, 2007, ANTICANCER RES, V27, P2973; Song JH, 2012, BRIT J CANCER, V107, P108, DOI 10.1038/bjc.2012.206; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Sudan S, 2014, ANTICANCER RES, V34, P1691; Syahruddin E, 1998, JPN J CANCER RES, V89, P855, DOI 10.1111/j.1349-7006.1998.tb00640.x; Szasz AM, 2016, ONCOTARGET, DOI 10.18632/oncotarget.10337; Vavrova A, 2012, INT J BIOCHEM CELL B, V44, P834, DOI 10.1016/j.biocel.2012.03.005; Viard T, 2007, BIOCHIMIE, V89, P456, DOI 10.1016/j.biochi.2006.10.013; Wang JC, 2009, ANNU REV BIOCHEM, V78, P31, DOI 10.1146/annurev.biochem.78.030107.090101; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665; Wang Y, 2002, P NATL ACAD SCI USA, V99, P12114, DOI 10.1073/pnas.192449499; Wu ZH, 2014, J CHEMOTHERAPY, V26, P342, DOI 10.1179/1973947813Y.0000000153; Xu Y, 2015, BIOMOLECULES, V5, P1652, DOI 10.3390/biom5031652; Xue XY, 2013, J BIOL CHEM, V288, P14221, DOI 10.1074/jbc.M113.465609; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131; Yang YZ, 2014, MOL CELL, V53, P484, DOI 10.1016/j.molcel.2014.01.011; Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998; Zhang HL, 2008, BIOCHEMISTRY-US, V47, P11196, DOI 10.1021/bi800774b; Zhang HL, 2014, NUCLEIC ACIDS RES, V42, P7259, DOI 10.1093/nar/gku384	67	113	118	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174515	10.1371/journal.pone.0174515	http://dx.doi.org/10.1371/journal.pone.0174515			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355294	gold, Green Submitted, Green Published			2022-12-26	WOS:000399174600058
J	Maslo, B; Valentin, R; Leu, K; Kerwin, K; Hamilton, GC; Bevan, A; Fefferman, NH; Fonseca, DM				Maslo, Brooke; Valentin, Rafael; Leu, Karen; Kerwin, Kathleen; Hamilton, George C.; Bevan, Amanda; Fefferman, Nina H.; Fonseca, Dina M.			Chirosurveillance: The use of native bats to detect invasive agricultural pests	PLOS ONE			English	Article							HALYOMORPHA-HALYS HEMIPTERA; LONG-EARED BATS; ENVIRONMENTAL DNA; GENERALIST PREDATOR; EPTESICUS-FUSCUS; ROOST SELECTION; INDIANA BAT; ABUNDANCE; SURVEILLANCE; IMPACT	Invasive insect pests cost the agricultural industry billions of dollars annually in crop losses. Timely detection of pests is critical for management efficiency. Innovative pest detection strategies, such as environmental DNA (eDNA) techniques, combined with efficient predators, maximize sampling resolution across space and time and may improve surveillance. We tested the hypothesis that temperate insectivorous bats can be important sentinels of agricultural insect pest surveillance. Specifically, we used a new high-sensitivity molecular assay for invasive brown marmorated stink bugs (Halyomorpha halys) to examine the extent to which big brown bats (Eptesicus fuscus) detect agricultural pests in the landscape. We documented consistent seasonal predation of stink bugs by big brown bats. Importantly, bats detected brown marmorated stink bugs 3-4 weeks earlier than the current standard monitoring tool, blacklight traps, across all sites. We highlight here the previously unrecognized potential ecosystem service of bats as agents of pest surveillance (or chirosurveillance). Additional studies examining interactions between other bat and insect pest species, coupled with comparisons of detectability among various conventional monitoring methods, are needed to verify the patterns extracted from this study. Ultimately, robust economic analyses will be needed to assess the cost-effectiveness of chirosurveillance as a standard strategy for integrated pest management.	[Maslo, Brooke; Valentin, Rafael; Leu, Karen; Kerwin, Kathleen; Bevan, Amanda; Fonseca, Dina M.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA; [Maslo, Brooke; Hamilton, George C.; Fonseca, Dina M.] Rutgers State Univ, Rutgers Cooperat Extens, New Jersey Agr Expt Stn, New Brunswick, NJ 08901 USA; [Hamilton, George C.; Fonseca, Dina M.] Rutgers State Univ, Dept Entomol, New Brunswick, NJ USA; [Fefferman, Nina H.] Univ Tennessee, Ecol & Evolutionary Biol, Knoxville, TN USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Tennessee System; University of Tennessee Knoxville	Maslo, B (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08901 USA.; Maslo, B (corresponding author), Rutgers State Univ, Rutgers Cooperat Extens, New Jersey Agr Expt Stn, New Brunswick, NJ 08901 USA.	brooke.maslo@rutgers.edu	Fonseca, Dina Madeira/B-9951-2011; Fonseca, Dina/HHS-1320-2022; Fefferman, Nina/AAQ-7378-2021	Fonseca, Dina Madeira/0000-0003-4726-7100; Fefferman, Nina/0000-0003-0233-1404	USDA-NRCS Award, Rutgers Cooperative Extension, Rutgers University [69-2B29-12-176]; USDA-NRCS Conservation Innovation Grant [69-2B29-12-176]; Rutgers startup funds; Rutgers Cooperative Extension	USDA-NRCS Award, Rutgers Cooperative Extension, Rutgers University; USDA-NRCS Conservation Innovation Grant; Rutgers startup funds; Rutgers Cooperative Extension	This work was supported by USDA-NRCS Award 69-2B29-12-176, Rutgers Cooperative Extension, Rutgers University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this project was provided by a USDA-NRCS Conservation Innovation Grant (69-2B29-12-176) to BM, Rutgers startup funds to DMF and Rutgers Cooperative Extension. Permission to access study sites was granted by Brad Burke, Ross Kiesling, Joe Nichols, Doug Race, Mike, Nick and Marion Russo, and John Schober. We would like to thank Julie L. Lockwood, Peter J. Morin, Dave Schmitt, Brittany Chrans, Danielle Podmayersky, Anne Nielsen, John F. Gumbs, and Dean Polk for useful technical assistance and support.	Acevedo-Whitehouse K, 2010, ANIM CONSERV, V13, P217, DOI 10.1111/j.1469-1795.2009.00326.x; Agosta SJ, 2003, J ZOOL, V260, P169, DOI 10.1017/S0952836903003601; Agosta SJ, 2002, MAMMAL REV, V32, P179, DOI 10.1046/j.1365-2907.2002.00103.x; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Bellemain E, 2007, BIOL CONSERV, V134, P537, DOI 10.1016/j.biocon.2006.09.004; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Britzke ER, 2003, SOUTHEAST NAT, V2, P235, DOI 10.1656/1528-7092(2003)002[0235:IBMSMR]2.0.CO;2; Buckles Elizabeth L., 2012, P432; Carter TC, 2005, FOREST ECOL MANAG, V219, P259, DOI 10.1016/j.foreco.2005.08.049; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Duchamp JE, 2004, CAN J ZOOL, V82, P1157, DOI [10.1139/z04-095, 10.1139/Z04-095]; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Harwood JD, 2009, BIOL INVASIONS, V11, P895, DOI 10.1007/s10530-008-9302-6; Hayes MA, 2013, BIOSCIENCE, V63, P975, DOI 10.1525/bio.2013.63.12.10; Herder J, 2013, ENV DNA REV POSS APP, V104; Hutson A, 2001, MICROCHIROPTERAN BAT; Jerde CL, 2013, CAN J FISH AQUAT SCI, V70, P522, DOI 10.1139/cjfas-2012-0478; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Kays R.W., 2009, MAMMALS N AM, V2nd; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; Leskey T. C., 2012, PSYCHE J ENTOMOLOGY, V2012; McCracken GF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043839; Michael A, 2001, HOME RANGE SIZE HABI; Nielsen AL, 2008, ENVIRON ENTOMOL, V37, P348, DOI 10.1603/0046-225X(2008)37[348:DREALT]2.0.CO;2; Nielsen AL, 2013, J ECON ENTOMOL, V106, P1495, DOI 10.1603/EC12472; Nielsen AL, 2009, J ECON ENTOMOL, V102, P1133, DOI 10.1603/029.102.0335; Perry RW, 2007, FOREST ECOL MANAG, V247, P220, DOI 10.1016/j.foreco.2007.04.041; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Rice KB, 2014, J INTEGR PEST MANAG, V5, DOI 10.1603/IPM14002; Roberts BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042532; Rondoni G, 2015, INSECT SCI, V22, P719, DOI 10.1111/1744-7917.12165; Rydell J, 2010, ACTA CHIROPTEROL, V12, P261, DOI 10.3161/150811010X537846; Schneeberger Karin, 2016, P263; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Smart AS, 2015, ECOL APPL, V25, P1944, DOI 10.1890/14-1751.1; Smart AS, 2016, METHODS ECOLOGY EVOL; Streicker DG, 2012, P ROY SOC B-BIOL SCI, V279, P3384, DOI 10.1098/rspb.2012.0538; Thogmartin WE, 2013, BIOL CONSERV, V160, P162, DOI 10.1016/j.biocon.2013.01.010; Truxa C, 2012, EUR J ENTOMOL, V109, P77, DOI 10.14411/eje.2012.010; Valentin RE, 2016, PEST MANAG SCI, V72, P1854, DOI 10.1002/ps.4217; WHITAKER JO, 1995, AM MIDL NAT, V134, P346, DOI 10.2307/2426304; Whitaker John O. Jr, 2009, P567; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Wilkinson LC, 1997, ECOSCIENCE, V4, P279, DOI 10.1080/11956860.1997.11682406; Wilson GJ, 2003, J APPL ECOL, V40, P658, DOI 10.1046/j.1365-2664.2003.00835.x	48	19	19	6	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0173321	10.1371/journal.pone.0173321	http://dx.doi.org/10.1371/journal.pone.0173321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355216	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174600013
J	Xiao, Y; Ouyang, CJ; Huang, WG; Tang, YL; Fu, WT; Cheng, A				Xiao, Ying; Ouyang, Chenjie; Huang, Weiguo; Tang, Yunlian; Fu, Weiting; Cheng, Ailan			Annexin A1 can inhibit the in vitro invasive ability of nasopharyngeal carcinoma cells possibly through Annexin Al/S100A9/Vimentin interaction	PLOS ONE			English	Article							QUANTITATIVE PROTEOMICS; MIGRATION; TRANSLOCATION; EXPRESSION; PROTEINS; GROWTH; DAMAGE; MRP14; S100	Annexin A1 is a member of a large superfamily of glucocorticoid-regulated, calcium- and phospholipid-binding proteins. Our previous studies have shown that the abnormal expression of Annexin Al is related to the occurrence and development of nasopharyngeal carcinoma (NPC). To understand the roles of Annexin Al in the tumorigenesis of NPC, targeted proteomic analysis was performed on Annexin Al-associated proteins from NPC cells. We identified 436 proteins associated with Annexin Al, as well as two Annexin Al-interacted key proteins, S100A9 and Vimentin, which were confirmed by co-immunoprecipitation. Gene function classification revealed that the Annexin Al-associated proteins can be grouped into 21 clusters based on their molecular functions. Protein-protein interaction analysis indicated that Annexin Al /S100A9/Vimentin interactions may be involved in the invasion and metastasis of NPC because they can form complexes in NPC cells. The down regulation of Annexin Al in NPC may lead to the overexpression of S100A9/Vimentin, which may increase the possibility of the invasion ability of NPC cells by adjusting the function of cytoskeleton proteins. Results suggested that the biological functions of Annexin Al in NPC were diverse, and that Annexin Al can inhibit the in vitro invasive ability of NPC cells through Annexin Al /S100A9/Vimentin interaction.	[Xiao, Ying; Huang, Weiguo; Tang, Yunlian; Fu, Weiting; Cheng, Ailan] Univ South China, Canc Res Inst, Hengyang, Peoples R China; [Xiao, Ying; Cheng, Ailan] Univ South China, Key Lab Tumor Cellular Mol Pathol, Coll Hunan Prov, Hengyang, Peoples R China; [Ouyang, Chenjie] Maternal & Childrens Hosp Foshan, Dept Pathol, Foshan, Guangdong, Peoples R China; [Huang, Weiguo; Tang, Yunlian] Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Hengyang, Peoples R China	University of South China; University of South China	Cheng, A (corresponding author), Univ South China, Canc Res Inst, Hengyang, Peoples R China.; Cheng, A (corresponding author), Univ South China, Key Lab Tumor Cellular Mol Pathol, Coll Hunan Prov, Hengyang, Peoples R China.	ailan_cheng@hotmail.com			National Natural Science Foundation of China [81372894, 81072198, 81272182]; Hunan Provincial Natural Science Foundation of China [10JJ6035]; Key Project of Hunan Provincial Education Department [10A104, 16K077]; construct program of the key discipline in Hunan Province, China (Basic Medicine Sciences in University of South China)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Key Project of Hunan Provincial Education Department(Hunan Provincial Education Department); construct program of the key discipline in Hunan Province, China (Basic Medicine Sciences in University of South China)	This work was supported by National Natural Science Foundation of China (No. 81372894, 81072198, 81272182), Hunan Provincial Natural Science Foundation of China (No. 10JJ6035), the Key Project of Hunan Provincial Education Department (No. 10A104, 16K077) and the construct program of the key discipline in Hunan Province, China (Basic Medicine Sciences in University of South China).	Almatroodi SA, 2015, CANCER GENOM PROTEOM, V12, P39; Belvedere R, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-961; Bizzarro V, 2010, J CELL PHYSIOL, V224, P757, DOI 10.1002/jcp.22178; Chan ATC, 2010, ANN ONCOL, V21, P308, DOI 10.1093/annonc/mdq277; Cheng AL, 2008, CLIN CANCER RES, V14, P435, DOI 10.1158/1078-0432.CCR-07-1215; Chiesa F, 2001, ORL J OTO-RHINO-LARY, V63, P214, DOI 10.1159/000055743; Fife CM, 2014, BRIT J PHARMACOL, V171, P5507, DOI 10.1111/bph.12704; Gu AD, 2009, CLIN VACCINE IMMUNOL, V16, P592, DOI 10.1128/CVI.00207-08; Guo CM, 2013, FUTURE ONCOL, V9, P1773, DOI [10.2217/FON.13.114, 10.2217/fon.13.114]; Ho HC, 2008, ACTA OTO-LARYNGOL, V128, P790, DOI 10.1080/00016480701714269; Huang WG, 2010, INT J BIOCHEM CELL B, V42, P137, DOI 10.1016/j.biocel.2009.10.001; Jaiswal JK, 2015, CELL CYCLE, V14, P502, DOI 10.1080/15384101.2014.995495; Jorge YC, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/152860; Li MX, 2009, J CELL BIOCHEM, V106, P570, DOI 10.1002/jcb.22028; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Lin Z, 2016, MOL CARCINOGEN, V55, P1467, DOI 10.1002/mc.22389; Liu AF, 2014, MOL MED REP, V10, P3059, DOI 10.3892/mmr.2014.2656; Liu FM, 2015, EUR J OBSTET GYN R B, V194, P119, DOI 10.1016/j.ejogrb.2015.08.028; Markowitz J, 2013, BBA-REV CANCER, V1835, P100, DOI 10.1016/j.bbcan.2012.10.003; Matsuda D, 2006, EXP CELL RES, V312, P1205, DOI 10.1016/j.yexcr.2006.02.003; Mussunoor S, 2008, J PATHOL, V216, P131, DOI 10.1002/path.2400; Poeter M, 2013, BBA-MOL CELL RES, V1833, P1700, DOI 10.1016/j.bbamcr.2012.12.006; Rodrigo JP, 2005, AM J RHINOL, V19, P483, DOI 10.1177/194589240501900511; Saito Susumu, 2007, Nihon Jibiinkoka Gakkai Kaiho, V110, P24; Sun B, 2015, BIOMED REP, V3, P603, DOI 10.3892/br.2015.494; Swa HLF, 2012, MOL CELL PROTEOMICS, V11, P381, DOI 10.1074/mcp.M111.011205; vandenBos C, 1996, J IMMUNOL, V156, P1247; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Xiao SA, 2015, J CANCER RES CLIN, V141, P1465, DOI 10.1007/s00432-015-1937-y	29	6	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174383	10.1371/journal.pone.0174383	http://dx.doi.org/10.1371/journal.pone.0174383			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355254	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174600047
J	Kidd, J; Manning, P; Simkin, J; Peacock, S; Stockdale, E				Kidd, Jonathan; Manning, Peter; Simkin, Janet; Peacock, Simon; Stockdale, Elizabeth			Impacts of 120 years of fertilizer addition on a temperate grassland ecosystem	PLOS ONE			English	Article							MEADOW HAY PLOTS; SOIL MICROBIAL COMMUNITIES; PLANT-SPECIES COMPOSITION; PARK GRASS; CARBON SEQUESTRATION; PALACE-LEAS; NITROGEN ADDITIONS; ORGANIC-MATTER; COCKLE-PARK; TERRESTRIAL ECOSYSTEMS	The widespread application of fertilizers has greatly influenced many processes and properties of agroecosystems, and agricultural fertilization is expected to increase even further in the future. To date, most research on fertilizer impacts has used short-term studies, which may be unrepresentative of long-term responses, thus hindering our capacity to predict long-term impacts. Here, we examined the effects of long-term fertilizer addition on key ecosystem properties in a long-term grassland experiment (Palace Leas Hay Meadow) in which farmyard manure (FYM) and inorganic fertilizer treatments have been applied consistently for 120 years in order to characterize the experimental site more fully and compare ecosystem responses with those observed at other long-term and short-term experiments. FYM inputs increased soil organic carbon (SOC) stocks, hay yield, nutrient availability and acted as a buffer against soil acidification (>pH 5). In contrast, N-containing inorganic fertilizers strongly acidified the soil (<pH 4.5) and increased surface SOC stocks by increasing the C stored in the coarse (2.8 mm-200 mu m) and fine (200-50 mu m) fractions. Application of N fertilizers also reduced plant species richness and the abundance of forbs and legumes. Overall, our results were broadly consistent with those observed in other very long-term studies (the Park Grass and Steinach Grassland experiments) in that fertilization effects on plant and soil properties appeared to be driven by differences in both nutrient input and changes to soil pH. We also established that the direction of long-term fertilization effects tended to be comparable with short-term experiments, but that their magnitude differed considerably, particularly where ammonium sulphate-induced acidification had occurred. We therefore conclude that short-term studies are unlikely to possess the required timeframe to accurately predict long-term responses, thus necessitating the use of long-term study sites. Such experiments should be strategically established in regions where future fertilizer use is expected to increase rapidly.	[Kidd, Jonathan; Simkin, Janet; Peacock, Simon; Stockdale, Elizabeth] Newcastle Univ, Sch Agr Food & Rural Dev, Newcastle Upon Tyne, Tyne & Wear, England; [Kidd, Jonathan] Scotlands Rural Coll SRUC, Crop & Soil Syst, Craibstone Estate, Aberdeen, Scotland; [Manning, Peter] Biodivers & Climate Res Ctr BiK F, Senckenberg Gesell Nat Forsch, Senckenberganlage 25, Frankfurt, Germany	Newcastle University - UK; Scotland's Rural College; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN)	Kidd, J (corresponding author), Newcastle Univ, Sch Agr Food & Rural Dev, Newcastle Upon Tyne, Tyne & Wear, England.; Kidd, J (corresponding author), Scotlands Rural Coll SRUC, Crop & Soil Syst, Craibstone Estate, Aberdeen, Scotland.	jonathan.kidd@ncl.ac.uk	Manning, Peter/I-6523-2012	Manning, Peter/0000-0002-7940-2023; Stockdale, Elizabeth/0000-0003-4834-8594	Scotland's Rural College (SRUC); School of Agriculture Food and Rural Development; Newcastle University providing a PhD studentship; Scottish Government Strategic Research Programme; BBSRC [BBS/E/C/000J0300] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/000J0300] Funding Source: researchfish	Scotland's Rural College (SRUC); School of Agriculture Food and Rural Development; Newcastle University providing a PhD studentship; Scottish Government Strategic Research Programme; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by Scotland's Rural College (SRUC) and the School of Agriculture Food and Rural Development, Newcastle University providing a PhD studentship for JK.Research at SRUC is supported by the Scottish Government Strategic Research Programme.The funders had no role in study design,data collection and analysis, decision to publish,or preparation of the manuscript	Alexandratos N., 2012, 1203 ESA FAO, DOI DOI 10.1016/S0264-8377(03)00047-4; Allan E, 2015, ECOL LETT, V18, P834, DOI 10.1111/ele.12469; Allison, 1977, COCKLE PARK SOIL MAP; ARNOLD PW, 1976, ANN AGRON, V27, P1027; Bardgett RD, 2006, NATURE, V439, P969, DOI 10.1038/nature04197; Bluthgen N, 2012, BASIC APPL ECOL, V13, P207, DOI 10.1016/j.baae.2012.04.001; Bradford MA, 2008, FUNCT ECOL, V22, P964, DOI 10.1111/j.1365-2435.2008.01404.x; Chen DM, 2016, FUNCT ECOL, V30, P658, DOI 10.1111/1365-2435.12525; Chen DM, 2015, SOIL BIOL BIOCHEM, V89, P99, DOI 10.1016/j.soilbio.2015.06.028; Christensen BT, 2001, EUR J SOIL SCI, V52, P345, DOI 10.1046/j.1365-2389.2001.00417.x; COLEMAN SY, 1987, GRASS FORAGE SCI, V42, P353, DOI 10.1111/j.1365-2494.1987.tb02125.x; Conyers MK, 1996, SOIL TILL RES, V37, P127, DOI 10.1016/0167-1987(95)01005-X; Crawley MJ, 2005, AM NAT, V165, P179, DOI 10.1086/427270; De Deyn GB, 2011, J APPL ECOL, V48, P600, DOI 10.1111/j.1365-2664.2010.01925.x; de Vries FT, 2006, SOIL BIOL BIOCHEM, V38, P2092, DOI 10.1016/j.soilbio.2006.01.008; Defra, 2010, FERT MAN RB209; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Erisman JW, 2008, NAT GEOSCI, V1, P636, DOI 10.1038/ngeo325; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Fisher RA, 1935, DESIGN EXPT; Fornara DA, 2011, GLOBAL CHANGE BIOL, V17, P1925, DOI 10.1111/j.1365-2486.2010.02328.x; Fornara DA, 2013, GLOBAL CHANGE BIOL, V19, P3848, DOI 10.1111/gcb.12323; Fornara DA, 2012, ECOLOGY, V93, P2030, DOI 10.1890/12-0292.1; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; HAYNES RJ, 1982, PLANT SOIL, V68, P289, DOI 10.1007/BF02197935; Haynes RJ, 2001, NUTR CYCL AGROECOSYS, V59, P47, DOI 10.1023/A:1009823600950; Hejcman M, 2014, AGR ECOSYST ENVIRON, V184, P76, DOI 10.1016/j.agee.2013.11.021; Hejcman M, 2010, FOLIA GEOBOT, V45, P125, DOI 10.1007/s12224-010-9062-9; Hill, 2015, TABLEFIT VERSION 2; Hopkins DW, 2011, EUR J SOIL SCI, V62, P95, DOI 10.1111/j.1365-2389.2010.01320.x; Hopkins DW, 2009, GLOBAL CHANGE BIOL, V15, P1739, DOI 10.1111/j.1365-2486.2008.01809.x; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/ngeo844, 10.1038/NGEO844]; Jenkins SN, 2009, ANTON LEEUW INT J G, V95, P319, DOI 10.1007/s10482-009-9317-8; Johnston AE, 2009, ADV AGRON, V101, P1, DOI 10.1016/S0065-2113(08)00801-8; Kemmitt SJ, 2006, SOIL BIOL BIOCHEM, V38, P898, DOI 10.1016/j.soilbio.2005.08.006; Kirkham FW, 2008, BIOL CONSERV, V141, P1411, DOI 10.1016/j.biocon.2008.03.010; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Lee M, 2010, PHILOS T R SOC B, V365, P2047, DOI 10.1098/rstb.2010.0028; Leff JW, 2015, P NATL ACAD SCI USA, V112, P10967, DOI 10.1073/pnas.1508382112; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; MAFF, 1986, ANAL AGR MAT MAT MAN, VThird; Maillard E, 2014, GLOBAL CHANGE BIOL, V20, P666, DOI 10.1111/gcb.12438; Manning P, 2015, ECOLOGY, V96, P1492, DOI 10.1890/14-1307.1; Manning P, 2015, J APPL ECOL, V52, P1188, DOI 10.1111/1365-2664.12478; Manning P, 2013, SOIL ECOLOGY AND ECOSYSTEM SERVICES, P256; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; O'Donnell AG, 2001, PLANT SOIL, V232, P135, DOI 10.1023/A:1010394221729; Phoenix GK, 2006, GLOBAL CHANGE BIOL, V12, P470, DOI 10.1111/j.1365-2486.2006.01104.x; Pietri JCA, 2008, SOIL BIOL BIOCHEM, V40, P1856, DOI [10.1016/j.soilbio.2008.03.020, 10.1016/i.soilbio.2008.03.020]; Pywell RF, 2004, J APPL ECOL, V41, P880, DOI 10.1111/j.0021-8901.2004.00940.x; R Core Team, 2015, R LANG ENV STAT COMP; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Rodwell JS, 1998, BRIT PLANT COMMUNITI, V3; Rothamsted Research, 2016, EL ROTH ARCH 2016; Rowell D.L., 1994, SOIL SCI METHODS APP, V1st ed., DOI 10.4324/9781315844855; Schroder A, 2005, OIKOS, V110, P3, DOI 10.1111/j.0030-1299.2005.13962.x; SHIEL RS, 1984, PLANT SOIL, V76, P349, DOI 10.1007/BF02205592; SHIEL RS, 1986, J SOIL SCI, V37, P249, DOI 10.1111/j.1365-2389.1986.tb00026.x; SHIEL RS, 1991, P N ENGLAND SOILS DI, V26, P35; SILVERTOWN J, 1980, J APPL ECOL, V17, P491, DOI 10.2307/2402344; Silvertown J, 2006, J ECOL, V94, P801, DOI 10.1111/j.1365-2745.2006.01145.x; Silvertown J, 2010, TRENDS ECOL EVOL, V25, P556, DOI 10.1016/j.tree.2010.06.015; Simkin J. M., 2015, Aspects of Applied Biology, P75; Stevens CJ, 2011, ENVIRON POLLUT, V159, P665, DOI 10.1016/j.envpol.2010.12.008; Storkey J, 2015, NATURE, V528, P401, DOI 10.1038/nature16444; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Sutton M.A, 2011, EUROPEAN NITROGEN AS, DOI DOI 10.1017/CBO9780511976988; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; TILMAN D, 1993, ECOLOGY, V74, P2179, DOI 10.2307/1939572; TILMAN D, 1987, ECOL MONOGR, V57, P189, DOI 10.2307/2937080; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Treseder KK, 2008, ECOL LETT, V11, P1111, DOI 10.1111/j.1461-0248.2008.01230.x; van Groenigen KJ, 2006, P NATL ACAD SCI USA, V103, P6571, DOI 10.1073/pnas.0509038103; Venterink HO, 2001, J ECOL, V89, P1033, DOI 10.1111/j.1365-2745.2001.00616.x; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Warren R. G., 1964, PARK GRASS EXPT, P240, DOI DOI 10.23637/ERA; WATANABE F. S., 1965, SOIL SCI SOC AMER PROC, V29, P677; Zhalnina K, 2015, MICROB ECOL, V69, P395, DOI 10.1007/s00248-014-0530-2	85	48	51	9	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174632	10.1371/journal.pone.0174632	http://dx.doi.org/10.1371/journal.pone.0174632			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350853	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174400068
J	Kumar, R; Mota, LC; Litoff, EJ; Rooney, JP; Boswell, WT; Courter, E; Henderson, CM; Hernandez, JP; Corton, JC; Moore, DD; Baldwin, WS				Kumar, Ramiya; Mota, Linda C.; Litoff, Elizabeth J.; Rooney, John P.; Boswell, W. Tyler; Courter, Elliott; Henderson, Charles M.; Hernandez, Juan P.; Corton, J. Christopher; Moore, David D.; Baldwin, William S.			Compensatory changes in CYP expression in three different toxicology mouse models: CAR-null, Cyp3a-null, and Cyp2b9/10/13-null mice	PLOS ONE			English	Article							PREGNANE-X RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; HEPATOCYTE NUCLEAR FACTORS; P450 GENE-EXPRESSION; CYTOCHROMES P450; DRUG-METABOLISM; XENOBIOTIC METABOLISM; LIVER-MICROSOMES; GROWTH-HORMONE; TESTOSTERONE BIOTRANSFORMATION	Targeted mutant models are common in mechanistic toxicology experiments investigating the absorption, metabolism, distribution, or elimination (ADME) of chemicals from individuals. Key models include those for xenosensing transcription factors and cytochrome P450s (CYP). Here we investigated changes in transcript levels, protein expression, and steroid hydroxylation of several xenobiotic detoxifying CYPs in constitutive androstane receptor (CAR)-null and two CYP-null mouse models that have subfamily members regulated by CAR; the Cyp3a-null and a newly described Cyp2b9/10/13-null mouse model. Compensatory changes in CYP expression that occur in these models may also occur in polymorphic humans, or may complicate interpretation of ADME studies performed using these models. The loss of CAR causes significant changes in several CYPs probably due to loss of CAR mediated constitutive regulation of these CYPs. Expression and activity changes include significant repression of Cyp2a and Cyp2b members with corresponding drops in 6 alpha- and 16 beta-testosterone hydroxylase activity. Further, the ratio of 6 alpha-/15 alpha-hydroxylase activity, a biomarker of sexual dimorphism in the liver, indicates masculinization of female CAR-null mice, suggesting a role for CAR in the regulation of sexually dimorphic liver CYP profiles. The loss of Cyp3a causes fewer changes than CAR. Nevertheless, there are compensatory changes including gender-specific increases in Cyp2a and Cyp2b. Cyp2a and Cyp2b were down-regulated in CAR-null mice, suggesting activation of CAR and potentially PXR following loss of the Cyp3a members. However, the loss of Cyp2b causes few changes in hepatic CYP transcript levels and almost no significant compensatory changes in protein expression or activity with the possible exception of 6a-hydroxylase activity. This lack of a compensatory response in the Cyp2b9/10/13-null mice is probably due to low CYP2B hepatic expression, especially in male mice. Overall, compensatory and regulatory CYP changes followed the order CAR-null > Cyp3a-null > Cyp2b-null mice.	[Kumar, Ramiya; Litoff, Elizabeth J.; Boswell, W. Tyler; Courter, Elliott; Henderson, Charles M.; Baldwin, William S.] Clemson Univ, Biol Sci, Clemson, SC 29634 USA; [Mota, Linda C.; Baldwin, William S.] Clemson Univ, Environm Toxicol, Pendleton, SC 29670 USA; [Rooney, John P.; Corton, J. Christopher] US EPA, NHEERL, Res Triangle Pk, NC 27711 USA; [Hernandez, Juan P.; Moore, David D.] Baylor Coll Med, Mol & Cellular Biol, Houston, TX 77030 USA	Clemson University; Clemson University; United States Environmental Protection Agency; Baylor College of Medicine	Baldwin, WS (corresponding author), Clemson Univ, Biol Sci, Clemson, SC 29634 USA.; Baldwin, WS (corresponding author), Clemson Univ, Environm Toxicol, Pendleton, SC 29670 USA.	Baldwin@clemson.edu		Mota, Linda/0000-0002-1261-5403	National Institutes of Health [R15ES017321, ES017321-S1, ES017321-S2, R01DK46546]; U.S. Environmental Protection Agency; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R15ES017321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Environmental Protection Agency(United States Environmental Protection Agency); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Primary research support for this study was provided by National Institutes of Health (www.nih.gov) grants R15ES017321 (WSB), ES017321-S1 and S2 (WSB, EC, CMH), and R01DK46546 (DDM). Some of the information in this document has been funded by the U.S. Environmental Protection Agency (www.epa.gov).	Acevedo R, 2005, J APPL TOXICOL, V25, P339, DOI 10.1002/jat.1078; Anakk S, 2003, FASEB J, V17, P1736, DOI 10.1096/fj.02-1004fje; Baldwin WS, 2009, TOXICOL SCI, V107, P93, DOI 10.1093/toxsci/kfn206; BALDWIN WS, 1992, CHEM-BIOL INTERACT, V83, P155, DOI 10.1016/0009-2797(92)90043-K; BURKHART BA, 1985, J BIOL CHEM, V260, P5357; Bylund J, 1998, J PHARMACOL EXP THER, V284, P51; CAPDEVILA JH, 1990, J BIOL CHEM, V265, P10865; Choi HK, 2000, GROWTH HORM IGF RES, pS1; Cui JY, 2012, DRUG METAB DISPOS, V40, P1226, DOI 10.1124/dmd.111.042697; Damiri B, 2012, TOXICOL SCI, V125, P368, DOI 10.1093/toxsci/kfr309; Dong BN, 2009, HEPATOLOGY, V50, P622, DOI 10.1002/hep.23025; Dostalek M, 2011, BRIT J PHARMACOL, V163, P937, DOI 10.1111/j.1476-5381.2011.01270.x; Du LP, 2005, ARCH BIOCHEM BIOPHYS, V435, P125, DOI 10.1016/j.abb.2004.11.023; Faucette SR, 2000, DRUG METAB DISPOS, V28, P1222; Finn RD, 2009, BIOCHEM J, V417, P43, DOI 10.1042/BJ20080740; Forman BM, 1998, NATURE, V395, P612, DOI 10.1038/26996; Foxenberg RJ, 2007, DRUG METAB DISPOS, V35, P189, DOI 10.1124/dmd.106.012427; Gaytan BD, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00110; Gelboin HV, 1995, BIOCHEM PHARMACOL, V50, P1841, DOI 10.1016/0006-2952(95)02077-2; Gu J, 2003, J BIOL CHEM, V278, P25895, DOI 10.1074/jbc.M303125200; Hasegawa M, 2011, MOL PHARMACOL, V80, P518, DOI 10.1124/mol.111.071845; Hashimoto M, 2013, J LIPID RES, V54, P2060, DOI 10.1194/jlr.M033464; Hashita T, 2008, DRUG METAB DISPOS, V36, P1080, DOI 10.1124/dmd.107.019729; Henderson CJ, 2003, J BIOL CHEM, V278, P13480, DOI 10.1074/jbc.M212087200; Hernandez J. P., 2009, Current Pharmacogenomics & Personalized Medicine, V7, P81; Hernandez JP, 2009, TOXICOLOGY, V256, P53, DOI 10.1016/j.tox.2008.11.002; Hernandez JP, 2007, TOXICOL SCI, V98, P416, DOI 10.1093/toxsci/kfm107; Hernandez JP, 2006, TOXICOL APPL PHARM, V216, P186, DOI 10.1016/j.taap.2006.05.014; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Horii T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04513; IMAOKA S, 1989, J BIOCHEM-TOKYO, V105, P939, DOI 10.1093/oxfordjournals.jbchem.a122783; Jarukamjorn K, 2002, BIOCHEM PHARMACOL, V63, P2037, DOI 10.1016/S0006-2952(02)00989-9; Jarukamjorn K, 2001, BIOCHEM PHARMACOL, V62, P161, DOI 10.1016/S0006-2952(01)00656-6; Je YT, 2015, ARCH TOXICOL, V89, P579, DOI 10.1007/s00204-014-1268-9; Kamiyama Y, 2007, DRUG METAB PHARMACOK, V22, P287, DOI 10.2133/dmpk.22.287; Kawamoto T, 2000, MOL ENDOCRINOL, V14, P1897, DOI 10.1210/me.14.11.1897; Keeney DS, 1998, J BIOL CHEM, V273, P32071, DOI 10.1074/jbc.273.48.32071; Kodama S, 2011, NUCLEIC ACIDS RES, V39, P8392, DOI 10.1093/nar/gkr458; Kretschmer XC, 2005, CHEM-BIOL INTERACT, V155, P111, DOI 10.1016/j.cbi.2005.06.003; Ledda-Columbano GM, 2003, CARCINOGENESIS, V24, P1059, DOI 10.1093/carcin/bgg063; Lee C, 2006, DRUG METAB DISPOS, V34, P1530, DOI 10.1124/dmd.106.009936; Lee PC, 1998, TOXICOL LETT, V99, P117, DOI 10.1016/S0378-4274(98)00153-2; Luisier R, 2014, TOXICOL SCI, V139, P501, DOI 10.1093/toxsci/kfu038; MAUREL P, 1996, CYTOCHROMES P450 MET, P241; Meibohm B, 2002, CLIN PHARMACOKINET, V41, P329, DOI 10.2165/00003088-200241050-00002; Mo SL, 2009, CURR DRUG METAB, V10, P730, DOI 10.2174/138920009789895534; Mota LC, 2011, TOXICOL APPL PHARM, V252, P259, DOI 10.1016/j.taap.2011.02.017; Mota LC, 2010, DRUG METAB DISPOS, V38, P1582, DOI 10.1124/dmd.110.032961; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Mutoh S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003705; NOSHIRO M, 1986, J BIOL CHEM, V261, P5923; Oshida K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150284; Park SH, 1999, J BIOL CHEM, V274, P7421, DOI 10.1074/jbc.274.11.7421; Patoine D, 2013, DRUG METAB DISPOS, V41, P952, DOI 10.1124/dmd.112.050641; Peng L, 2012, DRUG METAB DISPOS, V40, P1198, DOI 10.1124/dmd.112.045088; Perloff MD, 2000, J PHARMACOL EXP THER, V292, P618; Petrick JS, 2007, DRUG METAB DISPOS, V35, P1806, DOI 10.1124/dmd.107.015974; Renaud HJ, 2011, TOXICOL SCI, V124, P261, DOI 10.1093/toxsci/kfr240; RENAUD JP, 1995, NATURE, V378, P681, DOI 10.1038/378681a0; Scheer N, 2014, DRUG METAB DISPOS, V42, P1022, DOI 10.1124/dmd.114.057885; Scheer N, 2010, DRUG METAB DISPOS, V38, P1046, DOI 10.1124/dmd.109.031872; Shou MG, 2000, EUR J PHARMACOL, V394, P199, DOI 10.1016/S0014-2999(00)00079-0; Smith G, 1998, BIOCHEM J, V331, P783, DOI 10.1042/bj3310783; Staudinger J, 2001, DRUG METAB DISPOS, V29, P1467; Sueyoshi T, 2008, MOL PHARMACOL, V73, P1113, DOI 10.1124/mol.107.042960; Tien ES, 2006, XENOBIOTICA, V36, P1152, DOI 10.1080/00498250600861827; Tzameli I, 2000, MOL CELL BIOL, V20, P2951, DOI 10.1128/MCB.20.9.2951-2958.2000; van Herwaarden AE, 2007, J CLIN INVEST, V117, P3583, DOI 10.1172/JCI33435; van Waterschoot RAB, 2008, MOL PHARMACOL, V73, P1029, DOI 10.1124/mol.107.043869; VANDERHO.TA, 1974, J BIOL CHEM, V249, P6302; Vrzal R, 2010, TOXICOL LETT, V193, P183, DOI 10.1016/j.toxlet.2010.01.004; Wang HB, 2008, CURR DRUG METAB, V9, P598, DOI 10.2174/138920008785821710; Wang J, 2014, EXCLI J, V13, P728; Warner NA, 2009, ENVIRON SCI TECHNOL, V43, P114, DOI 10.1021/es802237u; WAXMAN DJ, 1983, J BIOL CHEM, V258, P1937; WAXMAN DJ, 1988, BIOCHEM PHARMACOL, V37, P71, DOI 10.1016/0006-2952(88)90756-3; Wei Y, 2013, DRUG METAB DISPOS, V41, P132, DOI 10.1124/dmd.112.048736; Wilson VS, 1998, TOXICOL APPL PHARM, V148, P158, DOI 10.1006/taap.1997.8319; Wilson VS, 1999, ENVIRON HEALTH PERSP, V107, P377, DOI 10.2307/3434541; Wiwi CA, 2005, J BIOL CHEM, V280, P3259, DOI 10.1074/jbc.M409294200; Wiwi CA, 2004, MOL ENDOCRINOL, V18, P1975, DOI 10.1210/me.2004-0129; Wiwi CA, 2004, GROWTH FACTORS, V22, P79, DOI 10.1080/08977190410001715172; Wortham M, 2007, DRUG METAB DISPOS, V35, P1700, DOI 10.1124/dmd.107.016436; Xie HJ, 2003, PHARMACOGENOMICS J, V3, P53, DOI 10.1038/sj.tpj.6500157; Xie W, 2000, GENE DEV, V14, P3014, DOI 10.1101/gad.846800; Yamada H, 2002, TOXICOL APPL PHARM, V180, P1, DOI 10.1006/taap.2002.9366	86	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174355	10.1371/journal.pone.0174355	http://dx.doi.org/10.1371/journal.pone.0174355			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350814	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174400027
J	Li, YR; Wang, J; Tang, YH; Han, X; Liu, B; Hu, H; Li, XL; Yang, K; Yuan, J; Miao, XP; Yao, P; Wei, S; Wang, YJ; Liang, Y; Zhang, XM; Guo, H; Pan, A; Yang, HD; Hu, FB; Wu, TC; He, MA				Li, Yaru; Wang, Jing; Tang, Yuhan; Han, Xu; Liu, Bing; Hu, Hua; Li, Xiulou; Yang, Kun; Yuan, Jing; Miao, Xiaoping; Yao, Ping; Wei, Sheng; Wang, Youjie; Liang, Yuan; Zhang, Xiaomin; Guo, Huan; Pan, An; Yang, Handong; Hu, Frank B.; Wu, Tangchun; He, Meian			Bidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: Evidence from the Dongfeng-Tongji cohort study	PLOS ONE			English	Article							INSULIN-RESISTANCE; METABOLIC SYNDROME; RISK-FACTORS; MELLITUS; PREVALENCE; DIAGNOSIS; STEATOHEPATITIS; OVERWEIGHT; MANAGEMENT; OBESITY	Objectives The aim of this study is to examine the bidirectional association between nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes mellitus (T2DM). Methods The data was derived from the Dongfeng-Tongji cohort study, which was established in 2008 and followed until October 2013. NAFLD was classified as none, mild, moderate/ severe based on ultrasound examination. The analysis to examine the association between NAFLD and incident T2DM risk included 18,111 participants free of diabetes at baseline and the duration of follow-up was 4.60 +/- 0.60 years. Cox proportional regression model was used to calculate the hazard ratio (HR) for the association. The analysis to investigate the association between T2DM and incident NAFLD risk included 12,435 participants free of NAFLD at baseline. Logistic regression model was used to calculate the odd ratio (OR) of NAFLD. Results Compared with those without NAFLD, individuals with mild or moderate/severe NAFLD had a monotonic elevated risk of developing T2DM (HR: 1.88 [95% CI: 1.63-2.18] and 2.34 [1.85-2.96], respectively) after adjustment for potential confounders. In a parallel analysis, compared to participants with fasting plasma glucose < 6.1 mmol/L, the ORs of developing NAFLD in subjects with impaired fasting glucose and T2DM were 1.35 (95% CI: 1.16-1.57) and 1.40 (95% CI: 1.22-1.62), respectively. Conclusions Our results provide compelling evidence that the NAFLD-T2DM association is bidirectional in Chinese population.	[Li, Yaru; Wang, Jing; Tang, Yuhan; Han, Xu; Liu, Bing; Hu, Hua; Yuan, Jing; Miao, Xiaoping; Yao, Ping; Wei, Sheng; Wang, Youjie; Liang, Yuan; Zhang, Xiaomin; Guo, Huan; Pan, An; Wu, Tangchun; He, Meian] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth, Wuhan, Hubei, Peoples R China; [Li, Yaru; Wang, Jing; Tang, Yuhan; Han, Xu; Liu, Bing; Hu, Hua; Yuan, Jing; Miao, Xiaoping; Yao, Ping; Wei, Sheng; Wang, Youjie; Liang, Yuan; Zhang, Xiaomin; Guo, Huan; Pan, An; Wu, Tangchun; He, Meian] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, State Key Lab Environm Hlth Incubating, Wuhan, Hubei, Peoples R China; [Li, Xiulou; Yang, Kun; Yang, Handong] Dongfeng Motor Corp, Dongfeng Cent Hosp, Shiyan, Hubei, Peoples R China; [Li, Xiulou; Yang, Kun; Yang, Handong] Hubei Univ Med, Shiyan, Hubei, Peoples R China; [Hu, Frank B.] Harvard Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Hu, Frank B.] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Dongfeng Motor; Hubei University of Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	He, MA (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth, Wuhan, Hubei, Peoples R China.; He, MA (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, State Key Lab Environm Hlth Incubating, Wuhan, Hubei, Peoples R China.	hemeian@hotmail.com	Zhang, Xiaomin/F-3206-2018; Zhang, Xiaomin/GVT-8927-2022; Pan, An/C-5572-2011; miao, xiaoping/C-4336-2011	Pan, An/0000-0002-1089-7945; miao, xiaoping/0000-0002-6818-9722	National Natural Science Foundation [NSFC-81522040, 81473051, 81230069]; 111 Project [B12004]; Program for Changjiang Scholars; Innovative Research Team in University of Ministry of Education of China [IRT1246]; China Medical Board [12-113]; Program for the New Century Excellent Talents in University [NCET-110169]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project); Program for Changjiang Scholars(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Innovative Research Team in University of Ministry of Education of China(Ministry of Education, China); China Medical Board; Program for the New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the grant from the National Natural Science Foundation (grant NSFC-81522040, 81473051, and 81230069); the 111 Project (No. B12004); the Program for Changjiang Scholars; Innovative Research Team in University of Ministry of Education of China (No. IRT1246); China Medical Board (No. 12-113) and the Program for the New Century Excellent Talents in University (NCET-110169) for Meian He.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc12-s004, 10.2337/dc35-S011]; [Anonymous], 2006, DEFINITION DIAGNOSIS; Ballestri S, 2016, HEPATOL RES, V46, P1074, DOI 10.1111/hepr.12656; Ballestri S, 2016, J GASTROEN HEPATOL, V31, P936, DOI 10.1111/jgh.13264; Ballestri S, 2015, EXPERT REV GASTROENT, V9, P603, DOI 10.1586/17474124.2015.1007955; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; Fan JG, 2011, J DIGEST DIS, V12, P38, DOI 10.1111/j.1751-2980.2010.00476.x; Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010; Fukuda T, 2016, EUR J GASTROEN HEPAT, V28, P1443, DOI 10.1097/MEG.0000000000000736; Fukuda T, 2016, LIVER INT, V36, P275, DOI 10.1111/liv.12912; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Kim CH, 2008, DIABETIC MED, V25, P476, DOI 10.1111/j.1464-5491.2008.02410.x; Lee IT, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-43; Leite NC, 2009, LIVER INT, V29, P113, DOI 10.1111/j.1478-3231.2008.01718.x; Li ZZ, 2014, J GASTROEN HEPATOL, V29, P42, DOI 10.1111/jgh.12428; Lonardo A, 2015, DIGEST LIVER DIS, V47, P997, DOI 10.1016/j.dld.2015.08.004; Lonardo A, 2011, EXPERT REV GASTROENT, V5, P279, DOI [10.1586/EGH.11.19, 10.1586/egh.11.19]; Lopez-Velazquez JA, 2014, ANN HEPATOL, V13, P166, DOI 10.1016/S1665-2681(19)30879-8; Loria P, 2013, HEPATOL RES, V43, P51, DOI 10.1111/j.1872-034X.2012.01031.x; Najarian RM, 2006, ARCH INTERN MED, V166, P106, DOI 10.1001/archinte.166.1.106; Nakahara T, 2014, J GASTROENTEROL, V49, P1477, DOI 10.1007/s00535-013-0911-1; Ortiz-Lopez C, 2012, DIABETES CARE, V35, P873, DOI 10.2337/dc11-1849; Park SK, 2013, HEPATOLOGY, V57, P1378, DOI 10.1002/hep.26183; Porepa L, 2010, CAN MED ASSOC J, V182, pE526, DOI 10.1503/cmaj.092144; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Smith BW, 2011, NAT REV ENDOCRINOL, V7, P456, DOI 10.1038/nrendo.2011.72; Sung KC, 2013, J CLIN ENDOCR METAB, V98, P3637, DOI 10.1210/jc.2013-1519; Targher G, 2016, DIABETES METAB, V42, P142, DOI 10.1016/j.diabet.2016.04.002; Valenti L, 2016, LIVER INT, V36, P1563, DOI 10.1111/liv.13185; Williams KH, 2013, ENDOCR REV, V34, P84, DOI 10.1210/er.2012-1009; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yamazaki H, 2015, DIABETES CARE, V38, P1673, DOI 10.2337/dc15-0140; Yki-Jarvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4; Zhang T, 2015, ATHEROSCLEROSIS, V240, P144, DOI 10.1016/j.atherosclerosis.2015.02.049; Zhang YY, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008204; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	43	36	38	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174291	10.1371/journal.pone.0174291	http://dx.doi.org/10.1371/journal.pone.0174291			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350839	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174400023
J	Lu, YZ; Jing, JJ; Sun, LP; Gong, YH; Chen, MY; Wang, ZY; Sun, MJ; Yuan, Y				Lu, Youzhu; Jing, Jingjing; Sun, Liping; Gong, Yuehua; Chen, Moye; Wang, Zeyang; Sun, Mingjun; Yuan, Yuan			Expression of claudin-11,-23 in different gastric tissues and its relationship with the risk and prognosis of gastric cancer	PLOS ONE			English	Article							TIGHT JUNCTIONS; EPITHELIAL-CELLS; CARCINOMA; PROTEIN; INVASIVENESS; TARGETS; GENE; PROLIFERATION; METASTASIS; NEOPLASMS	Claudins play an important role in regulating the permeability of epithelial and endothelial cells and in the maintenance of cell polarity. We aimed to investigate expression of claudin-11, -23 in different gastric tissues and its relationship with clinicopathologic parameters and prognosis of gastric cancer. We compared their expression levels in the paired cancerous tissues versus those in the adjacent noncancerous tissues by real-time PCR, western blotting and immunohistochemistry. The results showed that the expression of claudin-11, -23 was greatly increased in paracancerous gastric tissue compared with cancerous tissue. We also compared their expression levels of tissues from gastric cancer, superficial gastritis, and atrophic gastritis by immunohistochemistry. The results indicated that the expression of claudin-11 and 23 was significantly higher in superficial gastritis than that in atrophic gastritis and gastric cancer. The expression of claudin-23 was significantly lower in atrophic gastritis than that in gastric cancer, but no obviously difference was observed for claudin-11. As for analysis of clinicopathologic parameters of gastric cancer, logistic multiple regression indicated that claudin-11 was significantly associated with sex, smoking, alcohol, H. pylori infection and Borrmann classification while claudin-23 was significantly associated with vessel cancer embolus. Cox multivariate survival analysis indicated that gastric cancer patients with negative claudin-23 expression had significantly longer overall survival. In conclusion, the expression of claudin-11, -23 was remarkably downregulated in gastric cancer. Abnormal expression of these proteins was significantly correlated with some clinicopathologic parameters. In particular, claudin-23 positive expression was associated with poor prognostic outcomes of gastric cancer patients and may therefore serve as an independent prognosticator of patient survival.	[Lu, Youzhu; Chen, Moye; Sun, Mingjun] China Med Univ, Digest Dept, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China; [Jing, Jingjing; Sun, Liping; Gong, Yuehua; Wang, Zeyang; Yuan, Yuan] China Med Univ, Tumor Etiol & Screening Dept, Canc Inst & Gen Surg, Affiliated Hosp 1,Key Lab Canc Etiol & Prevent,Li, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Sun, MJ (corresponding author), China Med Univ, Digest Dept, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China.; Yuan, Y (corresponding author), China Med Univ, Tumor Etiol & Screening Dept, Canc Inst & Gen Surg, Affiliated Hosp 1,Key Lab Canc Etiol & Prevent,Li, Shenyang, Liaoning, Peoples R China.	smjmw@sina.com; yuanyuan@cmu.edu.cn	Yuan, Yuan/GVS-5120-2022		National Science-technology Support Plan Project [2015BA113B07]; National Natural Science Foundation [81670506]	National Science-technology Support Plan Project; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work is supported by grants from the National Science-technology Support Plan Project (ref no. 2015BA113B07) and National Natural Science Foundation (ref no. 81670506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008002; Awsare NS, 2011, ONCOL REP, V25, P1503, DOI 10.3892/or.2011.1244; Chang TL, 2010, GASTROENTEROLOGY, V138, P255, DOI 10.1053/j.gastro.2009.08.044; Cohn ML, 2005, J CUTAN PATHOL, V32, P533, DOI 10.1111/j.0303-6987.2005.00324.x; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Gonzalez CA, 2016, J GASTROEN HEPATOL, V31, P953, DOI 10.1111/jgh.13249; Gonzalez JE, 2009, FREE RADICAL BIO MED, V47, P1561, DOI 10.1016/j.freeradbiomed.2009.08.024; Hamilton SR, 2000, WHO CLASSIFICATION T; Huang J, 2015, ONCOTARGET, V6, P1652, DOI 10.18632/oncotarget.2936; Huang J, 2014, INT J ONCOL, V44, P1293, DOI 10.3892/ijo.2014.2298; Ishizaki T, 2003, EXP CELL RES, V290, P275, DOI 10.1016/S0014-4827(03)00354-9; Jung H, 2011, J SURG RES, V167, pE185, DOI 10.1016/j.jss.2010.02.010; Katoh M, 2003, INT J MOL MED, V11, P683; Kim DH, 2011, J SURG ONCOL, V104, P585, DOI 10.1002/jso.21919; Kominsky SL, 2003, ONCOGENE, V22, P2021, DOI 10.1038/sj.onc.1206199; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Kwon MJ, 2011, LAB INVEST, V91, P1652, DOI 10.1038/labinvest.2011.117; Li WJ, 2016, ONCOL LETT, V11, P2995, DOI 10.3892/ol.2016.4333; Lin Z, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-133; Liu Gui-Sheng, 2006, Ai Zheng, V25, P185; Maryan N, 2015, MOL MED REP, V12, P728, DOI 10.3892/mmr.2015.3378; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Nunbhakdi-Craig V, 2002, J CELL BIOL, V158, P967, DOI 10.1083/jcb.200206114; Oshima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074757; Peklak-Scott C, 2008, MOL CANCER THER, V7, P3247, DOI 10.1158/1535-7163.MCT-08-0250; Santiago JMR, 2011, CIR ESPAN, V89, P275, DOI 10.1016/j.ciresp.2010.10.011; Satake S, 2008, PATHOL INT, V58, P156, DOI 10.1111/j.1440-1827.2007.02204.x; Song X, 2013, CELL IMMUNOL, V286, P22, DOI 10.1016/j.cellimm.2013.10.008; Stolte M, 2001, CAN J GASTROENTEROL, V15, P591, DOI 10.1155/2001/367832; Tsukita S, 2000, ANN NY ACAD SCI, V915, P129, DOI 10.1111/j.1749-6632.2000.tb05235.x; Wang Q, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S85478; Wang W, 2010, MOL MED REP, V3, P845, DOI 10.3892/mmr.2010.334; Weinstein R S, 1976, Adv Cancer Res, V23, P23, DOI 10.1016/S0065-230X(08)60543-6; Wroblewski LE, 2015, GUT, V64, P720, DOI 10.1136/gutjnl-2014-307650; Yang JH, 2015, ONCOL REP, V34, P1415, DOI 10.3892/or.2015.4104; Zahraoui A, 2000, J CELL BIOL, V151, pF31, DOI 10.1083/jcb.151.5.F31; Zhang SJ, 2014, DIGEST DIS SCI, V59, P1754, DOI 10.1007/s10620-014-3107-5	39	13	15	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174476	10.1371/journal.pone.0174476	http://dx.doi.org/10.1371/journal.pone.0174476			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350854	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174400049
J	Mina, F; Attina, V; Duroc, Y; Veuillet, E; Truy, E; Hung, TV				Mina, Faten; Attina, Virginie; Duroc, Yvan; Veuillet, Evelyne; Truy, Eric; Hung Thai-Van			Auditory steady state responses and cochlear implants: Modeling the artifact-response mixture in the perspective of denoising	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; BRAIN-STEM RESPONSE; EVOKED POTENTIALS; ELECTRICAL-STIMULATION; SPEECH-PERCEPTION; MINIMIZATION; ATTENUATION; INFORMATION; ALGORITHMS; RECIPIENTS	Auditory steady state responses (ASSRs) in cochlear implant (CI) patients are contaminated by the spread of a continuous CI electrical stimulation artifact. The aim of this work was to model the electrophysiological mixture of the CI artifact and the corresponding evoked potentials on scalp electrodes in order to evaluate the performance of denoising algorithms in eliminating the CI artifact in a controlled environment. The basis of the proposed computational framework is a neural mass model representing the nodes of the auditory pathways. Six main contributors to auditory evoked potentials from the cochlear level and up to the auditory cortex were taken into consideration. The simulated dynamics were then projected into a 3-layer realistic head model. 32-channel scalp recordings of the CI artifact-response were then generated by solving the electromagnetic forward problem. As an application, the framework's simulated 32-channel datasets were used to compare the performance of 4 commonly used Independent Component Analysis (ICA) algorithms: infomax, extended infomax, jade and fastICA in eliminating the CI artifact. As expected, two major components were detectable in the simulated datasets, a low frequency component at the modulation frequency and a pulsatile high frequency component related to the stimulation frequency. The first can be attributed to the phase-locked ASSR and the second to the stimulation artifact. Among the ICA algorithms tested, simulations showed that infomax was the most efficient and reliable in denoising the CI artifact-response mixture. Denoising algorithms can induce undesirable deformation of the signal of interest in real CI patient recordings. The proposed framework is a valuable tool for evaluating these algorithms in a controllable environment ahead of experimental or clinical applications.	[Mina, Faten; Attina, Virginie; Duroc, Yvan; Veuillet, Evelyne; Truy, Eric; Hung Thai-Van] Claude Bernard Lyon 1 Univ, Lyon, France; [Mina, Faten; Attina, Virginie; Veuillet, Evelyne; Truy, Eric; Hung Thai-Van] CNRS, Lyon Neurosci Res Ctr, INSERM, U1028,UMR5292, Lyon, France; [Mina, Faten; Attina, Virginie; Veuillet, Evelyne; Hung Thai-Van] Civil Hosp Lyon, Dept Audiol & Otoneurol Evaluat, Lyon, France; [Truy, Eric] Civil Hosp Lyon, ENT Dept, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; CHU Lyon	Mina, F (corresponding author), Claude Bernard Lyon 1 Univ, Lyon, France.; Mina, F (corresponding author), CNRS, Lyon Neurosci Res Ctr, INSERM, U1028,UMR5292, Lyon, France.; Mina, F (corresponding author), Civil Hosp Lyon, Dept Audiol & Otoneurol Evaluat, Lyon, France.	faten.m.mina@gmail.com	Duroc, Yvan/C-1462-2017; truy, eric/J-9097-2017	truy, eric/0000-0002-1769-8623; THAI-VAN, Hung/0000-0002-6647-7640; Veuillet, Evelyne/0000-0002-4068-0130	French Fonds Unique Interministeriel (FUI) (Neurosyllabic)	French Fonds Unique Interministeriel (FUI) (Neurosyllabic)	This study is part of a larger project that is supported by funding from the French Fonds Unique Interministeriel (FUI) (Neurosyllabic). The funding was acquired and received by Prof. Hung Thai-Van. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBAS PJ, 1988, HEARING RES, V36, P153, DOI 10.1016/0378-5955(88)90057-3; Acar ZA, 2016, NEUROIMAGE, V124, P168, DOI 10.1016/j.neuroimage.2015.08.032; Acunzo DJ, 2012, J NEUROSCI METH, V209, P212, DOI 10.1016/j.jneumeth.2012.06.011; Akhoun I, 2013, HEARING RES, V302, P60, DOI 10.1016/j.heares.2013.04.005; Uriguen JA, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/3/031001; Arora K, 2009, INT J AUDIOL, V48, P561, DOI 10.1080/14992020902858967; Bakhos D, 2012, INT J PEDIATR OTORHI, V76, P1627, DOI 10.1016/j.ijporl.2012.07.034; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Cardoso J-F, 1993, RADAR SIGNAL PROCE F; Castaneda-Villa N, 2011, IEEE T BIO-MED ENG, V58, P348, DOI 10.1109/TBME.2010.2072957; Cosandier-Rimele D, 2007, IEEE T BIO-MED ENG, V54, P380, DOI 10.1109/TBME.2006.890489; Deprez H, 2014, 22ND EUROPEAN SIGNAL; Di Lella F, 2010, ACTA OTO-LARYNGOL, V130, P102, DOI 10.3109/00016480902896113; Freeman W. J., 1992, International Journal of Bifurcation and Chaos in Applied Sciences and Engineering, V2, P451, DOI 10.1142/S0218127492000653; Friesen LM, 2010, HEARING RES, V259, P95, DOI 10.1016/j.heares.2009.10.012; Gilley PM, 2006, CLIN NEUROPHYSIOL, V117, P1772, DOI 10.1016/j.clinph.2006.04.018; Goncalves SI, 2003, IEEE T BIO-MED ENG, V50, P754, DOI 10.1109/TBME.2003.812164; Gransier R, 2016, HEARING RES, V335, P149, DOI 10.1016/j.heares.2016.03.006; Guenser Geoffrey, 2015, Cochlear Implants Int, V16, P32, DOI 10.1179/1754762814Y.0000000082; Herdman AT, 2002, BRAIN TOPOGR, V15, P69, DOI 10.1023/A:1021470822922; Hofmann M, 2012, JARO-J ASSOC RES OTO, V13, P573, DOI 10.1007/s10162-012-0321-8; Hofmann M, 2010, JARO-J ASSOC RES OTO, V11, P267, DOI 10.1007/s10162-009-0201-z; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; James CJ, 2005, PHYSIOL MEAS, V26, pR15, DOI 10.1088/0967-3334/26/1/R02; KASPER A, 1992, ORL J OTO-RHINO-LARY, V54, P285, DOI 10.1159/000276317; Kullback S., 1968, INFORM THEORY STAT; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Macherey O, 2006, JARO-J ASSOC RES OTO, V7, P253, DOI 10.1007/s10162-006-0040-0; Makeig S, 2000, REMOVAL MUSCLE ARTIF; Martin BA, 2007, J AM ACAD AUDIOL, V18, P126, DOI 10.3766/jaaa.18.2.5; Mc Laughlin M, 2013, HEARING RES, V302, P84, DOI 10.1016/j.heares.2013.05.006; Menard M, 2004, INT J AUDIOL, V43, pS39; Menard M, 2008, HEARING RES, V235, P105, DOI 10.1016/j.heares.2007.10.007; Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Picton TW, 2003, INT J AUDIOL, V42, P177, DOI 10.3109/14992020309101316; Picton TW, 2001, CLIN NEUROPHYSIOL, V112, P1698, DOI 10.1016/S1388-2457(01)00608-3; RUSH S, 1968, ANESTH ANAL CURR RES, V47, P717; Safieddine D, 2012, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2012-127; Scott DW, 2010, WIRES COMPUT STAT, V2, P497, DOI 10.1002/wics.103; Small SA, 2004, EAR HEARING, V25, P611, DOI 10.1097/00003446-200412000-00009; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Thai-Van H, 2004, CLIN NEUROPHYSIOL, V115, P2811, DOI 10.1016/j.clinph.2004.06.024; Thai-Van H, 2001, INT J PEDIATR OTORHI, V58, P153, DOI 10.1016/S0165-5876(01)00426-8; Thai-Van H, 2007, CLIN NEUROPHYSIOL, V118, P676, DOI 10.1016/j.clinph.2006.11.010; Timm L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045375; Truy E, 1998, LARYNGOSCOPE, V108, P554, DOI 10.1097/00005537-199804000-00017; Vaerenberg B, 2014, SCIENTIFICWORLDJOURN, V2014; Vaerenberg B, 2014, EAR HEARING, V35, P533, DOI 10.1097/AUD.0000000000000039; Valdes AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090044; Viola FC, 2011, PSYCHOPHYSIOLOGY, V48, P1470, DOI 10.1111/j.1469-8986.2011.01224.x; Viola FC, 2012, HEARING RES, V284, P6, DOI 10.1016/j.heares.2011.12.010; Widmann A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00233; Witkowski M, 2015, NEUROIMAGE; Wong DDE, 2009, IEEE T BIO-MED ENG, V56, P2851, DOI 10.1109/TBME.2009.2029239	56	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174462	10.1371/journal.pone.0174462	http://dx.doi.org/10.1371/journal.pone.0174462			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350887	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174400046
J	Ruckert, KL; Oddo, PC; Keller, K				Ruckert, Kelsey L.; Oddo, Perry C.; Keller, Klaus			Impacts of representing sea-level rise uncertainty on future flood risks: An example from San Francisco Bay	PLOS ONE			English	Article							PROTECTION; DESIGN; TIDE	Rising sea levels increase the probability of future coastal flooding. Many decision-makers use risk analyses to inform the design of sea-level rise (SLR) adaptation strategies. These analyses are often silent on potentially relevant uncertainties. For example, some previous risk analyses use the expected, best, or large quantile (i.e., 90%) estimate of future SLR. Here, we use a case study to quantify and illustrate how neglecting SLR uncertainties can bias risk projections. Specifically, we focus on the future 100-yr (1% annual exceedance probability) coastal flood height (storm surge including SLR) in the year 2100 in the San Francisco Bay area. We find that accounting for uncertainty in future SLR increases the return level (the height associated with a probability of occurrence) by half a meter from roughly 2.2 to 2.7 m, compared to using the mean sea-level projection. Accounting for this uncertainty also changes the shape of the relationship between the return period (the inverse probability that an event of interest will occur) and the return level. For instance, incorporating uncertainties shortens the return period associated with the 2.2 m return level from a 100-yr to roughly a 7-yr return period (similar to 15% probability). Additionally, accounting for this uncertainty doubles the area at risk of flooding (the area to be flooded under a certain height; e.g., the 100-yr flood height) in San Francisco. These results indicate that the method of accounting for future SLR can have considerable impacts on the design of flood risk management strategies.	[Ruckert, Kelsey L.; Keller, Klaus] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Oddo, Perry C.; Keller, Klaus] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Keller, Klaus] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Carnegie Mellon University	Keller, K (corresponding author), Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA.; Keller, K (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.; Keller, K (corresponding author), Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA.	klaus@psu.edu	Oddo, Perry/AHA-8608-2022; Oddo, Perry/K-3046-2017; Keller, Klaus/A-6742-2013	Oddo, Perry/0000-0003-3061-0304; Ruckert, Kelsey/0000-0001-9513-2636	National Science Foundation through the Network or Sustainable Climate Risk Management (SCRiM) under NSF [GEO-1240507]; Penn State Center for Climate Risk Management; Directorate For Geosciences [1240507] Funding Source: National Science Foundation	National Science Foundation through the Network or Sustainable Climate Risk Management (SCRiM) under NSF; Penn State Center for Climate Risk Management; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was partially supported by the National Science Foundation through the Network or Sustainable Climate Risk Management (SCRiM) under NSF cooperative agreement GEO-1240507 and the Penn State Center for Climate Risk Management. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s). The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.; We thank Stefan Rahmstorf for providing his global sea-level model (http://www.sciencemag.org/content/317/5846/1866.4/suppl/DC1), Gregory Garner for providing his inverse survival function code, and Jared Oyler for testing the reproducibility of the GIS analysis. We also wish to thank Vivek Srikrishnan, Caitlin Spence, Yawen Guan, Patrick Applegate, Nancy Tuana, Alexander Bakker, Murali Haran, Rob Lempert, Chris and Bella Forest, as well as the editor, Lorilee Medders, and Ning Lin for valuable inputs. This work was partially supported by the National Science Foundation through the Network for Sustainable Climate Risk Management (SCRiM) under NSF cooperative agreement GEO-1240507 and the Penn State Center for Climate Risk Management. We also acknowledge the World Climate Research Programme's Working Group on Coupled Modelling and thank the climate modeling groups that participated in the Coupled Model Intercomparison Project Phase 5 (CMIP5; http://cmip-pcmdi.llnl.gov/cmip5/), which supplied the climate model output used in this paper (listed S1 Table). The US Department of Energy's Program for Climate Model Diagnosis and Intercomparison, in partnership with the Global Organization for Earth System Science Portals, provides coordinating support for CMIP5. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s).	[Anonymous], 2015, NAT MAP DOWNL EL; [Anonymous], 2013, NOAA TID CURR SAN FR; [Anonymous], 2016, GLOB SURF TEMP AN GL; [Anonymous], 2015, 2015 TIGER LIN SHAP; Bakker AMR, 2017, CLIMATIC CHANGE, V140, P339, DOI 10.1007/s10584-016-1864-1; Bayes T., 1997, A M F R S PHILOS T R, V53, P370, DOI DOI 10.1098/RSTL.1763.0053; Bloetscher F, 2012, WATER-SUI, V4, P367, DOI 10.3390/w4020367; Buchanan MK, 2016, CLIMATIC CHANGE, V137, P347, DOI 10.1007/s10584-016-1664-7; Church JA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024826; Coles S., 2001, INTRO STAT MODELING; Cooper MJP, 2008, CLIMATIC CHANGE, V90, P475, DOI 10.1007/s10584-008-9422-0; DeConto RM, 2016, NATURE, V531, P591, DOI 10.1038/nature17145; Dibajnia M, 2012, OCEAN COAST MANAGE, V63, P1, DOI 10.1016/j.ocecoaman.2012.02.012; Embrechts P., 1997, MODELLING EXTREMAL E, DOI 10.1007/978-3-642-33483-2; Fisher RA, 1928, P CAMB PHILOS SOC, V24, P180, DOI 10.1017/S0305004100015681; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gilks W.R., 1997, MARKOV CHAIN MONTE C; Hadka D, 2015, ENVIRON MODELL SOFTW, V74, P114, DOI 10.1016/j.envsoft.2015.07.014; Hanak E, 2012, CLIMATIC CHANGE, V111, P17, DOI 10.1007/s10584-011-0241-3; Hanson S, 2011, CLIMATIC CHANGE, V104, P89, DOI 10.1007/s10584-010-9977-4; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Heberger M., 2012, CALIFORNIA ENERGY CO; Houston JR, 2013, J WATERW PORT COAST, V139, P341, DOI 10.1061/(ASCE)WW.1943-5460.0000194; Institute for Water Resources, 2011, 2011R08 IWR US ARM C; Jevrejeva S, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/104008; Jonkman SN, 2009, J FLOOD RISK MANAG, V2, P170, DOI 10.1111/j.1753-318X.2009.01036.x; Jonkman SN, 2013, J COASTAL RES, V29, P1212, DOI 10.2112/JCOASTRES-D-12-00230.1; Kleinosky LR, 2007, NAT HAZARDS, V40, P43, DOI 10.1007/s11069-006-0004-z; Kopp RE, 2016, P NATL ACAD SCI USA, V113, pE1434, DOI 10.1073/pnas.1517056113; Kopp RE, 2014, EARTHS FUTURE, V2, P383, DOI 10.1002/2014EF000239; Lempert R, 2012, CALIFORNIA ENERGY CO; Lickley MJ, 2014, CLIM RISK MANAG, V6, P18, DOI 10.1016/j.crm.2015.01.001; Lin N, 2016, P NATL ACAD SCI USA, V113, P12071, DOI 10.1073/pnas.1604386113; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; McInnes KL, 2013, INT J CLIMATOL, V33, P33, DOI 10.1002/joc.3405; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Moore E., 2009, CALIFORNIA ENERGY CO, VCEC-500-2009-024-F; Murdukhayeva A, 2013, J COASTAL RES, V29, P1, DOI 10.2112/JCOASTRES-D-12-00196.1; Neumann J, 2011, WIRES CLIM CHANGE, V2, P89, DOI 10.1002/wcc.90; NIST, 2003, E HDB STAT METH; NOAA, 2013, NAT COAST POP REP PO; Orton P, 2015, ANN NY ACAD SCI, V1336, P1749; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; Rosenzweig C, 2014, GLOBAL ENVIRON CHANG, V28, P395, DOI 10.1016/j.gloenvcha.2014.05.003; Ruckert KL, 2017, CLIMATIC CHANGE, V140, P349, DOI 10.1007/s10584-016-1858-z; Ruckert KL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170052; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Sriver RL, 2012, CLIMATIC CHANGE, V115, P893, DOI 10.1007/s10584-012-0610-6; Synder JP, 1987, MAP PROJECTIONS WORK; Tebaldi C, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014032; Wuertz D, 2013, FEXTREMES RMETRICS R; ZELLNER A, 1964, J AM STAT ASSOC, V59, P763, DOI 10.2307/2283097	52	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174666	10.1371/journal.pone.0174666	http://dx.doi.org/10.1371/journal.pone.0174666			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350884	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174400071
J	Wang, XY; Liu, CH; Xu, Y; Chen, P; Shen, Y; Xu, YS; Zhao, YB; Chen, WH; Zhang, XY; Ouyang, Y; Wang, Y; Xie, CL; Zhou, MJ; Liu, CL				Wang, Xiyou; Liu, Chuanhai; Xu, Yong; Chen, Ping; Shen, Yue; Xu, Yansheng; Zhao, Yubo; Chen, Weihao; Zhang, Xinyu; Ouyang, Yun; Wang, Yi; Xie, Changliang; Zhou, Maojun; Liu, Cuilong			Combination of mesenchymal stem cell injection with icariin for the treatment of diabetes-associated erectile dysfunction	PLOS ONE			English	Article							MARROW STROMAL CELLS; OXIDATIVE STRESS; IN-VITRO; ADIPOSE-TISSUE; BONE-MARROW; RAT MODEL; IMPROVES ERECTILE; SIGNALING PATHWAY; GENE-THERAPY; VIVO	The present study was aimed to examine whether icariin, a traditional Chinese medicine, could improve therapeutic effects of adipose derived mesenchymal stem cells (ADSCs) for diabetes-associated erectile dysfunction (DMED). DMED were induced in rats by intraperitoneal injection of streptozotocin and confirmed by erectile function measurement. Then, rats of diabetic ED were randomly divided to receive the treatment of saline, ADSCs, icariin or ADSCs combined with icariin respectively. Compared with the treatment by ADSCs or icariin alone, intracavernosum injection of ADSCs combined with the following daily gastric gavage of icariin significantly augmented the value of ICP and ICP/MAP (p<0.01). Meanwhile, the survival of transplanted ADSCs was much improved due to the application of icariin. Similarly, immunofluorescent staining analysis demonstrated that the improved erectile tissue structure by combination of ADSCs and icariin was significantly associated with the increased expression of endothelial markers (vWF) (p<0.01) and smooth muscle markers (alpha-SMA) (p<0.01). Furthermore, the structure changes in corpus cavernosum were further confirmed by the Masson's trichrome staining. To explore the possible mechanism underlying icariin-enhanced therapeutic efficacy of MSCs, we employed an in vitro testing system by introducing H2O2 to imitate oxidative stress condition considering the oxidative environment faced by engrafted ADSCs and anti-oxidative capacity of icariin. In vitro, we found that the addition of icariin considerably reduced the apoptosis of ADSCs, and attenuated the intracellular reactive oxygen species (ROS), the superoxidase dismutase (SOD) activity and the lactate dehydrogenase (LDH). Subsequently, we examined the expression of apoptosis-related proteins and explored the potential signaling pathway through which icariin promoted the survival of ADSCs against oxidative stress. It was demonstrated that icariin significantly inhibited the upregulation of apoptosis-related proteins under oxidative condition, including Box and cleaved caspase-3, while promoted the expression of anti-apoptotic factor BCL2. These effects were accompanied with the activation of signal molecules, PI3K/Akt and STAT3. The further signal protein inhibition assays exhibited that the suppression of STAT3 abrogated the icariin-mediated anti-apoptotic effects observed above, while did not influence the expression of PI3K/Akt. However, P13K inhibition could abrogate icariin mediated STAT3 activation and achieved a similar effect as STAT3 inhibition. Our results suggested that icariin was an effective adjuvant for enhancing ADSC-based therapy of DMEM, which may be ascribed to their protection of ADSCs against oxidative stress via the regulation of PI3K/Akt-STAT3 signal pathway.	[Wang, Xiyou; Chen, Ping; Shen, Yue; Xu, Yansheng; Zhao, Yubo; Chen, Weihao; Zhang, Xinyu; Ouyang, Yun; Wang, Yi; Xie, Changliang; Zhou, Maojun; Liu, Cuilong] PLA Navy Gen Hosp, Dept Urol, Beijing, Peoples R China; [Liu, Chuanhai] Chinese Peoples Liberat Army, Dept Urol, Artillery Gen Hosp 2, Beijing, Peoples R China; [Xu, Yong] Peoples Liberat Army Gen Hosp, Dept Urol, Beijing, Peoples R China	Sixth Medical Center of Chinese PLA General Hospital; Chinese People's Liberation Army General Hospital	Liu, CL (corresponding author), PLA Navy Gen Hosp, Dept Urol, Beijing, Peoples R China.	510198870@qq.com						Ahn GJ, 2005, INT J ANDROL, V28, P260, DOI 10.1111/j.1365-2605.2005.00537.x; Alwaal A, 2015, ADV DRUG DELIVER REV, V82-83, P137, DOI 10.1016/j.addr.2014.11.012; [Anonymous], 2012, THE JOURNAL OF SEXUA, V9, P1801; Assaly-Kaddoum R, 2016, J UROLOGY, V196, P950, DOI 10.1016/j.juro.2016.03.147; Aytac IA, 1999, BJU INT, V84, P50; Belba A, 2016, CLIN BIOCHEM, V49, P70, DOI 10.1016/j.clinbiochem.2015.10.004; Bivalacqua TJ, 2005, J SEX MED, V2, P187, DOI 10.1111/j.1743-6109.2005.20228_1.x; Bivalacqua TJ, 2007, AM J PHYSIOL-HEART C, V292, pH1278, DOI 10.1152/ajpheart.00685.2006; Brant WO, 2007, ENDOCRIN METAB CLIN, V36, P465, DOI 10.1016/j.ecl.2007.02.001; Corbin JD, 2004, INT J IMPOT RES, V16, pS4, DOI 10.1038/sj.ijir.3901205; de Tejada IS, 2005, J SEX MED, V2, P26, DOI 10.1111/j.1743-6109.2005.20103.x; Del Bue M, 2008, VET RES COMMUN, V32, pS51, DOI 10.1007/s11259-008-9093-3; Efimenko A, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-10; Fall PA, 2009, EUR UROL, V56, P716, DOI 10.1016/j.eururo.2008.09.059; Girgih AT, 2014, NUTRIENTS, V6, P5652, DOI 10.3390/nu6125652; Gokce A, 2014, J SEX MED, V11, P1; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Haddad-Mashadrizeh A, 2013, CYTOTHERAPY, V15, P951, DOI 10.1016/j.jcyt.2013.03.003; HEATON JPW, 1991, J UROLOGY, V145, P1099, DOI 10.1016/S0022-5347(17)38543-9; Hsieh TP, 2011, PHYTOMEDICINE, V18, P176, DOI 10.1016/j.phymed.2010.04.003; Huang YP, 2011, J SEX MED, V8, P840, DOI 10.1111/j.1743-6109.2010.02141.x; Kadihasanoglu M, 2016, INT J UROL, V23, P348, DOI 10.1111/iju.13058; Lee M, 2014, BIOCHEM BIOPH RES CO, V446, P983, DOI 10.1016/j.bbrc.2014.03.051; Li Y, 2006, EXP NEUROL, V198, P313, DOI 10.1016/j.expneurol.2005.11.029; Liang Q, 2012, MOLECULES, V17, P13345, DOI 10.3390/molecules171113345; Liu GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072790; Liu T, 2012, J SEX MED, V9, P151; Liu T, 2011, J SEX MED, V8, P2761, DOI 10.1111/j.1743-6109.2011.02421.x; Liu ZQ, 2006, J PHYS CHEM A, V110, P6372, DOI 10.1021/jp053998z; Liu ZJ, 2015, IMMUNOBIOLOGY, V220, P947, DOI 10.1016/j.imbio.2015.02.004; Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044; Ma HP, 2014, CELL PROLIFERAT, V47, P527, DOI 10.1111/cpr.12147; Malavige LS, 2009, J SEX MED, V6, P1232, DOI 10.1111/j.1743-6109.2008.01168.x; Malgieri A, 2010, INT J CLIN EXP MED, V3, P248; Morizono K, 2003, HUM GENE THER, V14, P59, DOI 10.1089/10430340360464714; Qiu XF, 2011, J ANDROL, V33, P37, DOI 10.2164/jandrol.110.012666; Qiu XF, 2011, J SEX MED, V8, P427, DOI 10.1111/j.1743-6109.2010.02118.x; Saigal CS, 2006, ARCH INTERN MED, V166, P207, DOI 10.1001/archinte.166.2.207; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Schluesener JK, 2014, MOL NUTR FOOD RES, V58, P49, DOI 10.1002/mnfr.201300409; Stuckey BGA, 2003, DIABETES CARE, V26, P279, DOI 10.2337/diacare.26.2.279; Tan SS, 2016, ARCH PLAST SURG-APS, V43, P237, DOI 10.5999/aps.2016.43.3.237; Tang YB, 2015, STEM CELLS, V33, P1863, DOI 10.1002/stem.2005; Thorve VS, 2011, J DIABETES COMPLICAT, V25, P129, DOI 10.1016/j.jdiacomp.2010.03.003; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Wang J, 2015, ONCOTARGET, V6, P7325, DOI 10.18632/oncotarget.2621; Wang X.H., 2015, PLOS ONE, V10; Wang YK, 2005, PHARMACOL RES, V52, P174, DOI 10.1016/j.phrs.2005.02.023; Xu CQ, 2010, EUR J PHARMACOL, V642, P146, DOI 10.1016/j.ejphar.2010.05.012; Yang R, 2009, J SEX MED, V6, P696, DOI 10.1111/j.1743-6109.2008.01054.x; Zhang XM, 2015, CELL BIOCHEM FUNCT, V33, P113, DOI 10.1002/cbf.3092	51	37	43	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174145	10.1371/journal.pone.0174145	http://dx.doi.org/10.1371/journal.pone.0174145			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350842	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174400017
J	Kalyanaraman, H; Zhuang, SH; Pilz, RB; Casteel, DE				Kalyanaraman, Hema; Zhuang, Shunhui; Pilz, Renate B.; Casteel, Darren E.			The activity of cGMP-dependent protein kinase I alpha is not directly regulated by oxidation-induced disulfide formation at cysteine 43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDANT-INDUCED ACTIVATION; PKG I; BETA; PHOSPHORYLATION; BINDING; SITE; HYPERTENSION; MUTAGENESIS; MIGRATION; DYNAMICS	The type I cGMP-dependent protein kinases (PKGs) are key regulators of smooth muscle tone, cardiac hypertrophy, and other physiological processes. The two isoforms PKGI alpha and PKGI beta are thought to have unique functions because of their tissue-specific expression, different cGMP affinities, and isoform-specific protein-protein interactions. Recently, a non-canonical pathway of PKGI alpha activation has been proposed, in which PKGI alpha is activated in a cGMP-independent fashion via oxidation of Cys(43), resulting in disulfide formation within the PKGI alpha N-terminal dimerization domain. A "redox-dead" knock-in mouse containing a C43S mutation exhibits phenotypes consistent with decreased PKGI alpha signaling, but the detailed mechanism of oxidation-induced PKGI alpha activation is unknown. Therefore, we examined oxidation-induced activation of PKGI alpha, and in contrast to previous findings, we observed that disulfide formation at Cys(43) does not directly activate PKGI alpha in vitro or in intact cells. In transfected cells, phosphorylation of Ras homolog gene family member A(RhoA) and vasodilator-stimulated phosphoprotein was increased in response to 8-CPT-cGMP treatment, but not when disulfide formation in PKGI alpha was induced by H2O2. Using purified enzymes, we found that the Cys(43) oxidation had no effect on basal kinase activity or K-m and V-max values; however, PKGI alpha containing the C43S mutation was less responsive to cGMP-induced activation. This reduction in cGMP affinity may in part explain the PKGI alpha loss-of-function phenotype of the C43S knock-in mouse. In conclusion, disulfide formation at Cys(43) does not directly activate PKGI alpha, and the C43S-mutant PKGI alpha has a higher K-a for cGMP. Our results highlight that mutant enzymes should be carefully biochemically characterized before making in vivo inferences.	[Kalyanaraman, Hema; Zhuang, Shunhui; Pilz, Renate B.; Casteel, Darren E.] Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Casteel, DE (corresponding author), Univ Calif San Diego, Dept Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dcasteel@ucsd.edu			National Institutes of Health [RO1-HL132141]; University of California, San Diego, Department of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego, Department of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant RO1-HL132141 (to R. B. P.) and the University of California, San Diego, Department of Medicine ( to D. E. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Burgoyne JR, 2013, METHOD ENZYMOL, V528, P111, DOI 10.1016/B978-0-12-405881-1.00007-0; Casteel DE, 2008, CELL SIGNAL, V20, P1392, DOI 10.1016/j.cellsig.2008.03.009; Casteel DE, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.377499; Casteel DE, 2002, J BIOL CHEM, V277, P32003, DOI 10.1074/jbc.M112332200; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; GLASS DB, 1982, J BIOL CHEM, V257, P1196; GLASS DB, 1979, J BIOL CHEM, V254, P9728; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffmann LS, 2014, N-S ARCH PHARMACOL, V387, P707, DOI 10.1007/s00210-014-0999-8; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; Huang GY, 2014, STRUCTURE, V22, P116, DOI 10.1016/j.str.2013.09.021; Huang YPJ, 2005, NATURE, V438, P36, DOI 10.1038/438036a; Kato M, 2012, J BIOL CHEM, V287, P41342, DOI 10.1074/jbc.M112.421040; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kim JJ, 2016, STRUCTURE, V24, P710, DOI 10.1016/j.str.2016.03.009; Kim Jeong Joo, 2011, PLoS One, V6, pe18413, DOI 10.1371/journal.pone.0018413; LANDGRAF W, 1991, J BIOL CHEM, V266, P16305; Lee JH, 2011, INT J MASS SPECTROM, V302, P44, DOI 10.1016/j.ijms.2010.07.021; Lorenz JE, 2014, ANTIOXID REDOX SIGN, V21, P1504, DOI 10.1089/ars.2013.5585; Nakamura T, 2015, J CLIN INVEST, V125, P2468, DOI 10.1172/JCI80275; Osborne BW, 2011, STRUCTURE, V19, P1317, DOI 10.1016/j.str.2011.06.012; Prysyazhna O, 2016, J BIOL CHEM, V291, P17427, DOI 10.1074/jbc.M116.724070; Prysyazhna O, 2012, NAT MED, V18, P286, DOI 10.1038/nm.2603; Qin LY, 2015, BIOCHEMISTRY-US, V54, P4419, DOI 10.1021/acs.biochem.5b00572; Rudyk O, 2013, P NATL ACAD SCI USA, V110, P9909, DOI 10.1073/pnas.1301026110; Rudyk O, 2012, CIRCULATION, V126, P287, DOI 10.1161/CIRCULATIONAHA.112.101287; Ruth P, 1999, PHARMACOL THERAPEUT, V82, P355, DOI 10.1016/S0163-7258(98)00067-9; Ruth P, 1997, J BIOL CHEM, V272, P10522; RUTH P, 1991, EUR J BIOCHEM, V202, P1339, DOI 10.1111/j.1432-1033.1991.tb16509.x; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Schwappacher R, 2013, J CELL SCI, V126, P1626, DOI 10.1242/jcs.118190; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Yuasa K, 2000, J BIOL CHEM, V275, P4897, DOI 10.1074/jbc.275.7.4897; Zhuang SH, 2004, J BIOL CHEM, V279, P10397, DOI 10.1074/jbc.M313048200	37	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8262	8268		10.1074/jbc.C117.787358	http://dx.doi.org/10.1074/jbc.C117.787358			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28360102	Green Published, hybrid			2022-12-26	WOS:000401788600012
J	Wang, SY; Cao, ZY; Xue, JH; Li, H; Jiang, W; Cheng, YN; Li, G; Zhang, XW				Wang, Shuya; Cao, Zhengyi; Xue, Junhui; Li, Hui; Jiang, Wei; Cheng, Yuning; Li, Gang; Zhang, Xiaowei			A positive feedback loop between Pim-1 kinase and HBP1 transcription factor contributes to hydrogen peroxide-induced premature senescence and apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; CELL SENESCENCE; PROTEIN; PHOSPHORYLATION; HETEROZYGOSITY; REPRESSION; CARCINOMAS; PATHWAY; CANCER; GENE	Oxidative stress can induce cell dysfunction and lead to a broad range of degenerative alterations, including carcinogenesis, aging, and other oxidative stress-related conditions. To avoid undergoing carcinogenesis in response to oxidative stress, cells trigger a succession of checkpoint responses, including premature senescence and apoptosis. Increasing evidence indicates that H2O2, an important cause of oxidative stress, functions as an important physiological regulator of intracellular signaling pathways that participate in regulation of cell premature senescence and apoptosis. However, the precise mechanisms underlying this process remain to be studied extensively. In this study, we describe the importance of Pim-1 kinase in this checkpoint response to oxidative stress. Pim-1 binds to and phosphorylates the transcription factor high mobility group box transcription factor 1 (HBP1), activating it. H2O2 enhances the interaction between Pim-1 and HBP1 and promotes HBP1 accumulation. In turn, HBP1 rapidly and selectively up-regulates Pim-1 expression in H2O2-stimulated cells, thereby creating a Pim-1-HBP1 positive feedback loop that regulates H2O2-induced premature senescence and apoptosis. Furthermore, the Pim-1-HBP1 positive feedback loop exerts its effect by regulating the senescence markers DNMT1 and p16 and the apoptosis marker Bax. The Pim-1-HBP1 axis thus constitutes a novel checkpoint pathway critical for the inhibition of tumorigenesis.	[Wang, Shuya; Cao, Zhengyi; Xue, Junhui; Li, Hui; Jiang, Wei; Cheng, Yuning; Li, Gang; Zhang, Xiaowei] Peking Univ, Hlth Sci Ctr, Beijing Key Lab Prot Posttranslat Modificat & Cel, Dept Biochem & Mol Biol,Sch Basic Med Sci, Beijing 100191, Peoples R China	Peking University	Zhang, XW (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Xueyuan Rd 38, Beijing 100191, Peoples R China.	xiaoweizhang@bjmu.edu.cn	Cheng, Yuning/GSE-2360-2022	Cheng, Yuning/0000-0002-8171-8748	National Natural Science Foundation of China [81672717, 31471292, 81572705]; Beijing Natural Science Foundation [5162013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National Natural Science Foundation of China Grants 81672717, 31471292, and 81572705 and Beijing Natural Science Foundation Grant 5162013. The authors declare that they have no conflicts of interest with the contents of this article.	Berasi SP, 2004, MOL CELL BIOL, V24, P3011, DOI 10.1128/MCB.24.7.3011-3024.2004; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chen YC, 2010, ONCOGENE, V29, P3067, DOI 10.1038/onc.2010.97; Chen YF, 2016, J BIOL CHEM, V291, P12688, DOI 10.1074/jbc.M116.714147; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Driouch K, 1998, CANCER RES, V58, P2081; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Gartel AL, 1998, ONCOGENE, V17, P3463, DOI 10.1038/sj.onc.1202240; Hogan C, 2008, J BIOL CHEM, V283, P18012, DOI 10.1074/jbc.M709695200; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Jin B, 2014, AGING CELL, V13, P879, DOI 10.1111/acel.12249; Koike M, 1999, LEUKEMIA RES, V23, P307, DOI 10.1016/S0145-2126(98)00159-3; Lanigan F, 2011, ONCOGENE, V30, P2901, DOI 10.1038/onc.2011.34; Lee KY, 2007, BRAIN RES, V1129, P89, DOI 10.1016/j.brainres.2006.10.055; Lemercier C, 2000, MOL CELL BIOL, V20, P6627, DOI 10.1128/MCB.20.18.6627-6637.2000; Li HS, 2010, CHIN CONT DECIS CONF, P1, DOI 10.1109/CCDC.2010.5499147; Li ZY, 2014, J BIOL CHEM, V289, P26872, DOI 10.1074/jbc.M114.586651; Liang H, 1998, P NATL ACAD SCI USA, V95, P3781, DOI 10.1073/pnas.95.7.3781; Lilly M, 1999, ONCOGENE, V18, P4022, DOI 10.1038/sj.onc.1202741; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Macek B, 2009, ANNU REV PHARMACOL, V49, P199, DOI 10.1146/annurev.pharmtox.011008.145606; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pan KW, 2013, MOL CELL BIOL, V33, P887, DOI 10.1128/MCB.00637-12; Paulson KE, 2007, CANCER RES, V67, P6136, DOI 10.1158/0008-5472.CAN-07-0567; Reiser-Erkan C, 2008, CANCER BIOL THER, V7, P1352, DOI 10.4161/cbt.7.9.6418; Samse K, 2015, J BIOL CHEM, V290, P13935, DOI 10.1074/jbc.M114.617431; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Swanson KA, 2004, NAT STRUCT MOL BIOL, V11, P738, DOI 10.1038/nsmb798; Valencia A, 2004, FREE RADICAL BIO MED, V36, P1112, DOI 10.1016/j.freeradbiomed.2004.02.013; Wang W, 2014, INT CONF INSTR MEAS, P1, DOI [10.1109/IMCCC.2014.9, 10.1109/SNW.2014.7348528]; Wang Z, 2001, J Vet Sci, V2, P167; Warnecke-Eberz U, 2008, ONCOL REP, V20, P619, DOI 10.3892/or_00000050; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Xiu M, 2003, MOL CELL BIOL, V23, P8890, DOI 10.1128/MCB.23.23.8890-8901.2003; Yang JL, 2013, CANCER RES, V73, P4898, DOI 10.1158/0008-5472.CAN-12-4277; Yao CJ, 2005, LEUKEMIA, V19, P1958, DOI 10.1038/sj.leu.2403918; Yee Amy S., 1998, Frontiers in Bioscience, V3, pD532; Yin XY, 2016, ONCOTARGET, V7, P66512, DOI 10.18632/oncotarget.11614; Zemskova M, 2010, MOL CANCER RES, V8, P1126, DOI 10.1158/1541-7786.MCR-10-0174; Zemskova MY, 2015, CELL SIGNAL, V27, P135, DOI 10.1016/j.cellsig.2014.10.010; ZENKLUSEN JC, 1995, ONCOGENE, V11, P359; ZENKLUSEN JC, 1994, CANCER RES, V54, P6370; ZENKLUSEN JC, 1995, CANCER RES, V55, P1347; Zhang XW, 2006, MOL CELL BIOL, V26, P8252, DOI 10.1128/MCB.00604-06; Zhang Y, 2010, J NEUROCHEM, V112, P497, DOI 10.1111/j.1471-4159.2009.06476.x; Zhuma T, 1999, EMBO J, V18, P6396, DOI 10.1093/emboj/18.22.6396	53	14	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8207	8222		10.1074/jbc.M116.768101	http://dx.doi.org/10.1074/jbc.M116.768101			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28348080	Green Published, hybrid			2022-12-26	WOS:000401788600008
J	Fotokian, Z; Shahboulaghi, FM; Fallahi-Khoshknab, M; Pourhabib, A				Fotokian, Zahra; Shahboulaghi, Farahnaz Mohammadi; Fallahi-Khoshknab, Masoud; Pourhabib, Ali			The empowerment of elderly patients with chronic obstructive pulmonary disease: Managing life with the disease	PLOS ONE			English	Article							COPD; HEALTH; MANAGEMENT; CARE; OLD	Chronic obstructive pulmonary disease (COPD) is a serious health problem that has significant effects on the life status of elderly persons. Use of the empowerment approach is necessary for health promotion in older people with COPD, but little attention has so far been paid to all the dimensions of empowerment in the management of COPD, which would provide useful knowledge regarding elders with COPD. This article reports on a study exploring people's experiences of the empowerment of older people with COPD. This study adopted an exploratory qualitative design and was carried out using grounded theory methodology. Grounded theory was considered appropriate for this study because of its focus on how people respond to and act on the problems that they encounter. We collected data by conducting in-depth semi-structured interviews and taking field notes. Twenty-four participants were selected through purposive sampling. The results showed that in encountering the complexity of disease and in response to difficulties induced by COPD, three strategies were applied. Elderly persons with COPD, their family caregivers, and professional team members engaged in "managing life with COPD," "striving to keep abreast of life," "preparing for battle with disease," and "helping to stabilize the elder's life." The outcome of these strategies was "co-existence with disease." The potential of "managing life with COPD" was influenced by the following factors: "co-existence with ageing," "personal potential, " "a challenged health system, " and "weak social support. " "Managing life with COPD" enables the elder to feel in control and live optimally. This is a fragile balance, however, and the unpredictability of COPD can tip the elder into "selfefficacy." Understanding the experiences of the empowerment process of older people with COPD can help health professionals provide more focused elderly care.	[Fotokian, Zahra] Babol Univ Med Sci, Sch Nursing & Midwifery, Dept Nursing, Ramsar Nursing Care Res Ctr, Babol Sar, Mazandaran, Iran; [Shahboulaghi, Farahnaz Mohammadi] Univ Social Welf & Rehabil Sci USWR, Social Determinants Hlth Res Ctr, Tehran, Iran; [Fallahi-Khoshknab, Masoud] Univ Social Welf & Rehabil Sci USWR, Dept Nursing, Tehran, Iran; [Pourhabib, Ali] Babol Univ Med Sci, Sch Nursing & Midwifery, Dept Nursing, Babol Sar, Mazandaran, Iran	Babol University of Medical Sciences; Babol University of Medical Sciences	Shahboulaghi, FM (corresponding author), Univ Social Welf & Rehabil Sci USWR, Social Determinants Hlth Res Ctr, Tehran, Iran.	mohammadifarahnaz@gmail.com	Fallahi-Khoshknab, Masoud/W-4495-2019; Fallahi-Khoshknab, Masoud -/E-3150-2014; Pourhabib, Ali/AAG-9770-2021; mohammadi, farahnaz/D-9740-2017; Amin Marashi, Seyed Mahmoud/G-1287-2017	Fallahi-Khoshknab, Masoud/0000-0003-0507-0107; Fallahi-Khoshknab, Masoud -/0000-0003-0507-0107; Mohammadi Shahboulaghi, Farahnaz/0000-0001-8357-0882; Amin Marashi, Seyed Mahmoud/0000-0003-2703-1715	Welfare and Rehabilitation University [500271]	Welfare and Rehabilitation University	This work was funded by a grant to Zahra Fotokian and Farahnaz Mohammadi Shahboulaghi, Welfare and Rehabilitation University, no: 500271.	Aujoulat I., 2012, ORPHANET J RARE DIS, V7, pA31, DOI [10.1186/1750 -1172 -7 -s2 -a31, DOI 10.1186/1750-1172-7-S2-A31]; Blackstock F, 2007, HEALTH EDUC RES, V22, P703, DOI 10.1093/her/cyl150; Boot CRL, 2005, PATIENT EDUC COUNS, V59, P103, DOI 10.1016/j.pec.2004.10.007; Colombo C, 2012, INTERN EMERG MED, V7, P183, DOI 10.1007/s11739-012-0757-1; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Effing T, 2007, COCHRANE DATABASE SY, V17; Elkington H, 2004, RESP MED, V98, P439, DOI 10.1016/j.rmed.2003.11.006; Elofsson LC, 2004, PALLIATIVE MED, V18, P611, DOI 10.1191/0269216304pm922oa; Esbensen BA, 2010, SCAND J CARING SCI, V24, P648, DOI 10.1111/j.1471-6712.2009.00756.x; Fotoukian Z, 2014, MJIRI, V28, P1; Fotoukian Z, 2014, ASIAN NURS RES, V8, P118, DOI 10.1016/j.anr.2014.04.002; Fraser DD, 2006, J ADV NURS, V55, P550, DOI 10.1111/j.1365-2648.2006.03946.x; Gullick J, 2008, J ADV NURS, V64, P605, DOI 10.1111/j.1365-2648.2008.04823.x; Gungor G, 2011, EMPOWERING PATIENTS; Gysels M, 2008, J PAIN SYMPTOM MANAG, V36, P451, DOI 10.1016/j.jpainsymman.2007.11.008; Hallberg I, 2010, BMC NURS, V9, DOI 10.1186/1472-6955-9-7; Hyland ME, 2006, RESP MED, V100, P1807, DOI 10.1016/j.rmed.2006.01.018; Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419; Mirbagheri N, 2009, OFOGH E DANESH, V14, P19; Mohammadi Fahrahnaz, 2013, Br J Community Nurs, V18, P400; Moullec G, 2012, RESPIROLOGY, V17, P707, DOI 10.1111/j.1440-1843.2012.02168.x; Nygardh A, 2011, BMC NURS, V10, DOI 10.1186/1472-6955-10-21; Paulson M, 2003, J CLIN NURS, V12, P235, DOI 10.1046/j.1365-2702.2003.00733.x; Raherison C, 2009, EUR RESPIR REV, V18, P213, DOI 10.1183/09059180.00003609; Robinson T., 2011, NURS TIMES, V106, P38; Seamark DA, 2004, PALLIATIVE MED, V18, P619, DOI 10.1191/0269216304pm928oa; Sohanpal R, 2012, CHRON RESP DIS, V9, P163, DOI 10.1177/1479972312444630; Fonseca MDUP, 2010, REV SAUDE PUBL, V44, P159, DOI 10.1590/S0034-89102010000100017; van der Valk P, 2004, PATIENT EDUC COUNS, V52, P225, DOI 10.1016/S0738-3991(03)00095-8	29	15	17	6	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174028	10.1371/journal.pone.0174028	http://dx.doi.org/10.1371/journal.pone.0174028			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2IH	28369069	Green Published, gold, Green Submitted			2022-12-26	WOS:000399351000013
J	Li, YY; Lu, GS; Sun, DT; Zuo, HJ; Wang, DW; Yan, JT				Li, Yuanyuan; Lu, Gangsheng; Sun, Dating; Zuo, Houjuan; Wang, Dao Wen; Yan, Jiangtao			Inhibition of endoplasmic reticulum stress signaling pathway: A new mechanism of statins to suppress the development of abdominal aortic aneurysm	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; E-DEFICIENT MICE; ANGIOTENSIN-II; ACCELERATED ATHEROSCLEROSIS; MAMMALIAN-CELLS; MESSENGER-RNA; ER STRESS; RAT MODEL; INFLAMMATION; THERAPY	Background Abdominal aortic aneurysm (AAA) is a potentially lethal disease with extremely poor survival rates once the aneurysm ruptures. Statins may exert beneficial effects on the progression of AAA. However, the underlying mechanism is still not known. The purpose of the present study is to investigate whether statin could inhibit AAA formation by inhibiting the endoplasmic reticulum (ER) stress signal pathway. Methods A clinically relevant AAA model was induced in Apolipoprotein E-deficient (ApoE(-/-)) mice, which were infused with angiotensin II (Ang II) for 28 days. These mice were randomly divided into following 4 groups: saline infusion alone; Ang II infusion alone; Ang II infusion plus Atorvastatin (20mg/kg/d); and Ang II infusion plus Atorvastatin (30mg/kg/d). Besides, another AAA model was induced in C57 mice with extraluminal CaCl2, which were divided into 3 groups: sham group, CaCl2-induced AAA group, and CaCl2-induced AAA plus atorvastatin (20mg/kg/d) group. Then, aortic tissue was excised for further examinations, respectively. In vitro studies, Ang II with or without simvastatin treatment were applied to the vascular smooth muscle cells (VSMCS) and Raw 264.7 cells. The ER stress signal pathway, apoptosis and inflammatory response were evaluated by in vivo and in vitro assays. Results We found that higher dose of atorvastatin can effectively suppress the development and progression of AAA induced by Ang II or CaCl2. Mechanistically, the activation of ER stress and inflammatory response were found involved in Ang II-induced AAA formation. The atorvastatin infusion significantly reduced ER stress signaling proteins, the number of apoptotic cells, and the activation of Caspase12 and Bax in the Ang II-induced ApoE(-/-) mice, compared with mice treated by Ang II alone. Furthermore, proinflammatory cytokines such as IL-6, IL-8, IL-1 beta were all remarkably inhibited after atorvastatin treatment. In vitro, the inhibitory effect of simvastatin on the ER stress signal pathway could be observed in both vascular smooth muscle cells and macrophages, and these inhibitory effects of statin were in a dose-dependent manner. In addition, apoptosis was induced with Ang II treatment. The maximal inhibitory effect of simvastatin on apoptosis was observed at 10 mu mol/l. Conclusions We conclude that higher dose of statin can effectively suppress the development of AAA, and reduce ER stress, ER stress-associated apoptosis signaling pathways, and inflammatory response. These findings reveal a new mechanism underlying the inhibitory effect of statin on AAA formation/progression.	[Li, Yuanyuan; Lu, Gangsheng; Sun, Dating; Zuo, Houjuan; Wang, Dao Wen; Yan, Jiangtao] Huazhong Univ Sci & Technol, Div Cardiol, Dept Internal Med, Tongji Hosp,Tongji Med Coll, Wuhan, Peoples R China	Huazhong University of Science & Technology	Wang, DW; Yan, JT (corresponding author), Huazhong Univ Sci & Technol, Div Cardiol, Dept Internal Med, Tongji Hosp,Tongji Med Coll, Wuhan, Peoples R China.	dwwang@tjh.tjmu.edu.en; jtyan_tjh@163.com	li, yuanyuan/GZA-4435-2022	Wang, Dao Wen/0000-0002-9774-3980				Azuma J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149288; Bahia SS, 2016, BRIT J SURG, V103, P1626, DOI 10.1002/bjs.10269; Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Brady AR, 2004, CIRCULATION, V110, P16, DOI 10.1161/01.CIR.0000133279.07468.9F; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Cabrera E, 2017, ONCOGENE, V36, P678, DOI 10.1038/onc.2016.239; Daugherty A, 2001, BRIT J PHARMACOL, V134, P865, DOI 10.1038/sj.bjp.0704331; de Bruin JL, 2014, J VASC SURG, V59, P39, DOI 10.1016/j.jvs.2013.07.026; de Ceniga MV, 2013, CURR VASC PHARMACOL, V11, P299, DOI 10.2174/1570161111311030004; Eagleton MJ, 2012, VASCULAR, V20, P278, DOI 10.1258/vasc.2011.201207; Ferguson CD, 2011, J VASC SURG, V53, P1452, DOI 10.1016/j.jvs.2010.08.089; Fu HY, 2016, CIRC RES, V118, P798, DOI 10.1161/CIRCRESAHA.115.307604; Gokani VJ, 2015, VASC PHARMACOL, V65-66, P13, DOI 10.1016/j.vph.2014.11.006; Golledge J, 2010, CARDIOVASC DRUG THER, V24, P373, DOI 10.1007/s10557-010-6262-8; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hotamisligil GS, 2010, NAT MED, V16, P396, DOI 10.1038/nm0410-396; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kaneko H, 2011, ATHEROSCLEROSIS, V217, P350, DOI 10.1016/j.atherosclerosis.2011.03.042; Karrowni W, 2011, J INVEST MED, V59, P1239, DOI 10.2130/JIM.0b013e31823548e8; Kokje VBC, 2015, EUR J VASC ENDOVASC, V50, P702, DOI 10.1016/j.ejvs.2015.08.010; Mastoraki ST, 2012, ANN VASC SURG, V26, P250, DOI 10.1016/j.avsg.2011.09.003; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Obama T, 2015, CLIN SCI, V128, P559, DOI 10.1042/CS20140696; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2006, ADAPTATION TO ER STR, V4; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Shiraya S, 2009, ATHEROSCLEROSIS, V202, P34, DOI 10.1016/j.atherosclerosis.2008.03.020; Song XJ, 2011, INT J MED SCI, V8, P564, DOI 10.7150/ijms.8.564; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Takagi H, 2012, EUR J VASC ENDOVASC, V44, P287, DOI 10.1016/j.ejvs.2012.06.021; Takayanagi T, 2014, CLIN SCI, V126, P785, DOI 10.1042/CS20130660; van der Meij E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053882; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang QW, 2015, CIRC RES, V116, P600, DOI 10.1161/CIRCRESAHA.116.304899; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wang YX, 2005, CIRCULATION, V111, P2219, DOI 10.1161/01.CIR.0000163544.17221.BE; Wei SG, 2016, HYPERTENSION, V67, P229, DOI 10.1161/HYPERTENSIONAHA.115.06329; Wu Y., 2016, PLOS ONE, V11; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshimura K, 2015, INT J MOL SCI, V16, P11213, DOI 10.3390/ijms160511213; Zhang YL, 2009, ARTERIOSCL THROM VAS, V29, P1764, DOI 10.1161/ATVBAHA.109.192609; Zhou J, 2004, CIRCULATION, V110, P207, DOI 10.1161/01.CIR.0000134487.51510.97	42	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174821	10.1371/journal.pone.0174821	http://dx.doi.org/10.1371/journal.pone.0174821			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369137	Green Submitted, Green Published, gold			2022-12-26	WOS:000399351000051
J	Valero, MA; Perez-Crespo, I; Chillon-Marinas, C; Khoubbane, M; Quesada, C; Reguera-Gomez, M; Mas-Coma, S; Fresno, M; Girones, N				Adela Valero, M.; Perez-Crespo, Ignacio; Chillon-Marinas, Carlos; Khoubbane, Messaoud; Quesada, Carla; Reguera-Gomez, Marta; Mas-Coma, Santiago; Fresno, Manuel; Girones, Nuria			Fasciola hepatica reinfection potentiates a mixed Th1/Th2/Th17/Treg response and correlates with the clinical phenotypes of anemia	PLOS ONE			English	Article							REGULATORY T-CELLS; ALTERNATIVELY ACTIVATED MACROPHAGES; INTESTINAL NEMATODE PARASITES; CYTOKINE MESSENGER-RNA; GROWTH-FACTOR-BETA; IMMUNE-RESPONSES; PROTECTIVE IMMUNITY; PRIMARY INFECTION; INTERFERON-GAMMA; TH1 RESPONSES	Background Fascioliasis is a severe zoonotic disease of worldwide extension caused by liver flukes. In human fascioliasis hyperendemic areas, reinfection and chronicity are the norm and anemia is the main sign. Herein, the profile of the Th1/Th2/Th17/Treg expression levels is analyzed after reinfection, correlating them with their corresponding hematological biomarkers of morbidity. Methodology/Principal findings The experimental design reproduces the usual reinfection/chronicity conditions in human fascioliasis endemic areas and included Fasciola hepatica primo-infected Wistar rats (P1) and rats reinfected at 8 weeks (R8), and at 12 weeks (R12), and negative control rats. In a cross-sectional study, the expression of the genes associated with Th1 (Ifng, II12a, II12b, Nos2), Th2 (II4, Arg1), Treg (Foxp3, II10, Tgfb, Ebi3), and Th17 (II17) in the spleen and thymus was analyzed. After 20 weeks of primary infection, PI did not present significant changes in the expression of those genes when compared to non-infected rats (NI), but an increase of 114, Arg1 and Ifng mRNA in the spleen was observed in R12, suggesting the existence of an active mixed Th1/Th2 systemic immune response in reinfection. Foxp3, II10, Tgfb and Ebi3 levels increased in the spleen in R12 when compared to NI and PI, indicating that the Treg gene expression levels are potentiated in chronic phase reinfection. II17 gene expression levels in R12 in the spleen increased when compared to NI, PI and R8. Gene expression levels of II10 in the thymus increased when compared to NI and PI in R12. Ifng expression levels in the thymus increased in all reinfected rats, but not in PI. The clinical phenotype was determined by the fluke burden, the rat body weight and the hemogram. Multivariate mathematical models were built to describe the Th1/Th2/Th17/Treg expression levels and the clinical phenotype. In reinfection, two phenotypic patterns were detected: i) one which includes only increased splenic Ifng expression levels but no Treg expression, correlating with severe anemia; ii) another which includes increased splenic Ifng and Treg expression levels, correlating with a less severe anemia. Conclusions/Significance In animals with established F. hepatica infection a huge increase in the immune response occurs, being a mixed Th2/Treg associated gene expression together with an expression of Ifng. Interestingly, a Th17 associated gene expression is also observed. Reinfection in the chronic phase is able to activate a mixed immune response (Th1/Th2/Th17/Treg) against F. hepatica but T and B proliferation to mitogens is strongly suppressed in all infected rats vs control in the advanced chronic phase independently of reinfection The systemic immune response is different in each group, suggesting that suppression is mediated by different mechanisms in each case. Immune suppression could be due to the parasite in PI and R8 rats and the induction of suppressive cells such as Treg in R12. This is the first study to provide fundamental insight into the immune profile in fascioliasis reinfection and its relation with the clinical phenotypes of anemia.	[Adela Valero, M.; Perez-Crespo, Ignacio; Khoubbane, Messaoud; Quesada, Carla; Reguera-Gomez, Marta; Mas-Coma, Santiago] Univ Valencia, Fac Farm, Dept Parasitol, Av Vicent Andres Estelles S-N, Valencia, Spain; [Chillon-Marinas, Carlos; Fresno, Manuel; Girones, Nuria] UAM, CSIC, Ctr Biol Mol Severo Ochoa, C Nicolas Cabrera 1, Madrid, Spain	University of Valencia; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Valero, MA (corresponding author), Univ Valencia, Fac Farm, Dept Parasitol, Av Vicent Andres Estelles S-N, Valencia, Spain.	madela.valero@uv.es	Gironès, Núria/AAR-7436-2020; Valero, Maria Adela/AAA-1658-2020; Valero, M. Adela/K-6718-2016; Girones, Nuria/L-7865-2017	Gironès, Núria/0000-0002-8130-2750; Valero, Maria Adela/0000-0003-1584-8330; Valero, M. Adela/0000-0003-1584-8330; Girones, Nuria/0000-0002-8130-2750; Mas-Coma, Santiago/0000-0002-1685-7004	PROMETEO Programme, Generalitat Valenciana, Valencia, Spain [2012/042, 2016/099]; Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET, Institute de Salud Carlos III) [RD16/0027/0023]; Proyectos de Investigacion en Salud (Institute de Salud Carlos III, MINECO, Madrid, Spain) [PI16/00520]; Ministry of Economy and Competitiveness, Madrid, Spain [SAF2006-09278, SAF2010-20805]; Ministerio Ciencia y Tecnologia [SAF2005-02220, SAF2007-61716, SAF2010-18733]; ChagasEpiNet collaborative project, Seventh Framework Programme, European Union; Red de Investigacion Colaborativa en Enfermedades Tropicales (RICET, Institute de Salud Carlos III) [RD06/0021/0016]; Com unidad de Madrid [S-SAL-0159/2006, A/031735/10]; Fondo de Investigaciones Sanitarias [PI12/00289]; Fellowship of the Programa de Ayudas Predoctorales de Formacion de Personal Investigador, Spanish Ministry of Education and Science; Fellowship of the Programa de Ayudas de Formacion de Profesorado Universitario; Ministerio de Educacion, Cultura y Deporte, Spain	PROMETEO Programme, Generalitat Valenciana, Valencia, Spain; Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET, Institute de Salud Carlos III); Proyectos de Investigacion en Salud (Institute de Salud Carlos III, MINECO, Madrid, Spain); Ministry of Economy and Competitiveness, Madrid, Spain(Spanish Government); Ministerio Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ChagasEpiNet collaborative project, Seventh Framework Programme, European Union; Red de Investigacion Colaborativa en Enfermedades Tropicales (RICET, Institute de Salud Carlos III); Com unidad de Madrid(Comunidad de Madrid); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fellowship of the Programa de Ayudas Predoctorales de Formacion de Personal Investigador, Spanish Ministry of Education and Science; Fellowship of the Programa de Ayudas de Formacion de Profesorado Universitario; Ministerio de Educacion, Cultura y Deporte, Spain(Spanish Government)	This paper was generally supported by Projects No 2012/042 and No 2016/099 of the PROMETEO Programme, Generalitat Valenciana, Valencia, Spain. This study is also a part of the worldwide initiative of WHO (Headquarters Geneva, Switzerland) against human fascioliasis. SMC is also supported by the following sources: Red de Investigacion Cooperativa en Enfermedades Tropicales (RICET, Institute de Salud Carlos III RD16/0027/0023); Proyectos de Investigacion en Salud (Institute de Salud Carlos III, MINECO, Madrid, Spain PI16/00520); No. SAF2006-09278 and No. SAF2010-20805 of the Ministry of Economy and Competitiveness, Madrid, Spain. MF is supported by the following funding sources: Ministerio Ciencia y Tecnologia SAF2005-02220, SAF2007-61716 and SAF2010-18733); ChagasEpiNet collaborative project, Seventh Framework Programme, European Union; Red de Investigacion Colaborativa en Enfermedades Tropicales (RICET, Institute de Salud Carlos III RD06/0021/0016); Com unidad de Madrid S-SAL-0159/2006; A/031735/10 Institute de Cooperacion I beroamericana. NG was supported by the following funding sources: Fondo de Investigaciones Sanitarias (PI12/00289). IPC was supported by Fellowship of the Programa de Ayudas Predoctorales de Formacion de Personal Investigador, Spanish Ministry of Education and Science. MRG was supported by the Fellowship of the Programa de Ayudas de Formacion de Profesorado Universitario 2015, Ministerio de Educacion, Cultura y Deporte, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.D	Valero M, 2016, T ROY SOC TROP MED H, V110, P55, DOI 10.1093/trstmh/trv110; Apostolidis SA, 2011, J INTERF CYTOK RES, V31, P769, DOI 10.1089/jir.2011.0029; ARMOUR J, 1974, EXP PARASITOL, V35, P381, DOI 10.1016/0014-4894(74)90044-7; Barthlott T, 2005, INT IMMUNOL, V17, P279, DOI 10.1093/intimm/dxh207; Beiting DP, 2007, J IMMUNOL, V178, P1039, DOI 10.4049/jimmunol.178.2.1039; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Boissier J, 2016, LANCET INFECT DIS; Brady MT, 1999, INFECT IMMUN, V67, P5372, DOI 10.1128/IAI.67.10.5372-5378.1999; BURDEN DJ, 1983, PARASITOLOGY, V87, pR70; Cervi L, 2001, INT J PARASITOL, V31, P1467, DOI 10.1016/S0020-7519(01)00275-2; Cervi L, 1998, CLIN IMMUNOL IMMUNOP, V87, P145, DOI 10.1006/clin.1997.4499; CHAPMAN CB, 1982, INT J PARASITOL, V12, P81, DOI 10.1016/0020-7519(82)90099-6; CHAPMAN CB, 1981, AM J TROP MED HYG, V30, P1039, DOI 10.4269/ajtmh.1981.30.1039; CHAUVIN A, 1995, INT J PARASITOL, V25, P1227, DOI 10.1016/0020-7519(95)00039-5; Clery DG, 1998, RES VET SCI, V65, P169, DOI 10.1016/S0034-5288(98)90171-0; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Dalton JP, 2013, VET PARASITOL, V195, P272, DOI 10.1016/j.vetpar.2013.04.008; Dessein A, 2004, IMMUNOL REV, V201, P180, DOI 10.1111/j.0105-2896.2004.00195.x; Dewals B, 2010, EUR J IMMUNOL, V40, P2837, DOI 10.1002/eji.200940075; Donnelly S, 2005, INFECT IMMUN, V73, P166, DOI 10.1128/IAI.73.1.166-173.2005; Donnelly S, 2008, FASEB J, V22, P4022, DOI 10.1096/fj.08-106278; Dowling DJ, 2010, INFECT IMMUN, V78, P793, DOI 10.1128/IAI.00573-09; DOY TG, 1978, RES VET SCI, V25, P41, DOI 10.1016/S0034-5288(18)33006-6; Dujardin J.-P., 2007, ENCY INFECT DIS MODE, V25, P435, DOI DOI 10.1002/9780470114209.CH25; Espino AM, 2010, VET PARASITOL, V169, P82, DOI 10.1016/j.vetpar.2009.12.018; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Flynn RJ, 2007, INFECT IMMUN, V75, P1373, DOI 10.1128/IAI.01445-06; Flynn RJ, 2010, VET PARASITOL, V169, P235, DOI 10.1016/j.vetpar.2010.02.015; Flynn RJ, 2008, INT J PARASITOL, V38, P1673, DOI 10.1016/j.ijpara.2008.05.008; Girones N, 2007, J INFECT DIS, V195, P1504, DOI 10.1086/514822; Goerdt S, 1999, IMMUNITY, V10, P137, DOI 10.1016/S1074-7613(00)80014-X; Gomez-Escobar N, 2000, INFECT IMMUN, V68, P6402, DOI 10.1128/IAI.68.11.6402-6410.2000; Gravano DM, 2012, CELL MOL LIFE SCI, V69, P1997, DOI 10.1007/s00018-011-0907-z; Hacariz O, 2009, PARASITE IMMUNOL, V31, P613, DOI 10.1111/j.1365-3024.2009.01135.x; HAYES TJ, 1974, J PARASITOL, V60, P247, DOI 10.2307/3278458; HAYES TJ, 1974, J PARASITOL, V60, P930, DOI 10.2307/3278516; HAYES TJ, 1974, J PARASITOL, V60, P722, DOI 10.2307/3278747; HAYES TJ, 1977, J PARASITOL, V63, P584, DOI 10.2307/3280027; Helmby H, 2003, EUR J IMMUNOL, V33, P2382, DOI 10.1002/eji.200324082; Hesse M, 2004, J IMMUNOL, V172, P3157, DOI 10.4049/jimmunol.172.5.3157; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; HUGHES DL, 1977, NATURE, V267, P517, DOI 10.1038/267517a0; HUGHES DL, 1976, RES VET SCI, V20, P207, DOI 10.1016/S0034-5288(18)33458-1; Jager A, 2010, SCAND J IMMUNOL, V72, P173, DOI 10.1111/j.1365-3083.2010.02432.x; KEEGAN PS, 1992, PARASITE IMMUNOL, V14, P657, DOI 10.1111/j.1365-3024.1992.tb00037.x; KELLY JD, 1980, VET PARASITOL, V6, P359, DOI 10.1016/0304-4017(80)90080-1; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Maizels Rick, 2007, Novartis Found Symp, V281, P192; Mas-Coma S, 2014, PARASITOLOGY, V141, P1918, DOI 10.1017/S0031182014000869; Mas-Coma S, 2001, PARASITOLOGY, V123, pS115, DOI 10.1017/S0031182001008034; Mas-Coma S, 2014, ADV PARASIT, V84, P27, DOI 10.1016/B978-0-12-800099-1.00002-8; McKinley L, 2006, J IMMUNOL, V177, P6215, DOI 10.4049/jimmunol.177.9.6215; McManus DP, 2008, CLIN MICROBIOL REV, V21, P225, DOI 10.1128/CMR.00046-07; McSorley HJ, 2008, J IMMUNOL, V181, P6456, DOI 10.4049/jimmunol.181.9.6456; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; MITCHELL GBB, 1981, RES VET SCI, V30, P246, DOI 10.1016/S0034-5288(18)32591-8; Miyazaki Y, 2010, J IMMUNOL, V185, P1150, DOI 10.4049/jimmunol.0900047; Moreau E, 2002, VET PARASITOL, V108, P207, DOI 10.1016/S0304-4017(02)00196-6; Moreau E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/428593; Mulcahy G, 2005, TRENDS PARASITOL, V21, P273, DOI 10.1016/j.pt.2005.04.003; Mulcahy G, 1999, RES VET SCI, V67, P27, DOI 10.1053/rvsc.1998.0270; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; O'Neill SM, 2001, PARASITE IMMUNOL, V23, P541, DOI 10.1046/j.1365-3024.2001.00411.x; O'Neill SM, 2000, PARASITE IMMUNOL, V22, P147, DOI 10.1046/j.1365-3024.2000.00290.x; OLDHAM G, 1985, PARASITE IMMUNOL, V7, P503, DOI 10.1111/j.1365-3024.1985.tb00095.x; Omer FM, 1998, J EXP MED, V188, P39, DOI 10.1084/jem.188.1.39; Paz A, 1999, PARASITOL RES, V85, P770, DOI 10.1007/s004360050629; Paz-Silva A, 2002, PARASITOL RES, V88, P568, DOI 10.1007/s00436-002-0621-8; Piedrafita D, 2004, CAN J ZOOL, V82, P233, DOI 10.1139/Z03-216; Pleasance J, 2011, PARASITE IMMUNOL, V33, P495, DOI 10.1111/j.1365-3024.2011.01305.x; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; RAJASEKARIAH GR, 1981, INT J PARASITOL, V11, P59, DOI 10.1016/0020-7519(81)90026-6; RAJASEKARIAH GR, 1977, INT J PARASITOL, V7, P119, DOI 10.1016/0020-7519(77)90077-7; Reyes JL, 2007, PARASITE IMMUNOL, V29, P609, DOI 10.1111/j.1365-3024.2007.00973.x; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Suvas S, 2004, J IMMUNOL, V172, P4123, DOI 10.4049/jimmunol.172.7.4123; Taylor MD, 2007, J IMMUNOL, V179, P4626, DOI 10.4049/jimmunol.179.7.4626; Tliba O, 2000, PARASITE, V7, P9, DOI 10.1051/parasite/2000071009; Tliba O, 2002, VET RES, V33, P261, DOI 10.1051/vetres:2002014; Tliba O, 2002, VET PARASITOL, V103, P237, DOI 10.1016/S0304-4017(01)00584-2; Valero MA, 2006, ACTA TROP, V100, P17, DOI 10.1016/j.actatropica.2006.09.002; Valero MA, 2008, ACTA TROP, V108, P35, DOI 10.1016/j.actatropica.2008.08.007; Valero MA, 2000, PARASITOL RES, V86, P558, DOI 10.1007/s004360000201; van Milligen FJ, 1999, PARASITE IMMUNOL, V21, P243, DOI 10.1046/j.1365-3024.1999.00226.x; Van Milligen FJ, 1998, PARASITE IMMUNOL, V20, P285, DOI 10.1046/j.1365-3024.1998.00144.x; van Milligen FJ, 1998, J PARASITOL, V84, P771, DOI 10.2307/3284586; Vukman KV, 2013, J IMMUNOL, V190, P2873, DOI 10.4049/jimmunol.1203011; Walsh KP, 2009, J IMMUNOL, V183, P1577, DOI 10.4049/jimmunol.0803803; Weiss G, 2015, SEMIN HEMATOL, V52, P313, DOI 10.1053/j.seminhematol.2015.07.004; WHO, 2011, WHONMHNHDMNM111; YOSHIHARA S, 1985, RES VET SCI, V39, P383, DOI 10.1016/S0034-5288(18)31730-2; Zoller EE, 2011, J EXP MED, V208, P1203, DOI 10.1084/jem.20102538	93	26	31	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0173456	10.1371/journal.pone.0173456	http://dx.doi.org/10.1371/journal.pone.0173456			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362822	Green Published, gold, Green Submitted			2022-12-26	WOS:000399175000007
J	Das, JK; Choudhury, PP				Das, Jayanta Kumar; Choudhury, Pabitra Pal			Chemical property based sequence characterization of PpcA and its homolog proteins PpcB-E: A mathematical approach	PLOS ONE			English	Article							GEOBACTER-SULFURREDUCENS; GRAPHICAL REPRESENTATION; SIMILARITY/DISSIMILARITY; FAMILY; ALIGNMENT; PROFILE; C(7)	Periplasmic c7 type cytochrome A (PpcA) protein is determined in Geobacter sulfurreducens along with its other four homologs (PpcB-E). From the crystal structure viewpoint the observation emerges that PpcA protein can bind with Deoxycholate (DXCA), while its other homologs do not. But it is yet to be established with certainty the reason behind this from primary protein sequence information. This study is primarily based on primary protein sequence analysis through the chemical basis of embedded amino acids. Firstly, we look for the chemical group specific score of amino acids. Along with this, we have developed a new methodology for the phylogenetic analysis based on chemical group dissimilarities of amino acids. This new methodology is applied to the cytochrome c7 family members and pinpoint how a particular sequence is differing with others. Secondly, we build a graph theoretic model on using amino acid sequences which is also applied to the cytochrome c7 family members and some unique characteristics and their domains are highlighted. Thirdly, we search for unique patterns as subsequences which are common among the group or specific individual member. In all the cases, we are able to show some distinct features of PpcA that emerges PpcA as an outstanding protein compared to its other homologs, resulting towards its binding with deoxycholate. Similarly, some notable features for the structurally dissimilar protein PpcD compared to the other homologs are also brought out. Further, the five members of cytochrome family being homolog proteins, they must have some common significant features which are also enumerated in this study.	[Das, Jayanta Kumar; Choudhury, Pabitra Pal] Indian Stat Inst, Appl Stat Unit, 203 BT Rd, Kolkata 700108, W Bengal, India	Indian Statistical Institute; Indian Statistical Institute Kolkata	Das, JK (corresponding author), Indian Stat Inst, Appl Stat Unit, 203 BT Rd, Kolkata 700108, W Bengal, India.	dasjayantakumar89@gmail.com		Das, Jayanta Kumar/0000-0002-7630-7194				Bond DR, 2003, APPL ENVIRON MICROB, V69, P1548, DOI 10.1128/AEM.69.3.1548-1555.2003; CACCAVO F, 1994, APPL ENVIRON MICROB, V60, P3752, DOI 10.1128/AEM.60.10.3752-3759.1994; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chen J, 2016, BRIEF BIOINFORM; Chen J, 2016, SCI REPORTS, P6; Cope MJTV, 1996, STRUCTURE, V4, P969, DOI 10.1016/S0969-2126(96)00103-7; Das JK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167651; Deo N., 2016, GRAPH THEORY APPL EN, V1st; Deutscher M.P., 1990, GUIDE PROTEIN PURIFI, V182; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Li C, 2008, BMB REP, V41, P217, DOI 10.5483/BMBRep.2008.41.3.217; Li J, 2005, SHENG WU HUA XUE YU, V33, P1215; Li TP, 2003, PROTEIN ENG, V16, P323, DOI 10.1093/protein/gzg044; Liu B., 2015, BIOINFORMATICS; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Liu B, 2013, MOL INFORM, V32, P775, DOI 10.1002/minf.201300084; Morgado L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105566; Morgado L, 2010, BIOPHYS J, V99, P293, DOI 10.1016/j.bpj.2010.04.017; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pearson WR, 2013, CURR PROTOC BIOINFOR, V42, DOI 10.1002/0471250953.bi0301s42; Peterson EL, 2009, BIOINFORMATICS, V25, P1356, DOI 10.1093/bioinformatics/btp164; Pham TD, 2004, BIOINFORMATICS, V20, P3455, DOI 10.1093/bioinformatics/bth426; Pokkuluri PR, 2011, J STRUCT BIOL, V174, P223, DOI 10.1016/j.jsb.2010.11.022; Pokkuluri PR, 2010, BBA-BIOENERGETICS, V1797, P222, DOI 10.1016/j.bbabio.2009.10.007; Pokkuluri PR, 2004, BIOCHEMISTRY-US, V43, P849, DOI 10.1021/bi0301439; Rokas A, 2011, CURRENT PROTOCOLS MO, P19; Rotunda AM, 2005, J AM ACAD DERMATOL, V53, P973, DOI 10.1016/j.jaad.2005.07.068; Smith SA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003223; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Wen J, 2009, CHEM PHYS LETT, V476, P281, DOI 10.1016/j.cplett.2009.06.017; XIE XL, 2012, J ZHEJIANG UNIV SC B, V13, P152, DOI DOI 10.1631/JZUS.B1100052; Yao YH, 2010, J COMPUT CHEM, V31, P1045, DOI 10.1002/jcc.21391; Yao YH, 2008, PROTEINS, V73, P864, DOI 10.1002/prot.22110; Yao YH, 2014, EVOL BIOINFORM, V10, P87, DOI 10.4137/EBO.S14713; Zhang SL, 2010, MATCH-COMMUN MATH CO, V63, P701; Zhang S, 2009, J MOL STRUC-THEOCHEM, V909, P102, DOI 10.1016/j.theochem.2009.05.031	41	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0175031	10.1371/journal.pone.0175031	http://dx.doi.org/10.1371/journal.pone.0175031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362850	Green Submitted, Green Published, gold			2022-12-26	WOS:000399175000062
J	Stark, DJ; Vaughan, IP; Saldivar, DAR; Nathan, SKSS; Goossens, B				Stark, Danica J.; Vaughan, Ian P.; Saldivar, Diana A. Ramirez; Nathan, Senthilvel K. S. S.; Goossens, Benoit			Evaluating methods for estimating home ranges using GPS collars: A comparison using proboscis monkeys (Nasalis larvatus)	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEM; LOWER KINABATANGAN; BEHAVIOR; HABITAT; KERNEL; CONSERVATION; TELEMETRY; SELECTION; PRIMATE; PERFORMANCE	The development of GPS tags for tracking wildlife has revolutionised the study of home ranges, habitat use and behaviour. Concomitantly, there have been rapid developments in methods for estimating habitat use from GPS data. In combination, these changes can cause challenges in choosing the best methods for estimating home ranges. In primatology, this issue has received little attention, as there have been few GPS collar-based studies to date. However, as advancing technology is making collaring studies more feasible, there is a need for the analysis to advance alongside the technology. Here, using a high quality GPS collaring data set from 10 proboscis monkeys (Nasalis larvatus), we aimed to: 1) compare home range estimates from the most commonly used method in primatology, the grid-cell method, with three recent methods designed for large and/or temporally correlated GPS data sets; 2) evaluate how well these methods identify known physical barriers(e.g. rivers); and 3) test the robustness of the different methods to data containing either less frequent or random losses of GPS fixes. Biased random bridges had the best overall performance, combining a high level of agreement between the raw data and estimated utilisation distribution with a relatively low sensitivity to reduced fixed frequency or loss of data. It estimated the home range of proboscis monkeys to be 24-165 ha (mean 80.89 ha). The grid-cell method and approaches based on local convex hulls had some advantages including simplicity and excellent barrier identification, respectively, but lower overall performance. With the most suitable model, or combination of models, it is possible to understand more fully the patterns, causes, and potential consequences that disturbances could have on an animal, and accordingly be used to assist in the management and restoration of degraded landscapes.	[Stark, Danica J.; Vaughan, Ian P.; Nathan, Senthilvel K. S. S.; Goossens, Benoit] Cardiff Univ, Cardiff Sch Biosci, Organisms & Environm Div, Sir Martin Evans Bldg,Museum Ave, Cardiff, S Glam, Wales; [Stark, Danica J.; Goossens, Benoit] Sabah Wildlife Dept, Danau Girang Field Ctr, Kota Kinabalu, Sabah, Malaysia; [Saldivar, Diana A. Ramirez; Nathan, Senthilvel K. S. S.; Goossens, Benoit] Sabah Wildlife Dept, Kota Kinabalu 88100, Sabah, Malaysia; [Goossens, Benoit] Cardiff Univ, Sustainable Places Res Inst, 33 Pk Pl, Cardiff, S Glam, Wales	Cardiff University; Cardiff University	Stark, DJ; Goossens, B (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Organisms & Environm Div, Sir Martin Evans Bldg,Museum Ave, Cardiff, S Glam, Wales.; Stark, DJ; Goossens, B (corresponding author), Sabah Wildlife Dept, Danau Girang Field Ctr, Kota Kinabalu, Sabah, Malaysia.; Goossens, B (corresponding author), Sabah Wildlife Dept, Kota Kinabalu 88100, Sabah, Malaysia.; Goossens, B (corresponding author), Cardiff Univ, Sustainable Places Res Inst, 33 Pk Pl, Cardiff, S Glam, Wales.	danicastark@gmail.com; goossensbr@cardiff.ac.uk	Vaughan, Ian/A-4782-2010	Vaughan, Ian/0000-0002-7263-3822; Stark, Danica/0000-0002-3828-4518	Sime Darby Foundation; Margot Marsh Biodiversity Foundation [PR12-012]; Sabah Biodiversity Centre; Sabah Wildlife Department	Sime Darby Foundation; Margot Marsh Biodiversity Foundation; Sabah Biodiversity Centre; Sabah Wildlife Department	The authors greatly appreciate the financial support from Sime Darby Foundation and Margot Marsh Biodiversity Foundation (Award PR12-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the Sabah Biodiversity Centre and the Sabah Wildlife Department for their permission and support of the project. We thank Eco-Health Alliance (EHA), Wildlife Health Unit (WHU), the rangers of the Wildlife Rescue Unit (WRU), and the research assistants at Danau Girang Field Centre (DGFC) for their late-night efforts in collaring the animals and their consistent help throughout the study. We thank two anonymous reviewers for valuable suggestions and discussion points that improved this manuscript. A special thank you to C Calenge, S Durr, L Evans and A Lyons for their advice on the modelling details and assistance with scripts.	Abram NK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095388; Nascimento ATA, 2011, AM J PRIMATOL, V73, P1114, DOI 10.1002/ajp.20977; American Society of Mammalogist, 1998, J MAMMAL, V74, P1415; Ancrenaz M, 2004, ANIM CONSERV, V7, P375, DOI 10.1017/S136794300400157X; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arroyo-Rodriguez V, 2013, DEV PRIMATOL-PROG PR, P13, DOI 10.1007/978-1-4614-8839-2_2; Asensio N, 2012, PRIMATES, V53, P147, DOI 10.1007/s10329-011-0288-9; Austin D, 2004, OIKOS, V105, P15, DOI 10.1111/j.0030-1299.1999.12730.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benhamou S, 2004, J THEOR BIOL, V229, P209, DOI 10.1016/j.jtbi.2004.03.016; Benhamou S, 2012, BRB MKDE BRB D USER; Benhamou S, 2012, ECOL MODEL, V227, P112, DOI 10.1016/j.ecolmodel.2011.12.015; Benhamou S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014592; Benhamou S, 2010, J WILDLIFE MANAGE, V74, P1353, DOI 10.2193/2009-441; Beyer HL, 2010, GEOSPATIAL MODELLING; Bjorneraas K, 2010, J WILDLIFE MANAGE, V74, P1361, DOI 10.2193/2009-405; Blackie HM, 2010, J WILDLIFE MANAGE, V74, P1911, DOI 10.2193/2009-412; Boonratana R, 2000, INT J PRIMATOL, V21, P497, DOI 10.1023/A:1005496004129; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; Brodie JF, 2015, MAMM BIOL, V80, P7, DOI 10.1016/j.mambio.2014.06.001; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; Calenge C, 2015, PACKAGE ADEHABITATLT; Calenge C., 2015, PACKAGE ADEHABITATHR; Campbell Hamish A., 2012, Endangered Species Research, V17, P53, DOI 10.3354/esr00397; Campos FA, 2014, ANIM BEHAV, V91, P93, DOI 10.1016/j.anbehav.2014.03.007; CHAPMAN CA, 1993, AM J PRIMATOL, V31, P263, DOI 10.1002/ajp.1350310403; Chapman CA, 2001, EVOL ANTHROPOL, V10, P16, DOI 10.1002/1520-6505(2001)10:1<16::AID-EVAN1010>3.0.CO;2-O; Craighead J.J., 1995, GRIZZLY BEARS YELLOW; Cristescu B, 2016, SCI REP-UK, V6, DOI 10.1038/srep19177; Cumming GS, 2012, DIVERS DISTRIB, V18, P1057, DOI 10.1111/j.1472-4642.2012.00908.x; Di Fiore A, 2003, AM J PRIMATOL, V59, P47, DOI 10.1002/ajp.10065; Donovan TM, 2011, BIOL CONSERV, V144, P2799, DOI 10.1016/j.biocon.2011.06.026; Doran-Sheehy DM, 2004, AM J PRIMATOL, V64, P207, DOI 10.1002/ajp.20075; Dray S, 2010, ECOL RES, V25, P673, DOI 10.1007/s11284-010-0701-7; Durr S, 2014, PREV VET MED, V117, P340, DOI 10.1016/j.prevetmed.2014.07.008; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Fieberg J, 2007, J WILDLIFE MANAGE, V71, P1669, DOI 10.2193/2006-370; Fieberg J, 2012, J MAMMAL, V93, P890, DOI 10.1644/11-MAMM-S-172.1; Fieberg J, 2010, PHILOS T R SOC B, V365, P2233, DOI 10.1098/rstb.2010.0079; Gamo RS, 1999, BIOTELEMETRY, P464; Gehrt SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075718; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; Gitzen RA, 2006, J WILDLIFE MANAGE, V70, P1334, DOI 10.2193/0022-541X(2006)70[1334:BSFFAO]2.0.CO;2; Grueter CC, 2009, PRIMATES, V50, P81, DOI 10.1007/s10329-008-0113-2; Hargis CD, 1998, LANDSCAPE ECOL, V13, P167, DOI 10.1023/A:1007965018633; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Hulbert IAR, 2001, J APPL ECOL, V38, P869, DOI 10.1046/j.1365-2664.2001.00624.x; Johnson CJ, 2002, WILDLIFE BIOL, V8, P153, DOI 10.2981/wlb.2002.011; Kenward RE, 2001, MANUAL WILDLIFE RADI, P201; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; Knott C, 2008, INT J PRIMATOL, V29, P975, DOI 10.1007/s10764-008-9278-1; Lehmann J, 2003, BEHAV ECOL, V14, P642, DOI 10.1093/beheco/arg047; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Lichti NI, 2011, J WILDLIFE MANAGE, V75, P413, DOI 10.1002/jwmg.48; Lyons AJ, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-2; Markham AC, 2008, AM J PRIMATOL, V70, P495, DOI 10.1002/ajp.20515; Matsuda I, 2008, THESIS; Matsuda I, 2009, AM J PRIMATOL, V71, P478, DOI 10.1002/ajp.20677; Matsuda I, 2009, INT J PRIMATOL, V30, P313, DOI 10.1007/s10764-009-9344-3; Mattisson J, 2010, J WILDLIFE MANAGE, V74, P557, DOI 10.2193/2009-157; Mcgarigal K., 2015, HELP 4 2, P1; Millspaugh JJ, 2006, J WILDLIFE MANAGE, V70, P384, DOI 10.2193/0022-541X(2006)70[384:AORSUU]2.0.CO;2; Naidoo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036527; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Niemi Marja, 2012, Endangered Species Research, V19, P99, DOI 10.3354/esr00468; Oksanen J, 2009, PACKAGE VEGAN COMMUN; Osborn Ferrel V., 2004, Pachyderm, V37, P37; Ostro LET, 1999, J WILDLIFE MANAGE, V63, P748, DOI 10.2307/3802665; Page B, 2009, INNOVATIVE SOLUTIONS, P175; Papastamatiou YP, 2009, ECOLOGY, V90, P996, DOI 10.1890/08-0491.1; Pebsworth PA, 2012, PRIMATES, V53, P345, DOI 10.1007/s10329-012-0307-5; Piper SD, 2004, FOREST ECOL MANAG, V203, P361, DOI 10.1016/j.foreco.2004.08.005; Powell RA, 2012, J MAMMAL, V93, P948, DOI 10.1644/11-MAMM-S-177.1; R Core Team, 2021, R LANGUAGE ENV STAT; Sawyer SC, 2012, BIODIVERS CONSERV, V21, P1589, DOI 10.1007/s10531-012-0266-6; SCHOENER TW, 1981, THEOR POPUL BIOL, V20, P281, DOI 10.1016/0040-5809(81)90049-6; Schweiger AK, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0033-x; Shaffer CA, 2014, AM J PRIMATOL, V76, P472, DOI 10.1002/ajp.22227; Shaffer CA, 2013, AM J PHYS ANTHROPOL, V150, P235, DOI 10.1002/ajpa.22197; SWIHART RK, 1985, J WILDLIFE MANAGE, V49, P1019, DOI 10.2307/3801388; Tomkiewicz SM, 2010, PHILOS T R SOC B, V365, P2163, DOI 10.1098/rstb.2010.0090; Unwin Steve, 2011, P147; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; von Neumann J, 1941, ANN MATH STAT, V12, P153, DOI 10.1214/aoms/1177731746; Walter W.D., 2011, MODERN TELEMETRY, P249; Walter WD, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0039-4; Wilson PD, 2011, METHODS ECOL EVOL, V2, P623, DOI 10.1111/j.2041-210X.2011.00115.x; [周婷 ZHOU Ting], 2008, [生态学报, Acta Ecologica Sinica], V28, P3322; Zuur Alain F., 2009, P1	93	25	25	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174891	10.1371/journal.pone.0174891	http://dx.doi.org/10.1371/journal.pone.0174891			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362872	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000399175000047
J	Villa-Bellosta, R; Hamczyk, MR; Andres, V				Villa-Bellosta, Ricardo; Hamczyk, Magda R.; Andres, Vicente			Novel phosphate-activated macrophages prevent ectopic calcification by increasing extracellular ATP and pyrophosphate	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; CHRONIC KIDNEY-DISEASE; IN-VITRO; MEDIATED INFLAMMATION; CELL CALCIFICATION; METABOLISM; POLARIZATION; CALCIUM; ATHEROSCLEROSIS; HOMEOSTASIS	Purpose Phosphorus is an essential nutrient involved in many pathobiological processes. Less than 1% of phosphorus is found in extracellular fluids as inorganic phosphate ion (Pi) in solution. High serum Pi level promotes ectopic calcification in many tissues, including blood vessels. Here, we studied the effect of elevated Pi concentration on macrophage polarization and calcification. Macrophages, present in virtually all tissues, play key roles in health and disease and display remarkable plasticity, being able to change their physiology in response to environmental cues. Methods and results High-throughput transcriptomic analysis and functional studies demonstrated that Pi induces unpolarized macrophages to adopt a phenotype closely resembling that of alternatively -activated M2 macrophages, as revealed by arginine hydrolysis and energetic and antioxidant profiles. Pi-induced macrophages showed an anti-calcifying action mediated by increased availability of extracellular ATP and pyrophosphate. Conclusion We conclude that the ability of Pi-activated macrophages to prevent calcium-phosphate deposition is a compensatory mechanism protecting tissues from hyperphosphatemiainduced pathologic calcification.	[Villa-Bellosta, Ricardo; Hamczyk, Magda R.; Andres, Vicente] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain; [Villa-Bellosta, Ricardo; Hamczyk, Magda R.; Andres, Vicente] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain; [Villa-Bellosta, Ricardo] Fdn Jimenez Diaz FIIS FJD, Fdn Inst Invest Sanitaria, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Fundacion Jimenez Diaz	Villa-Bellosta, R; Andres, V (corresponding author), Ctr Nacl Invest Cardiovasc Carlos III CNIC, Madrid, Spain.; Villa-Bellosta, R; Andres, V (corresponding author), Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain.; Villa-Bellosta, R (corresponding author), Fdn Jimenez Diaz FIIS FJD, Fdn Inst Invest Sanitaria, Madrid, Spain.	ricardo.villa@fjd.es; vandres@cnic.es	Hamczyk, Magda/GSM-7074-2022; Andres, Vicente/I-6440-2014; Hamczyk, Magda/P-1715-2019	Hamczyk, Magda/0000-0003-2198-7353; Andres, Vicente/0000-0002-0125-7209; Hamczyk, Magda/0000-0003-2198-7353; Villa-Bellosta, Ricardo/0000-0002-1680-552X	Spanish Ministerio de Economia y Competitividad (MINECO) [JCI-2011-09663, SAF-201460699-JIN]; FPI [BES-2011-043938]; MINECO [SAF2013-4663-R]; Institute de Salud Carlos III [RD12/0042/0028]; Fondo Europeo de Desarrollo Regional (FEDER); MINECO; Pro-CNIC Foundation; Severo Ochoa Center of Excellence (MINECO) [SEV-2015-0505]	Spanish Ministerio de Economia y Competitividad (MINECO)(Spanish Government); FPI(Spanish Government); MINECO(Spanish Government); Institute de Salud Carlos III(Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); MINECO(Spanish Government); Pro-CNIC Foundation; Severo Ochoa Center of Excellence (MINECO)(Spanish Government)	The Spanish Ministerio de Economia y Competitividad (MINECO) supports R.V.-B. ("Juan de la Cierva" JCI-2011-09663 and SAF-201460699-JIN postdoctoral contracts) and M.R.H. (FPI predoctoral contract BES-2011-043938). This study was supported by research grants to V.A. from MINECO (SAF2013-4663-R) and the Institute de Salud Carlos III (RD12/0042/0028) with co-funding from the Fondo Europeo de Desarrollo Regional (FEDER). The CNIC is supported by the MINECO and the Pro-CNIC Foundation, and is a Severo Ochoa Center of Excellence (MINECO award SEV-2015-0505). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt T, 2007, ANNU REV PHYSIOL, V69, P341, DOI 10.1146/annurev.physiol.69.040705.141729; Berndt TJ, 2005, AM J PHYSIOL-RENAL, V289, pF1170, DOI 10.1152/ajprenal.00072.2005; Chinetti-Gbaguidi G, 2015, NAT REV CARDIOL, V12, P10, DOI 10.1038/nrcardio.2014.173; Classen Andrea, 2009, V531, P29, DOI 10.1007/978-1-59745-396-7_3; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hamczyk MR, 2015, METHODS MOL BIOL, V1339, P235, DOI 10.1007/978-1-4939-2929-0_16; Ho Victor W. H., 2009, V531, P173, DOI 10.1007/978-1-59745-396-7_12; Kovacic JC, 2011, CIRCULATION, V123, P1900, DOI 10.1161/CIRCULATIONAHA.110.009118; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Meng XM, 2015, KIDNEY DIS-BASEL, V1, P138, DOI 10.1159/000431214; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Otsuka F, 2014, ARTERIOSCL THROM VAS, V34, P724, DOI 10.1161/ATVBAHA.113.302642; Pello OM, 2011, IMMUNOBIOLOGY, V216, P1172, DOI 10.1016/j.imbio.2011.05.010; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Sun Y-Y, 2016, SCAND J IMMUNOL; Tintut Y, 2002, CIRCULATION, V105, P650, DOI 10.1161/hc0502.102969; Udalova IA, 2016, NAT REV RHEUMATOL, V12, P472, DOI 10.1038/nrrheum.2016.91; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Villa-Bellosta R, 2015, EUR HEART J; Villa-Bellosta R, 2015, CURR CARDIOL REV, V11, P341, DOI 10.2174/1573403X11666150805120505; Villa-Bellosta R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159858; Villa-Bellosta R, 2016, AM J PHYSIOL-CELL PH, V310, pC788, DOI 10.1152/ajpcell.00370.2015; Villa-Bellosta R, 2015, METHODS MOL BIOL, V1339, P119, DOI 10.1007/978-1-4939-2929-0_8; Villa-Bellosta R, 2013, CIRC J, V77, P2145, DOI 10.1253/circj.CJ-13-0016; Villa-Bellosta R, 2013, CIRCULATION, V127, P2442, DOI 10.1161/CIRCULATIONAHA.112.000571; Villa-Bellosta R, 2011, AM J PHYSIOL-HEART C, V301, pH61, DOI 10.1152/ajpheart.01020.2010; Villa-Bellosta R, 2011, AM J PHYSIOL-CELL PH, V300, pC210, DOI 10.1152/ajpcell.00229.2010; Villa-Bellosta R, 2009, ARTERIOSCL THROM VAS, V29, P761, DOI 10.1161/ATVBAHA.108.183384; Xiong XY, 2016, PROG NEUROBIOL, V142, P23, DOI 10.1016/j.pneurobio.2016.05.001; Yin TT, 2000, CIRCULATION, V102, P2636, DOI 10.1161/01.cir.102.21.2636	35	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174998	10.1371/journal.pone.0174998	http://dx.doi.org/10.1371/journal.pone.0174998			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362852	gold, Green Published			2022-12-26	WOS:000399175000058
J	Friedlander, AM; Golbuu, Y; Ballesteros, E; Caselle, JE; Gouezo, M; Olsudong, D; Sala, E				Friedlander, Alan M.; Golbuu, Yimnang; Ballesteros, Enric; Caselle, Jennifer E.; Gouezo, Marine; Olsudong, Dawnette; Sala, Enric			Size, age, and habitat determine effectiveness of Palau's Marine Protected Areas	PLOS ONE			English	Article							REEF FISH ASSEMBLAGES; CORAL-REEFS; PACIFIC ISLANDS; SUSTAINABLE USE; RESERVE SIZE; APO ISLAND; CONSERVATION; BIODIVERSITY; MANAGEMENT; WATERSHEDS	Palau has a rich heritage of conservation that has evolved from the traditional moratoria on fishing, or "bul", to more western Marine Protected Areas (MPAs), while still retaining elements of customary management and tenure. In 2003, the Palau Protected Areas Network (PAN) was created to conserve Palau's unique biodiversity and culture, and is the country's mechanism for achieving the goals of the Micronesia Challenge (MC), an initiative to conserve >= 30% of near-shore marine resources within the region by 2020. The PAN comprises a network of numerous MPAs within Palau that vary in age, size, level of management, and habitat, which provide an excellent opportunity to test hypotheses concerning MPA design and function using multiple discreet sampling units. Our sampling design provided a robust space for time comparison to evaluate the relative influence of potential drivers of MPA efficacy. Our results showed that no-take MPAs had, on average, nearly twice the biomass of resource fishes (i.e. those important commercially, culturally, or for subsistence) compared to nearby unprotected areas. Biomass of non-resource fishes showed no differences between no-take areas and areas open to fishing. The most striking difference between no take MPAs and unprotected areas was the more than 5-fold greater biomass of piscivorous fishes in the MPAs compared to fished areas. The most important determinates of no-take MPA success in conserving resource fish biomass were MPA size and years of protection. Habitat and distance from shore had little effect on resource fish biomass. The extensive network of MPAs in Palau likely provides important conservation and tourism benefits to the Republic, and may also provide fisheries benefits by protecting spawning aggregation sites, and potentially through adult spillover.	[Friedlander, Alan M.; Sala, Enric] Natl Geog Soc, Pristine Seas, Washington, DC 20036 USA; [Friedlander, Alan M.] Univ Hawaii, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [Golbuu, Yimnang; Gouezo, Marine; Olsudong, Dawnette] Palau Int Coral Reef Ctr, Koror, Palau; [Ballesteros, Enric] CSIC, CEAB, Blanes, Spain; [Caselle, Jennifer E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA	National Geographic Society; University of Hawaii System; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of California System; University of California Santa Barbara	Friedlander, AM (corresponding author), Natl Geog Soc, Pristine Seas, Washington, DC 20036 USA.; Friedlander, AM (corresponding author), Univ Hawaii, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA.	alan.friedlander@hawaii.edu	Gouezo, Marine/AAJ-5147-2021		National Geographic Society; Blancpain; Davidoff Cool Water; Jynwel Foundation; Leona M. and Harry B. Helmsley Charitable Trust	National Geographic Society(National Geographic Society); Blancpain; Davidoff Cool Water; Jynwel Foundation; Leona M. and Harry B. Helmsley Charitable Trust	This work was supported by the National Geographic Society, www.nationalgeographic.com, ES; Blancpain, http://www.blancpain.com/, ES; Davidoff Cool Water, http://www.zinodavidoff.com , ES; Jynwel Foundation, jynwelfoundation.org, ES; The Leona M. and Harry B. Helmsley Charitable Trust, www.helmsleytrustorg, ES; Lindblad Expeditions, www.expeditions.com, ES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airame S, 2003, ECOL APPL, V13, pS170; Allison GW, 2003, ECOL APPL, V13, pS8; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 1989, JMP PRO 12 2; Attwood CG, 1995, S AFR J MARINE SCI, V16, P227; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Baker N, 2010, J MAR BIOL, V29, P2011; Barrett NS, 2007, J EXP MAR BIOL ECOL, V345, P141, DOI 10.1016/j.jembe.2007.02.007; Bartholomew A, 2008, LANDSCAPE ECOL, V23, P55, DOI 10.1007/s10980-007-9136-0; Battista TA, 2007, 59 NOAA NOS NCCOS; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Browman HI, 2004, MAR ECOL PROG SER, V274, P269, DOI 10.3354/meps274269; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Dawson MN, 2001, HYDROBIOLOGIA, V451, P131, DOI 10.1023/A:1011868925383; Dayton PK, 2000, B MAR SCI, V66, P617; De Mitcheson YS, 2008, CONSERV BIOL, V22, P1233, DOI 10.1111/j.1523-1739.2008.01020.x; e Costa BH, 2016, MAR POLICY, V72, P192, DOI DOI 10.1016/J.MARPOL.2016.06.021; Edgar GJ, 1999, J EXP MAR BIOL ECOL, V242, P107, DOI 10.1016/S0022-0981(99)00098-2; Friedlander A. M., 2009, ENCY ISLANDS, P607; Friedlander AM, 2010, MAR ECOL PROG SER, V410, P219, DOI 10.3354/meps08634; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Froese R., 2012, FISHBASE; Golbuu Y, 2007, CORAL REEFS, V26, P319, DOI 10.1007/s00338-007-0200-7; Golbuu Y, 2010, J MAR BIOL, V7, P2011; Golbuu Y, 2011, ESTUAR COAST SHELF S, V92, P223, DOI 10.1016/j.ecss.2010.12.034; Golbuu Y, 2011, MAR POLLUT BULL, V62, P824, DOI 10.1016/j.marpolbul.2010.12.015; Golbuu Yimnang, 2005, NOAA Technical Memorandum NOS NCCOS, V11, P488; Gouezo M, 2015, MAR ECOL PROG SER, V540, P73, DOI 10.3354/meps11518; Grorud-Colvert K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102298; Gruby RL, 2013, ENVIRON SCI POLICY, V33, P260, DOI 10.1016/j.envsci.2013.06.006; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2006, ECOL LETT, V9, P2, DOI 10.1111/j.1461-0248.2005.00827.x; Harmelin-Vivien M, 2008, BIOL CONSERV, V141, P1829, DOI 10.1016/j.biocon.2008.04.029; Hazell LC, 2006, ARCHAEOL OCEAN, V41, P12, DOI 10.1002/j.1834-4453.2006.tb00601.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Houk P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130823; Hughes JD, 2005, CAPITALISM NATURE SO, V16, P85; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Johannes R.E., 1981, WORDS LAGOON FISHING; JOHANNES RE, 1978, ANNU REV ECOL SYST, V9, P349, DOI 10.1146/annurev.es.09.110178.002025; Johannes RE, 1998, TRENDS ECOL EVOL, V13, P243, DOI 10.1016/S0169-5347(98)01384-6; Johannes Robert E., 1997, P380; Jupiter Stacy, 2014, Pacific Conservation Biology, V20, P206; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Koike H, 1402 PICRC; Koshiba S, 2014, ESTUAR COAST SHELF S, V144, P19, DOI 10.1016/j.ecss.2014.02.006; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lubchenco J, 2015, SCIENCE, V350, P382, DOI 10.1126/science.aad5443; Malcolm HA, 2016, AQUAT CONSERV, V26, P1090, DOI 10.1002/aqc.2600; MAPSTONE BD, 1998, GREAT BARRIER REEF M, V47; Marino Sebastian, 2008, NOAA Technical Memorandum NOS NCCOS, V73, P511; McLeod E, 2009, FRONT ECOL ENVIRON, V7, P362, DOI 10.1890/070211; Palumbi SR, 2009, FRONT ECOL ENVIRON, V7, P204, DOI 10.1890/070135; Poonian C, 2010, PAC SCI, V64, P557, DOI 10.2984/64.4.557; Republic of Palau,, 2019, NATL TOUR REG REP PA; Richmond RH, 2007, BIOSCIENCE, V57, P598, DOI 10.1641/B570710; Roberts CM, 2005, PHILOS T R SOC B, V360, P123, DOI 10.1098/rstb.2004.1578; Ruckelshaus M, 2008, BIOSCIENCE, V58, P53, DOI 10.1641/B580110; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Russ GR, 2004, OECOLOGIA, V138, P622, DOI 10.1007/s00442-003-1456-4; Russ GR, 2003, MAR ECOL PROG SER, V264, P15, DOI 10.3354/meps264015; Russ GR, 1996, MAR ECOL PROG SER, V132, P1, DOI 10.3354/meps132001; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Sumaila UR, 2000, ICES J MAR SCI, V57, P752, DOI 10.1006/jmsc.2000.0732; Takeda J, 1996, KAGOSHIMA U RES CTR, V15, P91; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; TERBRAAK CJF, 1995, AQUAT SCI, V57, P255, DOI 10.1007/BF00877430; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Toonen RJ, 2013, MAR POLLUT BULL, V77, P7, DOI 10.1016/j.marpolbul.2013.10.039; Tupper MH, 2007, FISH B-NOAA, V105, P527; Vianna GMS, 2012, BIOL CONSERV, V145, P267, DOI 10.1016/j.biocon.2011.11.022; Yamashita S, 2000, CONTEMP PACIFIC, V12, P437, DOI 10.1353/cp.2000.0071	74	25	25	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174787	10.1371/journal.pone.0174787	http://dx.doi.org/10.1371/journal.pone.0174787			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358910	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174800091
J	Li, TH; Ding, Y				Li, Tianhong; Ding, Yao			Spatial disparity dynamics of ecosystem service values and GDP in Shaanxi Province, China in the last 30 years	PLOS ONE			English	Article							LAND-USE CHANGE; NORTHERN SHAANXI; GREEN; RESTORATION; VALUATION; PATTERNS; PROGRAM; SCIENCE; REGION; COUNTY	The regional policy in China is shifting from solely gross domestic product (GDP) orientation to development that is more balanced between economic growth and ecological protection, as well as achieving equality among regions. Using land use maps and the adjusted value coefficients to assess ecosystem service values (ESV) for the 1980s, 1995, 2000, and 2010, we estimated the ESV in Shaanxi Province for different years, and characterized the spatial and temporal distribution of ESV and GDP. The results demonstrated that the total value of ecosystem services in Shaanxi Province increased from 208.95 billion Yuan in the 1980s to 309.76 billion Yuan in 2010. Variation Coefficient (C-v) and Theil index (T) were used to reflect the disparities of GDP or ESV within the study area. The values of Cv in descending order are GDP, ESV per capita, ESV, and GDP per capita. The Theil indexes of GDP were much greater than the ones of ESV. Variations of Cv and T showed that disparity in GDP kept increasing from the 1980s to 2000, then decreased; while no significant change in regional disparity of ESV were detected in parallel. The cities with higher GDP usually contributed little to ESV, and vice versa. The variation in GDP and ESV, in terms of the prefectural totals and per capita values, increased from the 1980s to 2010. This study provides an accessible way for local decision makers to evaluate the regional balance between economic growth and ecosystem services.	[Li, Tianhong] Peking Univ, Coll Environm Sci & Engn, Beijing, Peoples R China; [Li, Tianhong] Minist Educ, Key Lab Water & Sediment Sci, Beijing, Peoples R China; [Li, Tianhong; Ding, Yao] Peking Univ, Shenzhen Grad Sch, Shenzhen, Guangdong, Peoples R China	Peking University; Peking University; University Town of Shenzhen	Li, TH (corresponding author), Peking Univ, Coll Environm Sci & Engn, Beijing, Peoples R China.; Li, TH (corresponding author), Minist Educ, Key Lab Water & Sediment Sci, Beijing, Peoples R China.; Li, TH (corresponding author), Peking Univ, Shenzhen Grad Sch, Shenzhen, Guangdong, Peoples R China.	lth@pku.edu.cn	BITOUN, RACHEL Elisabeth/AAC-9538-2021	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910	National Natural Science Foundation of China [50979003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China with Grant No. 50979003 and to Dr, Tianhong Li.	Bai JJ, 2014, IEEE J-STARS, V7, P4581, DOI 10.1109/JSTARS.2014.2365590; Bateman IJ, 2013, SCIENCE, V341, P45, DOI 10.1126/science.1234379; Boumans R, 2002, ECOL ECON, V41, P529, DOI 10.1016/S0921-8009(02)00098-8; Burkhard B, 2011, ECOL MODEL, V222, P2878, DOI 10.1016/j.ecolmodel.2011.05.016; Cai YB, 2013, ENVIRON MONIT ASSESS, V185, P5111, DOI 10.1007/s10661-012-2929-x; Camacho-Valdez V, 2013, OCEAN COAST MANAGE, V78, P1, DOI 10.1016/j.ocecoaman.2013.02.017; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Chen ZX, 2000, CHINESE SCI BULL, V45, P870, DOI 10.1007/BF02886190; Costanza R, 2000, BIOSCIENCE, V50, P149, DOI 10.1641/0006-3568(2000)050[0149:MOEP]2.3.CO;2; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Costanza R, 1998, ECOL ECON, V25, P3, DOI 10.1016/S0921-8009(98)00020-2; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Coulter P.B., 1989, MEASURING INEQUALITY; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; Daily GC, 2008, P NATL ACAD SCI; EHRLICH PR, 1983, BIOSCIENCE, V33, P248, DOI 10.2307/1309037; Ferreira P, 2000, YOUNG PERSONS GUIDE, V14; Gascoigne WR, 2011, ECOL ECON, V70, P1715, DOI 10.1016/j.ecolecon.2011.04.010; Jia XQ, 2014, ECOL INDIC, V43, P103, DOI 10.1016/j.ecolind.2014.02.028; Jing L, 2011, INT J ENVIRON RES, V5, P109; Kandziora M, 2013, ECOSYST SERV, V4, P47, DOI 10.1016/j.ecoser.2013.04.001; Klug H, 2010, ECOL COMPLEX, V7, P368, DOI 10.1016/j.ecocom.2009.12.005; Kreuter UP, 2001, ECOL ECON, V39, P333, DOI 10.1016/S0921-8009(01)00250-6; Kubiszewski I, 2013, ECOL ECON, V93, P57, DOI 10.1016/j.ecolecon.2013.04.019; Li GD, 2014, ECOL INDIC, V46, P293, DOI 10.1016/j.ecolind.2014.05.020; Li TH, 2010, ECOL ECON, V69, P1427, DOI 10.1016/j.ecolecon.2008.05.018; Li WJ, 2015, J GEOGR SCI, V25, P289, DOI 10.1007/s11442-015-1168-9; Liu CL, 2013, J NATUR RESOUR, V29, P1091; Liu JG, 2008, SCIENCE, V319, P37, DOI 10.1126/science.1150416; Liu JY, 2014, J GEOGR SCI, V24, P195, DOI 10.1007/s11442-014-1082-6; Liu JY, 2010, J GEOGR SCI, V20, P483, DOI 10.1007/s11442-010-0483-4; Liu Y, 2012, ECOL MODEL, V225, P127, DOI 10.1016/j.ecolmodel.2011.11.017; Loomis J, 2000, ECOL ECON, V33, P103, DOI 10.1016/S0921-8009(99)00131-7; Martinez ML, 2009, FOREST ECOL MANAG, V258, P1856, DOI 10.1016/j.foreco.2009.02.023; National Bureau of Statistics, 2011, CHIN STAT YB 2011; Ouyang Z, 2016, SCIENCE, V352, P1455, DOI 10.1126/science.aaf2295; Palomo I, 2014, REG ENVIRON CHANGE, V14, P237, DOI 10.1007/s10113-013-0488-5; Sawut M, 2013, CAN J SOIL SCI, V93, P99, DOI [10.4141/CJSS2012-010, 10.4141/cjss2012-010]; Shaanxi Provincial Bureau of Statistics, 2011, SHAANX STAT YB 2011; Sutton PC, 2002, ECOL ECON, V41, P509, DOI 10.1016/S0921-8009(02)00097-6; Uchida E, 2005, LAND ECON, V81, P247, DOI 10.3368/le.81.2.247; Wang JH, 2011, J GEOGR SCI, V21, P949, DOI 10.1007/s11442-011-0892-z; Wang YJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004641; Xiao JY, 2006, LANDSCAPE URBAN PLAN, V75, P69, DOI 10.1016/j.landurbplan.2004.12.005; Xie G.D., 2010, J RESOUR ECOL, V1, P51; [谢高地 XIE Gao-di], 2008, [自然资源学报, Journal of Natural Resources], V23, P911; Xie GaoDi, 2015, Journal of Resources and Ecology, V6, P355, DOI 10.5814/j.issn.1674-764x.2015.06.002; Yin RS, 2012, ECOL ECON, V73, P56, DOI 10.1016/j.ecolecon.2011.11.003; Yoshida A., 2010, ACTA ECOL SIN, V30, P56, DOI [10.1016/j.chnaes.2010.03.002, DOI 10.1016/J.CHNAES.2010.03.002]; You YL, 2012, POL J ENVIRON STUD, V21, P783; Yu SX, 2004, CHINESE GEOGR SCI, V14, P215, DOI 10.1007/s11769-003-0050-3; Yu ZY, 2011, ENRGY PROCED, V5, P64, DOI 10.1016/j.egypro.2011.03.012; Zhang P, 2015, SUSTAINABILITY-BASEL, V7, P7333, DOI 10.3390/su7067333; Zhang Zhou, 2013, Ying Yong Sheng Tai Xue Bao, V24, P556; Zhou DC, 2014, ECOL MODEL, V288, P47, DOI 10.1016/j.ecolmodel.2014.05.016; Zhou HJ, 2009, LAND USE POLICY, V26, P954, DOI 10.1016/j.landusepol.2008.11.006	56	11	12	11	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174562	10.1371/journal.pone.0174562	http://dx.doi.org/10.1371/journal.pone.0174562			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VI	28358918	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174800055
J	Tong, C; Tian, F; Zhang, CF; Zhao, K				Tong, Chao; Tian, Fei; Zhang, Cunfang; Zhao, Kai			The microRNA repertoire of Tibetan naked carp Gymnocypris przewalskii: A case study in Schizothoracinae fish on the Tibetan Plateau	PLOS ONE			English	Article							WIDE IDENTIFICATION; EVOLUTION; SELECTION; CYPRINIDAE; REVEALS; GENES; ADAPTATION; GENOMICS; AFFINITY; FAMILY	Tibetan naked carp Gymnocypris przewalskii is an ideal model system to study highland adaptation of fish, because it evolved specific genetic and phenotypic characteristics to adapt to chronic cold and alkaline environments in Lake Qinghai. MicroRNAs (miRNAs) are small noncoding RNAs that regulating gene expression post-transcriptionally in a wide range of biological processes. In this study, we focus on the role of miRNAs in adaptation of G. przewalskii to extreme conditions in Lake Qinghai. We generate the first miRNAome of G. przewalskii in Schizothoracinae fish. Using several genomic resources, we inferred 341 conserved miRNAs belonged to 152 miRNA families and 43 novel miRNAs in G. przewalskii, and also identified 15 teleost-specific miRNAs. Using a large scale of conserved miRNAs, we constructed a high-confidence phylogenetic tree between teleost and mammals than mitochondria and nuclear genes. In addition, we found that several miRNA family (e.g. miR-10 and let-7) members highly expressed in G. przewalskii, which may function in multiple biological processes. Finally, we predicted a total of 34,258 miRNA targets genes. Conserved miRNAs target genes participating in signal transduction, cell differentiation and biosynthetic process, and showed signature of functional constraint. While novel miRNAs in a species displayed species-specific targets and involved in ion binding, transport and oxidoreductase activity, may affect the expression patterns of targets with signature of gene family expansion or positive selection under extreme environment. Taken together, this study demonstrated that miRNAs may involve into roles of adaptation of G. przewalskiito highland aquatic environment, and also provide insights into miRNA regulatory network in Schizothoracinae fish as a case study.	[Tong, Chao; Tian, Fei; Zhang, Cunfang; Zhao, Kai] Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Adaptat & Evolut Plateau Biota, Xining, Peoples R China; [Tong, Chao; Tian, Fei; Zhang, Cunfang; Zhao, Kai] Chinese Acad Sci, Northwest Inst Plateau Biol, Lab Plateau Fish Evolutionary & Funct Genom, Xining, Peoples R China; [Tong, Chao; Tian, Fei; Zhang, Cunfang; Zhao, Kai] Chinese Acad Sci, Northwest Inst Plateau Biol, Qinghai Key Lab Anim Ecol Genom, Xining, Peoples R China; [Tong, Chao] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, CF; Zhao, K (corresponding author), Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Adaptat & Evolut Plateau Biota, Xining, Peoples R China.; Zhang, CF; Zhao, K (corresponding author), Chinese Acad Sci, Northwest Inst Plateau Biol, Lab Plateau Fish Evolutionary & Funct Genom, Xining, Peoples R China.; Zhang, CF; Zhao, K (corresponding author), Chinese Acad Sci, Northwest Inst Plateau Biol, Qinghai Key Lab Anim Ecol Genom, Xining, Peoples R China.	cfzhang@nwipb.cas.cn; zhaokai@nwipb.cas.cn	Tong, Chao/AAT-4685-2020; Tian, Fei/HDL-8149-2022	Tong, Chao/0000-0001-5202-5507; 	Natural Science Foundation of Qinghai Province, China [2016-ZJ-939Q]; National Natural Science Foundation of China [31572258, 31500306]; Key Innovation Plan from Chinese Academy of Sciences [KSCX2-EW-N-004]; Open Foundation from the Qinghai Key Laboratory of Tibetan Medicine Pharmacology and Safety Evaluation [2014-ZY-03]	Natural Science Foundation of Qinghai Province, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Innovation Plan from Chinese Academy of Sciences; Open Foundation from the Qinghai Key Laboratory of Tibetan Medicine Pharmacology and Safety Evaluation	This work was supported by Natural Science Foundation of Qinghai Province, China (2016-ZJ-939Q), National Natural Science Foundation of China (31572258 and 31500306), Key Innovation Plan from Chinese Academy of Sciences (KSCX2-EW-N-004) and Open Foundation from the Qinghai Key Laboratory of Tibetan Medicine Pharmacology and Safety Evaluation (2014-ZY-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Bizuayehu TT, 2014, GENOME BIOL EVOL, V6, P1911, DOI 10.1093/gbe/evu151; CAO WX, 1981, ORIGIN EVOLUTION SCH; Cao YB, 2008, J MOL EVOL, V67, P570, DOI 10.1007/s00239-008-9175-4; Chi W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023549; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; FARRIS JS, 1977, SYST ZOOL, V26, P77, DOI 10.2307/2412867; Field DJ, 2014, EVOL DEV, V16, P189, DOI 10.1111/ede.12081; Franchini P, 2016, GENOME BIOL EVOL, V8, P1543, DOI 10.1093/gbe/evw097; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Guan LH, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0192-1; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li GX, 2014, J CELL BIOCHEM, V115, P1768, DOI 10.1002/jcb.24843; Li JJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002578; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Rastorguev SM, 2016, MOL ECOLOGY RESOURCE; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Skinner MK, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-878, 10.1186/1471-2164-15-377]; Sperling Erik A., 2009, P157; Sun X., 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.1016/J.FUEL.2015.07.056; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tao WJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2636-z; Tehler D, 2011, RNA BIOL, V8, P728, DOI 10.4161/rna.8.5.16324; Tong C, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0925-z; Tong C, 2016, FISH SHELLFISH IMMUN, V50, P34, DOI 10.1016/j.fsi.2016.01.012; Tong C, 2015, FISH SHELLFISH IMMUN, V46, P366, DOI 10.1016/j.fsi.2015.06.025; Tong C, 2015, FISH SHELLFISH IMMUN, V46, P334, DOI 10.1016/j.fsi.2015.06.023; Tong C, 2015, GENE, V565, P201, DOI 10.1016/j.gene.2015.04.009; Wang XZ, 2007, MOL PHYLOGENET EVOL, V42, P157, DOI 10.1016/j.ympev.2006.06.014; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Warris Sven, 2014, BMC Res Notes, V7, P34, DOI 10.1186/1756-0500-7-34; Wen L. Y., 2014, Journal of Agricultural Science (Toronto), V6, P244; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu Y, 1992, FISHES QINGHAI XIZAN; Xu W, 2013, ADV MULTIMED, V2013, DOI 10.1155/2013/651650; Yang LD, 2015, GENE, V566, P242, DOI 10.1016/j.gene.2015.04.058; Yang LD, 2015, GENE, V561, P181, DOI 10.1016/j.gene.2015.02.055; Yang LD, 2015, GENOME BIOL EVOL, V7, P251, DOI 10.1093/gbe/evu279; Yi SK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-754; Zhang M, 1997, INTRO SALINE LAKES Q; Zhang RY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09780; Zhang RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071331; Zhu YF, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-15	47	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174534	10.1371/journal.pone.0174534	http://dx.doi.org/10.1371/journal.pone.0174534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358922	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174800050
J	van der Leeuw, C; Peeters, S; Gronenschild, E; Michielse, S; Verbeek, M; Menheere, P; van Os, J; Marcelis, M				van der Leeuw, Christine; Peeters, Sanne; Gronenschild, Ed; Michielse, Stijn; Verbeek, Marcel; Menheere, Paul; van Os, Jim; Marcelis, Machteld		Genetic Risk Outcome Psychosis	Serum S100B: A proxy marker for grey and white matter status in the absence and presence of (increased risk of) psychotic disorder?	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; COGNITIVE RECOVERY; BRAIN; SCHIZOPHRENIA; ENVIRONMENT; SYMPTOMS; INFUSION; SYSTEM; INJURY; MRI	S100B is a protein with dose-dependent neurotrophic and neurotoxic effects. Whether S100B in psychotic disorder mirrors pathophysiological mechanisms (which elicit exacerbation of disease) or compensatory action is unclear, as is its validity as a proxy marker for brain status. Insight may be gained by examining associations between serum S100B and indices of grey (cortical thickness (CT)) and white matter (fractional anisotropy (FA)), in relation to the absence or presence of (increased risk of) psychotic disorder. Blood samples and cerebral magnetic resonance imaging (MRI) scans were acquired in 32 patients with psychotic disorder, 44 non-psychotic siblings of patients with psychotic disorder and 26 controls. Interactions between S100B and group were examined in separate models of CT and FA measures with multilevel regression analyses weighted for number of vertices and voxels (i.e. units of volume) respectively. All analyses were adjusted for sex, age, body mass index (BMI), scan sequence, handedness and highest level of education. Neither CT nor FA was associated with S100B. There were no significant S100B x group interactions (CT: chi(2) = 0.044, p = 0.978; FA: chi(2) = 3.672, p = 0.159). No evidence was present for S100B as a proxy marker of grey or white matter status. The association between S100B and brain measures was not moderated by psychosis risk.	[van der Leeuw, Christine; Peeters, Sanne; Gronenschild, Ed; Michielse, Stijn; van Os, Jim; Marcelis, Machteld] Maastricht Univ, Dept Psychiat & Neuropsychol, Sch Mental Hlth & Neurosci, EURON,Med Ctr, Maastricht, Netherlands; [Peeters, Sanne] Open Univ Netherlands, Fac Psychol & Educ Sci, Heerlen, Netherlands; [Verbeek, Marcel] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Nijmegen, Netherlands; [Verbeek, Marcel] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Nijmegen, Netherlands; [Verbeek, Marcel] Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Menheere, Paul] Maastricht Univ, Med Ctr, Cent Diagnost Lab, Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Dept Psychosis Studies, Inst Psychiat, London, England; [Marcelis, Machteld] Inst Mental Hlth Care Eindhoven GGzE, Eindhoven, Netherlands	Maastricht University; Open University Netherlands; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Maastricht University; University of London; King's College London	van der Leeuw, C (corresponding author), Maastricht Univ, Dept Psychiat & Neuropsychol, Sch Mental Hlth & Neurosci, EURON,Med Ctr, Maastricht, Netherlands.	c.vanderleeuw@maastrichtuniversity.nl	Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Peeters, Sanne/AAA-9523-2021; van Os, Jim/V-8884-2019; van Os, Jim/C-2113-2014; Michielse, Stijn/H-9020-2019; Verbeek, Marcel M/D-1971-2010	van Os, Jim/0000-0002-7245-1586; Michielse, Stijn/0000-0003-3930-8646; Verbeek, Marcel M/0000-0003-4635-7876; Myin-Germeys, Inez/0000-0002-3731-4930; Marcelis, Machteld/0000-0003-0045-9244; Peeters, Sanne/0000-0002-3004-4261	Geestkracht programme of the Dutch Health Research Council (ZON-MW) [10000-1002]; European Community's Seventh Framework Programme [HEALTH-F2-2009-241909]	Geestkracht programme of the Dutch Health Research Council (ZON-MW); European Community's Seventh Framework Programme	This work was supported by the Geestkracht programme of the Dutch Health Research Council (ZON-MW, grant number 10000-1002), and the European Community's Seventh Framework Programme under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI). The sponsors had no further role in the study design; in the collection, analysis and interpretation of data; in the writing of the report, and in the decision to submit the paper for publication.	Aleksovska K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106342; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Buschert J, 2013, J PSYCHIATR RES, V47, P1791, DOI 10.1016/j.jpsychires.2013.08.001; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Goldstein H., 1987, MULTILEVEL MODELS ED; Habets P, 2011, BIOL PSYCHIAT, V69, P487, DOI 10.1016/j.biopsych.2010.08.010; Hills, 1993, STAT MODELS EPIDEMIO; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Kleindienst A, 2004, J NEUROTRAUM, V21, P541, DOI 10.1089/089771504774129874; Korver N, 2012, INT J METH PSYCH RES, V21, P205, DOI 10.1002/mpr.1352; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Schmitt A, 2005, SCHIZOPHR RES, V80, P305, DOI 10.1016/j.schres.2005.04.013; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Sen J, 2007, J NEUROSCI RES, V85, P1373, DOI 10.1002/jnr.21211; Smit LHM, 2005, INT J BIOL MARKER, V20, P34, DOI 10.1177/172460080502000106; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Streitburger DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043284; van Beveren NJM, 2006, EUR NEUROPSYCHOPHARM, V16, P469, DOI 10.1016/j.euroneuro.2006.02.001; van der Leeuw C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082535	29	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174752	10.1371/journal.pone.0174752	http://dx.doi.org/10.1371/journal.pone.0174752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358925	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174800082
J	Wowkonowicz, P; Kijenska, M				Wowkonowicz, Pawel; Kijenska, Marta			Phthalate release in leachate from municipal landfills of central Poland	PLOS ONE			English	Article							DI 2-ETHYLHEXYL PHTHALATE; ESTERS; REMOVAL; WATER; ENVIRONMENT; BEHAVIOR; ACID; FATE	Phthalate diesters (PAEs) are used as plasticizer additives to polymer chains to make the material more flexible and malleable. PAEs are bonded physically, not chemically, to the polymeric matrix and can migrate to and leach from the product surface, posing a serious danger to the environment and human health. There have been a number of studies on PAE concentrations in landfill leachate conducted in the EU and around the world, though few in Poland. In the present study, the leachate of five municipal landfills was analyzed for the presence of PAEs. Raw leachate was sampled four times over the period of one year in 2015/16. It was the first large study on this subject in Poland. PAEs were detected in the leachate samples on all of the landfills, thereby indicating that PAEs are ubiquitous environmental contaminants. The following PAEs were detected in at least one sample: Di(2-ethylhexyl) phthalate (DEHP), Diethyl phthalate (DEP), Dimethyl phthalate (DMP), Di-n-butyl phthalate (DBP), Di-isobutylphthalate (DIBP). Out of all ten PAEs, DEHP was the most predominant, with concentrations up to 73.9 mu g/L. DEHP was present in 65% of analyzed samples (in 100% of samples in spring, 80% in winter, and 40% in summer and autumn). In only 25% of all samples DEHP was below the acceptable UE limit for surface water (1.3 mu g/L), while 75% was from 1.7 to 56 times higher than that value. On the two largest landfills DEHP concentrations were observed during samples from all four seasons, including on a landfill which has been remediated and closed for the last 5 years.	[Wowkonowicz, Pawel; Kijenska, Marta] Natl Res Inst, Inst Environm Protect, Environm Chem & Risk Assessment Dept, Warsaw, Poland	Institute of Environmental Protection - National Research Institute	Wowkonowicz, P (corresponding author), Natl Res Inst, Inst Environm Protect, Environm Chem & Risk Assessment Dept, Warsaw, Poland.	p.wowkonowicz@ios.edu.pl	Kijenska, Marta/Q-8637-2018	Kijenska, Marta/0000-0002-5191-4318	Polish Ministry of Science and Higher Education [10-0Z-BI-1492/15, 10-0Z-131-1516/16]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the Polish Ministry of Science and Higher Education, grants numbers 10-0Z-BI-1492/15 and 10-0Z-131-1516/16. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakura H, 2004, WASTE MANAGE, V24, P613, DOI 10.1016/j.wasman.2004.02.004; Baderna D, 2011, ENVIRON RES, V111, P603, DOI 10.1016/j.envres.2011.01.015; Benjamin S, 2015, J HAZARD MATER, V298, P58, DOI 10.1016/j.jhazmat.2015.05.004; Chai C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095701; Erythropel HC, 2014, APPL MICROBIOL BIOT, V98, P9967, DOI 10.1007/s00253-014-6183-8; European Chemicals Bureau, 2008, EUR UN RISK ASS REP, P91; Gao DW, 2016, SCI TOTAL ENVIRON, V541, P986, DOI 10.1016/j.scitotenv.2015.09.148; Gao ML, 2016, CHEMOSPHERE, V151, P76, DOI 10.1016/j.chemosphere.2016.02.061; Gong YF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103242, 10.1371/journal.pone.0095597]; Grynkiewicz-Bylina B, 2011, ECOL CHEM ENG S, V18, P455; Gworek B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133130; Howdeshell KL, 2008, ENVIRON RES, V108, P168, DOI 10.1016/j.envres.2008.08.009; Huang X, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0052-8; Jonsson S, 2003, WATER RES, V37, P609, DOI 10.1016/S0043-1354(02)00304-4; Kloting N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143190; Liu H.-G., 2010, CHINA PLANT PROTECTI, V30, P30, DOI DOI 10.1016/J.WASMAN.2010.01.040; Magdouli S, 2013, J ENVIRON MANAGE, V127, P36, DOI 10.1016/j.jenvman.2013.04.013; Marttinen SK, 2003, SCI TOTAL ENVIRON, V301, P1, DOI 10.1016/S0048-9697(02)00302-9; Net S, 2015, SCI TOTAL ENVIRON, V515, P162, DOI 10.1016/j.scitotenv.2015.02.013; Net S, 2015, ENVIRON SCI TECHNOL, V49, P4019, DOI 10.1021/es505233b; Office of Environmental Enforcement Environmental Protection Agency Ireland, 2003, LANDF MAN LANDF MON; Przybylinska PA, 2016, ECOL CHEM ENG S, V23, P347, DOI 10.1515/eces-2016-0024; United States Environmental Protection Agency (USEPA), 2015, TOX REL INV REP FORM; Wowkonowicz P, 2013, PRZEM CHEM, V92, P2345; Zheng Z, 2009, CHEMOSPHERE, V75, P180, DOI 10.1016/j.chemosphere.2008.12.011; Zia AI, 2016, SMART SENSOR MEAS IN, V16, P55, DOI 10.1007/978-3-319-21671-3_3; Zolfaghari M, 2014, ENVIRON POLLUT, V194, P281, DOI 10.1016/j.envpol.2014.07.014	27	33	34	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174986	10.1371/journal.pone.0174986	http://dx.doi.org/10.1371/journal.pone.0174986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358912	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174800106
J	Andres-Franch, M; Galiana, A; Sanchez-Hellin, V; Ochoa, E; Hernandez-Illan, E; Lopez-Garcia, P; Castillejo, A; Castillejo, MI; Barbera, VM; Garcia-Dura, J; Gomez-Romero, FJ; Royo, G; Soto, JL				Andres-Franch, Maria; Galiana, Antonio; Sanchez-Hellin, Victoria; Ochoa, Enrique; Hernandez-Illan, Eva; Lopez-Garcia, Pilar; Castillejo, Adela; Castillejo, Maria Isabel; Barbera, Victor Manuel; Garcia-Dura, Josefa; Javier Gomez-Romero, Francisco; Royo, Gloria; Soto, Jose Luis			Streptococcus gallolyticus infection in colorectal cancer leand association with biological and clinical factors	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; METHYLATOR PHENOTYPE; MICROBIOTA	There is an unambiguous association of Streptococcus gallolyticus infection with colorectal cancer, although there is limited information about epidemiology or interaction between molecular and environmental factors. We performed an original quantitative analysis of S. gallolyticus in unselected colorectal cancer patients (n = 190) and their association with clinical, pathological tumor molecular profiles (microsatellite instability, hypermethylator phenotype and chromosomal instability pathways), and other biological factors in colorectal tumor and normal tissues (cytomegalovirus and Epstein-Barr virus infection). We developed a new quantitative method to assess bacterial load. Analytical validation was reached with a very high sensitivity and specificity. Our results showed a 3.2% prevalence of S. gallolyticus infection in our unselected cohort of colorectal cancer cases (6/190). The average S. gallolyticus copy number was 7,018 (range 44-34,585). No previous reports relating to S. gallolyticus infection have been published for unselected cohorts of patients. Finally, and despite a low prevalence of S. gallolyticus in this study, we were able to define a specific association with tumor tissue (p = 0.03) and with coinfection with Epstein-Barr virus (p = 0.042; OR: 9.49; 95% IC: 1.1-82.9). The prevalence data provided will be very useful in the design of future studies, and will make it possible to estimate the sample size needed to assess precise objectives. In conclusion, our results show a low prevalence of S. gallolyticus infection in unselected colorectal cancer patients and an association of positive S. gallolyticus infection with tumor tissue and Epstein-Barr virus coinfection. Further studies will be needed to definitively assess the prevalence of S. gallolyticus in colorectal cancer and the associated clinicopathological and molecular profiles.	[Andres-Franch, Maria; Galiana, Antonio; Sanchez-Hellin, Victoria; Lopez-Garcia, Pilar; Garcia-Dura, Josefa; Royo, Gloria] Hosp Gen Univ Elche, Dept Microbiol, Elche, Spain; [Ochoa, Enrique] Hosp Prov Castellon, Biopathol Dept, Castellon de La Plana, Spain; [Hernandez-Illan, Eva] Hosp Gen Univ Alicante, Res Lab, Alicante, Spain; [Hernandez-Illan, Eva; Castillejo, Adela; Castillejo, Maria Isabel; Barbera, Victor Manuel; Soto, Jose Luis] Inst Invest Sanitaria & Biomed Alicante ISABIAL F, Alicante, Spain; [Castillejo, Adela; Castillejo, Maria Isabel; Barbera, Victor Manuel; Soto, Jose Luis] Hosp Gen Univ Elche, Mol Genet Unit, Elche, Spain; [Javier Gomez-Romero, Francisco] Hosp Gen Univ Elche, Dept Prevent Med, Elche, Spain	General University Hospital of Alicante; General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL)	Sanchez-Hellin, V (corresponding author), Hosp Gen Univ Elche, Dept Microbiol, Elche, Spain.	sanchez_vichel@gva.es	Castillo, Adela Castillejo/AAD-3477-2020; Soto, José Luis/AAC-6520-2020	Castillo, Adela Castillejo/0000-0002-9581-6285; Barbera, Victor-Manuel/0000-0002-4012-6973; Ayestaran Soto, Juan/0000-0001-8027-8659; Gomez-Romero, Francisco Javier/0000-0003-0754-5129; Sanchez-Hellin, Victoria/0000-0002-4101-0120; Soto, Jose Luis/0000-0003-0234-9188; Castillejo Castillo, Maria Isabel/0000-0002-4545-6429; Galiana, Antonio/0000-0002-1134-1914	Conselleria d'Educacio Generalitat Valenciana, Spain [GV/2016/175]	Conselleria d'Educacio Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF))	This work was supported by Conselleria d'Educacio Generalitat Valenciana, Spain (GV/2016/175).	Abdulamir AS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-249; Berg M, 2014, PLOS ONE, V9; Boleij A, 2013, LANCET INFECT DIS, V13, P719, DOI 10.1016/S1473-3099(13)70107-5; Boleij A, 2011, CLIN INFECT DIS, V53, P870, DOI 10.1093/cid/cir609; Buhard O, 2006, J CLIN ONCOL, V24, P241, DOI 10.1200/JCO.2005.02.7227; Carethers JM, 2015, GASTROENTEROLOGY, V149, P1177, DOI 10.1053/j.gastro.2015.06.047; Collins D, 2011, LANCET ONCOL, V12, P504, DOI 10.1016/S1470-2045(10)70186-8; de la Chapelle A, 2010, J CLIN ONCOL, V28, P3380, DOI 10.1200/JCO.2009.27.0652; Duijf PHG, 2013, ONCOGENE, V32, P4727, DOI 10.1038/onc.2012.616; Edge SB, 2010, AJCC CANC STAGING MA; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gagniere J, 2016, WORLD J GASTROENTERO, V22, P501, DOI 10.3748/wjg.v22.i2.501; Gallois C, 2016, CRIT REV ONCOL HEMAT, V99, P74, DOI 10.1016/j.critrevonc.2015.11.001; Irrazabal T, 2014, MOL CELL, V54, P309, DOI 10.1016/j.molcel.2014.03.039; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Lee Yuan-Ming, 2001, Journal of Microbiology Immunology and Infection, V34, P87; Markoulatos P, 2001, J CLIN MICROBIOL, V39, P4426, DOI 10.1128/JCM.39.12.4426-4432.2001; Ogino S, 2007, J MOL DIAGN, V9, P305, DOI 10.2353/jmoldx.2007.060170; Salyakina D, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-23	19	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174305	10.1371/journal.pone.0174305	http://dx.doi.org/10.1371/journal.pone.0174305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355283	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174600042
J	Alcantara-Neves, NM; Veiga, RV; Ponte, JCM; da Cunha, SS; Simoes, SM; Cruz, AA; Yazdanbakhsh, M; Matos, SM; Silva, TM; Figueiredo, CA; Pontes-de-Carvalho, LC; Rodrigues, LC; Fiaccone, RL; Cooper, PJ; Barreto, ML				Alcantara-Neves, Neuza M.; Veiga, Rafael V.; Ponte, Joao C. M.; da Cunha, Sergio S.; Simoes, Silvia M.; Cruz, Alvaro A.; Yazdanbakhsh, Maria; Matos, Sheila M.; Silva, Thiago Magalhaes; Figueiredo, Camila A.; Pontes-de-Carvalho, Lain C.; Rodrigues, Laura C.; Fiaccone, Rosemeire L.; Cooper, Philip J.; Barreto, Mauricio L.			Dissociation between skin test reactivity and anti-aeroallergen IgE: Determinants among urban Brazilian children	PLOS ONE			English	Article							ASCARIS-LUMBRICOIDES; HELMINTH INFECTIONS; SCHOOL-AGE; RURAL AREA; SERUM IGE; ASTHMA; ATOPY; PARASITES; ALLERGY; INTERLEUKIN-10	Background The dissociation between specific IgE and skin prick test reactivity to aeroallergens, a common finding in populations living in low and middle-income countries, has important implications for the diagnosis and treatment of allergic diseases. Few studies have investigated the determinants of this dissociation. In the present study, we explored potential factors explaining this dissociation in children living in an urban area of Northeast Brazil, focusing in particular on factors associated with poor hygiene. Methods Of 1445 children from low income communities, investigated for risk factors of allergies, we studied 481 with specific IgE antibodies to any of Blomia tropicalis, Dermatophagoides pteronyssinus, Periplaneta americana and Blatella germanica allergens. Data on demographic, environmental and social exposures were collected by questionnaire; serum IgG and stool examinations were done to detect current or past infections with viral, bacterial, protozoan and intestinal helminth pathogens. We measured atopy by skin prick testing (SPT) and specific IgE (sIgE) to aerollergens in serum (by ImmunoCAP). SIgE reactivity to B. tropicalis extract depleted of carbohydrates was measured by an in-house ELISA. Total IgE was measured by in house capture ELISA. SNPs were typed using Illumina Omni 2.5. Results Negative skin prick tests in the presence of specific IgE antibodies were frequent. Factors independently associated with a reduced frequency of positive skin prick tests were large number of siblings, the presence of IgG to herpes simplex virus, Ascaris lumbricoides and Trichuris trichiura infections, living in neighborhoods with infrequent garbage collection, presence of rodents and cats in the household and sIgE reactivity to glycosylated B. tropicalis allergens. Also, SNP on IGHE (rs61737468) was negatively associated with SPT reactivity. Conclusions A variety of factors were found to be associated with decreased frequency of SPT such as unhygienic living conditions, infections, total IgE, IgE response to glycosylated allergens and genetic polymorphisms, indicating that multiple mechanisms may be involved. Our data, showing that exposures to an unhygienic environment and childhood infections modulate immediate allergen skin test reactivity, provide support for the "hygiene hypothesis".	[Alcantara-Neves, Neuza M.; Veiga, Rafael V.; Ponte, Joao C. M.; Figueiredo, Camila A.] Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil; [Veiga, Rafael V.] Univ Fed Juiz de Fora, Juiz De Fora, MG, Brazil; [da Cunha, Sergio S.] Univ Fed Pernambuco, Dept Med Social, Recife, PE, Brazil; [Simoes, Silvia M.] Univ Fed Sergipe, Dept Pediat, Aracaju, Sergipe, Brazil; [Cruz, Alvaro A.] Univ Fed Bahia, ProAR Nucleo Excelencia Asma, Salvador, BA, Brazil; [Yazdanbakhsh, Maria] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands; [Matos, Sheila M.; Silva, Thiago Magalhaes; Barreto, Mauricio L.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil; [Silva, Thiago Magalhaes] Univ Estadual Sudoeste Bahia, Dept Ciencias Biol, Vitoria Da Conquista, BA, Brazil; [Pontes-de-Carvalho, Lain C.] Fundacao Oswaldo Cruz, Ctr Pesquisas Goncalo Moniz, Salvador, BA, Brazil; [Rodrigues, Laura C.; Cooper, Philip J.] St Georges Univ London, Inst Infect & Immun, London, England; [Fiaccone, Rosemeire L.] Univ Fed Bahia, Inst Matemat, Dept Estat, Salvador, BA, Brazil; [Cooper, Philip J.] Univ Int Ecuador, Fac Fac Ciencias Med Salud & Vida, Quito, Ecuador	Universidade Federal da Bahia; Universidade Federal de Juiz de Fora; Universidade Federal de Pernambuco; Universidade Federal de Sergipe; Universidade Federal da Bahia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universidade Federal da Bahia; Universidade Estadual do Sudoeste da Bahia; Fundacao Oswaldo Cruz; St Georges University London; Universidade Federal da Bahia	Alcantara-Neves, NM (corresponding author), Univ Fed Bahia, Inst Ciencias Saude, Salvador, BA, Brazil.	neuzalcantara@gmail.com	Yazdanbakhsh, Maria/AAI-3996-2020; RODRIGUES, LAURA CUNHA/AAO-4130-2021; Barreto, Mauricio L/B-1752-2008; Figueiredo, Camila Alexandrina/H-3525-2015	Yazdanbakhsh, Maria/0000-0002-7666-1441; Barreto, Mauricio L/0000-0002-0215-4930; Figueiredo, Camila Alexandrina/0000-0003-1356-6188; Alcantara-Neves, Neuza Maria/0000-0002-2102-260X; Cooper, Philip/0000-0002-6770-6871; Souza da Cunha, Sergio/0000-0002-4926-3827	Wellcome Trust through the HCPC Latin America Excellence Centre Programme [072405/Z/03/Z, 088862/Z/09/Z]; INCT/MCT/CNPq Programme [5737862008-9]; CAPES; CNPq; FAPESB	Wellcome Trust through the HCPC Latin America Excellence Centre Programme(Wellcome Trust); INCT/MCT/CNPq Programme; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESB(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB))	This work was supported by : Wellcome Trust through the HCPC Latin America Excellence Centre Programme (072405/Z/03/Z) and grant 088862/Z/09/Z; and INCT/MCT/CNPq Programme (Contract no. 5737862008-9). We thank CAPES,CNPq and FAPESB for scholarships that supported some of the authors.	Acevedo N, 2009, ALLERGY, V64, P1635, DOI 10.1111/j.1398-9995.2009.02084.x; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Arkestal K, 2011, J ALLERGY CLIN IMMUN, V127, P1024, DOI 10.1016/j.jaci.2011.01.033; Baqueiro T, 2007, ALL ASTHM P, P362; Barreto Mauricio L, 2006, BMC Pulm Med, V6, P15, DOI 10.1186/1471-2466-6-15; Barreto ML, 2007, LANCET, V370, P1622, DOI 10.1016/S0140-6736(07)61638-9; Bonnelykke K, 2014, NAT GENET, V46, P51, DOI 10.1038/ng.2830; Chew FT, 1999, CLIN EXP ALLERGY, V29, P982, DOI 10.1046/j.1365-2222.1999.00543.x; Cooper PJ, 2008, J INFECT DIS, V197, P1333, DOI 10.1086/586904; Cooper PJ, 2003, J ALLERGY CLIN IMMUN, V111, P995, DOI 10.1067/mai.2003.1348; Costa GNO, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0296-7; de Vos G, 2013, ANN ALLERG ASTHMA IM, V110, P438, DOI 10.1016/j.anai.2013.03.006; Figueiredo CA, 2010, INFECT IMMUN, V78, P3160, DOI 10.1128/IAI.01228-09; Flohr C, 2009, CLIN EXP ALLERGY, V39, P20, DOI 10.1111/j.1365-2222.2008.03134.x; Golden DBK, 2001, J ALLERGY CLIN IMMUN, V107, P897, DOI 10.1067/mai.2001.114706; Handoyo S, 2009, CURR ALLERGY ASTHM R, V9, P439, DOI 10.1007/s11882-009-0065-7; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Julge K, 2001, CLIN EXP ALLERGY, V31, P1854, DOI 10.1046/j.1365-2222.2001.01235.x; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Matricardi PM, 2000, BMJ-BRIT MED J, V320, P412, DOI 10.1136/bmj.320.7232.412; Mendonca LR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001886; Obeng BB, 2008, CURR OPIN ALLERGY CL, V8, P391, DOI 10.1097/ACI.0b013e32830ebb70; Ober C, 2005, J ALLERGY CLIN IMMUN, V116, P274, DOI 10.1016/j.jaci.2005.04.039; Pelosi U, 2005, ALLERGY, V60, P626, DOI 10.1111/j.1398-9995.2005.00747.x; Pierson-Mullany LK, 2002, CLIN EXP ALLERGY, V32, P107, DOI 10.1046/j.0022-0477.2001.01244.x; Ponte JCM, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-34; PUNNONEN J, 1993, J IMMUNOL, V151, P1280; Rodrigues LC, 2008, CLIN EXP ALLERGY, V38, P1769, DOI 10.1111/j.1365-2222.2008.03027.x; Santos ABR, 2008, J ALLERGY CLIN IMMUN, V121, P1040, DOI 10.1016/j.jaci.2007.12.1147; Sharma V, 2014, ALLERGY, V69, P231, DOI 10.1111/all.12336; Shin HD, 2005, ALLERGY, V60, P1146, DOI 10.1111/j.1398-9995.2005.00839.x; Smits HH, 2007, ANN MED, V39, P428, DOI 10.1080/07853890701436765; van den Biggelaar AHJ, 2001, INT ARCH ALLERGY IMM, V126, P231, DOI 10.1159/000049519; vanderVeen MJ, 1997, J ALLERGY CLIN IMMUN, V100, P327, DOI 10.1016/S0091-6749(97)70245-8; Weinmayr G, 2010, ALLERGY, V65, P766, DOI 10.1111/j.1398-9995.2009.02283.x; Weinmayr G, 2007, AM J RESP CRIT CARE, V176, P565, DOI 10.1164/rccm.200607-994OC; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490	37	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174089	10.1371/journal.pone.0174089	http://dx.doi.org/10.1371/journal.pone.0174089			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350867	Green Accepted, gold, Green Published			2022-12-26	WOS:000399174400015
J	Simon, UK; Enzinger, SM; Fink, A				Simon, Uwe K.; Enzinger, Sonja M.; Fink, Andreas			"The evil virus cell": Students' knowledge and beliefs about viruses	PLOS ONE			English	Article							HIV; RISK; PERCEPTIONS; ADOLESCENTS; HIV/AIDS; IMPACT	Education about virus biology at school is of pivotal interest to raise public awareness concerning means of disease transmission and, thus, methods to prevent infection, and to reduce unnecessary antibiotic treatment due to patient pressure on physicians in case of viral diseases such as influenza. This study aimed at making visible the knowledge of Austrian high school and university students with respect to virus biology, virus structure and health-education issues. The data presented here stem from comprehensive questionnaire analyses, including the task to draw a virus, from a cross-sectional study with 133 grade 7 and 199 grade 10 high school students, and 133 first-year biology and 181 first-year nonbiology university students. Analyses were performed both quantitatively and qualitatively. ANOVA revealed a highly significant group effect for total knowledge relating to virus biology and health issues (F(3, 642) = 44.17, p < 0.01, eta(2)p = 0.17). Specific post-hoc tests by means of the Tukey test showed significant differences between all groups (p < .01) with the exception of 1 st year non-biology students and grade 10 high school students. Students enrolled in university-level biology outperformed all other groups, even though they had not yet encountered this topic at their courses; part of this phenomenon might be due to their affinity for learning about biological topics. However, even many first-year biology students had a high number of severe misconceptions, e.g., defining a virus as a pro-or eukaryotic cell, or falsely naming malaria as a viral disease. Since there was no significant difference in virus-related knowledge between high schools, virus biology seems to have been taught similarly among the tested schools. However, the majority of participants stated that the virus-related knowledge they had acquired at school was not sufficient. Based on the results presented here we urgently suggest improving and intensifying teaching this topic at school, since virus-related knowledge was by far too fragmentary among many participants. Such lack of health-relevant knowledge may contribute to pressure on physicians by patients to unnecessarily prescribe antibiotics, and possibly lead to potentially dangerous neglect concerning vaccination. The effectiveness of newly developed virus-related teaching units and material could be tested with the instrument used here.	[Simon, Uwe K.; Enzinger, Sonja M.] Karl Franzens Univ Graz, Ctr Didact Biol, Schubertstr, Graz, Austria; [Simon, Uwe K.] Univ Teacher Educ Weingarten, Dept Biol, Kirchpl, Weingarten, Germany; [Fink, Andreas] Karl Franzens Univ Graz, Inst Psychol, Univ Pl 2-DG, Graz, Austria	University of Graz; University of Graz	Simon, UK (corresponding author), Karl Franzens Univ Graz, Ctr Didact Biol, Schubertstr, Graz, Austria.; Simon, UK (corresponding author), Univ Teacher Educ Weingarten, Dept Biol, Kirchpl, Weingarten, Germany.	uwe.simon@uni-graz.at	Simon, Uwe K./D-4555-2015	Simon, Uwe K./0000-0003-4164-8287; Fink, Andreas/0000-0001-7316-3140				ADEJUYIGBE FF, 2015, AFR J REPROD HEALTH, V19, P140; Aylikci Bahadir Ugur, 2013, J Nat Sci Biol Med, V4, P81, DOI 10.4103/0976-9668.107265; BIRENBAUM M, 1987, APPL PSYCH MEAS, V11, P385, DOI 10.1177/014662168701100404; Dumais N, 2009, CBE-LIFE SCI EDUC, V8, P62, DOI 10.1187/cbe.08-08-0048; European Union, 2016, SPEC EUR 445; Hartig, 2010, PSYCHOL TEST ASSESSM, V52, P354; Keselman A, 2004, SCI EDUC, V88, P548, DOI 10.1002/sce.10135; Keselman A, 2007, J RES SCI TEACH, V44, P844, DOI 10.1002/tea.20173; Linder JA, 2014, JAMA INTERN MED, V174, P2029, DOI 10.1001/jamainternmed.2014.5225; Little P, 2013, LANCET, V382, P1175, DOI 10.1016/S0140-6736(13)60994-0; Lohrmann C, 2000, J ADV NURS, V31, P696, DOI 10.1046/j.1365-2648.2000.01326.x; McCusker SM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-264; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Mwamwenda TS, 2013, J AIDS HIV RES, V5, P472; Patel VL, 1999, ADV INSTRUCTIONAL PS, P329; Peate I, 2002, NURS EDUC TODAY, V22, P492, DOI 10.1054/nedt.2002.0747; Romine WL, 2013, INT J SCI EDUC, V35, P1874, DOI 10.1080/09500693.2013.778439; Simon UK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150014; Simonneaux L, 2000, INT J SCI EDUC, V22, P619, DOI 10.1080/095006900289705; Sisay Solomon, 2014, BMC Res Notes, V7, P518, DOI 10.1186/1756-0500-7-518; Sunil B, 2014, INT J RES HLTH SCI, V2, P182; Suominen T, 2015, BMC NURS, V14, DOI 10.1186/s12912-014-0053-7; Sutton MY, 2011, PUBLIC HEALTH REP, V126, P653, DOI 10.1177/003335491112600507; Sychareun V, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1126; Tahir S.S., 2009, J FM BAGHDAD, V51, P174; Tobin E. A., 2010, Benin Journal of Postgraduate Medicine, V12, P43; Tonkin-Crine S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h3413; Zeyer A, 2015, PRAVENT GESUNDHEIT, V10, P153, DOI 10.1007/s11553-014-0479-5	28	10	10	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174402	10.1371/journal.pone.0174402	http://dx.doi.org/10.1371/journal.pone.0174402			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VE	28350815	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174400037
J	Kim, SK; Bae, JC; Baek, JH; Jee, JH; Hur, KY; Lee, MK; Kim, JH				Kim, Soo Kyoung; Bae, Ji Cheol; Baek, Jong-Ha; Jee, Jae Hwan; Hur, Kyu Yeon; Lee, Moon-Kyu; Kim, Jae Hyeon			Decline in lung function rather than baseline lung function is associated with the development of metabolic syndrome: A six-year longitudinal study	PLOS ONE			English	Article							INSULIN-RESISTANCE; PULMONARY-FUNCTION; CARDIOVASCULAR RISK; OBESITY; INFLAMMATION; HEALTH; HEART; DISEASE; COHORT; ADULTS	This study was conducted to investigate whether baseline lung function or change in lung function is associated with the development of metabolic syndrome (MS) in Koreans. We analyzed clinical and laboratory data from 3,768 Koreans aged 40-60 years who underwent medical check-ups over a six-year period between 2006 and 2012. We calculated the percent change in forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1) over the study period. We tested for an association between baseline lung function or lung function change during the follow-up period and the development of MS. The 533 subjects (14.1%) developed MS after the six-year follow-up. The baseline FVC and FEV1 were not different between the subjects who developed MS after six years and the subject without MS after six years. The percent change in FVC over six years in subjects who developed MS after six years was higher than that in subjects who did not develop MS (-5.75 [-10.19 -1.17],-3.29 [-7.69-1.09], respectively, P = 0.001). The percent change in FVC over six years was associated with MS development after adjusting for age, sex, body mass index (BMI), glucose, HDL, triglyceride, waist circumferences (WC), and systolic blood pressure. However, these association was not significant after adjusting for change of BMI and change of WC over six years (P = 0.306). The greater change in vital capacity over six years of follow-up was associated with MS development, predominantly due to obesity and abdominal obesity. The prospective study is needed to determine the relationship between lung function decline and MS.	[Kim, Soo Kyoung; Baek, Jong-Ha] Gyeongsang Natl Univ, Sch Med, Gyeongsang Natl Univ Hosp, Dept Internal Med, Jinju, South Korea; [Kim, Soo Kyoung] Gyeongsang Natl Univ, Sch Med, Gyeongsang Natl Univ Hosp, Inst Hlth Sci, Jinju, South Korea; [Bae, Ji Cheol] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Chang Won, South Korea; [Jee, Jae Hwan] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Hlth Promot Ctr, Seoul, South Korea; [Hur, Kyu Yeon; Lee, Moon-Kyu; Kim, Jae Hyeon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul, South Korea	Gyeongsang National University; Gyeongsang National University Hospital; Gyeongsang National University; Gyeongsang National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul, South Korea.	jaehyeon@skku.edu						Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bolton C E, 2007, COPD, V4, P121, DOI 10.1080/15412550701341053; Cuttica MJ, 2015, AM J RESP CRIT CARE, V192, P76, DOI 10.1164/rccm.201501-0116OC; Davis WA, 2004, DIABETES CARE, V27, P752, DOI 10.2337/diacare.27.3.752; Engstrom G, 2003, J INTERN MED, V253, P574, DOI 10.1046/j.1365-2796.2003.01138.x; Engstrom G, 2002, CIRCULATION, V106, P2555, DOI 10.1161/01.CIR.0000037220.00065.0D; Engstrom G, 2001, J HYPERTENS, V19, P1203, DOI 10.1097/00004872-200107000-00004; Fimognari FL, 2007, J GERONTOL A-BIOL, V62, P760, DOI 10.1093/gerona/62.7.760; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Kim Soo Kyoung, 2010, Korean Diabetes J, V34, P253, DOI 10.4093/kdj.2010.34.4.253; Kip KE, 2004, CIRCULATION, V109, P706, DOI 10.1161/01.CIR.0000115514.44135.A8; Koo HK, 2013, INT J TUBERC LUNG D, V17, P1507, DOI 10.5588/ijtld.12.0906; Lawlor DA, 2004, DIABETOLOGIA, V47, P195, DOI 10.1007/s00125-003-1310-6; Lazarus R, 1998, EUR RESPIR J, V12, P641, DOI 10.1183/09031936.98.12030641; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; Lim SY, 2010, J KOREAN MED SCI, V25, P1480, DOI 10.3346/jkms.2010.25.10.1480; Lin WY, 2006, OBESITY, V14, P1654, DOI 10.1038/oby.2006.190; Mannino DM, 2003, AM J MED, V114, P758, DOI 10.1016/S0002-9343(03)00185-2; Nakajima K, 2008, CHEST, V134, P712, DOI 10.1378/chest.07-3003; Ochs-Balcom HM, 2006, CHEST, V129, P853, DOI 10.1378/chest.129.4.853; Park HY, 2010, RESP MED, V104, P1326, DOI 10.1016/j.rmed.2010.02.024; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Shore SA, 1985, J APPL PHYSIOL, V2010, P108; Yeh F, 2011, DIABETES CARE, V34, P2306, DOI 10.2337/dc11-0682; Yeh HC, 2005, DIABETES CARE, V28, P1472, DOI 10.2337/diacare.28.6.1472	25	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174228	10.1371/journal.pone.0174228	http://dx.doi.org/10.1371/journal.pone.0174228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346522	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174300032
J	Madapura, HS; Nagy, N; Ujvari, D; Kallas, T; Krohnke, MCL; Amu, S; Bjorkholm, M; Stenke, L; Mandal, PK; McMurray, JS; Keszei, M; Westerberg, LS; Cheng, H; Xue, F; Klein, G; Klein, E; Salamon, D				Madapura, H. S.; Nagy, N.; Ujvari, D.; Kallas, T.; Krohnke, M. C. L.; Amu, S.; Bjorkholm, M.; Stenke, L.; Mandal, P. K.; McMurray, J. S.; Keszei, M.; Westerberg, L. S.; Cheng, H.; Xue, F.; Klein, G.; Klein, E.; Salamon, D.			Interferon gamma is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells	ONCOGENE			English	Article							IFN-GAMMA; STEM-CELLS; T-CELLS; TARGETED THERAPY; INHIBITORS; REPRESSION; RESPONSES; SURVIVAL; CANCER; MCL-1	B-cell CLL/lymphoma 6 (BCL6) exerts oncogenic effects in several human hematopoietic malignancies including chronic myeloid leukemia (CML), where BCL6 expression was shown to be essential for CML stem cell survival and self-renewal during imatinib mesylate (IM) treatment. As several lines of evidence suggest that interferon gamma(IFN gamma) production in CML patients might have a central role in the response to tyrosine kinase inhibitor (TKI) therapy, we analyzed if IFN gamma modulates BCL6 expression in CML cells. Although separate IFN gamma or IM treatment only slightly upregulated BCL6 expression, combined treatment induced remarkable BCL6 upregulation in CML lines and primary human CD34+ CML stem cells. We proved that during combined treatment, inhibition of constitutive signal transducer and activator of transcription (STAT) 5 activation by IM allowed the specific enhancement of the STAT1 dependent, direct upregulation of BCL6 by IFN gamma in CML cells. By using colony-forming assay, we found that IFN gamma enhanced the ex vivo colony or cluster-forming capacity of human CML stem cells in the absence or presence of IM, respectively. Furthermore, inhibition of the transcriptional repressor function of BCL6 in the presence of IM and IFN gamma almost completely blocked the cluster formation of human CML stem cells. On the other hand, by using small interfering RNA knockdown of BCL6, we demonstrated that in an IM-treated CML line the antiapoptotic effect of IFN gamma was independent of BCL6 upregulation. We found that IFN gamma also upregulated several antiapoptotic members of the BCL2 and BIRC gene families in CML cells, including the long isoform of MCL1, which proved to be essential for the antiapoptotic effect of IFN gamma in an IM-treated CML line. Our results suggest that combination of TKIs with BCL6 and MCL1 inhibitors may potentially lead to the complete eradication of CML stem cells.	[Madapura, H. S.; Nagy, N.; Kallas, T.; Krohnke, M. C. L.; Amu, S.; Keszei, M.; Westerberg, L. S.; Klein, G.; Klein, E.; Salamon, D.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Ujvari, D.; Salamon, D.] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Bjorkholm, M.; Stenke, L.] Karolinska Univ, Hosp Solna, Dept Med, Div Hematol, Stockholm, Sweden; [Bjorkholm, M.; Stenke, L.] Karolinska Inst, Stockholm, Sweden; [Mandal, P. K.; McMurray, J. S.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Cheng, H.; Xue, F.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Texas System; UTMD Anderson Cancer Center; University System of Maryland; University of Maryland Baltimore	Salamon, D (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Nobels Vag 16, SE-17177 Stockholm, Sweden.	Daniel.Salamon@ki.se	Ujvari, Dorina/AAS-8724-2021; Salamon, Daniel/AAZ-4807-2021; Westerberg, Lisa/AAB-3808-2019; Nagy, Noemi/J-2936-2012; Keszei, Marton/F-3295-2014	Amu, Sylvie/0000-0001-9593-7952; Salamon, Daniel/0000-0001-6630-3993; Kallas, Tomasz/0000-0001-8838-697X; Westerberg, Lisa/0000-0003-2943-2192; Keszei, Marton/0000-0002-1158-2179; Nagy, Noemi/0000-0002-7800-3493	Swedish Cancer Society (Cancerfonden); Adolf H Lundin Charitable Foundation; Karolinska Institutet; Cancer Research Fellowship of the Cancer Research Institute (New York)/Concern Foundation (Los Angeles)	Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Adolf H Lundin Charitable Foundation; Karolinska Institutet(Karolinska Institutet); Cancer Research Fellowship of the Cancer Research Institute (New York)/Concern Foundation (Los Angeles)	This work was supported by grants from the the Swedish Cancer Society (Cancerfonden), Adolf H Lundin Charitable Foundation and Karolinska Institutet. HM, NN, TK and DS are or were recipients of Cancer Research Fellowship of the Cancer Research Institute (New York)/Concern Foundation (Los Angeles).	Aichberger KJ, 2005, BLOOD, V105, P3303, DOI 10.1182/blood-2004-02-0749; Aswald JM, 2002, CYTOKINES CELL MOL T, V7, P143, DOI 10.1080/13684730210002319; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Bonmort M, 2007, BIOCHIMIE, V89, P872, DOI 10.1016/j.biochi.2007.04.014; Bunting KL, 2013, CURR OPIN IMMUNOL, V25, P339, DOI 10.1016/j.coi.2013.05.003; Cardenas MG, 2016, J CLIN INVEST, V126, P3351, DOI 10.1172/JCI85795; Chomel JC, 2011, ONCOTARGET, V2, P713; Christiansson L, 2015, MOL CANCER THER, V14, P1181, DOI 10.1158/1535-7163.MCT-14-0849; Cunard R, 2004, J IMMUNOL, V172, P7530, DOI 10.4049/jimmunol.172.12.7530; de Mattos SF, 2004, MOL CELL BIOL, V24, P10058, DOI 10.1128/MCB.24.22.10058-10071.2004; DiNoto R, 1997, LEUKEMIA, V11, P1554; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Duy C, 2011, NATURE, V473, P384, DOI 10.1038/nature09883; Gough DJ, 2008, CYTOKINE GROWTH F R, V19, P383, DOI 10.1016/j.cytogfr.2008.08.004; Green MR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4904; Held SAE, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1065368; Hideshima T, 2010, BLOOD, V115, P3772, DOI 10.1182/blood-2010-02-270082; Huang BB, 2001, J INVEST DERMATOL, V116, P305, DOI 10.1046/j.1523-1747.2001.01242.x; Hurtz C, 2011, J EXP MED, V208, P2163, DOI 10.1084/jem.20110304; Jaras M, 2010, P NATL ACAD SCI USA, V107, P16280, DOI 10.1073/pnas.1004408107; Kim DH, 2010, CLIN CANCER RES, V16, P5339, DOI 10.1158/1078-0432.CCR-10-1638; KLEIN E, 1968, CANCER RES, V28, P1300; Krusch M, 2011, CURR MED CHEM, V18, P5174, DOI 10.2174/092986711798184271; KUBONISHI I, 1983, International Journal of Cell Cloning, V1, P105; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Kurosu T, 2003, ONCOGENE, V22, P4459, DOI 10.1038/sj.onc.1206755; Lee SK, 2012, IMMUNITY, V37, P880, DOI 10.1016/j.immuni.2012.10.010; Leverson JD, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.561; Mandal PK, 2015, J MED CHEM, V58, P8970, DOI 10.1021/acs.jmedchem.5b01321; Nakayamada S, 2014, J IMMUNOL, V192, P2156, DOI 10.4049/jimmunol.1300675; Nelson EA, 2011, BLOOD, V117, P3421, DOI 10.1182/blood-2009-11-255232; O'Hare T, 2012, NAT REV CANCER, V12, P513, DOI 10.1038/nrc3317; OHASHI K, 1995, BIOCHEM BIOPH RES CO, V214, P461, DOI 10.1006/bbrc.1995.2309; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Petzer AL, 1996, J EXP MED, V183, P2551, DOI 10.1084/jem.183.6.2551; Prost S, 2015, NATURE, V525, P380, DOI 10.1038/nature15248; Ritz O, 2013, ONCOTARGET, V4, P1093, DOI 10.18632/oncotarget.1149; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schurch C, 2013, J EXP MED, V210, P605, DOI 10.1084/jem.20121229; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Tsuyama N, 2005, BIOCHEM BIOPH RES CO, V337, P201, DOI 10.1016/j.bbrc.2005.09.036; Walker SR, 2007, ONCOGENE, V26, P224, DOI 10.1038/sj.onc.1209775; Walker SR, 2013, MOL CELL BIOL, V33, P2879, DOI 10.1128/MCB.01620-12; Warsch W, 2013, BLOOD, V122, P2167, DOI 10.1182/blood-2013-02-485573; Warsch W, 2011, BLOOD, V117, P3409, DOI 10.1182/blood-2009-10-248211; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang X, 2004, BLOOD, V104, P3276, DOI 10.1182/blood-2004-02-0664; Zhou G, 2005, EXP MOL PATHOL, V78, P25, DOI 10.1016/j.yexmp.2004.08.008; Zoubir Moustapha, 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P1	51	26	27	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 10	2017	36	32					4619	4628		10.1038/onc.2017.85	http://dx.doi.org/10.1038/onc.2017.85			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FD0RK	28368400				2022-12-26	WOS:000407246200009
J	Mertz, TM; Baranovskiy, AG; Wang, J; Tahirov, TH; Shcherbakova, PV				Mertz, T. M.; Baranovskiy, A. G.; Wang, J.; Tahirov, T. H.; Shcherbakova, P. V.			Nucleotide selectivity defect and mutator phenotype conferred by a colon cancer-associated DNA polymerase delta mutation in human cells	ONCOGENE			English	Article							MICROSATELLITE INSTABILITY; MISMATCH REPAIR; GERMLINE MUTATIONS; COLORECTAL-CANCER; HPRT LOCUS; REPLICATION; EPSILON; LINES; GENE; POLE	Mutations in the POLD1 and POLE genes encoding DNA polymerases delta (Pol delta) and epsilon (Pol epsilon) cause hereditary colorectal cancer (CRC) and have been found in many sporadic colorectal and endometrial tumors. Much attention has been focused on POLE exonuclease domain mutations, which occur frequently in hypermutated DNA mismatch repair (MMR)-proficient tumors and appear to be responsible for the bulk of genomic instability in these tumors. In contrast, somatic POLD1 mutations are seen less frequently and typically occur in MMR-deficient tumors. Their functional significance is often unclear. Here we demonstrate that expression of the cancer-associated POLD1-R689W allele is strongly mutagenic in human cells. The mutation rate increased synergistically when the POLD1-R689W expression was combined with a MMR defect, indicating that the mutator effect of POLD1-R689W results from a high rate of replication errors. Purified human Pol delta-R689W has normal exonuclease activity, but the nucleotide selectivity of the enzyme is severely impaired, providing a mechanistic explanation for the increased mutation rate in the POLD1-R689W-expressing cells. The vast majority of mutations induced by the POLD1-R689W are GC -> TA transversions and GC -> AT transitions, with transversions showing a strong strand bias and a remarkable preference for polypurine/polypyrimidine sequences. The mutational specificity of the Pol delta variant matches that of the hypermutated CRC cell line, HCT15, in which this variant was first identified. The results provide compelling evidence for the pathogenic role of the POLD1-R689W mutation in the development of the human tumor and emphasize the need to experimentally determine the significance of Pold variants present in sporadic tumors.	[Mertz, T. M.; Baranovskiy, A. G.; Wang, J.; Tahirov, T. H.; Shcherbakova, P. V.] Univ Nebraska, Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, 600 S 42nd St, Omaha, NE 68198 USA; [Mertz, T. M.] Washington State Univ, Sch Mol Biosci, Coll Vet Med, Pullman, WA 99164 USA	University of Nebraska System; University of Nebraska Medical Center; Washington State University	Shcherbakova, PV (corresponding author), Univ Nebraska, Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, 600 S 42nd St, Omaha, NE 68198 USA.	pshcherb@unmc.edu		Tahirov, Tahir/0000-0002-1238-0069	National Institutes of Health [ES015869, GM101167, CA140988]; Nebraska Department of Health and Human Services [LB506]; University of Nebraska Medical Center Graduate Studies Research Fellowship; Cancer Biology Training Grant from the National Cancer Institute [T32CA009476]; NATIONAL CANCER INSTITUTE [T32CA009476, R01CA140988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101167, P30GM106397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Department of Health and Human Services; University of Nebraska Medical Center Graduate Studies Research Fellowship; Cancer Biology Training Grant from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Rob Lewis and Mike Brattain for cell lines, and Elizabeth Moore and Krista Brown for technical assistance. This work was supported by the National Institutes of Health grants ES015869 to PVS, GM101167 to THT and CA140988 to JW and by Nebraska Department of Health and Human Services grants LB506 to PVS and THT. TMM was supported by a University of Nebraska Medical Center Graduate Studies Research Fellowship and by the Cancer Biology Training Grant T32CA009476 from the National Cancer Institute.	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Agbor AA, 2013, DNA REPAIR, V12, P954, DOI 10.1016/j.dnarep.2013.08.012; Briggs S, 2013, J PATHOL, V230, P148, DOI 10.1002/path.4185; Church DN, 2013, HUM MOL GENET, V22, P2820, DOI 10.1093/hmg/ddt131; Daee DL, 2010, P NATL ACAD SCI USA, V107, P157, DOI 10.1073/pnas.0907526106; Flohr T, 1999, INT J CANCER, V80, P919, DOI 10.1002/(SICI)1097-0215(19990315)80:6<919::AID-IJC19>3.0.CO;2-U; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Ghodgaonkar MM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5990; Giannakis M, 2016, CELL REP, V17, P1206, DOI 10.1016/j.celrep.2016.10.009; Glaab WE, 1997, CARCINOGENESIS, V18, P1, DOI 10.1093/carcin/18.1.1; Herr AJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002282; Imai K, 2008, CARCINOGENESIS, V29, P673, DOI 10.1093/carcin/bgm228; Kane DP, 2014, CANCER RES, V74, P1895, DOI 10.1158/0008-5472.CAN-13-2892; Keohavong Phouthone, 2005, Methods Mol Biol, V291, P161, DOI 10.1385/1-59259-840-4:161; KOI M, 1994, CANCER RES, V54, P4308; Li L, 2005, GENETICS, V170, P569, DOI 10.1534/genetics.104.040295; Liu XQ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.221697; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Masuda Y, 2007, NUCLEIC ACIDS RES, V35, P6904, DOI 10.1093/nar/gkm822; McElhinny SAN, 2007, J BIOL CHEM, V282, P2324, DOI 10.1074/jbc.M609591200; Mertz TM, 2015, P NATL ACAD SCI USA, V112, pE2467, DOI 10.1073/pnas.1422934112; Mouradov D, 2014, CANCER RES, V74, P3238, DOI 10.1158/0008-5472.CAN-14-0013; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ohzeki S, 1997, CARCINOGENESIS, V18, P1127, DOI 10.1093/carcin/18.6.1127; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Peltomaki P, 2004, DIS MARKERS, V20, P269, DOI 10.1155/2004/305058; Preston BD, 2010, SEMIN CANCER BIOL, V20, P281, DOI 10.1016/j.semcancer.2010.10.009; Seshagiri S, 2013, NAT GENET, V45, P121, DOI 10.1038/ng.2540; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; SHCHERBAKOVA PV, 1993, MUTAGENESIS, V8, P417, DOI 10.1093/mutage/8.5.417; Shinbrot E, 2014, GENOME RES, V24, P1740, DOI 10.1101/gr.174789.114; Shlien A, 2015, NAT GENET, V47, P257, DOI 10.1038/ng.3202; TIBBETTS LM, 1977, CANCER, V40, P2651, DOI 10.1002/1097-0142(197711)40:5+<2651::AID-CNCR2820400939>3.0.CO;2-V; Valle L, 2014, HUM MOL GENET, V23, P3506, DOI 10.1093/hmg/ddu058; Venkatesan RN, 2006, J BIOL CHEM, V281, P4486, DOI 10.1074/jbc.M510245200; Wong A, 2016, GYNECOL ONCOL, V141, P113, DOI 10.1016/j.ygyno.2015.12.031; Yoshida R, 2011, EUR J HUM GENET, V19, P320, DOI 10.1038/ejhg.2010.216	37	11	12	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 3	2017	36	31					4427	4433		10.1038/onc.2017.22	http://dx.doi.org/10.1038/onc.2017.22			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FC4JL	28368425	Green Accepted			2022-12-26	WOS:000406806000005
J	Song, ZY; Xiaoli, AM; Zhang, QW; Zhang, Y; Yang, EST; Wang, S; Chang, R; Zhang, ZDD; Yang, GS; Strich, R; Pessin, JE; Yang, FJ				Song, Ziyi; Xiaoli, Alus M.; Zhang, Quanwei; Zhang, Yi; Yang, Ellen S. T.; Wang, Sven; Chang, Rui; Zhang, Zhengdong D.; Yang, Gongshe; Strich, Randy; Pessin, Jeffrey E.; Yang, Fajun			Cyclin C regulates adipogenesis by stimulating transcriptional activity of CCAAT/enhancer-binding protein alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; adipogenesis; cell differentiation; gene expression; transcription coregulator; C; EBP; cyclin C; PPAR; brown adipocyte; Mediator complex	BROWN ADIPOSE-TISSUE; RNA-POLYMERASE-II; PROLIFERATOR-ACTIVATED RECEPTOR; ADIPOCYTE DIFFERENTIATION; MEDIATOR COMPLEX; PPAR-GAMMA; COACTIVATOR COMPLEX; MITOCHONDRIAL FISSION; NUCLEAR RECEPTORS; GENE-EXPRESSION	Brown adipose tissue is important for maintaining energy homeostasis and adaptive thermogenesis in rodents and humans. As disorders arising from dysregulated energy metabolism, such as obesity and metabolic diseases, have increased, so has interest in the molecular mechanisms of adipocyte biology. Using a functional screen, we identified cyclin C (CycC), a conserved subunit of the Mediator complex, as a novel regulator for brown adipocyte formation. siRNA-mediated CycC knockdown (KD) in brown preadipocytes impaired the early transcriptional program of differentiation, and genetic KO of CycC completely blocked the differentiation process. RNA sequencing analyses of CycC-KD revealed a critical role of CycC in activating genes co-regulated by peroxisome proliferator activated receptor gamma (PPAR alpha) and CCAAT/enhancer-binding protein alpha (C/EBP alpha). Overexpression of PPAR gamma(2) or addition of the PPAR gamma ligand rosiglitazone rescued the defects in CycC-KO brown preadipocytes and efficiently activated the PPAR gamma-responsive promoters in both WT and CycC-KO cells, suggesting that CycC is not essential for PPAR gamma transcriptional activity. In contrast, CycC-KO significantly reduced C/EBP alpha-dependent gene expression. Unlike for PPAR gamma, overexpression of C/EBP alpha could not induce C/EBP alpha target gene expression in CycC-KO cells or rescue the CycC-KO defects in brown adipogenesis, suggesting that CycC is essential for C/EBP alpha-mediated gene activation. CycC physically interacted with C/EBP, and this interaction was required for C/EBP alpha transactivation domain activity. Consistent with the role of C/EBP alpha in white adipogenesis, CycC-KD also inhibited differentiation of 3T3-L1 cells into white adipocytes. Together, these data indicate that CycC activates adipogenesis in part by stimulating the transcriptional activity of C/EBP alpha.	[Song, Ziyi; Yang, Gongshe] Northwest A&F Univ, Dept Anim Sci, Coll Anim Sci & Technol, Lab Anim Fat Deposit & Muscle Dev, Yangling 712100, Shaanxi, Peoples R China; [Song, Ziyi; Xiaoli, Alus M.; Zhang, Yi; Yang, Ellen S. T.; Pessin, Jeffrey E.; Yang, Fajun] Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10461 USA; [Song, Ziyi; Xiaoli, Alus M.; Zhang, Yi; Yang, Ellen S. T.; Pessin, Jeffrey E.; Yang, Fajun] Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10461 USA; [Xiaoli, Alus M.; Zhang, Yi; Yang, Ellen S. T.; Yang, Fajun] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Zhang, Quanwei; Zhang, Zhengdong D.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Wang, Sven; Chang, Rui] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Strich, Randy] Rowan Univ, Sch Osteopath Med, Dept Mol Biol, Stratford, NJ 08055 USA	Northwest A&F University - China; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; Rowan University; Rowan University School of Osteopathic Medicine	Yang, GS (corresponding author), Northwest A&F Univ, Dept Anim Sci, Coll Anim Sci & Technol, Lab Anim Fat Deposit & Muscle Dev, Yangling 712100, Shaanxi, Peoples R China.; Yang, FJ (corresponding author), Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10461 USA.; Yang, FJ (corresponding author), Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10461 USA.; Yang, FJ (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA.	gsyang999@hotmail.com; fajun.yang@einstein.yu.edu		Yang, Gongshe/0000-0003-2003-979X; SONG, ZIYI/0000-0003-4306-4648	National Science and Technology Major Project of China [2016ZX08006003]; National Institutes of Health [P30 DK020541, R01 DK093623, DK098439, DK110063]; China Scholarship Council; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541, R01DK093623, R01DK110063, R01DK098439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG023475] Funding Source: NIH RePORTER	National Science and Technology Major Project of China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Science and Technology Major Project of China Grant 2016ZX08006003 (to G. Y.) and the National Institutes of Health Grants P30 DK020541, R01 DK093623, DK098439, and DK110063. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of a scholarship from the China Scholarship Council.	Abdulla A, 2014, J BIOL CHEM, V289, P29937, DOI 10.1074/jbc.M114.573659; Allen BL, 2015, NAT REV MOL CELL BIO, V16, P155, DOI 10.1038/nrm3951; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Barette C, 2001, ONCOGENE, V20, P551, DOI 10.1038/sj.onc.1204129; Chen Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2742; Classon M, 2000, P NATL ACAD SCI USA, V97, P10826, DOI 10.1073/pnas.190343597; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Conaway RC, 2011, SEMIN CELL DEV BIOL, V22, P729, DOI 10.1016/j.semcdb.2011.07.021; Cooper KF, 2014, DEV CELL, V28, P161, DOI 10.1016/j.devcel.2013.12.009; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Cypess AM, 2015, CELL METAB, V21, P33, DOI 10.1016/j.cmet.2014.12.009; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Daniels D., 2013, J PROTEOM BIOINFORM, V2, P004, DOI DOI 10.4172/JPB.S2-004; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Feng DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126240; FLANAGAN PM, 1991, NATURE, V350, P436, DOI 10.1038/350436a0; Floyd ZE, 2003, DIABETES, V52, P308, DOI 10.2337/diabetes.52.2.308; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Ge K, 2008, MOL CELL BIOL, V28, P1081, DOI 10.1128/MCB.00967-07; Grontved L, 2010, MOL CELL BIOL, V30, P2155, DOI 10.1128/MCB.01238-09; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Harms MJ, 2015, GENE DEV, V29, P298, DOI 10.1101/gad.252734.114; Iida S, 2015, GENE DEV, V29, P308, DOI 10.1101/gad.252809.114; Jimenez MA, 2007, MOL CELL BIOL, V27, P743, DOI 10.1128/MCB.01557-06; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; KELLEHER RJ, 1990, CELL, V61, P1209, DOI 10.1016/0092-8674(90)90685-8; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Li H, 2008, J BIOL CHEM, V283, P13077, DOI 10.1074/jbc.M800604200; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Nanbu-Wakao R, 2002, MOL ENDOCRINOL, V16, P1565, DOI 10.1210/me.16.7.1565; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rachez C, 1998, GENE DEV, V12, P1787, DOI 10.1101/gad.12.12.1787; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shao ML, 2016, CELL METAB, V23, P1167, DOI 10.1016/j.cmet.2016.04.023; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Wang K, 2015, MOL BIOL CELL, V26, P1030, DOI 10.1091/mbc.E14-08-1315; Wang W, 2009, DEV CELL, V16, P764, DOI 10.1016/j.devcel.2009.04.006; Yin H, 2013, CELL METAB, V17, P210, DOI 10.1016/j.cmet.2013.01.004; Yin JW, 2012, GENE DEV, V26, P2192, DOI 10.1101/gad.192666.112; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zhao XP, 2014, DIABETES, V63, P2464, DOI 10.2337/db13-0835; Zhao XY, 2014, MOL CELL, V55, P372, DOI 10.1016/j.molcel.2014.06.004; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500	63	7	7	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8918	8932		10.1074/jbc.M117.776229	http://dx.doi.org/10.1074/jbc.M117.776229			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28351837	Green Published, hybrid			2022-12-26	WOS:000402153900044
J	Nagasawa-Masuda, A; Terai, K				Nagasawa-Masuda, Ayumi; Terai, Kenta			Yap/Taz transcriptional activity is essential for vascular regression via Ctgf expression and actin polymerization	PLOS ONE			English	Article							FLUID SHEAR-STRESS; DUCTUS-ARTERIOSUS CLOSURE; ZEBRAFISH DANIO-RERIO; ENDOTHELIAL-CELL; EMBRYONIC-DEVELOPMENT; TYPE-1 RECEPTOR; ANGIOTENSIN-II; HIPPO PATHWAY; IN-VITRO; YOLK-SAC	Vascular regression is essential to remove redundant vessels during the formation of an efficient vascular network that can transport oxygen and nutrient to every corner of the body. However, no mechanism is known to explain how major blood vessels regress during development. Here we use the dorsal part of the caudal vein plexus (dCVP) in Zebrafish to investigate the mechanism of regression and discover a new role of Yap/Taz in vascular regression. During regression, Yap/Taz is activated by blood circulation in the endothelial cells. This leads to induction of Ctgf and actin polymerization. Interference with Yap/Taz activation decreased Ctgf production, which decreased actin polymerization and vascular regression. These results implicate a novel role of Yap/Taz in vascular regression.	[Nagasawa-Masuda, Ayumi; Terai, Kenta] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Funct & Morphol, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Terai, K (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Funct & Morphol, Bunkyo Ku, Yayoi 1-1-1, Tokyo, Japan.	kt5m@iam.u-tokyo.ac.jp	寺井, 健太/AFQ-7663-2022	寺井, 健太/0000-0001-7638-3720	Program to Disseminate Tenure Tracking System, MEXT, Japan; Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST);  [24790304]	Program to Disseminate Tenure Tracking System, MEXT, Japan; Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); 	This work was supported by Grants-in-Aid for Young Scientists (B) [No. 24790304 to K. T.], the Program to Disseminate Tenure Tracking System, MEXT, Japan (to K.T.), and the Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST) (to K.T.).	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Amin L, 2011, SCI REP-UK, V1, DOI 10.1038/srep00153; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200; Clyman RI, 1996, PEDIATR RES, V40, P198, DOI 10.1203/00006450-199608000-00004; Coceani F, 2012, SEMIN PERINATOL, V36, P92, DOI 10.1053/j.semperi.2011.09.018; Costa M, 2006, PHYSIOL GENOMICS, V25, P250, DOI 10.1152/physiolgenomics.00231.2005; Dai XJ, 2013, J SLEEP DISORD TREAT, V2, P2; DAVIES PF, 1986, P NATL ACAD SCI USA, V83, P2114, DOI 10.1073/pnas.83.7.2114; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Esser S, 1998, J CELL BIOL, V140, P947, DOI 10.1083/jcb.140.4.947; Fukuhara S, 2014, DEV BIOL, V393, P10, DOI 10.1016/j.ydbio.2014.06.015; Fukui H, 2014, DEV CELL, V31, P128, DOI 10.1016/j.devcel.2014.08.014; Garcia MD, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00308; Gee ST, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020309; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Hogan BM, 2009, DEVELOPMENT, V136, P4001, DOI 10.1242/dev.039990; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hu JY, 2013, INT J BIOL SCI, V9, P267, DOI 10.7150/ijbs.4887; Inai T, 2004, AM J PATHOL, V165, P35, DOI 10.1016/S0002-9440(10)63273-7; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Junglas B, 2012, AM J PATHOL, V180, P2386, DOI 10.1016/j.ajpath.2012.02.030; Kashiwada T, 2015, DEVELOPMENT, V142, P497, DOI 10.1242/dev.115576; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Lenard A, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002126; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; OFFNER FA, 1992, AM J PATHOL, V141, P601; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Seebach J, 2000, LAB INVEST, V80, P1819, DOI 10.1038/labinvest.3780193; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; Takeuchi M, 2015, DEV BIOL, V397, P1, DOI 10.1016/j.ydbio.2014.09.030; Tamplin OJ, 2015, CELL, V160, P241, DOI 10.1016/j.cell.2014.12.032; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Totong R, 2011, DEVELOPMENT, V138, P4199, DOI 10.1242/dev.064261; Treszl A, 2003, PEDIATR RES, V54, P753, DOI 10.1203/01.PDR.0000088016.67117.39; Tuvia S, 1998, J CELL BIOL, V141, P1551, DOI 10.1083/jcb.141.7.1551; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wakayama Y, 2015, DEV CELL, V32, P109, DOI 10.1016/j.devcel.2014.11.024; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Watkins SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044018; Wiley DM, 2011, NAT CELL BIOL, V13, P686, DOI 10.1038/ncb2232; Yokoyama U, 2006, J CLIN INVEST, V116, P3026, DOI 10.1172/JCI28639; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137; Zygmunt T, 2011, DEV CELL, V21, P301, DOI 10.1016/j.devcel.2011.06.033	64	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174633	10.1371/journal.pone.0174633	http://dx.doi.org/10.1371/journal.pone.0174633			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369143	gold, Green Published, Green Submitted			2022-12-26	WOS:000399351000026
J	Lee, M; Jo, A; Lee, S; Kim, JB; Chang, Y; Nam, JY; Cho, H; Cho, YY; Cho, EJ; Lee, JH; Yu, SJ; Yoon, JH; Kim, YJ				Lee, Minjong; Jo, Ara; Lee, Seulki; Kim, Jong Bin; Chang, Young; Nam, Joon Yeul; Cho, Hyeki; Cho, Young Youn; Cho, Eun Ju; Lee, Jeong-Hoon; Yu, Su Jong; Yoon, Jung-Hwan; Kim, Yoon Jun			3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells	PLOS ONE			English	Article							DRUG-RESISTANCE; GLUTATHIONE; CANCER; NEUROBLASTOMA; THERAPY; LINES; METASTASIS; MECHANISMS; APOPTOSIS; DEPLETION	Background & aims Acquisition of anoikis resistance is a prerequisite for metastasis in hepatocellular carcinoma (HCC). However, little is known about how energy metabolism and antioxidant systems are altered in anoikis-resistant (AR) HCC cells. We evaluated anti-tumor effects of a combination treatment of 3-bromopyruvate (3-BP) and buthionine sulfoximine (BSO) in AR HCC cells. Methods We compared glycolysis, reactive oxygen species (ROS) production, and chemoresistance among Huh-BAT, HepG2 HCC cells, and the corresponding AR cells. Expression of hexokinase II, gamma-glutamylcysteine synthetase (rGCS), and epithelial mesenchymal transition (EMT) markers in AR cells was assessed. Anti-tumor effects of a combination treatment of 3-BP and BSO were evaluated in AR cells and an HCC xenograft mouse model. Results AR HCC cells showed significantly higher chemoresistance, glycolysis and lower ROS production than attached cells. Expression of hexokinase II, rGCS, and EMT markers was higher in AR HCC cells than attached cells. A combination treatment of 3-BP/BSO effectively suppressed proliferation of AR HCC cells through apoptosis by blocking glycolysis and enhancing ROS levels. In xenograft mouse models, tumor growth derived from AR HCC cells was significantly suppressed in the group treated with 3-BP/BSO compared to the group treated with 3-BP or sorafenib. Conclusions These results demonstrated that a combination treatment of 3-BP/BSO had a synergistic anti-tumor effect in an AR HCC model. This strategy may be an effective adjuvant therapy for patients with sorafenib-resistant HCC.	[Lee, Minjong; Jo, Ara; Lee, Seulki; Chang, Young; Nam, Joon Yeul; Cho, Hyeki; Cho, Young Youn; Cho, Eun Ju; Lee, Jeong-Hoon; Yu, Su Jong; Yoon, Jung-Hwan; Kim, Yoon Jun] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Lee, Minjong; Jo, Ara; Lee, Seulki; Chang, Young; Nam, Joon Yeul; Cho, Hyeki; Cho, Young Youn; Cho, Eun Ju; Lee, Jeong-Hoon; Yu, Su Jong; Yoon, Jung-Hwan; Kim, Yoon Jun] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Lee, Minjong] Kangwon Natl Univ Hosp, Dept Internal Med, Chunchon, South Korea; [Kim, Jong Bin] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN USA	Seoul National University (SNU); Seoul National University (SNU); Kangwon National University; Kangwon National University Hospital; University of Minnesota System	Kim, YJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Kim, YJ (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea.	yoonjun@snu.ac.kr		Yoon, Jung-Hwan/0000-0002-9128-3610; Cho, Young Youn/0000-0002-9384-5357; Cho, Hyeki/0000-0003-3694-8111; , minjong/0000-0002-3159-5444; Yu, Su Jong/0000-0001-8888-7977; Kim, Yoon Jun/0000-0001-9141-7773; Cho, Eun Ju/0000-0002-2677-3189	Seoul National University Hospital Research Fund [0320150210 [2015-1108]]; Ildong Pharmaceutical Co., Ltd [800-20140567]; Korea Health Technology RAMP;D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health AMP; Welfare, Republic of Korea [H116C1074]	Seoul National University Hospital Research Fund; Ildong Pharmaceutical Co., Ltd; Korea Health Technology RAMP;D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health AMP; Welfare, Republic of Korea	This study was supported by a grant from the Seoul National University Hospital Research Fund (0320150210 [2015-1108]), a grant (800-20140567) from the Ildong Pharmaceutical Co., Ltd. (Seoul, South Korea), and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (H116C1074).	Anderson CP, 1999, EXP CELL RES, V246, P183, DOI 10.1006/excr.1998.4303; Azevedo-Silva J, 2016, J BIOENERG BIOMEMBR, V48, P349, DOI 10.1007/s10863-016-9670-z; Benlloch M, 2005, J BIOL CHEM, V280, P6950, DOI 10.1074/jbc.M408531200; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Calvert P, 1998, CHEM-BIOL INTERACT, V112, P213, DOI 10.1016/S0009-2797(98)00008-8; Chan SL, 2014, WORLD J GASTROENTERO, V20, P3135, DOI 10.3748/wjg.v20.i12.3135; Chen D, 2006, CANCER RES, V66, P11416, DOI 10.1158/0008-5472.CAN-06-0409; Chen Y, 2015, ONCOTARGET, V6, P6406, DOI 10.18632/oncotarget.3444; Coller HA, 2014, AM J PATHOL, V184, P4, DOI 10.1016/j.ajpath.2013.07.035; D'Alessio M, 2004, FASEB J, V18, P1609, DOI 10.1096/fj.04-1813fje; Domenicotti C, 2003, FREE RADICAL BIO MED, V35, P504, DOI 10.1016/S0891-5849(03)00332-0; Estrela JM, 2006, CRIT REV CL LAB SCI, V43, P143, DOI 10.1080/10408360500523878; Friesen C, 2004, CELL DEATH DIFFER, V11, pS73, DOI 10.1038/sj.cdd.4401431; Go YM, 2015, FREE RADICAL BIO MED, V84, P227, DOI 10.1016/j.freeradbiomed.2015.03.022; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Gupta SC, 2012, ANTIOXID REDOX SIGN, V16, P1295, DOI 10.1089/ars.2011.4414; Hernandez-Breijo B, 2011, WORLD J GASTROENTERO, V17, P3899, DOI 10.3748/wjg.v17.i34.3899; Hochwald SN, 1997, ANN SURG ONCOL, V4, P303, DOI 10.1007/BF02303579; Huang ZZ, 2001, FASEB J, V15, P19, DOI 10.1096/fj.00-0445fje; Kamarajugadda S, 2012, MOL CELL BIOL, V32, P1893, DOI 10.1128/MCB.06248-11; KO YH, 1990, ARCH BIOCHEM BIOPHYS, V278, P373, DOI 10.1016/0003-9861(90)90273-2; LEWIS AD, 1988, CARCINOGENESIS, V9, P1283, DOI 10.1093/carcin/9.7.1283; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lu JR, 2015, CANCER LETT, V356, P156, DOI 10.1016/j.canlet.2014.04.001; Mailloux RJ, 2014, REDOX BIOL, V2, P123, DOI 10.1016/j.redox.2013.12.011; Marengo B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014661; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Niedzwiecka K, 2016, ONCOTARGET, V7, P65614, DOI 10.18632/oncotarget.11592; OBrien ML, 1996, EUR J CANCER, V32A, P967, DOI 10.1016/0959-8049(96)00051-2; Pedersen PL, 2002, BBA-BIOENERGETICS, V1555, P14, DOI 10.1016/S0005-2728(02)00248-7; Pinheiro C, 2012, J BIOENERG BIOMEMBR, V44, P127, DOI 10.1007/s10863-012-9428-1; Reber U, 1998, BIOCHEM PHARMACOL, V55, P349, DOI 10.1016/S0006-2952(97)00480-2; Reynolds CP, 2005, METH MOLEC MED, V111, P335; Sadowska-Bartosz I, 2016, PHARMACOL REP, V68, P502, DOI 10.1016/j.pharep.2015.11.007; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Strauss SJ, 2010, ONCOLOGIST, V15, P627, DOI 10.1634/theoncologist.2010-0093; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Villablanca JG, 2016, PEDIATR BLOOD CANCER, V63, P1349, DOI 10.1002/pbc.25994; Wondrak GT, 2009, ANTIOXID REDOX SIGN, V11, P3013, DOI [10.1089/ars.2009.2541, 10.1089/ARS.2009.2541]; Yang M, 2014, MOL CELL, V55, P782, DOI 10.1016/j.molcel.2014.07.018; Yu SJ, 2016, CLIN MOL HEPATOL, V22, P7, DOI 10.3350/cmh.2016.22.1.7	45	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174271	10.1371/journal.pone.0174271	http://dx.doi.org/10.1371/journal.pone.0174271			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362858	Green Published, gold, Green Submitted			2022-12-26	WOS:000399175000010
J	Meinert, C; Brandt, U; Helne, V; Beyert, J; Schmidl, S; Wubbeler, JH; Voigt, B; Riedel, K; Steinbuchel, A				Meinert, Christina; Brandt, Ulrike; Helne, Viktoria; Beyert, Jessica; Schmidl, Sina; Wuebbeler, Jan Hendrik; Voigt, Birgit; Riedel, Katharina; Steinbuechel, Alexander			Proteomic analysis of organic sulfur compound utilisation in Advenella mimigardefordensis strain DPN7(T)	PLOS ONE			English	Article							SULFITE-OXIDIZING ENZYMES; RALSTONIA-EUTROPHA H16; 3,3'-DITHIODIPROPIONIC ACID; ESCHERICHIA-COLI; COENZYME-A; SP NOV.; 3-MERCAPTOPROPIONIC ACID; MERCAPTOSUCCINIC ACID; ALCALIGENES-EUTROPHUS; KEY ENZYME	2-Mercaptosuccinate (MS) and 3,3"-ditiodipropionate (DTDP) were discussed as precursor substance for production of polythioesters (PTE). Therefore, degradation of MS and DTDP was investigated in Advenella mimigardefordensis strain DPN7(T), applying differential proteomic analysis, gene deletion and enzyme assays. Protein extracts of cells cultivated with MS, DTDP or 3-sulfinopropionic acid (SP) were compared with those cultivated with propionate (P) and/or succinate (S). The chaperone DnaK (ratio DTDP/P 9.2, 3SP/P 4.0, MS/S 6.1, DTDP/S 6.2) and a Do-like serine protease (DegP) were increased during utilization of all organic sulfur compounds. Furthermore, a putative bacterioferritin (locus tag MIM_c12960) showed high abundance (ratio DTDP/P 5.3, 3SP/P 3.2, MS/S 4.8, DTDP/S 3.9) and is probably involved in a thiol-specific stress response. The deletion of two genes encoding transcriptional regulators (LysR (MIM_c31370) and Xre (MIM_c31360)) in the close proximity of the relevant genes of DTDP catabolism (acdA, mdo and the genes encoding the enzymes of the methylcitric acid cycle; prpC,acnD, prpF and prpB) showed that these two regulators are essential for growth of A. mimigardefordensis strain DPN7T with DTDP and that they most probably regulate transcription of genes mandatory for this catabolic pathway. Furthermore, proteome analysis revealed a high abundance (ratio MS/S 10.9) of a hypothetical cupin-2-domain containing protein (MIM_c37420). This protein shows an amino acid sequence similarity of 60% to a newly identified MS dioxygenase from Variovorax paradoxus strain B4. Deletion of the gene and the adjacently located transcriptional regulator LysR, as well as heterologous expression of MIM_c37420, the putative mercaptosuccinate dioxygenase (Msdo) from A. mimigardefordensis, showed that this protein is the key enzyme of MS degradation in A. mimigardefordensis strain DPN7T (K-M 0.2 mM, specific activity 17.1 pmol mg(-1) min(-1)) and is controlled by LysR (MIM_c37410).	[Meinert, Christina; Brandt, Ulrike; Helne, Viktoria; Beyert, Jessica; Schmidl, Sina; Wuebbeler, Jan Hendrik; Steinbuechel, Alexander] Westfal Wilhelms Univ, Inst Mol Mikrobiol & Biotechnol, Munster, Germany; [Voigt, Birgit; Riedel, Katharina] Ernst Moritz Arndt Univ Greifswald, Inst Mikrobiol, Greifswald, Germany; [Steinbuechel, Alexander] King Abdulaziz Univ, Dept Environm Sci, Jeddah, Saudi Arabia	University of Munster; Ernst Moritz Arndt Universitat Greifswald; King Abdulaziz University	Steinbuchel, A (corresponding author), Westfal Wilhelms Univ, Inst Mol Mikrobiol & Biotechnol, Munster, Germany.; Steinbuchel, A (corresponding author), King Abdulaziz Univ, Dept Environm Sci, Jeddah, Saudi Arabia.	steinbu@uni-muenster.de	Heine, Viktoria/AAU-8052-2021	Heine, Viktoria/0000-0002-8667-3059; Riedel, Katharina/0000-0002-4629-3019	Open Access Publication Fund of the University of Muenster	Open Access Publication Fund of the University of Muenster	We acknowledge support by Open Access Publication Fund of the University of Muenster.	BAILEY JL, 1959, J BIOL CHEM, V234, P1733; Bamford VA, 2002, EMBO J, V21, P5599, DOI 10.1093/emboj/cdf566; Caracciolo AB, 2010, FEMS MICROBIOL ECOL, V71, P127, DOI 10.1111/j.1574-6941.2009.00787.x; Berlyn MKB, 1996, LINKAGE MAP ESCHERIC; Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradley JM, 2016, J BIOL INORG CHEM, V21, P13, DOI 10.1007/s00775-016-1336-0; Brandt U, 2015, APPL MICROBIOL BIOT, V99, P4545, DOI 10.1007/s00253-015-6605-2; Brandt U, 2014, J BIOL CHEM, V289, P30800, DOI 10.1074/jbc.M114.579730; Brandt U, 2014, ENVIRON MICROBIOL, V16, P3370, DOI 10.1111/1462-2920.12340; Brandt U, 2014, APPL MICROBIOL BIOT, V98, P6039, DOI 10.1007/s00253-014-5811-7; Carbajal-Rodriguez I, 2011, J BACTERIOL, V193, P527, DOI 10.1128/JB.00793-10; Celis RTF, 1999, J MOL BIOL, V294, P1087, DOI 10.1006/jmbi.1999.3308; Coenye T, 2005, INT J SYST EVOL MICR, V55, P251, DOI 10.1099/ijs.0.63267-0; Dahl C, 2013, MICROBIOL-SGM, V159, P2626, DOI 10.1099/mic.0.071019-0; DELEY J, 1986, INT J SYST BACTERIOL, V36, P405, DOI 10.1099/00207713-36-3-405; Devipriya S, 2013, ASIAN J CHEM, V25, P1521; Feng CJ, 2007, BBA-PROTEINS PROTEOM, V1774, P527, DOI 10.1016/j.bbapap.2007.03.006; FRIEDRICH B, 1981, J BACTERIOL, V147, P198, DOI 10.1128/JB.147.1.198-205.1981; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Ghosh W, 2011, J BACTERIOL, V193, P5553, DOI 10.1128/JB.05781-11; Ghyczy M, 2003, FASEB J, V17, P1124, DOI 10.1096/fj.02-0918fje; Gibello A, 2009, INT J SYST EVOL MICR, V59, P1914, DOI 10.1099/ijs.0.007443-0; GUNNISON AF, 1981, FOOD COSMET TOXICOL, V19, P667, DOI 10.1016/0015-6264(81)90519-8; HALL MR, 1968, CAN J MICROBIOL, V14, P515, DOI 10.1139/m68-087; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hernandez-Lucas I, 2008, J BACTERIOL, V190, P1658, DOI 10.1128/JB.01649-07; Heroven AK, 2006, MOL MICROBIOL, V62, P1469, DOI 10.1111/j.1365-2958.2006.05458.x; Kappler U, 2011, BBA-BIOENERGETICS, V1807, P1, DOI 10.1016/j.bbabio.2010.09.004; Kawada J, 2003, BIOMACROMOLECULES, V4, P1698, DOI 10.1021/bm0341327; Kloda A, 2001, BIOPHYS J, V80, P229, DOI 10.1016/S0006-3495(01)76009-2; LARKWORTHY LF, 1980, J INORG NUCL CHEM, V42, P551, DOI 10.1016/0022-1902(80)80084-4; Lutke-Eversloh T, 2001, MICROBIOL-UK, V147, P11; MARMUR J, 1963, METHOD ENZYMOL, V6, P726, DOI 10.1016/0076-6879(63)06240-6; MARVEL CS, 1951, J AM CHEM SOC, V73, P1100, DOI 10.1021/ja01147a063; Matsuoka M, 2012, INT J SYST EVOL MICR, V62, P2986, DOI 10.1099/ijs.0.037440-0; MCCARTY JS, 1994, J BACTERIOL, V176, P764, DOI 10.1128/jb.176.3.764-780.1994; Mubbeler JH, 2006, INT J SYST EVOL MICR, V56, P1305, DOI 10.1099/ijs.0.64126-0; Niu JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/32/325607; Picossi S, 2007, J MOL BIOL, V365, P1298, DOI 10.1016/j.jmb.2006.10.100; Pogliano J, 1997, GENE DEV, V11, P1169, DOI 10.1101/gad.11.9.1169; Potter M, 2005, MICROBIOL-SGM, V151, P825, DOI 10.1099/mic.0.27613-0; Raberg M, 2008, APPL ENVIRON MICROB, V74, P4477, DOI 10.1128/AEM.00440-08; Rabilloud T, 1999, ELECTROPHORESIS, V20, P3603, DOI 10.1002/(SICI)1522-2683(19991201)20:18&lt;3603::AID-ELPS3603&gt;3.0.CO;2-V; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; SCHLEGEL HG, 1961, ARCH MIKROBIOL, V38, P209, DOI 10.1007/BF00422356; Schurmann M, 2013, J BACTERIOL, V195, P1538, DOI 10.1128/JB.02105-12; Schurmann M, 2011, J BACTERIOL, V193, P3078, DOI 10.1128/JB.00049-11; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; van Keulen G, 2003, J BACTERIOL, V185, P1245, DOI 10.1128/JB.185.4.1245-1252.2003; VISICK JE, 1995, MOL MICROBIOL, V16, P835, DOI 10.1111/j.1365-2958.1995.tb02311.x; VISSCHER PT, 1993, APPL ENVIRON MICROB, V59, P93, DOI 10.1128/AEM.59.1.93-96.1993; Wang HM, 2016, INT J SYST EVOL MICR, V66, P906, DOI 10.1099/ijsem.0.000811; Weinitschke S, 2007, MICROBIOL-SGM, V153, P3055, DOI 10.1099/mic.0.2007/009845-0; WIECZOREK R, 1995, J BACTERIOL, V177, P2425, DOI 10.1128/jb.177.9.2425-2435.1995; Winter J, 2004, CRIT REV BIOCHEM MOL, V39, P297, DOI 10.1080/10409230490900658; Wolf C, 2008, PROTEOMICS, V8, P3139, DOI 10.1002/pmic.200701062; Woodmansee AN, 2002, J BIOL CHEM, V277, P34055, DOI 10.1074/jbc.M203977200; Wubbeler JH, 2008, APPL ENVIRON MICROB, V74, P4028, DOI 10.1128/AEM.00422-08; Wubbeler JH, 2014, CURR OPIN BIOTECH, V29, P85, DOI 10.1016/j.copbio.2014.02.017; Wubbeler JH, 2014, MICROBIOL-SGM, V160, P1401, DOI 10.1099/mic.0.078279-0; Wubbeler JH, 2010, APPL ENVIRON MICROB, V76, P7023, DOI 10.1128/AEM.01706-10; Xia YZ, 2012, APPL ENVIRON MICROB, V78, P3286, DOI 10.1128/AEM.00007-12	64	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174256	10.1371/journal.pone.0174256	http://dx.doi.org/10.1371/journal.pone.0174256			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358882	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174800025
J	Kong, H; Chevalier, M; Laffaille, P; Lek, S				Kong, Heng; Chevalier, Mathieu; Laffaille, Pascal; Lek, Sovan			Spatio-temporal variation of fish taxonomic composition in a South-East Asian flood-pulse system	PLOS ONE			English	Article							BETA-DIVERSITY; LAKE; ASSEMBLAGES; MANAGEMENT; FRAMEWORK; HABITATS; RIVER	The Tonle Sap Lake (TSL) is a flood-pulse system. It is the largest natural lake in South-East Asia and constitutes one of the largest fisheries over the world, supporting the livelihood of million peoples. Nonetheless, the Mekong River Basin is changing rapidly due to accelerating water infrastructure development (hydropower, irrigation, flood control, and water supply) and climate change, bringing considerable modifications to the annual flood-pulse of the TSL. Such modifications are expected to have strong impacts on fish biodiversity and abundance. This paper aims to characterize the spatio-temporal variations of fish taxonomic composition and to highlights the underlying determinants of these variations. For this purpose, we used data collected from a community catch monitoring program conducted at six sites during 141 weeks, covering two full hydrological cycles. For each week, we estimated beta diversity as the total variance of the site-by-species community matrix and partitioned it into Local Contribution to Beta Diversity (LCBD) and Species Contribution to Beta Diversity (SCBD). We then performed multiple linear regressions to determine whether species richness, species abundances and water level explained the temporal variation in the contribution of site and species to beta diversity. Our results indicate strong temporal variation of beta diversity due to differential contributions of sites and species to the spatial variation of fish taxonomic composition. We further found that the direction, the shape and the relative effect of species richness, abundances and water level on temporal variation in LCBD and SCBD values greatly varied among sites, thus suggesting spatial variation in the processes leading to temporal variation in community composition. Overall, our results suggest that fish taxonomic composition is not homogeneously distributed over space and time and is likely to be impacted in the future if the flood-pulse dynamic of the system is altered by human activities.	[Kong, Heng; Chevalier, Mathieu; Lek, Sovan] Univ Toulouse, EDB, CNRS, ENFA,UPS, Toulouse, France; [Kong, Heng; Laffaille, Pascal] Univ Toulouse, CNRS, EcoLab, INPT,UPS, Toulouse, France	Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Chevalier, M (corresponding author), Univ Toulouse, EDB, CNRS, ENFA,UPS, Toulouse, France.	mathieu.chevalier38@gmail.com	Chevalier, Mathieu/AAU-6540-2020	Chevalier, Mathieu/0000-0002-1170-5343	Erasmus Mundus TECHNO II Program; Belmont Forum; 'Investissement dAvenir' grants (CEBA) [ANR-10-LABX-0025]; 'Investissement dAvenir' grants (TULIP) [ANR-10-LABX-41]	Erasmus Mundus TECHNO II Program; Belmont Forum; 'Investissement dAvenir' grants (CEBA); 'Investissement dAvenir' grants (TULIP)	This work was supported by the Erasmus Mundus TECHNO II Program and the Belmont Forum. The EDB lab was supported by 'Investissement dAvenir' grants (CEBA, ref. ANR-10-LABX-0025; TULIP, ref. ANR-10-LABX-41). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Erasmus Mundus TECHNO II Program and the Belmont Forum for providing financial support for this study. We also thank the Mekong River Commission (MRC), Dr. So Nam and Mr. Ngor Peng Bun for providing the data. EDB lab was supported by 'Investissement d'Avenir' grants (CEBA, ref. ANR-10-LABX-0025; TULIP, ref. ANR-10-LABX-41).	Agostinho AA, 2004, REV FISH BIOL FISHER, V14, P11, DOI 10.1007/s11160-004-3551-y; Ahmed M, 1998, SOCIOECONOMIC ASSESS, P186; Allan JD, 2005, BIOSCIENCE, V55, P1041, DOI 10.1641/0006-3568(2005)055[1041:OOIW]2.0.CO;2; Allison EH, 2001, MAR POLICY, V25, P377, DOI 10.1016/S0308-597X(01)00023-9; Arias ME, 2014, ENVIRON CONSERV, V41, P165, DOI 10.1017/S0376892913000283; Arias ME, 2012, J ENVIRON MANAGE, V112, P53, DOI 10.1016/j.jenvman.2012.07.003; Baird IG, 2003, NATURAL HIST B SIAM, P5; Bennett MG, 2015, ECOL FRESHW FISH; Biguezoton A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1305-z; Chea R, 2016, ECOL FRESHW FISH, P1, DOI DOI 10.1111/EFF.12301; da Silva PG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111883; Devictor V, 2008, GLOBAL ECOL BIOGEOGR, V17, P252, DOI 10.1111/j.1466-8238.2007.00364.x; Froese R., 2016, FISHBASE; Genner MJ, 2004, ECOGRAPHY, V27, P601, DOI 10.1111/j.0906-7590.2004.03824.x; Halls AS, 2013, INTEGRATED ANAL DATA; Hu ZJ, 2014, CHIN J OCEANOL LIMN, V32, P799, DOI 10.1007/s00343-014-3193-4; Hubbell Stephen P., 2001, V32, pi; Ives AR, 2010, AM NAT, V176, pE128, DOI 10.1086/656486; Kafumbata D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0052; Lasne E, 2007, BIOL CONSERV, V139, P258, DOI 10.1016/j.biocon.2007.07.002; Layman CA, 2010, AQUAT ECOL, V44, P269, DOI 10.1007/s10452-009-9256-5; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Maire A, 2013, ECOL INDIC, V34, P450, DOI 10.1016/j.ecolind.2013.06.009; Menezes RF, 2015, FRESHWATER BIOL, V60, P745, DOI 10.1111/fwb.12526; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Qiao XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17043; R Core Team, 2021, R LANGUAGE ENV STAT; Rainboth W.J., 1996, FISHES CAMBODIAN MEK; Ropke CP, 2015, J FISH BIOL; Shoup DE, 2009, T AM FISH SOC, V138, P1076, DOI 10.1577/T07-272.1; Sithirith, 2015, J ENVIRON SCI ENG, V4, P331, DOI [10.17265/2162-5263/2015.06.004, DOI 10.17265/2162-5263/2015.06.004]; Tockner K, 2000, HYDROL PROCESS, V14, P2861, DOI 10.1002/1099-1085(200011/12)14:16/17&lt;2861::AID-HYP124&gt;3.0.CO;2-F; Tondato KK, 2013, J LIMNOL, V72, P95, DOI 10.4081/jlimnol.2013.e8; van Zalinge N., 2003, FISHERIES, P13; WALSH C., 2013, HIER PART HIERARCHIC; Yen NTH, 2009, J GREAT LAKES RES, V35, P169, DOI 10.1016/j.jglr.2008.11.014	37	27	27	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174582	10.1371/journal.pone.0174582	http://dx.doi.org/10.1371/journal.pone.0174582			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350829	gold, Green Submitted, Green Published			2022-12-26	WOS:000399174400061
J	Wang, H; Liu, TZ; Feng, S; Zhang, WH				Wang, Hong; Liu, Tongzhou; Feng, Shuai; Zhang, Weihua			Metal removal and associated binding fraction transformation in contaminated river sediment washed by different types of agents	PLOS ONE			English	Article							HEAVY-METALS; SOIL; EXTRACTION; EDTA; ACID; ZN; REMEDIATION; RELEASE; COPPER; CU	In ex-situ washing, HCl, EDTA and H2O2 solutions can effectively extract heavy metals in river sediment. Nevertheless they often target different sediment components, possibly transforming metal species into more bioavailable and hence toxic ones. This study, in batch settings, investigated the influences of different types of washing agents (i.e. HCl, EDTA and H2O2) on metal (i.e. Cu and Zn) removal from contaminated river sediment, destroy or dissolution of sediment components, and transformation of metal fractions during chemical washing treatment. Additionally, bioavailability of these metals left in the washed sediment was assessed. Results showed that HCl obtained the highest Cu and Zn removal through destroying the reducible, oxidizable and residual sediment components. Meanwhile, it transformed metal fractions to acid extractable one, resulting in an increase in metal bioavailability. Thus, the feasibility of washing with HCl for sediment remediation shall be reconsidered due to the caused high metal bioavailability. EDTA was capable of removing metals via direct complexation of labile metal species and indirect dissolution of reducible and oxidizable sediment components, where the transformation of corresponding metal binding fraction may occur. H2O2 obtained the lowest total Cu and Zn removal, but it preferentially removed the oxidizable metal species by oxidizing sulfides in the sediment. The bioavailable levels of Cu and Zn in the sediment washed by EDTA or H2O2 seemed not increase. To maintain a good balance between labile metal species removal and avoiding increase of metal bioavailability, EDTA and H2O2 are promising additives for metal removal by sediment washing.	[Wang, Hong] South Univ Sci & Technol China, Sch Environm Sci & Engn, Beijing, Peoples R China; [Wang, Hong] South Univ Sci & Technol China, Engn Innovat Ctr Beijing, Beijing, Peoples R China; [Liu, Tongzhou; Feng, Shuai] Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen Key Lab Water Resource Utilizat & Enviro, Shenzhen, Peoples R China; [Zhang, Weihua] Sun Yat Sen Univ, Sch Environm Sci & Engn, Guangzhou, Guangdong, Peoples R China; [Zhang, Weihua] Sun Yat Sen Univ, Shenzhen Res Inst, Shenzhen, Peoples R China	Southern University of Science & Technology; Southern University of Science & Technology; Harbin Institute of Technology; University Town of Shenzhen; Sun Yat Sen University; Sun Yat Sen University	Liu, TZ (corresponding author), Harbin Inst Technol, Shenzhen Grad Sch, Shenzhen Key Lab Water Resource Utilizat & Enviro, Shenzhen, Peoples R China.; Zhang, WH (corresponding author), Sun Yat Sen Univ, Sch Environm Sci & Engn, Guangzhou, Guangdong, Peoples R China.; Zhang, WH (corresponding author), Sun Yat Sen Univ, Shenzhen Res Inst, Shenzhen, Peoples R China.	liutongzhou@hitsz.edu.cn; zhangwh5@mail.sysu.edu.cn	zhang, weihua/GXV-1334-2022		National Natural Science Foundation of China [51208145, 41272383]; Shenzhen Municipal Science and Technology Plan Project [JCYJ20160519095007940]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Science and Technology Plan Project	This work was supported by National Natural Science Foundation of China (project no. 51208145, Liutong Zhou), National Natural Science Foundation of China (project no. 41272383, Weihua Zhang), and Shenzhen Municipal Science and Technology Plan Project(Contract no. JCYJ20160519095007940, Weihua Zhang).; The authors wish to thank the National Natural Science Foundation of China (project no. 51208145 and 41272383) and Shenzhen Municipal Science and Technology Plan Project (Contract no. JCYJ20160519095007940) for the financial support of this study.	Atkinson CA, 2007, CHEMOSPHERE, V69, P1428, DOI 10.1016/j.chemosphere.2007.04.068; Bacon JR, 2008, ANALYST, V133, P25, DOI 10.1039/b711896a; Barona A, 2001, ENVIRON POLLUT, V113, P79, DOI 10.1016/S0269-7491(00)00158-5; Cappuyns V, 2005, APPL GEOCHEM, V20, P1169, DOI 10.1016/j.apgeochem.2005.02.004; Dalmacija M, 2011, SCI TOTAL ENVIRON, V412, P366, DOI 10.1016/j.scitotenv.2011.10.006; Di Palma L, 2007, J HAZARD MATER, V147, P768, DOI 10.1016/j.jhazmat.2007.01.072; DITORO DM, 1992, ENVIRON SCI TECHNOL, V26, P96, DOI 10.1021/es00025a009; Ferraro A, 2016, WATER AIR SOIL POLL, V227, DOI 10.1007/s11270-016-2764-8; Gomez-Ariza JL, 1999, ANAL CHIM ACTA, V399, P295, DOI 10.1016/S0003-2670(99)00460-2; Gu YG, 2015, MAR POLLUT BULL, V101, P852, DOI 10.1016/j.marpolbul.2015.11.019; Gupta AK, 2007, J HAZARD MATER, V149, P144, DOI 10.1016/j.jhazmat.2007.03.062; Hammer D, 2002, J ENVIRON QUAL, V31, P1561, DOI 10.2134/jeq2002.1561; Harmsen J, 2013, J HAZARD MATER, V261, P840, DOI 10.1016/j.jhazmat.2012.12.044; Hong YS, 2011, ENVIRON TOXICOL CHEM, V30, P564, DOI 10.1002/etc.411; Karwowska B, 2014, DESALIN WATER TREAT, V52, P4000, DOI 10.1080/19443994.2014.887493; Kim KJ, 2011, SEP PURIF TECHNOL, V79, P164, DOI 10.1016/j.seppur.2011.02.010; Ko I, 2005, J HAZARD MATER, V127, P1, DOI 10.1016/j.jhazmat.2005.06.041; Kordel W, J HAZAR MAT, V261, P854; Kumpiene J, 2008, WASTE MANAGE, V28, P215, DOI 10.1016/j.wasman.2006.12.012; Kuo S, 2006, ENVIRON POLLUT, V144, P918, DOI 10.1016/j.envpol.2006.02.001; Labanowski J, 2008, ENVIRON POLLUT, V152, P693, DOI 10.1016/j.envpol.2007.06.054; Lei M, 2008, COMMUN SOIL SCI PLAN, V39, P1963, DOI 10.1080/00103620802134776; Li H, 2015, J ENVIRON SCI, V322, P28; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Magar VS, 2008, SCI TOTAL ENVIRON, V394, P103, DOI 10.1016/j.scitotenv.2008.01.007; Mulligan CN, 2001, J HAZARD MATER, V85, P145, DOI 10.1016/S0304-3894(01)00226-6; Nystroem GM, 2006, SCI TOTAL ENVIRON, V357, P25, DOI 10.1016/j.scitotenv.2005.04.040; Ortega LM, 2008, WATER RES, V42, P1943, DOI 10.1016/j.watres.2007.11.025; Peng JF, 2009, J HAZARD MATER, V161, P633, DOI 10.1016/j.jhazmat.2008.04.061; Rauret G, 1999, J ENVIRON MONITOR, V1, P57, DOI 10.1039/a807854h; Reddy KR, 2000, SOIL SEDIMENT CONTAM, V9, P449, DOI 10.1080/10588330091134347; Simpson SL, 2002, ENVIRON SCI TECHNOL, V36, P3772, DOI 10.1021/es025632v; Sun B, 2001, ENVIRON POLLUT, V113, P111, DOI 10.1016/S0269-7491(00)00176-7; Tsang DCW, 2007, CHEMOSPHERE, V68, P234, DOI 10.1016/j.chemosphere.2007.01.022; Tsang DCW, 2009, ENVIRON SCI TECHNOL, V43, P837, DOI 10.1021/es8020292; Udovic M, 2009, CHEMOSPHERE, V74, P1367, DOI 10.1016/j.chemosphere.2008.11.013; Udovic M, 2012, CHEMOSPHERE, V88, P718, DOI 10.1016/j.chemosphere.2012.04.040; Wang H, 2016, J SOILS SED IN PRESS; Yoo JC, 2015, ENVIRON SCI POLLUT R, V22, P9912, DOI 10.1007/s11356-015-4155-x; Yoo JC, 2015, SEP SCI TECHNOL, V50, P536, DOI 10.1080/01496395.2014.956762; Yoo JC, 2013, CHEM ENG J, V228, P688, DOI 10.1016/j.cej.2013.05.029; Zhang H, 2001, ENVIRON SCI TECHNOL, V35, P2602, DOI 10.1021/es000268q; Zhang WH, 2013, J SOIL SEDIMENT, V13, P354, DOI 10.1007/s11368-012-0616-8; Zhang WH, 2010, J HAZARD MATER, V173, P369, DOI 10.1016/j.jhazmat.2009.08.087; Zou Z, 2009, ENVIRON POLLUT, V157, P229, DOI 10.1016/j.envpol.2008.07.009	45	7	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174571	10.1371/journal.pone.0174571	http://dx.doi.org/10.1371/journal.pone.0174571			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350832	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174400059
J	Milekhina, ON; Nechaev, DI; Klishin, VO; Supin, AY				Milekhina, Olga N.; Nechaev, Dmitry I.; Klishin, Vladimir O.; Supin, Alexander Ya.			Discrimination of rippled-spectrum patterns in noise: A manifestation of compressive nonlinearity	PLOS ONE			English	Article							HEARING-IMPAIRED LISTENERS; AUDITORY FILTER SHAPES; FREQUENCY DISCRIMINATION; RESOLUTION DEPENDENCE; DENSITY RESOLUTION; NOTCHED-NOISE; MASKING; LEVEL; SELECTIVITY; MODULATION	In normal-hearing listeners, rippled-spectrum discrimination was psychophysically investigated in both silence and with a simultaneous masker background using the following two paradigms: measuring the ripple density resolution with the phase-reversal test and measuring the ripple-shift threshold with the ripple-shift test. The 0.5-oct wide signal was centered on 2 kHz, the signal levels were 50 and 80 dB SPL, and the masker levels varied from 30 to 100 dB SPL. The baseline ripple density resolutions were 8.7 oct(-1) and 8.6 oct(-1) for the 50-dB and 80-dB signals, respectively. The baseline ripple shift thresholds were 0.015 oct and 0.018 oct for the 50-dB and 80-dB signals, respectively. The maskers were 0.5-oct noises centered on 2 kHz (on-frequency) or 0.75 to 1.25 oct below the signal (off-frequency maskers). The effects of the maskers were as follows: (i) both on-and low-frequency maskers reduced the ripple density resolution and increased the ripple shift thresholds, (ii) the masker levels at threshold (the ripple density resolution decrease down to 3 oct(-1) or ripple shift threshold increased up to 0.1 oct) increased with increasing frequency spacing between the signal and masker, (iii) the masker levels at threshold were higher for the 80-dB signal than for the 50-dB signal, and (iv) the difference between the masker levels at threshold for the 50-dB and 80-dB signals decreased with increasing frequency spacing between the masker and signal. Within the 30-dB (from 50 to 80 dB SPL) signal level, the growth of the masker level at threshold was 27.8 dB for the on-frequency masker and 9 dB for the low-frequency masker. It is assumed that the difference between the on-and low-frequency masking of the rippled-spectrum discrimination reflects the cochlear compressive non-linearity. With this assumption, the compression was 0.3 dB/dB.	[Milekhina, Olga N.; Nechaev, Dmitry I.; Klishin, Vladimir O.; Supin, Alexander Ya.] Russian Acad Sci, Inst Ecol & Evolut, 33 Leninsky Prospect, Moscow, Russia	Russian Academy of Sciences	Supin, AY (corresponding author), Russian Acad Sci, Inst Ecol & Evolut, 33 Leninsky Prospect, Moscow, Russia.	alex_supin@mail.ru			Russian Foundation for basic research [14-04-00237]; Russian Science Foundation [16-15-10046]	Russian Foundation for basic research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	The Russian Foundation for basic research (Grant 14-04-00237 to AYS) and the Russian Science Foundation (Grant 16-15-10046 to AYS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	EMMERICH DS, 1983, J ACOUST SOC AM, V74, P1702, DOI 10.1121/1.390278; EMMERICH DS, 1986, J ACOUST SOC AM, V80, P1668, DOI 10.1121/1.394278; FANTINI DA, 1989, J ACOUST SOC AM, V85, P1691, DOI 10.1121/1.397958; Glasberg BR, 2000, J ACOUST SOC AM, V108, P2318, DOI 10.1121/1.1315291; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; GLASBERG BR, 1984, J ACOUST SOC AM, V75, P536, DOI 10.1121/1.390487; Goldstein J. L., 1977, PSYCHOPHYSICS PHYSL, P337; Green D., 1986, AUDITORY FREQUENCY S, P351; Green DM, 1987, PROFILE ANAL AUDITOR; HENNING GB, 1967, J ACOUST SOC AM, V41, P774, DOI 10.1121/1.1910405; HOUTGAST T, 1977, J ACOUST SOC AM, V62, P409, DOI 10.1121/1.381541; Houtgast T, 1974, FACTS MODELS HEARING, P258; JESTEADT W, 1975, J ACOUST SOC AM, V57, P1161, DOI 10.1121/1.380574; Lopez-Poveda EA, 2003, J ACOUST SOC AM, V113, P951, DOI 10.1121/1.1534838; Masking Zwicker E., 1970, FREQUENCY ANAL PERIO, P376; MOORE BCJ, 1992, J ACOUST SOC AM, V92, P3119, DOI 10.1121/1.404208; MOORE BCJ, 1989, J ACOUST SOC AM, V86, P1722, DOI 10.1121/1.398603; Nechaev DI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140313; Nechaev DI, 2013, J ACOUST SOC AM, V134, P2913, DOI 10.1121/1.4820789; Nelson DA, 2001, J ACOUST SOC AM, V110, P2045, DOI 10.1121/1.1404439; OLOUGHLIN BJ, 1981, J ACOUST SOC AM, V69, P1119, DOI 10.1121/1.385691; Oxenham AJ, 1997, J ACOUST SOC AM, V101, P3666, DOI 10.1121/1.418327; PATTERSON RD, 1977, J ACOUST SOC AM, V62, P649, DOI 10.1121/1.381578; PATTERSON RD, 1982, J ACOUST SOC AM, V72, P1788, DOI 10.1121/1.388652; PATTERSON RD, 1976, J ACOUST SOC AM, V59, P640, DOI 10.1121/1.380914; Pick G., 1977, PSYCHOPHYSICS PHYSL, P273; PICK GF, 1980, J ACOUST SOC AM, V68, P1085, DOI 10.1121/1.384979; SEK A, 1995, J ACOUST SOC AM, V97, P2479, DOI 10.1121/1.411968; Shower EG, 1931, J ACOUST SOC AM, V3, P275, DOI 10.1121/1.1915561; SIEBERT WM, 1970, PR INST ELECTR ELECT, V58, P723, DOI 10.1109/PROC.1970.7727; STELMACHOWICZ PG, 1987, J ACOUST SOC AM, V81, P1881, DOI 10.1121/1.394752; SUMMERS V, 1994, J ACOUST SOC AM, V95, P3518, DOI 10.1121/1.409969; Supin AY, 2005, HEARING RES, V204, P191, DOI 10.1016/j.heares.2005.01.010; Supin AY, 2003, HEARING RES, V185, P1, DOI 10.1016/S0378-5955(03)00215-6; Supin AY, 1999, J ACOUST SOC AM, V106, P2800, DOI 10.1121/1.428105; SUPIN AY, 1994, HEARING RES, V78, P31, DOI 10.1016/0378-5955(94)90041-8; Supin AY, 1997, HEARING RES, V108, P17, DOI 10.1016/S0378-5955(97)00035-X; Supin AY, 1998, J ACOUST SOC AM, V103, P2042, DOI 10.1121/1.421351; Supin AY, 2001, HEARING RES, V151, P157, DOI 10.1016/S0378-5955(00)00223-9; Tyler R. S, 1986, AUDITORY FREQUENCY S, P323; WIER CC, 1977, J ACOUST SOC AM, V61, P178, DOI 10.1121/1.381251; YOST WA, 1978, J ACOUST SOC AM, V63, P1166, DOI 10.1121/1.381824; ZWICKER E, 1982, PSYCHOACUSTIC; ZWICKER E, 1974, FACTS MODELS HEARING, P132	44	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174685	10.1371/journal.pone.0174685	http://dx.doi.org/10.1371/journal.pone.0174685			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346538	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174300069
J	Horiuchi, T; Sakata, N; Narumi, Y; Kimura, T; Hayashi, T; Nagano, K; Liu, KY; Nishibori, M; Tsukita, S; Yamada, T; Katagiri, H; Shirakawa, R; Horiuchi, H				Horiuchi, Takahiro; Sakata, Natsumi; Narumi, Yoshihiro; Kimura, Tomohiro; Hayashi, Takashi; Nagano, Keisuke; Liu, Keyue; Nishibori, Masahiro; Tsukita, Sohei; Yamada, Tetsuya; Katagiri, Hideki; Shirakawa, Ryutaro; Horiuchi, Hisanori			Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOBILITY GROUP BOX-1; CYTOKINE ACTIVITY; PROTEIN; INFLAMMATION; INJURY; HEPATOTOXICITY; CELLS	Metformin is the first-line drug in the treatment of type 2 diabetes. In addition to its hypoglycemic effect, metformin has an anti-inflammatory function, but the precise mechanism promoting this activity remains unclear. High mobility group box 1 (HMGB1) is an alarmin that is released from necrotic cells and induces inflammatory responses by its cytokine-like activity and is, therefore, a target of anti-inflammatory therapies. Here we identified HMGB1 as a novel metformin-binding protein by affinity purification using a biotinylated metformin analogue. Metformin directly bound to the C-terminal acidic tail of HMGB1. Both in vitro and in vivo, metformin inhibited inflammatory responses induced by full-length HMGB1 but not by HMGB1 lacking the acidic tail. In an acetaminophen-induced acute liver injury model in which HMGB1 released from injured cells exacerbates the initial injury, metformin effectively reduced liver injury and had no additional inhibitory effects when the extracellular HMGB1 was blocked by anti-HMGB1-neutralizing antibody. In summary, we report for the first time that metformin suppresses inflammation by inhibiting the extracellular activity of HMGB1. Because HMGB1 plays a major role in inflammation, our results suggest possible new ways to manage HMGB1-induced inflammation.	[Horiuchi, Takahiro; Sakata, Natsumi; Narumi, Yoshihiro; Kimura, Tomohiro; Shirakawa, Ryutaro; Horiuchi, Hisanori] Tohoku Univ, Inst Dev Aging & Canc, Dept Mol & Cellular Biol, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan; [Hayashi, Takashi] Otsuka Pharmaceut Co Ltd, Biomed Technol Res Ctr, Tokushima Res Inst, 463-10 Kagasuno, Kawaguchi, Tokushima 7710192, Japan; [Nagano, Keisuke] Otsuka Pharmaceut Co Ltd, Inst New Drug Discovery 1, 463-10 Kagasuno, Kawaguchi, Tokushima 7710192, Japan; [Liu, Keyue; Nishibori, Masahiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pharmacol, Okayama 7008558, Japan; [Tsukita, Sohei; Yamada, Tetsuya; Katagiri, Hideki] Tohoku Univ, Grad Sch Med, Dept Metab & Diabet, Sendai, Miyagi 9808575, Japan	Tohoku University; Otsuka Pharmaceutical; Otsuka Pharmaceutical; Okayama University; Tohoku University	Shirakawa, R; Horiuchi, H (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Mol & Cellular Biol, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	ryutaro.shirakawa.b1@tohoku.ac.jp; hisanori.horiuchi.e8@tohoku.ac.jp		Horiuchi, Takahiro/0000-0002-1907-2042; Sakata, Natsumi/0000-0001-5420-957X	Japan Society for the Promotion of Science KAKENHI Grant [15K19000]; Smart Aging Research Center, Tohoku University; Good Practice (GP) Program, "Nurturing MD researchers competitive in the world arena, Tohoku University School of Medicine" by the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Otsuka Pharmaceutical Co, Ltd.; Otsuka Pharmaceutical Co., Ltd.; Grants-in-Aid for Scientific Research [16K15486, 15K19000] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Smart Aging Research Center, Tohoku University; Good Practice (GP) Program, "Nurturing MD researchers competitive in the world arena, Tohoku University School of Medicine" by the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Otsuka Pharmaceutical Co, Ltd.(Otsuka Pharmaceutical); Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work supported in part by a Japan Society for the Promotion of Science KAKENHI Grant 15K19000 (to T. K.), the Smart Aging Research Center, Tohoku University, and a research fund from Otsuka Pharmaceutical Co., Ltd. It was also supported by the Good Practice (GP) Program, "Nurturing MD researchers competitive in the world arena, Tohoku University School of Medicine" by the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to T. Ho., N. S., and Y. N.). T. Hayashi and K. Nagano are employees of Otsuka Pharmaceutical Co., Ltd. H. Horiuchi received a research fund from Otsuka Pharmaceutical Co, Ltd.	Agresti A, 2003, BIOCHEM BIOPH RES CO, V302, P421, DOI 10.1016/S0006-291X(03)00184-0; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Bergheim I, 2006, GASTROENTEROLOGY, V130, P2099, DOI 10.1053/j.gastro.2006.03.020; BIANCHI ME, 1992, EMBO J, V11, P1055, DOI 10.1002/j.1460-2075.1992.tb05144.x; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Ellerman JE, 2007, CLIN CANCER RES, V13, P2836, DOI 10.1158/1078-0432.CCR-06-1953; Fink MP, 2007, CRIT CARE, V11, DOI 10.1186/cc6088; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Gandini S, 2014, CANCER PREV RES, V7, P867, DOI 10.1158/1940-6207.CAPR-13-0424; Goldstein RS, 2006, SHOCK, V25, P571, DOI 10.1097/01.shk.0000209540.99176.72; Gronich N, 2013, NAT REV CLIN ONCOL, V10, P625, DOI 10.1038/nrclinonc.2013.169; Hadi NR, 2012, J PHARMACOL PHARMACO, V3, P248, DOI 10.4103/0976-500X.99426; Hattori Y, 2015, DIABETES, V64, P1907, DOI 10.2337/db15-0090; He L, 2015, CELL METAB, V21, P159, DOI 10.1016/j.cmet.2015.01.003; Huang NL, 2009, INT J CARDIOL, V134, P169, DOI 10.1016/j.ijcard.2008.04.010; Huang WC, 2010, CYTOKINE, V51, P119, DOI 10.1016/j.cyto.2010.02.021; Huebener P, 2015, J CLIN INVEST, V125, P539, DOI 10.1172/JCI76887; Hyun Bobae, 2013, Immune Netw, V13, P123, DOI 10.4110/in.2013.13.4.123; Kanellakis P, 2011, ARTERIOSCL THROM VAS, V31, P313, DOI 10.1161/ATVBAHA.110.218669; Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001; Kim D, 2013, INT J MOL MED, V32, P1293, DOI 10.3892/ijmm.2013.1508; Kim J, 2014, J BIOL CHEM, V289, P23246, DOI 10.1074/jbc.M114.577908; Kim YH, 2015, J HEPATOL, V63, P75, DOI [10.1016/j.jhep.2015.02.050, 10.1016/j.jhep.2015.02.008]; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Li JH, 2003, MOL MED, V9, P37, DOI 10.1007/BF03402105; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; Lotze Michael T, 2003, Curr Opin Investig Drugs, V4, P1405; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Marchesini G, 2001, LANCET, V358, P893, DOI 10.1016/S0140-6736(01)06042-1; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Poon MKT, 2003, J PHARMACOL SCI, V93, P501, DOI 10.1254/jphs.93.501; Ramstein J, 1999, EUR J BIOCHEM, V260, P692, DOI 10.1046/j.1432-1327.1999.00185.x; Rena G, 2013, DIABETOLOGIA, V56, P1898, DOI 10.1007/s00125-013-2991-0; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Saisho Y, 2015, ENDOCR METAB IMMUNE, V15, P196, DOI 10.2174/1871530315666150316124019; Scheen AJ, 2015, DIABETES METAB, V41, P183, DOI 10.1016/j.diabet.2015.02.003; Stott K, 2010, J MOL BIOL, V403, P706, DOI 10.1016/j.jmb.2010.07.045; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Tsoyi K, 2011, BRIT J PHARMACOL, V162, P1498, DOI 10.1111/j.1476-5381.2010.01126.x; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yang H, 2012, MOL MED, V18, P250, DOI 10.2119/molmed.2011.00389; Yang RK, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-66	48	60	63	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8436	8446		10.1074/jbc.M116.769380	http://dx.doi.org/10.1074/jbc.M116.769380			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28373282	Green Published, hybrid			2022-12-26	WOS:000401788600027
J	Maeda, Y; Dobashi, H; Sugiyama, Y; Saeki, T; Lim, TK; Harada, M; Matsunaga, T; Yoshino, T; Tanaka, T				Maeda, Yoshiaki; Dobashi, Hironori; Sugiyama, Yui; Saeki, Tatsuya; Lim, Tae-Kyu; Harada, Manabu; Matsunaga, Tadashi; Yoshino, Tomoko; Tanaka, Tsuyoshi			Colony fingerprint for discrimination of microbial species based on lensless imaging of microcolonies	PLOS ONE			English	Article							BACTERIAL IDENTIFICATION; PSEUDOMONAS-AERUGINOSA; SCATTERING; MOTILITY; SENSOR	Detection and identification of microbial species are crucial in a wide range of industries, including production of beverages, foods, cosmetics, and pharmaceuticals. Traditionally, colony formation and its morphological analysis (e.g., size, shape, and color) with a naked eye have been employed for this purpose. However, such a conventional method is time consuming, labor intensive, and not very reproducible. To overcome these problems, we propose a novel method that detects microcolonies (diameter 10-500 mu m) using a lensless imaging system. When comparing colony images of five microorganisms from different genera (Escherichia coli, Salmonella enterica, Pseudomonas aeruginosa, Staphylococcus aureus, and Candida albicans), the images showed obvious different features. Being closely related species, St. aureus and St. epidermidis resembled each other, but the imaging analysis could extract substantial information (colony fingerprints) including the morphological and physiological features, and linear discriminant analysis of the colony fingerprints distinguished these two species with 100% of accuracy. Because this system may offer many advantages such as high-throughput testing, lower costs, more compact equipment, and ease of automation, it holds promise for microbial detection and identification in various academic and industrial areas.	[Maeda, Yoshiaki; Dobashi, Hironori; Sugiyama, Yui; Saeki, Tatsuya; Matsunaga, Tadashi; Yoshino, Tomoko; Tanaka, Tsuyoshi] Tokyo Univ Agr & Technol, Inst Engn, Div Biotechnol & Life Sci, Tokyo, Japan; [Lim, Tae-Kyu; Harada, Manabu] Malcom Co Ltd, Tokyo, Japan	Tokyo University of Agriculture & Technology	Tanaka, T (corresponding author), Tokyo Univ Agr & Technol, Inst Engn, Div Biotechnol & Life Sci, Tokyo, Japan.	tsuyo@cc.tuat.ac.jp	Maeda, Yoshiaki/H-9910-2013; Yoshino, Tomoko/E-9066-2013; Tanaka, Tsuyoshi/B-9949-2013; Matsunaga, Tadashi/A-6293-2015	Maeda, Yoshiaki/0000-0001-9206-2601; Yoshino, Tomoko/0000-0002-4505-2774; Tanaka, Tsuyoshi/0000-0003-2601-2256; Matsunaga, Tadashi/0000-0002-6216-3687	Core Research for Evolutional Science and Technology (CREST) [14532049]; Japan Science and Technology Agency (JST); CREST; JST	Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); CREST(Core Research for Evolutional Science and Technology (CREST)); JST(Japan Science & Technology Agency (JST))	This study is partially supported by Core Research for Evolutional Science and Technology (CREST, 14532049) from Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Malcom Co. Ltd provided support in the form of salaries for TL and MH but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; This study is partially supported by CREST, JST.	Bae E, 2011, BIOTECHNOL BIOENG, V108, P637, DOI 10.1002/bit.22980; Banada PP, 2007, BIOSENS BIOELECTRON, V22, P1664, DOI 10.1016/j.bios.2006.07.028; Banada PP, 2009, BIOSENS BIOELECTRON, V24, P1685, DOI 10.1016/j.bios.2008.08.053; EDINGER RC, 1985, J CLIN MICROBIOL, V22, P1063, DOI 10.1128/JCM.22.6.1063-1065.1985; Funke G, 1998, J CLIN MICROBIOL, V36, P1948, DOI 10.1128/JCM.36.7.1948-1952.1998; Huff K, 2012, MICROB BIOTECHNOL, V5, P607, DOI 10.1111/j.1751-7915.2012.00349.x; Ishii K, 2015, SCI REP-UK, V5, DOI 10.1038/srep17092; Javidi B, 2005, OPT EXPRESS, V13, P4492, DOI 10.1364/OPEX.13.004492; Jin G, 2012, BIOSENS BIOELECTRON, V38, P126, DOI 10.1016/j.bios.2012.05.022; Jo Y, 2015, OPT EXPRESS, V23, P15792, DOI 10.1364/OE.23.015792; Jung JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep21473; Kawamura Y, 1998, J CLIN MICROBIOL, V36, P2038, DOI 10.1128/JCM.36.7.2038-2042.1998; KLINGLER JM, 1992, APPL ENVIRON MICROB, V58, P2089, DOI 10.1128/AEM.58.6.2089-2092.1992; Matsuo M, 2015, ANTIMICROB AGENTS CH, V59, P4215, DOI 10.1128/AAC.00135-15; Murray TS, 2008, J BACTERIOL, V190, P2700, DOI 10.1128/JB.01620-07; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ozcan A, 2008, LAB CHIP, V8, P98, DOI 10.1039/b713695a; Pushkarsky I, 2014, SCI REP-UK, V4, DOI 10.1038/srep04717; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Roy M, 2016, DIAGNOSTICS, V6; Roy M, 2015, BIOSENS BIOELECTRON, V67, P715, DOI 10.1016/j.bios.2014.10.040; Saeki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089011; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Su PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048098; Su TW, 2012, P NATL ACAD SCI USA, V109, P16018, DOI 10.1073/pnas.1212506109; Su TW, 2009, BIOTECHNOL BIOENG, V102, P856, DOI 10.1002/bit.22116; Tanaka T, 2010, BIOSENS BIOELECTRON, V26, P1460, DOI 10.1016/j.bios.2010.07.081; Tang YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088267; Vercruysse D, 2015, LAB CHIP, V15, P1123, DOI 10.1039/c4lc01131g; Welker M, 2011, SYST APPL MICROBIOL, V34, P2, DOI 10.1016/j.syapm.2010.11.013; Wilson BK, 2013, BIOMED OPT EXPRESS, V4, P1692, DOI 10.1364/BOE.4.001692; Zhang SP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000564; Zheng GA, 2011, P NATL ACAD SCI USA, V108, P16889, DOI 10.1073/pnas.1110681108	33	11	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174723	10.1371/journal.pone.0174723	http://dx.doi.org/10.1371/journal.pone.0174723			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369067	Green Submitted, Green Published, gold			2022-12-26	WOS:000399351000037
J	Singh, N; Albert, FW; Plyusnina, I; Trut, L; Paabo, S; Harvati, K				Singh, Nandini; Albert, Frank W.; Plyusnina, Irina; Trut, Lyudmila; Paabo, Svante; Harvati, Katerina			Facial shape differences between rats selected for tame and aggressive behaviors	PLOS ONE			English	Article							VULPES-FULVUS-DESM; SONIC HEDGEHOG; UP-REGULATION; DOMESTICATION; EVOLUTION; FOX; GROWTH; EXPRESSION; MORPHOLOGY; RECEPTORS	Domestication has been consistently accompanied by a suite of traits called the domestication syndrome. These include increased docility, changes in coat coloration, prolonged juvenile behaviors, modified function of adrenal glands and reduced craniofacial dimensions. Wilkins et al recently proposed that the mechanistic factor underlying traits that encompass the domestication syndrome was altered neural crest cell (NCC) development. NCC form the precursors to a large number of tissue types including pigment cells, adrenal glands, teeth and the bones of the face. The hypothesis that deficits in NCC development can account for the domestication syndrome was partly based on the outcomes of Dmitri Belyaev's domestication experiments initially conducted on silver foxes. After generations of selecting for tameness, the foxes displayed phenotypes observed in domesticated species. Belyaev also had a colony of rats selected over 64 generations for either tameness or defensive aggression towards humans. Here we focus on the facial morphology of Belyaev's tame, 'domesticated' rats to test whether: 1) tameness in rats causes craniofacial changes similar to those observed in the foxes; 2) facial shape, i.e. NCC-derived region, is distinct in the tame and aggressive rats. We used computed-tomography scans of rat skulls and land-mark-based geometric morphometrics to quantify and analyze the facial skeleton. We found facial shape differences between the tame and aggressive rats that were independent of size and which mirrored changes seen in domesticated animals compared to their wild counterparts. However, there was no evidence of reduced sexual dimorphism in the face of the tame rats. This indicates that not all morphological changes in NCC-derived regions in the rats follow the pattern of shape change reported in domesticated animals or the silver foxes. Thus, certain phenotypic trends that are part of the domestication syndrome might not be consistently present in all experimental animal models.	[Singh, Nandini; Harvati, Katerina] Eberhard Karls Univ Tubingen, Paleoanthropol, Senckenberg Ctr Human Evolut & Paleoenvironm, Tubingen, Germany; [Singh, Nandini] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Albert, Frank W.; Paabo, Svante] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Albert, Frank W.] Univ Minnesota, Coll Biol Sci, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Plyusnina, Irina; Trut, Lyudmila] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk, Russia; [Harvati, Katerina] Eberhard Karls Univ Tubingen, DFG Ctr Adv Studies Words Bones Genes Tools Track, Tubingen, Germany	Eberhard Karls University of Tubingen; Senckenberg Gesellschaft fur Naturforschung (SGN); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Max Planck Society; University of Minnesota System; University of Minnesota Twin Cities; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Eberhard Karls University of Tubingen	Singh, N (corresponding author), Eberhard Karls Univ Tubingen, Paleoanthropol, Senckenberg Ctr Human Evolut & Paleoenvironm, Tubingen, Germany.; Singh, N (corresponding author), Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA.	nus22@psu.edu	Harvati, Katerina/A-5197-2008	Albert, Frank/0000-0002-1380-8063	Max Planck Society (FWA); Deutsche Forschungsgemeinschaft [DFG-INST 37/706-1]	Max Planck Society (FWA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was funded by the Max Planck Society (FWA) and the Deutsche Forschungsgemeinschaft (DFG-INST 37/706-1 to KH).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Iris Trautmann and Wieland Binczik for scanning and reconstructing the rat skulls. This project was funded by the Max Planck Society (FWA) and the Deutsche Forschungsgemeinschaft (DFG-INST 37/706-1 to KH). We have read and understood PLOS ONE's policy on declaration of interests and declare no competing interests.	Afshan K, 2013, PAK J ZOOL, V45, P1035; Albert FW, 2008, HORM BEHAV, V53, P413, DOI 10.1016/j.yhbeh.2007.11.010; Albert FW, 2009, GENETICS, V182, P541, DOI 10.1534/genetics.109.102186; BELYAEV DK, 1985, APPL ANIM BEHAV SCI, V13, P359, DOI 10.1016/0168-1591(85)90015-2; BELYAEV DK, 1969, SCI J, V5, P47; BENNETT JH, 1995, ARCH ORAL BIOL, V40, P847, DOI 10.1016/0003-9969(95)00047-S; Clutton-Brock Juliet, 1995, P7; Coppinger R., 2001, DOGSA STARTLING NEW; Darwin C, 1868, VARIATION PLANTS ANI; Drake AG, 2011, EVOL DEV, V13, P204, DOI 10.1111/j.1525-142X.2011.00470.x; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Duckworth RA, 2009, EVOL ECOL, V23, P513, DOI 10.1007/s10682-008-9252-6; Fopplano S, 2007, DEV BIOL, V312, P103, DOI 10.1016/j.ydbio.2007.09.016; FRANCISWEST PH, 1994, DEV DYNAM, V201, P168, DOI 10.1002/aja.1002010207; Hare B, 2005, CURR BIOL, V15, P226, DOI 10.1016/j.cub.2005.01.040; Hare B, 2012, ANIM BEHAV, V83, P573, DOI 10.1016/j.anbehav.2011.12.007; Jiang XB, 2002, MECH DEVELOP, V117, P115, DOI 10.1016/S0925-4773(02)00206-X; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Konoshenko MY, 2013, BEHAV BRAIN RES, V237, P103, DOI 10.1016/j.bbr.2012.09.022; Korte SM, 2001, NEUROSCI BIOBEHAV R, V25, P117, DOI 10.1016/S0149-7634(01)00002-1; LORD K, DOMEST DOG, V4, P42; Martinez-Abadias N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026425; Matthews SG, 2000, PEDIATR RES, V47, P291, DOI 10.1203/00006450-200003000-00003; McBratney-Owen B, 2008, DEV BIOL, V322, P121, DOI 10.1016/j.ydbio.2008.07.016; MOREY DF, 1994, AM SCI, V82, P336; Murrin LC, 2007, BIOCHEM PHARMACOL, V73, P1225, DOI 10.1016/j.bcp.2007.01.028; O'Regan HJ, 2005, MAMMAL REV, V35, P215, DOI 10.1111/j.1365-2907.2005.00070.x; Ornitz DM, 2001, GENOME BIOL, V2; Plyusnina I, 1997, PHYSIOL BEHAV, V61, P381, DOI 10.1016/S0031-9384(96)00445-3; Plyusnina IZ, 2011, BEHAV GENET, V41, P583, DOI 10.1007/s10519-010-9429-y; POPOVA NK, 1991, AGGRESSIVE BEHAV, V17, P207, DOI 10.1002/1098-2337(1991)17:4<207::AID-AB2480170403>3.0.CO;2-2; POPOVA NK, 1991, PHARMACOL BIOCHEM BE, V40, P751, DOI 10.1016/0091-3057(91)90080-L; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Sanchez-Villagra MR, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160107; Schneider RA, 2015, CURR TOP DEV BIOL, V115, P271, DOI 10.1016/bs.ctdb.2015.08.002; Singh N, 2016, DEV DYNAM, V245, P114, DOI [10.1002/DVDY.24361, 10.1002/dvdy.24361]; Singh N, 2015, DIS MODEL MECH, V8, P271, DOI 10.1242/dmm.017889; Slice DE, 2005, DEV PRIMATOL-PROG PR, P1, DOI 10.1007/0-387-27614-9_1; Tapadia MD, 2005, J ANAT, V207, P461, DOI 10.1111/j.1469-7580.2005.00484.x; Trut LN, 1999, AM SCI, V87, P160, DOI 10.1511/1999.20.813; Trut LN, 2004, RUSS J GENET+, V40, P644, DOI 10.1023/B:RUGE.0000033312.92773.c1; TRUT LN, 1991, GENETIKA+, V27, P1605; Trut L, 2009, BIOESSAYS, V31, P349, DOI 10.1002/bies.200800070; Trut N, 2000, CANID DOMESTICATION; Waller BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082686; Wayne R. K., 2001, The genetics of the dog, P43, DOI 10.1079/9780851995205.0043; WAYNE RK, 1986, EVOLUTION, V40, P243, DOI 10.1111/j.1558-5646.1986.tb00467.x; Wilkins AS, 2014, GENETICS, V197, P795, DOI 10.1534/genetics.114.165423; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007; Young NM, 2014, DEVELOPMENT, V141, P1059, DOI 10.1242/dev.099994; Young NM, 2010, DEVELOPMENT, V137, P3405, DOI 10.1242/dev.052340	51	18	18	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0175043	10.1371/journal.pone.0175043	http://dx.doi.org/10.1371/journal.pone.0175043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369080	Green Published, Green Submitted, gold			2022-12-26	WOS:000399351000069
J	Bhattacharyya, S; Bhakta, M; Munshi, NV				Bhattacharyya, Samadrita; Bhakta, Minoti; Munshi, Nikhil Vilas			Phenotypically silent Cre recombination within the postnatal ventricular conduction system	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; PURKINJE-FIBERS; EXPRESSION; CONTACTIN; MICE; TACHYCARDIA; HEART; TBX5; JUNCTIONS; AXONIN-1	The cardiac conduction system (CCS) is composed of specialized cardiomyocytes that initiate and maintain cardiac rhythm. Any perturbation to the normal sequence of electrical events within the heart can result in cardiac arrhythmias. To understand how cardiac rhythm is established at the molecular level, several genetically modified mouse lines expressing Cre recombinase within specific CCS compartments have been created. In general, Cre driver lines have been generated either by homologous recombination of Cre into an endogenous locus or Cre expression driven by a randomly inserted transgene. However, haploinsufficiency of the endogenous gene compromises the former approach, while position effects negatively impact the latter. To address these limitations, we generated a Cre driver line for the ventricular conduction system (VCS) that preserves endogenous gene expression by targeting the Contactin2 (Cntn2) 3' untranslated region (3'UTR). Here we show that cnin2(3'UTR-IRES-Cre-EGFP/+), mice recombine floxed alleles within the VCS and that Cre expression faithfully recapitulates the spatial distribution of Cntn2 within the heart. We further demonstrate that Cre expression initiates after birth with preservation of native Cntn2 protein. Finally, we show that Cntn2(3'UTR-IRES-Cre-EGFP/+), mice maintain normal cardiac mechanical and electrical function. Taken together, our results establish a novel VCS -specific Cre driver line without the adverse consequences of haploinsufficiency or position effects. We expect that our new mouse line will add to the accumulating toolkit of CCS-specific mouse reagents and aid characterization of the cell -autonomous molecular circuitry that drives VCS maintenance and function.	[Bhattacharyya, Samadrita; Bhakta, Minoti; Munshi, Nikhil Vilas] UT Southwestern Med Ctr, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA; [Munshi, Nikhil Vilas] UT Southwestern Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA; [Munshi, Nikhil Vilas] UT Southwestern Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Munshi, Nikhil Vilas] UT Southwestern Med Ctr, Ctr Regenerat Sci & Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Munshi, NV (corresponding author), UT Southwestern Med Ctr, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA.; Munshi, NV (corresponding author), UT Southwestern Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA.; Munshi, NV (corresponding author), UT Southwestern Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.; Munshi, NV (corresponding author), UT Southwestern Med Ctr, Ctr Regenerat Sci & Med, Dallas, TX 75390 USA.	nikhil.munshi@utsouthwestern.edu			National Heart, Lung, and Blood Institute [K08-HL094699]; Burroughs Wellcome Fund [1009838]; March of Dimes Foundation [5-FY14-203]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136604, K08HL094699] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); March of Dimes Foundation(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute (https://www.nhlbi.nih.gov/), K08-HL094699, NVM; Burroughs Wellcome Fund (http://www.bwfund.org/), 1009838, NVM; and March of Dimes Foundation (http://.www.marchofdimes.org/), 5-FY14-203, NVM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnolds DE, 2012, J CLIN INVEST, V122, P2509, DOI 10.1172/JCI62617; Arnolds DE, 2011, GENESIS, V49, P878, DOI 10.1002/dvg.20759; Arnolds DE, 2011, BIRTH DEFECTS RES A, V91, P578, DOI 10.1002/bdra.20800; Berglund EO, 1999, NEURON, V24, P739, DOI 10.1016/S0896-6273(00)81126-5; Beyer S, 2011, GENESIS, V49, P83, DOI 10.1002/dvg.20687; Bogun F, 2006, J AM COLL CARDIOL, V48, P2500, DOI 10.1016/j.jacc.2006.07.062; Boyle MET, 2001, NEURON, V30, P385, DOI 10.1016/S0896-6273(01)00296-3; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Hayashi M, 2006, HEART RHYTHM, V3, P908, DOI 10.1016/j.hrthm.2006.04.019; Hoesl E, 2008, J MOL CELL CARDIOL, V45, P62, DOI 10.1016/j.yjmcc.2008.04.008; Kang GX, 2010, CIRC RES, V107, P512, DOI 10.1161/CIRCRESAHA.110.221481; KOZLOV SV, 1995, GENOMICS, V30, P141, DOI 10.1006/geno.1995.9892; Liang XQ, 2013, CIRC RES, V113, P399, DOI 10.1161/CIRCRESAHA.113.301588; Lin JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052376; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Morishima I, 2008, J INTERV CARD ELECTR, V22, P233, DOI 10.1007/s10840-008-9268-4; Moskowitz IPG, 2004, DEVELOPMENT, V131, P4107, DOI 10.1242/dev.01265; Moskowitz IPG, 2007, CELL, V129, P1365, DOI 10.1016/j.cell.2007.04.036; Munshi NV, 2012, CIRC RES, V110, P1525, DOI 10.1161/CIRCRESAHA.111.260026; Pallante BA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P186, DOI 10.1161/CIRCEP.109.928820; Park DS, 2011, CIRCULATION, V123, P904, DOI 10.1161/CIRCULATIONAHA.110.942284; RANSCHT B, 1988, J CELL BIOL, V107, P1561, DOI 10.1083/jcb.107.4.1561; Rios JC, 2000, J NEUROSCI, V20, P8354, DOI 10.1523/JNEUROSCI.20-22-08354.2000; Rubart M, 2005, J CLIN INVEST, V115, P2305, DOI 10.1172/JCI26381; RUEGG MA, 1989, EMBO J, V8, P55, DOI 10.1002/j.1460-2075.1989.tb03348.x; Shekhar A, 2016, J CLIN INVEST, V126, P4444, DOI 10.1172/JCI87968; Spaeter D, 2013, NAT CELL BIOL, V15, P1098, DOI 10.1038/ncb2824; Sun C, 2013, GENESIS, V51, P515, DOI 10.1002/dvg.22397; van Weerd JH, 2016, DEVELOPMENT, V143, P197, DOI 10.1242/dev.124883; Wu M, 2014, GENESIS, V52, P134, DOI 10.1002/dvg.22730; ZUELLIG RA, 1992, EUR J BIOCHEM, V204, P453, DOI 10.1111/j.1432-1033.1992.tb16655.x	31	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174517	10.1371/journal.pone.0174517	http://dx.doi.org/10.1371/journal.pone.0174517			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358866	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174800048
J	Dezest, M; Bulteau, AL; Quinton, D; Chavatte, L; Le Bechec, M; Cambus, JP; Arbault, S; Negre-Salvayre, A; Clement, F; Cousty, S				Dezest, Marlene; Bulteau, Anne-Laure; Quinton, Damien; Chavatte, Laurent; Le Bechec, Mickael; Cambus, Jean Pierre; Arbault, Stephane; Negre-Salvayre, Anne; Clement, Franck; Cousty, Sarah			Oxidative modification and electrochemical inactivation of Escherichia coli upon cold atmospheric pressure plasma exposure	PLOS ONE			English	Article							PEROXYNITRITE DECOMPOSITION; NONCULTURABLE STATE; DRINKING-WATER; BACTERIA; MICROORGANISMS; DISCHARGE; STERILIZATION; ENVIRONMENT; RESPONSES; IMPACT	Cold atmospheric pressure plasmas (CAPPs) are known to have bactericidal effects but the mechanism of their interaction with microorganisms remains poorly understood. In this study the bacteria Escherichia coli were used as a model and were exposed to CAPPs. Different gas compositions, helium with or without adjunctions of nitrogen or oxygen, were used. Our results indicated that CAPP induced bacterial death at decontamination levels depend on the duration, post-treatment storage and the gas mixture composition used for the treatment. The plasma containing O-2 in the feeding gas was the most aggressive and showed faster bactericidal effects. Structural modifications of treated bacteria were observed, especially significant was membrane leakage and morphological changes. Oxidative stress caused by plasma treatment led to significant damage of E. coli. Biochemical analyses of bacterial macromolecules indicated massive intracellular protein oxidation. However, reactive oxygen and nitrogen species (RONS) are not the only actors involved in E. coli's death, electrical field and charged particles could play a significant role especially for He-O-2 CAPP.	[Dezest, Marlene; Bulteau, Anne-Laure; Chavatte, Laurent; Le Bechec, Mickael; Clement, Franck] Univ Pau & Pays Adour, UMR 5254, IPREM, Pau, France; [Quinton, Damien; Arbault, Stephane] Univ Bordeaux, NSysA Grp, ENSCBP, CNRS,UMR 5255,ISM, Pessac, France; [Cambus, Jean Pierre; Negre-Salvayre, Anne] Univ Paul Sabatier, INSERM, UMR 1048, I2MC, Toulouse, France; [Cousty, Sarah] Univ Paul Sabatier, Ctr Hosp Univ Toulouse, Fac Chirurg Dent Toulouse, Toulouse, France; [Bulteau, Anne-Laure] CNRS, UMR5242, IGFL, Ecole Normale Super ENS Lyon, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Pau et des Pays de l'Adour; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON)	Bulteau, AL (corresponding author), Univ Pau & Pays Adour, UMR 5254, IPREM, Pau, France.; Bulteau, AL (corresponding author), CNRS, UMR5242, IGFL, Ecole Normale Super ENS Lyon, Lyon, France.	anne-laure.bulteau@univ-pau.fr	Cousty, Sarah/AGZ-6395-2022; LE+BECHEC, Mickael/ABA-8124-2020; bulteau, anne-laure/AAN-4004-2020	Cousty, Sarah/0000-0003-4077-2796; LE+BECHEC, Mickael/0000-0002-9154-7559; Chavatte, Laurent/0000-0001-7696-2431; Negre-Salvayre, Anne/0000-0003-2136-5706; ARBAULT, Stephane/0000-0002-4994-2213; bulteau, anne-laure/0000-0002-3315-5100	French ANR program through the grant "PLASMAVIV" [ANR2010BLAN095001]; French Ministere de l'Education Nationale de la Recherche et de Technologie (MENRT); conseil regional d'Aquitaine	French ANR program through the grant "PLASMAVIV"(French National Research Agency (ANR)); French Ministere de l'Education Nationale de la Recherche et de Technologie (MENRT); conseil regional d'Aquitaine(Region Nouvelle-Aquitaine)	The work was supported by the French ANR program through the grant "PLASMAVIV", ANR2010BLAN095001 (http://www.agence-nationale-recherche.fr/?Projet=ANR-10-BLAN-0950). The recipient of the grant was Sarah Cousty. Marlene Dezest is a recipient of a fellowship from French Ministere de l'Education Nationale de la Recherche et de Technologie (MENRT). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.r The work was supported by the french ANR program through the grant "PLASMAVIV", ANR2010BLAN095001. The recipient of the grant was SC. Marlene Dezest is a recipient of a fellowship from French Ministere de l'Education Nationale de la Recherche et de Technologie (MENRT). Our thanks to Rosie Cox for improving the English, to conseil regional d'Aquitaine for the funding of Aquitraces facility and to Trigenotoul facility in Toulouse for microscopy analysis.	Amatore C, 2006, CHEMBIOCHEM, V7, P653, DOI 10.1002/cbic.200500359; ARBAULT S, 1995, ANAL CHEM, V67, P3382, DOI 10.1021/ac00115a004; Arndt S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079325; Babaeva NY, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/11/115203; Babaeva NY, 2010, J PHYS D, V43, P1; Borisov VB, 2015, BBA-BIOENERGETICS, V1847, P182, DOI 10.1016/j.bbabio.2014.10.006; Boudam MK, 2006, J PHYS D APPL PHYS, V39, P3494, DOI 10.1088/0022-3727/39/16/S07; Bourdon A, 2016, PLASMA SOURCES SCI T, V25, DOI 10.1088/0963-0252/25/3/035002; Boxhammer V, 2013, MUTAT RES-GEN TOX EN, V753, P23, DOI 10.1016/j.mrgentox.2012.12.015; BYRD JJ, 1991, APPL ENVIRON MICROB, V57, P875, DOI 10.1128/AEM.57.3.875-878.1991; Colwell RR, 1996, WORLD J MICROB BIOT, V12, P28, DOI 10.1007/BF00327795; Cooper M, 2010, J APPL MICROBIOL, V109, P2039, DOI 10.1111/j.1365-2672.2010.04834.x; Daeschlein G, 2010, PLASMA PROCESS POLYM, V7, P224, DOI 10.1002/ppap.200900059; Deng SX, 2010, CURR APPL PHYS, V10, P1164, DOI 10.1016/j.cap.2010.02.004; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; Dolezalova E, 2015, BIOELECTROCHEMISTRY, V103, P7, DOI 10.1016/j.bioelechem.2014.08.018; Ehlbeck J, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/1/013002; Emmert S, 2013, CLIN PLASMA MED, V1, P24, DOI 10.1016/j.cpme.2012.11.002; Fernandez A, 2012, FOOD RES INT, V45, P678, DOI 10.1016/j.foodres.2011.04.009; Fricke K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042539; Frohling A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00939; Gaunt LF, 2006, IEEE T PLASMA SCI, V34, P1257, DOI 10.1109/TPS.2006.878381; Gazeli K, 2015, J APPL PHYS, V117, DOI 10.1063/1.4914035; Gazeli K, 2013, J APPL PHYS, V114, DOI 10.1063/1.4820570; Gazeli K, 2013, PLASMA SOURCES SCI T, V22, DOI 10.1088/0963-0252/22/2/025020; Guionet A, 2015, BIOELECTROCHEMISTRY, V103, P65, DOI 10.1016/j.bioelechem.2014.08.021; Han L, 2016, APPL ENVIRON MICROB, V82, P450, DOI 10.1128/AEM.02660-15; Hensel K, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4919559; Ikawa S, 2010, PLASMA PROCESS POLYM, V7, P33, DOI 10.1002/ppap.200900090; Joshi SG, 2011, ANTIMICROB AGENTS CH, V55, P1053, DOI 10.1128/AAC.01002-10; Josset S, 2008, CHEM SOC REV, V37, P744, DOI 10.1039/b711748p; Julak J, 2012, PHYS MEDICA, V28, P230, DOI 10.1016/j.ejmp.2011.08.001; Klampfl TG, 2012, APPL ENVIRON MICROB, V78, P5077, DOI 10.1128/AEM.00583-12; Korachi M, 2010, J ELECTROSTAT, V68, P508, DOI 10.1016/j.elstat.2010.06.014; Lackmann JW, 2014, APPL MICROBIOL BIOT, V98, P6205, DOI 10.1007/s00253-014-5781-9; Laroussi M, 2005, PLASMA PROCESS POLYM, V2, P391, DOI 10.1002/ppap.200400078; Laroussi M, 2004, INT J MASS SPECTROM, V233, P81, DOI 10.1016/j.ijms.2003.11.016; Liu FX, 2010, PLASMA PROCESS POLYM, V7, P231, DOI 10.1002/ppap.200900070; Maheux S, 2015, RSC ADV, V5, P42135, DOI 10.1039/c5ra01109d; Mai-Prochnow A, 2014, INT J ANTIMICROB AG, V43, P508, DOI 10.1016/j.ijantimicag.2014.01.025; MATSUNAGA T, 1992, APPL ENVIRON MICROB, V58, P686, DOI 10.1128/AEM.58.2.686-689.1992; Negre-Salvayre A, 2010, FREE RADICAL RES, V44, P1125, DOI 10.3109/10715762.2010.498478; O'Connor N, 2014, J HOSP INFECT, V88, P59, DOI 10.1016/j.jhin.2014.06.015; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Pournaseh Y, 2014, BASIS RES J MED CLIN, V4; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Robert E., 2015, PHYS PLASMAS, V22; Sharma A, 2009, J APPL MICROBIOL, V107, P1440, DOI 10.1111/j.1365-2672.2009.04323.x; Slosky LM, 2015, EXPERT OPIN THER PAT, V25, P443, DOI 10.1517/13543776.2014.1000862; Stoffels E, 2006, PLASMA SOURCES SCI T, V15, pS169, DOI 10.1088/0963-0252/15/4/S03; Uhm HS, 2011, THIN SOLID FILMS, V519, P6974, DOI 10.1016/j.tsf.2011.01.208; Virard F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133120; von Woedtke T, 2013, PHYS REP, V530, P291, DOI 10.1016/j.physrep.2013.05.005; Weber D, 2015, REDOX BIOL, V5, P367, DOI 10.1016/j.redox.2015.06.005; Wende K, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4919710; Winter T, 2011, PROTEOMICS, V11, P3518, DOI 10.1002/pmic.201000637; Yamamoto M, 2009, ADV EXP MED BIOL, V667, P59, DOI 10.1007/978-1-4419-1603-7_6; Zerrouki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116083; Zimmermann JL, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/50/505201; Ziuzina D, 2013, J APPL MICROBIOL, V114, P778, DOI 10.1111/jam.12087	60	31	32	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0173618	10.1371/journal.pone.0173618	http://dx.doi.org/10.1371/journal.pone.0173618			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358809	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174800006
J	Sim, CK; Kim, SY; Brunmeir, R; Zhang, QY; Li, HY; Dharmasegaran, D; Leong, C; Lim, YY; Han, WP; Xu, F				Simi, Choon Kiat; Kim, Sun-Yee; Brunmeir, Reinhard; Zhang, Qiongyi; Li, Hongyu; Dharmasegaran, Dharmini; Leong, Carol; Lim, Ying Yan; Han, Weiping; Xu, Feng			Regulation of white and brown adipocyte differentiation by RhoGAP DLC1	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; PPAR-GAMMA; TRANSCRIPTION FACTOR; ACTIN CYTOSKELETON; TUMOR-SUPPRESSOR; BEIGE ADIPOCYTES; SUPER-ENHANCERS; ADIPOSE-TISSUE; RECEPTOR-GAMMA; CELL IDENTITY	Adipose tissues constitute an important component of metabolism, the dysfunction of which can cause obesity and type II diabetes. Here we show that differentiation of white and brown adipocytes requires Deleted in Liver Cancer 1 (DLC1), a Rho GTPase Activating Protein (RhoGAP) previously studied for its function in liver cancer. We identified DIcl as a super enhancer associated gene in both white and brown adipocytes through analyzing the genome-wide binding profiles of PPAR gamma, the master regulator of adipogenesis. We further observed that DIcl expression increases during differentiation, and knockdown of DIcl by siRNA in white adipocytes reduces the formation of lipid droplets and the expression of fat marker genes. Moreover, knockdown of DIcl in brown adipocytes reduces expression of brown fat-specific genes and diminishes mitochondrial respiration. DIc1(-/-)knockout mouse embryonic fibroblasts show a complete inability to differentiate into adipocytes, but this phenotype can be rescued by inhibitors of Rho-associated kinase (ROCK) and filamentous actin (F-actin), suggesting the involvement of Rho pathway in DLC1-regulated adipocyte differentiation. Furthermore, PPAR gamma binds to the promoter of DIcl gene to regulate its expression during both white and brown adipocyte differentiation. These results identify DLC1 as an activator of white and brown adipocyte differentiation, and provide a molecular link between PPAR gamma and Rho pathways.	[Simi, Choon Kiat; Kim, Sun-Yee; Brunmeir, Reinhard; Zhang, Qiongyi; Dharmasegaran, Dharmini; Leong, Carol; Lim, Ying Yan; Xu, Feng] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Kim, Sun-Yee; Li, Hongyu; Han, Weiping] ASTAR, Lab Metab Med, Singapore Bioimaging Consortium, Singapore, Singapore; [Han, Weiping; Xu, Feng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Simi, Choon Kiat] NHGRI, NIH, Bethesda, MD 20892 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); National University of Singapore; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Xu, F (corresponding author), ASTAR, Singapore Inst Clin Sci, Singapore, Singapore.; Xu, F (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.	xu_feng@sics.a-star.edu.sg	; Sim, Choon Kiat/B-1820-2014	Brunmeir, Reinhard/0000-0001-7545-2819; Sim, Choon Kiat/0000-0002-7871-2134; KIM, Sun-Yee/0000-0002-8061-2271; Xu, Feng/0000-0003-2016-7521	Agency for Science, Technology and Research (A*STAR) of Singapore; A*STAR of Singapore	Agency for Science, Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); A*STAR of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the intramural funding from the Agency for Science, Technology and Research (A*STAR) of Singapore to FX. Funding for the open-access charge was provided by A*STAR of Singapore. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Bren-Mattison Y, 2005, ONCOGENE, V24, P1412, DOI 10.1038/sj.onc.1208333; Brunmeir R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006474; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Clark BJ, 2012, J ENDOCRINOL, V212, P257, DOI 10.1530/JOE-11-0313; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Durkin ME, 2005, FEBS LETT, V579, P1191, DOI 10.1016/j.febslet.2004.12.090; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Esnault C, 2014, GENE DEV, V28, P943, DOI 10.1101/gad.239327.114; Gao M, 2014, CHEM COMMUN, V50, P8312, DOI 10.1039/c4cc00452c; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Haas B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000511; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; HUNT CR, 1986, P NATL ACAD SCI USA, V83, P3786, DOI 10.1073/pnas.83.11.3786; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Janani C, 2015, DIABETES METAB SYND, V9, P46, DOI 10.1016/j.dsx.2014.09.015; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Katoh K, 2007, GENES CELLS, V12, P623, DOI 10.1111/j.1365-2443.2007.01073.x; Kim SY, 2016, ARCH BIOCHEM BIOPHYS, V598, P1, DOI 10.1016/j.abb.2016.03.025; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Koppen A, 2010, FEBS LETT, V584, P3250, DOI 10.1016/j.febslet.2010.06.035; Liao XH, 2011, IUBMB LIFE, V63, P54, DOI 10.1002/iub.415; Lim GE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8671; Loft A, 2015, GENE DEV, V29, P7, DOI 10.1101/gad.250829.114; Long JZ, 2014, CELL METAB, V19, P810, DOI 10.1016/j.cmet.2014.03.025; Lukasik D, 2011, ONCOL LETT, V2, P763, DOI 10.3892/ol.2011.345; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McDonald ME, 2015, CELL, V160, P105, DOI 10.1016/j.cell.2014.12.005; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Nobusue H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4368; Noguchi M, 2007, J BIOL CHEM, V282, P29574, DOI 10.1074/jbc.M705972200; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Rajakumari S, 2013, CELL METAB, V17, P562, DOI 10.1016/j.cmet.2013.01.015; Sabbir MG, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-17; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Scholz RP, 2009, J CELL SCI, V122, P92, DOI 10.1242/jcs.036251; Sim CK, 2012, GENE DEV, V26, P2483, DOI 10.1101/gad.201665.112; Singla P, 2010, WORLD J DIABETES, V1, P76, DOI 10.4239/wjd.v1.i3.76; Sit ST, 2011, J CELL SCI, V124, P679, DOI 10.1242/jcs.064964; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; Strachan LR, 2003, DEV BIOL, V259, P288, DOI 10.1016/S0012-1606(03)00187-8; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; van Beekum O, 2008, ENDOCRINOLOGY, V149, P1840, DOI 10.1210/en.2007-0977; Westerberg R, 2006, J BIOL CHEM, V281, P4958, DOI 10.1074/jbc.M511588200; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Yamaga M, 2004, GENES CELLS, V9, P25, DOI 10.1111/j.1356-9597.2004.00698.x; Yau TO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006566; Zhang QY, 2012, CELL CYCLE, V11, P4310, DOI 10.4161/cc.22224; Zhong D, 2009, J CELL SCI, V122, P414, DOI 10.1242/jcs.027482; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	58	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174761	10.1371/journal.pone.0174761	http://dx.doi.org/10.1371/journal.pone.0174761			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358928	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174800084
J	Teng, XY; Dong, HB; Zhou, XR				Teng, Xuyang; Dong, Hongbin; Zhou, Xiurong			Adaptive feature selection using v-shaped binary particle swarm optimization	PLOS ONE			English	Article							ALGORITHM	Feature selection is an important preprocessing method in machine learning and data mining. This process can be used not only to reduce the amount of data to be analyzed but also to build models with stronger interpretability based on fewer features. Traditional feature selection methods evaluate the dependency and redundancy of features separately, which leads to a lack of measurement of their combined effect. Moreover, a greedy search considers only the optimization of the current round and thus cannot be a global search. To evaluate the combined effect of different subsets in the entire feature space, an adaptive feature selection method based on V-shaped binary particle swarm optimization is proposed. In this method, the fitness function is constructed using the correlation information entropy. Feature subsets are regarded as individuals in a population, and the feature space is searched using V-shaped binary particle swarm optimization. The above procedure overcomes the hard constraint on the number of features, enables the combined evaluation of each subset as a whole, and improves the search ability of conventional binary particle swarm optimization. The proposed algorithm is an adaptive method with respect to the number of feature subsets. The experimental results show the advantages of optimizing the feature subsets using the V-shaped transfer function and confirm the effectiveness and efficiency of the feature subsets obtained under different classifiers.	[Teng, Xuyang; Dong, Hongbin] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Zhou, Xiurong] Heilongjiang Prov Corps Hosp Chinese Peoples Arme, Internal Med, Harbin, Heilongjiang, Peoples R China	Harbin Engineering University	Dong, HB (corresponding author), Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China.	donghongbin@hrbeu.edu.cn						Alhaj TA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166017; [Anonymous], 1999, CORRELATION BASED FE; BATTITI R, 1994, IEEE T NEURAL NETWOR, V5, P537, DOI 10.1109/72.298224; Bennasar M, 2015, EXPERT SYST APPL, V42, P8520, DOI 10.1016/j.eswa.2015.07.007; Chuang LY, 2011, EXPERT SYST APPL, V38, P13367, DOI 10.1016/j.eswa.2011.04.165; Chuang LY, 2011, APPL SOFT COMPUT, V11, P239, DOI 10.1016/j.asoc.2009.11.014; Demsar J, 2006, J MACH LEARN RES, V7, P1; [董红斌 Dong Hongbin], 2016, [计算机研究与发展, Journal of Computer Research and Development], V53, P1684; Dong HB, 2015, IEEE C EVOL COMPUTAT, P672, DOI 10.1109/CEC.2015.7256955; Du WB, 2015, APPL MATH COMPUT, V268, P832, DOI 10.1016/j.amc.2015.06.062; Eberhart R., 1995, P 6 INT S MICR MACH, P39; Eesa AS, 2015, TURK J ELECTR ENG CO, V23, P615, DOI 10.3906/elk-1302-53; Eesa AS, 2015, EXPERT SYST APPL, V42, P2670, DOI 10.1016/j.eswa.2014.11.009; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Hu QH, 2010, NEUROCOMPUTING, V73, P2114, DOI 10.1016/j.neucom.2010.02.007; Kennedy J, 1997, IEEE SYS MAN CYBERN, P4104, DOI 10.1109/ICSMC.1997.637339; Liu JH, 2016, IEEE T EVOLUT COMPUT, V20, P666, DOI 10.1109/TEVC.2015.2503422; Liu Y, 2015, IEEE T CYBERNETICS, V45, P1209, DOI 10.1109/TCYB.2014.2347372; Meng JN, 2011, COMPUT MATH APPL, V62, P2793, DOI 10.1016/j.camwa.2011.07.045; Mirjalili S, 2013, SWARM EVOL COMPUT, V9, P1, DOI 10.1016/j.swevo.2012.09.002; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Soufan O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117988; Sun X, 2012, NEUROCOMPUTING, V97, P86, DOI 10.1016/j.neucom.2012.05.001; Sun X, 2012, PATTERN RECOGN, V45, P2992, DOI 10.1016/j.patcog.2012.02.001; Tang J, 2012, P 18 ACM SIGKDD INT, P904, DOI DOI 10.1145/2339530.2339673; Wang Q, 2004, IEEE T INSTRUM MEAS, V53, P1441, DOI 10.1109/TIM.2004.834094; Wang XY, 2007, PATTERN RECOGN LETT, V28, P459, DOI 10.1016/j.patrec.2006.09.003; Wang ZC, 2015, INFORM SCIENCES, V307, P73, DOI 10.1016/j.ins.2015.02.031; Yu L, 2004, J MACH LEARN RES, V5, P1205; Zhang Y, 2015, NEUROCOMPUTING, V148, P150, DOI 10.1016/j.neucom.2012.09.049; Zhao Z, 2010, TR10007 AL STAT U SC; Xuan Z, 2017, PATTERN RECOGN, V63, P56, DOI 10.1016/j.patcog.2016.09.007; Zhou Zhihua, 2016, MACH LEARN, P247	35	20	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0173907	10.1371/journal.pone.0173907	http://dx.doi.org/10.1371/journal.pone.0173907			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358850	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174800014
J	Yael, D; Bar-Gad, I				Yael, Dorin; Bar-Gad, Izhar			Filter based phase distortions in extracellular spikes	PLOS ONE			English	Article							WAVE-FORM; CHOLINERGIC INTERNEURONS; STRIATAL NEURONS; FIELD POTENTIALS; SUBTYPES; ORIGIN; SHAPE	Extracellular recordings are the primary tool for extracting neuronal spike trains in-vivo. One of the crucial pre-processing stages of this signal is the high-pass filtration used to isolate neuronal spiking activity. Filters are characterized by changes in the magnitude and phase of different frequencies. While filters are typically chosen for their effect on magnitudes, little attention has been paid to the impact of these filters on the phase of each frequency. In this study we show that in the case of nonlinear phase shifts generated by most online and offline filters, the signal is severely distorted, resulting in an alteration of the spike waveform. This distortion leads to a shape that deviates from the original waveform as a function of its constituent frequencies, and a dramatic reduction in the SNR of the waveform that disrupts spike detectability. Currently, the vast majority of articles utilizing extracellular data are subject to these distortions since most commercial and academic hardware and software utilize nonlinear phase filters. We show that this severe problem can be avoided by recording wide -band signals followed by zero phase filtering, or alternatively corrected by reversed filtering of a narrow -band filtered, and in some cases even segmented signals. Implementation of either zero phase filtering or phase correction of the nonlinear phase filtering reproduces the original spike waveforms and increases the spike detection rates while reducing the number of false negative and positive errors. This process, in turn, helps eliminate subsequent errors in downstream analyses and misinterpretations of the results.	[Yael, Dorin; Bar-Gad, Izhar] Bar Ilan Univ, Leslie & Susan Goldschmied Gonda Multidisciplinar, Ramat Gan, Israel	Bar Ilan University	Bar-Gad, I (corresponding author), Bar Ilan Univ, Leslie & Susan Goldschmied Gonda Multidisciplinar, Ramat Gan, Israel.	izhar.bar-gad@biu.ac.il		Bar-Gad, Izhar/0000-0002-2999-4083	Israel Science Foundation (ISF) [743/13]; Legacy Heritage bio-medical program of the ISF [38/15]	Israel Science Foundation (ISF)(Israel Science Foundation); Legacy Heritage bio-medical program of the ISF	This study was supported in part by an Israel Science Foundation (ISF) grant (743/13) and a Legacy Heritage bio-medical program of the ISF (138/15) grant to IBG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acunzo DJ, 2012, J NEUROSCI METH, V209, P212, DOI 10.1016/j.jneumeth.2012.06.011; Anastassiou CA, 2015, J NEUROPHYSIOL, V114, P608, DOI 10.1152/jn.00628.2014; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Bedard C, 2004, BIOPHYS J, V86, P1829, DOI 10.1016/S0006-3495(04)74250-2; Bedard C, 2009, BIOPHYS J, V96, P2589, DOI 10.1016/j.bpj.2008.12.3951; Bennett BD, 1999, J NEUROSCI, V19, P5586; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Gage GJ, 2010, NEURON, V67, P466, DOI 10.1016/j.neuron.2010.06.034; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; Gur M, 1999, J NEUROPHYSIOL, V82, P1451, DOI 10.1152/jn.1999.82.3.1451; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Holmes JN, 1975, LOW FREQUENCY PHASE, V58; Jog MS, 2002, J NEUROSCI METH, V117, P141, DOI 10.1016/S0165-0270(02)00092-4; Kravitz AV, 2013, BRAIN RES, V1511, P21, DOI 10.1016/j.brainres.2012.11.018; Lemon RN, 1984, METHODS NEURONAL REC; Martinez J, 2009, J NEUROSCI METH, V184, P285, DOI 10.1016/j.jneumeth.2009.08.017; Mizuhiki T, 2012, NEUROSCI RES, V72, P214, DOI 10.1016/j.neures.2011.12.004; Moran A, 2010, J NEUROSCI METH, V186, P116, DOI 10.1016/j.jneumeth.2009.10.024; Moran A, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00021; Navajas J, 2014, J NEUROSCI METH, V230, P51, DOI 10.1016/j.jneumeth.2014.04.018; Nelson MJ, 2008, J NEUROSCI METH, V169, P141, DOI 10.1016/j.jneumeth.2007.12.010; Nelson MJ, 2010, J NEUROPHYSIOL, V103, P2315, DOI 10.1152/jn.00157.2010; Obeid I, 2004, J NEUROSCI METH, V133, P27, DOI 10.1016/j.jneumeth.2003.09.024; Oppenheim Alan V., 1999, DISCRETE TIME SIGNAL; Quiroga RQ, 2009, J NEUROSCI METH, V177, P194, DOI 10.1016/j.jneumeth.2008.09.033; Rueda-Orozcol PE, 2015, NAT NEUROSCI, V18, P453, DOI 10.1038/nn.3924; Sawan M, 2009, P 22 ANN S INT CIRC; Sharott A, 2009, J NEUROSCI, V29, P4571, DOI 10.1523/JNEUROSCI.5097-08.2009; Waldert S, 2013, J PHYSIOL-LONDON, V591, P5291, DOI 10.1113/jphysiol.2013.258228; Widmann A, 2015, J NEUROSCI METH, V250, P34, DOI 10.1016/j.jneumeth.2014.08.002; Widmann A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00233; Wiltschko AB, 2008, J NEUROSCI METH, V173, P34, DOI 10.1016/j.jneumeth.2008.05.016; Yael D., 2013, FRONT SYST NEUROSCI, V7, P1, DOI DOI 10.HTTPS://D0I.0RG/10.3389/FNSYS.2013.00110; Yarom O, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00036	37	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e017479	10.1371/journal.pone.0174790	http://dx.doi.org/10.1371/journal.pone.0174790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358895	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174800092
J	Hong, EP; Go, MJ; Kim, HL; Park, JW				Hong, Eun Pyo; Go, Min Jin; Kim, Hyung-Lae; Park, Ji Wan			Risk prediction of pulmonary tuberculosis using genetic and conventional risk factors in adult Korean population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ASIANS IDENTIFY; SUSCEPTIBILITY; VARIANTS; DISEASE; CANCER; ANCESTRY; TRAITS; LOCUS; HIV	A complex interplay among host, pathogen, and environmental factors is believed to contribute to the risk of developing pulmonary tuberculosis (PTB). The lack of replication of published genome-wide association study (GWAS) findings limits the clinical utility of reported single nucleotide polymorphisms (SNPs). We conducted a GWAS using 467 PTB cases and 1,313 healthy controls obtained from two community -based cohorts in Korea. We evaluated the performance of PTB risk models based on different combinations of genetic and nongenetic factors and validated the results in an independent Korean population comprised of 179 PTB cases and 500 healthy controls. We demonstrated the polygenic nature of PTB and nongenetic factors such as age, sex, and body mass index (BMI) were strongly associated with PTB risk. None of the SNPs achieved genome-wide significance; instead, we were able to replicate the associations between PTB and ten SNPs near or in the genes, CDCA7, GBE1, GADL1, SPATA16, C6orf118, KIAA1432, DMRT2, CTR9, CCDC67, and CDH13, which may play roles in the immune and inflammatory pathways. Among the replicated SNPs, an intergenic SNP, rs9365798, located downstream of the C6orf118 gene showed the most significant association under the dominant model (OR = 1.59, 95% CI 1.32-1.92, P= 2.1x10-6). The performance of a risk model combining the effects of ten replicated SNPs and six nongenetic factors (i.e., age, sex, BMI, cigarette smoking, systolic blood pressure, and hemoglobin) were validated in the replication set (AUC = 0.80, 95% CI 0.76-0.84). The strategy of combining genetic and nongenetic risk factors ultimately resulted in better risk prediction for PTB in the adult Korean population.	[Hong, Eun Pyo; Park, Ji Wan] Hallym Univ, Coll Med, Dept Med Genet, Chuncheon Si, Ganwon Do, South Korea; [Go, Min Jin] Natl Inst Hlth, Ctr Genome Sci, Cheongju, Chungcheongbuk, South Korea; [Kim, Hyung-Lae] Ewha Womans Univ, Sch Med, Dept Biochem, Seoul, South Korea	Hallym University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Ewha Womans University	Park, JW (corresponding author), Hallym Univ, Coll Med, Dept Med Genet, Chuncheon Si, Ganwon Do, South Korea.	jwpark@hallym.ac.kr		Park, Ji Wan/0000-0003-0840-1696	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2014R1A1A3053168]; Korea Healthy Industry Development Institute (KHIDI) of the Ministry of Health & Welfare, Republic of Korea [H114C0072]; Hallym University Research Fund, Republic of Korea [HRF-201403-015]	Basic Science Research Program of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Korea Healthy Industry Development Institute (KHIDI) of the Ministry of Health & Welfare, Republic of Korea; Hallym University Research Fund, Republic of Korea	This research was supported by the Basic Science Research Program of the National Research Foundation of Korea (NRF) funded by of the Ministry of Education, Science and Technology (2014R1A1A3053168), the Korea Healthy Industry Development Institute (KHIDI) of the Ministry of Health & Welfare (H114C0072), Republic of Korea (H114C0072), and Hallym University Research Fund, 2014 (HRF-201403-015), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel L, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0428; Abraham G, 2015, CURR OPIN GENET DEV, V33, P10, DOI 10.1016/j.gde.2015.06.005; Chatterjee N, 2016, NAT REV GENET, V17, P392, DOI 10.1038/nrg.2016.27; Chatterjee N, 2013, NAT GENET, V45, P400, DOI 10.1038/ng.2579; Chimusa ER, 2014, HUM MOL GENET, V23, P796, DOI 10.1093/hmg/ddt462; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Curtis J, 2015, NAT GENET, V47, P523, DOI 10.1038/ng.3248; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Hou J, 2012, J THORAC ONCOL, V7, P105, DOI 10.1097/JTO.0b013e3182352a45; Iwakawa R, 2013, GENE CHROMOSOME CANC, V52, P802, DOI 10.1002/gcc.22076; Kee MK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-831; Kim YJ, 2011, NAT GENET, V43, P990, DOI 10.1038/ng.939; Korean Center for Disease Control and Prevention, 2004, ANN REP NOT TUB PAT; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Leung CC, 2007, ARCH INTERN MED, V167, P1297, DOI 10.1001/archinte.167.12.1297; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Mabuchi F, 2011, INVEST OPHTH VIS SCI, V52, P4626, DOI 10.1167/iovs.11-7382; Mahasirimongkol S, 2012, J HUM GENET, V57, P363, DOI 10.1038/jhg.2012.35; Moller M, 2010, FEMS IMMUNOL MED MIC, V58, P3, DOI 10.1111/j.1574-695X.2009.00600.x; Murray M, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P64, DOI 10.5588/ijtld.10.0535; Naggara O, 2011, AM J NEURORADIOL, V32, P437, DOI 10.3174/ajnr.A2425; Oliver PL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002338; Oni T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0750-1; Park SJ, 2012, CARCINOGENESIS, V33, P1494, DOI 10.1093/carcin/bgs178; Pavlou M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3868; Png E, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-5; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sveinbjornsson G, 2016, NAT GENET, V48, P318, DOI 10.1038/ng.3498; Teng MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122664; Thye T, 2012, NAT GENET, V44, P257, DOI 10.1038/ng.1080; Thye T, 2010, NAT GENET, V42, P739, DOI 10.1038/ng.639; Watanabe T, 2005, CANCER SCI, V96, P498, DOI 10.1111/j.1349-7006.2005.00073.x; Yau C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2753; Yim JJ, 2010, RESPIROLOGY, V15, P241, DOI 10.1111/j.1440-1843.2009.01690.x; Yuan YM, 2016, ACTA PHARMACOL SIN, V37, P390, DOI 10.1038/aps.2015.158; Zak DE, 2016, LANCET, V387, P2312, DOI 10.1016/S0140-6736(15)01316-1; Zhuang BQ, 2009, NEURON, V61, P359, DOI 10.1016/j.neuron.2008.12.022; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	38	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174642	10.1371/journal.pone.0174642	http://dx.doi.org/10.1371/journal.pone.0174642			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355295	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174600074
J	Iwase, T; Kobayashi, M; Yamamoto, K; Ra, E; Terasaki, H				Iwase, Takeshi; Kobayashi, Misato; Yamamoto, Kentaro; Ra, Eimei; Terasaki, Hiroko			Effects of photocoagulation on ocular blood flow in patients with severe non-proliferative diabetic retinopathy	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; LASER SPECKLE FLOWGRAPHY; PANRETINAL PHOTOCOAGULATION; NERVE HEAD; CHOROIDAL THICKNESS; MACULAR EDEMA; CIRCULATION; MICROCIRCULATION; BINARIZATION; OXYGENATION	Purpose To investigate ocular blood flow and correlations between ocular blood flow and variables in patients with severe non-proliferative diabetic retinopathy (S-NPDR) following panretinal photocoagulation (PRP). Methods In this retrospective, cross-sectional study, the blood flow on the optic nerve head (ONH) and choroid was assessed with laser speckle flowgraphy (LSFG) using the mean blur rate (MBR) in 76 eyes of 76 patients with S-NPDR who underwent PRP, 39 eyes of 39 patients with S-NPDR who did not undergo PRP, and 71 eyes of 71 normal subjects. The correlation between MBR and variables, including visual acuity (VA) and choroidal area determined by binarization method, was analyzed. Results The mean age was 62.9 11.9 years in the S-NPDR with PRP eyes, 55.6 11.4 years in the S-NPDR without PRP eyes, and 60.3 11.1 years in the normal subject eyes. The ONH MBR in vessel and tissue areas and the choroidal MBR were significantly lower in the SNDR with PRP group than in the other groups (p < 0.001, p < 0.001, and p < 0.001, respectively). The luminal and the stromal areas were significantly smaller in the S-NDR with PRP group than in the other groups (p < 0.001 and p < 0.001, respectively). LogMAR best corrected visual acuity (BCVA) exhibited significant negative correlation with the ONH MBR in vessel (r = 0.386, p < 0.001), tissue (r= 0.348, p < 0.001), and the choroid MBR (r= 0.339, p= 0.002) in the S-NDR with PRP group. Stepwise multiple regression analysis demonstrated that BCVA was a common independent factor associated with the ONH MBR in vessel, tissue, and the choroidal MBR in the S-NDR with PRP group. Conclusions ONH and choroid MBR in addition to choroidal component, including the luminal area, were significantly lower in eyes of patients with S-NPDR after PRP compared with no PRP and normal subjects group. This could suggest that the significantly reduced ocular blood flow in PRP-treated S-NPDR eyes correlated with long-term decreased post-PRP luminal area and visual acuity.	[Iwase, Takeshi; Kobayashi, Misato; Yamamoto, Kentaro; Ra, Eimei; Terasaki, Hiroko] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Showa Ku, Nagoya, Aichi, Japan	Nagoya University	Iwase, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Showa Ku, Nagoya, Aichi, Japan.	tiwase@med.nagoya-u.ac.jp			Grants-in-Aid for Scientific Research [26462635] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Aizawa N, 2011, CLIN OPHTHALMOL, V5, P1171, DOI 10.2147/OPTH.S22093; ALDER VA, 1987, INVEST OPHTH VIS SCI, V28, P1078; [Anonymous], 1976, AM J OPHTHALMOL, V81, P383; [Anonymous], 1981, OPHTHALMOLOGY, V88, P583; [Anonymous], 1987, Int Ophthalmol Clin, V27, P254; APPLE DJ, 1973, AM J OPHTHALMOL, V75, P595, DOI 10.1016/0002-9394(73)90812-X; Augsten R, 1998, OPHTHALMOLOGICA, V212, P105, DOI 10.1159/000027288; Avisar R, 2002, ANN PHARMACOTHER, V36, P992, DOI 10.1345/aph.1A279; Bressler NM, 2011, NEW ENGL J MED, V365, P1520, DOI 10.1056/NEJMct0908432; Budzynski E, 2008, INVEST OPHTH VIS SCI, V49, P380, DOI 10.1167/iovs.07-0065; Chew EY, 2003, OPHTHALMOLOGY, V110, P1683, DOI 10.1016/S0161-6420(03)00579-7; CLARIDGE KG, 1994, BRIT J OPHTHALMOL, V78, P321, DOI 10.1136/bjo.78.4.321; Early Treatment Diabetic Retinopathy Study Research Group, 1991, OPHTHALMOLOGY S, V98, P766; Esmaeelpour M, 2012, INVEST OPHTH VIS SCI, V53, P6803, DOI 10.1167/iovs.12-10314; FLOWER RW, 1995, INVEST OPHTH VIS SCI, V36, P1247; FUJII H, 1994, MED BIOL ENG COMPUT, V32, P302, DOI 10.1007/BF02512526; FUJIO N, 1994, BRIT J OPHTHALMOL, V78, P335, DOI 10.1136/bjo.78.5.335; GRUNWALD JE, 1989, OPHTHALMOLOGY, V96, P1518; GRUNWALD JE, 1986, OPHTHALMOLOGY, V93, P590; HOULE ROLAND E., 1967, INVEST OPHTHALMOL, V6, P145; Iwase T, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005102; Kim JT, 2013, INVEST OPHTH VIS SCI, V54, P3378, DOI 10.1167/iovs.12-11503; Lee CJ, 2011, INVEST OPHTH VIS SCI, V52, P3398, DOI 10.1167/iovs.10-6560; MacKinnon JR, 1997, ACTA OPHTHALMOL SCAN, V75, P661; MOLNAR I, 1985, INVEST OPHTH VIS SCI, V26, P1410; MORGAN CM, 1989, OPHTHALMOLOGY, V96, P96; Nagahara M, 2011, INVEST OPHTH VIS SCI, V52, P87, DOI 10.1167/iovs.09-4422; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Okuno T, 2004, EYE, V18, P697, DOI 10.1038/sj.eye.6700749; Ooto S, 2010, OPHTHALMOLOGY, V117, P1800, DOI 10.1016/j.ophtha.2010.01.042; PATEL V, 1992, BMJ-BRIT MED J, V305, P678, DOI 10.1136/bmj.305.6855.678; PETRIG BL, 1991, APPL OPTICS, V30, P2073, DOI 10.1364/AO.30.002073; PRUNTE C, 1988, GRAEF ARCH CLIN EXP, V226, P55, DOI 10.1007/BF02172719; Querques G, 2012, INVEST OPHTH VIS SCI, V53, P6017, DOI 10.1167/iovs.12-9692; Regatieri CV, 2012, RETINA-J RET VIT DIS, V32, P563, DOI [10.1097/IAE.0B013E31822F5678, 10.1097/IAE.0b013e31822f5678]; Savage HI, 2004, INVEST OPHTH VIS SCI, V45, P4504, DOI 10.1167/iovs.04-0077; Shimada N, 2004, GRAEF ARCH CLIN EXP, V242, P284, DOI 10.1007/s00417-003-0836-0; Sonoda S, 2015, AM J OPHTHALMOL, V159, P1123, DOI 10.1016/j.ajo.2015.03.005; Sonoda S, 2014, INVEST OPHTH VIS SCI, V55, P3893, DOI 10.1167/iovs.14-14447; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Stefansson E, 2006, SURV OPHTHALMOL, V51, P364, DOI 10.1016/j.survophthal.2006.04.005; STITT AW, 1995, GRAEF ARCH CLIN EXP, V233, P699, DOI 10.1007/BF00164672; Sugiyama T, 1996, JPN J OPHTHALMOL, V40, P339; Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; Takahashi A, 2008, BRIT J OPHTHALMOL, V92, P1369, DOI 10.1136/bjo.2007.136028; Takahashi H, 2013, EXP EYE RES, V108, P10, DOI 10.1016/j.exer.2012.12.003; Tamaki Y, 1997, JPN J OPHTHALMOL, V41, P49, DOI 10.1016/S0021-5155(96)00008-1; TAMAKI Y, 1994, INVEST OPHTH VIS SCI, V35, P3825; Viswanath K, 2003, Community Eye Health, V16, P21; Wang L, 2012, INVEST OPHTH VIS SCI, V53, P8303, DOI 10.1167/iovs.12-10911; WEITER JJ, 1980, OPHTHALMOLOGY, V87, P1133; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; WILSON DJ, 1987, ARCH OPHTHALMOL-CHIC, V105, P239, DOI 10.1001/archopht.1987.01060020093036; Zhang ZW, 2015, INVEST OPHTH VIS SCI, V56, P2631, DOI 10.1167/iovs.14-16226	54	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174427	10.1371/journal.pone.0174427	http://dx.doi.org/10.1371/journal.pone.0174427			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355247	gold, Green Submitted, Green Published			2022-12-26	WOS:000399174600050
J	Wallace, EK; Altschul, D; Korfer, K; Benti, B; Kaeser, A; Lambeth, S; Waller, BM; Slocombe, KE				Wallace, Emma K.; Altschul, Drew; Korfer, Karoline; Benti, Benjamin; Kaeser, Amanda; Lambeth, Susan; Waller, Bridget M.; Slocombe, Katie E.			Is music enriching for group-housed captive chimpanzees (Pan troglodytes)?	PLOS ONE			English	Article							ENVIRONMENTAL ENRICHMENT; AUDITORY ENRICHMENT; WILD CHIMPANZEES; BEHAVIOR; WELFARE; AGGRESSION; GORILLAS; PRIMATES	Many facilities that house captive primates play music for animal enrichment or for caregiver enjoyment. However, the impact on primates is unknown as previous studies have been inconclusive. We conducted three studies with zoo-housed chimpanzees (Pan troglodytes) and one with group-housed chimpanzees at the National Centre for Chimpanzee Care to investigate the effects of classical and pop/rock music on various variables that may be indicative of increased welfare. Study one compared the behaviour and use of space of 18 animals when silence, classical or pop/rock music was played into one of several indoor areas. Overall, chimpanzees did not actively avoid the area when music was playing but were more likely to exit the area when songs with higher beats per minute were broadcast. Chimpanzees showed significantly fewer active social behaviours when music, rather than silence, was playing. They also tended to be more active and engage in less abnormal behaviour during the music but there was no change to either self-grooming or aggression between music and silent conditions. The genre of music had no differential effects on the chimpanzees' use of space and behaviour. In the second study, continuous focal observations were carried out on three individuals with relatively high levels of abnormal behaviour. No differences in behaviour between music and silence periods were found in any of the individuals. The final two studies used devices that allowed chimpanzees to choose if they wanted to listen to music of various types or silence. Both studies showed that there were no persistent preferences for any type of music or silence. When taken together, our results do not suggest music is enriching for group-housed captive chimpanzees, but they also do not suggest that music has a negative effect on welfare.	[Wallace, Emma K.; Korfer, Karoline; Benti, Benjamin; Slocombe, Katie E.] Univ York, Dept Psychol, York, N Yorkshire, England; [Altschul, Drew] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Kaeser, Amanda; Lambeth, Susan] Univ Texas MD Anderson Canc Ctr, Dept Vet Med & Surg, Houston, TX 77030 USA; [Waller, Bridget M.] Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England	University of York - UK; University of Edinburgh; University of Texas System; UTMD Anderson Cancer Center; University of Portsmouth	Slocombe, KE (corresponding author), Univ York, Dept Psychol, York, N Yorkshire, England.	katie.slocombe@york.ac.uk	aubertin, rebeckah/O-9624-2015	aubertin, rebeckah/0000-0002-0558-7571; Waller, Bridget/0000-0001-6303-7458; Kaeser, Amanda/0000-0002-0446-4465; Benti, Benjamin/0000-0002-9973-4535				ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2006, APP A EUR CONV PROT; Birkett LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020101; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Chelluri GI, 2013, APPL ANIM BEHAV SCI, V147, P306, DOI 10.1016/j.applanim.2012.06.008; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cross I, 2001, ANN NY ACAD SCI, V930, P28, DOI 10.1111/j.1749-6632.2001.tb05723.x; Dunbar RIM, 2003, ANNU REV ANTHROPOL, V32, P163, DOI 10.1146/annurev.anthro.32.061002.093158; Gray J. A., 2003, NEUROPSYCHOLOGY ANXI; Hopper LM, 2016, APPL ANIM BEHAV SCI, V176, P112, DOI 10.1016/j.applanim.2016.01.002; Hosey GR, 2005, APPL ANIM BEHAV SCI, V90, P107, DOI 10.1016/j.applanim.2004.08.015; Howell S, 2003, LAB ANIMAL, V32, P31, DOI 10.1038/laban1103-31; McDermott J, 2007, COGNITION, V104, P654, DOI 10.1016/j.cognition.2006.07.011; Mellen J, 2001, ZOO BIOL, V20, P211, DOI 10.1002/zoo.1021; Mitani JC, 2010, CURR BIOL, V20, pR507, DOI 10.1016/j.cub.2010.04.021; Muller MN, 2004, ANIM BEHAV, V67, P113, DOI 10.1016/j.anbehav.2003.03.013; Norman-Haignere S, 2015, NEURON, V88, P1281, DOI 10.1016/j.neuron.2015.11.035; Pruetz JD, 1992, ANIM WELFARE, V1, P127; Quick DL, 1984, ZOO BIOL, V3, P65; Ritvo SE, 2016, J ZOO AQUAR RES, V4, P156; Robbins L, 2014, ZOO BIOL, V33, P197, DOI 10.1002/zoo.21127; Schel AM, 2013, AM J PRIMATOL, V75, P254, DOI 10.1002/ajp.22101; URSIN H, 1993, NEUROPSYCHOBIOLOGY, V28, P66, DOI 10.1159/000119002; Videan EN, 2007, J AM ASSOC LAB ANIM, V46, P66; Wallace EK, 2013, ZOO BIOL, V32, P423, DOI 10.1002/zoo.21074; Wells DL, 2006, APPL ANIM BEHAV SCI, V100, P327, DOI 10.1016/j.applanim.2005.12.003; Yamanashi Y, 2011, AM J PRIMATOL, V73, P1231, DOI 10.1002/ajp.20995	27	14	14	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0172672	10.1371/journal.pone.0172672	http://dx.doi.org/10.1371/journal.pone.0172672			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355212	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000399174600004
J	Han, H; Yang, B; Wang, W				Han, H.; Yang, B.; Wang, W.			Angiomotin-like 2 interacts with and negatively regulates AKT	ONCOGENE			English	Article							ORGAN SIZE CONTROL; HIPPO PATHWAY; CELL-PROLIFERATION; HEPATOCELLULAR-CARCINOMA; TUMOR-SUPPRESSOR; HUMAN CANCER; TISSUE HOMEOSTASIS; FAMILY PROTEINS; YAP ONCOPROTEIN; ACTIN-BINDING	Angiomotin-like 2 (AMOTL2) is a member of Angiomotin family proteins, which are potent inhibitors for the Hippo pathway effector YAP. However, additional cellular functions of AMOTL2 besides YAP inhibition are largely unknown. Here, we reported that AMOTL2 associates with and negatively regulates AKT. Mechanistically, AMOTL2 binds to AKT pleckstrin homology domain and interrupts AKT's membrane localization. Liver-specific depletion of AMOTL2 enlarged mouse liver and activated both YAP and AKT. Downregulation of AMOTL2 is found in human liver cancers, correlating with the concomitant activation of YAP and AKT. Together, our results provide novel insights into a dual tumor suppressive function of AMOTL2 by targeting both YAP and AKT in liver size control and cancer prevention.	[Han, H.; Yang, B.; Wang, W.] Univ Calif Irvine, Dept Dev & Cell Biol, 3302A,Nat Sci 1, Irvine, CA 92697 USA	University of California System; University of California Irvine	Wang, W (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, 3302A,Nat Sci 1, Irvine, CA 92697 USA.	wenqiw6@uci.edu	han, han/HDL-7807-2022; HAN, HAN/AAC-5464-2022	HAN, HAN/0000-0003-2222-5270; Wang, Wenqi/0000-0003-4053-5088	Breast Cancer Research Foundation [16-20-26-WANG]; American Cancer Society-Institutional Research Grant	Breast Cancer Research Foundation; American Cancer Society-Institutional Research Grant(American Cancer Society)	WW thanks Dr Junjie Chen at MD Anderson Cancer Center for his mentoring and continuous support. We also thank Kathryn E Aziz and My Kim Tran at MD Anderson Cancer Center for the technical help. WW is a recipient of American Association for Cancer Research Career Development Award for Translational Breast Cancer Research supported by the Breast Cancer Research Foundation (16-20-26-WANG). This work was also partially supported by the American Cancer Society-Institutional Research Grant to WW. WW is a member of Chao Family Comprehensive Cancer Center (P30 CA062203) and a member of Center for Complex Biological Systems at UC Irvine.	Aase K, 2007, GENE DEV, V21, P2055, DOI 10.1101/gad.432007; Adler JJ, 2013, P NATL ACAD SCI USA, V110, P17368, DOI 10.1073/pnas.1308236110; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan SW, 2013, J BIOL CHEM, V288, P37296, DOI 10.1074/jbc.M113.527598; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chan TO, 2015, BIOCHEM J, V471, P37, DOI 10.1042/BJ20150325; Dai XM, 2015, CELL RES, V25, P1175, DOI 10.1038/cr.2015.101; Dai XM, 2013, J BIOL CHEM, V288, P34041, DOI 10.1074/jbc.M113.518019; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Hirate Y, 2013, CURR BIOL, V23, P1181, DOI 10.1016/j.cub.2013.05.014; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Kim MJ, 2016, EMBO REP, V17, P64, DOI 10.15252/embr.201540809; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Leung CY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3251; Li YJ, 2015, CELL RES, V25, P801, DOI 10.1038/cr.2015.69; Li Y, 2016, HEPATOLOGY, V63, P1928, DOI 10.1002/hep.28507; Liu PD, 2014, CELL CYCLE, V13, P2162, DOI 10.4161/cc.29584; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Lv M, 2016, ONCOTARGET, V7, P12393, DOI 10.18632/oncotarget.7161; Matter MS, 2014, J HEPATOL, V60, P855, DOI 10.1016/j.jhep.2013.11.031; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Mojallal M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5557; Moleirinho S, 2014, FEBS LETT, V588, P2693, DOI 10.1016/j.febslet.2014.02.006; Moroishi T, 2015, GENE DEV, V29, P1271, DOI 10.1101/gad.262816.115; Nishio M, 2016, P NATL ACAD SCI USA, V113, pE71, DOI 10.1073/pnas.1517188113; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Troilo A, 2016, ONCOTARGET, V7, P28765, DOI 10.18632/oncotarget.9117; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang H, 2016, J BIOL CHEM, V291, P15256, DOI 10.1074/jbc.M116.722967; Wang WQ, 2008, J CELL SCI, V121, P1334, DOI 10.1242/jcs.018176; Wang WQ, 2015, CELL REP, V13, P524, DOI 10.1016/j.celrep.2015.09.014; Wang WQ, 2015, NAT CELL BIOL, V17, P490, DOI 10.1038/ncb3113; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yi CL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004060; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	45	9	10	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 10	2017	36	32					4662	4669		10.1038/onc.2017.101	http://dx.doi.org/10.1038/onc.2017.101			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FD0RK	28368415				2022-12-26	WOS:000407246200013
J	Rothert, M; Ronfeldt, D; Beitz, E				Rothert, Monja; Roenfeldt, Deike; Beitz, Eric			Electrostatic attraction of weak monoacid anions increases probability for protonation and passage through aquaporins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRAL SOLUTE CHANNEL; WATER CHANNEL; MOLECULAR CHARACTERIZATION; GLYCEROL; CELLS; UREA; PERMEABILITY; TRANSPORTER; SELECTIVITY; EXPRESSION	A positive electrostatic field emanating from the center of the aquaporin (AQP) water and solute channel is responsible for the repulsion of cations. At the same time, however, a positive field will attract anions. In this regard, L-lactate/lactic acid permeability has been shown for various isoforms of the otherwise highly water and neutral substrate selective AQP family. The structural requirements rendering certain AQPs permeable for weak monoacids and the mechanism of conduction have remained unclear. Here, we show by profiling pH-dependent substrate permeability, measurements of media alkalization, and proton decoupling that AQP9 acts as a channel for the protonated, neutral monocarboxylic acid species. Intriguingly, the obtained permeability rates indicate an up to 10 times higher probability of passage via AQP9 than given by the fraction of the protonated acid substrate at a certain pH. We generated AQP9 point mutants showing that this effect is independent from properties of the channel interior but caused by the protein surface electrostatics. Monocarboxylic acid-conducting AQPs thus employ a mechanism similar to the family of formate-nitrite transporters for weak monoacids. On a more general basis, our data illustrate semiquantitatively the contribution of surface electrostatics to the interaction of charged molecule substrates or ligands with target proteins, such as channels, transporters, enzymes, or receptors.	[Rothert, Monja; Roenfeldt, Deike; Beitz, Eric] Christian Albrechts Univ Kiel, Dept Pharmaceut & Med Chem, Gutenbergstr 76, D-24118 Kiel, Germany; [Roenfeldt, Deike] Univ Hamburg, Dept Biochem & Mol Biol, D-20148 Hamburg, Germany	University of Kiel; University of Hamburg	Beitz, E (corresponding author), Christian Albrechts Univ Kiel, Dept Pharmaceut & Med Chem, Gutenbergstr 76, D-24118 Kiel, Germany.	ebeitz@pharmazie.uni-kiel.de			NIGMS [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Henke and A. Fuchs for technical assistance, as well as M. Casal for providing the jen1 Delta ady2 Delta yeast strain. Molecular graphics and analyses were performed with the UCSF Chimera package. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (which is supported by NIGMS P41-GM103311).	Badaut J, 2004, NEUROSCIENCE, V129, P971, DOI 10.1016/j.neuroscience.2004.06.035; Badaut J, 2004, NEUROSCIENCE, V128, P27, DOI 10.1016/j.neuroscience.2004.05.042; Batra J, 2013, J BIOL CHEM, V288, P9848, DOI 10.1074/jbc.M113.457382; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Beitz E, 2006, P NATL ACAD SCI USA, V103, P269, DOI 10.1073/pnas.0507225103; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bienert GP, 2013, BIOCHEM J, V454, P559, DOI 10.1042/BJ20130388; Calamita G, 2012, BIOL CELL, V104, P342, DOI 10.1111/boc.201100061; Choi WG, 2007, J BIOL CHEM, V282, P24209, DOI 10.1074/jbc.M700982200; Czodrowski P, 2006, PROTEINS, V65, P424, DOI 10.1002/prot.21110; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Elkjaer ML, 2000, BIOCHEM BIOPH RES CO, V276, P1118, DOI 10.1006/bbrc.2000.3505; Eriksson UK, 2013, SCIENCE, V340, P1346, DOI 10.1126/science.1234306; Faghiri Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010451; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gena P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078139; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Ikeda M, 2002, J BIOL CHEM, V277, P39873, DOI 10.1074/jbc.M207008200; Ishibashi K, 2002, BBA-GENE STRUCT EXPR, V1576, P335, DOI 10.1016/S0167-4781(02)00393-7; Ishibashi K, 1997, J BIOL CHEM, V272, P20782, DOI 10.1074/jbc.272.33.20782; ISHIBASHI K, 1994, P NATL ACAD SCI USA, V91, P6269, DOI 10.1073/pnas.91.14.6269; Jelen S, 2012, AM J PHYSIOL-GASTR L, V303, pG1279, DOI 10.1152/ajpgi.00153.2012; Kirscht A, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002411; Li H, 2011, J MOL BIOL, V407, P607, DOI 10.1016/j.jmb.2011.01.036; Liu K, 2005, P NATL ACAD SCI USA, V102, P2192, DOI 10.1073/pnas.0409232102; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; NARAYSZABO G, 1989, J MOL GRAPHICS, V7, P76, DOI 10.1016/S0263-7855(89)80003-7; Osaka H, 1998, J BIOL CHEM, V273, P12758, DOI 10.1074/jbc.273.21.12758; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radic Z, 1997, J BIOL CHEM, V272, P23265, DOI 10.1074/jbc.272.37.23265; Rambow J, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00199; Song J, 2012, BBA-BIOMEMBRANES, V1818, P1218, DOI 10.1016/j.bbamem.2012.01.025; Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737; Tsukaguchi H, 1999, AM J PHYSIOL-RENAL, V277, pF685, DOI 10.1152/ajprenal.1999.277.5.F685; Viadiu H, 2007, J MOL BIOL, V367, P80, DOI 10.1016/j.jmb.2006.12.042; Wang Y, 2009, NATURE, V462, P467, DOI 10.1038/nature08610; Wiechert M, 2017, EMBO J, V36, P949, DOI 10.15252/embj.201695776; Wree D, 2011, FEBS J, V278, P740, DOI 10.1111/j.1742-4658.2010.07993.x; Wu B, 2007, CELL MOL LIFE SCI, V64, P2413, DOI 10.1007/s00018-007-7163-2; Wu BH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7284; Wu BH, 2009, EMBO J, V28, P2188, DOI 10.1038/emboj.2009.182; Yasui M, 1999, NATURE, V402, P184, DOI 10.1038/46045; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134	44	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9358	9364		10.1074/jbc.M117.782516	http://dx.doi.org/10.1074/jbc.M117.782516			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28360107	Green Published, hybrid			2022-12-26	WOS:000402538900029
J	Cai, DG; Zhu, ZL; Sun, HL; Qi, YH; Xing, LY; Zhao, XG; Wan, QY; Su, Q; Li, H				Cai, Dongge; Zhu, Zhongliang; Sun, Hongli; Qi, Yanhua; Xing, Lanying; Zhao, Xiaogui; Wan, Qiuyuan; Su, Qian; Li, Hui			Maternal PTSD following Exposure to the Wenchuan Earthquake Is Associated with Impaired Mental Development of Children	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; DUTCH-HUNGER-WINTER; WORLD-TRADE-CENTER; PRENATAL STRESS; NATURAL DISASTER; HPA AXIS; ANXIETY; DEPRESSION; SICHUAN; HEALTH	The purpose of this study was to explore whether earthquake-related maternal Post-Traumatic Stress Disorder (PTSD) is associated with impaired development of infants. Participants included 86 women who were pregnant during or after the earthquake in Ningqiang county, and their children. Data were collected from February to March of 2012. PTSD questionnaire (PTSD Checklist, Civilian Version (PCL-C)) was used to measure the effect of the earthquake on mothers, and that the scores greater than 50 were used to indicate presence of PTSD. Each child was assessed using the mental Developmental Screening Test (DST) according to age. Among the 86 women, PTSD scores equal to or greater than 50 accounted for 20.93%. Among the 86 children, 25.60% of development quotient (DQ) scores and 19.80% of mental index (MI) scores were less than 85. The correlation coefficient analysis showed that PTSD scores were inversely related to DQ and MI scores. Maternal PTSD following earthquake exposure is associated with relatively lower intellectual development in children age 0 - 3 years. Further research is needed to assess the persistent effects of this influence on offspring of mothers exposed to earthquake.	[Cai, Dongge] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Xian, Shaanxi, Peoples R China; [Cai, Dongge; Xing, Lanying; Zhao, Xiaogui; Wan, Qiuyuan] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Xian, Shaanxi, Peoples R China; [Zhu, Zhongliang] Northwestern Univ, Coll Life Sci, Shaanxi Prov Biomed Key Lab, Xian, Shaanxi, Peoples R China; [Zhu, Zhongliang] Xi An Jiao Tong Univ, Hlth Sci Ctr, Dept Pharmacol, Xian, Shaanxi, Peoples R China; [Sun, Hongli] Xian Childrens Hosp, Shaanxi Inst Pediat Dis, Xian, Shaanxi, Peoples R China; [Qi, Yanhua] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Ultrasound, Xian, Shaanxi, Peoples R China; [Li, Hui] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Neonatol, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Northwest University Xi'an; Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Li, H (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Neonatol, Xian, Shaanxi, Peoples R China.	yongyy123@yeah.net		Li, Hui/0000-0002-8438-0287	National Natural Science Foundation of China [81271497]; science and technology overall planning and innovation project of Shaanxi Province in China [2013KTCQ03-03]; Ningqiang People's Hospital	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); science and technology overall planning and innovation project of Shaanxi Province in China; Ningqiang People's Hospital	The work was funded by the National Natural Science Foundation of China (No. 81271497), http://www.nsfc.gov.cn/; science and technology overall planning and innovation project of Shaanxi Province in China (No. 2013KTCQ03-03), http://kszl.shaanxi.gov.cn/0/1/6/17/984/83376.htm.; We thank the 86 women and their children who participated in the study and the Ningqiang People's Hospital for support and assistance.	Afadlal S, 2010, NEUROSCI LETT, V470, P24, DOI 10.1016/j.neulet.2009.12.046; Arnberg FK, 2013, J ANXIETY DISORD, V27, P347, DOI 10.1016/j.janxdis.2013.03.011; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Brackbill RM, 2014, AM J EPIDEMIOL, V179, P1076, DOI 10.1093/aje/kwu022; BROWN AS, 1995, BRIT J PSYCHIAT, V166, P601, DOI 10.1192/bjp.166.5.601; Cao XJ, 2014, DEV PSYCHOBIOL, V56, P117, DOI 10.1002/dev.21085; Currie J, 2013, J HEALTH ECON, V32, P487, DOI 10.1016/j.jhealeco.2013.01.004; Davis EP, 2010, CHILD DEV, V81, P131, DOI 10.1111/j.1467-8624.2009.01385.x; de Rooij SR, 2011, J DEV ORIG HLTH DIS, V2, P136, DOI 10.1017/S2040174411000055; de Rooij SR, 2012, EARLY HUM DEV, V88, P321, DOI 10.1016/j.earlhumdev.2011.09.002; de Rooij SR, 2010, P NATL ACAD SCI USA, V107, P16881, DOI 10.1073/pnas.1009459107; DiPietro JA, 2004, CURR DIR PSYCHOL SCI, V13, P71, DOI 10.1111/j.0963-7214.2004.00277.x; Ehring T, 2011, PSYCHIAT RES, V185, P161, DOI 10.1016/j.psychres.2009.10.018; Engel SM, 2005, PAEDIATR PERINAT EP, V19, P334, DOI 10.1111/j.1365-3016.2005.00676.x; Fan F, 2011, J TRAUMA STRESS, V24, P44, DOI 10.1002/jts.20599; Fothergill A., 1996, INT J MASS EMERGENCI, V14, P33; Fothergill Alice, 2004, HEADS WATER GENDER C; FRIEDSAM HJ, 1961, GERONTOLOGIST, V1, P34, DOI 10.1093/geront/1.1.34; Fuller SC, 2014, DEMOGRAPHY, V51, P1501, DOI 10.1007/s13524-014-0310-0; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Goenjian AK, 2000, AM J PSYCHIAT, V157, P911, DOI 10.1176/appi.ajp.157.6.911; Josephs L, 1996, B MENNINGER CLIN, V60, P22; Keim SA, 2011, EARLY HUM DEV, V87, P373, DOI 10.1016/j.earlhumdev.2011.02.004; Khashan AS, 2008, ARCH GEN PSYCHIAT, V65, P146, DOI 10.1001/archgenpsychiatry.2007.20; Kun P, 2009, PUBLIC HEALTH, V123, P703, DOI 10.1016/j.puhe.2009.09.017; Kuo HW, 2007, J PSYCHOSOM RES, V62, P495, DOI 10.1016/j.jpsychores.2004.11.012; Laplante DP, 2008, J AM ACAD CHILD PSY, V47, P1063, DOI 10.1097/CHI.0b013e31817eec80; Laplante DP, 2004, PEDIATR RES, V56, P400, DOI 10.1203/01.PDR.0000136281.34035.44; Liu Shi-an, 2009, Zhonghua Yufang Yixue Zazhi, V43, P380, DOI 10.3760/cma.j.issn.0253-9624.2009.05.010; Machon RA, 1997, ARCH GEN PSYCHIAT, V54, P322; Malaspina D, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-71; MEISELS SJ, 1988, ANNU REV PUBL HEALTH, V9, P527; Modir F, 2014, PHYSIOL BEHAV, V129, P104, DOI 10.1016/j.physbeh.2014.02.040; Morley-Fletcher S, 2003, EUR J NEUROSCI, V18, P3367, DOI 10.1111/j.1460-9568.2003.03070.x; Morley-Fletcher S, 2011, PSYCHOPHARMACOLOGY, V217, P301, DOI 10.1007/s00213-011-2280-x; Norris FH, 1999, ANXIETY STRESS COPIN, V12, P363, DOI 10.1080/10615809908249317; O'Donnell K, 2009, DEV NEUROSCI-BASEL, V31, P285, DOI 10.1159/000216539; Oni Olurinde, 2012, Am J Disaster Med, V7, P199; Qu ZY, 2012, ARCH WOMEN MENT HLTH, V15, P49, DOI 10.1007/s00737-011-0255-x; Qu ZY, 2012, J AFFECT DISORDERS, V136, P117, DOI 10.1016/j.jad.2011.08.021; Ren ZJ, 2011, PSYCHIATRY, V74, P87, DOI 10.1521/psyc.2011.74.1.87; Rice F, 2010, PSYCHOL MED, V40, P335, DOI 10.1017/S0033291709005911; Salcioglu E, 2007, DISASTERS, V31, P115, DOI 10.1111/j.1467-7717.2007.01000.x; SUSSER ES, 1992, ARCH GEN PSYCHIAT, V49, P983; Thompson MP, 1998, ADDICT BEHAV, V23, P257, DOI 10.1016/S0306-4603(97)00032-4; Torche F, 2012, HUM REPROD, V27, P558, DOI 10.1093/humrep/der390; Torche F, 2011, DEMOGRAPHY, V48, P1473, DOI 10.1007/s13524-011-0054-z; Varela E, 2008, DISASTERS, V32, P280, DOI 10.1111/j.1467-7717.2008.01039.x; Walder DJ, 2014, PSYCHIAT RES, V219, P353, DOI 10.1016/j.psychres.2014.04.034; Weathers FW, 1993, ANN CONV INT SOC TRA; Weinstock M, 2007, NEUROCHEM RES, V32, P1730, DOI 10.1007/s11064-007-9339-4; Wilson CA, 2013, BEHAV BRAIN RES, V238, P279, DOI 10.1016/j.bbr.2012.10.003; Xiong X., 2010, AM J DISASTER MED, V5, P181, DOI DOI 10.5055/AJDM.2010.0016; Zheng MS, 1997, CHINESE J PEDIAT, V35, P117	54	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0168747	10.1371/journal.pone.0168747	http://dx.doi.org/10.1371/journal.pone.0168747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2IH	28369095	Green Published, gold, Green Submitted			2022-12-26	WOS:000399351000003
J	de Carvalho, LEW; Sarraf, JS; Semblano, AAP; Moreira, MA; de Lemos, MN; de Mello, VJ; Hamoy, M; Nazareth, MH; Paschoal, FM; Adami, F				Werneck de Carvalho, Luis Eduardo; Sarraf, Jonathan Souza; Pereira Semblano, Aluizio Augusto; Moreira, Matheus Acacio; de Lemos, Manuela Nascimento; de Mello, Vanessa Joia; Hamoy, Moises; Nazareth Junior, Mario Hermes; Paschoal Junior, Fernando Mendes; Adami, Fernando			Central nervous system tumours profile at a referral center in the Brazilian Amazon region, 1997-2014	PLOS ONE			English	Article							PRIMARY BRAIN; EPIDEMIOLOGY	Tumours of the Central Nervous System (CNS) are an important cause of mortality from cancer. Epidemiological data on neoplams affecting the CNS are scarce in Brazil, especially in the Amazon region. The study aims at describing the histopathological profile of CNS tumours cases at a high-complexity referral cancer center. This study has described a 17-year-series profile of CNS tumours, registered at a high-complexity referral cancer center in Para A state, from January 1997 until July 2014 in the Brazilian Amazon Region. Data was gathered from histopathology reports kept in the hospital's cancer registry and 949 cases of CNS tumours were analyzed. The most common histopathology were neuroepithelial tumours (approx. 40%) and meningioma was the most frequent especific tumor histologic subtype (22.2%). Neuroepithelial tumours were more frequent in patients with ages ranging from less than a year to 19 years, whereas metastatic tumours were prevalent in patients over 40 years of age. It was not found temporal trends during the studied period. The knowledge of these tumours profile is valuable for the understanding of cancer epidemiology in the region, since its prevalence is currently underreported and more awareness on the disease is needed.	[Werneck de Carvalho, Luis Eduardo; Sarraf, Jonathan Souza; Pereira Semblano, Aluizio Augusto; Moreira, Matheus Acacio; de Lemos, Manuela Nascimento; Adami, Fernando] Oncol Brasil Ensino & Pesquisa, Belem, Para, Brazil; [Werneck de Carvalho, Luis Eduardo; Adami, Fernando] Fac Med ABC, Lab Epidemiol & Data Anal, Santo Andre, SP, Brazil; [Sarraf, Jonathan Souza] Univ Fed Para, Post Grad Genet & Mol Biol, Belem, Para, Brazil; [Pereira Semblano, Aluizio Augusto; Moreira, Matheus Acacio; Paschoal Junior, Fernando Mendes] Ctr Univ Estado Para, Belem, Para, Brazil; [de Lemos, Manuela Nascimento; de Mello, Vanessa Joia; Hamoy, Moises] Univ Fed Para, Lab Pharmacol & Toxicol Nat Prod, Belem, Para, Brazil; [Nazareth Junior, Mario Hermes] Hosp Ophir Loyola, Neurosurg Dept, Belern, Para, Brazil	Faculdade de Medicina do ABC; Universidade Federal do Para; Centro Universitario do Estado do Para (CESUPA); Universidade Federal do Para	de Carvalho, LEW (corresponding author), Oncol Brasil Ensino & Pesquisa, Belem, Para, Brazil.; de Carvalho, LEW (corresponding author), Fac Med ABC, Lab Epidemiol & Data Anal, Santo Andre, SP, Brazil.	dreduardocarvalho@oncologica.com.br	Adami, Fernando/D-3855-2012	Adami, Fernando/0000-0003-1918-3364; Hamoy, Moises/0000-0002-2931-4324	Oncologica Brazil - Education and Research; Oncologica Brazil-Education and Research	Oncologica Brazil - Education and Research; Oncologica Brazil-Education and Research	The authors received specific funding from Oncologica Brazil - Education and Research.; The authors are grateful to the Neurosurgery Service of Hospital Ophir Loyola, which is a cancer referral center in the Amazon Region, for the constant incentive in the design of this project. Our group was supported by Oncologica Brazil-Education and Research, which has provided for working space, material and financial support for the completion of the present study.	Aguirre-Cruz L, 2016, SALUD PUBLICA MEXICO, V58, P171, DOI 10.21149/spm.v58i2.7786; Butowski Nicholas A, 2015, Continuum (Minneap Minn), V21, P301, DOI 10.1212/01.CON.0000464171.50638.fa; Cambruzzi E, 2010, REV AMRIGS, V54, P7; Crocetti E, 2012, EUR J CANCER, V48, P1532, DOI 10.1016/j.ejca.2011.12.013; Fox BD, 2011, NEUROSURG CLIN N AM, V22, P1, DOI 10.1016/j.nec.2010.08.007; Gigineishvili D, 2013, J NEURO-ONCOL, V112, P241, DOI 10.1007/s11060-013-1054-1; Instituto Nacional do Cancer (INCA), 2001, CANC BRAS DAD REG BA; Instituto Nacional do Cancer (INCA), 2001, REG CANC BAS POP CAN; Johannesen TB, 2004, NEUROEPIDEMIOLOGY, V23, P101, DOI 10.1159/000075952; JUNIOR MZH, 2013, REV PARAENSE MED, V27; Kleinschmidt-Demasters BK, 2003, HUM PATHOL, V34, P1137, DOI 10.1016/S0046-8177(03)00427-1; Lee CH, 2010, J KOREAN NEUROSURG S, V48, P145, DOI 10.3340/jkns.2010.48.2.145; Liigant A, 2000, NEUROEPIDEMIOLOGY, V19, P300, DOI 10.1159/000026269; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu YJ, 2016, INFLAMMATION, V39, P10, DOI 10.1007/s10753-015-0217-y; Materljan E, 2004, CROAT MED J, V45, P206; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Resende Ana Lúcia da Silva, 2006, Rev. Nutr., V19, P511; Wiemels J, 2010, J NEURO-ONCOL, V99, P307, DOI 10.1007/s11060-010-0386-3	19	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174439	10.1371/journal.pone.0174439	http://dx.doi.org/10.1371/journal.pone.0174439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369089	Green Submitted, Green Published, gold			2022-12-26	WOS:000399351000016
J	Ye, F; Lou, XY; Sun, LF				Ye, Fei; Lou, Xin Yuan; Sun, Lin Fu			An improved chaotic fruit fly optimization based on a mutation strategy for simultaneous feature selection and parameter optimization for SVM and its applications	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; PARTICLE SWARM OPTIMIZATION; BEARING FAULT-DIAGNOSIS; DECISION-MAKING; ALGORITHM; CLASSIFICATION; SYSTEM; MODEL	This paper proposes a new support vector machine (SVM) optimization scheme based on an improved chaotic fly optimization algorithm (FOA) with a mutation strategy to simultaneously perform parameter setting turning for the SVM and feature selection. In the improved FOA, the chaotic particle initializes the fruit fly swarm location and replaces the expression of distance for the fruit fly to find the food source. However, the proposed mutation strategy uses two distinct generative mechanisms for new food sources at the osphresis phase, allowing the algorithm procedure to search for the optimal solution in both the whole solution space and within the local solution space containing the fruit fly swarm location. In an evaluation based on a group of ten benchmark problems, the proposed algorithm's performance is compared with that of other well-known algorithms, and the results support the superiority of the proposed algorithm. Moreover, this algorithm is successfully applied in a SVM to perform both parameter setting turning for the SVM and feature selection to solve real-world classification problems. This method is called chaotic fruit fly optimization algorithm (CIFOA)-SVM and has been shown to be a more robust and effective optimization method than other well-known methods, particularly in terms of solving the medical diagnosis problem and the credit card problem.	[Ye, Fei; Lou, Xin Yuan; Sun, Lin Fu] Southwest Jiaotong Univ, Sch Informat Sci & Technol, Chengdu, Peoples R China	Southwest Jiaotong University	Ye, F (corresponding author), Southwest Jiaotong Univ, Sch Informat Sci & Technol, Chengdu, Peoples R China.	122404504@qq.com			national science and technology support program [2015BAF32B05]; science and technology project of SiChuan province [2015GZ0076]	national science and technology support program; science and technology project of SiChuan province	This work is financially supported by national science and technology support program (2015BAF32B05) and science and technology project of SiChuan province (2015GZ0076).; The authors would like to thank the associate editor and reviewers for their valuable comments and suggestions that improved the study's quality. This study was supported by National Science and Technology Support Program (2015BAF32B05) and Science and Technology Project of SiChuan Province (2015GZ0076).	Angeline P. J., 1998, Evolutionary Programming VII. 7th International Conference, EP98. Proceedings, P601, DOI 10.1007/BFb0040811; Bagheri A, 2010, FUTURE GENER COMP SY, V26, P533, DOI 10.1016/j.future.2009.10.004; Bagirov A., 2003, TOP, V11, P1; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Cai JJ, 2007, ENERG CONVERS MANAGE, V48, P645, DOI 10.1016/j.enconman.2006.05.020; Cherkassky V, 1999, IEEE T NEURAL NETWOR, V10, P985; Chu DL, 2016, J VIBROENG, V18, P151; Coelho LDS, 2008, EXPERT SYST APPL, V34, P1905, DOI 10.1016/j.eswa.2007.02.002; Coello CAC, 2004, IEEE T EVOLUT COMPUT, V8, P256, DOI [10.1109/TEVC.2004.826067, 10.1109/tevc.2004.826067]; Comak E, 2007, EXPERT SYST APPL, V32, P409, DOI 10.1016/j.eswa.2005.12.001; Cong YL, 2016, PROCEDIA ENGINEER, V138, P59, DOI 10.1016/j.proeng.2016.01.234; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Crawford B, 2015, INFORM SYSTEMS TECHN; Dastanpour A, 2014, IEEE CONF OPEN SYST, P72, DOI 10.1109/ICOS.2014.7042412; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Ding S, 2016, INT J MACHINE LEARNI, V7, P1; Eggermont Jeroen, 2004, SAC; Eggermont Jeroen, 2004, GENETIC PROGRAMMING; Fernandez-Francos D, 2013, COMPUT IND ENG, V64, P357, DOI 10.1016/j.cie.2012.10.013; Friedl MA, 1997, REMOTE SENS ENVIRON, V61, P399, DOI 10.1016/S0034-4257(97)00049-7; hang Y, 2013, MATH PROBL ENG, V2013, P147; Huang CL, 2008, APPL SOFT COMPUT, V8, P1381, DOI 10.1016/j.asoc.2007.10.007; Huang CL, 2006, EXPERT SYST APPL, V31, P231, DOI 10.1016/j.eswa.2005.09.024; Ji Y, 2013, PATTERN RECOGN, V46, P914, DOI 10.1016/j.patcog.2012.08.010; Lei XJ, 2016, KNOWL-BASED SYST, V105, P270, DOI 10.1016/j.knosys.2016.05.019; Li JQ, 2016, IEEE T AUTOM SCI ENG, V13, P932, DOI 10.1109/TASE.2015.2425404; Li MN, 2014, ADV MECH ENG, DOI 10.1155/2014/314797; Lin W.-Y., 2015, NEURAL COMPUT APPL, P1; Little Max A., 2008, IEEE T BIOMEDICAL EN; Liu B, 2005, CHAOS SOLITON FRACT, V25, P1261, DOI 10.1016/j.chaos.2004.11.095; Liu Q, 2016, ARAB J SCI ENG, V41, P807, DOI 10.1007/s13369-015-1905-5; Malar B, 2013, KNOWL INF SYST, V37, P531, DOI 10.1007/s10115-012-0579-5; Mitic M, 2015, KNOWL-BASED SYST, V89, P446, DOI 10.1016/j.knosys.2015.08.010; Mousavi SM, 2016, SOFT COMPUT, V20, P2281, DOI 10.1007/s00500-015-1641-5; Niu JW, 2015, KNOWL-BASED SYST, V88, P253, DOI 10.1016/j.knosys.2015.07.027; Pan QK, 2014, KNOWL-BASED SYST, V62, P69, DOI 10.1016/j.knosys.2014.02.021; Pan WT, 2012, KNOWL-BASED SYST, V26, P69, DOI 10.1016/j.knosys.2011.07.001; Rajendran C, 2004, EUR J OPER RES, V155, P426, DOI 10.1016/S0377-2217(02)00908-6; Shen L, 2016, KNOWL-BASED SYST, V96, P61, DOI 10.1016/j.knosys.2016.01.002; Si L, 2016, SENSORS, V16; Soman S, 2015, APPL SOFT COMPUT, V30, P305, DOI 10.1016/j.asoc.2015.01.018; Street William Nick, 1993, IS T SPIE 1993 INT S, V1905, P861; Szczypta J, 2016, P 36 INT C INF SYST; Tian YJ, 2014, IEEE T CYBERNETICS, V44, P1067, DOI 10.1109/TCYB.2013.2279167; Ticehurst JL, 2011, ENVIRON MODELL SOFTW, V26, P52, DOI 10.1016/j.envsoft.2010.03.032; Ubeyli ED, 2007, DIGIT SIGNAL PROCESS, V17, P675, DOI 10.1016/j.dsp.2006.11.009; Wang L, 2016, KNOWL-BASED SYST, V97, P158, DOI 10.1016/j.knosys.2016.01.006; Wang L, 2015, EXPERT SYST APPL, V42, P4310, DOI 10.1016/j.eswa.2015.01.048; Wang L, 2013, KNOWL-BASED SYST, V48, P17, DOI 10.1016/j.knosys.2013.04.003; Wang S, 2016, BIOMEDIZINISCHE TECH, V61; Wang WC, 2015, CHEMOMETR INTELL LAB, V141, P79, DOI 10.1016/j.chemolab.2014.12.007; Wu LH, 2015, KNOWL-BASED SYST, V89, P603, DOI 10.1016/j.knosys.2015.09.006; Wu LF, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/686501; WU YZ, 1993, RADIOLOGY, V187, P81, DOI 10.1148/radiology.187.1.8451441; Yu B, 2008, KNOWL-BASED SYST, V21, P355, DOI 10.1016/j.knosys.2008.01.001; Yuan XF, 2015, APPL MATH COMPUT, V268, P1267, DOI 10.1016/j.amc.2015.07.030; Yuan XF, 2014, APPL MATH COMPUT, V233, P260, DOI 10.1016/j.amc.2014.02.005; Zhan ZH, 2009, IEEE T SYST MAN CY B, V39, P1362, DOI 10.1109/TSMCB.2009.2015956; Zhang ML, 2007, PATTERN RECOGN, V40, P2038, DOI 10.1016/j.patcog.2006.12.019; Zhang Y, 2016, SIMULATION, V92; Zhang YD, 2011, SENSORS-BASEL, V11, P4721, DOI 10.3390/s110504721; Zhao JY, 2016, SOFT COMPUT, V20, P2841, DOI 10.1007/s00500-015-1685-6; Zheng XL, 2014, KNOWL-BASED SYST, V57, P95, DOI 10.1016/j.knosys.2013.12.011	63	15	18	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0173516	10.1371/journal.pone.0173516	http://dx.doi.org/10.1371/journal.pone.0173516			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369096	gold, Green Published, Green Submitted			2022-12-26	WOS:000399351000010
J	Hou, FF; Li, S; Wang, JY; Kang, XP; Weng, YQ; Xing, GM				Hou, Feifan; Li, Sen; Wang, Jinyao; Kang, Xiuping; Weng, Yiqun; Xing, Guoming			Identification and validation of reference genes for quantitative real-time PCR studies in long yellow daylily, Hemerocallis citrina Borani	PLOS ONE			English	Article							CANDIDATE REFERENCE GENES; TYROSINE AMINOTRANSFERASE; RT-QPCR; SELECTION; NORMALIZATION; EXPRESSION; QUANTIFICATION; SYSTEMS	Gene expression analysis using reverse transcription quantitative real-time PCR (RTqPCR) requires the use of reference gene(s) in the target species. The long yellow daylily, Hemerocallis citrina Baroni. is rich in beneficial secondary metabolites and is considered as a functional vegetable. It is widely cultivated and consumed in East Asian countries. However, reference genes for use in RT-qPCR in H. citrina are not available. In the present study, six potential reference genes, actin (ACT), AP-4 complex subunit (AP4), tubulin (TUB), ubiquitin (UBQ), 18S and 60S ribosomal RNA, were selected and their expression stability in different developmental stages, organs and accessions was evaluated using four statistical software packages (geNorm, NormFinder, BestKeeper, and RefFinder). For commercial flower buds of different landraces, the combination of 60S, TUB, and AP4 was appropriate whereas ACTand 60S was suitable for normalization of different organs. In addition, AP4 exhibited the most stable expression in flower buds among different developmental stages. UBQ was less stable than the other reference genes under the experimental conditions except under different organs was 18S. The relative expression levels of two genes, primary-amine oxidase (HcAOC3) and tyrosine aminotransferase (HcTA 7) which play important roles in alkaloid biosynthesis were also examined in different organs of the 'Datong' landrace, which further confirmed the results of selected reference genes. This is the first report to evaluate the stability of reference genes in the long yellow daylily that can serve as a foundation for RT-qPCR analysis of gene expression in this species.	[Hou, Feifan; Li, Sen; Wang, Jinyao; Kang, Xiuping; Xing, Guoming] Shanxi Agr Univ, Hort Coll, Taigu, Peoples R China; [Weng, Yiqun] Univ Wisconsin, Dept Hort, USDA ARS, Vegetable Crops Res Unit, Madison, WI 53706 USA	Shanxi Agricultural University; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison	Xing, GM (corresponding author), Shanxi Agr Univ, Hort Coll, Taigu, Peoples R China.	xingguoming@163.com			Research Fund for the Doctoral Program of Higher Education of China [20131403110005]; Shanxi Scholarship Council of China [2015-065]	Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shanxi Scholarship Council of China	This work was supported by the Research Fund for the Doctoral Program of Higher Education of China (20131403110005) received by GX. The study design, data collection and analysis were supported by this fund. It was also funded by Shanxi Scholarship Council of China (2015-065). The decision to publish and preparation of the manuscript were supported by this fund.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Borowski JM, 2014, PLANTA, V239, P1187, DOI 10.1007/s00425-014-2041-2; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2010, METHODS, V50, P217, DOI 10.1016/j.ymeth.2009.12.006; Campos MD, 2015, SCI HORTIC-AMSTERDAM, V186, P115, DOI 10.1016/j.scienta.2014.12.038; Chen Jin, 2013, Journal of Agricultural Biotechnology, V21, P489; Chen Y, 2015, PLANT CELL REP, V34, P1825, DOI 10.1007/s00299-015-1830-9; Chervoneva I, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-253; Colebatch G, 2002, NEW PHYTOL, V153, P27, DOI 10.1046/j.0028-646X.2001.00303.x; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Du BJ, 2014, BMC COMPLEM ALTERN M, V14, P1; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Ferradas Y, 2016, PLANT PHYSIOL BIOCH, V102, P27, DOI 10.1016/j.plaphy.2016.02.011; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Gu L, 2012, J ETHNOPHARMACOL, V139, P780, DOI 10.1016/j.jep.2011.11.059; Hotta M., 1985, ORIGIN EVOLUTION DIV, P18; Iffiu-Soltesz Z, 2011, J NEURAL TRANSM, V118, P1071, DOI 10.1007/s00702-011-0586-9; Kim YB, 2014, NAT PROD COMMUN, V9, P1311; Kong FN, 2015, J APPL PHYCOL, V27, P1003, DOI 10.1007/s10811-014-0359-6; Kong QS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130865; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090612; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087197; Li W, 2015, SCI HORTIC-AMSTERDAM, V197, P99, DOI 10.1016/j.scienta.2015.09.003; Li XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141323; Lin Shih-Hang, 2013, J Tradit Complement Med, V3, P53, DOI 10.4103/2225-4110.106548; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo HL, 2014, J HORTIC SCI BIOTECH, V89, P345, DOI 10.1080/14620316.2014.11513089; Marum L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035113; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Riewe D, 2012, PLANT J, V71, P850, DOI 10.1111/j.1365-313X.2012.05035.x; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI 10.1006/bojl.2000.0380; Sun HP, 2016, PLANT PHYSIOL BIOCH, V108, P286, DOI 10.1016/j.plaphy.2016.07.022; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Venugopalan A, 2015, BIOTECHNOL ADV, V33, P873, DOI 10.1016/j.biotechadv.2015.07.004; Wang MM, 2016, PHYTOCHEMISTRY, V132, P16, DOI 10.1016/j.phytochem.2016.09.007; Wu JX, 2014, SCI HORTIC-AMSTERDAM, V176, P180, DOI 10.1016/j.scienta.2014.06.040; Xiao XL, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1922-8; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Yan JW, 2012, MOL BIOL REP, V39, P1831, DOI 10.1007/s11033-011-0925-9; Yang ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119569; Yuan JS, 2008, TRENDS PLANT SCI, V13, P165, DOI 10.1016/j.tplants.2008.02.003	42	18	23	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174933	10.1371/journal.pone.0174933	http://dx.doi.org/10.1371/journal.pone.0174933			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362875	Green Submitted, Green Published, gold			2022-12-26	WOS:000399175000053
J	Iqbal, Z; Rydning, SL; Wedding, IM; Koht, J; Pihlstrom, L; Rengmark, AH; Henriksen, SP; Tallaksen, CME; Toft, M				Iqbal, Zafar; Rydning, Siri L.; Wedding, Iselin M.; Koht, Jeanette; Pihlstrom, Lasse; Rengmark, Aina H.; Henriksen, Sandra P.; Tallaksen, Chantal M. E.; Toft, Mathias			Targeted high throughput sequencing in hereditary ataxia and spastic paraplegia	PLOS ONE			English	Article							MOLECULAR DIAGNOSIS; CEREBELLAR ATAXIAS; MOTOR NEUROPATHY; MUTATIONS; DISEASE; CLASSIFICATION; GUIDELINES; VARIANTS; GENETICS; COLLEGE	Hereditary ataxia and spastic paraplegia are heterogeneous monogenic neurodegenerative disorders. To date, a large number of individuals with such disorders remain undiagnosed. Here, we have assessed molecular diagnosis by gene panel sequencing in 105 early and late-onset hereditary ataxia and spastic paraplegia probands, in whom extensive previous investigations had failed to identify the genetic cause of disease. Pathogenic and likely-pathogenic variants were identified in 20 probands (19%) and variants of uncertain significance in ten probands (10%). Together these accounted for 30 probands (29%) and involved 18 different genes. Among several interesting findings, dominantly inherited KIF1A variants, p.(Val8Met) and p.(Ile27Thr) segregated in two independent families, both presenting with a pure spastic paraplegia phenotype. Two homozygous missense variants, p.(Gly4230Ser) and p.(Leu4221Val) were found in SACS in one consanguineous family, presenting with spastic ataxia and isolated cerebellar atrophy. The average disease duration in probands with pathogenic and likely-pathogenic variants was 31 years, ranging from 4 to 51 years. In conclusion, this study confirmed and expanded the clinical phenotypes associated with known disease genes. The results demonstrate that gene panel sequencing and similar sequencing approaches can serve as efficient diagnostic tools for different heterogeneous disorders. Early use of such strategies may help to reduce both costs and time of the diagnostic process.	[Iqbal, Zafar; Rydning, Siri L.; Wedding, Iselin M.; Pihlstrom, Lasse; Rengmark, Aina H.; Henriksen, Sandra P.; Tallaksen, Chantal M. E.; Toft, Mathias] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Rydning, Siri L.; Wedding, Iselin M.; Koht, Jeanette; Pihlstrom, Lasse; Tallaksen, Chantal M. E.] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Koht, Jeanette] Vestre Viken Hosp Trust, Dept Neurol, Drammen Hosp, Drammen, Norway	University of Oslo; University of Oslo	Iqbal, Z (corresponding author), Oslo Univ Hosp, Dept Neurol, Oslo, Norway.	iqbal.z.phd@gmail.com	Toft, Mathias/AAY-5212-2021	Toft, Mathias/0000-0002-6723-6865; Lynne Rydning, Siri/0000-0001-9584-0325; Koht, Jeanette/0000-0002-5499-0818; Iqbal, Zafar/0000-0002-1334-6372; Iqbal, Zafar/0000-0002-6387-8019	South-Eastern Norway Regional Health Authority; Research Council of Norway	South-Eastern Norway Regional Health Authority; Research Council of Norway(Research Council of Norway)	Z.I., I.M.W., and L.P. have been supported by grants from the South-Eastern Norway Regional Health Authority. M.T. and A.H.R. have received funding from the Research Council of Norway. M.T. is also supported by a career fellowship from the South-Eastern Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Z.I., I.M.W., and L.P have been supported by grants from the South-Eastern Norway Regional Health Authority. M.T., and A.H.R have received funding from the Research Council of Norway. M.T is also supported by a career fellowship from the South-Eastern Norway Regional Health Authority. The sequencing service was provided by the Norwegian Sequencing Centre (www.sequencing.uio.no), a national technology platform hosted by the University of Oslo and supported by the "Functional Genomics" and "Infrastructure" programs of the Research Council of Norway and the South-Eastern Norway Regional Health Authority. We are thankful to the families and probands who participated in this study. We also thank Maninder Chawla for radiological assistance and Charalampos Tzoulis for assistance in clinical examination.	Amendola LM, 2015, GENOME RES, V25, P305, DOI 10.1101/gr.183483.114; Arnoldi A, 2008, HUM MUTAT, V29, P522, DOI 10.1002/humu.20682; Boycott K, 2015, J MED GENET, V52, P431, DOI 10.1136/jmedgenet-2015-103144; De Warrenburg BPV, 2016, EUR J HUM GENET, V24, P1460, DOI 10.1038/ejhg.2016.42; Dewey FE, 2014, JAMA-J AM MED ASSOC, V311, P1035, DOI 10.1001/jama.2014.1717; Durr A, 2010, LANCET NEUROL, V9, P885, DOI 10.1016/S1474-4422(10)70183-6; Erichsen AK, 2007, EUR J NEUROL, V14, P809, DOI 10.1111/j.1468-1331.2007.01861.x; Erichsen AK, 2009, BRAIN, V132, P1577, DOI 10.1093/brain/awp056; Erlich Y, 2011, GENOME RES, V21, P658, DOI 10.1101/gr.117143.110; Espinos C, 2009, ADV EXP MED BIOL, V652, P263, DOI 10.1007/978-90-481-2813-6_18; Fink JK, 1996, NEUROLOGY, V46, P1507, DOI 10.1212/WNL.46.6.1507; Fink JK, 2014, SEMIN NEUROL, V34, P293, DOI 10.1055/s-0034-1386767; Fogel BL, 2014, JAMA NEUROL, V71, P1237, DOI 10.1001/jamaneurol.2014.1944; Gasser T, 2010, EUR J NEUROL, V17, P179, DOI 10.1111/j.1468-1331.2009.02873.x; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; Goizet C, 2009, HUM MUTAT, V30, pE376, DOI 10.1002/humu.20920; HARDING AE, 1983, LANCET, V1, P1151; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hensiek A, 2015, J NEUROL, V262, P1601, DOI 10.1007/s00415-014-7598-y; Kara E, 2016, BRAIN, V139, P1904, DOI 10.1093/brain/aww111; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar KR, 2013, J NEUROL, V260, P2516, DOI 10.1007/s00415-013-7008-x; Langlois S, 2016, EUR J HUM GENET, V24, P949, DOI 10.1038/ejhg.2015.217; Lee YC, 2012, ANN NEUROL, V72, P859, DOI 10.1002/ana.23701; Lo Giudice T, 2014, EXP NEUROL, V261, P518, DOI 10.1016/j.expneurol.2014.06.011; Lupo V, 2016, J MOL DIAGN, V18, P225, DOI 10.1016/j.jmoldx.2015.10.005; Morgan S, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.12.017; Nemeth AH, 2013, BRAIN, V136, P3106, DOI 10.1093/brain/awt236; Neveling K, 2013, HUM MUTAT, V34, P1721, DOI 10.1002/humu.22450; Ohba C, 2013, NEUROGENETICS, V14, P225, DOI 10.1007/s10048-013-0375-8; Pihlstrom L, 2014, ANN HUM GENET, V78, P243, DOI 10.1111/ahg.12060; Pilliod J, 2015, ANN NEUROL, V78, P871, DOI 10.1002/ana.24509; Pyle A, 2015, BRAIN, V138, P276, DOI 10.1093/brain/awu348; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rydning SL, 2016, EUR J NEUROL, V23, P763, DOI 10.1111/ene.12937; Sanchez-Ferrero E, 2013, CLIN GENET, V83, P257, DOI 10.1111/j.1399-0004.2012.01896.x; Sandford E, 2014, GENES-BASEL, V5, P586, DOI 10.3390/genes5030586; Sawyer SL, 2014, HUM MUTAT, V35, P45, DOI 10.1002/humu.22451; Schulz JB, 2009, NAT REV NEUROL, V5, P222, DOI 10.1038/nrneurol.2009.26; Storey E, 2014, SEMIN NEUROL, V34, P280, DOI 10.1055/s-0034-1386766; Valencia CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053083; Vissers LELM, 2016, NAT REV GENET, V17, P9, DOI 10.1038/nrg3999; Wedding IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086340; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313; Ylikallio E, 2015, EUR J HUM GENET, V23, P1427, DOI 10.1038/ejhg.2014.297	45	38	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174667	10.1371/journal.pone.0174667	http://dx.doi.org/10.1371/journal.pone.0174667			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362824	Green Published, gold			2022-12-26	WOS:000399175000027
J	Kibira, SPS; Daniel, M; Atuyambe, LM; Makumbi, FE; Sandoy, IF				Kibira, Simon P. S.; Daniel, Marguerite; Atuyambe, Lynn Muhimbuura; Makumbi, Fredrick Edward; Sandoy, Ingvild Fossgard			Exploring drivers for safe male circumcision: Experiences with health education and understanding of partial HIV protection among newly circumcised men in Wakiso, Uganda	PLOS ONE			English	Article							MEDICAL MALE CIRCUMCISION; HUMAN-PAPILLOMAVIRUS; INFECTION RISK; YOUNG MEN; SCALE-UP; PREVENTION; RAKAI; TRIAL; WOMEN; MOTIVATORS	Introduction About 2.5 million men have voluntarily been circumcised since Uganda started implementing the WHO recommendation to scale up safe male circumcision to reduce HIV transmission. This study sought to understand what influences men's circumcision decisions, their experiences with health education at health facilities and their knowledge of partial HIV risk reduction in Wakiso district. Methods Data were collected in May and June 2015 at five public health facilities in Wakiso District. Twenty-five in-depth interviews were held with adult safe male circumcision clients. Data were analysed using thematic network analysis. Findings Safe male circumcision decisions were mainly influenced by sexual partners, a perceived need to reduce the risk of HIV/S-11s, community pressure and other benefits like hygiene. Sexual partners directly requested men to circumcise or indirectly influenced them in varied ways. Health education at facilities mainly focused on the surgical procedure, circumcision benefits especially HIV risk reduction, wound care and time to resumption of sex, with less focus on post-circumcision sexual behaviour. Five men reported no health education. All men reported that circumcision only reduces and does not eliminate HIV risk, and could mention ways it protects, although some extended the benefit to direct protection for women and prevention of other STIs. Five men thought social marketing messages were 'misleading' and feared risk compensation within the community. Conclusions Participants reported positive community perception about safe male circumcision campaigns, influencing men to seek services and enabling female partners to impact this decision-making process. However, there seemed to be gaps in safe male circumcision health education, although all participants correctly understood that circumcision offers only partial protection from HIV. Standard health education procedures, if followed at health facilities offering safe male circumcision, would ensure all clients are well informed, especially about post-circumcision sexual behaviour that is key to prevention of risk compensation.	[Kibira, Simon P. S.; Sandoy, Ingvild Fossgard] Univ Bergen, Dept Global Publ Hlth & Primary Care, Ctr Int Hlth, Bergen, Norway; [Kibira, Simon P. S.; Atuyambe, Lynn Muhimbuura] Makerere Univ, Sch Publ Hlth, Dept Community Hlth & Behav Sci, Kampala, Uganda; [Daniel, Marguerite] Univ Bergen, Dept Hlth Promot & Dev, Bergen, Norway; [Makumbi, Fredrick Edward] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda	University of Bergen; Makerere University; University of Bergen; Makerere University	Kibira, SPS (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Ctr Int Hlth, Bergen, Norway.; Kibira, SPS (corresponding author), Makerere Univ, Sch Publ Hlth, Dept Community Hlth & Behav Sci, Kampala, Uganda.	pskibira@gmail.com	Sandøy, Ingvild Fossgard/ABD-3557-2020	Sandoy, Ingvild/0000-0001-5567-4588; Kibira, Simon Peter Sebina/0000-0002-7385-423X	Norwegian State Education Loan Fund (Statens lanekasse); University of Bergen, Norway and Makerere University, Uganda; SPSK	Norwegian State Education Loan Fund (Statens lanekasse); University of Bergen, Norway and Makerere University, Uganda; SPSK	The study was supported by the Norwegian State Education Loan Fund (Statens lanekasse), the University of Bergen, Norway and Makerere University, Uganda. SPSK received the scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, WHO PROGR BRIEF VOL; [Anonymous], 2016, NAT POP HOUS CENS 20; Attride-Stirling J, 2001, QUAL RES, V1, P385, DOI DOI 10.1177/146879410100100307; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Cook R, 2015, AIDS BEHAV; Fleming PJ, 2016, J SEX RES, P1; Friedland BA, 2013, AIDS BEHAV, V17, P2269, DOI 10.1007/s10461-013-0424-1; Geldsetzer P, 2015, BENEFITS COSTS HIV A; George G, 2014, AJAR-AFR J AIDS RES, V13, P179, DOI 10.2989/16085906.2014.943253; Grabowski MK, 2016, J INFECT DIS, V213, P948, DOI 10.1093/infdis/jiv541; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hallett TB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002212; Herman-Roloff A, 2012, AIDS BEHAV, V16, P1173, DOI 10.1007/s10461-011-0073-1; Herman-Roloff A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019814; Humphries H, 2015, CULT HEALTH SEX, V17, P920, DOI 10.1080/13691058.2014.992045; Johns Hopkins Bloomberg School of Public Health Center for Communication Programs, 2012, HLTH COMM PARTN UG 2; Jones D, 2014, AIDS BEHAV, V18, P278, DOI 10.1007/s10461-013-0530-0; Kalichman S, 2007, PLOS MED, V4, P597, DOI 10.1371/journal.pmed.0040138; Kibira SPS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144843; Kong XR, 2014, AIDS BEHAV, V18, P880, DOI 10.1007/s10461-014-0740-0; L'Engle K, 2014, HEALTH EDUC RES, V29, P122, DOI 10.1093/her/cyt103; Layer EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074391; Maughan-Brown B, 2015, AIDS BEHAV, V19, P1170, DOI 10.1007/s10461-014-0882-0; Mehta SD, 2013, AIDS, V27, P2899, DOI 10.1097/01.aids.0000432444.30308.2d; Ministry of Health, 2012, IND HLTH PROF; Ministry of Health [Uganda] ICF International Centers for Disease Control and Prevention [Uganda] U. S. Agency for International Development & WHO Uganda, 2012, UG AIDS IND SURV 201; Muhamadi L, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.117.2540; Mukama T, 2015, PAN AFR MED J, V22, DOI 10.11604/pamj.2015.22.354.7125; Nevin PE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145543; Osaki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139009; Plotkin M, 2013, GLOB HEALTH-SCI PRAC, V1, P108, DOI 10.9745/GHSP-D-12-00037; Rakai Health Sciences Program and Johns Hopkins Bloomberg School of Public Health, 2012, GUID COMM GAM COMP S; Riess TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097748; Riess TH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012366; Shacham Enbal, 2014, J Int Assoc Provid AIDS Care, V13, P443, DOI 10.1177/2325957413508319; Ssekubugu R, 2013, QUAL HEALTH RES, V23, P795, DOI 10.1177/1049732313482189; The Republic of Uganda. Ministry of Health, 2010, SAF MAL CIRC HIV PRE; The Republic of Uganda. Ministry of Health, 2012, UND SAF MAL CIRC HIV; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Toefy Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133156; Uganda AIDS Commission, 2015, HIV AIDS UG PROGR RE; UNAIDS, 2016, 20162021 UNAIDS; United Nations, 2015, 2030 AG SUST DEV; Wawer MJ, 2011, LANCET, V377, P209, DOI 10.1016/S0140-6736(10)61967-8; Westercamp M, 2012, AIDS CARE, V24, P157, DOI 10.1080/09540121.2011.597944; WHO/UNAIDS, 2011, JOINT STRAT ACT FRAM; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Wirth KE, 2016, AIDS CARE, P1; World Health Organization, 2007, NEW DAT MAL CIRC HIV; World Health Organization, 2009, MAN MAL CIRC LOC AN; Zulu R, 2015, GLOB HEALTH-SCI PRAC, V3, P606, DOI 10.9745/GHSP-D-15-00163	53	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0175228	10.1371/journal.pone.0175228	http://dx.doi.org/10.1371/journal.pone.0175228			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VK	28362880	gold, Green Published, Green Submitted			2022-12-26	WOS:000399175000076
J	Masha, SC; Wahome, E; Vaneechoutte, M; Cools, P; Crucitti, T; Sanders, EJ				Masha, Simon Chengo; Wahome, Elizabeth; Vaneechoutte, Mario; Cools, Piet; Crucitti, Tania; Sanders, Eduard J.			High prevalence of curable sexually transmitted infections among pregnant women in a rural county hospital in Kilifi, Kenya	PLOS ONE			English	Article							ACUTE HIV-1 INFECTION; TRICHOMONAS-VAGINALIS; BACTERIAL VAGINOSIS; RISK-FACTORS; CHLAMYDIA; NAIROBI; ACQUISITION; POSTPARTUM; GONORRHEA; DIAGNOSIS	Background Women attending antenatal care (ANC) in resource-limited countries are frequently screened for syphilis and HIV, but rarely for other sexually transmitted infections (STIs). We assessed the prevalence of curable STIs, defined as infection with either Chlamydia trachomatis or Neisseria gonorrhoeae or Trichomonas vaginalis, from July to September 2015. Methods In a cross-sectional study, women attending ANC at the Kilifi County Hospital, Kenya, had a urine sample tested for C. trachomatis/N. gonorrhoeae by GeneXpert and a vaginal swab for T. vaginalis by culture. Bacterial vaginosis (BV) was defined as a Nugent score of 7-10 of the Gram stain of a vaginal smear in combination with self-reported vaginal discharge. Genital ulcers were observed during collection of vaginal swabs. All women responded to questions on socio-demographics and sexual health and clinical symptoms of STIs. Predictors for curable STIs were assessed in multivariable logistic regression. Results A total of 42/202 (20.8%, 95% confidence interval (CI):15.4-27.0) women had a curable STI. The prevalence was 14.9% for C. trachomatis (95% Cl:10.2-20.5), 1.0% for N. gonorrhoeae (95% CI: 0.1-3.5), 7.4% for T. vaginalis (95% CI:4.2-12.0), 19.3% for BV (95% CI: 14.1-25.4) and 2.5% for genital ulcers (95% CI: 0.8-5.7). Predictors for infection with curable STIs included women with a genital ulcer (adjusted odds ratio (AOR) = 35.0, 95% CI: 2.7-461.6) compared to women without a genital ulcer, women who used water for cleaning after visiting the toilet compared to those who used toilet paper or other solid means (AOR = 4.1, 95% CI:1.5-11.3), women who reported having sexual debut <= 17 years compared to women having sexual debut >= 18 years (AOR = 2.7, 95% Cl:1.1-6.6), and BV-positive women (AOR = 2.7, 95% Cl:1.1-6.6) compared to BV-negative women. Conclusion One in five women attending ANC had a curable STI. These infections were associated with genital ulcers, hygiene practices, early sexual debut and bacterial vaginosis.	[Masha, Simon Chengo; Wahome, Elizabeth; Sanders, Eduard J.] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya; [Masha, Simon Chengo; Vaneechoutte, Mario; Cools, Piet] Univ Ghent, Fac Med & Hlth Sci, Lab Bacteriol Res, Ghent, Belgium; [Masha, Simon Chengo] Pwani Univ, Fac Pure & Appl Sci, Dept Biol Sci, Kilifi, Kenya; [Crucitti, Tania] Inst Trop Med, Dept Clin Sci, HIV STI Reference Lab, Antwerp, Belgium; [Sanders, Eduard J.] Univ Oxford, Nuffield Dept Med, Headington, England	Kenya Medical Research Institute; Ghent University; Pwani University; Institute of Tropical Medicine (ITM); University of Oxford	Masha, SC (corresponding author), Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya.; Masha, SC (corresponding author), Univ Ghent, Fac Med & Hlth Sci, Lab Bacteriol Res, Ghent, Belgium.; Masha, SC (corresponding author), Pwani Univ, Fac Pure & Appl Sci, Dept Biol Sci, Kilifi, Kenya.	schengo@kemri-wellcome.org	Crucitti, Tania/AAH-1902-2021; Vaneechoutte, Mario/A-6189-2009; Crucitti, Tania/AEQ-9792-2022; Crucitti, Tania/AAB-9967-2019; Masha, Simon/R-4419-2017	Vaneechoutte, Mario/0000-0002-4586-203X; Crucitti, Tania/0000-0002-2235-6038; Crucitti, Tania/0000-0002-2235-6038; Masha, Simon/0000-0002-6283-2430; Cools, Piet/0000-0003-2980-5307	Belgian Development Cooperation; International AIDS Vaccine Initiative; USAID; Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP) at the Centre for Geographical Medicine Research-Kilifi is - from the Wellcome Trust [077092]	Belgian Development Cooperation; International AIDS Vaccine Initiative; USAID(United States Agency for International Development (USAID)); Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP) at the Centre for Geographical Medicine Research-Kilifi is - from the Wellcome Trust	SCM is supported for his PhD by the Belgian Development Cooperation. SCM received Investigator initiated research funds from International AIDS Vaccine Initiative, who are funded by USAID. The Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP) at the Centre for Geographical Medicine Research-Kilifi is supported by core funding from the Wellcome Trust (#077092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbai NS, 2015, INT J STD AIDS; Adachi K, 2016, BIOMED RES INT, V2016; Adachi K, 2015, SEX TRANSM DIS, V42, P554, DOI 10.1097/OLQ.0000000000000340; AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Balkus JE, 2016, J INFECT DIS, V213, P1932, DOI 10.1093/infdis/jiw043; Brown JE, 2000, SEX TRANSM DIS, V27, P183, DOI 10.1097/00007435-200004000-00001; Buve A, 2014, AIDS, V28, P2333, DOI 10.1097/QAD.0000000000000432; Chan Philip A, 2016, Infect Dis Obstet Gynecol, V2016, P5758387, DOI 10.1155/2016/5758387; Chersich MF, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-51; Cools P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148052; Crucitti T, 2010, SEX TRANSM DIS, V37, P223, DOI 10.1097/OLQ.0b013e3181c21f93; Duncan S, 2011, SEX TRANSM INFECT, V87, P231, DOI 10.1136/sti.2010.048777; El Aila NA, 2011, RES MICROBIOL, V162, P506, DOI 10.1016/j.resmic.2011.04.004; Fichorova RN, 2013, SEX TRANSM INFECT, V89, P460, DOI 10.1136/sextrans-2013-051052; Fonck K, 2000, SEX TRANSM INFECT, V76, P33, DOI 10.1136/sti.76.1.33; Gomih-Alakija A, 2014, J CLIN MICROBIOL, V52, P3660, DOI 10.1128/JCM.00850-14; Gunn JKL, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20605; Hallett TB, 2007, STUD FAMILY PLANN, V38, P1, DOI 10.1111/j.1728-4465.2007.00111.x; Kenya National Bureau of Statistics and Society for International Development, 2013, EXPL KEN IN PULL AP; Kenyon C, 2013, AM J OBSTET GYNECOL, V209, P505, DOI 10.1016/j.ajog.2013.05.006; Kimanga DO, 2014, JAIDS-J ACQ IMM DEF, V66, pS13, DOI 10.1097/QAI.0000000000000124; Kinuthia J, 2015, AIDS, V29, P2025, DOI 10.1097/QAD.0000000000000793; Kohli Ruchika, 2013, BMC Res Notes, V6, P44, DOI 10.1186/1756-0500-6-44; Kuznik A, 2015, SEX TRANSM DIS, V42, P369, DOI 10.1097/OLQ.0000000000000291; Ma QQ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-111; Madhivanan P, 2009, TROP MED INT HEALTH, V14, P703, DOI 10.1111/j.1365-3156.2009.02274.x; Maina Anne Njeri, 2016, BMC Res Notes, V9, P193, DOI 10.1186/s13104-016-1990-x; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; Ministry of Health Kenya National guidelines for Reproductive Tract Infection Services, 2006, NAT GUID REPR TRACT; Mullick S, 2005, SEX TRANSM INFECT, V81, P294, DOI 10.1136/sti.2002.004077; Naveca FG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063953; Ness RB, 2005, SEX TRANSM DIS, V32, P413, DOI 10.1097/01.olq.0000154493.87451.8d; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Nyiro JU, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-155; OFARRELL N, 1994, GENITOURIN MED, V70, P7; Pereira-Neves A, 2008, EXP PARASITOL, V118, P438, DOI 10.1016/j.exppara.2007.09.005; Pettifor A, 2000, SEX TRANSM DIS, V27, P371, DOI 10.1097/00007435-200008000-00002; Powers KA, 2007, AIDS, V21, P2237, DOI 10.1097/QAD.0b013e3282f08b4d; Rafferty H, ASSESSING TRAINING N; Sanders EJ, 2015, AIDS, V29, pS221, DOI 10.1097/QAD.0000000000000924; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; Sorvillo F, 1998, LANCET, V351, P213, DOI 10.1016/S0140-6736(05)78181-2; Terris-Prestholt Fern, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS73, DOI 10.1016/j.ijgo.2015.04.007; Unger JA, 2015, SEX TRANSM DIS, V42, P637, DOI 10.1097/OLQ.0000000000000355; Van Der Pol B, 2008, J INFECT DIS, V197, P548, DOI 10.1086/526496; WHO World Health Organisation STD Statistics, 2001, GLOB PREV INC SEL CU; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; World Health Organization, 2004, GUID MAN SEX TRANSM	50	28	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0175166	10.1371/journal.pone.0175166	http://dx.doi.org/10.1371/journal.pone.0175166			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362869	Green Published, Green Submitted, gold			2022-12-26	WOS:000399175000074
J	Reed, RM; Dransfield, MT; Eberlein, M; Miller, M; Netzer, G; Pavlovich, M; Pollin, TI; Scharf, SM; Shuldiner, AR; Sin, D; Mitchell, BD				Reed, Robert M.; Dransfield, Mark T.; Eberlein, Michael; Miller, Michael; Netzer, Giora; Pavlovich, Mary; Pollin, Toni I.; Scharf, Steven M.; Shuldiner, Alan R.; Sin, Don; Mitchell, Braxton D.			Gender differences in first and secondhand smoke exposure, spirometric lung function and cardiometabolic health in the old order Amish: A novel population without female smoking	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; PASSIVE SMOKING; PARENTAL SMOKING; NEVER-SMOKERS; RISK; WOMEN; DISEASE; ADULTS; ATHEROSCLEROSIS; ASSOCIATION	Due to their relatively homogeneous lifestyle and living environment, the Amish offer a novel opportunity to study the health associations of tobacco smoke exposure, particularly secondhand smoke. We hypothesized that secondhand smoke exposure is associated with worse pulmonary and cardiometabolic health. We examined cross-sectional data on 3568 Amish study participants, including tobacco use and secondhand smoke exposure from family members included in the study. Thirty-four percent of Amish men reported ever smoking. Of this proportion, 64% used cigars, 46% cigarettes, and 21% pipes. Less than 1% of women reported ever smoking. Smoking was associated with lower spirometric lung function, higher body mass index, lower HDL cholesterol, higher heart rate, lower ankle-brachial index, and larger aortic diameter in men. A greater number of sources of secondhand smoke exposure (defined from the total of spouses, parents, and siblings who smoke) was associated with higher body mass index (p = 0.03) and with higher fasting glucose in men (p = 0.01), but not in women (p = 0.007 for sex* secondhand smoke interaction). Second-hand smoke exposure was also associated with reduced HDL cholesterol only in women (p = 0.002) and a lower heart rate only in men (p = 0.006). Smoking habits among the Old Order Amish are notable for the absence of female participation and a high proportion of cigar and pipe use. Smoking is associated with decreased spirometric indices of lung function and increased cardiovascular risk in this population and secondhand smoke exposure is associated with a greater burden of risk factors for cardiovascular disease. Sex differences in correlations could reflect differences in exposure patterns, mechanisms, or susceptibilities.	[Reed, Robert M.; Netzer, Giora; Scharf, Steven M.] Univ Maryland, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA; [Dransfield, Mark T.] Univ Alabama Birmingham, Sch Med, Div Pulm & Crit Care Med, Birmingham, AL USA; [Eberlein, Michael] Univ Iowa, Sch Med, Div Pulm & Crit Care Med, Iowa City, IA 52242 USA; [Miller, Michael; Pavlovich, Mary; Pollin, Toni I.; Shuldiner, Alan R.; Mitchell, Braxton D.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Miller, Michael; Shuldiner, Alan R.; Mitchell, Braxton D.] GRECC, Dept Vet Affairs, Baltimore, MD USA; [Miller, Michael; Shuldiner, Alan R.; Mitchell, Braxton D.] GRECC, Vet Affairs Med Ctr Baltimore, Baltimore, MD USA; [Miller, Michael; Netzer, Giora; Pavlovich, Mary; Pollin, Toni I.; Shuldiner, Alan R.; Mitchell, Braxton D.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Sin, Don] Univ British Columbia, Resp Med, Vancouver, BC, Canada	University System of Maryland; University of Maryland Baltimore; University of Alabama System; University of Alabama Birmingham; University of Iowa; University System of Maryland; University of Maryland Baltimore; Geriatric Research Education & Clinical Center; Geriatric Research Education & Clinical Center; University System of Maryland; University of Maryland Baltimore; University of British Columbia	Reed, RM (corresponding author), Univ Maryland, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21201 USA.	rreed@medicine.umaryland.edu	Sin, Don/AAC-2219-2021; Miller, Michael/AGX-6773-2022; Mitchell, Braxton/CAF-0876-2022	Miller, Michael/0000-0002-1679-2095; Eberlein, Michael/0000-0001-6108-2546; Shuldiner, Alan/0000-0001-9921-4305	Flight Attendants Medical Research Institute; Institute for Clinical and Translational Science (ICTS) at the University of Iowa via the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program [2 UL1 TR000442-06]; Department of Veterans Affairs and Veterans Affairs Medical Center Baltimore Geriatric Research, Education and Clinical Center; University of Maryland General Clinical Research Center [M01 RR 16500];  [R01 HL088119-03];  [U01 GM074518-05];  [NIH K12 HD052224-05];  [R01 HL69313];  [U01 HL72515]	Flight Attendants Medical Research Institute; Institute for Clinical and Translational Science (ICTS) at the University of Iowa via the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program; Department of Veterans Affairs and Veterans Affairs Medical Center Baltimore Geriatric Research, Education and Clinical Center; University of Maryland General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; ; ; ; 	Robert M. Reed is supported in part by the Flight Attendants Medical Research Institute. Michael Eberlein is supported by a PILOT grant from the Institute for Clinical and Translational Science (ICTS) at the University of Iowa via the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program, grant 2 UL1 TR000442-06. Dr. Mitchell is funded in part by the Department of Veterans Affairs and Veterans Affairs Medical Center Baltimore Geriatric Research, Education and Clinical Center. This work was made possible by funding from: R01 HL088119-03, U01 GM074518-05, NIH K12 HD052224-05, R01 HL69313, U01 HL72515 and the University of Maryland General Clinical Research Center (grant M01 RR 16500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration SAaMHS, 2007, RES 2006 NAT SURV DR; [Anonymous], 2013, THE AMISH; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Brand JS, 2011, J CLIN ENDOCR METAB, V96, P3184, DOI 10.1210/jc.2011-1165; Carey IM, 1999, EPIDEMIOLOGY, V10, P319, DOI 10.1097/00001648-199905000-00022; Carson AP, 2007, ANN EPIDEMIOL, V17, P296, DOI 10.1016/j.annepidem.2006.07.009; Dockery DW, 1997, CANCER CAUSE CONTROL, V8, P333, DOI 10.1023/A:1018401120233; Durmus B, 2011, AM J CLIN NUTR, V94, P164, DOI 10.3945/ajcn.110.009225; El-Mas MM, 2012, J PHARMACOL EXP THER, V342, P568, DOI 10.1124/jpet.112.191940; Eze IC, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-74; Ferketich AK, 2008, J RURAL HEALTH, V24, P84, DOI 10.1111/j.1748-0361.2008.00141.x; FINGERHUT LA, 1990, AM J PUBLIC HEALTH, V80, P541, DOI 10.2105/AJPH.80.5.541; Geerts CC, 2008, ARTERIOSCL THROM VAS, V28, P2296, DOI 10.1161/ATVBAHA.108.173229; Hagstad S, 2014, CHEST, V145, P1298, DOI 10.1378/chest.13-1349; Hamer M, 2010, ARCH GEN PSYCHIAT, V67, P850, DOI 10.1001/archgenpsychiatry.2010.76; Jefferis BJ, 2010, ATHEROSCLEROSIS, V208, P550, DOI 10.1016/j.atherosclerosis.2009.07.044; KAUFFMANN F, 1989, INT J EPIDEMIOL, V18, P334, DOI 10.1093/ije/18.2.334; Kim HW, 2014, ENVIRON RES, V135, P354, DOI 10.1016/j.envres.2014.08.032; Law MR, 2003, PROG CARDIOVASC DIS, V46, P31, DOI 10.1016/S0033-0620(03)00078-1; Le-Ha C, 2013, J CLIN ENDOCR METAB, V98, P2126, DOI 10.1210/jc.2013-1016; Lu L, 2014, EUR J VASC ENDOVASC, V48, P703, DOI 10.1016/j.ejvs.2014.09.008; McConnell R, 2015, ENVIRON HEALTH PERSP, V123, P360, DOI 10.1289/ehp.1307031; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; National Cancer Institute (NCI), 1998, SMOKING TOBACCO CONT, V9; Nugent KL, 2014, NICOTINE TOB RES, V16, P923, DOI 10.1093/ntr/ntu006; Pan A, 2015, LANCET DIABETES ENDO; Post W, 2007, CIRCULATION, V115, P717, DOI 10.1161/CIRCULATIONAHA.106.637512; Reed RM, 2014, J ACAD NUTR DIET; SCHILLING RSF, 1977, AM J EPIDEMIOL, V106, P274, DOI 10.1093/oxfordjournals.aje.a112463; SEMMENS J, 1983, METABOLISM, V32, P428, DOI 10.1016/0026-0495(83)90002-1; Services U.S.D.o.H.a.H., 2014, HLTH CONS SMOK 50 YE; Services UDoHaH, 2006, HLTH CONS INV EXP TO; Simonetti GD, 2011, CIRCULATION, V123, P292, DOI 10.1161/CIRCULATIONAHA.110.958769; Sorkin J, 2005, MECH AGEING DEV, V126, P347, DOI 10.1016/j.mad.2004.08.027; SPITZER WO, 1990, CLIN INVEST MED, V13, P17; Sun C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103934; SVENDSEN KH, 1987, AM J EPIDEMIOL, V126, P783, DOI 10.1093/oxfordjournals.aje.a114715; (US) CfDCaP (US) NCfCDPaHP (US) OoSaH, 2010, TOB SMOK CAUS DIS BI; Wald NJ, 1997, BMJ-BRIT MED J, V314, P1860, DOI 10.1136/bmj.314.7098.1860; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Zhang XL, 2005, AM J EPIDEMIOL, V161, P213, DOI 10.1093/aje/kwi028	42	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174354	10.1371/journal.pone.0174354	http://dx.doi.org/10.1371/journal.pone.0174354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VK	28362870	Green Published, gold, Green Submitted			2022-12-26	WOS:000399175000014
J	Eastwood, MP; Joyeux, L; Pranpanus, S; Van der Merwe, J; Verbeken, E; De Vleeschauwer, S; Gayan-Ramirez, G; Deprest, J				Eastwood, Mary Patrice; Joyeux, Luc; Pranpanus, Savitree; Van der Merwe, Johannes; Verbeken, Eric; De Vleeschauwer, Stephanie; Gayan-Ramirez, Ghislaine; Deprest, Jan			A growing animal model for neonatal repair of large diaphragmatic defects to evaluate patch function and outcome	PLOS ONE			English	Article							RABBIT MODEL; FOLLOW-UP; HERNIA; INFANTS; RECONSTRUCTION; ABNORMALITIES; SURVIVAL; MUSCLES; FETUSES; WALL	Objectives We aimed to develop a more representative model for neonatal congenital diaphragmatic hernia repair in a large animal model, by creating a large defect in a fast-growing pup, using functional pulmonary and diaphragmatic read outs. Background Grafts are increasingly used to repair congenital diaphragmatic hernia with the risk of local complications. Growing animal models have been used to test novel materials. Methods 6-week-old rabbits underwent fiberoptic intubation, left subcostal laparotomy and hemi-diaphragmatic excision (either nearly complete (n = 13) or 3*3cm (n = 9)) and primary closure (Gore-Tex patch). Survival was further increased by moving to laryngeal mask airway ventilation (n = 15). Sham operated animals were used as controls (n = 6). Survivors (90 days) underwent chest X-Ray (scoliosis), measurements of maximum transdiaphragmatic pressure and breathing pattern (tidal volume, Pdi). Rates of herniation, lung histology and right hemi-diaphragmatic fiber cross-sectional area was measured. Results Rabbits surviving 90 days doubled their weight. Only one (8%) with a complete defect survived to 90 days. In the 3*3cm defect group all survived to 48 hours, however seven (78%) died later (16-49 days) from respiratory failure secondary to tracheal stricture formation. Use of a laryngeal mask airway doubled 90-day survival, one pup displaying herniation (17%). Cobb angel measurements, breathing pattern, and lung histology were comparable to sham. Under exertion, sham animals increased their maximum transdiaphragmatic pressure 134% compared to a 71% increase in patched animals (p<0.05). Patched animals had a compensatory increase in their right hemi-diaphragmatic fiber cross-sectional area (p<0.0001). Conclusions A primarily patched 3*3cm defect in growing rabbits, under laryngeal mask airway ventilation, enables adequate survival with normal lung function and reduced maximum trans diaphragmatic pressure compared to controls.	[Eastwood, Mary Patrice; Joyeux, Luc; Pranpanus, Savitree; Van der Merwe, Johannes; Deprest, Jan] Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium; [Pranpanus, Savitree] Prince Songkla Univ, Dept Obstet & Gynaecol, Hat Yai, Thailand; [Van der Merwe, Johannes; Deprest, Jan] Univ Hosp Leuven, Clin Dept Obstet & Gynaecol, Leuven, Belgium; [Verbeken, Eric] Univ Hosp Leuven, Dept Pathol, Grp Biomed Sci, Leuven, Belgium; [De Vleeschauwer, Stephanie] Katholieke Univ Leuven, Lab Anim Ctr, Leuven, Belgium; [Gayan-Ramirez, Ghislaine] Katholieke Univ Leuven, Lab Pneumol, Leuven, Belgium	KU Leuven; Prince of Songkla University; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven	Deprest, J (corresponding author), Katholieke Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium.; Deprest, J (corresponding author), Univ Hosp Leuven, Clin Dept Obstet & Gynaecol, Leuven, Belgium.	jan.deprest@uzleuven.be	van der Merwe, Hannes/H-7598-2019; Joyeux, Luc/H-7210-2019; van der Merwe, Hannes/GQP-1098-2022	van der Merwe, Hannes/0000-0002-1381-4033; Joyeux, Luc/0000-0001-7331-6354; Deprest, Jan/0000-0002-4920-945X; Eastwood, Mary/0000-0002-6437-8972; Gayan-Ramirez, Ghislaine/0000-0001-9652-7437	NIH Wellcome Trust; Engineering and Physical Sciences Research Council (EPSRC) [WT101957, NS/A000027/1]; Erasmus + Programme of the European Union [2013-0040]	NIH Wellcome Trust; Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Erasmus + Programme of the European Union	JDP is a Clinical Researcher of the Flanders Research Foundation (FWO Vlaanderen). LJ is a beneficiary of a NIH Wellcome Trust and Engineering and Physical Sciences Research Council (EPSRC) grant (GIFT-Surg project; WT101957 and NS/A000027/1). MPE and JvdM are funded with support of the Erasmus + Programme of the European Union (Framework Agreement number: 2013-0040). This publication reflects the views only of the author, and the Commission cannot be held responsible for any use which may be made of the information contained therein.	Aikawa M, 2013, SURG TODAY, V43, P1298, DOI 10.1007/s00595-012-0414-3; Al-Maary J, 2016, ANN SURG, V264, P929, DOI 10.1097/SLA.0000000000001675; Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; Bohm G, 2011, J BIOMATER APPL, V25, P771, DOI 10.1177/0885328209360423; Bojanic K, 2016, PEDIATR PULM, V51, P1320, DOI 10.1002/ppul.23481; Brouwer KM, 2014, J BIOMED MATER RES B, V102, P756, DOI 10.1002/jbm.b.33056; Ceglia L, 2013, BIOL PROCED ONLINE, V15, DOI 10.1186/1480-9222-15-6; Cruz FSF, 2010, VET ANAESTH ANALG, V37, P116, DOI 10.1111/j.1467-2995.2009.00513.x; Cruz-Martinez R, 2011, FETAL DIAGN THER, V29, P101, DOI 10.1159/000295262; Derrey S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-17; Dimitriou G, 2003, PEDIATR RES, V54, P502, DOI 10.1203/01.PDR.0000081299.22005.F0; Gonzalez R, 2011, J LAPAROENDOSC ADV S, V21, P449, DOI 10.1089/lap.2010.0409; Gubareva EA, 2016, BIOMATERIALS, V77, P320, DOI 10.1016/j.biomaterials.2015.11.020; Harting MT, 2014, SEMIN FETAL NEONAT M, V19, P370, DOI 10.1016/j.siny.2014.09.004; Jancelewicz T, 2013, J PEDIATR SURG, V48, P935, DOI 10.1016/j.jpedsurg.2013.02.005; Jani JC, 2009, ULTRASOUND OBST GYN, V33, P64, DOI 10.1002/uog.6141; Jani JC, 2007, RADIOLOGY, V244, P575, DOI 10.1148/radiol.2442061158; Kamaruzaman NA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/691830; Kassim Z, 2011, EUR RESPIR J, V37, P143, DOI 10.1183/09031936.00007910; KILARSKI W, 1990, J ANAT, V168, P13; Kumar SP, 2015, LARYNGOSCOPE, V125, pE23, DOI 10.1002/lary.24867; Lally KP, 2007, PEDIATRICS, V120, pE651, DOI 10.1542/peds.2006-3040; LALLY KP, 1993, J PEDIATR SURG, V28, P45, DOI 10.1016/S0022-3468(05)80352-5; Lansdale N, 2010, ANN SURG, V252, P20, DOI 10.1097/SLA.0b013e3181dca0e8; Lee HS, 2015, INT J PEDIATR OTORHI, V79, P2384, DOI 10.1016/j.ijporl.2015.10.049; MASOUD I, 1986, J ORTHOP RES, V4, P221, DOI 10.1002/jor.1100040211; Mayer S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132021; McGivern MR, 2015, ARCH DIS CHILD-FETAL, V100, pF137, DOI 10.1136/archdischild-2014-306174; Mehta HP, 2010, SPINE, V35, P153, DOI 10.1097/BRS.0b013e3181c4b8c7; Menezes SLS, 2000, CHEST, V117, P1443, DOI 10.1378/chest.117.5.1443; MOGNONI P, 1969, J PHYSIOL-LONDON, V202, P517, DOI 10.1113/jphysiol.1969.sp008825; OPENSHAW P, 1984, THORAX, V39, P624, DOI 10.1136/thx.39.8.624; Panitch HB, 2015, PEDIATR PULM, V50, P896, DOI 10.1002/ppul.23082; Pickering M, 2002, J ANAT, V201, P305, DOI 10.1046/j.1469-7580.2002.00095.x; PRINGLE KC, 1986, CLIN OBSTET GYNECOL, V29, P502, DOI 10.1097/00003081-198609000-00006; Puligandla PS, 2015, J PEDIATR SURG, V50, P1958, DOI 10.1016/j.jpedsurg.2015.09.010; Roubliova XI, 2010, HISTOL HISTOPATHOL, V25, P1105, DOI 10.14670/HH-25.1105; Rygl M, 2015, BIOMED PAP, V159, P497, DOI 10.5507/bp.2015.040; Sandoval JA, 2006, J PEDIATR SURG, V41, P518, DOI 10.1016/j.jpedsurg.2005.11.068; Takayasu H, 2016, PEDIATR INT, V58, P877, DOI 10.1111/ped.12922; Thrall KD, 2009, INHAL TOXICOL, V21, P531, DOI 10.1080/08958370802601452; TOULOUKIAN RJ, 1978, ANN SURG, V187, P47, DOI 10.1097/00000658-197801000-00009; Tsai J, 2012, J PEDIATR SURG, V47, P637, DOI 10.1016/j.jpedsurg.2011.11.054; Turner CG, 2011, J PEDIATR SURG, V46, P57, DOI 10.1016/j.jpedsurg.2010.09.063; University of California B, 2015, REC GUID SURG PROC L, P1; Vanamo K, 1996, J PEDIATR SURG, V31, P851, DOI 10.1016/S0022-3468(96)90152-9; Vogel J, 2015, PLOS ONE, V10	47	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174332	10.1371/journal.pone.0174332	http://dx.doi.org/10.1371/journal.pone.0174332			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358826	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174800031
J	Zhou, Y; Wang, SR; Ma, JZ				Zhou, Yu; Wang, Si-Rui; Ma, Jian-Zhang			Comprehensive species set revealing the phylogeny and biogeography of Feliformia (Mammalia, Carnivora) based on mitochondrial DNA	PLOS ONE			English	Article							MOLECULAR SYSTEMATICS; CONTINENTAL-MARGIN; MONGOOSES HERPESTIDAE; VIVERRIDAE; LEVEL; MADAGASCAR; SEQUENCE; HISTORY; AFRICA; TREES	Extant Feliformia species are one of the most diverse radiations of Carnivora (similar to 123 species). Despite substantial recent interest in their conservation, diversification, and systematic study, no previous phylogeny contains a comprehensive species set, and no biogeography of this group is available. Here, we present a phylogenetic estimate for Feliformia with a comprehensive species set and establish a historical biogeography based on mitochondrial DNA. Both the Bayesian and maximum likelihood phylogeny for Feliformia are elucidated in our analyses and are strongly consistent with many groups recognized in previous studies. The mitochondrial phylogenetic relationships of Felidae were for the first time successfully reconstructed in our analyses with strong supported. When divergence times and dispersal/vicariance histories were compared with historical sea level changes, four dispersal and six vicariance events were identified. These vicariance events were closely related with global sea level changes. The transgression of sea into the lowland plains between Eurasia and Africa may have caused the vicariance in these regions. A fall in the sea level during late Miocene to Pliocene produced the Bering strait land bridge, which assisted the migration of American Feliformia ancestors from Asia to North America. In contrast with the 'sweepstakes hypothesis', our results suggest that the climate cooling during 30-27 Ma assisted Feliformia migration from the African mainland to Madagascar by creating a short-lived ice bridge across the Mozambique Channel. Lineages-through-time plots revealed a large increase in lineages since the Mid-Miocene. During the Mid-Miocene Climatic Optimum, the ecosystems and population of Feliformia rapidly expanded. Subsequent climate cooling catalyzed immigration, speciation, and the extinction of Feliformia.	[Zhou, Yu; Wang, Si-Rui; Ma, Jian-Zhang] Northeast Forestry Univ, Coll Wildlife Resources, Harbin, Peoples R China; [Zhou, Yu; Wang, Si-Rui; Ma, Jian-Zhang] Northeast Forestry Univ, Feline Res Ctr, Chinese State Forestry Adm, Harbin, Peoples R China	Northeast Forestry University - China; Northeast Forestry University - China	Ma, JZ (corresponding author), Northeast Forestry Univ, Coll Wildlife Resources, Harbin, Peoples R China.; Ma, JZ (corresponding author), Northeast Forestry Univ, Feline Res Ctr, Chinese State Forestry Adm, Harbin, Peoples R China.	jianzhangma@163.com	Zhou, Yu/AAD-1788-2022; Zhou, Yu/K-2889-2015	Zhou, Yu/0000-0003-3079-7703	National Natural Science Fund of China [31372209, L1322010]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Fund of China (31372209, L1322010) and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2010, MOL PHYLOGENET EVOL, V54, P726, DOI 10.1016/j.ympev.2009.10.033; Ali JR, 2010, NATURE, V463, P653, DOI 10.1038/nature08706; Arjunan M, 2006, J ENVIRON MANAGE, V79, P188, DOI 10.1016/j.jenvman.2005.06.007; Bininda-Emonds ORP, 1999, BIOL REV, V74, P143, DOI 10.1017/S0006323199005307; Blois JL, 2009, ANNU REV EARTH PL SC, V37, P181, DOI 10.1146/annurev.earth.031208.100055; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cramer BS, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001683; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; DiesterHaass L, 1996, MAR GEOL, V130, P99, DOI 10.1016/0025-3227(95)00128-X; Driskell AC, 2004, SCIENCE, V306, P1172, DOI 10.1126/science.1102036; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eizirik E, 2010, MOL PHYLOGENET EVOL, V56, P49, DOI 10.1016/j.ympev.2010.01.033; Escutia C, 2005, GLOBAL PLANET CHANGE, V45, P51, DOI 10.1016/j.gloplacha.2004.09.010; FLOWER BP, 1994, PALAEOGEOGR PALAEOCL, V108, P537, DOI 10.1016/0031-0182(94)90251-8; Flynn JJ, 2005, SYST BIOL, V54, P317, DOI 10.1080/10635150590923326; Flynn JJ, 1998, MOL PHYLOGENET EVOL, V9, P414, DOI 10.1006/mpev.1998.0504; Flynn John J., 1996, P542; Gaubert P, 2004, BIOL J LINN SOC, V81, P589, DOI 10.1111/j.1095-8312.2004.00309.x; Gaubert P, 2003, P ROY SOC B-BIOL SCI, V270, P2523, DOI 10.1098/rspb.2003.2521; Gaubert P, 2006, MOL PHYLOGENET EVOL, V41, P266, DOI 10.1016/j.ympev.2006.05.034; Haq BU, 2005, GEOARABIA, V10, P127; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; HEMMER H, 1971, PROC K NED AKAD B-PH, V74, P35; Hunt RM, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)384<0001:IMONAM>2.0.CO;2; Hunt RM, 1991, AM MUS NOVIT; Hunt Robert M. Jr., 1996, P485; International Union for Conservation of Nature and Natural Resources, 2016, IUCN RED LIST THREAT; Janis Christine M., 1998, P511; Johnson WE, 2006, SCIENCE, V311, P73, DOI 10.1126/science.1122277; KEIGWIN L, 1984, GEOLOGY, V12, P16, DOI 10.1130/0091-7613(1984)12<16:MOCFEP>2.0.CO;2; KEIGWIN LD, 1986, GEOL SOC AM BULL, V97, P335, DOI 10.1130/0016-7606(1986)97<335:SIILME>2.0.CO;2; KERR RA, 1984, SCIENCE, V224, P141, DOI 10.1126/science.224.4645.141; Kjer KM, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-8; Koepfli KP, 2006, MOL PHYLOGENET EVOL, V38, P603, DOI 10.1016/j.ympev.2005.10.017; Krause DW, 2010, NATURE, V463, P613, DOI 10.1038/463613a; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Ma KY, 2016, MOL PHYLOGENET EVOL, V100, P21, DOI 10.1016/j.ympev.2016.02.012; McKenna Malcolm C., 1997, pi; McMahon MM, 2006, SYST BIOL, V55, P818, DOI 10.1080/10635150600999150; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P1, DOI 10.1029/PA002i001p00001; Miller KG, 2011, OCEANOGRAPHY, V24, P40, DOI 10.5670/oceanog.2011.26; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Montague MJ, 2014, P NATL ACAD SCI USA, V111, P17230, DOI 10.1073/pnas.1410083111; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Morgan GS, 2003, B AM MUS NAT HIST, P269, DOI 10.1206/0003-0090(2003)279<0269:C>2.0.CO;2; Patou ML, 2008, MOL PHYLOGENET EVOL, V47, P883, DOI 10.1016/j.ympev.2008.03.026; Patou ML, 2009, MOL PHYLOGENET EVOL, V53, P69, DOI 10.1016/j.ympev.2009.05.038; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Prothero DR, 1989, EVOLUTION PERRISSODA; Pyron RA, 2011, SYST BIOL, V60, P466, DOI 10.1093/sysbio/syr047; Rabinowitz PD, 2006, J AFR EARTH SCI, V44, P270, DOI 10.1016/j.jafrearsci.2005.12.005; RABINOWITZ PD, 1983, SCIENCE, V220, P67, DOI 10.1126/science.220.4592.67; Rambaut A., 2014, TRACER V1 6 BEAST; Rannala B, 1998, SYST BIOL, V47, P702, DOI 10.1080/106351598260680; Reyes A, 1998, MOL BIOL EVOL, V15, P499, DOI 10.1093/oxfordjournals.molbev.a025949; Reyes A, 2004, MOL BIOL EVOL, V21, P397, DOI 10.1093/molbev/msh033; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roskov Y, 2015, CATALOGUE LIFE 28 SE; ROTH C, 1988, Palaeontologische Zeitschrift, V62, P333; Saccone C, 1999, GENE, V238, P195, DOI 10.1016/S0378-1119(99)00270-X; Shackleton NJ, INITIAL REP DEEP SEA; Shen XX, 2013, MOL BIOL EVOL, V30, P2235, DOI 10.1093/molbev/mst122; SIMPSON GEORGE GAYLORD, 1940, JOUR WASHINGTON ACAD SCI, V30, P137; Stadler T, 2008, MATH BIOSCI, V216, P163, DOI 10.1016/j.mbs.2008.09.006; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thewissen J. G. M., 1994, Journal of Mammalian Evolution, V2, P157, DOI 10.1007/BF01473527; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thomson RC, 2010, SYST BIOL, V59, P42, DOI 10.1093/sysbio/syp075; Tilson RL, 1987, TIGERS WORLD BIOL BI, P28; Vences M, 2003, P ROY SOC B-BIOL SCI, V270, P2435, DOI 10.1098/rspb.2003.2516; Veron G, 2004, MOL PHYLOGENET EVOL, V30, P582, DOI 10.1016/S1055-7903(03)00229-X; Veron G, 2000, J ZOOL SYST EVOL RES, V38, P209, DOI 10.1046/j.1439-0469.2000.384132.x; Veron G, 2007, ZOOL SCR, V36, P1, DOI 10.1111/j.1463-6409.2006.00261.x; Wei L, 2011, SCI CHINA LIFE SCI, V54, P917, DOI 10.1007/s11427-011-4219-1; Werdelin L, 2005, ZOOL J LINN SOC-LOND, V144, P121, DOI 10.1111/j.1096-3642.2005.00165.x; Werdelin L., 1996, P271; Werdelin Lars, 2003, P261; Wiens JJ, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234625; Wilson D.E., 2005, MAMMAL SPECIES WORLD; Yoder AD, 2003, NATURE, V421, P734, DOI 10.1038/nature01303; Yu Ning, 1996, Acta Theriologica Sinica, V16, P105; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhang WQ, 2013, GENET MOL RES, V12, P3256, DOI 10.4238/2013.September.3.1; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	87	10	14	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174902	10.1371/journal.pone.0174902	http://dx.doi.org/10.1371/journal.pone.0174902			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358848	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174800101
J	Zieba, J; Miller, A; Gordiienko, O; Smith, GM; Krynska, B				Zieba, Jolanta; Miller, Amanda; Gordiienko, Oleg; Smith, George M.; Krynska, Barbara			Clusters of amniotic fluid cells and their associated early neuroepithelial markers in experimental myelomeningocele: Correlation with astrogliosis	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; TISSUE ENGINEERING APPROACH; FETAL SHEEP MODEL; OPEN SPINA-BIFIDA; STEM-CELLS; PRENATAL CLOSURE; THERAPY TRASCET; FOLIC-ACID; SURGERY; REPAIR	Myelomeningocele (MMC) is the most common and severe disabling type of spina bifida resulting in the exposure of vulnerable spinal cord to the hostile intrauterine environment. In this study, we sought to examine the cellular content of fetal amniotic fluid (AF) in MMC and explore a correlation between these cells and pathological development of MMC. MMC was induced in fetal rats by exposing pregnant mothers to all-trans retinoic acid and AF samples were collected before term. Cells were isolated from AF samples and morphologically and phenotypically characterized in short-term cultures. In addition, the spinal cord injury in MMC fetuses was assessed by immunohistochemical examination of astrogliosis. We identified a population of cells from the AF of MMC fetuses (MMC-AF) that formed adherent clusters of tightly packed cells, which were absent from the AF of normal control fetuses (norm AF). MMC-AF clusters contained cells co-expressing adherens junction associated proteins (ZO-1), N-cadherin and F-actin at sites of cell-cell contacts. In addition, they expressed markers of early neuroepithelial cells such as SOX-1 and Pax-6 along with other stem/progenitor cell markers such as SOX-2 and nestin. Subpopulations of cells in MMC-AF clusters also expressed more advanced differentiation markers such as doublecortin and GFAP. We found that the appearance of cluster forming cells in cultures from MMC-AF correlated with activation of astrogliosis associated with the spinal cord injury in MMC fetuses. In summary, we identified a neuroepithelial cell population in the AF of MMC fetuses that formed adherent clusters in culture and we characterized cellular markers of these cells. Our data suggests that the phase of the disease is a crucial factor in the emergence of these cells into the AF and that these cells may provide a new and important platform for studying the progression of MMC and development of improved strategies for the repair and diagnosis of MMC prenatally.	[Zieba, Jolanta; Miller, Amanda; Gordiienko, Oleg; Smith, George M.; Krynska, Barbara] Temple Univ, Lewis Katz Sch Med, Ctr Neural Repair & Rehabil, Shriners Hosp Pediat Res Ctr, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Shriners Hospitals Children Philadelphia	Krynska, B (corresponding author), Temple Univ, Lewis Katz Sch Med, Ctr Neural Repair & Rehabil, Shriners Hosp Pediat Res Ctr, Philadelphia, PA 19122 USA.	krynskb@tuhs.temple.edu			Shriners Hospitals for Pediatric Research	Shriners Hospitals for Pediatric Research	This work was made possible by grants awarded by the Shriners Hospitals for Pediatric Research to BK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AakuSaraste E, 1996, DEV BIOL, V180, P664, DOI 10.1006/dbio.1996.0336; Adzick NS, 2013, SEMIN PEDIATR SURG, V22, P10, DOI 10.1053/j.sempedsurg.2012.10.003; Adzick NS, 2011, NEW ENGL J MED, V364, P993, DOI 10.1056/NEJMoa1014379; ALLES AJ, 1990, DEVELOPMENT, V108, P73; AULA P, 1980, BRIT MED J, V281, P1456, DOI 10.1136/bmj.281.6253.1456; Barbe MF, 2014, BIRTH DEFECTS RES A, V100, P453, DOI 10.1002/bdra.23254; Botto LD, 1999, NEW ENGL J MED, V341, P1509, DOI 10.1056/NEJM199911113412006; Boulet SL, 2008, BIRTH DEFECTS RES A, V82, P527, DOI 10.1002/bdra.20468; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Ceccarelli G, 2015, J PEDIATR SURG, V50, P1521, DOI 10.1016/j.jpedsurg.2015.04.014; Chazotte B, 2010, COLD SPRING HARB PRO, V2010; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; CREMER M, 1981, HUM GENET, V56, P365, DOI 10.1007/BF00274694; Danzer E, 2005, EXP NEUROL, V194, P467, DOI 10.1016/j.expneurol.2005.03.011; Danzer E, 2008, NEUROSCI LETT, V430, P157, DOI 10.1016/j.neulet.2007.10.048; Danzer E, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.032; Dias M S, 1993, Neurosurg Clin N Am, V4, P715; Dionigi B, 2015, J PEDIATR SURG, V50, P1037, DOI 10.1016/j.jpedsurg.2015.03.034; Dionigi B, 2015, J PEDIATR SURG, V50, P69, DOI 10.1016/j.jpedsurg.2014.10.004; Duggal N, 1997, BRAIN RES, V768, P1, DOI 10.1016/S0006-8993(97)00588-X; Edri R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7500; Fauza D, 2004, BEST PRACT RES CL OB, V18, P877, DOI 10.1016/j.bpobgyn.2004.07.001; Feng C, 2016, J PEDIATR SURG, V51, P1010, DOI 10.1016/j.jpedsurg.2016.02.071; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Greenebaum E, 1997, DIAGN CYTOPATHOL, V16, P143, DOI 10.1002/(SICI)1097-0339(199702)16:2<143::AID-DC9>3.0.CO;2-I; HEFFEZ DS, 1990, NEUROSURGERY, V26, P987, DOI 10.1227/00006123-199006000-00011; HEFFEZ DS, 1993, NEUROSURGERY, V32, P1005, DOI 10.1227/00006123-199306000-00021; HUNT GM, 1995, DEV MED CHILD NEUROL, V37, P19; HUNT GM, 1990, DEV MED CHILD NEUROL, V32, P108; Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005; Imbard A, 2013, INT J ENV RES PUB HE, V10, P4352, DOI 10.3390/ijerph10094352; Kaufman BA, 2004, PEDIATR CLIN N AM, V51, P389, DOI 10.1016/S0031-3955(03)00207-4; Kibar Z, 2007, CLIN GENET, V71, P295, DOI 10.1111/j.1399-0004.2007.00793.x; Klein JD, 2011, METHODS MOL BIOL, V698, P75, DOI 10.1007/978-1-60761-999-4_7; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; MEULI M, 1995, NAT MED, V1, P342, DOI 10.1038/nm0495-342; Meuli M, 2013, EUR J PEDIATR SURG, V23, P103, DOI 10.1055/s-0033-1343082; Miyamoto Y, 2015, CELL ADHES MIGR, V9, P183, DOI 10.1080/19336918.2015.1005466; Moldenhauer JS, 2014, AM J PERINAT, V31, P595, DOI 10.1055/s-0034-1372429; Ornoy A, 2009, REPROD TOXICOL, V28, P1, DOI 10.1016/j.reprotox.2009.02.014; Osterhues A, 2013, CRIT REV FOOD SCI, V53, P1180, DOI 10.1080/10408398.2011.575966; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Pennington EC, 2015, FETAL DIAGN THER, V37, P65, DOI 10.1159/000362811; Pennington EC, 2013, J PEDIATR SURG, V48, P1205, DOI 10.1016/j.jpedsurg.2013.03.009; Perin L, 2008, METHOD CELL BIOL, V86, P85, DOI 10.1016/S0091-679X(08)00005-8; Roach JW, 2011, CLIN ORTHOP RELAT R, V469, P1246, DOI 10.1007/s11999-010-1594-z; Robel S, 2011, NAT REV NEUROSCI, V12, P88, DOI 10.1038/nrn2978; Simpson JL, 2011, NEW ENGL J MED, V364, P1076, DOI 10.1056/NEJMe1101228; Sival DA, 1997, EARLY HUM DEV, V50, P27, DOI 10.1016/S0378-3782(97)00090-X; Stiefel D, 2007, J NEUROSURG, V106, P213, DOI 10.3171/ped.2007.106.3.213; Turner CG, 2013, STEM CELLS DEV, V22, P548, DOI 10.1089/scd.2012.0215; VONKOSKULL H, 1984, ACTA CYTOL, V28, P393; Watanabe M, 2016, BIOMATERIALS, V76, P133, DOI 10.1016/j.biomaterials.2015.10.051; Watanabe M, 2015, FETAL DIAGN THER, V37, P197, DOI 10.1159/000362931; Watanabe M, 2011, TISSUE ENG PT A, V17, P1099, DOI [10.1089/ten.TEA.2010.0390, 10.1089/ten.tea.2010.0390]; Watanabe M, 2010, TISSUE ENG PT A, V16, P1645, DOI [10.1089/ten.tea.2009.0532, 10.1089/ten.TEA.2009.0532]; Yu PP, 2012, METHODS MOL BIOL, V814, P327, DOI 10.1007/978-1-61779-452-0_21	57	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174625	10.1371/journal.pone.0174625	http://dx.doi.org/10.1371/journal.pone.0174625			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358903	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174800061
J	Zotterman, J; Mirdell, R; Horsten, S; Farnebo, S; Tesselaar, E				Zotterman, Johan; Mirdell, Robin; Horsten, Sandra; Farnebo, Simon; Tesselaar, Erik			Methodological concerns with laser speckle contrast imaging in clinical evaluation of microcirculation	PLOS ONE			English	Article							MICROVASCULAR BLOOD-FLOW; SYSTEM; DEPTH	Background Laser Speckle Contrast Imaging (LSCI) is a non-invasive and fast technique for measuring microvascular blood flow that recently has found clinical use for burn assessment and evaluation of flaps. Tissue motion caused by for example breathing or patient movements may however affect the measurements in these clinical applications, as may distance between the camera and the skin and tissue curvature. Therefore, the aims of this study were to investigate the effect of frame rate, number of frames/image, movement of the tissue, measuring distance and tissue curvature on the measured perfusion. Methods Methyl nicotinate-induced vasodilation in the forearm skin was measured using LSCI during controlled motion at different speeds, using different combinations of frame rate and number of frames/image, and at varying camera angles and distances. Experiments were made on healthy volunteers and on a cloth soaked in a colloidal suspension of polystyrene microspheres. Results Measured perfusion increased with tissue motion speed. The relation was independent of the absolute perfusion in the skin and of frame rate and number of frames/image. The measured perfusion decreased with increasing angles (16% at 60, p = 0.01). Measured perfusion did not vary significantly between measurement distances from 15 to 40 cm (p = 0.77, %CV 0.9%). Conclusion Tissue motion increases and measurement angles beyond 45 decrease the measured perfusion in LSCI. These findings have to be taken into account when LSCI is used to assess moving or curved tissue surfaces, which is common in clinical applications.	[Zotterman, Johan; Farnebo, Simon] Linkoping Univ, Dept Hand Surg Plast Surg & Burns, Linkoping, Sweden; [Zotterman, Johan; Mirdell, Robin; Horsten, Sandra; Farnebo, Simon; Tesselaar, Erik] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Tesselaar, Erik] Linkoping Univ, Dept Radiat Phys, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University	Zotterman, J (corresponding author), Linkoping Univ, Dept Hand Surg Plast Surg & Burns, Linkoping, Sweden.; Zotterman, J (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	johan.zotterman@liu.se			ALF grants, Region Ostergotland	ALF grants, Region Ostergotland	This study has been financially supported by ALF grants, Region Ostergotland. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrozy E, 2009, WOUND REPAIR REGEN, V17, P19, DOI 10.1111/j.1524-475X.2008.00437.x; Briers D, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.066018; Draijer M, 2009, OPT EXPRESS, V17, P3211, DOI 10.1364/OE.17.003211; Droog EJ, 2001, BURNS, V27, P561, DOI 10.1016/S0305-4179(01)00021-3; Erba P, 2012, SKIN RES TECHNOL, V18, P456, DOI 10.1111/j.1600-0846.2011.00593.x; Iredahl F, 2016, MICROCIRCULATION, V23, P597, DOI 10.1111/micc.12325; Iredahl F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133760; Leutenegger M, 2011, BIOMED OPT EXPRESS, V2, P1470, DOI 10.1364/BOE.2.001470; Lindahl F, 2013, BURNS, V39, P662, DOI 10.1016/j.burns.2012.09.018; Mahe G, 2011, MICROVASC RES, V82, P439, DOI 10.1016/j.mvr.2011.06.014; Mahe G, 2011, MICROVASC RES, V81, P183, DOI 10.1016/j.mvr.2010.11.013; Milstein DMJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003875; Mirdell R, 2016, BURNS, V42, P648, DOI 10.1016/j.burns.2015.12.005; Monstrey S, 2008, BURNS, V34, P761, DOI 10.1016/j.burns.2008.01.009; Omarjee L, 2015, MICROVASC RES, V97, P75, DOI 10.1016/j.mvr.2014.09.005; Senarathna Janaka, 2013, IEEE Rev Biomed Eng, V6, P99, DOI 10.1109/RBME.2013.2243140; Zotterman J, 2016, J PLAST RECONSTR AES, V69, P936, DOI 10.1016/j.bjps.2016.02.015	17	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174703	10.1371/journal.pone.0174703	http://dx.doi.org/10.1371/journal.pone.0174703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358906	gold, Green Submitted, Green Published			2022-12-26	WOS:000399174800074
J	Burns, M; Amaya, A; Bodi, C; Ge, ZM; Bakthavatchalu, V; Ennis, K; Wang, TC; Georgieff, M; Fox, JG				Burns, Monika; Amaya, Aldo; Bodi, Caroline; Ge, Zhongming; Bakthavatchalu, Vasudevan; Ennis, Kathleen; Wang, Timothy C.; Georgieff, Michael; Fox, James G.			Helicobacter pylori infection and low dietary iron alter behavior, induce iron deficiency anemia, and modulate hippocampal gene expression in female C57BL/6 mice	PLOS ONE			English	Article							MEDICAL PROGRESS; ANXIETY; CANCER; METABOLISM; GASTRITIS; STORES; GROWTH; MODEL; HOST	Helicobacter pylori (H. pylori), a bacterial pathogen, is a causative agent of gastritis and peptic ulcer disease and is a strong risk factor for development of gastric cancer. Environmental conditions, such as poor dietary iron resulting in iron deficiency anemia (IDA), enhance H. pylori virulence and increases risk for gastric cancer. IDA affects billions of people worldwide, and there is considerable overlap between regions of high IDA and high H. pylori prevalence. The primary aims of our study were to evaluate the effect of H. pylori infection on behavior, iron metabolism, red blood cell indices, and behavioral outcomes following comorbid H. pylori infection and dietary iron deficiency in a mouse model. C57BL/6 female mice (n = 40) were used; half were placed on a moderately iron deficient (ID) diet immediately post-weaning, and the other half were maintained on an iron replete (IR) diet. Half were dosed with H. pylori SS1 at 5 weeks of age, and the remaining mice were sham-dosed. There were 4 study groups: a control group (-Hp, IR diet) as well as 3 experimental groups (-Hp, ID diet; +Hp, IR diet; +Hp, ID diet). All mice were tested in an open field apparatus at 8 weeks postinfection. Independent of dietary iron status, H. pylori -infected mice performed fewer exploratory behaviors in the open field chamber than uninfected mice (p<0.001). Hippocampal gene expression of myelination markers and dopamine receptor 1 was significantly downregulated in mice on an ID diet (both p<0.05), independent of infection status. At 12 months postinfection, hematocrit (Hct) and hemoglobin (Hgb) concentration were significantly lower in +Hp, ID diet mice compared to all other study groups. H. pylori infection caused IDA in mice maintained on a marginal iron diet. The mouse model developed in this study is a useful model to study the neurologic, behavioral, and hematologic impact of the common human co-morbidity of H. pylori infection and IDA.	[Burns, Monika; Bodi, Caroline; Ge, Zhongming; Bakthavatchalu, Vasudevan; Fox, James G.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Amaya, Aldo] Broad Inst Harvard & MIT, Cambridge, MA USA; [Ennis, Kathleen; Georgieff, Michael] Univ Minnesota, Dept Pediat, Div Neonatol, Med Sch, Minneapolis, MN 55455 USA; [Wang, Timothy C.] Columbia Univ, Dept Med, New York, NY USA; [Fox, James G.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Minnesota System; University of Minnesota Twin Cities; Columbia University; Massachusetts Institute of Technology (MIT)	Fox, JG (corresponding author), MIT, Div Comparat Med, Cambridge, MA 02139 USA.	jgfox@mit.edu		Wang, Timothy/0000-0001-5730-3019; Winn, Caroline/0000-0002-2512-4566	Office of The Director of the National Institutes of Health [T320D010978, R01CA093405, P01CA028842-23]; National Institute of Environmental Health Science [P30ES0022109]; NATIONAL CANCER INSTITUTE [P01CA028842] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD010978] Funding Source: NIH RePORTER	Office of The Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by Office of The Director of the National Institutes of Health under award number T320D010978, R01CA093405, P01CA028842-23 and National Institute of Environmental Health Sciences under award P30ES0022109. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health (www.nih.gov).	Abbaspour N, 2014, J RES MED SCI, V19, P164; Alvarez-Arellano Lourdes, 2014, World J Gastrointest Pathophysiol, V5, P400, DOI 10.4291/wjgp.v5.i4.400; Amieva M, 2016, GASTROENTEROLOGY, V150, P64, DOI 10.1053/j.gastro.2015.09.004; Annibale B, 2003, GUT, V52, P496, DOI 10.1136/gut.52.4.496; [Anonymous], 2001, IRON DEFICIENCY ANAE; [Anonymous], 2004, COMP QUANT HLTH RISK, V1; Arnold IC, 2011, GASTROENTEROLOGY, V140, P199, DOI 10.1053/j.gastro.2010.06.047; AVMA Panel on Euthanasia, 2013, AVMA GUIDELINES EUTH; Beard JL, 2001, J NUTR, V131, p568S, DOI 10.1093/jn/131.2.568S; Beard JL, 2006, AM J CLIN NUTR, V84, P1498, DOI 10.1093/ajcn/84.6.1498; Beckett AC, 2016, INFECT IMMUN, V84, P3338, DOI 10.1128/IAI.00479-16; Burns M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142630; Carlson ES, 2007, HIPPOCAMPUS, V17, P679, DOI 10.1002/hipo.20307; Carlson ES, 2009, J NUTR, V139, P672, DOI 10.3945/jn.108.096354; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Cherian S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004030; Cover TL, 2013, GUT MICROBES, V4, P482, DOI 10.4161/gmic.26262; Eusebi LH, 2014, HELICOBACTER, V19, P1, DOI 10.1111/hel.12165; EVANS T C, 1991, Journal of Emergency Medicine, V9, P71, DOI 10.1016/0736-4679(91)90592-4; Felt BT, 2006, BEHAV BRAIN RES, V171, P261, DOI 10.1016/j.bbr.2006.04.001; Fox JG, 2007, AM J PATHOL, V171, P1520, DOI 10.2353/ajpath.2007.070249; Fox JG, 2003, GASTROENTEROLOGY, V124, P1879, DOI 10.1016/S0016-5085(03)00406-2; Fox JG, 2003, CANCER RES, V63, P942; FUCHS CS, 1995, NEW ENGL J MED, V333, P32, DOI 10.1056/NEJM199507063330107; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Gobel R, 2006, HELICOBACTER, V11, P529, DOI 10.1111/j.1523-5378.2006.00455.x; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; Hubbard AC, 2013, COMPARATIVE MED, V63, P127; Hudak L, 2017, HELICOBACTER, V22, DOI 10.1111/hel.12330; Jorgenson LA, 2003, DEV NEUROSCI-BASEL, V25, P412, DOI 10.1159/000075667; Keenan JI, 2004, HELICOBACTER, V9, P643, DOI 10.1111/j.1083-4389.2004.00278.x; Kountouras J, 2015, ANN GASTROENTEROL, V28, P506; Kwik-Uribe CL, 2000, J NUTR, V130, P2821, DOI 10.1093/jn/130.11.2821; LEE A, 1990, GASTROENTEROLOGY, V99, P1315, DOI 10.1016/0016-5085(90)91156-Z; LOZOFF B, 1991, NEW ENGL J MED, V325, P687, DOI 10.1056/NEJM199109053251004; Lozoff Betsy, 2006, Semin Pediatr Neurol, V13, P158, DOI 10.1016/j.spen.2006.08.004; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; Lozoff B, 2011, J NUTR, V141, p740S, DOI 10.3945/jn.110.131169; Lukowski AF, 2010, NUTR NEUROSCI, V13, P54, DOI 10.1179/147683010X12611460763689; Lyte M, 2006, PHYSIOL BEHAV, V89, P350, DOI 10.1016/j.physbeh.2006.06.019; Mazzaccara C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003772; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Muhsen K, 2008, HELICOBACTER, V13, P323, DOI 10.1111/j.1523-5378.2008.00617.x; Noto JM, 2013, J CLIN INVEST, V123, P479, DOI 10.1172/JCI64373; Pisansky MT, 2013, HIPPOCAMPUS, V23, P952, DOI 10.1002/hipo.22151; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Qu XH, 2010, WORLD J GASTROENTERO, V16, P886, DOI 10.3748/wjg.v16.i7.886; Rogers AB, 2005, CANCER RES, V65, P10709, DOI 10.1158/0008-5472.CAN-05-1846; Romeo RD, 2003, HORM BEHAV, V43, P561, DOI 10.1016/S0018-506X(03)00063-1; Shanmugam NKN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038136; Sheh A, 2010, P NATL ACAD SCI USA, V107, P15217, DOI 10.1073/pnas.1009017107; Siddappa AJM, 2003, PEDIATR RES, V53, P800, DOI 10.1203/01.PDR.0000058922.67035.D5; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tan SM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002050; Thomson MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050194; Tran PV, 2009, PEDIATR RES, V65, P493, DOI 10.1203/PDR.0b013e31819d90a1; Unger EL, 2007, J NUTR, V137, P118, DOI 10.1093/jn/137.1.118; Yuan WZ, 2010, SCAND J GASTROENTERO, V45, P665, DOI 10.3109/00365521003663670	58	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0173108	10.1371/journal.pone.0173108	http://dx.doi.org/10.1371/journal.pone.0173108			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355210	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174600010
J	Wang, YT; Tao, J; Maimaiti, A; Adi, D; Yang, YN; Li, XM; Ma, X; Liu, F; Chen, BD; Ma, YT				Wang, Yong-Tao; Tao, Jing; Maimaiti, Ailifeire; Adi, Dilare; Yang, Yi-Ning; Li, Xiao-Mei; Ma, Xiang; Liu, Fen; Chen, Bang-Dang; Ma, Yi-Tong			Prevalence of valvular heart diseases and associated risk factors in Han, Uygur and Kazak population in Xinjiang, China	PLOS ONE			English	Article							AORTIC-VALVE SCLEROSIS; CALCIFICATION; ECHOCARDIOGRAPHY; PROGRESSION; MORBIDITY; MORTALITY	Background Valvular heart diseases (VHD) is very common in clinical practice and has became the subject of growing attention in the field of cardiovascular medicine. Our aim was to assess the prevalence and correlates of VHD in the general population in Xinjiang, China. Methods Using a 4-stage stratified cluster random sampling method, a total of 14618 participants were recruited in the Cardiovascular Risk Survey (CRS) study. The participants' personal information, medical history were assessed by questionnaire. VHD was diagnosed by trans thoracic echocardiography. We carried out the statistical analysis utilizing SPSS Statistics version 19.0. Results In the total study group, VHD was observed in 1397 (9.65%) individuals. The prevalence rates of VHD in Han, Uygur and Kazak group are 13.51%, 2.71% and 12.29% respectively. The prevalence rates of VHD increased strikingly with age (all P < 0.001). The results of multinomial regression analysis indicated that VHD were related to age in Han group, to age smoking and hypertension in Uygur group, to age and hypertension in Kazak group. Conclusion Our research provides a unique prevalence rate of VHD in Xinjiang natural population. The result suggests that VHD are notably common in this population (9.65%) and increase with age. There exists significant difference of prevalence rate between ethnics. The main risk factors of VHD are age, hypertension and smoking. Valvular heart diseases should be regarded as a serious and growing public-health problem.	[Wang, Yong-Tao; Tao, Jing; Maimaiti, Ailifeire; Adi, Dilare; Yang, Yi-Ning; Li, Xiao-Mei; Ma, Xiang; Ma, Yi-Tong] Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China; [Wang, Yong-Tao; Tao, Jing; Maimaiti, Ailifeire; Adi, Dilare; Yang, Yi-Ning; Li, Xiao-Mei; Ma, Xiang; Liu, Fen; Chen, Bang-Dang; Ma, Yi-Tong] Xinjiang Key Lab Cardiovasc Dis Res, Urumqi, Peoples R China	Xinjiang Medical University	Ma, YT (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China.; Ma, YT (corresponding author), Xinjiang Key Lab Cardiovasc Dis Res, Urumqi, Peoples R China.	myt_xj@sina.com			Key laboratory special fund project of Xinjiang Autonomous region [2014KL011]	Key laboratory special fund project of Xinjiang Autonomous region	Our work was supported by Key laboratory special fund project of Xinjiang Autonomous region (2014KL011).	American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; An Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128965; Bhatt H, 2014, ANGIOLOGY, V46, P3086; Boon A, 1997, HEART, V78, P472, DOI 10.1136/hrt.78.5.472; Coffey S, 2014, J AM COLL CARDIOL, V63, P2852, DOI 10.1016/j.jacc.2014.04.018; Ferreira-Gonzalez I, 2013, EUR J PREV CARDIOL, V20, P1022, DOI 10.1177/2047487312451238; Fox CS, 2003, CIRCULATION, V107, P1492, DOI 10.1161/01.CIR.0000058168.26163.BC; Helske S, 2006, EUR HEART J, V27, P1495, DOI 10.1093/eurheartj/ehi706; Iung B, 2011, NAT REV CARDIOL, V8, P162, DOI 10.1038/nrcardio.2010.202; Jiang CQ, 2009, ATHEROSCLEROSIS, V202, P529, DOI 10.1016/j.atherosclerosis.2008.03.004; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Lu S. L., 2003, MOL CARDIOLOGY CHINA, V3, P36; McAloon CJ, 2016, INT J CARDIOL, V224, P256, DOI 10.1016/j.ijcard.2016.09.026; Milin AC, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001111; Nadruz W, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.004950; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; Novaro GM, 2007, J AM COLL CARDIOL, V50, P1992, DOI 10.1016/j.jacc.2007.07.064; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Otto CM, 1999, NEW ENGL J MED, V341, P142, DOI 10.1056/NEJM199907153410302; Ozer N, 2013, TURK KARDIYOL DERN A, V41, P11, DOI 10.5543/tkda.2013.91112; Patel DK, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000879; Podolec Piotr, 2004, Przegl Lek, V61, P604; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Sashida Y, 2010, AM HEART J, V159, P698, DOI 10.1016/j.ahj.2009.12.031; Shu C, 2016, SCI REP-UK, V6, DOI 10.1038/srep27253; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015181; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013997; Yadeta D, 2016, INT J CARDIOL, V221, P260, DOI 10.1016/j.ijcard.2016.06.232; Yeung M, 2013, AM J CARDIOL, V112, P991, DOI 10.1016/j.amjcard.2013.05.030; Yin MH, 2016, SCI REP-UK, V6, DOI 10.1038/srep37020; Zheng Y, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1889681.1889683; Zhong XW, 2007, J PRACTICAL MED TECH, V14, P545	32	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174490	10.1371/journal.pone.0174490	http://dx.doi.org/10.1371/journal.pone.0174490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355290	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174600056
J	McNamee, LM; Ledley, FD				McNamee, Laura M.; Ledley, Fred D.			Modeling timelines for translational science in cancer; the impact of technological maturation	PLOS ONE			English	Article							DRUG DISCOVERY; GROWTH-CURVES; INNOVATION; TRENDS; PATTERNS; WAR	This work examines translational science in cancer based on theories of innovation that posit a relationship between the maturation of technologies and their capacity to generate successful products. We examined the growth of technologies associated with 138 anticancer drugs using an analytical model that identifies the point of initiation of exponential growth and the point at which growth slows as the technology becomes established. Approval of targeted and biological products corresponded with technological maturation, with first approval averaging 14 years after the established point and 44 years after initiation of associated technologies. The lag in cancer drug approvals after the increases in cancer funding and dramatic scientific advances of the 1970s thus reflects predictable timelines of technology maturation. Analytical models of technological maturation may be used for technological forecasting to guide more efficient translation of scientific discoveries into cures.	[McNamee, Laura M.; Ledley, Fred D.] Bentley Univ, Ctr Integrat Sci & Ind, Waltham, MA 02452 USA; [Ledley, Fred D.] Bentley Univ, Dept Nat & Appl Sci, Waltham, MA 02452 USA; [Ledley, Fred D.] Bentley Univ, Dept Management, Waltham, MA 02452 USA	Bentley University; Bentley University; Bentley University	Ledley, FD (corresponding author), Bentley Univ, Ctr Integrat Sci & Ind, Waltham, MA 02452 USA.; Ledley, FD (corresponding author), Bentley Univ, Dept Nat & Appl Sci, Waltham, MA 02452 USA.; Ledley, FD (corresponding author), Bentley Univ, Dept Management, Waltham, MA 02452 USA.	fledley@bentley.edu			National Biomedical Research Foundation	National Biomedical Research Foundation	This work was supported by a grant from the National Biomedical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the National Biomedical Research Foundation. The authors thank Dr. Kenneth Kaitin for providing data on drug approvals from the Tufts Center for Study of Drug Development as well as Aaron Perlman and Drs. Andrea Ballabeni, Michael Boss, Nancy Hsiung, David Nathan, and anonymous reviewers for their constructive contributions to this research. Portions of this work were described in testimony to the House Energy and Commerce Committee "Roundtable on 21st Century Cures" and at hearings on the "21st Century Cures" (May 6, 2014). An expanded transcript of this testimony was published in the Federal Register.	Agarwal P, 2009, NAT REV DRUG DISCOV, V8, P865, DOI 10.1038/nrd2973; Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Austin DH, RES DEV PHARM IND 20; Bailar JC, 1997, NEW ENGL J MED, V336, P1569, DOI 10.1056/NEJM199705293362206; Balconi M, 2010, RES POLICY, V39, P1, DOI 10.1016/j.respol.2009.09.013; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Beierlein JM, 2015, CLIN THER, V37, P1643, DOI 10.1016/j.clinthera.2015.07.003; Brown D, 2007, DRUG DISCOV TODAY, V12, P1007, DOI 10.1016/j.drudis.2007.10.017; Bush V, 1945, DTIC DOCUMENT; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; Christensen C., 2013, INNOVATORS DILEMMA N; Christensen C.M., 1992, PROD OPER MANAG, V1, P334; Christensen C.M., 1992, PROD OPER MANAG, V1, P358, DOI 10.1111/j.1937-5956.1992.tb00002.x; Christensen Clayton M., 2003, INNOVATORS DILEMMA R; CHRISTENSEN CM, 1995, RES POLICY, V24, P233, DOI 10.1016/0048-7333(93)00764-K; Cockburn IM, 1998, J IND ECON, V46, P157; Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309; Daim TU, 2006, TECHNOL FORECAST SOC, V73, P981, DOI 10.1016/j.techfore.2006.04.004; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Eder J, 2014, NAT REV DRUG DISCOV, V13, P577, DOI 10.1038/nrd4336; Edgerton D, THE LINEAR MODEL; Faguet G. B., 2005, THE WAR ON CANC; Firat A.K., 2008, 200815 CISL; FISHER JC, 1971, TECHNOL FORECAST SOC, V3, P75, DOI 10.1016/S0040-1625(71)80005-7; Foster R. N., 1988, INNOVATION ATTACKERS; Foster R. N., 1986, INNOVATION ATTACKERS; Gannon F, 2014, EMBO REP, V15, P1107, DOI 10.15252/embr.201439587; Garfield E, 1997, CELL DEATH DIFFER, V4, P352, DOI 10.1038/sj.cdd.4400261; Gibbs JB, 2000, SCIENCE, V287, P1969, DOI 10.1126/science.287.5460.1969; Gillum LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016837; Godin B, 2006, SCI TECHNOL HUM VAL, V31, P639, DOI 10.1177/0162243906291865; Haber DA, 2011, CELL, V145, P19, DOI 10.1016/j.cell.2011.03.026; Hutton J, 2007, TRANSFORMING TRANSLA; Jantsch Erich., 1967, TECHNOLOGICAL FORECA; Kamb A, 2007, NAT REV DRUG DISCOV, V6, P115, DOI 10.1038/nrd2155; Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0; Khoury MJ, 2010, AM J EPIDEMIOL, V172, P517, DOI 10.1093/aje/kwq211; Kim W, 2001, P AMIA S 2001 AM MED; Ledley F, 2013, GENE THERAPY; Lichtenberg FR, 2013, IMPACT BIOMEDICAL KN; Lipinski CA, 2012, ADV DRUG DELIVER REV, V64, P4, DOI 10.1016/j.addr.2012.09.019; Louie G, 2009, PERSISTENT FORECASTI; Mankins J. C., 1995, CISC VIS NETW IND GL; Mankins JC, 2009, ACTA ASTRONAUT, V65, P1216, DOI 10.1016/j.actaastro.2009.03.058; Marshall A, 2009, NAT BIOTECHNOL, V27, P789, DOI 10.1038/nbt0909-789; Martell RE, 2013, ONCOLOGIST, V18, P104, DOI 10.1634/theoncologist.2012-0235; Martino JP, 2003, TECHNOL FORECAST SOC, V70, P719, DOI 10.1016/S0040-1625(02)00375-X; McGeary M, 1999, SOURCES CANC RES FUN; McNamee L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082195; McNamee LM, 2012, NAT BIOTECHNOL, V30, P937, DOI 10.1038/nbt.2389; Meade N, 1998, MANAGE SCI, V44, P1115, DOI 10.1287/mnsc.44.8.1115; MEADE N, 1995, INT J FORECASTING, V11, P199, DOI 10.1016/0169-2070(94)00556-R; Morris ZS, 2011, J ROY SOC MED, V104, P510, DOI 10.1258/jrsm.2011.110180; Nagy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052669; Narayanamurti V., 2016, CYCLES INVENTION DIS; Nathan David G, 2007, Trans Am Clin Climatol Assoc, V118, P317; Nelson RR, 2011, RES POLICY, V40, P1339, DOI 10.1016/j.respol.2011.06.014; Office USGA, 2016, TECHN READ ASS GUID; Petrick IJ, 2004, TECHNOL FORECAST SOC, V71, P81, DOI 10.1016/S0040-1625(03)00064-7; Phaal R., 2001, TECHNOLOGY ROADMAPPI, P1; Pisano G., 2006, SCI BUSINESS PROMISE; Rekhert JM, 2008, DRUG DISCOV TODAY, V13, P30, DOI 10.1016/j.drudis.2007.09.003; Sampat BN, U NATL INNOVATION SY; Sansone SA, 2012, NAT GENET, V44, P121, DOI 10.1038/ng.1054; Schully S, 2009, PUBLIC HEALTH GENOM, V14, P1; Sorger P. K., 2011, QUANTITATIVE SYSTEMS; Stokes D. E, 2011, PASTEURS QUADRANT BA; Swinney DC, 2013, CLIN PHARMACOL THER, V93, P299, DOI 10.1038/clpt.2012.236; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Taroncher-Oldenburg G, 2008, NAT BIOTECHNOL, V26, P1062, DOI 10.1038/nbt1008-1062; Taroncher-Oldenburg G, 2007, NAT BIOTECHNOL, V25, P961, DOI 10.1038/nbt0907-961; Toole AA, 2012, RES POLICY, V41, P1, DOI 10.1016/j.respol.2011.06.004; Varmus H, 2006, SCIENCE, V312, P1162, DOI 10.1126/science.1126758; Varmus H, 2012, NATURE, V481, P436, DOI 10.1038/481436a; Vogelstein B, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004246; Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26; YOUNG P, 1993, TECHNOL FORECAST SOC, V44, P375, DOI 10.1016/0040-1625(93)90042-6	78	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174538	10.1371/journal.pone.0174538	http://dx.doi.org/10.1371/journal.pone.0174538			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VD	28346525	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174300053
J	Itoh, G; Chida, S; Yanagihara, K; Yashiro, M; Aiba, N; Tanaka, M				Itoh, G.; Chida, S.; Yanagihara, K.; Yashiro, M.; Aiba, N.; Tanaka, M.			Cancer-associated fibroblasts induce cancer cell apoptosis that regulates invasion mode of tumours	ONCOGENE			English	Article							MESENCHYMAL STEM-CELLS; EXTRACELLULAR VESICLES; CARCINOMA; MICROVESICLES; METASTASIS; ACTIVATION; BODIES	In the process of cancer spreading, different modes of invasion exist. One is expansive invasion, in which a group of cancer cells gradually expands along with cancer cell proliferation. Invasion of cancer cells is also modified by their interaction with stromal cells including cancer-associated fibroblasts (CAFs). Cancer cells co-invade with CAFs, and invasion by CAFs frequently precede invasion by cancer cells, which indicates CAF-led cancer cell invasion. Here, we show that CAFs induce apoptosis in gastric cancer cells, which prevented expansive invasion by cancer cells and instead facilitated CAF-led invasion. Death receptor 4 and activation of caspase-8 in cancer cells mediated cancer cell apoptosis induced by CAFs, which was dependent on contact between cancer cells and CAFs. Apoptotic cancer cells in turn released apoptotic vesicles and stimulated invasion of CAFs. Accordingly, cancer cells followed the migrating CAFs. Treatment with a caspase inhibitor, ZVAD, or forced expression of a death domain fragment in cancer cells prevented cancer cell apoptosis induced by CAFs and increased expansive invasion by cancer cells in extracellular gel invasion assays, while the rate of cancer cell invasion led by CAFs was decreased. Death domain-fragment expression also prevented intramural invasion by gastric cancer cells in the stomach. Because CAF-led invasion is characterized by the movement of individual cancer cells away from the tumour, adequate cancer cell apoptosis may promote cancer dissemination.	[Itoh, G.; Aiba, N.; Tanaka, M.] Akita Univ, Grad Sch Med, Dept Mol Med & Biochem, Akita, Japan; [Chida, S.] Akita Univ, Grad Sch Med, Biosci Educ & Res Support Ctr, Akita, Japan; [Yanagihara, K.] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Pathol, Chiba, Japan; [Yashiro, M.] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, Osaka, Japan	Akita University; Akita University; National Cancer Center - Japan; Osaka Metropolitan University	Tanaka, M (corresponding author), Akita Univ, Mol Med & Biochem, 1-1-1 Hondo, Akita, Akita 0108543, Japan.	mastanak@med.akita-u.ac.jp			JSPS KAKENHI [26640068, 16H04691]; Research Grant of the Princess Takamatsu Cancer Research Fund [14-24620]; Project Mirai Cancer Research grant; Grants-in-Aid for Scientific Research [17K19579] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Grant of the Princess Takamatsu Cancer Research Fund; Project Mirai Cancer Research grant; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grants (nos. 26640068 and 16H04691 to MT), a Research Grant of the Princess Takamatsu Cancer Research Fund (14-24620 to MT), and Project Mirai Cancer Research grants to MT	Alexander S, 2013, CURR OPIN CELL BIOL, V25, P659, DOI 10.1016/j.ceb.2013.07.001; Antwi-Baffour SS, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0174-7; Ciardiello C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020175; Clark AG, 2015, CURR OPIN CELL BIOL, V36, P13, DOI 10.1016/j.ceb.2015.06.004; Crescitelli R, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20677; Ding SM, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0588-8; Fuyuhiro Y, 2011, BRIT J CANCER, V105, P996, DOI 10.1038/bjc.2011.330; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Geraldo S, 2012, EUR J CELL BIOL, V91, P930, DOI 10.1016/j.ejcb.2012.07.005; Hsu HS, 2012, LUNG CANCER, V75, P167, DOI 10.1016/j.lungcan.2011.07.001; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jain MV, 2013, J CELL MOL MED, V17, P12, DOI 10.1111/jcmm.12001; Lee RH, 2012, CELL STEM CELL, V11, P825, DOI 10.1016/j.stem.2012.10.001; Lin JT, 2013, EXP CELL RES, V319, P2216, DOI 10.1016/j.yexcr.2013.06.003; Liu SL, 2011, CANCER RES, V71, P614, DOI 10.1158/0008-5472.CAN-10-0538; Lo YC, 2015, APOPTOSIS, V20, P124, DOI 10.1007/s10495-014-1054-4; Muhsin-Sharafaldine MR, 2016, ONCOTARGET, V7, P56279, DOI 10.18632/oncotarget.10783; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Qian ZR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/649161; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Sakamaki K, 2004, GENES CELLS, V9, P1249, DOI 10.1111/j.1365-2443.2004.00802.x; Sanchez-Lopez E, 2016, ONCOGENE, V35, P2634, DOI 10.1038/onc.2015.326; Satoyoshi R, 2015, ONCOGENE, V34, P650, DOI 10.1038/onc.2013.584; Sidani M, 2006, J MAMMARY GLAND BIOL, V11, P151, DOI 10.1007/s10911-006-9021-5; Siegelin MD, 2009, NEUROCHEM INT, V55, P423, DOI 10.1016/j.neuint.2009.04.011; Subramaniam KS, 2016, AM J CANCER RES, V6, P200; Tanaka M, 2016, CANCER SCI, V107, P803, DOI 10.1111/cas.12940; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tsai KS, 2011, GASTROENTEROLOGY, V141, P1046, DOI 10.1053/j.gastro.2011.05.045; Turiak L, 2011, J PROTEOMICS, V74, P2025, DOI 10.1016/j.jprot.2011.05.023; Waghray M, 2016, CANCER DISCOV, V6, P886, DOI 10.1158/2159-8290.CD-15-0947; Walczak Henning, 2008, V414, P221; Walczak H, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008698; Yanagihara K, 2005, CANCER SCI, V96, P323, DOI 10.1111/j.1349-7006.2005.00054.x; Yanagihara K, 2004, CANCER SCI, V95, P575, DOI 10.1111/j.1349-7006.2004.tb02489.x; Yoon N, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.90	36	41	46	4	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 3	2017	36	31					4434	4444		10.1038/onc.2017.49	http://dx.doi.org/10.1038/onc.2017.49			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FC4JL	28368418				2022-12-26	WOS:000406806000006
J	Chen, TH; Chen, CY; Wen, HC; Chang, CC; Wang, HD; Chuu, CP; Chang, CH				Chen, Ting-Huan; Chen, Chen-Yu; Wen, Hui-Chin; Chang, Chia-Chu; Wang, Horng-Dar; Chuu, Chih-Pin; Chang, Chung-Ho			YAP promotes myogenic differentiation via the MEK5-ERK5 pathway	FASEB JOURNAL			English	Article						myogenesis; C2C12 myoblasts; Src; TAZ; Abl	SKELETAL-MUSCLE; TARGETED INACTIVATION; SIGNALING PATHWAY; HIPPO PATHWAY; WW DOMAIN; ERK5; ACTIVATION; PROLIFERATION; COACTIVATOR; GROWTH	Yes-associated protein (YAP) is a transcriptional coactivator in the Hippo pathway that regulates cell proliferation, differentiation, and apoptosis. The MEK5/ERK5 MAPK cascade is essential for the early step of myogenesis. In this study, we generated C2C12 stable cell lines that expressed YAP (C2C12-YAP cells) and found that ERK5 and MEK5 were activated in C2C12-YAP cells compared with control C2C12 (C2C12-vector) cells. C2C12YAP stable cells also differentiated into myotubes better than C2C12-vector cells, and expressed elevated levels of myogenin, a transcription factor that regulates myogenesis, as well as elevated levels of myosin heavy chain, a skeletal muscle marker. Western blot analysis revealed that Src and c-Abl (Abelson murine leukemia viral oncogene homolog 1) activation were enhanced in C2C12-YAP cells. Conversely, treatment of inhibitors of c-Abl, Src, or MEK5 inhibited activation of MEK5 and ERK5 and myogenesis of C2C12 myoblasts. Specific interactions between YAP and proteins in the ERK5 pathway, such as MEK kinase 3 (MEKK3) and ERK5, were illustrated by coimmunoprecipitation experiments. MEKK3 contains the PPGY motif (aa 178-181), which may interact with YAP. Site-directed mutagenesis experiments revealed that expression of MEKK3 Y181F mutant inhibited MEK5/ERK5 activation and myogenic differentiation. These results suggest that YAP promotes muscle differentiation by activating the Abl/Src/MEKK3/MEK5/ERK5 kinase cascade. Chen, T.-H., Chen, C.-Y., Wen, H.-C., Chang, C.-C., Wang, H.-D., Chuu, C.-P., Chang, C.-H. YAP promotes myogenic differentiation via the MEK5-ERK5 pathway.	[Chen, Ting-Huan; Wang, Horng-Dar] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Chen, Ting-Huan; Chen, Chen-Yu; Wen, Hui-Chin; Chuu, Chih-Pin; Chang, Chung-Ho] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Chang, Chia-Chu; Chang, Chung-Ho] Changhua Christian Hosp, Dept Internal Med, Changhua, Taiwan	National Tsing Hua University; National Health Research Institutes - Taiwan; Changhua Christian Hospital	Chuu, CP; Chang, CH (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Zhunan Town 350, Miaoli County, Taiwan.	cpchuu@nhri.org.tw; changch@nhri.org.tw	Chuu, Chih-Pin/N-6697-2019	Wang, Horng-Dar/0000-0001-9570-3611	Ministry of Science and Technology [MOST 104-2320-B-400-008, 105-2314-B-371-005]; National Health Research Institutes [GS-PP03]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Research Institutes(National Health Research Institutes, Japan)	This work was supported by the Ministry of Science and Technology (Grants MOST 104-2320-B-400-008 and 105-2314-B-371-005), and by an intramural grant from the National Health Research Institutes (GS-PP03) to C.-H.G.	Arnold HH, 1996, INT J DEV BIOL, V40, P345; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; BUCKINGHAM M, 1993, CR ACAD SCI III-VIE, V316, P1040; Carter EJ, 2009, J CELL SCI, V122, P3104, DOI 10.1242/jcs.045757; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; di Bari MG, 2006, EMBO REP, V7, P727, DOI 10.1038/sj.embor.7400700; Dinev D, 2001, EMBO REP, V2, P829, DOI 10.1093/embo-reports/kve177; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Einbond A, 1996, FEBS LETT, V384, P1, DOI 10.1016/0014-5793(96)00263-3; Golubovskaya VM, 2005, J BIOL CHEM, V280, P25008, DOI 10.1074/jbc.M414172200; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Jeong H, 2010, FASEB J, V24, P3310, DOI 10.1096/fj.09-151324; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Lin YT, 2012, EXP CELL RES, V318, P1877, DOI 10.1016/j.yexcr.2012.05.005; Liu AM, 2010, EXPERT OPIN THER TAR, V14, P855, DOI 10.1517/14728222.2010.499361; Lu HG, 2002, J BIOL CHEM, V277, P46687, DOI 10.1074/jbc.M209643200; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Mauro A, 2002, J CELL SCI, V115, P3587, DOI 10.1242/jcs.00037; Menconi M, 2008, J CELL BIOCHEM, V105, P353, DOI 10.1002/jcb.21833; Mermelstein CS, 2007, DIFFERENTIATION, V75, P184, DOI 10.1111/j.1432-0436.2006.00129.x; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Nakamura K, 2003, J BIOL CHEM, V278, P36989, DOI 10.1074/jbc.C300313200; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; OLSON EN, 1995, DEV BIOL, V172, P2, DOI 10.1006/dbio.1995.0002; Posthaus H, 2002, J CELL SCI, V115, P4587, DOI 10.1242/jcs.00141; Scapoli L, 2004, ONCOGENE, V23, P805, DOI 10.1038/sj.onc.1207163; Shih-Ting Y., 2013, COMP MATH MATH PHYS, V2013, P1, DOI DOI 10.1109/NSSMIC.2013.6829689; SUDOL M, 1994, ONCOGENE, V9, P2145; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; Sunadome K, 2011, DEV CELL, V20, P192, DOI 10.1016/j.devcel.2010.12.005; Suzaki Y, 2002, J BIOL CHEM, V277, P9614, DOI 10.1074/jbc.M111790200; Vlug EJ, 2013, CELL ONCOL, V36, P375, DOI 10.1007/s13402-013-0143-7; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Watt KI, 2010, BIOCHEM BIOPH RES CO, V393, P619, DOI 10.1016/j.bbrc.2010.02.034; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhang HQ, 2012, DEV BIOL, V361, P103, DOI 10.1016/j.ydbio.2011.10.017; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606	46	19	20	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2963	2972		10.1096/fj.201601090R	http://dx.doi.org/10.1096/fj.201601090R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28356344				2022-12-26	WOS:000405931000021
J	Jeong, J; Kim, W; Kim, LK; VanHouten, J; Wysolmerski, JJ				Jeong, Jaekwang; Kim, Wonnam; Kim, Lark Kyun; VanHouten, Joshua; Wysolmerski, John J.			HER2 signaling regulates HER2 localization and membrane retention	PLOS ONE			English	Article							CANCER CELL-LINES; HER2-POSITIVE BREAST-CANCER; MAMMARY EPITHELIAL-CELLS; PLASMA-MEMBRANE; CALCIUM-TRANSPORT; DOWN-REGULATION; NEU PROTOONCOGENE; GLAND INVOLUTION; ERBB2; RECEPTOR	ErbB2/HER2/Neu is a receptor tyrosine kinase that is overexpressed in 25-30% of human breast cancers, usually associated with amplification of the ERBB2 gene. HER2 has no recognized ligands and heterodimers between HER2 and EGFR (ErbB1/HER1) or HER2 and ErbB3/HER3 are important in breast cancer. Unlike other ErbB family members, HER2 is resistant to internalization and degradation, and remains at the cell surface to signal for prolonged periods after it is activated. Although the mechanisms underlying retention of HER2 at the cell surface are not fully understood, prior studies have shown that, in order to avoid internalization, HER2 must interact with the chaperone, HSP90, and the calcium pump, PMCA2, within specific plasma membrane domains that protrude from the cell surface. In this report, we demonstrate that HER2 signaling, itself, is important for the formation and maintenance of membrane protrusions, at least in part, by maintaining PMCA2 expression and preventing increased intracellular calcium concentrations. Partial genetic knockdown of HER2 expression or pharmacologic inhibition of HER2 signaling causes the depletion of membrane protrusions and disruption of the interactions between HER2 and HSP90. This is associated with the ubiquitination of HER2, its internalization with EGFR or HER3, and its degradation. These results suggest a model by which some threshold of HER2 signaling is required for the formation and/or maintenance of multi-protein signaling complexes that reinforce and prolong HER2/EGFR or HER2/HER3 signaling by inhibiting HER2 ubiquitination and internalization.	[Jeong, Jaekwang; Kim, Wonnam; VanHouten, Joshua; Wysolmerski, John J.] Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, New Haven, CT 06510 USA; [Kim, Lark Kyun] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Kim, Lark Kyun] Yonsei Univ, Coll Med, PLUS Project Med Sci BK21, Severance Inst Vasc & Metab Res,Gangnam Severance, Seoul, South Korea	Yale University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Wysolmerski, JJ (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, New Haven, CT 06510 USA.	john.wysolmerski@yale.edu		Kim, Lark Kyun/0000-0001-5983-4470	National Institute of Health [CA153702, HD076248]; National Research Foundation of Korea [2016R1D1A1B01015292, NRF-2016R1D1A1B01015292]; Yonsei University College of Medicine [6-2016-0133, 2016-32-0027]; NIH [CA153702, HD076248]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea(National Research Foundation of Korea); Yonsei University College of Medicine(General Electric); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by National Institute of Health CA153702 and HD076248 to John Wysolmerski; National Research Foundation of Korea (NRF-2016R1D1A1B01015292) and Yonsei University College of Medicine (6-2016-0133 and 2016-32-0027) to Lark Kyun Kim. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Barbara Ehrlich for help with calcium imaging. This work was supported by the following grants: NIH CA153702 and NIH HD076248 to JJW. It was also supported by a grant from the National Research Foundation of Korea (NRF-2016R1D1A1B01015292), and faculty research/seed grants (6-2016-0133 and 2016-32-0027) from Yonsei University College of Medicine to L.K.K.	Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Arteaga CL, 2012, NAT REV CLIN ONCOL, V9, P16, DOI 10.1038/nrclinonc.2011.177; Azzi JR, 2013, J IMMUNOL, V191, P5785, DOI 10.4049/jimmunol.1390055; Ben-Kasus T, 2009, P NATL ACAD SCI USA, V106, P3294, DOI 10.1073/pnas.0812059106; Benlimame N, 2005, J CELL BIOL, V171, P505, DOI 10.1083/jcb.200504124; Bertelsen V, 2014, MEMBRANES, V4, P424, DOI 10.3390/membranes4030424; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; Carloni S, 2010, CURR CANCER DRUG TAR, V10, P422, DOI 10.2174/156800910791208580; Chevalier C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10765; Chung I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12742; Cuello M, 2001, CANCER RES, V61, P4892; DEPOTTER CR, 1993, CLIN EXP METASTAS, V11, P453, DOI 10.1007/BF00054936; Faddy HM, 2008, BIOCHEM BIOPH RES CO, V369, P977, DOI 10.1016/j.bbrc.2008.03.003; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hanker AB, 2013, ONCOTARGET, V4, P1866, DOI 10.18632/oncotarget.1481; Hartman Z, 2013, ONCOGENE, V32, P4169, DOI 10.1038/onc.2012.418; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hommelgaard AM, 2004, MOL BIOL CELL, V15, P1557, DOI 10.1091/mbc.E03-08-0596; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jeong J, 2016, P NATL ACAD SCI USA, V113, pE282, DOI 10.1073/pnas.1516138113; Lam PB, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-91; Lee WJ, 2005, BIOCHEM BIOPH RES CO, V337, P779, DOI 10.1016/j.bbrc.2005.09.119; Lee WJ, 2002, CELL SIGNAL, V14, P1015, DOI 10.1016/S0898-6568(02)00049-9; Lerdrup M, 2007, MOL BIOL CELL, V18, P3656, DOI 10.1091/mbc.e07-01-0025; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; MORI S, 1987, VIRCHOWS ARCH B, V54, P8, DOI 10.1007/BF02899192; Munnink THO, 2012, MOL PHARMACEUT, V9, P2995, DOI 10.1021/mp3002182; Peckys DB, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500165; Pust S, 2013, ONCOGENE, V32, P3443, DOI 10.1038/onc.2012.357; Reinhardt TA, 2004, J BIOL CHEM, V279, P42369, DOI 10.1074/jbc.M407788200; Reinhardt TA, 2009, BIOCHEM BIOPH RES CO, V378, P99, DOI 10.1016/j.bbrc.2008.11.004; Rubin I, 2001, ANN ONCOL, V12, P3, DOI 10.1023/A:1011195320446; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Shen F, 2008, CELL SIGNAL, V20, P779, DOI 10.1016/j.cellsig.2007.12.021; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Stagni V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7886; STERN DF, 1986, MOL CELL BIOL, V6, P1729, DOI 10.1128/MCB.6.5.1729; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Strehler EE, 2013, J PHARM PHARM SCI, V16, P190, DOI 10.18433/J3Z011; VanHouten J, 2010, P NATL ACAD SCI USA, V107, P11405, DOI 10.1073/pnas.0911186107; VanHouten JN, 2007, J MAMMARY GLAND BIOL, V12, P223, DOI 10.1007/s10911-007-9057-1; VanHouten JN, 2007, ENDOCRINOLOGY, V148, P5943, DOI 10.1210/en.2007-0850; Vaught DB, 2012, CANCER RES, V72, P2672, DOI 10.1158/0008-5472.CAN-11-3594; Wang SZE, 2006, CANCER RES, V66, P9591, DOI 10.1158/0008-5472.CAN-06-2071; Wang TL, 2012, J CELL PHYSIOL, V227, P2788, DOI 10.1002/jcp.23023; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Zagouri F, 2013, BREAST, V22, P569, DOI 10.1016/j.breast.2013.06.003; Zhang YQ, 2016, CANCER LETT, V382, P176, DOI 10.1016/j.canlet.2016.08.026; Zhou XD, 2012, CELL SIGNAL, V24, P140, DOI 10.1016/j.cellsig.2011.08.015	51	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174849	10.1371/journal.pone.0174849	http://dx.doi.org/10.1371/journal.pone.0174849			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369073	Green Published, gold, Green Submitted			2022-12-26	WOS:000399351000056
J	Cao, RY; Eves, R; Jia, L; Funk, CD; Jia, ZC; Mak, AS				Cao, Richard Yang; Eves, Robert; Jia, Lilly; Funk, Colin D.; Jia, Zongchao; Mak, Alan S.			Effects of p53-knockout in vascular smooth muscle cells on atherosclerosis in mice	PLOS ONE			English	Article							P53 GENE-TRANSFER; PODOSOME FORMATION; UP-REGULATION; INVASION; PROLIFERATION; MIGRATION; APOPTOSIS; INDUCTION; SUPPRESSOR; P53-PTEN	In vitro and in vivo evidence has indicated that the tumor suppressor, p53, may play a significant role in the regulation of atherosclerotic plaque formation. In vivo studies using global knockout mice models, however, have generated inconclusive results that do not address the roles of p53 in various cell types involved in atherosclerosis. In this study, we have specifically ablated p53 in vascular smooth muscle cells (VSMC) in the ApoE(-/-) mouse model to investigate the roles of p53 in VSMC in atherosclerotic plaque formation and stability. We found that p53 deficiency in VSMC alone did not affect the overall size of atherosclerotic lesions. However, there was a significant increase in the number of p53(-/-) VSMC in the fibrous caps of atherosclerotic plaques in the early stages of plaque development. Loss of p53 results in migration of VSMC at a faster rate using wound healing assays and augments PDGF-induced formation of circular dorsal ruffles (CDR), known to be involved in cell migration and internalization of surface receptors. Furthermore, aortic VSMC from ApoE(-/-) /p53(-/-) mice produce significantly more podosomes and are more invasive. We conclude that p53(-/-) VSMC are enriched in the fibrous caps of lesions at early stages of plaque formation, which is caused in part by an increase in VSMC migration and invasion as shown by p53(-/-) VSMC in culture having significantly higher rates of migration and producing more CDRs and invasive podosomes.	[Cao, Richard Yang; Eves, Robert; Jia, Lilly; Funk, Colin D.; Jia, Zongchao; Mak, Alan S.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Cao, Richard Yang] Chinese Acad Sci, Shanghai Clin Res Ctr, Fudan Univ, Zhongshan Xuhui Hosp, Shanghai, Peoples R China	Queens University - Canada; Chinese Academy of Sciences; Fudan University	Mak, AS (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	maka@queensu.ca	Cao, Richard/AAX-7489-2021	Cao, Richard/0000-0002-8743-9125; Funk, Colin/0000-0001-7029-4233				Bennett MR, 1997, CIRC RES, V81, P591, DOI 10.1161/01.RES.81.4.591; BOCHATONPIALLAT ML, 1992, DIFFERENTIATION, V49, P175, DOI 10.1111/j.1432-0436.1992.tb00665.x; Boucher P, 2004, TRENDS CARDIOVAS MED, V14, P55, DOI 10.1016/j.tcm.2003.12.001; Brozovich FV, 2016, PHARMACOL REV, V68, P476, DOI 10.1124/pr.115.010652; Burgstaller G, 2005, AM J PHYSIOL-HEART C, V288, pH3001, DOI 10.1152/ajpheart.01002.2004; Feil Susanne, 2009, V530, P343, DOI 10.1007/978-1-59745-471-1_18; George SJ, 2001, GENE THER, V8, P668, DOI 10.1038/sj.gt.3301431; Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115; GROTENDORST GR, 1982, J CELL PHYSIOL, V113, P261, DOI 10.1002/jcp.1041130213; Guevara NV, 1999, NAT MED, V5, P335, DOI 10.1038/6585; Guevara NV, 2001, PHARMACOL RES, V44, P59, DOI 10.1006/phrs.2001.0840; Kinscherf R, 1998, FASEB J, V12, P461, DOI 10.1096/fasebj.12.6.461; Li ZH, 1997, EXP MOL PATHOL, V64, P1, DOI 10.1006/exmp.1997.2204; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Louis SF, 2010, EXP CLIN CARDIOL, V15, pE75; Mak AS, 2011, CELL ADHES MIGR, V5, P144, DOI 10.4161/cam.5.2.14375; Mak AS, 2014, CELL ADHES MIGR, V8, P8, DOI DOI 10.4161/CAM.27841; Matsushita H, 2000, CIRCULATION, V101, P1447, DOI 10.1161/01.CIR.101.12.1447; Mercer J, 2006, CELL CYCLE, V5, P1907, DOI 10.4161/cc.5.17.3166; Merched AJ, 2003, ARTERIOSCL THROM VAS, V23, P1608, DOI 10.1161/01.ATV.0000084825.88022.53; Moghadasian MH, 1999, LAB INVEST, V79, P355; Mukhopadhyay UK, 2010, MOL CELL BIOL, V30, P4980, DOI 10.1128/MCB.00004-10; Mukhopadhyay UK, 2009, CELL CYCLE, V8, P2481, DOI 10.4161/cc.8.16.9269; Mukhopadhyay UK, 2009, MOL CELL BIOL, V29, P3088, DOI 10.1128/MCB.01816-08; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Newby AC, 1999, CARDIOVASC RES, V41, P345, DOI 10.1016/S0008-6363(98)00286-7; Orth JD, 2006, CANCER RES, V66, P11094, DOI 10.1158/0008-5472.CAN-06-3397; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Payne LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108257; Poon JS, 2010, CELL CYCLE, V9, P4450, DOI 10.4161/cc.9.22.13936; Scheinman M, 1999, J VASC SURG, V29, P360, DOI 10.1016/S0741-5214(99)70389-7; Tabas I, 2001, CIRC RES, V88, P747, DOI 10.1161/hh0801.090536; van Vlijmen BJM, 2001, CIRC RES, V88, P780, DOI 10.1161/hh0801.089261; von der Thusen JH, 2002, CIRCULATION, V105, P2064, DOI 10.1161/01.CIR.0000015502.97828.93; Wassmann S, 2007, J MOL CELL CARDIOL, V43, P301, DOI 10.1016/j.yjmcc.2007.06.001; Webb BA, 2005, AM J PHYSIOL-CELL PH, V289, pC898, DOI 10.1152/ajpcell.00095.2005; Williams H, 2002, ARTERIOSCL THROM VAS, V22, P788, DOI 10.1161/01.ATV.0000014587.66321.B4; Yoo SH, 2013, VASC PHARMACOL, V59, P44, DOI 10.1016/j.vph.2013.06.003	38	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0175061	10.1371/journal.pone.0175061	http://dx.doi.org/10.1371/journal.pone.0175061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362832	gold, Green Published, Green Submitted			2022-12-26	WOS:000399175000069
J	Azumaya, CM; Days, EL; Vinson, PN; Stauffer, S; Sulikowski, G; Weaver, CD; Nakagawa, T				Azumaya, Caleigh M.; Days, Emily L.; Vinson, Paige N.; Stauffer, Shaun; Sulikowski, Gary; Weaver, C. David; Nakagawa, Terunaga			Screening for AMPA receptor auxiliary subunit specific modulators	PLOS ONE			English	Article							IN-VITRO; PROTEIN; ANTAGONIST; PERAMPANEL; GSG1L; TARPS; DESENSITIZATION; POTENTIATORS; DISCOVERY; CHANNELS	AMPA receptors (AMPAR) are ligand gated ion channels critical for synaptic transmission and plasticity. Their dysfunction is implicated in a variety of psychiatric and neurological diseases ranging from major depressive disorder to amyotrophic lateral sclerosis. Attempting to potentiate or depress AMPAR activity is an inherently difficult balancing act between effective treatments and debilitating side effects. A newly explored strategy to target subsets of AMPARs in the central nervous system is to identify compounds that affect specific AMPAR-auxiliary subunit complexes. This exploits diverse spatio-temporal expression patterns of known AMPAR auxiliary subunits, providing means for designing brain region selective compounds. Here we report a high-throughput screening-based pipeline that can identify compounds that are selective for GIuA2-CNIH3 and GIuA2-stargazin complexes. These compounds will help us build upon the growing library of AMPAR-auxiliary subunit specific inhibitors, which have thus far all been targeted to TARP gamma-8. We used a cell-based assay combined with a voltage-sensitive dye (VSD) to identify changes in glutamate-gated cation flow across the membranes of HEK cells co-expressing GIuA2 and an auxiliary subunit. We then used a calcium flux assay to further validate hits picked from the VSD assay. VU0612951 and VU0627849 are candidate compounds from the initial screen that were identified as negative and positive allosteric modulators (NAM and PAM), respectively. They both have lower IC50/EC(50)s on complexes containing stargazin and CNIH3 than GSG1L or the AMPAR alone. We have also identified a candidate compound, VU0539491, that has NAM activity in GIuA2(R)-CNIH3 and GIuA2(Q) complexes and PAM activity in GluA2(Q)GSG1L complexes.	[Azumaya, Caleigh M.; Nakagawa, Terunaga] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Days, Emily L.; Vinson, Paige N.; Weaver, C. David] Vanderbilt Univ, Sch Med, Vanderbilt Inst Chem Biol High Throughput Screeni, Nashville, TN 37212 USA; [Stauffer, Shaun; Sulikowski, Gary] Vanderbilt Univ, Dept Chem, Nashville, TN USA; [Stauffer, Shaun; Weaver, C. David] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Nakagawa, Terunaga] Vanderbilt Univ, Sch Med, Struct Biol Ctr, Nashville, TN 37212 USA; [Nakagawa, Terunaga] Vanderbilt Univ, Sch Med, Vanderbilt Brain Inst, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Nakagawa, T (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.; Nakagawa, T (corresponding author), Vanderbilt Univ, Sch Med, Struct Biol Ctr, Nashville, TN 37212 USA.; Nakagawa, T (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Brain Inst, Nashville, TN 37212 USA.	terunaga.nakagawa@vanderbilt.edu			National Institute of Health [R21MH102546]; Foundation for the National Institutes of Health [T32GM008320]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH102546] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institute of Health grant R21MH102546 to TN and the Foundation for the National Institutes of Health (T32GM008320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28649; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; DIVIRGILIO F, 1990, CELL CALCIUM, V11, P57, DOI 10.1016/0143-4160(90)90059-4; French JA, 2012, NEUROLOGY, V79, P589, DOI 10.1212/WNL.0b013e3182635735; Gardinier KM, 2016, J MED CHEM, V59, P4753, DOI 10.1021/acs.jmedchem.6b00125; Gu XL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10873; Haering SC, 2014, MEMBRANES, V4, P469, DOI 10.3390/membranes4030469; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Kalashnikova E, 2010, NEURON, V65, P80, DOI 10.1016/j.neuron.2009.12.021; Kato AS, 2008, NEURON, V59, P986, DOI 10.1016/j.neuron.2008.07.034; Kato AS, 2016, NAT MED; Maher MP, 2016, J PHARMACOL EXP THER, V357, P394, DOI 10.1124/jpet.115.231712; Mathews DC, 2012, DRUGS, V72, P1313, DOI 10.2165/11633130-000000000-00000; McGee TP, 2015, J NEUROSCI, V35, P16171, DOI 10.1523/JNEUROSCI.2152-15.2015; Miu P, 2001, NEUROPHARMACOLOGY, V40, P976, DOI 10.1016/S0028-3908(01)00027-2; Montgomery KE, 2009, J PHARMACOL EXP THER, V331, P965, DOI 10.1124/jpet.109.158014; Morimoto-Tomita M, 2009, NEURON, V61, P101, DOI 10.1016/j.neuron.2008.11.009; Nagarajan N, 2001, NEUROPHARMACOLOGY, V41, P650, DOI 10.1016/S0028-3908(01)00133-2; Nibber A, 2016, EUR J PAEDIATR NEURO, V20, P222, DOI 10.1016/j.ejpn.2015.12.011; PATNEAU DK, 1992, J NEUROSCI, V12, P595; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Rogawski MA, 2011, EPILEPSY CURR, V11, P56, DOI 10.5698/1535-7511-11.2.56; RUETER SM, 1995, SCIENCE, V267, P1491, DOI 10.1126/science.7878468; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Semenov A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049282; Shanks NF, 2012, CELL REP, V1, P590, DOI 10.1016/j.celrep.2012.05.004; Shi Y, 2009, NEURON, V62, P633, DOI 10.1016/j.neuron.2009.05.016; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2006, P NATL ACAD SCI USA, V103, P10064, DOI 10.1073/pnas.0603128103; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; von Engelhardt J, 2010, SCIENCE, V327, P1518, DOI 10.1126/science.1184178; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; YAMADA KA, 1993, J NEUROSCI, V13, P3904; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244; Zwart R, 2014, J PHARMACOL EXP THER, V351, P124, DOI 10.1124/jpet.114.212779	40	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174742	10.1371/journal.pone.0174742	http://dx.doi.org/10.1371/journal.pone.0174742			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358902	gold, Green Submitted, Green Published			2022-12-26	WOS:000399174800081
J	Chitramuthu, BP; Kay, DG; Bateman, A; Bennett, HPJ				Chitramuthu, Babykumari P.; Kay, Denis G.; Bateman, Andrew; Bennett, Hugh P. J.			Neurotrophic effects of progranulin in vivo in reversing motor neuron defects caused by over or under expression of TDP-43 or FUS	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; HEXANUCLEOTIDE REPEAT; AXON OUTGROWTH; GENE FAMILY; MUTATIONS; ZEBRAFISH; DEMENTIA; NEUROPATHOLOGY; TOXICITY	Progranulin (PGRN) is a glycoprotein with multiple roles in normal and disease states. Mutations within the GRN gene cause frontotemporal lobar degeneration (FTLD). The affected neurons display distinctive TAR DNA binding protein 43 (TDP-43) inclusions. How partial loss of PGRN causes TDP-43 neuropathology is poorly understood. TDP-43 inclusions are also found in affected neurons of patients with other neurodegenerative diseases including amyotrophic lateral sclerosis (ALS) and Alzheimer's disease. In ALS, TDP-43 inclusions are typically also immunoreactive for fused in sarcoma (FUS). Mutations within TDP-43 or FUS are themselves neuropathogenic in ALS and some cases of FTLD. We used the outgrowth of caudal primary motor neurons (MNs) in zebrafish embryos to investigate the interaction of PGRN with TDP-43 and FUS in vivo. As reported previously, depletion of zebrafish PGRN-A (zfPGRN-A) is associated with truncated primary MNs and impaired motor function. Here we found that depletion of zfPGRN-A results in primary MNs outgrowth stalling at the horizontal myoseptum, a line of demarcation separating the myotome into dorsal and ventral compartments that is where the final destination of primary motor is assigned. Successful axonal outgrowth beyond the horizontal myoseptum depends in part upon formation of acetylcholine receptor clusters and this was found to be disorganized upon depletion of zfPGRN-A. PGRN reversed the effects of zfPGRN-A knockdown, but a related gene, zfPGRN-1, was without effect. Both knockdown of TDP-43 or FUS, as well as expression of human TDP-43 and FUS mutants results in MN abnormalities that are reversed by co-expression of hPGRN mRNA. Neither TDP-43 nor FUS reversed MN phenotypes caused by the depletion of PGRN. Thus TDP-43 and FUS lie upstream of PGRN in a gene complementation pathway. The ability of PGRN to override TDP-43 and FUS neurotoxicity due to partial loss of function or mutation in the corresponding genes may have therapeutic relevance.	[Chitramuthu, Babykumari P.; Bateman, Andrew; Bennett, Hugh P. J.] McGill Univ, Endocrine Res Lab, Royal Victoria Hosp, Hlth Ctr,Res Inst, Montreal, PQ, Canada; [Chitramuthu, Babykumari P.; Kay, Denis G.] Neurodyn Inc, Charlottetown, PE, Canada	McGill University; Royal Victoria Hospital	Chitramuthu, BP; Bennett, HPJ (corresponding author), McGill Univ, Endocrine Res Lab, Royal Victoria Hosp, Hlth Ctr,Res Inst, Montreal, PQ, Canada.; Chitramuthu, BP (corresponding author), Neurodyn Inc, Charlottetown, PE, Canada.	babykumari.chitramuthu@mail.mcgill.ca; hugh.bennett@mcgill.ca		Bateman, Andrew/0000-0003-0597-769X; Chitramuthu, Babykumari/0000-0001-5997-0915	Neurodyn Inc.; Natural sciences and Engineering Research Council of Canada Discovery Grant; Studentship award FRSQ; Studentship award NSERC(CGS)	Neurodyn Inc.; Natural sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Studentship award FRSQ; Studentship award NSERC(CGS)	The authors acknowledge the financial support of Neurodyn Inc. and the Natural sciences and Engineering Research Council of Canada Discovery Grant (H.B) and Studentship awards (to BC) FRSQ and NSERC(CGS). The funder provided support in the form of salaries for authors [BC and DGK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bassett DI, 2003, HUM MOL GENET, V12, pR265, DOI 10.1093/hmg/ddg279; BATEMAN A, 1990, BIOCHEM BIOPH RES CO, V173, P1161, DOI 10.1016/S0006-291X(05)80908-8; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Belzil VV, 2013, MOL CELL NEUROSCI, V56, P406, DOI 10.1016/j.mcn.2012.12.006; Brouwers N, 2010, J ALZHEIMERS DIS, V21, P423, DOI 10.3233/JAD-2010-100198; Cadieux B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-156; Chitramuthu BP, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-41; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; De Muynck L, 2013, NEUROBIOL AGING, V34, P2541, DOI 10.1016/j.neurobiolaging.2013.04.022; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2010, ANN NEUROL, V67, P739, DOI 10.1002/ana.22051; Drapeau P, 2001, J NEUROPHYSIOL, V86, P2951, DOI 10.1152/jn.2001.86.6.2951; Feldner J, 2005, DEV DYNAM, V234, P535, DOI 10.1002/dvdy.20520; Feldner J, 2007, J NEUROSCI, V27, P4978, DOI 10.1523/JNEUROSCI.1132-07.2007; Filiano AJ, 2013, J NEUROSCI, V33, P5352, DOI 10.1523/JNEUROSCI.6103-11.2013; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Ghoshal N, 2012, NEUROBIOL DIS, V45, P395, DOI 10.1016/j.nbd.2011.08.029; Gijselinck I, 2008, HUM MUTAT, V29, P1373, DOI 10.1002/humu.20785; Guo A, 2010, BRAIN RES, V1366, P1, DOI 10.1016/j.brainres.2010.09.099; Herdewyn S, 2013, NEUROBIOL AGING, V34, P2302, DOI 10.1016/j.neurobiolaging.2013.03.027; Hewamadduma CAA, 2013, HUM MOL GENET, V22, P2376, DOI 10.1093/hmg/ddt082; Huey ED, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.08.004; Huk KH, 2002, MOL NEUROBIOL, V25, P79; Josephs KA, 2007, J NEUROPATH EXP NEUR, V66, P142, DOI 10.1097/nen.0b013e31803020cf; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002214; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kao AW, 2011, P NATL ACAD SCI USA, V108, P4441, DOI 10.1073/pnas.1100650108; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kinsley L, 1993, GENEREVIEWS R; Kleinberger G, 2010, J NEUROCHEM, V115, P735, DOI 10.1111/j.1471-4159.2010.06961.x; Laird AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013368; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu YC, 2013, INT J MOL SCI, V14, P20079, DOI 10.3390/ijms141020079; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Mackenzie IRA, 2006, BRAIN, V129, P3081, DOI 10.1093/brain/awl271; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Mackenzie IRA, 2009, ACTA NEUROPATHOL, V117, P15, DOI 10.1007/s00401-008-0460-5; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; Minami SS, 2014, NAT MED, V20, P1157, DOI 10.1038/nm.3672; Moisse K, 2009, BRAIN RES, V1249, P202, DOI 10.1016/j.brainres.2008.10.021; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Panzer JA, 2006, J NEUROSCI, V26, P934, DOI 10.1523/JNEUROSCI.3656-05.2006; Petkau TL, 2012, NEUROBIOL DIS, V45, P711, DOI 10.1016/j.nbd.2011.10.016; Philips T, 2010, J NEUROPATH EXP NEUR, V69, P1191, DOI 10.1097/NEN.0b013e3181fc9aea; Pickering-Brown SM, 2002, BRAIN, V125, P732, DOI 10.1093/brain/awf069; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rohrer JD, 2009, NEUROLOGY, V73, P1451, DOI 10.1212/WNL.0b013e3181bf997a; Rohrer JD, 2015, LANCET NEUROL, V14, P253, DOI 10.1016/S1474-4422(14)70324-2; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Ryan CL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-130; Seelaar H, 2011, J NEUROL NEUROSUR PS, V82, P476, DOI 10.1136/jnnp.2010.212225; Solchenberger B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118956; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Tanaka Y, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0078-x; Tauffenberger A, 2013, HUM MOL GENET, V22, P782, DOI 10.1093/hmg/dds485; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; Van Kampen JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097032; Wils H, 2012, J PATHOL, V228, P67, DOI 10.1002/path.4043; Xiao Yan, 2010, Journal of Nanobiotechnology, V8, P13, DOI 10.1186/1477-3155-8-13; Xu JD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.017; Yin FF, 2010, FASEB J, V24, P4639, DOI 10.1096/fj.10-161471; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhang J, 2004, NAT NEUROSCI, V7, P1303, DOI 10.1038/nn1350; Zheng M, 2013, NEURAL REGEN RES, V8, P3284, DOI 10.3969/j.issn.1673-5374.2013.35.003; Zhou XL, 2015, J CELL BIOL, V210, P991, DOI 10.1083/jcb.201502029; Zhu SS, 2013, BRAIN RES, V1530, P54, DOI 10.1016/j.brainres.2013.07.023	76	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174784	10.1371/journal.pone.0174784	http://dx.doi.org/10.1371/journal.pone.0174784			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358904	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174800089
J	Connolly, NP; Stokum, JA; Schneider, CS; Ozawa, T; Xu, S; Galisteo, R; Castellani, RJ; Kim, AJ; Simard, JM; Winkles, JA; Holland, EC; Woodworth, GF				Connolly, Nina P.; Stokum, Jesse A.; Schneider, Craig S.; Ozawa, Tatsuya; Xu, Su; Galisteo, Rebeca; Castellani, Rudolph J.; Kim, Anthony J.; Simard, J. Marc; Winkles, Jeffrey A.; Holland, Eric C.; Woodworth, Graeme F.			Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer	PLOS ONE			English	Article							MOUSE MODELS; COMPARATIVE PHARMACOKINETICS; SUBVENTRICULAR ZONE; XENOGRAFT MODELS; MURINE MODELS; GENE-TRANSFER; GLIOBLASTOMA; CELL; MICE; DELIVERY	Previously rodent preclinical research in gliomas frequently involved implantation of cell lines such as C6 and 9L into the rat brain. More recently, mouse models have taken over, the genetic manipulability of the mouse allowing the creation of genetically accurate models outweighed the disadvantage of its smaller brain size that limited time allowed for tumor progression. Here we illustrate a method that allows glioma formation in the rat using the replication competent avian-like sarcoma (RCAS) virus / tumor virus receptor-A (tv-a) transgenic system of post-natal cell type-specific gene transfer. The RCAS/tv-a model has emerged as a particularly versatile and accurate modeling technology by enabling spatial, temporal, and cell type-specific control of individual gene transformations and providing de novo formed glial tumors with distinct molecular subtypes mirroring human GBM. Nestin promoter-driven tv-a (Ntv-a) transgenic Sprague-Dawley rat founder lines were created and RCAS PDGFA and p53 shRNA constructs were used to initiate intracranial brain tumor formation. Tumor formation and progression were confirmed and visualized by magnetic resonance imaging (MRI) and spectroscopy. The tumors were analyzed using histopathological and immunofluorescent techniques. All experimental animals developed large, heterogeneous brain tumors that closely resembled human GBM. Median survival was 92 days from tumor initiation and 62 days from the first point of tumor visualization on MRI. Each tumor-bearing animal showed time dependent evidence of malignant progression to high-grade glioma by MRI and neurological examination. Post-mortem tumor analysis demonstrated the presence of several key characteristics of human GBM, including high levels of tumor cell proliferation, pseudopalisading necrosis, microvascular proliferation, invasion of tumor cells into surrounding tissues, peri-tumoral reactive astrogliosis, lymphocyte infiltration, presence of numerous tumor-associated microglia-and bone marrow-derived macrophages, and the formation of stem-like cell niches within the tumor. This transgenic rat model may enable detailed interspecies comparisons of fundamental cancer pathways and clinically relevant experimental imaging procedures and interventions that are limited by the smaller size of the mouse brain.	[Connolly, Nina P.; Stokum, Jesse A.; Schneider, Craig S.; Kim, Anthony J.; Simard, J. Marc; Woodworth, Graeme F.] Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA; [Connolly, Nina P.; Kim, Anthony J.; Winkles, Jeffrey A.; Woodworth, Graeme F.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA; [Ozawa, Tatsuya; Holland, Eric C.] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Xu, Su] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA; [Galisteo, Rebeca; Winkles, Jeffrey A.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Castellani, Rudolph J.; Simard, J. Marc] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Woodworth, GF (corresponding author), Univ Maryland, Sch Med, Dept Neurosurg, Baltimore, MD 21201 USA.; Woodworth, GF (corresponding author), Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA.	gwoodworth@som.umaryland.edu			University of Maryland, School of Medicine; Department of Neurosurgery; NATIONAL CANCER INSTITUTE [P30CA134274, T32CA154274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS090430] Funding Source: NIH RePORTER	University of Maryland, School of Medicine; Department of Neurosurgery; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support was provided by the University of Maryland, School of Medicine and Department of Neurosurgery.	Abbott A, 2004, NATURE, V428, P464, DOI 10.1038/428464a; Ahronian Leanne G, 2014, Cold Spring Harb Protoc, V2014, P1128, DOI 10.1101/pdb.top069831; Barth RF, 1998, J NEURO-ONCOL, V36, P91, DOI 10.1023/A:1005805203044; Barth RF, 2009, J NEURO-ONCOL, V94, P299, DOI 10.1007/s11060-009-9875-7; Bedard LL, 2005, CANCER RES, V65, P1265, DOI 10.1158/0008-5472.CAN-04-3373; Bowman RL, 2016, CELL REP, V17, P2445, DOI 10.1016/j.celrep.2016.10.052; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9; Carlson Brett L, 2011, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1416s52; Charles N, 2010, CELL CYCLE, V9, P3012, DOI 10.4161/cc.9.15.12710; Chen C., 2013, APPL ANAL, V2013, P1, DOI DOI 10.1049/IC.2013.0013; Cloughesy TF, 2014, ANNU REV PATHOL-MECH, V9, P1, DOI 10.1146/annurev-pathol-011110-130324; DAHLSTRAND J, 1992, CANCER RES, V52, P5334; DAMOISEAUX JGMC, 1994, IMMUNOLOGY, V83, P140; Doucette TA, 2012, NEURO-ONCOLOGY, V14, P1136, DOI 10.1093/neuonc/nos139; Du Y, 2016, J CEREB BLOOD FLOW M; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Fisher GH, 1999, ONCOGENE, V18, P5253, DOI 10.1038/sj.onc.1203087; Fomchenko EI, 2006, CLIN CANCER RES, V12, P5288, DOI 10.1158/1078-0432.CCR-06-0438; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Hackett PB, 2011, CURR GENE THER, V11, P341; Halliday J, 2014, P NATL ACAD SCI USA, V111, P5248, DOI 10.1073/pnas.1321014111; Hambardzumyan D, 2009, TRANSL ONCOL, V2, P89, DOI 10.1593/tlo.09100; Herculano-Houzel S, 2006, P NATL ACAD SCI USA, V103, P12138, DOI 10.1073/pnas.0604911103; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Holland EC, 1998, P NATL ACAD SCI USA, V95, P1218, DOI 10.1073/pnas.95.3.1218; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Hrabak A, 2008, INFLAMM RES, V57, P75, DOI 10.1007/s00011-007-7057-7; Huse JT, 2009, BRAIN PATHOL, V19, P132, DOI 10.1111/j.1750-3639.2008.00234.x; Huszthy PC, 2012, NEURO-ONCOLOGY, V14, P979, DOI 10.1093/neuonc/nos135; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Joo KM, 2013, CELL REP, V3, P260, DOI 10.1016/j.celrep.2012.12.013; Joshi MU, 2008, BIOTECHNIQUES, V45, P247, DOI 10.2144/000112913; Kircher MF, 2012, NAT MED, V18, P829, DOI 10.1038/nm.2721; Kong LY, 2010, CLIN CANCER RES, V16, P5722, DOI 10.1158/1078-0432.CCR-10-1693; Kurland DB, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0599-2; LEVISON SW, 1993, DEVELOPMENT, V119, P611; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; Lindberg N, 2014, J NEUROSCI, V34, P14644, DOI 10.1523/JNEUROSCI.2977-14.2014; Luwor RB, 2015, J CLIN NEUROSCI, V22, P779, DOI 10.1016/j.jocn.2014.11.001; Masi BC, 2012, BIOMATERIALS, V33, P5768, DOI 10.1016/j.biomaterials.2012.04.048; Mukhopadhyay UK, 2009, MOL CELL BIOL, V29, P3088, DOI 10.1128/MCB.01816-08; O'Reilly T, 2010, CANCER CHEMOTH PHARM, V65, P625, DOI 10.1007/s00280-009-1068-8; Ohgaki H, 2006, J NEUROPATH EXP NEUR, V65, P1111, DOI 10.1097/01.jnen.0000248544.28423.48; Ozawa T, 2014, CANCER CELL, V26, P288, DOI 10.1016/j.ccr.2014.06.005; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pietras A, 2014, CELL STEM CELL, V14, P357, DOI 10.1016/j.stem.2014.01.005; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; SIDDIK ZH, 1987, BIOCHEM PHARMACOL, V36, P1925, DOI 10.1016/0006-2952(87)90490-4; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Szpirer C, 2010, METHODS MOL BIOL, V597, P445, DOI 10.1007/978-1-60327-389-3_30; Szulzewsky F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116644; TAMARGO RJ, 1993, CANCER RES, V53, P329; Uhrbom L, 2004, NAT MED, V10, P1257, DOI 10.1038/nm1120; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wei J, 2013, CANCER RES, V73, P3913, DOI 10.1158/0008-5472.CAN-12-4318; YANG MB, 1989, CANCER RES, V49, P5103; Yokoo H, 2008, NEUROPATHOLOGY, V28, P591, DOI 10.1111/j.1440-1789.2008.00923.x; Zheng SS, 2012, J GENET GENOMICS, V39, P261, DOI 10.1016/j.jgg.2012.05.003; Zhou QY, 2007, J PHARMACOL EXP THER, V321, P265, DOI 10.1124/jpet.106.118265; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	69	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174557	10.1371/journal.pone.0174557	http://dx.doi.org/10.1371/journal.pone.0174557			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358926	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174800052
J	Harlow, BE; Lawrence, LM; Harris, PA; Aiken, GE; Flythe, MD				Harlow, Brittany E.; Lawrence, Laurie M.; Harris, Patricia A.; Aiken, Glen E.; Flythe, Michael D.			Exogenous lactobacilli mitigate microbial changes associated with grain fermentation (corn, oats, and wheat) by equine fecal microflora ex vivo	PLOS ONE			English	Article							BACTERIA; HORSES; PROBIOTICS; STARCH; SUPPLEMENTATION; REUTERI; TRACT	Cereal grains are often included in equine diets. When starch intake exceeds foregut digestion starch will reach the hindgut, impacting microbial ecology. Probiotics (e.g., lactobacilli) are reported to mitigate GI dysbioses in other species. This study was conducted to determine the effect of exogenous lactobacilli on pH and the growth of amylolytic and lactate-utilizing bacteria. Feces were collected from 3 mature geldings fed grass hay with access to pasture. Fecal microbes were harvested by differential centrifugation, washed, and re-suspended in anaerobic media containing ground corn, wheat, or oats at 1.6% (w/v) starch and one of five treatments: Control (substrate only), L. acidophilus, L. buchneri, L. reuteri, or an equal mixture of all three (107 cells/mL, final concentration). After 24 h of incubation (37 degrees C, 160 rpm), samples were collected for pH and enumerations of total amylolytics, Group D Gram-positive cocci (GPC; Enterococci, Streptococci), lactobacilli, and lactate-utilizing bacteria. Enumeration data were log transformed prior to ANOVA (SAS, v. 9.3). Lactobacilli inhibited pH decline in corn and wheat fermentations (P < 0.0001). Specifically, addition of either L. reuteri or L. acidophilus was most effective at mitigating pH decline with both corn and wheat fermentation, in which the greatest acidification occurred (P < 0.05). Exogenous lactobacilli decreased amylolytics, while increasing lactate-utilizers in corn and wheat fermentations (P < 0.0001). In oat fermentations, L. acidophilus and L. reuteri inhibited pH decline and increased lactate-utilizers while decreasing amylolytics (P < 0.0001). For all substrates, L. reuteri additions (regardless of viability) had the lowest number of GPC and the highest number of lactobacilli and lactate-utilizers (P < 0.05). There were no additive effects when lactobacilli were mixed. Exogenous lactobacilli decreased the initial (first 8 h) rate of starch catalysis when wheat was the substrate, but did not decrease total (24 h) starch utilization in any case. These results indicate that exogenous lactobacilli can impact the microbial community and pH of cereal grain fermentations by equine fecal microflora ex vivo. Additionally, dead (autoclaved) exogenous lactobacilli had similar effects as live lactobacilli on fermentation. This latter result indicates that the mechanism by which lactobacilli impact other amylolytic bacteria is not simple resource competition.	[Harlow, Brittany E.; Lawrence, Laurie M.; Flythe, Michael D.] Univ Kentucky, Dept Anim & Food Sci, Lexington, KY 40506 USA; [Harris, Patricia A.] WALTHAM Ctr Pet Nutr, Equine Studies Grp, Melton Mowbray, Leics, England; [Aiken, Glen E.; Flythe, Michael D.] ARS, Forage Anim Prod Res Unit, USDA, Lexington, KY 40506 USA	University of Kentucky; Mars; WALTHAM Petcare Science Institute; United States Department of Agriculture (USDA)	Flythe, MD (corresponding author), Univ Kentucky, Dept Anim & Food Sci, Lexington, KY 40506 USA.; Flythe, MD (corresponding author), ARS, Forage Anim Prod Res Unit, USDA, Lexington, KY 40506 USA.	michael.flythe@ars.usda.gov		Flythe, Michael/0000-0002-8868-9169; Harlow, Brittany/0000-0002-2269-351X	USDA National Institute of Food and Agriculture (Hatch); WALTHAM BUCKEYE Equine Research; USDA Agricultural Research Service National Program	USDA National Institute of Food and Agriculture (Hatch); WALTHAM BUCKEYE Equine Research; USDA Agricultural Research Service National Program	This work was supported by USDA National Institute of Food and Agriculture (Hatch) and the WALTHAM BUCKEYE Equine Research Grant. MDF and GEA were supported by USDA Agricultural Research Service National Program 215. Co-author Patricia Harris is employed by the funder, WALTHAM BUCKEYE. She had a role in study design and preparation of the manuscript, but no role in data collection or analysis. Her employer has a general interest in how probiotic lactobacilli work, but their products were not included in the study (neither were any other commercial products).	Axelsson L.T., 1989, MICROB ECOL HEALTH D, V2, P131, DOI [DOI 10.3109/08910608909140210, 10.3109/08910608909140210]; Bernard WV, 2011, J EQUINE VET SCI, V31, P396, DOI 10.1016/j.jevs.2011.03.016; Cleusix V, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-101; Collins MD, 1999, AM J CLIN NUTR, V69, p1052S, DOI 10.1093/ajcn/69.5.1052s; de Fombelle A, 2003, ANIM SCI, V77, P293; Desrochers AM, 2005, JAVMA-J AM VET MED A, V227, P954, DOI 10.2460/javma.2005.227.954; Dougal K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087424; Elferink SJWHO, 2001, APPL ENVIRON MICROB, V67, P125, DOI 10.1128/AEM.67.1.125-132.2001; FASS, 2010, GUID CAR US AGR AGR; Faubladier C, 2013, BRIT J NUTR, V110, P1040, DOI 10.1017/S0007114512006162; FULLER R, 1991, GUT, V32, P439, DOI 10.1136/gut.32.4.439; GARNER HE, 1978, EQUINE VET J, V10, P249, DOI 10.1111/j.2042-3306.1978.tb02273.x; Harlow BE, 2015, J APPL MICROBIOL, V119, P1234, DOI 10.1111/jam.12927; Harlow BE, 2014, J APPL MICROBIOL, V117, P329, DOI 10.1111/jam.12532; Harlow BE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154037; Harlow BE, 2013, VET MICROBIOL, V166, P225, DOI 10.1016/j.vetmic.2013.05.003; Huang RH, 2015, J DAIRY SCI, V98, P5850, DOI 10.3168/jds.2014-9153; Kleinschmit DH, 2006, J DAIRY SCI, V89, P4005, DOI 10.3168/jds.S0022-0302(06)72444-4; Kopp-Hoolihan L, 2001, J AM DIET ASSOC, V101, P229, DOI 10.1016/S0002-8223(01)00060-8; MACKIE RI, 1979, APPL ENVIRON MICROB, V38, P416, DOI 10.1128/AEM.38.3.416-421.1979; Mantovani HC, 2001, APPL ENVIRON MICROB, V67, P808, DOI 10.1128/AEM.67.2.808-813.2001; Musa HH, 2009, J ANIM VET ADV, V8, P313; Sveinbjornsson J, 2007, ANIM FEED SCI TECH, V132, P171, DOI 10.1016/j.anifeedsci.2006.03.018; Swyers KL, 2008, J ANIM SCI, V86, P2596, DOI 10.2527/jas.2007-0608; Valeur N, 2004, APPL ENVIRON MICROB, V70, P1176, DOI 10.1128/AEM.70.2.1176-1181.2004; Vollenweider S, 2004, APPL MICROBIOL BIOT, V64, P16, DOI 10.1007/s00253-003-1497-y; Wells JE, 1997, FEMS MICROBIOL ECOL, V22, P237, DOI 10.1111/j.1574-6941.1997.tb00376.x; Willing B, 2009, EQUINE VET J, V41, P908, DOI 10.2746/042516409X447806	28	4	4	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174059	10.1371/journal.pone.0174059	http://dx.doi.org/10.1371/journal.pone.0174059			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358885	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174800019
J	Straus, MR; Whittaker, GR				Straus, Marco R.; Whittaker, Gary R.			A peptide-based approach to evaluate the adaptability of influenza A virus to humans based on its hemagglutinin proteolytic cleavage site	PLOS ONE			English	Article							RECEPTOR-BINDING; HUMAN INFECTION; H1N1 INFLUENZA; ACTIVATION; SUBTYPE; ORIGIN; PATHOGENICITY; MATRIPTASE; EVOLUTION; VACCINE	Cleavage activation of the hemagglutinin (HA) protein by host proteases is a crucial step in the infection process of influenza A viruses (IAV). However, IAV exists in eighteen different HA subtypes in nature and their cleavage sites vary considerably. There is uncertainty regarding which specific proteases activate a given HA in the human respiratory tract. Understanding the relationship between different HA subtypes and human-specific proteases will be valuable in assessing the pandemic potential of circulating viruses. Here we utilized fluorogenic peptides mimicking the HA cleavage motif of representative IAV strains causing disease in humans or of zoonotic/pandemic potential and tested them with a range of proteases known to be present in the human respiratory tract. Our results show that peptides from the H1, H2 and H3 subtypes are cleaved efficiently by a wide range of proteases including trypsin, matriptase, human airway tryptase (HAT), kallikrein-related peptidases 5 (KLK5) and 12 (KLK12) and plasmin. Regarding IAVs currently of concern for human adaptation, cleavage site peptides from H10 viruses showed very limited cleavage by respiratory tract proteases. Peptide mimics from H6 viruses showed broader cleavage by respiratory tract proteases, while H5, H7 and H9 subtypes showed variable cleavage; particularly matriptase appeared to be a key protease capable of activating IAVs. We also tested HA substrate specificity of Factor Xa, a protease required for HA cleavage in chicken embryos and relevant for influenza virus production in eggs. Overall our data provide novel tool allowing the assessment of human adaptation of IAV HA subtypes.	[Straus, Marco R.; Whittaker, Gary R.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Straus, Marco R.; Whittaker, Gary R.] Univ Rochester, Med Ctr, New York Ctr Excellence Influenza Res & Surveilla, Rochester, NY 14642 USA	Cornell University; University of Rochester	Whittaker, GR (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.; Whittaker, GR (corresponding author), Univ Rochester, Med Ctr, New York Ctr Excellence Influenza Res & Surveilla, Rochester, NY 14642 USA.	grw7@cornell.edu		Straus, Marco R/0000-0003-1087-2091	National Institute of Allergy and Infectious Diseases; National Institutes of Health, Department of Health and Human Services, under the Centers of Excellence for Influenza Research and Surveillance (CEIRS) [HHSN272201400005C]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health, Department of Health and Human Services, under the Centers of Excellence for Influenza Research and Surveillance (CEIRS)	This work was funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under the Centers of Excellence for Influenza Research and Surveillance (CEIRS) Contract No. HHSN272201400005C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly HAA, 2015, WHO TECH REP SER, V994, P1; [Anonymous], 2014, LANCET INFECT DIS, V14, P173; Baron J, 2013, J VIROL, V87, P1811, DOI 10.1128/JVI.02320-12; Beaulieu A, 2013, J VIROL, V87, P4237, DOI 10.1128/JVI.03005-12; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Beliveau F, 2009, FEBS J, V276, P2213, DOI 10.1111/j.1742-4658.2009.06950.x; Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Bin L, 2005, J VIROL, V79, P6763, DOI 10.1128/JVI.79.11.6763-6771.2005; Bottcher-Friebertshauser E, 2013, PATHOG DIS, V69, P87, DOI 10.1111/2049-632X.12053; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Bottcher-Friebertshauser Eva, 2012, CURR TOP MICROBIOL, P139; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; Chen ZY, 2014, J VIROL, V88, P7016, DOI 10.1128/JVI.00100-14; Chen ZY, 2010, J VIROL, V84, P44, DOI 10.1128/JVI.02106-09; Decha P, 2008, BIOPHYS J, V95, P128, DOI 10.1529/biophysj.107.127456; Domoto T, 2012, CANCER SCI, V103, P448, DOI 10.1111/j.1349-7006.2011.02162.x; Feldmann A, 2000, J VIROL, V74, P8018, DOI 10.1128/JVI.74.17.8018-8027.2000; Fineberg HV, 2014, NEW ENGL J MED, V370, P1335, DOI 10.1056/NEJMra1208802; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Fouchier RAM, 2013, TEXTBOOK OF INFLUENZA, 2ND EDITION, P175; Galloway SE, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003151; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; GOTOH B, 1992, FEBS LETT, V296, P274, DOI 10.1016/0014-5793(92)80303-X; GOTOH B, 1990, EMBO J, V9, P4189, DOI 10.1002/j.1460-2075.1990.tb07643.x; Hamilton BS, 2013, J BIOL CHEM, V288, P17399, DOI 10.1074/jbc.M112.440362; Hamilton BS, 2012, J VIROL, V86, P10579, DOI 10.1128/JVI.00306-12; Hamilton BS, 2012, VIRUSES-BASEL, V4, P1144, DOI 10.3390/v4071144; HORIMOTO T, 1994, J VIROL, V68, P6074, DOI 10.1128/JVI.68.9.6074-6078.1994; Horimoto T, 2006, VACCINE, V24, P3669, DOI 10.1016/j.vaccine.2005.07.005; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; Izidoro MA, 2009, ARCH BIOCHEM BIOPHYS, V487, P105, DOI 10.1016/j.abb.2009.05.013; Jhung MA, 2013, CLIN INFECT DIS, V57, P1703, DOI 10.1093/cid/cit649; Jin H, 2014, CURR OPIN VIROL, V6, P34, DOI 10.1016/j.coviro.2014.02.008; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; KLENK HD, 1975, VIROLOGY, V68, P426, DOI 10.1016/0042-6822(75)90284-6; Kuhn N, 2016, J VIROL, V90, P4298, DOI 10.1128/JVI.02693-15; LAZAROWITZ SG, 1975, VIROLOGY, V68, P440, DOI 10.1016/0042-6822(75)90285-8; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Lipsitch M, 2016, ELIFE, V5, DOI 10.7554/eLife.18491; Ma W, 2007, P NATL ACAD SCI USA, V104, P20949, DOI 10.1073/pnas.0710286104; Mair CM, 2014, BBA-BIOMEMBRANES, V1838, P1153, DOI 10.1016/j.bbamem.2013.10.004; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Munster VJ, 2005, EMERG INFECT DIS, V11, P1545, DOI 10.3201/eid1110.050546; Neumann G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002932; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Perdue M. L., 2008, AVIAN INFLUENZA, P23; Ping JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9148; Polgar L, 1989, GEN ASPECTS PROTEASE, P43; Pushko P, 2016, VACCINE, V34, P5235, DOI 10.1016/j.vaccine.2016.09.012; Ramos I, 2015, EMERG INFECT DIS, V21, P1197, DOI 10.3201/eid2107.141755; Reid AH, 1999, P NATL ACAD SCI USA, V96, P1651, DOI 10.1073/pnas.96.4.1651; Robertson JS, 2011, VACCINE, V29, P1836, DOI 10.1016/j.vaccine.2010.12.044; Russier M, 2016, P NATL ACAD SCI USA, V113, P1636, DOI 10.1073/pnas.1524384113; Sakai K, 2014, J VIROL, V88, P5608, DOI 10.1128/JVI.03677-13; Schicker RS, 2016, MMWR-MORBID MORTAL W, V65, P1157, DOI 10.15585/mmwr.mm6542a1; Schrauwen EJA, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.9; Shi WF, 2013, PROTEIN CELL, V4, P846, DOI 10.1007/s13238-013-3083-0; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Su S, 2014, CLIN INFECT DIS, V59, DOI 10.1093/cid/ciu345; Taubenberger JK, 1998, P NATL ACAD SCI USA, V95, P9713, DOI 10.1073/pnas.95.17.9713; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Trombetta C, 2015, VACCINES-BASEL, V3, P172, DOI 10.3390/vaccines3010172; Tse LV, 2015, VIROLOGY, V482, P1, DOI 10.1016/j.virol.2015.03.023; Tse LV, 2013, J VIROL, V87, P5161, DOI 10.1128/JVI.00210-13; Tweed SA, 2004, EMERG INFECT DIS, V10, P2196, DOI 10.3201/eid1012.040961; Wang F, 2015, EMBO J, V34, P1661, DOI 10.15252/embj.201590960; Wang J.W., 2009, PLANT QUARANTINE, V1, P1, DOI DOI 10.1371/J0URNAL.PGEN.1000350; Wang WJ, 2013, J VIROL, V87, P4642, DOI 10.1128/JVI.03271-12; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; Xu KM, 2007, J VIROL, V81, P2635, DOI 10.1128/JVI.02316-06; Yan ZQ, 2014, IRAN J PUBLIC HEALTH, V43, P1582; Yen HL, 2009, CURR TOP MICROBIOL, V333, P3, DOI 10.1007/978-3-540-92165-3_1; Zhang H, 2015, CELL HOST MICROBE, V17, P377, DOI 10.1016/j.chom.2015.02.006	80	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174827	10.1371/journal.pone.0174827	http://dx.doi.org/10.1371/journal.pone.0174827			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358853	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174800096
J	Haimovich, JS; Venkatesh, AK; Shojaee, A; Coppi, A; Warner, F; Li, SX; Krumholz, HM				Haimovich, Julian S.; Venkatesh, Arjun K.; Shojaee, Abbas; Coppi, Andreas; Warner, Frederick; Li, Shu-Xia; Krumholz, Harlan M.			Discovery of temporal and disease association patterns in condition-specific hospital utilization rates	PLOS ONE			English	Article							SEASONAL-VARIATION; AIR-POLLUTION; ADMISSIONS; DISORDERS; INFECTION; SYSTEM; 5-YEAR; REGION	Identifying temporal variation in hospitalization rates may provide insights about disease patterns and thereby inform research, policy, and clinical care. However, the majority of medical conditions have not been studied for their potential seasonal variation. The objective of this study was to apply a data-driven approach to characterize temporal variation in condition-specific hospitalizations. Using a dataset of 34 million inpatient discharges gathered from hospitals in New York State from 2008-2011, we grouped all discharges into 263 clinical conditions based on the principal discharge diagnosis using Clinical Classification Software in order to mitigate the limitation that administrative claims data reflect clinical conditions to varying specificity. After applying Seasonal-Trend Decomposition by LOESS, we estimated the periodicity of the seasonal component using spectral analysis and applied harmonic regression to calculate the amplitude and phase of the condition's seasonal utilization pattern. We also introduced four new indices of temporal variation: mean oscillation width, seasonal coefficient, trend coefficient, and linearity of the trend. Finally, K-means clustering was used to group conditions across these four indices to identify common temporal variation patterns. Of all 263 clinical conditions considered, 164 demonstrated statistically significant seasonality. Notably, we identified conditions for which seasonal variation has not been previously described such as ovarian cancer, tuberculosis, and schizophrenia. Clustering analysis yielded three distinct groups of conditions based on multiple measures of seasonal variation. Our study was limited to New York State and results may not directly apply to other regions with distinct climates and health burden. A substantial proportion of medical conditions, larger than previously described, exhibit seasonal variation in hospital utilization. Moreover, the application of clustering tools yields groups of clinically heterogeneous conditions with similar seasonal phenotypes. Further investigation is necessary to uncover common etiologies underlying these shared seasonal phenotypes.	[Haimovich, Julian S.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Venkatesh, Arjun K.; Shojaee, Abbas; Coppi, Andreas; Warner, Frederick; Li, Shu-Xia; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Venkatesh, Arjun K.] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT USA; [Krumholz, Harlan M.] Yale Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Sch Med, Dept Internal Med, Robert Wood Johnson Fdn, Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA	Yeshiva University; Albert Einstein College of Medicine; Yale University; Yale University; Robert Wood Johnson Foundation (RWJF); Yale University; Yale University	Krumholz, HM (corresponding author), Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA.; Krumholz, HM (corresponding author), Yale Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06510 USA.; Krumholz, HM (corresponding author), Yale Sch Med, Dept Internal Med, Robert Wood Johnson Fdn, Clin Scholars Program, New Haven, CT 06510 USA.; Krumholz, HM (corresponding author), Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020		Albert Einstein [College of Medicine] Summer Research Fellowship; Center for Cardiovascular Outcomes Research at Yale University [U01 HL105270]; NHLBI in Bethesda, Maryland; Emergency Medicine Foundation Health Policy Scholar Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001862] Funding Source: NIH RePORTER	Albert Einstein [College of Medicine] Summer Research Fellowship; Center for Cardiovascular Outcomes Research at Yale University; NHLBI in Bethesda, Maryland; Emergency Medicine Foundation Health Policy Scholar Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Julian Haimovich was supported by the Albert Einstein [College of Medicine] Summer Research Fellowship during the time the work was conducted. Dr. Krumholz was supported by grant U01 HL105270 (Center for Cardiovascular Outcomes Research at Yale University) from the NHLBI in Bethesda, Maryland, during the time the work was conducted. Dr. Venkatesh was supported by the Emergency Medicine Foundation Health Policy Scholar Award during the time the work was conducted. All other authors report no external funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Abdallat M, 2016, INFLUENZA OTHER RESP, V10, P91, DOI 10.1111/irv.12354; Almagro P, 2015, INT J CHRONIC OBSTR, V10, P899, DOI 10.2147/COPD.S75710; Amr M, 2012, J AFFECT DISORDERS, V137, P56, DOI 10.1016/j.jad.2011.12.039; Aronow W S, 2000, J Am Med Dir Assoc, V1, P258; Bigi A, 2010, ATMOS ENVIRON, V44, P2004, DOI 10.1016/j.atmosenv.2010.02.028; Boulay F, 1999, CIRCULATION, V100, P280, DOI 10.1161/01.CIR.100.3.280; Brown HK, 2009, THROMB HAEMOSTASIS, V102, P676, DOI 10.1160/TH09-04-0214; Choi JH, 2007, J EPIDEMIOL COMMUN H, V61, P314, DOI 10.1136/jech.2006.049205; Cleveland R.B., 1990, J OFF STAT, V6, P3; Elixhauser A, 2014, CLIN CLASSIFICATIONS; Frost L, 2002, EPIDEMIOLOGY, V13, P211, DOI 10.1097/00001648-200203000-00017; Gallerani M, 2007, CHRONOBIOL INT, V24, P143, DOI 10.1080/07420520601139755; Gallerani M, 2011, CLIN CARDIOL, V34, P389, DOI 10.1002/clc.20895; Geoffroy PA, 2014, J AFFECT DISORDERS, V168, P210, DOI 10.1016/j.jad.2014.07.002; HCUP State Emergency Department Databases (SEDD), 2008, HEALTHC COST UT PROJ; HCUP State Inpatient Databases (SID), 2008, HEALTHC COST UT PROJ; Hennig C, 2004, J COMPUT GRAPH STAT, V13, P930, DOI 10.1198/106186004X12740; Kessler RC, 1997, ARCH GEN PSYCHIAT, V54, P313; Lieberman D, 1999, J INFECTION, V39, P134, DOI 10.1016/S0163-4453(99)90005-1; MACLEAN MH, 1984, J EPIDEMIOL COMMUN H, V38, P99, DOI 10.1136/jech.38.2.99; MCLELLAN BA, 1990, J TRAUMA, V30, P418, DOI 10.1097/00005373-199030040-00008; Melamed RD, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S6-S3; Mohamed AS, 2014, PREV VET MED, V113, P249, DOI 10.1016/j.prevetmed.2013.11.006; Perencevich EN, 2008, INFECT CONT HOSP EP, V29, P1124, DOI 10.1086/592698; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Team R, 2015, RSTUDIO INT DEV R; Verbesselt J, 2010, REMOTE SENS ENVIRON, V114, P106, DOI 10.1016/j.rse.2009.08.014; Wang Y, 2003, STROKE, V34, P1144, DOI 10.1161/01.STR.0000067703.71251.B6; Yang R, 2010, BIOINFORMATICS, V26, pi168, DOI 10.1093/bioinformatics/btq189	29	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0172049	10.1371/journal.pone.0172049	http://dx.doi.org/10.1371/journal.pone.0172049			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355219	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174600002
J	Lambertus, S; Bax, NM; Fakin, A; Groenewoud, JMM; Klevering, BJ; Moore, AT; Michaelides, M; Webster, AR; van der Wilt, GJ; Hoyng, CB				Lambertus, Stanley; Bax, Nathalie M.; Fakin, Ana; Groenewoud, Joannes M. M.; Klevering, B. Jeroen; Moore, Anthony T.; Michaelides, Michel; Webster, Andrew R.; van der Wilt, Gert Jan; Hoyng, Carel B.			Highly sensitive measurements of disease progression in rare disorders: Developing and validating a multimodal model of retinal degeneration in Stargardt disease	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; FUNDUS AUTOFLUORESCENCE; MACULAR-DYSTROPHY; NATURAL-HISTORY; FLAVIMACULATUS; ATROPHY; LIPOFUSCIN; DESIGN; ACUITY; GENE	Background Each inherited retinal disorder is rare, but together, they affect millions of people worldwide. No treatment is currently available for these blinding diseases, but promising new options D including gene therapy D are emerging. Arguably, the most prevalent retinal dystrophy is Stargardt disease. In each case, the specific combination of ABCA4 variants (> 900 identified to date) and modifying factors is virtually unique. It accounts for the vast phenotypic heterogeneity including variable rates of functional and structural progression, thereby potentially limiting the ability of phase I/II clinical trials to assess efficacy of novel therapies with few patients. To accommodate this problem, we developed and validated a sensitive and reliable composite clinical trial endpoint for disease progression based on structural measurements of retinal degeneration. Methods and findings We used longitudinal data from early-onset Stargardt patients from the Netherlands (development cohort, n = 14) and the United Kingdom (external validation cohort, n = 18). The composite endpoint was derived from best-corrected visual acuity, fundus autofluorescence, and spectral-domain optical coherence tomography. Weighting optimization techniques excluded visual acuity from the composite endpoint. After optimization, the endpoint outperformed each univariable outcome, and showed an average progression of 0.41 E retinal eccentricity per year (95% confidence interval, 0.30-0.52). Comparing with actual longitudinal values, the model accurately predicted progression (R-2, 0.904). These properties were largely preserved in the validation cohort (0.43 degrees/year [0.33-0.53]; prediction: R-2, 0.872). We subsequently ran a two-year trial simulation with the composite endpoint, which detected a 25% decrease in disease progression with 80% statistical power using only 14 patients. Conclusions These results suggest that a multimodal endpoint, reflecting structural macular changes, provides a sensitive measurement of disease progression in Stargardt disease. It can be very useful in the evaluation of novel therapeutic modalities in rare disorders.	[Lambertus, Stanley; Bax, Nathalie M.; Klevering, B. Jeroen; Hoyng, Carel B.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Fakin, Ana; Moore, Anthony T.; Michaelides, Michel; Webster, Andrew R.] Moorfields Eye Hosp, London, England; [Fakin, Ana; Moore, Anthony T.; Michaelides, Michel; Webster, Andrew R.] UCL, Inst Ophthalmol, London, England; [Groenewoud, Joannes M. M.; van der Wilt, Gert Jan] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands	Radboud University Nijmegen; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; Radboud University Nijmegen	Hoyng, CB (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.	carel.hoyng@radboudumc.nl	Groenewoud, Hans JMM/R-3588-2017; Lambertus, Stanley/P-8153-2015; van der Wilt, G.J./H-8120-2014; Fakin, Ana/ABE-5099-2021	Groenewoud, Hans JMM/0000-0002-4974-150X; Lambertus, Stanley/0000-0001-9600-9592; van der Wilt, G.J./0000-0002-5856-762X; Fakin, Ana/0000-0001-6132-4808; Bax, Nathalie/0000-0002-1527-0463; Michaelides, Michel/0000-0002-1552-7046	Stichting A.F. Deutman Researchfonds Oogheelkunde, Nijmegen, The Netherlands; Nederlandse Oogonderzoek Stichting, Nijmegen, The Netherlands; Stichting MD fonds; Landelijke Stichting voor Blinden en Slechtzienden, and Oogfonds; NIHR Rare Disease Translational Research Consortium; National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital National Health Service Foundation Trust; UCL Institute of Ophthalmology; Fight For Sight(UK); Macular Society(UK); Moorfields Eye Hospital Special Trustees; Moorfields Eye Charity; Foundation Fighting Blindness (USA); Retinitis Pigmentosa Fighting Blindness; FFB Career Development Award	Stichting A.F. Deutman Researchfonds Oogheelkunde, Nijmegen, The Netherlands(Netherlands Government); Nederlandse Oogonderzoek Stichting, Nijmegen, The Netherlands; Stichting MD fonds; Landelijke Stichting voor Blinden en Slechtzienden, and Oogfonds; NIHR Rare Disease Translational Research Consortium; National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital National Health Service Foundation Trust; UCL Institute of Ophthalmology; Fight For Sight(UK); Macular Society(UK); Moorfields Eye Hospital Special Trustees; Moorfields Eye Charity; Foundation Fighting Blindness (USA); Retinitis Pigmentosa Fighting Blindness; FFB Career Development Award	This study was supported by the Stichting A.F. Deutman Researchfonds Oogheelkunde, Nijmegen, The Netherlands, Nederlandse Oogonderzoek Stichting, Nijmegen, The Netherlands, and by the following foundations that contributed through UitZicht: Stichting MD fonds, Landelijke Stichting voor Blinden en Slechtzienden, and Oogfonds. A.F. was funded by the NIHR Rare Disease Translational Research Consortium. The Moorfields Eye Hospital cohort of patients, clinical, imaging, and molecular data were ascertained and collected with the support of grants from the National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital National Health Service Foundation Trust and UCL Institute of Ophthalmology, Fight For Sight(UK), The Macular Society(UK), Moorfields Eye Hospital Special Trustees, Moorfields Eye Charity, the Foundation Fighting Blindness (USA), and Retinitis Pigmentosa Fighting Blindness. Prof. Michel Michaelides is a recipient of an FFB Career Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasakis A, 2011, RETINA-J RET VIT DIS, V31, P949, DOI 10.1097/IAE.0b013e3181f441f6; ANSTIS SM, 1974, VISION RES, V14, P589, DOI 10.1016/0042-6989(74)90049-2; Armstrong JD, 1998, OPHTHALMOLOGY, V105, P448, DOI 10.1016/S0161-6420(98)93026-3; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; Binley K, 2013, INVEST OPHTH VIS SCI, V54, P4061, DOI 10.1167/iovs.13-11871; Charbel Issa P, 2015, P NATL ACAD SCI US; Chen B, 2010, EXP EYE RES, V91, P143, DOI 10.1016/j.exer.2010.03.021; Cideciyan AV, 2015, INVEST OPHTH VIS SCI, V56, P5946, DOI 10.1167/iovs.15-17698; Cideciyan AV, 2009, HUM MOL GENET, V18, P931, DOI 10.1093/hmg/ddn421; Csaky KG, 2008, INVEST OPHTH VIS SCI, V49, P479, DOI 10.1167/iovs.07-1132; Cukras CA, 2012, ARCH OPHTHALMOL-CHIC, V130, P171, DOI 10.1001/archophthalmol.2011.332; DRASDO N, 1974, BRIT J OPHTHALMOL, V58, P709, DOI 10.1136/bjo.58.8.709; Dreyhaupt J, 2005, OPHTHAL EPIDEMIOL, V12, P353, DOI 10.1080/09286580591005723; Ergun E, 2005, INVEST OPHTH VIS SCI, V46, P310, DOI 10.1167/iovs.04-0212; Fujinami K, 2015, OPHTHALMOLOGY, V122, P326, DOI 10.1016/j.ophtha.2014.08.012; Fujinami K, 2013, INVEST OPHTH VIS SCI, V54, P8181, DOI 10.1167/iovs.13-12104; Fujinami K, 2013, AM J OPHTHALMOL, V156, P487, DOI 10.1016/j.ajo.2013.05.003; Gomes NL, 2009, INVEST OPHTH VIS SCI, V50, P3953, DOI 10.1167/iovs.08-2657; KAPLAN J, 1993, NAT GENET, V5, P308, DOI 10.1038/ng1193-308; Kellner S, 2009, AM J OPHTHALMOL, V147, P895, DOI 10.1016/j.ajo.2008.12.023; Kretschmann U, 1998, BRIT J OPHTHALMOL, V82, P267, DOI 10.1136/bjo.82.3.267; Kuehlewein L, 2016, RETINA-J RET VIT DIS, V36, P1216, DOI 10.1097/IAE.0000000000000870; Kuniyoshi K, 2014, OPHTHALMOLOGICA; Lambertus S, 2015, OPHTHALMOLOGY, V122, P335, DOI 10.1016/j.ophtha.2014.08.032; Langbaum JB, 2014, ALZHEIMERS DEMENT, V10, P666, DOI 10.1016/j.jalz.2014.02.002; Lazow MA, 2011, INVEST OPHTH VIS SCI, V52, P9581, DOI 10.1167/iovs.11-8554; Lee W, 2014, INVEST OPHTHALMOL VI; Liew G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004015; Lois N, 2004, AM J OPHTHALMOL, V138, P55, DOI 10.1016/j.ajo.2004.02.056; Mazzucato M, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-37; McBain VA, 2012, AM J OPHTHALMOL, V154, P146, DOI 10.1016/j.ajo.2012.01.019; Praidou A, 2014, INT OPHTHALMOL, V34, P613, DOI 10.1007/s10792-013-9812-9; Radu RA, 2003, P NATL ACAD SCI USA, V100, P4742, DOI 10.1073/pnas.0737855100; Ritter M, 2013, INVEST OPHTH VIS SCI, V54, P6416, DOI 10.1167/iovs.12-11550; Rotenstreich Y, 2003, OPHTHALMOLOGY, V110, P1151, DOI 10.1016/S0161-6420(03)00333-6; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; Smith RT, 2009, INVEST OPHTH VIS SCI, V50, P3907, DOI 10.1167/iovs.08-2448; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Strauss RW, 2016, OPHTHALMOLOGY, V123, P817, DOI 10.1016/j.ophtha.2015.12.009; Teussink MM, 2015, AM J OPHTHALMOL, V159, P964, DOI 10.1016/j.ajo.2015.02.004; Walia S, 2009, OPHTHALMIC GENET, V30, P63, DOI 10.1080/13816810802695550; Westeneng-van Haaften SC, 2012, OPHTHALMOLOGY, V119, P1199, DOI 10.1016/j.ophtha.2012.01.005	42	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							0174020	10.1371/journal.pone.0174020	http://dx.doi.org/10.1371/journal.pone.0174020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355279	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174600032
J	Sharma, R; Rosenberg, A; Bennett, ER; Laskowitz, DT; Acheson, SK				Sharma, Richa; Rosenberg, Alexandra; Bennett, Ellen R.; Laskowitz, Daniel T.; Acheson, Shawn K.			A blood-based biomarker panel to risk-stratify mild traumatic brain injury	PLOS ONE			English	Article							NEW-ORLEANS CRITERIA; C-REACTIVE PROTEIN; CREATINE-KINASE-BB; COMPUTED-TOMOGRAPHY SCANS; NECROSIS-FACTOR-ALPHA; MINOR HEAD TRAUMA; CEREBROSPINAL-FLUID; EXTERNAL VALIDATION; DIAGNOSTIC-TEST; ACUTE-PHASE	Mild traumatic brain injury (TBI) accounts for the vast majority of the nearly two million brain injuries suffered in the United States each year. Mild TBI is commonly classified as complicated (radiographic evidence of intracranial injury) or uncomplicated (radiographically negative). Such a distinction is important because it helps to determine the need for further neuroimaging, potential admission, or neurosurgical intervention. Unfortunately, imaging modalities such as computed tomography (CT) and magnetic resonance imaging (MRI) are costly and not without some risk. The purpose of this study was to screen 87 serum biomarkers to identify a select panel of biomarkers that would predict the presence of intracranial injury as determined by initial brain CT. Serum was collected from 110 patients who sustained a mild TBI within 24 hours of blood draw. Two models were created. In the broad inclusive model, 72kDa type IV collagenase (MMP-2), C-reactive protein (CRP), creatine kinase B type (CKBB), fatty acid binding protein heart (hFABP), granulocyte-macrophage colony-stimulating factor (GM-CSF) and malondialdehyde modified low density lipoprotein (MDA-LDL) significantly predicted injury visualized on CT, yielding an overall c-statistic of 0.975 and a negative predictive value (NPV) of 98.6. In the parsimonious model, MMP-2, CRP, and CKBB type significantly predicted injury visualized on CT, yielding an overall c-statistic of 0.964 and a negative predictive value (NPV) of 97.2. These results suggest that a serum based biomarker panel can accurately differentiate patients with complicated mild TBI from those with uncomplicated mild TBI. Such a panel could be useful to guide early triage decisions, including the need for further evaluation or admission, especially in those environments in which resources are limited.	[Sharma, Richa; Rosenberg, Alexandra; Laskowitz, Daniel T.] Duke Univ, Med Ctr, Sch Med, Durham, NC 27710 USA; [Bennett, Ellen R.; Laskowitz, Daniel T.] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA; [Acheson, Shawn K.] Durham VA Med Ctr, Durham, NC 27705 USA; [Acheson, Shawn K.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27708 USA	Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Sharma, R (corresponding author), Duke Univ, Med Ctr, Sch Med, Durham, NC 27710 USA.; Acheson, SK (corresponding author), Durham VA Med Ctr, Durham, NC 27705 USA.; Acheson, SK (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27708 USA.	rsharm23@jhmi.edu; shawn.acheson@duke.edu			Department of Veterans Affairs Biomedical Laboratory Research and Development Career Development [IK2BX001267]; Astute Medical, Inc.	Department of Veterans Affairs Biomedical Laboratory Research and Development Career Development; Astute Medical, Inc.	This work was funded in part by Department of Veterans Affairs Biomedical Laboratory Research and Development Career Development Award IK2BX001267 (to SKA). The study was subsidized by a research grant from Astute Medical, Inc., which performed the antibody-based assays used in this study.	Ahmed F, 2012, ELECTROPHORESIS, V33, P3705, DOI 10.1002/elps.201200299; [Anonymous], 2008, NEUR DIS PUBL HLTH C, V65, P154, DOI 10.1001/archneurol.2007.19; Arfanakis K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073107; BAKAY RAE, 1983, J NEUROSURG, V58, P27, DOI 10.3171/jns.1983.58.1.0027; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bouida W, 2013, ANN EMERG MED, V61, P521, DOI 10.1016/j.annemergmed.2012.07.016; Calcagnile O, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-13; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cardali S, 2006, J Neurosurg Sci, V50, P25; Concato J, 1995, J CLIN EPIDEMIOL, V48, P1495, DOI 10.1016/0895-4356(95)00510-2; COOPER PR, 1983, NEUROSURGERY, V12, P536, DOI 10.1227/00006123-198305000-00010; Coplin WM, 1999, ARCH NEUROL-CHICAGO, V56, P1348, DOI 10.1001/archneur.56.11.1348; Dickerson F, 2012, SCHIZOPHR RES, V134, P83, DOI 10.1016/j.schres.2011.10.003; Dikmen S, 2001, J CLIN EXP NEUROPSYC, V23, P729, DOI 10.1076/jcen.23.6.729.1019; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Giacoppo S, 2012, NEUROCRIT CARE, V16, P470, DOI 10.1007/s12028-012-9707-z; Ginde AA, 2008, ACAD EMERG MED, V15, P780, DOI 10.1111/j.1553-2712.2008.00192.x; Gourin CG, 1997, J TRAUMA, V42, P1101, DOI 10.1097/00005373-199706000-00020; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hergenroeder GW, 2008, MOL DIAGN THER, V12, P345, DOI 10.2165/1250444-200812060-00002; Hosmer DW., 2000, APPL LOGISTIC REGRES, V12; Hughes CM, 2014, J AM COLL RADIOLOGY; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Jagoda AS, 2002, ANN EMERG MED, V40, P231, DOI [10.1067/mem.2002.125782, 10.1016/j.jen.2008.12.010]; KASTE M, 1981, J NEUROSURG, V55, P511, DOI 10.3171/jns.1981.55.4.0511; KATZ RT, 1992, AM FAM PHYSICIAN, V46, P1491; Keller T, 2011, JAMA-J AM MED ASSOC, V306, P2684, DOI 10.1001/jama.2011.1896; Kelly JP, 1997, NEUROLOGY, V48, P581; Kleinert K, 2010, ZBL CHIR, V135, P277, DOI 10.1055/s-0028-1098766; Koenig W, 2003, AM J EPIDEMIOL, P158; Laskowitz DT, 2009, STROKE, V40, P77, DOI 10.1161/STROKEAHA.108.516377; Laskowitz DT, 2005, ANN NY ACAD SCI, V1053, P30, DOI 10.1196/annals.1344.051; LEVITT MA, 1995, ACAD EMERG MED, V2, P675, DOI 10.1111/j.1553-2712.1995.tb03617.x; Lynch JR, 2004, STROKE, V35, P57, DOI 10.1161/01.STR.0000105927.62344.4C; McGirt MJ, 2002, NEUROSURGERY, V51, P1128, DOI 10.1097/00006123-200211000-00005; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Parma C, 2014, AM SURGEON, V80, P664; Paul AB, 2015, J AM COLL RADIOL, V12, P453, DOI 10.1016/j.jacr.2014.12.016; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; PHILLIPS JP, 1980, BRIT MED J, V281, P777, DOI 10.1136/bmj.281.6243.777; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Planas AM, 2001, NEUROBIOL DIS, V8, P834, DOI 10.1006/nbdi.2001.0435; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Reynolds MA, 2003, CLIN CHEM, V49, P1733, DOI 10.1373/49.10.1733; Reynolds TA, 2013, ANN EMERG MED, V61, P528, DOI 10.1016/j.annemergmed.2012.12.006; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Rohacek M, 2012, INJURY, V43, P1415, DOI 10.1016/j.injury.2012.01.001; Rosenberg GA, 1995, BRAIN RES, V703, P151, DOI 10.1016/0006-8993(95)01089-0; Schachar JL, 2011, PEDIATR RADIOL, V41, P971, DOI 10.1007/s00247-011-2032-4; Sharma R, 2012, CURR NEUROL NEUROSCI, V12, P560, DOI 10.1007/s11910-012-0301-8; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Sjodin MOD, 2010, J CHROMATOGR B, V878, P2003, DOI 10.1016/j.jchromb.2010.05.036; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stein SC, 2009, ANN EMERG MED, V53, P180, DOI 10.1016/j.annemergmed.2008.01.002; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Unden Johan, 2013, Lakartidningen, V110, P1868; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wium-Andersen MK, 2014, BIOL PSYCHIAT, V76, P249, DOI 10.1016/j.biopsych.2013.10.009; Wright J, 2011, ENCY CLIN NEUROPSYCH, P1149; Yong VW, 2005, NAT REV NEUROSCI, V6, P931, DOI 10.1038/nrn1807; Zyluk A, 2015, NEUROL NEUROCHIR POL, V49, P52, DOI 10.1016/j.pjnns.2014.12.007	74	34	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0173798	10.1371/journal.pone.0173798	http://dx.doi.org/10.1371/journal.pone.0173798			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355230	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174600027
J	Trusca, VG; Fuior, EV; Fenyo, IM; Kardassis, D; Simionescu, M; Gafencu, AV				Trusca, Violeta Georgeta; Fuior, Elena Valeria; Fenyo, Ioana Madalina; Kardassis, Dimitris; Simionescu, Maya; Gafencu, Anca Violeta			Differential action of glucocorticoids on apolipoprotein E gene expression in macrophages and hepatocytes	PLOS ONE			English	Article							REVERSE CHOLESTEROL TRANSPORT; APOE-DEFICIENT MICE; SEVERE HYPERCHOLESTEROLEMIA; TRANSCRIPTIONAL INDUCTION; FED RABBITS; A-I; DEXAMETHASONE; RECEPTOR; ATHEROSCLEROSIS; CELLS	Apolipoprotein E (apoE) has anti-atherosclerotic properties, being involved in the transport and clearance of cholesterol-rich lipoproteins as well as in cholesterol efflux from cells. We hypothesized that glucocorticoids may exert anti-inflammatory properties by increasing the level of macrophage-derived apoE. Our data showed that glucocorticoids increased apoE expression in macrophages in vitro as well as in vivo. Dexamethasone increased similar to 6 fold apoE mRNA levels in cultured peritoneal macrophages and RAW 264.7 cells. Administered to C57BL/6J mice, dexamethasone induced a two-fold increase in apoE expression in peritoneal macrophages. By contrast, glucocorticoids did not influence apoE expression in hepatocytes, in vitro and in vivo. Moreover, dexamethasone enhanced apoE promoter transcriptional activity in RAW 264.7 macrophages, but not in HepG2 cells, as tested by transient transfections. Analysis of apoE proximal promoter deletion mutants, complemented by protein-DNA interaction assays demonstrated the functionality of a putative glucocorticoid receptors (GR) binding site predicted by in silico analysis in the -111/-104 region of the human apoE promoter. In hepatocytes, GR can bind to their specific site within apoE promoter but are not able to modulate the gene expression. The modulatory blockade in hepatocytes is a consequence of partial involvement of transcription factors and other signaling molecules activated through MEK1/2 and PLA2/PLC pathways. In conclusion, our study indicates that glucocorticoids (1) differentially target apoE gene expression; (2) induce a significant increase in apoE level specifically in macrophages. The local increase of apoE gene expression in macrophages at the level of the atheromatous plaque may have therapeutic implications in atherosclerosis.	[Trusca, Violeta Georgeta; Fuior, Elena Valeria; Fenyo, Ioana Madalina; Simionescu, Maya; Gafencu, Anca Violeta] Nicolae Simionescu Romanian Acad, Inst Cellular Biol & Pathol, Dept Genom Transcript & Mol Therapies, Bucharest, Romania; [Kardassis, Dimitris] Univ Crete, Sch Med, Dept Basic Sci, Iraklion, Crete, Greece; [Kardassis, Dimitris] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece	Romanian Academy of Sciences; Nicolae Simionescu Institute of Cellular Biology & Pathology; University of Crete; Foundation for Research & Technology - Hellas (FORTH)	Gafencu, AV (corresponding author), Nicolae Simionescu Romanian Acad, Inst Cellular Biol & Pathol, Dept Genom Transcript & Mol Therapies, Bucharest, Romania.	anca.gafencu@icbp.ro	Gafencu, Anca/C-3323-2011; Trusca, Violeta/AAS-9472-2021; Fenyo, Ioana Madalina/H-5517-2013; Fuior, Elena/AAP-2673-2020; Simionescu, Maya/C-4794-2011; Gafencu, Anca/AAP-8707-2020	Fenyo, Ioana Madalina/0000-0003-3898-0940; Fuior, Elena/0000-0001-9166-8417; Gafencu, Anca/0000-0002-1290-1346; Simionescu, Maya/0000-0003-2077-0400; Bivol (Trusca), Violeta Georgeta/0000-0003-2980-3811	Romanian Academy, Romanian National Authority for Scientific Research and Innovation, CNCS- UEFISCDI [PN-II-ID-PCE-2011-3-0591, PN-II-RU-TE-2014-4-2143, PN-II-RU-TE-2014-4-2660]; CNCS-UEFISCDI [583/2012]; Ministry of National Education and Religious Affairs [11 ROM 31_4_ET29]	Romanian Academy, Romanian National Authority for Scientific Research and Innovation, CNCS- UEFISCDI; CNCS-UEFISCDI; Ministry of National Education and Religious Affairs	Support was provided by Romanian Academy, Romanian National Authority for Scientific Research and Innovation, CNCS- UEFISCDI (http://uefiscdi.gov.ro) Projects: PN-II-ID-PCE-2011-3-0591 (AVG); PN-II-RU-TE-2014-4-2143 (AVG), PN-II-RU-TE-2014-4-2660 (VGT), a Collaborative grant supported by CNCS-UEFISCDI (RO) - contract 583/2012 (MS) and Ministry of National Education and Religious Affairs (GR) - contract 11 ROM 31_4_ET29 (DK).	Agelaki S, 2002, INFECT IMMUN, V70, P6068, DOI 10.1128/IAI.70.11.6068-6074.2002; Allan CM, 1997, J BIOL CHEM, V272, P29113, DOI 10.1074/jbc.272.46.29113; ASAI K, 1993, ARTERIOSCLER THROMB, V13, P892, DOI 10.1161/01.ATV.13.6.892; Baitsch D, 2011, ARTERIOSCL THROM VAS, V31, P1160, DOI 10.1161/ATVBAHA.111.222745; BALLARD PL, 1974, ENDOCRINOLOGY, V94, P998, DOI 10.1210/endo-94-4-998; Barnes PJ, 2006, EUR J PHARMACOL, V533, P2, DOI 10.1016/j.ejphar.2005.12.052; BASHEERUDDIN K, 1992, J BIOL CHEM, V267, P1219; Bellavance MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00136; BELLOSTA S, 1995, J CLIN INVEST, V96, P2170, DOI 10.1172/JCI118271; BOISVERT WA, 1995, J CLIN INVEST, V96, P1118, DOI 10.1172/JCI118098; BOUMPAS DT, 1993, ANN INTERN MED, V119, P1198, DOI 10.7326/0003-4819-119-12-199312150-00007; Chono S, 2006, J PHARM PHARMACOL, V58, P1219, DOI 10.1211/jpp.58.9.0008; DANG Q, 1995, J BIOL CHEM, V270, P22577, DOI 10.1074/jbc.270.38.22577; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; De Bosscher K, 2009, MOL ENDOCRINOL, V23, P281, DOI 10.1210/me.2008-0283; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Fazio S, 1997, P NATL ACAD SCI USA, V94, P4647, DOI 10.1073/pnas.94.9.4647; Gafencu AV, 2007, J BIOL CHEM, V282, P21776, DOI 10.1074/jbc.M611422200; GHISELLI G, 1981, SCIENCE, V214, P1239, DOI 10.1126/science.6795720; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Hasty AH, 2005, J LIPID RES, V46, P1433, DOI 10.1194/jlr.M400418-JLR200; Hasty AH, 1999, CIRCULATION, V99, P2571, DOI 10.1161/01.CIR.99.19.2571; Huang YD, 1998, J BIOL CHEM, V273, P26388, DOI 10.1074/jbc.273.41.26388; Kardassis D, 2015, HANDB EXP PHARMACOL, V224, P113, DOI 10.1007/978-3-319-09665-0_3; Langer C, 2000, J MOL MED, V78, P217, DOI 10.1007/s001090000096; Lu NZ, 2006, TRENDS CELL BIOL, V16, P301, DOI 10.1016/j.tcb.2006.04.005; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mavridou S, 2010, ENDOCRINOLOGY, V151, P3214, DOI 10.1210/en.2009-1302; Mazzone T, 1996, CURR OPIN LIPIDOL, V7, P303, DOI 10.1097/00041433-199610000-00008; NAITO M, 1992, J NUTR SCI VITAMINOL, V38, P255, DOI 10.3177/jnsv.38.255; Ng MKC, 2004, HEART, V90, P829, DOI 10.1136/hrt.2003.031492; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; RAMADORI G, 1991, HEPATOLOGY, V14, P875, DOI 10.1002/hep.1840140520; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Saladin R, 1996, EUR J BIOCHEM, V239, P451, DOI 10.1111/j.1432-1033.1996.0451u.x; Schepers A, 2006, J VASC SURG, V43, P809, DOI 10.1016/j.jvs.2005.11.019; Shih SJ, 2000, J BIOL CHEM, V275, P31567, DOI 10.1074/jbc.M005468200; Thymiakou E, 2007, BIOCHEMISTRY-US, V46, P11473, DOI 10.1021/bi700994m; Trusca VG, 2011, J BIOL CHEM, V286, P13891, DOI 10.1074/jbc.M110.179572; Wang XW, 2012, EUR J ENDOCRINOL, V167, P217, DOI 10.1530/EJE-12-0180; WARD E, 1951, ANN RHEUM DIS, V10, P477; ZANNIS VI, 1985, ADV HUM GENET, V14, P125; Zanotti I, 2011, ARTERIOSCL THROM VAS, V31, P74, DOI 10.1161/ATVBAHA.110.213892; Zhang WW, 2015, J CARDIOVASC PHARM, V66, P189, DOI 10.1097/FJC.0000000000000264; ZUCKERMAN SH, 1993, ATHEROSCLEROSIS, V103, P43, DOI 10.1016/0021-9150(93)90038-V	45	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174078	10.1371/journal.pone.0174078	http://dx.doi.org/10.1371/journal.pone.0174078			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355284	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174600036
J	Lu, CH; Zheng, YL; Zhong, Q				Lu, Chunhui; Zheng, Yuanli; Zhong, Qun			Corrosion of dental alloys in artificial saliva with Streptococcus mutans	PLOS ONE			English	Article							MICROBIOLOGICALLY INFLUENCED CORROSION; STAINLESS-STEEL; CASTING ALLOYS; BEHAVIOR; TITANIUM; BACTERIA; BIOCOMPATIBILITY; RESISTANCE; BIOFILMS; MODEL	A comparative study of the corrosion resistance of CoCr and NiCr alloys in artificial saliva (AS) containing tryptic soy broth (Solution 1) and Streptococcus mutans (S. mutans) species (Solution 2) was performed by electrochemical methods, including open circuit potential measurements, impedance spectroscopy, and potentiodynamic polarization. The adherence of S. mutans to the NiCr and CoCr alloy surfaces immersed in Solution 2 for 24 h was verified by scanning electron microscopy, while the results of electrochemical impedance spectroscopy confirmed the importance of biofilm formation for the corrosion process. The R(QR) equivalent circuit was successfully used to fit the data obtained for the AS mixture without S. mutans, while the R(Q(R(QR))) circuit was found to be more suitable for describing the biofilm properties after treatment with the AS containing S. mutans species. In addition, a negative shift of the open circuit potential with immersion time was observed for all samples regardless of the solution type. Both alloys exhibited higher charge transfer resistance after treatment with Solution 2, and lower corrosion current densities were detected for all samples in the presence of S. mutans. The obtained results suggest that the biofilm formation observed after 24 h of exposure to S. mutans bacteria might enhance the corrosion resistance of the studied samples by creating physical barriers that prevented oxygen interactions with the metal surfaces.	[Lu, Chunhui; Zhong, Qun] Fudan Univ, Shanghai Stomatol Hosp, Yongjia Clin, Shanghai, Peoples R China; [Lu, Chunhui; Zheng, Yuanli] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Stomatol, Stomatol Special Consultat Clin,Peoples Hosp 9, Shanghai, Peoples R China	Fudan University; Shanghai Jiao Tong University	Zheng, YL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Stomatol, Stomatol Special Consultat Clin,Peoples Hosp 9, Shanghai, Peoples R China.	zhengyuanli2015@sina.com			Research Fund of Science and Technology Commission of Shanghai [08DZ2271100]; Shanghai Leading Academic Discipline Project [T0202]	Research Fund of Science and Technology Commission of Shanghai; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	Supported by the Research Fund of Science and Technology Commission of Shanghai (Municipality Grant No.08DZ2271100), Shanghai Leading Academic Discipline Project (Grant No. T0202).	Bauer J, 2012, J PROSTHODONT RES, V56, P264, DOI 10.1016/j.jpor.2012.02.004; Chang JC, 2003, BIO-MED MATER ENG, V13, P281; Cheng S, 2009, MAT SCI ENG C-BIO S, V29, P751, DOI 10.1016/j.msec.2008.11.013; Correa CB, 2009, J PROSTHODONT, V18, P382, DOI 10.1111/j.1532-849X.2009.00463.x; Dubiel M, 2002, APPL ENVIRON MICROB, V68, P1440, DOI 10.1128/AEM.68.3.1440-1445.2002; Duffo GS, 2009, MATER CHEM PHYS, V115, P235, DOI 10.1016/j.matchemphys.2008.11.053; EASHWAR M, 1995, CORROS SCI, V37, P1169, DOI 10.1016/0010-938X(94)00166-4; Geurtsen W, 2002, CRIT REV ORAL BIOL M, V13, P71, DOI 10.1177/154411130201300108; Gunasekaran G, 2004, CORROS SCI, V46, P1953, DOI 10.1016/j.corsci.2003.10.023; Ibars Jose R., 1992, Microbiologia (Madrid), V8, P63; JACK RF, 1992, CORROS SCI, V33, P1843, DOI 10.1016/0010-938X(92)90188-9; Kameda T, 2014, DENT MATER J, V33, P187, DOI 10.4012/dmj.2013-297; Kip N, 2015, ISME J, V9, P542, DOI 10.1038/ismej.2014.169; Laurent F, 2001, BIOMATERIALS, V22, P2273, DOI 10.1016/S0142-9612(00)00416-6; Li FS, 2009, MATER CHEM PHYS, V113, P971, DOI 10.1016/j.matchemphys.2008.08.077; Liu CL, 2007, CORROS SCI, V49, P3783, DOI 10.1016/j.corsci.2007.03.041; MANSFELD F, 1991, CORROS SCI, V32, P247, DOI 10.1016/0010-938X(91)90072-W; Moos O, 2008, ELECTROCHIM ACTA, V54, P53, DOI 10.1016/j.electacta.2008.01.105; Mystkowska J, 2016, ACTA BIOENG BIOMECH, V18, P87, DOI 10.5277/ABB-00499-2015-03; Nagiub A, 2002, ELECTROCHIM ACTA, V47, P2319, DOI 10.1016/S0013-4686(02)00082-8; Oliveira NTC, 2009, ACTA BIOMATER, V5, P399, DOI 10.1016/j.actbio.2008.07.010; Rasperini G, 1998, CLIN ORAL IMPLAN RES, V9, P357, DOI 10.1034/j.1600-0501.1996.090601.x; Reclaru L, 2005, BIOMATERIALS, V26, P4358, DOI 10.1016/j.biomaterials.2004.11.018; Souza MEP, 2009, J MATER SCI-MATER M, V20, P549, DOI 10.1007/s10856-008-3623-y; Sun DS, 2002, J PROSTHET DENT, V87, P86, DOI 10.1067/mpr.2002.121239; Tamilselvi S, 2006, ELECTROCHIM ACTA, V52, P839, DOI 10.1016/j.electacta.2006.06.018; Tuna SH, 2009, J APPL ORAL SCI, V17, P467, DOI 10.1590/S1678-77572009000500022; Upadhyay D, 2006, MAT SCI ENG A-STRUCT, V432, P1, DOI 10.1016/j.msea.2006.05.003; Videla HA, 2005, INT MICROBIOL, V8, P169; VIDELA HA, 1994, INT BIODETER BIODEGR, V34, P245, DOI 10.1016/0964-8305(94)90086-8; Videla HA, 2009, INT BIODETER BIODEGR, V63, P896, DOI 10.1016/j.ibiod.2009.02.002; Wataha JC, 2000, J PROSTHET DENT, V83, P223, DOI 10.1016/S0022-3913(00)80016-5; Wen ZZT, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-111; Wylie CM, 2007, DENT MATER, V23, P714, DOI 10.1016/j.dental.2006.06.011; Xu LC, 2002, MATER CHARACT, V48, P195, DOI 10.1016/S1044-5803(02)00239-5; Zhou Debi, 2007, Journal of Chinese Society for Corrosion and Protection, V27, P84	36	17	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							E0174440	10.1371/journal.pone.0174440	http://dx.doi.org/10.1371/journal.pone.0174440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350880	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174400044
J	Ward, LJ; Ljunggren, SA; Karlsson, H; Li, W; Yuan, XM				Ward, Liam J.; Ljunggren, Stefan A.; Karlsson, Helen; Li, Wei; Yuan, Xi-Ming			Exposure to atheroma-relevant 7-oxysterols causes proteomic alterations in cell death, cellular longevity, and lipid metabolism in THP-1 macrophages	PLOS ONE			English	Article							MONOCYTE-DERIVED MACROPHAGES; LOW-DENSITY LIPOPROTEINS; ATP SYNTHASE BETA; OXYSTEROL MIXTURES; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; UP-REGULATION; APOPTOSIS; EXPRESSION; ACCUMULATION	The 7-oxysterols are recognised as strong enhancers of inflammatory processes in foamy macrophages. Atheroma-relevant 7-oxysterol mixtures induce a mixed type of cell death in macrophages, and trigger cellular oxidative stress responses, which mimic oxidative exposures observed in atherosclerotic lesions. However, the macrophage proteome has not previously been determined in the 7-oxysterol treated cell model. The aim of the present study was to determine the specific effects of an atheroma-relevant 7-oxysterol mixture on human macrophage proteome. Human THP-1 macrophages were exposed to an atheroma-relevant mixture of 7 beta-hydroxycholesterol and 7-ketocholesterol. Two-dimensional gel electrophoresis and mass spectrometry techniques were used to analyse the alterations in macrophage proteome, which resulted in the identification of 19 proteins with significant differential expression upon oxysterol loading; 8 increased and 11 decreased. The expression patterns of 11 out of 19 identified significant proteins were further confirmed by tandemmass spectrometry, including further validation of increased histone deacetylase 2 and macrophage scavenger receptor types I and II expressions by western blot analysis. Identified proteins with differential expression in the cell model have been associated with i) signalling imbalance in cell death and cellular longevity; ii) lipid uptake and metabolism in foam cells; and iii) inflammatory proteins. The presented findings highlight a new proteomic platform for further studies into the functional roles of macrophages in atherosclerosis, and present a cell model for future studies to modulate the macrophage proteome by potential anti-atherosclerotic agents.	[Ward, Liam J.; Ljunggren, Stefan A.; Karlsson, Helen; Yuan, Xi-Ming] Linkoping Univ, Occupat & Environm Med Ctr, Linkoping, Sweden; [Ward, Liam J.; Ljunggren, Stefan A.; Karlsson, Helen; Li, Wei; Yuan, Xi-Ming] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Ward, Liam J.; Li, Wei] Linkoping Univ, Div Obstet & Gynaecol, Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University	Ward, LJ; Yuan, XM (corresponding author), Linkoping Univ, Occupat & Environm Med Ctr, Linkoping, Sweden.; Ward, LJ; Yuan, XM (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.; Ward, LJ (corresponding author), Linkoping Univ, Div Obstet & Gynaecol, Linkoping, Sweden.	liam.ward@liu.se; ximing.yuan@liu.se	Ward, Liam J/GQA-7812-2022; Ljunggren, Stefan/M-2702-2019	Ward, Liam J/0000-0002-3320-1461; Ljunggren, Stefan/0000-0003-3984-3964; Karlsson, Helen/0000-0002-1620-6180; Yuan, Ximing/0000-0001-9328-7140	Torsten and Ragnar Soderbergs Foundation; Stroke Foundation; Olle Engkvist Foundation; Swedish Gamla Tjanarinnor Foundation; Linkoping University; Linkoping University Hospital Research Found	Torsten and Ragnar Soderbergs Foundation; Stroke Foundation; Olle Engkvist Foundation; Swedish Gamla Tjanarinnor Foundation; Linkoping University; Linkoping University Hospital Research Found	This work was supported by grants from the Torsten and Ragnar Soderbergs Foundation, the Stroke Foundation, the Olle Engkvist Foundation, the Swedish Gamla Tjanarinnor Foundation, the Linkoping University and Linkoping University Hospital Research Found. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; Barrionuevo P, 2007, J IMMUNOL, V178, P436, DOI 10.4049/jimmunol.178.1.436; Brandl A, 2012, J MOL CELL BIOL, V4, P284, DOI 10.1093/jmcb/mjs013; Chin RM, 2014, NATURE, V510, P397, DOI 10.1038/nature13264; Choi MR, 2007, APOPTOSIS, V12, P2025, DOI 10.1007/s10495-007-0121-5; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Dupont A, 2008, J PROTEOME RES, V7, P3572, DOI 10.1021/pr700683s; Eligini S, 2016, NUTR METAB CARDIOVAS, V26, P922, DOI 10.1016/j.numecd.2016.05.011; Garcia-Cruset S, 2001, FREE RADICAL RES, V35, P31, DOI 10.1080/10715760100300571; Gargiulo S, 2011, FREE RADICAL BIO MED, V51, P844, DOI 10.1016/j.freeradbiomed.2011.05.030; Genin M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1546-9; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Hanssen NMJ, 2014, CARDIOVASC RES, V104, P160, DOI 10.1093/cvr/cvu189; Hulten LM, 1996, J CLIN INVEST, V97, P461, DOI 10.1172/JCI118436; Iuliano L, 2011, CHEM PHYS LIPIDS, V164, P457, DOI 10.1016/j.chemphyslip.2011.06.006; Iwasa T, 2012, BBA-MOL BASIS DIS, V1822, P204, DOI 10.1016/j.bbadis.2011.10.013; Jeon YJ, 2010, CELL MOL LIFE SCI, V67, P2271, DOI 10.1007/s00018-010-0331-9; Kang JH, 2009, BBA-PROTEINS PROTEOM, V1794, P446, DOI 10.1016/j.bbapap.2008.11.015; Kang JH, 2006, PROTEOMICS, V6, P1261, DOI 10.1002/pmic.200500290; Karlsson H, 2010, CHEMICAL RESEARCH IN, V24, P45; Kim HE, 2013, INT J BIOCHEM CELL B, V45, P1217, DOI 10.1016/j.biocel.2013.03.006; Kim KM, 2012, EXP CELL RES, V318, P152, DOI 10.1016/j.yexcr.2011.10.013; Krause SW, 1996, J LEUKOCYTE BIOL, V60, P540, DOI 10.1002/jlb.60.4.540; Langmann T, 2003, J LIPID RES, V44, P968, DOI 10.1194/jlr.M300016-JLR200; Larsson DA, 2006, FREE RADICAL BIO MED, V41, P902, DOI 10.1016/j.freeradbiomed.2006.05.032; Lehtolainen P, 2000, ARTERIOSCL THROM VAS, V20, P52, DOI 10.1161/01.ATV.20.1.52; Leonarduzzi G, 2005, FREE RADICAL BIO MED, V39, P1152, DOI 10.1016/j.freeradbiomed.2005.06.024; Leonarduzzi G, 2008, AGING CELL, V7, P375, DOI 10.1111/j.1474-9726.2008.00386.x; Li W, 2001, ARTERIOSCL THROM VAS, V21, P1124, DOI 10.1161/hq0701.092145; Li W, 2012, FREE RADICAL BIO MED, V53, P2054, DOI 10.1016/j.freeradbiomed.2012.09.007; Li W, 2011, BIOCHEM BIOPH RES CO, V409, P711, DOI 10.1016/j.bbrc.2011.05.071; Liao HS, 2000, ARTERIOSCL THROM VAS, V20, P1968, DOI 10.1161/01.ATV.20.8.1968; Lizard G, 2006, FREE RADICAL BIO MED, V41, P872, DOI 10.1016/j.freeradbiomed.2006.05.033; Meaney S, 2002, J LIPID RES, V43, P2130, DOI 10.1194/jlr.M200293-JLR200; Moresi V, 2012, P NATL ACAD SCI USA, V109, P1649, DOI 10.1073/pnas.1121159109; Muller C, 2013, ANTIOXID REDOX SIGN, V18, P731, DOI 10.1089/ars.2012.4577; Nigro P, 2011, J EXP MED, V208, P53, DOI 10.1084/jem.20101174; Paclik D, 2011, CELL IMMUNOL, V271, P97, DOI 10.1016/j.cellimm.2011.06.003; Porsch-Ozcurumez M, 2001, J BIOL CHEM, V276, P12427, DOI 10.1074/jbc.M100218200; Qin ZY, 2012, ATHEROSCLEROSIS, V221, P2, DOI 10.1016/j.atherosclerosis.2011.09.003; Ragot K, 2013, BIOCHEM PHARMACOL, V86, P67, DOI 10.1016/j.bcp.2013.02.028; Rajesh S, 2011, J BIOL CHEM, V286, P39606, DOI 10.1074/jbc.M111.262402; Sanson M, 2008, CELL DEATH DIFFER, V15, P1255, DOI 10.1038/cdd.2008.36; Sanson M, 2009, CIRC RES, V104, P328, DOI 10.1161/CIRCRESAHA.108.183749; Seizer P, 2012, J MOL CELL CARDIOL, V53, P6, DOI 10.1016/j.yjmcc.2012.03.004; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Tesoriere L, 2013, BRIT J NUTR, V110, P230, DOI 10.1017/S000711451200493X; Tufo G, 2014, CELL DEATH DIFFER, V21, P685, DOI 10.1038/cdd.2013.193; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang TK, 2006, BBA-MOL CELL BIOL L, V1761, P1182, DOI 10.1016/j.bbalip.2006.08.009; Yuan W, 2013, INFLAMMATION, V36, P567, DOI 10.1007/s10753-012-9578-7; Yuan Xi-Ming, 2016, J Cell Death, V9, P1, DOI 10.4137/JCD.S37841; Yuan XM, 2000, FREE RADICAL BIO MED, V28, P208, DOI 10.1016/S0891-5849(99)00220-8; Zani IA, 2015, CELLS-BASEL, V4, P178, DOI 10.3390/cells4020178; Zhu XD, 2011, J BIOL CHEM, V286, P8231, DOI 10.1074/jbc.M110.145888	55	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174475	10.1371/journal.pone.0174475	http://dx.doi.org/10.1371/journal.pone.0174475			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350877	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174400048
J	Yan, H; Wang, J				Yan, Han; Wang, Jin			Quantification of motor network dynamics in Parkinson's disease by means of landscape and flux theory	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; GANGLIA-THALAMOCORTICAL CIRCUIT; BASAL GANGLIA; SUBTHALAMIC NUCLEUS; BETA-OSCILLATIONS; SYNAPTIC PLASTICITY; MOVEMENT-DISORDERS; NEURONAL-ACTIVITY; FIRING PATTERN; SYNCHRONIZATION	The basal ganglia neural circuit plays an important role in motor control. Despite the significant efforts, the understanding of the principles and underlying mechanisms of this modulatory circuit and the emergence of abnormal synchronized oscillations in movement disorders is still challenging. Dopamine loss has been proved to be responsible for Parkinson's disease. We quantitatively described the dynamics of the basal ganglia-thalamo-cortical circuit in Parkinson's disease in terms of the emergence of both abnormal firing rates and firing patterns in the circuit. We developed a potential landscape and flux framework for exploring the modulatory circuit. The driving force of the circuit can be decomposed into a gradient of the potential, which is associated with the steady-state probability distributions, and the curl probability flux term. We uncovered the underlying potential landscape as a Mexican hat-shape closed ring valley where abnormal oscillations emerge due to dopamine depletion. We quantified the global stability of the network through the topography of the landscape in terms of the barrier height, which is defined as the potential difference between the maximum potential inside the ring and the minimum potential along the ring. Both a higher barrier and a larger flux originated from detailed balance breaking result in more stable oscillations. Meanwhile, more energy is consumed to support the increasing flux. Global sensitivity analysis on the landscape topography and flux indicates how changes in underlying neural network regulatory wirings and external inputs influence the dynamics of the system. We validated two of the main hypotheses(direct inhibition hypothesis and output activation hypothesis) on the therapeutic mechanism of deep brain stimulation (DBS). We found GPe appears to be another effective stimulated target for DBS besides GPi and STN. Our approach provides a general way to quantitatively explore neural networks and may help for uncovering more efficacious therapies for movement disorders.	[Yan, Han; Wang, Jin] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun, Jilin, Peoples R China; [Wang, Jin] SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wang, J (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun, Jilin, Peoples R China.; Wang, J (corresponding author), SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA.	jin.wang.1@stonybrook.edu			National Natural Science Foundation of China [91430217]; Ministry of Science and Technology, China [2016YFA0203200, 2013YQ170585]; NSF [NSF-PHY-76066]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology, China(Ministry of Science and Technology, China); NSF(National Science Foundation (NSF))	HY acknowledges financial supports from National Natural Science Foundation of China (Grant no. 91430217) and Ministry of Science and Technology, China (Grant No. 2016YFA0203200 and 2013YQ170585). JW thanks the support from NSF (Grant no. NSF-PHY-76066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2008, NEURON, V60, P489, DOI 10.1016/j.neuron.2008.10.019; Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Belluscio MA, 2003, EUR J NEUROSCI, V17, P1046, DOI 10.1046/j.1460-9568.2003.02543.x; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Brown P, 2006, J NEURAL TRANSM-SUPP, P27, DOI 10.1007/978-3-211-45295-0_6; Brownell AL, 2003, NEUROIMAGE, V20, P1064, DOI 10.1016/S1053-8119(03)00348-3; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Dostrovsky J, 2004, BRAIN, V127, P721, DOI 10.1093/brain/awh164; Dostrovsky JO, 2000, J NEUROPHYSIOL, V84, P570, DOI 10.1152/jn.2000.84.1.570; Dovzhenok A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041598; Frank MJ, 2007, PHILOS T R SOC B, V362, P1641, DOI 10.1098/rstb.2007.2058; Frank MJ, 2005, J COGNITIVE NEUROSCI, V17, P51, DOI 10.1162/0898929052880093; Gatev P, 2006, MOVEMENT DISORD, V21, P1566, DOI 10.1002/mds.21033; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Hammond C, 2008, MOVEMENT DISORD, V23, P2111, DOI 10.1002/mds.22120; Hashimoto T, 2003, J NEUROSCI, V23, P1916; Holgado AJN, 2010, J NEUROSCI, V30, P12340, DOI 10.1523/JNEUROSCI.0817-10.2010; HOPFIELD JJ, 1986, SCIENCE, V233, P625, DOI 10.1126/science.3755256; HOPFIELD JJ, 1995, P NATL ACAD SCI USA, V92, P6655, DOI 10.1073/pnas.92.15.6655; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Hutchison WD, 2004, J NEUROSCI, V24, P9240, DOI 10.1523/JNEUROSCI.3366-04.2004; Johnson MD, 2008, NEUROTHERAPEUTICS, V5, P294, DOI 10.1016/j.nurt.2008.01.010; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Kumar A, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00086; Leblois A, 2006, J NEUROSCI, V26, P3567, DOI 10.1523/JNEUROSCI.5050-05.2006; Levy R, 2002, J NEUROSCI, V22, P2855, DOI 10.1523/JNEUROSCI.22-07-02855.2002; Levy R, 2000, J NEUROSCI, V20, P7766; McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003; Montgomery EB, 2008, NEUROSCI BIOBEHAV R, V32, P388, DOI 10.1016/j.neubiorev.2007.06.003; Moran RJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002124; Nambu A, 2014, FRONTIERS SYSTEMS NE, V8, pS8; Obeso JA, 2000, TRENDS NEUROSCI, V23, p1 ; Obeso JA, 2008, MOVEMENT DISORD, V23, pS548, DOI 10.1002/mds.22062; Obeso JA, 2008, ANN NEUROL, V64, pS30, DOI 10.1002/ana.21481; Park C, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.042901; Park C, 2010, J NEUROPHYSIOL, V103, P2707, DOI 10.1152/jn.00724.2009; Pavlides A, 2012, EUR J NEUROSCI, V36, P2229, DOI 10.1111/j.1460-9568.2012.08105.x; Prodoehl J, 2013, JAMA NEUROL, V70, P100, DOI 10.1001/jamaneurol.2013.582; Roitman JD, 2002, J NEUROSCI, V22, P9475; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Sharott A, 2005, EUR J NEUROSCI, V21, P1413, DOI 10.1111/j.1460-9568.2005.03973.x; Silkis I, 2001, BIOSYSTEMS, V59, P7, DOI 10.1016/S0303-2647(00)00135-0; Silkis I, 2000, BIOSYSTEMS, V57, P187, DOI 10.1016/S0303-2647(00)00134-9; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; Titcombe MS, 2001, CHAOS, V11, P766, DOI 10.1063/1.1408257; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Vitek JL, 1999, ANN NEUROL, V46, P22, DOI 10.1002/1531-8249(199907)46:1<22::AID-ANA6>3.0.CO;2-Z; Vitek JL, 2004, MOVEMENT DISORD, V19, P907, DOI 10.1002/mds.20137; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Wang J. Q., 2015, SCI WORLD J, V2015, P1, DOI [DOI 10.1371/J0URNAL.P0NE.0124261, DOI 10.2118/174392-MS]; Wang J, 2008, P NATL ACAD SCI USA, V105, P12271, DOI 10.1073/pnas.0800579105; Wang J, 2011, P NATL ACAD SCI USA, V108, P8257, DOI 10.1073/pnas.1017017108; Wang J, 2010, P NATL ACAD SCI USA, V107, P8195, DOI 10.1073/pnas.0910331107; Wichmann T, 1996, CURR OPIN NEUROBIOL, V6, P751, DOI 10.1016/S0959-4388(96)80024-9; Wichmann T, 2011, MOVEMENT DISORD, V26, P1032, DOI 10.1002/mds.23695; Wilson CL, 2006, NEUROSCIENCE, V143, P565, DOI 10.1016/j.neuroscience.2006.07.051; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006; Xu L, 2016, CHINESE PHYS B, V25, DOI 10.1088/1674-1056/25/1/016401; Yan H., 2016, CHINESE PHYS B, V25, DOI DOI 10.1088/1674-1056/25/7/078702; Yan H, 2013, P NATL ACAD SCI USA, V110, pE4185, DOI 10.1073/pnas.1310692110; Zhang F, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4734305	63	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174364	10.1371/journal.pone.0174364	http://dx.doi.org/10.1371/journal.pone.0174364			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350890	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174400028
J	Yang, J; Sun, H; Zhang, H; Zhou, H				Yang, Jian; Sun, Hui; Zhang, Hao; Zhou, Hui			Expression, purification of metallothionein genes from freshwater crab (Sinopotamon yangtsekiense) and development of an anti-metallothionein ELISA	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; CARCINUS-MAENAS; YELLOW-RIVER; CADMIUM; QUANTIFICATION; BINDING; CONTAMINATION; POLLUTION; VITELLIN; PROTEINS	Using the phoA-fusion technology, the recombinant metallothionein (MT) from freshwater crab (Sinopotamon yangtsekiense) has been successfully produced in Escherichia coli. MT purified from the bacterial suspension showed one polypeptide with a molecular weight of 7 kDa by tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis (Tricine-SDSPAGE). Western-blotting confirmed the polypeptides had a specific reactivity with mouse polyclonal MT anti-serum. Based on the purified MT and MT anti-serum, the reaction parameters for an enzyme-linked immunosorbent assay (ELISA) were developed. The direct coating ELISA showed a higher linear relationship compared to antibody sandwich coating ELISA. The optimal dilution rates of purified MT anti-serum and coating period were shown to be 1: 160,000 and 12 hours at 4 degrees C. At 37 degrees C, the appropriate reaction duration of the first antibody and the second antibody were 2 hours and 1 hour, respectively. According to these optimal parameters, the standard linear equation, y = 0.0032x + 0.1769 (R-2 = 0.9779, x, y representing MT concentration and OD450 value), was established for the determination of MT concentration with a valid range of 3.9-500 ng/ ml. In verification experiments, the mean coefficients of variation of the intra-assay and inter-assay were 3.260% and 3.736%, respectively. According to the result of MT recovery, ELISA with an approaching 100% MT recovery was more reliable and sensitive than the Cd saturation assay. In conclusion, the newly developed ELISA of this study was precise, stable and repeatable, and could be used as a biomarker tool to monitor pollution by heavy metals.	[Yang, Jian; Zhang, Hao; Zhou, Hui] Shanxi Med Univ, Translat Med Res Ctr, Taiyuan, Shanxi Province, Peoples R China; [Sun, Hui] Inst Sci & Technol Shanxi, Taiyuan, Shanxi Province, Peoples R China	Shanxi Medical University	Yang, J (corresponding author), Shanxi Med Univ, Translat Med Res Ctr, Taiyuan, Shanxi Province, Peoples R China.	jiany@sxmu.edu.cn			Research Foundation for the Doctorial Program of Shanxi Medical University [03201558]	Research Foundation for the Doctorial Program of Shanxi Medical University	This research was supported by a grant from the Research Foundation for the Doctorial Program of Shanxi Medical University (03201558). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiard JC, 2006, AQUAT TOXICOL, V76, P160, DOI 10.1016/j.aquatox.2005.08.015; Arcos FG, 2009, AQUAC RES, V40, P644, DOI 10.1111/j.1365-2109.2008.02138.x; Bai JH, 2012, J HYDROL, V450, P244, DOI 10.1016/j.jhydrol.2012.05.006; Barka S, 2001, COMP BIOCHEM PHYS C, V128, P479, DOI 10.1016/S1532-0456(00)00198-8; Ben-Khedher S, 2013, ENVIRON SCI POLLUT R, V20, P2616, DOI 10.1007/s11356-012-1156-x; BIENENGRABER M, 1995, ANAL BIOCHEM, V228, P69, DOI 10.1006/abio.1995.1316; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHAN HM, 1992, J BIOCHEM TOXICOL, V7, P219, DOI 10.1002/jbt.2570070405; Chen LQ, 2004, COMP BIOCHEM PHYS B, V138, P305, DOI 10.1016/j.cbpc.2004.04.012; CHEN RW, 1975, ENVIRON PHYSIOL BIOC, V5, P378; Chowdhury MJ, 2005, ARCH ENVIRON CON TOX, V48, P381, DOI 10.1007/s00244-004-0068-2; Ciliberti A, 2011, SCI TOTAL ENVIRON, V409, P4735, DOI 10.1016/j.scitotenv.2011.07.028; EATON DL, 1982, TOXICOL APPL PHARM, V66, P134, DOI 10.1016/0041-008X(82)90068-0; Eraly D, 2010, ENVIRON POLLUT, V158, P2124, DOI 10.1016/j.envpol.2010.02.026; Feng JL, 2010, SCI CHINA CHEM, V53, P1217, DOI 10.1007/s11426-010-0089-9; Ghekiere A, 2005, COMP BIOCHEM PHYS A, V142, P43, DOI 10.1016/j.cbpa.2005.07.006; Isani G, 1997, J MAR BIOL ASSOC UK, V77, P1187, DOI 10.1017/S0025315400038704; Langston W. J., 1998, METAL METABOLISM AQU, P219; LERCH K, 1982, J BIOL CHEM, V257, P2420; Li Yong-Quan, 2008, Acta Hydrobiologica Sinica, V32, P373; Liu DM, 2011, AQUAT TOXICOL, V105, P394, DOI 10.1016/j.aquatox.2011.07.013; MA W, 2007, ENVIRON TOXICOL, V23, P393; Ma XiuPing, 2010, Journal of Agro-Environment Science, V29, P1180; Malev O, 2010, COMP BIOCHEM PHYS C, V152, P433, DOI 10.1016/j.cbpc.2010.07.006; Matthiessen P., 2000, BIOL EFFECTS QUALITY, P24; Moreirinha C, 2011, ARCH ENVIRON CON TOX, V61, P211, DOI 10.1007/s00244-010-9610-6; Nakajima K, 2010, CLIN CHIM ACTA, V411, P758, DOI 10.1016/j.cca.2010.02.058; Pacyna JM, 2009, ATMOS ENVIRON, V43, P117, DOI 10.1016/j.atmosenv.2008.09.066; PEDERSEN KL, 1994, BIOCHEM J, V297, P609, DOI 10.1042/bj2970609; Pedersen KL, 2008, ENVIRON SCI TECHNOL, V42, P8426, DOI 10.1021/es8013584; Pedersen SN, 1996, BIOCHEM J, V319, P999, DOI 10.1042/bj3190999; Ramo J, 1995, MAR ENVIRON RES, V39, P121; Roeva N. N., 1999, Biology Bulletin of the Russian Academy of Sciences, V26, P617; Serra-Batiste M, 2010, J BIOL INORG CHEM, V15, P759, DOI 10.1007/s00775-010-0644-z; Shariati F, 2011, BIOL TRACE ELEM RES, V141, P340, DOI 10.1007/s12011-010-8740-z; Sousa R, 2008, ANN LIMNOL-INT J LIM, V44, P85, DOI 10.1051/limn:2008017; Volz DC, 2004, ENVIRON TOXICOL CHEM, V23, P298, DOI 10.1897/03-200; WINGE DR, 1986, ENVIRON HEALTH PERSP, V65, P211, DOI 10.2307/3430183; Zhang LC, 1996, CHEM ELEMENT WATER E	39	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174482	10.1371/journal.pone.0174482	http://dx.doi.org/10.1371/journal.pone.0174482			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350826	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174400050
J	Tatay-Dualde, J; Prats-van der Ham, M; de la Fe, C; Paterna, A; Sanchez, A; Corrales, JC; Contreras, A; Tola, S; Gomez-Martin, A				Tatay-Dualde, Juan; Prats-van der Ham, Miranda; de la Fe, Christian; Paterna, Ana; Sanchez, Antonio; Carlos Corrales, Juan; Contreras, Antonio; Tola, Sebastiana; Gomez-Martin, Angel			Antimicrobial susceptibility and multilocus sequence typing of Mycoplasma capricolum subsp capricolum	PLOS ONE			English	Article							IN-VITRO SUSCEPTIBILITIES; MOLECULAR CHARACTERIZATION; CONTAGIOUS AGALACTIA; MYCOIDES CLUSTER; COLONY TYPE; DIAGNOSIS; BOVIS; EPIDEMIOLOGY; PUTREFACIENS; PHYLOGENY	Mycoplasma capricolum subsp. capricolum is one of the causative agents of contagious agalactia (CA). Nevertheless, there is still a lack of information about its antimicrobial susceptibility and genetic characteristics. Therefore, the aim of this work was to study the antimicrobial and genetic variability of different Mycoplasma capricolum subsp. capricolum field isolates. For this purpose, the growth inhibition effect of 18 antimicrobials and a multilocus sequence typing (MLST) scheme based on five housekeeping genes (fusA, glpQ, gyrB, lepA and rpoB) were performed on 32 selected field isolates from Italy and Spain. The results showed a wide range of growth inhibitory effects for almost all the antimicrobials studied. Macrolides presented lower efficacy inhibiting Mcc growth than in previous works performed on other CA-causative mycoplasmas. Erythromycin was not able to inhibit the growth of any of the studied strains, contrary to doxycycline, which inhibited the growth of all of them from low concentrations. On the other hand, the study of the concatenated genes revealed a high genetic variability among the different Mcc isolates. Hence, these genetic variations were greater than the ones reported in prior works on other mycoplasma species.	[Tatay-Dualde, Juan; Prats-van der Ham, Miranda; de la Fe, Christian; Paterna, Ana; Sanchez, Antonio; Carlos Corrales, Juan; Contreras, Antonio; Gomez-Martin, Angel] Univ Murcia, Fac Vet Sci, Dept Anim Hlth, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain; [Tola, Sebastiana] Ist Zooprofilatt Sperimentale Sardegna G Pegreffi, Sassari, Italy	University of Murcia; IZS Della Sardegna	de la Fe, C (corresponding author), Univ Murcia, Fac Vet Sci, Dept Anim Hlth, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain.	cdelafe@um.es	Sánchez, Antonio/HCI-2643-2022; Sánchez, Antonio/AAA-6672-2020; DE LA FE, CHRISTIAN/F-3373-2016	Sánchez, Antonio/0000-0002-1868-3829; Sánchez, Antonio/0000-0002-1868-3829; Corrales, Juan Carlos/0000-0002-0096-4913; Contreras de Vera, Antonio/0000-0002-4455-8730; DE LA FE, CHRISTIAN/0000-0002-4354-1689; tola, sebastiana/0000-0002-8488-3773	Spanish Ministry of Economy, government of Spain [AGL2013-44771-R]; FEDER funds; University of Murcia	Spanish Ministry of Economy, government of Spain; FEDER funds(European Commission); University of Murcia	This study was funded by project AGL2013-44771-R awarded by the Spanish Ministry of Economy, government of Spain, and co-financed by FEDER funds. Juan Tatay-Dualde holds a fellowship awarded by the University of Murcia (F.P.U.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Momani W, 2006, TROP ANIM HEALTH PRO, V38, P1, DOI 10.1007/s11250-006-4334-3; ALBERS AC, 1982, APPL ENVIRON MICROB, V43, P958, DOI 10.1128/AEM.43.4.958-960.1982; Antunes NT, 2007, ANTIMICROB AGENTS CH, V51, P3452, DOI 10.1128/AAC.00420-07; Antunes NT, 2007, VET MICROBIOL, V119, P72, DOI 10.1016/j.vetmic.2006.08.013; Ariza-Miguel J, 2013, J CLIN MICROBIOL, V51, P656, DOI 10.1128/JCM.02835-12; Ayling RD, 2014, VET REC, V175, DOI 10.1136/vr.102303; Ayling RD, 2005, ANTIMICROB AGENTS CH, V49, P5162, DOI 10.1128/AAC.49.12.5162-5165.2005; Bergonier D, 1997, REV SCI TECH OIE, V16, P848, DOI 10.20506/rst.16.3.1062; Chazel M, 2010, BMC VET RES, P6; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; de Garnica ML, 2013, J APPL MICROBIOL, V114, P1575, DOI 10.1111/jam.12176; De la Fe C, 2007, VET J, V173, P440, DOI 10.1016/j.tvjl.2005.09.011; European Committee on Antimicrobial Susceptability Testing (EUCAST), 2016, BREAKP TABL INT MICS; Fischer A, 2012, PLOS ONE, V7, P6; Francoz D, 2005, VET MICROBIOL, V105, P57, DOI 10.1016/j.vetmic.2004.10.006; Gerchman I, 2009, VET MICROBIOL, V137, P268, DOI 10.1016/j.vetmic.2009.01.028; Gomez-Martin A, 2013, VET J, V198, P48, DOI 10.1016/j.tvjl.2013.04.015; Gomez-Martin A, 2012, VET MICROBIOL, V157, P355, DOI 10.1016/j.vetmic.2012.01.004; Hannan PCT, 2000, VET RES, V31, P373, DOI 10.1051/vetres:2000100; Hannan PCT, 1997, ANTIMICROB AGENTS CH, V41, P2037, DOI 10.1128/AAC.41.9.2037; Heller M, 2015, JMM CASE REPORTS; JHA VK, 1989, INDIAN J ANIM SCI, V59, P68; Khalil D, 2017, MICROB DRUG RESIST; Manso-Silvan L, 2007, INT J SYST EVOL MICR, V57, P2247, DOI 10.1099/ijs.0.64918-0; Manso-Silvan L, 2012, VET MICROBIOL, V161, P104, DOI 10.1016/j.vetmic.2012.07.015; McAuliffe L, 2011, J MED MICROBIOL, V60, P803, DOI 10.1099/jmm.0.028159-0; Nouvel LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-86; Olaogun OM, 2015, VET MICROBIOL, V180, P123, DOI 10.1016/j.vetmic.2015.07.028; Paterna A, 2013, J DAIRY SCI, V96, P7073, DOI 10.3168/jds.2012-6492; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seersholm FV, 2015, GEN ANNOUN, P3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatay-Dualde J, 2016, VET MICROBIOL, V191, P60, DOI 10.1016/j.vetmic.2016.06.002; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Waites B., 2014, MOLLICUTES MOL BIOL; Woubit S, 2007, MOL CELL PROBE, V21, P391, DOI 10.1016/j.mcp.2007.05.008	36	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174700	10.1371/journal.pone.0174700	http://dx.doi.org/10.1371/journal.pone.0174700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346546	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174300072
J	Luo, MW; Li, D; Wang, ZM; Guo, W; Kang, L; Zhou, ST				Luo, Maowu; Li, Dong; Wang, Zhiming; Guo, Wei; Kang, Le; Zhou, Shutang			Juvenile hormone differentially regulates two Grp78 genes encoding protein chaperones required for insect fat body cell homeostasis and vitellogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; endoplasmic reticulum stress (ER stress); GRP78; homeostasis; juvenile hormone (JH); vitellogenesis	ENDOPLASMIC-RETICULUM STRESS; KRUPPEL-HOMOLOG 1; METHOPRENE-TOLERANT; LOCUSTA-MIGRATORIA; INDUCED APOPTOSIS; ER STRESS; SIGNALING PATHWAY; BINDING-PROTEIN; QUALITY-CONTROL; CANCER CELLS	Juvenile hormone (JH) has a well known role in stimulating insect vitellogenesis (i.e. yolk deposition) and oocyte maturation, but the molecular mechanisms of JH action in insect reproduction are unclear. The 78-kDa glucose-regulated protein (Grp78) is a heat shock protein 70-kDa family member and one of the most abundant chaperones in the endoplasmic reticulum (ER) where it helps fold newly synthesized peptides. Because of its prominent role in protein folding, and also ER stress, we hypothesized that Grp78 might be involved in fat body cell homeostasis and vitellogenesis and a regulatory target of JH. We report here that the migratory locust Locusta migratoria possesses two Grp78 genes that are differentially regulated by JH. We found that Grp78-1 is regulated by JH through Mcm4/7-dependent DNA replication and polyploidization, whereas Grp78-2 expression is directly activated by the JH-receptor complex comprising methoprene-tolerant and Taiman proteins. Interestingly, Grp78-2 expression in the fat body is about 10-fold higher than that of Grp78-1. Knockdown of either Grp78-1 or Grp78-2 significantly reduced levels of vitellogenin (Vg) protein, accompanied by retarded maturation of oocytes. Depletion of both Grp78-1 and Grp78-2 resulted in ER stress and apoptosis in the fat body and in severely defective Vg synthesis and oocyte maturation. These results indicate a crucial role of Grp78 in JH-dependent vitellogenesis and egg production. The presence and differential regulation of two Grp78 genes in L. migratoria likely help accelerate the production of this chaperone in the fat body to facilitate folding of massively synthesized Vg and other proteins.	[Luo, Maowu; Wang, Zhiming; Guo, Wei; Kang, Le] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing 100101, Peoples R China; [Li, Dong; Zhou, Shutang] Henan Univ, Inst Plant Stress Biol, Sch Life Sci, State Key Lab Cotton Biol, Kaifeng 475004, Henan, Peoples R China; [Luo, Maowu] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Henan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Kang, L (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing 100101, Peoples R China.; Zhou, ST (corresponding author), Henan Univ, Inst Plant Stress Biol, Sch Life Sci, State Key Lab Cotton Biol, Kaifeng 475004, Henan, Peoples R China.	lkang@ioz.ac.cn; szhou@henu.edu.cn	Kang, Le/ABD-1116-2022	Kang, Le/0000-0003-4262-2329	National Natural Science Foundation of China [31630070, 31372258]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31630070 and 31372258. The authors declare that they have no conflicts of interest with the contents of this article.	Abdou MA, 2011, INSECT BIOCHEM MOLEC, V41, P938, DOI 10.1016/j.ibmb.2011.09.003; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Belles X, 2005, REPRO BIOL, V12, P157; Belles X, 2014, INSECT BIOCHEM MOLEC, V52, P60, DOI 10.1016/j.ibmb.2014.06.009; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bochkis IM, 2008, NAT MED, V14, P828, DOI 10.1038/nm.1853; Brewer JW, 1997, EMBO J, V16, P7207, DOI 10.1093/emboj/16.23.7207; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; Chen YN, 2013, TRENDS CELL BIOL, V23, P547, DOI 10.1016/j.tcb.2013.06.005; Clegg DJ, 2011, PHYSIOL BEHAV, V103, P10, DOI 10.1016/j.physbeh.2011.01.010; Cruz J, 2003, INSECT BIOCHEM MOLEC, V33, P1219, DOI 10.1016/j.ibmb.2003.06.004; Cui YJ, 2014, INSECT BIOCHEM MOLEC, V52, P23, DOI 10.1016/j.ibmb.2014.05.009; DALE JF, 1986, J INSECT PHYSIOL, V32, P763, DOI 10.1016/0022-1910(86)90079-X; Dorner S, 2006, P NATL ACAD SCI USA, V103, P11880, DOI 10.1073/pnas.0605210103; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; Gao YY, 2010, J CLIN ENDOCR METAB, V95, pE319, DOI 10.1210/jc.2010-1043; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Glembotski CC, 2008, J MOL CELL CARDIOL, V44, P453, DOI 10.1016/j.yjmcc.2007.10.017; GLINKA AV, 1995, INSECT BIOCHEM MOLEC, V25, P775, DOI 10.1016/0965-1748(94)00098-3; Guo W, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004702; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; HAAS IG, 1994, EXPERIENTIA, V50, P1012, DOI 10.1007/BF01923455; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; He QY, 2014, J BIOL CHEM, V289, P27874, DOI 10.1074/jbc.M114.582825; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; HUEBNER E, 1980, CAN J ZOOL, V58, P1617, DOI 10.1139/z80-222; Iwamune M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108997; Jindra M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005394; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kaneda S, 2000, J BIOCHEM-TOKYO, V128, P529, DOI 10.1093/oxfordjournals.jbchem.a022783; Kaser A, 2011, EXP CELL RES, V317, P2772, DOI 10.1016/j.yexcr.2011.07.008; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kayukawa T, 2012, P NATL ACAD SCI USA, V109, P11729, DOI 10.1073/pnas.1204951109; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Kusaczuk M, 2013, CURR PHARM DESIGN, V19, P2807, DOI 10.2174/1381612811319150016; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Li M, 2014, MOL CELL ENDOCRINOL, V394, P47, DOI 10.1016/j.mce.2014.06.021; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Liu X, 2015, J BIOL CHEM, V290, P27370, DOI 10.1074/jbc.M115.687293; Marchal E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106737; Matus S, 2011, CURR OPIN CELL BIOL, V23, P239, DOI 10.1016/j.ceb.2011.01.003; Mercado G, 2013, TRENDS MOL MED, V19, P165, DOI 10.1016/j.molmed.2012.12.005; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; Muller H, 2010, EMBO J, V29, P3344, DOI 10.1038/emboj.2010.210; Naidoo N, 2007, SLEEP, V30, P557, DOI 10.1093/sleep/30.5.557; NAIR KK, 1981, DEV BIOL, V81, P356, DOI 10.1016/0012-1606(81)90300-6; Namba T, 2007, MOL PHARMACOL, V71, P860, DOI 10.1124/mol.106.027698; OISHI M, 1985, CAN J BIOCHEM CELL B, V63, P1064, DOI 10.1139/o85-132; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pfaffenbach KT, 2012, J CELL PHYSIOL, V227, P3803, DOI 10.1002/jcp.24090; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Raikhel A, 2005, COMPREHENSIVE MOL IN, V3, P433; Raikhel AS, 2002, INSECT BIOCHEM MOLEC, V32, P1275, DOI 10.1016/S0965-1748(02)00090-5; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; Riddiford LM, 2012, GEN COMP ENDOCR, V179, P477, DOI 10.1016/j.ygcen.2012.06.001; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roussel BD, 2013, LANCET NEUROL, V12, P105, DOI 10.1016/S1474-4422(12)70238-7; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shin SW, 2012, P NATL ACAD SCI USA, V109, P16576, DOI 10.1073/pnas.1214209109; Shu CV, 2008, J CELL PHYSIOL, V215, P627, DOI 10.1002/jcp.21340; Smykal V, 2014, INSECT BIOCHEM MOLEC, V45, P69, DOI 10.1016/j.ibmb.2013.12.003; Song JS, 2014, INSECT BIOCHEM MOLEC, V52, P94, DOI 10.1016/j.ibmb.2014.07.001; Tamaki N, 2008, AM J PHYSIOL-GASTR L, V294, pG498, DOI 10.1152/ajpgi.00482.2007; Thon M, 2014, SCI REP-UK, V4, DOI 10.1038/srep07096; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Ugrankar R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8102; Urena E, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006020; Urena E, 2014, P NATL ACAD SCI USA, V111, P7024, DOI 10.1073/pnas.1401478111; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang HX, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00377; Wang XH, 2014, NAT COMMUN, V5, P1, DOI 10.1038/ncomms3957; Wang ZM, 2017, INSECT BIOCHEM MOLEC, V82, P31, DOI 10.1016/j.ibmb.2017.01.009; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Wu ZX, 2016, J BIOL CHEM, V291, P5418, DOI 10.1074/jbc.M115.698936; Wyatt G. R., 1996, ADV INSECT PHYSL, P213; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu D, 2009, AM J PHYSIOL-LUNG C, V297, pL44, DOI 10.1152/ajplung.90626.2008; Zhang GJ, 2011, J INSECT PHYSIOL, V57, P1115, DOI 10.1016/j.jinsphys.2011.02.016; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zou Z, 2013, P NATL ACAD SCI USA, V110, pE2173, DOI 10.1073/pnas.1305293110	88	33	38	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8823	8834		10.1074/jbc.M117.780957	http://dx.doi.org/10.1074/jbc.M117.780957			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28356351	Green Published, hybrid			2022-12-26	WOS:000402153900027
J	Lin, S; Voyton, C; Morris, MT; Ackroyd, PC; Morris, JC; Christensen, KA				Lin, Sheng; Voyton, Charles; Morris, Meredith T.; Ackroyd, P. Christine; Morris, James C.; Christensen, Kenneth A.			pH regulation in glycosomes of procyclic form Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR PH; BLOOD-STREAM; MOLECULAR CHARACTERIZATION; NUCLEAR TRANSPORT; ATP DEPLETION; METABOLISM; PEROXISOMES; PROTEIN; ACIDOCALCISOMES; DEHYDROGENASE	Here we report the use of a fluorescein-tagged peroxisomal targeting sequence peptide (F-PTS1, acetyl-C{K(FITC)} GGAKL) for investigating pH regulation of glycosomes in live procyclic form Trypanosoma brucei. When added to cells, this fluorescent peptide is internalized within vesicular structures, including glycosomes, and can be visualized after 30-60 min. Using F-PTS1 we are able to observe the pH conditions inside glycosomes in response to starvation conditions. Previous studies have shown that in the absence of glucose, the glycosome exhibits mild acidification from pH 7.4+/-0.2 to 6.8+/-0.2. Our results suggest that this response occurs under proline starvation as well. This pH regulation is found to be independent from cytosolic pH and requires a source of Na+ ions. Glycosomes were also observed to be more resistant to external pH changes than the cytosol; placement of cells in acidic buffers (pH 5) reduced the pH of the cytosol by 0.8+/-0.1 pH units, whereas glycosomalpHdecreases by 0.5+/-0.1 pH units. This observation suggests that regulation of glycosomal pH is different and independent from cytosolic pH regulation. Furthermore, pH regulation is likely to work by an active process, because cells depleted of ATP with 2-deoxyglucose and sodium azide were unable to properly regulate pH. Finally, inhibitor studies with bafilomycin and EIPA suggest that both V-ATPases and Na+/H+ exchangers are required for glycosomal pH regulation.	[Lin, Sheng; Voyton, Charles] Clemson Univ, Dept Chem, Clemson, SC 29634 USA; [Morris, Meredith T.; Morris, James C.] Clemson Univ, Dept Genet & Biochem, Clemson, SC 29634 USA; [Voyton, Charles; Ackroyd, P. Christine; Christensen, Kenneth A.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	Clemson University; Clemson University; Brigham Young University	Christensen, KA (corresponding author), Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA.	kenc@chem.byu.edu	Christensen, Kenneth/S-1670-2019; Morris, James/L-7253-2019	Christensen, Kenneth/0000-0002-3736-5500; Morris, James/0000-0003-2515-5714	NIAID, National Institutes of Health [R21AI105656]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI105656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109094] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIAID, National Institutes of Health Grant R21AI105656 (to K. A. C). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Allmann S, 2013, J BIOL CHEM, V288, P18494, DOI 10.1074/jbc.M113.462978; BARNARD JP, 1994, ARCH BIOCHEM BIOPHYS, V313, P77, DOI 10.1006/abbi.1994.1361; Ben Beard C., 2009, EMERG INFECT DIS, V15, P510, DOI 10.3201/eid1503.081597; Bhat R, 1996, J BIOL CHEM, V271, P32551, DOI 10.1074/jbc.271.51.32551; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Colasante C, 2006, PROTEOMICS, V6, P3275, DOI 10.1002/pmic.200500668; Colasante Claudia, 2013, F1000Res, V2, P27, DOI 10.12688/f1000research.2-27.v1; Coley April F, 2011, Mol Biol Int, V2011, P123702, DOI 10.4061/2011/123702; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; Dansen TB, 2000, NAT CELL BIOL, V2, P51, DOI 10.1038/71375; Dodson HC, 2011, J BIOL CHEM, V286, P33150, DOI 10.1074/jbc.M111.235705; DOUMA AC, 1990, YEAST, V6, P45, DOI 10.1002/yea.320060105; Drew ME, 2003, J BIOL CHEM, V278, P46596, DOI 10.1074/jbc.M309320200; FraserLhostis C, 1997, BIOL CHEM, V378, P1039, DOI 10.1515/bchm.1997.378.9.1039; GOULD SJ, 1990, J CELL BIOL, V110, P27, DOI 10.1083/jcb.110.1.27; Hannaert V, 2003, EUR J BIOCHEM, V270, P3205, DOI 10.1046/j.1432-1033.2003.03692.x; Jankowski A, 2001, J BIOL CHEM, V276, P48748, DOI 10.1074/jbc.M109003200; Kane PM, 2003, J BIOENERG BIOMEMBR, V35, P313, DOI 10.1023/A:1025724814656; KONDO T, 1979, J LAB CLIN MED, V94, P617; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Lemercier G, 2002, J BIOL CHEM, V277, P37369, DOI 10.1074/jbc.M204744200; Lin S, 2013, BIOCHEMISTRY-US, V52, P3629, DOI 10.1021/bi400029m; Liniger M, 2003, INT J PARASITOL, V33, P1319, DOI 10.1016/S0020-7519(03)00182-6; Luo SH, 2006, J BIOL CHEM, V281, P21963, DOI 10.1074/jbc.M601057200; McCann AK, 2008, MOL BIOCHEM PARASIT, V159, P146, DOI 10.1016/j.molbiopara.2008.02.003; McMahon RJ, 1996, AM J PHYSIOL-ENDOC M, V270, pE640, DOI 10.1152/ajpendo.1996.270.4.E640; Moyersoen J, 2004, FEMS MICROBIOL REV, V28, P603, DOI 10.1016/j.femsre.2004.06.004; Nolan DP, 2000, J BIOL CHEM, V275, P4072, DOI 10.1074/jbc.275.6.4072; OPPERDOES FR, 1987, ANNU REV MICROBIOL, V41, P127, DOI 10.1146/annurev.mi.41.100187.001015; REDDY JK, 1994, ANNU REV NUTR, V14, P343, DOI 10.1146/annurev.nu.14.070194.002015; Schwoebel ED, 2002, J CELL BIOL, V157, P963, DOI 10.1083/jcb.200111077; Sorensen M, 1999, MOL PHARMACOL, V55, P424; Stebeck CE, 1996, MOL BIOCHEM PARASIT, V76, P145, DOI 10.1016/0166-6851(95)02555-3; Stiles JK, 2003, ANN TROP MED PARASIT, V97, P351, DOI 10.1179/000349803235002362; ter Kuile BH, 2000, J BACTERIOL, V182, P3587, DOI 10.1128/JB.182.12.3587-3589.2000; Thomsson E, 2005, APPL ENVIRON MICROB, V71, P3007, DOI 10.1128/AEM.71.6.3007-3013.2005; Van Der Heyden N, 2000, MOL BIOCHEM PARASIT, V105, P237, DOI 10.1016/S0166-6851(99)00184-X; Vanderheyden N, 2000, BIOCHEM J, V346, P53, DOI 10.1042/0264-6021:3460053; Vercesi AE, 1996, BIOCHEM J, V315, P265, DOI 10.1042/bj3150265; WALTON PA, 1995, MOL BIOL CELL, V6, P675, DOI 10.1091/mbc.6.6.675; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	43	3	3	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					7795	7805		10.1074/jbc.M117.784173	http://dx.doi.org/10.1074/jbc.M117.784173			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28348078	Green Published, hybrid			2022-12-26	WOS:000401154100010
J	Xu, H; Sun, MZ; Zhao, X				Xu, Hui; Sun, Mingzhu; Zhao, Xin			Turing mechanism underlying a branching model for lung morphogenesis	PLOS ONE			English	Article							PATTERNS; CELLS	The mammalian lung develops through branching morphogenesis. Two primary forms of branching, which occur in order, in the lung have been identified: tip bifurcation and side branching. However, the mechanisms of lung branching morphogenesis remain to be explored. In our previous study, a biological mechanism was presented for lung branching pattern formation through a branching model. Here, we provide a mathematical mechanism underlying the branching patterns. By decoupling the branching model, we demonstrated the existence of Turing instability. We performed Turing instability analysis to reveal the mathematical mechanism of the branching patterns. Our simulation results show that the Turing patterns underlying the branching patterns are spot patterns that exhibit high local morphogen concentration. The high local morphogen concentration induces the growth of branching. Furthermore, we found that the sparse spot patterns underlie the tip bifurcation patterns, while the dense spot patterns underlies the side branching patterns. The dispersion relation analysis shows that the Turing wavelength affects the branching structure. As the wavelength decreases, the spot patterns change from sparse to dense, the rate of tip bifurcation decreases and side branching eventually occurs instead. In the process of transformation, there may exists hybrid branching that mixes tip bifurcation and side branching. Since experimental studies have reported that branching mode switching from side branching to tip bifurcation in the lung is under genetic control, our simulation results suggest that genes control the switch of the branching mode by regulating the Turing wavelength. Our results provide a novel insight into and understanding of the formation of branching patterns in the lung and other biological systems.	[Xu, Hui; Sun, Mingzhu; Zhao, Xin] Nankai Univ, Inst Robot & Automat Informat Syst, Tianjin, Peoples R China; [Xu, Hui; Sun, Mingzhu; Zhao, Xin] Nankai Univ, Tianjin Key Lab Intelligent Robot, Tianjin, Peoples R China	Nankai University; Nankai University	Zhao, X (corresponding author), Nankai Univ, Inst Robot & Automat Informat Syst, Tianjin, Peoples R China.; Zhao, X (corresponding author), Nankai Univ, Tianjin Key Lab Intelligent Robot, Tianjin, Peoples R China.	zhaoxin@nankai.edu.cn			National Natural Science Foundation of China [NSFC:61327802, U1613220]; Key Program of Science Foundation of Tianjin [14JCZDJC31800]; Advanced Technology [14JCQNJC04700]; Technology Project of Tianjin [14ZCDZGX00801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program of Science Foundation of Tianjin; Advanced Technology; Technology Project of Tianjin	This work was supported by the National Natural Science Foundation of China (NSFC:61327802, U1613220), the Key Program of Science Foundation of Tianjin under grant (14JCZDJC31800), Tianjin Research Program of Application Foundation and Advanced Technology (14JCQNJC04700), and Major Science and Technology Project of Tianjin (14ZCDZGX00801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Gonpot P., 2008, TRENDS APPL SCI RES, V3, P115, DOI [10.3923/tasr.2008.115.128, DOI 10.3923/TASR.2008.115.128]; Guo YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102718; Guo YN, 2014, J PHYSIOL-LONDON, V592, P313, DOI 10.1113/jphysiol.2013.261099; Hagiwara M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08054; JOHNSONWINT B, 1980, P NATL ACAD SCI-BIOL, V77, P5331, DOI 10.1073/pnas.77.9.5331; Marcon L, 2012, CURR OPIN GENET DEV, V22, P578, DOI 10.1016/j.gde.2012.11.013; Meinhardt H., 1982, MODELS BIOL PATTERN; Miura T, 2004, B MATH BIOL, V66, P627, DOI 10.1016/j.bulm.2003.09.009; Murray, 2002, MATH BIOL I INTRO IN; Murray J. D., 2001, MATH BIOL, V18; Nakamasu A, 2009, P NATL ACAD SCI USA, V106, P8429, DOI 10.1073/pnas.0808622106; Sheth R, 2012, SCIENCE, V338, P1476, DOI 10.1126/science.1226804; Smith R, 2009, PLOS BIOL, V6, pe323; Sun GQ Jusup M, 2016, PHYS LIFE REV; Sun GQ, 2012, NONLINEAR DYNAM, V69, P1097, DOI 10.1007/s11071-012-0330-5; Sun GQ, 2016, NONLINEAR DYNAM, V85, P1, DOI 10.1007/s11071-016-2671-y; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Warburton D, 2008, NATURE, V453, P733, DOI 10.1038/453733a; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Yu W, 2007, MOL BIOL CELL, V18, P1693, DOI 10.1091/mbc.E06-11-1052	21	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2017	12	4							e0174946	10.1371/journal.pone.0174946	http://dx.doi.org/10.1371/journal.pone.0174946			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IO	28376090	gold, Green Submitted, Green Published			2022-12-26	WOS:000399352000026
J	Ivanov, A; Mohamed, A; Asfour, A; Ho, J; Khan, SA; Chen, O; Klem, I; Ramasubbu, K; Brener, SJ; Heitner, JF				Ivanov, Alexander; Mohamed, Ambreen; Asfour, Ahmed; Ho, Jean; Khan, Saadat A.; Chen, Onn; Klem, Igor; Ramasubbu, Kumudha; Brener, Sorin J.; Heitner, John F.			Right atrial volume by cardiovascular magnetic resonance predicts mortality in patients with heart failure with reduced ejection fraction	PLOS ONE			English	Article							INDEPENDENT PREDICTOR; ECHOCARDIOGRAPHY; SURVIVAL; RECLASSIFICATION; ASSOCIATIONS; TIME; CMR	Background Right Atrial Volume Index (RAVI) measured by echocardiography is an independent predictor of morbidity in patients with heart failure (HF) with reduced ejection fraction (HFrEF). The aim of this study is to evaluate the predictive value of RAVI assessed by cardiac magnetic resonance (CMR) for all-cause mortality in patients with HFrEF and to assess its additive contribution to the validated Meta-Analysis Global Group in Chronic heart failure (MAGGIC) score. Methods and results We identified 243 patients (mean age 60 +/- 15; 33% women) with left ventricular ejection fraction (LVEF) <= 35% measured by CMR. Right atrial volume was calculated based on area in two-and four -chamber views using validated equation, followed by indexing to body surface area. MAGGIC score was calculated using online calculator. During mean period of 2.4 years 33 patients (14%) died. The mean RAVI was 53 +/- 26 ml/m(2); significantly larger in patients with than without an event (78.7 +/- 29 ml/m(2) vs. 48 +/- 22 ml/m(2), p< 0.001). RAVI (per ml/m 2) was an independent predictor of mortality [HR = 1.03 (1.01 +/- 1.04), p = 0.001]. RAVI has a greater discriminatory ability than LVEF, left atrial volume index and right ventricular ejection fraction (RVEF) (C-statistic 0.8 +/- 0.08 vs 0.55 +/- 0. 1, 0.62 +/- 0.11, 0.68 +/- 0.11, respectively, all p< 0.02). The addition of RAVI to the MAGGIC score significantly improves risk stratification (integrated discrimination improvement 13%, and category-free net reclassification improvement 73%, both p< 0.001). Conclusion RAVI by CMR is an independent predictor of mortality in patients with HFrEF. The addition of RAVI to MAGGIC score improves mortality risk stratification.	[Ivanov, Alexander; Mohamed, Ambreen; Asfour, Ahmed; Ho, Jean; Khan, Saadat A.; Ramasubbu, Kumudha; Brener, Sorin J.; Heitner, John F.] New York Presbyterian Brooklyn Methodist Hosp, Dept Med, Brooklyn, NY 11215 USA; [Chen, Onn] Maimonides Hosp, Dept Med, Brooklyn, NY 11219 USA; [Klem, Igor] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	NewYork-Presbyterian Brooklyn Methodist Hospital; NewYork-Presbyterian Hospital; Maimonides Medical Center; Duke University	Heitner, JF (corresponding author), New York Presbyterian Brooklyn Methodist Hosp, Dept Med, Brooklyn, NY 11215 USA.	ali9023@nyp.org; jfh9003@nyp.org						Abbasi SA, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-89; Association AH, CLASS HEART FAIL; Bellenger NG, 2000, EUR HEART J, V21, P1387, DOI 10.1053/euhj.2000.2011; Bourantas CV, 2011, EUR J HEART FAIL, V13, P52, DOI 10.1093/eurjhf/hfq161; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Damy T, 2012, J CARD FAIL, V18, P216, DOI 10.1016/j.cardfail.2011.12.003; de Groote P, 1998, J AM COLL CARDIOL, V32, P948, DOI 10.1016/S0735-1097(98)00337-4; Grothues F, 2002, AM J CARDIOL, V90, P29, DOI 10.1016/S0002-9149(02)02381-0; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Jenkins C, 2007, AM J CARDIOL, V99, P300, DOI 10.1016/j.amjcard.2006.08.026; Jiamsripong P, 2008, EUR J ECHOCARDIOGR, V9, P351, DOI 10.1016/j.euje.2007.05.004; Keller A M, 2000, Eur J Echocardiogr, V1, P55; Kjaergaard J, 2007, EUR J HEART FAIL, V9, P610, DOI 10.1016/j.ejheart.2007.03.001; Leening MJG, 2014, ANN INTERN MED, V160, P122, DOI 10.7326/M13-1522; Maceira AM, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-29; MATSUOKA H, 1993, ANGIOLOGY, V44, P321, DOI 10.1177/000331979304400409; MOHIADDIN RH, 1995, EUR HEART J, V16, P106, DOI 10.1093/eurheartj/16.1.106; MOSTELLER RD, 1987, NEW ENGL J MED, V317, P1098, DOI 10.1056/nejm198710223171717; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Neilan TG, 2013, JACC-CARDIOVASC IMAG, V6, P944, DOI 10.1016/j.jcmg.2013.05.013; Pellicori P, 2015, EUR HEART J, V36, P733, DOI 10.1093/eurheartj/ehu405; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pennell DJ, 2004, EUR HEART J, V25, P1940, DOI 10.1016/j.ehj.2004.06.040; Sallach JA, 2009, JACC-CARDIOVASC IMAG, V2, P527, DOI 10.1016/j.jcmg.2009.01.012; Sundstrom J, 2011, SCAND J PUBLIC HEALT, V39, P439, DOI 10.1177/1403494810396556; Whitlock M GA, 2012, AM J CARDIOL, V106; Zannad F, 2012, EUR HEART J, V33, P1049, DOI 10.1093/eurheartj/ehr437	28	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0173245	10.1371/journal.pone.0173245	http://dx.doi.org/10.1371/journal.pone.0173245			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369148	Green Submitted, Green Published, gold			2022-12-26	WOS:000399351000009
J	Jackson, EL; Spielman, SJ; Wilke, CO				Jackson, Eleisha L.; Spielman, Stephanie J.; Wilke, Claus O.			Computational prediction of the tolerance to amino-acid deletion in green-fluorescent protein	PLOS ONE			English	Article							LOCAL PACKING DENSITY; STRUCTURAL PLASTICITY; SECONDARY STRUCTURE; EVOLUTIONARY RATE; INDELS; INSERTIONS; CONSTRAINTS; POSITIONS; PATTERN; RATES	Proteins evolve through two primary mechanisms: substitution, where mutations alter a protein's amino-acid sequence, and insertions and deletions (indels), where amino acids are either added to or removed from the sequence. Protein structure has been shown to influence the rate at which substitutions accumulate across sites in proteins, but whether structure similarly constrains the occurrence of indels has not been rigorously studied. Here, we investigate the extent to which structural properties known to covary with protein evolutionary rates might also predict protein tolerance to indels. Specifically, we analyze a publicly available dataset of single D amino-acid deletion mutations in enhanced green fluorescent protein (eGFP) to assess how well the functional effect of deletions can be predicted from protein structure. We find that weighted contact number (WCN), which measures how densely packed a residue is within the protein's three-dimensional structure, provides the best single predictor for whether eGFP will tolerate a given deletion. We additionally find that using protein design to explicitly model deletions results in improved predictions of functional status when combined with other structural predictors. Our work suggests that structure plays fundamental role in constraining deletions at sites in proteins, and further that similar biophysical constraints influence both substitutions and deletions. This study therefore provides a solid foundation for future work to examine how protein structure influences tolerance of more complex indel events, such as insertions or large deletions.	[Jackson, Eleisha L.; Wilke, Claus O.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Jackson, Eleisha L.; Wilke, Claus O.] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Jackson, Eleisha L.; Wilke, Claus O.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Spielman, Stephanie J.] Temple Univ, Inst Genom & Evolutionary Med, Philadelphia, PA 19122 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Wilke, CO (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.; Wilke, CO (corresponding author), Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA.; Wilke, CO (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	wilke@austin.utexas.edu			Army Research Office Grant [W911NF-12-1-0390]; National Institutes of Health [R01 GM088344, R01 AI120560]; NIH grant [F31 GM113622-01]; NSF [GRFP DGE-1110007]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088344] Funding Source: NIH RePORTER	Army Research Office Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Army Research Office Grant W911NF-12-1-0390 and National Institutes of Health Grants R01 GM088344 and R01 AI120560 to COW, NIH grant F31 GM113622-01 to SJS, and NSF GRFP DGE-1110007 to ELJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by Army Research Office Grant W911NF-12-1-0390 and National Institutes of Health Grants R01 GM088344 and R01 AI120560 to COW, NIH grant F31 GM113622-01 to S.J.S., and NSF GRFP DGE-1110007 to E.L.J. The Texas Advanced Computing Center (TACC) at The University of Texas at Austin provided high-performance computing resources.	Arpino JAJ, 2014, STRUCTURE, V22, P889, DOI 10.1016/j.str.2014.03.014; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Conway P, 2014, PROTEIN SCI, V23, P47, DOI 10.1002/pro.2389; de la Chaux N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-191; Dean AM, 2002, MOL BIOL EVOL, V19, P1846, DOI 10.1093/oxfordjournals.molbev.a004009; Echave J, 2016, NAT REV GENET, V17, P109, DOI 10.1038/nrg.2015.18; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Franzosa EA, 2009, MOL BIOL EVOL, V26, P2387, DOI 10.1093/molbev/msp146; Guo BC, 2012, MOL BIOL EVOL, V29, P3005, DOI 10.1093/molbev/mss108; Huang PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024109; Huang TT, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-78; Jackson EL, 2016, PROTEIN SCI, V25, P1341, DOI 10.1002/pro.2920; Jones DD, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni077; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Kim R, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-24; Marcos ML, 2015, PEERJ, V3, DOI 10.7717/peerj.911; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Light S, 2013, MOL BIOL EVOL, V30, P2645, DOI 10.1093/molbev/mst157; Lin CP, 2008, PROTEINS, V72, P929, DOI 10.1002/prot.21983; Meyer D, 2015, MISC FUNCTIONS DEP S; Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911; Nivon LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059004; PASCARELLA S, 1992, J MOL BIOL, V224, P461, DOI 10.1016/0022-2836(92)91008-D; R Core Team, 2018, R LANG ENV STAT COMP; Ramsey DC, 2011, GENETICS, V188, P479, DOI 10.1534/genetics.111.128025; Shahmoradi A, 2016, PROTEINS, V84, P841, DOI 10.1002/prot.25034; Shahmoradi A, 2014, J MOL EVOL, V79, P130, DOI 10.1007/s00239-014-9644-x; Simm AM, 2007, FEBS LETT, V581, P3904, DOI 10.1016/j.febslet.2007.07.018; Taylor MS, 2004, GENOME RES, V14, P555, DOI 10.1101/gr.1977804; Tien MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080635; Toth-Petroczy A, 2013, MOL BIOL EVOL, V30, P761, DOI 10.1093/molbev/mst003; Vetter IR, 1996, PROTEIN SCI, V5, P2399, DOI 10.1002/pro.5560051203; Yeh SW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/572409; Yeh SW, 2014, MOL BIOL EVOL, V31, P135, DOI 10.1093/molbev/mst178; Zhang Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014316; Zhang Z, 2011, MOL BIOL EVOL, V28, P291, DOI 10.1093/molbev/msq196	38	8	8	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0164905	10.1371/journal.pone.0164905	http://dx.doi.org/10.1371/journal.pone.0164905			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369116	Green Published, Green Submitted, gold			2022-12-26	WOS:000399351000001
J	Li, N; Lu, YJ; Li, DM; Zheng, XY; Lian, JY; Li, SS; Cui, HJ; Zhang, LD; Sang, LQ; Wang, Y; Yu, JJ; Lu, TY				Li, Na; Lu, Yanjuan; Li, Daoming; Zheng, Xiangyu; Lian, Jingyao; Li, Shanshan; Cui, Huijuan; Zhang, Linda; Sang, Luqian; Wang, Ying; Yu, Jane J.; Lu, Taiying			All-trans retinoic acid suppresses the angiopoietin-Tie2 pathway and inhibits angiogenesis and metastasis in esophageal squamous cell carcinoma	PLOS ONE			English	Article							CANCER; PATHOGENESIS; APOPTOSIS; TARGET	Esophageal squamous cell carcinoma (ESCC) is the second common cancer in Henan province and is well-known for aggressiveness and dismal prognosis. Adjuvant therapies, chemotherapy, radiotherapy and endoscopic treatment have not improved survival rates in patients with late stage esophageal carcinoma. All-trans retinoic acid (ATRA) is the active ingredient of Vitamin A and affects a wide spectrum of biological processes including development, growth, neural function, immune function, reproduction, and vision. It is one of the most potent therapeutic agents used for treating cancers, especially lung adenocarcinomas. ATRA inhibits metastatic potential and angiogenesis in several tumor models. We investigated the effects of ATRA on the expression of angiopoietin 1 (Ang-1), angiopoietin 2 (Ang-2) and receptor Tie-2 in EC1 cells in vitro. We also assessed the growth and migration of EC1 cells in vitro. ATRA treatment caused 29.5% and 40.3% reduction of the growth of EC1 cells after 24 hours and 48 hours, relative to the control. ATRA plus fluorouracil treatment reduced the viability more strongly than either drug alone, indicating an additive effect. Moreover, ATRA decreased EC1 migration by 87%. Furthermore, ATRA treatment led to a marked decrease of the transcript levels of Ang-1, Ang-2, Tie-2, VEGF, and VEGF receptors, as assessed by real-time RT-PCR. Importantly, the protein levels of Ang-1, Ang-2 and Tie-2 were reduced by ATRA treatment. In vivo, we found ATRA treatment suppressed the tumor growth and improved the cachexia of mice. Importantly, ATRA treatment decreased the expression of CD31, Ang-1, Ang-2 and Tie-2 in subcutaneous tumors of EC1 cells. Collectively, our findings demonstrate that ATRA exhibits a dose-and temporal-dependent effect on the metastatic behavior, suppresses the angiopoietin-Tie2 pathway and inhibits angiogenesis and the progression of xenograft tumors of EC1 cells.	[Li, Na; Lu, Yanjuan; Sang, Luqian; Wang, Ying; Yu, Jane J.; Lu, Taiying] Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Zhengzhou, Henan Province, Peoples R China; [Li, Daoming; Zheng, Xiangyu] Zhengzhou Univ, Affiliated Hosp 1, Dept Pathol, Zhengzhou, Henan Province, Peoples R China; [Lian, Jingyao] Zhengzhou Univ, Sch Life Sci, Zhengzhou, Henan Province, Peoples R China; [Li, Shanshan] Zhengzhou First Peoples Hosp, Dept Oncol, Zhengzhou, Henan Province, Peoples R China; [Cui, Huijuan] Chinese Peoples Liberat Army 150 Cent Hosp, Dept Oncol, Luoyang, Henan Province, Peoples R China; [Zhang, Linda] Northeastern Univ, Dept Behav Neurosci, Boston, MA 02115 USA; [Yu, Jane J.] Univ Cincinnati, Coll Med, Div Pulm Crit Care & Sleep Med, Cincinnati, OH 45220 USA	Zhengzhou University; Zhengzhou University; Zhengzhou University; Northeastern University; University System of Ohio; University of Cincinnati	Yu, JJ; Lu, TY (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Oncol, Zhengzhou, Henan Province, Peoples R China.; Yu, JJ (corresponding author), Univ Cincinnati, Coll Med, Div Pulm Crit Care & Sleep Med, Cincinnati, OH 45220 USA.	jane.yu@uc.edu; wanlucying@163.com		Lu, Taiying/0000-0001-5690-8526	Science and technology research key project department of educationin Henan Province [14A32009]; National Natural Science Foundation of China [NSFC-81572747]	Science and technology research key project department of educationin Henan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project is funded by Science and technology research key project department of educationin Henan Province (14A32009) and National Natural Science Foundation of China (NSFC-81572747).	Ann HW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153493; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Biel NM, 2016, CANCER LETT, V380, P525, DOI 10.1016/j.canlet.2014.09.035; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Chan W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156994; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cheng J, 2015, INT J CLIN EXP MED, V8, P4220; Duprey-Diaz Mildred V, 2016, PLOS ONE, V11; Eklund L, 2013, EXP CELL RES, V319, P1271, DOI 10.1016/j.yexcr.2013.03.011; Eroglu Z, 2013, EXPERT OPIN INV DRUG, V22, P813, DOI 10.1517/13543784.2013.793306; Fagiani E, 2013, CANCER LETT, V328, P18, DOI 10.1016/j.canlet.2012.08.018; Figueroa-Vega N, 2010, ENDOCR-RELAT CANCER, V17, P897, DOI 10.1677/ERC-10-0020; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Gerald D, 2013, CANCER RES, V73, P1649, DOI 10.1158/0008-5472.CAN-12-4697; Hitoshi Ito, 2016, J RAD RES; Hu L, 2016, J PHARM PHARMACOL, V68, P1193, DOI 10.1111/jphp.12591; Huang HH, 2010, NAT REV CANCER, V10, P575, DOI 10.1038/nrc2894; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; Kopp HG, 2005, BLOOD, V106, P505, DOI 10.1182/blood-2004-11-4269; Liu SZ, 2016, CHINESE J CANCER RES, V28, P275, DOI 10.21147/j.issn.1000-9604.2016.03.02; Lu TY, 2011, CHINESE MED J-PEKING, V124, P2708, DOI 10.3760/cma.j.issn.0366-6999.2011.17.026; Lu Tai-Ying, 2010, Zhonghua Zhong Liu Za Zhi, V32, P892; Lu Tai-ying, 2010, Zhonghua Zhong Liu Za Zhi, V32, P663; Lu Tai-ying, 2007, Zhonghua Zhongliu Zazhi, V29, P822; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Napier KJ, 2014, WORLD J GASTRO ONCOL, V6, P112, DOI 10.4251/wjgo.v6.i5.112; Persaud SD, 2016, SCI REP-UK, V6, DOI 10.1038/srep22396; Saharinen P, 2010, CURR OPIN HEMATOL, V17, P198, DOI 10.1097/MOH.0b013e3283386673; Sajewicz Marek, 2016, Folia Med Cracov, V56, P27; Sakai Makoto, 2016, Kyobu Geka, V69, P718; Schweigert M, 2013, NAT REV GASTRO HEPAT, V10, P230, DOI 10.1038/nrgastro.2012.236; Tal R, 2014, HUM REPROD UPDATE, V20, P194, DOI 10.1093/humupd/dmt042; Turner HE, 2003, ENDOCR REV, V24, P600, DOI 10.1210/er.2002-0008; Wu W, 2016, ANN HEMATOL, V95, P1051, DOI 10.1007/s00277-016-2681-3; Yang P, 2015, J HUAZHONG U SCI-MED, V35, P615, DOI 10.1007/s11596-015-1479-1; Zhou L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004493	36	19	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174555	10.1371/journal.pone.0174555	http://dx.doi.org/10.1371/journal.pone.0174555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369068	gold, Green Submitted, Green Published			2022-12-26	WOS:000399351000021
J	Kang, B; Jiang, DM; Ma, R; He, H; Yi, ZX; Chen, ZY				Kang, Bo; Jiang, Dongmei; Ma, Rong; He, Hui; Yi, Zhixin; Chen, Ziyu			OAZ1 knockdown enhances viability and inhibits ER and LHR transcriptions of granulosa cells in geese	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; RECEPTOR-ALPHA EXPRESSION; SICHUAN WHITE GOOSE; BREAST-CANCER CELLS; ORNITHINE-DECARBOXYLASE; PROTEASOMAL DEGRADATION; CHEMICAL CARCINOGENESIS; CELLULAR POLYAMINES; MOLECULAR-CLONING; OVARIAN-FOLLICLES	An increasing number of studies suggest that ornithine decarboxylase antizyme 1 (OAZ1), which is regarded as a tumor suppressor gene, regulates follicular development, ovulation, and steroidogenesis. The granulosa cells in the ovary play a critical role in these ovarian functions. However, the action of OAZ1 mediating physiological functions of granulosa cells is obscure. OAZ1 knockdown in granulosa cells of geese was carried out in the current study. The effect of OAZ1 knockdown on polyamine metabolism, cell proliferation, apoptosis, and hormone receptor transcription of primary granulosa cells in geese was measured. The viability of granulosa cells transfected with the shRNA OAZ1 at 48 h was significantly higher than the control (p<0.05). The level of putrescine and spermidine in granulosa cells down-regulating OAZ1 was 7.04- and 2.11-fold higher compared with the control, respectively (p<0.05). The CCND1,SMAD1, and BCL-2 mRNA expression levels in granulosa cells down-regulating OAZ1 were each significantly higher than the control, respectively (p<0.05), whereas the PCNA and CASPASE 3 expression levels were significantly lower than the control (p<0.05). The estradiol concentration, ER and LHR mRNA expression levels were significantly lower in granulosa cells down-regulating OAZ1 compared with the control (p<0.05). Taken together, our results indicated that OAZ1 knockdown elevated the putrescine and spermidine contents and enhanced granulosa cell viability and inhibited ER and LHR transcriptions of granulosa cells in geese.	[Kang, Bo; Jiang, Dongmei; Ma, Rong; He, Hui; Yi, Zhixin; Chen, Ziyu] Sichuan Agr Univ, Coll Anim Sci & Technol, Chengdu, Sichuan, Peoples R China; [Kang, Bo; Jiang, Dongmei] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Kang, B; Jiang, DM (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Chengdu, Sichuan, Peoples R China.; Kang, B; Jiang, DM (corresponding author), Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Sichuan, Peoples R China.	bokang@sicau.edu.cn; jiangdm@sicau.edu.cn			National Natural Science Foundation of China [31201798]; Specialized Research Fund for the Doctoral Program of Higher Education [20105103120003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (31201798) and Specialized Research Fund for the Doctoral Program of Higher Education (20105103120003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinelli E, 2016, AMINO ACIDS, V48, P2273, DOI 10.1007/s00726-016-2326-9; Alm K, 2009, ESSAYS BIOCHEM, V46, P63, DOI [10.1042/BSE0460005, 10.1042/bse0460005]; An XP, 2012, REPROD DOMEST ANIM, V47, P498, DOI 10.1111/j.1439-0531.2011.01910.x; Bastida CM, 2005, ENDOCRINOLOGY, V146, P666, DOI 10.1210/en.2004-1004; Bercovich Z, 2011, J BIOL CHEM, V286, P33778, DOI 10.1074/jbc.M111.270637; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Feith DJ, 2007, MOL CARCINOGEN, V46, P453, DOI 10.1002/mc.20294; Feith DJ, 2001, CANCER RES, V61, P6073; Feith DJ, 2006, CARCINOGENESIS, V27, P1090, DOI 10.1093/carcin/bgi343; Fong LYY, 2003, CANCER RES, V63, P3945; Fraser AV, 2012, AMINO ACIDS, V42, P529, DOI 10.1007/s00726-011-1030-z; GILBERT AB, 1977, J REPROD FERTIL, V50, P179, DOI 10.1530/jrf.0.0500179; Gruendler C, 2001, J BIOL CHEM, V276, P46533, DOI 10.1074/jbc.M105500200; He H, 2014, GENE, V545, P247, DOI 10.1016/j.gene.2014.05.022; Huang Y, 2006, J BIOL CHEM, V281, P19055, DOI 10.1074/jbc.M600910200; Huber M, 1996, J CLIN ENDOCR METAB, V81, P113, DOI 10.1210/jc.81.1.113; Iwata S, 1999, ONCOGENE, V18, P165, DOI 10.1038/sj.onc.1202275; Kahana C, 2009, CELL MOL LIFE SCI, V66, P2479, DOI 10.1007/s00018-009-0033-3; Kang B, 2009, POULTRY SCI, V88, P1975, DOI 10.3382/ps.2008-00519; Lefevre PLC, 2011, ENDOCR REV, V32, P694, DOI 10.1210/er.2011-0012; Li WD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135251; Lim SK, 2007, ONCOGENE, V26, P6593, DOI 10.1038/sj.onc.1210482; Liu GY, 2006, APOPTOSIS, V11, P1773, DOI 10.1007/s10495-006-9512-2; Ma R, 2015, GENE, V568, P55, DOI 10.1016/j.gene.2015.05.014; Mangold U, 2008, ONCOGENE, V27, P604, DOI 10.1038/sj.onc.1210685; Mastracci TL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13269; Michael AJ, 2016, J BIOL CHEM, V291, P14896, DOI 10.1074/jbc.R116.734780; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Ocon-Grove OM, 2012, REPRODUCTION, V143, P825, DOI 10.1530/REP-11-0271; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; Pegg AE, 2007, BIOCHEM SOC T, V35, P295, DOI 10.1042/BST0350295; Pegg AE, 2016, J BIOL CHEM, V291, P14904, DOI 10.1074/jbc.R116.731661; Ray RM, 2014, AMINO ACIDS, V46, P2231, DOI 10.1007/s00726-014-1777-0; Ray RM, 2012, J BIOL CHEM, V287, P3674, DOI 10.1074/jbc.M111.232561; SUZUKI T, 1994, P NATL ACAD SCI USA, V91, P8930, DOI 10.1073/pnas.91.19.8930; SWIFT TA, 1986, BIOCHIM BIOPHYS ACTA, V885, P221, DOI 10.1016/0167-4889(86)90092-3; Tariq M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121015; Thomas TJ, 2016, AMINO ACIDS, V48, P2293, DOI 10.1007/s00726-016-2300-6; Tsuji T, 2007, BIOCHEMISTRY-US, V46, P8920, DOI 10.1021/bi7000328; Xiao S, 2016, BIOTECHNOL BIOENG, V113, P2403, DOI 10.1002/bit.26017; Xu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055496; Zhu QS, 2012, BREAST CANCER RES TR, V136, P57, DOI 10.1007/s10549-012-2235-x	43	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0175016	10.1371/journal.pone.0175016	http://dx.doi.org/10.1371/journal.pone.0175016			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362829	Green Submitted, Green Published, gold			2022-12-26	WOS:000399175000061
J	Lajoie, I; Tancredi, FB; Hoge, RD				Lajoie, Isabelle; Tancredi, Felipe B.; Hoge, Richard D.			The impact of inspired oxygen levels on calibrated fMRI measurements of M, OEF and resting CMRO2 using combined hypercapnia and hyperoxia	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; TEST-RETEST RELIABILITY; BRAIN IMAGES; REPRODUCIBILITY; MRI; RESPONSES; BOLD; TIME; METABOLISM; INHALATION	Recent calibrated fMRI techniques using combined hypercapnia and hyperoxia allow the mapping of resting cerebral metabolic rate of oxygen (CMRO2) in absolute units, oxygen extraction fraction (OEF) and calibration parameter M (maximum BOLD). The adoption of such technique necessitates knowledge about the precision and accuracy of the model derived parameters. One of the factors that may impact the precision and accuracy is the level of oxygen provided during periods of hyperoxia (HO). A high level of oxygen may bring the BOLD responses closer to the maximum Mvalue, and hence reduce the error associated with the M interpolation. However, an increased concentration of paramagnetic oxygen in the inhaled air may result in a larger susceptibility area around the frontal sinuses and nasal cavity. Additionally, a higher O-2 level may generate a larger arterial blood T-1 shortening, which require a bigger cerebral blood flow (CBF) T-1 correction. To evaluate the impact of inspired oxygen levels on M, OEF and CMRO2 estimates, a cohort of six healthy adults underwent two different protocols: one where 60% of 02 was administered during HO (low HO or LHO) and one where 100% O-2 was administered (high HO or HHO). The QUantitative O-2 (QUO2) MRI approach was employed, where CBF and R2* are simultaneously acquired during periods of hypercapnia (HC) and hyperoxia, using a clinical 3 T scanner. Scan sessions were repeated to assess repeatability of results at the different O-2 levels. Our T-1 values during periods of hyperoxia were estimated based on an empirical ex-vivo relationship between T-1 and the arterial partial pressure of O-2. As expected, our T-1 estimates revealed a larger T-1 shortening in arterial blood when administering 100% 02 relative to 60% 02 (T-1LHO= 1.56 +/- 0.01 sec vs. T-1HHO = 1.47 +/- 0.01 sec, P < 4*10(-13)). In regard to the susceptibility artifacts, the patterns and number of affected voxels were comparable irrespective of the O-2 concentration. Finally, the model-derived estimates were consistent regardless of the HO levels, indicating that the different effects are adequately accounted for within the model.	[Lajoie, Isabelle] Univ Montreal, Inst Genie Biomed, Dept Physiol Mol & Integrat, Montreal, PQ, Canada; [Lajoie, Isabelle; Hoge, Richard D.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Tancredi, Felipe B.] Hosp Israelita Albert Einstein, Dept Radiol, Ctr Pesquisa Imagem, Sao Palo, SP, Brazil	Universite de Montreal; McGill University; Hospital Israelita Albert Einstein	Lajoie, I (corresponding author), Univ Montreal, Inst Genie Biomed, Dept Physiol Mol & Integrat, Montreal, PQ, Canada.; Lajoie, I (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	isabelle.lajoie@mail.mcgill.ca			Canadian Institutes for Health Research [MOP 84378]; RDH; Canadian Foundation for Innovation, Leaders Opportunity [17380]; Canadian National Sciences and Engineering Research Council [R0018142]; Consortium quebecois sur la decouverte du medicament (CQDM); Fonds Quebecois de Recherche Nature et technologies (FQRNT)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); RDH; Canadian Foundation for Innovation, Leaders Opportunity; Canadian National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Consortium quebecois sur la decouverte du medicament (CQDM); Fonds Quebecois de Recherche Nature et technologies (FQRNT)	This study was supported by the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca/e/193.html, MOP 84378), received by RDH; the Canadian Foundation for Innovation, Leaders Opportunity (https.//www.innovation.ca/, Fund 17380), received by RDH; the Canadian National Sciences and Engineering Research Council (http://www.nserc-crsng.gc.ca/index eng.asp R0018142), received by RDH; the Consortium quebecois sur la decouverte du medicament (CQDM, http://www.cgdm.org/en/8534), received by RDH; and the Fonds Quebecois de Recherche Nature et technologies (FQRNT, http://www.frqnt.gouv.qc.ca/accueil), received by IL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benga G, 1995, COMP BIOCHEM PHYS B, V112, P653, DOI 10.1016/0305-0491(95)00116-6; Bland JM, 1996, BRIT MED J, V313, P106, DOI 10.1136/bmj.313.7049.106; Brannan S, 2001, P NATL ACAD SCI USA, V98, P2029, DOI 10.1073/pnas.98.4.2029; Bulte DP, 2007, J CEREBR BLOOD F MET, V27, P69, DOI 10.1038/sj.jcbfm.9600319; Chalela JA, 2000, STROKE, V31, P680, DOI 10.1161/01.STR.31.3.680; Chen YF, 2011, J MAGN RESON IMAGING, V33, P940, DOI 10.1002/jmri.22345; Chiarelli PA, 2007, NEUROIMAGE, V37, P808, DOI 10.1016/j.neuroimage.2007.05.033; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Donahue MJ, 2014, J CEREBR BLOOD F MET, V34, P1243, DOI 10.1038/jcbfm.2014.81; Floyd TF, 2003, J MAGN RESON IMAGING, V18, P649, DOI 10.1002/jmri.10416; Gauthier CJ, 2012, NEUROIMAGE, V63, P1353, DOI 10.1016/j.neuroimage.2012.07.065; Gauthier CJ, 2013, HUM BRAIN MAPP, V34, P1053, DOI 10.1002/hbm.21495; Goodwin JA, 2009, NEUROIMAGE, V47, P573, DOI 10.1016/j.neuroimage.2009.04.064; Iscoe S, 2005, CHEST, V128, P430, DOI 10.1378/chest.128.1.430; Jain V, 2012, RADIOLOGY, V263, P527, DOI 10.1148/radiol.12111509; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Klein A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00171; Lajoie I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163071; Lin AL, 2012, MAGN RESON MATER PHY, V25, P245, DOI 10.1007/s10334-011-0287-2; Liotti M, 2001, P NATL ACAD SCI USA, V98, P2035, DOI 10.1073/pnas.98.4.2035; Lu HZ, 2004, MAGN RESON MED, V52, P679, DOI 10.1002/mrm.20178; Ma YH, 2016, MAGN RESON MED, V76, P1905, DOI 10.1002/mrm.26069; Noseworthy MD, 1999, JMRI-J MAGN RESON IM, V9, P814, DOI 10.1002/(SICI)1522-2586(199906)9:6<814::AID-JMRI8>3.0.CO;2-5; Padhani AR, 2002, NMR BIOMED, V15, P143, DOI 10.1002/nbm.732; Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023; Pilkinton DT, 2012, MAGN RESON MED, V67, P1556, DOI 10.1002/mrm.23137; SEVERINGHAUS JW, 1989, ANESTHESIOLOGY, V70, P996, DOI 10.1097/00000542-198906000-00019; Sherif T, 2014, FRONT NEUROINFORM, V8, DOI [10.3389/fninf.2014.00054, 10.3389/fninf.2014.00089]; Tadamura E, 1997, J MAGN RESON IMAGING, V7, P220, DOI 10.1002/jmri.1880070134; Tancredi FB, 2015, J MAGN RESON IMAGING, V42, P1144, DOI 10.1002/jmri.24878; Tancredi Felipe B, 2014, BMC Res Notes, V7, P235, DOI 10.1186/1756-0500-7-235; Tjandra T, 2005, NEUROIMAGE, V27, P393, DOI 10.1016/j.neuroimage.2005.04.021; Wang JJ, 2003, MAGN RESON MED, V50, P599, DOI 10.1002/mrm.10559; Wise RG, 2013, NEUROIMAGE, V83, P135, DOI 10.1016/j.neuroimage.2013.06.008; Xu F, 2012, J CEREBR BLOOD F MET, V32, P1909, DOI 10.1038/jcbfm.2012.93; Zaharchuk G, 2008, AM J NEURORADIOL, V29, P663, DOI 10.3174/ajnr.A0896	37	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174932	10.1371/journal.pone.0174932	http://dx.doi.org/10.1371/journal.pone.0174932			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362834	Green Published, Green Submitted, gold			2022-12-26	WOS:000399175000052
J	Krol, E; Borges, AD; Kopacz, M; Scheffers, DJ				Krol, Ewa; Borges, Anabela de Sousa; Kopacz, Malgorzata; Scheffers, Dirk-Jan			Metal-dependent SpollE oligomerization stabilizes FtsZ during asymmetric division in Bacillus subtilis	PLOS ONE			English	Article							DIFFERENTIATION PROTEIN SPOIIE; CELL-SPECIFIC TRANSCRIPTION; RESPONSE REGULATOR SPO0F; SPORE FORMATION; SPORULATION; BINDING; MANGANESE; LOCALIZATION; PHOSPHATASE; PHOSPHORELAY	SpollE is a bifunctional protein involved in asymmetric septum formation and in activation of the forespore compartment-specific transcription factor sigma(F) through dephosphorylation of Spot IAA-P. The phosphatase activity of SpollE requires Mn2+ as a metal cofactor. Here, we show that the presence of a metal cofactor also influences SpollE oligomerization and asymmetric septum formation. Absence of Mn2+ from sporulation medium results in a delay of the formation of polar FtsZ-rings, similar to a spollE null mutant. We purified the entire cytoplasmic part of the SpollE protein, and show that the protein copurifies with bound metals. Metal binding both stimulates SpollE oligomerization, and results in the formation of larger oligomeric structures. The presence of SpollE oligomers reduces FtsZ GTP hydrolysis activity and stabilizes FtsZ polymers in a light scattering assay. Combined, these results indicate that metal binding is not just required for SpollE phosphatase activity but also is important for SpollE's role in asymmetric septum formation.	[Krol, Ewa; Borges, Anabela de Sousa; Kopacz, Malgorzata; Scheffers, Dirk-Jan] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Microbiol, Groningen, Netherlands	University of Groningen	Scheffers, DJ (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Microbiol, Groningen, Netherlands.	d.j.scheffers@rug.nl	Cendrowicz, Ewa/AAT-9419-2021	Cendrowicz, Ewa/0000-0002-8854-228X; Scheffers, Dirk-Jan/0000-0002-9439-9168; Kopacz, Malgorzata/0000-0002-2471-9306	VIDI fellowship from the Netherlands Organisation for Scientific Research (NWO) [864.09.010]; bilateral research programme "Biobased Economy" from NWO [729.004.005]; POPH/FSE and FCT (Fundagao para a Ciencia e Tecnologia) from Portugal [SFRH/BD/78061/2011]	VIDI fellowship from the Netherlands Organisation for Scientific Research (NWO); bilateral research programme "Biobased Economy" from NWO; POPH/FSE and FCT (Fundagao para a Ciencia e Tecnologia) from Portugal	Work in the Scheffers lab is supported by a VIDI fellowship (864.09.010) from the Netherlands Organisation for Scientific Research (NWO) and the bilateral research programme "Biobased Economy" from NWO (729.004.005). Anabela de Sousa Borges was supported by a doctoral grant (SFRH/BD/78061/2011) from POPH/FSE and FCT (Fundagao para a Ciencia e Tecnologia) from Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 1997, MOL MICROBIOL, V23, P57, DOI 10.1046/j.1365-2958.1997.1801552.x; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Arigoni F, 1996, P NATL ACAD SCI USA, V93, P3238, DOI 10.1073/pnas.93.8.3238; Barak I, 1996, J BACTERIOL, V178, P4984, DOI 10.1128/jb.178.16.4984-4989.1996; Barak I, 1996, MOL MICROBIOL, V19, P1047, DOI 10.1046/j.1365-2958.1996.433963.x; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Bradshaw N, 2015, ELIFE, V4, DOI 10.7554/eLife.08145; Carniol K, 2005, J BACTERIOL, V187, P3511, DOI 10.1128/JB.187.10.3511-3520.2005; Clarkson J, 2001, J MOL BIOL, V314, P359, DOI 10.1006/jmbi.2001.5142; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; de Jong IG, 2010, J BACTERIOL, V192, P2053, DOI 10.1128/JB.01484-09; Dudev T, 2014, CHEM REV, V114, P538, DOI 10.1021/cr4004665; DUNCAN L, 1995, SCIENCE, V270, P641, DOI 10.1126/science.270.5236.641; Eichenberger P, 2012, BACILLUS: CELLULAR AND MOLECULAR BIOLOGY, SECOND EDITION, P319; Errington J, 2003, NAT REV MICROBIOL, V1, P117, DOI 10.1038/nrmicro750; Eswaramoorthy P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004526; Feucht A, 2002, MOL MICROBIOL, V45, P1119, DOI 10.1046/j.1365-2958.2002.03082.x; Feucht A, 1996, GENE DEV, V10, P794, DOI 10.1101/gad.10.7.794; Foster AW, 2014, J BIOL CHEM, V289, P28095, DOI 10.1074/jbc.R114.588145; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; ILLING N, 1991, J BACTERIOL, V173, P3159, DOI 10.1128/JB.173.10.3159-3169.1991; Ingerman E, 2005, METHOD ENZYMOL, V404, P611, DOI 10.1016/S0076-6879(05)04053-X; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; Jeon YJ, 2016, J STRUCT BIOL, V195, P113, DOI 10.1016/j.jsb.2016.04.002; Khvorova A, 1998, J BACTERIOL, V180, P1256, DOI 10.1128/JB.180.5.1256-1260.1998; Kojetin DJ, 2005, BIOMETALS, V18, P449, DOI 10.1007/s10534-005-4303-8; Krol E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00390; Krol E, 2013, JOVE-J VIS EXP, DOI 10.3791/50844; Levdikov VM, 2012, J MOL BIOL, V415, P343, DOI 10.1016/j.jmb.2011.11.017; Levin PA, 1996, GENE DEV, V10, P478, DOI 10.1101/gad.10.4.478; Lu XB, 2008, NAT STRUCT MOL BIOL, V15, P700, DOI 10.1038/nsmb.1433; Lucet I, 2000, EMBO J, V19, P1467, DOI 10.1093/emboj/19.7.1467; Margalit DN, 2004, P NATL ACAD SCI USA, V101, P11821, DOI 10.1073/pnas.0404439101; Mohammadi T, 2009, BIOCHEMISTRY-US, V48, P11056, DOI 10.1021/bi901461p; Mukhopadhyay D, 2004, ACTA CRYSTALLOGR D, V60, P638, DOI 10.1107/S0907444904002148; Rawlings AE, 2010, PROTEIN ENG DES SEL, V23, P817, DOI 10.1093/protein/gzq057; Scheffers DJ, 2008, FEBS LETT, V582, P2601, DOI 10.1016/j.febslet.2008.06.038; Scheffers DJ, 2005, MICROBIOL-SGM, V151, P999, DOI 10.1099/mic.0.27692-0; Sharpe ME, 1998, J BACTERIOL, V180, P547, DOI 10.1128/JB.180.3.547-555.1998; Shemesh M, 2013, J BACTERIOL, V195, P2747, DOI 10.1128/JB.00028-13; Tan IS, 2014, ENV MICROBIOL REP, V6, P212, DOI 10.1111/1758-2229.12130; VASANTHA N, 1979, J GEN MICROBIOL, V112, P329, DOI 10.1099/00221287-112-2-329; Whittaker MM, 1999, J BIOL CHEM, V274, P34751, DOI 10.1074/jbc.274.49.34751	43	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174713	10.1371/journal.pone.0174713	http://dx.doi.org/10.1371/journal.pone.0174713			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358838	gold, Green Published			2022-12-26	WOS:000399174800076
J	Ryuge, S; Sato, Y; Nagashio, R; Hiyoshi, Y; Katono, K; Igawa, S; Nakashima, H; Shiomi, K; Ichinoe, M; Murakumo, Y; Saegusa, M; Satoh, Y; Masuda, N				Ryuge, Shinichiro; Sato, Yuichi; Nagashio, Ryo; Hiyoshi, Yasuhiro; Katono, Ken; Igawa, Satoshi; Nakashima, Hiroyasu; Shiomi, Kazu; Ichinoe, Masaaki; Murakumo, Yoshiki; Saegusa, Makoto; Satoh, Yukitoshi; Masuda, Noriyuki			Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy; relationship between nestin expression and epithelial to mesenchymal transition related markers	PLOS ONE			English	Article							VINORELBINE PLUS CISPLATIN; STEM-CELLS; CLINICAL-SIGNIFICANCE; CARCINOMA; CLASSIFICATION; SURVIVAL; CATENIN; IMPACT	Introduction Although adjuvant platinum-based chemotherapy (AC) has been shown to improve survival of patients with completely resected stage II and stage IIIA non-small cell lung cancer (NSCLC), its effect is limited. Nestin is a class VI intermediate filament protein expressed in neural stem cells and several cancer cells including NSCLC. In the present study, we aimed to determine its prognostic significance concerning survival in NSCLC patients receiving AC. Methods Nestin expression in cancer cells was immunohistochemically studied in 90 patients with completely resected stage II and stage IIIA NSCLC treated with AC and its association with clinicopathologic parameters, including ABCG2, E-cadherin, and vimentin expression, was evaluated. Kaplan-Meier survival analysis and Cox proportional hazards models were used to estimate the effect of nestin expression on survival. Results Nestin expression was observed in 28 of the 90 (31.1%) NSCLCs. Clinicopathologically, nestin expression was associated with loss of E-cadherin expression (P= 0.006) and vimentin positive expression (P< 0.001). In survival analysis, nestin expression was significantly associated with a poorer prognosis (P = 0.028). Multivariable analysis confirmed that nestin expression is an independent prognostic indicator in NSCLC patients receiving AC (HR = 2.56; 95% CI, 1.23-5.30, P= 0.01). Conclusion The present study reveals that nestin expression is a prognostic indicator of a poorer survival probability in NSCLC patients receiving AC, although its prognostic significance still requires confirmation with larger patient populations.	[Ryuge, Shinichiro; Hiyoshi, Yasuhiro; Igawa, Satoshi; Masuda, Noriyuki] Kitasato Univ, Sch Med, Dept Resp Med, Sagamihara, Kanagawa, Japan; [Sato, Yuichi; Nagashio, Ryo] Kitasato Univ, Sch Allied Hlth Sci, Dept Mol Diagnost, Sagamihara, Kanagawa, Japan; [Katono, Ken] Sagamihara Kyodo Hosp, Dept Resp Med, Sagamihara, Kanagawa, Japan; [Nakashima, Hiroyasu; Shiomi, Kazu; Satoh, Yukitoshi] Kitasato Univ, Sch Med, Dept Thorac Surg, Sagamihara, Kanagawa, Japan; [Ichinoe, Masaaki; Murakumo, Yoshiki; Saegusa, Makoto] Kitasato Univ, Sch Med, Dept Pathol, Sagamihara, Kanagawa, Japan	Kitasato University; Kitasato University; Kitasato University; Kitasato University	Sato, Y (corresponding author), Kitasato Univ, Sch Allied Hlth Sci, Dept Mol Diagnost, Sagamihara, Kanagawa, Japan.	yuichi@med.kitasato-u.ac.jp			Japan Society for the Promotion of Science [23590414]; Third Term Comprehensive Control Research for Cancer conducted by the Ministry of Health, Labour and Welfare of Japan; School of Allied Health Sciences, Kitasato University [2011-1006]; Grants-in-Aid for Scientific Research [15K21359] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Third Term Comprehensive Control Research for Cancer conducted by the Ministry of Health, Labour and Welfare of Japan; School of Allied Health Sciences, Kitasato University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded in part by Grants-in-Aid for Scientific Research C (23590414) from the Japan Society for the Promotion of Science, and for Third Term Comprehensive Control Research for Cancer conducted by the Ministry of Health, Labour and Welfare of Japan, and Research Project (No. 2011-1006) from the School of Allied Health Sciences, Kitasato University.	Chang WJ, 2014, LUNG CANCER, V84, P51, DOI 10.1016/j.lungcan.2014.01.017; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Iwatsuki M, 2010, CANCER SCI, V101, P293, DOI 10.1111/j.1349-7006.2009.01419.x; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Lechner A, 2002, BIOCHEM BIOPH RES CO, V293, P670, DOI 10.1016/S0006-291X(02)00275-9; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; Mo Wei, 2012, Int J Biochem Mol Biol, V3, P1; Mochizuki T, 2008, AM J SURG PATHOL, V32, P1727, DOI 10.1097/PAS.0b013e3181804302; Neradil J, 2015, CANCER SCI, V106, P803, DOI 10.1111/cas.12691; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Ryuge S, 2011, CHEST, V139, P862, DOI 10.1378/chest.10-1121; Shi YL, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-89; Shien K, 2012, LUNG CANCER, V77, P162, DOI 10.1016/j.lungcan.2012.02.006; Sui H, 2014, ONCOL RES TREAT, V37, P584, DOI 10.1159/000367802; Sung CO, 2011, MODERN PATHOL, V24, P1060, DOI 10.1038/modpathol.2011.59; Travis WD., 2004, TRAVIS WB WHO CLASSI; van Rens MTM, 2000, CHEST, V117, P374, DOI 10.1378/chest.117.2.374; Williams CD, 2014, CANCER-AM CANCER SOC, V120, P1939, DOI 10.1002/cncr.28679; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Zhang H, 2013, J CLIN PATHOL, V66, P937, DOI 10.1136/jclinpath-2013-201467; Zhao ZW, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0408-8	25	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0173886	10.1371/journal.pone.0173886	http://dx.doi.org/10.1371/journal.pone.0173886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358810	gold, Green Submitted, Green Published			2022-12-26	WOS:000399174800012
J	Tanaka, A; Kass, PH; -Lopez, BM; Hayama, S				Tanaka, Aki; Kass, Philip H.; -Lopez, Beatriz Martinez; Hayama, Shinichi			Epidemiological evaluation of cat health at a first-response animal shelter in Fukushima, following the Great East Japan Earthquakes of 2011	PLOS ONE			English	Article							RESPIRATORY-TRACT DISEASE; CHLAMYDOPHILA-FELIS; CHRONIC GINGIVOSTOMATITIS; DESCRIPTIVE EPIDEMIOLOGY; CALICIVIRUS INFECTION; EFFICACY; MANAGEMENT; DOGS; PRADOFLOXACIN; HERPESVIRUS	The Great East Japan Earthquakes of March 11, 2011 caused immense harm to the community and subsequent nuclear accident in Fukushima Prefecture extended the damage. Local residents were forced to evacuated without pets and the left behind animals were rescued from the restricted zone one month later. Unplanned animal rescue and unregulated sheltering caused secondary damage to animals such as disease epidemics at impounded animal shelter. The purpose of this study was to retrospectively evaluate the incidence of upper respiratory infection (URI) and diarrhea in cats at the first response animal shelter in Fukushima, and investigate factors affecting the duration of disease and determinants of treatments performed. Eighty percent and 59% of impounded cats developed URI, 71% and 54% of cats developed diarrhea, and 91% and 83% of cats had at least one disease in 2011 and 2012, respectively. Uses of multiple drug administration (more than five drugs) was associated with prolonged URI and diarrhea. Multiple antibiotics, antihistamines, interferon, and steroids were associated with relapse of and prolonged URI. Developing a standardized treatment protocol for commonly observed diseases at Japanese animal shelters to prevent and control diseases, to promote animal welfare, and protect public health in the face of future disasters is overdue.	[Tanaka, Aki; Kass, Philip H.] Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Tanaka, Aki; Hayama, Shinichi] Nippon Vet & Life Sci Univ, Dept Wildlife Med, Musashino, Tokyo, Japan; [-Lopez, Beatriz Martinez] Univ Calif Davis, Dept Med & Epidemiol, Davis, CA 95616 USA	University of California System; University of California Davis; Nippon Veterinary & Life Science University; University of California System; University of California Davis	Tanaka, A (corresponding author), Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.; Tanaka, A (corresponding author), Nippon Vet & Life Sci Univ, Dept Wildlife Med, Musashino, Tokyo, Japan.	atanaka@ucdavis.edu		HAYAMA, Shin-ichi/0000-0002-4882-7969	Fukushima Veterinary Medical Association	Fukushima Veterinary Medical Association	This work was supported by Fukushima Veterinary Medical Association, http://www.f-v-a.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannasch MJ, 2005, J FELINE MED SURG, V7, P109, DOI 10.1016/j.jfms.2004.07.004; Binns S H, 2000, J Feline Med Surg, V2, P123, DOI 10.1053/jfms.2000.0084; Cohn LA, 1997, SEM VET MED SURG SMA; Dinnage JD, 2009, J FELINE MED SURG, V11, P816, DOI 10.1016/j.jfms.2009.03.001; Foley JE, 2002, PREV VET MED, V54, P141, DOI 10.1016/S0167-5877(02)00022-3; GASKELL RM, 1977, VET REC, V100, P128, DOI 10.1136/vr.100.7.128; Gerhardt N, 2006, VET REC, V159, P591, DOI 10.1136/vr.159.18.591; Gourkow N, 2013, CAN VET J, V54, P132; Hartmann AD, 2008, J VET INTERN MED, V22, P44, DOI 10.1111/j.1939-1676.2007.0012.x; Helps CR, 2005, VET REC, V156, P669, DOI 10.1136/vr.156.21.669; Hill SL, 2000, J AM VET MED ASSOC, V216, P687, DOI 10.2460/javma.2000.216.687; Holst BS, 2010, J FELINE MED SURG, V12, P783, DOI 10.1016/j.jfms.2010.06.002; Hurley KF, 2005, VET CLIN N AM-SMALL, V35, P21, DOI 10.1016/j.cvsm.2004.08.002; Litster AL, 2012, JAVMA-J AM VET MED A, V241, P218, DOI 10.2460/javma.241.2.218; Lommer MJ, 2003, ORAL MICROBIOL IMMUN, V18, P131, DOI 10.1034/j.1399-302X.2003.00033.x; Lord LK, 2008, JAVMA-J AM VET MED A, V233, P1715, DOI 10.2460/javma.233.11.1715; Marks SL, 2011, J VET INTERN MED, V25, P1195, DOI 10.1111/j.1939-1676.2011.00821.x; McCobb EC, 2005, JAVMA-J AM VET MED A, V226, P548, DOI 10.2460/javma.2005.226.548; Miller L, 2009, INFECT DIS MANAGEMEN; Miller L, 2011, INFECT DIS MANAGEMEN; Moyaert H, 2006, RES VET SCI, V81, P1, DOI 10.1016/j.rvsc.2005.10.004; NASISSE MP, 1989, INVEST OPHTH VIS SCI, V30, P1758; Pedersen NC, 2004, J FELINE MED SURG, V6, P83, DOI 10.1016/j.jfms.2003.08.008; Radford AD, 2009, J FELINE MED SURG, V11, P556, DOI 10.1016/j.jfms.2009.05.004; Robben SRM, 2004, TIJDSCHR DIERGENEESK, V129, P2; Ruch-Gallie RA, 2008, J FELINE MED SURG, V10, P542, DOI 10.1016/j.jfms.2008.04.001; Sabshin SJ, 2012, JAVMA-J AM VET MED A, V241, P331, DOI 10.2460/javma.241.3.331; Scott DW, 1999, J SMALL ANIM PRACT, V40, P359, DOI 10.1111/j.1748-5827.1999.tb03099.x; SCOTT DW, 1995, NEW ZEAL VET J, V43, P29, DOI 10.1080/00480169.1995.35839; Southerden P, 2007, J SMALL ANIM PRACT, V48, P104, DOI 10.1111/j.1748-5827.2006.00166.x; Spindel ME, 2013, J FELINE MED SURG; Spindel ME, 2008, J FELINE MED SURG, V10, P472, DOI 10.1016/j.jfms.2008.04.003; Tanaka A, 2012, JAVMA-J AM VET MED A, V240, P570, DOI 10.2460/javma.240.5.570; THOMPSON RR, 1984, J SMALL ANIM PRACT, V25, P207, DOI 10.1111/j.1748-5827.1984.tb00470.x; Wright JG, 2005, EMERG INFECT DIS, V11, P1235, DOI 10.3201/eid1108.050111; Young VB, 2004, J CLIN MICROBIOL, V42, P1203, DOI 10.1128/JCM.42.3.1203-1206.2004	36	2	2	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174406	10.1371/journal.pone.0174406	http://dx.doi.org/10.1371/journal.pone.0174406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358820	Green Published, gold			2022-12-26	WOS:000399174800036
J	Tyrrell, LP; Fernandez-Juricic, E				Tyrrell, Luke P.; Fernandez-Juricic, Esteban			Avian binocular vision: It's not just about what birds can see, it's also about what they can't	PLOS ONE			English	Article							PIGEON COLUMBA-LIVIA; VISUAL-FIELDS; EYE-MOVEMENTS; PREDATOR DETECTION; ORBIT ORIENTATION; CALEDONIAN CROWS; VERTEBRATES; STEREOPSIS; VIGILANCE; PURSUIT	With the exception of primates, most vertebrates have laterally placed eyes. Binocular vision in vertebrates has been implicated in several functions, including depth perception, contrast discrimination, etc. However, the blind area in front of the head that is proximal to the binocular visual field is often neglected. This anterior blind area is important when discussing the evolution of binocular vision because its relative length is inversely correlated with the width of the binocular field. Therefore, species with wider binocular fields also have shorter anterior blind areas and objects along the mid-sagittal plane can be imaged at closer distances. Additionally, the anterior blind area is of functional significance for birds because the beak falls within this blind area. We tested for the first time some specific predictions about the functional role of the anterior blind area in birds controlling for phylogenetic effects. We used published data on visual field configuration in 40 species of birds and measured beak and skull parameters from museum specimens. We found that birds with proportionally longer beaks have longer anterior blind areas and thus narrower binocular fields. This result suggests that the anterior blind area and beak visibility do play a role in shaping binocular fields, and that binocular field width is not solely determined by the need for stereoscopic vision. In visually guided foragers, the ability to see the beak-and how much of the beak can be seen-varies predictably with foraging habits. For example, fish- and insect-eating specialists can see more of their own beak than birds eating immobile food can. But in non-visually guided foragers, there is no consistent relationship between the beak and anterior blind area. We discuss different strategies-wide binocular fields, large eye movements, and long beaks-that minimize the potential negative effects of the anterior blind area. Overall, we argue that there is more to avian binocularity than meets the eye.	[Tyrrell, Luke P.; Fernandez-Juricic, Esteban] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Tyrrell, LP (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	ltyrrell@purdue.edu		Tyrrell, Luke/0000-0001-8322-1930	National Science Foundation (IOS Award) [1146986]	National Science Foundation (IOS Award)	This study was funded by the National Science Foundation (IOS Award#1146986 to EFJ). http://www.nsf.gov/div/index.jsp?div=IOS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Alyssa Gleichsner for assistance with skull measurements and the Field Museum of Natural History for graciously allowing us to access their vast skeletal collection. We also thank Jeff Lucas for providing comments on an earlier version of this manuscript. This study was funded by the National Science Foundation (IOS Award#1146986).	Beecher W.J., 1978, Bulletin of the Chicago Academy of Sciences, V11, P269; BOWMAN ROBERT I., 1961, UNIV CALIFORNIA PUBL ZOOL, V58, P1; Collins E. T., 1921, T OPHTHAL SOC UK, V41, P10; Crompton RH, 1995, CREATURES OF THE DARK, P11; Fernandez-Juricic E, 2010, J COMP PHYSIOL A, V196, P879, DOI 10.1007/s00359-010-0570-0; FOX R, 1977, SCIENCE, V197, P79, DOI 10.1126/science.867054; GOODALE MA, 1983, BRAIN BEHAV EVOLUT, V22, P22, DOI 10.1159/000121504; Gottschaldt K.-M., 1985, P375; Gregory R.L., 1966, EYE BRAIN; Guillemain M, 2002, FUNCT ECOL, V16, P522, DOI 10.1046/j.1365-2435.2002.00652.x; Heesy CP, 2009, EVOL ANTHROPOL, V18, P21, DOI 10.1002/evan.20195; Heesy CP, 2004, ANAT REC PART A, V281A, P1104, DOI 10.1002/ar.a.20116; Iwaniuk AN, 2008, J COMP PHYSIOL A, V194, P267, DOI 10.1007/s00359-007-0304-0; JAGER R, 1991, BEHAV BRAIN RES, V45, P65, DOI 10.1016/S0166-4328(05)80181-0; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Kaby U, 2003, BEHAV ECOL SOCIOBIOL, V54, P534, DOI 10.1007/s00265-003-0665-5; KANDEL ER, 1991, PRINCIPLES NEURAL SC, P440; Kane SA, 2015, J EXP BIOL, V218, P212, DOI 10.1242/jeb.108597; Land MF, 2015, J COMP PHYSIOL A, V201, P195, DOI 10.1007/s00359-014-0964-5; MARTIN GR, 1986, J COMP PHYSIOL A, V159, P545, DOI 10.1007/BF00604174; Martin GR, 2005, NATURWISSENSCHAFTEN, V92, P351, DOI 10.1007/s00114-005-0010-0; Martin GR, 2004, IBIS, V146, P18, DOI 10.1111/j.1474-919X.2004.00211.x; Martin GR, 1999, BRAIN BEHAV EVOLUT, V53, P55, DOI 10.1159/000006582; MARTIN GR, 1994, J COMP PHYSIOL A, V174, P787; MARTIN GR, 1994, BRAIN BEHAV EVOLUT, V44, P74, DOI 10.1159/000113571; MARTIN GR, 1984, VISION RES, V24, P1739, DOI 10.1016/0042-6989(84)90005-1; Martin GR, 2008, IBIS, V150, P485, DOI 10.1111/j.1474-919X.2008.00808.x; Martin GR, 2007, J ORNITHOL, V148, pS547, DOI 10.1007/s10336-007-0213-6; Martin GR, 2009, J VISION, V9, DOI 10.1167/9.11.14; Martinho A, 2014, CURR BIOL, V24, DOI 10.1016/j.cub.2014.10.035; MARTINOYA C, 1984, NEUROSCI LETT, V45, P335, DOI 10.1016/0304-3940(84)90248-9; Moore BA, 2015, J EXP BIOL, V218, P1347, DOI 10.1242/jeb.108613; O'Rourke CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012802; Ott M, 1998, J COMP PHYSIOL A, V182, P319, DOI 10.1007/s003590050182; Potier S, 2016, J EXP BIOL; Rubolini D, 2015, CURR ZOOL, V61, P959, DOI 10.1093/czoolo/61.6.959; Schaeffel F., 1994, P35; Schwarz JS, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00091; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Tisdale V, 2009, BEHAV ECOL, V20, P936, DOI 10.1093/beheco/arp080; Troscianko J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2111; Tucker VA, 2000, J EXP BIOL, V203, P3745; Tyrrell LP., 2015, ESCAPING PREDATORS I, P322; Tyrrell LP, 2015, J EXP BIOL, V218, P2651, DOI 10.1242/jeb.122820; Tyrrell LP, 2014, METHODS ECOL EVOL, V5, P1070, DOI 10.1111/2041-210X.12249; Tyrrell LP, 2013, SCI REP-UK, V3, DOI 10.1038/srep03231; van der Willigen RF, 2011, J VISION, V11, DOI 10.1167/11.7.10; Voss J, 2009, J EXP BIOL, V212, P1568, DOI 10.1242/jeb.024950; ZEIGLER HP, 1980, J COMP PHYSIOL PSYCH, V94, P783, DOI 10.1037/h0077818	49	13	13	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0173235	10.1371/journal.pone.0173235	http://dx.doi.org/10.1371/journal.pone.0173235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355250	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174600012
J	Maltais, L; Montagne, M; Bedard, M; Tremblay, C; Soucek, L; Lavigne, P				Maltais, Loika; Montagne, Martin; Bedard, Mikael; Tremblay, Cynthia; Soucek, Laura; Lavigne, Pierre			Biophysical characterization of the b-HLH-LZ of Delta Max, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers	PLOS ONE			English	Article							C-MYC; STRUCTURAL DETERMINANTS; TRANSCRIPTION FACTORS; PROTEIN-PROTEIN; LEUCINE-ZIPPER; GENE-PRODUCT; DNA; BINDING; HETERODIMERIZATION; SPECIFICITY	It is classically recognized that the physiological and oncogenic functions of Myc proteins depend on specific DNA binding enabled by the dimerization of its C-terminal basic-region-Helix-Loop-Helix-Leucine Zipper (b-HLH-LZ) domain with that of Max. However, a new paradigm is emerging, where the binding of the c-Myc/Max heterodimer to non-specific sequences in enhancers and promoters drives the transcription of genes involved in diverse oncogenic programs. Importantly, Max can form a stable homodimer even in the presence of c-Myc and bind DNA ( specific and non-specific) with comparable affinity to the c-Myc/Max heterodimer. Intriguingly, alterations in the Max gene by germline and somatic mutations or changes in the gene product by alternative splicing ( e.g. Delta Max) were recently associated with pheochromocytoma and glioblastoma, respectively. This has led to the proposition that Max is, by itself, a tumor suppressor. However, the actual mechanism through which it exerts such an activity remains to be elucidated. Here, we show that contrary to the WT motif, the b-HLH-LZ of Delta Max does not homodimerize in the absence of DNA. In addition, although Delta Max can still bind the E-box sequence as a homodimer, it cannot bind non-specific DNA in that form, while it can heterodimerize with c-Myc and bind Ebox and non-specific DNA as a heterodimer with high affinity. Taken together, our results suggest that the WT Max homodimer is important for attenuating the binding of c-Myc to specific and non-specific DNA, whereas Delta Max is unable to do so. Conversely, the splicing of Max into Delta Max could provoke an increase in overall chromatin bound c-Myc. According to the new emerging paradigm, the splicing event and the stark reduction in homodimer stability and DNA binding should promote tumorigenesis impairing the tumor suppressor activity of the WT homodimer of Max.	[Maltais, Loika; Montagne, Martin; Bedard, Mikael; Tremblay, Cynthia; Lavigne, Pierre] Univ Sherbrooke, Inst Pharmacol Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ, Canada; [Maltais, Loika; Montagne, Martin; Bedard, Mikael; Tremblay, Cynthia; Lavigne, Pierre] Univ Laval, PROTEO Regrp Strateg Fonct Struct & Ingn Prot, Quebec City, PQ, Canada; [Soucek, Laura] Hosp Valle De Hebron, VHIO, Barcelona, Spain; [Soucek, Laura] ICREA, Barcelona, Spain; [Soucek, Laura] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Bellaterra, Spain	University of Sherbrooke; Laval University; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); ICREA; Autonomous University of Barcelona	Lavigne, P (corresponding author), Univ Sherbrooke, Inst Pharmacol Sherbrooke, Fac Med & Sci Sante, Dept Biochim, Sherbrooke, PQ, Canada.; Lavigne, P (corresponding author), Univ Laval, PROTEO Regrp Strateg Fonct Struct & Ingn Prot, Quebec City, PQ, Canada.	Pierre.Lavigne@USherbrooke.ca	Soucek, Laura/AAG-8377-2019; Miquel, Josep Maria/AAG-3508-2019; Soucek, Laura/AAG-7393-2019	Soucek, Laura/0000-0002-4750-7971	Natural Science and Engineering Council of Canada [227919]; European Research Council [ERC-2013-CoG]; ICREA Funding Source: Custom	Natural Science and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); European Research Council(European Research Council (ERC)European Commission); ICREA(ICREA)	This work was supported by the Natural Science and Engineering Council of Canada (http://www.nserc-crsng.gc.ca/), grant number:227919 (P.L.) and the European Research Council (https://erc.europa.eu/), grant number:ERC-2013-CoG (L. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Babic I, 2013, CELL METAB, V17, P1000, DOI 10.1016/j.cmet.2013.04.013; Banerjee A, 2006, BIOCHEMISTRY-US, V45, P2333, DOI 10.1021/bi0522551; Beaulieu ME, 2012, J MOL RECOGNIT, V25, P414, DOI 10.1002/jmr.2203; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Burnichon N, 2012, CLIN CANCER RES, V18, P2828, DOI 10.1158/1078-0432.CCR-12-0160; Cascon A, 2012, CANCER RES, V72, P3119, DOI 10.1158/0008-5472.CAN-11-3891; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Guo JN, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0482-3; HIRVONEN HE, 1994, BRIT J CANCER, V69, P16, DOI 10.1038/bjc.1994.3; Hsieh AL, 2015, SEMIN CELL DEV BIOL, V43, P11, DOI 10.1016/j.semcdb.2015.08.003; Hu JZ, 2005, BIOCHEMISTRY-US, V44, P11855, DOI 10.1021/bi050206i; Jean-Francois N, 2003, J MOL BIOL, V326, P1577, DOI 10.1016/S0022-2836(03)00029-9; Jung LA, 2016, ONCOGENE, P1; Kohler JJ, 1999, P NATL ACAD SCI USA, V96, P11735, DOI 10.1073/pnas.96.21.11735; KRETZNER L, 1992, NATURE, V359, P426, DOI 10.1038/359426a0; Lavigne P, 1998, J MOL BIOL, V281, P165, DOI 10.1006/jmbi.1998.1914; LAVIGNE P, 1995, J MOL BIOL, V254, P505, DOI 10.1006/jmbi.1995.0634; Li YL, 2014, CANCER CELL, V26, P262, DOI 10.1016/j.ccr.2014.06.014; LINDEMAN GJ, 1995, ONCOGENE, V10, P1013; Luscher B, 2012, GENE, V494, P145, DOI 10.1016/j.gene.2011.12.027; MAKELA TP, 1992, SCIENCE, V256, P373, DOI 10.1126/science.256.5055.373; McDuff FO, 2009, J MOL RECOGNIT, V22, P261, DOI 10.1002/jmr.938; Meier-Andrejszki L, 2007, BIOCHEMISTRY-US, V46, P12427, DOI 10.1021/bi701081q; Montagne M, 2005, BIOCHEMISTRY-US, V44, P12860, DOI 10.1021/bi0500731; Montagne M, 2008, J MOL BIOL, V376, P141, DOI 10.1016/j.jmb.2007.11.062; Montagne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032172; MUKHERJEE B, 1992, GENE DEV, V6, P1480, DOI 10.1101/gad.6.8.1480; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Naud JF, 2005, BIOCHEMISTRY-US, V44, P12746, DOI 10.1021/bi0500729; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Park S, 2004, BBA-GEN SUBJECTS, V1670, P217, DOI 10.1016/j.bbagen.2003.12.007; Romero OA, 2014, CANCER DISCOV, V4, P292, DOI 10.1158/2159-8290.CD-13-0799; Sauve S, 2004, J MOL BIOL, V342, P813, DOI 10.1016/j.jmb.2004.07.058; Soucek L, 1998, ONCOGENE, V17, P2463, DOI 10.1038/sj.onc.1202199; Wolf E, 2015, TRENDS CELL BIOL, V25, P241, DOI 10.1016/j.tcb.2014.10.006	38	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							E0174413	10.1371/journal.pone.0174413	http://dx.doi.org/10.1371/journal.pone.0174413			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350847	Green Submitted, gold, Green Published			2022-12-26	WOS:000399174400040
J	Militao, T; Dinis, HA; Zango, L; Calabuig, P; Stefan, LM; Gonzalez-Solis, J				Militao, Teresa; Andrade Dinis, Herculano; Zango, Laura; Calabuig, Pascual; Stefan, Laura M.; Gonzalez-Solis, Jacob			Population size, breeding biology and on-land threats of Cape Verde petrel (Pterodroma feae) in Fogo Island, Cape Verde	PLOS ONE			English	Article							FERAL CATS; CONSERVATION; MARK	Cape Verde petrel (Pterodroma feae) is currently considered near threatened, but little is known about its population size, breeding biology and on land threats, jeopardizing its management and conservation. To improve this situation, we captured, marked and recaptured (CMR) birds using mist-nets over 10 years; measured and sexed them; monitored up to 14 burrows, deployed GPS devices on breeders and analyzed activity data of geolocators retrieved from breeders in Fogo (Cape Verde). We set cat traps over the colony and investigated their domestic/feral origin by marking domestic cats from a nearby village with transponders, by deploying GPS devices on domestic cats and by performing stable isotope analyses of fur of the trapped and domestic cats. The population of Fogo was estimated to be 293 birds, including immatures (95% CI: 233-254, CMR modelling). Based on geolocator activity data and nest monitoring we determined the breeding phenology of this species and we found biometric differences between sexes. While monitoring breeding performance, we verified a still ongoing cat predation and human harvesting. Overall, data gathered from trapped cats without transponder, cats GPS trips and the distinct isotopic values between domestic and trapped cats suggest cats visiting the colony are of feral origin. GPS tracks from breeders showed birds left and returned to the colony using the sector NE of the islands, where high level of public lights should be avoided specially during the fledging period. Main threats for the Cape Verde petrel in the remaining breeding islands are currently unknown but likely to be similar to Fogo, calling for an urgent assessment of population trends and the control of main threats in all Cape Verde Islands and uplisting its conservation status.	[Militao, Teresa; Zango, Laura; Stefan, Laura M.; Gonzalez-Solis, Jacob] Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain; [Militao, Teresa; Zango, Laura; Stefan, Laura M.; Gonzalez-Solis, Jacob] Univ Barcelona, Dept Biol Evolut Ecol & Ciencies Ambientals, Barcelona, Spain; [Andrade Dinis, Herculano] Parque Nat Fogo, Sao Filipe, Cape Verde; [Calabuig, Pascual] Ctr Recuperac Fauna Silvestre Tafira, Tafira Baja, Spain	University of Barcelona; University of Barcelona	Militao, T (corresponding author), Univ Barcelona, Inst Recerca Biodiversitat IRBio, Barcelona, Spain.; Militao, T (corresponding author), Univ Barcelona, Dept Biol Evolut Ecol & Ciencies Ambientals, Barcelona, Spain.	tnetomilitao@ub.edu	Militao, Teresa/AAA-6151-2019; Calabuig, Pascual/AAB-1723-2019; Gonzalez-Solis, Jacob/C-3942-2008; González-Solís, Jacob/AAB-1161-2019; Gonzalez-Solis, Jacob/AAZ-5338-2021	Militao, Teresa/0000-0002-2862-1592; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Gonzalez-Solis, Jacob/0000-0002-8691-9397; Zango, Laura/0000-0003-0909-2493	Fundagao para a Giencia e Tecnologia (Portugal) [SFRH/BD/47467/2008]; Generalitat de Catalunya [2016F1_B 00787]; University of Barcelona; GEF Small Grant Programme [CPV/SGP/OP5/ Y2/CORE/BD/12/03]; MICIN, Spain [CGL2009-11278/BOS, CGL 2013-42585-P]; Fondos FEDER	Fundagao para a Giencia e Tecnologia (Portugal); Generalitat de Catalunya(Generalitat de Catalunya); University of Barcelona; GEF Small Grant Programme; MICIN, Spain(Spanish Government); Fondos FEDER(European Commission)	TM was supported by a PhD grant (SFRH/BD/47467/2008) from Fundagao para a Giencia e Tecnologia (Portugal), LZ by a PhD grant (2016F1_B 00787) from the Generalitat de Catalunya and LMS by a PhD grant (APIF) from the University of Barcelona. This study was funded by the GEF Small Grant Programme (CPV/SGP/OP5/ Y2/CORE/BD/12/03; https://sgp.undp.org/) and by the MICIN, Spain (CGL2009-11278/BOS, CGL 2013-42585-P); and Fondos FEDER.	[Anonymous], 2009, DESENVOLVIMENTO RURA; [Anonymous], 2021, LANG ENV STAT COMP; Arnholt AT, 2012, BSDA BASIC STAT DATA; BirdLife International, 2014, PTER FEAE; Biro Z, 2004, MAMM BIOL, V69, P302, DOI 10.1078/1616-5047-00149; Carey Mark J., 2011, Notornis, V58, P8; CROSBIE SF, 1985, BIOMETRICS, V41, P385, DOI 10.2307/2530864; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; ESRI, 2011, ARCGIS DESKT REL 10; Forin-Wiart MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129271; Friesen VL, 2007, P NATL ACAD SCI USA, V104, P18589, DOI 10.1073/pnas.0700446104; Gangloff B, 2013, MOL ECOL, V22, P495, DOI 10.1111/mec.12119; Genovart M, 2003, WATERBIRDS, V26, P72, DOI 10.1675/1524-4695(2003)026[0072:ADFFPS]2.0.CO;2; Jesus J, 2009, BIRD CONSERV INT, V19, P199, DOI 10.1017/S0959270909008296; Le Corre M, 2002, BIOL CONSERV, V105, P93, DOI 10.1016/S0006-3207(01)00207-5; Le Corre M, 2008, NATURE, V451, P134, DOI 10.1038/451134a; Lewison R., 2012, Endangered Species Research, V17, P93, DOI 10.3354/esr00419; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Martin J, 2013, POLAR BIOL, V36, P1531, DOI 10.1007/s00300-013-1365-x; Medina FM, 2011, GLOBAL CHANGE BIOL, V17, P3503, DOI 10.1111/j.1365-2486.2011.02464.x; Medina FM, 2010, ACTA THERIOL, V55, P241, DOI 10.4098/j.at.0001-7051.069.2009; Menezes D, 2011, MEDIDAS URGENTES REC; Nogales M, 2013, BIOSCIENCE, V63, P804, DOI 10.1525/bio.2013.63.10.7; Paleczny M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129342; Ramos R, 2016, SCI REP-UK, V6, DOI 10.1038/srep23447; Ratcliffe Norman, 2000, Atlantic Seabirds, V2, P73; Rich C., 2006, ECOLOGICAL CONSEQUEN; Robb M, 2008, PETRELS NIGHT DAY SO; Rodriguez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110114; Sanchez G, 2013, **DATA OBJECT**; Schreiber Elizabeth, 2002, BIOL MARINE BIRDS, DOI 10.1201/9781420036305; Sex N., 1994, POLAR BIOL, V14, P143; Shirihai Hadoram, 2010, Birding World, V23, P239; Spotte S, 2014, FREE-RANGING CATS: BEHAVIOR, ECOLOGY, MANAGEMENT, P1, DOI 10.1002/9781118884058; SPSS Inc. Released, 2009, PASW STAT WIND VERS; Tranquilla LAM, 2003, WATERBIRDS, V26, P108, DOI 10.1675/1524-4695(2003)026[0108:TROBPI]2.0.CO;2; Troy JR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00094.1; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Zino F, 2008, IBIS, V150, P326, DOI 10.1111/j.1474-919X.2007.00794.x; Zino Francis, 1996, P25	40	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174803	10.1371/journal.pone.0174803	http://dx.doi.org/10.1371/journal.pone.0174803			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369105	Green Submitted, Green Published, gold			2022-12-26	WOS:000399351000046
J	Huang, CI; Lin, LC; Tien, HC; Que, J; Ting, WC; Chen, PC; Wu, HM; Ho, CH; Wang, JJ; Wang, RH; Yang, CC				Huang, Chung-I; Lin, Li-Ching; Tien, Hung-Cheng; Que, Jenny; Ting, Wei Chen; Chen, Po-Chun; Wu, Hsin-Min; Ho, Chung-Han; Wang, Jhi-Joung; Wang, Ren-Hong; Yang, Ching-Chieh			Hyperlipidemia and statins use for the risk of new-onset anxiety/depression in patients with head and neck cancer: A population-based study	PLOS ONE			English	Article							QUALITY-OF-LIFE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; DEPRESSION; ANXIETY; INFLAMMATION; METAANALYSIS; MORTALITY; SYMPTOMS	Objective Anxiety/depression is common among patients with head and neck cancer (HNC), and can negatively affect treatment compliance and outcome. The aim of this study was to assess the association between hyperlipidemia and the risk of new-onset anxiety/depression after the diagnosis of HNC and the influence of administering statins. Methods A matched longitudinal cohort study of 1632 subjects (408 HNC patients with preexisting hyperlipidemia and 1224 age- and sex-matched HNC patients without hyperlipidemia) was included and analyzed by using data from Taiwan's National Health Insurance Research Database from January 1996 to December 2012. The incidence and hazard ratios (HRs) for the development of new-onset anxiety/depression were examined between the two groups. Cox proportional hazard regression was applied to estimate the relative risks of anxiety/depressive disorders adjusted for potential confounding factors. To estimate the risks of anxiety/depression in different sub-groups, a stratified analysis was also used. Results HNC patients with preexisting hyperlipidemia had a higher risk for comorbidities such as hypertension, diabetes mellitus, and cardiovascular disease (P <0.001). The incidence rate of anxiety/depression in the HNC patients with preexisting hyperlipidemia was also significantly higher than that among patients without hyperlipidemia (10.78% vs 7.27%, respectively; P = 0.03). A Cox regression model revealed that preexisting hyperlipidemia was an independent risk factor for anxiety/depression (aHR, 1.96; 95% CI, 1.30-2.94). Statins use was protective against anxiety/depression among HNC patients with hyperlipidemia ( aHR, 0.85; 95% CI, 0.46-1.57), especially for individuals older than 65 years and for females. Conclusions Preexisting hyperlipidemia was associated with increased risk of new-onset anxiety/depression in the HNC patients. Statins use for HNC patients with hyperlipidemia could decrease the risk of anxiety/depression, especially for those older than 65 years and for female patients.	[Huang, Chung-I] E Da Canc Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Lin, Li-Ching; Que, Jenny; Ting, Wei Chen; Yang, Ching-Chieh] Chi Mei Med Ctr, Dept Radiat Oncol, Tainan, Taiwan; [Tien, Hung-Cheng] Minist Hlth & Welf, Pingtung Hosp, Dept Psychiat, Pingtung, Taiwan; [Chen, Po-Chun] Pingtung Christian Hosp, Dept Radiat Oncol, Pingtung, Taiwan; [Wu, Hsin-Min] Natl Cheng Kung Univ, Dept Publ Hlth, Coll Med, Natl Cheng Kung Univ Hosp, Tainan, Taiwan; [Ho, Chung-Han; Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Pharm, Tainan, Taiwan; [Wang, Ren-Hong] Chi Mei Med Ctr, Dept Clin Pathol, Tainan, Taiwan; [Wang, Ren-Hong] Chung Hwa Univ Med Technol, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan; [Yang, Ching-Chieh] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan; [Yang, Ching-Chieh] Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan	E-Da Hospital; Chi Mei Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Chi Mei Hospital; Chung Hua University; National Sun Yat Sen University; Chia Nan University of Pharmacy & Science	Yang, CC (corresponding author), Chi Mei Med Ctr, Dept Radiat Oncol, Tainan, Taiwan.; Yang, CC (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan.; Yang, CC (corresponding author), Chia Nan Univ Pharm & Sci, Dept Biotechnol, Tainan, Taiwan.	cleanclear0905@gmail.com		Ho, Chung-Han/0000-0001-5925-8477				Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915; [Anonymous], 2014, ACTA CLIN CROAT, V53, P55, DOI DOI 10.3109/14992027.2013.839886; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Blum A, 2009, ATHEROSCLEROSIS, V203, P325, DOI 10.1016/j.atherosclerosis.2008.08.022; Can OD, 2012, BEHAV PHARMACOL, V23, P582, DOI 10.1097/FBP.0b013e328356c3f2; Chan CMH, 2015, PSYCHO-ONCOLOGY, V24, P718, DOI 10.1002/pon.3714; Chen YJ, 2008, CANCER SCI, V99, P1507, DOI 10.1111/j.1349-7006.2008.00863.x; Chuang CS, 2014, GEN HOSP PSYCHIAT, V36, P497, DOI 10.1016/j.genhosppsych.2014.05.008; Cohen M, 2014, PSYCHO-ONCOLOGY, V23, P151, DOI 10.1002/pon.3383; Curry Andrew, 2015, Diabetes Forecast, V68, P90; Dortland AKBV, 2010, ACTA PSYCHIAT SCAND, V122, P30, DOI 10.1111/j.1600-0447.2010.01565.x; Dortland AKBV, 2010, J CLIN PSYCHIAT, V71, P729, DOI 10.4088/JCP.08m04865blu; Duffy SA, 2007, PSYCHOSOMATICS, V48, P142, DOI 10.1176/appi.psy.48.2.142; Frampton M, 2001, BRIT J ORAL MAX SURG, V39, P67, DOI 10.1054/bjom.2000.0547; Hare DL, 2014, EUR HEART J, V35, P1365, DOI 10.1093/eurheartj/eht462; Ho CH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005269; Holland JC, 2003, J CLIN ONCOL, V21, p253S, DOI 10.1200/JCO.2003.09.133; Johansson R, 2013, PEERJ, V1, DOI 10.7717/peerj.98; Kawada T, 2015, INT J CARDIOL, V198, P40, DOI 10.1016/j.ijcard.2015.06.141; Levitt SH, 2003, INT J RADIAT ONCOL, V55, P645, DOI 10.1016/S0360-3016(02)04076-2; Lu JFR, 2011, HEALTH ECON POLICY L, V6, P85, DOI 10.1017/S1744133109990351; Maruyama K, 2005, NEW ENGL J MED, V352, P146, DOI 10.1056/NEJMoa040907; McFarland AJ, 2014, INT J MOL SCI, V15, P20607, DOI 10.3390/ijms151120607; Nugent NR, 2011, PSYCHOPHARMACOLOGY, V214, P175, DOI 10.1007/s00213-010-2151-x; O'Neil A, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-154; Olson MB, 2008, J WOMENS HEALTH, V17, P187, DOI 10.1089/jwh.2007.0379; Owonikoko TK, 2013, ONCOLOGIST, V18, P600, DOI 10.1634/theoncologist.2012-0480; Pranjic Nurka, 2016, Mater Sociomed, V28, P12, DOI 10.5455/msm.2016.28.12-16; Tietge UJF, 2014, CURR OPIN LIPIDOL, V25, P94, DOI 10.1097/MOL.0000000000000051; While A, 2012, EUR J CARDIOVASC NUR, V11, P85, DOI 10.1016/j.ejcnurse.2010.08.008; Wu YS, 2016, NEUROPSYCH DIS TREAT, V12, P1029, DOI 10.2147/NDT.S103203; Zeller JL, 2006, JAMA-J AM MED ASSOC, V296, P1716, DOI 10.1001/jama.296.14.1716; Zureik M, 1996, BMJ-BRIT MED J, V313, P649, DOI 10.1136/bmj.313.7058.649	33	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174574	10.1371/journal.pone.0174574	http://dx.doi.org/10.1371/journal.pone.0174574			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VK	28362860	Green Published, gold, Green Submitted			2022-12-26	WOS:000399175000019
J	Scott, EE				Scott, Emily E.			omega-versus (omega-1)-hydroxylation: Cytochrome P450 4B1 sterics make the call	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CYP4B1; CANCER; ACTIVATION; HUMANS; P450	Many family 4 cytochrome P450s play key roles in fatty acid hydroxylation at the terminal, or omega, carbon, but the mechanistic basis for this energetically disfavored regiostereochemistry has been less clear. A co-crystal structure of the rabbit family 4 enzyme CYP4B1 with its substrate octane reveals that the propensity for omega-hydroxylation is orchestrated by active-site sterics, partially mediated by an unusual heme-polypeptide ester bond.	[Scott, Emily E.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Scott, Emily E.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Scott, Emily E.] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Scott, EE (corresponding author), Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA.; Scott, EE (corresponding author), Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA.; Scott, EE (corresponding author), Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA.	scottee@umich.edu			National Institutes of Health [R37GM076343]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM076343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by National Institutes of Health R37GM076343. To whom correspondence should be addressed: Dept. of Medicinal Chemistry, Pharmacology, and Biophysics, University of Michigan, 428 Church St., Ann Arbor, MI 48109. E-mail: scottee@umich.edu.	Akhtar M Kalim, 2015, Metab Eng Commun, V2, P1, DOI 10.1016/j.meteno.2014.11.001; Baer BR, 2006, DRUG METAB REV, V38, P451, DOI 10.1080/03602530600688503; Cheesman MJ, 2003, ARCH BIOCHEM BIOPHYS, V416, P17, DOI 10.1016/S0003-9861(03)00278-9; Hsu MH, 2017, J BIOL CHEM, V292, P5610, DOI 10.1074/jbc.M117.775494; Imaoka S, 2000, BIOCHEM BIOPH RES CO, V277, P776, DOI 10.1006/bbrc.2000.3740; Lonsdale TH, 2015, CHEM COMMUN, V51, P16173, DOI 10.1039/c5cc06078h; Parkinson OT, 2013, TOXICOL SCI, V134, P243, DOI 10.1093/toxsci/kft123; Rainov NG, 1998, HUM GENE THER, V9, P1261, DOI 10.1089/hum.1998.9.9-1261; ROWINSKY EK, 1993, CANCER RES, V53, P1794	9	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 31	2017	292	13					5622	5623		10.1074/jbc.H117.775494	http://dx.doi.org/10.1074/jbc.H117.775494			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EQ2CI	28363936	Green Published, hybrid			2022-12-26	WOS:000397875500041
J	de Almeida, LG; de Moraes, LAB; Trigo, JR; Omoto, C; Consoli, FL				de Almeida, Luis Gustavo; Beraldo de Moraes, Luiz Alberto; Trigo, Jose Roberto; Omoto, Celso; Consoli, Fernando Luis			The gut microbiota of insecticide-resistant insects houses insecticide-degrading bacteria: A potential source for biotechnological exploitation	PLOS ONE			English	Article							SYMBIONTS; DEGRADATION; BIODEGRADATION; BIOREMEDIATION; CHLORPYRIFOS; POPULATIONS; PESTICIDES; EVOLUTION; APHIDS; BIOCATALYSIS	The exploration of new niches for microorganisms capable of degrading recalcitrant molecules is still required. We hypothesized the gut microbiota associated with insect-resistant lines carry pesticide degrading bacteria, and predicted they carry bacteria selected to degrade pesticides they were resistant to. We isolated and accessed the pesticide-degrading capacity of gut bacteria from the gut of fifth instars of Spodoptera frugiperda strains resistant to lambda-cyhalothrin, deltamethrin, chlorpyrifos ethyl, spinosad and lufenuron, using insecticide-selective media. Sixteen isolates belonging to 10 phylotypes were obtained, from which four were also associated with the susceptible strain. However, growth of gut bacteria associated with larvae from the susceptible strain was not obtained in any of the insecticide-based selective media tested. Growth of isolates was affected by the concentration of insecticides in the media, and all grew well up to 40 lag/ml. The insecticide degrading capacity of selected isolates was assessed by GC or LC-MS/MS analyses. In conclusion, resistant strains of S. frugiperda are an excellent reservoir of insecticide-degrading bacteria with bioremediation potential. Moreover, gut-associated bacteria are subjected to the selection pressure imposed by insecticides on their hosts and may influence the metabolization of pesticides in insects.	[de Almeida, Luis Gustavo; Omoto, Celso; Consoli, Fernando Luis] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Entomol & Acarol, Sao Paulo, Brazil; [Beraldo de Moraes, Luiz Alberto] Univ Sao Paulo, Fac Filosofia Ciencias & Letras, Dept Quim, Sao Paulo, Brazil; [Trigo, Jose Roberto] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas	Consoli, FL (corresponding author), Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Entomol & Acarol, Sao Paulo, Brazil.	fconsoli@usp.br	Moraes, Luiz Alberto B/K-2282-2012; Omoto, Celso/D-9794-2012; Trigo, Jose R/B-8398-2012; Consoli, Fernando Luis/D-5706-2012	Moraes, Luiz Alberto B/0000-0002-0853-1944; Omoto, Celso/0000-0002-6432-830X; Trigo, Jose R/0000-0003-3028-5353; Consoli, Fernando Luis/0000-0002-2287-0782	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo provided a fellowship (FAPESP) [2010/13714-3, 2011/50877-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo provided a fellowship (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo provided a fellowship to LGA ( FAPESP Process 2010/13714-3) and a research grant to the senior author (FAPESP Process 2011/50877-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad IA, 2011, NONPARAMETRIC STATISTICS AND MIXTURE MODELS: A FESTSCHRIFT IN HONOR OF THOMAS P HETTMANSPERGER, P1; Aislabie J, 2005, FEMS MICROBIOL ECOL, V52, P279, DOI 10.1016/j.femsec.2004.11.012; Alcalde M, 2007, BIOCATAL BIOTRANSFOR, V25, P113, DOI 10.1080/10242420701444397; Andow DA, 1998, J ECON ENTOMOL, V91, P572, DOI 10.1093/jee/91.3.572; BARTHA R, 1967, APPL MICROBIOL, V15, P67, DOI 10.1128/AEM.15.1.67-75.1967; Beard CB, 2001, INT J PARASITOL, V31, P621, DOI 10.1016/S0020-7519(01)00165-5; Berasategui A, 2016, APPL MICROBIOL BIOT, V100, P1567, DOI 10.1007/s00253-015-7186-9; Berlanga M, 2016, SYMBIOSIS, V68, P49, DOI 10.1007/s13199-016-0388-9; Boone CK, 2008, ENVIRON ENTOMOL, V37, P150, DOI 10.1603/0046-225X(2008)37[150:PADPEV]2.0.CO;2; BOUSH GM, 1967, J ECON ENTOMOL, V60, P918, DOI 10.1093/jee/60.4.918; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Cabrera JA, 2010, BIODEGRADATION, V21, P1017, DOI 10.1007/s10532-010-9362-z; Chaves Sandra, 2009, Biotechnology Journal, V4, P1753, DOI 10.1002/biot.200800237; Chen M, 2015, BIOTECHNOL ADV, V33, P745, DOI 10.1016/j.biotechadv.2015.05.003; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Chu CC, 2013, P NATL ACAD SCI USA, V110, P11917, DOI 10.1073/pnas.1301886110; DAUGHTON CG, 1977, APPL ENVIRON MICROB, V34, P175, DOI 10.1128/AEM.34.2.175-184.1977; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; Devine GJ, 2007, AGR HUM VALUES, V24, P281, DOI 10.1007/s10460-007-9067-z; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Douglas AE, 2009, FUNCT ECOL, V23, P38, DOI 10.1111/j.1365-2435.2008.01442.x; Dowd P.F., 1991, P411; DOWD PF, 1990, ENTOMOL EXP APPL, V56, P241, DOI 10.1007/BF00163695; DOWD PF, 1989, J ECON ENTOMOL, V82, P396, DOI 10.1093/jee/82.2.396; Dua M, 2002, APPL MICROBIOL BIOT, V59, P143, DOI 10.1007/s00253-002-1024-6; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Feldhaar H, 2011, ECOL ENTOMOL, V36, P533, DOI 10.1111/j.1365-2311.2011.01318.x; Frago E, 2012, TRENDS ECOL EVOL, V27, P705, DOI 10.1016/j.tree.2012.08.013; Fuentes MS, 2010, INT BIODETER BIODEGR, V64, P434, DOI 10.1016/j.ibiod.2010.05.001; Ghanim M, 2009, PEST MANAG SCI, V65, P939, DOI 10.1002/ps.1795; Gill H.K., 2014, PESTIC TOXIC ASPECTS, V8, DOI [DOI 10.5772/57399, 10.5772/57399]; Grant RJ, 2002, J APPL MICROBIOL, V92, P534, DOI 10.1046/j.1365-2672.2002.01558.x; Guerrero R, 2013, INT MICROBIOL, V16, P133, DOI 10.2436/20.1501.01.188; Haine ER, 2008, P ROY SOC B-BIOL SCI, V275, P353, DOI 10.1098/rspb.2007.1211; Hale KA, 1996, J ENVIRON SCI HEAL B, V31, P477, DOI 10.1080/03601239609373010; Hammer TJ, 2015, OECOLOGIA, V179, P1, DOI 10.1007/s00442-015-3327-1; Hansen AK, 2007, APPL ENVIRON MICROB, V73, P7531, DOI 10.1128/AEM.01672-07; Hansen AK, 2014, MOL ECOL, V23, P1473, DOI 10.1111/mec.12421; Harris HL, 2010, SYMBIOSIS, V51, P37, DOI 10.1007/s13199-010-0065-3; Hayashi A, 2007, APPL MICROBIOL BIOT, V75, P1437, DOI 10.1007/s00253-007-0969-x; Henry LM, 2015, ECOL LETT, V18, P516, DOI 10.1111/ele.12425; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Ibanez S, 2012, TOXINS, V4, P228, DOI 10.3390/toxins4040228; Indiragandhi P, 2007, J APPL MICROBIOL, V103, P2664, DOI 10.1111/j.1365-2672.2007.03506.x; Jaenike J, 2010, SCIENCE, V329, P212, DOI 10.1126/science.1188235; Jukes TH, 1969, MAMMALIAN PROTEIN ME, V3, P12; Khalid S, 2016, J ENVIRON MANAGE, V168, P1, DOI 10.1016/j.jenvman.2015.11.030; Kikuchi Y, 2012, P NATL ACAD SCI USA, V109, P8618, DOI 10.1073/pnas.1200231109; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Mallick K, 1999, B ENVIRON CONTAM TOX, V62, P48, DOI 10.1007/s001289900840; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Parales RE, 2002, APPL ENVIRON MICROB, V68, P4699, DOI 10.1128/AEM.68.10.4699-4709.2002; Pesaro M, 2004, APPL ENVIRON MICROB, V70, P2577, DOI 10.1128/AEM.70.5.2577-2587.2004; Piel J, 2009, NAT PROD REP, V26, P338, DOI 10.1039/b703499g; Ramadhar TR, 2014, J ANTIBIOT, V67, P53, DOI 10.1038/ja.2013.77; Rockne KJ, 2003, INT C MOD TRENDS FDN; Roe RM, 1998, PESTICIDES AND THE FUTURE, P169; Russell RJ, 2011, EVOL APPL, V4, P225, DOI 10.1111/j.1752-4571.2010.00175.x; Saikia N, 2005, BIODEGRADATION, V16, P581, DOI 10.1007/s10532-005-0211-4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2001, MOL CLONING; Sanchez-Contreras M, 2008, BIOTECHNOL GENET ENG, V25, P203, DOI 10.5661/bger-25-203; Sasikala C, 2012, WORLD J MICROB BIOT, V28, P1301, DOI 10.1007/s11274-011-0879-z; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Scott C, 2008, INDIAN J MICROBIOL, V48, P65, DOI 10.1007/s12088-008-0007-4; SIDDARAMAPPA R, 1973, APPL MICROBIOL, V26, P846, DOI 10.1128/AEM.26.6.846-849.1973; Singh BK, 2004, APPL ENVIRON MICROB, V70, P4855, DOI 10.1128/AEM.70.8.4855-4863.2004; Smagghe G, 2001, BIOCHEMICAL SITES OF INSECTICIDE ACTION AND RESISTANCE, P293; Stark JD, 2001, BIOSCIENCE, V51, P980, DOI 10.1641/0006-3568(2001)051[0980:SPATLH]2.0.CO;2; Strand MR, 2015, VIROLOGY, V479, P393, DOI 10.1016/j.virol.2015.01.018; Su Q, 2013, COMMUNICATIVE INTEGR, V6; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tehara SK, 2003, APPL ENVIRON MICROB, V69, P504, DOI 10.1128/AEM.69.1.504-508.2003; THEILING KM, 1988, AGR ECOSYST ENVIRON, V21, P191, DOI 10.1016/0167-8809(88)90088-6; TU CM, 1980, MICROB ECOL, V5, P321, DOI 10.1007/BF02020339; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; van Houte S, 2013, MOL ECOL, V22, P3458, DOI 10.1111/mec.12307; Vilanova C, 2012, BIOMASS BIOENERG, V45, P288, DOI 10.1016/j.biombioe.2012.06.017; Vorburger C, 2010, BIOL LETTERS, V6, P109, DOI 10.1098/rsbl.2009.0642; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wernegreen JJ, 2012, CURR OPIN MICROBIOL, V15, P255, DOI 10.1016/j.mib.2012.02.001; Zhang CL, 2005, APPL MICROBIOL BIOT, V67, P600, DOI 10.1007/s00253-004-1864-3; Zucchi TD, 2010, BIOCONTROL, V55, P811, DOI 10.1007/s10526-010-9295-9	88	81	93	11	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174754	10.1371/journal.pone.0174754	http://dx.doi.org/10.1371/journal.pone.0174754			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358907	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174800083
J	Hviid, CJ; Lund, M; Sorensen, A; Ellermann-Eriksen, S; Jespersen, B; Dam, MY; Dahlerup, JF; Benfield, T; Jespersen, S; Ostergaard, LJ; Laursen, AL				Hviid, Cecilie Juul; Lund, Marianne; Sorensen, Allan; Ellermann-Eriksen, Svend; Jespersen, Bente; Dam, Mette Yde; Dahlerup, Jens Frederik; Benfield, Thomas; Jespersen, Sanne; Ostergaard, Lars Jorgen; Laursen, Alex Lund		Bissau HIV Cohort Study Grp	Detection of Pneumocystis jirovecii in oral wash from immunosuppressed patients as a diagnostic tool	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; ASYMPTOMATIC CARRIAGE; BRONCHOALVEOLAR LAVAGE; CLINICAL-SIGNIFICANCE; PULMONARY INFECTIONS; PNEUMONIA; COLONIZATION; CARINII; DNA	Background Diagnosis of Pneumocystis jirovecii (PJ) pneumonia ordinarily requires invasive procedures that could be avoided by PCR methodologies, if these could be designed with adequate cutoff values for confounding background carriage. Methods We designed a novel quantitative real-time PCR assay to detect the mitochondrial large subunit rRNA gene of PJ in oral washes. To benchmark levels of PJ carriage versus infection, we tested asymptomatic immunosuppressed patients including Danish (n = 88) and West African HIV-infected (n = 142) patients, renal transplant recipients (n = 51), rheumatologic patients (n = 102), patients with inflammatory bowel diseases (n = 98), and healthy blood donors (controls, n = 50). The fungal burden in patients with PJ pneumonia (PCP, n = 7) was also investigated. Results Danish HIV-infected patients (with viremia/low CD4) and recent transplant recipients were at most risk of being carriers (prevalence of 23% and 16.7% respectively), whereas PJ was rarely detected among rheumatologic patients, patients with inflammatory bowel diseases, and untreated West African HIV patients. PJ was not detected among healthy controls. The fungal burden in patients with PCP fell rapidly on treatment. Conclusions The quantitative PCR method described could conceivably discriminate between carriage and disease, given suitable threshold values for the former, and predict treatment efficacy by measures of the fungal burden in daily oral washes.	[Hviid, Cecilie Juul; Jespersen, Sanne; Ostergaard, Lars Jorgen; Laursen, Alex Lund] Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark; [Lund, Marianne; Ellermann-Eriksen, Svend] Aarhus Univ Hosp, Dept Clin Microbiol, Aarhus, Denmark; [Sorensen, Allan; Jespersen, Sanne; Laursen, Alex Lund] Bissau HIV Cohort Study Grp, Bandim Hlth Project, Bissau, Guinea Bissau; [Jespersen, Bente] Aarhus Univ Hosp, Dept Nephrol, Aarhus, Denmark; [Dam, Mette Yde] Aarhus Univ Hosp, Dept Rheumatol, Aarhus, Denmark; [Dahlerup, Jens Frederik] Aarhus Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, Aarhus, Denmark; [Benfield, Thomas] Hvidovre Univ Hosp, Dept Infect Dis, Hvidovre, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; University of Copenhagen	Ostergaard, LJ; Laursen, AL (corresponding author), Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark.; Laursen, AL (corresponding author), Bissau HIV Cohort Study Grp, Bandim Hlth Project, Bissau, Guinea Bissau.	laroes@rm.dk; alexlaur@rm.dk	Ostergaard, Lars/AAA-3020-2020	Ostergaard, Lars/0000-0003-2459-0511; Dahlerup, Jens Frederik/0000-0002-1587-7636; Benfield, Thomas/0000-0003-0698-9385; Laursen, Alex Lund/0000-0002-1206-156X; Jespersen, Sanne/0000-0001-8493-2064; Christiansen, Cecilie Hviid/0000-0002-6184-8561; Ostergaard, Lars/0000-0002-7619-605X; Jespersen, Bente/0000-0001-7196-2870; Fomsgaard, Anders/0000-0003-4304-0603; Erikstrup, Christian/0000-0001-6551-6647	Danish Council for Independent Research/Medical sciences [0602-02951B]; Aase and Ejnar Danielsen Foundation; Hede Nielsen Foundation; President Emil C Hertz and wifr Inger C Hertz Foundation	Danish Council for Independent Research/Medical sciences(Det Frie Forskningsrad (DFF)); Aase and Ejnar Danielsen Foundation; Hede Nielsen Foundation; President Emil C Hertz and wifr Inger C Hertz Foundation	This work was funded by the Danish Council for Independent Research/Medical sciences. Grant number: 0602-02951B, Aase and Ejnar Danielsen Foundation, Hede Nielsen Foundation, and President Emil C Hertz and wifr Inger C Hertz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderaye G, 2007, SCAND J INFECT DIS, V39, P1045, DOI 10.1080/00365540701474508; Alanio A, 2011, CLIN MICROBIOL INFEC, V17, P1531, DOI 10.1111/j.1469-0691.2010.03400.x; Botterel F, 2012, J CLIN MICROBIOL, V50, P227, DOI 10.1128/JCM.06036-11; BROADDUS C, 1985, ANN INTERN MED, V102, P747, DOI 10.7326/0003-4819-102-6-747; Fritzsche C, 2013, NEPHROLOGY, V18, P382, DOI 10.1111/nep.12054; Goto N, 2011, TRANSPL INFECT DIS, V13, P551, DOI 10.1111/j.1399-3062.2011.00691.x; Guigue N, 2015, MED MYCOL, V53, P241, DOI 10.1093/mmy/myu087; Harigai M, 2007, NEW ENGL J MED, V357, P1874, DOI 10.1056/NEJMc070728; Hartung TK, 2011, AM J TROP MED HYG, V85, P105, DOI 10.4269/ajtmh.2011.10-0640; Helweg-Larsen J, 1998, J CLIN MICROBIOL, V36, P2068, DOI 10.1128/JCM.36.7.2068-2072.1998; Huang Laurence, 2011, Proc Am Thorac Soc, V8, P294, DOI 10.1513/pats.201009-062WR; Hugle B, 2010, ARTHRIT CARE RES, V62, P1661, DOI 10.1002/acr.20279; Jensen L, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-140; Larsen HH, 2004, J INFECT DIS, V189, P1679, DOI 10.1086/383322; LEIGH TR, 1993, RESP MED, V87, P525, DOI 10.1016/0954-6111(93)90008-N; Long MD, 2013, INFLAMM BOWEL DIS, P19; Maskell NA, 2003, THORAX, V58, P594, DOI 10.1136/thorax.58.7.594; Matos O, 2001, EUR J CLIN MICROBIOL, V20, P573, DOI 10.1007/s100960100563; Medrano FJ, 2005, EMERG INFECT DIS, V11, P245, DOI 10.3201/eid1102.040487; Mori S, 2008, MOD RHEUMATOL, V18, P240, DOI 10.1007/s10165-008-0037-0; Morris A, 2004, EMERG INFECT DIS, V10, P1713, DOI 10.3201/eid1010.030985; Morris A, 2004, AIDS, V18, P793, DOI 10.1097/00002030-200403260-00011; Morris A, 2008, J INFECT DIS, V197, P10, DOI 10.1086/523814; Muhlethaler K, 2012, EUR RESPIR J, V39, P971, DOI 10.1183/09031936.00095811; Nevez G, 1999, CLIN INFECT DIS, V29, P1331, DOI 10.1086/313478; Niesters HGM, 2001, METHODS, V25, P419, DOI 10.1006/meth.2001.1264; Robberts FJL, 2007, DIAGN MICR INFEC DIS, V58, P385, DOI 10.1016/j.diagmicrobio.2007.02.014; Rohner P, 2009, INFECTION, V37, P261, DOI 10.1007/s15010-008-8027-x; Rusan M, 2012, EUR J CLIN MICROBIOL, V31, P2335, DOI 10.1007/s10096-012-1573-2; Shelhamer JH, 1996, ANN INTERN MED, V124, P585, DOI 10.7326/0003-4819-124-6-199603150-00008; Valero C, 2016, FRONT MICROBIOL, V7, P1; van Oosterhout JJG, 2007, EMERG INFECT DIS, V13, P325, DOI 10.3201/eid1302.060462; Wakefield AE, 2003, J INFECT DIS, V187, P901, DOI 10.1086/368165; WAKEFIELD AE, 1990, LANCET, V336, P451, DOI 10.1016/0140-6736(90)92008-6; Walzer P D, 1976, Natl Cancer Inst Monogr, V43, P55	35	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174012	10.1371/journal.pone.0174012	http://dx.doi.org/10.1371/journal.pone.0174012			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358900	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174800018
J	Li, HT; Huang, YY; Xiao, Y				Li, Haotian; Huang, Yangyu; Xiao, Yi			A pair-conformation-dependent scoring function for evaluating 3D RNA-protein complex structures	PLOS ONE			English	Article							BINDING PROTEINS; WEB SERVER; DOCKING; PREDICTION; DESIGN; POTENTIALS; NETWORKS; ENERGY; SITES	Computational prediction of RNA-protein complex 3D structures includes two basic steps: one is sampling possible structures and another is scoring the sampled structures to pick out the correct one. At present, constructing accurate scoring functions is still not well solved and the performances of the scoring functions usually depend on used benchmarks. Here we propose a pair-conformation-dependent scoring function, 3dRPC-Score, for 3D RNA protein complex structure prediction by considering the nucleotide-residue pairs having the same energy if their conformations are similar, instead of the distance-only dependence of the most existing scoring functions. Benchmarking shows that 3dRPC-Score has a consistent performance in three test sets.	[Li, Haotian; Huang, Yangyu; Xiao, Yi] Huazhong Univ Sci & Technol, Biomol Phys & Modeling Grp, Sch Phys, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology	Xiao, Y (corresponding author), Huazhong Univ Sci & Technol, Biomol Phys & Modeling Grp, Sch Phys, Wuhan, Hubei, Peoples R China.	yxiao@hust.edu.cn			National Natural Science Foundation of China [11374113, 31570722]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported partially by the National Natural Science Foundation of China under Grant No. 11374113 and 31570722. (httplimm nsfc gov cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen R, 2003, PROTEINS, V51, P397, DOI 10.1002/prot.10334; Chen Y, 2004, NUCLEIC ACIDS RES, V32, P5147, DOI 10.1093/nar/gkh785; Ellis JJ, 2007, PROTEINS, V66, P903, DOI 10.1002/prot.21211; Guilhot-Gaudeffroy A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108928; Guo DC, 2013, J BIOMOL STRUCT DYN, V31, P716, DOI 10.1080/07391102.2012.708604; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Huang SY, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku077; Huang SY, 2013, J COMPUT CHEM, V34, P311, DOI 10.1002/jcc.23149; Huang YY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01887; Jones S, 2001, NUCLEIC ACIDS RES, V29, P943, DOI 10.1093/nar/29.4.943; Karaca E, 2010, MOL CELL PROTEOMICS, V9, P1784, DOI 10.1074/mcp.M000051-MCP201; Ke A, 2004, METHODS, V34, P408, DOI 10.1016/j.ymeth.2004.03.027; Li C.Q., 2011, SCI TECHNOLOGY MANAG, V14, P24, DOI DOI 10.1002/PR0T.23117; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Liu SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-280; Lorkovic ZJ, 2009, TRENDS PLANT SCI, V14, P229, DOI 10.1016/j.tplants.2009.01.007; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Mittal N, 2009, P NATL ACAD SCI USA, V106, P20300, DOI 10.1073/pnas.0906940106; Paz I, 2016, NUCLEIC ACIDS RES, V44, pW568, DOI 10.1093/nar/gkw454; Perez-Cano L, 2012, PROTEINS, V80, P1872, DOI 10.1002/prot.24075; Perez-Cano L, 2010, BIOCOMPUT-PAC SYM, P293; Perez-Cano L, 2010, PROTEINS, V78, P25, DOI 10.1002/prot.22527; Scott Lincoln G., 2008, V452, P29, DOI 10.1007/978-1-60327-159-2_2; Setny P, 2011, NUCLEIC ACIDS RES, V39, P9118, DOI 10.1093/nar/gkr636; Tuszynska I, 2015, NUCLEIC ACIDS RES, V43, pW425, DOI 10.1093/nar/gkv493; Tuszynska I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-348; Xiong P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6330; Zhao HY, 2011, NUCLEIC ACIDS RES, V39, P3017, DOI 10.1093/nar/gkq1266; Zheng S, 2007, FEBS J, V274, P6378, DOI 10.1111/j.1742-4658.2007.06155.x	31	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174662	10.1371/journal.pone.0174662	http://dx.doi.org/10.1371/journal.pone.0174662			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358834	Green Submitted, gold, Green Published			2022-12-26	WOS:000399174800069
J	Shen, L; Han, B; Geng, Y; Wang, JH; Wang, ZM; Wang, MW				Shen, Li; Han, Bing; Geng, Yuan; Wang, Jinhua; Wang, Zhengmin; Wang, Mingwei			Amelioration of cognitive impairments in APPswe/PS1dE9 mice is associated with metabolites alteration induced by total salvianolic acid	PLOS ONE			English	Article							MASS-SPECTROMETRY ANALYSIS; APP/PS1 TRANSGENIC MODEL; ALZHEIMERS-DISEASE; MOUSE MODEL; AMYLOID DEPOSITION; MEMORY DEFICIT; BETA-PROTEIN; WATER-MAZE; BRAIN; PATHOLOGY	Purpose Total salvianolic acid (TSA) is extracted from salvia miltiorrhiza; however, to date, there has been limited characterization of its effects on metabolites in Alzheimer's disease modelAPPswe/PS1dE9 mice. The main objective of this study was to investigate the metabolic changes in 7-month-old APPswe/PS1dE9 mice treated with TSA, which protects against learning and memory impairment. Methods APPswe/PS1dE9 mice were treated with TSA (30 mg/kg-d and 60 mg/kg-d, i.p.) and saline (i.p.) daily from 3.5 months old for 14 weeks; saline-treated (i.p.) WT mice were included as the controls. The effects of TSA on learning and memory were assessed by a series of behavioral tests, including the NOR, MWM and step-through tasks. The FBG and plasma lipid levels were subsequently assessed using the GOPOD and enzymatic color methods, respectively. Finally, the concentrations of A beta 42, A beta 40 and metabolites in the hippocampus of the mice were detected via ELISA and GC-TOF-MS, respectively. Results At 7 months of age, the APPswe/PS1dE9 mice treated with TSA exhibited an improvement in the preference index (PI) one hour after the acquisition phase in the NOR and the preservation of spatial learning and memory in the MWM. Treatment with TSA substantially decreased the LDL-C level, and 60 mg/kg TSA decreased the CHOL level compared with the plasma level of the APPswe/PS1dE9 group. The A beta 42 and A beta 40 levels in the hippocampus were decreased in the TSA-treated group compared with the saline-treated APPswe/ PS1dE9 group. The regulation of metabolic pathways relevant to TSA predominantly included carbohydrate metabolism, such as sorbitol, glucose-6-phosphate, sucrose-6-phosphate and galactose, vitamin metabolism involved in cholecalciferol and ascorbate in the hippocampus. Conclusions TSA induced a remarkable amelioration of learning and memory impairments in APPswe/PS1dE9 mice through the regulation of A beta 42, A beta 40, carbohydrate and vitamin metabolites in the hippocampus and LDL-C and CHOL in the plasma.	[Shen, Li; Wang, Zhengmin] Hebei Med Univ, Clin Lab, Hosp 1, Shijiazhuang, Hebei Province, Peoples R China; [Han, Bing; Wang, Jinhua; Wang, Mingwei] Hebei Med Univ, Dept Neurol, Hosp 1, Shijiazhuang, Hebei Province, Peoples R China; [Geng, Yuan] Hebei Med Univ, Brain Aging & Cognit Neurosci Lab Hebei Prov, Hosp 1, Shijiazhuang, Hebei Province, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University	Wang, MW (corresponding author), Hebei Med Univ, Dept Neurol, Hosp 1, Shijiazhuang, Hebei Province, Peoples R China.	mingweiwang7314@163.com			Natural Science Foundation of Hebei Province from Science and Technology Department of Hebei Province [H2015206238]	Natural Science Foundation of Hebei Province from Science and Technology Department of Hebei Province	This study was supported by the Natural Science Foundation of Hebei Province (H2015206238, 2015) from Science and Technology Department of Hebei Province. The corresponding author was responsible for the study design. The contents of this manuscript are solely the responsibility of the authors. The funders had important role in study design, animal experiment, data collection and analysis, and preparation of the manuscript.	Abdul HM, 2004, NEUROSCI LETT, V368, P148, DOI 10.1016/j.neulet.2004.06.077; Ahangarpour A, 2014, WORLD J MENS HEALTH, V32, P176, DOI 10.5534/wjmh.2014.32.3.176; Alley GM, 2010, J NEUROSCI RES, V88, P143, DOI 10.1002/jnr.22172; Begley P, 2009, ANAL CHEM, V81, P7038, DOI 10.1021/ac9011599; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Briones TL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-244; Chen CY, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-99; Cheng F, 2011, J BIOL CHEM, V286, P27559, DOI 10.1074/jbc.M111.243345; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cui X, 2006, J NEUROSCI RES, V84, P647, DOI 10.1002/jnr.20899; Dhingra D, 2006, J MED FOOD, V9, P281, DOI 10.1089/jmf.2006.9.281; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Ding Y, 2008, J NEUROSCI, V28, P11622, DOI 10.1523/JNEUROSCI.3153-08.2008; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Gao Y, 2015, NEUROPSYCH DIS TREAT, V11, P537, DOI 10.2147/NDT.S78025; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Garcion E, 2003, ACTA NEUROPATHOL, V105, P438, DOI 10.1007/s00401-002-0663-0; Geerts H, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00047; Golomb J, 2000, NEUROBIOL AGING, V21, P871, DOI 10.1016/S0197-4580(00)00185-8; Golomb J, 2000, NEUROBIOL AGING, V21, P5; Gonzalez-Dominguez R, 2015, J PHARMACEUT BIOMED, V107, P378, DOI 10.1016/j.jpba.2015.01.025; Gonzalez-Dominguez R, 2015, J PHARMACEUT BIOMED, V107, P75, DOI 10.1016/j.jpba.2014.10.010; Gonzalez-Dominguez R, 2015, BIOCHIMIE, V110, P119, DOI 10.1016/j.biochi.2015.01.005; Gonzalez-Dominguez R, 2015, J PHARMACEUT BIOMED, V102, P425, DOI 10.1016/j.jpba.2014.10.009; Gonzalez-Dominguez R, 2014, BBA-MOL BASIS DIS, V1842, P2395, DOI 10.1016/j.bbadis.2014.09.014; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harrison FE, 2009, PHARMACOL BIOCHEM BE, V93, P443, DOI 10.1016/j.pbb.2009.06.006; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Latimer CS, 2014, P NATL ACAD SCI USA, V111, pE4359, DOI 10.1073/pnas.1404477111; Lee YW, 2013, EUR J PHARMACOL, V704, P70, DOI 10.1016/j.ejphar.2013.02.015; Li J, 1993, Yao Xue Xue Bao, V28, P543; Li W, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0065-y; Lindon JC, 2004, EXPERT REV MOL DIAGN, V4, P189, DOI 10.1586/14737159.4.2.189; Lyssiotis CA, 2013, NATURE, V502, P181, DOI 10.1038/502181a; Malm Tarja, 2011, Int J Alzheimers Dis, V2011, P517160, DOI 10.4061/2011/517160; Masters CL, 2006, J NEUROCHEM, V97, P1700, DOI 10.1111/j.1471-4159.2006.03989.x; Masters CL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006262; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mosconi L, 2009, NEUROLOGY, V72, P513, DOI 10.1212/01.wnl.0000333247.51383.43; O'Neal-Moffitt G, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0027-6; Oresic M, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.55; Pasikanti KK, 2008, J CHROMATOGR B, V871, P202, DOI 10.1016/j.jchromb.2008.04.033; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Puolivali J, 2002, NEUROBIOL DIS, V9, P339, DOI 10.1006/nbdi.2002.0481; Reed B, 2014, JAMA NEUROL, V71, P195, DOI 10.1001/jamaneurol.2013.5390; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Sangster T, 2006, ANALYST, V131, P1075, DOI 10.1039/b604498k; Scholtzova H, 2008, J NEUROSCI RES, V86, P2784, DOI 10.1002/jnr.21713; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shokouhi S, 2013, J NUCL MED, V54, P1564, DOI 10.2967/jnumed.112.116137; St-Amour I, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-54; Tang MK, 2001, ACTA PHARMACOL SIN, V22, P380; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; Trushina E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032737; Van Assche R, 2015, METABOLOMICS, V11, P477, DOI 10.1007/s11306-014-0711-5; Vlassenko AG, 2010, P NATL ACAD SCI USA, V107, P17763, DOI 10.1073/pnas.1010461107; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang DC, 2012, NEUROBIOL AGING, V33, P1057, DOI 10.1016/j.neurobiolaging.2010.09.013; WANG J, 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/247948; Webster SJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00088; Webster SJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt182; West MJ, 2004, NEUROBIOL AGING, V25, P1205, DOI 10.1016/j.neurobiolaging.2003.12.005; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	68	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174763	10.1371/journal.pone.0174763	http://dx.doi.org/10.1371/journal.pone.0174763			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358909	Green Published, gold			2022-12-26	WOS:000399174800085
J	He, CB; Lin, XJ				He, Chao-Bin; Lin, Xiao-Jun			Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101	PLOS ONE			English	Article							TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; P53 GENE-THERAPY; CANCER; REPLICATION; CELLS; CYCLOOXYGENASE-2; COMBINATION; EFFICACY; IMPROVES; ONYX-015	Background The systemic inflammatory response plays an important role in cancer development and progression. An original inflammation-based staging system for predicting survival in patients undergoing transarterial chemoembolization (TACE) combined with recombinant human type-5 adenovirus H101 is not available. This study aimed to validate the prognostic value of inflammation scores for patients with hepatocellular carcinoma (HCC) who were treated with TACE combined with H101. Methods The data from 216 patients with HCC who underwent TACE combined with H101 from January 2007 to July 2015 were retrospectively collected, and the association of the inflammation scores with overall survival (OS) was analyzed. Univariate and multivariate analyses were performed to identify variables associated with OS. The prognostic value of the inflammation scores, including the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), neutrophil/ platelet-to-lymphocyte ratio (NLR-PLR), modified Glasgow Prognostic Score (mGPS), prognostic nutritional index (PNI), prognostic index (PI), tumor-node-metastasis (TNM), Barcelona Clinic Liver Cancer (BCLC) and Cancer of the Liver Italian Program (CLIP) staging systems were analyzed and compared using the areas under the receiver operating characteristic curves (AUROCs). Results The estimated 1-, 2-, and 3-year OS rates were 61.3%, 44.2%, and 40.5% for the entire study cohort, respectively; the median OS was 17 months. According to the multivariate Cox proportional hazards model, the pretreatment NLR, tumor diameter and pretreatment alpha-fetoprotein (AFP) levels were independent predictors of OS. The CLIP score had superior discriminative abilities compared with other staging systems, and the NLR-PLR score consistently displayed a higher AUROC value than the other inflammation-based prognostic scores. The combination of the NLR-PLR and CLIP scores exhibited a superior prognostic ability for OS compared to the NLR-PLR or CLIP scores alone. Conclusions The NLR-PLR score is a more powerful predictive system than the other inflammation based scores for patients with HCC who were treated with TACE and H101. The predictive ability may be improved by utilizing a combination of the NLR-PLR and CLIP scores.	[He, Chao-Bin; Lin, Xiao-Jun] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Hepatobiliary Oncol,Canc Ctr, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University	Lin, XJ (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Dept Hepatobiliary Oncol,Canc Ctr, Guangzhou, Guangdong, Peoples R China.	linxj@sysucc.org.cn		He, Chaobin/0000-0002-8149-1264				Abe T, 2016, HEPATOL RES, V46, P622, DOI 10.1111/hepr.12597; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; Bruix J, 2004, GASTROENTEROLOGY, V127, pS179, DOI 10.1053/j.gastro.2004.09.032; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cillo U, 2006, J HEPATOL, V44, P723, DOI 10.1016/j.jhep.2005.12.015; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; COWELL JK, 1992, ANN ONCOL, V3, P693, DOI 10.1093/oxfordjournals.annonc.a058319; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; Fu S, 2016, ONCOTARGET; Guan YS, 2011, WORLD J GASTROENTERO, V17, P2143, DOI 10.3748/wjg.v17.i16.2143; Hay JG, 1999, HUM GENE THER, V10, P579, DOI 10.1089/10430349950018652; Heise C, 1997, NAT MED, V3, P639, DOI 10.1038/nm0697-639; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Honda K, 1998, BRIT J CANCER, V77, P776, DOI 10.1038/bjc.1998.126; Hsu CY, 2016, ANN SURG ONCOL, V23, P994, DOI 10.1245/s10434-015-4929-x; Hsu CY, 2010, CANCER-AM CANCER SOC, V116, P3006, DOI 10.1002/cncr.25044; Huitzil-Melendez FD, 2010, J CLIN ONCOL, V28, P2889, DOI 10.1200/JCO.2009.25.9895; Ishigami S, 2000, CANCER, V88, P577, DOI 10.1002/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.3.CO;2-M; Jaiswal M, 2000, CANCER RES, V60, P184; Kasuya H, 2007, CURR CANCER DRUG TAR, V7, P123, DOI 10.2174/156800907780058826; Kasymjanova G, 2010, CURR ONCOL, V17, P52; Ke M., 2016, ONCOTARGET; Lee YH, 2014, J CLIN GASTROENTEROL, V48, P734, DOI 10.1097/MCG.0b013e3182a8a254; Lei J, 2015, INT J ONCOL, V47, P555, DOI 10.3892/ijo.2015.3045; Li C, 2015, J SURG RES, V198, P73, DOI 10.1016/j.jss.2015.05.003; Lin XJ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1715-x; Liu CH, 2001, J BIOL CHEM, V276, P18563, DOI 10.1074/jbc.M010787200; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Luo J, 2011, ANN SURG ONCOL, V18, P413, DOI 10.1245/s10434-010-1321-8; Manghisi G, 1998, HEPATOLOGY, V28, P751; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Reid T, 2002, CANCER RES, V62, P6070; Rothmann T, 1998, J VIROL, V72, P9470, DOI 10.1128/JVI.72.12.9470-9478.1998; Schoppmann SF, 2002, AM J PATHOL, V161, P947, DOI 10.1016/S0002-9440(10)64255-1; Shen A, 2015, J GASTROEN HEPATOL, V30, P1651, DOI 10.1111/jgh.13009; Song W, 2016, ONCOTARGET; Song X, 2010, INVEST OPHTH VIS SCI, V51, P2626, DOI 10.1167/iovs.09-3516; Tian G, 2009, ANTI-CANCER DRUG, V20, P389, DOI 10.1097/CAD.0b013e32832a2df9; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tu KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068574; Yang ZX, 2010, J CANCER RES CLIN, V136, P625, DOI 10.1007/s00432-009-0701-6; Yoshimitsu K, 2014, HEPATIC MED-EVID RES, V6, P89, DOI 10.2147/HMER.S31440; Zhang H, 2009, MOL THER, V17, P57, DOI 10.1038/mt.2008.236; Zhang N, 2016, ONCOTARGET; Zhou DS, 2015, WORLD J GASTROENTERO, V21, P5582, DOI 10.3748/wjg.v21.i18.5582; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	55	40	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174769	10.1371/journal.pone.0174769	http://dx.doi.org/10.1371/journal.pone.0174769			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355305	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174600087
J	Huang, YJ; Chang, CS; Peng, YC; Yeh, HZ; Yang, SS				Huang, Yi-Jie; Chang, Chi-Sen; Peng, Yen-Chun; Yeh, Hong-Zen; Yang, Sheng-Shun			On-treatment HBV DNA dynamics predict virological breakthrough in entecavir-treated HBeAg-positive chronic hepatitis B	PLOS ONE			English	Article							LAMIVUDINE THERAPY; CLINICAL-PRACTICE; VIRUS-DNA; RESISTANCE; MANAGEMENT; NAIVE; TENOFOVIR; ANALOGS; UPDATE	Background & aims Virological breakthrough (VBT) could be a manifestation of chronic hepatitis B (CHB) in patients treated with long-term nucleot(s)ide analogues. We aimed to determine the association of on-treatment serum hepatitis B virus (HBV) DNA with VBT in HBeAg-positive CHB patients receiving entecavir (ETV) treatment. Methods A retrospective cohort study, including 162 consecutive patients (95 men and 67 women; mean age, 43.1 +/- 13.4 years) with HBeAg-positive CHB treated with ETV for at least 48 weeks between August 2008 and May 2015, was conducted. Univariate and multivariate cox regression analysis were used to identify associations with VBT and clinical factors, including HBV DNA and HBeAg serum status. Results Among the 162 ETV-treated HBeAg-positive CHB patients, eighteen patients (11.1%) experienced VBT (VBT group), whereas the other 144 patients were without VBT (non-VBT group). The cumulative rate of HBV DNA < 100 IU/mL in the VBT group and the non-VBT group at week 48 were 44.44% and 70.14%, and at week 96 were 58.33% and 92.56%, respectively (p = 0.015). The cumulative rate of HBeAg seroclearance in the VBT group and non-VBT group at week 48 and week 96 were statistically significant (p = 0.014). Multivariate analysis disclosed that failure to achieve HBeAg seroclearance were the factors significantly associated with VBT. Conclusions Our results demonstrated that on-treatment HBV DNA could probably predict VBT in ETV-treated HBeAg-positive chronic hepatitis B patients. Failure to achieve HBeAg seroclearance was associated with VBT in ETV-treated HBeAg-positive CHB patients. HBV DNA > 100IU/mL at 48 weeks is potentially a predictor for VBT.	[Huang, Yi-Jie; Chang, Chi-Sen; Peng, Yen-Chun; Yeh, Hong-Zen; Yang, Sheng-Shun] Taichung Vet Gen Hosp, Div Gastroenterol, Dept Internal Med, Taichung, Taiwan; [Chang, Chi-Sen; Yang, Sheng-Shun] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Peng, Yen-Chun; Yeh, Hong-Zen] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan	Taichung Veterans General Hospital; Chung Shan Medical University; National Yang Ming Chiao Tung University	Peng, YC (corresponding author), Taichung Vet Gen Hosp, Div Gastroenterol, Dept Internal Med, Taichung, Taiwan.; Peng, YC (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.	pychunppp@gmail.com		Yang, Sheng-Shun/0000-0001-5800-1901; Peng, Yen-Chun/0000-0002-8993-3039				Bang KB, 2014, WORLD J GASTROENTERO, V20, P11641, DOI 10.3748/wjg.v20.i33.11641; Chen CH, 2014, J VIRAL HEPATITIS, V21, pE55, DOI 10.1111/jvh.12239; Chotiyaputta W, 2011, J HEPATOL, V54, P12, DOI 10.1016/j.jhep.2010.06.016; Degertekin B, 2009, J HEPATOL, V50, P42, DOI 10.1016/j.jhep.2008.08.020; European Association for the Study of the L, J HEPATOLOGY, V57, P167; Ghany MG, 2009, HEPATOLOGY, V49, pS174, DOI 10.1002/hep.22900; Hongthanakorn C, 2011, HEPATOLOGY, V53, P1854, DOI 10.1002/hep.24318; Jang JW, 2015, HEPATOLOGY, V61, P1809, DOI 10.1002/hep.27723; Keeffe EB, 2008, CLIN GASTROENTEROL H, V6, P268, DOI 10.1016/j.cgh.2007.12.043; Keeffe EB, 2007, CLIN GASTROENTEROL H, V5, P890, DOI 10.1016/j.cgh.2007.05.004; Kwon DH, 2013, GUT LIVER, V7, P712, DOI 10.5009/gnl.2013.7.6.712; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Liaw YF, 2009, GASTROENTEROLOGY, V136, P486, DOI 10.1053/j.gastro.2008.10.026; Liu J, 2010, GASTROENTEROLOGY, V139, P474, DOI 10.1053/j.gastro.2010.04.048; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Papatheodoridis GV, 2015, J HEPATOL, V62, P956, DOI 10.1016/j.jhep.2015.01.002; Petersen J, 2012, J HEPATOL, V56, P520, DOI 10.1016/j.jhep.2011.09.018; Pol S, 2012, J VIRAL HEPATITIS, V19, P377, DOI 10.1111/j.1365-2893.2012.01602.x; Su CW, 2013, J GASTROEN HEPATOL, V28, P1849, DOI 10.1111/jgh.12283; Tenney DJ, 2009, HEPATOLOGY, V49, P1503, DOI 10.1002/hep.22841; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Yuen MF, 2001, HEPATOLOGY, V34, P785, DOI 10.1053/jhep.2001.27563; Zeuzem S, 2009, J HEPATOL, V51, P11, DOI 10.1016/j.jhep.2008.12.019	23	3	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174046	10.1371/journal.pone.0174046	http://dx.doi.org/10.1371/journal.pone.0174046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350873	Green Submitted, gold, Green Published			2022-12-26	WOS:000399174400012
J	Le, B; Powers, GL; Tam, YT; Schumacher, N; Malinowski, RL; Steinke, L; Kwon, G; Marker, PC				Le, Bao; Powers, Ginny L.; Tam, Yu Tong; Schumacher, Nicholas; Malinowski, Rita L.; Steinke, Laura; Kwon, Glen; Marker, Paul C.			Multi-drug loaded micelles delivering chemotherapy and targeted therapies directed against HSP90 and the PI3K/AKT/mTOR pathway in prostate cancer	PLOS ONE			English	Article							ANDROGEN RECEPTOR; MOLECULAR ASPECTS; IN-VIVO; CELL; AKT; COMPLEX; PHOSPHORYLATION; PROGRESSION; INHIBITION; GENERATION	Background Advanced prostate cancers that are resistant to all current therapies create a need for new therapeutic strategies. One recent innovative approach to cancer therapy is the simultaneous use of multiple FDA-approved drugs to target multiple pathways. A challenge for this approach is caused by the different solubility requirements of each individual drug, resulting in the need for a drug vehicle that is non-toxic and capable of carrying multiple water-insoluble antitumor drugs. Micelles have recently been shown to be new candidate drug solubilizers for anti cancer therapy. Methods This study set out to examine the potential use of multi-drug loaded micelles for prostate cancer treatment in preclinical models including cell line and mouse models for prostate cancers with Pten deletions. Specifically antimitotic agent (d) under barocetaxel, mTOR inhibitor (r) under barapamycin, and HSP90 inhibitor (17) under bar-N-allylamino-17-demethoxygeldanamycin were incorporated into the micelle system (DR17) and tested for antitumor efficacy. Results In vitro growth inhibition of prostate cancer cells was greater when all three drugs were used in combination compared to each individual drug, and packaging the drugs into micelles enhanced the cytotoxic effects. At the molecular level DR17 targeted simultaneously several molecular signaling axes important in prostate cancer including androgen receptor, mTOR, and PI3K/AKT. In a mouse genetic model of prostate cancer, DR17 treatment decreased prostate weight, which was achieved by both increasing caspase-dependent cell death and decreasing cell proliferation. Similar effects were also observed when DR17 was administered to nude mice bearing prostate cancer cells xenografts. Conclusion These results suggest that combining these three cancer drugs in multi-drug loaded micelles may be a promising strategy for prostate cancer therapy.	[Le, Bao; Powers, Ginny L.; Tam, Yu Tong; Schumacher, Nicholas; Malinowski, Rita L.; Steinke, Laura; Kwon, Glen; Marker, Paul C.] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, 425 N Charter St, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Marker, PC (corresponding author), Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, 425 N Charter St, Madison, WI 53706 USA.	marker@wisc.edu		Tam, Yu Tong/0000-0002-2661-5412	National Institute of Health [R21CA195313]; National Cancer Institute [R01CA140217]; NCI [R21CA195313, R01CA140217]; NATIONAL CANCER INSTITUTE [R21CA195313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK104310] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by: National Institute of Health, https://www.nih.gov, National Cancer Institute, Grantnumber: R01CA140217; National Institute of Health, https://www.nih.gov, Grantnumber: R21CA195313.The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.; We thank veterinary pathologist Dr. Ruth Sullivan for her help in the assessment of histopathology of mouse tissues. This work is supported by NCI grants R01CA140217 and R21CA195313.	Amato R, 2013, CANCER CHEMOTH PHARM, V71, P1629, DOI 10.1007/s00280-013-2163-4; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bharadwaj S, 1999, MOL CELL BIOL, V19, P8033; Buresh-Stiemke RA, 2012, DEV DYNAM, V241, P2005, DOI 10.1002/dvdy.23886; Charles-River, NU NU MOUS HEM; Chen XG, 2010, MOL CARCINOGEN, V49, P603, DOI 10.1002/mc.20628; DeMarzo AM, 2003, LANCET, V361, P955, DOI 10.1016/S0140-6736(03)12779-1; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Fang YF, 1996, J BIOL CHEM, V271, P28697, DOI 10.1074/jbc.271.45.28697; Gerber DE, 2008, AM FAM PHYSICIAN, V77, P311; Hasenstein JR, 2012, MOL CANCER THER, V11, P2233, DOI 10.1158/1535-7163.MCT-11-0987; Jiao J, 2007, CANCER RES, V67, P6083, DOI 10.1158/0008-5472.CAN-06-4202; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Kosaka T, 2011, J UROLOGY, V185, P2376, DOI 10.1016/j.juro.2011.02.016; Kwon GS, 2008, PHARM RES-DORD, V25, P2053, DOI 10.1007/s11095-008-9644-x; Maddika S, 2008, J CELL SCI, V121, P979, DOI 10.1242/jcs.009530; Maroto P, 2015, CRIT REV ONCOL HEMAT; MCKINNEY TD, 1976, J REPROD FERTIL, V47, P115, DOI 10.1530/jrf.0.0470115; Morgan TM, 2009, CURR CANCER DRUG TAR, V9, P237, DOI 10.2174/156800909787580999; Murphy ME, 2013, CARCINOGENESIS, V34, P1181, DOI 10.1093/carcin/bgt111; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; OKADA H, 1992, VIRCHOWS ARCH A, V421, P157, DOI 10.1007/BF01607049; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Shin HC, 2011, MOL PHARMACEUT, V8, P1257, DOI 10.1021/mp2000549; Solit DB, 2007, CLIN CANCER RES, V13, P1775, DOI 10.1158/1078-0432.CCR-06-1863; ten Tije AJ, 2003, CLIN PHARMACOKINET, V42, P665, DOI 10.2165/00003088-200342070-00005; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang Y, 2007, CURR CANCER DRUG TAR, V7, P591, DOI 10.2174/156800907781662248; Wang ZA, 2014, CELL REP, V8, P1339, DOI 10.1016/j.celrep.2014.08.002; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	33	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174658	10.1371/journal.pone.0174658	http://dx.doi.org/10.1371/journal.pone.0174658			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350865	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174400070
J	Saito, Y; Sugimoto, C; Mituyama, T; Wakao, H				Saito, Yutaka; Sugimoto, Chie; Mituyama, Toutai; Wakao, Hiroshi			Epigenetic silencing of V(D)J recombination is a major determinant for selective differentiation of mucosal-associated invariant t cells from induced pluripotent stem cells	PLOS ONE			English	Article							EXPRESSION; INDUCTION	Mucosal-associated invariant T cells (MAITs) are innate-like T cells that play a pivotal role in the host defense against infectious diseases, and are also implicated in autoimmune diseases, metabolic diseases, and cancer. Recent studies have shown that induced pluripotent stem cells (iPSCs) derived from MAITs selectively redifferentiate into MAITs without altering their antigen specificity. Such a selective differentiation is a prerequisite for the use of MAITs in cell therapy and/or regenerative medicine. However, the molecular mechanisms underlying this phenomenon remain unclear. Here, we performed methylome and transcriptome analyses of MAITs during the course of differentiation from iPSCs. Our multi-omics analyses revealed that recombination-activating genes (RAG1 and RAG2) and DNA nucleotidylexotransferase (DNTT) were highly methylated with their expression being repressed throughout differentiation. Since these genes are essential for V(D) J recombination of the T cell receptor (TCR) locus, this indicates that nascent MAITs are kept from further rearrangement that may alter their antigen specificity. Importantly, we found that the repression of RAGs was assured in two layers: one by the modulation of transcription factors for RAGs, and the other by DNA methylation at the RAG loci. Together, our study provides a possible explanation for the unaltered antigen specificity in the selective differentiation of MAITs from iPSCs.	[Saito, Yutaka; Mituyama, Toutai] Natl Inst Adv Ind Sci & Technol, Artificial Intelligence Res Ctr, Koto Ku, Tokyo, Japan; [Saito, Yutaka] Natl Inst Adv Ind Sci & Technol, Computat Bio Big Data Open Innovat Lab CBBD OIL, Shinjuku Ku, Tokyo, Japan; [Saito, Yutaka; Mituyama, Toutai] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan; [Sugimoto, Chie; Wakao, Hiroshi] Hokkaido Univ, Grad Sch Med, Dept Hyg & Cellular Prevent Med, Sapporo, Hokkaido, Japan; [Wakao, Hiroshi] Dokkyo Med Univ, Int Epidemiol, Mibu, Tochigi, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); Hokkaido University; Dokkyo Medical University	Wakao, H (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Hyg & Cellular Prevent Med, Sapporo, Hokkaido, Japan.; Wakao, H (corresponding author), Dokkyo Med Univ, Int Epidemiol, Mibu, Tochigi, Japan.	hwakao@dokkyomed.ac.jp	Saito, Yutaka/A-9895-2017; Mituyama, Toutai/A-5610-2017	Saito, Yutaka/0000-0002-4853-0153; Mituyama, Toutai/0000-0002-1110-6375	Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS) [15K16089]; JSPS [26430084]; Asubio Pharma Co., LTD; Grants-in-Aid for Scientific Research [15K16089] Funding Source: KAKEN	Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Asubio Pharma Co., LTD; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST; http://www.jst.go.jp/EN/index.html) to TM and YS; a Grant-in-Aid for Young Scientists (B) (15K16089) from the Japan Society for the Promotion of Science (JSPS; http://www. jsps.go.jp/english/index.html) to YS; and a Grant-in-Aid for Scientific Research (C) (26430084) from JSPS to CS and HW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HW receives are search fund from Asubio Pharma Co., LTD for the data collection of DNA methylation in reMAITs. However, the funder had no role in data analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Franciszkiewicz K, 2016, IMMUNOL REV, V272, P120, DOI 10.1111/imr.12423; Gremme G, 2013, IEEE ACM T COMPUT BI, V10, P645, DOI 10.1109/TCBB.2013.68; Hauser J, 2014, J IMMUNOL, V192, P2460, DOI 10.4049/jimmunol.1302216; Hauser J, 2010, MOL IMMUNOL, V47, P1031, DOI 10.1016/j.molimm.2009.11.015; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johnson K, 2010, ESSAYS BIOCHEM, V48, P221, DOI [10.1042/BSE0480221, 10.1042/bse0480221]; Kuo TC, 2009, CURR OPIN IMMUNOL, V21, P173, DOI 10.1016/j.coi.2009.03.008; Kurioka A, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.51; La Motte-Mohs RN, 2005, BLOOD, V105, P1431, DOI 10.1182/blood-2004-04-1293; Lopez-Romero P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-64; Nishimura T, 2013, CELL STEM CELL, V12, P114, DOI 10.1016/j.stem.2012.11.002; Patra AK, 2006, J IMMUNOL, V177, P4567, DOI 10.4049/jimmunol.177.7.4567; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schatz DG, 2011, NAT REV IMMUNOL, V11, P251, DOI 10.1038/nri2941; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Sugimoto C, 2016, WORLD J STEM CELLS, V8, P158, DOI 10.4252/wjsc.v8.i4.158; Vizcardo R, 2013, CELL STEM CELL, V12, P31, DOI 10.1016/j.stem.2012.12.006; Wakao H, 2013, CELL STEM CELL, V12, P546, DOI 10.1016/j.stem.2013.03.001; Wang D, 2012, BIOINFORMATICS, V28, P729, DOI 10.1093/bioinformatics/bts013	24	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174699	10.1371/journal.pone.0174699	http://dx.doi.org/10.1371/journal.pone.0174699			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346544	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174300071
J	Arora, K; Sequeira, JM; Quadros, EV				Arora, Kaveri; Sequeira, Jeffrey M.; Quadros, Edward V.			Maternofetal transport of vitamin B-12: role of TCblR/CD320 and megalin	FASEB JOURNAL			English	Article						cobalamin; placenta; fetal development; yolk sac; brain	CENTRAL-NERVOUS-SYSTEM; TRANSCOBALAMIN-BOUND COBALAMIN; VISCERAL YOLK-SAC; MOUSE SPINAL-CORD; CELLULAR UPTAKE; CEREBROSPINAL-FLUID; DEFICIENCY; RECEPTOR; BINDING; GENE	Vitamin B-12 deficiency causes megaloblastic anemia and neurologic disorder in humans. Gene defects of transcobalamin (TC) and the transcobalamin receptor (TCb1R), needed for cellular uptake of the TC-bound B-12, do not confer embryonic lethality. TC deficiency can produce the hematologic and neurologic complications after birth, whereas TCb1R/CD320 gene defects appear to produce mild metabolic changes. Alternate maternofetal transport mechanisms appear to provide adequate B-12 to the fetus. To understand this mechanism, we evaluated the role of TC, TCb1R/CD320, and megalin in maternofetal transport of B-12 in a TCb1R/CD320-knockout (KO) mouse. Our results showed high expression of TCb1R/CD320 in the labyrinth of the placenta, embryonic brain, and spinal column in wild-type (WT) mice. Megalin expression was about the same in both WT and KO mouse visceral yolk sac, brain, and spinal column. Megalin mRNA was down-regulated in the KO embryonic spinal cord (SC) and kidneys. Megalin expression remained unaltered in adult WT and KO mouse brain, SC, and kidneys. Injected dsRed-TC-B-12 and TC-57CoBi2 accumulated in the visceral yolk sac of KO mice where megalin is expressed and provides an alternate mechanism for the maternofetal transport of Cbl during fetal development. Arora, K., Sequeira, J. M., Quadros, E. V. Maternofetal transport of vitamin B-12: role of TCb1R/CD320 and megalin.	[Arora, Kaveri] Suny Downstate Med Ctr, Sch Grad Studies, Dept Cell Biol, Brooklyn, NY 11203 USA; [Sequeira, Jeffrey M.; Quadros, Edward V.] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Quadros, EV (corresponding author), Suny Downstate Med Ctr, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	edward.quadros@downstate.edu		Pohlman, Kaveri/0000-0002-1154-1406	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK064732]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK064732, R01DK064732] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Scott Argraves (Medical University of South Carolina, Charleston, SC, USA) for the generous gift of antibody to megalin. This work was supported, in part, by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant DK064732 (to E.V.Q.). The recombinant mouse TCb1R was a gift from Dr. Jeffrey Browning (Biogen-Idec, Cambridge MA, USA). The authors declare no conflicts of interest.	Abuyaman O, 2015, SCAND J CLIN LAB INV, V75, P514, DOI 10.3109/00365513.2015.1057761; Birn H, 2002, AM J PHYSIOL-RENAL, V282, pF408, DOI 10.1152/ajprenal.00206.2000; CHANARIN I, 1985, BLOOD, V66, P479; Christensen EI, 2002, PEDIATR NEPHROL, V17, P993, DOI 10.1007/s00467-002-0956-5; Dali-Youcef N, 2009, QJM-INT J MED, V102, P17, DOI 10.1093/qjmed/hcn138; Drake CJ, 2004, ANAT REC PART A, V277A, P163, DOI 10.1002/ar.a.10123; FERNANDESCOSTA F, 1979, BRIT J HAEMATOL, V43, P625, DOI 10.1111/j.1365-2141.1979.tb03795.x; GRABER SE, 1971, J CLIN INVEST, V50, P1000, DOI 10.1172/JCI106569; HANSEN M, 1985, SCAND J HAEMATOL, V34, P209; HARTE RA, 1953, J NUTR, V49, P669, DOI 10.1093/jn/49.4.669; Jiang WX, 2011, DRUG DELIV, V18, P74, DOI 10.3109/10717544.2010.509745; JOLLIE WP, 1990, TERATOLOGY, V41, P361, DOI 10.1002/tera.1420410403; Komhoff M, 2013, PEDIATRICS, V132, pE540, DOI 10.1542/peds.2012-2581; Lachner C, 2012, J NEUROPSYCH CLIN N, V24, P5, DOI 10.1176/appi.neuropsych.11020052; Lai SC, 2013, FASEB J, V27, P2468, DOI 10.1096/fj.12-219055; Lai SC, 2011, EXP CELL RES, V317, P1603, DOI 10.1016/j.yexcr.2011.02.016; LAZAR GS, 1981, J LAB CLIN MED, V97, P123; LERMAN S, 1986, TERATOLOGY, V34, P335, DOI 10.1002/tera.1420340313; Lipton SA, 1997, P NATL ACAD SCI USA, V94, P5923, DOI 10.1073/pnas.94.11.5923; Lloyd JB, 1998, REPROD TOXICOL, V12, P193, DOI 10.1016/S0890-6238(97)00148-2; McCaddon A, 2013, BIOCHIMIE, V95, P1066, DOI 10.1016/j.biochi.2012.11.017; McCarthy RA, 2003, J CELL SCI, V116, P955, DOI 10.1242/jcs.00313; Moestrup SK, 1996, P NATL ACAD SCI USA, V93, P8612, DOI 10.1073/pnas.93.16.8612; Mossman HW, 1987, VERTEBRATE FETAL MEM; Obeid R, 2006, CLIN CHEM, V52, P263, DOI 10.1373/clinchem.2005.057810; Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231; Prasad C, 2008, J INHERIT METAB DIS, V31, pS287, DOI 10.1007/s10545-008-0864-3; Quadros EV, 2010, HUM MUTAT, V31, P924, DOI 10.1002/humu.21297; Quadros EV, 2010, BRIT J HAEMATOL, V148, P195, DOI 10.1111/j.1365-2141.2009.07937.x; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; QUADROS EV, 1986, J BIOL CHEM, V261, P5455; Rasmussen SA, 2001, J PEDIATR-US, V138, P10, DOI 10.1067/mpd.2001.112160; Ratschmann R, 2009, MOL GENET METAB, V98, P285, DOI 10.1016/j.ymgme.2009.06.003; ROSENBLATT DS, 1985, LANCET, V1, P1127; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Scalabrino G, 2009, PROG NEUROBIOL, V88, P203, DOI 10.1016/j.pneurobio.2009.04.004; SCOTT JSD, 1984, CLIN SCI, V67, P299, DOI 10.1042/cs0670299; SHEVELL MI, 1992, CAN J NEUROL SCI, V19, P472, DOI 10.1017/S0317167100041676; Shipton MJ, 2015, CLIN MED, V15, P145, DOI 10.7861/clinmedicine.15-2-145; STABLER SP, 1990, BLOOD, V76, P871; Takeyama A, 2011, BIOCHEM BIOPH RES CO, V407, P108, DOI 10.1016/j.bbrc.2011.02.118; Unal S, 2014, INT J HEMATOL, V99, P659, DOI 10.1007/s12185-014-1545-7; Unal S, 2015, TURK J HEMATOL, V32, P317, DOI 10.4274/tjh.2014.0154; WADDELL WJ, 1981, PHARMACOL THERAPEUT, V14, P375, DOI 10.1016/0163-7258(81)90034-6; Wicher G, 2005, J COMP NEUROL, V492, P123, DOI 10.1002/cne.20673; Wicher G, 2008, NEUROREPORT, V19, P559, DOI 10.1097/WNR.0b013e3282f94267; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; ZHENG G, 1994, J HISTOCHEM CYTOCHEM, V42, P531, DOI 10.1177/42.4.7510321	48	19	20	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3098	3106		10.1096/fj.201700025R	http://dx.doi.org/10.1096/fj.201700025R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28351841	Green Published			2022-12-26	WOS:000405931000033
J	King, EC; Patel, V; Anand, M; Zhao, XL; Crump, SM; Hu, ZY; Weisleder, N; Abbott, GW				King, Elizabeth C.; Patel, Vishal; Anand, Marie; Zhao, Xiaoli; Crump, Shawn M.; Hu, Zhaoyang; Weisleder, Noah; Abbott, Geoffrey W.			Targeted deletion of Kcne3 impairs skeletal muscle function in mice	FASEB JOURNAL			English	Article						K(v)3.4; MiRP2; myotonia; periodic paralysis; potassium channel	HYPERKALEMIC PERIODIC PARALYSIS; POTASSIUM CHANNELS; ATRIAL-FIBRILLATION; FIBER-TYPE; MUTATION; MOUSE; EXPRESSION; KV3.4; GENE; DYSFUNCTION	KCNE3 (MiRP2) forms heteromeric voltage-gated K+ channels with the skeletal muscle-expressed KCNC4 (Kv3.4) alpha subunit. KCNE3 was the first reported skeletal muscle K+ channel disease gene, but the requirement for KCNE3 in skeletal muscle has been questioned. Here, we confirmed KCNE3 transcript and protein expression in mouse skeletal muscle using Kcne3(-/-) tissue as a negative control. Whole-transcript microarray analysis (770,317 probes, interrogating 28,853 transcripts) findings were consistent with Kcne3 deletion increasing gastrocnemius oxidative metabolic gene expression and the proportion of type Ila fast-twitch oxidative muscle fibers, which was verified using immunofluorescence. The down-regulated transcript set overlapped with muscle unloading gene expression profiles (>= 1.5-fold change; P < 0.05). Gastrocnemius K+ channel a subunit remodeling arising from Kcne3 deletion was highly specific, involving just 3 of 69 alpha subunit genes probed: known KCNE3 partners KCNC4 and KCNH2 (mERG) were down-regulated, and KCNK4 (TRAAK) was up-regulated (P < 0.05). Functionally, Kcne3(-/-) mice exhibited abnormal hind-limb clasping upon tail suspension (63% of Kcne3-1- mice 10-mo-old vs. 0% age-matched Kcne3(+/+) littermates). Whereas 5 of 5 Kcne3(+/+) mice exhibited the typical biphasic decline in contractile force with repetitive stimuli of hind-limb muscle, both in vivo and in vitro, this was absent in 6 of 6 Kcne3(-/-) mice tested. Finally, myoblasts isolated from Kcne3(-/-) mice exhibit faster-inactivating and smaller sustained outward currents than those from Kcne3(+/+) mice. Thus, Kcne3 deletion impairs skeletal muscle function in mice.	[King, Elizabeth C.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Patel, Vishal; Zhao, Xiaoli; Weisleder, Noah] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Anand, Marie; Crump, Shawn M.; Hu, Zhaoyang; Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Pharmacol, 360 Med Surge 2, Irvine, CA 92697 USA; [Anand, Marie; Crump, Shawn M.; Hu, Zhaoyang; Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, 360 Med Surge 2, Irvine, CA 92697 USA; [Zhao, Xiaoli] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23501 USA; [Weisleder, Noah] Ohio State Univ, Davis Heart & Lung Res Inst, Dept Physiol & Cell Biol, 473 W 12th Ave, Columbus, OH 43210 USA	Cornell University; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of California System; University of California Irvine; University of California System; University of California Irvine; Eastern Virginia Medical School; University System of Ohio; Ohio State University	Abbott, GW (corresponding author), Univ Calif Irvine, Sch Med, Dept Pharmacol, 360 Med Surge 2, Irvine, CA 92697 USA.; Abbott, GW (corresponding author), Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, 360 Med Surge 2, Irvine, CA 92697 USA.; Weisleder, N (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Dept Physiol & Cell Biol, 473 W 12th Ave, Columbus, OH 43210 USA.	noah.weisleder@osumc.edu; abbottg@uci.edu		Weisleder, Noah/0000-0003-2710-3088	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) [R01 HL079275]; University of California, Irvine setup funds; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR063084]; NIH NHLBI [R01 HL116826]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079275, R01HL116826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI133465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063084] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of California, Irvine setup funds; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) (Grant R01 HL079275 to G.W.A.), and University of California, Irvine setup funds (to G.W.A.). N.W. was supported by the NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grant R01 AR063084). X.Z. is grateful for support from NIH NHLBI Grant R01 HL116826. The authors thank R. Kant and C. Cao (University of California, Irvine) for technical support.	Abbott GW, 2006, FASEB J, V20, P293, DOI 10.1096/fj.05-5070com; Abbott GW, 2016, FASEB J, V30, P2959, DOI 10.1096/fj.201600467R; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abbott GW, 2001, CELL, V104, P217, DOI 10.1016/S0092-8674(01)00207-0; Afzali AM, 2016, AM J PHYSIOL-CELL PH, V311, pC583, DOI 10.1152/ajpcell.00363.2015; Banzet S, 2007, BIOCHEM BIOPH RES CO, V353, P713, DOI 10.1016/j.bbrc.2006.12.074; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Delpon E, 2008, CIRC-ARRHYTHMIA ELEC, V1, P209, DOI 10.1161/CIRCEP.107.748103; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; GEORGE AL, 1995, KIDNEY INT, V48, P1180, DOI 10.1038/ki.1995.401; Hayasaki Hana, 2001, Cellular and Molecular Biology Online Papers, V47, pOL135; Hayward LJ, 2008, J CLIN INVEST, V118, P1437, DOI 10.1172/JCI32638; Joliffe I. T., 1986, PRINCIPAL COMPONENT; Jurkat-Rott K, 2004, NEUROLOGY, V62, P1012, DOI 10.1212/01.WNL.0000119392.29624.88; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; Lee CS, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-014-0027-1; Lewis A, 2004, J BIOL CHEM, V279, P7884, DOI 10.1074/jbc.M310501200; Lisewski U, 2016, FASEB J, V30, P2476, DOI 10.1096/fj.201600317R; Lundby A, 2008, CELL PHYSIOL BIOCHEM, V21, P47, DOI 10.1159/000113746; Mille M, 2009, PFLUG ARCH EUR J PHY, V457, P1023, DOI 10.1007/s00424-008-0570-x; MULLER KE, 1984, COMPUT STAT DATA AN, V2, P143, DOI 10.1016/0167-9473(84)90002-1; Nakajima T, 2012, CIRC J, V76, P2763, DOI 10.1253/circj.CJ-12-0551; Ohno S, 2009, HUM MUTAT, V30, P557, DOI 10.1002/humu.20834; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Preston P, 2010, J BIOL CHEM, V285, P7165, DOI 10.1074/jbc.M109.047829; PTACEK LJ, 1991, AM J HUM GENET, V49, P851; Ritter DM, 2015, CHANNELS, V9, P209, DOI 10.1080/19336950.2015.1056949; Roepke TK, 2011, FASEB J, V25, P727, DOI 10.1096/fj.10-173682; Ryan DP, 2010, CELL, V140, P88, DOI 10.1016/j.cell.2009.12.024; Sanchez JA, 2000, PFLUG ARCH EUR J PHY, V440, P34, DOI 10.1007/s004240051019; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Sternberg D, 2003, NEUROLOGY, V61, P857, DOI 10.1212/01.WNL.0000082392.66713.E3; Tamhane AC, 2006, STAT DATA ANAL ELEME; Vullhorst D, 1998, FEBS LETT, V421, P259, DOI 10.1016/S0014-5793(97)01577-9; Wang X, 2006, FASEB J, V20, P1531, DOI 10.1096/fj.05-5350fje; Weber H, 2012, J APPL PHYSIOL, V112, P2087, DOI 10.1152/japplphysiol.00871.2011; Weisleder N, 2007, CELL CALCIUM, V42, P548, DOI 10.1016/j.ceca.2007.01.009; Weisleder N, 2006, J CELL BIOL, V174, P639, DOI 10.1083/jcb.200604166; Zhang DF, 2005, CHINESE MED J-PEKING, V118, P1735; Zhao XL, 2010, BIOPHYS J, V99, P1556, DOI 10.1016/j.bpj.2010.06.050	43	1	1	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2937	2947		10.1096/fj.201600965RR	http://dx.doi.org/10.1096/fj.201600965RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28356343	Green Submitted, Green Published			2022-12-26	WOS:000405931000019
J	Gillard, BK; Bassett, GR; Gotto, AM; Rosales, C; Pownall, HJ				Gillard, Baiba K.; Bassett, G. Randall; Gotto, Antonio M., Jr.; Rosales, Corina; Pownall, Henry J.			Scavenger receptor B1 (SR-B1) profoundly excludes high density lipoprotein (HDL) apolipoprotein AII as it nibbles HDL-cholesteryl ester	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apolipoprotein; atherosclerosis; cholesterol; high-density lipoprotein (HDL); lipid; scavenger receptor; apolipoprotein AII; reverse cholesterol transport; scavenger receptor B1; selective lipid uptake	SERUM OPACITY FACTOR; PHOSPHOLIPID TRANSFER PROTEIN; SELECTIVE LIPID UPTAKE; SR-BI; A-I; DEFICIENT MICE; MECHANISM; CELLS; ATHEROSCLEROSIS; EXPRESSION	Reverse cholesterol transport (transfer of macrophage-cholesterol in the subendothelial space of the arterial wall to the liver) is terminated by selective high density lipoprotein (HDL)-cholesteryl ester (CE) uptake, mediated by scavenger receptor class B, type 1 (SR-B1). We tested the validity of two models for this process: "gobbling," i.e. one-step transfer of all HDL-CE to the cell and "nibbling," multiple successive cycles of SR-B1-HDL association during which a few CEs transfer to the cell. Concurrently, we compared cellular uptake of apoAI with that of apoAII, which is more lipophilic than apoAI, using HDL-[H-3]CE labeled with [I-125]apoAI or [I-125]apoAII. The studies were conducted in CHO-K1 and CHO-ldlA7 cells (LDLR-/-) with (CHO-SR-B1) and without SR-B1 overexpression and in human Huh7 hepatocytes. Relative to CE, both apoAI and apoAII were excluded from uptake by all cells. However, apoAII was more highly excluded from uptake (2-4x) than apoAI. To distinguish gobbling versus nibbling mechanisms, media from incubations of HDL with CHO-SR-B1 cells were analyzed by non-denaturing PAGE, size-exclusion chromatography, and the distribution of apoAI, apoAII, cholesterol, and phospholipid among HDL species as a function of incubation time. HDL size gradually decreased, i.e. nibbling, with the concurrent release of lipid-free apoAI; apoAII was retained in an HDL remnant. Our data support an SR-B1 nibbling mechanism that is similar to that of streptococcal serum opacity factor, which also selectively removes CE and releases apoAI, leaving an apoAII-rich remnant.	[Gillard, Baiba K.; Gotto, Antonio M., Jr.; Rosales, Corina; Pownall, Henry J.] Houston Methodist Res Inst, 6670 Bertner Ave,Rm. R11-218, Houston, TX 77030 USA; [Gillard, Baiba K.; Gotto, Antonio M., Jr.; Rosales, Corina; Pownall, Henry J.] Weill Cornell Med, New York, NY 10065 USA; [Bassett, G. Randall] Baylor Coll Med, Houston, TX 77030 USA; [Bassett, G. Randall] Medtron Aort Therapies, 3576 Unocal Pl, Santa Rosa, CA 95403 USA	The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University; Baylor College of Medicine	Gillard, BK (corresponding author), Houston Methodist Res Inst, 6670 Bertner Ave,Rm. R11-218, Houston, TX 77030 USA.; Gillard, BK (corresponding author), Weill Cornell Med, New York, NY 10065 USA.	bgillard@houstonmethodist.org; g.randy.bassett@medtronic.com		Pownall, Henry/0000-0001-8412-506X; Gillard, Baiba/0000-0002-2527-5102	National Institutes of Health [HL-56865, HL-129767]; Bass Foundation; Houston Methodist Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056865, R01HL129767] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bass Foundation; Houston Methodist Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL-56865 (to H. J. P.) and HL-129767 (to H. J. P. and C. R.). This work was also supported by the Bass Foundation (to A. M. G.) and Houston Methodist Foundation funding from Charif Souki, Patrick Studdert, and the Jerold B. Katz family. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Arai T, 1999, J BIOL CHEM, V274, P2366, DOI 10.1074/jbc.274.4.2366; BISGAIER CL, 1991, J LIPID RES, V32, P21; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; BREWER HB, 1986, METHOD ENZYMOL, V128, P223; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; CHEUNG MC, 1977, J CLIN INVEST, V60, P43, DOI 10.1172/JCI108767; Connelly MA, 2003, TRENDS ENDOCRIN MET, V14, P467, DOI 10.1016/j.tem.2003.10.002; Connelly MA, 1999, J BIOL CHEM, V274, P41, DOI 10.1074/jbc.274.1.41; de Beer MC, 2005, J LIPID RES, V46, P2143, DOI 10.1194/jlr.M500068-JLR200; EDELSTEIN C, 1982, J BIOL CHEM, V257, P7189; Eyvazian VA, 2017, CARDIOL REV, V25, P43, DOI 10.1097/CRD.0000000000000137; Gillard BK, 2007, BIOCHEMISTRY-US, V46, P12968, DOI 10.1021/bi701525w; Gillard BK, 2013, ARTERIOSCL THROM VAS, V33, P1714, DOI 10.1161/ATVBAHA.113.301538; Gillard BK, 2010, BIOCHEMISTRY-US, V49, P9866, DOI 10.1021/bi101412m; Gillard BK, 2009, BBA-MOL CELL BIOL L, V1791, P1125, DOI 10.1016/j.bbalip.2009.07.004; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; HAMILTON JA, 1982, J BIOL CHEM, V257, P7318; Han M, 2009, BIOCHEMISTRY-US, V48, P1481, DOI 10.1021/bi802287q; Handa D, 2015, BIOCHEMISTRY-US, V54, P1123, DOI 10.1021/bi501345j; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Havel RJ, 1980, METABOLIC CONTROL DI, P393; Huszar D, 2000, ARTERIOSCL THROM VAS, V20, P1068, DOI 10.1161/01.ATV.20.4.1068; KOIZUMI J, 1985, ATHEROSCLEROSIS, V58, P175, DOI 10.1016/0021-9150(85)90064-4; Kozarsky KF, 2000, ARTERIOSCL THROM VAS, V20, P721, DOI 10.1161/01.ATV.20.3.721; KUNITAKE ST, 1982, J LIPID RES, V23, P936; Levinson SS, 2015, CLIN CHIM ACTA, V439, P154, DOI 10.1016/j.cca.2014.10.018; LI WH, 1988, J LIPID RES, V29, P245; Liang HQ, 1996, J LIPID RES, V37, P1962; Mehta R, 2003, J MOL BIOL, V328, P183, DOI 10.1016/S0022-2836(03)00155-4; Nieland TJF, 2002, P NATL ACAD SCI USA, V99, P15422, DOI 10.1073/pnas.222421399; Pagler TA, 2006, J BIOL CHEM, V281, P11193, DOI 10.1074/jbc.M510261200; Pownall HJ, 2007, BIOCHEMISTRY-US, V46, P7449, DOI 10.1021/bi700496w; Pownall HJ, 2016, TRENDS ENDOCRIN MET, V27, P44, DOI 10.1016/j.tem.2015.11.004; POWNALL HJ, 1981, BIOCHEMISTRY-US, V20, P6630, DOI 10.1021/bi00526a017; Rader DJ, 2012, NAT MED, V18, P1344, DOI 10.1038/nm.2937; Rao R, 1997, BIOCHEMISTRY-US, V36, P3645, DOI 10.1021/bi962776b; Rodriguez PJ, 2016, BIOCHEMISTRY-US, V55, P5845, DOI 10.1021/acs.biochem.6b00946; Rodrigueza WV, 1999, J BIOL CHEM, V274, P20344, DOI 10.1074/jbc.274.29.20344; Rosales C, 2011, ARTERIOSCL THROM VAS, V31, P1834, DOI 10.1161/ATVBAHA.111.224360; Schwartz CC, 2004, J LIPID RES, V45, P1594, DOI 10.1194/jlr.M300511-JLR200; Settasatian N, 2001, J BIOL CHEM, V276, P26898, DOI 10.1074/jbc.M010708200; SILVER ET, 1990, J BIOL CHEM, V265, P22487; Thuahnai ST, 2001, J BIOL CHEM, V276, P43801, DOI 10.1074/jbc.M106695200; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Ueda Y, 2000, J BIOL CHEM, V275, P20368, DOI 10.1074/jbc.M000730200; Van Eck M, 2003, J BIOL CHEM, V278, P23699, DOI 10.1074/jbc.M211233200; Webb NR, 2004, J LIPID RES, V45, P1666, DOI 10.1194/jlr.M400026-JLR200; Webb NR, 2002, J LIPID RES, V43, P1890, DOI 10.1194/jlr.M200173-JLR200; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; Zanoni P, 2016, SCIENCE, V351, P1166, DOI 10.1126/science.aad3517; Zhang L, 2012, NAT CHEM BIOL, V8, P342, DOI [10.1038/NCHEMBIO.796, 10.1038/nchembio.796]	52	20	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8864	8873		10.1074/jbc.M117.781963	http://dx.doi.org/10.1074/jbc.M117.781963			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28373285	Green Published, hybrid			2022-12-26	WOS:000402153900040
J	Hirata, Y; Takahashi, M; Kudoh, Y; Kano, K; Kawana, H; Makide, K; Shinoda, Y; Yabuki, Y; Fukunaga, K; Aoki, J; Noguchi, T; Matsuzawa, A				Hirata, Yusuke; Takahashi, Miki; Kudoh, Yuki; Kano, Kuniyuki; Kawana, Hiroki; Makide, Kumiko; Shinoda, Yasuharu; Yabuki, Yasushi; Fukunaga, Kohji; Aoki, Junken; Noguchi, Takuya; Matsuzawa, Atsushi			trans-Fatty acids promote proinflammatory signaling and cell death by stimulating the apoptosis signal-regulating kinase 1 (ASK1)-p38 pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; DIETARY FATS; ATHEROSCLEROSIS; INFLAMMATION; ACTIVATION; RECEPTOR; DISEASE; BRAIN; AUTOPHOSPHORYLATION; PHOSPHORYLATION	Food-borne trans-fatty acids (TFAs) are mainly produced as byproducts during food manufacture. Recent epidemiological studies have revealed that TFA consumption is a major risk factor for various disorders, including atherosclerosis. However, the underlying mechanisms in this disease etiology are largely unknown. Here we have shown that TFAs potentiate activation of apoptosis signal-regulating kinase 1 (ASK1) induced by extracellular ATP, a damage-associated molecular pattern leaked from injured cells. Major food-associated TFAs such as elaidic acid (EA), linoelaidic acid, and trans-vaccenic acid, but not their corresponding cis isomers, dramatically enhanced extracellular ATP-induced apoptosis, accompanied by elevated activation of the ASK1-p38 pathway in a macrophage-like cell line, RAW264.7. Moreover, knocking out the ASK1-encoding gene abolished EA-mediated enhancement of apoptosis. We have reported previously that extracellular ATP induces apoptosis through the ASK1-p38 pathway activated by reactive oxygen species generated downstream of the P2X purinoceptor 7 (P2X(7)). However, here we show that EA did not increase ATP-induced reactive oxygen species generation but, rather, augmented the effects of calcium/calmodulin-dependentkinase II-dependent ASK1 activation. These results demonstrate that TFAs promote extracellular ATP-induced apoptosis by targeting ASK1 and indicate novel TFA-associated pathways leading to inflammatory signal transduction and cell death that underlie the pathogenesis and progression of TFA-induced atherosclerosis. Our study thus provides insight into the pathogenic mechanisms of and proposes potential therapeutic targets for these TFA-related disorders.	[Hirata, Yusuke; Takahashi, Miki; Kudoh, Yuki; Noguchi, Takuya; Matsuzawa, Atsushi] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Hlth Chem, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan; [Kano, Kuniyuki; Kawana, Hiroki; Makide, Kumiko; Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Biochem, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan; [Shinoda, Yasuharu; Yabuki, Yasushi; Fukunaga, Kohji] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan; [Kano, Kuniyuki; Aoki, Junken] Japan Agcy Med Res & Dev, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1000004, Japan	Tohoku University; Tohoku University; Tohoku University	Noguchi, T; Matsuzawa, A (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Hlth Chem, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	noguchi@m.tohoku.ac.jp; matsushi@m.tohoku.ac.jp	Fukunaga, Kohji/AAI-8811-2021; Yabuki, Yasushi/AAF-7931-2021; Shinoda, Yasuharu/AAE-6135-2019; Matsuzawa, Atsushi/GLU-1387-2022; Hirata, Yusuke/T-9580-2019; Noguchi, Takuya/T-6767-2019	Shinoda, Yasuharu/0000-0001-9910-048X; Hirata, Yusuke/0000-0002-1428-2075; Noguchi, Takuya/0000-0001-6187-6645; Kano, Kuniyuki/0000-0002-4539-5750; Matsuzawa, Atsushi/0000-0001-8303-3905; Fukunaga, Kohji/0000-0001-8526-2824	Nagai Memorial Research Scholarship from the Pharmaceutical Society of Japan; KAKENHI from the Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [16H05219] Funding Source: KAKEN	Nagai Memorial Research Scholarship from the Pharmaceutical Society of Japan; KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Nagai Memorial Research Scholarship from the Pharmaceutical Society of Japan, KAKENHI from the Japan Society for the Promotion of Science, and the Ministry of Education, Culture, Sports, Science and Technology. The authors declare that they have no conflicts of interest with the contents of this article.	Baer DJ, 2004, AM J CLIN NUTR, V79, P969; Bassett CMC, 2009, METABOLISM, V58, P1802, DOI 10.1016/j.metabol.2009.06.010; CENEDELL.RJ, 1971, LIPIDS, V6, P475, DOI 10.1007/BF02531232; Chung MY, 2015, J MED FOOD, V18, P648, DOI 10.1089/jmf.2014.0048; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cousin SP, 2001, ENDOCRINOLOGY, V142, P229, DOI 10.1210/en.142.1.229; Dorfman SE, 2009, OBESITY, V17, P1200, DOI 10.1038/oby.2008.662; Druart C, 2013, BRIT J NUTR, V110, P998, DOI 10.1017/S0007114513000123; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; Estadella D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/137579; Ferrari D, 2015, TRENDS MOL MED, V21, P184, DOI 10.1016/j.molmed.2014.12.008; FUKUNAGA K, 1988, J NEUROCHEM, V51, P1070, DOI 10.1111/j.1471-4159.1988.tb03070.x; Gebauer SK, 2007, LIPIDS, V42, P787, DOI 10.1007/s11745-007-3095-8; Gendron FP, 2003, AM J PHYSIOL-CELL PH, V284, pC571, DOI 10.1152/ajpcell.00286.2002; Han SN, 2002, J LIPID RES, V43, P445; Hayakawa R, 2012, P JPN ACAD B-PHYS, V88, P434, DOI 10.2183/pjab.88.434; Hussein O, 2007, WORLD J GASTROENTERO, V13, P361, DOI 10.3748/wjg.v13.i3.361; Ibrahim A, 2005, METABOLISM, V54, P240, DOI 10.1016/j.metabol.2004.08.019; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Iwata NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029600; Jimenez-Gomez Yolanda, 2009, Atherosclerosis, V204, pe70, DOI 10.1016/j.atherosclerosis.2008.09.011; LAI Y, 1986, P NATL ACAD SCI USA, V83, P4253, DOI 10.1073/pnas.83.12.4253; Leamy AK, 2013, PROG LIPID RES, V52, P165, DOI 10.1016/j.plipres.2012.10.004; Leon D, 2006, EUR J NEUROSCI, V23, P2999, DOI 10.1111/j.1460-9568.2006.04832.x; Liu WH, 2010, J AGR FOOD CHEM, V58, P10247, DOI 10.1021/jf102379n; Lopez-Garcia E, 2005, J NUTR, V135, P562, DOI 10.1093/jn/135.3.562; Machado RM, 2012, ATHEROSCLEROSIS, V224, P66, DOI 10.1016/j.atherosclerosis.2012.06.059; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Mattiazzi A, 2015, AM J PHYSIOL-HEART C, V308, pH1177, DOI 10.1152/ajpheart.00007.2015; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; MEYER T, 1992, SCIENCE, V256, P1199, DOI 10.1126/science.256.5060.1199; Micallef MA, 2009, ATHEROSCLEROSIS, V204, P476, DOI 10.1016/j.atherosclerosis.2008.09.020; Michas G, 2014, ATHEROSCLEROSIS, V234, P320, DOI 10.1016/j.atherosclerosis.2014.03.013; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Mori K, 2015, CIRC J, V79, P2017, DOI 10.1253/circj.CJ-14-0750; Morris MC, 2006, ARCH NEUROL-CHICAGO, V63, P1085, DOI 10.1001/archneur.63.8.1085; Morris MC, 2004, NEUROLOGY, V62, P1573, DOI 10.1212/01.WNL.0000123250.82849.B6; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P194, DOI 10.1001/archneur.60.2.194; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Noguchi T, 2008, J BIOL CHEM, V283, P7657, DOI 10.1074/jbc.M708402200; Ouellet V, 2008, J NUTR, V138, P2386, DOI 10.3945/jn.108.092346; Peng K, 2015, INT J MOL MED, V35, P1179, DOI 10.3892/ijmm.2015.2129; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shapiro H, 2011, NAT REV NEPHROL, V7, P110, DOI 10.1038/nrneph.2010.156; Shioda N, 2015, J BIOL CHEM, V290, P21663, DOI 10.1074/jbc.M115.664920; Siddiqui RA, 2009, BRIT J NUTR, V102, P1811, DOI 10.1017/S0007114509992030; Strack S, 1997, J NEUROCHEM, V68, P2119; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Takeda K, 2004, EMBO REP, V5, P161, DOI 10.1038/sj.embor.7400072; Teixeira AM, 2012, BEHAV BRAIN RES, V226, P504, DOI 10.1016/j.bbr.2011.10.005; Tewari M, 2015, AGEING RES REV, V24, P328, DOI 10.1016/j.arr.2015.10.001; Vesper HW, 2012, JAMA-J AM MED ASSOC, V307, P562, DOI 10.1001/jama.2012.112; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x; Yang EY, 1999, J BIOL CHEM, V274, P26199, DOI 10.1074/jbc.274.37.26199	58	30	34	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8174	8185		10.1074/jbc.M116.771519	http://dx.doi.org/10.1074/jbc.M116.771519			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28360100	Green Published, hybrid			2022-12-26	WOS:000401788600005
J	Lai, LL; Chan, WK; Sthaneshwar, P; Mustapha, NRN; Goh, KL; Mahadeva, S				Lai, Lee-Lee; Chan, Wah-Kheong; Sthaneshwar, Pavai; Mustapha, Nik Raihan Nik; Goh, Khean-Lee; Mahadeva, Sanjiv			Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in non-alcoholic fatty liver disease	PLOS ONE			English	Article							METABOLIC SYNDROME; FIBROSIS; ASSOCIATION; VALIDATION; CRITERIA; BIOPSY; MARKER; SYSTEM	Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP) has been suggested to be useful for the assessment of disease severity in non-alcoholic fatty liver disease (NAFLD). Consecutive adult NAFLD patients who had a liver biopsy were included. Serum WFA(+)-M2BP level was measured using a lectin-antibody sandwich immunoassay using a chemiluminescence enzyme immunoassay machine (HISCL-5000, Sysmex, Kobe, Japan). The measured levels were indexed using the following equation: Cut-off index (COI) = ([WFA(+)-M2BP](sample) -[WFA(+)-M2BP](NC)) /([WFA(+)-M2BP](PC) -[WFA(+)-M2BP](NC)), where PC = positive control and NC = negative control. Histopathological examination of liver biopsy specimen was reported according to Non-Alcoholic Steatohepatitis (NASH) Clinical Research Network Scoring System. Data for 220 cases were analyzed. The AUROC of the COI for the diagnosis of NASH was 0.65. The AUROC of the COI for the diagnosis of steatosis grade >= 2 and 3 was 0.64 and 0.53, respectively. The AUROC of the COI for the diagnosis of lobular inflammation grade >= 1, >= 2 and 3 was 0.57, 0.68 and 0.59, respectively. The AUROC of the COI for the diagnosis of hepatocyte ballooning grade >= 1 and 2 was 0.64 and 0.65, respectively. The AUROC of the COI for the diagnosis of fibrosis stage >= 1, >= 2, >= 3 and 4 was 0.61, 0.71, 0.74 and 0.84, respectively. Out of the 220 cases, 152 cases were the same 76 patients who had a repeat liver biopsy after 48 weeks of intervention. The AUROC of the change in the COI to detect improvement in steatosis, lobular inflammation, hepatocyte ballooning and fibrosis was 0.57, 0.54, 0.59 and 0.52, respectively. In conclusion, serum WFA(+)-M2BP was most useful for the diagnosis of significant fibrosis, advanced fibrosis and cirrhosis in NAFLD patients. However, it was less useful for differentiating NASH from non-NASH, and for diagnosis and follow-up of the individual histopathological components of NASH.	[Lai, Lee-Lee; Chan, Wah-Kheong; Goh, Khean-Lee; Mahadeva, Sanjiv] Univ Malaya, Dept Med, Gastroenterol & Hepatol Unit, Fac Med, Kuala Lumpur, Malaysia; [Sthaneshwar, Pavai] Univ Malaya, Dept Pathol, Clin Diagnost Lab, Fac Med, Kuala Lumpur, Malaysia; [Mustapha, Nik Raihan Nik] Hosp Sultanah Bahiyah, Dept Pathol, Alor Setar, Kedah, Malaysia	Universiti Malaya; Universiti Malaya	Chan, WK (corresponding author), Univ Malaya, Dept Med, Gastroenterol & Hepatol Unit, Fac Med, Kuala Lumpur, Malaysia.	wahkheong2003@hotmail.com	Goh, Khean-Lee/B-6404-2009; Chan, Wah Kheong/AGA-6636-2022; STHANESHWAR, PAVAI/B-9489-2010; Mahadeva, Sanjiv/E-1711-2011; Chan, Wah-Kheong/H-2329-2016; Lai, Lee Lee/D-6540-2016; Lai, Lee Lee/AAA-4569-2022	Goh, Khean-Lee/0000-0002-9965-1561; Chan, Wah Kheong/0000-0002-9105-5837; STHANESHWAR, PAVAI/0000-0002-7518-4217; Mahadeva, Sanjiv/0000-0001-5824-0590; Chan, Wah-Kheong/0000-0002-9105-5837; Lai, Lee Lee/0000-0002-0783-6340; Lai, Lee Lee/0000-0002-0783-6340	University of Malaya Research Grant Project [RG536-13HTM]; Sysmex Corporation	University of Malaya Research Grant Project; Sysmex Corporation	Support was provided by the University of Malaya Research Grant Project No. RG536-13HTM [www.um.edu.my]. The University of Malaya had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Support was also provided by Sysmex Corporation [www.sysmex.com]. Sysmex provided suggestion for the study design and supplied the test kit and equipment but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2015, J GASTROENTEROL, V50, P776, DOI 10.1007/s00535-014-1007-2; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Anuurad E, 2003, J OCCUP HEALTH, V45, P335, DOI 10.1539/joh.45.335; Boursier J, 2013, HEPATOLOGY, V57, P1182, DOI 10.1002/hep.25993; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Kamada Y, 2013, PROTEOM CLIN APPL, V7, P648, DOI 10.1002/prca.201200137; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kruger FC, 2011, SAMJ S AFR MED J, V101, P477; Kuno A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01065; Mahadeva S, 2015, EUR J GASTROEN HEPAT, V27, P1378, DOI 10.1097/MEG.0000000000000465; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Nishikawa H, 2016, HEPATOL RES, V17, P1500; PICCININO F, 1986, J HEPATOL, V2, P165, DOI 10.1016/S0168-8278(86)80075-7; Sumida Y, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-2; Toshima T, 2015, J GASTROENTEROL, V50, P76, DOI 10.1007/s00535-014-0946-y; Wah-Kheong C, 2013, HEPATOL INT, V7, P65, DOI 10.1007/s12072-012-9384-1	17	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174982	10.1371/journal.pone.0174982	http://dx.doi.org/10.1371/journal.pone.0174982			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369100	Green Submitted, Green Published, gold			2022-12-26	WOS:000399351000066
J	Simm, D; Hatje, K; Kollmar, M				Simm, Dominic; Hatje, Klas; Kollmar, Martin			Distribution and evolution of stable single alpha-helices (SAH domains) in myosin motor proteins	PLOS ONE			English	Article							SMOOTH-MUSCLE CALDESMON; SIDE-CHAIN INTERACTIONS; COILED-COIL; ION-PAIRS; SALT BRIDGES; LIGHT-MEROMYOSIN; PEPTIDES; MOTIF; ROD; GLU	Stable single-alpha helices (SAHs) are versatile structural elements in many prokaryotic and eukaryotic proteins acting as semi-flexible linkers and constant force springs. This way SAH-domains function as part of the lever of many different myosins. Canonical myosin levers consist of one or several IQ-motifs to which light chains such as calmodulin bind. SAH-domains provide flexibility in length and stiffness to the myosin levers, and may be particularly suited for myosins working in crowded cellular environments. Although the function of the SAH-domains in human class-6 and class-10 myosins has well been characterised, the distribution of the SAH-domain in all myosin subfamilies and across the eukaryotic tree of life remained elusive. Here, we analysed the largest available myosin sequence dataset consisting of 7919 manually annotated myosin sequences from 938 species representing all major eukaryotic branches using the SAH-prediction algorithm of Waggawagga, a recently developed tool for the identification of SAH-domains. With this approach we identified SAH-domains in more than one third of the supposed 79 myosin subfamilies. Depending on the myosin class, the presence of SAH-domains can range from a few to almost all class members indicating complex patterns of independent and taxon-specific SAH-domain gain and loss.	[Simm, Dominic; Hatje, Klas; Kollmar, Martin] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Grp Syst Biol Motor Prot, Gottingen, Germany; [Simm, Dominic] Georg August Univ Gottingen, Inst Comp Sci, Theoret Comp Sci & Algorithm Methods, Gottingen, Germany; [Hatje, Klas] F Hoffmann La Roche Ltd, Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev, Pharmaceut Sci, Basel, Switzerland	Max Planck Society; University of Gottingen; Roche Holding	Kollmar, M (corresponding author), Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, Grp Syst Biol Motor Prot, Gottingen, Germany.	mako@nmr.mpibpc.mpg.de	Kollmar, Martin/AAF-4966-2020; Hatje, Klas/D-1076-2014	Kollmar, Martin/0000-0002-9768-1855; Simm, Dominic/0000-0003-1689-1947				Alexander PA, 2007, P NATL ACAD SCI USA, V104, P11963, DOI 10.1073/pnas.0700922104; Andrew CD, 2001, PROTEINS, V45, P449, DOI 10.1002/prot.1161; Baboolal TG, 2009, P NATL ACAD SCI USA, V106, P22193, DOI [10.1073/pnas.0909851106, 10.1073/pnas.09098S1106]; Batchelor M, 2015, BIOCHEM SOC T, V43, P58, DOI 10.1042/BST20140302; CHANG YC, 1994, BIOPHYS CHEM, V49, P113, DOI 10.1016/0301-4622(93)E0058-D; Gaspari Z, 2012, BBA-PROTEINS PROTEOM, V1824, P637, DOI 10.1016/j.bbapap.2012.01.012; He YA, 2012, STRUCTURE, V20, P283, DOI 10.1016/j.str.2011.11.018; HUYGHUESDESPOINTES BMP, 1993, PROTEIN SCI, V2, P80; Kammerer RA, 2005, P NATL ACAD SCI USA, V102, P13891, DOI 10.1073/pnas.0502390102; KING L, 1989, BIOCHEMISTRY-US, V28, P3498, DOI 10.1021/bi00434a052; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Li Y, 2003, NATURE, V424, P341, DOI 10.1038/nature01801; LOCKHART DJ, 1993, SCIENCE, V260, P198, DOI 10.1126/science.8469972; LYU PC, 1990, SCIENCE, V250, P669, DOI 10.1126/science.2237416; LYU PC, 1989, J AM CHEM SOC, V111, P2733, DOI 10.1021/ja00189a067; LYU PCC, 1992, J MOL BIOL, V223, P343, DOI 10.1016/0022-2836(92)90735-3; MARQUSEE S, 1987, P NATL ACAD SCI USA, V84, P8898, DOI 10.1073/pnas.84.24.8898; MARQUSEE S, 1989, P NATL ACAD SCI USA, V86, P5286, DOI 10.1073/pnas.86.14.5286; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Odronitz F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-300; Olson CA, 2001, PROTEINS, V44, P123, DOI 10.1002/prot.1079; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Peckham M, 2011, BIOCHEM SOC T, V39, P1142, DOI 10.1042/BST0391142; Peckham M, 2009, SOFT MATTER, V5, P2493, DOI 10.1039/b822339d; PHILLIPS GN, 1992, PROTEINS, V14, P425, DOI 10.1002/prot.340140403; Samejima K, 2015, J BIOL CHEM, V290, P21460, DOI 10.1074/jbc.M115.645317; SCHOLTZ JM, 1993, BIOCHEMISTRY-US, V32, P9668, DOI 10.1021/bi00088a019; SEO J, 1993, PROTEINS, V15, P223, DOI 10.1002/prot.340150302; SHALONGO W, 1994, J AM CHEM SOC, V116, P8288, DOI 10.1021/ja00097a039; Simm D, 2015, BIOINFORMATICS, V31, P767, DOI 10.1093/bioinformatics/btu700; Sivaramakrishnan S, 2008, P NATL ACAD SCI USA, V105, P13356, DOI 10.1073/pnas.0806256105; Smith JS, 1998, BIOCHEMISTRY-US, V37, P33, DOI 10.1021/bi972026h; Spek EJ, 1998, PROTEIN SCI, V7, P2431, DOI 10.1002/pro.5560071121; Spink BJ, 2008, NAT STRUCT MOL BIOL, V15, P591, DOI 10.1038/nsmb.1429; Steinmetz MO, 2007, P NATL ACAD SCI USA, V104, P7062, DOI 10.1073/pnas.0700321104; Suveges D, 2009, PROTEINS, V74, P905, DOI 10.1002/prot.22183; Swanson CJ, 2014, J BIOL CHEM, V289, P25460, DOI 10.1074/jbc.R114.583906; Umeki N, 2009, P NATL ACAD SCI USA, V106, P8483, DOI 10.1073/pnas.0812930106; WANG CLA, 1991, J BIOL CHEM, V266, P13958; Wang EZ, 1996, ARCH BIOCHEM BIOPHYS, V329, P156, DOI 10.1006/abbi.1996.0204; Wolny M, 2014, J BIOL CHEM, V289, P27825, DOI 10.1074/jbc.M114.585679; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106; Zhou X, 1998, J MOL BIOL, V276, P829, DOI 10.1006/jmbi.1997.1571	43	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174639	10.1371/journal.pone.0174639	http://dx.doi.org/10.1371/journal.pone.0174639			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369123	Green Published, gold, Green Submitted			2022-12-26	WOS:000399351000027
J	Wagner, RD; Johnson, SJ; Danielsen, ZY; Lim, JH; Mudalige, T; Linder, S				Wagner, R. Doug; Johnson, Shemedia J.; Danielsen, Zhixia Yan; Lim, Jin-Hee; Mudalige, Thilak; Linder, Sean			Polyethylene glycol-functionalized poly (Lactic Acid-co-Glycolic Acid) and graphene oxide nanoparticles induce pro-inflammatory and apoptotic responses in Candida albicans-infected vaginal epithelial cells	PLOS ONE			English	Article							ACTIVATION; EXPRESSION; CHALLENGES; DELIVERY; PATHWAY; SAFETY; NOD2	Mucous-penetrating nanoparticles consisting of poly lactic acid-co-glycolic acid (PLGA)polyethylene glycol (PEG) could improve targeting of microbicidal drugs for sexually transmitted diseases by intravaginal inoculation. Nanoparticles can induce inflammatory responses, which may exacerbate the inflammation that occurs in the vaginal tracts of women with yeast infections. This study evaluated the effects of these drug-delivery nanoparticles on VK2(E6/E7) vaginal epithelial cell proinflammatory responses to Candida albicans yeast infections. Vaginal epithelial cell monolayers were infected with C. albicans and exposed to 100 mu g/ml 49.5 nm PLGA-PEG nanospheres or 20 mu g/ml 1.1 x 500 nm PEG-functionalized graphene oxide (GO-PEG) sheets. The cells were assessed for changes in mRNA and protein expression of inflammation-related genes by RT-qPCR and physiological markers of cell stress using high content analysis and flow cytometry. C. albicans exposure suppressed apoptotic gene expression, but induced oxidative stress in the cells. The nanomaterials induced cytotoxicity and programmed cell death responses alone and with C. albicans. PLGA-PEG nanoparticles induced mRNA expression of apoptosis-related genes and induced poly (ADP-ribose) polymerase (PARP) cleavage, increased BAX/BCL2 ratios, and chromatin condensation indicative of apoptosis. They also induced autophagy, endoplasmic reticulum stress, and DNA damage. They caused the cells to excrete inflammatory recruitment molecules chemokine (C-X-C motif) ligand 1 (CXCL1), interleukin-1 alpha (IL1A), interleukin-1 beta (IL1B), calprotectin (S100A8), and tumor necrosis factor alpha (TNF). GO-PEG nanoparticles induced expression of necrosis-related genes and cytotoxicity. They reduced autophagy and endoplasmic reticulum stress, and apoptotic gene expression responses. The results show that stealth nanoparticle drug-delivery vehicles may cause intracellular damage to vaginal epithelial cells by several mechanisms and that their use for intravaginal drug delivery may exacerbate inflammation in active yeast infections by increased inflammatory recruitment.	[Wagner, R. Doug; Johnson, Shemedia J.] Natl Ctr Toxicol Res, Microbiol Div, Jefferson, AR 72079 USA; [Danielsen, Zhixia Yan] Food & Drug Adm, Ctr Drug Evaluat & Res, Off Translat Sci, Div Clin Pharmacol 4,Off Clin Pharmacol, White Oak, MA USA; [Lim, Jin-Hee; Mudalige, Thilak; Linder, Sean] NCTR ORA Nanotechnol Core Facil Jefferson, Jefferson, AR USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Wagner, RD (corresponding author), Natl Ctr Toxicol Res, Microbiol Div, Jefferson, AR 72079 USA.	doug.wagner@fda.hhs.gov			United States Food and Drug Administration Office of Women's Health	United States Food and Drug Administration Office of Women's Health	RDW received funding from the United States Food and Drug Administration Office of Women's Health. The funder had no role in study design, data collection and analysis, decision to publish, or pre paration of the manuscript.	Betancourt T, 2009, J BIOMED MATER RES A, V91A, P263, DOI 10.1002/jbm.a.32247; Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004; Cu Y, 2011, J CONTROL RELEASE, V156, P258, DOI 10.1016/j.jconrel.2011.06.036; Ferguson LM, 2011, THER DELIV, V2, P1535, DOI [10.4155/tde.11.126, 10.4155/TDE.11.126]; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; GESHNIZGANI AM, 1992, J CLIN MICROBIOL, V30, P1323, DOI 10.1128/JCM.30.5.1323-1326.1992; Hollmer Cara, 2006, Infect Dis Obstet Gynecol, V2006, P98218; Hussain S, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-28; Jeong YJ, 2014, IMMUNOLOGY, V143, P269, DOI 10.1111/imm.12307; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Li Y, 2012, BIOMATERIALS, V33, P402, DOI 10.1016/j.biomaterials.2011.09.091; McGowan I, 2011, AIDS, V25, P1057, DOI 10.1097/QAD.0b013e328346bd3e; McNeil SE, 2011, METHODS MOL BIOL, V697, P9, DOI 10.1007/978-1-60327-198-1_2; Motulsky H., 1995, INTUITIVE BIOSTATIST; Niebler M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003536; Oostingh GJ, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-8; Price CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024095; Reisetter AC, 2011, J BIOL CHEM, V286, P21844, DOI 10.1074/jbc.M111.238519; Ryter S.W., 2014, INT J CELL BIOL, V2014; Sanchez VC, 2012, CHEM RES TOXICOL, V25, P15, DOI 10.1021/tx200339h; Schaller M, 2006, NAT PROTOC, V1, P2767, DOI 10.1038/nprot.2006.474; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Sharma V, 2012, APOPTOSIS, V17, P852, DOI 10.1007/s10495-012-0705-6; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Toduka Y, 2012, ENVIRON SCI TECHNOL, V46, P7629, DOI 10.1021/es300433x; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; U.S. Food and Drug Administration, VAG MICR DEV PREV HI; Vissers M, 2014, INFECT IMMUN, V82, P4952, DOI 10.1128/IAI.02150-14; Wagner RD, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-58; Wagner RD, 2012, OPEN J MED MICROBIOL, V02, P54, DOI [10.4236/ojmm.2012.23008, DOI 10.4236/OJMM.2012.23008]; Watanabe T, 2014, MUCOSAL IMMUNOL, V7, P1312, DOI 10.1038/mi.2014.19; Whaley KJ, 2010, ANTIVIR RES, V88, pS55, DOI 10.1016/j.antiviral.2010.09.006; Woodrow KA, 2009, NAT MATER, V8, P526, DOI [10.1038/NMAT2444, 10.1038/nmat2444]; Yano J, 2012, CYTOKINE, V58, P118, DOI 10.1016/j.cyto.2011.11.021; Yu JJ, 2014, P NATL ACAD SCI USA, V111, P15514, DOI 10.1073/pnas.1414859111; Zhang LF, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0361-x; Zhang T, 2011, EUR J PHARM BIOPHARM, V79, P526, DOI 10.1016/j.ejpb.2011.06.007; Zhang Y, 2012, NANOSCALE, V4, P3833, DOI 10.1039/c2nr31040f	39	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0175250	10.1371/journal.pone.0175250	http://dx.doi.org/10.1371/journal.pone.0175250			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369145	Green Published, Green Submitted, gold			2022-12-26	WOS:000399351000081
J	Koh, J; Lee, HE; Kim, WH; Lee, HS				Koh, Jiwon; Lee, Hee Eun; Kim, Woo Ho; Lee, Hye Seung			Clinicopathologic implication of meticulous pathologic examination of regional lymph nodes in gastric cancer patients	PLOS ONE			English	Article							TNM STAGING SYSTEM; PROGNOSTIC-FACTOR; EXTENDED LYMPHADENECTOMY; LOG ODDS; RATIO; NUMBER; SURVIVAL; SURGERY; CLASSIFICATION; SUPERIORITY	Background We aimed to investigate effect of increased number of examined lymph nodes (LNs) to pN category, and compare various N categories in gastric cancer: American Joint Committee on Cancer (AJCC) 7th edition, metastatic LN ratio (MLR), and log odds of positive LNs (LODDS). Methods Four cohorts with a total of 2,309 gastric cancer patients were enrolled. For cohort 1 and 2, prognostic significance of each method by disease-specific survival was analyzed using Akaike and Bayesian information criterion (AIC and BIC). Results The total LNs in four cohorts significantly differed [median (range), 28 (6-97) in cohort 1, 37 (8-120) in cohort 2, 48 (7-122) in cohort 3, and 54 (4-221) in cohort 4; p<0.001]. The numbers of negative LNs increased with increase of total LN (p<0.001), but the numbers of metastatic LNs did not increase from cohort 1 to 4. MLR and LODDS in four cohorts had decreasing tendency with increase of total LNs in each pT3 and pT4 category (p<0.001), while the numbers of metastatic LNs did not differ significantly in any pT category (p>0.05). The AIC and BIC varied according to different cut-off values for MLR; model by cut-offs of 0.2 and 0.5 being better for cohort 1, while cut-offs 0.1 and 0.25 was better for cohort 2. Conclusion Our study showed that the number of metastatic LNs did not increase with maximal pathologic examination of regional LNs. AJCC 7th system is suggested as the simplest method with single cut-off value, but prognostic significance of MLR may be influenced by various cut-offs.	[Koh, Jiwon; Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Lee, Hee Eun] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Lee, Hye Seung] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Seongnam, South Korea	Seoul National University (SNU); Mayo Clinic; Seoul National University (SNU)	Lee, HS (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Pathol, Seongnam, South Korea.	hye2@snu.ac.kr	Lee, Hye Seung/G-6419-2011	Lee, Hye Seung/0000-0002-1667-7986				Alatengbaolide, 2013, AM J CLIN ONCOL-CANC, V36, P325, DOI 10.1097/COC.0b013e318246b4e9; Aurello P, 2013, AM SURGEON, V79, P483; Bilici A, 2010, ONKOLOGIE, V33, P101, DOI 10.1159/000277927; Bouvier AM, 2002, CANCER, V94, P2862, DOI 10.1002/cncr.10550; Bunt AMG, 1996, J CLIN ONCOL, V14, P2289, DOI 10.1200/JCO.1996.14.8.2289; Choi YY, 2016, J PATHOL TRANSL MED, V50, P1, DOI 10.4132/jptm.2015.09.10; Coburn NG, 2006, CANCER-AM CANCER SOC, V107, P2143, DOI 10.1002/cncr.22229; Huang CM, 2011, EJSO-EUR J SURG ONC, V37, P481, DOI 10.1016/j.ejso.2011.01.012; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiao XG, 2014, WORLD J GASTROENTERO, V20, P3640, DOI 10.3748/wjg.v20.i13.3640; Kim SH, 2011, J GASTRIC CANCER, V11, P94, DOI 10.5230/jgc.2011.11.2.94; Kong SH, 2012, ANN SURG, V255, P50, DOI 10.1097/SLA.0b013e31821d4d75; Kutlu OC, 2015, SURG ONCOL, V24, P84, DOI 10.1016/j.suronc.2015.03.001; Lee SY, 2010, INT J ONCOL, V36, P1461, DOI 10.3892/ijo_00000632; Lee SR, 2012, WORLD J SURG, V36, P1096, DOI 10.1007/s00268-012-1520-5; Lorenzon L, 2014, EUR SURG RES, V53, P1, DOI 10.1159/000360937; Nelen SD, 2013, ACTA ONCOL, V52, P1751, DOI 10.3109/0284186X.2012.754991; NIO Y, 1993, ANN SURG, V218, P47, DOI 10.1097/00000658-199307000-00008; Qiu MZ, 2014, INT J CANCER, V134, P2468, DOI 10.1002/ijc.28559; Qiu MZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031736; Schmidt B, 2013, J SURG ONCOL, V107, P259, DOI 10.1002/jso.23127; Son T, 2012, CANCER-AM CANCER SOC, V118, P4687, DOI 10.1002/cncr.27426; Strong V, 2013, WORLD J SURG, V37, P1773, DOI 10.1007/s00268-013-2070-1; Sun Z, 2010, CANCER-AM CANCER SOC, V116, P2571, DOI 10.1002/cncr.24989; Tamura S, 2011, INT J SURG ONCOLOGY, V2011, P1; Wang JP, 2008, J GASTROINTEST SURG, V12, P1790, DOI 10.1007/s11605-008-0651-3; Wang JP, 2012, ANN SURG, V255, P478, DOI 10.1097/SLA.0b013e31824857e2; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Wong J, 2013, J GASTROINTEST SURG, V17, P2059, DOI 10.1007/s11605-013-2380-5; Xiao LB, 2011, WORLD J GASTROENTERO, V17, P5123, DOI 10.3748/wjg.v17.i46.5123; Yokota T, 2004, SCAND J GASTROENTERO, V39, P380, DOI 10.1080/00365520310008629; Zeng WJ, 2013, ONCOL LETT, V6, P1693, DOI 10.3892/ol.2013.1615; Zhang BY, 2014, AM J SURG, V207, P555, DOI 10.1016/j.amjsurg.2013.05.004; Zhou YB, 2013, GASTRIC CANCER, V16, P309, DOI 10.1007/s10120-012-0190-1; 김우호, 2005, Journal of Pathology and Translational Medicine, V39, P106	35	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174814	10.1371/journal.pone.0174814	http://dx.doi.org/10.1371/journal.pone.0174814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362845	Green Published, gold, Green Submitted			2022-12-26	WOS:000399175000038
J	Fang, SF; Yuan, JH; Shi, Q; Xu, TT; Fu, Y; Wu, Z; Guo, WH				Fang, Sufen; Yuan, Jinhua; Shi, Qing; Xu, Tiantian; Fu, Yao; Wu, Zheng; Guo, Wuhua			Downregulation of UBC9 promotes apoptosis of activated human LX-2 hepatic stellate cells by suppressing the canonical NF-kappa B signaling pathway	PLOS ONE			English	Article							LIVER FIBROSIS; SUMOYLATION; INHIBITION; INJURY; SUMO; INTERLEUKIN-6; EXPRESSION; CARCINOMA	UBC9, the only known E2-conjugating enzyme involved in SUMOylation, is a key regulator in fibrosis. However, the roles of UBC9 in liver fibrosis remain unclear. Therefore, in this study, we investigated the roles of UBC9 in HSC apoptosis and liver fibrogenesis. Our results showed that the UBC9 levels in activated LX-2 cells, HepG2 and SMMC-7721 were increased compared with LO2, and the expression of UBC9 in activated LX-2 cells, HepG2 and SMMC-7721 were no significant differences. The expression of UBC9 was effectively down-regulated by the UBC9-shRNA plasmid, and this effect was accompanied by the attenuated expression of the myofibroblast markers smooth muscle actin (alpha-SMA) and Collagen I. Downregulation of UBC9 also promotes activated HSCs apoptosis by up-regulating cell apoptosis-related proteins. Further, knockdown of UBC9 in activated HSCs inhibited cell viability and caused cell cycle arrest in the G2 phase. Moreover, knockdown of UBC9 suppressed the activation of NF-kappa B signaling pathways. In conclusion, these results demonstrated that down-regulation of UBC9 expression induced activated LX-2 cell apoptosis and promoted cells to return to a quiescent state by inhibiting the NF-kappa B signaling pathway. These results provide novel mechanistic insights for the anti-fibrotic effect of UBC9.	[Fang, Sufen; Yuan, Jinhua; Shi, Qing; Xu, Tiantian; Fu, Yao; Wu, Zheng] Nanchang Univ, Affiliated Hosp 2, Dept Gastroenterol, Nanchang, Jiangxi, Peoples R China; [Guo, Wuhua] Fujian Med Univ, Mengchao Hepatobiliary Hosp, Dept Intervent Radiol, Fuzhou, Peoples R China	Nanchang University; Fujian Medical University	Guo, WH (corresponding author), Fujian Med Univ, Mengchao Hepatobiliary Hosp, Dept Intervent Radiol, Fuzhou, Peoples R China.	guowuhua@aliyun.com			National Natural Science Foundation of China [81260360, 91029720]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China, no. 81260360 and no. 91029720.	Aillet F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051672; Akar CA, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-12; Anan A, 2006, HEPATOLOGY, V43, P335, DOI 10.1002/hep.21036; Berrieman HK, 2005, CANCER-AM CANCER SOC, V103, P1415, DOI 10.1002/cncr.20907; Cohen-Naftaly Michal, 2011, Therap Adv Gastroenterol, V4, P391, DOI 10.1177/1756283X11413002; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Deyrieux AF, 2007, J CELL SCI, V120, P125, DOI 10.1242/jcs.03317; Elsharkawy AM, 2005, APOPTOSIS, V10, P927, DOI 10.1007/s10495-005-1055-4; Faouzi S, 1999, LAB INVEST, V79, P485; Gadient RA, 1999, STEM CELLS, V17, P127, DOI 10.1002/stem.170127; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; Gill G, 2005, MOL CELL, V20, P495, DOI 10.1016/j.molcel.2005.11.004; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Ihara M, 2007, J BIOL CHEM, V282, P16465, DOI 10.1074/jbc.M610723200; Khodzhigorova A, 2012, ANN RHEUM DIS, V71, P1904, DOI 10.1136/annrheumdis-2012-201746; Kong DS, 2013, BIOMED PHARMACOTHER, V67, P246, DOI 10.1016/j.biopha.2012.10.002; Lang A, 2000, J HEPATOL, V33, P49, DOI 10.1016/S0168-8278(00)80159-2; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728; Oakley F, 2005, GASTROENTEROLOGY, V128, P108, DOI 10.1053/j.gastro.2004.10.003; Pandey D, 2011, ARTERIOSCL THROM VAS, V31, P1634, DOI 10.1161/ATVBAHA.111.226621; Pecoits R, 2003, NEPHROL DIAL TRANSPL, V18, P1042, DOI 10.1093/ndt/gfg111; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Popov Y, 2009, HEPATOLOGY, V50, P1294, DOI 10.1002/hep.23123; Reeves HL, 2002, FRONT BIOSCI-LANDMRK, V7, pD808, DOI 10.2741/reeves; Schon Hans-Theo, 2014, Hepatobiliary Surg Nutr, V3, P386, DOI 10.3978/j.issn.2304-3881.2014.11.06; Sivaramakrishnan V, 2009, CHEM-BIOL INTERACT, V180, P353, DOI 10.1016/j.cbi.2009.02.004; Son G, 2007, AM J PHYSIOL-GASTR L, V293, pG631, DOI 10.1152/ajpgi.00185.2007; Tashiro K, 1997, P NATL ACAD SCI USA, V94, P7862, DOI 10.1073/pnas.94.15.7862; Thalheimer U, 2005, GUT, V54, P556, DOI 10.1136/gut.2004.048181; Trautwein C, 2015, J HEPATOL, V62, pS15, DOI 10.1016/j.jhep.2015.02.039; Wright MC, 2001, GASTROENTEROLOGY, V121, P685, DOI 10.1053/gast.2001.27188	33	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174374	10.1371/journal.pone.0174374	http://dx.doi.org/10.1371/journal.pone.0174374			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358817	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174800034
J	Parfenov, VA; Golyk, VA; Matsnev, EI; Morozova, SV; Melnikov, OA; Antonenko, LM; Sigaleva, EE; Situkho, MI; Asaulenko, OI; Popovych, VI; Zamergrad, MV				Parfenov, Vladimir A.; Golyk, Volodymyr A.; Matsnev, Eduard I.; Morozova, Svetlana V.; Melnikov, Oleg A.; Antonenko, Ludmila M.; Sigaleva, Elena E.; Situkho, Maksym I.; Asaulenko, Olena I.; Popovych, Vasyl I.; Zamergrad, Maxim V.			Effectiveness of betahistine (48 mg/day) in patients with vestibular vertigo during routine practice: The VIRTUOSO study	PLOS ONE			English	Article							COMMUNITY; DIHYDROCHLORIDE; EPIDEMIOLOGY; DISORDERS; DIZZINESS; ATTACKS; DISEASE	Background Vestibular vertigo is associated with substantially reduced quality of life. Betahistine is effective in improving vertigo-associated symptoms, with longer treatment periods leading to greater improvements; however, it is not known whether these effects persist after treatment cessation. Methods VIRTUOSO was a prospective, multinational, non-comparative, post-marketing observational programme investigating the effectiveness of betahistine (48 mg/day) and the course of vertigo after the discontinuation of treatment. Patients with vestibular vertigo who were prescribed 48 mg/day betahistine were enrolled in Russia and Ukraine. Treatment duration was up to 2 months, and patients were followed up for 2 months after discontinuation of betahistine. Efficacy endpoints included clinical response (assessed by change in vertigo severity), monthly attack frequency, and physician and patient grading of overall clinical response and improvement of vertigo-associated symptoms. Results Overall, 309 patients were enrolled and 305 completed the study. Clinical response was rated as good, very good or excellent in 74.1% of patients at end of treatment, with vertigo severity significantly decreased from baseline (p<0.001). Monthly vertigo attack frequency decreased significantly during the 2 months of treatment (p<0.001 from baseline) and further decreased during the 2-month follow-up (p<0.001 from end of treatment). Overall, clinical response was graded as good or excellent by 94.4% of physicians and 95.4% of patients. Clinical improvement was considered either good or excellent by 82.6-90.5% of physicians and patients for nausea, vomiting and faintness. Only one adverse event was reported, with no serious adverse events. Conclusion Our findings suggest that betahistine (48 mg/day) therapy is effective in treating vertigo in routine clinical settings. The observed effects persisted for 2 months after treatment cessation, suggesting that betahistine may facilitate lasting vestibular compensation.	[Parfenov, Vladimir A.; Antonenko, Ludmila M.] IM Sechenov First Moscow State Med Univ, Dept Neurol, Moscow, Russia; [Golyk, Volodymyr A.] Minist Publ Hlth Ukraine, Neurol & Border States Dept, Ukrainian State Inst Med & Social Problems Disabi, Dnepropetrovsk, Ukraine; [Matsnev, Eduard I.; Sigaleva, Elena E.] Russian Acad Sci, Inst Biomed Problems, State Sci Ctr Russian Federat, Moscow, Russia; [Morozova, Svetlana V.] IM Sechenov First Moscow State Med Univ, ENT Dept, Moscow, Russia; [Melnikov, Oleg A.; Zamergrad, Maxim V.] ANO Guta Clin, Moscow, Russia; [Situkho, Maksym I.] OS Kolomyichenko Otolaryngol Inst, Clin Audiol & Vestibol Dept, Kiev, Ukraine; [Asaulenko, Olena I.] Kyiv City Clin Hosp 9, Dept Neurol, Kiev, Ukraine; [Asaulenko, Olena I.] PL Shupyk Natl Med Acad Postgrad Educ, Kiev, Ukraine; [Popovych, Vasyl I.] Ivano Frankivsk Reg Clin Hosp, ENT Dept, Ivano Frankivsk, Ukraine; [Popovych, Vasyl I.] Ivano Frankivsk Natl Med Univ, Ivano Frankivsk, Ukraine; [Zamergrad, Maxim V.] Russian Med Acad Postgrad Educ, Dept Neurol, Moscow, Russia	Sechenov First Moscow State Medical University; Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences; Sechenov First Moscow State Medical University; National Academy of Medical Sciences of Ukraine; Kolomiychenko Institute of Otolaryngology of the National Academy of Medical Sciences of Ukraine; Shupyk National Healthcare University of Ukraine; Ivano-Frankivsk National Medical University; Ministry of Health of the Russian Federation	Zamergrad, MV (corresponding author), ANO Guta Clin, Moscow, Russia.; Zamergrad, MV (corresponding author), Russian Med Acad Postgrad Educ, Dept Neurol, Moscow, Russia.	zamergrad@hotmail.com	Morozova, Svetlana/AAL-2787-2021; Golyk, Volodymyr A./M-4610-2015; Matsnev, Eduard/L-5731-2019; Parfenov, Vladimir/AAG-7021-2019	Morozova, Svetlana/0000-0003-1458-6279; Golyk, Volodymyr A./0000-0001-5106-6382; Parfenov, Vladimir/0000-0002-1992-7960; Sigaleva, Elena/0000-0001-9899-1604; Situkho, Maksym/0000-0002-9021-4621; Matsnev, Eduard/0000-0003-0250-861X	Abbott Laboratories LLC	Abbott Laboratories LLC	This study was funded by Abbott Laboratories LLC (http/www.abbott-russia.ru), who provided grants to all the authors to support data collection and analysis. Editorial assistance for the preparation of the manuscript from Alpharmaxim Healthcare Communications was funded by Abbott Laboratories LLC. The funder developed the study design, contracted an external vendor to analyse the data, and took the decision to publish. In addition, they funded editorial support for the preparation of the manuscript.	Benecke Heike, 2010, Int Tinnitus J, V16, P14; Cavaliere M, 2005, Acta Otorhinolaryngol Ital, V25, P107; ClinicalTrials. gov, 2015, EFF BET BET DIH PAT; Conraux C., 1988, IMPACT MED; FISCHER AJEM, 1985, TGO-TIJDSCHR THER GE, V10, P933; Gananca MM, 2009, ACTA OTO-LARYNGOL, V129, P487, DOI 10.1080/00016480802273082; Guneri EA, 2012, OTOLARYNG HEAD NECK, V146, P104, DOI 10.1177/0194599811419093; Koo JW, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008224; Lacour M, 2001, CNS DRUGS, V15, P853, DOI 10.2165/00023210-200115110-00004; Legent F, 1988, CONCOURS MED, V110, P2539; Mira E, 2003, EUR ARCH OTO-RHINO-L, V260, P73, DOI 10.1007/s00405-002-0524-4; Murdin L, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010696.pub2; Murdin L, 2015, OTOL NEUROTOL, V36, P387, DOI 10.1097/MAO.0000000000000691; Neuhauser HK, 2008, ARCH INTERN MED, V168, P2118, DOI 10.1001/archinte.168.19.2118; Neuhauser HK, 2005, NEUROLOGY, V65, P898, DOI 10.1212/01.wnl.0000175987.59991.3d; OOSTERVELD WJ, 1984, J LARYNGOL OTOL, V98, P37, DOI 10.1017/S0022215100146158; Petrova Dorina, 2004, Int Tinnitus J, V10, P177; Strupp M, 2008, ACTA OTO-LARYNGOL, V128, P520, DOI 10.1080/00016480701724912; Thompson TL, 2009, OCHSNER J, V9, P20; World Health Organization, 2016, INT STAT CLASS DIS R, V10th; Yardley L, 1998, BRIT J GEN PRACT, V48, P1131	21	10	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174114	10.1371/journal.pone.0174114	http://dx.doi.org/10.1371/journal.pone.0174114			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358888	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174800021
J	Alves, GHZ; Hoeinghaus, DJ; Manetta, GI; Benedito, E				Zaia Alves, Gustavo H.; Hoeinghaus, David J.; Manetta, Gislaine I.; Benedito, Evanilde			Dry season limnological conditions and basin geology exhibit complex relationships with delta C-13 and delta N-15 of carbon sources in four Neotropical floodplains	PLOS ONE			English	Article							DISSOLVED INORGANIC CARBON; STABLE-ISOTOPE RATIOS; FOOD-CHAIN LENGTH; NITROGEN ISOTOPES; ORGANIC-MATTER; MOVEMENT PATTERNS; RIVER-FLOODPLAIN; FISH; FLOW; WEB	Studies in freshwater ecosystems are seeking to improve understanding of carbon flow in food webs and stable isotopes have been influential in this work. However, variation in isotopic values of basal production sources could either be an asset or a hindrance depending on study objectives. We assessed the potential for basin geology and local limnological conditions to predict stable carbon and nitrogen isotope values of six carbon sources at multiple locations in four Neotropical floodplain ecosystems (Parana, Pantanal, Araguaia, and Amazon). Limnological conditions exhibited greater variation within than among systems. delta N-15 differed among basins for most carbon sources, but delta C-13 did not (though high within -basin variability for periphyton, phytoplankton and particulate organic carbon was observed). Although delta C-13 and delta N-15 values exhibited significant correlations with some limnological factors within and among basins, those relationships differed among carbon sources. Regression trees for both carbon and nitrogen isotopes for all sources depicted complex and in some cases nested relationships, and only very limited similarity was observed among trees for different carbon sources. Although limnological conditions predicted variation in isotope values of carbon sources, we suggest the resulting models were too complex to enable mathematical corrections of source isotope values among sites based on these parameters. The importance of local conditions in determining variation in source isotope values suggest that isotopes may be useful for examining habitat use, dispersal and patch dynamics within heterogeneous floodplain ecosystems, but spatial variability in isotope values needs to be explicitly considered when testing ecosystem models of carbon flow in these systems.	[Zaia Alves, Gustavo H.; Benedito, Evanilde] Univ Estadual Maringa, Programa Posgrad Ecol Ambientes Aquat Continentai, Maringa, Parana, Brazil; [Zaia Alves, Gustavo H.] Natl Council Sci & Technol Dev CNPq, Brasilia, DF, Brazil; [Hoeinghaus, David J.] Univ North Texas, Dept Biol Sci, Denton, TX USA; [Hoeinghaus, David J.] Univ North Texas, Adv Environm Res Inst, Denton, TX USA; [Manetta, Gislaine I.; Benedito, Evanilde] Univ Estadual Maringa, Programa Posgrad Biol Comparada PGB, Maringa, Parana, Brazil	Universidade Estadual de Maringa; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; Universidade Estadual de Maringa	Alves, GHZ (corresponding author), Univ Estadual Maringa, Programa Posgrad Ecol Ambientes Aquat Continentai, Maringa, Parana, Brazil.; Alves, GHZ (corresponding author), Natl Council Sci & Technol Dev CNPq, Brasilia, DF, Brazil.	alvesghz@yahoo.com.br	Benedito, Evanilde/F-2418-2012; Alves, Gustavo Henrique Zaia/C-9347-2019	Benedito, Evanilde/0000-0002-3494-9949; Alves, Gustavo Henrique Zaia/0000-0002-9233-2824	Brazilian National Council of Technological and Scientific Development CNPq/SISBIOTA [503243/2010-4]; CAPES	Brazilian National Council of Technological and Scientific Development CNPq/SISBIOTA; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by the Brazilian National Council of Technological and Scientific Development CNPq/SISBIOTA (grant #503243/2010-4) and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho AA, 2000, BIODIVERSITY IN WETLANDS: ASSESSMENT, FUNCTION AND CONSERVATION, VOL 1, P89; Alvarenga SM, 1984, SERIE GEOMORFOLOGIA, V187, P89; [Anonymous], 1981, AQUATIC CHEM INTRO E; [Anonymous], 2015, SCI TOTAL ENVIRON, V513, P167; Aquino S, 2009, REV BRAS GEOMORFOL, V10, P43; Arrieira RL, 2016, J FRESHWATER ECOL; Bade DL, 2004, LIMNOL OCEANOGR, V49, P1160, DOI 10.4319/lo.2004.49.4.1160; Benedito-Cecilio E, 2002, J FISH BIOL, V60, P1603, DOI 10.1006/jfbi.2002.2012; Benedito-Cecilio E, 2000, FISHERIES MANAG ECOL, V7, P305, DOI 10.1046/j.1365-2400.2000.007004305.x; BERGAMIN H, 1978, ANAL CHIM ACTA, V97, P427, DOI 10.1016/S0003-2670(01)93455-5; Bouillon S, 2008, J SEA RES, V59, P44, DOI 10.1016/j.seares.2007.05.001; Bowen GJ, 2010, ANNU REV EARTH PL SC, V38, P161, DOI 10.1146/annurev-earth-040809-152429; Brosi BJ, 2009, FOREST ECOL MANAG, V258, P1846, DOI 10.1016/j.foreco.2009.02.027; Bullen TD, 1998, ISOTOPE TRACERS IN CATCHMENT HYDROLOGY, P611; Bunn SE, 2003, FRESHWATER BIOL, V48, P619, DOI 10.1046/j.1365-2427.2003.01031.x; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; Carvalho PD., 2001, ACTA SCI, V23, P265; Casey MM, 2011, EARTH-SCI REV, V106, P131, DOI 10.1016/j.earscirev.2011.02.001; Chen ZX, 2014, ENVIRON EARTH SCI, V71, P217, DOI 10.1007/s12665-013-2425-9; Cloern JE, 2002, LIMNOL OCEANOGR, V47, P713, DOI 10.4319/lo.2002.47.3.0713; Como S, 2012, ESTUAR COAST SHELF S, V115, P300, DOI 10.1016/j.ecss.2012.07.032; Connolly RM, 2004, OECOLOGIA, V138, P161, DOI 10.1007/s00442-003-1415-0; Costas N, 2015, AQUAT SCI, V77, P231, DOI 10.1007/s00027-014-0383-2; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; deBruyn AMH, 2002, ECOL APPL, V12, P511, DOI 10.1890/1051-0761(2002)012[0511:QAOSDO]2.0.CO;2; Doi H, 2007, MAR FRESHWATER RES, V58, P811, DOI 10.1071/MF07067; Fellerhoff C, 2003, AQUAT ECOL, V37, P361, DOI 10.1023/B:AECO.0000007049.25535.12; Fellman JB, 2013, FRESHW SCI, V32, P217, DOI 10.1899/11-117.1; Figueiredo AJA, 1974, PROIETO ALTO GUAPORE, P173; Finlay JC, 2007, ECOL METHOD CONCEPT, P283, DOI 10.1002/9780470691854.ch10; Finlay JC, 2010, FRESHWATER BIOL, V55, P941, DOI 10.1111/j.1365-2427.2009.02327.x; Finlay JC, 2003, BIOGEOCHEMISTRY, V62, P231, DOI 10.1023/A:1021183023963; Finlay JC, 2002, ECOLOGY, V83, P1845, DOI 10.1890/0012-9658(2002)083[1845:SSOCFI]2.0.CO;2; Fry B, 1999, CAN J FISH AQUAT SCI, V56, P590, DOI 10.1139/cjfas-56-4-590; Fry B., 2006, STABLE ISOTOPE ECOLO; Fry B, 2011, LIMNOL OCEANOGR, V56, P1563, DOI 10.4319/lo.2011.56.5.1563; Furch K., 1997, CENTRAL AMAZON FLOOD, P69, DOI DOI 10.1007/978-3-662-03416-34; GINE MF, 1980, ANAL CHIM ACTA, V114, P191, DOI 10.1016/S0003-2670(01)84290-2; Golterman HL, 1978, METHODS PHYS CHEM AN; Gomes LC, 2001, REGUL RIVER, V17, P67, DOI 10.1002/1099-1646(200101/02)17:1<67::AID-RRR615>3.0.CO;2-P; Gray DP, CARBON CYCLING FLOOD; Gu B, 2009, OECOLOGIA, V160, P421, DOI 10.1007/s00442-009-1323-z; Hadwen WL, 2010, HYDROBIOLOGIA, V651, P239, DOI 10.1007/s10750-010-0303-y; Hamilton S. K., 2002, The ecohydrology of South American rivers and wetlands, P133; HAMILTON SK, 1992, GEOCHIM COSMOCHIM AC, V56, P4237, DOI 10.1016/0016-7037(92)90264-J; Hill WR, 2008, LIMNOL OCEANOGR, V53, P1217, DOI 10.4319/lo.2008.53.4.1217; Hobson KA, 1999, OECOLOGIA, V120, P397, DOI 10.1007/s004420050872; Hobson KA, 2014, J FIELD ORNITHOL, V85, P237, DOI 10.1111/jofo.12065; Hobson KA, 2012, J GREAT LAKES RES, V38, P58, DOI 10.1016/j.jglr.2010.11.008; Hoeinghaus DJ, 2006, ECOL FRESHW FISH, V15, P398, DOI 10.1111/j.1600-0633.2006.00152.x; Hoeinghaus DJ, 2008, OIKOS, V117, P984, DOI 10.1111/j.0030-1299.2008.16459.x; Hoeinghaus DJ, 2007, ECOSYSTEMS, V10, P1019, DOI 10.1007/s10021-007-9075-2; Hondula KL, 2014, AQUAT SCI, V76, P217, DOI 10.1007/s00027-013-0331-6; Humphries P, 2014, BIOSCIENCE, V64, P870, DOI 10.1093/biosci/biu130; Inglett PW, 2007, OECOLOGIA, V153, P99, DOI 10.1007/s00442-007-0711-5; Inglett PW, 2006, LIMNOL OCEANOGR, V51, P2380, DOI 10.4319/lo.2006.51.5.2380; Jardine TD, 2014, RIVER RES APPL, V30, P155, DOI 10.1002/rra.2630; Jardine TD, 2013, RIVER RES APPL, V29, P560, DOI 10.1002/rra.2554; Jardine TD, 2012, OECOLOGIA, V168, P829, DOI 10.1007/s00442-011-2148-0; Jepsen DB, 2007, ECOL FRESHW FISH, V16, P267, DOI 10.1111/j.1600-0633.2006.00218.x; Ochoa-Izaguirre MJ, 2015, J PHYCOL, V51, P46, DOI 10.1111/jpy.12250; Junk WJ, 1989, CANADIAN SPECIAL PUB, V106, P110, DOI DOI 10.1016/J.MATCHEMPHYS.2012.10.032; Junk WJ, 2006, AQUAT SCI, V68, P278, DOI 10.1007/s00027-006-0851-4; KLINGE H, 1990, FOREST ECOL MANAG, V33-4, P81, DOI 10.1016/0378-1127(90)90186-F; Kumar BSK, 2013, ENVIRON EARTH SCI, V69, P1033, DOI 10.1007/s12665-012-2210-1; Lacerda Filho JW, RECURSOS MINERAIS ES; Lake JL, 2001, CAN J FISH AQUAT SCI, V58, P870, DOI 10.1139/cjfas-58-5-870; LATRUBESSE EM, 2002, Z GEOMORPHOL, P109; Lewis WM, 2001, J N AM BENTHOL SOC, V20, P241, DOI 10.2307/1468319; LIN G, 1992, AUST J PLANT PHYSIOL, V19, P509, DOI 10.1071/PP9920509; Logan JM, 2008, J ANIM ECOL, V77, P838, DOI 10.1111/j.1365-2656.2008.01394.x; Mackereth FYH., 1978, FRESHWATER BIOL ASS, V36, P1, DOI DOI 10.1086/411247; MacLeod NA, 1998, CAN J FISH AQUAT SCI, V55, P1919, DOI 10.1139/cjfas-55-8-1919; Marshall JD, 2007, ECOL METHOD CONCEPT, P22, DOI 10.1002/9780470691854.ch2; McKee KL, 2002, ECOLOGY, V83, P1065, DOI 10.2307/3071914; Medeiros ESF, 2011, ENVIRON BIOL FISH, V90, P1, DOI 10.1007/s10641-010-9706-x; MICHAELSEN J, 1994, J VEG SCI, V5, P673, DOI 10.2307/3235882; Miyajima T, 1997, BIOGEOCHEMISTRY, V36, P205, DOI 10.1023/A:1005702707183; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; OANA S, 1960, AM J SCI, V258, P253; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Peres-Neto PR, 2005, COMPUT STAT DATA AN, V49, P974, DOI 10.1016/j.csda.2004.06.015; Pinheiro CSS, 2013, GEOL USP SER CIENT, V13, P107; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; Powell RL, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00162.1; R Core Team, 2014, R LANG ENV STAT COMP; Radabaugh KR, 2013, CONT SHELF RES, V68, P112, DOI 10.1016/j.csr.2013.08.010; Roach KA, 2013, FRESHW SCI, V32, P283, DOI 10.1899/12-063.1; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Sara G, 2004, AQUACULTURE, V234, P199, DOI 10.1016/j.aquaculture.2003.11.020; Schubert PR, 2013, MAR POLLUT BULL, V72, P64, DOI 10.1016/j.marpolbul.2013.04.029; Sigleo AC, 2002, ESTUAR COAST SHELF S, V54, P701, DOI 10.1006/ecss.2001.0853; Sioli H., 1975, TROPICAL ECOLOGICAL, P275; Sioli H., 1984, AMAZON LIMNOLOGY LAN, DOI [10.1007/978-94-009-6542-3_5, DOI 10.1007/978-94-009-6542-3_5]; Sousa RGC, 2016, FISHERIES MANAG ECOL, V23, P76, DOI 10.1111/fme.12166; Souza EE, 2009, BRAZ J BIOL, V69, P707, DOI 10.1590/S1519-69842009000300024; Souza-Filho EE, 2004, STRUCTURE FUNCTIONIN, V6, P101; Striegl RG, 2001, LIMNOL OCEANOGR, V46, P941, DOI 10.4319/lo.2001.46.4.0941; TAN FC, 1993, ESTUAR COAST SHELF S, V36, P541, DOI 10.1006/ecss.1993.1033; Therneau T., 2015, PACKAGE RPART, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/PACKAGE=RPART; Thomaz SM, 2007, HYDROBIOLOGIA, V579, P1, DOI 10.1007/s10750-006-0285-y; Thomaz Sidinei M., 1992, Revue d'Hydrobiologie Tropicale, V25, P269; Thorp JH, 2006, RIVER RES APPL, V22, P123, DOI 10.1002/rra.901; THORP JH, 1994, OIKOS, V70, P305, DOI 10.2307/3545642; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Veuger B, 2007, LIMNOL OCEANOGR, V52, P1930, DOI 10.4319/lo.2007.52.5.1930; Wang XF, 2000, GEOCHIM COSMOCHIM AC, V64, P3775, DOI 10.1016/S0016-7037(00)00477-4; Wantzen KM, 2002, AQUAT SCI, V64, P239, DOI 10.1007/PL00013196; Winemiller KO, 2011, RIVER RES APPL, V27, P791, DOI 10.1002/rra.1396; Winemiller KO, 2004, FOOD WEB AT THE LANDSCAPE LEVEL, P115; Yu J, 2014, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2014033; Yu JL, 2013, HYDROBIOLOGIA, V710, P39, DOI 10.1007/s10750-012-1205-y	113	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174499	10.1371/journal.pone.0174499	http://dx.doi.org/10.1371/journal.pone.0174499			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358822	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174800044
J	Davies, TK; Mees, CC; Milner-Gulland, EJ				Davies, Tim K.; Mees, Chris C.; Milner-Gulland, E. J.			Use of a counterfactual approach to evaluate the effect of area closures on fishing location in a tropical tuna fishery	PLOS ONE			English	Article							MARINE RESERVES; INDIAN-OCEAN; MANAGEMENT; BENEFITS; ADJACENT; FLEET	Spatial closures are widely used in marine conservation and fisheries management and it is important to understand their contribution to achieving management objectives. Many previous evaluations of closed area effects have used before-after comparisons, which, without controlling for a full range of factors, cannot ascribe changes in fleet behaviour to area closures per se. In this study we used a counterfactual approach to disentangle the effect of two closed areas on fishing location from other competing effects on the behaviour of the Indian Ocean tuna purse seine fishery. Our results revealed an inconsistent effect of the one of the closed areas between years, after taking into account the influence of environmental conditions on fleet behaviour. This suggests that the policy of closing the area per se was not the main driver for the fleet allocating its effort elsewhere. We also showed a marked difference in effect between the two closed areas resulting from their different locations in the fishery area. These findings highlight the need to account for other key fleet behavioural drivers when predicting or evaluating the contribution of area closures to achieving conservation and fishery management objectives.	[Davies, Tim K.] Imperial Coll London, Dept Biol, London, England; [Davies, Tim K.; Mees, Chris C.] MRAG Ltd, London, England; [Milner-Gulland, E. J.] Univ Oxford, Dept Zool, Oxford, England	Imperial College London; University of Oxford	Davies, TK (corresponding author), Imperial Coll London, Dept Biol, London, England.; Davies, TK (corresponding author), MRAG Ltd, London, England.	t.davies@mrag.co.uk			NERC/ESRC [ES/1029273/1]; Pew Marine Fellowship	NERC/ESRC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)Economic & Social Research Council (ESRC)); Pew Marine Fellowship	The study was part of a PhD funded under a joint NERC/ESRC grant. Grant number ES/1029273/1. (The Natural Environment Research Council (NERC), http://www.nerc.ac.uk/, The Economic and Social Research Council (ESRC), http://www.esrc.ac.uk/) EJMG acknowledges the support of a Pew Marine Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dagorn L, 2013, FISH FISH, V14, P391, DOI 10.1111/j.1467-2979.2012.00478.x; Davies TK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114037; Davies TK, 2014, MAR POLICY, V45, P163, DOI 10.1016/j.marpol.2013.12.014; Dunne RP, 2014, ADV MAR BIOL, V69, P79, DOI 10.1016/B978-0-12-800214-8.00003-7; Fogarty MJ, 1998, OCEANOGR LIT REV, V8, P1448; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Hilborn R, 2004, OCEAN COAST MANAGE, V47, P197, DOI 10.1016/j.ocecoaman.2004.04.001; Kaplan DM, 2014, ICES J MAR SCI, V71, P1728, DOI 10.1093/icesjms/fst233; Kaplan DM, 2013, SCIENCE, V340, P810, DOI 10.1126/science.340.6134.810-b; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; McClanahan TR, 1996, CONSERV BIOL, V10, P1187, DOI 10.1046/j.1523-1739.1996.10041187.x; MRAG Ltd, 2010, CONS WHETH EST MAR P; Murawski SA, 2005, ICES J MAR SCI, V62, P1150, DOI 10.1016/j.icesjms.2005.04.005; Murua H, 2011, IOTC2011SC1439, P32; Rijnsdorp AD, 2000, ICES J MAR SCI, V57, P927, DOI 10.1006/jmsc.2000.0580; Russ GR, 2004, ECOL APPL, V14, P597, DOI 10.1890/03-5076; Sheppard CRC, 2012, AQUAT CONSERV, V22, P232, DOI 10.1002/aqc.1248; Smith MD, 2006, CAN J FISH AQUAT SCI, V63, P153, DOI 10.1139/F05-205; Sumaila UR, 2007, MAR ECOL PROG SER, V345, P305, DOI 10.3354/meps07065; Torres-Irineo E, 2011, AQUAT LIVING RESOUR, V24, P337, DOI 10.1051/alr/2011143; Wilcox C, 2003, N AM J FISH MANAGE, V23, P241, DOI 10.1577/1548-8675(2003)023<0241:DCFAAM>2.0.CO;2	21	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174758	10.1371/journal.pone.0174758	http://dx.doi.org/10.1371/journal.pone.0174758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355269	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174600085
J	Meyer, B; Ansorge, C; Nakagaki, T				Meyer, Bernd; Ansorge, Cedrick; Nakagaki, Toshiyuki			The role of noise in self-organized decision making by the true slime mold Physarum polycephalum	PLOS ONE			English	Article							NETWORK; ENVIRONMENTS; DYNAMICS; TIME; ANTS	Self-organized mechanisms are frequently encountered in nature and known to achieve flexible, adaptive control and decision-making. Noise plays a crucial role in such systems: It can enable a self-organized system to reliably adapt to short-term changes in the environment while maintaining a generally stable behavior. This is fundamental in biological systems because they must strike a delicate balance between stable and flexible behavior. In the present paper we analyse the role of noise in the decision-making of the true slime mold Physarum polycephalum, an important model species for the investigation of computational abilities in simple organisms. We propose a simple biological experiment to investigate the reaction of P. polycephalum to time-variant risk factors and present a stochastic extension of an established mathematical model for P. polycephalum to analyze this experiment. It predicts that-due to the mechanism of stochastic resonance D noise can enable P. polycephalum to correctly assess time-variant risk factors, while the corresponding noise-free system fails to do so. Beyond the study of P. polycephalum we demonstrate that the influence of noise on self-organized decision-making is not tied to a specific organism. Rather it is a general property of the underlying process dynamics, which appears to be universal across a wide range of systems. Our study thus provides further evidence that stochastic resonance is a fundamental component of the decision-making in self-organized macroscopic and microscopic groups and organisms.	[Meyer, Bernd] Monash Univ, Fac Informat Technol, Melbourne, Vic, Australia; [Ansorge, Cedrick] Univ Cologne, Inst Geophys & Meteorol, Cologne, Germany; [Nakagaki, Toshiyuki] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido, Japan	Monash University; University of Cologne; Hokkaido University	Meyer, B (corresponding author), Monash Univ, Fac Informat Technol, Melbourne, Vic, Australia.	bernd.meyer@monash.edu	Nakagaki, Toshiyuki/L-3049-2013; Ansorge, Cedrick/Q-7839-2018	Nakagaki, Toshiyuki/0000-0002-3446-4888; Ansorge, Cedrick/0000-0001-9913-3759	Australian Research Council [DP110101413]	Australian Research Council(Australian Research Council)	BM and TN received funding from the Australian Research Council (http://www.arc.gov.au/) under grant no. DP110101413. The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, HDB STOCHASTIC METHO; Ben-Jacob E, 2000, ADV PHYS, V49, P395, DOI 10.1080/000187300405228; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Capasso V., 2021, INTRO CONTINUOUS TIM, DOI [10.1007/978-3-030-69653-5, DOI 10.1007/978-3-030-69653-5]; Denny AJ, 2001, ANIM BEHAV, V62, P139, DOI 10.1006/anbe.2001.1718; Dimonte A, 2016, BIOSYSTEMS, V140, P23, DOI 10.1016/j.biosystems.2015.12.008; Dussutour A, 2009, P ROY SOC B-BIOL SCI, V276, P4353, DOI 10.1098/rspb.2009.1235; Fewell JH, 2003, SCIENCE, V301, P1867, DOI 10.1126/science.1088945; GILLESPIE DT, 1992, MARKOV PROCESSES; Hamann H, 2010, SIMULATION ADAPTIVE; HATO M, 1976, Cell Structure and Function, V1, P269; Ito K, 2010, NONLINEAR THEORY ITS, V1, P26; Meyer B, 2008, IEEE INT C SELF AD S; Meyer B, 2008, SIMULATION OF ADAPTI; Nakagaki T, 2000, NATURE, V407, P470, DOI 10.1038/35035159; Nakagaki T, 2008, SOFT MATTER, V4, P57, DOI 10.1039/b706317m; Nakagaki T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.068104; Nakagaki T, 2008, NEW GENERAT COMPUT, V27, P57, DOI 10.1007/s00354-008-0054-8; Nicolis SC, 1999, J THEOR BIOL, V198, P575, DOI 10.1006/jtbi.1999.0934; PIERCE GJ, 1987, OIKOS, V49, P111, DOI 10.2307/3565560; Reid CR, 2012, P NATL ACAD SCI USA, V109, P17490, DOI 10.1073/pnas.1215037109; Risken H., 1989, FOKKER PLANCK EQUATI, DOI DOI 10.1007/978-3-642-61544-3; Saigusa T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018101; Sole R. V., 1996, Complexity, V2, P49, DOI 10.1002/(SICI)1099-0526(199611/12)2:2<49::AID-CPLX13>3.0.CO;2-T; Tero A, 2008, THEOR BIOSCI, V127, P89, DOI 10.1007/s12064-008-0037-9; Tero A, 2007, J THEOR BIOL, V244, P553, DOI 10.1016/j.jtbi.2006.07.015; Tero A, 2010, SCIENCE, V327, P439, DOI 10.1126/science.1177894; Vicsek T, 2001, NATURE, V411, P421, DOI 10.1038/35078161; Weisbuch G, 2000, PHYSICA A, V287, P563, DOI 10.1016/S0378-4371(00)00393-9; Yates CA, 2009, P NATL ACAD SCI USA, V106, P5464, DOI 10.1073/pnas.0811195106	30	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0172933	10.1371/journal.pone.0172933	http://dx.doi.org/10.1371/journal.pone.0172933			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355213	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174600006
J	Ramirez-Lopez, MT; Vazquez, M; Lomazzo, E; Hofmann, C; Blanco, RN; Alen, F; Anton, M; Decara, J; Arco, R; Orio, L; Suarez, J; Lutz, B; de Heras, RG; Bindila, L; de Fonseca, FR				Teresa Ramirez-Lopez, Maria; Vazquez, Mariam; Lomazzo, Ermelinda; Hofmann, Clementine; Noemi Blanco, Rosario; Alen, Francisco; Anton, Maria; Decara, Juan; Arco, Rocio; Orio, Laura; Suarez, Juan; Lutz, Beat; Gomez de Heras, Raquel; Bindila, Laura; Rodriguez de Fonseca, Fernando			A moderate diet restriction during pregnancy alters the levels of endocannabinoids and endocannabinoid-related lipids in the hypothalamus, hippocampus and olfactory bulb of rat offspring in a sex-specific manner	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIORS; LOW-BIRTH-WEIGHT; FATTY-ACIDS; PRENATAL EXPOSURE; CALORIC RESTRICTION; PROTEIN RESTRICTION; ENERGY HOMEOSTASIS; EATING-DISORDERS; DUTCH FAMINE; BODY-WEIGHT	Undernutrition during pregnancy has been associated to increased vulnerability to develop metabolic and behavior alterations later in life. The endocannabinoid system might play an important role in these processes. Therefore, we investigated the effects of a moderate maternal calorie-restricted diet on the levels of the endocannabinoid 2-arachidonoyl glycerol (2-AG), arachidonic acid (AA) and the N-acylethanolamines (NAEs) anandamide (AEA), oleoylethanolamide (OEA) and palmitoylethanolamide (PEA) in the brain of newborn rat offspring. We focused on brain structures involved in metabolism, feeding behavior, as well as emotional and cognitive responses. Female Wistar rats were assigned during the entire pregnancy to either control diet (C) or restriction diet (R), consisting of a 20% calorierestricted diet. Weight gain and caloric intake of rat dams were monitored and birth outcomes were assessed. 2-AG, AA and NAE levels were measured in hypothalamus, hippocampus and olfactory bulb of the offspring. R dams displayed lower gain weight from the middle pregnancy and consumed less calories during the entire pregnancy. Offspring from R dams were underweight at birth, but litter size was unaffected. In hypothalamus, R male offspring displayed decreased levels of AA and OEA, with no change in the levels of the endocannabinoids 2-AG and AEA. R female exhibited decreased 2-AG and PEA levels. The opposite was found in the hippocampus, where R male displayed increased 2-AG and AA levels, and R female exhibited elevated levels of AEA, AA and PEA. In the olfactory bulb, only R female presented decreased levels of AEA, AA and PEA. Therefore, a moderate diet restriction during the entire pregnancy alters differentially the endocannabinoids and/or endocannabinoid-related lipids in hypothalamus and hippocampus of the underweight offspring, similarly in both sexes, whereas sex-specific alterations occur in the olfactory bulb. Consequently, endocannabinoid and endocannabinoid-related lipid signaling alterations might be involved in the long-term and sexual dimorphism effects commonly observed after undernutrition and low birth weight.	[Teresa Ramirez-Lopez, Maria; Vazquez, Mariam; Noemi Blanco, Rosario; Alen, Francisco; Anton, Maria; Orio, Laura; Gomez de Heras, Raquel; Rodriguez de Fonseca, Fernando] Univ Complutense Madrid, Fac Psicol, Dept Psicobiol, Campus Somosaguas S-N, Madrid, Spain; [Vazquez, Mariam; Decara, Juan; Arco, Rocio; Suarez, Juan; Rodriguez de Fonseca, Fernando] Univ Malaga, Hosp Reg Univ Malaga, Unidad Gest Clin Salud Mental, IBIMA, Malaga, Spain; [Lomazzo, Ermelinda; Hofmann, Clementine; Lutz, Beat; Bindila, Laura] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, Mainz, Germany; [Suarez, Juan] Univ Malaga, Fac Ciencias, IBIMA, Dept Biol Celular Genet & Fisiol, Campus Teatinos S-N, Malaga, Spain	Complutense University of Madrid; Universidad de Malaga; Johannes Gutenberg University of Mainz; Universidad de Malaga	de Heras, RG; de Fonseca, FR (corresponding author), Univ Complutense Madrid, Fac Psicol, Dept Psicobiol, Campus Somosaguas S-N, Madrid, Spain.; de Fonseca, FR (corresponding author), Univ Malaga, Hosp Reg Univ Malaga, Unidad Gest Clin Salud Mental, IBIMA, Malaga, Spain.	rgomezhe@psi.ucm.es; fernando.rodriguez@ibima.eu	Alen, Francisco/I-3890-2017; de Heras, Raquel Gomez/F-3484-2016; Ramírez-López, María Teresa/AAB-5705-2021; Lutz, Beat/AAG-4538-2022; Suarez, Juan/I-5188-2015; Orio, Laura/F-4827-2016; Lutz, Beat/AFK-6229-2022; Anton, Maria/A-9767-2016; Decara Del Olmo, Juan Manuel/I-1931-2015	Alen, Francisco/0000-0002-3847-3503; de Heras, Raquel Gomez/0000-0002-5846-1059; Ramírez-López, María Teresa/0000-0002-3944-5264; Suarez, Juan/0000-0001-5254-9802; Orio, Laura/0000-0002-9614-4062; Anton, Maria/0000-0002-7232-6291; Decara Del Olmo, Juan Manuel/0000-0002-9868-015X; RODRIGUEZ DE FONSECA, FERNANDO/0000-0002-4516-5795; Blanco Velilla, Rosario Noemi/0000-0003-0265-6655; Arco Gonzalez, Rocio/0000-0002-5618-5687	Institute de Salud Carlos III, Ministerio de Economia y Competitividad [PI12/02261, PI16/11698, PI16/01374, CP12/03109, PSI 2012-35388]; Red de Trastornos Adictivos UE/ERDF [RD12/0028/0001]; CIBERobn; Consejeria de Economia, Innovacion y Ciencia; Junta de Andalucia; UE/ERDF [PI45403, CTS-8221, CTS-433]; Consejeria de Salud, Junta de Andalucia [SAS111224]; German Research Foundation DFG [FOR926, CRC1080]; FPU predoctoral fellowship of the Spanish Ministerio de Educacion, Cultura y Deporte [AP-2009-0225]; National System of Health, ISCIII [CP12/03109]	Institute de Salud Carlos III, Ministerio de Economia y Competitividad; Red de Trastornos Adictivos UE/ERDF; CIBERobn; Consejeria de Economia, Innovacion y Ciencia; Junta de Andalucia(Junta de Andalucia); UE/ERDF; Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); German Research Foundation DFG(German Research Foundation (DFG)); FPU predoctoral fellowship of the Spanish Ministerio de Educacion, Cultura y Deporte; National System of Health, ISCIII	This work was supported by the Institute de Salud Carlos III, Ministerio de Economia y Competitividad (PI12/02261 and PI16/11698 to FRF, PI16/01374 and CP12/03109 to JS, and PSI 2012-35388 to RGH), Red de Trastornos Adictivos UE/ERDF (RD12/0028/0001 to FRF), CIBERobn, Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, UE/ERDF (PI45403, CTS-8221, CTS-433 to FRF), Consejeria de Salud, Junta de Andalucia (SAS111224 to FRF), and the German Research Foundation DFG (FOR926, project CP1 to BL; CRC1080, subproject B08 to BL). MTRL has been funded by a FPU predoctoral fellowship of the Spanish Ministerio de Educacion, Cultura y Deporte (AP-2009-0225); JS holds "Miguel Servet" research contract from the National System of Health, ISCIII (grant numbers CP12/03109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CE, 2013, REPRODUCTION, V145, pR1, DOI 10.1530/REP-11-0489; Akitake Y, 2015, NUTR RES, V35, P76, DOI 10.1016/j.nutres.2014.10.014; Almeida SS, 1996, PHYSIOL BEHAV, V60, P675, DOI 10.1016/S0031-9384(96)80047-3; Amusquivar E, 2003, BIOL NEONATE, V83, P136, DOI 10.1159/000067963; Antonelli T, 2005, CEREB CORTEX, V15, P2013, DOI 10.1093/cercor/bhi076; Artmann A, 2008, BBA-MOL CELL BIOL L, V1781, P200, DOI 10.1016/j.bbalip.2008.01.006; Avraham Y, 2011, J NUTR BIOCHEM, V22, P766, DOI 10.1016/j.jnutbio.2010.07.001; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bernard C, 2005, P NATL ACAD SCI USA, V102, P9388, DOI 10.1073/pnas.0409641102; Berrendero F, 1999, SYNAPSE, V33, P181, DOI 10.1002/(SICI)1098-2396(19990901)33:3<181::AID-SYN3>3.0.CO;2-R; Bieswal F, 2006, OBESITY, V14, P1330, DOI 10.1038/oby.2006.151; Bindila L, 2016, METHODS MOL BIOL, V1412, P9, DOI 10.1007/978-1-4939-3539-0_2; Bolton JL, 2014, DIALOGUES CLIN NEURO, V16, P307; Campos AC, 2010, NEUROSCIENCE, V167, P238, DOI 10.1016/j.neuroscience.2010.01.062; Cetin I, 2009, J PHYSIOL-LONDON, V587, P3441, DOI 10.1113/jphysiol.2009.173062; Clarke DJ, 2017, PROG NEURO-PSYCHOPH, V72, P9, DOI 10.1016/j.pnpbp.2016.08.006; CoupE B, 2009, J NEUROENDOCRINOL, V21, P40, DOI 10.1111/j.1365-2826.2008.01806.x; Coupe B, 2010, ENDOCRINOLOGY, V151, P702, DOI 10.1210/en.2009-0893; Cristino L, 2014, BIOFACTORS, V40, P389, DOI 10.1002/biof.1168; D'Asti E, 2010, ENDOCRINOLOGY, V151, P1685, DOI 10.1210/en.2009-1092; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; de Salas-Quiroga A, 2015, P NATL ACAD SCI USA, V112, P13693, DOI 10.1073/pnas.1514962112; de Souza MA, 2012, PHYSIOL BEHAV, V105, P850, DOI 10.1016/j.physbeh.2011.10.012; DEFONSECA FR, 1991, NEUROSCIENCE, V43, P713, DOI 10.1016/0306-4522(91)90329-M; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; Desai M, 2005, AM J PHYSIOL-REG I, V288, pR91, DOI 10.1152/ajpregu.00340.2004; Desai M, 2007, AM J PHYSIOL-REG I, V293, pR2306, DOI 10.1152/ajpregu.00783.2006; DeVader SR, 2007, OBSTET GYNECOL, V110, P745, DOI 10.1097/01.AOG.0000284451.37882.85; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Dyall SC, 2016, NEUROPHARMACOLOGY, V107, P387, DOI 10.1016/j.neuropharm.2016.03.055; Easter A, 2013, EUR EAT DISORD REV, V21, P340, DOI 10.1002/erv.2229; Fezza F, 2014, MOLECULES, V19, P17078, DOI 10.3390/molecules191117078; Gabory A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047986; Gallou-Kabani C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014398; Garcia AP, 2010, DIABETES OBES METAB, V12, P403, DOI 10.1111/j.1463-1326.2009.01174.x; Guggenhuber S, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv091; Hadley KB, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040216; Hansen HS, 2008, J NEUROENDOCRINOL, V20, P94, DOI 10.1111/j.1365-2826.2008.01687.x; Hansen HS, 2013, CNS NEUROL DISORD-DR, V12, P17; Herrera E, 2002, PLACENTA, V23, pS9, DOI 10.1053/plac.2002.0771; Hoareau L, 2010, DRUG DISCOVERY TODAY, V7, pe205, DOI [10.1016/j.ddmec.2011.01.002, DOI 10.1016/J.DDMEC.2011.01.002]; Jamshidi N, 2001, BRIT J PHARMACOL, V134, P1151, DOI 10.1038/sj.bjp.0704379; Jenniches I, 2016, BIOL PSYCHIAT, V79, P858, DOI 10.1016/j.biopsych.2015.03.033; Keimpema E, 2014, EUR J NEUROSCI, V39, P334, DOI 10.1111/ejn.12431; Keimpema E, 2013, BIOCHEM SOC T, V41, P1569, DOI 10.1042/BST20130117; Lafourcade M, 2011, NAT NEUROSCI, V14, P345, DOI 10.1038/nn.2736; Larrieu T, 2012, J PHYSIOL BIOCHEM, V68, P671, DOI 10.1007/s13105-012-0179-6; Levay EA, 2008, BEHAV BRAIN RES, V191, P164, DOI 10.1016/j.bbr.2008.03.021; LUCAS A, 1991, CIBA F SYMP, V156, P38; Lukaszewski MA, 2011, AM J PHYSIOL-ENDOC M, V301, pE548, DOI 10.1152/ajpendo.00011.2011; Lussana F, 2008, AM J CLIN NUTR, V88, P1648, DOI 10.3945/ajcn.2008.26140; Lutz B, 2015, NAT REV NEUROSCI, V16, P705, DOI 10.1038/nrn4036; Lutz B, 2009, CURR OPIN PHARMACOL, V9, P46, DOI 10.1016/j.coph.2008.12.001; Maccarrone M, 2014, NAT REV NEUROSCI, V15, P786, DOI 10.1038/nrn3846; Madore C, 2014, BRAIN BEHAV IMMUN, V41, P22, DOI 10.1016/j.bbi.2014.03.021; Marques AH, 2015, BRAIN RES, V1617, P28, DOI 10.1016/j.brainres.2014.10.051; Matias I, 2003, CELL MOL LIFE SCI, V60, P382, DOI 10.1007/s000180300031; McMillen IC, 2004, ENDOCR RES, V30, P845, DOI 10.1081/ERC-200044106; Micali N, 2007, J PSYCHOSOM RES, V63, P297, DOI 10.1016/j.jpsychores.2007.05.003; Micali N, 2007, BRIT J PSYCHIAT, V190, P255, DOI 10.1192/bjp.bp.106.020768; Moreno M, 2005, BEHAV PHARMACOL, V16, P423, DOI 10.1097/00008877-200509000-00015; Morgese MG, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6030024; Morgese MG, 2016, MOL NEUROBIOL; Nomura Y, 2007, COMPR PSYCHIAT, V48, P470, DOI 10.1016/j.comppsych.2007.04.005; Palou M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-69; Garcia AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017313; Pu SH, 2016, BRIT J NUTR, V115, P1012, DOI 10.1017/S0007114515005425; Ramirez-Lopez MT, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00241; Ramirez-Lopez MT, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00208; Rana JS, 2007, DIABETES OBES METAB, V9, P218, DOI 10.1111/j.1463-1326.2006.00594.x; Raso GM, 2014, ENDOCRINOLOGY, V155, P1291, DOI 10.1210/en.2013-1823; Reyes-Castro LA, 2012, BEHAV BRAIN RES, V227, P324, DOI 10.1016/j.bbr.2011.06.008; Reyes-Castro LA, 2012, INT J DEV NEUROSCI, V30, P39, DOI 10.1016/j.ijdevneu.2011.10.002; Rickards AL, 2001, J DEV BEHAV PEDIATR, V22, P11, DOI 10.1097/00004703-200102000-00002; Rivera P, 2013, EUR J NEUROSCI, V37, P105, DOI 10.1111/ejn.12012; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Soria-Gomez E, 2014, NAT NEUROSCI, V17, P407, DOI 10.1038/nn.3647; Suzuki M, 2010, J NUTR SCI VITAMINOL, V56, P293, DOI 10.3177/jnsv.56.293; Ramirez-Lopez MT, 2016, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00339; Tibirica E, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-5; Watanabe S, 2003, PROSTAG LEUKOTR ESS, V69, P51, DOI 10.1016/S0952-3278(03)00056-5; Wenzel D, 2013, P NATL ACAD SCI USA, V110, P18710, DOI 10.1073/pnas.1308130110; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Williams CM, 1999, PSYCHOPHARMACOLOGY, V143, P315, DOI 10.1007/s002130050953; Zhang S, 2013, REPRODUCTION, V146, P443, DOI 10.1530/REP-13-0219	85	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174307	10.1371/journal.pone.0174307	http://dx.doi.org/10.1371/journal.pone.0174307			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VD	28346523	gold, Green Submitted, Green Published			2022-12-26	WOS:000399174300037
J	Dovmark, TH; Saccomano, M; Hulikova, A; Alves, F; Swietach, P				Dovmark, T. H.; Saccomano, M.; Hulikova, A.; Alves, F.; Swietach, P.			Connexin-43 channels are a pathway for discharging lactate from glycolytic pancreatic ductal adenocarcinoma cells	ONCOGENE			English	Article							GAP-JUNCTION; TUMOR-CELLS; CANCER; HYPOXIA; ACID; PH; EXPRESSION; GROWTH; MCT4; COMMUNICATION	Glycolytic cancer cells produce large quantities of lactate that must be removed to sustain metabolism in the absence of oxidative phosphorylation. The only venting mechanism described to do this at an adequate rate is H--(+) coupled lactate efflux on monocarboxylate transporters (MCTs). Outward MCT activity is, however, thermodynamically inhibited by extracellular acidity, a hallmark of solid tumours. This inhibition would feedback unfavourably on metabolism and growth, raising the possibility that other venting mechanisms become important in under-perfused tumours. We investigated connexin-assembled gap junctions as an alternative route for discharging lactate from pancreatic ductal adenocarcinoma (PDAC) cells. Diffusive coupling (calcein transmission) in vitro was strong between Colo357 cells, weaker yet hypoxia-inducible between BxPC3 cells, and very low between MiaPaCa2 cells. Coupling correlated with levels of connexin-43 (Cx43), a protein previously linked to late-stage disease. Evoked lactate dynamics, imaged in Colo357 spheroids using cytoplasmic pH as a read-out, indicated that lactate anions permeate gap junctions faster than highly-buffered H+ ions. At steady-state, junctional transmission of lactate (a chemical base) from the spheroid core had an alkalinizing effect on the rim, producing therein a milieu conducive for growth. Metabolite assays demonstrated that Cx43 knockdown increased cytoplasmic lactate retention in Colo357 spheroids (diameter similar to 150 mu m). MiaPaCa2 cells, which are Cx43 negative in monolayer culture, showed markedly increased Cx43 immunoreactivity at areas of invasion in orthotopic xenograft mouse models. These tissue areas were associated with chronic extracellular acidosis (as indicated by the marker LAMP2 near/at the plasmalemma), which can explain the advantage of junctional transmission over MCT in vivo. We propose that Cx43 channels are important conduits for dissipating lactate anions from glycolytic PDAC cells. Furthermore, lactate entry into the better-perfused recipient cells has a favourable alkalinizing effect and supplies substrate for oxidative phosphorylation. Cx43 is thus a novel target for influencing metabolite handling in junctionally-coupled tumours.	[Dovmark, T. H.; Hulikova, A.; Swietach, P.] Univ Oxford, Dept Physiol Anat & Genet, Pk Rd, Oxford OX1 3PT, England; [Saccomano, M.; Alves, F.] Max Planck Inst Expt Med, Gottingen, Germany; [Alves, F.] Univ Med Ctr Goettingen, Inst Diagnost & Intervent Radiol, Gottingen, Germany; [Alves, F.] Univ Med Ctr Goettingen, Dept Haematol & Med Oncol, Gottingen, Germany	University of Oxford; Max Planck Society; University of Gottingen; University of Gottingen	Swietach, P (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Pk Rd, Oxford OX1 3PT, England.	pawel.swietach@dpag.ox.ac.uk	Swietach, Pawel/AAK-4169-2020	Swietach, Pawel/0000-0002-9945-9473	European Commission through the IONTRAC Marie Curie Initial Training Network (FP7-PEOPLE-ITN Grant) [289648]; Worldwide Cancer Research [2012/0027]; Royal Society; Worldwide Cancer Research [12-0027] Funding Source: researchfish	European Commission through the IONTRAC Marie Curie Initial Training Network (FP7-PEOPLE-ITN Grant); Worldwide Cancer Research; Royal Society(Royal Society of London); Worldwide Cancer Research	We thank Barbel Heidrich, Sabine Wolfgramm and Bettina Jeep for excellent technical assistance. We thank Vicky Ball for performing measurements on the ABX Pentra 400 system. This study is supported by the European Commission through the IONTRAC Marie Curie Initial Training Network (FP7-PEOPLE-2011-ITN Grant 289648), Royal Society and Worldwide Cancer Research (2012/0027).	Damaghi M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9752; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; ELSABBAN ME, 1991, J CELL BIOL, V115, P1375, DOI 10.1083/jcb.115.5.1375; Elzarrad MK, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-20; Faller BA, 2009, BIOL-TARGETS THER, V3, P419; Gadaleta E, 2011, NUCLEIC ACIDS RES, V39, P7900, DOI 10.1093/nar/gkr533; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gillies RJ, 2002, J MAGN RESON IMAGING, V16, P430, DOI 10.1002/jmri.10181; Grillo-Hill BK, 2015, ELIFE, V4, DOI 10.7554/eLife.03270; Guillaumond F, 2013, P NATL ACAD SCI USA, V110, P3919, DOI 10.1073/pnas.1219555110; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hulikova A, 2016, P NATL ACAD SCI USA, V113, pE5344, DOI 10.1073/pnas.1610954113; Hulikova A, 2014, J BIOL CHEM, V289, P25418, DOI 10.1074/jbc.M114.547844; Hulikova A, 2011, J BIOL CHEM, V286, P13815, DOI 10.1074/jbc.M111.219899; Ito A, 2000, J CLIN INVEST, V105, P1189, DOI 10.1172/JCI8257; Kennedy KM, 2010, FUTURE ONCOL, V6, P127, DOI [10.2217/fon.09.145, 10.2217/FON.09.145]; Koong AC, 2000, INT J RADIAT ONCOL, V48, P919, DOI 10.1016/S0360-3016(00)00803-8; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Le Floch R, 2011, P NATL ACAD SCI USA, V108, P16663, DOI 10.1073/pnas.1106123108; Lin JHC, 2002, J NEUROSCI, V22, P4302, DOI 10.1523/JNEUROSCI.22-11-04302.2002; LOEWENSTEIN WR, 1966, NATURE, V209, P1248, DOI 10.1038/2091248a0; Maupin KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013002; McLachlan E, 2006, CANCER RES, V66, P9886, DOI 10.1158/0008-5472.CAN-05-4302; Mesnil M, 2002, BIOL CELL, V94, P493, DOI 10.1016/S0248-4900(02)00025-4; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Moll W, 2008, J APPL PHYSIOL, V105, P365, DOI 10.1152/japplphysiol.zdg-8016-pcpcomm.2008; MORGAN RT, 1980, INT J CANCER, V25, P591, DOI 10.1002/ijc.2910250507; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; Ojugo ASE, 1999, NMR BIOMED, V12, P495, DOI 10.1002/(SICI)1099-1492(199912)12:8<495::AID-NBM594>3.0.CO;2-K; Oliveira-Cunha Melissa, 2011, Cancers (Basel), V3, P1513, DOI 10.3390/cancers3021513; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Putney LK, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-46; Richards M, 2016, CARDIOVASC RES, V110, P395, DOI 10.1093/cvr/cvw080; Saccomano M, 2016, INT J CANCER, V139, P2277, DOI 10.1002/ijc.30277; San Martin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057712; Schilling F, 2013, NMR BIOMED, V26, P557, DOI 10.1002/nbm.2892; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Swietach P, 2007, CIRC RES, V100, P1045, DOI 10.1161/01.RES.0000264071.11619.47; Swietach P, 2009, J BIOL CHEM, V284, P20299, DOI 10.1074/jbc.M109.006478; TANNOCK IF, 1989, CANCER RES, V49, P4373; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; VAUPEL P, 1990, ADV EXP MED BIOL, V277, P895; Whitaker-Menezes D, 2011, CELL CYCLE, V10, P1772, DOI 10.4161/cc.10.11.15659; Zhang A, 2015, ONCOTARGET, V6, P11640, DOI 10.18632/oncotarget.3449	45	40	42	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 10	2017	36	32					4538	4550		10.1038/onc.2017.71	http://dx.doi.org/10.1038/onc.2017.71			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FD0RK	28368405	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-26	WOS:000407246200002
J	Yin, YT; de Waal, PW; He, YZ; Zhao, LH; Yang, DH; Cai, XQ; Jiang, Y; Melcher, K; Wang, MW; Xu, HE				Yin, Yanting; de Waal, Parker W.; He, Yuanzheng; Zhao, Li-Hua; Yang, Dehua; Cai, Xiaoqing; Jiang, Yi; Melcher, Karsten; Wang, Ming-Wei; Xu, H. Eric			Rearrangement of a polar core provides a conserved mechanism for constitutive activation of class B G protein-coupled receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; BETA(2) ADRENERGIC-RECEPTOR; CROSS-LINKING STRATEGY; GLUCAGON RECEPTOR; METAPHYSEAL CHONDRODYSPLASIA; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; LIGAND-BINDING; IONIC LOCK; PEPTIDE	The glucagon receptor (GCGR) belongs to the secretin-like (class B) family of G protein-coupled receptors (GPCRs) and is activated by the peptide hormone glucagon. The structures of an activated class B GPCR have remained unsolved, preventing a mechanistic understanding of how these receptors are activated. Using a combination of structural modeling and mutagenesis studies, we present here two modes of ligand-independent activation of GCGR. First, we identified a GCGR-specific hydrophobic lock comprising Met-338 and Phe-345 within the IC3 loop and transmembrane helix 6 (TM6) and found that this lock stabilizes the TM6 helix in the inactive conformation. Disruption of this hydrophobic lock led to constitutive G protein and arrestin signaling. Second, we discovered a polar core comprising conserved residues in TM2, TM3, TM6, and TM7, and mutations that disrupt this polar core led to constitutive GCGR activity. On the basis of these results, we propose a mechanistic model of GCGR activation in which TM6 is held in an inactive conformation by the conserved polar core and the hydrophobic lock. Mutations that disrupt these inhibitory elements allow TM6 to swing outward to adopt an active TM6 conformation similar to that of the canonical beta(2)-adrenergic receptor complexed with G protein and to that of rhodopsin complexed with arrestin. Importantly, mutations in the corresponding polar core of several other members of class B GPCRs, including PTH1R, PAC1R, VIP1R, and CRFR1, also induce constitutive G protein signaling, suggesting that the rearrangement of the polar core is a conserved mechanism for class B GPCR activation.	[Yin, Yanting; Zhao, Li-Hua; Jiang, Yi; Xu, H. Eric] Chinese Acad Sci, Van Andel Res Inst, Shanghai Inst Mat Med VARI SIMM Ctr,Shanghai Inst, Ctr Struct & Funct Drug Targets,CAS Key Lab Recep, Shanghai 201203, Peoples R China; [Yin, Yanting; de Waal, Parker W.; He, Yuanzheng; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Yin, Yanting; de Waal, Parker W.; He, Yuanzheng; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Lab Struct Biol & Biochem, Grand Rapids, MI 49503 USA; [Yin, Yanting; Xu, H. Eric] Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China; [Yang, Dehua; Cai, Xiaoqing; Wang, Ming-Wei] Chinese Acad Sci, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China; [Yang, Dehua; Cai, Xiaoqing; Wang, Ming-Wei] Chinese Acad Sci, CAS Key Lab Receptor Res, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Wang, Ming-Wei] Fudan Univ, Sch Pharm, 826 Zhangheng Rd, Shanghai 201203, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Van Andel Institute; Van Andel Institute; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Fudan University	Wang, MW (corresponding author), Natl Ctr Drug Screening, 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China.; Xu, HE (corresponding author), Van Andel Res Inst, Ctr Struct Biol & Drug Discovery, Lab Struct Sci, Grand Rapids, MI 49503 USA.	mwwang@simm.ac.cn; Eric.Xu@vai.org	Yang, Dehua/M-5789-2019; Melcher, Karsten/AAZ-3861-2020; Xu, H. Eric/ABD-7487-2021; Yang, Dehua/S-6156-2017; de Waal, Parker/M-1138-2017	Melcher, Karsten/0000-0002-9125-4027; Xu, H. Eric/0000-0002-6829-8144; de Waal, Parker/0000-0001-6922-9768; Yin, Yanting/0000-0001-9310-1094; He, Yuanzheng/0000-0001-9131-140X	National Natural Science Foundation of China [31300245]; Jay and Betty Van Andel Foundation, Ministry of Science and Technology of China [2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, 2013ZX09507001]; Amway (China); National Institutes of Health [DK071662, GM102545, GM104212]; Outstanding Young Scientist Foundation of CAS; Youth Innovation Promotion Association of CAS; Shanghai Science and Technology Development Fund [15DZ2291600, 14431901200]; National Natural Science Foundation [81373463]; CAS; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102545, R01GM104212] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jay and Betty Van Andel Foundation, Ministry of Science and Technology of China; Amway (China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Outstanding Young Scientist Foundation of CAS; Youth Innovation Promotion Association of CAS; Shanghai Science and Technology Development Fund; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Natural Science Foundation of China Grant 31300245 (to L. H. Z.) and in part by the Jay and Betty Van Andel Foundation, Ministry of Science and Technology of China Grants 2012ZX09301001, 2012CB910403, 2013CB910600, XDB08020303, and 2013ZX09507001; Amway (China); National Institutes of Health Grants DK071662 (to H. E. X.) and GM102545 and GM104212 (to K. M.); the Outstanding Young Scientist Foundation of CAS; the Youth Innovation Promotion Association of CAS; Shanghai Science and Technology Development Fund Grants 15DZ2291600 and 14431901200 (to M. W. W.); National Natural Science Foundation Grant 81373463 (to D. Y.); and the CAS-Novo Nordisk Research Fund (to D. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Fortin JP, 2009, P NATL ACAD SCI USA, V106, P8049, DOI 10.1073/pnas.0900149106; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Han SJ, 2005, J BIOL CHEM, V280, P34849, DOI 10.1074/jbc.M506711200; Hancock AS, 2010, MOL ENDOCRINOL, V24, P1605, DOI 10.1210/me.2010-0120; Hennen S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26236; Hjorth SA, 1998, MOL ENDOCRINOL, V12, P78, DOI 10.1210/mend.12.1.0045; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Jazayeri A, 2016, NATURE, V533, P274, DOI 10.1038/nature17414; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019682; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Mason JS, 2012, TRENDS PHARMACOL SCI, V33, P249, DOI 10.1016/j.tips.2012.02.005; Mukund S, 2013, J BIOL CHEM, V288, P36168, DOI 10.1074/jbc.M113.496984; Nampoothiri S, 2016, J CLIN ENDOCR METAB, V101, P4283, DOI 10.1210/jc.2016-2054; Nolte WM, 2014, NAT CHEM BIOL, V10, P629, DOI 10.1038/nchembio.1581; Pabreja K, 2014, BRIT J PHARMACOL, V171, P1114, DOI 10.1111/bph.12313; Pal K, 2012, ACTA PHARMACOL SIN, V33, P300, DOI 10.1038/aps.2011.170; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; PEI G, 1994, P NATL ACAD SCI USA, V91, P2699, DOI 10.1073/pnas.91.7.2699; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Rasmussen SGF, 1999, MOL PHARMACOL, V56, P175, DOI 10.1124/mol.56.1.175; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; REN Q, 1993, J BIOL CHEM, V268, P16483; Schipani E, 1997, MOL ENDOCRINOL, V11, P851, DOI 10.1210/me.11.7.851; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Siu FY, 2010, STRUCTURE, V18, P1067, DOI 10.1016/j.str.2010.08.004; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Ward SDC, 2002, J BIOL CHEM, V277, P2247, DOI 10.1074/jbc.M107647200; Ward SDC, 2006, BIOCHEMISTRY-US, V45, P676, DOI 10.1021/bi051503q; Wittelsberger A, 2006, BIOCHEMISTRY-US, V45, P2027, DOI 10.1021/bi051833a; Yang LL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8859; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Yin YT, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.42; Zhao LH, 2016, J BIOL CHEM, V291, P15119, DOI 10.1074/jbc.M116.726620	38	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 16	2017	292	24					9865	9881		10.1074/jbc.M117.782987	http://dx.doi.org/10.1074/jbc.M117.782987			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX9LW	28356352	hybrid, Green Published			2022-12-26	WOS:000403580600002
J	Chen, L; Bi, DL; Lu, ZH; McClafferty, H; Shipston, MJ				Chen, Lie; Bi, Danlei; Lu, Zen Huat; McClafferty, Heather; Shipston, Michael J.			Distinct domains of the beta 1-subunit cytosolic N terminus control surface expression and functional properties of large-conductance calcium-activated potassium (BK) channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						channel activation; electrophysiology; membrane trafficking; membrane transport; potassium channel	CA2+-ACTIVATED K+ CHANNEL; BETA-SUBUNIT; STRUCTURE PREDICTION; SWISS-MODEL; WEB SERVER; VOLTAGE; ALPHA; MODULATION; TRAFFICKING; PALMITOYLATION	The properties and function of large-conductance calcium- and voltage-activated potassium (BK) channels are modified by the tissue-specific expression of regulatory beta 1-subunits. Although the short cytosolic N-terminal domain of the beta 1-subunit is important for controlling both BK channel trafficking and function, whether the same, or different, regions of the N terminus control these distinct processes remains unknown. Here we demonstrate that the first six N-terminal residues including Lys-3, Lys-4, and Leu-5 are critical for controlling functional regulation, but not trafficking, of BK channels. This membrane-distal region has features of an amphipathic helix that is predicted to control the orientation of the first transmembrane-spanning domain (TM1) of the beta 1-subunit. In contrast, a membrane-proximal leucine residue (Leu-17) controls trafficking without affecting functional coupling, an effect that is in part dependent on controlling efficient endoplasmic reticulum exit of the pore-forming alpha-subunit. Thus cell surface trafficking and functional coupling with BK channels are controlled by distinct domains of the beta 1-subunit N terminus.	[Chen, Lie; Bi, Danlei; McClafferty, Heather; Shipston, Michael J.] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Chen, Lie; Lu, Zen Huat] Univ Brunei Darussalam, PAPRSB Inst Hlth Sci, Jalan Tungku Link, BE-1410 Gadong, Brunei; [Bi, Danlei] Univ Sci & Technol China, Sch Life Sci, Neurodegenerat Dis Res Ctr, Hefei 230026, Peoples R China; [Lu, Zen Huat] Univ Edinburgh, Roslin Inst, Div Genet & Genom, Edinburgh EH25 9RG, Midlothian, Scotland	University of Edinburgh; University Brunei Darussalam; Chinese Academy of Sciences; University of Science & Technology of China, CAS; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Shipston, MJ (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland.	mike.shipston@ed.ac.uk	Shipston, Michael/C-7309-2013	Shipston, Michael/0000-0001-7544-582X; Lu, Zen H./0000-0002-9408-0579; Chen, Lie/0000-0001-9764-4299	Wellcome Trust; Diabetes UK; Medical Research Council	Wellcome Trust(Wellcome Trust); Diabetes UK(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a in part by grants from the Wellcome Trust, Diabetes UK, and Medical Research Council (to M. J. S.).	Castillo JP, 2016, P NATL ACAD SCI USA, V113, pE3231, DOI 10.1073/pnas.1606381113; Castillo K, 2015, P NATL ACAD SCI USA, V112, P4809, DOI 10.1073/pnas.1504378112; Chen L, 2013, J BIOL CHEM, V288, P13136, DOI 10.1074/jbc.M113.461830; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Contreras GF, 2013, CHANNELS, V7, P442, DOI 10.4161/chan.26242; Dworetzky SI, 1996, J NEUROSCI, V16, P4543; Foss SM, 2013, J NEUROSCI, V33, P10647, DOI 10.1523/JNEUROSCI.5662-12.2013; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Ge LS, 2014, INT IMMUNOPHARMACOL, V22, P427, DOI 10.1016/j.intimp.2014.06.040; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hekkelman ML, 2010, NUCLEIC ACIDS RES, V38, pW719, DOI 10.1093/nar/gkq453; Hoshi T, 2013, P NATL ACAD SCI USA, V110, P4816, DOI 10.1073/pnas.1221997110; Hoshi T, 2013, P NATL ACAD SCI USA, V110, P4822, DOI 10.1073/pnas.1222003110; Jeffries O, 2012, J BIOL CHEM, V287, P1468, DOI 10.1074/jbc.M111.224840; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim EY, 2007, J NEUROPHYSIOL, V97, P3508, DOI 10.1152/jn.00009.2007; Kuntamallappanavar G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109306; Latorre R, 2017, PHYSIOL REV, V97, P39, DOI 10.1152/physrev.00001.2016; Leo MD, 2014, P NATL ACAD SCI USA, V111, P2361, DOI 10.1073/pnas.1317527111; Lippiat JD, 2003, J MEMBRANE BIOL, V192, P141, DOI 10.1007/s00232-002-1070-0; Liu GX, 2015, J GEN PHYSIOL, V145, P185, DOI 10.1085/jgp.201411337; Liu HW, 2014, J BIOL CHEM, V289, P16914, DOI 10.1074/jbc.M114.557991; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Morrow JP, 2006, P NATL ACAD SCI USA, V103, P5096, DOI 10.1073/pnas.0600907103; Oeggerli M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041664; Orio P, 2006, J GEN PHYSIOL, V127, P191, DOI 10.1085/jgp.200509370; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rai BK, 2006, PROTEINS, V63, P644, DOI 10.1002/prot.20835; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shipston MJ, 2016, INT REV NEUROBIOL, V128, P91, DOI 10.1016/bs.irn.2016.02.012; Steinle M, 2011, RADIOTHER ONCOL, V101, P122, DOI 10.1016/j.radonc.2011.05.069; Sun XH, 2013, J NEUROSCI, V33, P11253, DOI 10.1523/JNEUROSCI.0620-13.2013; Sun XH, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00063; Toro B, 2006, NEUROSCIENCE, V142, P661, DOI 10.1016/j.neuroscience.2006.06.061; Torres YP, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00383; Wang B, 2006, J GEN PHYSIOL, V128, P731, DOI 10.1085/jgp.200609596; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Zhang JY, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00401; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	40	5	5	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8694	8704		10.1074/jbc.M116.769505	http://dx.doi.org/10.1074/jbc.M116.769505			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28373283	hybrid, Green Published			2022-12-26	WOS:000402153900016
J	Echelman, DJ; Lee, AQ; Fernandez, JM				Echelman, Daniel J.; Lee, Alex Q.; Fernandez, Julio M.			Mechanical forces regulate the reactivity of a thioester bond in a bacterial adhesin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesin; atomic force microscopy (AFM); bacterial adhesion; Gram-positive bacteria; single-molecule biophysics; pilus mechanics; thioester bond	COMPLEMENT COMPONENT C3; INTERNAL THIOESTER; SINGLE PROTEIN; KINETICS; TITIN; ELASTICITY; INSIGHTS; PILUS	Bacteria must withstand large mechanical shear forces when adhering to and colonizing hosts. Recent structural studies on a class of Gram-positive bacterial adhesins have revealed an intramolecular Cys-Gln thioester bond that can react with surface-associated ligands to covalently anchor to host surfaces. Two other examples of such internal thioester bonds occur in certain anti-proteases and in the immune complement system, both of which react with the ligand only after the thioester bond is exposed by a proteolytic cleavage. We hypothesized that mechanical forces in bacterial adhesion could regulate thioester reactivity to ligand analogously to such proteolytic gating. Studying the pilus tip adhesin Spy0125 of Streptococcus pyogenes, we developed a single molecule assay to unambiguously resolve the state of the thioester bond. We found that when Spy0125 was in a folded state, its thioester bond could be cleaved with the small-molecule nucleophiles methylamine and histamine, but when Spy0125 was mechanically unfolded and subjected to forces of 50-350 piconewtons, thioester cleavage was no longer observed. For folded Spy0125 without mechanical force exposure, thioester cleavage was in equilibrium with spontaneous thioester reformation, which occurred with a half-life of several minutes. Functionally, this equilibrium reactivity allows thioester-containing adhesins to sample potential substrates without irreversible cleavage and inactivation. We propose that such reversible thioester reactivity would circumvent potential soluble inhibitors, such as histamine released at sites of inflammation, and allow the bacterial adhesin to selectively associate with surface-bound ligands.	[Echelman, Daniel J.; Lee, Alex Q.; Fernandez, Julio M.] Columbia Univ, Dept Biol Sci, 550 West 120th St, New York, NY 10027 USA	Columbia University	Echelman, DJ (corresponding author), Columbia Univ, Dept Biol Sci, 550 West 120th St, New York, NY 10027 USA.	dje2122@columbia.edu		Lee, Alex/0000-0002-9615-8894	National Institutes of Health [GM116122, HL061228]; National Institutes of Health Medical Scientist Training Program Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Medical Scientist Training Program Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM116122 and HL061228 (to J. M. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a National Institutes of Health Medical Scientist Training Program Grant to Columbia University.	Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Alegre-Cebollada J, 2014, CELL, V156, P1235, DOI 10.1016/j.cell.2014.01.056; Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P11235, DOI 10.1074/jbc.M110.102962; Baker EN, 2015, BIOCHEM SOC T, V43, P787, DOI 10.1042/BST20150066; Bhaumik P, 2005, CURR OPIN STRUC BIOL, V15, P621, DOI 10.1016/j.sbi.2005.10.010; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Ding AM, 2010, APPL ENVIRON MICROB, V76, P1294, DOI 10.1128/AEM.02083-09; Dodds AW, 1996, NATURE, V379, P177, DOI 10.1038/379177a0; Echelman DJ, 2016, P NATL ACAD SCI USA, V113, P2490, DOI 10.1073/pnas.1522946113; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Garcia-Ferrer I, 2015, P NATL ACAD SCI USA, V112, P8290, DOI 10.1073/pnas.1506538112; George NPE, 2006, ARTERIOSCL THROM VAS, V26, P2394, DOI 10.1161/01.ATV.0000237606.90523.94; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Kahn TB, 2015, J BIOL CHEM, V290, P14518, DOI 10.1074/jbc.M115.646000; KHAN SA, 1986, BIOCHEMISTRY-US, V25, P5165, DOI 10.1021/bi00366a027; Law SKA, 1997, PROTEIN SCI, V6, P263; Linke-Winnebeck C, 2014, J BIOL CHEM, V289, P177, DOI 10.1074/jbc.M113.523761; Mitchell CA, 2012, BIOCHEMISTRY-US, V51, P3252, DOI 10.1021/bi300112e; Mitchell SC, 2001, CLIN CHIM ACTA, V312, P107, DOI 10.1016/S0009-8981(01)00608-8; Moller J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02884; Nilsson B, 2012, IMMUNOBIOLOGY, V217, P1106, DOI 10.1016/j.imbio.2012.07.008; Nishida N, 2006, P NATL ACAD SCI USA, V103, P19737, DOI 10.1073/pnas.0609791104; Oberhauser AF, 2001, P NATL ACAD SCI USA, V98, P468, DOI 10.1073/pnas.021321798; PANGBURN MK, 1992, J BIOL CHEM, V267, P8584; Peng Q, 2009, J AM CHEM SOC, V131, P14050, DOI 10.1021/ja903589t; Pointon JA, 2010, J BIOL CHEM, V285, P33858, DOI 10.1074/jbc.M110.149385; Popa I, 2013, NAT PROTOC, V8, P1261, DOI 10.1038/nprot.2013.056; Prussin Calman, 2003, Journal of Allergy and Clinical Immunology, V111, pS486; Reardon-Robinson ME, 2016, J BACTERIOL, V198, P746, DOI 10.1128/JB.00769-15; Rivas-Pardo JA, 2016, CELL REP, V14, P1339, DOI 10.1016/j.celrep.2016.01.025; Sauer MM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10738; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Schwartz DJ, 2013, P NATL ACAD SCI USA, V110, P15530, DOI 10.1073/pnas.1315203110; SIM RB, 1981, BIOCHEM J, V193, P115, DOI 10.1042/bj1930115; Smith WD, 2010, J BACTERIOL, V192, P4651, DOI 10.1128/JB.00071-10; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; Walden M, 2015, ELIFE, V4, DOI 10.7554/eLife.06638; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Wong SG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5917	43	24	24	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8988	8997		10.1074/jbc.M117.777466	http://dx.doi.org/10.1074/jbc.M117.777466			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28348083	hybrid, Green Published			2022-12-26	WOS:000402153900049
J	Ithychanda, SS; Dou, K; Robertson, SP; Qin, J				Ithychanda, Sujay S.; Dou, Kevin; Robertson, Stephen P.; Qin, Jun			Structural and thermodynamic basis of a frontometaphyseal dysplasia mutation in filamin A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHENOTYPIC DIVERSITY; MOLECULAR-BASIS; LIGAND-BINDING; PHOSPHORYLATION; PROTEIN; FLNA; FLUORESCENCE; MECHANISM; TRANSITIONS; COMPETITION	Filamin-mediated linkages between transmembrane receptors (TR) and the actin cytoskeleton are crucial for regulating many cytoskeleton-dependent cellular processes such as cell shape change and migration. A major TR binding site in the immunoglobulin repeat 21 (Ig21) of filamin is masked by the adjacent repeat Ig20, resulting in autoinhibition. The TR binding to this site triggers the relief of Ig20 and protein kinase A (PKA)-mediated phosphorylation of Ser-2152, thereby dynamically regulating the TR-actin linkages. A P2204L mutation in Ig20 reportedly cause frontometaphyseal dysplasia, a skeletal disorder with unknown pathogenesis. We show here that the P2204L mutation impairs a hydrophobic core of Ig20, generating a conformationally fluctuating molten globule-like state. Consequently, unlike in WT filamin, where PKA-mediated Ser-2152 phosphorylation is ligand-dependent, the P2204L mutant is readily accessible to PKA, promoting ligand-independent phosphorylation on Ser-2152. Strong TR peptide ligands from platelet GP1b alpha and G-protein-coupled receptor MAS effectively bound Ig21 by displacing Ig20 from autoinhibited WT filamin, but surprisingly, the capacity of these ligands to bind the P2204L mutant was much reduced despite the mutation-induced destabilization of the Ig20 structure that supposedly weakens the autoinhibition. Thermodynamic analysis indicated that compared with WT filamin, the conformationally fluctuating state of the Ig20 mutant makes Ig21 enthalpically favorable to bind ligand but with substantial entropic penalty, resulting in total higher free energy and reduced ligand affinity. Overall, our results reveal an unusual structural and thermodynamic basis for the P2204L-induced dysfunction of filamin and frontometaphyseal dysplasia disease.	[Ithychanda, Sujay S.; Dou, Kevin; Qin, Jun] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Robertson, Stephen P.] Univ Otago, Dunedin Sch Med, Dunedin 9016, New Zealand	Cleveland Clinic Foundation; University of Otago	Qin, J (corresponding author), Cleveland Clin, Lerner Res Inst, NB2-88,9500 Euclid Ave, Cleveland, OH 44195 USA.	qinj@ccf.org		Robertson, Stephen/0000-0002-5181-7809; Ithychanda, Sujay Subbayya/0000-0001-8979-246X; Qin, Jun/0000-0002-2647-9270	NIH [1S10RR031537-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062823] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Peptides were synthesized by the Molecular Biotechnology Core at the Lerner Research Institute (Cleveland Clinic, Cleveland, OH). We acknowledge Dr. Smarajit Bandyopadhyay and Weizhen Shen for excellent peptide preparations. We thank Dr. Belinda Willard of the Proteomics and Metabolomics laboratory for help with mass spectrometry (NIH shared instrument Grant 1S10RR031537-01). We also sincerely thank David Schumick from the Center for Medical Art and Photography at the Cleveland Clinic (Cleveland, OH) for help with graphic illustrations. We thank Dr. Mohammed Mahfuzul Haque and Yue Dai of the Department of Pathobiology for help with use of the fluorimeter.	Bertola D, 2015, AM J MED GENET A, V167, P1161, DOI 10.1002/ajmg.a.36981; Clark AR, 2009, HUM MOL GENET, V18, P4791, DOI 10.1093/hmg/ddp442; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; Ghisaidoobe ABT, 2014, INT J MOL SCI, V15, P22518, DOI 10.3390/ijms151222518; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; Henkels KM, 2015, FASEB J, V29, P1299, DOI 10.1096/fj.14-260992; Ithychanda SS, 2015, J BIOL CHEM, V290, P8527, DOI 10.1074/jbc.M114.633446; Ithychanda SS, 2011, BIOCHEMISTRY-US, V50, P4229, DOI 10.1021/bi2003229; Ithychanda SS, 2009, J BIOL CHEM, V284, P35113, DOI 10.1074/jbc.M109.060954; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Jay D, 2004, MOL CELL BIOCHEM, V260, P49, DOI 10.1023/B:MCBI.0000026052.76418.55; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim KH, 2016, J MOL RECOGNIT, V29, P446, DOI 10.1002/jmr.2543; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Li LZ, 2015, ONCOTARGET, V6, P12009, DOI 10.18632/oncotarget.3617; Li M, 2000, MOL PHARMACOL, V57, P446, DOI 10.1124/mol.57.3.446; Mezawa M, 2016, FASEB J, V30, P3613, DOI 10.1096/fj.201600354RR; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Onoprishvili I, 2003, MOL PHARMACOL, V64, P1092, DOI 10.1124/mol.64.5.1092; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Robertson SP, 2005, CURR OPIN GENET DEV, V15, P301, DOI 10.1016/j.gde.2005.04.001; Robertson SP, 2006, AM J MED GENET A, V140A, P1726, DOI 10.1002/ajmg.a.31322; Royer CA, 2006, CHEM REV, V106, P1769, DOI 10.1021/cr0404390; Sawyer GM, 2009, J MOL BIOL, V390, P1030, DOI 10.1016/j.jmb.2009.06.009; Scott MGH, 2006, MOL CELL BIOL, V26, P3432, DOI 10.1128/MCB.26.9.3432-3445.2006; Seppala J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136969; Smith L, 2010, J BIOL CHEM, V285, P17166, DOI 10.1074/jbc.M109.080911; Tirupula KC, 2015, BIOCHEMISTRY-US, V54, P6673, DOI 10.1021/acs.biochem.5b00975; Travis MA, 2004, FEBS LETT, V569, P185, DOI 10.1016/j.febslet.2004.04.099; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; van Kogelenberg M, 2015, J MOL MED, V93, P773, DOI 10.1007/s00109-015-1261-7; WALLACH D, 1978, J BIOL CHEM, V253, P4739; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; Zenker M, 2004, AM J HUM GENET, V74, P731, DOI 10.1086/383094; Zhang J. Q., 2013, ADV MATER SCI ENG, V2013, P2, DOI DOI 10.1371/J0URNAL.P0NE.0057251; Zhang JP, 2012, J NEUROSCI, V32, P12619, DOI 10.1523/JNEUROSCI.1063-12.2012; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001	41	2	2	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8390	8400		10.1074/jbc.M117.776740	http://dx.doi.org/10.1074/jbc.M117.776740			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28348077	Green Published, hybrid			2022-12-26	WOS:000401788600023
J	Seydlova, G; Beranova, J; Bibova, I; Dienstbier, A; Drzmisek, J; Masin, J; Fiser, R; Konopasek, I; Vecerek, B				Seydlova, Gabriela; Beranova, Jana; Bibova, Ilona; Dienstbier, Ana; Drzmisek, Jakub; Masin, Jiri; Fiser, Radovan; Konopasek, Ivo; Vecerek, Branislav			The extent of the temperature-induced membrane remodeling in two closely related Bordetella species reflects their adaptation to diverse environmental niches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERTUSSIS ADENYLATE-CYCLASE; VIRULENCE FACTORS; PHYSICAL-PROPERTIES; FATTY-ACIDS; LIPIDS; EXPRESSION; FLUIDITY; PROTEIN; PHOSPHATIDYLCHOLINES; BRONCHISEPTICA	Changes in environmental temperature represent one of the major stresses faced by microorganisms as they affect the function of the cytoplasmic membrane. In this study, we have analyzed the thermal adaptation in two closely related respiratory pathogens Bordetella pertussis and Bordetella bronchiseptica. Although B. pertussis represents a pathogen strictly adapted to the human body temperature, B. bronchiseptica causes infection in a broad range of animals and survives also outside of the host. We applied GC-MS to determine the fatty acids of both Bordetella species grown at different temperatures and analyzed the membrane fluidity by fluorescence anisotropy measurement. In parallel, we also monitored the effect of growth temperature changes on the expression and production of several virulence factors. In response to low temperatures, B. pertussis adapted its fatty acid composition and membrane fluidity to a considerably lesser extent when compared with B. bronchiseptica. Remarkably, B. pertussis maintained the production of virulence factors at 24 degrees C, whereas B. bronchiseptica cells resumed the production only upon temperature upshift to 37 degrees C. This growth temperature-associated differential modulation of virulence factor production was linked to the phosphorylation state of transcriptional regulator BvgA. The observed differences in low-temperature adaptation between B. pertussis and B. bronchiseptica may result from selective adaptation of B. pertussis to the human host. We propose that the reduced plasticity of the B. pertussis membranes ensures sustained production of virulence factors at suboptimal temperatures and may play an important role in the transmission of the disease.	[Seydlova, Gabriela; Beranova, Jana; Fiser, Radovan; Konopasek, Ivo] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Vinicna 5, Prague 12843, Czech Republic; [Bibova, Ilona; Dienstbier, Ana; Drzmisek, Jakub; Vecerek, Branislav] Acad Sci Czech Republ, Inst Microbiol Vvi, Lab Posttranscript Control Gene Express, Videnska 1083, Prague 14220, Czech Republic; [Masin, Jiri] Acad Sci Czech Republ, Inst Microbiol Vvi, Lab Mol Biol Bacterial Pathogens, Videnska 1083, Prague 14220, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Vecerek, B (corresponding author), AS CR, Inst Microbiol Vvi, Videnska 1083, Prague 14220, Czech Republic.	vecerek@biomed.cas.cz	Konopásek, Ivo/AAE-9034-2021; Vecerek, Branislav/H-2545-2014; Fiser, Radovan/E-4908-2012; Seydlová, Gabriela/H-2050-2014; Masin, Jiri/H-3125-2014; Držmíšek, Jakub/S-5903-2017	Konopásek, Ivo/0000-0002-6824-5974; Vecerek, Branislav/0000-0001-9520-6324; Fiser, Radovan/0000-0003-4516-0086; Seydlová, Gabriela/0000-0001-8424-9249; Držmíšek, Jakub/0000-0002-8585-3189; Masin, Jiri/0000-0001-6258-4599; Bibova, Ilona/0000-0002-0839-8434	Czech Science Foundation [16-34825L, 16-05919S, 13-18051P]; Czech Health Research Council [16-30782A]; Research concept of the Institute of Microbiology v.v.i. [RVO61388971]; Ministry of Education, Youth and Sports of the Czech Republic [CZ.1.07/2.3.00/20.0055, CZ.1.07/2.3.00/30.0003]; European Regional Development Fund Project "BIOCEV-Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University" [CZ.1.05/1.1.00/02.0109]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Health Research Council; Research concept of the Institute of Microbiology v.v.i.; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Regional Development Fund Project "BIOCEV-Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University"	This work was supported by Czech Science Foundation Grants 16-34825L (to B. V.), 16-05919S (to J. M.), and 13-18051P (to G. S.); Czech Health Research Council Grant 16-30782A (to B. V.); Research concept of the Institute of Microbiology v.v.i., RVO61388971; Ministry of Education, Youth and Sports of the Czech Republic Projects CZ.1.07/2.3.00/20.0055 (to B. V. and I. B.) and CZ.1.07/2.3.00/30.0003 (to B. V.); and European Regional Development Fund Project "BIOCEV-Biotechnology and Biomedicine Centre of the Academy of Sciences and Charles University" CZ.1.05/1.1.00/02.0109 (to B. V., A. D., and I. B.). The authors declare that they have no conflicts of interest with the contents of this article.	ADLER M, 1988, BIOPHYS J, V53, P989, DOI 10.1016/S0006-3495(88)83179-5; ARICO B, 1989, P NATL ACAD SCI USA, V86, P6671, DOI 10.1073/pnas.86.17.6671; BALDASSARE JJ, 1976, BIOCHEMISTRY-US, V15, P2986, DOI 10.1021/bi00659a008; Bart MJ, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01301-14; Bart MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-627; Bibova I, 2013, INFECT IMMUN, V81, P4081, DOI 10.1128/IAI.00345-13; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boulanger A, 2013, MOL MICROBIOL, V88, P156, DOI 10.1111/mmi.12177; Chang YY, 1999, MOL MICROBIOL, V33, P249, DOI 10.1046/j.1365-2958.1999.01456.x; CONFER DL, 1982, SCIENCE, V217, P948, DOI 10.1126/science.6287574; Cotter PA, 1997, MOL MICROBIOL, V24, P671, DOI 10.1046/j.1365-2958.1997.3821741.x; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; CRONAN JE, 1975, BACTERIOL REV, V39, P232, DOI 10.1128/MMBR.39.3.232-256.1975; CRONAN JE, 1973, J BIOL CHEM, V248, P1188; Cummings CA, 2004, J BACTERIOL, V186, P1484, DOI 10.1128/JB.186.5.1484-1492.2004; DEMENDOZA D, 1983, J BIOL CHEM, V258, P2098; deTejada GM, 1996, MOL MICROBIOL, V22, P895, DOI 10.1046/j.1365-2958.1996.01538.x; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Dupre E, 2015, J BIOL CHEM, V290, P26473, DOI 10.1074/jbc.A115.655720; Dupre E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004700; FRIEDMAN RL, 1987, INFECT IMMUN, V55, P135, DOI 10.1128/IAI.55.1.135-140.1987; FULCO AJ, 1974, ANNU REV BIOCHEM, V43, P215, DOI 10.1146/annurev.bi.43.070174.001243; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; GLASS RL, 1970, ANAL BIOCHEM, V37, P219, DOI 10.1016/0003-2697(70)90286-1; Hamidou Soumana Illiassou, 2017, Front Microbiol, V8, P28, DOI 10.3389/fmicb.2017.00028; JUNGKIND DL, 1974, BIOCHIM BIOPHYS ACTA, V337, P298, DOI 10.1016/0005-2760(74)90211-2; KAWAI Y, 1982, J BACTERIOL, V151, P996, DOI 10.1128/JB.151.2.996-1005.1982; LACEY B. W., 1960, JOUR HYG, V58, P57; LADANT D, 1988, J BIOL CHEM, V263, P2612; Lakowicz JR, 1999, ANAL BIOCHEM, V267, P397, DOI 10.1006/abio.1998.3029; LAKOWICZ JR, 1979, BIOCHEMISTRY-US, V18, P508, DOI 10.1021/bi00570a021; Lam O, 2014, VIRULENCE, V5, P852, DOI 10.4161/21505594.2014.970949; Locht C, 1999, Int Microbiol, V2, P137; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; MANETTI R, 1994, GENE, V150, P123, DOI 10.1016/0378-1119(94)90870-2; Mansilla MC, 2004, J BACTERIOL, V186, P6681, DOI 10.1128/JB.186.20.6681-6688.2004; MARR AG, 1962, J BACTERIOL, V84, P1260, DOI 10.1128/JB.84.6.1260-1267.1962; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; MCGARRITY JT, 1981, BIOCHIM BIOPHYS ACTA, V640, P544, DOI 10.1016/0005-2736(81)90478-8; MELTON AR, 1989, J BACTERIOL, V171, P6206, DOI 10.1128/jb.171.11.6206-6212.1989; MELTON AR, 1993, INFECT IMMUN, V61, P807, DOI 10.1128/IAI.61.3.807-815.1993; MOSS J, 1983, J BIOL CHEM, V258, P1879; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; PEARSON RD, 1987, J IMMUNOL, V139, P2749; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PORTER JF, 1991, APPL ENVIRON MICROB, V57, P1202, DOI 10.1128/AEM.57.4.1202-1206.1991; PRUGNOLA A, 1995, MICROBIOL-UK, V141, P2529, DOI 10.1099/13500872-141-10-2529; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; RUSSELL NJ, 1983, BIOCHEM SOC T, V11, P333, DOI 10.1042/bst0110333; Schneider B, 2000, INFECT IMMUN, V68, P7039, DOI 10.1128/IAI.68.12.7039-7048.2000; SHINITZKY M, 1978, BIOCHIM BIOPHYS ACTA, V515, P367, DOI 10.1016/0304-4157(78)90010-2; SILVIUS JR, 1979, CHEM PHYS LIPIDS, V25, P125, DOI 10.1016/0009-3084(79)90062-8; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x; UHL MA, 1994, P NATL ACAD SCI USA, V91, P1163, DOI 10.1073/pnas.91.3.1163; WEISS AA, 1984, INFECT IMMUN, V43, P263, DOI 10.1128/IAI.43.1.263-269.1984	58	8	8	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 12	2017	292	19					8048	8058		10.1074/jbc.M117.781559	http://dx.doi.org/10.1074/jbc.M117.781559			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EU6OU	28348085	Green Published, hybrid			2022-12-26	WOS:000401154100029
J	Lehmann, JS; Campo, JJ; Ciceron, M; Raccurt, CP; Boncy, J; De Rochars, VEMB; Cannella, AP				Lehmann, Jason S.; Campo, Joseph J.; Ciceron, Micheline; Raccurt, Christian P.; Boncy, Jacques; De Rochars, Valery E. M. Beau; Cannella, Anthony P.			T cell subtypes and reciprocal inflammatory mediator expression differentiate P. falciparum memory recall responses in asymptomatic and symptomatic malaria patients in southeastern Haiti	PLOS ONE			English	Article							BLOOD-STAGE INFECTION; TUMOR-NECROSIS-FACTOR; PLASMODIUM-FALCIPARUM; IMMUNE-RESPONSE; TGF-BETA; IN-VITRO; MEROZOITE ANTIGENS; CLINICAL MALARIA; PARASITE GROWTH; SOLUBLE CD163	Asymptomatic Plasmodium falciparum infection is responsible for maintaining malarial disease within human populations in low transmission countries such as Haiti. Investigating differential host immune responses to the parasite as a potential underlying mechanism could help provide insight into this highly complex phenomenon and possibly identify asymptomatic individuals. We performed a cross-sectional analysis of individuals who were diagnosed with malaria in Sud-Est, Haiti by comparing the cellular and humoral responses of both symptomatic and asymptomatic subjects. Plasma samples were analyzed with a P. falciparum protein microarray, which demonstrated serologic reactivity to 3,877 P. falciparum proteins of known serologic reactivity; however, no antigen-antibody reactions delineating asymptomatics from symptomatics were identified. In contrast, differences in cellular responses were observed. Flow cytometric analysis of patient peripheral blood mononuclear cells co-cultured with P. falciparum infected erythrocytes demonstrated a statistically significant increase in the proportion of T regulatory cells (CD4(+) CD25(+) CD127(-)), and increases in unique populations of both NKT-like cells (CD3(+) CD8(+) CD56(+)) and CD8(mid) T cells in asymptomatics compared to symptomatics. Also, CD38(+)/HLA-DR+ expression on gamma delta T cells, CD8(mid) (CD56(-)) T cells, and CD8(mid) CD56(+) NKT-like cells decreased upon exposure to infected erythrocytes in both groups. Cytometric bead analysis of the co-culture supernatants demonstrated an upregulation of monocyte-activating chemokines/cytokines in asymptomatics, while immunomodulatory soluble factors were elevated in symptomatics. Principal component analysis of these expression values revealed a distinct clustering of individual responses within their respective phenotypic groups. This is the first comprehensive investigation of immune responses to P. falciparum in Haiti, and describes unique cell-mediated immune repertoires that delineate individuals into asymptomatic and symptomatic phenotypes. Future investigations using large scale biological data sets analyzing multiple components of adaptive immunity, could collectively define which cellular responses and molecular correlates of disease outcome are malaria region specific, and which are truly generalizable features of asymptomatic Plasmodium immunity, a research goal of critical priority.	[Lehmann, Jason S.; Cannella, Anthony P.] Univ Florida, Coll Med, Dept Med, Div Infect Dis & Global Med, Gainesville, FL 32611 USA; [Lehmann, Jason S.; De Rochars, Valery E. M. Beau; Cannella, Anthony P.] Univ Florida, Emerging Pathogen Inst, Gainesville, FL 32611 USA; [Campo, Joseph J.] Antigen Discovery Inc, Irvine, CA USA; [Ciceron, Micheline; Raccurt, Christian P.; Boncy, Jacques] MSPP, LNSP, Port Au Prince, Haiti; [De Rochars, Valery E. M. Beau] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Hlth Serv Res Management & Policy, Gainesville, FL USA; [Cannella, Anthony P.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Lehmann, JS; Cannella, AP (corresponding author), Univ Florida, Coll Med, Dept Med, Div Infect Dis & Global Med, Gainesville, FL 32611 USA.; Lehmann, JS; Cannella, AP (corresponding author), Univ Florida, Emerging Pathogen Inst, Gainesville, FL 32611 USA.; Cannella, AP (corresponding author), Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA.	jl.epi.uf@gmail.com; anthony.cannella@medicine.ufl.edu			National Institute of Allergy and Infectious Diseases (NIAID) [5K08A1104773]; University of Florida Emerging Pathogens Institute; NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI104773] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Florida Emerging Pathogens Institute; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institute of Allergy and Infectious Diseases (NIAID) (5K08A1104773) to APC, and by the University of Florida Emerging Pathogens Institute to APC. The funder (NIAID) provided support in the form of salary for author APC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, METHODS IN MALARIA R; Arama C, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv118; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Barry AE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008326; Fratus ASB, 2014, MEM I OSWALDO CRUZ, V109, P598, DOI 10.1590/0074-0276140027; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bezie S, 2015, J CLIN INVEST, V125, P3952, DOI 10.1172/JCI81227; Boncy PJ, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0753-9; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; Boyle MJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005041; Boyle MJ, 2015, J INFECT DIS, V212, P416, DOI 10.1093/infdis/jiv054; Bretscher MT, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0813-1; Campo JJ, 2015, MOL CELL PROTEOMICS, V14, P519, DOI 10.1074/mcp.M114.044677; Carter TE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140416; Charles M, 2016, EMERG INFECT DIS, V22, P786, DOI 10.3201/eid2205.150359; Chemel M, 2017, AM J PATHOL, V187, P156, DOI 10.1016/j.ajpath.2016.09.015; Chen I, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001942; Chilosi M, 1996, EUR J IMMUNOL, V26, P329, DOI 10.1002/eji.1830260209; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Cummings JF, 2010, VACCINE, V28, P5135, DOI 10.1016/j.vaccine.2009.08.046; D'Ombrain MC, 2008, CLIN INFECT DIS, V47, P1380, DOI 10.1086/592971; D'Ombrain MC, 2007, EUR J IMMUNOL, V37, P1864, DOI 10.1002/eji.200636889; Daou M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0567-9; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; Davis BH, 2005, CYTOM PART B-CLIN CY, V63B, P16, DOI 10.1002/cyto.b.20031; Dent AE, 2015, J INFECT DIS, V212, P1429, DOI 10.1093/infdis/jiv224; Driguez P, 2015, METHODS MOL BIOL, V1201, P221, DOI 10.1007/978-1-4939-1438-8_13; Elbadry MA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1051-2; ElBadry MA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-426; Finney OC, 2009, EUR J IMMUNOL, V39, P1288, DOI 10.1002/eji.200839112; Foucher ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056045; GASSON JC, 1991, BLOOD, V77, P1131, DOI 10.1182/blood.V77.6.1131.1131; GYSIN J, 1992, MEM I OSWALDO CRUZ, V87, P145, DOI 10.1590/S0074-02761992000900023; Hillier CJ, 2005, INFECT IMMUN, V73, P2109, DOI 10.1128/IAI.73.4.2109-2115.2005; Hirano R, 2011, INFLAMM RES, V60, P605, DOI 10.1007/s00011-011-0310-0; HO M, 1990, IMMUNOL LETT, V25, P139, DOI 10.1016/0165-2478(90)90105-Y; Horie R, 1998, SEMIN IMMUNOL, V10, P457, DOI 10.1006/smim.1998.0156; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; Imai T, 2010, EUR J IMMUNOL, V40, P1053, DOI 10.1002/eji.200939525; Ismail HA, 2013, CLIN VACCINE IMMUNOL, V20, P1170, DOI 10.1128/CVI.00156-13; Jagannathan P, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003864; Jiang YJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/863625; Kangoye DT, 2016, VACCINE, V34, P160, DOI 10.1016/j.vaccine.2015.10.058; Kelly-Rogers J, 2006, HUM IMMUNOL, V67, P863, DOI 10.1016/j.humimm.2006.08.292; Kemp K, 2002, CLIN DIAGN LAB IMMUN, V9, P720, DOI 10.1128/CDLI.9.3.720-722.2002; King T, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005118; Kumaratilake LM, 1996, PARASITE IMMUNOL, V18, P115, DOI 10.1046/j.1365-3024.1996.d01-64.x; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Lau LS, 2011, J INFECT DIS, V204, P1989, DOI 10.1093/infdis/jir656; Laurens MB, 2016, CLIN VACCINE IMMUNOL, V23, P80, DOI 10.1128/CVI.00697-15; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]; Lourembam SD, 2013, CYTOKINE, V64, P503, DOI 10.1016/j.cyto.2013.08.007; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; MacKellar DC, 2011, CELL MICROBIOL, V13, P1755, DOI 10.1111/j.1462-5822.2011.01656.x; Malaguarnera L, 2002, EUR CYTOKINE NETW, V13, P425; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Mandala WL, 2016, PARASITE IMMUNOL, V38, P317, DOI 10.1111/pim.12319; Mandala WL, 2016, CLIN VACCINE IMMUNOL, V23, P95, DOI 10.1128/CVI.00564-15; MCGREGOR IA, 1964, AM J TROP MED HYG, V13, P237, DOI 10.4269/ajtmh.1964.13.237; Mendonca VRR, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-69; Mendonca VRR, 2012, INFECT IMMUN, V80, P1445, DOI 10.1128/IAI.05933-11; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Miyakoda M, 2008, J IMMUNOL, V181, P1420, DOI 10.4049/jimmunol.181.2.1420; Miyakoda M, 2012, J IMMUNOL, V189, P4396, DOI 10.4049/jimmunol.1200781; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Murungi LM, 2016, INFECT IMMUN, V84, P950, DOI 10.1128/IAI.01120-15; Neuberger A, 2012, EMERG INFECT DIS, V18, P1487, DOI 10.3201/eid1809.120605; Nguetse CN, 2015, IMMUNOGENETICS, V67, P67, DOI 10.1007/s00251-014-0816-z; Nowell MA, 2003, J IMMUNOL, V171, P3202, DOI 10.4049/jimmunol.171.6.3202; Ochiel DO, 2005, INFECT IMMUN, V73, P4190, DOI 10.1128/IAI.73.7.4190-4197.2005; OEUVRAY C, 1994, BLOOD, V84, P1594; Omer FM, 2000, PARASITOL TODAY, V16, P18, DOI 10.1016/S0169-4758(99)01562-8; PERIGNON JL, 1994, MEM I OSWALDO CRUZ, V89, P51, DOI 10.1590/S0074-02761994000600013; Pleass RJ, 2016, TRENDS PARASITOL, V32, P108, DOI 10.1016/j.pt.2015.09.007; Raccurt C P, 2015, Bull Soc Pathol Exot, V108, P14, DOI 10.1007/s13149-014-0367-4; Raccurt CP, 2012, MED SANTE TROP, V22, P435, DOI 10.1684/mst.2013.0124; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Riopel J, 2001, INFECT IMMUN, V69, P129, DOI 10.1128/IAI.69.1.129-136.2001; Robinson LJ, 2009, INFECT IMMUN, V77, P3033, DOI 10.1128/IAI.00211-09; Rochman Y, 2008, J IMMUNOL, V181, P7699, DOI 10.4049/jimmunol.181.11.7699; Rodrigues-da-Silva RN, 2014, MEM I OSWALDO CRUZ, V109, P154, DOI 10.1590/0074-0276140275; ROMAGNANI S, 1995, J LEUKOCYTE BIOL, V57, P726, DOI 10.1002/jlb.57.5.726; Rose-John S, 2006, J LEUKOCYTE BIOL, V80, P227, DOI 10.1189/jlb.1105674; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Scholzen A, 2010, TRENDS PARASITOL, V26, P16, DOI 10.1016/j.pt.2009.10.004; Scholzen A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000543; Schwenk R, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-376; SHERRY BA, 1995, J INFLAMM, V45, P85; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spielmann T, 2006, MOL MICROBIOL, V59, P779, DOI 10.1111/j.1365-2958.2005.04983.x; Stanisic DI, 2016, PARASITOLOGY, V143, P208, DOI 10.1017/S0031182015001092; Stanisic DI, 2014, J INFECT DIS, V210, P295, DOI 10.1093/infdis/jiu083; Trieu A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007948; Tsutsui N, 1999, INFECT IMMUN, V67, P2306, DOI 10.1128/IAI.67.5.2306-2311.1999; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Wammes LJ, 2013, J INFECT DIS, V207, P1590, DOI 10.1093/infdis/jit058; Wang C, 2015, SCI REP-UK, V5, DOI 10.1038/srep14124; Weppelmann TA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-30; World Health Organization, 2015, WORLD MAL REP 2015; Wunderlich CM, 2012, J IMMUNOL, V188, P4141, DOI 10.4049/jimmunol.1102137; WYLER DJ, 1976, CLIN EXP IMMUNOL, V23, P471; Zhou RP, 2016, IMMUNOLOGY, V149, P362, DOI 10.1111/imm.12660	107	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174718	10.1371/journal.pone.0174718	http://dx.doi.org/10.1371/journal.pone.0174718			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369062	Green Published, gold, Green Submitted			2022-12-26	WOS:000399351000036
J	Dworkis, DA; Taylor, LA; Peak, DA; Bearnot, B				Dworkis, Daniel A.; Taylor, Lauren A.; Peak, David A.; Bearnot, Benjamin			Geospatial analysis of emergency department visits for targeting community-based responses to the opioid epidemic	PLOS ONE			English	Article								The opioid epidemic in the United States carries significant morbidity and mortality and requires a coordinated response among emergency providers, outpatient providers, public health departments, and communities. Anecdotally, providers across the spectrum of care at Massachusetts General Hospital (MGH) in Boston, MA have noticed that Charlestown, a community in northeast Boston, has been particularly impacted by the opioid epidemic and needs both emergency and longer-term resources. We hypothesized that geospatial analysis of the home addresses of patients presenting to the MGH emergency department (ED) with opioid-related emergencies might identify "hot spots" of opioid-related healthcare needs within Charlestown that could then be targeted for further investigation and resource deployment. Here, we present a geospatial analysis at the United States census tract level of the home addresses of all patients who presented to the MGH ED for opioid-related emergency visits between 7/1/2012 and 6/30/2015, including 191 visits from 100 addresses in Charlestown, MA. Among the six census tracts that comprise Charlestown, we find a 9.5 fold difference in opioid-related ED visits, with 45% of all opioid-related visits from Charlestown originating in tract 040401. The signal from this census tract remains strong after adjusting for population differences between census tracts, and while this tract is one of the higher utilizing census tracts in Charlestown of the MGH ED for all cause visits, it also has a 2.9-fold higher rate of opioid-related visits than the remainder of Charlestown. Identifying this hot spot of opioid-related emergency needs within Charlestown may help re-distribute existing resources efficiently, empower community and ED-based physicians to advocate for their patients, and serve as a catalyst for partnerships between MGH and local community groups. More broadly, this analysis demonstrates that EDs can use geospatial analysis to address the emergency and longer-term health needs of the communities they are designed to serve.	[Dworkis, Daniel A.; Peak, David A.] Harvard Med Sch, Dept Emergency Med, Boston, MA 02115 USA; [Dworkis, Daniel A.; Peak, David A.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Taylor, Lauren A.] Harvard Management Business Sch, Boston, MA USA; [Bearnot, Benjamin] Harvard Med Sch, Dept Med, Boston, MA USA; [Bearnot, Benjamin] Massachusetts Gen Hosp, Dept Med, Div Gen Internal Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Dworkis, DA (corresponding author), Harvard Med Sch, Dept Emergency Med, Boston, MA 02115 USA.; Dworkis, DA (corresponding author), Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA.	ddworkis@partners.org	Bearnot, Benjamin/ABE-6316-2020	Bearnot, Benjamin/0000-0002-2554-8422; Dworkis, Daniel/0000-0003-0706-5117	Massachusetts General Hospital Division of General Internal Medicine Innovation Fellowship	Massachusetts General Hospital Division of General Internal Medicine Innovation Fellowship	Funding to support publication costs for open access publication have been provided by The Massachusetts General Hospital Division of General Internal Medicine Innovation Fellowship. These funds were provided solely to support publication costs and were not used to perform any of the work described in the manuscript.	Bearnot B, 2015, STAT NEWS       0922; Center for Community Health Improvement Massachusetts General Hospital, 2016, 2016 COMM HLTH NEEDS; Dworkis DA, 2016, WEST J EMERG MED, V17, P484, DOI 10.5811/westjem.2016.5.30244; Lee DC, 2015, HEALTHCARE, V4, P98; MacQuarrie B, 2015, BOSTON GLOBE; Massachusetts Department of Health and Human Services, 2016, MASS OP EP DAT VIS F; Massachusetts Department of Health and Human Services Department of Public Health, 2016, OV DEATHS CIT TOWN; Massachusetts Department of Health and Human Services Department of Public Health, 2016, DAT BRIEF OP REL OV; Massachusetts Governor's Opioid Working Group, 2015, REC GOV OP WORK GROU; QGIS Development Team, 2016, QGIS GEOGR INF SYST; R_Core_Team, 2015, R LANG ENV STAT COMP; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality, 2015, BEH HLTH TRENDS US R	13	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0175115	10.1371/journal.pone.0175115	http://dx.doi.org/10.1371/journal.pone.0175115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362828	Green Published, gold, Green Submitted			2022-12-26	WOS:000399175000072
J	Lee, SM; Park, KH; Jung, EY; Jang, JA; Yoo, HN				Lee, Seung Mi; Park, Kyo Hoon; Jung, Eun Young; Jang, Ji Ae; Yoo, Ha-Na			Frequency and clinical significance of short cervix in patients with preterm premature rupture of membranes	PLOS ONE			English	Article							INTRAAMNIOTIC INFECTION; INTACT MEMBRANES; RISK-FACTOR; LENGTH; WOMEN; INFLAMMATION; DELIVERY; LABOR; AMNIOCENTESIS; PREDICTION	Objective Cervical length measurement has been uggested as a useful tool for predicting intra-amniotic infection/inflammation in preterm labor, but little information is available in the setting of preterm premature rupture of membranes (pPROM). We aimed to determine whether a short cervical length is independently associated with an increased risk of intra-amniotic infection or inflammation and impending preterm delivery in women with pPROM. Methods This was a retrospective cohort study involving 171 consecutive singleton pregnant women with pPROM (21+0-33+6 weeks' gestation), who underwent amniocentesis. Amniotic fluid (AF) was cultured, and assayed for interleukin (IL)-6 and IL-8. Cervical length was measured at the time of amniocentesis by transvaginal ultrasonography with an aseptic technique. Short cervical length was defined as a cervical length of <15 mm. Intra-amniotic infection was defined as a positive AF culture for microorganisms and intra-amniotic inflammation was defined as elevated AF concentrations of IL-6 or IL-8 (IL-6 >1.5 ng/mL and/or IL-8 >1.3 ng/mL). Results Fifty (29.2%) women had a sonographic cervical length of <15mm. On univariate analysis, short cervical length was associated with an increased risk for intra-amniotic infection and/ or inflammation; no other parameters studied showed a significant association. Multivariable analyses indicated that short cervical length was significantly associated with a higher risk of impending preterm delivery (within 2 days of measurement, within 7 days of measurement, and before 34 weeks), and remained significant after adjustment for potential confounders. Conclusion In women with pPROM, short cervical length is associated with an increased risk for intraamniotic infection/inflammation and associated with impending preterm delivery, independent of the presence of intra-amniotic infection/inflammation.	[Lee, Seung Mi; Park, Kyo Hoon; Jung, Eun Young; Jang, Ji Ae; Yoo, Ha-Na] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Lee, Seung Mi] Seoul Natl Univ Hosp, Dept Obstet & Gynecol, Seoul, South Korea; [Park, Kyo Hoon; Jung, Eun Young; Jang, Ji Ae; Yoo, Ha-Na] Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Park, KH (corresponding author), Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.; Park, KH (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Obstet & Gynecol, Seongnam, South Korea.	pkh0419@snubh.org			Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI 14C1798]	Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant from the Korea Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (grant no. HI 14C1798).	[Anonymous], 2015, AM J OBSTET GYNECOL; Berghella V, 2003, CLIN OBSTET GYNECOL, V46, P947, DOI 10.1097/00003081-200312000-00026; Berghella V, 2011, OBSTET GYNECOL, V117, P663, DOI 10.1097/AOG.0b013e31820ca847; Carlan SJ, 1997, OBSTET GYNECOL, V89, P458, DOI 10.1016/S0029-7844(97)00002-1; Cobo T, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.050; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; GARITE TJ, 1979, OBSTET GYNECOL, V54, P226; GAUTHIER DW, 1991, AM J OBSTET GYNECOL, V165, P1105, DOI 10.1016/0002-9378(91)90480-F; Gire C, 2002, ULTRASOUND OBST GYN, V19, P565, DOI 10.1046/j.1469-0705.2002.00666.x; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gomez R, 2005, AM J OBSTET GYNECOL, V192, P678, DOI 10.1016/j.ajog.2004.10.624; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; Heath VCF, 1998, ULTRASOUND OBST GYN, V12, P304, DOI 10.1046/j.1469-0705.1998.12050304.x; Holst RM, 2006, ULTRASOUND OBST GYN, V28, P768, DOI 10.1002/uog.3837; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; Jung HJ, 2011, ULTRASOUND OBST GYN, V37, P82, DOI 10.1002/uog.8869; KALTREIDER D F, 1980, Clinical Obstetrics and Gynecology, V23, P17, DOI 10.1097/00003081-198003000-00005; Kiefer DG, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.047; Lee SY, 2013, J KOREAN MED SCI, V28, P1226, DOI 10.3346/jkms.2013.28.8.1226; Leung TN, 2005, ULTRASOUND OBST GYN, V26, P713, DOI 10.1002/uog.2617; Park KH, 2012, REPROD SCI, V19, P658, DOI 10.1177/1933719111432869; Park KH, 2012, J PERINAT MED, V40, P151, DOI 10.1515/JPM.2011.124; PHELAN JP, 1987, J REPROD MED, V32, P601; Rizzo G, 1998, ULTRASOUND OBST GYN, V11, P23, DOI 10.1046/j.1469-0705.1998.11010023.x; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Romero R, 2015, J MATERN-FETAL NEO M, V28, P1343, DOI 10.3109/14767058.2014.954243; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Ryu A, 2013, ACTA OBSTET GYN SCAN, V92, P517, DOI 10.1111/aogs.12073; Shim SS, 2004, AM J OBSTET GYNECOL, V191, P1339, DOI 10.1016/j.ajog.2004.06.085; To MS, 2004, LANCET, V363, P1849, DOI 10.1016/S0140-6736(04)16351-4; Tsoi E, 2004, ULTRASOUND OBST GYN, V24, P550, DOI 10.1002/uog.1122; VINTZILEOS AM, 1986, OBSTET GYNECOL, V67, P579	32	13	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174657	10.1371/journal.pone.0174657	http://dx.doi.org/10.1371/journal.pone.0174657			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358839	gold, Green Submitted, Green Published			2022-12-26	WOS:000399174800068
J	Rodriguez-Agirretxe, I; Garcia, I; Soria, J; Suarez, TM; Acera, A				Rodriguez-Agirretxe, Inaki; Garcia, Iker; Soria, Javier; Maria Suarez, Tatiana; Acera, Arantxa			Custom RT-qPCR-array for glaucoma filtering surgery prognosis	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; ENDOTHELIAL GROWTH-FACTOR; FILTRATION SURGERY; CORNEAL EPITHELIUM; GENE-EXPRESSION; DRY EYE; C-MYC; TRABECULECTOMY; INHIBITION; CELLS	Excessive subconjunctival scarring is the main reason of failure of glaucoma filtration surgery. We analyzed conjunctival and systemic gene expression patterns after non penetrating deep sclerectomy (NPDS). To find expression patterns related to surgical failure and their correlation with the clinical outcomes. This study consisted of two consecutive stages. The first was a prospective analysis of wound-healing gene expression profile of six patients after NPDS. Conjunctival samples and peripheral blood samples were collected before and 15, 90,180, and 360 days after surgery. In the second stage, we conducted a retrospective analysis correlating the late conjunctival gene expression and the outcome of the NPDS for 11 patients. We developed a RT-qPCR Array for 88 key genes associated to wound healing. RT-qPCR Array analysis of conjunctiva samples showed statistically significant differences in 29/88 genes in the early stages after surgery, 20/88 genes between 90 and 180 days after surgery, and only 2/88 genes one year after surgery. In the blood samples, the most important changes occurred in 12/88 genes in the first 15 days after surgery. Correspondence analyses (COA) revealed significant differences between the expression of 20/88 genes in patients with surgical success and failure one year after surgery. Different expression patterns of mediators of the bleb wound healing were identified. Examination of such patterns might be used in surgery prognosis. RT-qPCR Array provides a powerful tool for investigation of differential gene expression wound healing after glaucoma surgery.	[Rodriguez-Agirretxe, Inaki] Inst Clin Quirurg Oftalmol, Bilbao, Spain; [Rodriguez-Agirretxe, Inaki] Hosp Univ Donostia, San Sebastian, Spain; [Garcia, Iker; Soria, Javier; Maria Suarez, Tatiana; Acera, Arantxa] Bioftalm Appl Res, Derio, Spain		Acera, A (corresponding author), Bioftalm Appl Res, Derio, Spain.	arantxa.acera@bioftalmik.com		RODRIGUEZ AGIRRETXE, INAKI/0000-0001-8645-4991; ACERA, ARANTXA/0000-0002-6942-6144; Garcia Jimenez, Iker/0000-0003-1844-5705	Ministry of Science and innovation through PROFIT program [dex-580000-2008-41]; Ministry of Science and innovation through Apply Research [PPT-010000-2009-30]	Ministry of Science and innovation through PROFIT program; Ministry of Science and innovation through Apply Research	This work has been partially supported by the Ministry of Science and innovation through PROFIT program, grant dex-580000-2008-41, and the Ministry of Science and innovation through Apply Research, grant PPT-010000-2009-30. The funding organizations had no role in the design or conduct of this research.	Araujo SV, 1995, OPHTHALMOLOGY, V102, P1753, DOI 10.1016/S0161-6420(95)30797-X; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bo Qiyu, 2014, Zhonghua Yan Ke Za Zhi, V50, P471; BROADWAY DC, 1994, ARCH OPHTHALMOL-CHIC, V112, P1446, DOI 10.1001/archopht.1994.01090230060021; Chang L, 2000, SURV OPHTHALMOL, V45, P49, DOI 10.1016/S0039-6257(00)00135-1; CHEN CW, 1990, J OCUL PHARMACOL, V6, P175, DOI 10.1089/jop.1990.6.175; Cocho L, 2015, INVEST OPHTH VIS SCI, V56, P4570, DOI 10.1167/iovs.15-16736; COHEN LB, 1959, AM J OPHTHALMOL, V47, P54, DOI 10.1016/S0002-9394(14)78140-1; Cordeiro MF, 1999, INVEST OPHTH VIS SCI, V40, P2225; Corrales RM, 2011, INVEST OPHTH VIS SCI, V52, P8363, DOI 10.1167/iovs.11-7655; Daniels JT, 2003, INVEST OPHTH VIS SCI, V44, P1104, DOI 10.1167/iovs.02-0412; Dell S, 2006, INVEST OPHTH VIS SCI, V47, P1928, DOI 10.1167/iovs.05-1071; Garcia I, 2013, INVEST OPHTH VIS SCI, V54, P5643, DOI 10.1167/iovs.13-11933; Garcia I, 2012, OPHTHALMOLOGY, V119, P923, DOI 10.1016/j.ophtha.2011.10.031; Grewal DS, 2008, OPHTHALMOLOGY, V115, P2141, DOI 10.1016/j.ophtha.2008.06.009; HEUER DK, 1984, OPHTHALMOLOGY, V91, P384; HITCHINGS RA, 1983, T OPHTHAL SOC UK, V103, P84; Jo N, 2006, AM J PATHOL, V168, P2036, DOI 10.2353/ajpath.2006.050588; Kampfer H, 2000, EUR CYTOKINE NETW, V11, P626; KHAW PT, 1994, EYE, V8, P188, DOI 10.1038/eye.1994.44; Kirwan JF, 2009, COCHRANE DB SYST REV, V2; Kong TQ, 2004, P NATL ACAD SCI USA, V101, P10440, DOI 10.1073/pnas.0401339101; Lang SA, 2007, MOL CANCER THER, V6, P1123, DOI 10.1158/1535-7163.MCT-06-0628; Li DQ, 1999, CURR EYE RES, V19, P154, DOI 10.1076/ceyr.19.2.154.5321; Li ZQ, 2009, INVEST OPHTH VIS SCI, V50, P5217, DOI 10.1167/iovs.08-2662; Lichter PR, 2001, OPHTHALMOLOGY, V108, P1943, DOI 10.1016/S0161-6420(01)00873-9; Lindblom B, 2006, ACTA OPHTHALMOL SCAN, V84, P74, DOI 10.1111/j.1600-0420.2005.00560.x; Lockwood CB., 1885, J ANAT PHYSL, V2, pI2; Lopez-Garcia JS, 2016, CORNEA, V35, P336, DOI 10.1097/ICO.0000000000000726; Lopez-Miguel A, 2017, CORNEA, V36, P59, DOI 10.1097/ICO.0000000000000977; Mahale A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122409; Mermoud A, 1999, J CATARACT REFR SURG, V25, P323, DOI 10.1016/S0886-3350(99)80079-0; MIGDAL C, 1994, OPHTHALMOLOGY, V101, P1651; Moore F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031062; Moore QL, 2015, AM J OPHTHALMOL, V160, P135, DOI 10.1016/j.ajo.2015.04.008; Neufeld Gera, 1994, Progress in Growth Factor Research, V5, P89, DOI 10.1016/0955-2235(94)90019-1; Niu LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126277; Pan HW, 2009, MOL VIS, V15, P2279; Pflugfelder SC, 2015, INVEST OPHTH VIS SCI, V56, P7545, DOI 10.1167/iovs.15-17627; RAO GN, 1989, CURR EYE RES, V8, P405, DOI 10.3109/02713688908996388; Reidy T, 2013, J BIOL CHEM, V288, P8269, DOI 10.1074/jbc.M112.351064; RIVAS L, 1991, ACTA OPHTHALMOL, V69, P371; Rulli E, 2013, JAMA OPHTHALMOL, V131, P1573, DOI 10.1001/jamaophthalmol.2013.5059; Saika S, 2007, AM J PHYSIOL-CELL PH, V293, pC75, DOI 10.1152/ajpcell.00332.2006; Seet LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009415; Seibold LK, 2012, SURV OPHTHALMOL, V57, P530, DOI 10.1016/j.survophthal.2012.01.008; Servold S A, 1991, Clin Podiatr Med Surg, V8, P937; SMITH MF, 1992, AM J OPHTHALMOL, V114, P737, DOI 10.1016/S0002-9394(14)74053-X; Sriram S, 2014, EXP EYE RES, V125, P173, DOI 10.1016/j.exer.2014.06.014; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Wang Z, 2011, MOL VIS, V17, P3137; Whittaker KW, 2001, EYE, V15, P449, DOI 10.1038/eye.2001.153; Wree A, 2014, J MOL MED, V92, P1069, DOI 10.1007/s00109-014-1170-1; Yoshida S, 1997, MOL CELL BIOL, V17, P4015, DOI 10.1128/MCB.17.7.4015; Zhang LJ, 2015, IEEE T CONTR SYST T, V23, P1117, DOI 10.1109/TCST.2014.2349793; Zheng X, 2013, GENE CHROMOSOME CANC, V52, P225, DOI 10.1002/gcc.22022	56	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174559	10.1371/journal.pone.0174559	http://dx.doi.org/10.1371/journal.pone.0174559			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358901	gold, Green Submitted, Green Published			2022-12-26	WOS:000399174800053
J	Wu, J; Xu, Y; Ma, J				Wu, Juan; Xu, Yong; Ma, Jun			Levy noise improves the electrical activity in a neuron under electromagnetic radiation	PLOS ONE			English	Article							STOCHASTIC RESONANCE; REGIME SHIFTS; TIME-DELAY; NETWORK; MODEL; DYNAMICS; SYSTEM	As the fluctuations of the internal bioelectricity of nervous system is various and complex, the external electromagnetic radiation induced by magnet flux on membrane can be described by the non-Gaussian type distribution of Levy noise. Thus, the electrical activities in an improved Hindmarsh-Rose model excited by the external electromagnetic radiation of Levy noise are investigated and some interesting modes of the electrical activities are exhibited. The external electromagnetic radiation of Levy noise leads to the mode transition of the electrical activities and spatial phase, such as from the rest state to the firing state, from the spiking state to the spiking state with more spikes, and from the spiking state to the bursting state. Then the time points of the firing state versus Levy noise intensity are depicted. The increasing of Levy noise intensity heightens the neuron firing. Also the stationary probability distribution functions of the membrane potential of the neuron induced by the external electromagnetic radiation of Levy noise with different intensity, stability index and skewness papremeters are analyzed. Moreover, through the positive largest Lyapunov exponent, the parameter regions of chaotic electrical mode of the neuron induced by the external electromagnetic radiation of Levy noise distribution are detected.	[Wu, Juan; Xu, Yong] Northwestern Polytech Univ, Dept Appl Math, Xian, Peoples R China; [Wu, Juan; Xu, Yong] Beifang Univ Nationalities, Sch Math & Informat Sci, Yinchuan, Peoples R China; [Wu, Juan; Xu, Yong] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Wu, Juan; Xu, Yong] Humboldt Univ, Dept Phys, Berlin, Germany; [Ma, Jun] Lanzhou Univ Technol, Dept Phys, Lanzhou, Peoples R China	Northwestern Polytechnical University; North Minzu University; Potsdam Institut fur Klimafolgenforschung; Humboldt University of Berlin; Lanzhou University of Technology	Xu, Y (corresponding author), Northwestern Polytech Univ, Dept Appl Math, Xian, Peoples R China.; Xu, Y (corresponding author), Beifang Univ Nationalities, Sch Math & Informat Sci, Yinchuan, Peoples R China.; Xu, Y (corresponding author), Potsdam Inst Climate Impact Res, Potsdam, Germany.; Xu, Y (corresponding author), Humboldt Univ, Dept Phys, Berlin, Germany.	hsux3@nwpu.edu.cn	Ma, Jun/G-2376-2010; Xu, Yong/D-7348-2017	Ma, Jun/0000-0002-6127-000X; Xu, Yong/0000-0002-8407-4650	National Natural Science Foundation of China [11602003, 11572247, 11672122]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under grant Nos. 11602003, 11572247 and, 11672122. YX thanks to the Alexander von Humboldt Foundation and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2011, BRAIN RES, V1383, P22, DOI 10.1016/j.brainres.2011.01.097; Dhamala M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.028101; Dubkov AA, 2016, EPL-EUROPHYS LETT, V113, DOI 10.1209/0295-5075/113/30009; Dubkov AA, 2008, INT J BIFURCAT CHAOS, V18, P2649, DOI 10.1142/S0218127408021877; HINDMARSH JL, 1984, PROC R SOC SER B-BIO, V221, P87, DOI 10.1098/rspb.1984.0024; Janicki A, 1994, SIMULATION CHAOTIC B; Li YG, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.042222; Lv M, 2016, NONLINEAR DYNAM, V85, P1479, DOI 10.1007/s11071-016-2773-6; Lv M, 2016, NEUROCOMPUTING, V205, P375, DOI 10.1016/j.neucom.2016.05.004; Ma J, 2010, SCI CHINA PHYS MECH, V53, P672, DOI 10.1007/s11433-010-0097-y; Nurzaman SG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016168; Qin HX, 2014, SCI CHINA TECHNOL SC, V57, P936, DOI 10.1007/s11431-014-5534-0; Reato D, 2010, J NEUROSCI, V30, P15067, DOI 10.1523/JNEUROSCI.2059-10.2010; Russell DF, 1999, NATURE, V402, P291, DOI 10.1038/46279; Song X, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/298356; Tang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080324; Wang H, 2014, CHAOS, V24, P5880; Wang HT, 2016, NONLINEAR DYNAM, V85, P881, DOI 10.1007/s11071-016-2730-4; Wang HT, 2014, COMMUN NONLINEAR SCI, V19, P3242, DOI 10.1016/j.cnsns.2014.02.018; Wang ZQ, 2016, SCI CHINA TECHNOL SC, V59, P371, DOI 10.1007/s11431-015-6001-2; Xu Y, 2016, CHAOS SOLITON FRACT, V92, P91, DOI 10.1016/j.chaos.2016.09.015; Xu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep31505; Xu Y, 2013, CHAOS, V23, DOI 10.1063/1.4775758; Xu Y, 2012, NONLINEAR DYNAM, V70, P531, DOI 10.1007/s11071-012-0473-4; Yang T, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/11/P11005; Yi GS, 2015, BIOL CYBERN, V109, P287, DOI 10.1007/s00422-014-0642-2; Zeng CH, 2015, ECOL COMPLEX, V22, P102, DOI 10.1016/j.ecocom.2015.02.005; Zeng CH, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/10/P10017; Zeng CH, 2012, ECOL MODEL, V233, P52, DOI 10.1016/j.ecolmodel.2012.03.025	29	54	54	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174330	10.1371/journal.pone.0174330	http://dx.doi.org/10.1371/journal.pone.0174330			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358824	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174800030
J	Broad, KD; Kawano, G; Fierens, I; Rocha-Ferreira, E; Hristova, M; Ezzati, M; Rostami, J; Alonso-Alconada, D; Chaban, B; Hassell, J; Fleiss, B; Gressens, P; Sanders, RD; Robertson, NJ				Broad, Kevin D.; Kawano, Go; Fierens, Igor; Rocha-Ferreira, Eridan; Hristova, Mariya; Ezzati, Mojgan; Rostami, Jamshid; Alonso-Alconada, Daniel; Chaban, Badr; Hassell, Jane; Fleiss, Bobbi; Gressens, Pierre; Sanders, Robert D.; Robertson, Nicola J.			Surgery increases cell death and induces changes in gene expression compared with anesthesia alone in the developing piglet brain	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; GAMMA-AMINOBUTYRIC-ACID; COGNITIVE DYSFUNCTION; SYNAPTIC PLASTICITY; CHILDHOOD EXPOSURE; RAT-BRAIN; RECEPTORS; MICE; ALDOSTERONE; THROMBIN	In a range of animal species, exposure of the brain to general anaesthesia without surgery during early infancy may adversely affect its neural and cognitive development. The mechanisms mediating this are complex but include an increase in brain cell death. In humans, attempts to link adverse cognitive development to infantile anaesthesia exposure have yielded ambiguous results. One caveat that may influence the interpretation of human studies is that infants are not exposed to general anaesthesia without surgery, raising the possibility that surgery itself, may contribute to adverse cognitive development. Using piglets, we investigated whether a minor surgical procedure increases cell death and disrupts neurodevelopmental and cognitively salient gene transcription in the neonatal brain. We randomly assigned neonatal male piglets to a group who received 6h of 2% isoflurane anaesthesia or a group who received an identical anaesthesia plus 15 mins of surgery designed to replicate an inguinal hernia repair. Compared to anesthesia alone, surgery-induced significant increases in cell death in eight areas of the brain. Using RNAseq data derived from all 12 piglets per group we also identified significant changes in the expression of 181 gene transcripts induced by surgery in the cingulate cortex, pathway analysis of these changes suggests that surgery influences the thrombin, aldosterone, axonal guidance, B cell, ERK-5, eNOS and GABA(A) signalling pathways. This suggests a number of novel mechanisms by which surgery may influence neural and cognitive development independently or synergistically with the effects of anaesthesia.	[Broad, Kevin D.; Kawano, Go; Fierens, Igor; Rocha-Ferreira, Eridan; Hristova, Mariya; Ezzati, Mojgan; Rostami, Jamshid; Alonso-Alconada, Daniel; Chaban, Badr; Hassell, Jane; Robertson, Nicola J.] UCL, Inst Womens Hlth, London, England; [Fleiss, Bobbi; Gressens, Pierre] Kings Coll London, Ctr Developing Brain, St Thomas Campus, London, England; [Fleiss, Bobbi; Gressens, Pierre] INSERM, U1141, Paris, France; [Fleiss, Bobbi; Gressens, Pierre] Univ Paris Diderot, Sorbonne Paris Cite, UMRS 1141, Paris, France; [Sanders, Robert D.] Univ Wisconsin, Dept Anesthesiol, Madison, WI USA	University of London; University College London; University of London; King's College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Wisconsin System; University of Wisconsin Madison	Robertson, NJ (corresponding author), UCL, Inst Womens Hlth, London, England.	n.robertson@ucl.ac.uk	Fleiss, Bobbi/F-9899-2011; Kawano, Go/AAI-5080-2021; Robertson, Nicola/GWR-2021-2022; gressens, pierre/M-7557-2017; Blanco, Leire/O-5114-2017	Fleiss, Bobbi/0000-0001-7828-673X; Kawano, Go/0000-0003-2962-0556; gressens, pierre/0000-0002-0909-4221; Sanders, Robert/0000-0003-0113-0328; Rocha Ferreira, Eridan/0000-0002-9342-4691; Alonso-Alconada, Daniel/0000-0002-9874-2947	UK Department of Health's National Institute for Health Research Biomedical Research Centre's funding scheme; MRC [MR/J00457X/1]; Basque Government Postdoctoral Program [POS_2013_1_191]; Medical Research Council [MR/J00457X/1] Funding Source: researchfish	UK Department of Health's National Institute for Health Research Biomedical Research Centre's funding scheme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Basque Government Postdoctoral Program; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was undertaken at University College London Hospitals/University College London, which received a proportion of funding from the UK Department of Health's National Institute for Health Research Biomedical Research Centre's funding scheme. This study was funded by the MRC (Grant: MR/J00457X/1) as part of a larger project. DAA was funded by the Basque Government Postdoctoral Program (POS_2013_1_191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was undertaken at University College London Hospitals/University College London, which received a proportion of funding from the UK Department of Health's National Institute for Health Research Biomedical Research Centre's funding scheme.	Aisa B, 2009, HIPPOCAMPUS, V19, P1222, DOI 10.1002/hipo.20586; Antkowiak B, 2016, CURR OPIN ANESTHESIO, V29, P447, DOI 10.1097/ACO.0000000000000358; Bartels M, 2009, TWIN RES HUM GENET, V12, P246, DOI 10.1375/twin.12.3.246; Brambrink AM, 2012, ANN NEUROL, V72, P525, DOI 10.1002/ana.23652; Briner A, 2011, ANESTHESIOLOGY, V115, P282, DOI 10.1097/ALN.0b013e318221fbbd; Broad KD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166784; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Creeley CE, 2014, ANESTHESIOLOGY, V120, P626, DOI 10.1097/ALN.0000000000000037; Davidson AJ, 2016, LANCET, V387, P239, DOI 10.1016/S0140-6736(15)00608-X; Devesa P, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-100; DiMaggio C, 2011, ANESTH ANALG, V113, P1143, DOI 10.1213/ANE.0b013e3182147f42; DiMaggio C, 2009, J NEUROSURG ANESTH, V21, P286, DOI 10.1097/ANA.0b013e3181a71f11; Dinh QN, 2016, BRAIN RES, V1637, P146, DOI 10.1016/j.brainres.2016.02.034; Garry PS, 2015, EXP NEUROL, V263, P235, DOI 10.1016/j.expneurol.2014.10.017; Geerling JC, 2009, AM J PHYSIOL-RENAL, V297, pF559, DOI 10.1152/ajprenal.90399.2008; Hansen KD, 2011, NAT BIOTECHNOL, V29, P572, DOI 10.1038/nbt.1910; Hansen TG, 2011, ANESTHESIOLOGY, V114, P1076, DOI 10.1097/ALN.0b013e31820e77a0; Hartley C, 2014, PAIN, V155, P2368, DOI 10.1016/j.pain.2014.09.006; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; Helmbrecht MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123643; Ing C, 2012, PEDIATRICS, V130, pE476, DOI 10.1542/peds.2011-3822; Istaphanous GK, 2013, ANESTH ANALG, V116, P845, DOI 10.1213/ANE.0b013e318281e988; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Krenzlin H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010084; Langsjo JW, 2012, J NEUROSCI, V32, P4935, DOI 10.1523/JNEUROSCI.4962-11.2012; Lee BH, 2014, NEUROPHARMACOLOGY, V83, P9, DOI 10.1016/j.neuropharm.2014.03.011; Lee KR, 1997, J NEUROSURG, V86, P272, DOI 10.3171/jns.1997.86.2.0272; Lin HY, 2010, STROKE, V41, P1543, DOI 10.1161/STROKEAHA.109.574004; Lundblad C, 2009, J NEUROTRAUM, V26, P1953, DOI 10.1089/neu.2009.0955; Martorell L, 2007, J THROMB HAEMOST, V5, P1766, DOI 10.1111/j.1538-7836.2007.02627.x; Nithianandarajah-Jones GN, 2012, CELL SIGNAL, V24, P2187, DOI 10.1016/j.cellsig.2012.07.007; Paule MG, 2011, NEUROTOXICOL TERATOL, V33, P220, DOI 10.1016/j.ntt.2011.01.001; Raper J, 2015, ANESTHESIOLOGY, V123, P1084, DOI 10.1097/ALN.0000000000000851; Roberts OL, 2009, BIOCHEM SOC T, V37, P1254, DOI 10.1042/BST0371254; Rocha-Ferreira E, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5763743; Rucklidge JJ, 2010, PSYCHIAT CLIN N AM, V33, P357, DOI 10.1016/j.psc.2010.01.006; Sanchez V, 2011, ANESTHESIOLOGY, V115, P992, DOI 10.1097/ALN.0b013e3182303a63; Sanders RD, 2015, J NEUROIMMUNOL, V282, P97, DOI 10.1016/j.jneuroim.2015.04.001; Sanders RD, 2013, CRIT CARE MED, V41, P1627, DOI 10.1097/CCM.0b013e31827c0c8d; Schurch NJ, 2016, RNA, V22, P839, DOI 10.1261/rna.053959.115; Schwarzmaier SM, 2015, J NEUROTRAUM, V32, P731, DOI 10.1089/neu.2014.3650; Shen K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001842; Shu Y, 2012, NEUROBIOL DIS, V45, P743, DOI 10.1016/j.nbd.2011.10.021; Sprung J, 2012, MAYO CLIN PROC, V87, P120, DOI 10.1016/j.mayocp.2011.11.008; Tillo M, 2012, CELL ADHES MIGR, V6, P541, DOI 10.4161/cam.22408; Tracey I, 2008, BRIT J ANAESTH, V101, P32, DOI 10.1093/bja/aen102; Van Battum EY, 2015, LANCET NEUROL, V14, P532, DOI 10.1016/S1474-4422(14)70257-1; Wang H, 2003, BIOL CHEM, V384, P193, DOI 10.1515/BC.2003.021; Wang HW, 2016, NEUROSCIENCE, V314, P90, DOI 10.1016/j.neuroscience.2015.11.055; Waters M J, 2011, Pediatr Endocrinol Rev, V9, P549; Webb EA, 2012, BRAIN, V135, P216, DOI 10.1093/brain/awr305; Wu J, 2016, ANESTHESIOLOGY, V124, P624, DOI 10.1097/ALN.0000000000000981; Zheng B, J IMMUNOLOGY S, V194	54	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0173413	10.1371/journal.pone.0173413	http://dx.doi.org/10.1371/journal.pone.0173413			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355229	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174600016
J	Caballes, CF; Pratchett, MS				Caballes, Ciemon Frank; Pratchett, Morgan S.			Environmental and biological cues for spawning in the crown-of-thorns starfish	PLOS ONE			English	Article							GREAT-BARRIER-REEF; GREEN SEA-URCHIN; ACANTHASTER-PLANCI; STRONGYLOCENTROTUS-DROEBACHIENSIS; FERTILIZATION SUCCESS; PHYTOPLANKTON; OUTBREAKS; BEHAVIOR; SPERM; CONSEQUENCES	Sporadic outbreaks of the coral-eating crown-of-thorns starfish are likely to be due, at least in part, to spatial and temporal variation in reproductive and settlement success. For gonochoric and broadcast spawning species such as crown-of-thorns starfish, spawning synchrony is fundamental for achieving high rates of fertilization. Highly synchronized gamete release within and among distinct populations is typically the result of the entrainment of neurohormonal endogenous rhythms by cues from the environment. In this study, we conducted multiple spawning assays to test the effects of temperature change, reduced salinity and nutrient enrichment of seawater, phytoplankton, gametes (sperm and eggs), and the combined effect of sperm and phytoplankton on the likelihood of spawning in male and female crown-of-thorns starfish. We also investigated sex-specific responses to each of these potential spawning cues. We found that (1) abrupt temperature change (an increase of 4 E C) induced spawning in males, but less so in females; (2) males often spawned in response to the presence of phytoplankton, but none of the females spawned in response to these cues; (3) the presence of sperm in the water column induced males and females to spawn, although additive and synergistic effects of sperm and phytoplankton were not significant; and (4) males are more sensitive to the spawning cues tested and most likely spawn prior to females. We propose that environmental cues act as spawning `inducers' by causing the release of hormones (gonad stimulating substance) in sensitive males, while biological cues (pheromones) from released sperm, in turn, act as spawning `synchronizers' by triggering a hormonal cascade resulting in gamete shedding by conspecifics. Given the immediate temporal linkage between the timing of spawning and fertilization events, variability in the extent and synchronicity of gamete release will significantly influence reproductive success and may account for fluctuations in the abundance of crown-of-thorns starfish.	[Caballes, Ciemon Frank; Pratchett, Morgan S.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia	James Cook University	Caballes, CF (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia.	ciemon.caballes@my.jcu.edu.au	Pratchett, Morgan/AAW-5179-2020; Caballes, Ciemon Frank/D-7846-2016	Pratchett, Morgan/0000-0002-1862-8459; Caballes, Ciemon Frank/0000-0003-1865-6713	Great Barrier Reef Marine Park Authority Science for Management Award; Ian Potter Foundation Commemorative COTS Research Grant; ARC Centre of Excellence for Coral Reef Studies	Great Barrier Reef Marine Park Authority Science for Management Award; Ian Potter Foundation Commemorative COTS Research Grant; ARC Centre of Excellence for Coral Reef Studies(Australian Research Council)	Funding for this study was provided by the Great Barrier Reef Marine Park Authority Science for Management Award to CFC, the Ian Potter Foundation Commemorative COTS Research Grant to MSP and CFC, and the ARC Centre of Excellence for Coral Reef Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this study was provided by the Great Barrier Reef Marine Park Authority Science for Management Award to CFC, the Ian Potter Foundation Commemorative COTS Research Grant to MSP and CFC, and the ARC Centre of Excellence for Coral Reef Studies. We would like to thank Jairo Rivera-Posada, Lyle Vail, Anne Hoggett, Andrew Hoey, Vanessa Messmer, Maya Santangelo, and the staff at the Lizard Island Research Station for field and laboratory assistance. We are also grateful to Maia Raymundo for assistance in preparing the manuscript for publication. Comments from Russ Babcock, James McClintock, and an anonymous reviewer substantially improved the content and clarity of the manuscript.	Agresti A, 1996, INTRODUCTION TO CATE; Ayukai T, 1996, AIMS REP, V22, P1; Babcock R, 1995, REPROD FERT DEVELOP, V7, P943, DOI 10.1071/RD9950943; BABCOCK R, 1992, INVERTEBR REPROD DEV, V22, P213, DOI 10.1080/07924259.1992.9672274; BABCOCK RC, 1992, AUST J MAR FRESH RES, V43, P525; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; BABCOCK RC, 1994, BIOL BULL-US, V186, P17, DOI 10.2307/1542033; Babcock RC, 1992, P 7 INT COR REEF S, P757; Babcock RC, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-3009-5; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; BEACH DH, 1975, NATURE, V254, P135, DOI 10.1038/254135a0; BENZIE JAH, 1994, BIOL BULL-US, V186, P139, DOI 10.2307/1542048; Berkelmans R, 1999, CORAL REEFS, V18, P219, DOI 10.1007/s003380050186; Berkelmans R, 2001, THESIS; Berkelmans R, 2010, LIMNOL OCEANOGR, V55, P2634, DOI 10.4319/lo.2010.55.6.2634; BRAUER RW, 1970, NATURE, V228, P344, DOI 10.1038/228344a0; Brodie J, 2005, MAR POLLUT BULL, V51, P266, DOI 10.1016/j.marpolbul.2004.10.035; Caballes C.F., 2014, ECHINODERMS ECOLOGY, DOI DOI 10.13140/RG.2.1.3719.5129; Caballes CF, 2017, DIVERSITY-BASEL, V9, DOI 10.3390/d9010010; Core Team R., 2016, LANG ENV STAT COMP; DENNY MW, 1989, AM NAT, V134, P859, DOI 10.1086/285018; Devlin MJ, 2012, MAR POLLUT BULL, V65, P224, DOI 10.1016/j.marpolbul.2012.03.001; Devlin M.J., 2013, PHYTOPLANKTON GREAT, P68; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; Gaudette J, 2006, LIMNOL OCEANOGR, V51, P1485, DOI 10.4319/lo.2006.51.3.1485; Giese A.C., 1987, P251; GLADSTONE W, 1992, AUST J MAR FRESH RES, V43, P535, DOI 10.1071/MF9920535; HAMEL JF, 1995, BIOL BULL-US, V188, P32, DOI 10.2307/1542065; HIMMELMAN JH, 1975, J EXP MAR BIOL ECOL, V20, P199, DOI 10.1016/0022-0981(75)90024-6; Himmelman JH., 1999, ENCY REPROD, P524; Himmelman JH, 2008, MAR ECOL PROG SER, V361, P161, DOI 10.3354/meps07415; Jones RJ, 2000, MAR FRESHWATER RES, V51, P63, DOI 10.1071/MF99100; KANATANI H, 1973, INT REV CYTOL, V35, P253, DOI 10.1016/S0074-7696(08)60356-3; KUBOTA J, 1977, EXP CELL RES, V106, P63, DOI 10.1016/0014-4827(77)90241-5; Levitan Don R., 1995, P123; Levitan DR, 2005, AM NAT, V165, P682, DOI 10.1086/429733; LEVITAN DR, 1992, ECOLOGY, V73, P248, DOI 10.2307/1938736; Levitan DR, SPERM COMPETITION SE; Mellin C, 2016, ECOL LETT, V19, P629, DOI 10.1111/ele.12598; Mercier A, 2009, ADV MAR BIOL, V55, P1, DOI 10.1016/S0065-2881(09)55001-8; Mercier A, 2008, MAR BIOL, V156, P205, DOI 10.1007/s00227-008-1077-x; MILLER RL, 1989, J EXP MAR BIOL ECOL, V130, P205, DOI 10.1016/0022-0981(89)90164-0; MINCHIN D, 1987, MAR BIOL, V95, P139, DOI 10.1007/BF00447495; MITA M, 1993, INVERTEBR REPROD DEV, V24, P237, DOI 10.1080/07924259.1993.9672357; Mita M, 2015, INVERTEBR REPROD DEV, V59, P212, DOI 10.1080/07924259.2015.1086828; Okaji K., 1991, P291; OLIVE PJW, 1995, J THERM BIOL, V20, P79, DOI 10.1016/0306-4565(94)00030-M; ORMOND RFG, 1973, NATURE, V246, P167, DOI 10.1038/246167a0; PEARSE JS, 1986, AM ZOOL, V26, P417; PENTREATH VW, 1972, BIOL REV, V47, P363, DOI 10.1111/j.1469-185X.1972.tb00977.x; Pratchett MS, 2014, OCEANOGR MAR BIOL, V52, P133; Quinn GP, 2003, EXPT DESIGN DATA ANA; Reuter KE, 2010, BIOL BULL-US, V219, P198, DOI 10.1086/BBLv219n3p198; REVELANTE N, 1982, J PLANKTON RES, V4, P47, DOI 10.1093/plankt/4.1.47; Scheibling RE, 2008, B MAR SCI, V82, P221; Schroeder T, 2012, MAR POLLUT BULL, V65, P210, DOI 10.1016/j.marpolbul.2012.02.022; Selvakumaraswamy P, 2000, INVERTEBR BIOL, V119, P394; Sloan N.A., 1982, P3; Soong K, 2005, MAR ECOL PROG SER, V292, P195, DOI 10.3354/meps292195; STARR M, 1993, CAN J FISH AQUAT SCI, V50, P894, DOI 10.1139/f93-103; STARR M, 1992, MAR ECOL PROG SER, V79, P275; STARR M, 1990, SCIENCE, V247, P1071, DOI 10.1126/science.247.4946.1071; UNGER B, 1994, ECHINODERMS THROUGH TIME, P913; Uthicke S, 2009, ECOL MONOGR, V79, P3, DOI 10.1890/07-2136.1; Walker G.A., 2010, COMMON STAT METHODS, Vthird; Watson GJ, 2000, MAR BIOL, V136, P1003, DOI 10.1007/s002270000283; Wooldridge SA, 2015, MAR POLLUT BULL, V101, P805, DOI 10.1016/j.marpolbul.2015.08.049	67	17	17	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0173964	10.1371/journal.pone.0173964	http://dx.doi.org/10.1371/journal.pone.0173964			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355236	Green Published, Green Accepted, gold			2022-12-26	WOS:000399174600031
J	Robertson, JK; Muir, C; Hurd, CS; Hing, JS; Quinn, JS				Robertson, Joshua K.; Muir, Cameron; Hurd, Conner S.; Hing, Jing S.; Quinn, James S.			The effect of social group size on feather corticosterone in the co-operatively breeding Smooth-billed Ani (Crotophaga ani): An assay validation and analysis of extreme social living	PLOS ONE			English	Article							MATERNAL CORTICOSTERONE; LAYING ORDER; AVIAN YOLK; LONG-TERM; STRESS; TESTOSTERONE; DEPOSITION; CHALLENGE; BEHAVIOR; DOMINANCE	Living closely with others can provide a myriad of fitness benefits, from shared territory defense to co-operative resource acquisition. Costs of social aggregation are not absent, however, and likely influence optimal and observed groups' sizes in a social species. Here, we explored optimal group size in a joint -nesting cuckoo species (the Smooth -billed Ani, Crotophaga an!) using endocrine markers of stress physiology (corticosterone, or CORT). Smooth -billed Anis exhibit intense reproductive competition that is exacerbated in atypically large groups. We therefore hypothesized that intra-group competition (measured by social group size) mediates the desirability and physiological cost of social group membership in this species. To test this hypothesis, we captured 47 adult Smooth -billed Anis (31 males, 16 females) during the breeding seasons of 2012-2014 in south-western Puerto Rico, and documented social group sizes. Tail feathers were sampled and used to quantify CORT (pg/ mg) in enzyme -linked immunosorbent assays (ELISAs) (n = 50). Our analyses show significant differences in feather-CORT of adults between categorical group sizes, with individuals from atypically large social groups (> x+ 1SD) having highest mean concentrations (33.319 pg/mg), and individuals from atypically small social groups (< x- 1SD) having lowest mean concentrations (8.969 pg/mg). Whether reproductive competition or effort is responsible for elevated CORT in atypically large social groups, however, remains unclear. Our results suggest that living in atypically large groups is physiologically expensive and may represent an evolutionarily unstable strategy. To our knowledge, this is the first study to explore a correlation between stress physiology and group size in a joint -nesting species.	[Robertson, Joshua K.; Hurd, Conner S.; Hing, Jing S.; Quinn, James S.] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Muir, Cameron] Brock Univ, Ctr Neurosci, Dept Psychol, St Catharines, ON, Canada	McMaster University; Brock University	Robertson, JK (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	roberjk@mcmaster.ca		Tabh, Joshua/0000-0002-9519-7488	NSERC Discovery Grant [138790-2011]	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by NSERC Discovery Grant (Grant # 138790-2011);	Abbott DH, 2003, HORM BEHAV, V43, P67, DOI 10.1016/S0018-506X(02)00037-5; Akirav I, 2004, LEARN MEMORY, V11, P188, DOI 10.1101/lm.61704; Al-Rawi B., 1975, Applied Animal Ethology, V2, P69, DOI 10.1016/0304-3762(75)90066-8; Almasi B, 2012, GEN COMP ENDOCR, V178, P139, DOI 10.1016/j.ygcen.2012.04.032; Arnold KE, 2005, BEHAVIOUR, V142, P1577, DOI 10.1163/156853905774831927; Arnold KE, 2000, ETHOLOGY, V106, P385, DOI 10.1046/j.1439-0310.2000.00545.x; Astheimer LB, 2000, HORM BEHAV, V37, P31, DOI 10.1006/hbeh.1999.1555; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berk SA, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow020; Blanchard L., 2000, THESIS; BOONSTRA R, 1993, GEN COMP ENDOCR, V91, P126, DOI 10.1006/gcen.1993.1113; Bortolotti GR, 2008, FUNCT ECOL, V22, P494, DOI 10.1111/j.1365-2435.2008.01387.x; Bortolotti GR, 2010, ECOL APPL, V20, P1766, DOI 10.1890/09-1473.1; Bortolotti GR, 2009, J EXP BIOL, V212, P1477, DOI 10.1242/jeb.022152; Breuner CW, 2008, GEN COMP ENDOCR, V157, P288, DOI 10.1016/j.ygcen.2008.05.017; Brown C. R., 1996, COLONIALITY CLIFF SW; BROWN JL, 1974, AM ZOOL, V14, P63; Chapman CA, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P24; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Davis D. E., 1940, Auk, V1940, P179; FOSTER MS, 1975, CONDOR, V77, P304, DOI 10.2307/1366226; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Goymann W, 2004, ANIM BEHAV, V67, P591, DOI 10.1016/j.anbehav.2003.08.007; Green P, 2016, METHODS ECOL EVOL; Grieves LA, 2014, ANIM BEHAV, V89, P215, DOI 10.1016/j.anbehav.2014.01.008; Griffiths R, 1996, P ROY SOC B-BIOL SCI, V263, P1251, DOI 10.1098/rspb.1996.0184; Grunst ML, 2014, BEHAV ECOL; HAMILTON WD, 1971, J THEOR BIOL, V31, P295, DOI 10.1016/0022-5193(71)90189-5; Hayward LS, 2004, GEN COMP ENDOCR, V135, P365, DOI 10.1016/j.ygcen.2003.11.002; HEGNER RE, 1986, HORM BEHAV, V20, P313, DOI 10.1016/0018-506X(86)90040-1; HEINRICH B, 1988, BEHAV ECOL SOCIOBIOL, V23, P141, DOI 10.1007/BF00300349; Horak P, 2013, GEN COMP ENDOCR, V191, P210, DOI 10.1016/j.ygcen.2013.07.002; JOHNSON AL, 1981, GEN COMP ENDOCR, V43, P10, DOI 10.1016/0016-6480(81)90025-3; Kennedy EA, 2013, BEHAV ECOL SOCIOBIOL, V67, P341, DOI 10.1007/s00265-012-1454-9; Kokko H, 2001, P ROY SOC B-BIOL SCI, V268, P187, DOI 10.1098/rspb.2000.1349; Koren L, 2012, P ROY SOC B-BIOL SCI, V279, P1560, DOI 10.1098/rspb.2011.2062; Kotrschal K, 1998, ANIM BEHAV, V55, P171, DOI 10.1006/anbe.1997.0597; Landys MM, 2007, PHYSIOL BIOCHEM ZOOL, V80, P228, DOI 10.1086/510564; Landys MM, 2010, HORM BEHAV, V58, P317, DOI 10.1016/j.yhbeh.2010.02.013; Lattin CR, 2011, J AVIAN BIOL, V42, P247, DOI 10.1111/j.1600-048X.2010.05310.x; Lendvai AZ, 2013, BEHAV ECOL SOCIOBIOL, V67, P1817, DOI 10.1007/s00265-013-1591-9; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; MEYERS JM, 1993, J FIELD ORNITHOL, V64, P270; Mock DW, 1999, J FIELD ORNITHOL, V70, P276; Poisbleau M, 2005, HORM BEHAV, V47, P485, DOI 10.1016/j.yhbeh.2005.01.001; Pravosudov VV, 2003, P ROY SOC B-BIOL SCI, V270, P2599, DOI 10.1098/rspb.2003.2551; Pravosudov VV, 2003, HORM BEHAV, V44, P93, DOI 10.1016/S0018-506X(03)00119-3; Pride E., 2005, BEHAV ECOL; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; Quinn James S., 2000, Birds of North America, V539, P1; Raouf SA, 2006, ANIM BEHAV, V71, P39, DOI 10.1016/j.anbehav.2005.03.027; REHDER NB, 1986, GEN COMP ENDOCR, V62, P386, DOI 10.1016/0016-6480(86)90048-1; Rettenbacher S, 2005, ANN NY ACAD SCI, V1046, P193, DOI 10.1196/annals.1343.016; REYER HU, 1986, BEHAVIOUR, V96, P277, DOI 10.1163/156853986X00522; Rivers JW, 2012, FUNCT ECOL, V26, P1127, DOI 10.1111/j.1365-2435.2012.02025.x; Robertson JK, 2016, THESIS; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Saldanha CJ, 2000, HORM BEHAV, V37, P109, DOI 10.1006/hbeh.2000.1571; Samuelsen A., 2008, THESIS; Sandi C, 1997, EUR J NEUROSCI, V9, P637, DOI 10.1111/j.1460-9568.1997.tb01412.x; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schmaltz G, 2008, ANIM BEHAV, V76, P153, DOI 10.1016/j.anbehav.2007.12.018; Schmaltz G, 2008, HORM BEHAV, V53, P82, DOI 10.1016/j.yhbeh.2007.09.001; Schmaltz G, 2016, GEN COMP ENDOCR, V232, P145, DOI 10.1016/j.ygcen.2016.04.022; SCHOECH SJ, 1991, CONDOR, V93, P354, DOI 10.2307/1368951; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; SKUTCH ALEXANDER F., 1961, CONDOR, V63, P198, DOI 10.2307/1365683; Sloman KA, 2001, PHYSIOL BIOCHEM ZOOL, V74, P383, DOI 10.1086/320426; Smith TE, 1997, AM J PRIMATOL, V42, P253, DOI 10.1002/(SICI)1098-2345(1997)42:4<253::AID-AJP1>3.0.CO;2-W; SNOW D. W., 1964, ZOOLOGICA [NEW YORK], V49, P1; Sorenson LG, 1997, ANIM BEHAV, V54, P1117, DOI 10.1006/anbe.1997.0554; Van Duyse E, 2004, BEHAVIOUR, V141, P451, DOI 10.1163/156853904323066739; VANSCHAIK CP, 1983, BEHAV ECOL SOCIOBIOL, V13, P173, DOI 10.1007/BF00299920; VEHRENCAMP SL, 1977, SCIENCE, V197, P403, DOI 10.1126/science.197.4301.403; VEHRENCAMP SL, 1986, ANIM BEHAV, V34, P347, DOI 10.1016/S0003-3472(86)80103-8; Wingfield J.C., 2001, HANDBK PHYSL, P211, DOI [10.1002/cphy.cp070411, DOI 10.1002/CPHY.CP070411]; WRANGHAM RW, 1980, BEHAVIOUR, V75, P262, DOI 10.1163/156853980X00447	77	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174650	10.1371/journal.pone.0174650	http://dx.doi.org/10.1371/journal.pone.0174650			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355280	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174600076
J	Salas, BH; Haslun, JA; Strychar, KB; Ostrom, PH; Cervino, JM				Salas, Briana Hauff; Haslun, Joshua A.; Strychar, Kevin B.; Ostrom, Peggy H.; Cervino, James M.			Site-specific variation in gene expression from Symbiodinium spp. associated with offshore and inshore Porites astreoides in the lower Florida Keys is lost with bleaching and disease stress	PLOS ONE			English	Article							CORAL MONTASTRAEA-FAVEOLATA; REEF-BUILDING CORALS; THERMAL-STRESS; CLIMATE-CHANGE; HEAT-STRESS; ENVIRONMENTAL-CONDITIONS; SCLERACTINIAN CORALS; ZOOXANTHELLAE; TEMPERATURE; PROTEIN	Scleractinian coral are experiencing unprecedented rates of mortality due to increases in sea surface temperatures in response to global climate change. Some coral species however, survive high temperature events due to a reduced susceptibility to bleaching. We investigated the relationship between bleaching susceptibility and expression of five metabolically related genes of Symbiodinium spp. from the coral Porites astreoides originating from an inshore and offshore reef in the Florida Keys. The acclimatization potential of Symbiodinium spp. to changing temperature regimes was also measured via a two-year reciprocal transplant between the sites. Offshore coral fragments displayed significantly higher expression in Symbiodinium spp. genes PCNA, SCP2, G3PDH, PCP and psaE than their inshore counterparts (p<0.05), a pattern consistent with increased bleaching susceptibility in offshore corals. Additionally, gene expression patterns in Symbiodinium spp. from site of origin were conserved throughout the two-year reciprocal transplant, indicating acclimatization did not occur within this multi-season time frame. Further, laboratory experiments were used to investigate the influence of acute high temperature (32 degrees C for eight hours) and disease (lipopolysaccharide of Serratia marcescens) on the five metabolically related symbiont genes from the same offshore and inshore P. astreoides fragments. Gene expression did not differ between reef fragments, or as a consequence of acute exposure to heat or heat and disease, contrasting to results found in the field. Gene expression reported here indicates functional variation in populations of Symbiodinium spp. associated with P. astreoides in the Florida Keys, and is likely a result of localized adaptation. However, gene expression patterns observed in the lab imply that functional variation in zooxanthellae observed under conditions of chronic moderate stress is lost under the acute extreme conditions studied here.	[Salas, Briana Hauff] Univ Texas San Antonio, Sch Med, San Antonio, TX 78249 USA; [Haslun, Joshua A.; Ostrom, Peggy H.] Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA; [Strychar, Kevin B.] Grand Valley State Univ, Annis Water Resources Inst, Muskegon, MI USA; [Cervino, James M.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	University of Texas System; University of Texas at San Antonio (UTSA); Michigan State University; Grand Valley State University; Woods Hole Oceanographic Institution	Salas, BH (corresponding author), Univ Texas San Antonio, Sch Med, San Antonio, TX 78249 USA.	SalasB3@UTHSCSA.edu			Coastal Preservation network	Coastal Preservation network	Funding for this research was provided by Coastal Preservation network (KBS, BHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoub L, 2009, CAN COLORED DISSOLVE; Baker C., 2003, FLEXIBILITY SPECIFIC, V34, P661; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; BENGIS C, 1977, J BIOL CHEM, V252, P4564; Bhagooli R, 2010, 11 INT COR REEF S, P113; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Cervino JM, 2008, J APPL MICROBIOL, V105, P1658, DOI 10.1111/j.1365-2672.2008.03871.x; Cervino JM, 2004, BAND DISEASE IN CARI; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Dikou A, 2006, MAR POLLUT BULL, V52, P1340, DOI 10.1016/j.marpolbul.2006.02.011; Downs CA, 2000, MAR BIOTECHNOL, V2, P533, DOI 10.1007/s101260000038; Downs CA, 2012, ECOTOXICOLOGY, V21, P768, DOI 10.1007/s10646-011-0837-4; Edge SE, 2008, J EXP MAR BIOL ECOL, V355, P114, DOI 10.1016/j.jembe.2007.12.004; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Haslun JA, J MAR BIOL; Hauff Briana, 2016, International Journal of Biology, V8, P9; Hauff B, 2014, DIS AQUAT ORGAN, V112, P149, DOI 10.3354/dao02802; HOEGHGULDBERG O, 1989, J EXP MAR BIOL ECOL, V129, P279, DOI 10.1016/0022-0981(89)90109-3; Iglesias-Prieto R, 1997, MAR BIOL, V130, P23, DOI 10.1007/s002270050221; IGLESIASPRIETO R, 1992, P NATL ACAD SCI USA, V89, P10302, DOI 10.1073/pnas.89.21.10302; Jeanjean R, 2008, BBA-BIOENERGETICS, V1777, P308, DOI 10.1016/j.bbabio.2007.11.009; Jones RJ, 2001, PLANT CELL ENVIRON, V24, P89, DOI 10.1046/j.1365-3040.2001.00648.x; Karako-Lampert S, 2005, J EXP MAR BIOL ECOL, V318, P11, DOI 10.1016/j.jembe.2004.11.024; Kenkel CD, 2014, MOL ECOL RESOUR, V14, P667, DOI 10.1111/1755-0998.12218; Kenkel CD, 2013, MOL ECOL, V22, P4322, DOI 10.1111/mec.12390; Kenkel CD, 2015, HEREDITY EDINB, P1; Kneeland J, 2013, CORAL REEFS, V32, P923, DOI 10.1007/s00338-013-1076-3; LaJeunesse TC, 2010, J BIOGEOGR, V37, P785, DOI 10.1111/j.1365-2699.2010.02273.x; Leggat W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026687; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Lirman D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023047; Loh W, 2006, DIVERSITY ZOOXANTHEL; Luo YJ, 2009, CORAL REEFS, V28, P289, DOI 10.1007/s00338-008-0462-8; Matz MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071448; Maverakis E, 2015, J AUTOIMMUN, V57, P1, DOI 10.1016/j.jaut.2014.12.002; Mayfield AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026529; McGinley MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050439; MUSCATINE L, 1989, PROC R SOC SER B-BIO, V236, P311, DOI 10.1098/rspb.1989.0025; NORRIS BJ, 1994, PLANT MOL BIOL, V24, P673, DOI 10.1007/BF00023563; Palmer CD, 2011, COLI, V90, P1; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Rosic NN, 2011, MAR BIOTECHNOL, V13, P355, DOI 10.1007/s10126-010-9308-9; Rosic NN, 2011, CELL STRESS CHAPERON, V16, P69, DOI 10.1007/s12192-010-0222-x; Rosic NN, 2010, APPL ENVIRON MICROB, V76, P2823, DOI 10.1128/AEM.02984-09; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Ruiz-Jones LJ, 2015, BIOL BULL-US, V228, P227, DOI 10.1086/BBLv228n3p227; Ruzicka RR, 2013, MAR ECOL PROG SER, V489, P125, DOI 10.3354/meps10427; Sammarco Paul W., 2009, Environmental Bioindicators, V4, P4, DOI 10.1080/15555270902915194; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Sirover MA, 1997, J CELL BIOCHEM, V66, P133, DOI 10.1002/(SICI)1097-4644(19970801)66:2<133::AID-JCB1>3.3.CO;2-V; STEEN RG, 1987, BIOL BULL, V172, P246, DOI 10.2307/1541797; Strychar KB, 2004, PHYCOLOGIA, V43, P768, DOI 10.2216/i0031-8884-43-6-768.1; Strychar KB, 2004, J EXP MAR BIOL ECOL, V304, P99, DOI 10.1016/j.jembe.2003.11.023; SUHARSONO, 1992, J EXP MAR BIOL ECOL, V158, P179, DOI 10.1016/0022-0981(92)90225-Y; Sutherland KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023468; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; THOMA S, 1993, PLANT J, V3, P427, DOI 10.1046/j.1365-313X.1993.t01-21-00999.x; Ziegler-heitbrocksb HWL, 1994, TOLERANCE LIPOPOLYSA	65	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0173350	10.1371/journal.pone.0173350	http://dx.doi.org/10.1371/journal.pone.0173350			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355291	Green Published, gold			2022-12-26	WOS:000399174600014
J	Yu, ZG; Guo, FX; Guo, YY; Zhang, ZR; Wu, F; Luo, XQ				Yu, Zugong; Guo, Fanxi; Guo, Yangyang; Zhang, Zhenrui; Wu, Feng; Luo, Xiaoqing			Optimization and evaluation of astragalus polysaccharide injectable thermoresponsive in-situ gels	PLOS ONE			English	Article							IMMUNE-ENHANCING ACTIVITY; IMMUNOSUPPRESSION; MEMBRANACEUS; CYCLOPHOSPHAMIDE; DELIVERY; SYSTEM; GAMMA; MICE	The objective of this study was to develop an injectable in situ forming gel system based on Poloxamer for sustained release of Astragalus polysaccharide (APS), thus achieved once or twice administration instead of frequent dosing during long-term treatment. The optimal formulation is 10 g APS, 18 g poloxamer 407, 2 g poloxamer 188, 0.15 g CMC-Na, 0.85 g sodium chloride in 100 ml gel in situ which had a preferable sol-gel transition temperature(T sol-gel) (34.1 +/- 0.4 degrees C), and good stability. In vitro release studies, all formulations containing polymer additives had prolonged release time and decreased initial burst to some extent. The optimal formulation containing 0.15% CMC-Na showed a best sustained release profile for about 132 h with the lowest initial burst in vitro about 16.30% in 12 h). In vivo, Male BALB/c mice (18 - 20 g) were administrated with APS in-situ gel just once, the values of immune organ indices, spleen lymphocyte proliferation, and serum IgM, IgG, IL-2 and IL-6 had significant increase, which was consistent with the mice given daily APS injections (7 times), while the above indices were increased more significantly in which administrated with APS in-situ gel twice. Based on these results, it can be concluded that the Poloxamer depot is a promising carrier for the sustained release of APS with an ideal release behavior.	[Yu, Zugong; Guo, Fanxi; Guo, Yangyang; Zhang, Zhenrui; Wu, Feng; Luo, Xiaoqing] Nanjing Agr Univ, Coll Vet Med, Lab Vet Pharmacol & Toxicol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Yu, ZG (corresponding author), Nanjing Agr Univ, Coll Vet Med, Lab Vet Pharmacol & Toxicol, Nanjing, Jiangsu, Peoples R China.	yuzugong@njau.edu.cn						Asasutjarit R, 2011, INT J PHARMACEUT, V411, P128, DOI 10.1016/j.ijpharm.2011.03.054; CAO Y, 2014, OXID MED CELL LONGEV, V2014, DOI DOI 10.1155/2014/674219; Chang WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122374; Chen XM, 2012, CARBOHYD POLYM, V90, P1114, DOI 10.1016/j.carbpol.2012.06.052; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Dumortier G, 2006, PHARM RES-DORDR, V23, P2709, DOI 10.1007/s11095-006-9104-4; Fan YP, 2012, INT J BIOL MACROMOL, V50, P125, DOI 10.1016/j.ijbiomac.2011.10.008; Fu J, 2014, PHYTOTHER RES, V28, P1275, DOI 10.1002/ptr.5188; Garala K, 2013, INT J PHARM INVESTIG, V3, P29, DOI 10.4103/2230-973X.108961; Guo LW, 2012, CARBOHYD POLYM, V90, P1055, DOI 10.1016/j.carbpol.2012.06.042; Klouda L, 2008, EUR J PHARM BIOPHARM, V68, P34, DOI 10.1016/j.ejpb.2007.02.025; Letsch A, 2003, METHODS, V31, P143, DOI 10.1016/S1046-2023(03)00124-5; Li MX, 2011, J ETHNOPHARMACOL, V133, P412, DOI 10.1016/j.jep.2010.10.012; Li XT, 2012, INT J MOL SCI, V13, P1747, DOI 10.3390/ijms13021747; Nguyen XN, 2010, BIOORG MED CHEM LETT, V20, P4927, DOI 10.1016/j.bmcl.2010.06.044; Qi HY, 2007, INT J PHARM, V337, P178, DOI 10.1016/j.ijpharm.2006.12.038; Ren Z, 2014, INT J BIOL MACROMOL, V70, P590, DOI 10.1016/j.ijbiomac.2014.07.044; Wei G, 2002, J CONTROL RELEASE, V83, P65, DOI 10.1016/S0168-3659(02)00175-X; Wojcikowski K, 2010, PHYTOTHER RES, V24, P875, DOI 10.1002/ptr.3038; Yu ZG, 2015, J VET PHARMACOL THER, V38, P271, DOI 10.1111/jvp.12171; Yuan HM, 2006, CANCER LETT, V243, P228, DOI 10.1016/j.canlet.2005.11.032; Yuan Y, 2009, WORLD J GASTROENTERO, V15, P3676, DOI 10.3748/wjg.15.3676; Zhang J, 2013, INT J BIOL MACROMOL, V52, P212, DOI 10.1016/j.ijbiomac.2012.09.025; Zhao XH, 2015, INT J CLIN EXP MED, V8, P558	24	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0173949	10.1371/journal.pone.0173949	http://dx.doi.org/10.1371/journal.pone.0173949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350799	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174400010
J	Le, MH; Devaki, P; Ha, NB; Jun, DW; Te, HS; Cheung, RC; Nguyen, MH				Le, Michael H.; Devaki, Pardha; Ha, Nghiem B.; Jun, Dae Won; Te, Helen S.; Cheung, Ramsey C.; Nguyen, Mindie H.			Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States	PLOS ONE			English	Article							EXTERNAL VALIDATION; HEPATIC STEATOSIS; INDEX; DIAGNOSIS; ASSOCIATION; POPULATION; MARKERS; SCORE	In the United States, non-alcoholic fatty liver disease (NAFLD) is the most common liver disease and associated with higher mortality according to data from earlier National Health and Nutrition Examination Survey (NHANES) 1988-1994. Our goal was to determine the NAFLD prevalence in the recent 1999-2012 NHANES, risk factors for advanced fibrosis (stage 3-4) and mortality. NAFLD was defined as having a United States Fatty Liver Index (USFLI) > 30 in the absence of heavy alcohol use and other known liver diseases. The probability of low/high risk of having advanced fibrosis was determined by the NAFLD Fibrosis Score (NFS). In total, 6000 persons were included; of which, 30.0% had NAFLD and 10.3% of these had advanced fibrosis. Five and eight-year overall mortality in NAFLD subjects with advanced fibrosis was significantly higher than subjects without NAFLD ((18% and 35% vs. 2.6% and 5.5%, respectively) but not NAFLD subjects without advanced fibrosis (1.1% and 2.8%, respectively). NAFLD with advanced fibrosis (but not those without) is an independent predictor for mortality on multivariate analysis (HR = 3.13, 95% CI 1.93-5.08, p<0.001). In conclusion, in this most recent NHANES, NAFLD prevalence remains at 30% with 10.3% of these having advanced fibrosis. NAFLD per se was not a risk factor for increased mortality, but NAFLD with advanced fibrosis was. Mexican American ethnicity was a significant risk factor for NAFLD but not for advanced fibrosis or increased mortality.	[Le, Michael H.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA USA; [Devaki, Pardha] Cleveland Clin, Digest Dis Inst, Cleveland, OH 44106 USA; [Ha, Nghiem B.] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA; [Ha, Nghiem B.; Cheung, Ramsey C.; Nguyen, Mindie H.] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA; [Jun, Dae Won] Hanyang Univ, Dept Gastroenterol, Med Ctr, Seoul, South Korea; [Te, Helen S.] Univ Chicago Med, Dept Med, Sect Gastroenterol Hepatol & Nutr, Chicago, IL USA; [Cheung, Ramsey C.] Vet Affairs Palo Alto Hlth Care Syst, Div Gastroenterol & Hepatol, Palo Alto, CA USA	Stanford University; Cleveland Clinic Foundation; University of California System; University of California Davis; Stanford University; Hanyang University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Nguyen, MH (corresponding author), Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA.	mindiehn@stanford.edu	Devaki, Pardha/ABC-1593-2020	Le, Michael/0000-0001-5051-3160				Abd El-Kader SM, 2015, WORLD J HEPATOL, V7, P846, DOI 10.4254/wjh.v7.i6.846; Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Castera L, 2013, NAT REV GASTRO HEPAT, V10, P666, DOI 10.1038/nrgastro.2013.175; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chitturi S, 2007, J GASTROEN HEPATOL, V22, P778, DOI 10.1111/j.1440-1746.2007.05001.x; Cuthbertson DJ, 2014, EUR J ENDOCRINOL, V171, P561, DOI 10.1530/EJE-14-0112; Data Linkage Team, 2015, COMP AN NHIS PUBL US; Ditah IC, 2016, GASTROENTEROLOGY S1, V150; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Huang XL, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001682; Johnson CL., 2013, ANAL GUIDELINES 1999; Kim CH, 2008, CLEV CLIN J MED, V75, P721, DOI 10.3949/ccjm.75.10.721; Kim D, 2013, HEPATOLOGY, V57, P1357, DOI 10.1002/hep.26156; Koehler EM, 2013, CLIN GASTROENTEROL H, V11, P1201, DOI 10.1016/j.cgh.2012.12.031; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Lee YH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0098961, 10.1371/journal.pone.0108317]; Machado MV, 2013, J HEPATOL, V58, P1007, DOI 10.1016/j.jhep.2012.11.021; Meffert PJ, 2014, AM J GASTROENTEROL, V109, P1404, DOI 10.1038/ajg.2014.155; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; National Center for Health Statistics, 2010, VITAL HLTH STAT, V1, P1; National Center for Health Statistics, 2013, NCHS 2011 LINK MORT; National Center for Health Statistics [NCHS],, NAT HLTH NUTR EX SUR; NCHS, KEY CONC WEIGHT NHAN; Nettschwander-Tetri BA, 2010, HEPATOLOGY, V52, P913, DOI 10.1002/hep.23784; Ong JP, 2008, J HEPATOL, V49, P608, DOI 10.1016/j.jhep.2008.06.018; Paschos P, 2009, HIPPOKRATIA, V13, P9; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Ruhl CE, 2015, ALIMENT PHARM THER, V41, P65, DOI 10.1111/apt.13012; StataCorp LP, 1985, STAT SURV AN EP TABL; Unalp-Arida A, 2016, HEPATOLOGY, V63, P1170, DOI 10.1002/hep.28390; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wiley TE, 2002, AM J GASTROENTEROL, V97, P700, DOI 10.1111/j.1572-0241.2002.05555.x; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Yang BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120443; Zein CO, 2011, J HEPATOL, V54, P753, DOI 10.1016/j.jhep.2010.07.040	40	147	150	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0173499	10.1371/journal.pone.0173499	http://dx.doi.org/10.1371/journal.pone.0173499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346543	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174300007
J	Melville, JM; McDonald, CA; Bischof, RJ; Polglase, GR; Lim, R; Wallace, EM; Jenkin, G; Moss, TJ				Melville, Jacqueline M.; McDonald, Courtney A.; Bischof, Robert J.; Polglase, Graeme R.; Lim, Rebecca; Wallace, Euan M.; Jenkin, Graham; Moss, Timothy J.			Human amnion epithelial cells modulate the inflammatory response to ventilation in preterm lambs	PLOS ONE			English	Article							LUNG INFLAMMATION; IMMUNE-RESPONSE; INJURY; FETAL; MACROPHAGES; MEMBRANE; TRANSPLANTATION; INTERLEUKIN-8; ACTIVATION; EXPRESSION	Ventilation of preterm neonates causes pulmonary inflammation that can contribute to lung injury, propagate systemically and result in long-term disease. Modulation of this initial response may reduce lung injury and its sequelae. We aimed to determine the effect of human amnion epithelial cells (hAECs) on immune activation and lung injury in preterm neonatal lambs. Preterm lambs received intratracheal hAECs (90x10(6)) or vehicle, prior to 2 h of mechanical ventilation. Within 5 min of ventilation onset, lambs also received intravenous hAECs (90x10(6)) or vehicle. Lung histology, bronchoalveolar lavage (BAL) cell phenotypes, and cytokine profiles were examined after 2 h of ventilation, and in unventilated controls. Histological indices of lung injury were higher than control, in vehicle-treated ventilated lambs but not in hAEC-treated ventilated lambs. Ventilation-induced pulmonary leukocyte recruitment was greater in hAEC-treated lambs than in vehicle-treated lambs. Lung IL-1 beta and IL-6 mRNA expression was higher in vehicle-and hAEC-treated ventilated lambs than in controls but IL-8 mRNA levels were greater than control only in vehicle-treated ventilated lambs. Numbers of CD44(+) and CD21(+) lymphocytes and macrophages from the lungs were altered in vehicle-and hAEC-treated ventilated lambs. Numbers of CD8(+) macrophages were lower in hAEC-treated ventilated lambs than in vehicle-treated ventilated lambs. Indices of systemic inflammation were not different between vehicle-and hAEC-treated lambs. Human amnion epithelial cells modulate the pulmonary inflammatory response to ventilation in preterm lambs, and reduce acute lung injury. Immunomodulatory effects of hAECs reduce lung injury in preterm neonates and may protect against longer-term respiratory disease.	[Melville, Jacqueline M.; McDonald, Courtney A.; Bischof, Robert J.; Polglase, Graeme R.; Lim, Rebecca; Wallace, Euan M.; Jenkin, Graham; Moss, Timothy J.] Hudson Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Polglase, Graeme R.; Lim, Rebecca; Wallace, Euan M.; Jenkin, Graham; Moss, Timothy J.] Monash Univ, Dept Obstet & Gynaecol, Clayton, Vic, Australia	Hudson Institute of Medical Research; Monash University	Bischof, RJ (corresponding author), Hudson Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia.	robert.bischof@hudson.org.au	Lim, Rebecca/K-5175-2019; Moss, Timothy/A-6633-2008; Wallace, Euan M/K-6774-2015	Lim, Rebecca/0000-0002-0410-497X; Moss, Timothy/0000-0002-9408-4027; Wallace, Euan M/0000-0002-4506-5233; Polglase, Graeme/0000-0002-8906-614X; McDonald, Courtney/0000-0001-8421-461X; Bischof, Robert/0000-0002-6649-9612	National Health and Medical Research Council; State Government of Victoria	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); State Government of Victoria	This work was supported by the National Health and Medical Research Council (https://www.nhmrc.gov.au/), and the State Government of Victoria (http://www.vic.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeynaike L, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-46; Attar Mohammad Ali, 2002, Semin Neonatol, V7, P353, DOI 10.1053/siny.2002.0129; Azuara-Blanco A, 1999, BRIT J OPHTHALMOL, V83, P399, DOI 10.1136/bjo.83.4.399; Ballabh P, 2003, AM J PERINAT, V20, P465; Barton SK, 2015, DEV NEUROSCI; Bischof RJ, 2003, CLIN EXP ALLERGY, V33, P367, DOI 10.1046/j.1365-2222.2003.01534.x; Bischof RJ, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-16; Bose CL, 2008, ARCH DIS CHILD-FETAL, V93, P1455, DOI 10.1136/adc.2007.121327; Gahler A, 2000, PEDIATR RES, V48, P299; Gien J, 2011, CURR OPIN PEDIATR, V23, P305, DOI 10.1097/MOP.0b013e328346577f; Gulbahar MY, 2009, VET PARASITOL, V160, P272, DOI 10.1016/j.vetpar.2008.11.012; Herrmann LM, 2003, AM J PATHOL, V162, P1075, DOI 10.1016/S0002-9440(10)63904-1; Hillman NH, 2011, AM J PHYSIOL-LUNG C, V300, pL232, DOI 10.1152/ajplung.00294.2010; Hiraki K, 2009, J NEUROSCI RES, V87, P1175, DOI 10.1002/jnr.21924; Hirji N, 1997, J IMMUNOL, V158, P1833; Hodges RJ, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.038; Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Ko JH, 2016, P NATL ACAD SCI USA, V113, P158, DOI 10.1073/pnas.1522905113; KOTECHA S, 1995, ARCH DIS CHILD-FETAL, V72, pF90, DOI 10.1136/fn.72.2.F90; Kwong LS, 2002, VET IMMUNOL IMMUNOP, V85, P213, DOI 10.1016/S0165-2427(02)00007-7; Li Z, 2013, AUSTR MOTHERS BABIES, V28; Lin TJ, 2000, J IMMUNOL, V164, P1783, DOI 10.4049/jimmunol.164.4.1783; Liravi B, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0097-9; Makita N, 2014, INT IMMUNOL; McDonald CA, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt495; Miki T, 2005, STEM CELLS, V23, P1549, DOI 10.1634/stemcells.2004-0357; Moodley Y, 2010, AM J RESP CRIT CARE, V182, P643, DOI 10.1164/rccm.201001-0014OC; Moss TJM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.044; Murphy Sean, 2010, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01e06s13; Murphy S, 2011, CELL TRANSPLANT, V20, P909, DOI 10.3727/096368910X543385; Murphy SV, 2012, CELL TRANSPLANT, V21, P1477, DOI 10.3727/096368911X601028; Murphy SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040924; Naik AS, 2001, AM J RESP CRIT CARE, V164, P494, DOI 10.1164/ajrccm.164.3.2010127; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Perlman JM, 2006, PEDIATRICS, V117, pE978, DOI 10.1542/ped.2006-0350; Polglase GR, 2014, J PHYSIOL-LONDON, V592, P1993, DOI 10.1113/jphysiol.2013.270348; Polglase GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039535; Stern M, 1913, J AMER MED ASSOC, V60, P973, DOI 10.1001/jama.1913.04340130021008; Tan JL, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt542; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Turunen R, 2009, NEONATOLOGY, V96, P248, DOI 10.1159/000220764; van der Windt GJW, 2011, AM J RESP CELL MOL, V44, P377, DOI 10.1165/rcmb.2010-0158OC; Vosdoganes P, 2013, CYTOTHERAPY; Vosdoganes P, 2012, CELL TRANSPLANT; Vosdoganes P, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.054; Wallace MJ, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-19; Westover AJ, 2012, AM J PHYSIOL-LUNG C, V302, P1664, DOI 10.1152/ajplung.00297.2011; Yawno T, 2013, DEV NEUROSCI-BASEL, V35, P272, DOI 10.1159/000346683	49	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0173572	10.1371/journal.pone.0173572	http://dx.doi.org/10.1371/journal.pone.0173572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346529	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174300008
J	Shakya, R; Tarulli, GA; Sheng, L; Lokman, NA; Ricciardelli, C; Pishas, KI; Selinger, CI; Kohonen-Corish, MRJ; Cooper, WA; Turner, AG; Neilsen, PM; Callen, DF				Shakya, R.; Tarulli, G. A.; Sheng, L.; Lokman, N. A.; Ricciardelli, C.; Pishas, K. I.; Selinger, C. I.; Kohonen-Corish, M. R. J.; Cooper, W. A.; Turner, A. G.; Neilsen, P. M.; Callen, D. F.			Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancer	ONCOGENE			English	Article							WILD-TYPE; PROGNOSTIC-SIGNIFICANCE; TUMOR-SUPPRESSOR; POOR-PROGNOSIS; MOUSE MODELS; GAIN; MUTATIONS; P63; INHIBITION; COMPLEX	Missense mutations in the TP53 tumor-suppressor gene inactivate its antitumorigenic properties and endow the incipient cells with newly acquired oncogenic properties that drive invasion and metastasis. Although the oncogenic effect of mutant p53 transcriptome has been widely acknowledged, the global influence of mutant p53 on cancer cell proteome remains to be fully elucidated. Here, we show that mutant p53 drives the release of invasive extracellular factors (the 'secretome') that facilitates the invasion of lung cancer cell lines. Proteomic characterization of the secretome from mutant p53-inducible H1299 human non-small cell lung cancer cell line discovered that the mutant p53 drives its oncogenic pathways through modulating the gene expression of numerous targets that are subsequently secreted from the cells. Of these genes, alpha-1 antitrypsin (A1AT) was identified as a critical effector of mutant p53 that drives invasion in vitro and in vivo, together with induction of epithelial-mesenchymal transition markers expression. Mutant p53 upregulated A1AT transcriptionally through the involvement with its family member p63. Conditioned medium containing secreted A1AT enhanced cell invasion, while an A1AT-blocking antibody attenuated the mutant p53-driven migration and invasion. Importantly, high A1AT expression correlated with increased tumor stage, elevated p53 staining and shorter overall survival in lung adenocarcinoma patients. Collectively, these findings suggest that A1AT is an indispensable target of mutant p53 with prognostic and therapeutic potential in mutant p53-expressing tumors.	[Shakya, R.; Sheng, L.; Pishas, K. I.; Turner, A. G.; Callen, D. F.] Univ Adelaide, Sch Med, Fac Hlth Sci, Ctr Personalised Canc Med,Canc Therapeut Lab, Level 3,Hanson Inst Bldg,Frome Rd, Adelaide, SA 5005, Australia; [Tarulli, G. A.] Univ Adelaide, Fac Hlth Sci, Sch Med, DRMCRL, Adelaide, SA, Australia; [Lokman, N. A.; Ricciardelli, C.] Univ Adelaide, Robinson Res Inst, Fac Hlth Sci, Sch Med,Discipline Obstet & Gynaecol, Adelaide, SA, Australia; [Lokman, N. A.] Univ Adelaide, Sch Mol & Biol Sci, Adelaide Prote Ctr, Adelaide, SA, Australia; [Selinger, C. I.] Royal Prince Alfred Hosp, Camperdown, NSW, Australia; [Kohonen-Corish, M. R. J.] Garvan Inst Med Res, Kinghorn Canc Ctr, Sydney, NSW, Australia; [Kohonen-Corish, M. R. J.] UNSW Australia, St Vincents Clin Sch, Sydney, NSW, Australia; [Kohonen-Corish, M. R. J.; Cooper, W. A.] Univ Western Sydney, Sch Med, Parramatta, NSW, Australia; [Cooper, W. A.] Royal Prince Alfred Hosp, Tissue Pathol & Diagnost Oncol, Camperdown, NSW, Australia; [Cooper, W. A.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Neilsen, P. M.] Swinburne Univ Technol Sarawak Campus, Kuching, Sarawak, Malaysia	Hanson Institute; University of Adelaide; University of Adelaide; Robinson Research Institute; University of Adelaide; University of Adelaide; University of Sydney; Garvan Institute of Medical Research; University of New South Wales Sydney; Western Sydney University; University of Sydney; University of Sydney	Shakya, R (corresponding author), Univ Adelaide, Sch Med, Fac Hlth Sci, Ctr Personalised Canc Med,Canc Therapeut Lab, Level 3,Hanson Inst Bldg,Frome Rd, Adelaide, SA 5005, Australia.	reshma.shakya@adelaide.edu.au	Tarulli, Gerard A/D-8863-2013; Ricciardelli, Carmela/U-1814-2019; Ricciardelli, Carmela/K-2212-2015; Kohonen-Corish, Maija/Q-9763-2019	Ricciardelli, Carmela/0000-0001-7415-1854; Ricciardelli, Carmela/0000-0001-7415-1854; Kohonen-Corish, Maija/0000-0002-4073-1479; Lokman, Noor/0000-0002-2071-5308; Turner, Andrew/0000-0003-0374-1181; Neilsen, Paul/0000-0001-7937-3675; Tarulli, Gerard/0000-0002-1327-4655; Sheng, Lei/0000-0003-1814-809X; Shakya, Reshma/0000-0002-8154-432X	NHMRC Project [44107714, 44112162]; University of Adelaide Florey Medical Research Foundation Clinical Cancer Research Fellowship	NHMRC Project(National Health and Medical Research Council (NHMRC) of Australia); University of Adelaide Florey Medical Research Foundation Clinical Cancer Research Fellowship	We thank TCGA research network for publicly sharing their data. The results published here are in part based upon data generated by the TCGA project, which was established by the NCI and NHGRI. Information about TCGA and the investigators and institutions who constitute the TCGA research network can be found at http://cancergenome.nih.gov. We also thank Rebecca C Haycox for her technical assistance. This work was supported by the NHMRC Project grants (44107714 and 44112162). K Pishas acknowledges financial contributions from the University of Adelaide Florey Medical Research Foundation Clinical Cancer Research Fellowship.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Ahrendt SA, 2003, J NATL CANCER I, V95, P961, DOI 10.1093/jnci/95.13.961; Alamanova D, 2010, BMC BIOINFORMATICS, V11, P1; Alexandrova EM, 2015, NATURE, V523, P352, DOI 10.1038/nature14430; Aryee DNT, 2013, BRIT J CANCER, V109, P2696, DOI 10.1038/bjc.2013.635; Baker L, 2010, BRIT J CANCER, V102, P719, DOI 10.1038/sj.bjc.6605540; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chang YH, 2012, MOL CELL PROTEOMICS, V11, P1320, DOI 10.1074/mcp.M112.017384; Chee JLY, 2013, CELL CYCLE, V12, P278, DOI 10.4161/cc.23054; Chen JT, 2000, ANTICANCER RES, V20, P2687; Chen N, 2011, CANCER BIOL THER, V11, P157, DOI 10.4161/cbt.11.2.14622; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Coffill CR, 2012, EMBO REP, V13, P638, DOI 10.1038/embor.2012.74; Cordani M, 2016, CANCER LETT, V376, P303, DOI 10.1016/j.canlet.2016.03.046; Do PM, 2012, GENE DEV, V26, P830, DOI 10.1101/gad.181685.111; El-Akawi ZJ, 2008, NEUROENDOCRINOL LETT, V29, P482; El-Telbany Ahmed, 2012, Genes Cancer, V3, P467, DOI 10.1177/1947601912465177; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Frenzel E, 2015, J IMMUNOL, V195, P3605, DOI 10.4049/jimmunol.1500740; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Grellety T, 2015, BMC CANCER, V15, P1; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hanel W, 2013, CELL DEATH DIFFER, V20, P898, DOI 10.1038/cdd.2013.17; Janicke RU, 2008, CELL DEATH DIFFER, V15, P959, DOI 10.1038/cdd.2008.33; Katkoori VR, 2009, CLIN CANCER RES, V15, P2406, DOI 10.1158/1078-0432.CCR-08-1719; Kwon CH, 2014, BRIT J CANCER, V111, P1993, DOI 10.1038/bjc.2014.490; Kwon CH, 2015, ONCOTARGET, V6, P20312, DOI 10.18632/oncotarget.3964; LAINE A, 1990, CLIN CHIM ACTA, V190, P163, DOI 10.1016/0009-8981(90)90170-W; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lehmann BD, 2012, J CLIN ONCOL, V30, P3648, DOI 10.1200/JCO.2012.44.0412; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Liu G, 2006, J CELL BIOCHEM, V97, P448, DOI 10.1002/jcb.20700; Liu K, 2011, MOL CELL BIOL, V31, P4464, DOI 10.1128/MCB.05574-11; Mandinova A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001366; Melino G, 2011, CELL DEATH DIFFER, V18, P1487, DOI 10.1038/cdd.2011.81; Miyake M, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-322; Mohammed H, 2015, NATURE, V523, P313, DOI 10.1038/nature14583; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Neilsen PM, 2011, ONCOTARGET, V2, P1203; Noll JE, 2012, ONCOGENE, V31, P2836, DOI 10.1038/onc.2011.456; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Park SW, 2004, EXP MOL MED, V36, P211, DOI 10.1038/emm.2004.29; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; Pishas KI, 2015, SCI REP-UK, V5, DOI 10.1038/srep11465; Polotskaia A, 2015, P NATL ACAD SCI USA, V112, pE1220, DOI 10.1073/pnas.1416318112; Rivlin N, 2014, P NATL ACAD SCI USA, V111, P7006, DOI 10.1073/pnas.1320428111; Russo D, 2013, BBA-MOL CELL RES, V1833, P1904, DOI 10.1016/j.bbamcr.2013.03.020; Samowitz WS, 2002, INT J CANCER, V99, P597, DOI 10.1002/ijc.10405; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Skaug V, 2000, CLIN CANCER RES, V6, P1031; Stambolsky P, 2010, CANCER CELL, V17, P273, DOI 10.1016/j.ccr.2009.11.025; Strano S, 2002, J BIOL CHEM, V277, P18817, DOI 10.1074/jbc.M201405200; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; TAIPALE J, 1995, J BIOL CHEM, V270, P4689, DOI 10.1074/jbc.270.9.4689; Trinidad AG, 2013, MOL CELL, V50, P805, DOI 10.1016/j.molcel.2013.05.002; Tseng IC, 2008, AM J PHYSIOL-CELL PH, V295, pC423, DOI 10.1152/ajpcell.00164.2008; Walerych D, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00289; Wang B, 2012, ACTA BIOCH BIOPH SIN, V44, P685, DOI 10.1093/abbs/gms053; Wu L, 1997, MOL MED, V3, P441, DOI 10.1007/BF03401691; Yousef GM, 2003, BBA-GENE STRUCT EXPR, V1628, P88, DOI 10.1016/S0167-4781(03)00116-7; Zelvyte I, 2004, CANCER CELL INT, V4, DOI 10.1186/1475-2867-4-7; Zhang G, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0200-1	68	28	29	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 3	2017	36	31					4469	4480		10.1038/onc.2017.66	http://dx.doi.org/10.1038/onc.2017.66			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FC4JL	28368395				2022-12-26	WOS:000406806000009
J	Barison, MJ; Rapado, LN; Merino, EF; Pral, EMF; Mantilla, BS; Marchese, L; Nowicki, C; Silber, AM; Cassera, MB				Barison, Maria Julia; Rapado, Ludmila Nakamura; Merino, Emilio F.; Furusho Pral, Elizabeth Mieko; Mantilla, Brian Suarez; Marchese, Leticia; Nowicki, Cristina; Silber, Ariel Mariano; Cassera, Maria Belen			Metabolomic profiling reveals a finely tuned, starvation-induced metabolic switch in Trypanosoma cruzi epimastigotes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell growth; cell metabolism; energy metabolism; metabolomics; Trypanosoma cruzi; Chagas disease; epimastigotes; oxidative imbalance	AEROBIC GLUCOSE FERMENTATION; L-PROLINE; FUNCTIONAL-CHARACTERIZATION; ACTIVE-TRANSPORT; ATP PRODUCTION; ACID; DIFFERENTIATION; BIOSYNTHESIS; GROWTH; MS/MS	Trypanosoma cruzi, the etiological agent of Chagas disease, is a protozoan parasite with a complex life cycle involving a triatomine insect and mammals. Throughout its life cycle, the T. cruzi parasite faces several alternating events of cell division and cell differentiation in which exponential and stationary growth phases play key biological roles. It is well accepted that arrest of the cell division in the epimastigote stage, both in the midgut of the triatomine insect and in vitro, is required for metacyclogenesis, and it has been previously shown that the parasites change the expression profile of several proteins when entering this quiescent stage. However, little is known about the metabolic changes that epimastigotes undergo before they develop into the metacyclic trypomastigote stage. We applied targeted metabolomics to measure the metabolic intermediates in the most relevant pathways for energy metabolism and oxidative imbalance in exponentially growing and stationary growth-arrested epimastigote parasites. We show for the first time that T. cruzi epimastigotes transitioning from the exponential to the stationary phase exhibit a finely tuned adaptive metabolic mechanism that enables switching from glucose to amino acid consumption, which is more abundant in the stationary phase. This metabolic plasticity appears to be crucial for survival of the T. cruzi parasite in the myriad different environmental conditions to which it is exposed during its life cycle.	[Barison, Maria Julia; Rapado, Ludmila Nakamura; Furusho Pral, Elizabeth Mieko; Mantilla, Brian Suarez; Marchese, Leticia; Silber, Ariel Mariano] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Lab Biochem Tryps LaBTryps, BR-05508000 Sao Paulo, Brazil; [Merino, Emilio F.; Cassera, Maria Belen] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Merino, Emilio F.; Cassera, Maria Belen] Virginia Tech, Virginia Tech Ctr Drug Discovery, Blacksburg, VA 24061 USA; [Nowicki, Cristina] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fis Quim Biol IQUIFIB, CONICET, RA-1113 Buenos Aires, DF, Argentina	Universidade de Sao Paulo; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Silber, AM (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil.; Cassera, MB (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, CTEGD, Athens, GA 30602 USA.	asilber@usp.br; maria.cassera@uga.edu	BARISON, MARIA JULIA/ABF-8078-2020; Silber, Ariel/O-6951-2015	BARISON, MARIA JULIA/0000-0003-1774-2281; Suarez Mantilla, Brian/0000-0001-7839-1222; Silber, Ariel/0000-0003-4528-4732	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/18970-6, 2016/06034-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [2013/18970-6, 308351/2013-4]; National Institutes of Health [AI108819]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108819] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grants 2013/18970-6 and 2016/06034-2 (to A. M. S.) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Grants 2013/18970-6 and 308351/2013-4 (to A. M. S.). Metabolomics analysis was supported by National Institutes of Health Grant AI108819 (to M. B. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADROHER FJ, 1987, J PARASITOL, V73, P438, DOI 10.2307/3282112; Antunes LCM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077283; Armenta JM, 2010, ANAL CHEM, V82, P548, DOI 10.1021/ac901790q; Barison MJ, 2016, J BIOENERG BIOMEMBR, V48, P437, DOI 10.1007/s10863-016-9665-9; BARRETT FM, 1975, COMP BIOCHEM PHYS B, V52, P427; Birkler RID, 2010, J PHARMACEUT BIOMED, V53, P983, DOI 10.1016/j.jpba.2010.06.005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRENER Z, 1965, J PARASITOL, V51, P922, DOI 10.2307/3275869; BRENER Z, 1971, Revista do Instituto de Medicina Tropical de Sao Paulo, V13, P171; Carrillo C, 1999, FEBS LETT, V454, P192, DOI 10.1016/S0014-5793(99)00804-2; CAZZULO JJ, 1985, MOL BIOCHEM PARASIT, V16, P329, DOI 10.1016/0166-6851(85)90074-X; Cazzulo Juan Jose, 1992, V18, P235; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Creek DJ, 2013, ANTIMICROB AGENTS CH, V57, P2768, DOI 10.1128/AAC.00044-13; Dias Fde A., 2015, PLOS NEGLECT TROP D, V9; ENGEL JC, 1987, MOL BIOCHEM PARASIT, V26, P1, DOI 10.1016/0166-6851(87)90123-X; de Godoy LMF, 2012, PROTEOMICS, V12, P2694, DOI 10.1002/pmic.201200078; Goldenberg S, 2011, ADV PARASIT, V75, P285, DOI 10.1016/B978-0-12-385863-4.00013-7; Gonzalez NS, 2001, FEBS LETT, V508, P323, DOI 10.1016/S0014-5793(01)03091-5; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Henriques C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0950-y; Hernandez R, 2012, PARASITOL RES, V111, P509, DOI 10.1007/s00436-012-2974-y; HUNTER KJ, 1994, EUR J BIOCHEM, V226, P1019, DOI 10.1111/j.1432-1033.1994.t01-1-01019.x; Li QL, 2014, J LIPID RES, V55, P592, DOI 10.1194/jlr.D045112; Magdaleno A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004534; Manchola NC, 2016, J EUKARYOT MICROBIOL, V63, P299, DOI 10.1111/jeu.12278; MANCILLA R, 1967, EXP PARASITOL, V21, P154, DOI 10.1016/0014-4894(67)90077-X; Mantilla BS, 2015, J BIOL CHEM, V290, P7767, DOI 10.1074/jbc.M114.574525; Marciano D, 2012, MOL BIOCHEM PARASIT, V185, P114, DOI [10.10, 10.1016/j.molbiopara.2012.07.009]; Martins RM, 2009, INFECT IMMUN, V77, P3023, DOI 10.1128/IAI.00138-09; Maugeri DA, 2011, ESSAYS BIOCHEM, V51, P15, DOI [10.1042/BSE0510015, 10.1042/bse0510015]; MEZL VA, 1976, ANAL BIOCHEM, V74, P430, DOI 10.1016/0003-2697(76)90223-2; Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Nogueira NP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116712; Nozaki T, 2001, J BIOL CHEM, V276, P6516, DOI 10.1074/jbc.M009774200; Paes LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069419; Paes LS, 2011, CURR PHARM DESIGN, V17, P2074, DOI 10.2174/138161211796904786; Saye M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092028; Shaw AK, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00051-16; Silber AM, 2006, INT J PARASITOL, V36, P157, DOI 10.1016/j.ijpara.2005.10.006; Silber AM, 2002, J EUKARYOT MICROBIOL, V49, P441, DOI 10.1111/j.1550-7408.2002.tb00225.x; Silber Ariel Mariano, 2005, Current Drug Targets - Infectious Disorders, V5, P53, DOI 10.2174/1568005053174636; Tonelli RR, 2004, CELL MICROBIOL, V6, P733, DOI 10.1111/j.1462-5822.2004.00397.x; Xia J, 2011, CURR PROTOC BIOINFOR, DOI [10.1002/0471250953.bi1410s34, DOI 10.1002/0471250953.BI1410S34]; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374	47	37	37	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8964	8977		10.1074/jbc.M117.778522	http://dx.doi.org/10.1074/jbc.M117.778522			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28356355	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000402153900047
J	Zhao, XH; Rodriguez, R; Silberman, RE; Ahearn, JM; Saidha, S; Cummins, KC; Eisenberg, E; Greene, LE				Zhao, Xiaohong; Rodriguez, Ramon; Silberman, Rebecca E.; Ahearn, Joseph M.; Saidha, Sheela; Cummins, Kaelyn C.; Eisenberg, Evan; Greene, Lois E.			Heat shock protein 104 (Hsp104)-mediated curing of [PSI+] yeast prions depends on both [PSI+] conformation and the properties of the Hsp104 homologs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; molecular chaperone; prion; protein folding; yeast; Hsp104	SACCHAROMYCES-CEREVISIAE PSI+; N-TERMINAL DOMAIN; GUANIDINE-HYDROCHLORIDE; MOLECULAR CHAPERONE; PROPAGATION; OVEREXPRESSION; THERMOTOLERANCE; DISAGGREGATION; SUPPORT; PSI(+)	Prions arise from proteins that have two possible conformations: properly folded and non-infectious or misfolded and infectious. The [PSI+] yeast prion, which is the misfolded and self-propagating form of the translation termination factor eRF3 (Sup35), can be cured of its infectious conformation by overexpression of Hsp104, which helps dissolve the prion seeds. This dissolution depends on the trimming activity of Hsp104, which reduces the size of the prion seeds without increasing their number. To further understand the relationship between trimming and curing, trimming was followed by measuring the loss of GFP-labeled Sup35 foci from both strong and weak [PSI+] variants; the former variant has more seeds and less soluble Sup35 than the latter. Overexpression of Saccharomyces cerevisiae Hsp104 (Sc-Hsp104) trimmed the weak [PSI+] variants much faster than the strong variants and cured the weak variants an order of magnitude faster than the strong variants. Overexpression of the fungal Hsp104 homologs from Schizosaccharomyces pombe (Sp-Hsp104) or Candida albicans (Ca-Hsp104) also trimmed and cured the weak variants, but interestingly, it neither trimmed nor cured the strong variants. These results show that, because Sc-Hsp104 has greater trimming activity than either Ca-Hsp104 or Sp-Hsp104, it cures both the weak and strong variants, whereas Ca-Hsp104 and Sp-Hsp104 only cure the weak variants. Therefore, curing by Hsp104 overexpression depends on both the trimming ability of the fungal Hsp104 homolog and the strength of the [PSI+] variant: the greater the trimming activity of the Hsp104 homolog and the weaker the variant, the greater the curing.	[Zhao, Xiaohong; Rodriguez, Ramon; Silberman, Rebecca E.; Ahearn, Joseph M.; Saidha, Sheela; Cummins, Kaelyn C.; Eisenberg, Evan; Greene, Lois E.] NHLBI, Cell Biol Lab, NIH, 50 South Dr,Rm 2537,MSC 8017, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Greene, LE (corresponding author), NHLBI, Cell Biol Lab, NIH, 50 South Dr,Rm 2537,MSC 8017, Bethesda, MD 20892 USA.	greenel@helix.nih.gov			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000516] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Cashikar AG, 2002, MOL CELL, V9, P751, DOI 10.1016/S1097-2765(02)00499-9; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Cox B, 2003, GENETICS, V165, P23; Derkatch IL, 1996, GENETICS, V144, P1375; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Eaglestone SS, 2000, P NATL ACAD SCI USA, V97, P240, DOI 10.1073/pnas.97.1.240; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; Frederick KK, 2014, CHEM BIOL, V21, P295, DOI 10.1016/j.chembiol.2013.12.013; Gorkovskiy A, 2014, P NATL ACAD SCI USA, V111, pE4615, DOI 10.1073/pnas.1417974111; Greene LE, 2009, PROTEIN PEPTIDE LETT, V16, P635, DOI 10.2174/092986609788490221; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Helsen CW, 2012, J BIOL CHEM, V287, P542, DOI 10.1074/jbc.M111.302869; Hung GC, 2006, GENETICS, V173, P611, DOI 10.1534/genetics.106.056820; Jordan B E, 1996, Methods Mol Biol, V53, P193; Kiktev DA, 2012, MOL CELL BIOL, V32, P4960, DOI 10.1128/MCB.00875-12; Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9; Mackay RG, 2008, BIOCHEMISTRY-US, V47, P1918, DOI 10.1021/bi701714s; Mathur V, 2009, J MOL BIOL, V390, P155, DOI 10.1016/j.jmb.2009.04.063; McGlinchey RP, 2011, P NATL ACAD SCI USA, V108, P5337, DOI 10.1073/pnas.1102762108; Miot M, 2011, P NATL ACAD SCI USA, V108, P6915, DOI 10.1073/pnas.1102828108; Moosavi B, 2010, YEAST, V27, P167, DOI 10.1002/yea.1742; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Ness F, 2017, MOL MICROBIOL, V104, P125, DOI 10.1111/mmi.13617; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Park YN, 2014, EUKARYOT CELL, V13, P635, DOI 10.1128/EC.00300-13; Park YN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037692; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Reidy M, 2013, EUKARYOT CELL, V12, P739, DOI 10.1128/EC.00301-12; Reidy M, 2012, GENETICS, V192, P185, DOI 10.1534/genetics.112.142307; Reidy M, 2010, MOL CELL BIOL, V30, P3542, DOI 10.1128/MCB.01292-09; Satpute-Krishnan P, 2005, NATURE, V437, P262, DOI 10.1038/nature03981; Satpute-Krishnan P, 2007, PLOS BIOL, V5, P251, DOI 10.1371/journal.pbio.0050024; Senechal P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006939; Sharma J, 2012, MOL MICROBIOL, V86, P866, DOI 10.1111/mmi.12024; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Sielaff B, 2010, J MOL BIOL, V402, P30, DOI 10.1016/j.jmb.2010.07.030; Sweeny EA, 2015, MOL CELL, V57, P836, DOI 10.1016/j.molcel.2014.12.021; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Tipton KA, 2008, MOL CELL, V32, P584, DOI 10.1016/j.molcel.2008.11.003; Tkach JM, 2004, J BIOL CHEM, V279, P35692, DOI 10.1074/jbc.M400782200; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Wickner RB, 2015, MICROBIOL MOL BIOL R, V79, P1, DOI 10.1128/MMBR.00041-14; Wickner RB, 2012, METHODS MOL BIOL, V849, P321, DOI 10.1007/978-1-61779-551-0_22; Wong SH, 2015, J BIOL CHEM, V290, P25062, DOI 10.1074/jbc.M115.676379; Wu YX, 2006, METHODS, V39, P43, DOI 10.1016/j.ymeth.2006.04.004; Zenthon JF, 2006, EUKARYOT CELL, V5, P217, DOI 10.1128/EC.5.2.217-225.2006	50	23	23	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8630	8641		10.1074/jbc.M116.770719	http://dx.doi.org/10.1074/jbc.M116.770719			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28373280	Green Published, hybrid			2022-12-26	WOS:000402153900011
J	Norris, NC; Joseph, S; Aditya, S; Karunasekara, Y; Board, PG; Dulhunty, AF; Oakley, AJ; Casarotto, MG				Norris, Nicole C.; Joseph, Soumya; Aditya, Shouvik; Karunasekara, Yamuna; Board, Philip G.; Dulhunty, Angela F.; Oakley, Aaron J.; Casarotto, Marco G.			Structural and biophysical analyses of the skeletal dihydropyridine receptor beta subunit beta(1a) reveal critical roles of domain interactions for stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CA2+ CHANNELS; RYANODINE RECEPTOR; MUSCLE; PROTEINS; COMPLEX	Excitation-contraction (EC) coupling in skeletal muscle requires a physical interaction between the voltage-gated calcium channel dihydropyridine receptor (DHPR) and the ryanodine receptor Ca2+ release channel. Although the exact molecular mechanism that initiates skeletal EC coupling is unresolved, it is clear that both the alpha(1) and beta subunits ofDHPR are essential for this process. Here, we employed a series of techniques, including size-exclusion chromatography-multi-angle light scattering, differential scanning fluorimetry, and isothermal calorimetry, to characterize various biophysical properties of the skeletal DHPR beta subunit beta(1a). Removal of the intrinsically disordered N and C termini and the hook region of beta(1a) prevented oligomerization, allowing for its structural determination by X-ray crystallography. The structure had a topology similar to that of previously determined beta isoforms, which consist of SH3 and guanylate kinase domains. However, transition melting temperatures derived from the differential scanning fluorimetry experiments indicated a significant difference in stability of similar to 2-3 degrees C between the beta(1a) and beta(2a) constructs, and the addition of the DHPR alpha(1s) I-II loop (alpha -interaction domain) peptide stabilized both beta isoforms by similar to 6-8 degrees C. Similar to other beta isoforms, beta(1a) bound with nanomolar affinity to the alpha-interaction domain, but binding affinities were influenced by amino acid substitutions in the adjacent SH3 domain. These results suggest that intramolecular interactions between the SH3 and guanylate kinase domains play a role in the stability of beta(1a) while also providing a conduit for allosteric signaling events.	[Norris, Nicole C.; Joseph, Soumya; Aditya, Shouvik; Karunasekara, Yamuna; Board, Philip G.; Dulhunty, Angela F.; Casarotto, Marco G.] Australian Natl Univ, John Curtin Sch Med Res, POB 334, Canberra, ACT 2601, Australia; [Oakley, Aaron J.] Univ Wollongong, Dept Chem, Wollongong, NSW 2522, Australia	Australian National University; John Curtin School of Medical Research; University of Wollongong	Casarotto, MG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, POB 334, Canberra, ACT 2601, Australia.	Marco.Casarotto@anu.edu.au	Dulhunty, Angela/AAO-5421-2020; Oakley, Aaron/A-9464-2013	Oakley, Aaron/0000-0002-4764-014X; Dulhunty, Angela/0000-0001-9493-4944; Casarotto, Marco/0000-0002-0571-7671; Joseph, Soumya/0000-0002-0487-1378	Australian National Health; Medical Research Council [APP1020589, APP1002589]	Australian National Health(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by grants from Australian National Health and Medical Research Council Grants APP1020589 and APP1002589 (to A.F.D., P.G.B., A.J.O., and M.G.C.) The authors declare that they have no conflicts of interest with the contents of this article.	Bonita R., 2006, BASIC EPIDEMIOLOGY, P73; Campiglio M, 2013, J CELL SCI, V126, P2092, DOI 10.1242/jcs.jcs124537; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Coronado R, 2004, BIOL RES, V37, P565; Dayal A, 2013, P NATL ACAD SCI USA, V110, P7488, DOI 10.1073/pnas.1301087110; DeWaard M, 1996, FEBS LETT, V380, P272, DOI 10.1016/0014-5793(96)00007-5; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Eltit JM, 2014, J BIOL CHEM, V289, P36116, DOI 10.1074/jbc.M114.615526; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hidalgo P, 2006, J BIOL CHEM, V281, P24104, DOI 10.1074/jbc.M605930200; Karunasekara Y, 2012, FASEB J, V26, P5049, DOI 10.1096/fj.12-211334; Lao QZ, 2010, FASEB J, V24, P5013, DOI 10.1096/fj.10-165381; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Miranda-Laferte E, 2011, J BIOL CHEM, V286, P22203, DOI 10.1074/jbc.M110.201871; Newman J, 2005, ACTA CRYSTALLOGR D, V61, P1426, DOI [10.1107/S0907444905024984, 10.1107/S090744905024984]; Obermair GJ, 2008, CURR OPIN PHARMACOL, V8, P311, DOI 10.1016/j.coph.2008.01.008; Opatowsky Y., 2004, NEURON; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Richards MW, 2007, CHANNELS, V1, P92, DOI 10.4161/chan.4145; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Ristic M, 2015, ACTA CRYSTALLOGR F, V71, P1359, DOI 10.1107/S2053230X15012662; Schredelseker J, 2009, J BIOL CHEM, V284, P1242, DOI 10.1074/jbc.M807767200; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Wu JP, 2016, NATURE, V537, P191, DOI 10.1038/nature19321; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; Zhang Y, 2010, J BIOL CHEM, V285, P2527, DOI 10.1074/jbc.M109.022236	30	4	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8401	8411		10.1074/jbc.M116.763896	http://dx.doi.org/10.1074/jbc.M116.763896			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28351836	hybrid, Green Published			2022-12-26	WOS:000401788600024
J	Bleeker, K; de Jong, K; van Kessel, N; Hinde, CA; Nagelkerke, LAJ				Bleeker, Katinka; de Jong, Karen; van Kessel, Nils; Hinde, Camilla A.; Nagelkerke, Leopold A. J.			Evidence for ontogenetically and morphologically distinct alternative reproductive tactics in the invasive Round Goby Neogobius melanostomus	PLOS ONE			English	Article							ZOSTERISESSOR-OPHIOCEPHALUS TELEOSTEI; MALE MATING TACTICS; SPERM COMPETITION; BOURGEOIS; SUCCESS; FISH; FERTILIZATION; INVESTMENT; STRATEGIES; BEHAVIOR	Alternative reproductive tactics are characterized by the occurrence of discrete alternative morphs that differ in behavioural, morphological and physiological traits within the same sex. Although much effort has been made to describe the behaviour, morphology and physiology of such alternative morphs, less effort has been invested investigating how much overlap there is in the characteristics of such morphs in natural populations. We studied random population samples of the invasive Round Goby Neogobius melanostomus from five different localities in the river Rhine system in the Netherlands. We found two morphologically and physiologically distinct male morphs which likely represent alternative reproductive tactics. Almost all mature males under 9.35 cm total length had a gonadosomatic index > 3%, suggestive of a sneaker tactic, while nearly all males above 9.35 cm has a gonadosomatic index of < 3%, suggestive of a parental tactic. Cheek size and eye diameter alone were sufficient to distinguish the two morphs. Gonads had a different relationship with size in the two morphs, indicating separate growth trajectories. The gonad mass of sneaker morphs would be ca. 7.5 times as high as the gonad mass of parental morphs of the same total length after extrapolation. Few (9%) intermediates were found, suggesting that the expression of alternative reproductive tactics is determined before the first breeding season. This contrasts with studies on other goby species, which show evidence of plastic tactics that can be affected by social circumstances. We conclude that it is possible to distinguish two alternative male morphs in the Dutch Round Goby population using morphological measurements alone. Although behavioural observations are needed to provide conclusive evidence, the difference in GSI between these morphs indicates that these morphs reflect alternative reproductive tactics.	[Bleeker, Katinka; Hinde, Camilla A.] Wageningen Univ & Res, Behav Ecol Grp, Wageningen, Netherlands; [de Jong, Karen] Univ Cologne, Inst Zool, Res Stn Grieterbusch, D-50923 Cologne, Germany; [van Kessel, Nils] Bur Waardenburg Bv, Aj Culemborg, Netherlands; [van Kessel, Nils] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Environm Sci, Nijmegen, Netherlands; [Nagelkerke, Leopold A. J.] Wageningen Univ & Res, Aquaculture & Fisheries Grp, Wageningen, Netherlands; [Bleeker, Katinka] Univ Agder, Dept Nat Sci, Marine Ecol Grp, Kristiansand, Norway	Wageningen University & Research; University of Cologne; Radboud University Nijmegen; Wageningen University & Research; University of Agder	Bleeker, K (corresponding author), Wageningen Univ & Res, Behav Ecol Grp, Wageningen, Netherlands.; Bleeker, K (corresponding author), Univ Agder, Dept Nat Sci, Marine Ecol Grp, Kristiansand, Norway.	katinkableeker@gmail.com	de Jong, Karen/D-1808-2010; Nagelkerke, Leo/C-4758-2008; Hinde, Camilla/AAF-1597-2019	de Jong, Karen/0000-0001-9239-7268; Nagelkerke, Leo/0000-0003-1130-749X; Hinde, Camilla/0000-0001-9376-4023; Bleeker, Katinka/0000-0002-6968-4805				Alonzo SH, 2000, EVOL ECOL RES, V2, P149; Berejikian BA, 2011, T AM FISH SOC, V140, P1206, DOI 10.1080/00028487.2011.618351; Brockmann HJ, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P25, DOI 10.1017/CBO9780511542602.003; Cammaerts R, 2012, AQUAT INVASIONS, V7, P251, DOI 10.3391/ai.2012.7.2.011; Charlebois P, 1997, ROUND GOB C, V60; Claude J, 2013, HYSTRIX, V24, P94, DOI 10.4404/hystrix-24.1-6316; Cleveland WS., 1991, STAT COMPUT, V1, P47, DOI [10.1007/BF01890836, DOI 10.1007/BF01890836]; Dierkes P, 1999, BEHAV ECOL, V10, P510, DOI 10.1093/beheco/10.5.510; Fagundes T, 2015, FUNCT ECOL, V29, P1533, DOI 10.1111/1365-2435.12465; Gertzen S, 2016, LIMNOLOGICA, V56, P39, DOI 10.1016/j.limno.2015.10.005; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Guo ZQ, 2013, HYDROBIOLOGIA, V709, P89, DOI 10.1007/s10750-012-1439-8; Hunt J, 2001, P ROY SOC B-BIOL SCI, V268, P2409, DOI 10.1098/rspb.2001.1758; Immler S, 2004, J EXP ZOOL PART A, V301A, P177, DOI 10.1002/jez.a.20019; Jones MW, 2002, ECOL APPL, V12, P184, DOI 10.1890/1051-0761(2002)012[0184:IVIASF]2.0.CO;2; Kornis MS, 2012, J FISH BIOL, V80, P235, DOI 10.1111/j.1095-8649.2011.03157.x; Kvarnemo C, 2010, J FISH BIOL, V76, P1609, DOI 10.1111/j.1095-8649.2010.02587.x; MacInnis AJ, 2000, T AM FISH SOC, V129, P136, DOI 10.1577/1548-8659(2000)129<0136:FARSOT>2.0.CO;2; MAGNHAGEN C, 1992, ANIM BEHAV, V44, P182, DOI 10.1016/S0003-3472(05)80772-9; Marentette JR, 2008, ENVIRON BIOL FISH, V81, P447, DOI 10.1007/s10641-007-9240-7; Marentette JR, 2009, J GREAT LAKES RES, V35, P302, DOI 10.1016/j.jglr.2009.01.009; Mazzoldi C, 2002, J FISH BIOL, V61, P157, DOI 10.1006/jfbi.2002.2028; Mazzoldi C, 2000, MAR BIOL, V137, P1041, DOI 10.1007/s002270000417; MOSIMANN JE, 1970, J AM STAT ASSOC, V65, P930, DOI 10.2307/2284599; Neff BD, 2003, BEHAV ECOL, V14, P634, DOI 10.1093/beheco/arg032; Neff BD, 2001, J HERED, V92, P111, DOI 10.1093/jhered/92.2.111; Oliveira RF, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P1, DOI 10.1017/CBO9780511542602; Oliveira Rui F., 2006, Fish Physiology, V24, P297; Polacik M, 2012, FOLIA ZOOL, V61, P1; Quinn GP, 2003, EXPT DESIGN DATA ANA; Rasotto MB, 2002, J FISH BIOL, V61, P173, DOI 10.1006/jfbi.2002.2029; Scaggiante M, 1999, J EXP ZOOL, V283, P81, DOI 10.1002/(SICI)1097-010X(19990101)283:1<81::AID-JEZ9>3.0.CO;2-9; SCHELLING TC, 1971, J MATH SOCIOL, V1, P143, DOI 10.1080/0022250X.1971.9989794; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Taborsky M, 2001, J HERED, V92, P100, DOI 10.1093/jhered/92.2.100; Taborsky M, 1998, TRENDS ECOL EVOL, V13, P222, DOI 10.1016/S0169-5347(97)01318-9; Taborsky M, 1997, BEHAV ECOL SOCIOBIOL, V41, P361, DOI 10.1007/s002650050396; TABORSKY M, 1994, ADV STUD BEHAV, V23, P1, DOI 10.1016/S0065-3454(08)60351-4; Taborsky M, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P251, DOI 10.1017/CBO9780511542602.011; Taborsky M, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P537, DOI 10.1007/978-3-642-02624-9_18; Taborsky M, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P1, DOI 10.1017/CBO9780511542602.002; Takegaki T, 2012, BEHAV ECOL, V23, P742, DOI 10.1093/beheco/ars022; Thorpe J.E., 1986, Canadian Special Publication of Fisheries and Aquatic Sciences, V89, P7; Utami SS, 2002, BEHAV ECOL, V13, P643, DOI 10.1093/beheco/13.5.643; Utne-Palm AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143487; van Beek Ge C.W., 2006, Aquatic Invasions, V1, P42, DOI 10.3391/ai.2006.1.1.10; Van Kessel N, 2013, MITIGATIE EFFECTEN U; Van Kessel N, 2014, JAARRAPPORTAGE ACTIE; VIETH E, 1989, J APPL PHYSIOL, V67, P390, DOI 10.1152/jappl.1989.67.1.390; WARNER RR, 1975, SCIENCE, V190, P633, DOI 10.1126/science.1188360; West-Eberhard Mary Jane, 2003, pi	51	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174828	10.1371/journal.pone.0174828	http://dx.doi.org/10.1371/journal.pone.0174828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369128	Green Published, gold, Green Submitted			2022-12-26	WOS:000399351000053
J	de Mestral, C; Marques-Vidal, P; Gaspoz, JM; Theler, JM; Guessous, I				de Mestral, Carlos; Marques-Vidal, Pedro; Gaspoz, Jean-Michel; Theler, Jean-Marc; Guessous, Idris			Independent association between socioeconomic indicators and macro-and micro-nutrient intake in Switzerland	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; NUTRITION EDUCATION; FOOD-CONSUMPTION; NATIONAL-HEALTH; PRICE DISCOUNTS; NUTRIENT INTAKE; DIETARY HABITS; VITAMIN-D; POSITION; INEQUALITIES	Background Socioeconomic differences in diet are rarely assessed with more than one indicator. We aimed to assess differences in macro-and micro-nutrient intake in both sexes according to education, income, and occupation. Methods We used data from validated food frequency questionnaire measured dietary intake in 5087 participants (2157 women) from yearly adult population-based cross-sectional surveys conducted from 2005 to 2012 in the canton of Geneva, Switzerland. We used two ANOVA models: age-adjusted and multivariable adjusted simultaneously for all three socioeconomic indicators. Results Low-education men consumed more calcium but less vitamin D than high-education men; low-income men consumed less total and animal protein (80.9 +/- 0.9 vs 84.0 +/- 0.6 g/d; 55.6 +/- 1.0 vs 59.5 +/- 0.7 g/d) and more total carbohydrates and sugars (246 +/- 2 vs 235 +/- 2 g/d; 108 +/- 2 vs 103 +/- 1 g/d) than high-income men. Occupation and diet showed no association. Low-education women consumed less vegetable protein (20.7 +/- 0.2 vs 21.6 +/- 0.2 g/d), fibre (15.7 +/- 0.3 vs 16.8 +/- 0.2 g/d), and carotene (4222 +/- 158 vs 4870 +/- 128 mu g/d) than high-education women; low-income women consumed more total carbohydrates (206 +/- 2 vs 197 +/- 1 g/d) and less monounsaturated fat (27.7 +/- 0.4 vs 29.3 +/- 0.3 g/d) than high-income women. Finally, low-occupation women consumed more total energy (1792 +/- 27 vs 1714 +/- 15 kcal/d) and total carbohydrates (206 +/- 2 vs 200 +/- 1 g/d), but less saturated fat (23.0 +/- 0.3 vs 24.4 +/- 0.2 g/d), calcium (935 +/- 17 vs 997 +/- 10 mg/d) and vitamin D (2.5 +/- 0.1 vs 2.9 +/- 0.1 mu g/d), than high-occupation women. Conclusion In Switzerland, the influence of socioeconomic factors on nutrient intake differs by sex; income and education, but not occupation, drive differences among men; among women, all three indicators seem to play a role. Interventions to reduce inequalities should consider the influence of education, income, and occupation in diet to be most effective.	[de Mestral, Carlos; Guessous, Idris] Lausanne Univ Hosp, Inst Social & Prevent Med, Lausanne, Switzerland; [Marques-Vidal, Pedro] Lausanne Univ Hosp, Internal Med, Dept Internal Med, Lausanne, Switzerland; [Gaspoz, Jean-Michel; Theler, Jean-Marc; Guessous, Idris] Geneva Univ Hosp, Dept Community Med Primary Care & Emergency Med, Div Primary Care Med, Unit Populat Epidemiol, Geneva, Switzerland; [Guessous, Idris] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; Emory University; Rollins School Public Health	Guessous, I (corresponding author), Lausanne Univ Hosp, Inst Social & Prevent Med, Lausanne, Switzerland.	idris.guessous@hcuge.ch	Marques-Vidal, Pedro M/C-9449-2009	Marques-Vidal, Pedro M/0000-0002-4548-8500; de Mestral, Carlos/0000-0002-0237-882X	University Hospitals of Genevaand the General Directorate of Health, Canton of Geneva, Switzerland; Swiss National Science Foundation [406940_145187]	University Hospitals of Genevaand the General Directorate of Health, Canton of Geneva, Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The "Bus Sante" study is funded by the University Hospitals of Genevaand the General Directorate of Health, Canton of Geneva, Switzerland (no reference number). This work is supported by the Swiss National Science Foundation (Grant ref 406940_145187). The funding sources had no involvement in the study design,the data collection, analysis and interpretation, the writing of the report, or the decision to submit the article for publication.	BOLTONSMITH C, 1991, BRIT J NUTR, V65, P321, DOI 10.1079/BJN19910093; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Darmon N, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-66; Dubois L, 2001, EUR J CLIN NUTR, V55, P366, DOI 10.1038/sj.ejcn.1601165; Faeh D, 2011, OBES REV, V12, P151, DOI 10.1111/j.1467-789X.2010.00793.x; Freedman LS, 2014, AM J EPIDEMIOL, V180, P172, DOI 10.1093/aje/kwu116; Friel S, 2003, EUR J CLIN NUTR, V57, P865, DOI 10.1038/sj.ejcn.1601620; Galobardes B, 2001, INT J EPIDEMIOL, V30, P334, DOI 10.1093/ije/30.2.334; Galobardes B, 2003, AM J PUBLIC HEALTH, V93, P1302, DOI 10.2105/AJPH.93.8.1302; Gill TK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1001; Grange M, 2015, PREV MED, V76, P68, DOI 10.1016/j.ypmed.2015.03.024; Groth MV, 2014, SCAND J PUBLIC HEALT, V42, P611, DOI 10.1177/1403494814547668; Groth MV, 2001, EUR J CLIN NUTR, V55, P959, DOI 10.1038/sj.ejcn.1601251; Hassen WS, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030158; Heuer T, 2015, BRIT J NUTR, V113, P1603, DOI 10.1017/S0007114515000744; Hulshof KFAM, 2003, EUR J CLIN NUTR, V57, P128, DOI 10.1038/sj.ejcn.1601503; Kachan D, 2012, J OCCUP ENVIRON MED, V54, P101, DOI 10.1097/JOM.0b013e31823ccafa; Kant AK, 2007, PUBLIC HEALTH NUTR, V10, P158, DOI 10.1017/S1368980007246749; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Liberato SC, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-919; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Maguire ER, 2014, BR J NUTR, P1; Marques-Vidal P, 2015, NUTRIENTS, V7, P9558, DOI 10.3390/nu7115481; Marques-Vidal P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-87; McGill R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1781-7; MORABIA A, 1994, SOZ PRAVENTIV MED, V39, P345, DOI 10.1007/BF01299666; Morabia A, 1997, PREV MED, V26, P311, DOI 10.1006/pmed.1997.0146; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Ni Mhurchu C, 2010, AM J CLIN NUTR, V91, P736, DOI 10.3945/ajcn.2009.28742; Novakovic R, 2014, PUBLIC HEALTH NUTR, V17, P1031, DOI 10.1017/S1368980013001341; Rush L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-679; Sanchez-Villegas A, 2003, EUR J CLIN NUTR, V57, P917, DOI 10.1038/sj.ejcn.1601626; Stallone DD, 1997, EUR J CLIN NUTR, V51, P815, DOI 10.1038/sj.ejcn.1600491; Thompson FE, 2009, J AM DIET ASSOC, V109, P1376, DOI 10.1016/j.jada.2009.05.002; Turrell G, 2003, PUBLIC HEALTH NUTR, V6, P191, DOI 10.1079/PHN2002416; Unions Suisse de Paysans, 2015, VIAND POIS REC PRIX; Waterlander WE, 2013, AM J CLIN NUTR, V97, P886, DOI 10.3945/ajcn.112.041632; Willett WC, 2013, ANNU REV PUBL HEALTH, V34, P77, DOI 10.1146/annurev-publhealth-031811-124646	39	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174578	10.1371/journal.pone.0174578	http://dx.doi.org/10.1371/journal.pone.0174578			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2IH	28369086	Green Published, gold, Green Submitted			2022-12-26	WOS:000399351000022
J	Joosten, R; Sonder, G; Parkkali, S; Brandwagt, D; Fanoy, E; Mughini-Gras, L; Lodder, W; Ruland, E; Siedenburg, E; Kliffen, S; van Pelt, W				Joosten, Rosa; Sonder, Gerard; Parkkali, Saara; Brandwagt, Diederik; Fanoy, Ewout; Mughini-Gras, Lapo; Lodder, Willemijn; Ruland, Erik; Siedenburg, Evelien; Kliffen, Suzanne; van Pelt, Wilfrid			Risk factors for gastroenteritis associated with canal swimming in two cities in the Netherlands during the summer of 2015: A prospective study	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; WATER-QUALITY INDICATORS; RECREATIONAL WATER; NOROVIRUS; EXPOSURE; ILLNESS; DISEASE; PATHOGENS; OUTBREAKS; RUNOFF	Urban canal swimming events are popular in the Netherlands. In 2015, two city canal swimming events took place, in Utrecht (Utrecht Singel Swim, USS) and in Amsterdam (Amsterdam City Swim, ACS). This prospective study characterizes the health risks associated with swimming in urban waters. Online questionnaires were sent to 160 (USS) and 2,692 (ACS) participants, with relatives of participants who did not swim completing the questionnaire as a control. Swimming water specimens and stool specimens of diarrheic participants in the ACS group were analysed. A total of 49% of USS and 51% of ACS swimmers returned their questionnaires. Nine percent of USS swimmers and 4% of non-swimmers reported gastrointestinal complaints (aRR 2.1; 95% CI: 0.3-16), while a total of 31% of ACS swimmers and 5% of non-swimmers reported gastrointestinal complaints (aRR 6.3; 95% CI: 4.1-9.5). AGI risk among ACS participants was directly related to increasing number of mouthfuls of water swallowed. Various norovirus genotypes were detected in five out of seven stool specimens taken from ACS participants and in all three tested ACS water samples. We conclude that the AGI risk among open-water swimmers in urban areas depends on the circumstances around the event. The epidemiological curve, the statistical association between swimming and AGI, and the microbiological evidence for norovirus in stool and water specimens suggest that AGI outbreak after the ACS event was due to water contamination by multiple norovirus strains, which is possibly linked to sewage overflow due to prior heavy rainfall. There is need for more targeted preventive measurements and recommendations for organizers, municipal authorities and participants to prevent this reoccurring in the future.	[Joosten, Rosa; Brandwagt, Diederik; Fanoy, Ewout; Ruland, Erik] Publ Hlth Serv Utrecht Reg, Zeist, Netherlands; [Sonder, Gerard; Siedenburg, Evelien; Kliffen, Suzanne] Publ Hlth Serv Amsterdam, Amsterdam, Netherlands; [Sonder, Gerard] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, Div Infect Dis, Amsterdam, Netherlands; [Parkkali, Saara; Fanoy, Ewout; Mughini-Gras, Lapo; Lodder, Willemijn; van Pelt, Wilfrid] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Epidemiol & Surveillance, Bilthoven, Netherlands; [Parkkali, Saara] European Ctr Dis Prevent & Control ECDC, European Programme Intervent Epidemiol Training, Stockholm, Sweden	Public Health Service Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands National Institute for Public Health & the Environment; European Centre for Disease Prevention & Control	Joosten, R (corresponding author), Publ Hlth Serv Utrecht Reg, Zeist, Netherlands.	rjoosten@ggdru.nl	fanoy, Eb/ABE-8382-2020					[Anonymous], 2015, ZORGREGISTRATIES EER; Arnold BF, 2013, EPIDEMIOLOGY, V24, P845, DOI 10.1097/01.ede.0000434431.06765.4a; Auld H, 2004, J TOXICOL ENV HEAL A, V67, P1879, DOI 10.1080/15287390490493475; Colford JM, 2007, EPIDEMIOLOGY, V18, P27, DOI 10.1097/01.ede.0000249425.32990.b9; Curriero FC, 2001, AM J PUBLIC HEALTH, P91; de Man H, 2014, WATER RES, V48, P90, DOI 10.1016/j.watres.2013.09.022; de Man H, 2015, EPIDEMIOLOGY INFECT, P1; Environmental Protection Agency US, 2015, REVIEW OF COLIPHAGES; Fewtrell Lorna, 2015, Curr Environ Health Rep, V2, P85, DOI 10.1007/s40572-014-0036-6; Grondahl-Rosado RC, 2014, FOOD ENVIRON VIROL, V6, P232, DOI 10.1007/s12560-014-9161-5; Haile RW, 1999, EPIDEMIOLOGY, V10, P355, DOI 10.1097/00001648-199907000-00004; Harder-Lauridsen NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078371; Hoogheemraadschap Stichtse Rijnlanden RvdK, 2015, MEASUREMENTS WATER Q; Marion JW, 2010, WATER RES, V44, P4796, DOI 10.1016/j.watres.2010.07.065; Pang XLL, 2004, J MED VIROL, V72, P496, DOI 10.1002/jmv.20009; Pruss A, 1998, INT J EPIDEMIOL, V27, P1, DOI 10.1093/ije/27.1.1; Rondy M, 2011, EPIDEMIOL INFECT, V139, P453, DOI 10.1017/S0950268810000993; Sanborn M, 2013, CAN FAM PHYSICIAN, V59, P491; Sartorius B, 2007, SCAND J INFECT DIS, V39, P323, DOI 10.1080/00365540601053006; Schets FA, 2008, APPL ENVIRON MICROB, V74, P2069, DOI 10.1128/AEM.01609-07; Schets FM, 2011, EPIDEMIOL INFECT, V139, P1114, DOI 10.1017/S0950268810002347; Smith JL, 2003, J FOOD PROTECT, V66, P1292, DOI 10.4315/0362-028X-66.7.1292; Union TEPatCotE, 2006, OFFICIAL JOURNAL OF, V64, P14; van Asperen IA, 1998, INT J EPIDEMIOL, V27, P309, DOI 10.1093/ije/27.2.309; Vega E, 2011, EMERG INFECT DIS, V17, P1389, DOI 10.3201/eid1708.101837; Vennema H, 2002, J CLIN VIROL, V25, P233, DOI 10.1016/S1386-6532(02)00126-9; Verhaelen K, 2012, INT J FOOD MICROBIOL, V160, P137, DOI 10.1016/j.ijfoodmicro.2012.10.008; Viau EJ, 2011, ENVIRON SCI TECHNOL, V45, P7158, DOI 10.1021/es200984b; Waternet A, 2015, MEASUREMENTS WATER Q; Wright H, 2011, CLIN J SPORT MED, V21, P337, DOI 10.1097/JSM.0b013e31822148b8	30	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174732	10.1371/journal.pone.0174732	http://dx.doi.org/10.1371/journal.pone.0174732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369101	Green Published, gold, Green Submitted			2022-12-26	WOS:000399351000038
J	Loredo-Ranjel, R; Fanjul-Moles, ML; Escamilla-Chimal, EG				Loredo-Ranjel, Rosaura; Luisa Fanjul-Moles, Maria; Escamilla-Chimal, Elsa G.			Crustacean hyperglycemic hormone is synthesized in the eyestalk and brain of the crayfish Procambarus clarkii	PLOS ONE			English	Article							LOBSTER HOMARUS-AMERICANUS; GONAD-INHIBITING HORMONE; IN-SITU HYBRIDIZATION; SINUS GLAND COMPLEX; ORCONECTES-LIMOSUS; PERICARDIAL ORGAN; CARCINUS-MAENAS; SHORE CRAB; CHH; LOCALIZATION	Crustacean hyperglycemic hormone (CHH) is a neuropeptide that is synthesized, stored, and released by brain and eyestalk structures in decapods. CHH participates in the regulation of several mechanisms, including increasing the level of glucose in hemolymph. Although CHH mRNA levels have been quantified and the CHH protein has been localized in various structures of the crayfish P. clarkii, CHH synthesis has only been reported in the X-organ-sinus gland (XO-SG). Therefore, the aim of this study was to use in situ hybridization to determine whether CHH mRNA is located in other structures, including the putative pacemaker, eyestalk and brain, of crayfish P. clarkii at two times of day. CHH mRNA was observed in both the eyestalk and the brain of P. clarkii, indicating that CHH is synthesized in several structures in common with other crustaceans, possibly to provide metabolic support for these regions by increasing glucose levels.	[Loredo-Ranjel, Rosaura; Luisa Fanjul-Moles, Maria; Escamilla-Chimal, Elsa G.] Univ Nacl Autonoma Mexico, Fac Ciencias, Lab Neurofisiol & Ritmos Biol, Dept Ecol & Recursos Nat, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Escamilla-Chimal, EG (corresponding author), Univ Nacl Autonoma Mexico, Fac Ciencias, Lab Neurofisiol & Ritmos Biol, Dept Ecol & Recursos Nat, Mexico City, DF, Mexico.	elsaec@ciencia.unam.mx			Consejo Nacional de Ciencia Y Tecnologia [178526]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica; Uiversidad Nacional Autonoma de Mexico project [IN210913]	Consejo Nacional de Ciencia Y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Uiversidad Nacional Autonoma de Mexico project	This work was supported by Consejo Nacional de Ciencia Y Tecnologia project number 178526 and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Uiversidad Nacional Autonoma de Mexico project number IN210913 to EGEC.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang ES, 1999, J COMP NEUROL, V414, P50; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chung JS, 2008, FEBS J, V275, P693, DOI 10.1111/j.1742-4658.2007.06231.x; DEKLEIJN DPV, 1992, NEUROSCIENCE, V51, P121, DOI 10.1016/0306-4522(92)90476-I; DEKLEIJN DPV, 1995, BBA-GENE STRUCT EXPR, V1260, P62, DOI 10.1016/0167-4781(94)00173-Z; Dircksen H, 2001, BIOCHEM J, V356, P159, DOI 10.1042/0264-6021:3560159; Escamilla-Chimal EG, 2002, GEN COMP ENDOCR, V125, P283, DOI 10.1006/gcen.2001.7752; Escamilla-Chimal EG, 2010, J EXP BIOL, V213, P3723, DOI 10.1242/jeb.047548; Escamllla-Chimal EG, 2001, J EXP BIOL, V204, P1073; Fanjul-Moles ML, 2006, COMP BIOCHEM PHYS C, V142, P390, DOI 10.1016/j.cbpc.2005.11.021; GORGELSKALLEN JL, 1985, CELL TISSUE RES, V241, P361, DOI 10.1007/BF00217181; HAMANN A, 1974, J COMP PHYSIOL, V89, P197, DOI 10.1007/BF00694791; Herp F. van, 1998, Recent advances in arthropod endocrinology., P53; Hoelters L, 2016, GEN COMP ENDOCR, V237, P43, DOI 10.1016/j.ygcen.2016.07.024; KALLEN JL, 1990, BIOL BULL-US, V179, P351, DOI 10.2307/1542327; KALLEN JL, 1988, BIOL BULL-US, V175, P137, DOI 10.2307/1541901; KELLER R, 1985, AM ZOOL, V25, P207; KELLER R, 1992, EXPERIENTIA, V48, P439, DOI 10.1007/BF01928162; Fanjul-Moles ML, 2013, FRONT BIOSCI-LANDMRK, V18, P665, DOI 10.2741/4129; Fanjul-Moles ML, 2010, CHRONOBIOL INT, V27, P34, DOI 10.3109/07420520903398526; Meyer-Rochow V. Benno, 1999, P97; Nelson-Mora J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083937; ODSELIUS R, 1981, CELL TISSUE RES, V216, P205; Ollivaux C, 2000, EUR J BIOCHEM, V267, P5106, DOI 10.1046/j.1432-1327.2000.01574.x; Portaluppi F, 2010, CHRONOBIOL INT, V27, P1911, DOI 10.3109/07420528.2010.516381; ROTLLANT G, 1993, CELL TISSUE RES, V271, P507, DOI 10.1007/BF02913734; SANDEMAN DC, 1988, J COMP NEUROL, V269, P465, DOI 10.1002/cne.902690402; SANTOS EA, 1993, COMP BIOCHEM PHYS A, V106, P405, DOI 10.1016/0300-9629(93)90234-U; Santos EA, 2001, BRAZ J MED BIOL RES, V34, P75, DOI 10.1590/S0100-879X2001000100009; TENSEN CP, 1991, NEUROSCI LETT, V124, P178, DOI 10.1016/0304-3940(91)90088-B; Ventura-Lopez C, 2016, GENE, V582, P148, DOI 10.1016/j.gene.2016.02.011; Webster SG, 2000, CELL TISSUE RES, V300, P193; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; Wu SH, 2012, COMP BIOCHEM PHYS A, V161, P463, DOI 10.1016/j.cbpa.2012.01.007	34	12	12	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0175046	10.1371/journal.pone.0175046	http://dx.doi.org/10.1371/journal.pone.0175046			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369112	Green Submitted, gold, Green Published			2022-12-26	WOS:000399351000070
J	Peach, MS; Ramos, DM; James, R; Morozowich, NL; Mazzocca, AD; Doty, SB; Allcock, HR; Kumbar, SG; Laurencin, CT				Peach, M. Sean; Ramos, Daisy M.; James, Roshan; Morozowich, Nicole L.; Mazzocca, Augustus D.; Doty, Steven B.; Allcock, Harry R.; Kumbar, Sangamesh G.; Laurencin, Cato T.			Engineered stem cell niche matrices for rotator cuff tendon regenerative engineering	PLOS ONE			English	Article							RAT SUPRASPINATUS TENDON; EXTRACELLULAR-MATRIX; TISSUE REGENERATION; ACUTE INJURY; BONE; REPAIR; MODEL; DIFFERENTIATION; MICROENVIRONMENTS; BIOMATERIALS	Rotator cuff (RC) tears represent a large proportion of musculoskeletal injuries attended to at the clinic and thereby make RC repair surgeries one of the most widely performed musculoskeletal procedures. Despite the high incidence rate of RC tears, operative treatments have provided minimal functional gains and suffer from high re-tear rates. The hypocellular nature of tendon tissue poses a limited capacity for regeneration. In recent years, great strides have been made in the area of tendonogenesis and differentiation towards tendon cells due to a greater understanding of the tendon stem cell niche, development of advanced materials, improved scaffold fabrication techniques, and delineation of the phenotype development process. Though in vitro models for tendonogenesis have shown promising results, in vivo models have been less successful. The present work investigates structured matrices mimicking the tendon microenvironment as cell delivery vehicles in a rat RC tear model. RC injuries augmented with a matrix delivering rat mesenchymal stem cells (rMSCs) showed enhanced regeneration over suture repair alone or repair with augmentation, at 6 and 12-weeks post-surgery. The local delivery of rMSCs led to increased mechanical properties and improved tissue morphology. We hypothesize that the mesenchymal stem cells function to modulate the local immune and bioactivity environment through autocrine/paracrine and/or cell homing mechanisms. This study provides evidence for improved tendon healing with biomimetic matrices and delivered MSCs with the potential for translation to larger, clinical animal models. The enhanced regenerative healing response with stem cell delivering biomimetic matrices may represent a new treatment paradigm for massive RC tendon tears.	[Peach, M. Sean; Ramos, Daisy M.; James, Roshan; Kumbar, Sangamesh G.; Laurencin, Cato T.] Univ Connecticut, Hlth Ctr, Inst Regenerat Engn, Farmington, CT 06269 USA; [Peach, M. Sean; Ramos, Daisy M.; Kumbar, Sangamesh G.; Laurencin, Cato T.] Raymond & Beverly Sackler Ctr Biomed Biol Phys &, Farmington, CT USA; [Peach, M. Sean; James, Roshan; Mazzocca, Augustus D.; Kumbar, Sangamesh G.; Laurencin, Cato T.] Univ Connecticut, Hlth Ctr, Dept Orthopaed Surg, Farmington, CT 06269 USA; [Ramos, Daisy M.; Kumbar, Sangamesh G.; Laurencin, Cato T.] Univ Connecticut, Dept Mat Sci & Engn, Storrs, CT 06269 USA; [Morozowich, Nicole L.; Allcock, Harry R.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Doty, Steven B.] Hosp Special Surg, Analyt Microscopy Lab, New York, NY 10021 USA	University of Connecticut; University of Connecticut; University of Connecticut; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kumbar, SG; Laurencin, CT (corresponding author), Univ Connecticut, Hlth Ctr, Inst Regenerat Engn, Farmington, CT 06269 USA.; Kumbar, SG; Laurencin, CT (corresponding author), Raymond & Beverly Sackler Ctr Biomed Biol Phys &, Farmington, CT USA.; Kumbar, SG; Laurencin, CT (corresponding author), Univ Connecticut, Hlth Ctr, Dept Orthopaed Surg, Farmington, CT 06269 USA.; Kumbar, SG; Laurencin, CT (corresponding author), Univ Connecticut, Dept Mat Sci & Engn, Storrs, CT 06269 USA.	kumbar@uchc.edu; laurencin@uchc.edu	Mazzocca, Augustus/AAD-7507-2021; /P-6752-2014	/0000-0001-7672-4783	Raymond and Beverly Sackler Endowment; National Science Foundation [EFRI-1332329]; National Institutes of Health [R01 AR063698]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	Raymond and Beverly Sackler Endowment; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Raymond and Beverly Sackler Endowment to CTL, the National Science Foundation (Award Number EFRI-1332329) to CTL, and the National Institutes of Health (R01 AR063698) to CTL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amy J Wagers, CELL STEM CELL, V10, P362; Baiguera S, 2012, MESENCHYMAL STROMAL; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Becerra J, 2011, STEM CELL REV REP, V7, P248, DOI 10.1007/s12015-010-9195-5; Bedi A, 2010, J SHOULDER ELB SURG, V19, P384, DOI 10.1016/j.jse.2009.07.010; Beitzel K, 2012, ARTHROSCOPY, V28, P74, DOI 10.1016/j.arthro.2011.06.035; Bilodeau M, 2006, NAT CELL BIOL, V8, P1048, DOI 10.1038/ncb1006-1048; Blevins FT, 1997, ORTHOP CLIN N AM, V28, P1, DOI 10.1016/S0030-5898(05)70260-1; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Chen X, 2009, STEM CELLS, V27, P1276, DOI 10.1002/stem.61; Chong AKS, 2007, J BONE JOINT SURG AM, V89A, P74, DOI 10.2106/JBJS.E.01396; Cofield RH, 2001, J BONE JOINT SURG AM, V83A, P71, DOI 10.2106/00004623-200101000-00010; Cohen DB, 2006, AM J SPORT MED, V34, P362, DOI 10.1177/0363546505280428; Das RK, 2014, BIOMATERIALS, V35, P5278, DOI 10.1016/j.biomaterials.2014.03.044; Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037; Dourte LM, 2010, CLIN ORTHOP RELAT R, V468, P1485, DOI 10.1007/s11999-009-1206-y; Gomes JLE, 2012, KNEE SURG SPORT TR A, V20, P373, DOI 10.1007/s00167-011-1607-9; Fealy S, 2006, AM J SPORT MED, V34, P120, DOI 10.1177/0363546505280212; Fu TS, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-52; Galatz LM, 2006, J ORTHOP RES, V24, P541, DOI 10.1002/jor.20067; Garrett WE, 2006, J BONE JOINT SURG AM, V88A, P660, DOI 10.2106/JBJS.E.01208; Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Gulotta LV, 2011, AM J SPORT MED, V39, P1282, DOI 10.1177/0363546510395485; Gulotta LV, 2011, AM J SPORT MED, V39, P180, DOI 10.1177/0363546510379339; Gulotta LV, 2009, AM J SPORT MED, V37, P2126, DOI 10.1177/0363546509339582; Hatzistergos KE, 2010, CIRC RES, V107, P913, DOI 10.1161/CIRCRESAHA.110.222703; Helps SC, 2012, APPL IMMUNOHISTO M M, V20, P82, DOI 10.1097/PAI.0b013e31821fc8cd; Hettrich CM, 2011, J SHOULDER ELB SURG, V20, P688, DOI 10.1016/j.jse.2010.09.016; Ichinose R, 2010, ACTA ORTHOP, V81, P634, DOI 10.3109/17453674.2010.524595; Ide J, 2009, J SHOULDER ELB SURG, V18, P391, DOI 10.1016/j.jse.2009.01.013; Ide J, 2009, J SHOULDER ELB SURG, V18, P288, DOI 10.1016/j.jse.2008.09.004; Ide J, 2009, ARTHROSCOPY, V25, P608, DOI 10.1016/j.arthro.2008.11.011; James R, 2013, CONVERGENCE ENG LIFE, V43, P8; James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Juncosa-Melvin N, 2006, TISSUE ENG, V12, P369, DOI 10.1089/ten.2006.12.369; Keung AJ, 2010, WIRES SYST BIOL MED, V2, P49, DOI 10.1002/wsbm.46; Kfoury Y, 2015, CELL STEM CELL, V16, P239, DOI 10.1016/j.stem.2015.02.019; Kobolak J, 2016, METHODS, V99, P62, DOI 10.1016/j.ymeth.2015.09.016; Kovacevic D, 2011, AM J SPORT MED, V39, P811, DOI 10.1177/0363546511399378; Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002; Lane SW, 2014, NAT BIOTECHNOL, V32, P795, DOI 10.1038/nbt.2978; Lorda-Diez CI, 2014, ACS CHEM BIOL, V9, P72, DOI 10.1021/cb400713v; Lund AW, 2009, TISSUE ENG PART B-RE, V15, P371, DOI [10.1089/ten.teb.2009.0270, 10.1089/ten.TEB.2009.0270]; Manning CN, 2011, J ORTHOP RES, V29, P1099, DOI 10.1002/jor.21301; Marklein RA, 2010, ADV MATER, V22, P175, DOI 10.1002/adma.200901055; Marx V, 2013, NAT METHODS, V10, P111, DOI 10.1038/nmeth.2336; Mesa KR, 2015, STEM CELL REP, V4, P961, DOI 10.1016/j.stemcr.2015.05.001; Meyer DC, 2005, J ORTHOP RES, V23, P254, DOI 10.1016/j.orthres.2004.06.010; Ni M, 2012, J ORTHOPAEDIC RES; Nourissat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012248; Peach MS, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045016; Peach MS, 2012, J BIOMED NANOTECHNOL, V8, P107, DOI 10.1166/jbn.2012.1368; Peerani R, 2010, J CLIN INVEST, V120, P60, DOI 10.1172/JCI41158; Reichert W, 2011, J BIOMED MATER RES A, V96A, P275, DOI 10.1002/jbm.a.32969; RILEY GP, 1994, ANN RHEUM DIS, V53, P359, DOI 10.1136/ard.53.6.359; Ringe J, 2002, NATURWISSENSCHAFTEN, V89, P338, DOI 10.1007/s00114-002-0344-9; Sarukhan A, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14229; Shin L, 2013, STEM CELL TRANSL MED, V2, P33, DOI 10.5966/sctm.2012-0041; Smith AN, 2010, EXP CELL RES, V316, P48, DOI 10.1016/j.yexcr.2009.08.001; Sohni A, 2013, MESENCHYMAL STEM CEL; Thaker H, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/309187; Thomopoulos S, 2002, J ORTHOP RES, V20, P454, DOI 10.1016/S0736-0266(01)00144-9; Thomopoulos S, 2002, J SHOULDER ELB SURG, V11, P239, DOI 10.1067/mse.2002.122228; Yokoya S, 2012, AM J SPORT MED, V40, P1259, DOI 10.1177/0363546512442343; Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403; Zalavras CG, 2006, J SHOULDER ELB SURG, V15, P224, DOI 10.1016/j.jse.2005.06.007	70	43	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174789	10.1371/journal.pone.0174789	http://dx.doi.org/10.1371/journal.pone.0174789			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369135	Green Published, gold, Green Submitted			2022-12-26	WOS:000399351000044
J	Kiire, CA; Horak, K; Lee, KE; Klein, BEK; Klein, R				Kiire, Christine A.; Horak, Kayla; Lee, Kristine E.; Klein, Barbara E. K.; Klein, Ronald			The period effect in the prevalence of proliferative diabetic retinopathy, gross proteinuria, and peripheral neuropathy in type 1 diabetes: A longitudinal cohort study	PLOS ONE			English	Article							DECLINING INCIDENCE; RISK; HYPERTENSION; NEPHROPATHY; ADOLESCENTS; PROGRESSION; POPULATION; CHILDREN; DISEASE	Aims To investigate whether, for a specific duration of type 1 diabetes, there is a significant change in the prevalence of proliferative diabetic retinopathy, gross proteinuria and peripheral neuropathy in those more recently diagnosed with diabetes (a period effect), in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Where present, to determine how common risk factors for diabetic complications might be associated with it, and what might be driving it. Materials and methods Longitudinal cohort study with seven examination phases between 1980 and 2014. Multivariate logistic regression models and ordinal parameterization were used to test for and evaluate any period effect. Results There is a period effect in the prevalence of gross proteinuria and peripheral neuropathy (decreasing), as seen with proliferative diabetic retinopathy (p<0.001). Adjusting for changing levels of common risk factors attenuates the period effect, particularly for proliferative diabetic retinopathy. For gross proteinuria and peripheral neuropathy, however there is a persistent period effect in spite of adjusting for the major risk factors. Conclusions There are period effects in the prevalence of proliferative diabetic retinopathy, gross proteinuria and peripheral neuropathy that cannot be fully explained by changes in common risk factors for complications of type 1 diabetes in this cohort. The role of other potential confounders warrants further exploration.	[Kiire, Christine A.; Horak, Kayla; Lee, Kristine E.; Klein, Barbara E. K.; Klein, Ronald] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Kiire, CA (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA.	ckiire@gmail.com			National Institutes of Health [EY03083, EY016379]; Research to Prevent Blindness, New York, NY, USA; Senior Scientific Investigator Awards, New York, NY, USA; National Eye Institute; charity Fight for Sight, London, UK [1111438]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, New York, NY, USA(Research to Prevent Blindness (RPB)); Senior Scientific Investigator Awards, New York, NY, USA; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); charity Fight for Sight, London, UK	This research is supported by National Institutes of Health (https://www.nih.gov/grants funding) grant EY03083 and EY016379 (B.E.K.K and R.K.) and, in part, by the Research to Prevent Blindness (https://www.rpbusa.org/rpb/grants-and-research/grants/overview/)(B.E.K.K and R.K, Senior Scientific Investigator Awards), New York, NY, USA. The National Eye Institute (https://nei.nih.gov/funding) provided funding for the entire study including collection and analyses and of data; Research to Prevent Blindness provided further additional support for data analyses. C.A.K. is a UK- US Fulbright Scholar (http://www.fulbrightorg.uk/fulbright-awards/exchanges-to-the-usa) funded by the charity Fight for Sight, London, UK(http://www.fightforsight.org.uk/apply-for-funding/ funding-opportunities/, registered charity number 1111438). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BILD D, 1987, PUBLIC HEALTH REP, V102, P522; BOJESTIG M, 1994, NEW ENGL J MED, V330, P15, DOI 10.1056/NEJM199401063300103; CHRISTLIEB AR, 1981, DIABETES, V30, P90; Herman WH, 2012, DIABETIC MED, V29, P937, DOI 10.1111/j.1464-5491.2012.03644.x; Hovind P, 2003, DIABETES CARE, V26, P1258, DOI 10.2337/diacare.26.4.1258; Javitt IC, 1991, OPHTHALMOLOGY, V98, P74; Klein R, 1998, OPHTHALMOLOGY, V105, P1801, DOI 10.1016/S0161-6420(98)91020-X; KLEIN R, 1986, OPHTHALMOLOGY, V93, P1183; Klein R, 2008, OPHTHALMOLOGY, V115, P1859, DOI 10.1016/j.ophtha.2008.08.023; KNOWLER WC, 1980, NEW ENGL J MED, V302, P645, DOI 10.1056/NEJM198003203021201; LeCaire T, 2006, AM J EPIDEMIOL, V164, P143, DOI 10.1093/aje/kwj166; LeCaire TJ, 2014, DIABETES CARE, V37, P381, DOI 10.2337/dc13-1287; Louraki M, 2016, DIABETES RES CLIN PR, V117, P82, DOI 10.1016/j.diabres.2016.04.044; Marketou NP, 2016, DIABETES-METAB RES, P1; Nordwall M, 2004, DIABETOLOGIA, V47, P1266, DOI 10.1007/s00125-004-1431-6; Papanas Nikolaos, 2015, Rev Diabet Stud, V12, P48, DOI 10.1900/RDS.2015.12.48; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186	19	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174979	10.1371/journal.pone.0174979	http://dx.doi.org/10.1371/journal.pone.0174979			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362881	Green Submitted, Green Published, gold			2022-12-26	WOS:000399175000057
J	Huertas, I; Jesus, S; Lojo, JA; Garcia-Gomez, FJ; Caceres-Redondo, MT; Oropesa-Ruiz, JM; Carrillo, F; Vargas-Gonzalez, L; Rodriguez, JFM; Gomez-Garre, P; Garcia-Solis, D; Mir, P				Huertas, Ismael; Jesus, Silvia; Antonio Lojo, Jose; Javier Garcia-Gomez, Francisco; Teresa Caceres-Redondo, Maria; Manuel Oropesa-Ruiz, Juan; Carrillo, Fatima; Vargas-Gonzalez, Laura; Martin Rodriguez, Juan Francisco; Gomez-Garre, Pilar; Garcia-Solis, David; Mir, Pablo			Lower levels of uric acid and striatal dopamine in non-tremor dominant Parkinson's disease subtype	PLOS ONE			English	Article							MOTOR SUBTYPES; SPECT; ASSOCIATION; PREDICTOR; URATE; HETEROGENEITY; PROGRESSION; PATTERNS; ATROPHY	Parkinson's disease (PD) patients who present with tremor and maintain a predominance of tremor have a better prognosis. Similarly, PD patients with high levels of uric acid (UA), a natural neuroprotectant, have also a better disease course. Our aim was to investigate whether PD motor subtypes differ in their levels of UA, and if these differences correlate with the degree of dopamine transporter (DAT) availability. We included 75 PD patients from whom we collected information about their motor symptoms, DAT imaging and UA concentration levels. Based on the predominance of their motor symptoms, patients were classified into postural instability and gait disorder (PIGD, n = 36), intermediate (I, n = 22), and tremor dominant (TD, n = 17) subtypes. The levels of UA and striatal DAT were compared across subtypes and the correlation between these two measures was also explored. We found that PIGD patients had lower levels of UA (3.7 vs 4.5 vs 5.3 mg/dL; P<0.001) and striatal DAT than patients with an intermediate or TD phenotype. Furthermore, UA levels significantly correlated with the levels of striatal DAT. We also observed that some PIGD (25%) and I (45%) patients had a predominance of tremor at disease onset. We speculate that UA might be involved in the maintenance of the less damaging TD phenotype and thus also in the conversion from TD to PIGD. Low levels of this natural antioxidant could lead to a major neuronal damage and therefore influence the conversion to a more severe motor phenotype.	[Huertas, Ismael; Jesus, Silvia; Teresa Caceres-Redondo, Maria; Manuel Oropesa-Ruiz, Juan; Carrillo, Fatima; Vargas-Gonzalez, Laura; Martin Rodriguez, Juan Francisco; Gomez-Garre, Pilar; Mir, Pablo] Univ Seville, CSIC, Hosp Univ Virgen del Rocio,Unidad Trastornos Movi, Inst Biomed Sevilla IBiS,Serv Neurol & Neurofisio, Seville, Spain; [Antonio Lojo, Jose; Javier Garcia-Gomez, Francisco; Garcia-Solis, David] Hosp Univ Virgen del Rocio, UDIM, Serv Med Nucl, Seville, Spain; [Gomez-Garre, Pilar; Garcia-Solis, David; Mir, Pablo] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Virgen del Rocio University Hospital; CIBERNED	Mir, P (corresponding author), Univ Seville, CSIC, Hosp Univ Virgen del Rocio,Unidad Trastornos Movi, Inst Biomed Sevilla IBiS,Serv Neurol & Neurofisio, Seville, Spain.; Mir, P (corresponding author), Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.	pmir@us.es	Gómez-Garre, Pilar/AAG-8048-2020; Garcia Gomez, Francisco Javier/D-2553-2015	Gómez-Garre, Pilar/0000-0002-0437-6182; Lojo Ramirez, Jose Antonio/0000-0003-4945-8250; JESUS MAESTRE, SILVIA/0000-0002-1874-4628; Huertas, Ismael/0000-0002-4317-0662; Vargas-Gonzalez, Laura/0000-0003-1173-3704; Garcia Gomez, Francisco Javier/0000-0001-9307-5017	Institute de Salud Carlos III [PI14/01823, PI16/01575, F114/00497]; Consejeria de Economia, Innovacion, Ciencia y Empleo de la Junta de Andalucia [CVI-02526, CTS-7685]; Consejena de Salud y Bienestar Social de la Junta de Andalucia [PI-0437-2012, PI-0471/2013]; Sociedad Andaluza de Neurologia; Jacques and Gloria Gossweiler Foundation; Fundacion Alicia Koplowitz; Fundacion Mutua Madrilena	Institute de Salud Carlos III(Instituto de Salud Carlos III); Consejeria de Economia, Innovacion, Ciencia y Empleo de la Junta de Andalucia(Junta de Andalucia); Consejena de Salud y Bienestar Social de la Junta de Andalucia; Sociedad Andaluza de Neurologia; Jacques and Gloria Gossweiler Foundation; Fundacion Alicia Koplowitz; Fundacion Mutua Madrilena(Instituto de Salud Carlos III)	This work was supported by grants from the Institute de Salud Carlos III [PI14/01823, PI16/01575], the Consejeria de Economia, Innovacion, Ciencia y Empleo de la Junta de Andalucia [CVI-02526, CTS-7685], the Consejena de Salud y Bienestar Social de la Junta de Andalucia [PI-0437-2012, PI-0471/2013], the Sociedad Andaluza de Neurologia, the Jacques and Gloria Gossweiler Foundation, the Fundacion Alicia Koplowitz and the Fundacion Mutua Madrilena. Ismael Huertas was supported by the "PFIS" programme [F114/00497], Silvia Jesiis by the "Rio Hortega" programme, Juan Francisco Martin Rodriguez by the "Sara Borrell" programme, and Pilar Gomez-Garre by the "Miguel Servet" programme, all from the Institute de Salud Carlos III.	Ascherio A, 2009, ARCH NEUROL-CHICAGO, V66, P1460, DOI 10.1001/archneurol.2009.247; Chen XQ, 2013, P NATL ACAD SCI USA, V110, P300, DOI 10.1073/pnas.1217296110; Chen XQ, 2012, CURR NEUROL NEUROSCI, V12, P367, DOI 10.1007/s11910-012-0282-7; Eggers C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046813; Foltynie T, 2002, J NEUROL, V249, P138, DOI 10.1007/PL00007856; Helmich RC, 2012, BRAIN, V135, P3206, DOI 10.1093/brain/aws023; HERSHEY LA, 1991, ARCH NEUROL-CHICAGO, V48, P1049, DOI 10.1001/archneur.1991.00530220069021; Huertas-Fernandez I, 2015, EUR J NUCL MED MOL I, V42, P112, DOI 10.1007/s00259-014-2882-8; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Jesus S, 2013, EUR J NEUROL, V20, P208, DOI 10.1111/j.1468-1331.2012.03745.x; Kaasinen V, 2014, EUR J NUCL MED MOL I, V41, P1931, DOI 10.1007/s00259-014-2796-5; Lewis SJG, 2005, J NEUROL NEUROSUR PS, V76, P343, DOI 10.1136/jnnp.2003.033530; Lolekha P, 2015, J CLIN NEUROSCI, V22, P1264, DOI 10.1016/j.jocn.2015.02.015; Moccia M, 2015, ACTA NEUROL SCAND, V131, P127, DOI 10.1111/ane.12295; Oh M, 2012, J NUCL MED, V53, P399, DOI 10.2967/jnumed.111.095224; PAULUS W, 1991, J NEUROPATH EXP NEUR, V50, P743, DOI 10.1097/00005072-199111000-00006; Pirker W, 2003, MOVEMENT DISORD, V18, pS43, DOI 10.1002/mds.10579; Rajput AH, 2009, NEUROLOGY, V73, P206, DOI 10.1212/WNL.0b013e3181ae7af1; Ravina B, 2012, MOVEMENT DISORD, V27, P1392, DOI 10.1002/mds.25157; Reijnders JSAM, 2009, PARKINSONISM RELAT D, V15, P379, DOI 10.1016/j.parkreldis.2008.09.003; Rosenberg-Katz K, 2013, NEUROLOGY, V80, P1476, DOI 10.1212/WNL.0b013e31828cfaa4; Rossi C, 2010, EUR J NEUROL, V17, P626, DOI 10.1111/j.1468-1331.2009.02898.x; Schillaci O, 2011, INT J MOL MED, V28, P881, DOI 10.3892/ijmm.2011.764; Schlesinger I, 2008, MOVEMENT DISORD, V23, P1653, DOI 10.1002/mds.22139; Schwarzschild MA, 2008, ARCH NEUROL-CHICAGO, V65, P716, DOI 10.1001/archneur.2008.65.6.nct70003; Schwarzschild MA, 2011, MOVEMENT DISORD, V26, P1864, DOI 10.1002/mds.23741; Selikhova M, 2009, BRAIN, V132, P2947, DOI 10.1093/brain/awp234; Spiegel J, 2007, J NEURAL TRANSM, V114, P331, DOI 10.1007/s00702-006-0518-2; Sun CC, 2012, CHINESE MED J-PEKING, V125, P583, DOI 10.3760/cma.j.issn.0366-6999.2012.04.005; Varrone A, 2013, EUR J NUCL MED MOL I, V40, P213, DOI 10.1007/s00259-012-2276-8; Zaidel A, 2009, CURR OPIN NEUROL, V22, P387, DOI 10.1097/WCO.0b013e32832d9d67	31	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174644	10.1371/journal.pone.0174644	http://dx.doi.org/10.1371/journal.pone.0174644			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358829	Green Published, gold			2022-12-26	WOS:000399174800066
J	Li, JB; Li, CS; Yuan, W; Wu, JY; Li, J; Li, ZH; Zhao, YZ				Li, Jiebin; Li, Chunsheng; Yuan, Wei; Wu, Junyuan; Li, Jie; Li, Zhenhua; Zhao, Yongzhen			Mild hypothermia alleviates brain oedema and blood-brain barrier disruption by attenuating tight junction and adherens junction breakdown in a swine model of cardiopulmonary resuscitation	PLOS ONE			English	Article							GLOBAL CEREBRAL-ISCHEMIA; HOSPITAL CARDIAC-ARREST; VASCULAR-PERMEABILITY; NEUROLOGICAL FUNCTION; RATS; SURVIVAL; INJURY; NEUROPROTECTION; PATHOGENESIS; EXPRESSION	Mild hypothermia improves survival and neurological recovery after cardiac arrest (CA) and cardiopulmonary resuscitation (CPR). However, the mechanism underlying this phenomenon is not fully elucidated. The aim of this study was to determine whether mild hypothermia alleviates early blood-brain barrier (BBB) disruption. We investigated the effects of mild hypothermia on neurologic outcome, survival rate, brain water content, BBB permeability and changes in tight junctions (TJs) and adherens junctions (AJs) after CA and CPR. Pigs were subjected to 8 min of untreated ventricular fibrillation followed by CPR. Mild hypothermia (33 degrees C) was intravascularly induced and maintained at this temperature for 12 h, followed by active rewarming. Mild hypothermia significantly reduced cortical water content, decreased BBB permeability and attenuated TJ ultrastructural and basement membrane breakdown in brain cortical microvessels. Mild hypothermia also attenuated the CPR-induced decreases in TJ (occludin, claudin-5, ZO-1) and AJ (VE-cadherin) protein and mRNA expression. Furthermore, mild hypothermia decreased the CA-and CPR-induced increases in matrix metalloproteinase-9 (MMP-9) and vascular endothelial growth factor (VEGF) expression and increased angiogenin-1 (Ang-1) expression. Our findings suggest that mild hypothermia attenuates the CA-and resuscitation-induced early brain oedema and BBB disruption, and this improvement might be at least partially associated with attenuation of the breakdown of TJ and AJ, suppression of MMP-9 and VEGF expression, and upregulation of Ang-1 expression.	[Li, Jiebin; Li, Chunsheng; Yuan, Wei; Wu, Junyuan; Zhao, Yongzhen] Capital Med Univ, Beijing Chaoyang Hosp, Dept Emergency Med, Beijing Key Lab Cardiopul Cerebral Resuscitat, Beijing, Peoples R China; [Li, Jie] Capital Med Univ, Beijing FuXing Hosp, Dept Emergency Med, Beijing, Peoples R China; [Li, Zhenhua] Capital Med Univ, Beijing Friendship Hosp, Dept Emergency Med, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Li, CS (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Emergency Med, Beijing Key Lab Cardiopul Cerebral Resuscitat, Beijing, Peoples R China.	lcscyyy@163.com	ZHAO, YUAN/HCI-5831-2022; zhao, YZ/GXH-6401-2022		annual special cultivation and development project for Technology Innovation Base of Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation [Z151100001615056]	annual special cultivation and development project for Technology Innovation Base of Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation	This work was supported by the 2015 annual special cultivation and development project for Technology Innovation Base of Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation (No.Z151100001615056).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Almutairi MMA, 2016, CELL MOL LIFE SCI, V73, P57, DOI 10.1007/s00018-015-2050-8; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Baumann E, 2009, BRAIN RES, V1269, P185, DOI 10.1016/j.brainres.2009.02.062; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Cardoso FL, 2010, BRAIN RES REV, V64, P328, DOI 10.1016/j.brainresrev.2010.05.003; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; del Zoppo GJ, 2009, CEREBROVASC DIS, V27, P65, DOI 10.1159/000200442; Derwall M, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1050-2; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Feldman GJ, 2005, ADV DRUG DELIVER REV, V57, P883, DOI 10.1016/j.addr.2005.01.009; Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367; Geng YJ, 2015, J CEREBR BLOOD F MET, V35, P494, DOI 10.1038/jcbfm.2014.223; Gidday JM, 1997, AM J PHYSIOL-HEART C, V272, pH2622, DOI 10.1152/ajpheart.1997.272.6.H2622; Gong P, 2013, J CEREBR BLOOD F MET, V33, P928, DOI 10.1038/jcbfm.2013.33; Gong P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035313; GREEN EJ, 1992, BRAIN RES, V580, P197, DOI 10.1016/0006-8993(92)90945-6; Hang Y, 2012, J MOL NEUROSCI, V46, P236, DOI 10.1007/s12031-011-9584-5; Hsu CH, 2014, CRIT CARE MED, V42, P2575, DOI 10.1097/CCM.0000000000000547; Idris AH, 1996, RESUSCITATION, V33, P69, DOI 10.1016/S0300-9572(96)01055-6; Janata A, 2009, PROG CARDIOVASC DIS, V52, P168, DOI 10.1016/j.pcad.2009.07.001; Jiao HX, 2011, J MOL NEUROSCI, V44, P130, DOI 10.1007/s12031-011-9496-4; Katz LM, 2001, NEUROREPORT, V12, P3751, DOI 10.1097/00001756-200112040-00029; Liu WY, 2012, CNS NEUROSCI THER, V18, P609, DOI 10.1111/j.1755-5949.2012.00340.x; Meybohm P, 2010, CRIT CARE, V14, DOI 10.1186/cc8879; Miclescu A, 2010, CRIT CARE MED, V38, P2199, DOI 10.1097/CCM.0b013e3181f26b0c; MORIMOTO Y, 1993, CRIT CARE MED, V21, P104, DOI 10.1097/00003246-199301000-00020; Morrison LJ, 2010, CIRCULATION, V122, P8345, DOI 10.1161/CIRCULATIONAHA.110.971051; Nag S, 2011, NEUROPATH APPL NEURO, V37, P3, DOI 10.1111/j.1365-2990.2010.01138.x; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Pichiule P, 1999, MOL BRAIN RES, V74, P83, DOI 10.1016/S0169-328X(99)00261-2; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; PLUTA R, 1994, BRAIN RES, V633, P41, DOI 10.1016/0006-8993(94)91520-2; Preston E, 2004, ACTA NEUROPATHOL, V108, P406, DOI 10.1007/s00401-004-0905-4; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Sawada Norimasa, 2003, Medical Electron Microscopy, V36, P147, DOI 10.1007/s00795-003-0219-y; Schultz Jason, 2011, Resuscitation, V82 Suppl 2, pS35, DOI 10.1016/S0300-9572(11)70149-6; Sharma HS, 2011, J NEURAL TRANSM, V118, P87, DOI 10.1007/s00702-010-0486-4; Sheth P, 2003, J BIOL CHEM, V278, P49239, DOI 10.1074/jbc.M305654200; Sideris G, 2014, RESUSCITATION, V85, P292, DOI 10.1016/j.resuscitation.2013.10.023; Valable S, 2005, J CEREBR BLOOD F MET, V25, P1491, DOI 10.1038/sj.jcbfm.9600148; Vorbrodt AW, 2003, BRAIN RES REV, V42, P221, DOI 10.1016/S0165-0173(03)00177-2; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Xiao F, 2002, ACAD EMERG MED, V9, P933, DOI 10.1111/j.1553-2712.2002.tb02196.x; Xiao F, 2002, ACAD EMERG MED, V9, P105, DOI 10.1111/j.1553-2712.2002.tb00224.x; Xu L, 2015, GEOSCIENCE REMOTE SE, V1, P1; Zhang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082677; Zhao H, 2012, RESUSCITATION, V83, P913, DOI 10.1016/j.resuscitation.2012.01.001	54	25	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174596	10.1371/journal.pone.0174596	http://dx.doi.org/10.1371/journal.pone.0174596			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355299	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174600070
J	Gatti, FAD; Ceolan, E; Greco, FSR; Santos, PC; Klafke, GB; de Oliveira, GR; Von Groll, A; de Martinez, AMB; Goncalves, CV; Scaini, CJ				dos Anjos Gatti, Fabiane Aguiar; Ceolan, Etienne; Rodrigues Greco, Fernando Salles; Santos, Paula Costa; Klafke, Gabriel Baracy; de Oliveira, Gisele Rodrigues; Von Groll, Andrea; Barral de Martinez, Ana Maria; Goncalves, Carla Vitola; Scaini, Carlos James			The prevalence of trichomoniasis and associated factors among women treated at a university hospital in southern Brazil	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; REPRODUCTIVE-AGE; PREGNANT-WOMEN; VAGINALIS; INFECTIONS; HIV	Background Trichomoniasis is the most prevalent non-viral sexually transmitted disease (STD) in the world; however, it remains a neglected parasitic disease. This study aimed to determine the prevalence of trichomoniasis and its associated epidemiological factors among women treated at a hospital in southern Brazil. Methodology/Principal findings A cross-sectional study was performed to determine the prevalence of this infection in women treated at Hospital Universitario (HU) in Rio Grande, Rio Grande do Sul, Brazil, between January 2012 and January 2015. This study consisted a self-administered questionnaire regarding demographic, clinical, and behavioural data and a molecular diagnosis with polymerase chain reaction (PCR) using the TVK3/7 primer set, which was confirmed with sequence analysis. Of the 345 women surveyed, the overall prevalence of Trichomonas vaginalis (T. vaginalis) was 4.1% (14/345). The prevalence rates were 5.9% among pregnant women, 8.5% among HIV-positive women, and 10.1% among HIV-positive pregnant women. The rates for groups with other significant demographic and clinical features were as follows: 6.6% among women with white skin, 12.3% among women with an income below the minimum monthly wage, 7.4% among women with a vaginal pH greater than or equal to 4.6, and 7.9% among women with a comorbid STD. The multivariate analysis confirmed that pregnant women who were HIV-positive (p = 0.001) and had low incomes (p = 0.026) were the most likely to have this infection. Conclusions A multivariate analysis confirmed that HIV-positive pregnant women with low incomes were the participants most likely to have trichomoniasis. These results are important because this Brazilian region presents a high prevalence of HIV-1 subtype C, which is associated with greater transmissibility. Additionally, low family income reveals a socioeconomic fragility that might favour the transmission of this STD.	[dos Anjos Gatti, Fabiane Aguiar; Ceolan, Etienne; Rodrigues Greco, Fernando Salles; Santos, Paula Costa; Klafke, Gabriel Baracy; Scaini, Carlos James] Fed Univ Rio Grande, Sch Med, Parasitol Lab, Porto Alegre, RS, Brazil; [de Oliveira, Gisele Rodrigues; Von Groll, Andrea; Barral de Martinez, Ana Maria] Fed Univ Rio Grande, Sch Med, Mol Biol Lab, Porto Alegre, RS, Brazil; [Goncalves, Carla Vitola] Fed Univ Rio Grande, Obstet & Gynaecol Ctr, Univ Hosp, Porto Alegre, RS, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio Grande; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio Grande; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio Grande; Universidade Federal do Rio Grande do Sul	Gatti, FAD (corresponding author), Fed Univ Rio Grande, Sch Med, Parasitol Lab, Porto Alegre, RS, Brazil.	fafagatti@gmail.com	Santos, Paula/P-2969-2017	Santos, Paula/0000-0002-8599-4176; Baracy Klafke, Gabriel/0000-0002-1397-4926				[Anonymous], 2011, PREVALENCE INCIDENCE; Benzaken AS, 2004, DST J BRAS DOENCAS S, V16, P15; Benzaken AS, 2002, J BRAS DOENCAS SEX T, V14, P9; Brotman RM, 2012, SEX TRANSM DIS, V39, P807, DOI 10.1097/OLQ.0b013e3182631c79; CDC, 2010, SEX TRANSM DIS TREAT; Chesson HW, 2004, SEX TRANSM DIS, V31, P547, DOI 10.1097/01.olq.0000137900.63660.98; Crucitti T, 2003, SEX TRANSM INFECT, V79, P393, DOI 10.1136/sti.79.5.393; Davey DLJ, 2016, SEX TRANSM DIS, V43, P450, DOI 10.1097/OLQ.0000000000000460; Martínez Ana Maria Barral de, 2002, Rev. Soc. Bras. Med. Trop., V35, P471, DOI 10.1590/S0037-86822002000500008; Silva LCF, 2013, BRAZ J INFECT DIS, V17, P701, DOI 10.1016/j.bjid.2013.03.006; Grama DF, 2013, T ROY SOC TROP MED H, V107, P584, DOI 10.1093/trstmh/trt063; Harrington KF, 2001, SEX TRANSM DIS, V28, P468, DOI 10.1097/00007435-200108000-00009; Helms DJ, SEX, P484; Hogniberg BM, 1994, PARASITIC PROTOZOA, V9, P1; Johnston VJ, 2008, CURR OPIN INFECT DIS, V21, P56, DOI 10.1097/QCO.0b013e3282f3d999; KENGNE P, 1994, CELL MOL BIOL, V40, P819; Kissinger P, 2013, SEX TRANSM INFECT, V89, P426, DOI 10.1136/sextrans-2012-051005; Levine WC, 1998, J INFECT DIS, V177, P167, DOI 10.1086/513820; Lobo TT, 2003, SEX TRANSM DIS, V30, P694, DOI 10.1097/01.OLQ.0000079525.04451.05; Luppi Carla Gianna, 2011, Rev. bras. epidemiol., V14, P467, DOI 10.1590/S1415-790X2011000300011; Lusk MJ, 2010, SEX TRANSM INFECT, V86, P227, DOI 10.1136/sti.2009.039362; Maciel GP, 2004, J BRAS PATOL MED LAB, V40, P153; Martins TA, 2004, J BRAS DOENCA SEX TR, V16, P50; Mascarenhas Rita Elizabeth Moreira, 2012, Infect Dis Obstet Gynecol, V2012, P378640, DOI 10.1155/2012/378640; Michel RV, 2006, REV BRAS ANAL CLIN, V38, P127; Miller WC, 2005, SEX TRANSM DIS, V32, P593, DOI 10.1097/01.olq.0000179874.76360.ad; Miranda AE, 2000, SEX TRANSM DIS, V27, P491, DOI 10.1097/00007435-200010000-00001; Miranda AE, 2014, BRAZ J INFECT DIS, V18, P669, DOI 10.1016/j.bjid.2014.07.002; Moodley P, 2002, CLIN INFECT DIS, V34, P519, DOI 10.1086/338399; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; O'Hanlon DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080074; Oliveira FA, 2007, MEM I OSWALDO CRUZ, V102, P751, DOI 10.1590/S0074-02762007000600015; Pastorek JG, 1996, CLIN INFECT DIS, V23, P1075, DOI 10.1093/clinids/23.5.1075; Pavletic Adriana J, 2004, Infect Dis Obstet Gynecol, V12, P63, DOI 10.1080/10647440400009839; Petrin D, 1998, CLIN MICROBIOL REV, V11, P300, DOI 10.1128/CMR.11.2.300; Rogers SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090548; Rottingen JA, 2001, SEX TRANSM DIS, V28, P579; Salawu Oyetunde Timothy, 2016, J Reprod Infertil, V17, P61; Silva Filho Amadeu Ramos da, 2004, Rev. Bras. Ginecol. Obstet., V26, P509, DOI 10.1590/S0100-72032004000700002; Soares EAJM, 2005, AIDS, V19, pS81, DOI 10.1097/01.aids.0000191497.00928.e4; Soares VD, 2003, TROP MED INT HEALTH, V8, P595, DOI 10.1046/j.1365-3156.2003.01078.x; SOBEL JD, 1990, BRIT J CLIN PRACT, V44, P65; Sorvillo F, 1998, AM J TROP MED HYG, V58, P495, DOI 10.4269/ajtmh.1998.58.495	43	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0173604	10.1371/journal.pone.0173604	http://dx.doi.org/10.1371/journal.pone.0173604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346531	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174300010
J	Po, A; Silvano, M; Miele, E; Capalbo, C; Eramo, A; Salvati, V; Todaro, M; Besharat, ZM; Catanzaro, G; Cucchi, D; Coni, S; Di Marcotullio, L; Canettieri, G; Vacca, A; Stassi, G; De Smaele, E; Tartaglia, M; Screpanti, I; De Maria, R; Ferretti, E				Po, A.; Silvano, M.; Miele, E.; Capalbo, C.; Eramo, A.; Salvati, V.; Todaro, M.; Besharat, Z. M.; Catanzaro, G.; Cucchi, D.; Coni, S.; Di Marcotullio, L.; Canettieri, G.; Vacca, A.; Stassi, G.; De Smaele, E.; Tartaglia, M.; Screpanti, I.; De Maria, R.; Ferretti, E.			Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma	ONCOGENE			English	Article							HEDGEHOG PATHWAY; ABC TRANSPORTERS; SONIC HEDGEHOG; CELL-SURVIVAL; CANCER-CELLS; EXPRESSION; IDENTIFICATION; NEUROPILIN-2; ACTIVATION; TARGET	Aberrant Hedgehog/GLIsignaling has been implicated in a diverse spectrum of human cancers, but its role in lung adenocarcinoma (LAC) is still under debate. We show that the downstream effector of the Hedgehog pathway, GLI1, is expressed in 76% of LACs, but in roughly half of these tumors, the canonical pathway activator, Smoothened, is expressed at low levels, possibly owing to epigenetic silencing. In LAC cells including the cancer stem cell compartment, we show that GLI1 is activated noncanonically by MAPK/ERK signaling. Different mechanisms can trigger the MAPK/ERK/GLI1 cascade including KRAS mutation and stimulation of NRP2 by VEGF produced by the cancer cells themselves in an autocrine loop or by stromal cells as paracrine cross talk. Suppression of GLI1, by silencing or drug-mediated, inhibits LAC cells proliferation, attenuates their stemness and increases their susceptibility to apoptosis in vitro and in vivo. These findings provide insight into the growth of LACs and point to GLI1 as a downstream effector for oncogenic pathways. Thus, strategies involving direct inhibition of GLI1 may be useful in the treatment of LACs.published online 3 April 2017	[Po, A.; Silvano, M.; Capalbo, C.; Besharat, Z. M.; Cucchi, D.; Coni, S.; Di Marcotullio, L.; Canettieri, G.; Screpanti, I.] Sapienza Univ, Dept Mol Med, Rome, Italy; [Miele, E.; Screpanti, I.] IIT, Ctr Life NanoSci Sapienza, Rome, Italy; [Eramo, A.; Salvati, V.; De Maria, R.] Ist Super Sanita, Dept Hematol Oncol & Mol Med, Rome, Italy; [Todaro, M.; Stassi, G.] Univ Palermo, Surg & Oncol Sci, Palermo, Italy; [Todaro, M.] Univ Palermo, Cent Lab Adv Diag & Biomed Res CLADIBIOR, Palermo, Italy; [Catanzaro, G.; Vacca, A.; De Smaele, E.; Ferretti, E.] Sapienza Univ, Dept Expt Med, Viale Regina Elena,291, I-00161 Rome, Italy; [Tartaglia, M.] Osped Pediat Bambino Gesu, Genet & Rare Dis Res Div, Rome, Italy; [De Maria, R.] Univ Cattolica Sacro Cuore, Inst Gen Pathol, Largo Francesco Vito,1, I-00168 Rome, Italy; [Ferretti, E.] IRCCS Neuromed, Pozzilli, Italy; [Miele, E.] IRCCS, Bambino Gesu Childrens Hosp, Dept Hematol Oncol & Stem Cell Transplantat, I-00165 Rome, Italy	Sapienza University Rome; Istituto Italiano di Tecnologia - IIT; Istituto Superiore di Sanita (ISS); University of Palermo; University of Palermo; Sapienza University Rome; IRCCS Bambino Gesu; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Neuromed; IRCCS Bambino Gesu	Ferretti, E (corresponding author), Sapienza Univ, Dept Expt Med, Viale Regina Elena,291, I-00161 Rome, Italy.; De Maria, R (corresponding author), Univ Cattolica Sacro Cuore, Inst Gen Pathol, Largo Francesco Vito,1, I-00168 Rome, Italy.	ruggero.demaria@unicatt.it; elisabetta.ferretti@uniroma1.it	De Smaele, Enrico/C-1124-2013; Miele, Evelina/M-4611-2013; De Maria, Ruggero/S-6385-2019; Po, Agnese/AEQ-0192-2022; todaro, matilde/AAC-1003-2022; Po, Agnese/G-8754-2015; Tartaglia, Marco/K-2955-2018; catanzaro, giuseppina/AGZ-8080-2022; Miele, Evelina/ABB-7545-2021; Eramo, Adriana/K-6694-2016; salvati, Valentina/J-1264-2018; Miele, Evelina/AAK-1963-2021; Stassi, Giorgio/AAC-1175-2022; Besharat, Zein Mersini/G-5413-2013; Ferretti, Elisabetta/G-5413-2013	De Smaele, Enrico/0000-0003-4524-4423; Miele, Evelina/0000-0002-4747-1032; De Maria, Ruggero/0000-0003-2255-0583; Po, Agnese/0000-0002-9346-8782; todaro, matilde/0000-0001-8686-8043; Po, Agnese/0000-0002-9346-8782; Tartaglia, Marco/0000-0001-7736-9672; catanzaro, giuseppina/0000-0001-8427-9691; Miele, Evelina/0000-0002-4747-1032; Eramo, Adriana/0000-0002-0814-6683; salvati, Valentina/0000-0002-0322-3504; Besharat, Zein Mersini/0000-0003-0317-9854; CANETTIERI, Gianluca/0000-0001-6694-2613; Ferretti, Elisabetta/0000-0001-7265-6429; VACCA, Alessandra/0000-0002-0006-5379; DI MARCOTULLIO, LUCIA/0000-0003-0274-7178; Cucchi, Danilo/0000-0002-9934-510X	Associazione Italiana Ricerca Cancro (AIRC); Ministry of University and Research (FIRB); Ministry of University and Research (PRIN); Ministry of University and Research (PON); Sapienza University of Rome (Ateneo); Pasteur Institute/Cenci Bolognetti Foundation; Umberto Di Mario ONLUS Foundation; Italian Institute of Technology (IIT) projects; Societa Italiana Articoli Laboratorio S.r.l (Rome, Italy)	Associazione Italiana Ricerca Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministry of University and Research (FIRB)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Ministry of University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Ministry of University and Research (PON); Sapienza University of Rome (Ateneo); Pasteur Institute/Cenci Bolognetti Foundation(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Umberto Di Mario ONLUS Foundation; Italian Institute of Technology (IIT) projects; Societa Italiana Articoli Laboratorio S.r.l (Rome, Italy)	We thank Alberto Gulino, friend, mentor and colleague, who passed away while the manuscript was in preparation, for his inspiring vision and continued support. This work was supported by Associazione Italiana Ricerca Cancro (AIRC and AIRC 5XMILLE), Ministry of University and Research (FIRB, PRIN and PON), Sapienza University of Rome (Ateneo), Pasteur Institute/Cenci Bolognetti Foundation, Umberto Di Mario ONLUS Foundation, Italian Institute of Technology (IIT) projects. Medical writing support was provided by ME Kent (EMWA) and funded by the Societa Italiana Articoli Laboratorio S.r.l (Rome, Italy).	Agyeman A, 2014, ONCOTARGET, V5, P4492, DOI 10.18632/oncotarget.2046; Amakye D, 2013, NAT MED, V19, P1410, DOI 10.1038/nm.3389; Atwood SX, 2013, NATURE, V494, P484, DOI 10.1038/nature11889; Beauchamp EM, 2011, J CLIN INVEST, V121, P148, DOI 10.1172/JCI42874; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Belani CP, 2016, CANCER-AM CANCER SOC, V122, P2371, DOI 10.1002/cncr.30062; Bermudez O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063226; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Cao X, 2012, ONCOGENE, V31, P104, DOI 10.1038/onc.2011.219; Caunt M, 2008, CANCER CELL, V13, P331, DOI 10.1016/j.ccr.2008.01.029; Chen X, 2008, STEM CELLS, V26, P2759, DOI 10.1634/stemcells.2008-0398; Chen Y, 2014, MOL CARCINOGEN, V53, P625, DOI 10.1002/mc.22015; Chenge J, 2016, SCI REP-UK, V6, DOI 10.1038/srep26628; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; D'Amico D, 2015, DEV CELL, V35, P21, DOI 10.1016/j.devcel.2015.09.008; Davidson MR, 2013, J THORAC DIS, V5, pS463, DOI 10.3978/j.issn.2072-1439.2013.08.43; De Smaele E, 2010, CURR OPIN INVEST DR, V11, P707; Di Marcotullio L, 2004, P NATL ACAD SCI USA, V101, P10833, DOI 10.1073/pnas.0400690101; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Favier B, 2006, BLOOD, V108, P1243, DOI 10.1182/blood-2005-11-4447; Fletcher JI, 2010, NAT REV CANCER, V10, P147, DOI 10.1038/nrc2789; Garvalov BK, 2011, J MOL MED, V89, P95, DOI 10.1007/s00109-010-0685-3; Glinka Y, 2012, BIOCHEM BIOPH RES CO, V425, P775, DOI 10.1016/j.bbrc.2012.07.151; Goel HL, 2013, EMBO MOL MED, V5, P488, DOI 10.1002/emmm.201202078; Gonnissen A, 2015, ONCOTARGET, V6, P13899, DOI 10.18632/oncotarget.4224; Hamerlik P, 2012, J EXP MED, V209, P507, DOI 10.1084/jem.20111424; Huang LL, 2014, CLIN CANCER RES, V20, P1566, DOI 10.1158/1078-0432.CCR-13-2195; Huang W-Y, 2014, NUCLEIC ACIDS RES, V43; Hwang J, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-268; Infante P, 2015, EMBO J, V34, P200, DOI 10.15252/embj.201489213; Ingram WJ, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-26; Ingram WJ, 2002, ONCOGENE, V21, P8196, DOI 10.1038/sj.onc.1205975; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Johnson DH, 2014, J CLIN ONCOL, V32, P1389, DOI 10.1200/JCO.2014.55.1929; Justilien V, 2015, CLIN CANCER RES, V21, P505, DOI 10.1158/1078-0432.CCR-14-0507; Justilien V, 2014, CANCER CELL, V25, P139, DOI 10.1016/j.ccr.2014.01.008; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Kawakami T, 2002, CANCER, V95, P2196, DOI 10.1002/cncr.10936; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; Kober P, 2011, MOL CARCINOGEN, V50, P846, DOI 10.1002/mc.20763; Lantuejoul S, 2003, J PATHOL, V200, P336, DOI 10.1002/path.1367; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Lee RTH, 2016, DEVELOPMENT, V143, P367, DOI 10.1242/dev.120154; Matchett KB, 2014, STEM CELLS, V32, P2563, DOI 10.1002/stem.1798; Mills LD, 2013, J BIOL CHEM, V288, P11786, DOI 10.1074/jbc.M112.438846; Nasarre P, 2013, CANCER RES, V73, P7111, DOI 10.1158/0008-5472.CAN-13-1755; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Park JT, 2015, ONCOGENE, V34, P2801, DOI 10.1038/onc.2014.223; Park KS, 2011, NAT MED, V17, P1504, DOI 10.1038/nm.2473; Pinato DJ, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1213934; Po A, 2010, EMBO J, V29, P2646, DOI 10.1038/emboj.2010.131; Raz G, 2012, LUNG CANCER, V76, P191, DOI 10.1016/j.lungcan.2011.10.015; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Rodriguez-Blanco J, 2013, ONCOGENE, V32, P2335, DOI 10.1038/onc.2012.243; Ronci M, 2015, MOL BIOSYST, V11, P1603, DOI 10.1039/c5mb00034c; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Seluanov Andrei, 2010, J Vis Exp, DOI 10.3791/2033; Seto M, 2009, MOL CARCINOGEN, V48, P703, DOI 10.1002/mc.20516; Sette G, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.217; Silvano M, 2015, J STEM CELL RES THER, V5, P2; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Singh RR, 2011, ONCOGENE, V30, P4874, DOI 10.1038/onc.2011.195; Singh S, 2011, CANCER RES, V71, P4454, DOI 10.1158/0008-5472.CAN-10-2313; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Sullivan JP, 2010, CANCER RES, V70, P9937, DOI 10.1158/0008-5472.CAN-10-0881; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; Thomas A, 2015, NAT REV CLIN ONCOL, V12, P511, DOI 10.1038/nrclinonc.2015.90; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Varnat F, 2010, EMBO MOL MED, V2, P440, DOI 10.1002/emmm.201000098; Wang Y, 2012, CANCER CELL, V21, P374, DOI 10.1016/j.ccr.2011.12.028; Yuan Z, 2007, ONCOGENE, V26, P1046, DOI 10.1038/sj.onc.1209860; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137; Zhu YH, 2004, CANCER LETT, V207, P205, DOI 10.1016/j.canlet.2003.10.025; Zinzi L, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00163	83	64	66	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 10	2017	36	32					4641	4652		10.1038/onc.2017.91	http://dx.doi.org/10.1038/onc.2017.91			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FD0RK	28368412	Green Published, hybrid			2022-12-26	WOS:000407246200011
J	He, JQ; Zhang, F; Tay, LWR; Boroda, S; Nian, WQ; Levental, KR; Levental, I; Harris, TE; Chang, JT; Du, GW				He, Jingquan; Zhang, Feng; Tay, Li Wei Rachel; Boroda, Salome; Nian, Weiqi; Levental, Kandice R.; Levental, Ilya; Harris, Thurl E.; Chang, Jeffrey T.; Du, Guangwei			Lipin-1 regulation of phospholipid synthesis maintains endoplasmic reticulum homeostasis and is critical for triple-negative breast cancer cell survival	FASEB JOURNAL			English	Article						TNBC; LPIN1; membrane biogenesis; IRE1 alpha; endoplasmic reticulum stress	UNFOLDED PROTEIN RESPONSE; PHOSPHATIDIC-ACID PHOSPHATASE; FATTY-ACIDS; TUMOR-GROWTH; ER STRESS; METABOLISM; PATHWAY; PHOSPHORYLATION; LOCALIZATION; ACTIVATION	Cancer cells reprogram their metabolism to increase the synthesis of macromolecules for rapid proliferation. Compared to fatty acids, much less is known about the synthesis of phospholipids, which is essential for membrane biogenesis in cancer cells. We found that LPIN1, which encodes lipin-1, a phosphatidic acid phosphatase (PAP) controlling the rate-limiting step in the phospholipid synthesis pathway, is highly up-regulated in basal-like triple-negative breast cancer (TNBC). Moreover, high LPIN1 expression correlates with the poor prognosis of these patients. Knockdown of LPIN1 increases apoptosis in basal-like TNBC cell lines, whereas it has minimal or less effect on normal human mammary gland epithelial cells (HMECs) and estrogen receptor-positive breast cancer cell lines. Fatty acid incorporation and lipidomics analyses showed that LPIN1 knockdown blocks phospholipid synthesis and changes membrane lipid compositions that ultimately induce the activation of 1 of the 3 branches of unfolded protein responses, the inositol-requiring enzyme-1 alpha pathway. We also show for the first time, to our knowledge, that lipin-1 knockdown significantly inhibits tumor growth in vivo using an orthotopic xenograft breast mouse model. Our results suggest that lipin-1 is a potential target for cancer therapy. He, J., Zhang, F., Tay, L. W. R., Boroda, S., Nian, W., Levental, K. R., Levental, I., Harris, T. E., Chang, J. T., Du, G. Lipin-1 regulation of phospholipid synthesis maintains endoplasmic reticulum homeostasis and is critical for triple-negative breast cancer cell survival.	[He, Jingquan; Zhang, Feng; Tay, Li Wei Rachel; Nian, Weiqi; Levental, Kandice R.; Levental, Ilya; Chang, Jeffrey T.; Du, Guangwei] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA; [Chang, Jeffrey T.] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA; [Zhang, Feng] Quzhou Peoples Hosp, Dept Clin Lab, Core Facil, Quzhou, Peoples R China; [Boroda, Salome; Harris, Thurl E.] Univ Virginia Hlth Syst, Dept Pharmacol, Charlottesville, VA USA; [Nian, Weiqi] Chongqing Canc Hosp & Inst & Canc Ctr, Key Lab Oncol, Chongqing, Peoples R China	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Virginia	Du, GW (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	guangwei.du@uth.tmc.edu	Levental, Ilya/F-4707-2011	Levental, Ilya/0000-0002-1206-9545; Du, Guangwei/0000-0003-4193-6975	Cancer Prevention and Research Institute of Texas (CPRIT) [RP130425, RP160775]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114282, T32GM007055] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Symeon Siniossoglou (University of Cambridge, Cambridge, United Kingdom) for generously providing lipin-1 antibody and the pGEX-4T1-lipin-1 (aa 190-526) bacterial expression vector for lipin-1 antibody production. This study was supported by Cancer Prevention and Research Institute of Texas (CPRIT) Grants RP130425 and RP160775 (to G.D.). The authors declare no conflicts of interest.	Ackerman D, 2014, TRENDS CELL BIOL, V24, P472, DOI 10.1016/j.tcb.2014.06.001; Brohee L, 2015, ONCOTARGET, V6, P11264, DOI 10.18632/oncotarget.3595; Cai M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.355; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Chevet E, 2015, CANCER DISCOV, V5, P586, DOI 10.1158/2159-8290.CD-14-1490; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Eaton JM, 2013, J BIOL CHEM, V288, P9933, DOI 10.1074/jbc.M112.441493; Engebraaten O, 2013, AM J PATHOL, V183, P1064, DOI 10.1016/j.ajpath.2013.05.033; Fagone P, 2009, J LIPID RES, V50, pS311, DOI 10.1194/jlr.R800049-JLR200; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Griffiths B, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-3; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Han Gil-Soo, 2004, Methods Mol Biol, V284, P209; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Harris TE, 2011, TRENDS ENDOCRIN MET, V22, P226, DOI 10.1016/j.tem.2011.02.006; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hermansson M, 2011, PROG LIPID RES, V50, P240, DOI 10.1016/j.plipres.2011.02.004; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hou NS, 2014, P NATL ACAD SCI USA, V111, pE2271, DOI 10.1073/pnas.1318262111; Iorio E, 2010, CANCER RES, V70, P2126, DOI 10.1158/0008-5472.CAN-09-3833; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Levental KR, 2016, BIOPHYS J, V110, P1800, DOI 10.1016/j.bpj.2016.03.012; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Padanad MS, 2016, CELL REP, V16, P1614, DOI 10.1016/j.celrep.2016.07.009; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schweitzer GG, 2015, J LIPID RES, V56, P848, DOI 10.1194/jlr.M055962; Siniossoglou S, 2013, BBA-MOL CELL BIOL L, V1831, P575, DOI 10.1016/j.bbalip.2012.09.014; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Trousil S, 2014, CANCER RES, V74, P6867, DOI 10.1158/0008-5472.CAN-13-2409; Urra H, 2013, BBA-MOL CELL RES, V1833, P3507, DOI 10.1016/j.bbamcr.2013.07.024; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Zaidi N, 2013, PROG LIPID RES, V52, P585, DOI 10.1016/j.plipres.2013.08.005; Zhang F, 2014, MOL CELL BIOL, V34, P84, DOI 10.1128/MCB.00987-13	41	33	33	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2893	2904		10.1096/fj.201601353R	http://dx.doi.org/10.1096/fj.201601353R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28347999	Green Published			2022-12-26	WOS:000405931000015
J	Tsirkone, VG; Blokken, J; De Wit, F; Breemans, J; De Houwer, S; Debyser, Z; Christ, F; Strelkov, SV				Tsirkone, Vicky G.; Blokken, Jolien; De Wit, Flore; Breemans, Jolien; De Houwer, Stephanie; Debyser, Zeger; Christ, Frauke; Strelkov, Sergei V.			N-terminal half of transportin SR2 interacts with HIV integrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-SCATTERING; NUCLEAR IMPORT; STRUCTURAL BASIS; MACROMOLECULAR STRUCTURES; REVERSE TRANSCRIPTION; NONDIVIDING CELLS; CRYSTAL-STRUCTURE; PROTEIN; DNA; INFECTION	The karyopherin transportin SR2 (TRN-SR2, TNPO3) is responsible for shuttling specific cargoes such as serine/arginine-rich splicing factors from the cytoplasm to the nucleus. This protein plays a key role in HIV infection by facilitating the nuclear import of the pre-integration complex (PIC) that contains the viral DNA as well as several cellular and HIV proteins, including the integrase. The process of nuclear import is considered to be the bottleneck of the viral replication cycle and therefore represents a promising target for anti-HIV drug design. Previous studies have demonstrated that the direct interaction between TRN-SR2 and HIV integrase predominantly involves the catalytic core domain (CCD) and the C-terminal domain (CTD) of the integrase. We aimed at providing a detailed molecular view of this interaction through a biochemical characterization of the respective protein complex. Size-exclusion chromatography was used to characterize the interaction of TRN-SR2 with a truncated variant of the HIV-1 integrase, including both the CCD and CTD. These experiments indicate that one TRN-SR2 molecule can specifically bind one CCD-CTD dimer. Next, the regions of the solenoid-like TRN-SR2 molecule that are involved in the interaction with integrase were identified using AlphaScreen binding assays, revealing that the integrase interacts with the N-terminal half of TRN-SR2 principally through the HEAT repeats 4, 10, and 11. Combining these results with small-angle X-ray scattering data for the complex of TRN-SR2 with truncated integrase, we propose a molecular model of the complex. We speculate that nuclear import of the PIC may proceed concurrently with the normal nuclear transport.	[Tsirkone, Vicky G.; Breemans, Jolien; Strelkov, Sergei V.] Katholieke Univ Leuven, Lab Biocrystallog, B-3000 Leuven, Belgium; [Blokken, Jolien; De Wit, Flore; De Houwer, Stephanie; Debyser, Zeger; Christ, Frauke] Katholieke Univ Leuven, Lab Mol Virol & Gene Therapy, B-3000 Leuven, Belgium	KU Leuven; KU Leuven	Strelkov, SV (corresponding author), Herestr 49 Bus 822, B-3000 Leuven, Belgium.	sergei.strelkov@kuleuven.be	Blokken, Jolien/H-7626-2018; Christ, Frauke/H-7513-2018; debyser, zeger/H-1310-2013	Blokken, Jolien/0000-0002-8152-824X; debyser, zeger/0000-0002-3982-1565; Christ, Frauke/0000-0001-9580-3874	Belgian IAP BelVir; Seventh Framework Programme of the EC [6131]	Belgian IAP BelVir; Seventh Framework Programme of the EC	We thank Dr. Stephen D. Weeks for guidance on cloning and protein expression as well as for help with SAXS data collection and Dr. Alexander V. Shkumatov for valuable advice on SAXS data collection and processing. An expression plasmid for human CDC-like kinase 1 was a kind gift of Prof. Peter Cherepanov. Research at the Laboratory of Molecular Virology and Gene Therapy was also funded by Belgian IAP BelVir. Support from the Seventh Framework Programme of the EC under the BioStruct-X initiative (Project Number 6131) toward the synchrotron SAXS measurements is acknowledged.	ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Ao ZJ, 2010, J VIROL, V84, P8650, DOI 10.1128/JVI.00508-10; Ao ZJ, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-62; Arhel N, 2010, BBA-MOL BASIS DIS, V1802, P313, DOI 10.1016/j.bbadis.2009.12.003; Ballandras-Colas A, 2017, SCIENCE, V355, P93, DOI 10.1126/science.aah7002; Ballandras-Colas A, 2016, NATURE, V530, P358, DOI 10.1038/nature16955; Bhattacharya A, 2014, P NATL ACAD SCI USA, V111, P18625, DOI 10.1073/pnas.1419945112; Bono F, 2010, MOL CELL, V37, P211, DOI 10.1016/j.molcel.2010.01.007; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2011, CURR OPIN STRUC BIOL, V21, P249, DOI 10.1016/j.sbi.2010.12.005; Chin CR, 2015, CELL REP, V13, P1717, DOI 10.1016/j.celrep.2015.10.036; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Colwill K, 1996, J BIOL CHEM, V271, P24569, DOI 10.1074/jbc.271.40.24569; De Houwer S, 2014, J BIOL CHEM, V289, P25351, DOI 10.1074/jbc.M113.533281; De Houwer S, 2012, J BIOL CHEM, V287, P34059, DOI 10.1074/jbc.M112.387944; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; Eijkelenboom APAM, 1999, PROTEINS, V36, P556, DOI 10.1002/(SICI)1097-0134(19990901)36:4<556::AID-PROT18>3.0.CO;2-6; Engelman A, 2012, NAT REV MICROBIOL, V10, P279, DOI 10.1038/nrmicro2747; Fassati A, 2003, EMBO J, V22, P3675, DOI 10.1093/emboj/cdg357; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Graewert MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10734; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Hare S, 2012, EMBO J, V31, P3020, DOI 10.1038/emboj.2012.118; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hori T, 2013, J VIROL, V87, P7726, DOI 10.1128/JVI.00124-13; Hutten S, 2009, J CELL SCI, V122, P1100, DOI 10.1242/jcs.040154; Imasaki T, 2007, MOL CELL, V28, P57, DOI 10.1016/j.molcel.2007.08.006; Jayappa Kallesh Danappa, 2012, Int J Biochem Mol Biol, V3, P70; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Lai MC, 2003, EMBO J, V22, P1359, DOI 10.1093/emboj/cdg126; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Larue R, 2012, J BIOL CHEM, V287, P34044, DOI 10.1074/jbc.M112.384669; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Levin A, 2010, NUCLEUS-PHILA, V1, P422, DOI 10.4161/nucl.1.5.12903; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; Luban J, 2008, CURR BIOL, V18, pR710, DOI 10.1016/j.cub.2008.07.037; Lusic M, 2017, NAT REV MICROBIOL, V15, DOI 10.1038/nrmicro.2017.22; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Maertens GN, 2014, P NATL ACAD SCI USA, V111, P2728, DOI 10.1073/pnas.1320755111; Matreyek KA, 2013, VIRUSES-BASEL, V5, P2483, DOI 10.3390/v5102483; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Panjkovich A, 2016, PHYS CHEM CHEM PHYS, V18, P5707, DOI 10.1039/c5cp04540a; Passos DO, 2017, SCIENCE, V355, P89, DOI 10.1126/science.aah5163; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Shkumatov AV, 2015, ACTA CRYSTALLOGR D, V71, P1347, DOI 10.1107/S1399004715007154; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suzuki Y, 2007, NAT REV MICROBIOL, V5, P187, DOI 10.1038/nrmicro1579; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Taltynov O, 2013, J BIOL CHEM, V288, P25603, DOI 10.1074/jbc.M113.484345; Taltynov Oliver, 2012, Mol Biol Int, V2012, P863405, DOI 10.1155/2012/863405; Thys W, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-7; Tsirkone VG, 2014, ACTA CRYSTALLOGR F, V70, P723, DOI 10.1107/S2053230X14009492; Valle-Casuso JC, 2012, J VIROL, V86, P5931, DOI 10.1128/JVI.00451-12; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; Woodward CL, 2009, J VIROL, V83, P6522, DOI 10.1128/JVI.02061-08; Yamashita M, 2006, VIROLOGY, V344, P88, DOI 10.1016/j.virol.2005.09.012; Yin ZQ, 2016, NATURE, V530, P362, DOI 10.1038/nature16950; Zhou LH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002194; ZUO P, 1993, EMBO J, V12, P4727, DOI 10.1002/j.1460-2075.1993.tb06161.x	72	10	11	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 9	2017	292	23					9699	9710		10.1074/jbc.M117.777029	http://dx.doi.org/10.1074/jbc.M117.777029			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EX3DU	28356354	Green Published, hybrid			2022-12-26	WOS:000403113000020
J	Batiuk, MY; de Vin, F; Duque, SI; Li, C; Saito, T; Saido, T; Fiers, M; Belgard, TG; Holt, MG				Batiuk, Mykhailo Y.; de Vin, Filip; Duque, Sandra I.; Li, Chen; Saito, Takashi; Saido, Takaomi; Fiers, Mark; Belgard, T. Grant; Holt, Matthew G.			An immunoaffinity-based method for isolating ultrapure adult astrocytes based on ATP1B2 targeting by the ACSA-2 antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						astrocyte; cell surface protein; membrane protein; neuroscience; plasma membrane; flow cytometry; immunoblotting; immunohistochemistry; immunoisolation; single-cell RNA-seq	ADHESION MOLECULE; GLUTAMATE TRANSPORTERS; FUNCTIONAL-CHARACTERIZATION; GLIA AMOG; IN-VIVO; CELLS; BRAIN; PROTEINS; NEURONS; TRANSCRIPTOME	Astrocytes are a major cell type in the mammalian CNS. Astrocytes are now known to play a number of essential roles in processes including synapse formation and function, as well as blood-brain barrier formation and control of cerebral blood flow. However, our understanding of the molecular mechanisms underlying astrocyte development and function is still rudimentary. This lack of knowledge is at least partly due to the lack of tools currently available for astrocyte biology. ACSA-2 is a commercially available antibody originally developed for the isolation of astrocytes from young postnatal mouse brain, using magnetic cell-sorting methods, but its utility in isolating cells from adult tissue has not yet been published. Using a modified protocol, we now show that this tool can also be used to isolate ultrapure astrocytes from the adult brain. Furthermore, using a variety of techniques (including single-cell sequencing, overexpression and knockdown assays, immunoblotting, and immunohistochemistry), we identify the ACSA-2 epitope for the first time as ATP1B2 and characterize its distribution in the CNS. Finally, we show that ATP1B2 is stably expressed in multiple models of CNS injury and disease. Hence, we show that the ACSA-2 antibody possesses the potential to be an extremely valuable tool for astrocyte research, allowing the purification and characterization of astrocytes (potentially including injury and disease models) without the need for any specialized and expensive equipment. In fact, our results suggest that ACSA-2 should be a first-choice method for astrocyte isolation and characterization.	[Batiuk, Mykhailo Y.; de Vin, Filip; Duque, Sandra I.; Li, Chen; Holt, Matthew G.] Katholieke Univ Leuven, Lab Glia Biol, VIB KU Leuven Ctr Brain & Dis Res, Herestr 49, B-3000 Leuven, Belgium; [Batiuk, Mykhailo Y.; de Vin, Filip; Duque, Sandra I.; Li, Chen; Holt, Matthew G.] Katholieke Univ Leuven, Lab Glia Biol, KU Leuven Dept Neurosci, Herestr 49, B-3000 Leuven, Belgium; [Fiers, Mark] Katholieke Univ Leuven, VIB KU Leuven Ctr Brain & Dis Res, Herestr 49, B-3000 Leuven, Belgium; [Saito, Takashi; Saido, Takaomi] RIKEN Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510106, Japan; [Belgard, T. Grant] Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genom Unit, South Parks Rd, Oxford OX1 3PT, England; [Belgard, T. Grant] Verge Genom, 42A Dore St,Ste 201, San Francisco, CA 94103 USA	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; RIKEN; University of Oxford	Holt, MG (corresponding author), VIB KU Leuven Ctr Brain & Dis Res, KU Leuven Dept Neurosci, Lab Glia Biol, Herestr 49, B-3000 Leuven, Belgium.	Matthew.Holt@kuleuven.vib.be	Holt, Matthew/AAJ-1813-2020; please delete, please delete/AAY-7192-2021; Saito, Takashi/G-2563-2015; Saido, Takaomi C/N-5472-2015; Fiers, Mark WEJ/E-6755-2010; Sado, Takaomi/AAN-2759-2021; Batiuk, Mykhailo Y./AAY-7125-2021	Holt, Matthew/0000-0002-8958-4027; Saito, Takashi/0000-0002-9659-9251; Saido, Takaomi C/0000-0003-1970-6903; Fiers, Mark WEJ/0000-0001-5694-2409; Sado, Takaomi/0000-0003-1970-6903; Batiuk, Mykhailo Y./0000-0001-6681-4048; Belgard, Tildon/0000-0002-6962-7894	European Research Council (ERC) [AstroFunc: 281961]; Inframouse (VIB-KU Leuven), through a Hercules type 3 grant [ZW09-03]	European Research Council (ERC)(European Research Council (ERC)); Inframouse (VIB-KU Leuven), through a Hercules type 3 grant	The Leica SP8 confocal microscope used in this study was provided by Inframouse (VIB-KU Leuven), through a Hercules type 3 grant (ZW09-03). We thank Dr. Enrico Radaelli for help with dissections of brains and Dr. Carlos Dotti for advice and critical reading of the manuscript. M. G. H. thanks Dr. Ben Barres for generous support, advice, and the gift of several reagents during the early phase of this work. M. G. H. and F. d. V. also acknowledge Ian Hutchinson, Bruce Anstey, and John McGuinness. Artwork for Fig. 1 was made by David Pennington (Pennington Art).	Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; ANTONICEK H, 1987, J CELL BIOL, V104, P1587, DOI 10.1083/jcb.104.6.1587; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Bouabe H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1119; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Foo LC, 2011, NEURON, V71, P799, DOI 10.1016/j.neuron.2011.07.022; GLOOR S, 1992, GENE, V120, P307, DOI 10.1016/0378-1119(92)90111-2; GLOOR S, 1990, J CELL BIOL, V110, P165, DOI 10.1083/jcb.110.1.165; Grosche A, 2016, MOL CELL PROTEOMICS, V15, P462, DOI 10.1074/mcp.M115.052183; HAAS RJ, 1970, J ANAT, V107, P421; Hampton DW, 2007, EUR J NEUROSCI, V26, P3024, DOI 10.1111/j.1460-9568.2007.05940.x; He P, 2015, GLYCOBIOLOGY, V25, P836, DOI 10.1093/glycob/cwv024; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Holt M, 2008, CURR BIOL, V18, P715, DOI 10.1016/j.cub.2008.04.069; Holt M, 2006, J BIOL CHEM, V281, P17076, DOI 10.1074/jbc.M513838200; Huang WH, 2014, GLIA, V62, P896, DOI 10.1002/glia.22648; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; Jungblut M, 2012, GLIA, V60, P894, DOI 10.1002/glia.22322; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Kantzer C. G., 2015, THESIS; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; Maltecca F, 2009, J NEUROSCI, V29, P9244, DOI 10.1523/JNEUROSCI.1532-09.2009; Maragakis NJ, 2004, NEUROBIOL DIS, V15, P461, DOI 10.1016/j.nbd.2003.12.007; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Molofsky AV, 2014, NATURE, V509, P189, DOI 10.1038/nature13161; Nolte C, 2001, GLIA, V33, P72; PAGLIUSI SR, 1990, EUR J NEUROSCI, V2, P471, DOI 10.1111/j.1460-9568.1990.tb00438.x; Pavlidis P, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-10-research0042; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Regan MR, 2007, J NEUROSCI, V27, P6607, DOI 10.1523/JNEUROSCI.0790-07.2007; Rodriguez-Arellano JJ, 2016, NEUROSCIENCE, V323, P170, DOI 10.1016/j.neuroscience.2015.01.007; Saito T, 2014, NAT NEUROSCI, V17, P661, DOI 10.1038/nn.3697; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schubert V, 2011, GLIA, V59, P1472, DOI 10.1002/glia.21190; Sharma K, 2015, NAT NEUROSCI, V18, P1819, DOI 10.1038/nn.4160; Sirko S, 2015, GLIA, V63, P2340, DOI 10.1002/glia.22898; SKOFF RP, 1991, GLIA, V4, P165, DOI 10.1002/glia.440040208; Slezak M, 2013, GLIA, V61, P623, DOI 10.1002/glia.22460; Tatsumi K, 2008, J NEUROSCI RES, V86, P3494, DOI 10.1002/jnr.21862; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Voutsinos-Porche B, 2003, CEREB CORTEX, V13, P1110, DOI 10.1093/cercor/13.10.1110; White JK, 2004, BIOCHEM J, V382, P811, DOI 10.1042/BJ20040808; Wilhelm A, 2004, NEUROSCI RES, V48, P249, DOI 10.1016/j.neures.2003.11.002; Yang YJ, 2011, GLIA, V59, P200, DOI 10.1002/glia.21089; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005; Zuo Y, 2004, J NEUROSCI, V24, P10999, DOI 10.1523/JNEUROSCI.3934-04.2004	54	44	44	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8874	8891		10.1074/jbc.M116.765313	http://dx.doi.org/10.1074/jbc.M116.765313			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28373281	Green Published, hybrid			2022-12-26	WOS:000402153900041
J	Liu, K; Tani, LJ; Wang, P; Chen, XD; Zhu, LH; Zeng, Q; Hu, Y; Deng, HW				Liu, Kun; Tani, Li-Jun; Wang, Peng; Chen, Xiang-Ding; Zhu, Li-Hua; Zeng, Qin; Hu, Yuan; Deng, Hong-Wen			Functional relevance for associations between osteoporosis and genetic variants	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BONE-MINERAL DENSITY; CIRCULATING MONOCYTES; REGULATORY VARIATION; B-CELLS; EXPRESSION; MECHANISMS; DIFFERENTIATION; OSTEOBLAST; FRACTURES	Osteoporosis is characterized by increased bone loss and deterioration of bone microarchi-tecture, which will lead to reduced bone strength and increased risk of fragility fractures. Previous studies have identified many genetic loci associated with osteoporosis, but functional mechanisms underlying the associations have rarely been explored. In order to explore the potential molecular functional mechanisms underlying the associations for osteoporosis, we performed integrative analyses by using the publically available datasets and resources. We searched 128 identified osteoporosis associated SNPs (P<10(-6)), and 8 SNPs exert cis-regulation effects on 11 eQTL target genes. Among the 8 SNPs, 2 SNPs (RPL31 rs2278729 and LRP5 rs3736228) were confirmed to impact the expression of 3 genes (RPL31, CPT1A and MTL5) that were differentially expressed between human subjects of high BMD group and low BMD group. All of the functional evidence suggested the important functional mechanisms underlying the associations of the 2 SNPs (rs2278729 and rs3736228) and 3 genes (RPL31, CPT1A and MTL5) with osteoporosis. This study may provide novel insights into the functional mechanisms underlying the osteoporosis associated genetic variants, which will help us to comprehend the potential mechanisms underlying the genetic association for osteoporosis.	[Liu, Kun; Tani, Li-Jun; Chen, Xiang-Ding; Zeng, Qin; Hu, Yuan; Deng, Hong-Wen] Hunan Normal Univ, Coll Life Sci, Lab Mol & Stat Genet, Changsha, Hunan, Peoples R China; [Wang, Peng; Zhu, Li-Hua] Guangxi Med Univ, Affiliated Hosp 1, Phys Examinat Dept, Nanning, Guangxi, Peoples R China; [Deng, Hong-Wen] Tulane Univ, Ctr Bioinformat & Genom, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA	Hunan Normal University; Guangxi Medical University; Tulane University	Tani, LJ; Deng, HW (corresponding author), Hunan Normal Univ, Coll Life Sci, Lab Mol & Stat Genet, Changsha, Hunan, Peoples R China.; Deng, HW (corresponding author), Tulane Univ, Ctr Bioinformat & Genom, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA.	ljtan@hunnu.edu.cn; hdeng2@tulane.edu	Tan, Li-Jun/AAO-1130-2020					Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Cauley JA, 2013, J GERONTOL A-BIOL, V68, P1243, DOI 10.1093/gerona/glt093; COHENSOLAL ME, 1993, J CLIN ENDOCR METAB, V77, P1648, DOI 10.1210/jc.77.6.1648; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cooper C, 2011, OSTEOPOROSIS INT, V22, P1277, DOI 10.1007/s00198-011-1601-6; Deng FY, 2013, J RHEUMATOL, V40, P1063, DOI 10.3899/jrheum.121119; Deng FY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053037; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; El Hage R, 2012, OSTEOPOROSIS INT, V23, P1593, DOI 10.1007/s00198-011-1754-3; Funakoshi Yayoi, 2011, Environmental Health and Preventive Medicine, V16, P106, DOI 10.1007/s12199-010-0172-z; Higuchi S, 1998, J BONE MINER RES, V13, P44, DOI 10.1359/jbmr.1998.13.1.44; Horowitz MC, 2005, IMMUNOL REV, V208, P141, DOI 10.1111/j.0105-2896.2005.00328.x; Hsu YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000977; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kiel DP, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S14; Kotani M, 2013, J IMMUNOL, V190, P605, DOI 10.4049/jimmunol.1201345; Kwan T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000608; Lei SF, 2009, BONE, V44, P1010, DOI 10.1016/j.bone.2008.05.016; Leung R, 2011, BLOOD, V117, P2044, DOI 10.1182/blood-2010-05-282574; Lin X, 2015, IMMUNOGENETICS, V67, P7, DOI 10.1007/s00251-014-0803-4; Liu YZ, 2005, J BIOL CHEM, V280, P29011, DOI 10.1074/jbc.M501164200; Lunetta KL, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S13; Massey HM, 1999, BRIT J HAEMATOL, V106, P167; Mo XB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121811; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger Barbara E., 2005, Human Genomics, V2, P126; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Sugihara T, 1999, GENOMICS, V57, P130, DOI 10.1006/geno.1999.5756; Sun WD, 2003, NATURE, V422, P294, DOI 10.1038/nature01482; Tripuwabhrut P, 2013, ARCH ORAL BIOL, V58, P826, DOI 10.1016/j.archoralbio.2013.01.004; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Weitzmann MN, 2000, J CELL BIOCHEM, V78, P318, DOI 10.1002/(SICI)1097-4644(20000801)78:2<318::AID-JCB13>3.0.CO;2-N; Xiao P, 2008, J BONE MINER RES, V23, P644, DOI [10.1359/jbmr.080105, 10.1359/JBMR.080105]; Yu W, 2011, EUR J HUM GENET, V19, P1095, DOI 10.1038/ejhg.2011.91; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zeng Y, 2016, J PROTEOMICS, V142, P45, DOI 10.1016/j.jprot.2016.04.044; Zhu XW, 2015, J DIABETES COMPLICAT, V29, P497, DOI 10.1016/j.jdiacomp.2015.02.007	47	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174808	10.1371/journal.pone.0174808	http://dx.doi.org/10.1371/journal.pone.0174808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369098	Green Published, gold, Green Submitted			2022-12-26	WOS:000399351000048
J	Brusamarello-Santos, LC; Gilard, F; Brule, L; Quillere, I; Gourion, B; Ratet, P; de Souza, EM; Lea, PJ; Hirel, B				Brusamarello-Santos, Liziane Cristina; Gilard, Francoise; Brule, Lenaig; Quillere, Isabelle; Gourion, Benjamin; Ratet, Pascal; de Souza, Emanuel Maltempi; Lea, Peter J.; Hirel, Bertrand			Metabolic profiling of two maize (Zea mays L.) inbred lines inoculated with the nitrogen fixing plant-interacting bacteria Herbaspirillum seropedicae and Azospirillum brasilense	PLOS ONE			English	Article							DIAZOTROPHIC BACTERIA; USE EFFICIENCY; GENETIC-VARIABILITY; GROWTH PROMOTION; GRAIN-YIELD; CROP PLANTS; NIFA GENE; FIXATION; ROOTS; EXPRESSION	Maize roots can be colonized by free-living atmospheric nitrogen (N-2)-fixing bacteria (diazotrophs). However, the agronomic potential of non-symbiotic N-2-fixation in such an economically important species as maize, has still not been fully exploited. A preliminary approach to improve our understanding of the mechanisms controlling the establishment of such N-2-fixing associations has been developed, using two maize inbred lines exhibiting different physiological characteristics. The bacterial-plant interaction has been characterized by means of a metabolomic approach. Two established model strains of Nif(+) diazotrophic bacteria, Herbaspirillum seropedicae and Azospirillum brasilense and their Nif(-) couterparts defficient in nitrogenase activity, were used to evaluate the impact of the bacterial inoculation and of N-2 fixation on the root and leaf metabolic profiles. The two N-2-fixing bacteria have been used to inoculate two genetically distant maize lines (FV252 and FV2), already characterized for their contrasting physiological properties. Using a well-controlled gnotobiotic experimental system that allows inoculation of maize plants with the two diazotrophs in a N-free medium, we demonstrated that both maize lines were efficiently colonized by the two bacterial species. We also showed that in the early stages of plant development, both bacterial strains were able to reduce acetylene, suggesting that they contain functional nitrogenase activity and are able to efficiently fix atmospheric N-2 (Fix(+)). The metabolomic approach allowed the identification of metabolites in the two maize lines that were representative of the N-2 fixing plant-bacterial interaction, these included mannitol and to a lesser extend trehalose and isocitrate. Whilst other metabolites such as asparagine, although only exhibiting a small increase in maize roots following bacterial infection, were specific for the two Fix(+) bacterial strains, in comparison to their Fix(-) counterparts. Moreover, a number of metabolites exhibited a maize-genotype specific pattern of accumulation, suggesting that the highly diverse maize genetic resources could be further exploited in terms of beneficial plant-bacterial interactions for optimizing maize growth, with reduced N fertilization inputs.	[Brusamarello-Santos, Liziane Cristina; de Souza, Emanuel Maltempi] Univ Fed Parana, Ctr Politecn, Dept Biochem & Mol Biol, Curutiba, Parana, Brazil; [Brusamarello-Santos, Liziane Cristina; Brule, Lenaig; Quillere, Isabelle; Hirel, Bertrand] INRA, Inst Jean Pierre Bourgin, Unite Mixte Rech INRA AgroparisTech 1318,CNRS, Ctr Versailles Grignon,Equipe Rech Labellisee 355, Versailles, France; [Gilard, Francoise] Univ Paris Saclay, Univ Paris Diderot,Univ Paris Sud, Univ Evry,CNRS,INRA,Inst Plant Sci Paris Saclay, Plateforme Metab Metabolome, Orsay, France; [Gourion, Benjamin; Ratet, Pascal] Univ Paris Saclay, Univ Paris Diderot, Univ Evry, Inst Plant Sci Paris Saclay,CNRS,INRS,Univ Paris, Orsay, France; [Lea, Peter J.] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England	Universidade Federal do Parana; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Lancaster University	Hirel, B (corresponding author), INRA, Inst Jean Pierre Bourgin, Unite Mixte Rech INRA AgroparisTech 1318,CNRS, Ctr Versailles Grignon,Equipe Rech Labellisee 355, Versailles, France.	hirel@versailles.inra.fr	Hirel, Bertrand/AAG-5662-2020; Gourion, Benjamin/AAG-9063-2019; Gilard, Francoise/C-8022-2016; Ratet, Pascal/GPP-3654-2022	Hirel, Bertrand/0000-0002-5518-3671; Gourion, Benjamin/0000-0001-5768-6961; Gilard, Francoise/0000-0001-9314-1555; Ratet, Pascal/0000-0002-8621-1495	National Institute of Science and Technology-Biological Nitrogen Fixation (INCT-FBN) through the Brazilian Research Council (CNPq/MCT) Glenda Sem Fronteiras Program, Brazil; Empresa Brasileira de Pesquisa Agropecuaria (BR); Institut National de la Recherche Agronomique; Centre National de la Recherche Scientifique; National Institute of Science and Technology-Biological Nitrogen Fixation (INCT-FBN) through the Brazilian Research Council (CNPq/MCT); Ciencia Sem Fronteiras Program, Brazil	National Institute of Science and Technology-Biological Nitrogen Fixation (INCT-FBN) through the Brazilian Research Council (CNPq/MCT) Glenda Sem Fronteiras Program, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Empresa Brasileira de Pesquisa Agropecuaria (BR); Institut National de la Recherche Agronomique; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); National Institute of Science and Technology-Biological Nitrogen Fixation (INCT-FBN) through the Brazilian Research Council (CNPq/MCT)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ciencia Sem Fronteiras Program, Brazil	This study was supported by the National Institute of Science and Technology-Biological Nitrogen Fixation (INCT-FBN) through the Brazilian Research Council (CNPq/MCT) Glenda Sem Fronteiras Program, Brazil; Empresa Brasileira de Pesquisa Agropecuaria (BR); Institut National de la Recherche Agronomique; and Centre National de la Recherche Scientifique.r We are particularly grateful to Prof. Gary Stacey for fruitful discussions and advice to set up the experiments. Liziane Cristina Brusamarello-Santos was supported by a grant from the National Institute of Science and Technology-Biological Nitrogen Fixation (INCT-FBN) through the Brazilian Research Council (CNPq/MCT) and the Ciencia Sem Fronteiras Program, Brazil.	Aguiar NO, 2016, ANN APPL BIOL, V168, P203, DOI 10.1111/aab.12256; Ahemad Munees, 2014, Journal of King Saud University Science, V26, P1, DOI 10.1016/j.jksus.2013.05.001; Alberton D, 2013, J PROTEOME RES, V12, P4757, DOI 10.1021/pr400425f; Alves GC, 2015, PLANT SOIL, V387, P307, DOI 10.1007/s11104-014-2295-2; Amiour N, 2012, J EXP BOT, V63, P5017, DOI 10.1093/jxb/ers186; Bacon CW, 2006, PLANT-ASSOCIATED BACTERIA, P155; Baldani JI, 2002, FUNCT PLANT BIOL, V29, P417, DOI 10.1071/PP01083; Berrabah F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091866; Bhattacharjee RB, 2008, APPL MICROBIOL BIOT, V80, P199, DOI 10.1007/s00253-008-1567-2; Brader G, 2014, CURR OPIN BIOTECH, V27, P30, DOI 10.1016/j.copbio.2013.09.012; Camus-Kulandaivelu L, 2006, GENETICS, V172, P2449, DOI 10.1534/genetics.105.048603; Carvalhais LC, 2011, J PLANT NUTR SOIL SC, V174, P3, DOI 10.1002/jpln.201000085; Carvalho TLG, 2016, PLANT MOL BIOL, V90, P561, DOI 10.1007/s11103-016-0435-1; Carvalho TLG, 2014, J EXP BOT, V65, P5631, DOI 10.1093/jxb/eru319; Cocking EC, 2003, PLANT SOIL, V252, P169, DOI 10.1023/A:1024106605806; COMPANT S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI DOI 10.1016/J.S0ILBI0.2009.11.024; de Souza R, 2015, GENET MOL BIOL, V38, P401, DOI 10.1590/S1415-475738420150053; deSalamone IEG, 1996, BIOL FERT SOILS, V23, P249, DOI 10.1007/s003740050168; Ding ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140629; do Amaral FP, 2014, SYMBIOSIS, V62, P41, DOI 10.1007/s13199-014-0270-6; Edmonds DE, 2013, J PLANT NUTR, V36, P1013, DOI 10.1080/01904167.2011.585198; Faleiro AC, 2013, SYMBIOSIS, V61, P125, DOI 10.1007/s13199-013-0262-y; Ferrari CS, 2014, APPL BIOCHEM BIOTECH, V174, P2267, DOI 10.1007/s12010-014-1197-3; Fiehn Oliver, 2006, V323, P439; Gallais A, 2004, J EXP BOT, V55, P295, DOI 10.1093/jxb/erh006; GarciadeSalomone I, 1996, BIOL FERT SOILS, V21, P193, DOI 10.1007/BF00335934; Good AG, 2004, TRENDS PLANT SCI, V9, P597, DOI 10.1016/j.tplants.2004.10.008; Gupta G., 2012, SUSTAINABLE AGR REV, P183, DOI DOI 10.1007/978-94-007-5449-2_8; Hirel B, 2005, PHYSIOL PLANTARUM, V124, P167, DOI 10.1111/j.1399-3054.2005.00510.x; Hirel B, 2001, PLANT NITROGEN, P79; Hirel B, 2011, ADV MAIZE 3 ESSENTIA, P285; Hirel B, 2007, J EXP BOT, V58, P2369, DOI 10.1093/jxb/erm097; Hirel B, 2011, SUSTAINABILITY-BASEL, V3, P1452, DOI 10.3390/su3091452; Hoagland D. R., 1950, CIRCULAR; Hubbard M, 2014, J APPL MICROBIOL, V116, P109, DOI 10.1111/jam.12311; Hungria M, 2010, PLANT SOIL, V331, P413, DOI 10.1007/s11104-009-0262-0; Ikeda AC, 2013, MICROB ECOL, V65, P154, DOI 10.1007/s00248-012-0104-0; Johnston-Monje D, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0233-3; Johnston-Monje D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020396; Klassen G, 1997, CAN J MICROBIOL, V43, P887, DOI 10.1139/m97-129; Kuan KB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152478; Leveau V, 2011, ADV MAIZE, P509; Liu YY, 2011, AGRON SUSTAIN DEV, V31, P155, DOI 10.1051/agro/2010008; Lunn JE, 2014, PLANT J, V79, P544, DOI 10.1111/tpj.12509; MACHADO HB, 1991, CAN J MICROBIOL, V37, P549, DOI 10.1139/m91-092; Martin A, 2006, PLANT CELL, V18, P3252, DOI 10.1105/tpc.106.042689; McAllister CH, 2012, PLANT BIOTECHNOL J, V10, P1011, DOI 10.1111/j.1467-7652.2012.00700.x; Mehnaz S, 2010, SOIL BIOL BIOCHEM, V42, P1848, DOI 10.1016/j.soilbio.2010.07.003; Mercier J, 2000, APPL ENVIRON MICROB, V66, P369, DOI 10.1128/AEM.66.1.369-374.2000; Montanez A, 2009, BIOL FERTIL SOILS; Montanez A, 2013, BASIC RES J AGR SCI, V2, P102; Montanez A, 2012, APPL SOIL ECOL, V58, P21, DOI 10.1016/j.apsoil.2012.02.009; Monteiro RA, 2012, PLANT SOIL, V356, P175, DOI 10.1007/s11104-012-1125-7; Nogueira ED, 2001, GENET MOL BIOL, V24, P199, DOI 10.1590/S1415-47572001000100027; Pankievicz VCS, 2015, PLANT J, V81, P907, DOI 10.1111/tpj.12777; Patel TK, 2016, TRENDS PLANT SCI, V21, P486, DOI 10.1016/j.tplants.2016.01.006; PEDROSA FO, 1984, FEMS MICROBIOL LETT, V23, P95, DOI 10.1016/0378-1097(84)90080-6; Pereg L, 2016, PLANT SOIL, V399, P389, DOI 10.1007/s11104-015-2778-9; Perez-Montano F, 2014, MICROBIOL RES, V169, P325, DOI 10.1016/j.micres.2013.09.011; Raun WR, 1999, AGRON J, V91, P357, DOI 10.2134/agronj1999.00021962009100030001x; Reis VM, 2000, CRIT REV PLANT SCI, V19, P227, DOI 10.1016/S0735-2689(00)80003-9; Rocha FR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-71; Rodriguez-Blanco A, 2015, BIOL FERT SOILS, V51, P391, DOI 10.1007/s00374-014-0986-8; Roesch LFW, 2008, PLANT SOIL, V302, P91, DOI 10.1007/s11104-007-9458-3; Roesch LFW, 2007, REV BRAS CIENC SOLO, V31, P1367, DOI 10.1590/S0100-06832007000600015; Roncato-Maccari LDB, 2003, FEMS MICROBIOL ECOL, V45, P39, DOI 10.1016/S0168-6496(03)00108-9; Santi C, 2013, ANN BOT-LONDON, V111, P743, DOI 10.1093/aob/mct048; Simons M, 2014, PLANT PHYSIOL, V166, P1659, DOI 10.1104/pp.114.245787; Souza EM, 2000, MICROBIOL-UK, V146, P1407, DOI 10.1099/00221287-146-6-1407; Tcherkez G, 2009, PLANT PHYSIOL, V151, P620, DOI 10.1104/pp.109.142976; Thiebaut F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-766; Tkacz A, 2015, J EXP BOT, V66, P2167, DOI 10.1093/jxb/erv157; Ul Haq I, 2014, ADV APPL MICROBIOL, V89, P185, DOI 10.1016/B978-0-12-800259-9.00005-6; Vacheron J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00356; Weckwerth W, 2004, PROTEOMICS, V4, P78, DOI 10.1002/pmic.200200500; WEINER H, 1991, PLANT PHYSIOL BIOCH, V29, P19; Wu SC, 2005, GEODERMA, V125, P155, DOI 10.1016/j.geoderma.2004.07.003; Yesbergenova-Cuny Z, 2016, PLANT SCI, V252, P347, DOI 10.1016/j.plantsci.2016.08.007	78	39	41	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174576	10.1371/journal.pone.0174576	http://dx.doi.org/10.1371/journal.pone.0174576			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362815	Green Published, gold, Green Submitted			2022-12-26	WOS:000399175000020
J	Ong, TH; Chitra, E; Ramamurthy, S; Siddalingam, RP; Yuen, KH; Ambu, SP; Davamani, F				Ong, Teik Hwa; Chitra, Ebenezer; Ramamurthy, Srinivasan; Siddalingam, Rajinikanth Paruvathanahalli; Yuen, Kah Hay; Ambu, Stephen Periathamby; Davamani, Fabian			Chitosan-propolis nanoparticle formulation demonstrates anti-bacterial activity against Enterococcus faecalis biofilms	PLOS ONE			English	Article							TARGETED DRUG-DELIVERY; CHEMICAL-COMPOSITION; GENE-EXPRESSION; VIRULENCE; RELEASE; MICROSPHERES; EVOLUTION; CARRIER; MATRIX	Propolis obtained from bee hives is a natural substance with antimicrobial properties. It is limited by its insolubility in aqueous solutions; hence ethanol and ethyl acetate extracts of Malaysian propolis were prepared. Both the extracts displayed antimicrobial and anti-biofilm properties against Enterococcus faecalis, a common bacterium associated with hospital-acquired infections. High performance liquid chromatography (HPLC) analysis of propolis revealed the presence of flavonoids like kaempferol and pinocembrin. This study investigated the role of propolis developed into nanoparticles with chitosan for its antimicrobial and anti-biofilm properties against E. faecalis. Bacteria that grow in a slimy layer of biofilm are resistant to penetration by antibacterial agents. The use of nanoparticles in medicine has received attention recently due to better bioavailability, enhanced penetrative capacity and improved efficacy. A chitosan-propolis nanoformulation was chosen based on ideal physicochemical properties such as particle size, zeta potential, polydispersity index, encapsulation efficiency and the rate of release of the active ingredients. This formulation inhibited E. faecalis biofilm formation and reduced the number of bacteria in the biofilm by similar to 90% at 200 mu g/ml concentration. When tested on pre-formed biofilms, the formulation reduced bacterial number in the biofilm by similar to 40% and similar to 75% at 200 and 300 mu g/ml, respectively. The formulation not only reduced bacterial numbers, but also physically disrupted the biofilm structure as observed by scanning electron microscopy. Treatment of biofilms with chitosan-propolis nanoparticles altered the expression of biofilm-associated genes in E. faecalis. The results of this study revealed that chitosan-propolis nanoformulation can be deemed as a potential anti-biofilm agent in resisting infections involving biofilm formation like chronic wounds and surgical site infections.	[Ong, Teik Hwa] Int Med Univ, Sch Postgrad Studies, Kuala Lumpur, Malaysia; [Chitra, Ebenezer; Ramamurthy, Srinivasan; Siddalingam, Rajinikanth Paruvathanahalli; Ambu, Stephen Periathamby; Davamani, Fabian] Int Med Univ, Sch Hlth Sci, Div Appl Biomed Sci & Biotechnol, Kuala Lumpur, Malaysia; [Yuen, Kah Hay] Univ Sains Malaysia, Sch Pharmaceut Sci, Gelugor, Penang, Malaysia; [Siddalingam, Rajinikanth Paruvathanahalli] Taylors Univ, Sch Pharm, Selangor, Malaysia	International Medical University Malaysia; International Medical University Malaysia; Universiti Sains Malaysia; Taylor's University	Davamani, F (corresponding author), Int Med Univ, Sch Hlth Sci, Div Appl Biomed Sci & Biotechnol, Kuala Lumpur, Malaysia.	fabian_davamani@imu.edu.my	Chitra, Ebenezer/F-5984-2019; Ambu, Stephen/A-7204-2013; Davamani, Fabian/F-5794-2019	Chitra, Ebenezer/0000-0002-5818-6587; Ambu, Stephen/0000-0001-7840-6113; Davamani, Fabian/0000-0001-7297-5948	Exploratory Research Grants Scheme of Ministry of Higher Education, Malaysia [ERGS/1/2013/SKK11/IMU/03/01]	Exploratory Research Grants Scheme of Ministry of Higher Education, Malaysia	Exploratory Research Grants Scheme ERGS/1/2013/SKK11/IMU/03/01 of Ministry of Higher Education, Malaysia to Dr. Fabian Davamani and approved by the joint committee on research and ethics of the International Medical University.; Project was funded by Exploratory Research Grants Scheme ERGS/1/2013/SKK11/IMU/03/01 of Ministry of Higher Education, Malaysia to Dr. Fabian Davamani and approved by the joint committee on research and ethics of the International Medical University.	Adhikari MD, 2013, ADV HEALTHC MATER, V2, P599, DOI 10.1002/adhm.201200278; Anderson AC, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01534; Arias CA, 2010, CLIN MICROBIOL INFEC, V16, P555, DOI 10.1111/j.1469-0691.2010.03214.x; Baelo A, 2015, J CONTROL RELEASE, V209, P150, DOI 10.1016/j.jconrel.2015.04.028; Bagalkot V, 2006, ANGEW CHEM INT EDIT, V45, P8149, DOI 10.1002/anie.200602251; Bagge N, 2004, ANTIMICROB AGENTS CH, V48, P1175, DOI 10.1128/AAC.48.4.1175-1187.2004; Baldry M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168305; Bhattarai N, 2006, INT J NANOMED, V1, P181, DOI 10.2147/nano.2006.1.2.181; Chaillou LL, 2009, J SCI FOOD AGR, V89, P978, DOI 10.1002/jsfa.3542; Cheung RCF, 2015, MAR DRUGS, V13, P5156, DOI 10.3390/md13085156; Cho Youngnam, 2010, J Biol Eng, V4, P2, DOI 10.1186/1754-1611-4-2; Cunha IBS, 2004, J BRAZIL CHEM SOC, V15, P964, DOI 10.1590/S0103-50532004000600026; Daugsch A, 2008, EVID-BASED COMPL ALT, V5, P435, DOI 10.1093/ecam/nem057; De Campos AM, 2001, INT J PHARM, V224, P159, DOI 10.1016/S0378-5173(01)00760-8; Dev A, 2010, CARBOHYD POLYM, V80, P833, DOI 10.1016/j.carbpol.2009.12.040; Drewes SE, 2008, PHYTOCHEMISTRY, V69, P1745, DOI 10.1016/j.phytochem.2008.02.022; Elchinger PH, 2015, INT J BIOL MACROMOL, V72, P1063, DOI 10.1016/j.ijbiomac.2014.09.061; Gan Q, 2007, COLLOID SURFACE B, V59, P24, DOI 10.1016/j.colsurfb.2007.04.009; Garnett JA, 2012, CURR PROTEIN PEPT SC, V13, P739; HOUGHTON PJ, 1995, PHYTOCHEM ANALYSIS, V6, P207, DOI 10.1002/pca.2800060406; Howlin RP, 2015, ANTIMICROB AGENTS CH, V59, P111, DOI 10.1128/AAC.03676-14; Hua S, 2015, NANOMED-NANOTECHNOL, V11, P1117, DOI 10.1016/j.nano.2015.02.018; Huang SA, 2014, MOLECULES, V19, P19610, DOI 10.3390/molecules191219610; Huycke MM, 1998, EMERG INFECT DIS, V4, P239, DOI 10.3201/eid0402.980211; Jayakumar R, 2007, INT J BIOL MACROMOL, V40, P175, DOI 10.1016/j.ijbiomac.2006.06.021; Jayakumar R, 2010, CARBOHYD POLYM, V79, P1, DOI 10.1016/j.carbpol.2009.08.026; Kandi V, 2015, EPIDEMIOL HEALTH, V37, DOI 10.4178/epih/e2015020; Khantamat O, 2015, ACS APPL MATER INTER, V7, P3981, DOI 10.1021/am506516r; Kirpotin DB, 2006, CANCER RES, V66, P6732, DOI 10.1158/0008-5472.CAN-05-4199; Koo H, 2000, ARCH ORAL BIOL, V45, P141, DOI 10.1016/S0003-9969(99)00117-X; Koukaras EN, 2012, MOL PHARMACEUT, V9, P2856, DOI 10.1021/mp300162j; Krauland AH, 2007, INT J PHARMACEUT, V340, P134, DOI 10.1016/j.ijpharm.2007.03.005; Kujumgiev A, 1999, J ETHNOPHARMACOL, V64, P235, DOI 10.1016/S0378-8741(98)00131-7; Kuo YL, 2016, NANOMEDICINE-UK, V11, P2497, DOI 10.2217/nnm-2016-0232; Lins RX, 2013, J DENT, V41, P779, DOI 10.1016/j.jdent.2013.07.004; Liu KF, 2016, SCI REP-UK, V6, DOI 10.1038/srep29461; MAKINEN PL, 1989, J BIOL CHEM, V264, P3325; MARCUCCI MC, 1995, APIDOLOGIE, V26, P83, DOI 10.1051/apido:19950202; Mati-Baouche N, 2014, EUR POLYM J, V60, P198, DOI 10.1016/j.eurpolymj.2014.09.008; Mirzoeva OK, 1997, MICROBIOL RES, V152, P239, DOI 10.1016/S0944-5013(97)80034-1; Mitra A, 2011, INDIAN J PHARM SCI, V73, P355, DOI 10.4103/0250-474X.95607; Muller RH, 2000, EUR J PHARM BIOPHARM, V50, P161, DOI 10.1016/S0939-6411(00)00087-4; NIGALAYE AG, 1990, DRUG DEV IND PHARM, V16, P449, DOI 10.3109/03639049009114897; Nina N, 2015, MOLECULES, V20, P18144, DOI 10.3390/molecules201018144; Padilla C, 2012, REV CHIL INFECTOL, V29, P55, DOI 10.4067/S0716-10182012000100010; Pangburn TO, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3160763; Park YK, 2002, J AGR FOOD CHEM, V50, P2502, DOI 10.1021/jf011432b; Peniche H, 2011, POLYM INT, V60, P883, DOI 10.1002/pi.3056; Pillar CM, 2004, FRONT BIOSCI-LANDMRK, V9, P2335, DOI 10.2741/1400; Rampino A, 2013, INT J PHARMACEUT, V455, P219, DOI 10.1016/j.ijpharm.2013.07.034; Rasul A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/379850; Ravikumar P, 2016, NANOMED-NANOTECHNOL, V12, P811, DOI 10.1016/j.nano.2015.10.004; Saber SEM, 2012, EUR J DENT, V6, P43; Sabnis S, 1997, Pharm Dev Technol, V2, P243, DOI 10.3109/10837459709031444; Samiei M, 2015, MINERVA STOMATOL, V64, P275; Sarmah JK, 2011, INT J BIOL MACROMOL, V49, P390, DOI 10.1016/j.ijbiomac.2011.05.020; Savka MA, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/472593; Sedgley CM, 2005, INT ENDOD J, V38, P735, DOI 10.1111/j.1365-2591.2005.01009.x; Singh KV, 1998, FEMS IMMUNOL MED MIC, V21, P323, DOI 10.1016/S0928-8244(98)00087-X; Sinha VR, 2004, INT J PHARMACEUT, V274, P1, DOI 10.1016/j.ijpharm.2003.12.026; Soromou LW, 2013, J APPL MICROBIOL, V115, P41, DOI 10.1111/jam.12221; Barreras US, 2016, MAT SCI ENG C-MATER, V58, P1182, DOI 10.1016/j.msec.2015.09.085; Machado BAS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134489; UPADRASHTA SM, 1992, DRUG DEV IND PHARM, V18, P1701, DOI 10.3109/03639049209040896; Uzel A, 2005, MICROBIOL RES, V160, P189, DOI 10.1016/j.micres.2005.01.002; Van Tyne D, 2014, ANNU REV MICROBIOL, V68, P337, DOI 10.1146/annurev-micro-091213-113003; Wang EC, 2014, INTEGR BIOL-UK, V6, P9, DOI 10.1039/c3ib40165k; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Yuan Q, 2010, ACTA BIOMATER, V6, P1140, DOI 10.1016/j.actbio.2009.08.027	69	53	55	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174888	10.1371/journal.pone.0174888	http://dx.doi.org/10.1371/journal.pone.0174888			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362873	gold, Green Published, Green Submitted			2022-12-26	WOS:000399175000046
J	Pellon, A; Ramirez-Garcia, A; Buldain, I; Antoran, A; Rementeria, A; Hernando, FL				Pellon, Aize; Ramirez-Garcia, Andoni; Buldain, Idoia; Antoran, Aitziber; Rementeria, Aitor; Hernando, Fernando L.			Molecular and cellular responses of the pathogenic fungus Lomentospora prolificans to the antifungal drug voriconazole	PLOS ONE			English	Article							CANDIDA-ALBICANS; SCEDOSPORIUM-PROLIFICANS; CYSTIC-FIBROSIS; WALL; RESISTANCE; IDENTIFICATION; PROTEOME; TERBINAFINE; VIRULENCE; MUTANTS	The filamentous fungus Lomentospora (Scedosporium) prolificans is an emerging opportunistic pathogen associated with fatal infections in patients with disturbed immune function. Unfortunately, conventional therapies are hardly of any use against this fungus due to its intrinsic resistance. Therefore, we performed an integrated study of the L. prolificans responses to the first option to treat these mycoses, namely voriconazole, with the aim of unveiling mechanisms involved in the resistance to this compound. To do that, we used a wide range of techniques, including fluorescence and electron microscopy to study morphological alterations, ion chromatography to measure changes in cell-wall carbohydrate composition, and proteomics-based techniques to identify the proteins differentially expressed under the presence of the drug. Significantly, we showed drastic changes occurring in cell shape after voriconazole exposure, L. prolificans hyphae being shorter and wider than under control conditions. Interestingly, we proved that the architecture and carbohydrate composition of the cell wall had been modified in the presence of the drug. Specifically, L. prolificans constructed a more complex organelle with a higher presence of glucans and mannans. In addition to this, we identified several differentially expressed proteins, including Srp1 and heat shock protein 70 (Hsp70), as the most overexpressed under voriconazole-induced stress conditions. The mechanisms described in this study, which may be directly related to L. prolificans antifungal resistance or tolerance, could be used as targets to improve existing therapies or to develop new ones in order to successfully eliminate these mycoses.	[Pellon, Aize; Ramirez-Garcia, Andoni; Buldain, Idoia; Antoran, Aitziber; Rementeria, Aitor; Hernando, Fernando L.] Univ Basque Country UPV EHU, Fac Sci & Technol, Dept Immunol Microbiol & Parasitol, Fungal & Bacterial Biom Res Grp, Leioa, Spain	University of Basque Country	Ramirez-Garcia, A (corresponding author), Univ Basque Country UPV EHU, Fac Sci & Technol, Dept Immunol Microbiol & Parasitol, Fungal & Bacterial Biom Res Grp, Leioa, Spain.	andoni.ramirez@ehu.eus	Pellon, Aize/K-6083-2019; Pellon, Aize/I-2870-2015; Ramirez-Garcia, Andoni/I-1697-2015; Hernando, Fernando/I-2763-2015; Rementeria, Aitor/B-3936-2008; Antoran, Aitziber/AAA-4435-2019; Buldain, Idoia/ABB-8822-2021	Pellon, Aize/0000-0003-0415-6566; Pellon, Aize/0000-0003-0415-6566; Ramirez-Garcia, Andoni/0000-0003-2696-162X; Hernando, Fernando/0000-0002-7151-9083; Rementeria, Aitor/0000-0003-0478-1038; Antoran, Aitziber/0000-0003-2594-8220; 	UPV/EHU [GIU15/36, UFI11/25]; Basque Government	UPV/EHU; Basque Government(Basque Government)	This work has been supported by grants (GIU15/36 and UFI11/25) from the UPV/EHU. AP was supported by a predoctoral fellowship from the UPV/EHU, and IB and AA were supported by predoctoral fellowships from the Basque Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alastruey-Izquierdo A, 2013, ANTIMICROB AGENTS CH, V57, P3380, DOI 10.1128/AAC.00383-13; Blatzer M, 2015, ANTIMICROB AGENTS CH, V59, P3778, DOI 10.1128/AAC.05164-14; Blyth CC, 2010, J CLIN MICROBIOL, V48, P314, DOI 10.1128/JCM.01470-09; Blyth CC, 2010, MED MYCOL, V48, pS37, DOI 10.3109/13693786.2010.500627; Buldain I, 2016, PROTEOM CLIN APPL, V10, P1058, DOI 10.1002/prca.201600080; Cagas SE, 2011, ANTIMICROB AGENTS CH, V55, P146, DOI 10.1128/AAC.00884-10; Chiou CC, 2001, ANTIMICROB AGENTS CH, V45, P3310, DOI 10.1128/AAC.45.12.3310-3321.2001; Chong HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042835; Cortez KJ, 2008, CLIN MICROBIOL REV, V21, P157, DOI 10.1128/CMR.00039-07; Costa-de-Oliveira S, 2013, CYTOM PART A, V83A, P324, DOI 10.1002/cyto.a.22250; Cowen LE, 2008, NAT REV MICROBIOL, V6, P187, DOI 10.1038/nrmicro1835; Dallies N, 1998, YEAST, V14, P1297, DOI 10.1002/(SICI)1097-0061(1998100)14:14<1297::AID-YEA310>3.0.CO;2-L; de Groot PWJ, 2008, EUKARYOT CELL, V7, P1951, DOI 10.1128/EC.00284-08; Ene IV, 2012, CELL MICROBIOL, V14, P1319, DOI 10.1111/j.1462-5822.2012.01813.x; Hoehamer CF, 2010, ANTIMICROB AGENTS CH, V54, P1655, DOI 10.1128/AAC.00756-09; Juvvadi PR, 2014, MYCOPATHOLOGIA, V178, P341, DOI 10.1007/s11046-014-9794-9; Kniemeyer O, 2011, PROTEOMICS, V11, P3232, DOI 10.1002/pmic.201100087; KOWALSKI LRZ, 1995, MOL MICROBIOL, V15, P341, DOI 10.1111/j.1365-2958.1995.tb02248.x; Lackner M, 2014, FUNGAL DIVERS, V67, P1, DOI 10.1007/s13225-014-0295-4; Lackner M, 2012, ANTIMICROB AGENTS CH, V56, P2635, DOI 10.1128/AAC.05910-11; Lamoth F, 2015, ANTIMICROB AGENTS CH, V59, P4727, DOI 10.1128/AAC.00946-15; Lee KK, 2012, ANTIMICROB AGENTS CH, V56, P208, DOI 10.1128/AAC.00683-11; Lopes LCL, 2011, MYCOSES, V54, P28, DOI 10.1111/j.1439-0507.2011.02105.x; Rodriguez-Tudela JL, 2009, MED MYCOL, V47, P359, DOI 10.1080/13693780802524506; Matthiesen R, 2005, J PROTEOME RES, V4, P2338, DOI 10.1021/pr050264q; Meletiadis J, 2003, ANTIMICROB AGENTS CH, V47, P106, DOI 10.1128/AAC.47.1.106-117.2003; Pellon A, 2016, J PROTEOME RES, V15, P595, DOI 10.1021/acs.jproteome.5b00978; Pellon A, 2014, FUNGAL BIOL-UK, V118, P94, DOI 10.1016/j.funbio.2013.11.006; Pitarch A, 2002, MOL CELL PROTEOMICS, V1, P967, DOI 10.1074/mcp.M200062-MCP200; Ram AFJ, 2006, NAT PROTOC, V1, P2253, DOI 10.1038/nprot.2006.397; Slavin M, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.12.021; Sorgo AG, 2011, EUKARYOT CELL, V10, P1071, DOI 10.1128/EC.05011-11; Thornton CR, 2015, ENVIRON MICROBIOL, V17, P1023, DOI 10.1111/1462-2920.12470; Tortorano AM, 2014, CLIN MICROBIOL INFEC, V20, P27, DOI 10.1111/1469-0691.12465; Troke P, 2008, ANTIMICROB AGENTS CH, V52, P1743, DOI 10.1128/AAC.01388-07; Walker LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000040; Wirk Baldeep, 2011, Recent Pat Antiinfect Drug Discov, V6, P38, DOI 10.2174/157489111794407840; YANO R, 1992, MOL CELL BIOL, V12, P5640, DOI 10.1128/MCB.12.12.5640; Zhang WL, 2009, APPL MICROBIOL BIOT, V82, P1123, DOI 10.1007/s00253-009-1908-9	39	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174885	10.1371/journal.pone.0174885	http://dx.doi.org/10.1371/journal.pone.0174885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362854	Green Published, gold, Green Submitted			2022-12-26	WOS:000399175000045
J	Polsek, D; Bago, M; Zivaljic, M; Rosenzweig, I; Lacza, Z; Gajovic, S				Polsek, Dora; Bago, Marcel; Zivaljic, Marija; Rosenzweig, Ivana; Lacza, Zsombor; Gajovic, Srecko			A novel adjustable automated system for inducing chronic intermittent hypoxia in mice	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; EPISODIC HYPOXIA; BRAIN; PERFORMANCE; REACTIVITY; RESISTANCE; IMPACT; MODEL; RAT; CA1	Background Sleep apnea is a chronic, widely underdiagnosed condition characterized by disruption of sleep architecture and intermittent hypoxia due to short cessations of breathing. It is a major independent risk factor for myocardial infarction, congestive heart failure and stroke as well as one of the rare modifiable risk factors for Alzheimer's Dementia. Reliable animal disease models are needed to understand the link between sleep apnea and the various clinically linked disorders. New method An automated system for inducing hypoxia was developed, in which the major improvement was the possibility to efficiently adjust the length and intensity of hypoxia in two different periods. The chamber used a small volume of gas allowing for fast exchanges of different oxygen levels. The mice were kept in their cages adapted with the system on the cage lid. As a proof of principle, they were exposed to a three week period of intermittent hypoxia for 8 hours a day, with 90 s intervals of 5, 7% and 21% oxygen to validate the model. Treated (n = 8) and control mice (no hypoxia, n = 7) were handled in the same manner and their hippocampal brain regions compared by histology. Results The chamber provided a fast, reliable and precise intermittent hypoxia, without inducing noticeable side effects to the animals. The validation experiment showed that apoptotic neurons in the hippocampus were more numerous in the mice exposed to intermittent hypoxia than in the control group, in all tested hippocampal regions (cornu ammonis 1 (CA1) P <0.001; cornu ammonis 3 (CA3) P <0.001; and dentate gyrus (DG) P = 0.023). In both, control and hypoxic conditions, there was a significantly higher number of apoptotic neurons in the DG compared to the CA1 and CA3 subfields (P <0.001). Conclusion The new design of a hypoxic chamber provides a fast, adjustable and reliable model of obstructive sleep apnea, which was validated by apoptosis of hippocampal neurons.	[Polsek, Dora; Gajovic, Srecko] Univ Zagreb, Sch Med, Croatian Inst Brain Res, Zagreb, Croatia; [Bago, Marcel; Lacza, Zsombor] Semmelweis Univ, Inst Expt Clin Res, Budapest, Hungary; [Bago, Marcel] Univ Phys Educ, Budapest, Hungary; [Rosenzweig, Ivana] Kings Coll London, Dept Neuroimaging, Sleep & Brain Plast Ctr, London, England; [Rosenzweig, Ivana] Guys & St Thomass Hosp NHS Trust, Sleep Disorders Ctr, London, England	University of Zagreb; Semmelweis University; University of Physical Education; University of London; King's College London	Gajovic, S (corresponding author), Univ Zagreb, Sch Med, Croatian Inst Brain Res, Zagreb, Croatia.	srecko.gajovic@hiim.hr	Gajovic, Srecko/Z-1720-2018	Gajovic, Srecko/0000-0001-8668-5239	FP7 project GlowBrain - European Commission [FP7-REGPOT-2012-CT2012-316120]; European Social Fund [20152016, HR.3.2.01]	FP7 project GlowBrain - European Commission; European Social Fund(European Social Fund (ESF))	This work was funded by the FP7 project GlowBrain funded by the European Commission (FP7-REGPOT-2012-CT2012-316120, https://ec.europa.eu/research/fp7/index_en.ctm) awarded to SG, as well as Young Brain (HR.3.2.01; 20152016) funded by European Social Fund, http://ec.europa.eu/esf/home.jsp and provided support to DP and SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the FP7 project GlowBrain funded by the European Commission (FP7-REGPOT-2012-CT2012-316120) as well as Young Brain (HR.3.2.01; 2015-2016) funded by European Social Fund. The authors would like to thank dr. Camilla Simmons and dr. Diana Cash of the Neuroimaging department, IoPPN, KCL for their valuable advice in developing the quantification method used in the biological part of the study. The authors would also like to thank Karoly Peter Balazs, Marton Nemeth and Gyula Nemeth for the technical support in developing the intermittent hypoxia system.	Bradley TD, 2009, LANCET, V373, P82, DOI 10.1016/S0140-6736(08)61622-0; Emamian F, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00078; FLETCHER EC, 1992, HYPERTENSION, V19, P555, DOI 10.1161/01.HYP.19.6.555; Franklin KA, 2015, J THORAC DIS, V7, P1311, DOI 10.3978/j.issn.2072-1439.2015.06.11; Gildeh N, 2016, J THORAC DIS, V8, pE901, DOI 10.21037/jtd.2016.09.23; Goldbart A, 2003, NEUROSCIENCE, V122, P585, DOI 10.1016/j.neuroscience.2003.08.054; Gozal D, 2003, EUR J NEUROSCI, V18, P2335, DOI 10.1046/j.1460-9568.2003.02947.x; Gozal D, 2001, J NEUROSCI, V21, P2442, DOI 10.1523/JNEUROSCI.21-07-02442.2001; Gozal E, 2001, NEUROSCI LETT, V305, P197, DOI 10.1016/S0304-3940(01)01853-5; Greenberg HE, 1999, J APPL PHYSIOL, V86, P298, DOI 10.1152/jappl.1999.86.1.298; Jackman KA, 2014, STROKE, V45, P1460, DOI 10.1161/STROKEAHA.114.004816; Kent BD, 2015, J THORAC DIS, V7, P1343, DOI 10.3978/j.issn.2072-1439.2015.08.11; Kent BD, 2011, RESP PHYSIOL NEUROBI, V178, P475, DOI 10.1016/j.resp.2011.03.015; Klein JB, 2003, RESP PHYSIOL NEUROBI, V136, P91, DOI 10.1016/S1569-9048(03)00074-0; Lefebvre B, 2006, RESP PHYSIOL NEUROBI, V150, P278, DOI 10.1016/j.resp.2005.05.020; Levy P, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.15; Li CG, 2012, SLEEP BREATH, V16, P177, DOI 10.1007/s11325-010-0470-0; Lim J, 2010, PSYCHOL BULL, V136, P375, DOI 10.1037/a0018883; Pan YY, 2016, CHINESE MED J-PEKING, V129, P838, DOI 10.4103/0366-6999.178969; Pedroso D, 2016, BRAIN RES; Phillips SA, 2006, J APPL PHYSIOL, V100, P1117, DOI 10.1152/japplphysiol.00994.2005; Rosenzweig I, 2015, LANCET RESP MED, V3, P404, DOI 10.1016/S2213-2600(15)00090-9; Rosenzweig I, 2014, CURR OPIN PULM MED, V20, P565, DOI 10.1097/MCP.0000000000000099; Tagaito Y, 2001, J APPL PHYSIOL, V91, P2758, DOI 10.1152/jappl.2001.91.6.2758; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; Xu W, 2004, NEUROSCIENCE, V126, P313, DOI 10.1016/j.neuroscience.2004.03.055	26	3	4	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174896	10.1371/journal.pone.0174896	http://dx.doi.org/10.1371/journal.pone.0174896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362813	Green Published, Green Submitted, gold			2022-12-26	WOS:000399175000049
J	Shields, KJ; Mollnes, TE; Eidet, JR; Mikkelsen, K; Almdahl, SM; Bottazzi, B; Lyberg, T; Manzi, S; Ahearn, JM; Hollan, I				Shields, Kelly J.; Mollnes, Tom Eirik; Eidet, Jon Roger; Mikkelsen, Knut; Almdahl, Sven M.; Bottazzi, Barbara; Lyberg, Torstein; Manzi, Susan; Ahearn, Joseph M.; Hollan, Ivana			Plasma complement and vascular complement deposition in patients with coronary artery disease with and without inflammatory rheumatic diseases	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; LONG PENTRAXIN PTX3; CARDIOVASCULAR-DISEASE; ADIPOSE-TISSUE; PLATELET C4D; RISK-FACTORS; ATHEROSCLEROSIS; CALCIFICATION; PREDICTORS; ACTIVATION	Purpose Inflammatory rheumatic diseases (IRD) are associated with accelerated coronary artery disease (CAD), which may result from both systemic and vascular wall inflammation. There are indications that complement may be involved in the pathogenesis of CAD in Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis (RA). This study aimed to evaluate the associations between circulating complement and complement activation products with mononuclear cell infiltrates (MCI, surrogate marker of vascular inflammation) in the aortic media and adventitia in IRDCAD and non-IRDCAD patients undergoing coronary artery bypass grafting (CABG). Furthermore, we compared complement activation product deposition patterns in rare aorta adventitial and medial biopsies from SLE, RA and non-IRD patients. Methods We examined plasma C3 (p-C3) and terminal complement complexes (p-TCC) in 28 IRDCAD (SLE = 3; RA = 25), 52 non-IRDCAD patients, and 32 IRDNo (CAD) (RA = 32) from the Feiring Heart Biopsy Study. Aortic biopsies taken from the CAD only patiens during CABG were previously evaluated for adventitial MCIs. The rare aortic biopsies from 3 SLE, 3 RA and 3 non-IRDCAD were assessed for the presence of C3 and C3d using immunohistochemistry. Results IRDCAD patients had higher p-TCC than non-IRDCAD or IRDNo (CAD) patients (p< 0.0001), but a similar p-C3 level (p = 0.42). Circulating C3 was associated with IRD duration (p, p-value: 0.46, 0.03). In multiple logistic regression analysis, IRD remained significantly related to the presence and size of MCI (p< 0.05). C3 was present in all tissue samples. C3d was detected in the media of all patients and only in the adventitia of IRD patients (diffuse in all SLE and focal in one RA). Conclusion The independent association of IRD status with MCI and the observed C3d deposition supports the unique relationship between rheumatic disease, and, in particular, SLE with the complement system. Exaggerated systemic and vascular complement activation may accelerate CVD, serve as a CVD biomarker, and represent a target for new therapies.	[Shields, Kelly J.; Manzi, Susan; Ahearn, Joseph M.] Allegheny Hlth Network, Dept Med, Autoimmun Inst, Lupus Ctr Excellence, Pittsburgh, PA 15212 USA; [Mollnes, Tom Eirik] Univ Oslo, Oslo Univ Hosp, Dept Immunol, Oslo, Norway; [Mollnes, Tom Eirik] Univ Oslo, KG Jebsen IRC, Oslo, Norway; [Mollnes, Tom Eirik] Nordland Hosp, Res Lab, Bodo, Norway; [Mollnes, Tom Eirik] Univ Tromso, KG Jebsen TREC, Fac Hlth Sci, Tromso, Norway; [Mollnes, Tom Eirik] Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, Trondheim, Norway; [Eidet, Jon Roger; Lyberg, Torstein] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Mikkelsen, Knut; Hollan, Ivana] Lillehammer Hosp Rheumat Dis, Dept Rheumatol, Lillehammer, Norway; [Almdahl, Sven M.] Univ Hosp North Norway, Dept Cardiothorac & Vasc Surg, Tromso, Norway; [Bottazzi, Barbara] Humanitas Clin & Res Ctr, Rozzano, Italy; [Hollan, Ivana] Innlandet Hosp Trust, Res Dept, Brumunddal, Norway; [Hollan, Ivana] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA; [Hollan, Ivana] Harvard Univ, Sch Med, Boston, MA USA	University of Oslo; University of Oslo; UiT The Arctic University of Tromso; Norwegian University of Science & Technology (NTNU); University of Oslo; UiT The Arctic University of Tromso; University Hospital of North Norway; IRCCS Humanitas Research Hospital; Innlandet Hospital Trust; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Shields, KJ (corresponding author), Allegheny Hlth Network, Dept Med, Autoimmun Inst, Lupus Ctr Excellence, Pittsburgh, PA 15212 USA.	Kelly.SHIELDS@ahn.org	bottazzi, barbara/ABH-9274-2020; Mollnes, Tom/ABI-5183-2020	bottazzi, barbara/0000-0002-1930-9257; Shields, Kelly/0000-0002-5699-7773	South-Eastern Norway Regional Health Authority; Norwegian Women's Public Health Association; Scandinavian Research Foundation; Norwegian Rheumatism Association; Italian Ministry of Health; European Community's Seventh Framework Programme [602699]	South-Eastern Norway Regional Health Authority; Norwegian Women's Public Health Association; Scandinavian Research Foundation; Norwegian Rheumatism Association; Italian Ministry of Health(Ministry of Health, Italy); European Community's Seventh Framework Programme(European Commission)	This study was supported by the South-Eastern Norway Regional Health Authority, Norwegian Women's Public Health Association, the Scandinavian Research Foundation, the Norwegian Rheumatism Association, the Italian Ministry of Health, and the European Community's Seventh Framework Programme under grant agreement no 602699 (DIREKT).	Aubry MC, 2004, CARDIOVASC PATHOL, V13, P233, DOI 10.1016/j.carpath.2004.02.005; Bergseth G, 2013, MOL IMMUNOL, V56, P232, DOI 10.1016/j.molimm.2013.05.221; Deban L, 2010, NAT IMMUNOL, V11, P328, DOI 10.1038/ni.1854; Doni A, 2012, IMMUNOBIOLOGY, V217, P1122, DOI 10.1016/j.imbio.2012.07.004; Esdaile JM, 1996, ARTHRITIS RHEUM, V39, P370, DOI 10.1002/art.1780390304; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Hollan I, 2007, ARTHRITIS RHEUM, V56, P2072, DOI 10.1002/art.22690; Hollan I, 2013, AUTOIMMUN REV, V12, P1004, DOI 10.1016/j.autrev.2013.03.013; Hollan I, 2010, ARTHRIT CARE RES, V62, P378, DOI 10.1002/acr.20094; Hollan I, 2008, CIRC J, V72, P1986, DOI 10.1253/circj.CJ-08-0473; Kao AH, 2008, AM J CARDIOL, V102, P755, DOI 10.1016/j.amjcard.2008.04.059; Kao AH, 2014, TRANSL STROKE RES, V5, P510, DOI 10.1007/s12975-013-0295-9; Knoll F, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-161; Leff T, 2010, ADIPOSE TISSUE IN HEALTH AND DISEASE, P1; Manzi S, 2004, ARTHRITIS RHEUM-US, V50, P3596, DOI 10.1002/art.20561; Mollnes TE, 2007, MOL IMMUNOL, V44, P3838, DOI 10.1016/j.molimm.2007.06.150; Morgan B.P., 2015, IMMUNOBIOLOGY; Navratil JS, 2006, ARTHRITIS RHEUM-US, V54, P670, DOI 10.1002/art.21627; Norata GD, 2009, CIRCULATION, V120, P699, DOI 10.1161/CIRCULATIONAHA.108.806547; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Santelices LC, 2008, CTS-CLIN TRANSL SCI, V1, P62, DOI 10.1111/j.1752-8062.2008.00014.x; SCHUR PH, 1968, NEW ENGL J MED, V278, P533, DOI 10.1056/NEJM196803072781004; Selzer F, 2001, HYPERTENSION, V37, P1075, DOI 10.1161/01.HYP.37.4.1075; Shields KJ, 2013, ATHEROSCLEROSIS, V231, P129, DOI 10.1016/j.atherosclerosis.2013.09.004; Shields KJ, 2011, CTS-CLIN TRANSL SCI, V4, P146, DOI 10.1111/j.1752-8062.2011.00304.x; STURFELT G, 1984, INT ARCH ALLER A IMM, V75, P75, DOI 10.1159/000233593; Zhu HF, 2014, TRANSPL INT, V27, P87, DOI 10.1111/tri.12197	29	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174577	10.1371/journal.pone.0174577	http://dx.doi.org/10.1371/journal.pone.0174577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362874	Green Published, gold, Green Submitted			2022-12-26	WOS:000399175000021
J	Li, YY; Urban, A; Midura, D; Simon, HG; Wang, QT				Li, Yanyang; Urban, Alexander; Midura, Devin; Simon, Hans-Georg; Wang, Q. Tian			Proteomic characterization of epicardialmyocardial signaling reveals novel regulatory networks including a role for NF-kappa B in epicardial EMT	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; CONGENITAL HEART-DISEASE; VASCULAR SMOOTH-MUSCLE; TGF-BETA RECEPTOR; GROWTH-FACTOR; CELL INVASION; AVIAN HEART; TRANSCRIPTION FACTORS; CARDIAC DEVELOPMENT; IMMUNE-RESPONSES	Signaling between the epicardium and underlying myocardium is crucial for proper heart development. The complex molecular interactions and regulatory networks involved in this communication are not well understood. In this study, we integrated mass spectrometry with bioinformatics to systematically characterize the secretome of embryonic chicken EPDCheart explant (EHE) co-cultures. The 150-protein secretome dataset established greatly expands the knowledge base of the molecular players involved in epicardial-myocardial signaling. We identified proteins and pathways that are implicated in epicardial-myocardial signaling for the first time, as well as new components of pathways that are known to regulate the crosstalk between epicardium and myocardium. The large size of the dataset enabled bioinformatics analysis to deduce networks for the regulation of specific biological processes and predicted signal transduction nodes within the networks. We performed functional analysis on one of the predicted nodes, NF-kappa B, and demonstrate that NF-kappa B activation is an essential step in TGEF beta 2/PDGFBB-induced cardiac epithelial-to-mesenchymal transition. In summary, we have generated a global perspective of epicardial-myocardial signaling for the first time, and our findings open exciting new avenues for investigating the molecular basis of heart development and regeneration.	[Li, Yanyang; Wang, Q. Tian] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Urban, Alexander; Midura, Devin; Simon, Hans-Georg] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Stanley Manne Childrens Res Inst, Chicago, IL 60611 USA; [Wang, Q. Tian] Congressionally Directed Med Res Programs, Frederick, MD 21702 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Feinberg School of Medicine	Wang, QT (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.; Simon, HG (corresponding author), Northwestern Univ, Dept Pediat, Feinberg Sch Med, Stanley Manne Childrens Res Inst, Chicago, IL 60611 USA.; Wang, QT (corresponding author), Congressionally Directed Med Res Programs, Frederick, MD 21702 USA.	hgsimon@northwestern.edu; quntianw@gmail.com			Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust	Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust	This work was funded by the Chicago Biomedical Consortium with support from the Searle Funds at The Chicago Community Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin AF, 2008, DEV DYNAM, V237, P366, DOI 10.1002/dvdy.21421; Bax NAM, 2011, BASIC RES CARDIOL, V106, P829, DOI 10.1007/s00395-011-0181-0; Bax NAM, 2009, DEV DYNAM, V238, P2658, DOI 10.1002/dvdy.22073; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bin-Nun N, 2014, DEVELOPMENT, V141, P410, DOI 10.1242/dev.095984; Blanco MA, 2012, CELL RES, V22, P1339, DOI 10.1038/cr.2012.89; Brade T, 2006, CARDIOVASC RES, V72, P198, DOI 10.1016/j.cardiores.2006.06.025; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chevallet M, 2007, PROTEOMICS, V7, P1757, DOI 10.1002/pmic.200601024; Clark CR, 2016, CELL SIGNAL, V28, P688, DOI 10.1016/j.cellsig.2016.03.004; Cooley JR, 2014, DEV DYNAM, V243, P497, DOI 10.1002/dvdy.24085; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; Craig EA, 2010, EXP CELL RES, V316, P3397, DOI 10.1016/j.yexcr.2010.07.006; Darehzereshki A, 2015, DEV BIOL, V399, P91, DOI 10.1016/j.ydbio.2014.12.018; Dawn B, 2001, J MOL CELL CARDIOL, V33, P161, DOI 10.1006/jmcc.2000.1291; DeLaughter DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159710; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Dokic D, 2006, DEV BIOL, V299, P489, DOI 10.1016/j.ydbio.2006.08.054; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Garriock RJ, 2014, METHODS, V66, P365, DOI 10.1016/j.ymeth.2013.06.030; Germani A, 2015, J MOL MED, V93, P735, DOI 10.1007/s00109-015-1290-2; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gittenberger-de Groot AC, 1998, CIRC RES, V82, P1043, DOI 10.1161/01.RES.82.10.1043; Govind S, 1999, ONCOGENE, V18, P6875, DOI 10.1038/sj.onc.1203223; Greutmann M, 2015, CONGENIT HEART DIS, V10, P117, DOI 10.1111/chd.12201; Hernandez-Gutierrez S, 2006, APOPTOSIS, V11, P1101, DOI 10.1007/s10495-006-6984-z; Hikoso S, 2009, CIRC RES, V105, P70, DOI 10.1161/CIRCRESAHA.108.193318; Hill CR, 2012, CELL SIGNAL, V24, P1012, DOI 10.1016/j.cellsig.2011.12.022; HIRUMA T, 1989, AM J ANAT, V184, P129, DOI 10.1002/aja.1001840204; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishii Y, 2010, DEV CELL, V19, P307, DOI 10.1016/j.devcel.2010.07.017; Kanegae Y, 1998, NATURE, V392, P611, DOI 10.1038/33429; Kelley MW, 2008, DEV CELL, V15, P7, DOI 10.1016/j.devcel.2008.06.008; Krainock M, 2016, J CLIN MED, V5, DOI 10.3390/jcm5020027; Kraut B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141591; Lavine KJ, 2005, DEV CELL, V8, P85, DOI 10.1016/j.devcel.2004.12.002; Lavine KJ, 2006, GENE DEV, V20, P1651, DOI 10.1101/gad.1411406; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Li P, 2011, DEVELOPMENT, V138, P1795, DOI 10.1242/dev.054338; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Ma Y, 2008, BLOOD, V111, P2339, DOI 10.1182/blood-2007-09-112128; Maleszewska M, 2013, IMMUNOBIOLOGY, V218, P443, DOI 10.1016/j.imbio.2012.05.026; Perez-Pomares JM, 2011, CIRC RES, V109, P1429, DOI 10.1161/CIRCRESAHA.111.245589; Martinsen BJ, 2005, DEV DYNAM, V233, P1217, DOI 10.1002/dvdy.20468; Masters M, 2014, STEM CELL RES, V13, P683, DOI 10.1016/j.scr.2014.04.007; Mellgren AM, 2008, CIRC RES, V103, P1393, DOI 10.1161/CIRCRESAHA.108.176768; Mercer SE, 2013, DEV BIOL, V382, P457, DOI 10.1016/j.ydbio.2013.08.002; Molin DGM, 2003, DEV DYNAM, V227, P431, DOI 10.1002/dvdy.10314; Morabito CJ, 2001, DEV BIOL, V234, P204, DOI 10.1006/dbio.2001.0254; Muraoka RS, 2000, DEV BIOL, V225, P322, DOI 10.1006/dbio.2000.9824; Nickel W, 2010, CURR OPIN BIOTECH, V21, P621, DOI 10.1016/j.copbio.2010.06.004; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Olivey HE, 2010, CIRC RES, V106, P818, DOI 10.1161/CIRCRESAHA.109.209197; Pae SH, 2008, DEV DYNAM, V237, P962, DOI 10.1002/dvdy.21488; Person AD, 2005, DEV BIOL, V278, P35, DOI 10.1016/j.ydbio.2004.10.013; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ross RS, 2001, CIRC RES, V88, P1112, DOI 10.1161/hh1101.091862; Ruiz-Villalba A, 2012, CURR OPIN PEDIATR, V24, P569, DOI 10.1097/MOP.0b013e328357a532; Ryzhakov G, 2013, J BIOL CHEM, V288, P11546, DOI 10.1074/jbc.M113.451153; Sanchez NS, 2012, CELL SIGNAL, V24, P539, DOI 10.1016/j.cellsig.2011.10.006; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Sarkar P, 2012, MOL CELL PROTEOMICS, V11, P1829, DOI 10.1074/mcp.M112.020503; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Shin HM, 2004, FEBS LETT, V571, P50, DOI 10.1016/j.febslet.2004.06.056; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smith CL, 2011, CIRC RES, V108, pE15, DOI 10.1161/CIRCRESAHA.110.235531; Stuckmann I, 2003, DEV BIOL, V255, P334, DOI 10.1016/S0012-1606(02)00078-7; Van den Arker NMS, 2005, DEV DYNAM, V233, P1579, DOI 10.1002/dvdy.20476; Van den Berg G, 2007, ANAT REC, V290, P783, DOI 10.1002/ar.20559; Vega-Hernandez M, 2011, DEVELOPMENT, V138, P3331, DOI 10.1242/dev.064410; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; von Gise A, 2012, CIRC RES, V110, P1628, DOI 10.1161/CIRCRESAHA.111.259960; Wang JH, 2013, DEV BIOL, V382, P427, DOI 10.1016/j.ydbio.2013.08.012; Wei K, 2015, NATURE, V525, P479, DOI 10.1038/nature15372; Welikson RE, 2007, DEV DYNAM, V236, P2512, DOI 10.1002/dvdy.21276; Wu H, 1999, DEVELOPMENT, V126, P3597; Wu MF, 2010, DEV CELL, V19, P114, DOI 10.1016/j.devcel.2010.06.011; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	80	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174563	10.1371/journal.pone.0174563	http://dx.doi.org/10.1371/journal.pone.0174563			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358917	Green Published, gold			2022-12-26	WOS:000399174800056
J	Nguyen, YL; Porcher, R; Argaud, L; Piquilloud, L; Guitton, C; Tamion, F; Hraiech, S; Mira, JP				Nguyen, Yen-Lan; Porcher, Raphael; Argaud, Laurent; Piquilloud, Lise; Guitton, Christophe; Tamion, Fabienne; Hraiech, Sami; Mira, Jean-Paul			"ReaNet", the Internet utilization among surrogates of critically ill patients with sepsis	PLOS ONE			English	Article							HEALTH INFORMATION; PUBLIC AWARENESS; CARE; INTERVENTION; POPULATION; PERCEPTION; SEEKING; ADULTS	Context Health-related Internet utilization is common but its use by proxies of critically ill patients is unknown. Our objective was to describe the prevalence and the Internet utilization characteristics among surrogates of critically ill septic patients. We conducted a prospective observational study in French ICUs. Three survey instruments were used to describe ICU organization regarding information delivery, patients and surrogates characteristics Results 169 surrogates of 146 septic patients hospitalized in 19 ICUs were included. One sixth of ICUs (n = 3, 16%) had their own website. Majority of patients were males (n = 100, 68%), aged 64 1 years old, with a SAPS2 score at 53 17 and required vasopressors (n = 117, 83%), mechanical ventilation (n =116, 82%). More than one quarter required renal replacement therapy (n = 36, 26%). Majority of surrogates were female, in their fifties. Only one in five knew the word sepsis (n = 27, 16%). Majority of proxies internet users (n = 77; 55%) search on the internet about sepsis. The main motivation was curiosity. Majority of surrogates found the information online reliable, suitable for request and concordant. Prior use of health-related Internet (OR = 20.7 [4.30-100.1]), the presence of a nursing staff during family -physician meetings (OR = 3.33 [1.17-9.53]), a younger patient age (OR = 1.32 [1.01-1.72]) and renal replacement therapy requirement (OR = 2.58 [1.06-6.26]) were associated with health-related Internet use. Neither satisfaction with medical care or information provision, neither presence of anxiety-depression symptoms, were associated with health related Internet use. Majority of surrogates (N = 76 (52%)) would have like receiving a list of selected websites on sepsis. Conclusions Majority of proxies of critically ill patients with sepsis use Internet to learn more about sepsis. Internet utilization is independent of satisfaction with global ICU care, perceived quality of information delivery by doctors or the existence of anxiety-depression symptoms during ICU stay. The delivery of a list of recommended web sites on sepsis would have been appreciated.	[Nguyen, Yen-Lan; Mira, Jean-Paul] Paris Descartes Univ, Cochin Hosp, AP HP, Med Intens Care Unit, Paris, France; [Nguyen, Yen-Lan] Paris Descartes Univ, Cochin Acad Hosp, AP HP, Anesthesiol & Surg Crit Care Med Dept, Paris, France; [Porcher, Raphael] Paris Descartes Univ, Hotel Dieu Acad Hosp, AP HP, Clin Epidemiol Ctr,INSERM U1153, Paris, France; [Argaud, Laurent] Edouard Herriot Acad Hosp, Med Intens Care Unit, Hosp Civils Lyon, Lyon, France; [Piquilloud, Lise] Univ Angers, Angers Acad Hosp, Med Intens Care Unit, Angers, France; [Guitton, Christophe] Univ Nantes, Nantes Acad Hosp, Med Intens Care Unit, Nantes, France; [Tamion, Fabienne] Univ Rouen, Rouen Acad Hosp, Med Intens Care Unit, Rouen, France; [Hraiech, Sami] North Hosp Marseille, AP HM, Med Intens Care Unit, Marseille, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; Universite d'Angers; Nantes Universite; CHU de Nantes; CHU de Rouen; Universite de Rouen Normandie; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Nguyen, YL (corresponding author), Paris Descartes Univ, Cochin Hosp, AP HP, Med Intens Care Unit, Paris, France.; Nguyen, YL (corresponding author), Paris Descartes Univ, Cochin Acad Hosp, AP HP, Anesthesiol & Surg Crit Care Med Dept, Paris, France.	yen-lan.nguyen@aphp.fr	Carmen, Team3/Y-7384-2019; Piquilloud, Lise/ABC-4402-2021	Carmen, Team3/0000-0002-3614-0924; Lab, Carmen/0000-0002-5935-3236; Porcher, Raphael/0000-0002-5277-4679				[Anonymous], 2010, CONS US INT REL PAT; Azoulay E, 2001, AM J RESP CRIT CARE, V163, P135, DOI 10.1164/ajrccm.163.1.2005117; Bouju P, 2014, INTENS CARE MED, V40, P1175, DOI 10.1007/s00134-014-3371-z; Cote J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2310-4; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Dhillon Amrit S, 2003, J Perinatol, V23, P420, DOI 10.1038/sj.jp.7210945; Fassier P, 2016, BRIT J NUTR, V115, P2039, DOI 10.1017/S0007114516001355; Fitzmaurice GM, 2007, BIOMETRICS, V63, P942, DOI 10.1111/j.1541-0420.2007.00775.x; Kazley AS, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-112; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Martinez CH, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-66; Nolan RP, 2014, JMIR RES PROTOC, V3, DOI 10.2196/resprot.2957; Phua J, 2013, ANN ACAD MED SINGAP, V42, P269; R Core Team, 2021, R LANGUAGE ENV STAT; Roehr B, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7738; Rubulotta FM, 2009, CRIT CARE MED, V37, P167, DOI 10.1097/CCM.0b013e3181926883; Tan SSL, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.5729; van den Broek JM, 2015, CRIT CARE MED, V43, P1731, DOI 10.1097/CCM.0000000000000980	18	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174292	10.1371/journal.pone.0174292	http://dx.doi.org/10.1371/journal.pone.0174292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358883	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174800027
J	Kuo, CF; Tsao, N; Hsieh, IC; Lin, YS; Wu, JJ; Hung, YT				Kuo, Chih-Feng; Tsao, Nina; Hsieh, I-Chen; Lin, Yee-Shin; Wu, Jiunn-Jong; Hung, Yu-Ting			Immunization with a streptococcal multiple-epitope recombinant protein protects mice against invasive group A streptococcal infection	PLOS ONE			English	Article							PYROGENIC EXOTOXIN-B; FIBRONECTIN-BINDING PROTEIN; SOFT-TISSUE INFECTIONS; STREPTOLYSIN-S; CYSTEINE PROTEINASE; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; SFB PROTEIN; MOUSE MODEL; M1 PROTEIN	Streptococcus pyogenes (group A Streptococcus; GAS) causes clinical diseases, including pharyngitis, scarlet fever, impetigo, necrotizing fasciitis and streptococcal toxic shock syndrome. A number of group A streptococcus vaccine candidates have been developed, but only one 26-valent recombinant M protein vaccine has entered clinical trials. Differing from the design of a 26-valent recombinant M protein vaccine, we provide here a vaccination using the polyvalence epitope recombinant FSBM protein (rFSBM), which contains four different epitopes, including the fibronectin-binding repeats domain of streptococcal fibronectin binding protein Sfbl, the C-terminal immunogenic segment of streptolysin S, the C3-binding motif of streptococcal pyrogenic exotoxin B, and the C-terminal conserved segment of M protein. Vaccination with the rFSBM protein successfully prevented mortality and skin lesions caused by several emm strains of GAS infection. Anti-FSBM antibodies collected from the rFSBM-immunized mice were able to opsonize at least six emm strains and can neutralize the hemolytic activity of streptolysin S. Furthermore, the internalization of GAS into nonphagocytic cells is also reduced by anti-FSBM serum. These findings suggest that rFSBM can be applied as a vaccine candidate to prevent different emm strains of GAS infection.	[Kuo, Chih-Feng] I Shou Univ, Dept Nursing, Coll Med, Kaohsiung, Taiwan; [Tsao, Nina; Hsieh, I-Chen; Hung, Yu-Ting] I Shou Univ, Dept Biol Sci & Technol, Coll Med, Kaohsiung, Taiwan; [Lin, Yee-Shin] Natl Cheng Kung Univ, Dept Microbiol & Immunol, Coll Med, Tainan, Taiwan; [Wu, Jiunn-Jong] Natl Cheng Kung Univ, Dept Med Lab Sci & Biotechnol, Coll Med, Tainan, Taiwan; [Wu, Jiunn-Jong] Natl Yang Ming Univ, Sch Biomed Sci & Engn, Dept Biotechnol & Lab Sci Med, Taipei, Taiwan	I Shou University; I Shou University; National Cheng Kung University; National Cheng Kung University; National Yang Ming Chiao Tung University	Kuo, CF (corresponding author), I Shou Univ, Dept Nursing, Coll Med, Kaohsiung, Taiwan.	kuo@isu.edu.tw			Ministry of Science and Technology [MOST104-2320-B-214-004, MOST105-2320-B006-011, MOST 105-2320-B-214-004]; I-Shou University, Taiwan [ISU103-04-05A]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); I-Shou University, Taiwan	This work was supported by grants MOST104-2320-B-214-004, MOST105-2320-B006-011, and MOST 105-2320-B-214-004 from the Ministry of Science and Technology, and ISU103-04-05A from I-Shou University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amelung S, 2011, CELL MICROBIOL, V13, P1200, DOI 10.1111/j.1462-5822.2011.01610.x; Anderson EL, 2014, J BIOL CHEM, V289, P3539, DOI 10.1074/jbc.M113.529537; Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; Baldassarri L, 2007, J CLIN MICROBIOL, V45, P1284, DOI 10.1128/JCM.02119-06; Bao YJ, 2015, J BACTERIOL, V197, P3191, DOI 10.1128/JB.00511-15; Baroux N, 2014, CLIN INFECT DIS, V59, pE84, DOI 10.1093/cid/ciu490; Batzloff MR, 2003, J INFECT DIS, V187, P1598, DOI 10.1086/374800; BEACHEY EH, 1977, J EXP MED, V145, P1469, DOI 10.1084/jem.145.6.1469; Berggard K, 2001, MOL MICROBIOL, V42, P539, DOI 10.1046/j.1365-2958.2001.02664.x; Bessen DE, 1997, ADV EXP MED BIOL, V418, P537; Bessen DE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-59; Brandt CM, 2009, CLIN INFECT DIS, V49, P766, DOI 10.1086/605085; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carlsson F, 2005, MOL MICROBIOL, V56, P28, DOI 10.1111/j.1365-2958.2005.04527.x; Chiang-Ni C, 2014, PATHOG DIS, V70, P194, DOI 10.1111/2049-632X.12114; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Cole JN, 2010, MBIO, V1, DOI 10.1128/mBio.00191-10; Dale JB, 2002, INFECT IMMUN, V70, P2166, DOI 10.1128/IAI.70.4.2166-2170.2002; Datta V, 2005, MOL MICROBIOL, V56, P681, DOI 10.1111/j.1365-2958.2005.04583.x; Egesten A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004769; Eriksson A, 2003, INFECT IMMUN, V71, P211, DOI 10.1128/IAI.71.1.211-217.2003; Feng WC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162742; Friaes A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12057; Gorton D, 2016, AUTOIMMUNITY, V25, P1; Guzman CA, 1999, J INFECT DIS, V179, P901, DOI 10.1086/314655; Honda-Ogawa M, 2013, J BIOL CHEM, V288, P15854, DOI 10.1074/jbc.M113.469106; Hotomi M, 2009, J INFECT CHEMOTHER, V15, P367, DOI 10.1007/s10156-009-0724-6; Hu MC, 2002, INFECT IMMUN, V70, P2171, DOI 10.1128/IAI.70.4.2171-2177.2002; Hung CH, 2012, MED MICROBIOL IMMUN, V201, P357, DOI 10.1007/s00430-012-0241-6; Ikebe T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000832; Jadoun J, 1998, J INFECT DIS, V178, P147, DOI 10.1086/515589; Johansson L, 2008, INFECT IMMUN, V76, P3399, DOI 10.1128/IAI.01392-07; Kansal RG, 2010, J INFECT DIS, V201, P855, DOI 10.1086/651019; KAPUR V, 1994, MICROB PATHOGENESIS, V16, P443, DOI 10.1006/mpat.1994.1044; KAPUR V, 1993, MICROB PATHOGENESIS, V15, P327, DOI 10.1006/mpat.1993.1083; Kuo CF, 2004, MICROB PATHOGENESIS, V36, P273, DOI 10.1016/j.micpath.2004.01.003; Kuo CF, 1998, INFECT IMMUN, V66, P3931, DOI 10.1128/IAI.66.8.3931-3935.1998; Kuo CF, 2008, INFECT IMMUN, V76, P1163, DOI 10.1128/IAI.01116-07; Kuo CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117268; Liang Z, 2013, J BIOL CHEM, V288, P6561, DOI 10.1074/jbc.M112.442657; Lin A, 2009, INFECT IMMUN, V77, P5190, DOI 10.1128/IAI.00420-09; Lin JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081700; Lin JN, 2011, J CLIN MICROBIOL, V49, P3632, DOI 10.1128/JCM.00531-11; Lu SL, 2015, MBIO, V6, DOI 10.1128/mBio.01435-15; Luca-Harari B, 2009, J CLIN MICROBIOL, V47, P1155, DOI 10.1128/JCM.02155-08; McNeil SA, 2005, CLIN INFECT DIS, V41, P1114, DOI 10.1086/444458; Medina E, 1999, J IMMUNOL, V163, P3396; Miyoshi-Akiyama T, 2005, J INFECT DIS, V192, P107, DOI 10.1086/430617; Nelson DC, 2011, BIOL CHEM, V392, P1077, DOI [10.1515/BC-2011-208, 10.1515/BC.2011.208]; Ochel A, 2014, J INNATE IMMUN, V6, P585, DOI 10.1159/000358085; OKADA N, 1994, J CLIN INVEST, V94, P965, DOI 10.1172/JCI117463; PEREZCASAL J, 1995, MOL MICROBIOL, V15, P907, DOI 10.1111/j.1365-2958.1995.tb02360.x; Plainvert C, 2012, CLIN MICROBIOL INFEC, V18, P702, DOI 10.1111/j.1469-0691.2011.03624.x; Purushothaman SS, 2003, INFECT IMMUN, V71, P5823, DOI 10.1128/IAI.71.10.5823-5830.2003; Rato MG, 2011, J CLIN MICROBIOL, V49, P2470, DOI 10.1128/JCM.00008-11; Sanderson-Smith M, 2014, J INFECT DIS, V210, P1325, DOI 10.1093/infdis/jiu260; Shea PR, 2011, EMERG INFECT DIS, V17, P2010, DOI 10.3201/eid1711.110159; Steer AC, 2009, CURR OPIN INFECT DIS, V22, P544, DOI 10.1097/QCO.0b013e328332bbfe; Takahashi T, 2011, J INFECT CHEMOTHER, V17, P1, DOI 10.1007/s10156-010-0084-2; TALAY SR, 1994, MOL MICROBIOL, V13, P531, DOI 10.1111/j.1365-2958.1994.tb00448.x; Tatsuno Ichiro, 2013, BMC Res Notes, V6, P126, DOI 10.1186/1756-0500-6-126; Timmer AM, 2006, MOL MICROBIOL, V62, P15, DOI 10.1111/j.1365-2958.2006.05337.x; Tsao N, 2006, BIOCHEM BIOPH RES CO, V339, P779, DOI 10.1016/j.bbrc.2005.11.078; Tsao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055028; VALENTINWEIGAND P, 1994, MICROB PATHOGENESIS, V17, P111, DOI 10.1006/mpat.1994.1057; WANG JR, 1994, INFECT IMMUN, V62, P442, DOI 10.1128/IAI.62.2.442-448.1994; Williamson DA, 2015, J INFECTION, V70, P127, DOI 10.1016/j.jinf.2014.09.001; Zheng PX, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00149-12	68	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174464	10.1371/journal.pone.0174464	http://dx.doi.org/10.1371/journal.pone.0174464			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355251	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174600052
J	Byrum, SD; Burdine, MS; Orr, L; Mackintosh, SG; Authier, S; Pouliot, M; Hauer-Jensen, M; Tackett, AJ				Byrum, Stephanie D.; Burdine, Marie S.; Orr, Lisa; Mackintosh, Samuel G.; Authier, Simon; Pouliot, Mylene; Hauer-Jensen, Martin; Tackett, Alan J.			Time- and radiation-dose dependent changes in the plasma proteome after total body irradiation of non-human primates: Implications for biomarker selection	PLOS ONE			English	Article							ACTIVATION	Acute radiation syndrome (ARS) is a complex multi-organ disease resulting from total body exposure to high doses of radiation. Individuals can be exposed to total body irradiation (TBI) in a number of ways, including terrorist radiological weapons or nuclear accidents. In order to determine whether an individual has been exposed to high doses of radiation and needs countermeasure treatment, robust biomarkers are needed to estimate radiation exposure from biospecimens such as blood or urine. In order to identity such candidate biomarkers of radiation exposure, high-resolution proteomics was used to analyze plasma from non-human primates following whole body irradiation (Co-60 at 6.7 Gy and 7.4 Gy) with a twelve day observation period. A total of 663 proteins were evaluated from the plasma proteome analysis. A panel of plasma proteins with characteristic time- and dose-dependent changes was identified. In addition to the plasma proteomics study reported here, we recently identified candidate biomarkers using urine from these same non-human primates. From the proteomic analysis of both plasma and urine, we identified ten overlapping proteins that significantly differentiate both time and dose variables. These shared plasma and urine proteins represent optimal candidate biomarkers of radiation exposure.	[Byrum, Stephanie D.; Burdine, Marie S.; Orr, Lisa; Mackintosh, Samuel G.; Tackett, Alan J.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Authier, Simon; Pouliot, Mylene] CIToxLAB, Laval, PQ, Canada; [Hauer-Jensen, Martin] Univ Arkansas Med Sci, Div Radiat Hlth, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Tackett, AJ (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	ajtackett@uams.edu	Burdine, Marie Schluterman/GLU-1812-2022	Burdine, Marie Schluterman/0000-0002-3940-5748	Biomedical Advanced Research and Development Authority [HHSO100201100045C]; National Institute for General Medical Sciences [R01GM106024, P20GM103429, P20GM109005]; National Cancer Institute [R33CA173264]; National Institute of Environmental Health Sciences [R21ES025268]; National Center for Advancing Translational Sciences [UL1TR000039]; Office of the ASPR; BARDA [HHSO100201100045C]; NIH grants [R01GM106024, P20GM103429, P20GM109005, R33CA173264, R21ES025268, UL1TR000039]	Biomedical Advanced Research and Development Authority; National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Office of the ASPR; BARDA; NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Biomedical Advanced Research and Development Authority (http://www.phe.gov/about/BARDA/ Pages/default.aspx): HHSO100201100045C (MHJ); National Institute for General Medical Sciences (https://www.nigms.nih.gov/Pages/ default.aspx): R01GM106024 (AT), P20GM103429 (N/A), and P20GM109005 (MHJ); National Cancer Institute (https://www.cancer.gov/): R33CA173264 (AT); National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/): R21ES025268 (AT) and the National Center for Advancing Translational Sciences (https://ncats. nih.gov/): UL1TR000039 (N/A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project has been partially funded with Federal funds from the Office of the ASPR, BARDA under contract # HHSO100201100045C. The ideas presented are the authors and not those of the Government. Additional funding for this work has come from NIH grants R01GM106024, R33CA173264, R21ES025268, UL1TR000039, P20GM103429, and P20GM109005. The mass spectrometric data was collected by the UAMS proteomics core facility.	ANDERSON RGW, 1977, CELL, V10, P351, DOI 10.1016/0092-8674(77)90022-8; Bujold K, 2016, RADIAT RES, V186, P71, DOI 10.1667/RR14305.1; Byrum SD, 2016, J PROTEOMICS BIOIN S, V9; Ding L, 2014, INT J ENDOCRINOL, V2014, P13; Guipaud O, 2013, ADV EXP MED BIOL, V990, P61, DOI 10.1007/978-94-007-5896-4_4; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Krey JF, 2014, J PROTEOME RES, V13, P1034, DOI 10.1021/pr401017h; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Moshage H, 1997, J PATHOL, V181, P257, DOI 10.1002/(SICI)1096-9896(199703)181:3<257::AID-PATH756>3.0.CO;2-U; Murthy S, 2002, J LIPID RES, V43, P1054, DOI 10.1194/jlr.M100358-JLR200; Nylund R, 2014, J RADIAT RES, V55, P674, DOI 10.1093/jrr/rru007; Palta S, 2014, INDIAN J ANAESTH, V58, P515, DOI 10.4103/0019-5049.144643; Schley G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145042; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Stojancevic M, 2012, CAN J GASTROENTEROL, V26, P631, DOI 10.1155/2012/538452	15	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174771	10.1371/journal.pone.0174771	http://dx.doi.org/10.1371/journal.pone.0174771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350824	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174400075
J	Mohanty, B; Rimmer, K; McMahon, RM; Headey, SJ; Vazirani, M; Shouldice, SR; Coincon, M; Tay, S; Morton, CJ; Simpson, JS; Martin, JL; Scanlon, MJ				Mohanty, Biswaranjan; Rimmer, Kieran; McMahon, Roisin M.; Headey, Stephen J.; Vazirani, Mansha; Shouldice, Stephen R.; Coincon, Mathieu; Tay, Stephanie; Morton, Craig J.; Simpson, Jamie S.; Martin, Jennifer L.; Scanlon, Martin J.			Fragment library screening identifies hits that bind to the non-catalytic surface of Pseudomonas aeruginosa DsbA1	PLOS ONE			English	Article							PROTEIN-LIGAND COMPLEXES; NMR STRUCTURE DETERMINATION; CRYSTAL-STRUCTURE; INTERACTION SITE; LEAD DISCOVERY; IN-VIVO; ASSIGNMENT; REVEALS; SOFTWARE; DESIGN	At a time when the antibiotic drug discovery pipeline has stalled, antibiotic resistance is accelerating with catastrophic implications for our ability to treat bacterial infections. Globally we face the prospect of a future when common infections can once again kill. Anti-virulence approaches that target the capacity of the bacterium to cause disease rather than the growth or survival of the bacterium itself offer a tantalizing prospect of novel antimicrobials. They may also reduce the propensity to induce resistance by removing the strong selection pressure imparted by bactericidal or bacteriostatic agents. In the human pathogen Pseudomonas aeruginosa, disulfide bond protein A (PaDsbA1) plays a central role in the oxidative folding of virulence factors and is therefore an attractive target for the development of new anti-virulence antimicrobials. Using a fragment-based approach we have identified small molecules that bind to PaDsbA1. The fragment hits show selective binding to PaDsbA1 over the DsbA protein from Escherichia coli, suggesting that developing species-specific narrowspectrum inhibitors of DsbA enzymes may be feasible. Structures of a co-complex of PaDsbA1 with the highest affinity fragment identified in the screen reveal that the fragment binds on the non-catalytic surface of the protein at a domain interface. This biophysical and structural data represent a starting point in the development of higher affinity compounds, which will be assessed for their potential as selective PaDsbA1 inhibitors.	[Mohanty, Biswaranjan; Rimmer, Kieran; Headey, Stephen J.; Vazirani, Mansha; Simpson, Jamie S.; Scanlon, Martin J.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic, Australia; [McMahon, Roisin M.; Shouldice, Stephen R.; Coincon, Mathieu; Tay, Stephanie; Martin, Jennifer L.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia; [Morton, Craig J.] Biota Holdings Ltd, Notting Hill, Vic, Australia; [McMahon, Roisin M.; Martin, Jennifer L.] Griffith Univ, Inst Drug Discovery, Nathan, Qld, Australia; [Coincon, Mathieu] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, Stockholm, Sweden; [Morton, Craig J.] St Vincents Inst Med Res, Australian Canc Res Fdn, Rat Drug Discovery Ctr, Fitzroy, Vic, Australia	Monash University; University of Queensland; Griffith University; Stockholm University; St. Vincent's Institute of Medical Research	Scanlon, MJ (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic, Australia.	martin.scanlon@monash.edu	Mohanty, Biswaranjan/E-2080-2018; Simpson, Jamie/ABC-7083-2020; Simpson, Jamie S/A-1700-2012; McMahon, Roisin/A-9823-2014; Morton, Craig/GON-8638-2022	Mohanty, Biswaranjan/0000-0002-6921-343X; Simpson, Jamie/0000-0002-8894-422X; Simpson, Jamie S/0000-0002-8894-422X; McMahon, Roisin/0000-0001-5437-0355; Morton, Craig/0000-0001-5452-5193; Headey, Stephen/0000-0001-8015-7064; Scanlon, Martin/0000-0002-9230-7506	Australian Research Council [LP0990166, FL0992138]; Industry Partner - Biota Holdings Ltd.; Laureate Award; National Health and Medical Research Council [1061241]	Australian Research Council(Australian Research Council); Industry Partner - Biota Holdings Ltd.; Laureate Award; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The study was funded through a Linkage Grant from the Australian Research Council (arc.gov.au) (LP0990166), which was supported by an Industry Partner - Biota Holdings Ltd. JLM was supported by an Australian Research Council (arc.gov.au) Australian Laureate Fellowship during this research (FL0992138). RMM, MC and ST were supported by the same Laureate Award. RMM and BM were supported in part by a National Health and Medical Research Council (nhmrc.gov.au) Project Grant (1061241). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2015, ANGEW CHEM INT EDIT, V54, P2179, DOI 10.1002/anie.201410341; Afonine PV, 2005, ACTA CRYSTALLOGR D, V61, P850, DOI 10.1107/S0907444905007894; Arts IS, 2013, MBIO, V4, DOI 10.1128/mBio.00912-13; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Braun P, 2001, J BIOL CHEM, V276, P26030, DOI 10.1074/jbc.M007122200; Cabrita LD, 2007, PROTEIN SCI, V16, P2360, DOI 10.1110/ps.072822507; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dacheux D, 2002, INFECT IMMUN, V70, P3973, DOI 10.1128/IAI.70.7.3973-3977.2002; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Devine SM, 2015, J MED CHEM, V58, P1205, DOI 10.1021/jm501402x; Doak BC, 2013, AUST J CHEM, V66, P1465, DOI 10.1071/CH13280; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferenczy GG, 2013, J MED CHEM, V56, P2478, DOI 10.1021/jm301851v; Fiorito F, 2008, J BIOMOL NMR, V42, P23, DOI 10.1007/s10858-008-9259-x; Ha UH, 2003, INFECT IMMUN, V71, P1590, DOI 10.1128/IAI.71.3.1590-1595.2003; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hubbard RE, 2011, METHOD ENZYMOL, V493, P509, DOI 10.1016/B978-0-12-381274-2.00020-0; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Ireland PM, 2014, ANTIOXID REDOX SIGN, V20, P606, DOI 10.1089/ars.2013.5375; Jahnke W, 2010, NAT CHEM BIOL, V6, P660, DOI [10.1038/NCHEMBIO.421, 10.1038/nchembio.421]; Keller R., 2004, COMPUTER AIDED RESON, P33; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 2000, COMPUT PHYS COMMUN, V124, P139, DOI 10.1016/S0010-4655(99)00436-1; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon RM, 2014, BIOCH BIOPHYS ACTA; McMahon RM, 2015, ACTA CRYSTALLOGR D, V71, P2386, DOI 10.1107/S1399004715018519; Mohanty B, 2016, J BIOMOL NMR, V66, P195, DOI 10.1007/s10858-016-0067-4; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Mortenson PN, 2011, J COMPUT AID MOL DES, V25, P663, DOI 10.1007/s10822-011-9435-z; Murray JB, 2014, J MED CHEM, V57, P2845, DOI 10.1021/jm401848a; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Orts J, 2016, J AM CHEM SOC, V138, P4393, DOI 10.1021/jacs.5b12391; Paxman JJ, 2009, J BIOL CHEM, V284, P17835, DOI 10.1074/jbc.M109.011502; Premkumar L, 2014, J BIOL CHEM, V289, P19869, DOI 10.1074/jbc.M114.571737; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sethi A, 2015, PROTEIN SCI, V24, P1013, DOI 10.1002/pro.2671; Shah DM, 2012, J MED CHEM, V55, P10786, DOI 10.1021/jm301396d; Shouldice SR, 2010, ANTIOXID REDOX SIGN, V12, P921, DOI 10.1089/ars.2009.2736; Silvestre HL, 2013, P NATL ACAD SCI USA, V110, P12984, DOI 10.1073/pnas.1304045110; Totsika M, 2009, J BACTERIOL, V191, P3901, DOI 10.1128/JB.00143-09; Urban A, 2001, J BACTERIOL, V183, P587, DOI 10.1128/JB.183.2.587-596.2001; Valkov E, 2012, TOP CURR CHEM, V317, P145, DOI 10.1007/128_2011_265; Volk J, 2008, J BIOMOL NMR, V41, P127, DOI 10.1007/s10858-008-9243-5; Walden PM, 2012, ACTA CRYSTALLOGR D, V68, P1290, DOI 10.1107/S0907444912026388; Wielens J, 2013, J BIOMOL SCREEN, V18, P147, DOI 10.1177/1087057112465979; Ziarek JJ, 2011, METHOD ENZYMOL, V493, P241, DOI 10.1016/B978-0-12-381274-2.00010-8	55	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0173436	10.1371/journal.pone.0173436	http://dx.doi.org/10.1371/journal.pone.0173436			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346540	Green Published, gold			2022-12-26	WOS:000399174300006
J	Park, CK; Ho, CH; Jeong, SJ; Lee, EJ; Kim, J				Park, Chang-Kyun; Ho, Chang-Hoi; Jeong, Su-Jong; Lee, Eun Ju; Kim, Jinwon			Spatial and temporal changes in leaf coloring date of Acer palmatum and Ginkgo biloba in response to temperature increases in South Korea	PLOS ONE			English	Article							GROWING-SEASON LENGTH; CLIMATE-CHANGE; EASTERN CHINA; PHENOLOGY; VEGETATION; EUROPE; FOREST; ECOSYSTEMS; SENESCENCE; PREDICTION	Understanding shifts in autumn phenology associated with climate changes is critical for preserving forest ecosystems. This study examines the changes in the leaf coloring date (LCD) of two temperate deciduous tree species, Acer palmatum (Acer) and Ginkgo biloba (Ginkgo), in response to surface air temperature (Ts) changes at 54 stations of South Korea for the period 1989 - 2007. The variations of Acer and Ginkgo in South Korea are very similar: they show the same mean LCD of 295th day of the year and delays of about 0.45 days year - 1 during the observation period. The delaying trend is closely correlated (correlation coefficient > 0.77) with increases in Ts in mid-autumn by 2.8 days degrees C-1. It is noted that the LCD delaying and temperature sensitivity (days degrees C-1) for both tree species show negligible dependences on latitudes and elevations. Given the significant LCD-Ts relation, we project LCD changes for 2016 - 35 and 2046 - 65 using a process-based model forced by temperature from climate model simulation. The projections indicate that the mean LCD would be further delayed by 3.2 (3.7) days in 2016 - 35 (2046 - 65) due to mid-autumn Ts increases. This study suggests that the mid-autumn warming is largely responsible for the observed LCD changes in South Korea and will intensify the delaying trends in the future.	[Park, Chang-Kyun; Ho, Chang-Hoi] Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea; [Jeong, Su-Jong] South Univ Sci & Technol China, Sch Environm Sci & Engn, Shenzhen, Peoples R China; [Lee, Eun Ju] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Kim, Jinwon] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA USA	Seoul National University (SNU); Southern University of Science & Technology; Seoul National University (SNU); University of California System; University of California Los Angeles	Ho, CH (corresponding author), Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea.	hoch@cpl.snu.ac.kr	Ho, Chang-Hoi/H-8354-2015	Park, Chang-Kyun/0000-0001-9485-5007	Korea Ministry of Environment (MOE) as part of the Climate Change Correspondence Program; MOE under the Climate Change Correspondence Program	Korea Ministry of Environment (MOE) as part of the Climate Change Correspondence Program; MOE under the Climate Change Correspondence Program	This study was funded by the Korea Ministry of Environment (MOE) as part of the Climate Change Correspondence Program. The work by JK and CKP were partially supported by salaries from the MOE under the Climate Change Correspondence Program. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Archetti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057373; Bassow SL, 1998, ECOLOGY, V79, P2660, DOI 10.1890/0012-9658(1998)079[2660:HECACL]2.0.CO;2; Bell GD, 1999, B AM METEOROL SOC, V80, pS1, DOI 10.1175/1520-0477-80.5s.S1; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bowers JE, 2007, SOUTHWEST NAT, V52, P347, DOI 10.1894/0038-4909(2007)52[347:HCWASF]2.0.CO;2; Chen XQ, 2012, INT J BIOMETEOROL, V56, P695, DOI 10.1007/s00484-011-0471-0; Chen XQ, 2005, GLOBAL CHANGE BIOL, V11, P1118, DOI 10.1111/j.1365-2486.2005.00974.x; Chmura DJ, 2011, FOREST ECOL MANAG, V261, P1121, DOI 10.1016/j.foreco.2010.12.040; Chuine I, 2001, ECOL LETT, V4, P500, DOI 10.1046/j.1461-0248.2001.00261.x; Dai JH, 2014, INT J BIOMETEOROL, V58, P521, DOI 10.1007/s00484-013-0679-2; Delpierre N, 2009, AGR FOREST METEOROL, V149, P938, DOI 10.1016/j.agrformet.2008.11.014; Doi H, 2008, GLOBAL ECOL BIOGEOGR, V17, P556, DOI 10.1111/j.1466-8238.2008.00398.x; Estrella N, 2006, CLIM RES, V32, P253, DOI 10.3354/cr032253; Fu YSH, 2014, P NATL ACAD SCI USA, V111, P7355, DOI 10.1073/pnas.1321727111; Garonna I, 2014, GLOBAL CHANGE BIOL, V20, P3457, DOI 10.1111/gcb.12625; Ge QS, 2011, ECOL RES, V26, P713, DOI 10.1007/s11284-011-0830-7; Ho CH, 2005, TERR ATMOS OCEAN SCI, V16, P1163, DOI 10.3319/TAO.2005.16.5.1163(A); Ho CH, 1988, J KOREAN METEOR SOC, V24, P38; Ho CH, 2006, INT J CLIMATOL, V26, P2117, DOI 10.1002/joc.1356; Hong SY, 2010, ASIA-PAC J ATMOS SCI, V46, P425, DOI 10.1007/s13143-010-0024-1; Iler AM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0489; IPCC, 2014, BIOL SCI; Jenerette GD, 2010, J VEG SCI, V21, P16, DOI 10.1111/j.1654-1103.2009.01118.x; Jeong JH, 2011, INT J CLIMATOL, V31, P1488, DOI 10.1002/joc.2178; Jeong SJ, 2014, GLOBAL ECOL BIOGEOGR, V23, P1245, DOI 10.1111/geb.12206; Jeong SJ, 2011, GLOBAL CHANGE BIOL, V17, P2385, DOI 10.1111/j.1365-2486.2011.02397.x; Jung HS, 2002, INT J CLIMATOL, V22, P1327, DOI 10.1002/joc.797; Keenan TF, 2015, GLOBAL CHANGE BIOL, V21, P2634, DOI 10.1111/gcb.12890; Klanderud K, 2005, J ECOL, V93, P127, DOI 10.1111/j.1365-2745.2004.00944.x; KOIKE T, 1990, TREE PHYSIOL, V7, P21, DOI 10.1093/treephys/7.1-2-3-4.21; Lebourgeois F, 2010, INT J BIOMETEOROL, V54, P563, DOI 10.1007/s00484-010-0305-5; Lee DW, 2003, ECOL RES, V18, P677, DOI 10.1111/j.1440-1703.2003.00588.x; Matsumoto K, 2003, GLOBAL CHANGE BIOL, V9, P1634, DOI 10.1046/j.1365-2486.2003.00688.x; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Min SK, 2015, ASIA-PAC J ATMOS SCI, V51, P103, DOI 10.1007/s13143-015-0066-5; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nooden L.D., 2004, PLANT CELL DEATH PRO; Olsson C, 2015, ECOL MODEL, V316, P41, DOI 10.1016/j.ecolmodel.2015.08.002; Park CK, 2015, J HYDROL, V526, P221, DOI 10.1016/j.jhydrol.2014.10.043; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Piao SL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002888; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; Richardson AD, 2013, AGR FOREST METEOROL, V169, P156, DOI 10.1016/j.agrformet.2012.09.012; Schaber J, 2003, INT J BIOMETEOROL, V47, P193, DOI 10.1007/s00484-003-0171-5; Schwartz M.D., 2003, PHENOLOGY INTEGRATIV; Shen MG, 2013, P NATL ACAD SCI USA, V110, pE2329, DOI 10.1073/pnas.1304625110; Vitasse Y, 2011, AGR FOREST METEOROL, V151, P969, DOI 10.1016/j.agrformet.2011.03.003; Vitasse Y, 2009, OECOLOGIA, V161, P187, DOI 10.1007/s00442-009-1363-4; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Winder M, 2010, PHILOS T R SOC B, V365, P3215, DOI 10.1098/rstb.2010.0125; Wu CY, 2012, GLOBAL PLANET CHANGE, V92-93, P179, DOI 10.1016/j.gloplacha.2012.05.021; Xu L, 2013, GLOBAL CHANGE BIOL, V19, P1275, DOI 10.1111/gcb.12095; Yang YT, 2015, GLOBAL CHANGE BIOL, V21, P652, DOI 10.1111/gcb.12778; Yu ET, 2015, CLIM DYNAM, V45, P2013, DOI 10.1007/s00382-014-2452-6; Yu R, 2016, INT J BIOMETEOROL, V60, P335, DOI 10.1007/s00484-015-1031-9; Zhang NN, 2009, CLIMATIC CHANGE, V95, P341, DOI 10.1007/s10584-009-9568-4; Zhu WQ, 2012, GLOBAL ECOL BIOGEOGR, V21, P260, DOI 10.1111/j.1466-8238.2011.00675.x	58	11	16	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174390	10.1371/journal.pone.0174390	http://dx.doi.org/10.1371/journal.pone.0174390			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346534	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174300042
J	Shiraya, T; Kato, S; Araki, F; Ueta, T; Miyaji, T; Yamaguchi, T				Shiraya, Tomoyasu; Kato, Satoshi; Araki, Fumiyuki; Ueta, Takashi; Miyaji, Tempei; Yamaguchi, Takuhiro			Aqueous cytokine levels are associated with reduced macular thickness after intravitreal ranibizumab for diabetic macular edema	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; COHERENCE TOMOGRAPHIC FEATURES; TUMOR-NECROSIS-FACTOR; INDUCIBLE PROTEIN-10; VITREOUS LEVELS; HUMOR CYTOKINE; RETINOPATHY; BEVACIZUMAB; THERAPY; INTERLEUKIN-8	Purpose It is controversial whether the administration of anti-vascular endothelial growth factor drugs for diabetic macular edema (DME) affects intraocular inflammatory cytokines. In this study, we measured cytokine concentration in aqueous humor before and after intravitreal injection of ranibizumab (IVR). The aim was to determine changes in cytokine concentration and their effects on DME reduction. Methods Twelve patients (13 eyes) with DME received two IVR (0.5 mg) with a 1 month interval, and a total of 26 aqueous humor samples were obtained. Macular thickness was measured with an optical coherence tomography (OCT) using thickness-map mode with an Early Treatment Diabetic Retinopathy Study (ETDRS) 9-zone grid that was divided into two zones: a central circle with a diameter of 1 mm (zone1); and an outer circle with a diameter of 6 mm (zone2). Results The concentration of eotaxin-1 in aqueous humor samples decreased significantly after IVR. Baseline cytokine concentration was associated with IVR-induced DME reduction. In zone1, higher baseline concentration of interferon-induced protein (IP)-10, and in zone 2, higher baseline concentration of granulocyte-macrophage colony-stimulating factor, IP-10, and tumor necrosis factor (TNF) alpha; and lower baseline concentration of eotaxin-1, interleukin (IL)-5, and IL-8 were associated with improved DME. Cytokine changes were associated with IVR-induced DME reduction. In zone1, lower concentration of IP-10 compared to baseline or higher concentration of macrophage inflammatory protein (MIP) -alpha, and in zone 2, lower concentration of IL-5 compared to baseline, IL-8, and IP-10 or higher concentration of eotaxin-1 and MIP-1 beta were associated with improved DME. Conclusions These findings suggest that ranibizumab affects the concentration of cytokines in aqueous humor. Various cytokines contribute to a decrease in retinal thickness, both in the center of the macula and in a larger area of the retina.	[Shiraya, Tomoyasu; Kato, Satoshi; Araki, Fumiyuki; Ueta, Takashi] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan; [Miyaji, Tempei; Yamaguchi, Takuhiro] Univ Tokyo, Grad Sch Med, Dept Clin Trial Data Management, Tokyo, Japan; [Yamaguchi, Takuhiro] Tohoku Univ, Grad Sch Med, Div Biostat, Sendai, Miyagi, Japan	University of Tokyo; University of Tokyo; Tohoku University	Shiraya, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan.	shiraya01@gmail.com			JSPS KAKENHI [JP 25861617]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (Grants-in-Aid for Scientific Research) Grant Number JP 25861617 (https://www.jsps.go.jp/english/e-grants/index.html).	Alkuraya Hisham, 2005, International Ophthalmology, V26, P93, DOI 10.1007/s10792-006-9007-8; ANGIOLILLO AL, 1995, J EXP MED, V182, P155, DOI 10.1084/jem.182.1.155; Arevalo JF, 2007, OPHTHALMOLOGY, V114, P743, DOI 10.1016/j.ophtha.2006.12.028; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Cheung CMG, 2012, MOL VIS, V18, P830; Demircan N, 2006, EYE, V20, P1366, DOI 10.1038/sj.eye.6702138; Elner SG, 1998, ARCH OPHTHALMOL-CHIC, V116, P1597, DOI 10.1001/archopht.116.12.1597; ELNER SG, 1995, CURR EYE RES, V14, P1045, DOI 10.3109/02713689508998529; Ferrara N, 2006, RETINA-J RET VIT DIS, V26, P859, DOI 10.1097/01.iae.0000242842.14624.e7; Forooghian F, 2016, CAN J OPHTHALMOL, V51, P87, DOI 10.1016/j.jcjo.2015.11.001; Forooghian F, 2010, INVEST OPHTH VIS SCI, V51, P2388, DOI 10.1167/iovs.09-4065; Funatsu H, 2006, OPHTHALMOLOGY, V113, P294, DOI 10.1016/j.ophtha.2005.10.030; Funatsu H, 2002, AM J OPHTHALMOL, V133, P70, DOI 10.1016/S0002-9394(01)01269-7; Funk M, 2010, RETINA-J RET VIT DIS, V30, P1412, DOI 10.1097/IAE.0b013e3181e095c0; Petrovic MG, 2007, AM J OPHTHALMOL, V143, P175, DOI 10.1016/j.ajo.2006.07.032; Haritoglou C, 2006, RETINA-J RET VIT DIS, V26, P999, DOI 10.1097/01.iae.0000247165.38655.bf; Hernandez C, 2005, DIABETIC MED, V22, P719, DOI 10.1111/j.1464-5491.2005.01538.x; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kang SW, 2004, AM J OPHTHALMOL, V137, P313, DOI 10.1016/j.ajo.2003.09.016; Kim M, 2015, INDIAN J OPHTHALMOL, V63, P312, DOI 10.4103/0301-4738.158069; Kim M, 2011, OPHTHALMOLOGICA, V226, DOI 10.1159/000330045; Liu GQ, 2015, CURR EYE RES, V40, P891, DOI 10.3109/02713683.2014.968934; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Oh IK, 2010, CURR EYE RES, V35, P1116, DOI 10.3109/02713683.2010.510257; Photocoagulation for diabetic macular edema, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI DOI 10.1001/ARCH0PHT.1985.01050120030015; Roh MI, 2009, OPHTHALMOLOGY, V116, P80, DOI 10.1016/j.ophtha.2008.09.036; Selim KM, 2010, INDIAN J OPHTHALMOL, V58, P375, DOI 10.4103/0301-4738.67042; Shimura M, 2008, AM J OPHTHALMOL, V145, P854, DOI 10.1016/j.ajo.2007.12.031; Shimura M, 2013, RETINA-J RET VIT DIS, V33, P740, DOI 10.1097/IAE.0b013e31826b6763; Shiraya T, 2016, ACTA OPHTHA IN PRESS; Sohn HJ, 2011, AM J OPHTHALMOL, V152, P686, DOI 10.1016/j.ajo.2011.03.033; STRIETER RM, 1995, BIOCHEM BIOPH RES CO, V210, P51, DOI 10.1006/bbrc.1995.1626; Takatsu K, 2011, P JPN ACAD B-PHYS, V87, P463, DOI 10.2183/pjab.87.463; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Wang HB, 2011, INVEST OPHTH VIS SCI, V52, P8271, DOI 10.1167/iovs.11-8230	35	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174340	10.1371/journal.pone.0174340	http://dx.doi.org/10.1371/journal.pone.0174340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346545	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174300039
J	Heider, MR; Burkhart, BW; Santangelo, TJ; Gardner, AF				Heider, Margaret R.; Burkhart, Brett W.; Santangelo, Thomas J.; Gardner, Andrew F.			Defining the RNaseH2 enzyme-initiated ribonucleotide excision repair pathway in Archaea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						archaea; DNA damage; DNA repair; DNA replication; DNA synthesis; enzyme kinetics; pre-steady-state kinetics; RNaseH2; ribonucleotide excision repair	AICARDI-GOUTIERES-SYNDROME; D DNA-POLYMERASE; THERMOCOCCUS-KODAKARENSIS; CRYSTAL-STRUCTURES; GENOME INTEGRITY; 2-HYDROXYL GROUP; REPLICATION; H2; TRIPHOSPHATES; KODAKARAENSIS	Incorporation of ribonucleotides during DNA replication has severe consequences for genome stability. Although eukaryotes possess a number of redundancies for initiating and completing repair of misincorporated ribonucleotides, archaea such as Thermococcus rely only upon RNaseH2 to initiate the pathway. Because Thermococcus DNA polymerases incorporate as many as 1,000 ribonucleotides per genome, RNaseH2 must be efficient at recognizing and nicking at embedded ribonucleotides to ensure genome integrity. Here, we show that ribonucleotides are incorporated by the hyperthermophilic archaeon Thermococcus kodakarensis both in vitro and in vivo and a robust ribonucleotide excision repair pathway is critical to keeping incorporation levels low in wild-type cells. Using pre-steady-state and steady-state kinetics experiments, we also show that archaeal RNaseH2 rapidly cleaves at embedded ribonucleotides (200-450 s(-1)), but exhibits an approximate to 1,000-fold slower turnover rate (0.06-0.17 s(-1)), suggesting a potential role for RNaseH2 in protecting or marking nicked sites for further processing. We found that following RNaseH2 cleavage, the combined activities of polymerase B (PolB), flap endonuclease (Fen1), and DNA ligase are required to complete ribonucleotide processing. PolB formed a ribonucleotide-containing flap by strand displacement synthesis that was cleaved by Fen1, and DNA ligase sealed the nick for complete repair. Our study reveals conservation of the overall mechanism of ribonucleotide excision repair across domains of life. The lack of redundancies in ribonucleotide repair in archaea perhaps suggests a more ancestral form of ribonucleotide excision repair compared with the eukaryotic pathway.	[Heider, Margaret R.; Gardner, Andrew F.] New England Biolabs Inc, Ipswich, MA 01938 USA; [Burkhart, Brett W.; Santangelo, Thomas J.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80521 USA	New England Biolabs; Colorado State University	Gardner, AF (corresponding author), New England Biolabs Inc, Ipswich, MA 01938 USA.	gardner@neb.com	Santangelo, Tom/L-8206-2019	Santangelo, Tom/0000-0003-4559-3244	New England Biolabs, Inc.	New England Biolabs, Inc.	This work was supported by New England Biolabs, Inc. The authors declare that they have no conflicts of interest with the contents of this article.	BAN C, 1994, J MOL BIOL, V236, P275, DOI 10.1006/jmbi.1994.1134; Berquist BR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-31; Brown JA, 2011, BIOCHEMISTRY-US, V50, P1135, DOI 10.1021/bi101915z; Cerritelli SM, 2016, TRENDS BIOCHEM SCI, V41, P434, DOI 10.1016/j.tibs.2016.02.005; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Chon HG, 2009, NUCLEIC ACIDS RES, V37, P96, DOI 10.1093/nar/gkn913; Clausen A. R., 2015, DNA REPLICATION METH, P123; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Cubonova L, 2013, J BACTERIOL, V195, P2322, DOI 10.1128/JB.02037-12; EDER PS, 1991, J BIOL CHEM, V266, P6472; EGLI M, 1993, BIOCHEMISTRY-US, V32, P3221, DOI 10.1021/bi00064a004; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Fukui T, 2005, GENOME RES, V15, P352, DOI 10.1101/gr.3003105; Gardner AF, 1999, NUCLEIC ACIDS RES, V27, P2545, DOI 10.1093/nar/27.12.2545; Ghodgaonkar MM, 2013, MOL CELL, V50, P323, DOI 10.1016/j.molcel.2013.03.019; Greenough L, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv899; Greenough L, 2015, J BIOL CHEM, V290, P12514, DOI 10.1074/jbc.M115.638130; Greenough L, 2014, EXTREMOPHILES, V18, P653, DOI 10.1007/s00792-014-0646-9; Hileman TH, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00195; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; KONG HM, 1993, J BIOL CHEM, V268, P1965; Ladner JE, 2011, P NATL ACAD SCI USA, V108, P2711, DOI 10.1073/pnas.1019179108; Lai LH, 2000, STRUCTURE, V8, P897, DOI 10.1016/S0969-2126(00)00179-9; Li YF, 1999, J AM CHEM SOC, V121, P5364, DOI 10.1021/ja990592p; Li Z, 2010, MBIO, V1, DOI 10.1128/mBio.00221-10; LIPKIN D, 1954, J AM CHEM SOC, V76, P2871, DOI 10.1021/ja01640a004; Maher RL, 2007, J BIOL CHEM, V282, P30577, DOI 10.1074/jbc.M704341200; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Muroya A, 2001, PROTEIN SCI, V10, P707, DOI 10.1110/ps.48001; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rychlik MP, 2010, MOL CELL, V40, P658, DOI 10.1016/j.molcel.2010.11.001; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; Sarmiento F, 2013, P NATL ACAD SCI USA, V110, P4726, DOI 10.1073/pnas.1220225110; Schermerhorn KM, 2015, J BIOL CHEM, V290, P21800, DOI 10.1074/jbc.M115.662841; Spaans SK, 2015, EXTREMOPHILES, V19, P741, DOI 10.1007/s00792-015-0750-5; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vaisman A, 2014, MUTAT RES-FUND MOL M, V761, P21, DOI 10.1016/j.mrfmmm.2014.01.005; Wahl MC, 2000, NUCLEIC ACIDS RES, V28, P4356, DOI 10.1093/nar/28.21.4356; Williams JS, 2016, NAT REV MOL CELL BIO, V17, P350, DOI 10.1038/nrm.2016.37; Yao NY, 2013, P NATL ACAD SCI USA, V110, P12942, DOI 10.1073/pnas.1309506110	46	20	20	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8835	8845		10.1074/jbc.M117.783472	http://dx.doi.org/10.1074/jbc.M117.783472			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28373277	Green Published, hybrid			2022-12-26	WOS:000402153900028
J	Colomb, F; Wang, WK; Simpson, D; Zafar, M; Beynon, R; Rhodes, JM; Yu, LG				Colomb, Florent; Wang, Weikun; Simpson, Deborah; Zafar, Mudaser; Beynon, Robert; Rhodes, Jonathan M.; Yu, Lu-Gang			Galectin-3 interacts with the cell-surface glycoprotein CD146 (MCAM, MUC18) and induces secretion of metastasis-promoting cytokines from vascular endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; CIRCULATING GALECTIN-3; ADHESION MOLECULE; CANCER-PATIENTS; TUMOR; MELANOMA; ANGIOGENESIS; PROGRESSION; RECEPTOR; INTERLEUKIN-6	The galactoside-binding protein galectin-3 is increasingly recognized as an important player in cancer development, progression, and metastasis via its interactions with various galactoside- terminated glycans. We have shown previously that circulating galectin-3, which is increased up to 30-fold in cancer patients, promotes blood-borne metastasis in an animal cancer model. This effect is partly attributable to the interaction of galectin-3 with unknown receptor(s) on vascular endothelial cells and causes endothelial secretion of several metastasis-promoting cytokines. Here we sought to identify the galectin-3binding molecule(s) on the endothelial cell surface responsible for the galectin-3-mediated cytokine secretion. Using two different galectin-3 affinity purification processes, we extracted four cell membrane glycoproteins, CD146/melanoma cell adhesion molecule (MCAM)/MUC18, CD31/platelet endothelial cell adhesion molecule-1 (PECAM-1), CD144/VE-cadherin, and CD106/Endoglin, from vascular endothelial cells. CD146 was the major galectin-3-binding ligand and strongly co-localized with galectin-3 on endothelial cell surfaces treated with exogenous galectin-3. Moreover, galectin-3 bound to N-linked glycans on CD146 and induced CD146 dimerization and subsequent activation of AKT signaling. siRNA-mediatedsuppressionof CD146 expression completely abolished the galectin-3-induced secretion of IL-6 and G-CSF cytokines from the endothelial cells. Thus, CD146/MCAM is the functional galectin-3-binding ligand on endothelial cell surfaces responsible for galectin-3induced secretion of metastasis-promoting cytokines. We conclude that CD146/MCAM interactions with circulating galectin- 3 may have an important influence on cancer progression and metastasis.	[Colomb, Florent; Wang, Weikun; Zafar, Mudaser; Rhodes, Jonathan M.; Yu, Lu-Gang] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Gastroenterol Res Unit, Liverpool L69 3GE, Merseyside, England; [Simpson, Deborah; Beynon, Robert] Univ Liverpool, Inst Integrat Biol, Ctr Proteome Res, Liverpool L69 7ZB, Merseyside, England	University of Liverpool; University of Liverpool	Yu, LG (corresponding author), Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Gastroenterol Res Unit, Liverpool L69 3GE, Merseyside, England.	lgyu@liv.ac.uk	Beynon, Robert/K-1408-2014	Beynon, Robert/0000-0003-0857-495X; Zafar, Mudaser/0000-0001-5424-6514	North West Cancer Research Fund [CR975]	North West Cancer Research Fund	This work was supported by North West Cancer Research Fund Grant CR975. The authors declare that they have no conflicts of interest with the contents of this article.	Ara T, 2010, EUR J CANCER, V46, P1223, DOI 10.1016/j.ejca.2010.02.026; Barrow H, 2011, CLIN CANCER RES, V17, P7035, DOI 10.1158/1078-0432.CCR-11-1462; Bu PC, 2007, BBA-MOL CELL RES, V1773, P513, DOI 10.1016/j.bbamcr.2007.01.009; Chen C, 2013, CLIN CANCER RES, V19, P1693, DOI 10.1158/1078-0432.CCR-12-2940; Duckworth CA, 2015, ONCOTARGET, V6, P23671, DOI 10.18632/oncotarget.4409; Erdbruegger U, 2010, CURR STEM CELL RES T, V5, P294, DOI 10.2174/157488810793351721; Flanagan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040443; Iurisci I, 2000, CLIN CANCER RES, V6, P1389; Jiang GQ, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0313-3; Jiang TX, 2012, BLOOD, V120, P2330, DOI 10.1182/blood-2012-01-406108; Jouve N, 2015, INT J CANCER, V137, P50, DOI 10.1002/ijc.29370; Jouve N, 2013, J BIOL CHEM, V288, P2571, DOI 10.1074/jbc.M112.418848; Kitazume S, 2014, GLYCOBIOLOGY, V24, P1260, DOI 10.1093/glycob/cwu094; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Newlaczyl AU, 2011, CANCER LETT, V313, P123, DOI 10.1016/j.canlet.2011.09.003; Nodomi S, 2016, ONCOGENE, V35, P5317, DOI 10.1038/onc.2016.72; Pop VV, 2017, IMMUNOL LETT, V181, P45, DOI 10.1016/j.imlet.2016.11.010; Ruma IMW, 2016, CLIN EXP METASTAS, V33, P609, DOI 10.1007/s10585-016-9801-2; Sakaki M, 2008, J MED INVESTIG, V55, P127, DOI 10.2152/jmi.55.127; Saussez S, 2008, THYROID, V18, P705, DOI 10.1089/thy.2007.0361; Senapati S, 2011, CLIN CANCER RES, V17, P267, DOI 10.1158/1078-0432.CCR-10-1937; SERS C, 1994, CANCER RES, V54, P5689; SHIH IM, 1994, CANCER RES, V54, P2514; Sindrewicz P, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00079; Taylor-Papadimitriou J, 1999, BBA-MOL BASIS DIS, V1455, P301, DOI 10.1016/S0925-4439(99)00055-1; Tu T, 2015, CELL RES, V25, P275, DOI 10.1038/cr.2015.15; Ulmansky R, 2015, J IMMUNOL, V194, P5103, DOI 10.4049/jimmunol.1500023; Undi RB, 2016, CYTOKINE, V83, P245, DOI 10.1016/j.cyto.2016.05.007; Vereecken P, 2006, CLIN EXP DERMATOL, V31, P105, DOI 10.1111/j.1365-2230.2005.01992.x; Wang J, 2015, ONCOGENE, V34, P5781, DOI 10.1038/onc.2015.36; Wang ZQ, 2013, CANCER LETT, V330, P150, DOI 10.1016/j.canlet.2012.11.049; Wei LH, 2003, ONCOGENE, V22, P1517, DOI 10.1038/sj.onc.1206226; Yu LG, 2007, J BIOL CHEM, V282, P773, DOI 10.1074/jbc.M606862200; Zhao QC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-154; Zhao QC, 2009, CANCER RES, V69, P6799, DOI 10.1158/0008-5472.CAN-09-1096	36	43	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8381	8389		10.1074/jbc.M117.783431	http://dx.doi.org/10.1074/jbc.M117.783431			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28364041	hybrid, Green Published			2022-12-26	WOS:000401788600022
J	Dong, XD; Guan, JH; Zheng, CF; Zheng, XF				Dong, Xiaodong; Guan, Junhong; Zheng, Chunfu; Zheng, Xiaofeng			The herpes simplex virus 1 UL36USP deubiquitinase suppresses DNA repair in host cells via deubiquitination of proliferating cell nuclear antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE TEGUMENT PROTEIN; POLYMERASE-ETA; MONOUBIQUITINATED PCNA; DAMAGE; REPLICATION; PATHWAY; TYPE-1; DOMAIN; VP1/2; UBIQUITINATION	Herpes simplex virus 1 (HSV-1) infection manipulates distinct host DNA-damage responses to facilitate virus proliferation, but the molecular mechanisms remain to be elucidated. One possible HSV-1 target might be DNA damage-tolerance mechanisms, such as the translesion synthesis (TLS) pathway. In TLS, proliferating cell nuclear antigen (PCNA) is monoubiquitinated in response to DNA damage-caused replication fork stalling. Ubiquitinated PCNA then facilitates the error-prone DNA polymerase eta (pol eta)-mediated TLS, allowing the fork to bypass damaged sites. Because of the involvement of PCNA ubiquitination in DNA-damage repair, we hypothesized that the function of PCNA might be altered by HSV-1. Here we show that PCNA is a substrate of the HSV-1 deubiquitinase UL36USP, which has previously been shown to be involved mainly in virus uptake and maturation. In HSV-1-infected cells, viral infection-associated UL36USP consistently reduced PCNA ubiquitination. The deubiquitination of PCNA inhibited the formation of pol eta foci and also increased cell sensitivity to DNA-damage agents. Moreover, the catalytically inactive mutant UL36C40A failed to deubiquitinate PCNA. Of note, the levels of virus marker genes increased strikingly in cells infected with wild-type HSV-1, but only moderately in UL36C40A mutant virus-infected cells, indicating that the UL36USP deubiquitinating activity supports HSV-1 virus replication during infection. These findings suggest a role of UL36USP in the DNA damage-response pathway.	[Dong, Xiaodong; Guan, Junhong; Zheng, Xiaofeng] Peking Univ, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Dong, Xiaodong; Guan, Junhong; Zheng, Xiaofeng] Peking Univ, Dept Biochem & Mol Biol, Sch Life Sci, Beijing 100871, Peoples R China; [Zheng, Chunfu] Soochow Univ, Inst Biol & Med Sci, Suzhou 215123, Peoples R China; [Zheng, Chunfu] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB T2N 1N4, Canada	Peking University; Peking University; Soochow University - China; University of Calgary	Zheng, XF (corresponding author), Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China.	xiaofengz@pku.edu.cn	zheng, Chunfu/F-2404-2012; 关, 俊宏/AAG-1046-2021; Guan, Junhong/HIK-0559-2022	zheng, Chunfu/0000-0002-8797-1322; 关, 俊宏/0000-0003-4900-0610; 	National Science Foundation of China [31470754, 31670786]; National Key Research and Development Program of China [2016YFC1302401]; Doctoral Fund of Ministry of Education of China [20130001130003]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This work was supported by National Science Foundation of China Grants 31470754 and 31670786, the National Key Research and Development Program of China Grant 2016YFC1302401, and Doctoral Fund of Ministry of Education of China Grant 20130001130003. The authors declare that they have no conflicts of interest with the contents of this article.	Acharya N, 2008, P NATL ACAD SCI USA, V105, P17724, DOI 10.1073/pnas.0809844105; Bolstad M, 2011, J VIROL, V85, P8738, DOI 10.1128/JVI.00798-11; Bucks MA, 2007, VIROLOGY, V361, P316, DOI 10.1016/j.virol.2006.11.031; Cardone G, 2012, J VIROL, V86, P4058, DOI 10.1128/JVI.00012-12; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chaurushiya MS, 2009, DNA REPAIR, V8, P1166, DOI 10.1016/j.dnarep.2009.04.016; Copeland AM, 2009, J VIROL, V83, P1660, DOI 10.1128/JVI.01139-08; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; Gastaldello S, 2010, NAT CELL BIOL, V12, P351, DOI 10.1038/ncb2035; GIBSON W, 1972, J VIROL, V10, P1044, DOI 10.1128/JVI.10.5.1044-1052.1972; Han JH, 2014, J CELL BIOL, V205, P811, DOI 10.1083/jcb.201311007; Haracska L, 2005, MOL CELL BIOL, V25, P1183, DOI 10.1128/MCB.25.3.1183-1190.2005; Hedglin M, 2016, ELIFE, V5, DOI 10.7554/eLife.19788; Hishiki A, 2009, J BIOL CHEM, V284, P10552, DOI 10.1074/jbc.M809745200; Hu B, 2014, NUCLEIC ACIDS RES, V42, P5582, DOI 10.1093/nar/gku230; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Karttunen H, 2014, MOL CELL, V55, P111, DOI 10.1016/j.molcel.2014.05.020; Kashiwaba S, 2015, CELL REP, V13, P2072, DOI 10.1016/j.celrep.2015.11.014; Kattenhorn LM, 2005, MOL CELL, V19, P547, DOI 10.1016/j.molcel.2005.07.003; Kim ET, 2009, J VIROL, V83, P12046, DOI 10.1128/JVI.00411-09; Kumar R, 2014, J VIROL, V88, P6411, DOI 10.1128/JVI.00536-14; Lee JIH, 2006, J VIROL, V80, P12086, DOI 10.1128/JVI.01184-06; Lilley CE, 2005, P NATL ACAD SCI USA, V102, P5844, DOI 10.1073/pnas.0501916102; Luftig MA, 2014, ANNU REV VIROL, V1, P605, DOI 10.1146/annurev-virology-031413-085548; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Newcomb WW, 2010, J VIROL, V84, P9408, DOI 10.1128/JVI.00361-10; Park JM, 2014, MOL CELL, V54, P626, DOI 10.1016/j.molcel.2014.03.031; Roberts APE, 2009, J VIROL, V83, P105, DOI 10.1128/JVI.01032-08; Sale JE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012708; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Sanders I, 2015, J NEUROVIROL, V21, P358, DOI 10.1007/s13365-015-0321-7; Schlieker C, 2005, J VIROL, V79, P15582, DOI 10.1128/JVI.79.24.15582-15585.2005; Schumacher AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002862; Shanda SK, 2008, J VIROL, V82, P7388, DOI 10.1128/JVI.00225-08; Taylor TJ, 2004, J VIROL, V78, P5856, DOI 10.1128/JVI.78.11.5856-5866.2004; Vidal AE, 2004, J BIOL CHEM, V279, P48360, DOI 10.1074/jbc.M406511200; Wang S, 2013, J VIROL, V87, P11851, DOI 10.1128/JVI.01211-13; Weitzman MD, 2014, CELL HOST MICROBE, V15, P283, DOI 10.1016/j.chom.2014.02.010; Weller SK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013011; Whitehurst CB, 2012, J VIROL, V86, P8097, DOI 10.1128/JVI.00588-12; Whitley RJ, 1998, CLIN INFECT DIS, V26, P541, DOI 10.1086/514600; WILCOCK D, 1991, NATURE, V349, P429, DOI 10.1038/349429a0; Zaichick SV, 2013, CELL HOST MICROBE, V13, P193, DOI 10.1016/j.chom.2013.01.009; Zeman MK, 2014, J CELL BIOL, V206, P183, DOI 10.1083/jcb.201311063; Zhang J, 2014, ONCOGENE, V33, P246, DOI 10.1038/onc.2012.560; Zhou ZH, 1999, J VIROL, V73, P3210, DOI 10.1128/JVI.73.4.3210-3218.1999	47	8	9	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8472	8483		10.1074/jbc.M117.778076	http://dx.doi.org/10.1074/jbc.M117.778076			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28348081	Green Published, hybrid			2022-12-26	WOS:000401788600030
J	Wang, S; Wang, S; Asgar, J; Joseph, J; Ro, JY; Wei, F; Campbell, JN; Chung, MK				Wang, Sheng; Wang, Sen; Asgar, Jamila; Joseph, John; Ro, Jin Y.; Wei, Feng; Campbell, James N.; Chung, Man-Kyo			Ca2+ and calpain mediate capsaicin-induced ablation of axonal terminals expressing transient receptor potential vanilloid 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; PRIMARY AFFERENT NEURONS; ROOT GANGLION NEURONS; NEUROPATHIC PAIN; PLASMA-MEMBRANE; ION-CHANNEL; DEGENERATION; INJURY; TRPV1; DEATH	Capsaicin is an ingredient in spicy peppers that produces burning pain by activating transient receptor potential vanilloid 1 (TRPV1), a Ca2+-permeable ion channel in nociceptors. Capsaicin has also been used as an analgesic, and its topical administration is approved for the treatment of certain pain conditions. The mechanisms underlying capsaicin-induced analgesia likely involve reversible ablation of nociceptor terminals. However, the mechanisms underlying these effects are not well understood. To visualize TRPV1-lineage axons, a genetically engineered mouse model was used in which a fluorophore is expressed under the TRPV1 promoter. Using a combination of these TRPV1-lineage reporter mice and primary afferent cultures, we monitored capsaicin-induced effects on afferent terminals in real time. We found that Ca2+ influx through TRPV1 is necessary for capsaicin-induced ablation of nociceptive terminals. Although capsaicin-induced mitochondrial Ca2+ uptake was TRPV1-dependent, dissipation of the mitochondrial membrane potential, inhibition of the mitochondrial transition permeability pore, and scavengers of reactive oxygen species did not attenuate capsaicin-induced ablation. In contrast, MDL28170, an inhibitor of the Ca2+-dependent protease calpain, diminished ablation. Furthermore, overexpression of calpastatin, an endogenous inhibitor of calpain, or knockdown of calpain 2 also decreased ablation. Quantitative assessment of TRPV1-lineage afferents in the epidermis of the hind paws of the reporter mice showed that EGTA and MDL28170 diminished capsaicin-induced ablation. Moreover, MDL28170 prevented capsaicin-induced thermal hypoalgesia. These results suggest that TRPV1/Ca2+/calpain-dependent signaling plays a dominant role in capsaicin-induced ablation of nociceptive terminals and further our understanding of the molecular mechanisms underlying the effects of capsaicin on nociceptors.	[Wang, Sheng; Wang, Sen; Asgar, Jamila; Joseph, John; Ro, Jin Y.; Wei, Feng; Chung, Man-Kyo] Univ Maryland, Sch Dent, Ctr Adv Chron Pain Res, Dept Neural & Pain Sci,Program Neurosci, Baltimore, MD 21201 USA; [Campbell, James N.] Centrexion, Baltimore, MD 21202 USA	University System of Maryland; University of Maryland Baltimore	Chung, MK (corresponding author), Univ Maryland, Sch Dent, Dept Neural & Pain Sci, 650 W Baltimore St,8 South, Baltimore, MD 21201 USA.	mchung@umaryland.edu	Chung, Man-Kyo/S-7433-2019	Chung, Man-Kyo/0000-0001-7637-1148	National Institutes of Health [R01 DE023846]; Maryland Industrial Partnership [5403]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS091296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Industrial Partnership; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health Grant R01 DE023846 (to M. K. C.) and Maryland Industrial Partnership Grant 5403 (to M. K. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anand P, 2011, BRIT J ANAESTH, V107, P490, DOI 10.1093/bja/aer260; Barrientos SA, 2011, J NEUROSCI, V31, P966, DOI 10.1523/JNEUROSCI.4065-10.2011; Borbiro I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005667; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; Campbell CM, 2016, PAIN, V157, P1297, DOI 10.1097/j.pain.0000000000000544; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caudle RM, 2003, NEUROTOXICOLOGY, V24, P895, DOI 10.1016/S0161-813X(03)00146-3; Cavanaugh DJ, 2011, J NEUROSCI, V31, P10119, DOI 10.1523/JNEUROSCI.1299-11.2011; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; CHARD PS, 1995, NEUROSCIENCE, V65, P1099, DOI 10.1016/0306-4522(94)00548-J; Chiang H, 2015, ACTA NEUROPATHOL, V129, P81, DOI 10.1007/s00401-014-1354-3; Chung MK, 2012, J DENT RES, V91, P777, DOI 10.1177/0022034512450298; Chung MK, 2016, PHARMACEUTICALS-BASE, V9, DOI 10.3390/ph9040066; Chung MK, 2016, MOL PAIN, V12, DOI 10.1177/1744806916668526; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Dedov VN, 2001, NEUROSCIENCE, V103, P219, DOI 10.1016/S0306-4522(00)00540-6; Duchen MR, 2004, DIABETES, V53, pS96, DOI 10.2337/diabetes.53.2007.S96; GEORGE EB, 1995, J NEUROSCI, V15, P6445; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Goswami C, 2004, J NEUROCHEM, V91, P1092, DOI 10.1111/j.1471-4159.2004.02795.x; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Iadarola Michael J, 2013, Open Pain J, V6, P95; Jackson JG, 2006, J NEUROPHYSIOL, V96, P1093, DOI 10.1152/jn.00283.2006; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Karai LJ, 2004, J BIOL CHEM, V279, P16377, DOI 10.1074/jbc.M310891200; Kilinc D, 2009, EXP NEUROL, V219, P553, DOI 10.1016/j.expneurol.2009.07.014; Kim HK, 2010, ANESTHESIOLOGY, V112, P432, DOI 10.1097/ALN.0b013e3181ca31bd; Kunz S, 2004, PAIN, V110, P409, DOI 10.1016/j.pain.2004.04.031; Liu L, 2001, J NEUROPHYSIOL, V85, P745, DOI 10.1152/jn.2001.85.2.745; Ma M, 2013, NEUROBIOL DIS, V60, P61, DOI 10.1016/j.nbd.2013.08.010; Ma M, 2013, NEUROBIOL DIS, V56, P34, DOI 10.1016/j.nbd.2013.03.009; Ma XL, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0019-0; Malmberg AB, 2004, PAIN, V111, P360, DOI 10.1016/j.pain.2004.07.017; Mou J, 2013, PAIN, V154, P1632, DOI 10.1016/j.pain.2013.04.044; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Neubert JK, 2003, PAIN, V104, P219, DOI 10.1016/S0304-3959(03)00009-5; Neukomm LJ, 2014, TRENDS CELL BIOL, V24, P515, DOI 10.1016/j.tcb.2014.04.003; Polydefkis M, 2004, BRAIN, V127, P1606, DOI 10.1093/brain/awh175; Premkumar L. S., 2015, OPEN PAIN J, V8, P1; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; Schattling B, 2012, NAT MED, V18, P1805, DOI 10.1038/nm.3015; Shin CY, 2003, MOL CELL NEUROSCI, V24, P57, DOI 10.1016/S1044-7431(03)00121-0; Shutov LP, 2013, J PHYSIOL-LONDON, V591, P2443, DOI 10.1113/jphysiol.2012.249219; Simone DA, 1998, J NEUROSCI, V18, P8947; Stantcheva KK, 2016, EMBO REP, V17, P585, DOI 10.15252/embr.201540983; Stout AK, 1998, NAT NEUROSCI, V1, P366, DOI 10.1038/1577; Szallasi A, 1999, PHARMACOL REV, V51, P159; Takayama Y, 2015, P NATL ACAD SCI USA, V112, P5213, DOI 10.1073/pnas.1421507112; Tsantoulas C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080722; Villegas R, 2014, J NEUROSCI, V34, P7179, DOI 10.1523/JNEUROSCI.4784-13.2014; Wang S., 2015, COMPUT MATH METHOD M, V2015, P1, DOI DOI 10.1016/J.EC0C0M.2015.04.004; Wang S, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-22; Wang YB, 2013, J NEUROSCI, V33, P18880, DOI 10.1523/JNEUROSCI.3293-13.2013; Wu JH, 2014, BIOCHEM J, V464, P13, DOI 10.1042/BJ20140931; Yang J, 2013, NEURON, V80, P1175, DOI 10.1016/j.neuron.2013.08.034; Zang Y, 2015, BRAIN BEHAV IMMUN, V44, P37, DOI 10.1016/j.bbi.2014.08.003; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X	57	21	21	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8291	8303		10.1074/jbc.M117.778290	http://dx.doi.org/10.1074/jbc.M117.778290			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28360106	hybrid, Green Published			2022-12-26	WOS:000401788600015
J	Llaurado, G; Cano, A; Hernandez, C; Gonzalez-Sastre, M; Rodriguez, AA; Punti, J; Berianga, E; Albert, L; Simo, R; Vendrell, J; Clemente, JMG				Llaurado, Gemma; Cano, Albert; Hernandez, Cristina; Gonzalez-Sastre, Montserrat; Rodriguez, Ato-Antonio; Punti, Jordi; Berianga, Eugenio; Albert, Lara; Simo, Rafael; Vendrell, Joan; Gonzalez Clemente, Jose-Miguel			Type 1 diabetes: Developing the first riskestimation model for predicting silent myocardial ischemia. The potential role of insulin resistance	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; PITTSBURGH EPIDEMIOLOGY; HEART-ASSOCIATION; RISK; STIFFNESS; COMPLICATIONS; MORTALITY; MELLITUS	Objectives The aim of the study was to develop a novel risk estimation model for predicting silent myocardial ischemia (SMI) in patients with type 1 diabetes (T1DM) and no clinical cardiovascular disease, evaluating the potential role of insulin resistance in such a model. Additionally, the accuracy of this model was compared with currently available models for predicting clinical coronary artery disease (CAD) in general and diabetic populations. Research, design and methods Patients with T1DM (35-65years, >10-year duration) and no clinical cardiovascular disease were consecutively evaluated for: 1) clinical and anthropometric data (including classical cardiovascular risk factors), 2) insulin sensitivity (estimate of glucose disposal rate (eGDR)), and 3) SMI diagnosed by stress myocardial perfusion gated SPECTs. Results Eighty-four T1DM patients were evaluated [50.1 +/- 9.3 years, 50% men, 36.9% active smokers, T1DM duration: 19.0(15.9-27.5) years and eGDR 7.8(5.5-9.4) mg.kg(-1).min(-1)]. Of these, ten were diagnosed with SMI (11.9%). Multivariate logistic regression models showed that only eGDR (OR = -0.593, p = 0.005) and active smoking (OR = 7.964, p = 0.018) were independently associated with SMI. The AUC of the ROC curve of this risk estimation model for predicting SMI was 0.833 (95% CI:0.692-0.974), higher than those obtained with the use of currently available models for predicting clinical CAD (Framingham Risk Equation: 0.833 vs. 0.688, p = 0.122; UKPDS Risk Engine (0.833 vs. 0.559; p = 0.001) and EDC equation: 0.833 vs. 0.558, p = 0.027). Conclusion This study provides the first ever reported risk-estimation model for predicting SMI in T1DM. The model only includes insulin resistance and active smoking as main predictors of SMI.	[Llaurado, Gemma] Hosp del Mar, Dept Endocrinol & Nutr, Barcelona, Spain; [Llaurado, Gemma; Hernandez, Cristina; Simo, Rafael; Vendrell, Joan; Gonzalez Clemente, Jose-Miguel] Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Cano, Albert; Albert, Lara; Gonzalez Clemente, Jose-Miguel] Univ Autonoma Barcelona, Inst Invest & Innovacio Parc Tauli I3PT, Parc Tauli Hosp Univ, Dept Endocrinol & Nutr, Sabadell, Spain; [Hernandez, Cristina; Simo, Rafael] Univ Autonoma Barcelona, Inst Recerca, Hosp Univ Vail dHebron, Diabet & Metab Res Unit, Barcelona, Spain; [Gonzalez-Sastre, Montserrat] Univ Autonoma Barcelona, Inst Invest & Innovacio Parc Tauli I3PT, Parc Tauli Hosp Univ, Ophthalmol Dept, Sabadell, Spain; [Rodriguez, Ato-Antonio] Univ Autonoma Barcelona, Inst Invest & Innovacio Parc Tauli I3PT, UDIAT Ctr Diagnost, Nucl Med Dept, Sabadell, Spain; [Punti, Jordi] Univ Autonoma Barcelona, Inst Invest & Innovacio Parc Tauli I3PT, Parc Tauli Hosp Univ, Cardiol Dept, Sabadell, Spain; [Berianga, Eugenio] Univ Autonoma Barcelona, Inst Invest & Innovacio Parc Tauli I3PT, UDIAT Ctr Diagnost, Biochem Dept, Sabadell, Spain; [Vendrell, Joan] Univ Rovira & Virgili, IISPV, Hosp Univ Joan 23 Tarragona, Tarragona, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV)	Clemente, JMG (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain.; Clemente, JMG (corresponding author), Univ Autonoma Barcelona, Inst Invest & Innovacio Parc Tauli I3PT, Parc Tauli Hosp Univ, Dept Endocrinol & Nutr, Sabadell, Spain.	josmi.gonza@gmail.com	Stefanadis, Christodoulos/ABH-2232-2020; Llauradó, Gemma/AAB-9839-2020; Vendrell, Joan j/V-4034-2018	Stefanadis, Christodoulos/0000-0001-5974-6454; Vendrell, Joan j/0000-0002-6994-6115; Simo Canonge, Rafael/0000-0003-0475-3096; Cano Palomares, Albert/0000-0002-2804-3745; Albert Fabregas, Lara/0000-0003-3711-918X; Hernandez, Cristina/0000-0002-3109-1721	Associacio Catalana de Diabetis (Beca Goncal Lloveras); Fondo de Investigacion Sanitaria (FIS) as part of the National R+D+I [PI12/00954]; Institute de Salud Carlos III - General Evaluation Branch (Spanish Ministry of Economy and Competitiveness); European Regional Development Fund (ERDF); "Rio Hortega" research fellowship from the Institute de Salud Carlos III (Spain) [CM12/00044]	Associacio Catalana de Diabetis (Beca Goncal Lloveras); Fondo de Investigacion Sanitaria (FIS) as part of the National R+D+I; Institute de Salud Carlos III - General Evaluation Branch (Spanish Ministry of Economy and Competitiveness); European Regional Development Fund (ERDF)(European Commission); "Rio Hortega" research fellowship from the Institute de Salud Carlos III (Spain)	Financial support was provided through a grant from the Associacio Catalana de Diabetis (Beca Goncal Lloveras 2012) and the Fondo de Investigacion Sanitaria (FIS) PI12/00954 as part of the National R+D+I (2008-2011) and was cofinanced by the Institute de Salud Carlos III - General Evaluation Branch (Spanish Ministry of Economy and Competitiveness) and the European Regional Development Fund (ERDF). G. Llaurado was supported by a "Rio Hortega" research fellowship (CM12/00044) from the Institute de Salud Carlos III (Spain).	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Cavalcante JL, 2011, J AM COLL CARDIOL, V57, P1511, DOI 10.1016/j.jacc.2010.12.017; Cleland SJ, 2012, NAT REV ENDOCRINOL, V8, P476, DOI 10.1038/nrendo.2012.47; Cosson E, 2003, DIABETES CARE, V26, P1313, DOI 10.2337/diacare.26.4.1313; Cosson E, 2003, DIABETES METAB, V29, P470, DOI 10.1016/S1262-3636(07)70060-5; de Ferranti SD, 2014, CIRCULATION, V130, P1110, DOI [10.1161/CIR.0000000000000034, 10.2337/dc14-1720]; Diabetes C, 2016, DIABETES CARE, V39, P686, DOI DOI 10.2337/DC15-1990; FAVA S, 1993, DIABETES CARE, V16, P1615, DOI 10.2337/diacare.16.12.1615; FAZZINI PF, 1993, AM J CARDIOL, V72, P1383, DOI 10.1016/0002-9149(93)90184-E; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gonzalez-Clemente JM, 2005, EUR J ENDOCRINOL, V153, P687, DOI 10.1530/eje.1.02016; Greenland P, 2010, J AM COLL CARDIOL, V56, P2182, DOI 10.1016/j.jacc.2010.09.002; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hallal PC, 2004, MED SCI SPORT EXER, V36, P556, DOI 10.1249/01.MSS.0000117161.66394.07; International Diabetes Federation, 2003, IDF CONS WORLDW DEF; Kilpatrick ES, 2007, DIABETES CARE, V30, P707, DOI 10.2337/dc06-1982; Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6; Larsen J, 2002, DIABETES, V51, P2637, DOI 10.2337/diabetes.51.8.2637; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Libby P, 2005, CIRCULATION, V111, P3489, DOI 10.1161/CIRCULATIONAHA.104.529651; Livingstone SJ, 2015, JAMA-J AM MED ASSOC, V313, P37, DOI 10.1001/jama.2014.16425; Llaurado G, 2012, DIABETES CARE, V35, P1083, DOI 10.2337/dc11-1475; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Nathan DM, 2016, DIABETES, V65, P1370, DOI 10.2337/db15-1517; Orasanu G, 2009, J AM COLL CARDIOL, V53, pS35, DOI 10.1016/j.jacc.2008.09.055; Orchard TJ, 2003, DIABETES CARE, V26, P1374, DOI 10.2337/diacare.26.5.1374; Orchard TJ, 2006, DIABETES CARE, V29, P2528, DOI 10.2337/dc06-1161; Pambianco G, 2007, DIABETES CARE, V30, P1248, DOI 10.2337/dc06-2053; Reynolds K, 2011, J PEDIATR-US, V158, P594, DOI 10.1016/j.jpeds.2010.10.011; Schwab KO, 2008, INT J ADOLESC MED HL, V20, P285, DOI DOI 10.1515/IJAMH.2008.20.3.285; Secrest AM, 2010, DIABETES, V59, P3216, DOI 10.2337/db10-0862; Senior PA, 2005, DIABETES CARE, V28, P866, DOI 10.2337/diacare.28.4.866; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Sultan A, 2004, DIABETES CARE, V27, P1745, DOI 10.2337/diacare.27.7.1745; Thorn LM, 2005, DIABETES CARE, V28, P2019, DOI 10.2337/diacare.28.8.2019; Valensi P, 2005, DIABETES CARE, V28, P2722, DOI 10.2337/diacare.28.11.2722; Vistisen D, 2016, CIRCULATION, V133, P1058, DOI 10.1161/CIRCULATIONAHA.115.018844; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Williams KV, 2000, DIABETES, V49, P626, DOI 10.2337/diabetes.49.4.626; [World Health Organization Departement Noncommunicable Disease Surveillance], 1999, DEF DIAGN CLASS DIAB, P31; YKIJARVINEN H, 1986, NEW ENGL J MED, V315, P224, DOI 10.1056/NEJM198607243150404; Young LH, 2009, JAMA-J AM MED ASSOC, V301, P1547, DOI 10.1001/jama.2009.476; Zgibor JC, 2010, DIABETES RES CLIN PR, V88, P314, DOI 10.1016/j.diabres.2010.02.009; Zgibor JC, 2006, DIABETES CARE, V29, P1860, DOI 10.2337/dc06-0290	45	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174640	10.1371/journal.pone.0174640	http://dx.doi.org/10.1371/journal.pone.0174640			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369151	Green Submitted, gold, Green Published			2022-12-26	WOS:000399351000028
J	Paterniti, I; Campolo, M; Siracusa, R; Cordaro, M; Di Paola, R; Calabrese, V; Navarra, M; Cuzzocrea, S; Esposito, E				Paterniti, Irene; Campolo, Michela; Siracusa, Rosalba; Cordaro, Marika; Di Paola, Rosanna; Calabrese, Vittorio; Navarra, Michele; Cuzzocrea, Salvatore; Esposito, Emanuela			Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson's disease	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; NITRIC-OXIDE; ALZHEIMERS-DISEASE; DEFICIENT MICE; MODEL; PALMITOYLETHANOLAMIDE; DEGENERATION; REDUCTION; MICROGLIA; MELATONIN	Parkinson's disease (PD) is a neurodegenerative disease in which degeneration of nigrostriatal neurons and inflammation are key players. The aim of our study was to analyze the function of LXRs in neurodegenerative diseases as PD using in vivo, ex vivo and in vitro models of PD; for this purpose, we observed the effects of the LXR agonist, TO901317, in neuroinflammatory pathway related to PD. We performed an in vivo model of PD using the neurotoxin 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP) and our results clearly showed that TO901317 administration reduces all of the inflammatory markers involved in PD such as iNOS and COX2, I kappa B-alpha and NF-kappa B. Moreover, to confirm the neuroprotective properties of TO901317, that we obtained with the in vivo model, we performed also an ex vivo and in vitro models of PD. All the results taken, confirmed that TO901317 is able to modulate the neuroinflammatory pathway involved in PD increasing the locomotors function. Therefore, TO901317, LXR synthetic agonist, could be studied as a new target in a neurodegenerative disorder like PD.	[Paterniti, Irene; Campolo, Michela; Siracusa, Rosalba; Cordaro, Marika; Di Paola, Rosanna; Cuzzocrea, Salvatore; Esposito, Emanuela] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Messina, Italy; [Calabrese, Vittorio] Univ Catania, Dept Chem, Fac Med, Catania, Italy; [Navarra, Michele] Univ Messina, Dept Drug Sci & Hlth Prod, Messina, Italy; [Cuzzocrea, Salvatore] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	University of Messina; University of Catania; University of Messina; Saint Louis University	Cuzzocrea, S (corresponding author), Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Messina, Italy.; Cuzzocrea, S (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA.	salvator@unime.it	Siracusa, Rosalba/AAC-3110-2022; Calabrese, Vittorio/AAC-8157-2021; Cordaro, Marika/K-7329-2016; Cuzzocrea, Salvatore/K-4734-2016; Campolo, Michela/K-6432-2016; di paola, rosanna/U-4356-2019	Siracusa, Rosalba/0000-0001-7868-2505; Calabrese, Vittorio/0000-0002-0478-985X; Cordaro, Marika/0000-0002-3980-0043; di paola, rosanna/0000-0001-6725-8581; Esposito, Emanuela/0000-0002-2663-6387; Campolo, Michela/0000-0002-5124-3876; Cuzzocrea, Salvatore/0000-0001-6131-3690; Navarra, Michele/0000-0002-6492-7820				Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Abe K, 2000, NEUROSCI RES, V38, P325, DOI 10.1016/S0168-0102(00)00188-7; Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Andersson S, 2005, P NATL ACAD SCI USA, V102, P3857, DOI 10.1073/pnas.0500634102; Araki T, 2001, BRAIN RES, V918, P176, DOI 10.1016/S0006-8993(01)02944-4; Beal MF, 2003, ANN NY ACAD SCI, V991, P120; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; Bortolato M, 2009, NEUROPSYCHOPHARMACOL, V34, P2746, DOI 10.1038/npp.2009.118; CHAO CC, 1992, J IMMUNOL, V149, P2736; Emborg ME, 2007, ILAR J, V48, P339, DOI 10.1093/ilar.48.4.339; Hirsch EC, 2009, LANCET NEUROL, V8, P382, DOI 10.1016/S1474-4422(09)70062-6; Hunot S, 1999, J NEUROSCI, V19, P3440; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; Liedhegner EAS, 2011, CHEM RES TOXICOL, V24, P1644, DOI 10.1021/tx200082h; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Ortiz GG, 2008, CURR NEUROPHARMACOL, V6, P203, DOI 10.2174/157015908785777201; Paterniti I, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-91; Paterniti I, 2010, J NEUROCHEM, V112, P611, DOI 10.1111/j.1471-4159.2009.06471.x; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PORSOLT RD, 1979, EUR J PHARMACOL, V57, P201, DOI 10.1016/0014-2999(79)90366-2; Przuntek H, 2004, J NEURAL TRANSM, V111, P201, DOI 10.1007/s00702-003-0102-y; Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011; Schulz JB, 2004, CELL TISSUE RES, V318, P135, DOI 10.1007/s00441-004-0954-y; Singhal NK, 2012, MOL NEUROBIOL, V45, P186, DOI 10.1007/s12035-011-8225-x; Siracusa R, 2015, CNS NEUROL DISORD-DR, V14, P1350, DOI 10.2174/1871527314666150821102823; Song X, 1997, NEUROTOXICOLOGY, V18, P341; Tripanichkul W, 2013, EUR REV MED PHARMACO, V17, P1360; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Wang L, 2002, P NATL ACAD SCI USA, V99, P13878, DOI 10.1073/pnas.172510899; Xu P, 2013, MOL NEUROBIOL, V48, P715, DOI 10.1007/s12035-013-8461-3	32	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174470	10.1371/journal.pone.0174470	http://dx.doi.org/10.1371/journal.pone.0174470			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369131	Green Published, Green Submitted, gold			2022-12-26	WOS:000399351000017
J	Cabral, AS; Lessa, MM; Junger, PC; Thompson, FL; Paranhos, R				Cabral, Anderson S.; Lessa, Mariana M.; Junger, Pedro C.; Thompson, Fabiano L.; Paranhos, Rodolfo			Virioplankton dynamics are related to eutrophication levels in a tropical urbanized bay	PLOS ONE			English	Article							MARINE VIRUSES; FLOW-CYTOMETRY; SPATIAL-DISTRIBUTION; VIRAL PRODUCTION; RIVER ESTUARY; ABUNDANCE; BACTERIAL; BACTERIOPLANKTON; WATERS; ENUMERATION	Virioplankton are an important and abundant biological component of marine and freshwater ecosystems. Often overlooked, aquatic viruses play an important role in biogeochemical cycles on a global scale, infecting both autotrophic and heterotrophic microbes. Viral diversity, abundance, and viral interactions at different trophic levels in aqueous environments are not well understood. Tropical ecosystems are less frequently studied than temperate ecosystems, but could provide new insights into how physical and chemical variability can shape or force microbial community changes. In this study, we found high viral abundance values in Guanabara Bay relative to other estuaries around the world. Viral abundance was positively correlated with bacterioplankton abundance and chlorophyll a concentrations. Moreover, prokaryotic and viral abundance were positively correlated with eutrophication, especially in surface waters. These results provide novel baseline data on the quantitative distribution of aquatic viruses in tropical estuaries. They also provide new information on a complex and dynamic relationship in which environmental factors influence the abundance of bacterial hosts and consequently their viruses. Guanabara Bay is characterized by spatial and seasonal variations, and the eutrophication process is the most important factor explaining the structuring of virioplankton abundance and distribution in this tropical urbanized bay.	[Cabral, Anderson S.; Lessa, Mariana M.; Paranhos, Rodolfo] Fed Univ Rio de Janeiro UFRJ, Inst Biol, Lab Hydrobiol, Rio De Janeiro, Brazil; [Cabral, Anderson S.; Lessa, Mariana M.; Junger, Pedro C.; Paranhos, Rodolfo] Fed Univ Rio de Janeiro UFRJ, Inst Biol, Grad Program Ecol, Rio De Janeiro, Brazil; [Cabral, Anderson S.; Thompson, Fabiano L.] Fed Univ Rio de Janeiro UFRJ, Inst Biol, Microbiol Lab, Rio De Janeiro, Brazil; [Junger, Pedro C.] Fed Univ Rio de Janeiro UFRJ, Inst Biol, Dept Ecol, Lab Limnol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Cabral, AS (corresponding author), Fed Univ Rio de Janeiro UFRJ, Inst Biol, Lab Hydrobiol, Rio De Janeiro, Brazil.; Cabral, AS (corresponding author), Fed Univ Rio de Janeiro UFRJ, Inst Biol, Grad Program Ecol, Rio De Janeiro, Brazil.; Cabral, AS (corresponding author), Fed Univ Rio de Janeiro UFRJ, Inst Biol, Microbiol Lab, Rio De Janeiro, Brazil.	andersonscabral@yahoo.com.br	Junger, Pedro C/K-8270-2015	Junger, Pedro C/0000-0001-8774-0738; Thompson, Fabiano/0000-0002-7562-1683	CAPES Edital Ciencias do Mar [09/2009]; FAPERJE [26/103.692/2012]; CNPq [158537/2015-7]; CNPq Universal grant [483.758/2010-8]; CNP qresearch Fellowship [312.949/2014-6]; FAPERJ APQ1 grant [111.649/2011, 110.586/2014]	CAPES Edital Ciencias do Mar(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJE; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq Universal grant(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNP qresearch Fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ APQ1 grant(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Post-doctoral fellowships to ASC (CAPES Edital Ciencias do Mar 09/2009; FAPERJE 26/103.692/2012; CNPq 158537/2015-7), CNPq Universal grant to RP (483.758/2010-8), CNP qresearch Fellowship to RP (312.949/2014-6), and FAPERJ APQ1 grants to RP (111.649/2011 and 110.586/2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to INFRAERO for providing access and logistics for sampling expeditions. This work is a contribution from the "Microbiological Observatory of Rio de Janeiro - MORio". funded by CNPq (Universal Grant No. 483.758/2010-8, and Research Fellowship Grant No. 312.949/2014-6), and FAPERJ (APQ1 Grant Nos. 111.649/2011 and 110.586/2014) to RP. ASC received fellowships from CAPES (Edital Ciencias do Mar 09/2009), FAPERJ (E26/103.692/2012) and CNPq (158537/2015-7). We are grateful to Dr Andrew Macrae (Institute of Microbiology at UFRJ) for English and content review. Our thanks to the Lab. Hydrobiology team for sampling, and especially to Fernanda R. Ferreira and Anderson A. dos Santos Junior for support in flow cytometry analysis. We would like to thank the anonymous reviewers for their valuable suggestions.	Auguet JC, 2005, MICROB ECOL, V50, P337, DOI 10.1007/s00248-005-0183-2; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Bettarel Y, 2008, ESTUAR COAST SHELF S, V80, P425, DOI 10.1016/j.ecss.2008.08.018; Bettarel Y, 2011, MICROB ECOL, V62, P143, DOI 10.1007/s00248-011-9835-6; BOEHME J, 1993, MAR ECOL PROG SER, V97, P1, DOI 10.3354/meps097001; Boras JA, 2009, ENVIRON MICROBIOL, V11, P1181, DOI 10.1111/j.1462-2920.2008.01849.x; Brussaard CPD, 2008, ISME J, V2, P575, DOI 10.1038/ismej.2008.31; Brussaard CPD, 2004, APPL ENVIRON MICROB, V70, P1506, DOI 10.1128/AEM.70.3.1506-1513.2004; Brussaard CPD, 2000, J VIROL METHODS, V85, P175, DOI 10.1016/S0166-0934(99)00167-6; Cissoko M, 2008, FRESHWATER BIOL, V53, P1154, DOI 10.1111/j.1365-2427.2007.01930.x; COCHLAN WP, 1993, MAR ECOL PROG SER, V92, P77, DOI 10.3354/meps092077; Corinaldesi C, 2003, APPL ENVIRON MICROB, V69, P2664, DOI 10.1128/AEM.69.5.2664-2673.2003; Danovaro R, 2003, MAR POLLUT BULL, V46, P301, DOI 10.1016/S0025-326X(02)00461-7; Danovaro R, 2008, NATURE, V454, P1084, DOI 10.1038/nature07268; Danovaro R, 2011, FEMS MICROBIOL REV, V35, P993, DOI 10.1111/j.1574-6976.2010.00258.x; Fistarol GO, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01232; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Gasol JM, 2000, SCI MAR, V64, P197, DOI 10.3989/scimar.2000.64n2197; GONZALEZ JM, 1993, MAR ECOL PROG SER, V94, P1, DOI 10.3354/meps094001; Grasshoff K, 1999, METHODS SEAWATER ANA; Gregoracci GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031408; Helton RR, 2006, APPL ENVIRON MICROB, V72, P4767, DOI 10.1128/AEM.00297-06; Hewson I, 2001, LIMNOL OCEANOGR, V46, P1734, DOI 10.4319/lo.2001.46.7.1734; Jacquet S, 2002, AQUAT MICROB ECOL, V27, P111, DOI 10.3354/ame027111; Jacquet S., 2010, ADV OCEANOGR LIMNOL, V1, P97, DOI [10.1080/19475721003743843, DOI 10.1080/19475721003743843]; Jiang SC, 1998, APPL ENVIRON MICROB, V64, P535; JIANG SC, 1994, MAR ECOL PROG SER, V104, P163, DOI 10.3354/meps104163; Jiao NZ, 2006, J MAR BIOL ASSOC UK, V86, P543, DOI 10.1017/S0025315406013452; Knowles B, 2016, NATURE, V531, P466, DOI 10.1038/nature17193; Le Bouteiller A, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC000914; LEE S, 1987, APPL ENVIRON MICROB, V53, P1298, DOI 10.1128/AEM.53.6.1298-1303.1987; Legendre P., 2014, IMODEL2 MODEL 2 REGR; Legendre P., 1998, NUMERICAL ECOLOGY, V24; MARANGER R, 1995, MAR ECOL PROG SER, V121, P217, DOI 10.3354/meps121217; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; Marie D., 2005, ALGAL CULTURING TECH, P253, DOI DOI 10.1016/B978-012088426-1/50018-4; Mayr L. M., 1989, HYDROBIOLOGICAL CHAR, P124; Mojica KDA, 2014, AQUAT MICROB ECOL, V71, P203, DOI 10.3354/ame01672; Motegi C, 2007, AQUAT MICROB ECOL, V48, P27, DOI 10.3354/ame048027; Noble RT, 1998, AQUAT MICROB ECOL, V14, P113, DOI 10.3354/ame014113; PAINCHAUD J, 1995, ESTUARIES, V18, P433, DOI 10.2307/1352362; Pan LA, 2007, J PLANKTON RES, V29, P187, DOI 10.1093/plankt/fbm006; Paranhos R, 1998, ENVIRON MONIT ASSESS, V50, P131, DOI 10.1023/A:1005855914215; Parsons T. R., 1984, MANUAL CHEM BIOL MET, DOI [10.1016/B978-0-08-030287-4.50004-9, DOI 10.1016/C2009-0-07774-5]; Parvathi A, 2013, ENVIRON MONIT ASSESS, V185, P8077, DOI 10.1007/s10661-013-3156-9; Payet J. P., 2010, MAN AQUAT VIRAL ECOL, P102, DOI [10.4319/mave.2010.978-0-9845591-0-7.102, DOI 10.4319/MAVE.2010.978-0-9845591-0-7.102]; Payet JP, 2013, LIMNOL OCEANOGR, V58, P465, DOI 10.4319/lo.2013.58.2.0465; Rochelle-Newall EJ, 2002, MAR CHEM, V77, P23, DOI 10.1016/S0304-4203(01)00073-1; Rohwer F, 2009, ENVIRON MICROBIOL, V11, P2771, DOI 10.1111/j.1462-2920.2009.02101.x; Seymour JR, 2006, J MAR BIOL ASSOC UK, V86, P551, DOI 10.1017/S0025315406013464; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Team C. R, 2015, R LANG ENV STAT COMP; Troussellier M, 2002, AQUAT MICROB ECOL, V28, P13, DOI 10.3354/ame028013; Tsai AY, 2015, ESTUAR COAST SHELF S, V153, P54, DOI 10.1016/j.ecss.2014.11.032; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Warton DI, 2002, BIOMETRICAL J, V44, P161, DOI 10.1002/1521-4036(200203)44:2<161::AID-BIMJ161>3.0.CO;2-N; Weinbauer MG, 2004, ENVIRON MICROBIOL, V6, P1, DOI 10.1046/j.1462-2920.2003.00539.x; Williamson SJ, 2002, APPL ENVIRON MICROB, V68, P4307, DOI 10.1128/AEM.68.9.4307-4314.2002; Winget DM, 2011, P NATL ACAD SCI USA, V108, P11506, DOI 10.1073/pnas.1101907108; Winget DM, 2009, ENVIRON MICROBIOL, V11, P2904, DOI 10.1111/j.1462-2920.2009.02038.x; Wommack KE, 2015, J MICROBIOL, V53, P181, DOI 10.1007/s12275-015-5068-6; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Wommack KE, 1999, APPL ENVIRON MICROB, V65, P231	64	10	12	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174653	10.1371/journal.pone.0174653	http://dx.doi.org/10.1371/journal.pone.0174653			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362842	Green Published, gold, Green Submitted			2022-12-26	WOS:000399175000026
J	Mori, Y; Miyata, K; Ono, T; Yagi, Y; Kamiya, K; Amano, S				Mori, Yosai; Miyata, Kazunori; Ono, Takashi; Yagi, Yusuke; Kamiya, Kazutaka; Amano, Shiro			Comparison of laser in situ ketatomileusis and photorefractive keratectomy for myopia using a mixed-effects model	PLOS ONE			English	Article							10-YEAR FOLLOW-UP; LONG-TERM; THAN-6 DIOPTERS; KERATOMILEUSIS; SURGERY; LASIK	Purpose To compare the results of laser in situ keratomileusis (LASIK) and photorefractive keratectomy (PRK) for myopia using a mixed-effects model. Methods This comparative retrospective study was conducted in 1,127 eyes of 579 patients after LASIK and 270 eyes of 144 patients after PRK who had two or more postoperative followups after 3 months. Uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), manifest refractive spherical equivalent (MRSE), percentage of eyes within 0.5 diopters (D) and 1.0 D of targeted refraction, and central corneal thickness were compared between PRK and LASIK groups using a mixed-effects model. Results Compared with the LASIK group, UCVA in the PRK group was significantly worse in the initial year but was significantly better after 4 years. The average BSCVA was not significantly different between the LASIK and PRK groups after 4 years. The average gain of BSCVA in the PRK group was significantly larger than that of the LASIK group after 2 years. MRSE in the LASIK and PRK groups showed a gradual myopic shift until 6 years after surgery. After 6 years, MRSE in the PRK group remained stable whereas MRSE in the LASIK group continued a myopic shift. The percentages of eyes within +/- 0.5 D or +/- 1.0 D in the LASIK group were significantly higher than those in the PRK group at 3 months but were significantly lower than those in the PRK group at 10 years. Conclusions PRK for myopia shows better efficacy than LASIK for myopia after 4 years.	[Mori, Yosai; Miyata, Kazunori; Ono, Takashi; Yagi, Yusuke] Miyata Eye Hosp, Miyakonojo, Japan; [Kamiya, Kazutaka] Kitasato Univ, Sch Med, Dept Ophthalmol, Tokyo, Kanagawa, Japan; [Amano, Shiro] Inouye Eye Hosp, Tokyo, Japan	Kitasato University	Amano, S (corresponding author), Inouye Eye Hosp, Tokyo, Japan.	amanoshiro1126@gmail.com	Ono, Takashi/Q-7570-2019	Ono, Takashi/0000-0002-1288-2798				Alio JL, 2009, BRIT J OPHTHALMOL, V93, P1313, DOI 10.1136/bjo.2007.131748; Alio JL, 2008, AM J OPHTHALMOL, V145, P55, DOI 10.1016/j.ajo.2007.08.035; Alio JL, 2008, AM J OPHTHALMOL, V145, P37, DOI 10.1016/j.ajo.2007.09.009; Alio JL, 2008, AM J OPHTHALMOL, V145, P46, DOI 10.1016/j.ajo.2007.09.010; Alio JL, 2008, AM J OPHTHALMOL, V145, P29, DOI 10.1016/j.ajo.2007.09.007; Dirani M, 2010, J CATARACT REFR SURG, V36, P1709, DOI 10.1016/j.jcrs.2010.04.041; El Danasoury MA, 1999, OPHTHALMOLOGY, V106, P411, DOI 10.1016/S0161-6420(99)90084-2; El-Maghraby A, 1999, OPHTHALMOLOGY, V106, P447, DOI 10.1016/S0161-6420(99)90102-1; Erie JC, 2006, AM J OPHTHALMOL, V141, P799, DOI 10.1016/j.ajo.2005.12.014; Fitzmaurice GM, 2011, APPL LONGITUDINAL AN; Hersh PS, 2000, OPHTHALMOLOGY, V107, P925, DOI 10.1016/S0161-6420(00)00059-2; Hersh PS, 1998, OPHTHALMOLOGY, V105, P1512, DOI 10.1016/S0161-6420(98)98038-1; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Miyai T, 2008, J CATARACT REFR SURG, V34, P1527, DOI 10.1016/j.jcrs.2008.04.038; O'Brart DPS, 2014, AM J OPHTHALMOL, V158, P651, DOI 10.1016/j.ajo.2014.06.013; Pedersen T, 2005, J CATARACT REFR SURG, V31, P21; Rajan MS, 2004, OPHTHALMOLOGY, V111, P1813, DOI 10.1016/j.ophtha.2004.05.019; Rosman M, 2010, J REFRACT SURG, V26, P168, DOI 10.3928/1081597X-20100224-02; Shortt AJ, 2006, OPHTHALMOLOGY, V113, P1897, DOI 10.1016/j.ophtha.2006.08.013; Vestergaard AH, 2013, J REFRACT SURG, V29, P312, DOI 10.3928/1081597X-20130415-02; Wang Z, 1997, J REFRACT SURG, V13, P528; Yuen LH, 2010, OPHTHALMOLOGY, V117, P1236, DOI 10.1016/j.ophtha.2009.10.042	22	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174810	10.1371/journal.pone.0174810	http://dx.doi.org/10.1371/journal.pone.0174810			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362808	Green Submitted, Green Published, gold			2022-12-26	WOS:000399175000037
J	Kuo, HW; Shih, CL; Tsung, JH; Liu, SW; Chu, SK; Yang, HC; Tsou, HH; Wang, ZH; Chen, ACH; Liu, YL				Kuo, Hsiang-Wei; Shih, Chia-Lung; Tsung, Jieh-Hen; Liu, Sheng-Wen; Chu, Shih-Kai; Yang, Hsin-Chou; Tsou, Hsiao-Hui; Wang, Zih-Hsiang; Chen, Andrew C. H.; Liu, Yu-Li			Pharmacogenomics study on cadherin 2 network with regard to HIV infection and methadone treatment outcome	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; N-CADHERIN; MAINTENANCE PATIENTS; GENETIC POLYMORPHISMS; PLASMA; LOCALIZATION; SUPERFAMILY; MIGRATION; PRESSURE; CLEAVAGE	Heroin dependent patients have a high incidence of HIV infection. In contrast to the gene expression method, we developed a systemic correlation analysis method built upon the results of pharmacogenomics study in a methadone maintenance treatment (MMT) cohort consisting of 344 Taiwanese heroin dependent patients. We identified genetic variants and their encoding proteins that may be involved with HIV infection and MMT treatment outcome. Cadherin 2 (CDH2) genetic determinants were identified through the genome-wide pharmacogenomic study. We found significant correlations among HIV infection status, plasma levels of CDH2, cytokine IL-7, ADAM10, and the treatment responses to methadone. Two single nucleotide polymorphisms located within CDH2 gene showed associations with blood pressure and plasma CDH2 concentration. Plasma concentration of CDH2 showed correlations with the level of cytokine IL-7, status of HIV infection, and urine morphine test result. Plasma level of IL-7 was correlated with corrected QT interval (QTc) and gooseflesh skin withdrawal symptom score, while level of ADAM10 was correlated with plasma concentrations of vitamin D metabolite, nicotine metabolite, and R-methadone. The results suggest a novel network involving HIV infection and methadone treatment outcome.	[Kuo, Hsiang-Wei; Shih, Chia-Lung; Tsung, Jieh-Hen; Liu, Sheng-Wen; Liu, Yu-Li] Natl Hlth Res Inst, Ctr Neuropsychiat Res, Miaoli, Taiwan; [Chu, Shih-Kai; Yang, Hsin-Chou] Acad Sinica, Inst Stat Sci, Taipei, Taiwan; [Tsou, Hsiao-Hui] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Biostat & Bioinformat, Miaoli, Taiwan; [Tsou, Hsiao-Hui] China Med Univ, Coll Publ Hlth, Grad Inst Biostat, Taichung, Taiwan; [Wang, Zih-Hsiang] Natl Taiwan Univ, Dept Psychol, Taipei, Taiwan; [Chen, Andrew C. H.] Northwell Hlth, Zucker Hillside Hosp, Dept Psychiat, Glen Oaks, NY USA; [Chen, Andrew C. H.] Hofstra Univ, Hofstra Northwell Sch Med, Feinstein Inst Med Res, Manhasset, NY USA; [Liu, Yu-Li] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan	National Health Research Institutes - Taiwan; Academia Sinica - Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan; National Taiwan University; Northwell Health; Hofstra University; Northwell Health; China Medical University Taiwan	Liu, YL (corresponding author), Natl Hlth Res Inst, Ctr Neuropsychiat Res, Miaoli, Taiwan.; Liu, YL (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan.	ylliou@nhri.org.tw	Yang, Hsin-Chou/AAP-2547-2021	Yang, Hsin-Chou/0000-0001-6853-7881	National Research Program for Genomic Medicine [NSC 100-3112-B-400-015]; National Science Council [NSC] [100-2314-B-400-002-MY3]; National Health Research Institutes, Taiwan [NP-104-PP-04, NP-105-PP-04, NP-104-SP-04, NP-105-SP-04]	National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan); National Science Council [NSC](Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by grants from the National Research Program for Genomic Medicine [NSC 100-3112-B-400-015], National Science Council [NSC 100-2314-B-400-002-MY3] and the National Health Research Institutes, Taiwan [NP-104-PP-04, NP-105-PP-04, NP-104-SP-04 and NP-105-SP-04]. YLL received these fundings.	Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Blindt R, 2004, CARDIOVASC RES, V62, P212, DOI 10.1016/j.cardiores.2004.01.004; Chan YY, 2015, PSYCHIAT RES, V226, P230, DOI 10.1016/j.psychres.2014.12.053; Chen YT, 2013, J HUM GENET, V58, P84, DOI 10.1038/jhg.2012.139; Derycke L, 2006, CLIN EXP METASTAS, V23, P187, DOI 10.1007/s10585-006-9029-7; Fonseca F, 2009, DRUG ALCOHOL DEPEN, V99, P327, DOI 10.1016/j.drugalcdep.2008.06.018; Fonseca SG, 2007, SCAND J IMMUNOL, V66, P362, DOI 10.1111/j.1365-3083.2007.01987.x; Gelernter J, 2014, BIOL PSYCHIAT, V76, P66, DOI 10.1016/j.biopsych.2013.08.034; George Sanju, 2008, Curr Drug Abuse Rev, V1, P297; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Jackson TY, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00165; Joseph H, 2000, MT SINAI J MED, V67, P347; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; Kutukculer N, 1995, SCAND J RHEUMATOL, V24, P383; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Liu S., 2015, TKDD, V10, P10, DOI DOI 10.1145/2735634; Moiseeva EP, 2001, CARDIOVASC RES, V52, P372, DOI 10.1016/S0008-6363(01)00399-6; Musumeci G, 2014, ACTA HISTOCHEM, V116, P1148, DOI 10.1016/j.acthis.2014.06.002; Navarro P, 1998, J CELL BIOL, V140, P1475, DOI 10.1083/jcb.140.6.1475; Ozaki C, 2010, J BIOCHEM, V147, P415, DOI 10.1093/jb/mvp192; Saitoh H, 2009, CTS-CLIN TRANSL SCI, V2, P50, DOI 10.1111/j.1752-8062.2008.00085.x; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Wang MY, 2012, HYPERTENSION, V60, P459, DOI 10.1161/HYPERTENSIONAHA.112.191270; Wang SC, 2013, OMICS, V17, P519, DOI 10.1089/omi.2012.0068; Wang SC, 2010, BIOMED CHROMATOGR, V24, P782, DOI 10.1002/bmc.1363; WELCH PA, 1990, INT IMMUNOL, V2, P697, DOI 10.1093/intimm/2.8.697; Wesson DR, 2003, J PSYCHOACTIVE DRUGS, V35, P253, DOI 10.1080/02791072.2003.10400007; Wu HM, 2010, COMPUT STAT DATA AN, V54, P767, DOI 10.1016/j.csda.2008.09.029; Xie Hong-Guang, 2005, Per Med, V2, P325, DOI 10.2217/17410541.2.4.325; Yagi T, 2000, GENE DEV, V14, P1169; Yamanaka K, 2006, BLOOD, V107, P2440, DOI 10.1182/blood-2005-03-1139; Yang HZ, 2016, SCAND ACTUAR J, P1, DOI 10.1080/03461238.2014.884017; Yang WS, 2015, MOL PHARMACOL, V87, P533, DOI 10.1124/mol.114.097147; Zuppinger C, 2000, Heart Fail Rev, V5, P251, DOI 10.1023/A:1009809520194	35	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174647	10.1371/journal.pone.0174647	http://dx.doi.org/10.1371/journal.pone.0174647			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358908	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174800067
J	Ma, C; Wei, Q; Cao, B; Cheng, XC; Tian, JL; Pu, HW; Yusufu, A; Cao, L				Ma, Chuang; Wei, Qin; Cao, Bo; Cheng, Xinchun; Tian, Juling; Pu, Hongwei; Yusufu, Aihemaitijiang; Cao, Li			A multifunctional bioactive material that stimulates osteogenesis and promotes the vascularization bone marrow stem cells and their resistance to bacterial infection	PLOS ONE			English	Article							MESOPOROUS SILICA NANOPARTICLES; GROWTH FACTOR-BB; ANTIBACTERIAL ACTIVITY; IN-VITRO; ANGIOGENESIS; GLASS; OSTEOMYELITIS; CEMENT; MICROPARTICLES; CYTOTOXICITY	The main limitation of tissue engineering lies in the inability to stimulate osteogenesis, angiogenesis of stem cells and broad-spectrum antimicrobial activity. However, the development of multifunctional bioactive materials with these capabilities remains a great challenge. In this study, we prepared mesoporous silica nanoparticles encapsulated with silver nanocrystals (AG-MSN) with uniform sphere size and mesopores. Platelet-derived growth factor BB (PDGF-BB) was effectively loaded in the AG-MSN mesopores (P-AG-MSN). The silicon ions (Si) released by P-AG-MSN stimulate osteogenic differentiation of bone marrow stromal cells (BMSC) by activating the alkaline phosphatase (ALP) activity of bone-related genes and increasing protein (OCN, RUNX2 and OPN) expression. Ag+ ions could be slowly released from the interior of the shell, highlighting their durable antibacterial activity. The sustained release of PDGF-BB from P-AG-MSN stimulated the angiogenic differentiation of BMSC, as indicated by the enhanced secretion of vascular endothelial growth factor (VEGF), HIF-1 alpha, HGF and ANG-1 and protein expression. Our results show that P-AG-MSN can clearly promote BMSC osteostimulation and vascularization. This research serves as a preliminary study of the utilization of this multifunctional mixture to fabricate a new active biological scaffold that integrates BMSC osteostimulation, vascularization and bactericidal effects by 3D printing technology.	[Ma, Chuang; Cao, Bo; Yusufu, Aihemaitijiang; Cao, Li] Xinjiang Med Univ, Dept Orthoped Ctr, Affiliated Hosp 1, Urumqi, Peoples R China; [Ma, Chuang] Xinjiang Med Univ, Dept Orthoped Ctr, Affiliated Hosp 1, Chang Ji Branch, Chang Ji, Peoples R China; [Wei, Qin] Xinjiang Med Univ, Clin Med Res Inst, Affiliated Hosp 1, Xinjiang Key Lab Med Anim Model Res, Urumqi, Peoples R China; [Cheng, Xinchun] Xinjiang Uygur Autonomous Reg Peoples Hosp, Carders Hlth Care Dept 4, Urumqi, Peoples R China; [Tian, Juling] First Peoples Hosp Urumqi, Dept Clin Lab, Urumqi, Peoples R China; [Pu, Hongwei] Xinjiang Med Univ, Dept Sci & Res Educ Ctr, Affiliated Hosp 1, Urumqi, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University; Xinjiang Medical University	Yusufu, A; Cao, L (corresponding author), Xinjiang Med Univ, Dept Orthoped Ctr, Affiliated Hosp 1, Urumqi, Peoples R China.	Aihemaitijiang@163.com; 1978589785@qq.com			National Natural Science Foundation of China [81560350]; Science and Technology Planning Project of Xinjiang Uygur Autonomous Province [201430123]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Xinjiang Uygur Autonomous Province	This work was supported by National Natural Science Foundation of China (81560350) and the Science and Technology Planning Project of Xinjiang Uygur Autonomous Province (201430123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zube L, 2009, J ORTHOP RES, V27, P1074, DOI 10.1002/jor.20842; Bellantone M, 2002, ANTIMICROB AGENTS CH, V46, P1940, DOI 10.1128/AAC.46.6.1940-1945.2002; Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917; CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279; Chen Y, 2013, ADV MATER, V25, P3144, DOI 10.1002/adma.201205292; Conconi MT, 2010, J PEPT SCI, V16, P349, DOI 10.1002/psc.1251; Das I, 2016, MAT SCI ENG C-MATER, V62, P206, DOI 10.1016/j.msec.2016.01.053; EDELMAN ER, 1991, BIOMATERIALS, V12, P619, DOI 10.1016/0142-9612(91)90107-L; Ferris DP, 2009, J AM CHEM SOC, V131, P1686, DOI 10.1021/ja807798g; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Gaharwar AK, 2013, ADV MATER, V25, P3329, DOI 10.1002/adma.201300584; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; Glatt AE, 1997, NEW ENGL J MED, V337, P428; Guglielmo BJ, 2000, CLIN INFECT DIS, V30, P205, DOI 10.1086/313620; Habibovic P, 2011, ACTA BIOMATER, V7, P3013, DOI 10.1016/j.actbio.2011.03.027; He QJ, 2009, SMALL, V5, P2722, DOI 10.1002/smll.200900923; Heikkila T, 2010, EUR J PHARM BIOPHARM, V74, P483, DOI 10.1016/j.ejpb.2009.12.006; HOFF SF, 1981, J BONE JOINT SURG AM, V63, P798, DOI 10.2106/00004623-198163050-00015; Hollinger JO, 2008, J ORTHOP RES, V26, P83, DOI 10.1002/jor.20453; Jensen T, 2011, J BIOMED MATER RES A, V99A, P94, DOI 10.1002/jbm.a.33166; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lindfors NC, 2008, J BIOMED MATER RES B, V87B, P73, DOI 10.1002/jbm.b.31070; Ma C, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.17; Meyer ML, 2012, AM J PHYSIOL-LUNG C, V303, pL181, DOI 10.1152/ajplung.00084.2012; Mezawa M, 2009, GENE, V435, P80, DOI 10.1016/j.gene.2008.12.020; Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0; Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004; Park AM, 2010, SEMIN FETAL NEONAT M, V15, P196, DOI 10.1016/j.siny.2010.05.006; PICKNELL B, 1977, J BONE JOINT SURG BR, V59, P302, DOI 10.1302/0301-620X.59B3.408356; Portal-Nunez S, 2012, HISTOL HISTOPATHOL, V27, P559, DOI 10.14670/HH-27.559; QUINDOS G, 1990, DIAGN MICR INFEC DIS, V13, P297, DOI 10.1016/0732-8893(90)90020-V; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107; SCHURMAN DJ, 1978, J BONE JOINT SURG AM, V60, P978, DOI 10.2106/00004623-197860070-00019; Slowing II, 2008, ADV DRUG DELIVER REV, V60, P1278, DOI 10.1016/j.addr.2008.03.012; Tang JL, 2010, J NANOSCI NANOTECHNO, V10, P6313, DOI 10.1166/jnn.2010.2625; Ulici V, 2009, BONE, V45, P1133, DOI 10.1016/j.bone.2009.08.003; Vallet-Regi M, 2011, ADV MATER, V23, P5177, DOI 10.1002/adma.201101586; WALDVOGEL FA, 1980, NEW ENGL J MED, V303, P360, DOI 10.1056/NEJM198008143030703; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030503; Wei LN, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/044103; Wu CT, 2014, J CONTROL RELEASE, V193, P282, DOI 10.1016/j.jconrel.2014.04.026; Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066; Wu CT, 2010, ACTA BIOMATER, V6, P2237, DOI 10.1016/j.actbio.2009.12.022; Xie H, 2014, NAT MED, V20, P1270, DOI 10.1038/nm.3668	46	9	10	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0172499	10.1371/journal.pone.0172499	http://dx.doi.org/10.1371/journal.pone.0172499			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358890	gold, Green Submitted, Green Published			2022-12-26	WOS:000399174800003
J	Ossowicki, A; Jafra, S; Garbeva, P				Ossowicki, Adam; Jafra, Sylwia; Garbeva, Paolina			The antimicrobial volatile power of the rhizospheric isolate Pseudomonas donghuensis P482	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; BACTERIAL VOLATILES; BIOLOGICAL-CONTROL; BIOCONTROL AGENTS; HYDROGEN-CYANIDE; FLUORESCENS; AERUGINOSA; RESISTANCE; TOLERANCE; PATHOGENS	Soil and rhizosphere bacteria produce an array of secondary metabolites including a wide range of volatile organic compounds (VOCs). These compounds play an important role in the long-distance interactions and communication between (micro)organisms. Furthermore, bacterial VOCs are involved in plant pathogens inhibition and induction of soil fungistasis and suppressivenes. In the present study, we analysed the volatile blend emitted by the rhizospheric isolate Pseudomonas donghuensis P482 and evaluated the volatile effect on the plant pathogenic fungi and bacteria as well as one oomycete. Moreover, we investigated the role of the GacS/GacA system on VOCs production in P. donghuensis P482. The results obtained demonstrated that VOCs emitted by P. donghuensis P482 have strong antifungal and antioomycete, but not antibacterial activity. The production of certain volatiles such as dimethyl sulfide, S-methyl thioacetate, methyl thiocyanate, dimethyl trisulfide, 1-undecan and HCN is depended on the GacS/GacA two-component regulatory system. Apparently, these compounds play an important role in the pathogens suppression as the gacA mutant entirely lost the ability to inhibit via volatiles the growth of tested plant pathogens.	[Ossowicki, Adam; Jafra, Sylwia] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Biotechnol, Lab Biol Plant Protect, Gdansk, Poland; [Ossowicki, Adam; Jafra, Sylwia] Med Univ Gdansk, Gdansk, Poland; [Ossowicki, Adam; Garbeva, Paolina] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Jafra, S (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Biotechnol, Lab Biol Plant Protect, Gdansk, Poland.; Jafra, S (corresponding author), Med Univ Gdansk, Gdansk, Poland.; Garbeva, P (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands.	sylwia.jafra@biotech.ug.edu.pl; p.garbeva@nioo.knaw.nl	Ossowicki, Adam/B-6787-2018; Garbeva, Paolina/C-3727-2011; KNAW, NIOO-KNAW/A-4320-2012	Ossowicki, Adam/0000-0003-1903-9688; Garbeva, Paolina/0000-0002-2359-5719; Jafra, Sylwia/0000-0002-4194-6180; KNAW, NIOO-KNAW/0000-0002-3835-159X	Polish National Science Centre research [DEC-2012/07/B/NZ9/01623]; Netherlands Organization for Scientific Research (NWO) [864.11.015]	Polish National Science Centre research; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Support was provided by Polish National Science Centre research grant no. DEC-2012/07/B/NZ9/01623 and the Netherlands Organization for Scientific Research (NWO), (864.11.015).	Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Audrain B, 2015, FRONT MICROBIOL, P6; Blom D, 2011, ENVIRON MICROBIOL, V13, P3047, DOI 10.1111/j.1462-2920.2011.02582.x; Blom D, 2011, APPL ENVIRON MICROB, V77, P1000, DOI 10.1128/AEM.01968-10; Blumer C, 2000, ARCH MICROBIOL, V173, P170, DOI 10.1007/s002039900127; CASTRIC KF, 1983, APPL ENVIRON MICROB, V45, P701, DOI 10.1128/AEM.45.2.701-702.1983; Cheng X, 2013, ENV MICROBIOL REP, V5, P608, DOI 10.1111/1758-2229.12061; Cox SD, 2007, J APPL MICROBIOL, V103, P930, DOI 10.1111/j.1365-2672.2007.03353.x; Dandurishvili N, 2011, J APPL MICROBIOL, V110, P341, DOI 10.1111/j.1365-2672.2010.04891.x; De Vrieze M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01295; Effmert U, 2012, J CHEM ECOL, V38, P665, DOI 10.1007/s10886-012-0135-5; Farag MA, 2013, J CHEM ECOL, V39, P1007, DOI 10.1007/s10886-013-0317-9; FIDDAMAN PJ, 1993, J APPL BACTERIOL, V74, P119, DOI 10.1111/j.1365-2672.1993.tb03004.x; Gao JW, 2015, ANTON LEEUW INT J G, V107, P83, DOI 10.1007/s10482-014-0306-1; Garbeva P, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00289; Garbeva P, 2014, FEMS MICROBIOL ECOL, V87, P639, DOI 10.1111/1574-6941.12252; Garbeva P, 2011, SOIL BIOL BIOCHEM, V43, P469, DOI 10.1016/j.soilbio.2010.11.020; Garbeva P, 2009, MICROB ECOL, V58, P36, DOI 10.1007/s00248-009-9502-3; Glover D.M, 1985, DNA CLONING PRACTICA; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Heeb S, 2001, MOL PLANT MICROBE IN, V14, P1351, DOI 10.1094/MPMI.2001.14.12.1351; Hunziker L, 2015, APPL ENVIRON MICROB, V81, P821, DOI 10.1128/AEM.02999-14; Kai M, 2009, APPL MICROBIOL BIOT, V81, P1001, DOI 10.1007/s00253-008-1760-3; Kai M, 2008, PLANT SIGNAL BEHAV, V3, P482, DOI 10.4161/psb.3.7.5681; Kim KS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2789; Krzyzanowska DM, 2012, J PLANT PATHOL, V94, P367; Krzyzanowska DM, 2014, GENOME ANNOUNC, V2, P3; Krzyzanowska DM, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016.00782, 10.3389/fmicb.2076.00782]; Lanteigne C, 2012, PHYTOPATHOLOGY, V102, P967, DOI 10.1094/PHYTO-11-11-0312; LAVILLE J, 1992, P NATL ACAD SCI USA, V89, P1562, DOI 10.1073/pnas.89.5.1562; Longbottom CJ, 2004, J ANTIMICROB CHEMOTH, V54, P386, DOI 10.1093/jac/dkh359; Pessi G, 2000, J BACTERIOL, V182, P6940, DOI 10.1128/JB.182.24.6940-6949.2000; Pierson LS, 2010, APPL MICROBIOL BIOT, V86, P1659, DOI 10.1007/s00253-010-2509-3; Popova AA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/125704; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; Ramette A, 2003, FEMS MICROBIOL ECOL, V44, P35, DOI 10.1111/j.1574-6941.2003.tb01088.x; Reimmann C, 1997, MOL MICROBIOL, V24, P309, DOI 10.1046/j.1365-2958.1997.3291701.x; Ryu CM, 2004, PLANT PHYSIOL, V134, P1017, DOI 10.1104/pp.103.026583; Schmidt R, 2015, ISME J, V9, P2329, DOI 10.1038/ismej.2015.42; Sonnleitner E, 2011, APPL MICROBIOL BIOT, V91, P63, DOI 10.1007/s00253-011-3332-1; Thoma S, 2009, FEMS MICROBIOL LETT, V294, P127, DOI 10.1111/j.1574-6968.2009.01556.x; Tyc O, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01412; Weise T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063538; Weller DM, 2007, PHYTOPATHOLOGY, V97, P250, DOI 10.1094/PHYTO-97-2-0250; Winsor GL, 2016, NUCLEIC ACIDS RES, V44, pD646, DOI 10.1093/nar/gkv1227; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Zou CS, 2007, SOIL BIOL BIOCHEM, V39, P2371, DOI 10.1016/j.soilbio.2007.04.009	49	83	84	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174362	10.1371/journal.pone.0174362	http://dx.doi.org/10.1371/journal.pone.0174362			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358818	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174800032
J	Tavakolan, M; Frehlick, Z; Yong, X; Menon, C				Tavakolan, Mojgan; Frehlick, Zack; Yong, Xinyi; Menon, Carlo			Classifying three imaginary states of the same upper extremity using time-domain features	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; SINGLE-TRIAL EEG; CLASSIFICATION; FREQUENCY; REPRESENTATION; MOVEMENTS; SELECTION; PATTERNS; REAL	Brain-computer interface (BCI) allows collaboration between humans and machines. It translates the electrical activity of the brain to understandable commands to operate a machine or a device. In this study, we propose a method to improve the accuracy of a 3 class BCI using electroencephalographic (EEG) signals. This BCI discriminates rest against imaginary grasps and elbow movements of the same limb. This classification task is challenging because imaginary movements within the same limb have close spatial representations on the motor cortex area. The proposed method extracts time-domain features and classifies them using a support vector machine (SVM) with a radial basis kernel function (RBF). An average accuracy of 74.2% was obtained when using the proposed method on a dataset collected, prior to this study, from 12 healthy individuals. This accuracy was higher than that obtained when other widely used methods, such as common spatial patterns (CSP), filter bank CSP (FBCSP), and band power methods, were used on the same dataset. These results are encouraging and the proposed method could potentially be used in future applications including BCI-driven robotic devices, such as a portable exoskeleton for the arm, to assist individuals with impaired upper extremity functions in performing daily tasks.	[Menon, Carlo] Simon Fraser Univ, Menrva Res Grp, Sch Mechatron Syst Engn, Burnaby, BC, Canada; Simon Fraser Univ, Sch Engn Sci, Burnaby, BC, Canada	Simon Fraser University; Simon Fraser University	Menon, C (corresponding author), Simon Fraser Univ, Menrva Res Grp, Sch Mechatron Syst Engn, Burnaby, BC, Canada.	cmenon@sfu.ca	Menon, Carlo/GZG-8210-2022	Menon, Carlo/0000-0002-2309-9977	CIHR; NSERC; MSFHR	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); MSFHR(Michael Smith Foundation for Health Research)	This research was funded by CIHR, NSERC, and MSFHR.	Anderson C. W., 1996, Solving Engineering Problems with Neural Networks. Proceedings of the International Conference on Engineering Applications of Neural Networks (EANN'96), P407; Ang KK, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00039; Ang KK, 2012, PATTERN RECOGN, V45, P2137, DOI 10.1016/j.patcog.2011.04.018; Ang KK, 2010, IEEE ENG MED BIO, P5549, DOI 10.1109/IEMBS.2010.5626782; Ang KK, 2008, IEEE IJCNN, P2390, DOI 10.1109/IJCNN.2008.4634130; Ben-Hur A, 2010, METHODS MOL BIOL, V609, P223, DOI 10.1007/978-1-60327-241-4_13; Bishop C. M, 2006, PATTERN RECOGNITION; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; Dornhege G., 2007, BRAIN COMPUTER INTER; Dornhege G, 2002, ADV NEURAL INFORM PR, P1115; Dornhege G., 2005, ADV NEURAL INF P SYS, V18, P315; Edelman BJ, 2016, IEEE T BIO-MED ENG, V63, P4, DOI 10.1109/TBME.2015.2467312; Geethanjali P., 2012, 2012 9th International Conference on Fuzzy Systems and Knowledge Discovery, P1136, DOI 10.1109/FSKD.2012.6234336; Ghani Farid, 2013, Journal of Next Generation Information Technology, V4, P29; Graimann B, 2010, FRONT COLLECT, P1, DOI 10.1007/978-3-642-02091-9_1; Gu Y, 2009, CLIN NEUROPHYSIOL, V120, P1596, DOI 10.1016/j.clinph.2009.05.006; Guger C, 2000, IEEE T REHABIL ENG, V8, P447, DOI 10.1109/86.895947; Hamedi M, 2014, FUNCT EL STIM SOC AN, P1; Hamedi M, 2014, IEEE REGION 10 SYMP, P204, DOI 10.1109/TENCONSpring.2014.6863026; He B, 2015, P IEEE, V103, P907, DOI [10.1109/JPROC.2015.2407272, 10.1109/jproc.2015.2407272]; Herman P, 2008, IEEE T NEUR SYS REH, V16, P317, DOI 10.1109/TNSRE.2008.926694; Hollander M., 2013, NONPARAMETRIC STAT M, VVolume 751; Hubbard IJ, 2009, OCCUP THER INT, V16, P175, DOI 10.1002/oti.275; Khorshidtalab A, 2013, PHYSIOL MEAS, V34, P1563, DOI 10.1088/0967-3334/34/11/1563; Khorshidtalab A., 2012, 2012 International Joint Conference on Computer Science and Software Engineering (JCSSE 2012), P17, DOI 10.1109/JCSSE.2012.6261918; Liao K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085192; Liu QY, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/5/056012; Looned R, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-51; Lopez-Larraz E, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-153; McFarland DJ, 2006, IEEE T NEUR SYS REH, V14, P135, DOI 10.1109/TNSRE.2006.875637; Mulert C, 2008, NEUROIMAGE, V42, P158, DOI 10.1016/j.neuroimage.2008.04.236; Navarro I, 2005, P ANN INT IEEE EMBS, P2118, DOI 10.1109/IEMBS.2005.1616878; Pfurtscheller G, 1998, IEEE Trans Rehabil Eng, V6, P316, DOI 10.1109/86.712230; Pfurtscheller G, 2001, P IEEE, V89, P1123, DOI 10.1109/5.939829; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Plow EB, 2010, CORTEX, V46, P310, DOI 10.1016/j.cortex.2009.02.024; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; RAO SM, 1993, NEUROLOGY, V43, P2311, DOI 10.1212/WNL.43.11.2311; Rensink M, 2009, J ADV NURS, V65, P737, DOI 10.1111/j.1365-2648.2008.04925.x; SANES JN, 1995, SCIENCE, V268, P1775, DOI 10.1126/science.7792606; Schloegl A, 1997, P ANN INT IEEE EMBS, V19, P1530; Schlogl A, 2005, J NEURAL ENG, V2, pL14, DOI 10.1088/1741-2560/2/4/L02; Schlogl A, 1997, ENG MED BIOL SOC, P1533; TSENG SY, 1995, MED ENG PHYS, V17, P71, DOI 10.1016/1350-4533(95)90380-T; Tsui CSL, 2009, MED BIOL ENG COMPUT, V47, P257, DOI 10.1007/s11517-009-0459-7; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Vapnik V, 1998, NONLINEAR MODELING, P55; Vuckovic A, 2008, MED BIOL ENG COMPUT, V46, P529, DOI 10.1007/s11517-008-0345-8; Vuckovic A, 2012, MED ENG PHYS, V34, P964, DOI 10.1016/j.medengphy.2011.11.001; Wang YJ, 2005, P ANN INT IEEE EMBS, P5392; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Yamawaki N, 2006, IEEE T NEUR SYS REH, V14, P250, DOI 10.1109/TNSRE.2006.875567; Yong XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121896	56	18	18	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174161	10.1371/journal.pone.0174161	http://dx.doi.org/10.1371/journal.pone.0174161			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358916	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174800023
J	Chevillot, X; Drouineau, H; Lambert, P; Carassou, L; Sautour, B; Lobry, J				Chevillot, Xavier; Drouineau, Hilaire; Lambert, Patrick; Carassou, Laure; Sautour, Benoit; Lobry, Jeremy			Toward a phenological mismatch in estuarine pelagic food web?	PLOS ONE			English	Article							CLIMATE-CHANGE; GIRONDE ESTUARY; MATCH-MISMATCH; MIGRATION PHENOLOGY; MACROTIDAL ESTUARY; FISH POPULATIONS; ORGANIC-MATTER; LIFE-HISTORY; SHIFTS; ENVIRONMENT	Alterations of species phenology in response to climate change are now unquestionable. Until now, most studies have reported precocious occurrence of life cycle events as a major phenological response. Desynchronizations of biotic interactions, in particular predatorprey relationships, are however assumed to strongly impact ecosystems' functioning, as formalized by the MatchMismatch Hypothesis (MMH). Temporal synchronicity between juvenile fish and zooplankton in estuaries is therefore of essential interest since estuaries are major nursery grounds for many commercial fish species. The Gironde estuary (SW France) has suffered significant alterations over the last three decades, including two Abrupt Ecosystem Shifts (AES), and three contrasted intershift periods. The main objective of this study was to depict modifications in fish and zooplankton phenology among intershift periods and discuss the potential effects of the resulting mismatches at a community scale. A flexible Bayesian method was used to estimate and compare yearly patterns of species abundance in the estuary among the three predefined periods. Results highlighted (1) an earlier peak of zooplankton production and entrance of fish species in the estuary and (2) a decrease in residence time of both groups in the estuary. Such speciesspecific phenological changes led to changes in temporal overlap between juvenile fish and their zooplanktonic prey. This situation questions the efficiency and potentially the viability of nursery function of the Gironde estuary, with potential implications for coastal marine fisheries of the Bay of Biscay.	[Chevillot, Xavier; Drouineau, Hilaire; Lambert, Patrick; Carassou, Laure; Lobry, Jeremy] Irstea, UR EABX, Cestas, France; [Sautour, Benoit] Univ Bordeaux, Stn Marine Arcachon, UMR CNRS EPOC OASU 5805, Arcachon, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux	Chevillot, X (corresponding author), Irstea, UR EABX, Cestas, France.	xavier.chevillot@irstea.fr		Carassou, Laure/0000-0001-8024-8038; Lobry, Jeremy/0000-0002-4567-3714; Drouineau, Hilaire/0000-0001-9206-0040; Chevillot, Xavier/0000-0002-4008-1859	LITEAU program of the French Ministry in charge of Ecology; Regional council of Aquitaine through the TRAJEST project	LITEAU program of the French Ministry in charge of Ecology; Regional council of Aquitaine through the TRAJEST project	This study was funded by the LITEAU program of the French Ministry in charge of Ecology and by the Regional council of Aquitaine through the TRAJEST project.	Able KW, 2005, ESTUAR COAST SHELF S, V64, P5, DOI 10.1016/j.ecss.2005.02.002; ALLEN GP, 1980, SEDIMENT GEOL, V26, P69, DOI 10.1016/0037-0738(80)90006-8; Attrill MJ, 2002, NATURE, V417, P275, DOI 10.1038/417275a; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Beaugrand G, 2008, ECOL LETT, V11, P1157, DOI 10.1111/j.1461-0248.2008.01218.x; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Beguer M, 2012, ESTUAR COAST, V35, P1082, DOI 10.1007/s12237-012-9506-y; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Chaalali A, 2013, PLOS ONE, P8; Chaalali A, 2013, ESTUAR COAST, V36, P1193, DOI 10.1007/s12237-013-9628-x; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Chevillot X, 2016, MAR ECOL PROG SER, V549, P137, DOI 10.3354/meps11681; COLEBROOK JM, 1979, MAR BIOL, V51, P23, DOI 10.1007/BF00389027; Crozier LG, 2014, EVOL APPL, V7, P68, DOI 10.1111/eva.12135; CUSHING DH, 1969, J CONSEIL, V33, P81; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; David V, 2005, ESTUAR COAST SHELF S, V64, P171, DOI 10.1016/j.ecss.2005.01.014; David V, 2007, ESTUAR COAST SHELF S, V71, P429, DOI 10.1016/j.ecss.2006.08.018; Denwood MJ, 2014, J STAT SOFTWARE; Durant JM, 2005, ECOL LETT, V8, P952, DOI 10.1111/j.1461-0248.2005.00798.x; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Elliott M., 1995, Netherlands Journal of Aquatic Ecology, V29, P397, DOI 10.1007/BF02084239; Elliott M, 2002, FISHES IN ESTUARIES, P124, DOI 10.1002/9780470995228.ch4; FORTIER L, 1990, CAN J FISH AQUAT SCI, V47, P1898, DOI 10.1139/f90-214; Garcia AM, 2012, MAR ECOL PROG SER, V461, P121, DOI 10.3354/meps09798; Genner MJ, 2010, J PLANKTON RES, V32, P699, DOI 10.1093/plankt/fbp082; GIBSON RN, 1994, NETH J SEA RES, V32, P191, DOI 10.1016/0077-7579(94)90040-X; Girardin M, 2014, SURVEILLANCE HALIEUT, V105; Girardin M, 2005, SURVEILLANCE HALIEUT, V105; Goberville E, 2010, MAR ECOL PROG SER, V408, P129, DOI 10.3354/meps08564; Greve W, 2005, ICES J MAR SCI, V62, P1216, DOI 10.1016/j.icesjms.2005.03.011; [HLT Environnemental RD], 2013, IMPACTS CHANGEMENT C; Holbrook SJ, 1997, ECOL APPL, V7, P1299; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; Knudsen E, 2007, CLIM RES, V35, P59, DOI 10.3354/cr00714; Kromkamp JC, 2010, ESTUAR COAST, V33, P270, DOI 10.1007/s12237-009-9215-3; Le Pape O, 2003, ESTUAR COAST SHELF S, V58, P793, DOI 10.1016/S0272-7714(03)00185-9; Leakey R, 1997, 6 EXTINCTION PATTERN, V1997, P29; Liu YZ, 2011, ECOLOGY, V92, P1201, DOI 10.1890/10-2060.1; Lobry J, 2003, AQUAT LIVING RESOUR, V16, P47, DOI 10.1016/S0990-7440(03)00031-7; Lobry J, 2008, MAR ECOL PROG SER, V358, P13, DOI 10.3354/meps07294; Lobry J, 2006, ESTUAR COAST SHELF S, V70, P239, DOI 10.1016/j.ecss.2006.06.014; Luczak C, 2012, BIOL LETTERS, V8, P821, DOI 10.1098/rsbl.2012.0474; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Mauchline J., 1998, ADV MAR BIOL, V33, P1, DOI DOI 10.1163/156854008784513492; Nicolas D, 2010, ESTUAR COAST SHELF S, V86, P137, DOI 10.1016/j.ecss.2009.11.006; Ohlberger J, 2014, P ROYAL SOC B, P281; Ottersen G, 2001, OECOLOGIA, V128, P1, DOI 10.1007/s004420100655; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pasquaud S, 2012, ESTUAR COAST SHELF S, V104, P46, DOI 10.1016/j.ecss.2012.03.021; Pasquaud S, 2010, MAR ECOL PROG SER, V400, P207, DOI 10.3354/meps08387; Peer AC, 2014, N AM J FISH MANAGE, V34, P94, DOI 10.1080/02755947.2013.847877; Petitgas P, 2013, FISH OCEANOGR, V22, P121, DOI 10.1111/fog.12010; Philippart CJM, 2003, LIMNOL OCEANOGR, V48, P2171, DOI 10.4319/lo.2003.48.6.2171; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; Pronier O, 1998, B FRANCAIS PECHE PIS, V350-51, P479, DOI DOI 10.1051/kmae:1998018; Quinn II TJ, 1991, COPEIA, V1991, P861; Quinn TP, 1996, ECOLOGY, V77, P1151, DOI 10.2307/2265584; R Core Team, 2021, R LANGUAGE ENV STAT; Richardson AJ, 2008, ICES J MAR SCI, V65, P279, DOI 10.1093/icesjms/fsn028; Rodionov SN, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019448; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Russell IC, 2012, ICES J MAR SCI, V69, P1563, DOI 10.1093/icesjms/fsr208; Savoye N, 2012, ESTUAR COAST SHELF S, V108, P16, DOI 10.1016/j.ecss.2011.12.005; Selleslagh J, 2008, ESTUAR COAST SHELF S, V79, P507, DOI 10.1016/j.ecss.2008.05.006; Selleslagh J, 2015, ESTUAR COAST, V38, P1431, DOI 10.1007/s12237-014-9911-5; Selleslagh J, 2012, ESTUAR COAST SHELF S, V112, P243, DOI 10.1016/j.ecss.2012.07.030; Sims DW, 2004, J ANIM ECOL, V73, P333, DOI 10.1111/j.0021-8790.2004.00810.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sottolichio A, 2011, J COASTAL RES, P1579; Stenseth NC, 2002, P NATL ACAD SCI USA, V99, P13379, DOI 10.1073/pnas.212519399; Thackeray SJ, 2012, J PLANKTON RES, V34, P1001, DOI 10.1093/plankt/fbs066; Vadadi-Fulop C, 2014, J LIMNOLOGY, P73; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Visser ME, 2004, ADV ECOL RES, V35, P89, DOI 10.1016/S0065-2504(04)35005-1; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	83	20	20	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0173752	10.1371/journal.pone.0173752	http://dx.doi.org/10.1371/journal.pone.0173752			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355281	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174600024
J	Fereczkowski, M; Jepsen, ML; Dau, T; MacDonald, EN				Fereczkowski, Michal; Jepsen, Morten L.; Dau, Torsten; MacDonald, Ewen N.			Investigating time-efficiency of forward masking paradigms for estimating basilar membrane input-output characteristics	PLOS ONE			English	Article							SENSORINEURAL HEARING-LOSS; IMPAIRED HEARING; LISTENERS; COMPRESSION; NONLINEARITY	It is well known that pure-tone audiometry does not sufficiently describe individual hearing loss (HL) and that additional measures beyond pure-tone sensitivity might improve the diagnostics of hearing deficits. Specifically, forward masking experiments to estimate basilar-membrane (BM) input-output (I/O) function have been proposed. However, such measures are very time consuming. The present study investigated possible modifications of the temporal masking curve (TMC) paradigm to improve time and measurement efficiency. In experiment 1, estimates of knee point (KP) and compression ratio (CR) of individual BM l/Os were derived without considering the corresponding individual "off-frequency" TMC. While accurate estimation of KPs was possible, it is difficult to ensure that the tested dynamic range is sufficient. Therefore, in experiment 2, a TMC-based paradigm, referred to as the "gap method", was tested. In contrast to the standard TMC paradigm, the maker level was kept fixed and the "gap threshold" was obtained, such that the masker just masks a low-level (12 dB sensation level) signal. It is argued that this modification allows for better control of the tested stimulus level range, which appears to be the main drawback of the conventional TMC method. The results from the present study were consistent with the literature when estimating KP levels, but showed some limitations regarding the estimation of the CR values. Perspectives and limitations of both approaches are discussed.	[Fereczkowski, Michal; Dau, Torsten; MacDonald, Ewen N.] DTU, Elektro, Lyngby, Denmark; [Jepsen, Morten L.] Widex AS, Copenhagen, Denmark	Technical University of Denmark	Fereczkowski, M (corresponding author), DTU, Elektro, Lyngby, Denmark.	mfer@elektro.dtu.dk	Dau, Torsten/AAJ-3709-2020; Dau, Torsten/H-3828-2017; MacDonald, Ewen/AAJ-3688-2020	Dau, Torsten/0000-0001-8110-4343; Dau, Torsten/0000-0001-8110-4343; MacDonald, Ewen/0000-0002-6973-2926	Technical University of Denmark; Widex A/S	Technical University of Denmark; Widex A/S	Author MF received a stipend from the Technical University of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Widex A/S provided support in the form of salaries for authors [MLJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Jepsen ML, 2011, J ACOUST SOC AM, V129, P262, DOI 10.1121/1.3518768; Johannesen PT, 2016, TRENDS HEAR, V20, DOI 10.1177/2331216516641055; Jurgens T., 2010, THESIS; KAERNBACH C, 1990, J ACOUST SOC AM, V88, P2645, DOI 10.1121/1.399985; Kollmeier B, 2016, INT J AUDIOL, P1; Lecluyse W, 2009, J ACOUST SOC AM, V126, P2570, DOI 10.1121/1.3238248; Lopez-Poveda EA, 2003, J ACOUST SOC AM, V113, P951, DOI 10.1121/1.1534838; Lopez-Poveda EA, 2008, J ACOUST SOC AM, V123, P1544, DOI 10.1121/1.2835418; Lopez-Poveda EA, 2012, JARO-J ASSOC RES OTO, V13, P485, DOI 10.1007/s10162-012-0327-2; Macmillan NA, 2005, DETECTION THEORY USE, P214; Moore BCJ, 2002, HEARING RES, V163, P101, DOI 10.1016/S0378-5955(01)00390-2; Nelson DA, 1997, J ACOUST SOC AM, V101, P2186, DOI 10.1121/1.418203; Nelson DA, 2001, J ACOUST SOC AM, V110, P2045, DOI 10.1121/1.1404439; Oxenham AJ, 1997, J ACOUST SOC AM, V101, P3666, DOI 10.1121/1.418327; Panda MR, 2014, INT J AUDIOL, V53, P699, DOI 10.3109/14992027.2014.917206; Pearson RK, 2011, EXPLORING DATA BLOG; Plack CJ, 2010, J ACOUST SOC AM, V128, P771, DOI 10.1121/1.3455844; Plack CJ, 2004, J ACOUST SOC AM, V115, P1684, DOI 10.1121/1.1675812; Poling GL, 2012, JARO-J ASSOC RES OTO, V13, P91, DOI 10.1007/s10162-011-0291-2; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Rosengard PS, 2005, J ACOUST SOC AM, V117, P3028, DOI 10.1121/1.1883367; van Esch TEM, 2013, INT J AUDIOL, V52, P305, DOI 10.3109/14992027.2012.759665	24	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174776	10.1371/journal.pone.0174776	http://dx.doi.org/10.1371/journal.pone.0174776			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355275	Green Submitted, gold, Green Published			2022-12-26	WOS:000399174600089
J	Zarella, MD; Yeoh, C; Breen, DE; Garcia, FU				Zarella, Mark D.; Yeoh, Chan; Breen, David E.; Garcia, Fernando U.			An alternative reference space for H&E color normalization	PLOS ONE			English	Article							SEGMENTATION; IMAGES; STANDARDIZATION; QUANTIFICATION; DECONVOLUTION; HEMATOXYLIN; PATHOLOGY; MODEL; STAIN	Digital imaging of H&E stained slides has enabled the application of image processing to support pathology workflows. Potential applications include computer-aided diagnostics, advanced quantification tools, and innovative visualization platforms. However, the intrinsic variability of biological tissue and the vast differences in tissue preparation protocols often lead to significant image variability that can hamper the effectiveness of these computational tools. We developed an alternative representation for H&E images that operates within a space that is more amenable to many of these image processing tools. The algorithm to derive this representation operates by exploiting the correlation between color and the spatial properties of the biological structures present in most H&E images. In this way, images are transformed into a structure-centric space in which images are segregated into tissue structure channels. We demonstrate that this framework can be extended to achieve color normalization, effectively reducing inter-slide variability.	[Zarella, Mark D.] Drexel Univ, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Yeoh, Chan] Drexel Univ, Dept Elect & Comp Engn, Philadelphia, PA 19104 USA; [Breen, David E.] Drexel Univ, Dept Comp Sci, Philadelphia, PA 19104 USA; [Garcia, Fernando U.] Eastern Reg Med Ctr, Canc Treatment Ctr Amer, Dept Pathol & Lab Med, Philadelphia, PA USA	Drexel University; Drexel University; Drexel University	Zarella, MD (corresponding author), Drexel Univ, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	mark.zarella@drexelmed.edu	Zarella, Mark/F-6628-2018	Zarella, Mark/0000-0002-1722-6773	Center for Visual and Decision Informatics; National Science Foundation Industry/University Cooperative Research Center (NSF) [11P-1160960]	Center for Visual and Decision Informatics; National Science Foundation Industry/University Cooperative Research Center (NSF)	This work was supported by the Center for Visual and Decision Informatics, a National Science Foundation Industry/University Cooperative Research Center (NSF grant #11P-1160960).	Al-Kofahi Y, 2010, IEEE T BIO-MED ENG, V57, P841, DOI 10.1109/TBME.2009.2035102; Ballaro B, 2008, MED IMAGE ANAL, V12, P703, DOI 10.1016/j.media.2008.04.001; Basavanhally AN, 2010, IEEE T BIO-MED ENG, V57, P642, DOI 10.1109/TBME.2009.2035305; Bautista Pinky A, 2014, J Pathol Inform, V5, P4, DOI 10.4103/2153-3539.126153; Chapelle O, 2002, MACH LEARN, V46, P131, DOI 10.1023/A:1012450327387; Cruz-Roa Angel, 2011, J Pathol Inform, V2, pS4, DOI 10.4103/2153-3539.92031; Elisa Drelie Gelasca JB, 2008, IEEE INT C IM PROC; Gurcan M. N., 2009, BIOMED ENG IEEE REV, V2, P147, DOI DOI 10.1109/RBME.2009.2034865; Irshad Humayun, 2013, J Pathol Inform, V4, pS12, DOI 10.4103/2153-3539.109870; Janowczyk Andrew, 2013, J Pathol Inform, V4, pS8, DOI 10.4103/2153-3539.109865; Kayser K, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-S1-S11; Khan AM, 2014, IEEE T BIO-MED ENG, V61, P1729, DOI 10.1109/TBME.2014.2303294; Kuse Manohar, 2011, J Pathol Inform, V2, pS2, DOI 10.4103/2153-3539.92028; Latson L, 2003, ANAL QUANT CYTOL, V25, P321; Macenko M, 2009, 2009 IEEE INT S BIOM; Mouelhi A, 2013, BIOMED SIGNAL PROCES, V8, P421, DOI 10.1016/j.bspc.2013.04.003; Ruifrok AC, 2003, APPL IMMUNOHISTO M M, V11, P85, DOI 10.1097/00022744-200303000-00014; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; SCHULTE EKW, 1991, HISTOCHEMISTRY, V95, P319, DOI 10.1007/BF00266958; Sethi Amit, 2016, J Pathol Inform, V7, P17, DOI 10.4103/2153-3539.179984; Smolle J, 1996, ANAL QUANT CYTOL, V18, P323; Tani S, 2012, ANAL CELL PATHOL, V35, P107, DOI [10.3233/ACP-2011-0037, 10.1155/2012/154735]; Tek F Boray, 2013, J Pathol Inform, V4, P12, DOI 10.4103/2153-3539.112697; Vahadane A., 2016, IEEE T MED IMAGING; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Wienert S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00503; Wittekind D, 2003, BIOTECH HISTOCHEM, V78, P261, DOI 10.1080/10520290310001633725; Zarella Mark D, 2015, J Pathol Inform, V6, P33, DOI 10.4103/2153-3539.158910; Zhou Y., 2013, J PATHOL INFORM, V4, P6	29	31	32	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174489	10.1371/journal.pone.0174489	http://dx.doi.org/10.1371/journal.pone.0174489			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355298	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174600055
J	Payne, JT; Millar, JJ; Jackson, CR; Ochs, CA				Payne, Jason T.; Millar, Justin J.; Jackson, Colin R.; Ochs, Clifford A.			Patterns of variation in diversity of the Mississippi river microbiome over 1,300 kilometers	PLOS ONE			English	Article							BACTERIAL COMMUNITY STRUCTURE; SEQUENCE DATA; BACTERIOPLANKTON; BIOGEOGRAPHY; TRIBUTARIES; CATCHMENT; ECOLOGY; IMPACT; SCALE; BASIN	We examined the downriver patterns of variation in taxonomic diversity of the Mississippi River bacterioplankton microbiome along 1,300 river kilometers, or approximately one third the total length of the river. The study section included portions of the Upper, Middle, and Lower Mississippi River, confluences with five tributaries draining distinct sub-basins, river cities, and extended stretches without major inputs to the Mississippi. The composition and proportional abundance of dominant bacterial phyla was distinct for free-living and particle associated cells, and constant along the entire reach, except for a substantial but transient disturbance near the city of Memphis, Tennessee. At a finer scale of taxonomic resolution (operational taxonomic units, OTUs), however, there were notable patterns in downriver variation in bacterial community alpha diversity (richness within a site) and beta diversity (variation in composition among sites). There was a strong and steady increase downriver in alpha diversity of OTUs on suspended particles, suggesting an increase in particle niche heterogeneity, and/or particle colonization. Relatively large shifts in beta diversity of free-living and particle-associated communities occurred following major tributary confluences and transiently at Memphis, while in long stretches between these points diversity typically varied more gradually. We conclude that the Mississippi River possesses a bacterioplankton microbiome distinct in diversity from other large river microbiomes in the Mississippi River Basin, that at major river confluences or urban point sources its OTU diversity may shift abruptly and substantially, presumably by immigration of distinct external microbiomes, but that where environmental conditions are more stable along the downriver gradient, micro biome diversity tends to vary gradually, presumably by a process of successional change in community composition.	[Payne, Jason T.; Millar, Justin J.; Jackson, Colin R.; Ochs, Clifford A.] Univ Mississippi, Dept Biol, University, MS 38677 USA; [Millar, Justin J.] Univ Florida, Sch Forest & Conservat, Gainesville, FL USA	University of Mississippi; State University System of Florida; University of Florida	Ochs, CA (corresponding author), Univ Mississippi, Dept Biol, University, MS 38677 USA.	byochs@olemiss.edu	Millar, Justin/AAJ-3425-2020	Millar, Justin/0000-0002-6866-7544	National Science Foundation Division of Environmental Biology [1049911]	National Science Foundation Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by the National Science Foundation Division of Environmental Biology grant 1049911 to Clifford Ochs and Colin Jackson.	Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Blaser MJ, 2016, MBIO, V7, DOI 10.1128/mBio.00714-16; Borer ET, 2013, BASIC APPL ECOL, V14, P533, DOI 10.1016/j.baae.2013.08.009; Bussan DD, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-5785-x; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Christian N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00869; Core Team R, 2013, R LANG ENV STAT COMP; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Crump BC, 1999, APPL ENVIRON MICROB, V65, P3192; Crump BC, 2007, ECOLOGY, V88, P1365, DOI 10.1890/06-0387; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Gibbons SM, 2015, CURR OPIN GENET DEV, V35, P66, DOI 10.1016/j.gde.2015.10.003; Goni-Urriza M, 1999, CAN J MICROBIOL, V45, P826, DOI 10.1139/cjm-45-10-826; Goolsby D A, 1999, NOAA COASTAL PROGRAM, V17; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jackson CR, 2014, APPL ENVIRON MICROB, V80, P7186, DOI 10.1128/AEM.01844-14; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kulshreshtha NM, 2013, INT J SYST EVOL MICR, V63, P4374, DOI 10.1099/ijs.0.039123-0; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Lundin D, 2012, ENV MICROBIOL REP, V4, P367, DOI 10.1111/j.1758-2229.2012.00345.x; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Millar JJ, 2015, BIOGEOCHEMISTRY, V124, P255, DOI 10.1007/s10533-015-0096-1; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Ochs CA, 2010, HYDROBIOLOGIA, V637, P19, DOI 10.1007/s10750-009-9981-8; Oksanen J, 2022, R PACKAGE VERSION; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Read DS, 2015, ISME J, V9, P516, DOI 10.1038/ismej.2014.166; Savio D, 2015, ENVIRON MICROBIOL, V17, P4994, DOI 10.1111/1462-2920.12886; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Staley C, 2013, J APPL MICROBIOL, V115, P1147, DOI 10.1111/jam.12323; Staley C, 2015, SCI TOTAL ENVIRON, V505, P435, DOI 10.1016/j.scitotenv.2014.10.012; Staley C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00524; Stone BWG, 2016, MICROB ECOL, V71, P954, DOI 10.1007/s00248-016-0738-4; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turner RE, 2004, HYDROBIOLOGIA, V511, P79, DOI 10.1023/B:HYDR.0000014031.12067.1a; Walter J, 2011, ANNU REV MICROBIOL, V65, P411, DOI 10.1146/annurev-micro-090110-102830; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Wetzel R.G., 2000, LIMNOLOGICAL ANAL, V3; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winter C, 2007, APPL ENVIRON MICROB, V73, P421, DOI 10.1128/AEM.01849-06	46	18	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174890	10.1371/journal.pone.0174890	http://dx.doi.org/10.1371/journal.pone.0174890			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350888	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174400078
J	Wan, XG; Zhao, X; Yau, SST				Wan, Xiaogeng; Zhao, Xin; Yau, Stephen S. T.			An information-based network approach for protein classification	PLOS ONE			English	Article							ORIGIN; GENOME; SPACE	Protein classification is one of the critical problems in bioinformatics. Early studies used geometric distances and polygenetic-tree to classify proteins. These methods use binary trees to present protein classification. In this paper, we propose a new protein classification method, whereby theories of information and networks are used to classify the multivariate relationships of proteins. In this study, protein universe is modeled as an undirected network, where proteins are classified according to their connections. Our method is unsupervised, multivariate, and alignment-free. It can be applied to the classification of both protein sequences and structures. Nine examples are used to demonstrate the efficiency of our new method.	[Wan, Xiaogeng; Zhao, Xin; Yau, Stephen S. T.] Tsinghua Univ, Dept Math Sci, Beijing, Peoples R China	Tsinghua University	Wan, XG; Zhao, X; Yau, SST (corresponding author), Tsinghua Univ, Dept Math Sci, Beijing, Peoples R China.	wxgbj88@sina.com; zhao-x15@mails.tsinghua.edu.cn; yau@uic.edu			National Natural Sciences Foundation of China [31271408]; Tsinghua University startup fund; Tsinghua University independent research project	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University startup fund; Tsinghua University independent research project	This work is supported by the National Natural Sciences Foundation of China (31271408, http://www.nsfc.gov.cn/publish/portal1/), Tsinghua University startup fund (http://www.tsinghua.edu.cn/publish/newthu/index.html) and Tsinghua University independent research project grant (http://www.tsirighua.edu.cn/publish/newthu/index.html).	Cao Y, 1998, J MOL EVOL, V47, P307, DOI 10.1007/PL00006389; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen J, 2016, BRIEF BIOINFORM; COVER T. M., 2012, ELEMENTS INFORM THEO, DOI 10.1002/0471200611; Dayhoff MO, 1978, MODEL EVOLUTIONARY C, V5, P345; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Gelfand I, 1959, AM MATH SOC TRANSL S, V2, P3; Hashimoto T, 1996, ADV BIOPHYS, V32, P73, DOI 10.1016/0065-227X(96)84742-3; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; Hsu C.-W., 2010, PRACTICAL GUIDE SUPP; Janke A, 1997, P NATL ACAD SCI USA, V94, P1276, DOI 10.1073/pnas.94.4.1276; Ju Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep33870; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Liu B, NUCL ACIDS RES, V43, pW65 ; Liu B, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0960-6; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Raina SZ, 2005, GENOME RES, V15, P665, DOI 10.1101/gr.3128605; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Razak FA, 2017, EDWARD EIGE IN PRESS; Saidi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-175; Shen HB, 2008, ANAL BIOCHEM, V373, P386, DOI 10.1016/j.ab.2007.10.012; Song L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-298; Tian K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136577; Vejmelka M, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026214; Wei LY, 2015, IEEE T NANOBIOSCI, V14, P339, DOI 10.1109/TNB.2014.2352454; Xia XH, 1998, J MOL EVOL, V47, P557, DOI 10.1007/PL00006412; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055844; Yau SST, 2008, DNA CELL BIOL, V27, P241, DOI 10.1089/dna.2007.0676; Yu CL, 2013, GENE, V529, P250, DOI 10.1016/j.gene.2013.07.092; Yu CL, 2013, J THEOR BIOL, V318, P197, DOI 10.1016/j.jtbi.2012.11.005; Yu CL, 2011, GENE, V486, P110, DOI 10.1016/j.gene.2011.07.002; Yu CL, 2010, DNA RES, V17, P155, DOI 10.1093/dnares/dsq008; Zhao B, 2011, MOL PHYLOGENET EVOL, V59, P438, DOI 10.1016/j.ympev.2011.02.020; Zhao X, 2016, MOL PHYLOGENET EVOL, V98, P271, DOI 10.1016/j.ympev.2016.02.015; Zhou Y., 2006, BASICS INFORM THEORY, V3rd	37	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174386	10.1371/journal.pone.0174386	http://dx.doi.org/10.1371/journal.pone.0174386			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350835	Green Submitted, gold, Green Published			2022-12-26	WOS:000399174400032
J	Batisse-Lignier, M; Sahut-Barnola, I; Tissier, F; Dumontet, T; Mathieu, M; Drelon, C; Pointud, JC; Damon-Soubeyrand, C; Marceau, G; Kemeny, JL; Bertherat, J; Tauveron, I; Val, P; Martinez, A; Lefrancois-Martinez, AM				Batisse-Lignier, M.; Sahut-Barnola, I.; Tissier, F.; Dumontet, T.; Mathieu, M.; Drelon, C.; Pointud, J-C; Damon-Soubeyrand, C.; Marceau, G.; Kemeny, J-L; Bertherat, J.; Tauveron, I.; Val, P.; Martinez, A.; Lefrancois-Martinez, A-M			P53/Rb inhibition induces metastatic adrenocortical carcinomas in a preclinical transgenic model	ONCOGENE			English	Article							BETA-CATENIN; GENOMIC CHARACTERIZATION; PROGNOSTIC ROLE; TUMORS; CANCER; TUMORIGENESIS; MUTATIONS; PATHWAYS; REVEALS; GROWTH	Adrenocortical carcinoma (ACC) is a rare cancer with poor prognosis. Pan-genomic analyses identified p53/Rb and WNT/beta-catenin signaling pathways as main contributors to the disease. However, isolated beta-catenin constitutive activation failed to induce malignant progression in mouse adrenocortical tumors. Therefore, there still was a need for a relevant animal model to study ACC pathogenesis and to test new therapeutic approaches. Here, we have developed a transgenic mice model with adrenocortical specific expression of SV40 large T-antigen (AdTAg mice), to test the oncogenic potential of p53/Rb inhibition in the adrenal gland. All AdTAg mice develop large adrenal carcinomas that eventually metastasize to the liver and lungs, resulting in decreased overall survival. Consistent with ACC in patients, adrenal tumors in AdTAg mice autonomously produce large amounts of glucocorticoids and spontaneously activate WNT/beta-catenin signaling pathway during malignant progression. We show that this activation is associated with downregulation of secreted frizzled related proteins (Sfrp) and Znrf3 that act as inhibitors of the WNT signaling. We also show that mTORC1 pathway activation is an early event during neoplasia expansion and further demonstrate that mTORC1 pathway is activated in ACC patients. Preclinical inhibition of mTORC1 activity induces a marked reduction in tumor size, associated with induction of apoptosis and inhibition of proliferation that results in normalization of corticosterone plasma levels in AdTAg mice. Altogether, these data establish AdTAg mice as the first preclinical model for metastatic ACC.	[Batisse-Lignier, M.; Sahut-Barnola, I.; Dumontet, T.; Mathieu, M.; Drelon, C.; Pointud, J-C; Damon-Soubeyrand, C.; Tauveron, I.; Val, P.; Martinez, A.; Lefrancois-Martinez, A-M] Univ Clermont Auvergne, CNRS UMR6293, INSERM U1103, GReD, Campus Univ Cezeaux,10 Ave Blaise Pascal, F-63178 Aubiere, France; [Batisse-Lignier, M.; Tauveron, I.] Ctr Hosp Univ, Endocrinol Diabetol & Metab Dis Dept, Sch Med, Clermont Ferrand, France; [Tissier, F.; Bertherat, J.] Hop Cochin, Assistance Publ Hop Paris, Reference Ctr Rare Adrenal Dis, Dept Pathol, Paris, France; [Tissier, F.] Univ Paris 06, Hop Pitie Salpetriere, Dept Pathol, Paris, France; [Marceau, G.] Ctr Hosp Univ, Dept Biochem & Mol Biol, Clermont Ferrand, France; [Kemeny, J-L] Clermont Ferrand Hosp, Dept Anatomopathol, Clermont Ferrand, France; [Bertherat, J.] Univ Paris 05, CNRS UMR8104, INSERM U1016, Inst Cochin, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Universite de Franche-Comte; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Martinez, A; Lefrancois-Martinez, AM (corresponding author), Univ Clermont Auvergne, CNRS UMR6293, INSERM U1103, GReD, Campus Univ Cezeaux,10 Ave Blaise Pascal, F-63178 Aubiere, France.	antoine.martinez@uca.fr; a-marie.lefrancois-martinez@uca.fr	Dumontet, Typhanie/AAA-3605-2022	MARCEAU, GEOFFROY/0000-0003-4713-7162; BERTHERAT, Jerome/0000-0003-2551-3008	Universite Blaise Pascal; Universite d'Auvergne; CNRS; INSERM; Agence National de la Recherche [ANR-14-CE12-0007]; Fondation ARC pour la Recherche sur le Cancer [PJA 20141201894]; La Fondation de France	Universite Blaise Pascal; Universite d'Auvergne; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence National de la Recherche(French National Research Agency (ANR)); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); La Fondation de France(Fondation de France)	We thank Lucile Mounier for technical assistance and Sandrine Plantade, Khirredine Ouchen and Philippe Mazuel for animal care. Tissue analyses were performed at Anipath Clermont core facility. This work was supported by Universite Blaise Pascal, Universite d'Auvergne, CNRS, INSERM, Agence National de la Recherche (grant ANR-14-CE12-0007), grants from Fondation ARC pour la Recherche sur le Cancer (PJA 20141201894) and from La Fondation de France. We thank the Cochin tumor bank and COMETE (COrtico MEdullo Tumeurs Endocrines) network for the provision of ACA and ACC tissue samples.	Abiven G, 2006, J CLIN ENDOCR METAB, V91, P2650, DOI 10.1210/jc.2005-2730; Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Allolio B, 2006, J CLIN ENDOCR METAB, V91, P2027, DOI 10.1210/jc.2005-2639; Assie G, 2014, NAT GENET, V46, P607, DOI 10.1038/ng.2953; Assie G, 2010, TRENDS ENDOCRIN MET, V21, P325, DOI 10.1016/j.tem.2009.12.009; Baudin E, 2015, ENDOCRIN METAB CLIN, V44, P411, DOI 10.1016/j.ecl.2015.03.001; Bernichtein S, 2008, ENDOCRINOLOGY, V149, P651, DOI 10.1210/en.2007-0925; Berruti A, 2014, EUR UROL, V65, P832, DOI 10.1016/j.eururo.2013.11.006; Berthon A, 2010, HUM MOL GENET, V19, P1561, DOI 10.1093/hmg/ddq029; Beuschlein F, 2015, J CLIN ENDOCR METAB, V100, P841, DOI 10.1210/jc.2014-3182; Bocchetta M, 2008, CANCER RES, V68, P1022, DOI 10.1158/0008-5472.CAN-07-5203; De Martino MC, 2012, ENDOCR-RELAT CANCER, V19, P351, DOI 10.1530/ERC-11-0270; de Reynies A, 2009, J CLIN ONCOL, V27, P1108, DOI 10.1200/JCO.2008.18.5678; Doghman M, 2012, MOL CELL ENDOCRINOL, V364, P101, DOI 10.1016/j.mce.2012.08.014; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Drelon C, 2016, HUM MOL GENET, V25, P2789, DOI 10.1093/hmg/ddw136; Drelon C, 2013, J CLIN ENDOCR METAB, V98, P505, DOI 10.1210/jc.2012-3310; Drelon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044171; Else T, 2014, ENDOCR REV, V35, P282, DOI 10.1210/er.2013-1029; Faillot S, 2016, EUR J ENDOCRINOL, V174, pR249, DOI 10.1530/EJE-15-1118; Fassnacht M, 2015, LANCET ONCOL, V16, P426, DOI 10.1016/S1470-2045(15)70081-1; Fassnacht M, 2012, NEW ENGL J MED, V366, P2189, DOI 10.1056/NEJMoa1200966; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Feng ZH, 2010, TRENDS CELL BIOL, V20, P427, DOI 10.1016/j.tcb.2010.03.004; Fraenkel M, 2013, ENDOCRINE, V44, P187, DOI 10.1007/s12020-013-9878-1; Gangadhar TC, 2011, CLIN CANCER RES, V17, P1956, DOI 10.1158/1078-0432.CCR-10-2061; Gaujoux S, 2011, CLIN CANCER RES, V17, P328, DOI 10.1158/1078-0432.CCR-10-2006; Gibb N, 2013, DEVELOPMENT, V140, P1537, DOI 10.1242/dev.088047; Giordano TJ, 2009, CLIN CANCER RES, V15, P668, DOI 10.1158/1078-0432.CCR-08-1067; Heaton JH, 2012, AM J PATHOL, V181, P1017, DOI 10.1016/j.ajpath.2012.05.026; Heikkila M, 2002, ENDOCRINOLOGY, V143, P4358, DOI 10.1210/en.2002-220275; Heinze B, 2014, EUR J ENDOCRINOL, V170, P707, DOI 10.1530/EJE-13-0788; Hershkovitz L, 2007, ENDOCRINOLOGY, V148, P976, DOI 10.1210/en.2006-1100; Hisada M, 1998, JNCI-J NATL CANCER I, V90, P606, DOI 10.1093/jnci/90.8.606; Juhlin CC, 2015, J CLIN ENDOCR METAB, V100, pE493, DOI 10.1210/jc.2014-3282; Kananen K, 1996, MOL ENDOCRINOL, V10, P1667, DOI 10.1210/me.10.12.1667; Lambert-Langlais S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007309; Latronico AC, 2001, J CLIN ENDOCR METAB, V86, P4970, DOI 10.1210/jc.86.10.4970; Libe R, 2005, EUR J ENDOCRINOL, V153, P477, DOI 10.1530/eje.1.02004; Libe R, 2007, CLIN CANCER RES, V13, P844, DOI 10.1158/1078-0432.CCR-06-2085; Martino MCD, 2014, ENDOCR-RELAT CANCER, V21, P601; Naing A, 2011, CLIN CANCER RES, V17, P6052, DOI 10.1158/1078-0432.CCR-10-2979; Paglin S, 2006, AUTOPHAGY, V2, P291, DOI 10.4161/auto.2835; Papotti Mauro, 2011, Hormones & Cancer, V2, P333, DOI 10.1007/s12672-011-0088-0; Ragazzon B, 2006, ENDOCRINOLOGY, V147, P1805, DOI 10.1210/en.2005-1279; Ragazzon B, 2014, EUR J ENDOCRINOL, V170, P385, DOI 10.1530/EJE-13-0778; Ragazzon B, 2010, CANCER RES, V70, P8276, DOI 10.1158/0008-5472.CAN-10-2014; REINCKE M, 1994, J CLIN ENDOCR METAB, V78, P790, DOI 10.1210/jc.78.3.790; Ribeiro RC, 2001, P NATL ACAD SCI USA, V98, P9330, DOI 10.1073/pnas.161479898; Romero DG, 2007, ENDOCRINOLOGY, V148, P2644, DOI 10.1210/en.2006-1509; Sun Y, 2016, ONCOGENE, V35, P4321, DOI 10.1038/onc.2015.494; Surana R, 2014, BBA-REV CANCER, V1845, P53, DOI 10.1016/j.bbcan.2013.11.004; Tissier F, 2004, EUR J ENDOCRINOL, V150, P809, DOI 10.1530/eje.0.1500809; Tissier F, 2012, AM J SURG PATHOL, V36, P1194, DOI 10.1097/PAS.0b013e31825a6308; Yamamura S, 2010, MOL CANCER THER, V9, P1680, DOI 10.1158/1535-7163.MCT-10-0012; Zheng SY, 2016, CANCER CELL, V29, P723, DOI 10.1016/j.ccell.2016.04.002	56	20	20	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 3	2017	36	31					4445	4456		10.1038/onc.2017.54	http://dx.doi.org/10.1038/onc.2017.54			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FC4JL	28368424				2022-12-26	WOS:000406806000007
J	Capoor, MN; Ruzicka, F; Schmitz, JE; James, GA; Machackova, T; Jancalek, R; Smrcka, M; Lipina, R; Ahmed, FS; Alamin, TF; Anand, N; Baird, JC; Bhatia, N; Demir-Deviren, S; Eastlack, RK; Fisher, S; Garfin, SR; Gogia, JS; Gokaslan, ZL; Kuo, CC; Lee, YP; Mavrommatis, K; Michu, E; Noskova, H; Raz, A; Sana, J; Shamie, AN; Stewart, PS; Stonemetz, JL; Wang, JC; Witham, TF; Coscia, MF; Birkenmaier, C; Fischetti, VA; Slaby, O				Capoor, Manu N.; Ruzicka, Filip; Schmitz, Jonathan E.; James, Garth A.; Machackova, Tana; Jancalek, Radim; Smrcka, Martin; Lipina, Radim; Ahmed, Fahad S.; Alamin, Todd F.; Anand, Neel; Baird, John C.; Bhatia, Nitin; Demir-Deviren, Sibel; Eastlack, Robert K.; Fisher, Steve; Garfin, Steven R.; Gogia, Jaspaul S.; Gokaslan, Ziya L.; Kuo, Calvin C.; Lee, Yu-Po; Mavrommatis, Konstantinos; Michu, Elleni; Noskova, Hana; Raz, Assaf; Sana, Jiri; Shamie, A. Nick; Stewart, Philip S.; Stonemetz, Jerry L.; Wang, Jeffrey C.; Witham, Timothy F.; Coscia, Michael F.; Birkenmaier, Christof; Fischetti, Vincent A.; Slaby, Ondrej			Propionibacterium acnes biofilm is present in intervertebral discs of patients undergoing microdiscectomy	PLOS ONE			English	Article							LOW-BACK-PAIN; SARCOIDOSIS; INFECTIONS; ASSOCIATION; INVOLVEMENT; DIAGNOSIS; PATHOGEN; SCIATICA; SPINE	Background In previous studies, Propionibacterium acnes was cultured from intervertebral disc tissue of similar to 25% of patients undergoing microdiscectomy, suggesting a possible link between chronic bacterial infection and disc degeneration. However, given the prominence of P. acnes as a skin commensal, such analyses often struggled to exclude the alternate possibility that these organisms represent perioperative microbiologic contamination. This investigation seeks to validate P. acnes prevalence in resected disc cultures, while providing microscopic evidence of P. acnes biofilm in the intervertebral discs. Methods Specimens from 368 patients undergoing microdiscectomy for disc herniation were divided into several fragments, one being homogenized, subjected to quantitative anaerobic culture, and assessed for bacterial growth, and a second fragment frozen for additional analyses. Colonies were identified by MALDI-TOF mass spectrometry and P. acnes phylotyping was conducted by multiplex PCR. For a sub-set of specimens, bacteria localization within the disc was assessed by microscopy using confocal laser scanning and FISH. Results Bacteria were cultured from 162 discs (44%), including 119 cases (32.3%) with P. acnes. In 89 cases, P. acnes was cultured exclusively; in 30 cases, it was isolated in combination with other bacteria (primarily coagulase-negative Staphylococcus spp.) Among positive specimens, the median P. acnes bacterial burden was 350 CFU/g (12 - similar to 20,000 CFU/g). Thirtyeight P. acnes isolates were subjected to molecular sub-typing, identifying 4 of 6 defined phylogroups: IA1, IB, IC, and II. Eight culture-positive specimens were evaluated by fluorescence microscopy and revealed P. acnes in situ. Notably, these bacteria demonstrated a biofilm distribution within the disc matrix. P. acnes bacteria were more prevalent in males than females (39% vs. 23%, p = 0.0013). Conclusions This study confirms that P. acnes is prevalent in herniated disc tissue. Moreover, it provides the first visual evidence of P. acnes biofilms within such specimens, consistent with infection rather than microbiologic contamination.	[Capoor, Manu N.; Raz, Assaf; Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10021 USA; [Capoor, Manu N.; Machackova, Tana; Ahmed, Fahad S.; Baird, John C.; Michu, Elleni; Noskova, Hana; Sana, Jiri; Slaby, Ondrej] Masaryk Univ, Dept Mol Oncol, Cent European Inst Technol CEITEC, Brno, Czech Republic; [Ruzicka, Filip] Masaryk Univ, St Annes Fac Hosp, Dept Microbiol, Fac Med, Brno, Czech Republic; [Schmitz, Jonathan E.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [James, Garth A.; Fisher, Steve; Stewart, Philip S.] Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA; [Jancalek, Radim] Masaryk Univ, St Annes Univ Hosp, Dept Neurosurg, Brno, Czech Republic; [Smrcka, Martin] Masaryk Univ, Univ Hosp Brno, Dept Neurosurg, Brno, Czech Republic; [Lipina, Radim] Ostrava Univ, Univ Hosp Ostrava, Dept Neurosurg, Ostrava, Czech Republic; [Alamin, Todd F.] Stanford Univ, Med Ctr, Dept Orthoped Surg, Stanford, CA 94305 USA; [Anand, Neel] Cedars Sinai Inst Spinal Disorders, Los Angeles, CA USA; [Bhatia, Nitin; Lee, Yu-Po] Univ Calif Irvine, Sch Med, Dept Orthopaed Surg, Irvine, CA 92717 USA; [Demir-Deviren, Sibel] UCSF Med Ctr, Spine Ctr, San Francisco, CA USA; [Eastlack, Robert K.] Scripps Clin, Div Orthoped Surg, San Diego, CA USA; [Garfin, Steven R.] Univ Calif San Diego, Dept Orthopaed Surg, San Diego, CA 92103 USA; [Gogia, Jaspaul S.] Kaiser Permanente, San Jose Med Ctr, Dept Orthoped Surg, San Jose, CA USA; [Gokaslan, Ziya L.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Neurosurg, Providence, RI 02903 USA; [Kuo, Calvin C.] Kaiser Permanente, Oakland Med Ctr, Dept Orthoped Surg, Oakland, CA USA; [Mavrommatis, Konstantinos] Celgene Corp, Informat Knowledge & Utilizat, San Francisco, CA USA; [Shamie, A. Nick] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90095 USA; [Stonemetz, Jerry L.] Johns Hopkins Univ Hosp, Dept Anesthesia, Baltimore, MD 21287 USA; [Wang, Jeffrey C.] Univ Southern Calif, Dept Orthoped Surg, Los Angeles, CA USA; [Witham, Timothy F.] Johns Hopkins Univ Hosp, Dept Neurosurg, Baltimore, MD 21287 USA; [Coscia, Michael F.] Ortholndy Hosp, Dept Orthoped Surg, Indianapolis, IN USA; [Birkenmaier, Christof] Univ Munich LMU, Dept Orthoped Phys Med & Rehabil, Munich, Germany	Rockefeller University; Masaryk University Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Vanderbilt University; Montana State University System; Montana State University Bozeman; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); Masaryk University Brno; University Hospital Brno; University Hospital Ostrava; University of Ostrava; Stanford University; Cedars Sinai Medical Center; University of California System; University of California Irvine; University of California System; University of California San Francisco; UCSF Medical Center; Scripps Research Institute; University of California System; University of California San Diego; Kaiser Permanente; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Kaiser Permanente; Bristol-Myers Squibb; Celgene Corporation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johns Hopkins University; Johns Hopkins Medicine; University of Southern California; Johns Hopkins University; Johns Hopkins Medicine; University of Munich	Slaby, O (corresponding author), Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, 1230 York Ave, New York, NY 10021 USA.	mcappor@mail.rockefeller.edu; ondrej.slaby@ceitec.muni.cz	Růžička, Filip/K-6360-2015; Smrčka, Martin/AAM-8872-2021; Jancalek, Radim/AAP-9193-2020; Palova, Hana/DKZ-9414-2022; capoor, manu/AAI-2709-2021	Smrčka, Martin/0000-0002-9191-8700; Jancalek, Radim/0000-0001-6834-6567; Capoor, Manu/0000-0002-0861-4993; Witham, Timothy/0000-0002-9397-8344; Mavrommatis, Konstantinos/0000-0003-4549-385X; Ruzicka, Filip/0000-0001-5679-0513; Machackova, Tana/0000-0001-5055-7147; Stewart, Philip/0000-0001-7773-8570	DiscitisDx, Inc.; Neither DiscitisDX, Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER	DiscitisDx, Inc.; Neither DiscitisDX, Inc.; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	DiscitisDx, Inc. provided support in the form of a research grant which was used to pay for culturing, microscopy, and materials. Neither DiscitisDX, Inc. nor any other commercial organization provided any support in the form of salaries for authors and did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. KM's commercial affiliation with Celgene did not play a role in the study.	Agarwal V, 2011, J SPINAL DISORD TECH, V24, P397, DOI 10.1097/BSD.0b013e3182019f3a; Aghazadeh J, 2016, EUR SPINE J; Albert HB, 2013, EUR SPINE J, V22, P690, DOI 10.1007/s00586-013-2674-z; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amital H, 2008, CLIN EXP RHEUMATOL, V26, pS27; Arndt J, 2012, J SPINAL DISORD TECH, V25, pE211, DOI 10.1097/BSD.0b013e318269851a; Asahina A, 2013, J DERMATOL, V40, P501, DOI 10.1111/1346-8138.12120; Bae Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090324; Barnard E, 2015, J CLIN MICROBIOL, V53, P1149, DOI 10.1128/JCM.02460-14; Bayston R, 2007, J BIOMED MATER RES A, V81A, P705, DOI 10.1002/jbm.a.31145; Ben-Galim P, 2006, SPINE, V31, P2507, DOI 10.1097/01.brs.0000238657.13263.b2; Capoor MN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161676; Carneiro S, 2013, RHEUM DIS CLIN N AM, V39, P401, DOI 10.1016/j.rdc.2013.02.009; Carricajo A, 2007, J HOSP INFECT, V66, P275, DOI 10.1016/j.jhin.2007.04.007; Chen Z, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9612437; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; Coscia M, 2003, SCOL RES SOC SRS ANN; Dudli S, 2016, J ORTHOP RES, V34, P1447, DOI 10.1002/jor.23265; EISHI Y, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/935289; Fischer N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/603046; Gaillard C, 2013, INT J LOW EXTR WOUND, V12, P301, DOI 10.1177/1534734613489990; Gausden EB, 2016, J ORTHOP TRAUMA; Han A, 2011, WOUND REPAIR REGEN, V19, P532, DOI 10.1111/j.1524-475X.2011.00720.x; Holmberg A, 2009, CLIN MICROBIOL INFEC, V15, P787, DOI 10.1111/j.1469-0691.2009.02747.x; Jakab E, 1996, YALE J BIOL MED, V69, P477; Johannes CB, 2010, J PAIN, V11, P1230, DOI 10.1016/j.jpain.2010.07.002; Lee MJ, 2014, J BONE JOINT SURG AM, V96A, P1447, DOI 10.2106/JBJS.M.01474; Lutz JA, 2012, EUR SPINE J, V21, P2573, DOI 10.1007/s00586-012-2366-0; McDowell A, 2005, J CLIN MICROBIOL, V43, P326, DOI 10.1128/JCM.43.1.326-334.2005; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Oliveira F, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv175; Omori M, 2015, J EUR ACAD DERMATOL, V29, P2059, DOI 10.1111/jdv.12594; Parker SL, 2015, CLIN ORTHOP RELAT R, V473, P1988, DOI 10.1007/s11999-015-4193-1; Perry A, 2011, EXPERT REV ANTI-INFE, V9, P1149, DOI [10.1586/ERI.11.137, 10.1586/eri.11.137]; Rigal J, 2016, EUR SPINE J, V25, P1000, DOI 10.1007/s00586-016-4396-5; Rollason J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/530382; Satoh F, 2013, AM J MED SCI, V346, P250, DOI 10.1097/MAJ.0b013e31828bdf9f; Shifflett GD, 2016, EUR SPINE J, V25, P3902, DOI 10.1007/s00586-016-4539-8; Singh JA, 2012, J SHOULDER ELB SURG, V21, P1534, DOI 10.1016/j.jse.2012.01.006; Stirling A, 2001, LANCET, V357, P2024, DOI 10.1016/S0140-6736(00)05109-6; Stirling A, 2002, J BONE JOINT SURG BR, V84B, P147, DOI DOI 10.1302/0301-620X.84B1.0840147c; Urquhart DM, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0267-x; Zhou Y, 2013, SARCOIDOSIS VASC DIF, V30, P262; Zimmermann P, 2016, J INFECTION, V72, pS106, DOI 10.1016/j.jinf.2016.04.030	44	53	57	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174518	10.1371/journal.pone.0174518	http://dx.doi.org/10.1371/journal.pone.0174518			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369127	gold, Green Published			2022-12-26	WOS:000399351000019
J	Zhu, JH; Wu, J; Pei, XC; Tan, ZJ; Shi, JQ; Lubman, DM				Zhu, Jianhui; Wu, Jing; Pei, Xiucong; Tan, Zhijing; Shi, Jiaqi; Lubman, David M.			Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma	PLOS ONE			English	Article							PAPILLARY-MUCINOUS NEOPLASM; MEMBRANE-BINDING PROTEINS; SERRATED PATHWAY; EXPRESSION; CANCER; CLASSIFICATION; BIOLOGY; CD24; DIAGNOSIS; CONSENSUS	Annexins are a multigene family of calcium and phospholipid-binding proteins that play important roles in calcium signaling, cell motility, differentiation and proliferation. Our previous mass spectrometry-based proteomics study revealed that annexin A10 (ANXA10) was uniquely overexpressed in pancreatic CD24(+) adenocarcinoma cells that were dissected from clinical PDAC tissues but was absent in CD24(-) adjacent normal cells. The correlation between ANXA10 expression and the progression of pancreatic cancer remains unknown. In this study, we performed an immunostaining assay to evaluate ANXA10 expression in 155 primary human tissue specimens, including normal pancreas, chronic pancreatitis (CP), pancreatic adenocarcinoma (PDAC), pancreatic intraepithelial neoplasia (PanIN, the most important precursor of PDAC), and intraductal papillary mucinous neoplasm (IPMN). The immunostaining result showed that ANXA10 was significantly overexpressed in PanINs, IPMNs, and PDACs but negative in normal pancreas and the majority of chronic pancreatitis tissues. Statistical analysis revealed that ANXA10 expression was significantly associated with PDAC and its precursor lesions (p < 0.0001). Abundant ANXA10 expression was predominantly present in pancreatic ductal epithelial cells of PanINs, IPMNs, and tumor cells of PDACs. Since PDAC develops through a series of PanINs which in turn arise from pancreatic ducts, the consistent overexpression of ANXA10 in ductal epithelial cells in PanINs and PDACs but negative in normal pancreatic ducts suggests that ANXA10 could serve as a potential marker indicating the presence of PDAC at its earliest precancerous stages. Double immunostaining of ANXA10 and CD24 showed that there was a large overlap between these two markers in PDAC and high-grade neoplasia lesions. The statistical analysis showed that the coexpression of ANXA10 and CD24 was significantly correlated with the progression of pancreatic precursor lesions towards PDACs.	[Zhu, Jianhui; Wu, Jing; Pei, Xiucong; Tan, Zhijing; Lubman, David M.] Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA; [Pei, Xiucong] Shenyang Med Coll, Sch Publ Hlth, Dept Toxicol, Liaoning, Peoples R China; [Shi, Jiaqi] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; Shenyang Medical College; University of Michigan System; University of Michigan	Lubman, DM (corresponding author), Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA.	dmlubman@umich.edu	Zhu, Jianhui/H-4665-2011	Zhu, Jianhui/0000-0002-0051-7777; Shi, Jiaqi/0000-0003-4893-1587	National Institutes of Health [R01GM49500 (DML)]; National Cancer Institute [1R01CA154455 (DML)]; NATIONAL CANCER INSTITUTE [R01CA154455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported under the National Institutes of Health (https://www.nih.gov/) Grant R01GM49500 (DML) and the National Cancer Institute (https://www.cancer.gov/) Grant 1R01CA154455 (DML).The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscript.	Bae JM, 2015, WORLD J GASTROENTERO, V21, P9749, DOI 10.3748/wjg.v21.i33.9749; Bai XF, 2004, WORLD J GASTROENTERO, V10, P1466; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Basturk O, 2015, AM J SURG PATHOL, V39, P1730, DOI 10.1097/PAS.0000000000000533; Baumann P, 2005, CANCER RES, V65, P10783, DOI 10.1158/0008-5472.CAN-05-0619; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Castellano-Megias VM, 2014, WORLD J GASTRO ONCOL, V6, P311, DOI 10.4251/wjgo.v6.i9.311; Chu GC, 2007, J CELL BIOCHEM, V101, P887, DOI 10.1002/jcb.21209; Esposito I, 2006, J PATHOL, V208, P673, DOI 10.1002/path.1935; Furukawa T, 2005, VIRCHOWS ARCH, V447, P794, DOI 10.1007/s00428-005-0039-7; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Hayes MJ, 2004, BIOCHEM BIOPH RES CO, V322, P1166, DOI 10.1016/j.bbrc.2004.07.124; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hruban RH, 2004, AM J SURG PATHOL, V28, P977, DOI 10.1097/01.pas.0000126675.59108.80; Ikenaga N, 2010, HUM PATHOL, V41, P1466, DOI 10.1016/j.humpath.2010.04.004; Jacob J, 2004, PANCREATOLOGY, V4, P454, DOI 10.1159/000079824; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; LIEMANN S, 1995, STRUCTURE, V3, P233, DOI 10.1016/S0969-2126(01)00152-6; Lu SH, 2013, HISTOPATHOLOGY, V63, P640, DOI 10.1111/his.12229; Lu SH, 2011, J GASTROEN HEPATOL, V26, P90, DOI 10.1111/j.1440-1746.2010.06480.x; Morgan RO, 1999, GENOMICS, V60, P40, DOI 10.1006/geno.1999.5895; Mussunoor S, 2008, J PATHOL, V216, P131, DOI 10.1002/path.2400; Pei XC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158021; Real FX, 2008, GASTROENTEROLOGY, V135, P724, DOI 10.1053/j.gastro.2008.07.033; Reichert M, 2011, J CLIN INVEST, V121, P4572, DOI 10.1172/JCI57131; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Sagiv E, 2006, BIOMED PHARMACOTHER, V60, P280, DOI 10.1016/j.biopha.2006.06.006; Sajanti SA, 2015, VIRCHOWS ARCH, V466, P5, DOI 10.1007/s00428-014-1683-6; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; STEER ML, 1995, NEW ENGL J MED, V332, P1482, DOI 10.1056/NEJM199506013322206; Tsai JH, 2015, MODERN PATHOL, V28, P268, DOI 10.1038/modpathol.2014.96; Witt H, 2007, GASTROENTEROLOGY, V132, P1557, DOI 10.1053/j.gastro.2007.03.001; Xiao SY, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/893632; Zhu JH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115507, 10.1371/journal.pone.0097616]; Zhu JH, 2013, J PROTEOME RES, V12, P2791, DOI 10.1021/pr400139c	36	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0175039	10.1371/journal.pone.0175039	http://dx.doi.org/10.1371/journal.pone.0175039			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369074	Green Published, gold, Green Submitted			2022-12-26	WOS:000399351000068
J	Devarajooh, C; Chinna, K				Devarajooh, Cassidy; Chinna, Karuthan			Depression, distress and self-efficacy: The impact on diabetes self-care practices	PLOS ONE			English	Article							MANAGEMENT; ADULTS; HEALTH; BEHAVIOR; ADHERENCE; SYMPTOMS; SUPPORT; STRESS; PEOPLE; WOMEN	The prevalence of type 2 diabetes is increasing in Malaysia, and people with diabetes have been reported to suffer from depression and diabetes distress which influences their self efficacy in performing diabetes self-care practices. This interviewer administered, cross sectional study, conducted in the district of Hulu Selangor, Malaysia, involving 371 randomly selected patients with type 2 diabetes, recruited from 6 health clinics, aimed to examine a conceptual model regarding the association between depression, diabetes distress and self-efficacy with diabetes self-care practices using the partial least square approach of structural equation modeling. In this study, diabetes self-care practices were similar regardless of sex, age group, ethnicity, education level, diabetes complications or type of diabetes medication. This study found that self-efficacy had a direct effect on diabetes self-care practice (path coefficient = 0.438, p<0.001). Self-care was not directly affected by depression and diabetes distress, but indirectly by depression (path coefficient = -0.115, p<0.01) and diabetes distress (path coefficient = -0.122, p<0.001) via self-efficacy. In conclusion, to improve self-care practices, effort must be focused on enhancing self-efficacy levels, while not forgetting to deal with depression and diabetes distress, especially among those with poorer levels of self-efficacy.	[Devarajooh, Cassidy; Chinna, Karuthan] Univ Malaya, Fac Med, Dept Social & Prevent Med, Jalan Univ, Kuala Lumpur, Malaysia	Universiti Malaya	Devarajooh, C (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Jalan Univ, Kuala Lumpur, Malaysia.	cassdeva@hotmail.com						Adam J, 2014, JNP-J NURSE PRACT, V10, P42, DOI 10.1016/j.nurpra.2014.07.033; Adebayo SO, 2014, ONLINE J SOCIAL SCI, V3; Al Johani KA, 2015, E MEDITERR HEALTH J, V21, P621, DOI 10.26719/2015.21.9.621; Al-Khawaldeh OA, 2012, J DIABETES COMPLICAT, V26, P10, DOI 10.1016/j.jdiacomp.2011.11.002; Anita TF, 2013, J NURSING ED PRACTIC, V3, P61; Atak N, 2013, AUSTR J ADV NURSING, V26, P66; Bai YL, 2009, J CLIN NURS, V18, P3308, DOI 10.1111/j.1365-2702.2009.02992.x; Bandura A., 1994, SELF EFFICACY; Beckerle C. M., 2013, Diabetes Spectrum, V26, P172, DOI 10.2337/diaspect.26.3.172; Campbell MD, 2015, BMJ OPEN DIAB RES CA, V3, DOI [10.1136/bmjdrc-2015-000085, 10.1136/bmjdrc-2015000085]; Carper MM, 2014, J BEHAV MED, V37, P501, DOI 10.1007/s10865-013-9505-x; Chan HL, 2012, DIABETES RES CLIN PR, V98, pE4, DOI 10.1016/j.diabres.2012.06.003; Choi SE, 2009, DIABETES EDUCATOR, V35, P978, DOI 10.1177/0145721709349220; Clark DO, 1999, HEALTH EDUC BEHAV, V26, P535, DOI 10.1177/109019819902600410; Diane OR, 2010, SOUTHERN ONLINE JOUR, V10; Dunlop DD, 2003, AM J PUBLIC HEALTH, V93, P1945, DOI 10.2105/AJPH.93.11.1945; Engum A, 2005, DIABETES CARE, V28, P1904, DOI 10.2337/diacare.28.8.1904; Fisher L, 2009, DIABETIC MED, V26, P622, DOI 10.1111/j.1464-5491.2009.02730.x; Fisher L, 2008, ANN FAM MED, V6, P246, DOI 10.1370/afm.842; Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572; Freitas SS, 2014, ACTA SCI-HEALTH SCI, V36, P73, DOI 10.4025/actascihealthsci.v36i1.16251; Gillani SW, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.1000252; Gonzalez JS, 2008, DIABETOLOGIA, V51, P1822, DOI 10.1007/s00125-008-1113-x; Gonzalez JS, 2011, PSYCHOLOGICAL CO-MORBIDITIES OF PHYSICAL ILLNESS: A BEHAVIORAL MEDICINE PERSPECTIVE, P73, DOI 10.1007/978-1-4419-0029-6_2; Gopichandran V, 2012, NATL MED J INDIA, V25, P14; Grewal K, 2010, HEART LUNG, V39, P180, DOI 10.1016/j.hrtlng.2009.06.016; Habtewold TD, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0809-6; Hair JF, 2011, J MARKET THEORY PRAC, V19, P139, DOI 10.2753/MTP1069-6679190202; Henseler Jr, 2009, USE PARTIAL LEAST SQ; Huang MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095138; Ikeda K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109323; Jalaludin My, 2012, Malays Fam Physician, V7, P10; Joseph Nitin, 2013, Indian J Endocrinol Metab, V17, P681, DOI 10.4103/2230-8210.113761; Kaur G, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-69; Koopman C, 2003, AM J HEALTH PROMOT, V17, P259, DOI 10.4278/0890-1171-17.4.259; Lin EHB, 2004, DIABETES CARE, V27, P2154, DOI 10.2337/diacare.27.9.2154; Ludman EJ, 2013, BEHAV MED, V39, P1, DOI 10.1080/08964289.2012.708682; Mohamed HJBJ, 2015, ASIA-PAC J PUBLIC HE, V27, P123, DOI 10.1177/1010539514562447; Mohammad AH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/302097; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Nwasuruba C, 2009, J DIABETES COMPLICAT, V23, P112, DOI 10.1016/j.jdiacomp.2007.11.005; Nyunt SW, 2010, SE ASIAN J TROP MED, V41, P943; O'Reilly KB, 2011, TACTICS IMPROVE DRUG; Peyrot M, 2010, DIABETES CARE, V33, P240, DOI 10.2337/dc09-1348; Polonsky W.H., 2004, CLIN DIABETES, V22, P147, DOI DOI 10.2337/diaclin.22.3.147; Pouwer F, 2005, DIABETES RES CLIN PR, V70, P166, DOI 10.1016/j.diabres.2005.03.031; Pouwer F, 2013, DIABETIC MED, V30, pE25, DOI 10.1111/dme.12031; Primozic S, 2012, DIABETES RES CLIN PR, V95, P48, DOI 10.1016/j.diabres.2011.09.004; Rifkin DE, 2010, AM J KIDNEY DIS, V56, P439, DOI 10.1053/j.ajkd.2010.04.021; Robert RW, 2014, J DIABETES METABOLIS; Senecal C, 2000, HEALTH PSYCHOL, V19, P452, DOI 10.1037//0278-6133.19.5.452; Sharoni SKA, 2012, NURS HEALTH SCI, V14, P38, DOI 10.1111/j.1442-2018.2011.00658.x; Sherina M S, 2004, Asia Pac J Public Health, V16, P109, DOI 10.1177/101053950401600206; Sherina M S, 2012, Med J Malaysia, V67, P309; Song Y, 2012, DIABETES EDUCATOR, V38, P77, DOI 10.1177/0145721711432456; Tadele A, 2014, WORLD J MED MED SCI, V2; Taherdoost H., 2022, ADV APPL PURE MATH, V27, P375, DOI DOI 10.2139/SSRN.3205035; Tahmasebi R, 2015, ASIA-PAC J PUBLIC HE, V27, pNP524, DOI 10.1177/1010539513475652; Tan MY, 2008, PATIENT EDUC COUNS, V72, P252, DOI 10.1016/j.pec.2008.03.017; Tanenbaum ML, 2016, J DIABETES COMPLICAT, V30, P1060, DOI 10.1016/j.jdiacomp.2016.04.023; Thanakwang K, 2014, CLIN INTERV AGING, V9, P1353, DOI 10.2147/CIA.S67200; Venkataraman K, 2012, J COMMUN HEALTH, V37, P653, DOI 10.1007/s10900-011-9496-x; Wardian J, 2014, SOC WORK HEALTH CARE, V53, P364, DOI 10.1080/00981389.2014.884038; Weiss EL, 1999, AM J PSYCHIAT, V156, P816, DOI 10.1176/ajp.156.6.816; Whittemore R, 2005, J CLIN NURS, V14, P195, DOI 10.1111/j.1365-2702.2004.00937.x; Wyatt LC, 2015, J HEALTH CARE POOR U, V26, P191, DOI 10.1353/hpu.2015.0059; Yong A. G., 2013, TUTORIALS QUANTITATI, V9; Zgibor JC, 2002, DIABETES CARE, V25, P1772, DOI 10.2337/diacare.25.10.1772	68	58	64	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0175096	10.1371/journal.pone.0175096	http://dx.doi.org/10.1371/journal.pone.0175096			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VK	28362861	Green Published, Green Submitted, gold			2022-12-26	WOS:000399175000071
J	Erguler, K; Chandra, NL; Proestos, Y; Lelieveld, J; Christophides, GK; Parham, PE				Erguler, Kamil; Chandra, Nastassya L.; Proestos, Yiannis; Lelieveld, Jos; Christophides, George K.; Parham, Paul E.			A large-scale stochastic spatiotemporal model for Aedes albopictus-borne chikungunya epidemiology	PLOS ONE			English	Article							INDIAN-OCEAN; DIPTERA-CULICIDAE; 1ST RECORD; VIRUS; INFECTION; OUTBREAK; VECTOR; AEGYPTI; TRANSMISSION; PATTERNS	Chikungunya is a viral disease transmitted to humans primarily via the bites of infected Aedes mosquitoes. The virus caused a major epidemic in the Indian Ocean in 2004, affecting millions of inhabitants, while cases have also been observed in Europe since 2007. We developed a stochastic spatiotemporal model of Aedes albopictus-borne chikungunya transmission based on our recently developed environmentally-driven vector population dynamics model. We designed an integrated modelling framework incorporating large-scale gridded climate datasets to investigate disease outbreaks on Reunion Island and in Italy. We performed Bayesian parameter inference on the surveillance data, and investigated the validity and applicability of the underlying biological assumptions. The model successfully represents the outbreak and measures of containment in Italy, suggesting wider applicability in Europe. In its current configuration, the model implies two different viral strains, thus two different outbreaks, for the two-stage Reunion Island epidemic. Characterisation of the posterior distributions indicates a possible relationship between the second larger outbreak on Reunion Island and the Italian outbreak. The model suggests that vector control measures, with different modes of operation, are most effective when applied in combination: adult vector intervention has a high impact but is short-lived, larval intervention has a low impact but is long-lasting, and quarantining infected territories, if applied strictly, is effective in preventing large epidemics. We present a novel approach in analysing chikungunya outbreaks globally using a single environmentally-driven mathematical model. Our study represents a significant step towards developing a globally applicable Ae. albopictus-borne chikungunya transmission model, and introduces a guideline for extending such models to other vectorborne diseases.	[Erguler, Kamil; Proestos, Yiannis; Lelieveld, Jos] Cyprus Inst, Energy Environm & Water Res Ctr, CY-2121 Nicosia, Cyprus; [Chandra, Nastassya L.] Imperial Coll London, Fac Med, Dept Infect Dis Epidemiol, London W2 1PG, England; [Lelieveld, Jos] Max Planck Inst Chem, Dept Atmospher Chem, D-55128 Mainz, Germany; [Christophides, George K.] Imperial Coll London, Fac Nat Sci, Dept Life Sci, South Kensington Campus, London SW7 2AZ, England; [Christophides, George K.] Cyprus Inst, Computat Based Sci & Technol Res Ctr, CY-2121 Nicosia, Cyprus; [Parham, Paul E.] Univ Liverpool, Fac Hlth & Life Sci, Dept Publ Hlth & Policy, Liverpool L69 3GL, Merseyside, England	Imperial College London; Max Planck Society; Imperial College London; University of Liverpool	Erguler, K (corresponding author), Cyprus Inst, Energy Environm & Water Res Ctr, CY-2121 Nicosia, Cyprus.; Parham, PE (corresponding author), Univ Liverpool, Fac Hlth & Life Sci, Dept Publ Hlth & Policy, Liverpool L69 3GL, Merseyside, England.	k.erguler@cyi.ac.cy; paul.parham@liverpool.ac.uk	Lelieveld, Jos/A-1986-2013; Erguler, Kamil/ABD-4636-2020; Erguler, Kamil/Y-5990-2019	Lelieveld, Jos/0000-0001-6307-3846; Erguler, Kamil/0000-0002-2674-592X; Proestos, Yiannis/0000-0001-5991-0322; Christophides, George/0000-0002-3323-1687; Chandra, Nastassya/0000-0002-6259-230X	European Regional Development Fund [NEW INFRASTRUCTURE/STRATEGIC/0308/31]; Republic of Cyprus through the Research Promotion Foundation [YGammaA/DeltaGammaA/0311(BIE)/13]; European Union Scholarship Programme for the Turkish Cypriot Community	European Regional Development Fund(European Commission); Republic of Cyprus through the Research Promotion Foundation; European Union Scholarship Programme for the Turkish Cypriot Community	This work was co-funded by the European Regional Development Fund and the Republic of Cyprus through the Research Promotion Foundation (Project Y Gamma A/Delta Gamma A/0311(BIE)/13). KE would like to acknowledge the European Union Scholarship Programme for the Turkish Cypriot Community for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the E-OBS dataset from the EU-FP6 project ENSEMBLES (http://ensembles-eu.metoffice.com) and the data providers in the ECA&D project (http://www.ecad.eu). We acknowledge the Cy-Tera Project (NEW INFRASTRUCTURE/STRATEGIC/0308/31), which is co-funded by the European Regional Development Fund and the Republic of Cyprus through the Research Promotion Foundation, for providing the computational resources used in this research. This work was co-funded by the European Regional Development Fund and the Republic of Cyprus through the Research Promotion Foundation (Project Y Gamma A/Delta Gamma A/0311(BIE)/13). KE would like to acknowledge the European Union Scholarship Programme for the Turkish Cypriot Community for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar e Oliveira Junior H., 2012, STOCHASTIC GLOBAL OP, P33, DOI [10.1007/978-3-642-27479-4_4, DOI 10.1007/978-3-642-27479-4_4]; ANDERSON R M, 1991; [Anonymous], 2009, J MED ENTOMOL, V46, P33; Bacaer N, 2007, B MATH BIOL, V69, P1067, DOI 10.1007/s11538-006-9166-9; Beltrame A, 2007, EMERG INFECT DIS, V13, P1264, DOI 10.3201/eid1308.070161; Boelle PY, 2008, VECTOR-BORNE ZOONOT, V8, P207, DOI 10.1089/vbz.2006.0620; Borgherini G, 2008, CLIN INFECT DIS, V47, P469, DOI 10.1086/590003; Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351; Mari RB, 2010, REV ESP SALUD PUBLIC, V84, P255; Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135; Carrieri M, 2012, J MED ENTOMOL, V49, P388, DOI 10.1603/ME10259; Carrieri M, 2011, J VECTOR ECOL, V36, P108, DOI 10.1111/j.1948-7134.2011.00147.x; Centers for Disease Control and Prevention website, CHIK FEV; Chhabra M, 2008, INDIAN J MED MICROBI, V26, P5, DOI 10.4103/0255-0857.38850; Chitnis N, 2013, J BIOL DYNAM, V7, P11, DOI 10.1080/17513758.2012.733427; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; Coffinet T, 2007, J AM MOSQUITO CONTR, V23, P471, DOI 10.2987/5636.1; de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33; Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026; Dommar CJ, 2014, ACTA TROP, V129, P61, DOI 10.1016/j.actatropica.2013.08.004; Drovandi CC, 2011, J R STAT SOC C-APPL, V60, P317, DOI 10.1111/j.1467-9876.2010.00747.x; Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895; Dumont Y, 2008, MATH BIOSCI, V213, P80, DOI 10.1016/j.mbs.2008.02.008; ECDC, 2008, EXP M CHIK MOD STOCK; Enserink M, 2014, SCIENCE, V344, P678, DOI 10.1126/science.344.6185.678; Erguler K., ENV DRIVEM POPULATIO; Erguler K, 2018, HOPPMCMC ADAPTIVE BA; Erguler K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149282; Erguler K, 2011, MOL BIOSYST, V7, P1593, DOI 10.1039/c0mb00107d; Erickson RA, 2010, ECOL MODEL, V221, P2899, DOI 10.1016/j.ecolmodel.2010.08.036; European Centre for Disease Control and Prevention (ECDC), 2007, MISS REP  CHIK IT JO, P1; Filippi Sarah, 2013, Stat Appl Genet Mol Biol, V12, P87, DOI 10.1515/sagmb-2012-0069; Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99; Giorgetta M.E.M., 2003, REPORTMAX PLANCK INS, DOI DOI 10.17617/2.995269; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; Grassly NC, 2008, NAT REV MICROBIOL, V6, P477, DOI 10.1038/nrmicro1845; Gridded Population of the World: Future Estimates (GPWFE), GRIDD POP WORLD FUT; Guzzetta G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004762; HANSON SM, 1994, J MED ENTOMOL, V31, P192, DOI 10.1093/jmedent/31.2.192; Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005; Jockel P, 2006, ATMOS CHEM PHYS, V6, P5067; Kamgang B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002590; Keeling, 2008, MODELING INFECT DIS; Komorowski M, 2011, P NATL ACAD SCI USA, V108, P8645, DOI 10.1073/pnas.1015814108; Kucharz EJ, 2012, EUR J INTERN MED, V23, P325, DOI 10.1016/j.ejim.2012.01.009; Lahariya Chandrakant, 2006, Journal of Vector Borne Diseases, V43, P151; Liepe J, 2014, NAT PROTOC, V9, P439, DOI 10.1038/nprot.2014.025; Liepe J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002888; Lloyd AL, 2007, J R SOC INTERFACE, V4, P851, DOI 10.1098/rsif.2007.1064; Macdonald G, 1957, EPIDEMIOLOGY CONTROL; Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033; MATTINGLY PF, 1953, ANN TROP MED PARASIT, V47, P294, DOI 10.1080/00034983.1953.11685571; Mohan Alladi, 2010, Indian J Dermatol, V55, P54, DOI 10.4103/0019-5154.60355; MORI A, 1981, Tropical Medicine, V23, P79; Moro ML, 2010, AM J TROP MED HYG, V82, P508, DOI 10.4269/ajtmh.2010.09-0322; Ng LFP, 2009, MICROBES INFECT, V11, P1163, DOI 10.1016/j.micinf.2009.09.001; Paquet C., 2006, EUROSURVEILLANCE, V11; Parham PE, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0551; Parola P, 2006, EMERG INFECT DIS, V12, P1493, DOI 10.3201/eid1210.060610; Paupy C, 2001, HEREDITY, V87, P273, DOI 10.1046/j.1365-2540.2001.00866.x; Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860; POZZA GLD, 1994, J AM MOSQUITO CONTR, V10, P589; Proestos Y, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0554; Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2; Robinson M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003120; Rogers DJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0562; Rossi GC, 1999, J AM MOSQUITO CONTR, V15, P422; Ruiz-Moreno D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001918; SATTENSPIEL L, 1995, MATH BIOSCI, V128, P71, DOI 10.1016/0025-5564(94)00068-B; Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Silk D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003650; Simon F, 2007, MEDICINE, V86, P123, DOI 10.1097/MD/0b013e31806010a5; Simon Fabrice, 2011, Curr Infect Dis Rep, V13, P218, DOI 10.1007/s11908-011-0180-1; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Solet J. L., 2007, PLOS BIOL, V77, P727; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; Stephenson TS, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009127; Stumpf Michael P H, 2014, F1000Prime Rep, V6, P60, DOI 10.12703/P6-60; Tandon Neelam, 2000, Dengue Bulletin, V24, P117; Taylor K. E., 2000, 60 PCMDI LAWR LIV NA, P1; Thiboutot MM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000623; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Vazeille M, 2008, ACTA TROP, V105, P200, DOI 10.1016/j.actatropica.2007.09.009; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100; Wang R. l., 1966, Acta Entomologica Sinica, V15, P75; Wearing HJ, 2005, PLOS MED, V2, P621, DOI 10.1371/journal.pmed.0020174; Wilkinson RD, 2013, STAT APPL GENET MOL, V12, P129, DOI 10.1515/sagmb-2013-0010; Wilson Mary E, 2004, J Agromedicine, V9, P161; Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448	94	10	10	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174293	10.1371/journal.pone.0174293	http://dx.doi.org/10.1371/journal.pone.0174293			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362820	Green Submitted, Green Published, gold			2022-12-26	WOS:000399175000011
J	Hanshew, AS; Jette, ME; Tadayon, S; Thibeault, SL				Hanshew, Alissa S.; Jette, Marie E.; Tadayon, Stephanie; Thibeault, Susan L.			A comparison of sampling methods for examining the laryngeal microbiome	PLOS ONE			English	Article							CONTAMINATION; DISEASE	Shifts in healthy human microbial communities have now been linked to disease in numerous body sites. Noninvasive swabbing remains the sampling technique of choice in most locations; however, it is not well known if this method samples the entire community, or only those members that are easily removed from the surface. We sought to compare the communities found via swabbing and biopsied tissue in true vocal folds, a location that is difficult to sample without causing potential damage and impairment to tissue function. A secondary aim of this study was to determine if swab sampling of the false vocal folds could be used as proxy for true vocal folds. True and false vocal fold mucosal samples (swabbed and biopsied) were collected from six pigs and used for 454 pyrosequencing of the V3-V5 region of the 16S rRNA gene. Most of the alpha and beta measures of diversity were found to be significantly similar between swabbed and biopsied tissue samples. Similarly, the communities found in true and false vocal folds did not differ considerably. These results suggest that samples taken via swabs are sufficient to assess the community, and that samples taken from the false vocal folds may be used as proxies for the true vocal folds. Assessment of these techniques opens an avenue to less traumatic means to explore the role microbes play in the development of diseases of the vocal folds, and perhaps the rest of the respiratory tract.	[Hanshew, Alissa S.; Jette, Marie E.; Tadayon, Stephanie; Thibeault, Susan L.] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Hanshew, Alissa S.] Penn State Univ, Environm Hlth & Safety, University Pk, PA 16802 USA; [Jette, Marie E.] Univ Colorado, Dept Otolaryngol, Colorado Sch Med, Aurora, CO USA	University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Colorado System; University of Colorado Anschutz Medical Campus	Thibeault, SL (corresponding author), Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Madison, WI 53706 USA.	thibeault@surgery.wisc.edu	Jetté, Marie/I-5289-2014	Jetté, Marie/0000-0003-4705-1289	National Institute on Deafness; National Institutes of Health [T32DC009401, R01009600]; University of Wisconsin School of Medicine and Public Health Shapiro Summer Research Program; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC009401] Funding Source: NIH RePORTER	National Institute on Deafness(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin School of Medicine and Public Health Shapiro Summer Research Program; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Research reported in this publication was supported by the National Institute on Deafness and other Communication Disorders of the National Institutes of Health under award numbers T32DC009401 and R01009600. This research was also supported by the University of Wisconsin School of Medicine and Public Health Shapiro Summer Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo-Perez F, 2012, GUT MICROBES, V3, P530, DOI 10.4161/gmic.22157; Bassiouni A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123216; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Fillon SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042938; Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598; Gong H, 2014, APPL ENV MICROBIOLOG; Gong HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066476; Hanshew AS, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-43; Hanshew AS, 2013, J MICROBIOL METH, V95, P149, DOI 10.1016/j.mimet.2013.08.007; Jette ME, 2016, SCI REP-UK, V6, DOI 10.1038/srep35882; Kim R, 2013, INT FORUM ALLERGY RH, V3, P349, DOI [10.1002/alr.21117, 10.2500/ajra.2013.27.3974]; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Thibeault SL, 2009, MUCOSAL IMMUNOL, V2, P122, DOI 10.1038/mi.2008.82; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhang Y, 2004, J ACOUST SOC AM, V115, P1266, DOI 10.1121/1.1648974	24	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174765	10.1371/journal.pone.0174765	http://dx.doi.org/10.1371/journal.pone.0174765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362810	Green Published, gold, Green Submitted			2022-12-26	WOS:000399175000033
J	Lippi, G; Salvagno, GL; Brocco, G; Gelati, M; Danese, E; Favaloro, EJ				Lippi, Giuseppe; Salvagno, Gian Luca; Brocco, Giorgio; Gelati, Matteo; Danese, Elisa; Favaloro, Emmanuel J.			Impact of experimental hypercalcemia on routine haemostasis testing	PLOS ONE			English	Article							QUALITY STANDARDS; COAGULATION; MEDICINE	Background The blood to anticoagulant ratio is standardized according to the physiological calcium concentration in blood samples conventionally used for hemostasis testing. Specifically, one fixed volume of 0.109 mmol/L sodium citrate is added to 9 volumes of blood. Since little is known about the impact of hypercalcemia on the calcium-binding capacity of citrate, this study was planned to investigate the effect of experimental hypercalcemia on routine hemostasis testing. Methods Fifteen pooled citrated plasmas with matching lithium-heparin pooled plasma from patients with different values of prothrombin time (PT) were divided in three aliquots of 0.6mL each. The first paired aliquots of both citrate and lithium-heparin plasma were supplemented with 60 mu L of saline, the second paired aliquots with 30 mu L of saline and 30 mu L of calcium chloride and the third paired aliquots with 60 mu L of calcium chloride. Total and ionized calcium was measured in all aliquots of citrate and lithium-heparin plasma, whereas PT, activated partial thromboplastin time (APTT) and fibrinogen were measured in citrate plasma aliquots. Results Total calcium concentration gradually increased in both lithium-heparin and citrate plasma aliquots 2 and 3 compared to baseline aliquot 1. The concentration of ionized calcium also gradually increased in lithium-heparin plasma aliquots 2 and 3, whereas it remained immeasurable (i.e., <0.10 mmol/L) in all citrate plasma aliquots. No significant differences were observed for values of PT, APTT and fibrinogen in citrate plasma aliquots 2 and 3 compared to the baseline aliquot 1, with a mean bias was always comprised within the desirable quality specifications derived from biological variability data. Conclusion Hypercalcemia, up to severe hypercalcemia does not generate significant bias in results of first-line coagulations tests, so that hypothetical consideration of adjusting citrate-blood ratio is unjustified in hypercalcemic patients.	[Lippi, Giuseppe; Salvagno, Gian Luca; Brocco, Giorgio; Gelati, Matteo; Danese, Elisa] Univ Verona, Clin Biochem Sect, Verona, Italy; [Favaloro, Emmanuel J.] Westmead Hosp, Dept Haematol, Sydney Ctr Thrombosis, Inst Clin Pathol & Med Res,NSW Hlth Pathol, Westmead, NSW, Australia; [Favaloro, Emmanuel J.] Westmead Hosp, Dept Haematol, Sydney Ctr Haemostasis, Inst Clin Pathol & Med Res,NSW Hlth Pathol, Westmead, NSW, Australia	University of Verona; University of Sydney; University of Sydney	Danese, E (corresponding author), Univ Verona, Clin Biochem Sect, Verona, Italy.	elisa.danese@univr.it	Salvagno, Gian Luca/R-3857-2016; Lippi, Giuseppe/X-7198-2018; Gelati, Matteo/AAR-1692-2020; Favaloro, Emmanuel J./J-7689-2019	Lippi, Giuseppe/0000-0001-9523-9054; Favaloro, Emmanuel J/0000-0002-2103-1661; SALVAGNO, GIAN LUCA/0000-0003-0487-9051; Danese, Elisa/0000-0002-2454-0410				Adcock DM, 2016, CLIN BIOCHEM, V49, P1315, DOI 10.1016/j.clinbiochem.2016.08.022; Bristow SM, 2015, BRIT J NUTR, V114, P1868, DOI 10.1017/S0007114515003694; Carroll MF, 2003, AM FAM PHYSICIAN, V67, P1959; Clinical Laboratory Standards Institute, 2007, H3A6 CLSI; Funk DMA, 2012, SEMIN THROMB HEMOST, V38, P576, DOI 10.1055/s-0032-1319768; HILGARD P, 1973, J CLIN PATHOL, V26, P616, DOI 10.1136/jcp.26.8.616; Horvath A Rita, 2013, Clin Biochem Rev, V34, P47; HUMPHREYS RE, 1970, J AMER MED ASSOC, V214, P1702, DOI 10.1001/jama.1970.03180090066018; James MFM, 2004, J CARDIOTHOR VASC AN, V18, P581, DOI 10.1053/j.jvca.2004.07.016; KING WH, 1988, ANESTHESIOLOGY, V68, P115, DOI 10.1097/00000542-198801000-00019; Lippi G, 2016, SEMIN THROMB HEMOST, V42, P471, DOI 10.1055/s-0036-1571311; Lippi G, 2015, CLIN CHEM LAB MED, V53, P1655, DOI 10.1515/cclm-2015-0719; Lippi G, 2014, SEMIN THROMB HEMOST, V40, P812, DOI 10.1055/s-0034-1394108; Lippi G, 2012, SEMIN THROMB HEMOST, V38, P565, DOI 10.1055/s-0032-1315961; Marlar RA, 2006, AM J CLIN PATHOL, V126, P400, DOI 10.1309/RRQKT2JEYV33D19D; Marlar RA, 2014, SEMIN THROMB HEMOST, V40, P186, DOI 10.1055/s-0033-1364186; Milos M, 2009, INT J LAB HEMATOL, V31, P26, DOI 10.1111/j.1751-553X.2007.00999.x; QUICK AJ, 1948, J GEN PHYSIOL, V32, P191, DOI 10.1085/jgp.32.2.191; Ricos C, 1999, SCAND J CLIN LAB INV, V59, P491; SMALL SD, 1982, NEW ENGL J MED, V307, P684	20	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0175094	10.1371/journal.pone.0175094	http://dx.doi.org/10.1371/journal.pone.0175094			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362859	Green Published, gold, Green Submitted			2022-12-26	WOS:000399175000070
J	Anbesse, DH; Kassa, T; Kefyalew, B; Tasew, A; Atnie, A; Desta, B				Anbesse, Dereje Hayilu; Kassa, Tsehay; Kefyalew, Biruktayit; Tasew, Atirsaw; Atnie, Abie; Desta, Beredu			Prevalence and associated factors of pterygium among adults living in Gondar city, Northwest Ethiopia	PLOS ONE			English	Article							RISK-FACTORS; EYE; PINGUECULA; SEVERITY	Purpose The aim of this study was to assess the prevalence and associated factors of pterygium among adults living in Gondar city, Northwest Ethiopia. Methods A cross sectional design study was carried out in 390 participants in Gondar city from April 15 to May 7, 2016. Basic ophthalmic examination was performed using portable slit lamb, 3.5x magnifying loop with torch light and a pretested and structured questionnaire was completed. The raw data has been entered into EPI INFO 3.5.1 and analyzed by SPPSS version 20. Descriptive statistics was summarized descriptive data. Logistic regression was used to summarize the predictors of pterygium. The variables with p-value less than 0.05 were considered as significant risks of pterygium. Result The prevalence of pterygium among study participants was 151(38.7% (95%Cl; 33.8-43.8)). Among those who have pterygium, 149(98.7%) were developed pterygium on the nasal side and 15(9.9%) on temporal side of the either eye and 13(8.6%) have both. Age between 41-60(AOR = 2.20(95%Cl: 1.22, 3.39)), age between 61-86(AOR = 7.97(95%Cl: 2.74, 23.17)), male sex (AOR = 2.20(95%Cl: 1.28, 3.82)), outdoor working area(AOR = 3.75(95%Cl: 2.18, 6.46)), the use of traditional eye medication (AOR = 2.55 (95%Cl: 1.04, 5.90)) and family history of pterygium (AOR = 6.68(95% CI: 2.53, 17.60)) were positively associated with pterygium whereas use of sunglass/hat (AOR = 0.40(95%C1:0.20, 0.78)) was negatively associated. Conclusion There is a high prevalence of pterygium in Gondar city northwest Ethiopia. Old age, male sex, outdoor working area, utilization of traditional eye medication and family history of pterygium were statistically significant predictors of pterygium. The use of sunglass/hat was protective against pterygium.	[Anbesse, Dereje Hayilu; Kassa, Tsehay; Kefyalew, Biruktayit; Tasew, Atirsaw; Atnie, Abie; Desta, Beredu] Univ Gondar, Coll Med Hlth Sci, Sch Med, Dept Optometry, Gondar City, Ethiopia	University of Gondar	Anbesse, DH (corresponding author), Univ Gondar, Coll Med Hlth Sci, Sch Med, Dept Optometry, Gondar City, Ethiopia.	derejemk2004@gmail.com			University of Gondar	University of Gondar	The study was funded by University of Gondar and the funding is specifically for designing of the study, field work, analysis and write up. There was no specific fund for publication fee.	Alemwork Meseret, 2008, Ethiopian Journal of Health Development, V22, P191; Anguria P, 2012, SAMJ S AFRICAN MED J, V102; Chui J, 2011, AM J PATHOLOGY, V178; Durkin SR, 2008, BRIT J OPHTHALMOL, V92, P25, DOI 10.1136/bjo.2007.119842; DUSHKU N, 1994, CURR EYE RES, V13, P473, DOI 10.3109/02713689408999878; Fotouhi A, 2009, EYE, V23, P1125, DOI 10.1038/eye.2008.200; Gazzard G, 2002, BRIT J OPHTHALMOL, V86, P1341, DOI 10.1136/bjo.86.12.1341; Ke M, 2007, CORNEA, V26, P1184; Li ZJ, 2013, CORNEA, V32, P806, DOI 10.1097/ICO.0b013e31826dff30; Liu L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003787; Lu P, 2009, INT J OPHTHALMOL-CHI, V2, P82; Luthra R, 2001, FREQUENCY RISK FACTO, V119, P1872; Nangia V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082439; Nemesure B, 2008, OPHTHALMOLOGY, V115, P2153, DOI 10.1016/j.ophtha.2008.08.003; Panchapakesan J, 1998, AUST NZ J OPHTHALMOL, V26, pS2, DOI 10.1111/j.1442-9071.1998.tb01362.x; Paula JS, 2006, EYE, V20, P533, DOI 10.1038/sj.eye.6701917; Sarac O, 2012, TURK J MED SCI, V42, P1006, DOI 10.3906/sag-1108-36; Shiroma H, 2009, AM J OPHTHALMOL, V148, P766, DOI 10.1016/j.ajo.2009.06.006; Ukponmwan C U, 2007, East Afr Med J, V84, P516; Wu Kaili, 2002, Yan Ke Xue Bao, V18, P181	20	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174450	10.1371/journal.pone.0174450	http://dx.doi.org/10.1371/journal.pone.0174450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358813	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174800041
J	Cesareo, M; Ciuffoletti, E; Martucci, A; Sebastiani, J; Sorge, RP; Lamantea, E; Garavaglia, B; Ricci, F; Cusumano, A; Nucci, C; Brancati, F				Cesareo, Massimo; Ciuffoletti, Elena; Martucci, Alessio; Sebastiani, Jacopo; Sorge, Roberto Pietro; Lamantea, Eleonora; Garavaglia, Barbara; Ricci, Federico; Cusumano, Andrea; Nucci, Carlo; Brancati, Francesco			Assessment of the retinal posterior pole in dominant optic atrophy by spectral-domain optical coherence tomography and microperimetry	PLOS ONE			English	Article							NERVE-FIBER LAYER; OPA1 MUTATIONS; THICKNESS; PENETRANCE; FEATURES; CELLS; OCT	Background To assess posterior pole (PP) retinal structure in patients with genetically confirmed autosomal dominant optic atrophy (ADOA) using new spectral domain optical coherence tomography (SD-OCT) segmentation technology. To analyze retinal PP thickness in relation to retinal sensitivity data from microperimetry (MP) in ADOA patients. Methods and findings This prospective cross-sectional study included 11 patients with ADOA and 11 age-matched healthy subjects. All participants underwent both a "Posterior Pole" and "peripapillary RNFL (pRNFL)" scanning protocol using SD-OCT. Functional mapping of the PP was also performed using MP. A customized program was implemented in order to achieve accurate superimposition of MP sensitivity map onto SD-OCT map. The thickness of the PP different retinal layers and pRNFL was obtained and measured for each eye. Mean retinal sensitivity values and fixation stability were obtained and compared between ADOA patients and healthy subjects. Correlation analysis was performed on a point-to-point basis to evaluate the association between mean thickness and retinal sensitivity of each retinal layer. Total retinal thickness (TRT), Retinal Nerve Fiber Layer (RNFL), Ganglion Cell Layer (GCL), Inner Plexiform Layer (IPL), Inner Nuclear Layer (INL) and Inner Retinal Layers (IRL) at the posterior pole as well as pRNFL were significantly thinner in ADOA patients (P < 0.0001). On the contrary, the Outer Plexiform Layer (OPL) and the Outer Nuclear Layer (ONL) were significantly thicker in the ADOA group (P < 0.001). No significant differences were found in Retinal Pigment Epithelium (RPE) and Outer Retinal Layers (ORL) thickness between ADOA and controls. The average PP retinal sensitivity was significantly reduced in ADOA patients compared with controls (P < 0.001), as measured by microperimeter Nidek MP-1 (MP1). Fixation stability was significantly worse in the ADOA group (P = 0.01). The most severe sensitivity defects in ADOA patients were found at the level of the papillo-macular bundle (PMB). Conclusions Inner retinal layers showed pathological changes in ADOA patients. In addition, the whole retinal PP (not only the PMB) was significantly altered in ADOA, both in terms of retinal thickness and sensitivity.	[Cesareo, Massimo; Ciuffoletti, Elena; Martucci, Alessio; Sebastiani, Jacopo; Ricci, Federico; Cusumano, Andrea; Nucci, Carlo] Univ Roma Tor Vergata, Dept Expt Med & Surg, Ophthalmol Unit, Rome, Italy; [Sorge, Roberto Pietro] Univ Roma Tor Vergata, Dept Syst Med, Lab Biometry, Rome, Italy; [Lamantea, Eleonora; Garavaglia, Barbara] Neurol Inst C Besta IRCCS, Mol Neurogenet Unit, Milan, Italy; [Brancati, Francesco] Univ LAquila, Dept Life Hlth & Environm Sci, Laquila, Italy; [Brancati, Francesco] Ist Dermopat Immacolata IRCCS, Lab Mol & Cell Biol, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; University of L'Aquila; IRCCS Istituto Dermopatico dell'Immacolata (IDI)	Cesareo, M (corresponding author), Univ Roma Tor Vergata, Dept Expt Med & Surg, Ophthalmol Unit, Rome, Italy.	massimo.cesareo@uniroma2.it	Lamantea, Eleonora/J-8339-2016; Garavaglia, Barbara/J-5257-2018; Brancati, Francesco/AAC-3778-2022; ricci, federico/AAC-3836-2020; Martucci, Alessio/L-9653-2019	Lamantea, Eleonora/0000-0001-5090-6028; Garavaglia, Barbara/0000-0003-4323-9145; Brancati, Francesco/0000-0003-3624-2354; ricci, federico/0000-0002-4224-9280; Martucci, Alessio/0000-0002-3725-8211	"Fondazione Pierfranco e Luisa Mariani" [CM23]; "Italian Association of Mitochondrial Disease Patients and Families" (MitoconONLUS), Italian Ministry of Health; "Cellline and DNA Bank of Genetic Movement Disorders and Mitochondrial Diseases" of Telethon Network of Genetics Biobanks [GTB12001]; "Macula & Genoma Foundation", Rome, Italy	"Fondazione Pierfranco e Luisa Mariani"; "Italian Association of Mitochondrial Disease Patients and Families" (MitoconONLUS), Italian Ministry of Health; "Cellline and DNA Bank of Genetic Movement Disorders and Mitochondrial Diseases" of Telethon Network of Genetics Biobanks(Fondazione Telethon); "Macula & Genoma Foundation", Rome, Italy	This work was supported in part by "Fondazione Pierfranco e Luisa Mariani" (CM23), "Italian Association of Mitochondrial Disease Patients and Families" (MitoconONLUS), Italian Ministry of Health,"Cellline and DNA Bank of Genetic Movement Disorders and Mitochondrial Diseases" of Telethon Network of Genetics Biobanks (grant GTB12001) and "Macula & Genoma Foundation", Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegg M, 2014, OPHTHALMOLOGY, V121, P142, DOI 10.1016/j.ophtha.2013.08.045; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Amati-Bonneau P, 2005, CLIN GENET, V67, P102, DOI 10.1111/j.1399-0004.2004.00358.x; Barboni P, 2005, OPHTHALMOLOGY, V112, P120, DOI 10.1016/j.ophtha.2004.06.034; Barboni P, 2014, AM J OPHTHALMOL, V158, P628, DOI 10.1016/j.ajo.2014.05.034; Barboni P, 2011, OPHTHALMOLOGY, V118, P2076, DOI 10.1016/j.ophtha.2011.02.027; Bellusci C, 2008, GRAEF ARCH CLIN EXP, V246, P641, DOI 10.1007/s00417-008-0767-x; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Carbonelli M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127906; Cesareo M, 2015, INT OPHTHALMOL, V35, P11, DOI 10.1007/s10792-014-9924-x; Cesareo M., 2016, J CLIN EXP OPHTHALMO, V7, P538, DOI [DOI 10.4172/2155-9570.1000538, 10.4172/2155-9570.1000538]; Cohn AC, 2007, AM J OPHTHALMOL, V143, P656, DOI 10.1016/j.ajo.2006.12.038; Crossland MD, 2009, RETINA-J RET VIT DIS, V29, P651, DOI 10.1097/IAE.0b013e318196bd65; Delettre C, 2002, MOL GENET METAB, V75, P97, DOI 10.1006/mgme.2001.3278; ELIOTT D, 1993, AM J OPHTHALMOL, V115, P360, DOI 10.1016/S0002-9394(14)73589-5; Gocho K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/676803; Issa PC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012864; Ito Y, 2007, INVEST OPHTH VIS SCI, V48, P4079, DOI 10.1167/iovs.07-0024; Johnston RL, 1999, OPHTHALMOLOGY, V106, P123, DOI 10.1016/S0161-6420(99)90013-1; Kameda T, 2009, JPN J OPHTHALMOL, V53, P580, DOI 10.1007/s10384-009-0735-y; Kamei S, 2005, INVEST OPHTH VIS SCI, V46, P4288, DOI 10.1167/iovs.03-1407; Kim TW, 2007, J GLAUCOMA, V16, P655, DOI 10.1097/IJG.0b013e31804d23aa; Kjer B, 1996, ACTA OPHTHALMOL SCAN, V74, P3; KJER P, 1983, ACTA OPHTHALMOL, V61, P300; Leung CKS, 2009, OPHTHALMOLOGY, V116, P1257, DOI 10.1016/j.ophtha.2009.04.013; Milea D, 2010, ACTA OPHTHALMOL, V88, P342, DOI 10.1111/j.1755-3768.2008.01469.x; Mwanza JC, 2012, OPHTHALMOLOGY, V119, P1151, DOI 10.1016/j.ophtha.2011.12.014; Olichon A, 2006, BBA-MOL CELL RES, V1763, P500, DOI 10.1016/j.bbamcr.2006.04.003; Orzalesi N, 1998, VISION RES, V38, P763, DOI 10.1016/S0042-6989(97)00171-5; Pan BX, 2012, INVEST OPHTH VIS SCI, V53, P7608, DOI 10.1167/iovs.12-10452; Park SW, 2015, GRAEF ARCH CLIN EXP, V253, P135, DOI 10.1007/s00417-014-2852-7; Pesch UEA, 2001, HUM MOL GENET, V10, P1359, DOI 10.1093/hmg/10.13.1359; Ronnback C, 2014, DAN MED J, V61; Ronnback C, 2013, OPHTHALMOLOGY, V120, P2672, DOI 10.1016/j.ophtha.2013.08.008; Savini G, 2011, CURR OPIN OPHTHALMOL, V22, P115, DOI 10.1097/ICU.0b013e3283437222; Schild AM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/121398; Schuman JS, 1996, OPHTHALMOLOGY, V103, P1889, DOI 10.1016/S0161-6420(96)30410-7; Toomes C, 2001, HUM MOL GENET, V10, P1369, DOI 10.1093/hmg/10.13.1369; Votruba M, 1998, ARCH OPHTHALMOL-CHIC, V116, P351, DOI 10.1001/archopht.116.3.351; Yu-Wai-Man P, 2010, OPHTHALMOLOGY, V117, P1538, DOI 10.1016/j.ophtha.2009.12.038; Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002	41	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174560	10.1371/journal.pone.0174560	http://dx.doi.org/10.1371/journal.pone.0174560			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358911	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174800054
J	Hankins, MJ; Yablonsky, GS; Kiss, IZ				Hankins, Michael J.; Yablonsky, Gregory S.; Kiss, Istvan Z.			Dual kinetic curves in reversible electrochemical systems	PLOS ONE			English	Article							THERMODYNAMIC TIME-INVARIANCES; FREQUENCY-RESPONSE ANALYSIS; IRREVERSIBLE-PROCESSES; RECIPROCAL RELATIONS	We introduce dual kinetic chronoamperometry, in which reciprocal relations are established between the kinetic curves of electrochemical reactions that start from symmetrical initial conditions. We have performed numerical and experimental studies in which the kinetic curves of the electron-transfer processes are analyzed for a reversible first order reaction. Experimental tests were done with the ferrocyanide/ferricyanide system in which the concentrations of each component could be measured separately using the platinum disk/gold ring electrode. It is shown that the proper ratio of the transient kinetic curves obtained from cathodic and anodic mass transfer limited regions give thermodynamic time invariances related to the reaction quotient of the bulk concentrations. Therefore, thermodynamic time invariances can be observed at any time using the dual kinetic curves for reversible reactions. The technique provides a unique possibility to extract the non-steady state trajectory starting from one initial condition based only on the equilibrium constant and the trajectory which starts from the symmetrical initial condition. The results could impact battery technology by predicting the concentrations and currents of the underlying non-steady state processes in a wide domain from thermodynamic principles and limited kinetic information.	[Hankins, Michael J.; Kiss, Istvan Z.] St Louis Univ, Dept Chem, Laclede Ave, St Louis, MO 63103 USA; [Yablonsky, Gregory S.] St Louis Univ, Pk Coll Engn Aviat & Technol, Lindell Blvd, St Louis, MO 63103 USA	Saint Louis University; Washington University (WUSTL); Saint Louis University	Kiss, IZ (corresponding author), St Louis Univ, Dept Chem, Laclede Ave, St Louis, MO 63103 USA.	izkiss@slu.edu	Kiss, Istvan Z/C-1801-2008	Kiss, Istvan Z/0000-0003-0993-3184	National Science Foundation [CHE-1465013]; Division Of Chemistry [1465013] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge the financial support from the National Science Foundation CHE-1465013.	Bard A. J., 1980, ELECTROCHEMICAL METH; BRUCKENSTEIN S, 1979, ANAL CHEM, V51, P250, DOI 10.1021/ac50038a023; Constales D, 2012, CHEM ENG SCI, V73, P20, DOI 10.1016/j.ces.2012.01.017; Constales D, 2011, CHEM ENG SCI, V66, P4683, DOI 10.1016/j.ces.2011.06.033; KLINGLER RJ, 1981, J PHYS CHEM-US, V85, P1731, DOI 10.1021/j150612a028; MILLER DG, 1960, CHEM REV, V60, P15, DOI 10.1021/cr60203a003; Onsager L, 1931, PHYS REV, V37, P405, DOI 10.1103/PhysRev.37.405; Onsager L, 1931, PHYS REV, V38, P2265, DOI 10.1103/PhysRev.38.2265; Ozer M, 2005, J THEOR BIOL, V233, P237, DOI 10.1016/j.jtbi.2004.10.005; Panic VV, 2011, J PHYS CHEM C, V115, P17352, DOI 10.1021/jp201300a; Suli E., 2010, NUMERICAL SOLUTION O; VANKAMPEN NG, 1973, PHYSICA, V67, P1, DOI 10.1016/0031-8914(73)90020-7; Vidakovic-Koch TR, 2011, J PHYS CHEM C, V115, P17341, DOI 10.1021/jp201297v; WIGHTMAN RM, 1981, ANAL CHEM, V53, P1125; Yablonsky GS, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/20004; Yablonsky GS, 2011, CHEM ENG SCI, V66, P111, DOI 10.1016/j.ces.2010.10.014	16	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0173786	10.1371/journal.pone.0173786	http://dx.doi.org/10.1371/journal.pone.0173786			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358881	Green Published, gold			2022-12-26	WOS:000399174800010
J	Hofmann, ME; Andresen, MC				Hofmann, Mackenzie E.; Andresen, Michael C.			Dynasore blocks evoked release while augmenting spontaneous synaptic transmission from primary visceral afferents	PLOS ONE			English	Article							SOLITARY TRACT; GLUTAMATE RELEASE; NEURONS; NUCLEUS; DYNAMIN; INHIBITION; CONVERGENCE; RELIABILITY; ENDOCYTOSIS; ACTIVATION	The recycling of vesicle membrane fused during exocytosis is essential to maintaining neurotransmission. The GTPase dynamin is involved in pinching off membrane to complete endocytosis and can be inhibited by dynasore resulting in activity-dependent depletion of release-competent synaptic vesicles. In rat brainstem slices, we examined the effects of dynasore on three different modes of glutamate release spontaneous, evoked, and asynchronous release at solitary tract (ST) inputs to neurons in the nucleus of the solitary tract (NTS). Intermittent bursts of stimuli to the ST interspersed with pauses in stimulation allowed examination of these three modes in each neuron continuously. Application of 100 mu M dynasore rapidly increased the spontaneous EPSC (sEPSC) frequency which was followed by inhibition of both ST-evoked EPSCs (ST-EPSC) as well as asynchronous EPSCs. The onset of ST-EPSC failures was not accompanied by amplitude reduction a pattern more consistent with conduction block than reduced probability of vesicle release. Neither result suggested that dynasore interrupted endocytosis. The dynasore response profile resembled intense presynaptic TRPV1 activation. The TRPV1 antagonist capsazepine failed to prevent dynasore increases in sEPSC frequency but did prevent the block of the ST-EPSC. In contrast, the TRPV1 antagonist JNJ 17203212 prevented both actions of dynasore in neurons with TRPV1-expressing ST inputs. In a neuron lacking TRPV1-expressing ST inputs, however, dynasore promptly increased sEPSC rate followed by block of ST-evoked EPSCs. Together our results suggest that dynasore actions on ST-NTS transmission are TRPV1-independent and changes in glutamatergic transmission are not consistent with changes in vesicle recycling and endocytosis.	[Hofmann, Mackenzie E.; Andresen, Michael C.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; [Hofmann, Mackenzie E.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA	Oregon Health & Science University; University of Pennsylvania	Hofmann, ME (corresponding author), Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA.; Hofmann, ME (corresponding author), Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA.	hofmannwfu@gmail.com		Hofmann, Mackenzie/0000-0002-0469-3823	National Heart, Lung and Blood Institute [R01-HL-105703, HL-133505, F32-HL-112419]; Oregon Health and Science University Presidential Bridge Funding (MCA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105703] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Oregon Health and Science University Presidential Bridge Funding (MCA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung and Blood Institute: R01-HL-105703 (MCA); HL-133505 (MCA); F32-HL-112419 (MEH) and the Oregon Health and Science University Presidential Bridge Funding (MCA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen MC., 2011, CENTRAL REGULATION A, P23, DOI DOI 10.1093/ACPROF:OSO/9780195306637.003.0002; Andresen MC, 2008, AM J PHYSIOL-HEART C, V295, pH2032, DOI 10.1152/ajpheart.00568.2008; Andresen MC, 2012, AM J PHYSIOL-REG I, V303, pR1207, DOI 10.1152/ajpregu.00398.2012; Arranz AM, 2015, J CELL SCI, V128, P541, DOI 10.1242/jcs.158196; Bailey TW, 2008, J NEUROPHYSIOL, V99, P1712, DOI 10.1152/jn.00038.2008; Bailey TW, 2006, J NEUROSCI, V26, P11893, DOI 10.1523/JNEUROSCI.2044-06.2006; Boxwell AJ, 2013, J NEUROPHYSIOL, V109, P2815, DOI 10.1152/jn.00711.2012; Cavanaugh DJ, 2011, J NEUROSCI, V31, P10119, DOI 10.1523/JNEUROSCI.1299-11.2011; Chung C, 2010, J NEUROSCI, V30, P1363, DOI 10.1523/JNEUROSCI.3427-09.2010; Cui RJ, 2012, NEUROSCIENCE, V222, P181, DOI 10.1016/j.neuroscience.2012.07.010; Derbenev AV, 2004, J PHYSIOL-LONDON, V559, P923, DOI 10.1113/jphysiol.2004.067470; Douthitt HL, 2011, NEUROSCIENCE, V172, P187, DOI 10.1016/j.neuroscience.2010.10.002; Doyle MW, 2002, J NEUROSCI, V22, P8222; Doyle MW, 2001, J NEUROPHYSIOL, V85, P2213, DOI 10.1152/jn.2001.85.5.2213; Fa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091954; FAWLEY JA, 2016, NEUROSCIENCE, V36, P8957; Fawley JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127764; Fawley JA, 2014, J NEUROSCI, V34, P8324, DOI 10.1523/JNEUROSCI.0315-14.2014; Fawley JA, 2011, J NEUROPHYSIOL, V106, P1833, DOI 10.1152/jn.00476.2011; Hofmann ME, 2016, NEUROPHARMACOLOGY, V101, P401, DOI 10.1016/j.neuropharm.2015.10.011; Hofmann ME, 2014, J NEUROPHYSIOL, V112, P2697, DOI 10.1152/jn.00316.2014; Hofmann ME, 2011, J PHYSIOL-LONDON, V589, P3801, DOI 10.1113/jphysiol.2011.211482; Hofmann MEA, 2012, ANN M SOC NEUR; Hua YF, 2013, NEURON, V80, P343, DOI 10.1016/j.neuron.2013.08.010; Jansson ET, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-1; Kaeser PS, 2014, ANNU REV PHYSIOL, V76, P333, DOI 10.1146/annurev-physiol-021113-170338; Kavalali ET, 2015, NAT REV NEUROSCI, V16, P5, DOI 10.1038/nrn3875; Largent-Milnes TM, 2014, J NEUROPHYSIOL, V111, P2222, DOI 10.1152/jn.00912.2013; Linden DJ, 2012, J NEUROPHYSIOL, V107, P448, DOI 10.1152/jn.00824.2011; LoGiudice L, 2009, NEUROSCIENCE, V164, P1546, DOI 10.1016/j.neuroscience.2009.09.023; Lu WB, 2009, J BIOL CHEM, V284, P1930, DOI 10.1074/jbc.M803691200; McDougall SJ, 2013, J NEUROPHYSIOL, V109, P507, DOI 10.1152/jn.00726.2012; McDougall SJ, 2009, J NEUROSCI, V29, P12886, DOI 10.1523/JNEUROSCI.3491-09.2009; Nankoe SR, 2006, TRENDS CELL BIOL, V16, P607, DOI 10.1016/j.tcb.2006.10.004; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Parker JC, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.121; Peters JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025015; Peters JH, 2010, NEURON, V65, P657, DOI 10.1016/j.neuron.2010.02.017; Preta G, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0102-1; Preta G, 2015, FASEB J, V29, P1516, DOI 10.1096/fj.14-265207; Saghy E, 2015, PHARMACOL RES, V100, P101, DOI 10.1016/j.phrs.2015.07.028; Shoudai K, 2010, J NEUROSCI, V30, P14470, DOI 10.1523/JNEUROSCI.2557-10.2010; Smith AJ, 2010, J NEUROSCI, V30, P6116, DOI 10.1523/JNEUROSCI.0170-10.2010; Stone TW, 2016, NEUROSCIENCE, V336, P49, DOI 10.1016/j.neuroscience.2016.08.043; Swanson DM, 2005, J MED CHEM, V48, P1857, DOI 10.1021/jm0495071; Szolcsanyi J, 2012, TRENDS PHARMACOL SCI, V33, P646, DOI 10.1016/j.tips.2012.09.002; WALPOLE CSJ, 1994, J MED CHEM, V37, P1942, DOI 10.1021/jm00039a006; Wasser CR, 2007, J PHYSIOL-LONDON, V579, P413, DOI 10.1113/jphysiol.2006.123133; Yao J, 2011, CELL, V147, P666, DOI 10.1016/j.cell.2011.09.046; Zhang WR, 2010, HYPERTENSION, V55, P481, DOI 10.1161/HYPERTENSIONAHA.109.145151	50	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174915	10.1371/journal.pone.0174915	http://dx.doi.org/10.1371/journal.pone.0174915			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358887	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174800104
J	Zheng, LL; Huang, P; Zhong, X; Li, TF; Mo, L				Zheng, Liling; Huang, Ping; Zhong, Xiao; Li, Tianfeng; Mo, Lei			Color adaptation induced from linguistic description of color	PLOS ONE			English	Article							REPRESENTATIONS; PERCEPTION; AFTERIMAGES; MOTION; HYPOTHESIS; ATTENTION; LEVEL	Recent theories propose that language comprehension can influence perception at the low level of perceptual system. Here, we used an adaptation paradigm to test whether processing language caused color adaptation in the visual system. After prolonged exposure to a color linguistic context, which depicted red, green, or non-specific color scenes, participants immediately performed a color detection task, indicating whether they saw a green color square in the middle of a white screen or not. We found that participants were more likely to perceive the green color square after listening to discourses denoting red compared to discourses denoting green or conveying non-specific color information, revealing that language comprehension caused an adaptation aftereffect at the perceptual level. Therefore, semantic representation of color may have a common neural substrate with color perception. These results are in line with the simulation view of embodied language comprehension theory, which predicts that processing language reactivates the sensorimotor systems that are engaged during real experience.	[Mo, Lei] South China Normal Univ, Sch Psychol, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; South China Normal Univ, Key Lab Mental Hlth & Cognit Sci Guangdong Prov, Guangzhou, Guangdong, Peoples R China	South China Normal University; South China Normal University	Mo, L (corresponding author), South China Normal Univ, Sch Psychol, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.	molei@scnu.edu.cn			National Natural Science Foundation of China [31170997]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China; 31170997; http://www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW HB, 1963, NATURE, V200, P1345, DOI 10.1038/2001345a0; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Dils AT, 2010, P NATL ACAD SCI USA, V107, P16396, DOI 10.1073/pnas.1009438107; Eskenazi T, 2009, PSYCHOL RES-PSYCH FO, V73, P477, DOI 10.1007/s00426-009-0231-5; Fodor BJA, 1975, LANGUAGE THOUGHT; Glenberg AM, 2000, J MEM LANG, V43, P379, DOI 10.1006/jmla.2000.2714; Glenberg AM, 1999, DISCOURSE PROCESS, V28, P1, DOI 10.1080/01638539909545067; Heurley LP, 2013, COGN PROCESS, V14, P19, DOI 10.1007/s10339-012-0527-z; Kan IP, 2003, COGN NEUROPSYCHOL, V20, P525, DOI 10.1080/02643290244000257; Kaschak MP, 2005, COGNITION, V94, pB79, DOI 10.1016/j.cognition.2004.06.005; LOOMIS JM, 1972, VISION RES, V12, P1587, DOI 10.1016/0042-6989(72)90031-4; Mahon BZ, 2008, J PHYSIOL-PARIS, V102, P59, DOI 10.1016/j.jphysparis.2008.03.004; Mather G., 1998, MOTION AFTEREFFECT M; Meteyard L, 2007, PSYCHOL SCI, V18, P1007, DOI 10.1111/j.1467-9280.2007.02016.x; Nijboer Tanja C W, 2006, Cogn Process, V7, P269, DOI 10.1007/s10339-006-0153-8; Pavan A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00134; Pavan A, 2013, PSYCHOL SCI, V24, P181, DOI 10.1177/0956797612450882; Pylyshyn Z., 1984, COMPUTATION COGNITIO; Richter T, 2009, COGNITION, V111, P383, DOI 10.1016/j.cognition.2009.02.011; Shimojo S, 2001, SCIENCE, V293, P1677, DOI 10.1126/science.1060161; Stanfield RA, 2001, PSYCHOL SCI, V12, P153, DOI 10.1111/1467-9280.00326; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Suzuki S, 2003, J EXP PSYCHOL HUMAN, V29, P793, DOI 10.1037/0096-1523.29.4.793; Thompson-Schill SL, 2003, NEUROPSYCHOLOGIA, V41, P280, DOI 10.1016/S0028-3932(02)00161-6; van Boxtel JJA, 2010, P NATL ACAD SCI USA, V107, P8883, DOI 10.1073/pnas.0913292107; Yaxley RH, 2007, COGNITION, V105, P229, DOI 10.1016/j.cognition.2006.09.003; Zwaan RA, 2002, PSYCHOL SCI, V13, P168, DOI 10.1111/1467-9280.00430; Zwaan RA, 2004, PSYCHOL LEARN MOTIV, V44, P35; Zwaan RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051382	30	2	2	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0173755	10.1371/journal.pone.0173755	http://dx.doi.org/10.1371/journal.pone.0173755			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VI	28358807	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174800009
J	Ayuso, T; Aznar, P; Soriano, L; Olaskoaga, A; Roldan, M; Otano, M; Ajuria, I; Soriano, G; Lacruz, F; Mendioroz, M				Ayuso, Teresa; Aznar, Patricia; Soriano, Luis; Olaskoaga, Ander; Roldan, Miren; Otano, Maria; Ajuria, Iratxe; Soriano, Gerardo; Lacruz, Francisco; Mendioroz, Maite			Vitamin D receptor gene is epigenetically altered and transcriptionally up-regulated in multiple sclerosis	PLOS ONE			English	Article							CELLS; DNA	Objective Vitamin D deficiency has been linked to increased risk of multiple sclerosis (MS) and poor outcome. However, the specific role that vitamin D plays in MS still remains unknown. In order to identify potential mechanisms underlying vitamin D effects in MS, we profiled epigenetic changes in vitamin D receptor (VDR) gene to identify genomic regulatory elements relevant to MS pathogenesis. Methods Human T cells derived from whole blood by negative selection were isolated in a set of 23 relapsing-remitting MS (RRMS) patients and 12 controls matched by age and gender. DNA methylation levels were assessed by bisulfite cloning sequencing in two regulatory elements of VDR. mRNA levels were measured by RT-qPCR to assess changes in VDR expression between patients and controls. Results An alternative VDR promoter placed at exon 1c showed increased DNA methylation levels in RRMS patients (median 30.08%, interquartile range 19.2%) compared to controls (18.75%, 9.5%), p-value<0.05. Moreover, a 6.5-fold increase in VDR mRNA levels was found in RRMS patients compared to controls (p-value<0.001). Conclusions An alternative promoter of the VDR gene shows altered DNA methylation levels in patients with multiple sclerosis, and it is associated with VDR mRNA upregulation. This locus may represent a candidate regulatory element in the genome relevant to MS pathogenesis.	[Ayuso, Teresa; Otano, Maria; Ajuria, Iratxe; Soriano, Gerardo; Lacruz, Francisco] Complejo Hosp Navarra, Dept Neurol, Multiple Sclerosis Unit, Navarra, Spain; [Aznar, Patricia; Olaskoaga, Ander; Mendioroz, Maite] Complejo Hosp Navarra, Dept Neurol, Navarra, Spain; [Soriano, Luis; Roldan, Miren; Mendioroz, Maite] Navarrabiomed Navarra Inst Hlth Res IdiSNA, Neuroepigenet Lab, Navarra, Spain	Servicio Navarro de Salud - Osasunbidea; Servicio Navarro de Salud - Osasunbidea; Navarrabiomed	Mendioroz, M (corresponding author), Complejo Hosp Navarra, Dept Neurol, Navarra, Spain.; Mendioroz, M (corresponding author), Navarrabiomed Navarra Inst Hlth Res IdiSNA, Neuroepigenet Lab, Navarra, Spain.	maitemendilab@gmail.com	mendioroz, maite/P-9162-2019; Roldan, Miren/AAA-9078-2019	mendioroz, maite/0000-0002-4179-5781; Roldan, Miren/0000-0002-7102-569X	Novartis; Genzyme Foundation [FG EM02_2014]	Novartis(Novartis); Genzyme Foundation	This work was supported by Novartis (https://www.novartis.es/) funding and a competitive grant from the Genzyme Foundation (http://www.fundaciongenzyme.es/lnicio.aspx), grant# FG EM02_2014. The funding sources had no involvement in the study design, collection, analysis, and interpretation of data; in writing of the report; and in the decision to submit the article for publication.	Ascherio A, 2014, JAMA NEUROL, V71, P306, DOI 10.1001/jamaneurol.2013.5993; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; Duffy MM, 2014, AM J PHYSIOL-RENAL, V307, pF1412, DOI 10.1152/ajprenal.00024.2014; Fernandez DR, 2009, J IMMUNOL, V182, P2063, DOI 10.4049/jimmunol.0803600; Fetahu IS, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00164; Halsall JA, 2007, J STEROID BIOCHEM, V103, P352, DOI 10.1016/j.jsbmb.2006.12.046; Iridoy Zulet M, 2015, NEUROLOGIA; Janson PCJ, 2011, J IMMUNOL, V186, P92, DOI 10.4049/jimmunol.1000960; Joshi S, 2011, MOL CELL BIOL, V31, P3653, DOI 10.1128/MCB.05020-11; Koch MW, 2013, NAT REV NEUROL, V9, P35, DOI 10.1038/nrneurol.2012.226; Kucukali CI, 2015, NEUROMOL MED, V17, P83, DOI 10.1007/s12017-014-8298-6; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liggett T, 2010, J NEUROL SCI, V290, P16, DOI 10.1016/j.jns.2009.12.018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lublin FD, 2014, NEUROLOGY, V83, P278, DOI 10.1212/WNL.0000000000000560; Maltby VE, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0152-7; Mastronardi FG, 2007, J NEUROSCI RES, V85, P2006, DOI 10.1002/jnr.21329; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mokry LE, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001866; Mowry EM, 2012, ANN NEUROL, V72, P234, DOI 10.1002/ana.23591; Peelen E, 2011, AUTOIMMUN REV, V10, P733, DOI 10.1016/j.autrev.2011.05.002; Pelechano V, 2013, NAT REV GENET, V14, P880, DOI 10.1038/nrg3594; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Saccone D, 2015, GENE, V561, P171, DOI 10.1016/j.gene.2015.02.024; Smolders J, 2008, MULT SCLER J, V14, P1220, DOI 10.1177/1352458508094399; Smolders J, 2013, J NEUROPATH EXP NEUR, V72, P91, DOI 10.1097/NEN.0b013e31827f4fcc; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341	29	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174726	10.1371/journal.pone.0174726	http://dx.doi.org/10.1371/journal.pone.0174726			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355272	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174600083
J	Chu, YW; Lin, HM; Wang, JJ; Weng, SF; Lin, CC; Chien, CC				Chu, Yeh-Wen; Lin, Hsuan-Ming; Wang, Jhi-Joung; Weng, Shih-Feng; Lin, Chih-Ching; Chien, Chih-Chiang			Epidemiology and outcomes of hypoglycemia in patients with advanced diabetic kidney disease on dialysis: A national cohort study	PLOS ONE			English	Article							COMPLICATIONS SEVERITY INDEX; 10-YEAR FOLLOW-UP; RISK-FACTORS; SYMPTOMATIC HYPOGLYCEMIA; GLYCEMIC CONTROL; GLUCOSE; HEMODIALYSIS; INSULIN; CARE; HOSPITALIZATION	Background Patients with advanced diabetic kidney disease (DKD) behave differently to diabetic patients without kidney disease. We aimed to investigate the associations of hypoglycemia and outcomes after initiation of dialysis in patients with advanced DKD on dialysis. Methods Using National Health Insurance Research Database, 20,845 advanced DKD patients beginning long-term dialysis between 2002 and 2006 were enrolled. We investigated the incidence of severe hypoglycemia episodes before initiation of dialysis. Patients were followed from date of first dialysis to death, end of dialysis, or 2008. Main outcomes measured were all-cause mortality, myocardial infarction (MI), and subsequent severe hypoglycemic episodes after dialysis. Results 19.18% patients had at least one hypoglycemia episode during 1-year period before initiation of dialysis. Advanced DKD patients with higher adapted Diabetes Complications Severity Index (aDCSI) scores were associated with more frequent hypoglycemia (P for trend < 0.001). Mortality and subsequent severe hypoglycemia after dialysis both increased with number of hypoglycemic episodes. Compared to those who had no hypoglycemic episodes, those who had one had a 15% higher risk of death and a 2.3-fold higher risk of subsequent severe hypoglycemia. Those with two or more episodes had a 19% higher risk of death and a 3.9-fold higher risk of subsequent severe hypoglycemia. However, previous severe hypoglycemia was not correlated with risk of MI after dialysis. Conclusions The rate of severe hypoglycemia was high in advanced DKD patients. Patients with higher aDCSI scores tended to have more hypoglycemic episodes. Hypoglycemic episodes were associated with subsequent hypoglycemia and mortality after initiation of dialysis. We studied the associations and further study is needed to establish cause. In addition, more attention is needed for hypoglycemia prevention in advanced DKD patients, especially for those at risk patients.	[Chu, Yeh-Wen; Chien, Chih-Chiang] Chi Mei Med Ctr, Dept Nephrol, Tainan, Taiwan; [Lin, Hsuan-Ming] China Med Univ, An Nan Hosp, Dept Nephrol, Tainan, Taiwan; [Wang, Jhi-Joung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Weng, Shih-Feng] Kaohsiung Med Univ, Dept Healthcare Adm & Med Informat, Kaohsiung, Taiwan; [Lin, Chih-Ching] Taipei Vet Gen Hosp, Dept Nephrol, Taipei, Taiwan	Chi Mei Hospital; China Medical University Taiwan; Chi Mei Hospital; Kaohsiung Medical University; Taipei Veterans General Hospital	Chien, CC (corresponding author), Chi Mei Med Ctr, Dept Nephrol, Tainan, Taiwan.	ccchien58@yahoo.com.tw		Weng, Shih-Feng/0000-0001-8684-3487	ChiMei Medical Center [CMFHR10267, CMFHR10543]; National Health Research Institutes in Taiwan [NHRI-NHIRD-99182]	ChiMei Medical Center; National Health Research Institutes in Taiwan(National Health Research Institutes - Taiwan)	The study was supported by grant CMFHR10267 for Dr. Yeh-Wen Chu and CMFHR10543 for Dr. Chih-Chiang Chien from ChiMei Medical Center and grant NHRI-NHIRD-99182 from the National Health Research Institutes in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allon M, 2013, J AM SOC NEPHROL, V24, P1934, DOI 10.1681/ASN.2013060632; Alsahli M, 2014, MAYO CLIN PROC, V89, P1564, DOI 10.1016/j.mayocp.2014.07.013; Biesenbach G, 2003, DIABETIC MED, V20, P642, DOI 10.1046/j.1464-5491.2003.01025.x; Bonds Denise E, 2010, BMJ, V340, pb4909, DOI 10.1136/bmj.b4909; Burmeister JE, 2007, NEPHROL DIAL TRANSPL, V22, P1184, DOI 10.1093/ndt/gfl710; Burmeister Jayme Eduardo, 2012, J Bras Nefrol, V34, P323; Chang HY, 2012, AM J MANAG CARE, V18, P721; Chen HL, 2014, J DIABETES COMPLICAT, V28, P612, DOI 10.1016/j.jdiacomp.2014.05.011; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Davis SN, 2000, DIABETES, V49, P1897, DOI 10.2337/diabetes.49.11.1897; Duran-Nah JJ, 2008, REV INVEST CLIN, V60, P451; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Giorda CB, 2015, ACTA DIABETOL, V52, P845, DOI 10.1007/s00592-015-0713-4; Gitt AK, 2012, EUR J PREV CARDIOL, V19, P765, DOI 10.1177/1741826711411104; Goto A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4533; Himmelfarb J, 2010, NEW ENGL J MED, V363, P1833, DOI 10.1056/NEJMra0902710; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; HORTON ES, 1968, ANN INTERN MED, V68, P63, DOI 10.7326/0003-4819-68-1-63; Kan WC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068748; Kostev K, 2014, PRIM CARE DIABETES, V8, P127, DOI 10.1016/j.pcd.2013.10.001; Lin CH, 2013, J INTERN MED, V273, P102, DOI 10.1111/joim.12000; Lin YY, 2010, YONSEI MED J, V51, P367, DOI 10.3349/ymj.2010.51.3.367; LINDHOLM B, 1986, ACTA MED SCAND, V220, P477; Liu JN, 2010, KIDNEY INT, V77, P141, DOI 10.1038/ki.2009.413; Mellbin LG, 2013, EUR HEART J, V34, P3137, DOI 10.1093/eurheartj/eht332; Miller CD, 2001, ARCH INTERN MED, V161, P1653, DOI 10.1001/archinte.161.13.1653; Moen MF, 2009, CLIN J AM SOC NEPHRO, V4, P1121, DOI 10.2215/CJN.00800209; Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112; Papademetriou V, 2015, KIDNEY INT, V87, P649, DOI 10.1038/ki.2014.296; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pathak RD, 2016, DIABETES CARE, V39, P363, DOI 10.2337/dc15-0858; Quilliam BJ, 2011, CLIN THER, V33, P1781, DOI 10.1016/j.clinthera.2011.09.020; Raimann JG, 2012, NEPHROL DIAL TRANSPL, V27, P1559, DOI 10.1093/ndt/gfr520; Rhee CM, 2014, SEMIN DIALYSIS, V27, P135, DOI 10.1111/sdi.12198; Simic-Ogrizovic S, 2001, INT J ARTIF ORGANS, V24, P863, DOI 10.1177/039139880102401210; Snyder RW, 2004, SEMIN DIALYSIS, V17, P365, DOI 10.1111/j.0894-0959.2004.17346.x; Szeto CC, 2007, AM J KIDNEY DIS, V49, P524, DOI 10.1053/j.ajkd.2007.01.018; Thompson Amy E, 2015, JAMA, V313, P1284, DOI 10.1001/jama.2015.0876; Tuttle KR, 2014, AM J KIDNEY DIS, V64, P510, DOI [10.1053/j.ajkd.2014.08.001, 10.2337/dc14-1296]; TZAMALOUKAS AH, 1992, INT J ARTIF ORGANS, V15, P390, DOI 10.1177/039139889201500702; WIDEROE TE, 1984, KIDNEY INT, V25, P82, DOI 10.1038/ki.1984.11; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yakubovich N, 2011, CIRCULATION, V123, P342, DOI 10.1161/CIRCULATIONAHA.110.948489; Young BA, 2008, AM J MANAG CARE, V14, P15; Yun JS, 2013, DIABETES CARE, V36, P1283, DOI 10.2337/dc12-1408; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	46	21	24	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174601	10.1371/journal.pone.0174601	http://dx.doi.org/10.1371/journal.pone.0174601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355264	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174600072
J	Gao, B; Zhang, XM; Huang, YM; Yang, ZP; Zhang, YG; Zhang, WH; Gao, ZH; Xue, DB				Gao, Bo; Zhang, Xueming; Huang, Yongming; Yang, Zhengpeng; Zhang, Yuguo; Zhang, Weihui; Gao, Zu-hua; Xue, Dongbo			Coding and non-coding gene regulatory networks underlie the immune response in liver cirrhosis	PLOS ONE			English	Article							EXPRESSION; CELLS; CONTRIBUTES; ACTIVATION; FIBROSIS; BINDING; RECOGNITION; KINASE; GROWTH; GRB2	Liver cirrhosis is recognized as being the consequence of immune-mediated hepatocyte damage and repair processes. However, the regulation of these immune responses underlying liver cirrhosis has not been elucidated. In this study, we used GEO datasets and bioinformatics methods to established coding and non-coding gene regulatory networks including transcription factor-/lncRNA-microRNA-mRNA, and competing endogenous RNA interaction networks. Our results identified 2224 mRNAs, 70 lncRNAs and 46 microRNAs were differentially expressed in liver cirrhosis. The transcription factor -/lncRNA-microRNAmRNA network we uncovered that results in immune-mediated liver cirrhosis is comprised of 5 core microRNAs (e.g., miR-203; miR-219-5p), 3 transcription factors (i.e., FOXP3, ETS1 and FOS) and 7 lncRNAs (e.g., ENTS00000671336, ENST00000575137). The competing endogenous RNA interaction network we identified includes a complex immune response regulatory subnetwork that controls the entire liver cirrhosis network. Additionally, we found 10 overlapping GO terms shared by both liver cirrhosis and hepatocellular carcinoma including "immune response" as well. Interestingly, the overlapping differentially expressed genes in liver cirrhosis and hepatocellular carcinoma were enriched in immune response-related functional terms. In summary, a complex gene regulatory network underlying immune response processes may play an important role in the development and progression of liver cirrhosis, and its development into hepatocellular carcinoma.	[Gao, Bo; Zhang, Xueming; Huang, Yongming; Yang, Zhengpeng; Zhang, Weihui; Xue, Dongbo] Harbin Med Univ, Affiliated Hosp 1, Dept Gen Surg, Harbin, Peoples R China; [Gao, Bo; Gao, Zu-hua] McGill Univ, Ctr Hlth, Res Inst, Dept Pathol, Montreal, PQ, Canada; [Zhang, Yuguo] Hebei Med Univ, Hosp 3, Dept Tradit & Western Med Hepatol, Shijiazhuang, Peoples R China	Harbin Medical University; McGill University; Hebei Medical University	Zhang, WH; Xue, DB (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Gen Surg, Harbin, Peoples R China.; Gao, ZH (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Dept Pathol, Montreal, PQ, Canada.	zhangweihui626@outlook.com; zuhua.gao@mcgill.ca; hmu_xuedongbo@163.com		Huang, Yongming/0000-0002-8180-7708; Huang, Yongming/0000-0002-5955-3457	National Natural Science Foundation of China [81370566, 81170397, 81570579, 81570581]; Harbin Medical University Postgraduate Innovative Research Projects [YJSCX2015-19HYD]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Harbin Medical University Postgraduate Innovative Research Projects	This study was supported by the National Natural Science Foundation of China (grant no. 81370566; grant no. 81170397; grant no. 81570579; grant no.81570581) and Harbin Medical University Postgraduate Innovative Research Projects (grant no.YJSCX2015-19HYD). The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YX, 2012, WORLD J GASTROENTERO, V18, P1397, DOI 10.3748/wjg.v18.i12.1397; Cho JW, 2012, J GASTROEN HEPATOL, V27, P1362, DOI 10.1111/j.1440-1746.2012.07137.x; Das S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098965; Dong H, 2013, PHARM BIOL; Feng L, 2013, INFLAMMATION, V36, P1374, DOI 10.1007/s10753-013-9677-0; Franz M., 2015, BIOINFORMATICS; Harring TR, 2011, WORLD J SURG, V35, P1746, DOI 10.1007/s00268-010-0954-x; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Holt AP, 2008, CLIN LIVER DIS, V12, P861, DOI 10.1016/j.cld.2008.07.002; Kireva T, 2011, HEPATOLOGY, V53, P1259, DOI 10.1002/hep.24175; Krutzfeldt J, 2012, HEPATOLOGY, V55, P98, DOI 10.1002/hep.24658; Lankry D, 2010, J IMMUNOL, V185, P2877, DOI 10.4049/jimmunol.0903347; Levy-Apter E, 2014, J BIOL CHEM, V289, P36048, DOI 10.1074/jbc.M114.603548; Li RM, 2009, CANCER BIOL THER, V8, P1402, DOI 10.4161/cbt.8.14.8882; Liu TM, 2015, MOL MED REP, V12, P7403, DOI 10.3892/mmr.2015.4374; Liu T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/276850; Lu G, 2014, CANCER CELL, V26, P222, DOI 10.1016/j.ccr.2014.06.026; Nishikawa T, 2015, J CLIN INVEST, V125, P1533, DOI 10.1172/JCI73137; Osella M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001101; Pineda-Tenor D, 2015, JAIDS-J ACQ IMM DEF, V68, P386, DOI 10.1097/QAI.0000000000000491; Polansky JK, 2010, J MOL MED, V88, P1029, DOI 10.1007/s00109-010-0642-1; Qian Cheng, 2012, Zhonghua Yi Xue Za Zhi, V92, P2265; Ramachandran S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070744; Ruan Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.47; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Sekiya Y, 2011, BIOCHEM BIOPH RES CO, V412, P74, DOI 10.1016/j.bbrc.2011.07.041; Shan HL, 2009, CARDIOVASC RES, V83, P465, DOI 10.1093/cvr/cvp130; Shim SM, 2013, BIOCHEM BIOPH RES CO, V441, P438, DOI 10.1016/j.bbrc.2013.10.081; Song YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089725; Sonkoly E, 2008, SEMIN CANCER BIOL, V18, P131, DOI 10.1016/j.semcancer.2008.01.005; Sorek M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003179; Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5; Wargo JA, 2009, CANCER IMMUNOL IMMUN, V58, P383, DOI 10.1007/s00262-008-0562-x; Weinger JG, 2008, J NEUROCHEM, V106, P134, DOI 10.1111/j.1471-4159.2008.05343.x; Wickert L, 2004, J HEPATOL, V40, P69, DOI 10.1016/j.jhep.2003.09.026; Xia T, 2015, SCI REP-UK, V5, DOI 10.1038/srep13445; Zeiser R, 2007, BIOL BLOOD MARROW TR, V13, P1427, DOI 10.1016/j.bbmt.2007.08.041; Zhang Qingyang, 2014, BMC Syst Biol, V8, P1338, DOI 10.1186/s12918-014-0136-9; Zhang YX, 2014, HEPATOLOGY, V60, P919, DOI 10.1002/hep.27121; Zhou Q, 2014, BBA-MOL BASIS DIS, V1842, P2367, DOI 10.1016/j.bbadis.2014.10.001	41	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174142	10.1371/journal.pone.0174142	http://dx.doi.org/10.1371/journal.pone.0174142			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355233	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174600037
J	Gunn, JKL; Ehiri, JE; Jacobs, ET; Ernst, KC; Pettygrove, S; Center, KE; Osuji, A; Ogidi, AG; Musei, N; Obiefune, MC; Ezeanolue, CO; Ezeanolue, EE				Gunn, Jayleen K. L.; Ehiri, John E.; Jacobs, Elizabeth T.; Ernst, Kacey C.; Pettygrove, Sydney; Center, Katherine E.; Osuji, Alice; Ogidi, Amaka G.; Musei, Nnabundo; Obiefune, Michael C.; Ezeanolue, Chinenye O.; Ezeanolue, Echezona E.			Prevalence of Caesarean sections in Enugu, southeast Nigeria: Analysis of data from the Healthy Beginning Initiative	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; CARE; PREGNANCY; SERVICES; DELIVERY; OUTCOMES; MALARIA; RATES; INFECTION; APPRAISAL	Background In order to meet the Sustainable Development Goal to decrease maternal mortality, increased access to obstetric interventions such as Caesarean sections (CS) is of critical importance. As a result of women's limited access to routine and emergency obstetric services in Nigeria, the country is a major contributor to the global burden of maternal mortality. In this analysis, we aim to establish rates of CS and determine socioeconomic or medical risk factors associated with having a CS in Enugu, southeast Nigeria. Methods Data for this study originated from the Healthy Beginning Initiative study. Participant characteristics were obtained from 2300 women at baseline via a semi-structured questionnaire. Only women between the ages of 17-45 who had singleton deliveries were retained for this analysis. Post-delivery questionnaires were used to ascertain mode-of-delivery. Crude and adjusted logistic regressions with Caesarean as the main outcome are presented. Results In this sample, 7.22% women had a CS. Compared to women who lived in an urban setting, those who lived in a rural setting had a significant reduction in the odds of having a CS (aOR: 0.58; 0.38-0.89). Significantly higher odds of having a CS were seen among those with high peripheral malaria parasitemia compared to those with low parasitemia (aOR: 1.54; 1.04-2.28). Conclusion This study revealed that contrary to the increasing trend in use of CS in low-income countries, women in this region of Nigeria had limited access to this intervention. Increasing age and socioeconomic proxies for income and access to care (e.g., having a tertiary -level education, full-time employment, and urban residence) were shown to be key determinants of access to CS. Further research is needed to ascertain the obstetric conditions under which women in this region receive CS, and to further elucidate the role of socioeconomic factors in accessing CS.	[Gunn, Jayleen K. L.; Jacobs, Elizabeth T.; Ernst, Kacey C.; Pettygrove, Sydney] Univ Arizona, Dept Epidemiol & Biostat, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ 85721 USA; [Ehiri, John E.] Univ Arizona, Dept Hlth Promot Sci, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA; [Jacobs, Elizabeth T.] Univ Arizona, Ctr Canc, Tucson, AZ USA; [Center, Katherine E.] BrightOutcome Inc, Buffalo Grove, IL USA; [Osuji, Alice; Ogidi, Amaka G.; Musei, Nnabundo; Ezeanolue, Chinenye O.; Ezeanolue, Echezona E.] Prevent Educ Treatment Training & Res Global Solu, Enugu, Enugu State, Nigeria; [Obiefune, Michael C.; Ezeanolue, Echezona E.] Hlth Sunrise Fdn, Castle Ridge Ave, Las Vegas, NV USA; [Obiefune, Michael C.] Univ Maryland, Inst Human Virol, Baltimore, MD 21201 USA; [Ezeanolue, Echezona E.] Univ Nevada, Sch Med, Dept Pediat, Las Vegas, NV 89154 USA	University of Arizona; University of Arizona; University of Arizona; University System of Maryland; University of Maryland Baltimore; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Gunn, JKL (corresponding author), Univ Arizona, Dept Epidemiol & Biostat, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ 85721 USA.	jayleeng85@gmail.com		Ezeanolue, Echezona/0000-0002-6294-9479	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Mental Health (NIMH); President's Emergency Plan for AIDS Relief (PEPFAR) [R01HD075050]; Healthy Sunrise Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD075050] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Healthy Sunrise Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This paper is based on the first author's dissertation Barriers to Use of Healthcare During Pregnancy in Nigeria, which is held in the University of Arizona Campus Repository. Healthy Beginning Initiative was funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Mental Health (NIMH) and the President's Emergency Plan for AIDS Relief (PEPFAR) under award number R01HD075050 to Echezona Ezeanolue, MD. Additional support for this study was provided by the Healthy Sunrise Foundation. The funding agencies played no role in the study conception, design, data collection, data analysis, data interpretation or writing of the report. One of the authors is employed by a commercial company, BrightOutcome, Inc. This funder provided support in the form of a salary for author KC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Akinola OI, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-217; Alkire BC, 2015, GLOBAL ACCESS SURG C; Althabe F, 2006, LANCET, V368, P1472, DOI 10.1016/S0140-6736(06)69616-5; Aziken M, 2007, ACTA OBSTET GYN SCAN, V86, P42, DOI 10.1080/00016340600994950; Babalola S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-43; Bank TW, 2015, BIRTH RAT CRUD PER 1; Betran AP, 2016, BJOG-INT J OBSTET GY, V123, P667, DOI 10.1111/1471-0528.13526; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; BETRAN AP, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0148343; Bhutta AZ, 2010, LANCET, V2032, P375; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Buchanan AM, 2009, CLIN MICROBIOL REV, V22, P493, DOI 10.1128/CMR.00054-08; Burgard S, 2004, SOC SCI MED, V59, P1127, DOI 10.1016/j.socscimed.2004.01.006; Calvert C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074848; Cross S, 2010, B WORLD HEALTH ORGAN, V88, P147, DOI 10.2471/BLT.09.063537; Drabkin DL, 1935, J BIOL CHEM, V112, P51; Enugu State Government, 2017, WELC EN STAT GEOGR L; Ezeanolue EE, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-62; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; GILLES HM, 1969, ANN TROP MED PARASIT, V63, P245, DOI 10.1080/00034983.1969.11686625; HUCH R, 1994, HEMATOL ONCOL CLIN N, V8, P1021, DOI 10.1016/S0889-8588(18)30145-X; Huddle JM, 1999, EUR J CLIN NUTR, V53, P792, DOI 10.1038/sj.ejcn.1600851; Jejeebhoy S., 1995, WOMENS ED AUTONOMY R; Jeremiah I., 2011, Journal of Public Health and Epidemiology, V3, P617; Kwast BE, 1998, MIDWIFERY, V14, P66; Mekonnen Y, 2003, J HEALTH POPUL NUTR, V21, P374; Muganyizi P., 2013, DETERMINANTS ADVERSE; NWAKOBY BN, 1994, J ROY SOC HEALTH, V114, P132, DOI 10.1177/146642409411400304; Odum C, 2001, W AFRICAN J MED, V21, P19; Olofinbiyi BA, 2015, NIGER J CLIN PRACT, V18, P489, DOI 10.4103/1119-3077.156883; Olusanya BO, 2010, J BIOSOC SCI, V42, P341, DOI 10.1017/S0021932009990526; Onah HE, 2004, INT J GYNECOL OBSTET, V84, P79, DOI 10.1016/S0020-7292(03)00269-8; Onoh RC, 2015, INT J WOMENS HEALTH, V7, P531, DOI 10.2147/IJWH.S81338; Oteng-Ntim E, 2015, BLOOD; Prevention CfDCa, 2015, HIV PREGN WOM INF CH; Roberts CL, 2015, LANCET GLOB HEALTH, V3, pE241, DOI 10.1016/S2214-109X(15)70111-7; Ronsmans C, 2006, LANCET, V368, P1516, DOI 10.1016/S0140-6736(06)69639-6; Royal College of Obstetricians & Gynaecologists, 2010, DIAGN TREATM MAL PRE; Samanta S, 2014, INDIAN J ANAESTH, V58, P55, DOI 10.4103/0019-5049.126797; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Shah A, 2009, INT J GYNECOL OBSTET, V107, P191, DOI 10.1016/j.ijgo.2009.08.013; Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71; Sunday-Adeoye I, 2011, NIGER J CLIN PRACT, V14, P276, DOI 10.4103/1119-3077.86766; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; United Nations, 2016, SUSTAINABLE DEV GOAL; Vogel JP, 2015, LANCET GLOB HEALTH, V3, pE260, DOI 10.1016/S2214-109X(15)70094-X; WHO, 2010, WOR HEALT REP, P1; Wilson NO, 2012, AM J TROP MED HYG, V86, P936, DOI 10.4269/ajtmh.2012.11-0625; WONG RD, 1992, AM J MED, V92, P561, DOI 10.1016/0002-9343(92)90755-Z; World Health Organization, 2013, CONGUID UANT DRU; World Health Organization, 1991, BAS LAB METH MED PAR; World Health Organization, 2016, SICKL CELL DIS PREV; World Health Organization, 2006, GUID APPR EV HIV TES; World Health Organization, 1981, DEVELOPMENT OF INDIC; World Health Organization, 2016, HIV AIDS 2015; World Health Organization, TRENDS MAT MORT 1990; Wylie BJ, 2008, CLIN PERINATOL, V35, P571, DOI 10.1016/j.clp.2008.06.002	57	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174369	10.1371/journal.pone.0174369	http://dx.doi.org/10.1371/journal.pone.0174369			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VG	28355302	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174600046
J	Stensaeth, KH; Sovik, E; Haig, INY; Skomedal, E; Jorgensen, A				Stensaeth, Knut Haakon; Sovik, Edmund; Haig, Ingrid Natasha Ylva; Skomedal, Erna; Jorgensen, Arve			Fluoroscopy-free Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) for controlling life threatening postpartum hemorrhage	PLOS ONE			English	Article							CESAREAN HYSTERECTOMY; ABDOMINAL-TRAUMA; SHOCK; PERCRETA; MODEL	Background Severe postpartum hemorrhage occurs in 1/1000 women giving birth. This condition is often dramatic and may be life threatening. Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) has in recent years been introduced as a novel treatment for hemorrhagic shock. We present a series of fluoroscopy-free REBOA for controlling life threatening postpartum hemorrhage. Methods In 2008 an 'aortic occlusion kit' was assembled and used in three Norwegian university hospitals. The on-call interventional radiologist (IR) was to be contacted with a response time <30 minutes in case of life threatening PPH. Demographics and characteristics were noted from the medical records. Results This retrospective study includes 36 patients treated with fluoroscopy-free REBOA for controlling severe postpartum hemorrhage in the years 2008-2015. The REBOA success rate was 100% and no patients died from REBOA related complications. Uterine artery embolization was performed in 17 (47%) patients and a hysterectomy in 16 (44%) patients. A short (11cm) introducer length was strongly associated with iliac artery thrombus formation (p = 0.50, P= 0.002). In addition, there was a strong negative correlation between uterine artery embolization and hysterectomy (p =-0.50, P= 0.002). Conclusions Our Norwegian experience indicates the clinical safety and feasibility of REBOA in life threatening PPH. Also, REBOA can be used in an emergency situation without the use of fluoroscopy with a high degree of technical success. It is important that safety implementation of REBOA is established, especially through limited aortic balloon occlusion time and a thorough balloon deflation regime.	[Stensaeth, Knut Haakon; Sovik, Edmund; Jorgensen, Arve] St Olavs Univ Hosp, Dept Radiol & Nucl Med, Trondheim, Norway; [Stensaeth, Knut Haakon; Jorgensen, Arve] Norwegian Univ Sci & Technol, Inst Circulat & Med Imaging, Trondheim, Norway; [Haig, Ingrid Natasha Ylva] Univ Oslo, Ullevaal Hosp, Dept Radiol & Nucl Med, Oslo, Norway; [Skomedal, Erna] Stavanger Univ Hosp, Dept Radiol & Nucl Med, Stavanger, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Oslo; Stavanger University Hospital	Stensaeth, KH (corresponding author), St Olavs Univ Hosp, Dept Radiol & Nucl Med, Trondheim, Norway.; Stensaeth, KH (corresponding author), Norwegian Univ Sci & Technol, Inst Circulat & Med Imaging, Trondheim, Norway.	knutsten@gmail.com						Berg CJ, 2005, OBSTET GYNECOL, V106, P1228, DOI 10.1097/01.AOG.0000187894.71913.e8; Brenner ML, 2013, J TRAUMA ACUTE CARE, V75, P506, DOI 10.1097/TA.0b013e31829e5416; Carroli G, 2008, BEST PRACT RES CL OB, V22, P999, DOI 10.1016/j.bpobgyn.2008.08.004; Davis AE, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-9; Della Torre M, 2011, AM J PERINAT, V28, P753, DOI 10.1055/s-0031-1280856; EDWARDS WS, 1953, SURG FORUM, V4, P496; Ford JB, 2007, INT J GYNECOL OBSTET, V98, P237, DOI 10.1016/j.ijgo.2007.03.011; Godoy G, 2009, J UROLOGY, V181, P2438, DOI 10.1016/j.juro.2009.02.026; Guliani S, 2015, J TRAUMA ACUTE CARE, V79, P549, DOI 10.1097/TA.0000000000000818; GUPTA BK, 1989, J TRAUMA, V29, P861, DOI 10.1097/00005373-198906000-00026; Harma M, 2004, AUST NZ J OBSTET GYN, V44, P170, DOI 10.1111/j.1479-828X.2004.00181.x; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Lee JS, 2010, CLIN OBSTET GYNECOL, V53, P209, DOI 10.1097/GRF.0b013e3181ce09f5; Masamoto H, 2009, GYNECOL OBSTET INVES, V67, P92, DOI 10.1159/000164685; Morrison JJ, 2014, J SURG RES, V191, P423, DOI 10.1016/j.jss.2014.04.012; Ogura T, 2015, J TRAUMA ACUTE CARE, V78, P132, DOI 10.1097/TA.0000000000000473; Paull JD, 1995, ANAESTH INTENS CARE, V23, P731, DOI 10.1177/0310057X9502300616; Rossen J, 2010, ACTA OBSTET GYN SCAN, V89, P1248, DOI 10.3109/00016349.2010.514324; Russo RM, 2016, J AM COLL SURGEONS, V223, P359, DOI 10.1016/j.jamcollsurg.2016.04.037; Saito N, 2015, J TRAUMA ACUTE CARE, V78, P897, DOI 10.1097/TA.0000000000000614; Scott DJ, 2013, J TRAUMA ACUTE CARE, V75, P122, DOI 10.1097/TA.0b013e3182946746; Sovik E, 2012, ACTA ANAESTH SCAND, V56, P388, DOI 10.1111/j.1399-6576.2011.02611.x; Stannard A, 2011, J TRAUMA, V71, P1869, DOI 10.1097/TA.0b013e31823fe90c; Teeter WA, 2016, J TRAUMA ACUTE CARE; Xu JQ, 2015, EUR REV MED PHARMACO, V19, P372	25	38	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174520	10.1371/journal.pone.0174520	http://dx.doi.org/10.1371/journal.pone.0174520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355242	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174600059
J	Liu, LR; Shi, MJ; Wang, YY; Zhang, CZ; Su, B; Xiao, Y; Guo, B				Liu, Lirong; Shi, Mingjun; Wang, Yuanyuan; Zhang, Changzhi; Su, Bo; Xiao, Ying; Guo, Bing			SnoN upregulation ameliorates renal fibrosis in diabetic nephropathy	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; TGF-BETA; EXTRACELLULAR-MATRIX; NEGATIVE REGULATORS; TUMOR-METASTASIS; DEGRADATION; SKI	Progressive reduction of SnoN is associated with gradual elevation of TGF-beta 1 during diabetic nephropathy progression, suggesting SnoN to be a possible mediator of TGF-beta 1 signaling, with potential therapeutic benefits against TGF-beta 1 -induced renal fibrosis. To characterize SnoN for its role in renal fibrosis, we assessed SnoN expression patterns in response to high glucose stress, and evaluated the effects of upregulating SnoN on renal fibrosis. High glucose stress induced significantly elevated SnoN, TGF-beta 1, and Arkadia transcription; however, significantly reduced SnoN protein levels were observed under these conditions. Upregulating the SnoN protein was achieved by Arkadia knockdown, which resulted in inhibited high glucose-induced epithelial-mesenchymal transition (EMT) in renal tubular cells, the onset phase of renal fibrosis. Alternatively, EMT was suppressed by dominantly expressed exogenous SnoN without interfering with TGF-beta 1. Overall, renal SnoN upregulation ameliorates renal fibrosis by relieving high glucose-induced EMT; these findings support a translational approach targeting SnoN for the treatment of diabetic nephropathy.	[Liu, Lirong] Guizhou Med Univ, Dept Clin Hematol, Affiliated Hosp, Guiyang, Guizhou, Peoples R China; [Shi, Mingjun; Wang, Yuanyuan; Xiao, Ying; Guo, Bing] Guizhou Med Univ, Dept Pathophysiol, Guiyang, Guizhou, Peoples R China; [Zhang, Changzhi] Peoples Hosp Guizhou Prov, Dept Resp Med, Guiyang, Guizhou, Peoples R China; [Su, Bo] Nanyang Cent Hosp, Dept Pathol, Nanyang, Henan, Peoples R China	Guizhou Medical University; Guizhou Medical University	Guo, B (corresponding author), Guizhou Med Univ, Dept Pathophysiol, Guiyang, Guizhou, Peoples R China.	guobingbs@126.com	wang, yuanyuan/AAY-2671-2020	wang, yuanyuan/0000-0002-6693-643X; guo, bing/0000-0001-8998-2597	National Natural Science Foundation of China [81160094, 81460144]; special project for Traditional Chinese medicine research and development of Guizhou Province [[2012] 5037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special project for Traditional Chinese medicine research and development of Guizhou Province	This work was supported by the National Natural Science Foundation of China (Grant Nos. 81160094 and 81460144), and the special project for Traditional Chinese medicine research and development of Guizhou Province (Grant No. [2012] 5037).	Bonventre JV, 2012, SEMIN NEPHROL, V32, P452, DOI 10.1016/j.semnephrol.2012.07.008; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Briones-Orta MA, 2013, CANCER RES, V73, P1800, DOI 10.1158/0008-5472.CAN-12-1916; Cao CX, 2007, BIOCHEM BIOPH RES CO, V353, P509, DOI 10.1016/j.bbrc.2006.12.057; Decleves AE, 2010, NAT REV NEPHROL, V6, P371, DOI 10.1038/nrneph.2010.57; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Herbach N, 2012, PATHOLOGE, V33, P318, DOI 10.1007/s00292-012-1637-1; Hills CE, 2011, CYTOKINE GROWTH F R, V22, P131, DOI 10.1016/j.cytogfr.2011.06.002; Hills CE, 2010, AM J NEPHROL, V31, P68, DOI 10.1159/000256659; Kolset SO, 2012, J HISTOCHEM CYTOCHEM, V60, P976, DOI 10.1369/0022155412465073; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Le Scolan E, 2008, CANCER RES, V68, P3277, DOI 10.1158/0008-5472.CAN-07-6793; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Liu LR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151986; Liu RX, 2012, KIDNEY BLOOD PRESS R, V35, P517, DOI 10.1159/000339172; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Luo KX, 2004, CURR OPIN GENET DEV, V14, P65, DOI 10.1016/j.gde.2003.11.003; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Miyazono K, 2011, J BIOCHEM, V149, P1, DOI 10.1093/jb/mvq133; Moustakas A, 2013, MOL CELL, V51, P555, DOI 10.1016/j.molcel.2013.08.034; Nagano Y, 2007, J BIOL CHEM, V282, P20492, DOI 10.1074/jbc.M701294200; Sun YM, 2013, BIOCHEM BIOPH RES CO, V433, P359, DOI 10.1016/j.bbrc.2013.02.120; Tan RY, 2006, J AM SOC NEPHROL, V17, P2781, DOI 10.1681/ASN.2005101055	23	14	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174471	10.1371/journal.pone.0174471	http://dx.doi.org/10.1371/journal.pone.0174471			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350874	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174400047
J	Di Giacomo, V; Tian, TV; Mas, A; Pecoraro, M; Batlle-Morera, L; Noya, L; Martin-Caballero, J; Ruberte, J; Keyes, WM				Di Giacomo, V.; Tian, T. V.; Mas, A.; Pecoraro, M.; Batlle-Morera, L.; Noya, L.; Martin-Caballero, J.; Ruberte, J.; Keyes, W. M.			Delta Np63 alpha promotes adhesion of metastatic prostate cancer cells to the bone through regulation of CD82	ONCOGENE			English	Article							PROGENITOR CELLS; SUPPRESSOR GENE; P53 HOMOLOG; STEM-CELLS; P63; PROLIFERATION; SURVIVAL; PC3; COMMITMENT; EXPRESSION	Delta Np63 alpha is a critical mediator of epithelial development and stem cell function in a variety of tissues including the skin and breast, while overexpression of Delta Np63 alpha acts as an oncogene to drive tumor formation and cancer stem cell properties in squamous cell carcinoma. However, with regards to the prostate, while Delta Np63 alpha is expressed in the basal stem cells of the mature gland, during adenocarcinoma development, its expression is lost and its absence is used to clinically diagnose the malignant state. Surprisingly, here we identify a sub-population of bone metastatic prostate cancer cells in the PC3 cell line that express Delta Np63 alpha. Interestingly, we discovered that Delta Np63 alpha favors adhesion and stem-like growth of these cells in the bone microenvironment. In addition, we show that these properties require expression of the target gene CD82. Together, this work uncovers a population of bone metastatic prostate cancer cells that express Delta Np63 alpha, and provides important information about the mechanisms of bone metastatic colonization. Finally, we identify metastasis-promoting properties for the tetraspanin family member CD82.	[Di Giacomo, V.; Tian, T. V.; Mas, A.; Pecoraro, M.; Batlle-Morera, L.; Keyes, W. M.] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Gene Regulat Stem Cells & Canc Program, Barcelona, Spain; [Di Giacomo, V.; Tian, T. V.; Mas, A.; Pecoraro, M.; Batlle-Morera, L.; Keyes, W. M.] UPF, Barcelona, Spain; [Noya, L.] Univ Autonoma Barcelona, Dept Anim Hlth & Anat, Barcelona, Spain; [Noya, L.] Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy, Barcelona, Spain; [Martin-Caballero, J.] PRBB, Unidad Anim Lab, Barcelona, Spain; [Keyes, W. M.] Univ Strasbourg, Inserm U964, CNRS UMR7104,Dev & Stem Cells program, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Di Giacomo, V.] ZeClinics, Barcelona, Spain; [Pecoraro, M.] Max Planck Inst Biochem, Dept Prote & Signal Transduct, Martinsried, Germany	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Autonomous University of Barcelona; Autonomous University of Barcelona; Pompeu Fabra University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Max Planck Society	Keyes, WM (corresponding author), Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Carrer Dr Aiguader 88, Barcelona 08003, Spain.	bill.keyes@crg.eu	Ruberte, Jesus/AAS-9240-2021; TIAN, TIAN/O-1726-2015	BATLLE MORERA, LAURA/0000-0002-6924-9002; TIAN, TIAN/0000-0002-9906-0980; RUBERTE, JESUS/0000-0003-1540-1432	La Caixa; Spanish Ministry; Ministerio de Economia y Competitividad [SAF2010-18829, SAF2013-49082-P]; Marie Curie International Reintegration Grant [PIRG5-GA-2009-248262]	La Caixa(La Caixa Foundation); Spanish Ministry(Spanish Government); Ministerio de Economia y Competitividad(Spanish Government); Marie Curie International Reintegration Grant(European Commission)	We thank Roger Gomis and Marc Guiu for help with tumor imaging analysis, Jason Doles for help in the short hairpin design and the CRG Bioinformatics facility for assistance with microarray and sequencing data analysis. VDG was supported by a fellowship from 'La Caixa', and MP with an F. P. I. fellowship from the Spanish Ministry. This work was funded by Grants SAF2010-18829 (WMK) and SAF2013-49082-P (WMK) from the Ministerio de Economia y Competitividad and a Marie Curie International Reintegration Grant PIRG5-GA-2009-248262 (WMK).	Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Burchert A, 1999, BRIT J HAEMATOL, V107, P494, DOI 10.1046/j.1365-2141.1999.01741.x; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chae YS, 2012, FEBS LETT, V586, P1128, DOI 10.1016/j.febslet.2012.03.021; Crum CP, 2010, ANNU REV PATHOL-MECH, V5, P349, DOI 10.1146/annurev-pathol-121808-102117; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Doherty RE, 2011, BIOCHEM BIOPH RES CO, V414, P801, DOI 10.1016/j.bbrc.2011.10.010; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; Ferone G, 2015, CELL TISSUE RES, V360, P513, DOI 10.1007/s00441-014-2108-1; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Graziano V, 2011, BBA-REV CANCER, V1816, P57, DOI 10.1016/j.bbcan.2011.04.002; Grisanzio C, 2008, J CELL BIOCHEM, V103, P1354, DOI 10.1002/jcb.21555; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Harma V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010431; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Keyes WM, 2011, CELL STEM CELL, V8, P164, DOI 10.1016/j.stem.2010.12.009; Kurita T, 2004, DEVELOPMENT, V131, P4955, DOI 10.1242/dev.01384; Larochelle A, 2012, BLOOD, V119, P1848, DOI 10.1182/blood-2011-08-371583; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Lee HA, 2011, CELL PHYSIOL BIOCHEM, V27, P575, DOI 10.1159/000329979; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Litvinov IV, 2006, PROSTATE, V66, P1329, DOI 10.1002/pros.20483; Liu QX, 2013, CANCER RES, V73, P3297, DOI 10.1158/0008-5472.CAN-12-3970; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Nishioka C, 2013, INT J CANCER, V132, P2006, DOI 10.1002/ijc.27904; Olsen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062547; Osada M, 2005, J INVEST DERMATOL, V125, P52, DOI 10.1111/j.0022-202X.2005.23801.x; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Park SI, 2010, CURR PROTOC PHARM, V51, P14, DOI [DOI 10.1002/0471141755.PH1415S51, 10.1002/0471141755.ph1415s51]; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Signoretti S, 2005, P NATL ACAD SCI USA, V102, P11355, DOI 10.1073/pnas.0500165102; Termini CM, 2014, MOL BIOL CELL, V25, P1560, DOI 10.1091/mbc.E13-11-0660; Tien JCY, 2013, CANCER RES, V73, P3997, DOI 10.1158/0008-5472.CAN-12-3929; Tonoli H, 2005, TRENDS MOL MED, V11, P563, DOI 10.1016/j.molmed.2005.10.002; Tsai YC, 2011, FEBS LETT, V585, P3166, DOI 10.1016/j.febslet.2011.08.031; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; Valkenburg KC, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/895238; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wu J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.239; Wu N, 2012, J BIOL CHEM, V287, P5627, DOI 10.1074/jbc.M111.328120; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zhang KX, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-319	49	13	13	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 3	2017	36	31					4381	4392		10.1038/onc.2017.42	http://dx.doi.org/10.1038/onc.2017.42			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FC4JL	28368419	Green Published, hybrid			2022-12-26	WOS:000406806000001
J	Shi, Z; He, F; Chen, M; Hua, L; Wang, W; Jiao, S; Zhou, Z				Shi, Z.; He, F.; Chen, M.; Hua, L.; Wang, W.; Jiao, S.; Zhou, Z.			DNA-binding mechanism of the Hippo pathway transcription factor TEAD4	ONCOGENE			English	Article							ORGAN SIZE CONTROL; EMERGING ROLES; YAP; TEF-1; GENE; INSIGHTS; MOTIFS; DOMAIN; TAZ	TEA domain (TEAD) family transcription factors are key regulators in development, tissue homeostasis and cancer progression. TEAD4 acts as a critical downstream effector of the evolutionarily conserved Hippo signaling pathway. The well-studied oncogenic protein YAP forms a complex with TEAD4 to regulate gene transcription; so does the tumor suppressor VGLL4. Although it is known that TEAD proteins can bind promoter regions of target genes through the TEA domain, the specific and detailed mechanism of DNA recognition by the TEA domain remains partially understood. Here, we report the crystal structure of TEAD4 TEA domain in complex with a muscle-CAT DNA element. The structure revealed extensive interactions between the TEA domain and the DNA duplex involving both the major and minor grooves of DNA helix. The DNA recognition helix, a3 helix, determines the specificity of the TEA domain binding to DNA sequence. Structure-guided biochemical analysis identified two major binding sites on the interface of the TEA domain-DNA complex. Mutation of TEAD4 at either site substantially decreases its occupancy on the promoter region of target genes, and largely impaired YAP-induced TEAD4 transactivation and target gene transcription, leading to inhibition of growth and colony formation of gastric cancer cell HGC-27. Collectively, our work provides a structural basis for understanding the regulatory mechanism of TEAD-mediated gene transcription.	[Shi, Z.; He, F.; Chen, M.; Hua, L.; Wang, W.; Jiao, S.; Zhou, Z.] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci,State Key Lab Cel, 320 Yue Yang Rd, Shanghai 200031, Peoples R China; [Zhou, Z.] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University	Zhou, Z (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, CAS Ctr Excellence Mol Cell Sci,State Key Lab Cel, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	zczhou@sibcb.ac.cn	Shi, Zhubing/F-9490-2010	Shi, Zhubing/0000-0002-9624-4960; He, Feng/0000-0002-6286-8134	Ministry of Science and Technology of China [2012CB910204]; National Natural Science Foundation of China [31270808, 31300734, 31470736, 31470868, 31600731, 91442125, 91542125]; Youth Innovation Promotion Association of Chinese Academy of Sciences; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2014KIP202]; Chinese Academy of Sciences [XDA12020342, XDB19020202]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association of Chinese Academy of Sciences; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank the staff at beamline BL17U of Shanghai Synchrotron Radiation Facility (SSRF) for assistance with data collection. This work was supported by the 973 program of the Ministry of Science and Technology of China (2012CB910204), the National Natural Science Foundation of China (31270808, 31300734, 31470736, 31470868, 31600731, 91442125 and 91542125), the Youth Innovation Promotion Association of Chinese Academy of Sciences, the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (2014KIP202), and the 'Strategic Priority Research Program' of the Chinese Academy of Sciences (XDA12020342 and XDB19020202).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ADRIANOPOULOS A, 1991, PLANT CELL, V3, P747, DOI 10.1105/tpc.3.8.747; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Anbanandam A, 2006, P NATL ACAD SCI USA, V103, P17225, DOI 10.1073/pnas.0607171103; Aravind L, 2005, FEMS MICROBIOL REV, V29, P231, DOI 10.1016/j.fmrre.2004.12.008; BURGLIN TR, 1991, CELL, V66, P11, DOI 10.1016/0092-8674(91)90132-I; Chan P, 2016, NAT CHEM BIOL, V12, P282, DOI [10.1038/nchembio.2036, 10.1038/NCHEMBIO.2036]; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Chen LM, 2010, GENE DEV, V24, P290, DOI 10.1101/gad.1865310; DAVIDSON I, 1988, CELL, V54, P931, DOI 10.1016/0092-8674(88)90108-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Guo T, 2013, CELL RES, V23, P1201, DOI 10.1038/cr.2013.120; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Koontz LM, 2013, DEV CELL, V25, P388, DOI 10.1016/j.devcel.2013.04.021; Lee DS, 2016, J MOL BIOL, V428, P2557, DOI 10.1016/j.jmb.2016.03.008; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Lim B, 2014, CARCINOGENESIS, V35, P1020, DOI 10.1093/carcin/bgt409; Maeda T, 2002, J BIOL CHEM, V277, P48889, DOI 10.1074/jbc.M206858200; MAR JH, 1988, P NATL ACAD SCI USA, V85, P6404, DOI 10.1073/pnas.85.17.6404; MAR JH, 1990, MOL CELL BIOL, V10, P4271, DOI 10.1128/MCB.10.8.4271; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; NIKOVITS W, 1986, NUCLEIC ACIDS RES, V14, P3377, DOI 10.1093/nar/14.8.3377; Noland CL, 2016, STRUCTURE, V24, P179, DOI 10.1016/j.str.2015.11.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Pobbati AV, 2013, CANCER BIOL THER, V14, P390, DOI 10.4161/cbt.23788; Pobbati AV, 2012, STRUCTURE, V20, P1135, DOI 10.1016/j.str.2012.04.004; Shi ZB, 2015, ACTA BIOCH BIOPH SIN, V47, P29, DOI 10.1093/abbs/gmu107; Vaudin P, 1999, DEVELOPMENT, V126, P4807; Wang WQ, 2015, NAT CELL BIOL, V17, P490, DOI 10.1038/ncb3113; XIAO JH, 1987, EMBO J, V6, P3005, DOI 10.1002/j.1460-2075.1987.tb02606.x; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zhang WJ, 2014, CELL RES, V24, P331, DOI 10.1038/cr.2014.10; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhou YH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010138	37	36	39	3	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 27	2017	36	30					4362	4369		10.1038/onc.2017.24	http://dx.doi.org/10.1038/onc.2017.24			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FB8AH	28368398				2022-12-26	WOS:000406360600012
J	Nguyen, TB; Jayaraman, P; Bergseng, E; Madhusudhan, MS; Kim, CY; Sollid, LM				Thanh-Binh Nguyen; Jayaraman, Priya; Bergseng, Elin; Madhusudhan, M. S.; Kim, Chu-Young; Sollid, Ludvig M.			Unraveling the structural basis for the unusually rich association of human leukocyte antigen DQ2.5 with class-II-associated invariant chain peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX CLASS-II; CELIAC-DISEASE; HLA-DM; MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; BINDING MOTIF; MOLECULES; PROTEIN; CLIP; DQ	Human leukocyte antigen (HLA)-DQ2.5 (DQA1* 05/ DQB1* 02) is a class-II major histocompatibility complex protein associated with both type 1 diabetes and celiac disease. One unusual feature of DQ2.5 is its high class-II-associated invariant chain peptide (CLIP) content. Moreover, HLA-DQ2.5 preferentially binds the non-canonical CLIP2 over the canonical CLIP1. To better understand the structural basis of HLA-DQ2.5 ' s unusual CLIP association characteristics, better insight into the HLADQ2.5.CLIP complex structures is required. To this end, we determined the X-ray crystal structure of the HLA-DQ2.5.CLIP1 and HLA-DQ2.5.CLIP2 complexes at 2.73 and 2.20 angstrom, respectively. We found that HLA-DQ2.5 has an unusually large P4 pocket and a positively charged peptide-binding groove that together promote preferential binding of CLIP2 over CLIP1. An alpha 9-alpha 22-alpha 24-alpha 31-beta 86-beta 90 hydrogen bond network located at the bottom of the peptide-binding groove, spanning from the P1 to P4 pockets, renders the residues in this region relatively immobile. This hydrogen bond network, along with a deletion mutation at alpha 53, may lead to HLA-DM insensitivity in HLA-DQ2.5. A molecular dynamics simulation experiment reported here and recent biochemical studies by others support this hypothesis. The diminished HLA-DM sensitivity is the likely reason for the CLIP-rich phenotype of HLA-DQ2.5.	[Kim, Chu-Young] Univ Texas El Paso, Dept Chem, 1852 Hawthorne St, El Paso, TX 79968 USA; [Kim, Chu-Young] Univ Texas El Paso, Sch Pharm, El Paso, TX 79968 USA; [Kim, Chu-Young] Natl Univ Singapore, Life Sci Inst, Synthet Biol Clin & Technol Innovat, Singapore 117456, Singapore; [Thanh-Binh Nguyen; Jayaraman, Priya] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Thanh-Binh Nguyen] Bioinformat Inst, Singapore 138671, Singapore; [Madhusudhan, M. S.] Indian Inst Sci Educ & Res, Pune 411008, Maharashtra, India; [Bergseng, Elin; Sollid, Ludvig M.] Univ Oslo, Ctr Immune Regulat, N-0372 Oslo, Norway; [Bergseng, Elin; Sollid, Ludvig M.] Univ Oslo, Dept Immunol, N-0372 Oslo, Norway; [Bergseng, Elin; Sollid, Ludvig M.] Oslo Univ Hosp, N-0372 Oslo, Norway	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Indian Institute of Science Education & Research (IISER) Pune; University of Oslo; University of Oslo; University of Oslo	Kim, CY (corresponding author), Univ Texas El Paso, Dept Chem, 1852 Hawthorne St, El Paso, TX 79968 USA.; Sollid, LM (corresponding author), Natl Hosp Norway, Oslo Univ Hosp, Ctr Immune Regulat, N-0372 Oslo, Norway.; Sollid, LM (corresponding author), Natl Hosp Norway, Oslo Univ Hosp, Dept Immunol, N-0372 Oslo, Norway.	ckim7@utep.edu; l.m.sollid@medisin.uio.no	Kim, Chu-Young/D-8849-2012	Kim, Chu-Young/0000-0003-3744-7802; Nguyen, Thanh Binh/0000-0002-4150-5991	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; United States Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data collection was performed at the Stanford Synchrotron Radiation Lightsource (SSRL), SLAC National Accelerator Laboratory, which is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the United States Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including Grant P41GM103393). We thank Dr. I. I. Mathews at SSRL for assistance with X-ray data collection and processing and Dr. Chandra Verma at the Bioinformatics Institute for discussion on molecular dynamics simulation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; Bergseng E, 2005, J BIOL CHEM, V280, P21791, DOI 10.1074/jbc.M501558200; Bergseng E, 2015, IMMUNOGENETICS, V67, P73, DOI 10.1007/s00251-014-0819-9; Busch R, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/erm.2012.9; Camacho CJ, 1999, BIOPHYS J, V76, P1166, DOI 10.1016/S0006-3495(99)77281-4; Case DA, 2012, AMBER 12; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Chu XK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002608; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Doebele RC, 2000, IMMUNITY, V13, P517, DOI 10.1016/S1074-7613(00)00051-0; Drozdov-Tikhomirov LN, 2001, J BIOMOL STRUCT DYN, V19, P279, DOI 10.1080/07391102.2001.10506738; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FALK K, 1994, IMMUNOGENETICS, V39, P230; Fallang LE, 2008, J IMMUNOL, V181, P5451, DOI 10.4049/jimmunol.181.8.5451; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Gunther S, 2010, P NATL ACAD SCI USA, V107, P22219, DOI 10.1073/pnas.1014708107; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hou TY, 2011, J IMMUNOL, V187, P2442, DOI 10.4049/jimmunol.1100255; JARDETZKY TS, 1990, EMBO J, V9, P1797, DOI 10.1002/j.1460-2075.1990.tb08304.x; Kalandadze A, 1996, J BIOL CHEM, V271, P20156, DOI 10.1074/jbc.271.33.20156; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Kim CY, 2004, P NATL ACAD SCI USA, V101, P4175, DOI 10.1073/pnas.0306885101; Kumar V, 2011, INT J PHARMACEUT, V421, P82, DOI 10.1016/j.ijpharm.2011.09.017; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li YC, 2009, CHEM BIOL DRUG DES, V74, P611, DOI 10.1111/j.1747-0285.2009.00896.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogata K, 2002, PROTEIN ENG, V15, P697, DOI 10.1093/protein/15.8.697; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter CA, 2011, P NATL ACAD SCI USA, V108, P19329, DOI 10.1073/pnas.1108074108; Petersen J, 2014, NAT STRUCT MOL BIOL, V21, P480, DOI 10.1038/nsmb.2817; Petrone PM, 2004, J MOL BIOL, V338, P419, DOI 10.1016/j.jmb.2004.02.039; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pos W, 2012, CELL, V151, P1557, DOI 10.1016/j.cell.2012.11.025; Quarsten H, 2001, J IMMUNOL, V167, P4861, DOI 10.4049/jimmunol.167.9.4861; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; RICHARDS FM, 1974, J MOL BIOL, V82, P1, DOI 10.1016/0022-2836(74)90570-1; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; Schlundt A, 2012, J MOL BIOL, V423, P294, DOI 10.1016/j.jmb.2012.07.008; SETTE A, 1995, J EXP MED, V181, P677, DOI 10.1084/jem.181.2.677; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; SOLLID LM, 1989, J EXP MED, V169, P345, DOI 10.1084/jem.169.1.345; Stepniak D, 2008, J IMMUNOL, V180, P3268, DOI 10.4049/jimmunol.180.5.3268; Stratikos E, 2004, J IMMUNOL, V172, P1109, DOI 10.4049/jimmunol.172.2.1109; Tinto N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138324; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; TRIER JS, 1991, NEW ENGL J MED, V325, P1709, DOI 10.1056/NEJM199112123252406; Uchikoga N, 2005, PROTEIN SCI, V14, P74, DOI 10.1110/ps.04984505; vandeWal Y, 1996, IMMUNOGENETICS, V44, P246, DOI 10.1007/s002510050120; Vartdal F, 1996, EUR J IMMUNOL, V26, P2764, DOI 10.1002/eji.1830261132; VIKEN HD, 1995, HUM IMMUNOL, V42, P319, DOI 10.1016/0198-8859(94)00110-C; Volz T, 2004, HUM IMMUNOL, V65, P594, DOI 10.1016/j.humimm.2004.02.027; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wiesner M, 2008, IMMUNOGENETICS, V60, P551, DOI 10.1007/s00251-008-0310-6; Yin LS, 2014, J BIOL CHEM, V289, P23449, DOI 10.1074/jbc.M114.585539; Zhou ZM, 2016, EUR J IMMUNOL, V46, P834, DOI 10.1002/eji.201545942; Zhu YR, 2003, J MOL BIOL, V326, P1157, DOI 10.1016/S0022-2836(02)01437-7	61	13	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9218	9228		10.1074/jbc.M117.785139	http://dx.doi.org/10.1074/jbc.M117.785139			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28364043	Green Published, hybrid			2022-12-26	WOS:000402538900017
J	Grishkovskaya, I; Paumann-Page, M; Tscheliessnig, R; Stampler, J; Hofbauer, S; Soudi, M; Sevcnikar, B; Oostenbrink, C; Furtmuller, PG; Djinovic-Carugo, K; Nauseef, WM; Obinger, C				Grishkovskaya, Irina; Paumann-Page, Martina; Tscheliessnig, Rupert; Stampler, Johanna; Hofbauer, Stefan; Soudi, Monika; Sevcnikar, Benjamin; Oostenbrink, Chris; Furtmueller, Paul G.; Djinovic-Carugo, Kristina; Nauseef, William M.; Obinger, Christian			Structure of human promyeloperoxidase (proMPO) and the role of the propeptide in processing and maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELOID LYSOSOMAL-ENZYME; HUMAN MYELOPEROXIDASE; MACROMOLECULAR STRUCTURES; REDOX THERMODYNAMICS; CELL-LINE; HEME; BIOSYNTHESIS; HL-60; PROTEIN; IMPACT	Myeloperoxidase (MPO) is synthesized by neutrophil and monocyte precursor cells and contributes to host defense by mediating microbial killing. Although several steps in MPO biosynthesis and processing have been elucidated, many questions remained, such as the structure-function relationship of monomeric unprocessed proMPO versus the mature dimeric MPO and the functional role of the propeptide. Here we have presented the first and high resolution (at 1.25 angstrom) crystal structure of proMPO and its solution structure obtained by small-angle X-ray scattering. Promyeloperoxidase hosts five occupied glycosylation sites and six intrachain cystine bridges with Cys-158 of the very flexible N-terminal propeptide being covalently linked to Cys-319 and thereby hindering homodimerization. Furthermore, the structure revealed (i) the binding site of proMPO-processing proconvertase, (ii) the structural motif for subsequent cleavage to the heavy and light chains of mature MPO protomers, and (iii) three covalent bonds between heme and the protein. Studies of the mutants C158A, C319A, and C158A/C319A demonstrated significant differences from the wild-type protein, including diminished enzymatic activity and prevention of export to the Golgi due to prolonged association with the chaperone calnexin. These structural and functional findings provide novel insights into MPO biosynthesis and processing.	[Grishkovskaya, Irina; Hofbauer, Stefan; Djinovic-Carugo, Kristina] Univ Vienna, Max F Perutz Labs, Dept Struct & Computat Biol, A-1030 Vienna, Austria; [Paumann-Page, Martina; Stampler, Johanna; Soudi, Monika; Sevcnikar, Benjamin; Furtmueller, Paul G.; Obinger, Christian] BOKU Univ Nat Resources & Life Sci, Dept Chem, Div Biochem, Muthgasse 18, A-1190 Vienna, Austria; [Tscheliessnig, Rupert] ACIB, Muthgasse 11, A-1190 Vienna, Austria; [Oostenbrink, Chris] BOKU Univ Nat Resources & Life Sci, Inst Mol Modeling & Simulat, Dept Mat Sci & Proc Engn, A-1190 Vienna, Austria; [Nauseef, William M.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Inflammat Program, Iowa City, IA 52242 USA; [Nauseef, William M.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Med, Iowa City, IA 52242 USA; [Djinovic-Carugo, Kristina] Univ Ljubljana, Fac Chem & Chem Technol, Dept Biochem, Vecna Pot 113, Ljubljana 1000, Slovenia	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Natural Resources & Life Sciences, Vienna; Austrian Centre of Industrial Biotechnology; University of Natural Resources & Life Sciences, Vienna; University of Iowa; University of Iowa; University of Ljubljana	Obinger, C (corresponding author), BOKU Univ Nat Resources & Life Sci, Dept Chem, Div Biochem, Muthgasse 18, A-1190 Vienna, Austria.; Nauseef, WM (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Inflammat Program, Iowa City, IA 52242 USA.; Nauseef, WM (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Med, Iowa City, IA 52242 USA.	william-nauseef@uiowa.edu; christian.obinger@boku.ac.at	Obinger, Christian/AAV-3173-2021; Oostenbrink, Chris/S-8002-2019; Furtmüller, Paul G./Y-5819-2018; Djinovic-Carugo, Kristina/AAW-1167-2021; Hofbauer, Stefan/I-3889-2014	Oostenbrink, Chris/0000-0002-4232-2556; Furtmüller, Paul G./0000-0002-1199-2469; Djinovic-Carugo, Kristina/0000-0003-0252-2972; Hofbauer, Stefan/0000-0003-3375-7715; Obinger, Christian/0000-0002-7133-3430; Nauseef, William/0000-0003-4032-757X; Grishkovskaya, Irina/0000-0003-0164-9373	Federal Ministry of Economy, Family, and Youth (BMWFJ); Federal Ministry of Traffic, Innovation, and Technology (BMVIT); Styrian Business Promotion Agency (SFG); Standortagentur Tirol; ZIT-Technology Agency of the City of Vienna through the COMET; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116546, P01AI044642] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000513] Funding Source: NIH RePORTER	Federal Ministry of Economy, Family, and Youth (BMWFJ); Federal Ministry of Traffic, Innovation, and Technology (BMVIT); Styrian Business Promotion Agency (SFG); Standortagentur Tirol; ZIT-Technology Agency of the City of Vienna through the COMET; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	The Austrian Centre of Industrial Biotechnology was supported by the Federal Ministry of Economy, Family, and Youth (BMWFJ), the Federal Ministry of Traffic, Innovation, and Technology (BMVIT), the Styrian Business Promotion Agency (SFG), and the Standortagentur Tirol and ZIT-Technology Agency of the City of Vienna through the COMET-Funding Program managed by the Austrian Research Promotion Agency (FFG). The Nauseef laboratory had the use of facilities at the Iowa City Dept. of Veterans Affairs Medical Center, Iowa City, IA.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AKIN DT, 1986, J BIOL CHEM, V261, P8370; Andersson E, 1998, J BIOL CHEM, V273, P4747, DOI 10.1074/jbc.273.8.4747; ANDREWS PC, 1984, ARCH BIOCHEM BIOPHYS, V228, P439, DOI 10.1016/0003-9861(84)90008-0; Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; Banerjee S, 2011, BBA-PROTEINS PROTEOM, V1814, P375, DOI 10.1016/j.bbapap.2010.09.015; Battistuzzi G, 2006, BIOCHEMISTRY-US, V45, P12750, DOI 10.1021/bi061647k; Battistuzzi G, 2011, BIOCHEMISTRY-US, V50, P7987, DOI [10.1021/bi20084321, 10.1021/bi2008432]; Blair-Johnson M, 2001, BIOCHEMISTRY-US, V40, P13990, DOI 10.1021/bi0111808; Brogioni S, 2006, J RAMAN SPECTROSC, V37, P263, DOI 10.1002/jrs.1442; Brogioni S, 2008, BBA-PROTEINS PROTEOM, V1784, P843, DOI 10.1016/j.bbapap.2008.02.014; Carpena X, 2009, J BIOL CHEM, V284, P25929, DOI 10.1074/jbc.M109.002154; CASTANEDA VL, 1992, EXP HEMATOL, V20, P916; Chemical Computing Group, 2016, MOE MOL OP ENV 2013; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; de Montellano PRO, 2016, RSC METALLOBIO SER, V4, P3; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DeLeo FR, 1998, J CLIN INVEST, V101, P2900, DOI 10.1172/JCI2649; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Franke D, 2015, NAT METHODS, V12, P419, DOI [10.1038/NMETH.3358, 10.1038/nmeth.3358]; Furtmuller PG, 2001, FEBS LETT, V503, P147, DOI 10.1016/S0014-5793(01)02725-9; Goedken M, 2007, J BIOL CHEM, V282, P27994, DOI 10.1074/jbc.M701984200; Hansson M, 2006, ARCH BIOCHEM BIOPHYS, V445, P214, DOI 10.1016/j.abb.2005.08.009; HASILIK A, 1984, EMBO J, V3, P2671, DOI 10.1002/j.1460-2075.1984.tb02192.x; Helenius A, 1997, TRENDS CELL BIOL, V7, P193; Hofbauer S, 2016, BIOCHEMISTRY-US, V55, P5398, DOI 10.1021/acs.biochem.6b00701; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kettle AJ, 2016, RSC METALLOBIO SER, V4, P272; McCormick S, 2012, ARCH BIOCHEM BIOPHYS, V527, P31, DOI 10.1016/j.abb.2012.07.013; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MOGUILEVSKY N, 1991, EUR J BIOCHEM, V197, P605, DOI 10.1111/j.1432-1033.1991.tb15950.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nauseef WM, 2014, CELL MICROBIOL, V16, P1146, DOI 10.1111/cmi.12312; NAUSEEF WM, 1988, EUR J HAEMATOL, V40, P97; NAUSEEF WM, 1983, J CLIN INVEST, V71, P1297, DOI 10.1172/JCI110880; Nauseef WM, 1996, J BIOL CHEM, V271, P9546, DOI 10.1074/jbc.271.16.9546; NAUSEEF WM, 1995, J BIOL CHEM, V270, P4741, DOI 10.1074/jbc.270.9.4741; NAUSEEF WM, 1986, BLOOD, V68, P442; NAUSEEF WM, 1987, BLOOD, V70, P1143; NAUSEEF WM, 1992, BLOOD, V80, P2622; Nauseef WM, 1998, J BIOL CHEM, V273, P7107, DOI 10.1074/jbc.273.12.7107; OLSSON I, 1984, BIOCHEM J, V223, P911, DOI 10.1042/bj2230911; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; PINNIX IB, 1994, ARCH BIOCHEM BIOPHYS, V312, P447, DOI 10.1006/abbi.1994.1331; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; TAYLOR KL, 1990, BIOCHEMISTRY-US, V29, P1533, DOI 10.1021/bi00458a026; Van Antwerpen P, 2010, J BIOL CHEM, V285, P16351, DOI 10.1074/jbc.M109.089748; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; YAMADA M, 1990, BIOCHEM BIOPH RES CO, V166, P852, DOI 10.1016/0006-291X(90)90888-T; YAMADA M, 1982, J BIOL CHEM, V257, P5980; Zamocky M, 2008, PROTEINS, V72, P589, DOI 10.1002/prot.21950; Zamocky M, 2015, ARCH BIOCHEM BIOPHYS, V574, P108, DOI 10.1016/j.abb.2014.12.025; Zederbauer M, 2005, BIOCHEMISTRY-US, V44, P6482, DOI 10.1021/bi0501737; Zederbauer M, 2007, NAT PROD REP, V24, P571, DOI 10.1039/b604178g; Zederbauer M, 2007, J BIOL CHEM, V282, P17041, DOI 10.1074/jbc.M610685200; Zederbauer M, 2007, BIOCHEM BIOPH RES CO, V356, P450, DOI 10.1016/j.bbrc.2007.02.157	62	31	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8244	8261		10.1074/jbc.M117.775031	http://dx.doi.org/10.1074/jbc.M117.775031			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28348079	Green Published, hybrid			2022-12-26	WOS:000401788600011
J	Liu, M; Yuan, C; Jensen, JK; Zhao, BY; Jiang, YB; Jiang, LG; Huang, MD				Liu, Min; Yuan, Cai; Jensen, Jan K.; Zhao, Baoyu; Jiang, Yunbin; Jiang, Longguang; Huang, Mingdong			The crystal structure of a multidomain protease inhibitor (HAI-1) reveals the mechanism of its auto-inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; FACTOR ACTIVATOR INHIBITOR; PHYSIOLOGICAL INHIBITOR; SERINE PROTEINASE; KUNITZ DOMAINS; TYPE-1; MATRIPTASE; PURIFICATION; RECEPTOR; DYNAMICS	Hepatocyte growth factor activator inhibitor 1 (HAI-1) is a membrane-bound multidomain protein essential to the integrity of the basement membrane during placental development and is also important in maintaining postnatal homeostasis in many tissues. HAI-1 is a Kunitz-type serine protease inhibitor, and soluble fragments of HAI-1 with variable lengths have been identified in vivo. The full-length extracellular portion of HAI-1 (sHAI-1) shows weaker inhibitory activity toward target proteases than the smaller fragments, suggesting auto-inhibition of HAI-1. However, this possible regulatory mechanism has not yet been evaluated. Here, we solved the crystal structure of sHAI-1 and determined the solution structure by small-angle X-ray scattering. These structural analyses revealed that, despite the presence of long linkers, sHAI-1 exists in a compact conformation in which sHAI-1 active sites in Kunitz domain 1 are sterically blocked by neighboring structural elements. Wealso found that in the presence of target proteases, sHAI-1 adopts an extended conformation that disables the auto-inhibition effect. Our results also reveal the roles of non-inhibitory domains of this multidomain protein and explain the low activity of the full-length protein. The structural insights gained here improve our understanding of the regulation of HAI-1 inhibitory activities and point to new approaches for better controlling these activities.	[Liu, Min; Zhao, Baoyu; Jiang, Yunbin; Jiang, Longguang; Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China; [Liu, Min; Jiang, Yunbin] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Yuan, Cai] Fuzhou Univ, Coll Biosci & Biotechnol, Fuzhou 350108, Fujian, Peoples R China; [Yuan, Cai] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Jiang, Longguang; Huang, Mingdong] Fuzhou Univ, Coll Chem, Fuzhou 350108, Fujian, Peoples R China	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fuzhou University; Aarhus University; Fuzhou University	Huang, MD (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China.; Yuan, C (corresponding author), Fuzhou Univ, Coll Biosci & Biotechnol, Fuzhou 350108, Fujian, Peoples R China.; Huang, MD (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, Danish Chinese Ctr Proteases & Canc, Fuzhou 350002, Fujian, Peoples R China.	cyuan@fzu.edu.cn; mhuang@fjirsm.ac.cn	Huang, Mingdong/J-4278-2017	Huang, Mingdong/0000-0003-0085-9141; Jiang, Longguang/0000-0002-4734-3778	National Natural Science Foundation of China [31170707, 31570745, 31370737, 31400637, 31670739, U1405229]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 31170707, 31570745, 31370737, 31400637, 31670739, and U1405229 from the National Natural Science Foundation of China. The authors declare that they have no conflicts of interest with the contents of this article.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bhaskara RM, 2013, J BIOMOL STRUCT DYN, V31, P1467, DOI 10.1080/07391102.2012.743438; Clayton D, 2000, FEBS LETT, V479, P118, DOI 10.1016/S0014-5793(00)01842-1; Delaria KA, 1997, J BIOL CHEM, V272, P12209, DOI 10.1074/jbc.272.18.12209; Denda K, 2002, J BIOL CHEM, V277, P14053, DOI 10.1074/jbc.M112263200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan B, 2005, J BIOL CHEM, V280, P34513, DOI 10.1074/jbc.M502119200; Fan B, 2007, DEV BIOL, V303, P222, DOI 10.1016/j.ydbio.2006.11.005; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Friedrich R, 2002, J BIOL CHEM, V277, P2160, DOI 10.1074/jbc.M109830200; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Headd JJ, 2012, ACTA CRYSTALLOGR D, V68, P381, DOI 10.1107/S0907444911047834; Hong ZB, 2016, J BIOL CHEM, V291, P14340, DOI 10.1074/jbc.M115.707240; Hong ZB, 2015, BIOCHEM J, V466, P299, DOI 10.1042/BJ20141236; Inouye K, 2010, J BIOL CHEM, V285, P33394, DOI 10.1074/jbc.M110.115816; Itoh H, 2000, AM J PHYSIOL-GASTR L, V278, pG635, DOI 10.1152/ajpgi.2000.278.4.G635; Itoh H, 1999, BIOCHEM BIOPH RES CO, V255, P740, DOI 10.1006/bbrc.1999.0268; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kataoka H, 2000, J BIOL CHEM, V275, P40453, DOI 10.1074/jbc.M006412200; Kataoka H, 1999, J HISTOCHEM CYTOCHEM, V47, P673, DOI 10.1177/002215549904700509; Kawaguchi M, 2015, AM J PATHOL, V185, P1610, DOI 10.1016/j.ajpath.2015.02.009; Kawaguchi M, 2011, AM J PATHOL, V179, P1815, DOI 10.1016/j.ajpath.2011.06.038; Kawaguchi T, 1997, J BIOL CHEM, V272, P27558, DOI 10.1074/jbc.272.44.27558; Kirchhofer D, 2005, FEBS LETT, V579, P1945, DOI 10.1016/j.febslet.2005.01.085; Koivuniemi R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056117; Kojima K, 2008, J BIOL CHEM, V283, P2478, DOI 10.1074/jbc.M709073200; Kojima K, 2009, J BIOCHEM, V145, P783, DOI 10.1093/jb/mvp036; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; Liu HG, 2012, J STRUCT BIOL, V180, P226, DOI 10.1016/j.jsb.2012.05.011; Liu M, 2017, ACTA CRYSTALLOGR F, V73, P45, DOI 10.1107/S2053230X16020082; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nagaike K, 2008, AM J PATHOL, V173, P1464, DOI 10.2353/ajpath.2008.071142; Nakamura K, 2009, ANN ONCOL, V20, P63, DOI 10.1093/annonc/mdn556; Papaleo E, 2016, CHEM REV, V116, P6391, DOI 10.1021/acs.chemrev.5b00623; Parr C, 2010, ANTI-CANCER AGENT ME, V10, P47, DOI 10.2174/1871520611009010047; Roy A, 2016, J CHEM THEORY COMPUT, V12, P274, DOI 10.1021/acs.jctc.5b00796; Salameh MA, 2010, J BIOL CHEM, V285, P36884, DOI 10.1074/jbc.M110.171348; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; Shia S, 2005, J MOL BIOL, V346, P1335, DOI 10.1016/j.jmb.2004.12.048; Shimomura T, 1999, J BIOCHEM-TOKYO, V126, P821, DOI 10.1093/oxfordjournals.jbchem.a022522; Shimomura T, 1997, J BIOL CHEM, V272, P6370, DOI 10.1074/jbc.272.10.6370; Skou S, 2014, NAT PROTOC, V9, P1727, DOI 10.1038/nprot.2014.116; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Vadivel K, 2014, J BIOL CHEM, V289, P31647, DOI 10.1074/jbc.M114.569665; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wen B, 2013, J THEOR COMPUT CHEM, V12, DOI 10.1142/S0219633613410083; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wriggers W, 2005, BIOPOLYMERS, V80, P736, DOI 10.1002/bip.20291; Xu YB, 1998, J MOL BIOL, V276, P955, DOI 10.1006/jmbi.1997.1582; Zhao B., 2013, ADV MATER SCI ENG, V2013, P1, DOI DOI 10.1155/2013/390285; Zheng QL, 2014, MOL MED REP, V10, P2779, DOI 10.3892/mmr.2014.2628	56	8	8	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8412	8423		10.1074/jbc.M117.779256	http://dx.doi.org/10.1074/jbc.M117.779256			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28348076	Green Published, hybrid			2022-12-26	WOS:000401788600025
J	Meyer-Cifuentes, I; Martinez-Lavanchy, PM; Marin-Cevada, V; Bohnke, S; Harms, H; Muller, JA; Heipieper, HJ				Meyer-Cifuentes, Ingrid; Martinez-Lavanchy, Paula M.; Marin-Cevada, Vianey; Boehnke, Stefanie; Harms, Hauke; Mueller, Jochen A.; Heipieper, Hermann J.			Isolation and characterization of Magnetospirillum sp strain 15-1 as a representative anaerobic toluene-degrader from a constructed wetland model	PLOS ONE			English	Article							GROWN THAUERA-AROMATICA; PSEUDOMONAS-PUTIDA S12; DENITRIFYING BACTERIUM; ORGANIC-SOLVENTS; DESULFOCOCCUS-MULTIVORANS; GEOBACTER-SULFURREDUCENS; SP NOV.; DEGRADATION; ADAPTATION; METABOLISM	Previously, Planted Fixed-Bed Reactors (PFRs) have been used to investigate microbial toluene removal in the rhizosphere of constructed wetlands. Aerobic toluene degradation was predominant in these model systems although bulk redox conditions were hypoxic to anoxic. However, culture-independent approaches indicated also that microbes capable of anaerobic toluene degradation were abundant. Therefore, we aimed at isolating anaerobic-toluene degraders from one of these PFRs. From the obtained colonies which consisted of spirilli-shaped bacteria, a strain designated 15-1 was selected for further investigations. Analysis of its 16S rRNA gene revealed greatest similarity (99%) with toluene-degrading Magnetospirillum sp. TS-6. Isolate 15-1 grew with up to 0.5 mM of toluene under nitratereducing conditions. Cells reacted to higher concentrations of toluene by an increase in the degree of saturation of their membrane fatty acids. Strain 15-1 contained key genes for the anaerobic degradation of toluene via benzylsuccinate and subsequently the benzoyl-CoA pathway, namely bssA, encoding for the alpha subunit of benzylsuccinate synthase, bcrC for subunit C of benzoyl-CoA reductase and bamA for 6-oxocyclohex-1-ene-1-carbonyl-CoA hydrolase. Finally, most members of a clone library of bssA generated from the PFR had highest similarity to bssA from strain 15-1. Our study provides insights about the physiological capacities of a strain of Magnetospirillum isolated from a planted system where active rhizoremediation of toluene is taking place.	[Meyer-Cifuentes, Ingrid; Martinez-Lavanchy, Paula M.; Marin-Cevada, Vianey; Boehnke, Stefanie; Mueller, Jochen A.; Heipieper, Hermann J.] UFZ, Helmholtz Ctr Environm Res, Dept Environm Biotechnol, Leipzig, Germany; [Martinez-Lavanchy, Paula M.] Tech Univ Denmark, Dept Innovat & Sector Serv, Bibliometr & Data Management, Lyngby, Denmark; [Harms, Hauke] UFZ, Helmholtz Ctr Environm Res, Dept Environm Microbiol, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technical University of Denmark; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Heipieper, HJ (corresponding author), UFZ, Helmholtz Ctr Environm Res, Dept Environm Biotechnol, Leipzig, Germany.	hermann.heipieper@ufz.de	Harms, Hauke/I-4406-2012; Müller, Jochen A./T-7318-2019; Heipieper, Hermann/D-1864-2010	Harms, Hauke/0000-0002-7316-7341; Müller, Jochen A./0000-0002-0935-1523; Heipieper, Hermann/0000-0002-3723-9600; Martinez Lavanchy, Paula Maria/0000-0003-1448-0917	CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica) [72140034]	CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was funded by CONICYT (Comision Nacional de Investigacion Cientifica y Tecnologica) (http Nowt conicyt cli), Grant number 72140034. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKEMORE RP, 1979, J BACTERIOL, V140, P720, DOI 10.1128/JB.140.2.720-729.1979; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boll M, 1995, EUR J BIOCHEM, V234, P921, DOI 10.1111/j.1432-1033.1995.921_a.x; Carmona M, 2009, MICROBIOL MOL BIOL R, V73, P71, DOI 10.1128/MMBR.00021-08; Duldhardt I, 2007, APPL MICROBIOL BIOT, V77, P705, DOI 10.1007/s00253-007-1179-2; Duldhardt I, 2010, MICROB BIOTECHNOL, V3, P201, DOI 10.1111/j.1751-7915.2009.00124.x; Egland PG, 1997, P NATL ACAD SCI USA, V94, P6484, DOI 10.1073/pnas.94.12.6484; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fuchs G, 2008, ANN NY ACAD SCI, V1125, P82, DOI 10.1196/annals.1419.010; Fuchs G, 2011, NAT REV MICROBIOL, V9, P803, DOI 10.1038/nrmicro2652; Gorlenko VM, 2011, MICROBIOLOGY+, V80, P692, DOI 10.1134/S0026261711050055; Harwood CS, 1998, FEMS MICROBIOL REV, V22, P439, DOI 10.1016/S0168-6445(98)00026-6; HEIPIEPER HJ, 1994, APPL ENVIRON MICROB, V60, P4440, DOI 10.1128/AEM.60.12.4440-4444.1994; HEIPIEPER HJ, 1995, CHEMOSPHERE, V30, P1041, DOI 10.1016/0045-6535(95)00015-Z; Hutsch BW, 2002, J PLANT NUTR SOIL SC, V165, P397, DOI 10.1002/1522-2624(200208)165:4<397::AID-JPLN397>3.0.CO;2-C; Jones DL, 2009, PLANT SOIL, V321, P5, DOI 10.1007/s11104-009-9925-0; Kappelmeyer U, 2002, CHEM-ING-TECH, V73, P1218, DOI DOI 10.1002/1618-2863(20021008)2:10<311::AID-ELSC311>3.0.CO;2-9; Kawaguchi K, 2006, FEMS MICROBIOL LETT, V257, P208, DOI 10.1111/j.1574-6968.2006.00165.x; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kube M, 2004, ARCH MICROBIOL, V181, P182, DOI 10.1007/s00203-003-0627-3; Kuiper I, 2004, MOL PLANT MICROBE IN, V17, P6, DOI 10.1094/MPMI.2004.17.1.6; Kuntze K, 2008, ENVIRON MICROBIOL, V10, P1547, DOI 10.1111/j.1462-2920.2008.01570.x; Lahme S, 2012, APPL ENVIRON MICROB, V78, P1606, DOI 10.1128/AEM.06552-11; Leuthner B, 1998, MOL MICROBIOL, V28, P615, DOI 10.1046/j.1365-2958.1998.00826.x; Lu YH, 2006, ENVIRON MICROBIOL, V8, P1351, DOI 10.1111/j.1462-2920.2006.01028.x; Lunsmann V, 2016, APPL ENVIRON MICROB, V82, P4126, DOI 10.1128/AEM.00493-16; Lunsmann V, 2016, ENVIRON MICROBIOL, V18, P1176, DOI 10.1111/1462-2920.13133; Martinez-Lavanchy PM, 2015, APPL ENVIRON MICROB, V81, P6241, DOI 10.1128/AEM.01822-15; Martinez-Lavanchy PM, 2010, APPL ENVIRON MICROB, V76, P6715, DOI 10.1128/AEM.01039-10; MATSUNAGA T, 1991, APPL MICROBIOL BIOT, V35, P651; MORRISON WR, 1964, J LIPID RES, V5, P600; Parales RE, 2008, ADV APPL MICROBIOL, V64, P1, DOI 10.1016/S0065-2164(08)00401-2; Porter AW, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00302; Ramamoorthy D., 2011, Journal of Phytology, V3, P13; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J., 2001, MOL CLONING LAB MANU; SCHLEIFER KH, 1991, SYST APPL MICROBIOL, V14, P379, DOI 10.1016/S0723-2020(11)80313-9; Shinoda Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1483, DOI 10.1271/bbb.69.1483; Shinoda Y, 2000, APPL ENVIRON MICROB, V66, P1286, DOI 10.1128/AEM.66.4.1286-1291.2000; SIKKEMA J, 1995, MICROBIOL REV, V59, P201, DOI 10.1128/MMBR.59.2.201-222.1995; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thrash JC, 2010, APPL ENVIRON MICROB, V76, P4730, DOI 10.1128/AEM.00015-10; Trautwein K, 2008, APPL ENVIRON MICROB, V74, P2267, DOI 10.1128/AEM.02381-07; TSCHECH A, 1987, ARCH MICROBIOL, V148, P213, DOI 10.1007/BF00414814; Weber FJ, 1996, BBA-REV BIOMEMBRANES, V1286, P225, DOI 10.1016/S0304-4157(96)00010-X; Weelink SAB, 2010, REV ENVIRON SCI BIO, V9, P359, DOI 10.1007/s11157-010-9219-2; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Woodman ME, 2008, CURR PROTOC MICROBIO	50	8	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174750	10.1371/journal.pone.0174750	http://dx.doi.org/10.1371/journal.pone.0174750			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369150	Green Published, gold, Green Submitted			2022-12-26	WOS:000399351000041
J	Suang, S; Manaboon, M; Singtripop, T; Hiruma, K; Kaneko, Y; Tiansawat, P; Neumann, P; Chantawannakul, P				Suang, Suphawan; Manaboon, Manaporn; Singtripop, Tippawan; Hiruma, Kiyoshi; Kaneko, Yu; Tiansawat, Pimonrat; Neumann, Peter; Chantawannakul, Panuwan			Larval diapause termination in the bamboo borer, Omphisa fuscidentalis	PLOS ONE			English	Article							BIOSYNTHESIS-ACTIVATING NEUROPEPTIDE; JUVENILE-HORMONE REGULATION; BEETLE TRIBOLIUM-CASTANEUM; TRANSCRIPTION FACTOR E75; ORPHAN NUCLEAR RECEPTOR; STATUS-QUO ACTION; MANDUCA-SEXTA; BOMBYX-MORI; TOBACCO HORNWORM; GENE-EXPRESSION	In insects, juvenile hormone (JH) and 20-hydroxyecdysone (20E) regulate larval growth and molting. However, little is known about how this cooperative control is terminating larval diapause especially in the bamboo borer, Omphisa fuscidentalis. In both in vivo and in vitro experiments, we here measured the expression levels of genes which were affected by juvenile hormone analogue (JHA: S-methoprene) and 20-hydroxyecdysone (20E) in diapausing O. fuscidentalis larvae. Corresponding mRNA expression changes in the subesophageal ganglion (SG) and prothoracic gland (PG) were evaluated using qRT-PCR. The data showed similar response patterns of JH receptor gene (OfMet), diapause hormone gene (OfDH-PBAN), ecdysone receptor genes (OfEcR-A and OfEcR-B1) and ecdysone inducible genes (OfBr-C, OfE75A, OfE75B, OfE75C and OfHR3). JHA induced the expressions of OfMet and OfDH-PBAN in both SG and PG, whereas ecdysone receptor genes and ecdysone inducible genes were induced by JHA only in PG. For 20E treatment group, expressions of ecdysone receptor genes and ecdysone inducible genes in both SG and PG were increased by 20E injection. In addition, the in vitro experiments showed that OfMet and OfDH-PBAN were up-regulated by JHA alone, but ecdysone receptor genes and ecdysone inducible genes were up-regulated by JHA and 20E. However, OfMet and OfDH-PBAN in the SG was expressed faster than OfMet and OfDH-PBAN in the PG and the expression of ecdysone receptor genes and ecdysone inducible genes induced by JHA was much later than observed for 20E. These results indicate that JHA might stimulate the PG indirectly via factors (OfMet and OfDH-PBAN) in the SG, which might be a regulatory mechanism for larval diapause termination in O. fuscidentalis.	[Suang, Suphawan; Manaboon, Manaporn; Singtripop, Tippawan; Chantawannakul, Panuwan] Chiang Mai Univ, Dept Biol, Endocrinol Res Lab, Fac Sci, Chiang Mai, Thailand; [Hiruma, Kiyoshi; Kaneko, Yu] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan; [Tiansawat, Pimonrat; Neumann, Peter; Chantawannakul, Panuwan] Chiang Mai Univ, Dept Biol, Bee Protect Lab, Fac Sci, Chiang Mai, Thailand; [Neumann, Peter] Univ Bern, Inst Bee Hlth, Vetsuisse Fac, Bern, Switzerland; [Neumann, Peter] Agroscope, Swiss Bee Res Ctr, Bern, Switzerland	Chiang Mai University; Hirosaki University; Chiang Mai University; University of Bern; Swiss Federal Research Station Agroscope	Manaboon, M; Chantawannakul, P (corresponding author), Chiang Mai Univ, Dept Biol, Endocrinol Res Lab, Fac Sci, Chiang Mai, Thailand.; Chantawannakul, P (corresponding author), Chiang Mai Univ, Dept Biol, Bee Protect Lab, Fac Sci, Chiang Mai, Thailand.	m_manaboon@hotmail.com; panuwan@gmail.com	Neumann, Peter/C-9964-2015	Neumann, Peter/0000-0001-5163-5215; Tiansawat, Pimonrat/0000-0003-1354-1247	Thailand Research Fund through a Royal Golden Jubilee Ph.D. scholarship [PHD/0357/2552]; Graduate School of Chiang Mai University fellowship; Chiang Mai University fund	Thailand Research Fund through a Royal Golden Jubilee Ph.D. scholarship; Graduate School of Chiang Mai University fellowship; Chiang Mai University fund	This research was supported by the Thailand Research Fund through a Royal Golden Jubilee Ph.D. scholarship awarded to SS and PC (PHD/0357/2552) and a Graduate School of Chiang Mai University fellowship to SS. PC and PN acknowledge a Chiang Mai University fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Thailand Research Fund through a Royal Golden Jubilee Ph.D. scholarship awarded to S.S. and P.C. (PHD/0357/2552) and a Graduate School of Chiang Mai University fellowship to S.S. P.C. and P.N. acknowledge Chiang Mai University fund.	Beckstead RB, 2007, INSECT BIOCHEM MOLEC, V37, P570, DOI 10.1016/j.ibmb.2007.03.001; Bigot L, 2012, INSECT BIOCHEM MOLEC, V42, P22, DOI 10.1016/j.ibmb.2011.10.003; Davis NT, 1996, MICROSC RES TECHNIQ, V35, P201, DOI 10.1002/(SICI)1097-0029(19961015)35:3&lt;201::AID-JEMT3&gt;3.0.CO;2-Q; Denlinger D.L., 1985, P353; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Dubrovskaya VA, 2004, GENE, V340, P171, DOI 10.1016/j.gene.2004.07.022; Dubrovsky EB, 2004, DEV BIOL, V268, P258, DOI 10.1016/j.ydbio.2004.01.009; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Dubrovsky EB, 2014, ADV INSECT PHYSIOL, V46, P305, DOI 10.1016/B978-0-12-417010-0.00004-5; Eystathioy T, 2001, MECH DEVELOP, V103, P107, DOI 10.1016/S0925-4773(01)00335-5; GELMAN DB, 1992, J INSECT PHYSIOL, V38, P383, DOI 10.1016/0022-1910(92)90063-J; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; Henrich VC, 2003, INSECT BIOCHEM MOLEC, V33, P1239, DOI 10.1016/j.ibmb.2003.08.002; Herman WS, 1966, GEN CAMP ENDOCR, V7; Hiruma K, 1999, DEV GENES EVOL, V209, P18, DOI 10.1007/s004270050223; Hiruma K, 2009, INSECT BIOCHEM MOLEC, V39, P245, DOI 10.1016/j.ibmb.2009.01.008; Hossain M, 2006, FEBS J, V273, P3861, DOI 10.1111/j.1742-4658.2006.05398.x; Jindra M, 1996, DEV BIOL, V180, P258, DOI 10.1006/dbio.1996.0299; Jindra M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005394; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kaneko Y, 2011, INSECT BIOCHEM MOLEC, V41, P788, DOI 10.1016/j.ibmb.2011.05.009; Kayukawa T, 2014, DEV BIOL, V388, P48, DOI 10.1016/j.ydbio.2014.01.022; Keshan B, 2006, DEV BIOL, V295, P623, DOI 10.1016/j.ydbio.2006.03.049; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Li K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12114; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozano J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103614; MA PWK, 1994, P NATL ACAD SCI USA, V91, P6506, DOI 10.1073/pnas.91.14.6506; Matsuoka T, 2000, DEV GENES EVOL, V210, P120, DOI 10.1007/s004270050018; Minakuchi C, 2009, DEV BIOL, V325, P341, DOI 10.1016/j.ydbio.2008.10.016; Minakuchi C, 2008, MECH DEVELOP, V125, P91, DOI 10.1016/j.mod.2007.10.002; Minakuchi C, 2011, INSECT BIOCHEM MOLEC, V41, P125, DOI 10.1016/j.ibmb.2010.11.004; Nijhout H.F., 1994, INSECT HORMONES; Orth AP, 1999, MOL CELL ENDOCRINOL, V149, P61, DOI 10.1016/S0303-7207(98)00258-5; Palli SR, 1996, INSECT BIOCHEM MOLEC, V26, P485, DOI 10.1016/0965-1748(96)00004-5; Parthasarathy R, 2008, MECH DEVELOP, V125, P601, DOI 10.1016/j.mod.2008.03.004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RICHARD DS, 1987, J INSECT PHYSIOL, V33, P385, DOI 10.1016/0022-1910(87)90016-3; Riddiford LM, 1996, ARCH INSECT BIOCHEM, V32, P271, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;271::AID-ARCH2&gt;3.0.CO;2-W; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; Riddiford LM, 2012, GEN COMP ENDOCR, V179, P477, DOI 10.1016/j.ygcen.2012.06.001; Ritdachyeng E, 2012, J INSECT PHYSIOL, V58, P1493, DOI 10.1016/j.jinsphys.2012.09.002; ROUNTREE DB, 1986, J EXP BIOL, V120, P41; Ruaud AF, 2010, DEVELOPMENT, V137, P123, DOI 10.1242/dev.042036; SAFRANEK L, 1989, BIOL BULL, V177, P396, DOI 10.2307/1541599; Sekimoto T, 2006, INSECT MOL BIOL, V15, P281, DOI 10.1111/j.1365-2583.2006.00641.x; Siaussat D, 2004, EUR J BIOCHEM, V271, P3017, DOI 10.1111/j.1432-1033.2004.04233.x; Singtripop T, 2002, J INSECT PHYSIOL, V48, P817, DOI 10.1016/S0022-1910(02)00104-X; Singtripop T, 1999, ZOOL SCI, V16, P725, DOI 10.2108/zsj.16.725; Singtripop T, 2000, INSECT BIOCHEM MOLEC, V30, P847, DOI 10.1016/S0965-1748(00)00057-6; Singtripop T, 2008, J INSECT PHYSIOL, V54, P137, DOI 10.1016/j.jinsphys.2007.08.011; Suang S, 2015, PHYSIOL ENTOMOL, V40, P247, DOI 10.1111/phen.12109; Suzuki MG, 2008, MOL CELL BIOL, V28, P333, DOI 10.1128/MCB.01528-07; Swevers L, 2002, INSECT BIOCHEM MOLEC, V32, P1643, DOI 10.1016/S0965-1748(02)00104-2; Thummel CS, 1996, TRENDS GENET, V12, P306, DOI 10.1016/0168-9525(96)10032-9; Uhlirova M, 2003, P NATL ACAD SCI USA, V100, P15607, DOI 10.1073/pnas.2136837100; Wang HB, 2010, INSECT BIOCHEM MOLEC, V40, P453, DOI 10.1016/j.ibmb.2010.04.004; Watanabe K, 2007, MOL CELL ENDOCRINOL, V273, P51, DOI 10.1016/j.mce.2007.05.008; Wigglesworth V.B.S., 1954, PHYSL INSECT METAMOR; Willis DK, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.6601; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; YIN CM, 1973, J INSECT PHYSIOL, V19, P2403, DOI 10.1016/0022-1910(73)90244-8; Zhang TY, 2004, J INSECT PHYSIOL, V50, P547, DOI 10.1016/j.jinsphys.2004.03.011; Zhao JY, 2004, REGUL PEPTIDES, V118, P25, DOI 10.1016/j.regpep.2003.10.024; Zhou BH, 1998, DEV BIOL, V193, P127, DOI 10.1006/dbio.1997.8798; Zhou BH, 1998, DEV BIOL, V203, P233, DOI 10.1006/dbio.1998.9059; Zhou BH, 2001, DEV BIOL, V231, P125, DOI 10.1006/dbio.2000.0143; Zhou XF, 2002, DEVELOPMENT, V129, P2259; Zou Z, 2013, P NATL ACAD SCI USA, V110, pE2173, DOI 10.1073/pnas.1305293110	72	2	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174919	10.1371/journal.pone.0174919	http://dx.doi.org/10.1371/journal.pone.0174919			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369111	Green Published, Green Submitted, gold			2022-12-26	WOS:000399351000063
J	Beni, MS; Ng, CYP; Krstic, D; Nikezic, D; Yu, KN				Beni, Mehrdad Shahmohammadi; Ng, C. Y. P.; Krstic, D.; Nikezic, D.; Yu, K. N.			Conversion coefficients for determination of dispersed photon dose during radiotherapy: NRUrad input code for MCNP	PLOS ONE			English	Article							RADIATION-THERAPY; MONTE-CARLO; LINEAR ACCELERATORS; 6 MV; BEAM; SIMULATION; ORGANS; IMRT; RISK; ROOM	Radiotherapy is a common cancer treatment module, where a certain amount of dose will be delivered to the targeted organ. This is achieved usually by photons generated by linear accelerator units. However, radiation scattering within the patient's body and the surrounding environment will lead to dose dispersion to healthy tissues which are not targets of the primary radiation. Determination of the dispersed dose would be important for assessing the risk and biological consequences in different organs or tissues. In the present work, the concept of conversion coefficient (F) of the dispersed dose was developed, in which F = (D-d/D-t), where D-d was the dispersed dose in a non-targeted tissue and D-t is the absorbed dose in the targeted tissue. To quantify D-d and D-t, a comprehensive model was developed using the Monte Carlo N-Particle (MCNP) package to simulate the linear accelerator head, the human phantom, the treatment couch and the radiotherapy treatment room. The present work also demonstrated the feasibility and power of parallel computing through the use of the Message Passing Interface (MPI) version of MCNP5.	[Beni, Mehrdad Shahmohammadi; Ng, C. Y. P.; Nikezic, D.; Yu, K. N.] City Univ Hong Kong, Dept Phys & Mat Sci, Tat Chee Ave, Kowloon Tong, Hong Kong, Peoples R China; [Krstic, D.; Nikezic, D.] Univ Kragujevac, Fac Sci, Kragujevac, Serbia	City University of Hong Kong; University of Kragujevac	Yu, KN (corresponding author), City Univ Hong Kong, Dept Phys & Mat Sci, Tat Chee Ave, Kowloon Tong, Hong Kong, Peoples R China.	peter.yu@cityu.edu.hk	Nikezic, Dragoslav R/B-9343-2009; Beni, Mehrdad Shahmohammadi/ABA-8764-2020; Yu, Peter K.N./C-7051-2013	Yu, Peter K.N./0000-0003-1669-5348; Nikezic, Dragoslav/0000-0002-3236-4912; Krstic, Dragana/0000-0002-3517-9210	Department of Physics and Materials Science, City University of Hong Kong	Department of Physics and Materials Science, City University of Hong Kong	We acknowledge the support of the Neutron computer cluster from the Department of Physics and Materials Science, City University of Hong Kong, for the computational work involved in this paper.	[Anonymous], 1991, ANN ICRP, V21, P1; Becker J, 2007, PHYS MED BIOL, V52, P6375, DOI 10.1088/0031-9155/52/21/002; Bednarz B, 2009, PHYS MED BIOL, V54, pN43, DOI 10.1088/0031-9155/54/4/N01; Bencheikh M, 2016, MOROC J CHEM, V4, P722; Beni MS, 2016, J RADIAT RES, V57, P492, DOI 10.1093/jrr/rrw063; FRANCOIS P, 1988, MED PHYS, V15, P879, DOI 10.1118/1.596170; Garnica-Garza HM, 2005, PHYS MED BIOL, V50, P531, DOI 10.1088/0031-9155/50/3/010; Ghiasi H, 2010, IRAN J RADIAT RES, V8, P187; Goorley T., MCNP MED PHYS GEOMET; Hall EJ, 2003, INT J RADIAT ONCOL, V56, P83, DOI 10.1016/S0360-3016(03)00073-7; Howell RM, 2006, MED PHYS, V33, P360, DOI 10.1118/1.2140119; Krstic D, 2007, COMPUT PHYS COMMUN, V176, P33, DOI 10.1016/j.cpc.2006.06.016; Kry SF, 2005, INT J RADIAT ONCOL, V62, P1204, DOI 10.1016/j.ijrobp.2004.12.091; Lewis RD, 1999, PHYS MED BIOL, V44, P1219, DOI 10.1088/0031-9155/44/5/010; Maarouf M, 2005, STRAHLENTHER ONKOL, V181, P463, DOI 10.1007/s00066-005-1391-x; Mesbahi A, 2010, RADIAT PROT DOSIM, V140, P242, DOI 10.1093/rpd/ncp303; Mesbahi A, 2010, JPN J RADIOL, V28, P398, DOI 10.1007/s11604-010-0432-2; National Institute for Health and Clinical Excellence, 2005, REF SUSP CANC; NCRP, 1993, 116 NCRP; Rafi Uddin M, 2003, BANGLADESH J MED PHY, V2, P41; Reis JP, 2014, PROG NUCL ENERG, V70, P64, DOI 10.1016/j.pnucene.2013.07.013; Scottish Intercollegiate Guidelines Network, 2005, MAN PAT LUNG CANC; Seco J, 2013, MONTE CARLO TECHNIQU; Taylor ML, 2011, J MED PHYS, V36, P59, DOI 10.4103/0971-6203.79686; Van Dyk J, 1986, PHYS ASPECT TOTAL HA; vanderGiessen PH, 1996, INT J RADIAT ONCOL, V35, P399, DOI 10.1016/0360-3016(96)00083-1; Verhaegen F, 2003, PHYS MED BIOL, V48, pR107, DOI 10.1088/0031-9155/48/21/R01; X-5 Monte Carlo Team, 2000, LAUR031987, VI, P3; Xu XG, 2008, PHYS MED BIOL, V53, pR193, DOI 10.1088/0031-9155/53/13/R01; Zabihinpoor S., 2011, ADV STUDIES THEOR PH, V5, P421	30	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174836	10.1371/journal.pone.0174836	http://dx.doi.org/10.1371/journal.pone.0174836			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362837	Green Published, Green Submitted, gold			2022-12-26	WOS:000399175000041
J	Min, M; Chen, XB; Wang, P; Landeck, L; Chen, JQ; Li, W; Cai, SQ; Zheng, M; Man, XY				Min, Min; Chen, Xi-Bei; Wang, Ping; Landeck, Lilla; Chen, Jia-Qi; Li, Wei; Cai, Sui-Qing; Zheng, Min; Man, Xiao-Yong			Role of keratin 24 in human epidermal keratinocytes	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN ORAL KERATINOCYTES; KINASE-C-DELTA; PKC-DELTA; CANCER-CELLS; MICROTUBULE CYTOSKELETON; INDUCED APOPTOSIS; HUMAN-SKIN; DIFFERENTIATION; AUTOPHAGY	Keratin 24 (K24) is a new kind of keratin genes, which encodes a novel keratin protein, K24 that bears high similarity to the type I keratins and displays a unique expression profile. However, the role of K24 is incompletely understood. In our study, we investigated the localization of K24 within the epidermis and possible functions. Keratin 24 was found to be modestly overexpressed in senescent keratinocytes and was mainly restricted to the upper stratum spinosum of epidermis. The protein was required for terminal differentiation upon CaCl2-induced differentiation. In vitro results showed that increased K24 in keratinocytes dramatically changed the differentiation of primary keratinocytes. It also inhibited cell survival by G1/S phase cell cycle arrest and induced senescence, autophagy and apoptosis of keratinocytes. In addition, K24 activated PKC delta signal pathway involving in cellular survival. In summary, K24 may be suggested as a potential differentiation marker and anti-proliferative factor in the epidermis.	[Min, Min; Chen, Xi-Bei; Wang, Ping; Chen, Jia-Qi; Li, Wei; Cai, Sui-Qing; Zheng, Min; Man, Xiao-Yong] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Dermatol, Hangzhou, Zhejiang, Peoples R China; [Landeck, Lilla] Humboldt Univ, Teaching Hosp Charite, Ernst von Bergmann Gen Hosp, Potsdam, Germany	Zhejiang University; Humboldt University of Berlin; Klinikum Ernst von Bergmann	Zheng, M; Man, XY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Dermatol, Hangzhou, Zhejiang, Peoples R China.	minz@zju.edu.cn; manxy@zju.edu.cn			National Natural Science Foundation of China (NSFC) [81371740, 81371741, 81573039, 91542124]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research was supported by the grants from the National Natural Science Foundation of China (NSFC) (81371740, 81371741, 81573039 and 91542124).	Aymard E, 2011, EXP DERMATOL, V20, P263, DOI 10.1111/j.1600-0625.2010.01157.x; Balasubramanian S, 2007, TOXICOL APPL PHARM, V224, P214, DOI 10.1016/j.taap.2007.03.020; Barrette K, 2014, BRIT J DERMATOL, V171, P1014, DOI 10.1111/bjd.12967; Bowles DK, 2007, AM J PHYSIOL-CELL PH, V293, pC805, DOI 10.1152/ajpcell.00127.2007; Chen JL, 2009, AUTOPHAGY, V5, P244, DOI 10.4161/auto.5.2.7549; Cross T, 2000, ONCOGENE, V19, P2331, DOI 10.1038/sj.onc.1203555; Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919; DiTommaso T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004706; Fortier AM, 2013, J BIOL CHEM, V288, P11555, DOI 10.1074/jbc.M112.428920; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Ghosh M, 2011, AM J RESP CELL MOL, V45, P403, DOI 10.1165/rcmb.2010-0283OC; Gosselin K, 2009, AM J PATHOL, V174, P423, DOI 10.2353/ajpath.2009.080332; Graczyk A, 2014, INT J BIOCHEM CELL B, V57, P135, DOI 10.1016/j.biocel.2014.10.007; Halder K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091656; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Hong Y, 2007, CLIN CANCER RES, V13, P1107, DOI 10.1158/1078-0432.CCR-06-1633; Jang DH, 2015, J GERONTOL A-BIOL, V70, P20, DOI 10.1093/gerona/glt212; Kim RH, 2010, EXP CELL RES, V316, P2600, DOI 10.1016/j.yexcr.2010.04.013; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Kraft CA, 2007, ARCH DERMATOL RES, V299, P71, DOI 10.1007/s00403-006-0727-4; Kumar V, 2015, J CELL BIOL, V211, P1057, DOI 10.1083/jcb.201404147; Kumari S, 2015, CURRENT TOPICS MICRO; Lopez BJ, 2015, BBA-MOL CELL RES, V1853, P3015, DOI 10.1016/j.bbamcr.2015.07.016; Man XY, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150032; Man XY, 2013, CELL MOL LIFE SCI, V70, P2205, DOI 10.1007/s00018-012-1255-3; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marshall WF, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-101; Martinez LA, 1999, ONCOGENE, V18, P397, DOI 10.1038/sj.onc.1202300; Missero C, 1996, GENE DEV, V10, P3065, DOI 10.1101/gad.10.23.3065; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; MURPHY GF, 1984, J INVEST DERMATOL, V82, P453, DOI 10.1111/1523-1747.ep12260945; Nieto-Miguel T, 2011, MOL VIS, V17, P2102; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Shi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054355; Shirai Y, 2011, MOL BIOL CELL, V22, P1340, DOI 10.1091/mbc.E10-09-0754; Sprecher E, 2002, J INVEST DERMATOL, V119, P692, DOI 10.1046/j.1523-1747.2002.01855.x; Sukhorukov VM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13924; Titushkin I, 2009, BIOPHYS J, V96, P717, DOI 10.1016/j.bpj.2008.09.035; Tsai PC, 2016, TISSUE ENG PT A, V22, P111, DOI [10.1089/ten.tea.2015.0209, 10.1089/ten.TEA.2015.0209]; Vasconcelos A, 2013, CURR DRUG TARGETS, V14, P612, DOI 10.2174/1389450111314050010; Vitale N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080728; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang RC, 2011, J INVEST DERMATOL, V131, P990, DOI 10.1038/jid.2010.423; Wu N, 2014, CELL MOL LIFE SCI, V71, P4697, DOI 10.1007/s00018-014-1758-1; Yin SP, 2010, J CELL BIOCHEM, V111, P979, DOI 10.1002/jcb.22786; Yoshihara N, 2015, ARCH DERMATOL RES, V307, P159, DOI 10.1007/s00403-014-1508-0; Zhang J, 2016, TUMOR BIOL, V37, P5847, DOI 10.1007/s13277-015-4405-z; Zhang JS, 2001, GENE CHROMOSOME CANC, V30, P123, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1070>3.0.CO;2-W	50	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174626	10.1371/journal.pone.0174626	http://dx.doi.org/10.1371/journal.pone.0174626			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362807	gold, Green Published, Green Submitted			2022-12-26	WOS:000399175000024
J	Schibilsky, D; Haller, C; Lange, B; Schibilsky, B; Haeberle, H; Seizer, P; Gawaz, M; Rosenberger, P; Walker, T; Schlensak, C				Schibilsky, David; Haller, Christoph; Lange, Bruno; Schibilsky, Barbara; Haeberle, Helene; Seizer, Peter; Gawaz, Meinrad; Rosenberger, Peter; Walker, Tobias; Schlensak, Christian			Extracorporeal life support prior to left ventricular assist device implantation leads to improvement of the patients INTERMACS levels and outcome	PLOS ONE			English	Article							RISK SCORE; FAILURE; NEED	Background The objective of this study was to evaluate the outcome of left ventricular assist device (LVAD) implantation after initial extracorporeal life support (ECLS) in patients with cardiogenic shock and the incidence of post implantation right ventricular failure. Methods & results All patients on ECLS therapy for cardiogenic shock prior to LVAD implantation (n = 15) between October 2011 and January 2014 were analyzed. Baseline patient characteristics, as well as detailed pre-operative treatment and postoperative outcome data were collected retrospectively. At time of admission to our unit all patients were classified INTERMACS II or higher (12 [80%] INTERMACS I). Improvement to INTERMACS III temporary cardiac support (TCS) at time of LVAD implantation was successful in 14 patients (93.3%). End organ function recovered during ECLS support. No patient needed ongoing ECLS or additional right ventricular support after LVAD implantation. Both in-hospital and 30-day mortality was 6.7% (n = 1). The median duration of LVAD support was 687.9 +/- 374.5 days. At the end of the study (follow-up 810.7 +/- 338.9 days), 13 (86.7%) patients were alive. The majority of patients (10 [66.7%]) remained on LVAD support. Transplantation could be performed in 1 (6.7%) patient, 2 (13.3%) patients could be successfully weaned. Conclusion LVAD implantation in ECLS patients leads to improvement of INTERMACS level to INTER MACS III TCS status. Excellent mid-term survival comparable to true INTERMACS III-IV patients could be shown. ECLS prior to LVAD as a bridge-to-bridge therapy may help to lower mortality in primarily unstable patients.	[Schibilsky, David; Haller, Christoph; Lange, Bruno; Schibilsky, Barbara; Walker, Tobias; Schlensak, Christian] Univ Med Ctr Tuebingen, Dept Thorac & Cardiovasc Surg, Tubingen, Germany; [Haeberle, Helene; Rosenberger, Peter] Univ Med Ctr Tuebingen, Dept Anesthesiol & Intens Care Med, Tubingen, Germany; [Seizer, Peter; Gawaz, Meinrad] Univ Med Ctr Tuebingen, Dept Cardiol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Haller, C (corresponding author), Univ Med Ctr Tuebingen, Dept Thorac & Cardiovasc Surg, Tubingen, Germany.	christophmhaller@gmail.com	Schibilsky, David/AAM-2187-2020	Schibilsky, David/0000-0002-7597-7778				Abdeen MSKM, 2016, EUR J CARDIO-THORAC, V50, P542, DOI 10.1093/ejcts/ezw073; Bhama JK, 2009, J HEART LUNG TRANSPL, V28, P971, DOI 10.1016/j.healun.2009.04.015; Boyle AJ, 2011, J HEART LUNG TRANSPL, V30, P402, DOI 10.1016/j.healun.2010.10.016; Fitzpatrick JR, 2008, J HEART LUNG TRANSPL, V27, P1286, DOI 10.1016/j.healun.2008.09.006; Lahpor J, 2010, EUR J CARDIO-THORAC, V37, P357, DOI 10.1016/j.ejcts.2009.05.043; Lebreton G, 2011, EUR J CARDIO-THORAC, V40, pE165, DOI 10.1016/j.ejcts.2011.06.012; Matthews JC, 2008, J AM COLL CARDIOL, V51, P2163, DOI 10.1016/j.jacc.2008.03.009; Mohite PN, 2013, EUROPEAN J CARDIOTHO; Morgan JA, 2004, ANN THORAC SURG, V77, P859, DOI 10.1016/j.athoracsur.2003.09.048; Riebandt J, 2014, EUROPEAN J CARDIOTHO; Schaffer JM, 2009, ANN THORAC SURG, V88, P1889, DOI 10.1016/j.athoracsur.2009.08.011; Scherer M, 2011, EUR J CARDIO-THORAC, V39, P939, DOI 10.1016/j.ejcts.2010.09.044; Stepanenko A, 2010, J HEART LUNG TRANSPL, V29, P61, DOI 10.1016/j.healun.2009.10.008; Struber M, 2008, EUR J CARDIO-THORAC, V34, P289, DOI 10.1016/j.ejcts.2008.05.011; Tsiouris A, 2014, ASAIO J, P1; Zahr F, 2008, J CARD FAIL, V14, P844, DOI 10.1016/j.cardfail.2008.08.009	16	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174262	10.1371/journal.pone.0174262	http://dx.doi.org/10.1371/journal.pone.0174262			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358849	gold, Green Submitted, Green Published			2022-12-26	WOS:000399174800026
J	Bomblies, R; Luitz, MP; Scanu, S; Madl, T; Zacharias, M				Bomblies, Rainer; Luitz, Manuel Patrick; Scanu, Sandra; Madl, Tobias; Zacharias, Martin			Transient helicity in intrinsically disordered Axin-1 studied by NMR spectroscopy and molecular dynamics simulations	PLOS ONE			English	Article							BETA-CATENIN; UNSTRUCTURED PROTEINS; STRUCTURAL BASIS; HUMAN-DISEASES; FORCE-FIELDS; ASSOCIATION; WATER; ENSEMBLES; PATHWAY; REGIONS	Many natural proteins are, as a whole or in part, intrinsically disordered. Frequently, such intrinsically disordered regions (IDRs) undergo a transition to a defined and often helical conformation upon binding to partner molecules. The intrinsic propensity of an IDR sequence to fold into a helical conformation already in the absence of a binding partner can have a decisive influence on the binding process and affinity. Using a combination of NMR spectroscopy and molecular dynamics (MD) simulations we have investigated the tendency of regions of Axin-1, an intrinsically disordered scaffolding protein of the WNT signaling pathway, to form helices in segments interacting with binding partners. Secondary chemical shifts from NMR measurements show an increased helical population in these regions. Systematic application of MD advanced sampling approaches on peptide segments of Axin-1 reproduces the experimentally observed tendency and allows insights into the distribution of segment conformations and free energies of helix formation. The results, however, were found to dependent on the force field water model. Recent water models specifically designed for IDRs significantly reduce the predicted helical content and do not improve the agreement with experiment.	[Bomblies, Rainer; Luitz, Manuel Patrick; Zacharias, Martin] Tech Univ Munich, Phys Dept, Garching, Germany; [Scanu, Sandra] Tech Univ Munich, Dept Chem, Garching, Germany; [Madl, Tobias] Helmholtz Zentrum Munchen, Inst Struct Biol, Neuherberg, Germany; [Madl, Tobias] Med Univ Graz, Inst Mol Biol & Biochem, Ctr Mol Med, Graz, Austria	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Medical University of Graz	Zacharias, M (corresponding author), Tech Univ Munich, Phys Dept, Garching, Germany.	martin.zacharias@ph.tum.de	Madl, Tobias/B-1682-2012	Madl, Tobias/0000-0002-9725-5231	Deutsche Forschungsgemeinschaft [DFG/SFB1035]; LRZ supercomputer center (Leibniz Rechenzentrum)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LRZ supercomputer center (Leibniz Rechenzentrum)	The authors thank the Deutsche Forschungsgemeinschaft (DFG/SFB1035 project B02) for financial support. This work was also supported by the LRZ supercomputer center (Leibniz Rechenzentrum) through grant pr48po. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Best RB, 2014, J CHEM THEORY COMPUT, V10, P5113, DOI 10.1021/ct500569b; Best RB, 2009, J PHYS CHEM B, V113, P9004, DOI 10.1021/jp901540t; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dunker AK, 2008, NAT CHEM BIOL, V4, P229, DOI 10.1038/nchembio0408-229; Fisher CK, 2011, CURR OPIN STRUC BIOL, V21, P426, DOI 10.1016/j.sbi.2011.04.001; Fogh Rasmus, 2002, Nature Structural Biology, V9, P416, DOI 10.1038/nsb0602-416; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Noutsou M, 2011, J MOL BIOL, V405, P773, DOI 10.1016/j.jmb.2010.11.013; Pancsa R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034687; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Petrov D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003638; Piana S, 2015, J PHYS CHEM B, V119, P5113, DOI 10.1021/jp508971m; Rauscher S, 2015, J CHEM THEORY COMPUT, V11, P5513, DOI 10.1021/acs.jctc.5b00736; Rauscher S, 2010, BIOCHEM CELL BIOL, V88, P269, DOI [10.1139/O09-169, 10.1139/o09-169]; Romero P, 1998, Pac Symp Biocomput, P437; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Schrodinger L. L. C., 2015, THE PYMOL MOLECULAR; Spink KE, 2000, EMBO J, V19, P2270, DOI 10.1093/emboj/19.10.2270; Stamos JL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a007898; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Tamiola K, 2012, BIOCHEM SOC T, V40, P1014, DOI 10.1042/BST20120171; Theillet FX, 2014, CHEM REV, V114, P6661, DOI 10.1021/cr400695p; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2014, CHEM REV, V114, P6844, DOI 10.1021/cr400713r; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Xing Y, 2003, GENE DEV, V17, P2753, DOI 10.1101/gad.1142603; Xue B, 2012, J BIOMOL STRUCT DYN, V29, P843, DOI 10.1080/073911012010525024; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	49	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174337	10.1371/journal.pone.0174337	http://dx.doi.org/10.1371/journal.pone.0174337			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355271	Green Published, gold			2022-12-26	WOS:000399174600044
J	Chan, SCY; Karczmarski, L				Chan, Stephen C. Y.; Karczmarski, Leszek			Indo-Pacific humpback dolphins (Sousa chinensis) in Hong Kong: Modelling demographic parameters with markrecapture techniques	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; PEARL RIVER ESTUARY; CAPTURE-RECAPTURE DATA; ALGOA BAY-REGION; POPULATION-DYNAMICS; TEMPORARY EMIGRATION; SEASONAL-VARIATIONS; CONSERVATION STATUS; AUSTRALIAN SNUBFIN; HECTORS DOLPHIN	Indo-Pacific humpback dolphins (Sousa chinensis) inhabiting Hong Kong waters are thought to be among the world's most anthropogenically impacted coastal delphinids. We have conducted a 5-year (2010-2014) photo-ID study and performed the first in this region comprehensive mark-recapture analysis applying a suite of open population models and robust design models. Cormack-Jolly-Seber (CJS) models suggested a significant transient effect and seasonal variation in apparent survival probabilities as result of a fluid movement beyond the study area. Given the spatial restrictions of our study, limited by an administrative border, if emigration was to be considered negligible the estimated survival rate of adults was 0.980. Super-population estimates indicated that at least 368 dolphins used Hong Kong waters as part of their range. Closed robust design models suggested an influx of dolphins from winter to summer and increased site fidelity in summer; and outflux, although less prominent, during summer-winter intervals. Abundance estimates in summer (N = 144-231) were higher than that in winter (N = 87-111), corresponding to the availability of prey resources which in Hong Kong waters peaks during summer months. We point out that the current population monitoring strategy used by the Hong Kong authorities is ill-suited for a timely detection of a population change and should be revised.	[Chan, Stephen C. Y.; Karczmarski, Leszek] Univ Hong Kong, Swire Inst Marine Sci & Sch Biol Sci, Fac Sci, Cape Daguilar, Shek O, Peoples R China	University of Hong Kong	Karczmarski, L (corresponding author), Univ Hong Kong, Swire Inst Marine Sci & Sch Biol Sci, Fac Sci, Cape Daguilar, Shek O, Peoples R China.	leszek@hku.hk	Chan, Stephen C.Y./AAE-2740-2020; Karczmarski, Leszek/D-3166-2009	Chan, Stephen C.Y./0000-0002-0157-9574; Karczmarski, Leszek/0000-0001-9712-1172	Research Grants Council (RGC) of Hong Kong [HKU768110M, HKU768913M]; Professorial Sponsorship Programme from Ocean Park Conservation Foundation Hong Kong (OPCFHK); OPCFHK [MM01_1415]	Research Grants Council (RGC) of Hong Kong(Hong Kong Research Grants Council); Professorial Sponsorship Programme from Ocean Park Conservation Foundation Hong Kong (OPCFHK); OPCFHK	LK received research funding (General Research Fund HKU768110M and HKU768913M) from Research Grants Council (RGC) of Hong Kong (http://www.ugc.edu.hk/eng/rgc/), and support under Professorial Sponsorship Programme from Ocean Park Conservation Foundation Hong Kong (OPCFHK) (www.opcf.org.hk). SCYC received research grant (MM01_1415) from OPCFHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFCD HKSAR, 2010, REP COMM SUST FISH; AFCD HKSAR, 2015, HONG KONG MAR FISH D; AFCD HKSAR, 2006, LAT STAT PORT SURV 2; Akcakaya H. Resit, 2000, Ecological Bulletins, V48, P9; [Anonymous], 2014, EIA223; Ansmann IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065239; ARUP, 2009, HONG KONG ZHUH MAC B; Barros Nelio B., 2004, Aquatic Mammals, V30, P179, DOI 10.1578/AM.30.1.2004.179; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Burnham K.P., 1987, American Fisheries Society Monograph, P1; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cagnazzi DD, 2011, MAR MAMMAL SCI, V27, P255, DOI 10.1111/j.1748-7692.2009.00296.x; Cantor M, 2012, MAR MAMMAL SCI, V28, P63, DOI 10.1111/j.1748-7692.2010.00456.x; Caswell, 2000, MATRIX POPULATION MO; Chang WL, 2016, REG STUD MAR SCI, V8, P459, DOI 10.1016/j.rsma.2016.08.001; Chen BY, 2016, ADV MAR BIOL, V73, P119, DOI 10.1016/bs.amb.2015.10.001; Chen BY, 2009, INTEGR ZOOL, V4, P240, DOI 10.1111/j.1749-4877.2009.00160.x; Chen T, 2010, MAMMALIA, V74, P117, DOI 10.1515/MAMM.2010.024; Choquet R, 2009, ECOGRAPHY, V32, P1071, DOI 10.1111/j.1600-0587.2009.05968.x; Christensen V, 1998, ECOL APPL, V8, pS104, DOI 10.2307/2641367; CORMACK RM, 1964, BIOMETRIKA, V51, P429, DOI 10.1093/biomet/51.3-4.429; Currey RJC, 2011, MAR MAMMAL SCI, V27, P554, DOI 10.1111/j.1748-7692.2010.00417.x; Currey RJC, 2009, AQUAT CONSERV, V19, P658, DOI 10.1002/aqc.1015; Dong LX, 2006, ENVIRONMENT IN ASIA PACIFIC HARBOURS, P127, DOI 10.1007/1-4020-3655-8_9; ERM, 1998, FISH RES FISH OP HON; Ferster B, 2010, J INSECT CONSERV, V14, P31, DOI 10.1007/s10841-009-9222-5; Friday N, 2000, MAR MAMMAL SCI, V16, P355, DOI 10.1111/j.1748-7692.2000.tb00930.x; Fury CA, 2011, ESTUAR COAST SHELF S, V93, P389, DOI 10.1016/j.ecss.2011.05.003; Gailey G., 2012, DISCOVERY PHOTO IDEN; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; Gordon, 2008, DECADE MANAGEMENT PL; Gowans S, 2008, ADV MAR BIOL, V53, P195, DOI 10.1016/S0065-2881(07)53003-8; Grange S, 2015, POPUL ECOL, V57, P201, DOI 10.1007/s10144-014-0469-7; Gui D, 2017, ENVIRON SCI TECHNOL, V51, P1848, DOI 10.1021/acs.est.6b05566; Gui D, 2014, CHEMOSPHERE, V114, P106, DOI 10.1016/j.chemosphere.2014.04.028; Guissamulo Almeida, 2004, Aquatic Mammals, V30, P94, DOI 10.1578/AM.30.1.2004.94; Hammond P. S., 1990, REPORT INT WHALING C; Harrison PJ, 2008, CONT SHELF RES, V28, P1405, DOI 10.1016/j.csr.2007.02.011; Henderson SD, 2014, MAR MAMMAL SCI, V30, P1067, DOI 10.1111/mms.12109; Holmes EE, 2003, CONSERV BIOL, V17, P1794, DOI 10.1111/j.1523-1739.2003.00191.x; Hoyt E, 2012, DOLPHINS PORPOISES W; Huang S-L., 2014, PRIMATES CETACEANS F, P249, DOI [10.1007/978-4-431-54523-1_13, DOI 10.1007/978-4-431-54523-1_13]; Huang SL, 2014, ENDANGER SPECIES RES, V26, P147, DOI 10.3354/esr00619; Huang SL, 2012, BIOL CONSERV, V147, P234, DOI 10.1016/j.biocon.2012.01.004; Hung K, 2008, THESIS; Hung S. K., 2014, MONITORING MAR UNPUB; Hung Samuel K., 2004, Aquatic Mammals, V30, P159, DOI 10.1578/AM.30.1.2004.159; Hung SKY, 2015, MONITORING MAR UNPUB; James BS, 2015, AFR J MAR SCI, V37, P383, DOI 10.2989/1814232X.2015.1083477; Jefferson TA, 2000, WILDLIFE MONOGR, P1; Jefferson TA, 2005, MONITORING IND UNPUB; Jefferson TA, 2007, MONITORING CHI UNPUB; Jefferson TA, 2011, MAMMALIAN SPECIES, V655, P1; Jefferson Thomas A., 2006, Journal of Cetacean Research and Management, V8, P181; Jefferson Thomas A., 2004, Aquatic Mammals, V30, P149, DOI 10.1578/AM.30.1.2004.149; Jefferson TA, 2016, ADV MAR BIOL, V73, P1, DOI 10.1016/bs.amb.2015.04.002; Jefferson TA, 2014, MAR MAMMAL SCI, V30, P1494, DOI 10.1111/mms.12152; Jefferson TA, 2012, MAR MAMMAL SCI, V28, P84, DOI 10.1111/j.1748-7692.2010.00462.x; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Kaiya Zhou, 1995, Asian Marine Biology, V12, P119; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Karczmarski L, 2000, MAR MAMMAL SCI, V16, P65, DOI 10.1111/j.1748-7692.2000.tb00904.x; Karczmarski L, 1999, J ZOOL, V249, P283, DOI 10.1017/S0952836999009978; Karczmarski L, 2005, BEHAV ECOL, V16, P675, DOI 10.1093/beheco/ari028; Karczmarski L, 1999, MAR MAMMAL SCI, V15, P1115, DOI 10.1111/j.1748-7692.1999.tb00880.x; Karczmarski L, 1999, S AFR J MARINE SCI, V21, P89; Karczmarski L., 1996, THESIS; Karczmarski L, 2014, INDOPACIFIC HUMPBACK; Karczmarski L, 2017, CHINESE WHITE DOLPHI; Karczmarski L, 2017, ESTUAR COAST, V40, P594, DOI 10.1007/s12237-016-0146-5; Karczmarski L, 2017, SCI REP-UK, V7, DOI 10.1038/srep42900; Karczmarski L, 2016, ADV MAR BIOL, V73, P27, DOI 10.1016/bs.amb.2015.09.003; Keith M, 2002, S AFR J WILDL RES, V32, P153; Kendall WL, 1997, ECOLOGY, V78, P563; KENDALL WL, 1995, BIOMETRICS, V51, P293, DOI 10.2307/2533335; Kendall WL, 1995, J APPL STAT, V22, P751, DOI 10.1080/02664769524595; Kendall WL, 1999, ECOLOGY, V80, P2517, DOI 10.1890/0012-9658(1999)080[2517:ROCCRM]2.0.CO;2; Lam JCW, 2009, ENVIRON SCI TECHNOL, V43, P6944, DOI 10.1021/es901408t; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lin TH, 2015, ESTUAR COAST, V38, P1376, DOI 10.1007/s12237-014-9886-2; Mak KY, 2015, INT C BIOD EC CONS M; Monk MH, 2011, POPUL ECOL, V53, P165, DOI 10.1007/s10144-010-0205-x; Morris W. F., 2002, QUANTITATIVE CONSERV; MORTON B, 1989, MAR POLLUT BULL, V20, P310, DOI 10.1016/0025-326X(89)90153-7; Morton B, 2011, MAR POLLUT BULL, V62, P1153, DOI 10.1016/j.marpolbul.2010.12.001; Neumann DR, 2001, NEW ZEAL J MAR FRESH, V35, P371, DOI 10.1080/00288330.2001.9517007; Or C.K.M., 2016, THESIS; Palmer C, 2014, WILDLIFE RES, V41, P35, DOI 10.1071/WR14031; Parra GJ, 2006, BIOL CONSERV, V129, P167, DOI 10.1016/j.biocon.2005.10.031; Parra GJ, 2006, ECOGRAPHY, V29, P396; Pitcher TJ, 1998, FISHERIES CTR RES RE, V6; POLLOCK KH, 1982, J WILDLIFE MANAGE, V46, P752, DOI 10.2307/3808568; Pradel R, 1997, BIOMETRICS, V53, P60, DOI 10.2307/2533097; Rayment W, 2010, AQUAT CONSERV, V20, P106, DOI 10.1002/aqc.1049; Reeves RR, 2008, IUCN 2010 RED LIST T; Reeves RR, 2008, IUCN 2008 RED LIST T; Reisinger RR, 2010, MAR MAMMAL SCI, V26, P86, DOI 10.1111/j.1748-7692.2009.00324.x; Ross PS, 2010, AQUAT CONSERV, V20, P685, DOI 10.1002/aqc.1141; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; Schwarz CJ, 1999, STAT SCI, V14, P427; SEBER GAF, 1965, BIOMETRIKA, V52, P249; Silva MA, 2009, MAR ECOL PROG SER, V392, P263, DOI 10.3354/meps08233; Slooten E, 2000, CONSERV BIOL, V14, P1264, DOI 10.1046/j.1523-1739.2000.00099-411.x; Slooten E, 2013, ENDANGER SPECIES RES, V22, P99, DOI 10.3354/esr00518; Smith HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076574; Speakman Todd R., 2010, Journal of Cetacean Research and Management, V11, P153; Stensland E, 2006, MAR MAMMAL SCI, V22, P667, DOI 10.1111/j.1748-7692.2006.00051.x; Strauss MKL, 2015, POPUL ECOL, V57, P505, DOI 10.1007/s10144-015-0499-9; Tam YK, 2013, ICES J MAR SCI, V70, P1206, DOI 10.1093/icesjms/fst046; Urian K, 2015, MAR MAMMAL SCI, V31, P298, DOI 10.1111/mms.12141; Wang JY, 2012, B MAR SCI, V88, P885, DOI 10.5343/bms.2010.1097; [王先艳 Wang Xianyan], 2012, [台湾海峡, Journal of Oceanography in Taiwan Strait], V31, P225; Wedekin LL., 2007, Braz. J. Biol., V67, P1, DOI 10.1590/S1519-69842007000100002; Weir CR, 2015, ADV MAR BIOL, V72, P79, DOI 10.1016/bs.amb.2015.08.001; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Whitehead H, 2001, ECOLOGY, V82, P1417, DOI 10.1890/0012-9658(2001)082[1417:AOAMUO]2.0.CO;2; Whitehead H, 2007, COMMUN STAT-SIMUL C, V36, P1233, DOI 10.1080/03610910701569531; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Wilson B, 1997, J APPL ECOL, V34, P1365, DOI 10.2307/2405254; Wong CWM, 2017, ENV SCI TECHNOL; Xu XR, 2015, SCI REP-UK, V5, DOI 10.1038/srep08147; Yin KD, 2002, MAR ECOL PROG SER, V245, P111, DOI 10.3354/meps245111; YORK AE, 1994, MAR MAMMAL SCI, V10, P38, DOI 10.1111/j.1748-7692.1994.tb00388.x; Zheng RQ, 2016, J ETHOL, V34, P299, DOI 10.1007/s10164-016-0475-7; Zhou KY, 2007, NEW ZEAL J ZOOL, V34, P35, DOI 10.1080/03014220709510061	126	31	32	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174029	10.1371/journal.pone.0174029	http://dx.doi.org/10.1371/journal.pone.0174029			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355228	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174600033
J	Wang, YC; Chou, CT; Lin, CP; Chen, YL; Chen, YF; Chen, RC				Wang, Yi-Chun; Chou, Chen-Te; Lin, Ching-Po; Chen, Yao-Li; Chen, Yung-Fang; Chen, Ran-Chou			The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; HEPATOBILIARY-PHASE; DYSPLASTIC NODULES; HISTOLOGIC GRADE; TUMOR SIZE; BENIGN; MDCT	Purpose To evaluate the utility of Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) in characterizing atypically enhanced cirrhotic nodules detected on conventional Gd-DTPAenhanced MR images. Materials and methods We enrolled 61 consecutive patients with 88 atypical nodules seen on conventional GdDTPA- enhanced MR images who underwent Gd-EOB-DTPA-enhanced MRI within a 3month period. Using a reference standard, we determined that 58 of the nodules were hepatocellular carcinoma (HCC) and 30 were dysplastic nodules (DNs). Tumor size, signal intensity on precontrast T1-weighted images (T1WI), T2-weighted images (T2WI) and diffusion-weighted images (DWI), and the enhancement patterns seen on dynamic phase and hepatocyte phase images were determined. Results There were significant differences between DNs and HCC in hyperintensity on T2WI, hypointensity on T1WI, hypervascularity on arterial phase images, typical HCC enhancement patterns on dynamic MR images, hypointensity on hepatocyte phase images, and hyperintensity on DWI. The sensitivity and specificity were 79.3% and 83.3% for T2WI, 50.0% and 80.0% for T1WI, 82.8% and 76.7% for DWI, 17.2% and 100% for dynamic MR imaging, 93.1% and 83.3% for hepatocyte phase imaging, and 46.8% and 100% when arterial hypervascularity was combined with hypointensity on hepatocyte-phase imaging. Conclusion Gd-EOB-DTPA-enhanced hepatocyte phase imaging is recommended for patients at high risk for HCC who present with atypical lesions on conventional Gd-DTPA-enhanced MR images.	[Wang, Yi-Chun; Chou, Chen-Te; Lin, Ching-Po; Chen, Ran-Chou] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan; [Wang, Yi-Chun] China Med Univ Hosp, Dept Radiol, Taichung, Taiwan; [Chou, Chen-Te; Chen, Yung-Fang] Changhua Christian Hosp, Dept Radiol, Changhua, Taiwan; [Chou, Chen-Te; Chen, Yao-Li] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan; [Chen, Yao-Li] Changhua Christian Hosp, Dept Surg, Changhua, Taiwan; [Chen, Ran-Chou] Minist Hlth & Welf, Hlth Promot Adm, Taipei, Taiwan	National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Changhua Christian Hospital; Kaohsiung Medical University; Changhua Christian Hospital	Chen, RC (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan.; Chen, RC (corresponding author), Minist Hlth & Welf, Hlth Promot Adm, Taipei, Taiwan.	chenranchou@yahoo.com.tw						Borzio M, 2003, J HEPATOL, V39, P208, DOI 10.1016/S0168-8278(03)00190-9; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chou CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107869; EGUCHI A, 1992, HEPATOLOGY, V15, P843, DOI 10.1002/hep.1840150516; Frericks BB, 2009, AM J ROENTGENOL, V193, P1053, DOI 10.2214/AJR.08.1946; Golfieri R, 2012, J MAGN RESON IMAGING, V36, P648, DOI 10.1002/jmri.23685; Haimerl M, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-41; Huang B, 2016, RADIOLOGY, V281, P150, DOI 10.1148/radiol.2016151205; Huppertz A, 2004, RADIOLOGY, V230, P266, DOI 10.1148/radiol.2301020269; Hussain SM, 2002, RADIOGRAPHICS, V22, P1023, DOI 10.1148/radiographics.22.5.g02se061023; Hwang J, 2015, RADIOLOGY, V276, P137, DOI 10.1148/radiol.15141350; Hyodo T, 2013, RADIOLOGY, V266, P480, DOI 10.1148/radiol.12112677; KENMOCHI K, 1987, LIVER, V7, P18; Kim HS, 2015, EUR J RADIOL, V84, P555, DOI 10.1016/j.ejrad.2014.12.023; Kim SH, 2009, AM J ROENTGENOL, V192, P1675, DOI 10.2214/AJR.08.1262; Kobayashi M, 2006, CANCER-AM CANCER SOC, V106, P636, DOI 10.1002/cncr.21607; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Kudo Masatoshi, 2008, Oncology, V75 Suppl 1, P1, DOI 10.1159/000181865; Lee MH, 2011, AM J ROENTGENOL, V197, pW868, DOI 10.2214/AJR.10.6237; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Ouedraogo W, 2011, J RADIOL, V92, P688, DOI 10.1016/j.jradio.2011.03.020; Pawlik TM, 2005, LIVER TRANSPLANT, V11, P1086, DOI 10.1002/lt.20472; Reimer P, 1997, EUR RADIOL, V7, P275, DOI 10.1007/s003300050150; Rhee H, 2012, BRIT J RADIOL, V85, pE837, DOI 10.1259/bjr/13212920; Shimofusa R, 2010, J HEPATO-BIL-PAN SCI, V17, P583, DOI 10.1007/s00534-009-0198-z; Sun HY, 2010, INVEST RADIOL, V45, P96, DOI 10.1097/RLI.0b013e3181c5faf7; Vandecaveye V, 2009, EUR RADIOL, V19, P2456, DOI 10.1007/s00330-009-1431-5	27	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174594	10.1371/journal.pone.0174594	http://dx.doi.org/10.1371/journal.pone.0174594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355258	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174600069
J	Yoo, J; Koper, N				Yoo, Jenny; Koper, Nicola			Effects of shallow natural gas well structures and associated roads on grassland songbird reproductive success in Alberta, Canada	PLOS ONE			English	Article							NEST-SITE SELECTION; VEGETATION STRUCTURE; ENERGY DEVELOPMENT; HABITAT USE; PREDATION; SURVIVAL; BIRDS; CONSERVATION; CATTLE; FRAGMENTATION	Grassland songbird populations across North America have experienced dramatic population declines due to habitat loss and degradation. In Canada, energy development continues to fragment and disturb prairie habitat, but effects of oil and gas development on reproductive success of songbirds in North American mixed-grass prairies remains largely unknown. From 2010-2012, in southeastern Alberta, Canada, we monitored 257 nests of two groundnesting grassland songbird species, Savannah sparrow (Passerculus sandwichensis) and chestnut-collared longspur (Calcarius ornatus). Nest locations varied with proximity to and density of conventional shallow gas well structures and associated roads in forty-two 258-ha mixed-grass prairie sites. We estimated the probabilities of nest success and clutch size relative to gas well structures and roads. There was little effect of distance to or density of gas well structure on nest success; however, Savannah sparrow experienced lower nest success near roads. Clutch sizes were lower near gas well structures and cattle water sources. Minimizing habitat disturbance surrounding gas well structures, and reducing abundance of roads and trails, would help minimize impacts on reproductive success for some grassland songbirds.	[Yoo, Jenny; Koper, Nicola] Univ Manitoba, Nat Resources Inst, Winnipeg, MB, Canada	University of Manitoba	Yoo, J; Koper, N (corresponding author), Univ Manitoba, Nat Resources Inst, Winnipeg, MB, Canada.	jennygyoo@gmail.com; nicola.koper@umanitoba.ca		Koper, Nicola/0000-0003-3576-9525	Natural Sciences and Engineering Research Council of Canada (NSERC); Cenovus Energy Incorporated (NSERC's sponsoring organization); Cenovus Energy Incorporated; Canadian Foundation for Innovation; Manitoba Research and Innovation Fund; Clayton H. Riddell Endowment Fund of the University of Manitoba	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cenovus Energy Incorporated (NSERC's sponsoring organization)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cenovus Energy Incorporated; Canadian Foundation for Innovation(Canada Foundation for Innovation); Manitoba Research and Innovation Fund; Clayton H. Riddell Endowment Fund of the University of Manitoba	The author J.Y. received two main sources of funding (listed below). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 1. Natural Sciences and Engineering Research Council of Canada (NSERC), Industrial; http://www.nserc-crsng.gc.ca/Students-Etudiants/ PG-CS/IPS-BESII_eng.asp. 2. Cenovus Energy Incorporated (NSERC's sponsoring organization); http://www.cenovus.com/.; We thank Cenovus Energy Incorporated, Natural Sciences and Engineering Research Council of Canada (NSERC), Canadian Foundation for Innovation, Manitoba Research and Innovation Fund, and the Clayton H. Riddell Endowment Fund of the University of Manitoba for their support. We thank Susan Patey-LeDrew, Rene Dorval, and Joel Heese at Cenvous Energy Inc. for their assistance. We thank Rick Martin and Alberta Eastern Irrigation District for giving permission to access land. We also thank Antelope Creek Ranch, Bow Island Grazing Preserve, Circle E Grazing Association, Ducks Unlimited, Lomond Grazing Association, Lonesome Lake Grazing Preserve, Vauxhall Grazing Association and George Ketchmark for giving access to land and their kind co-operation. Special thanks to all the field assistants that helped collect data: Y. Khatti, C. Hines, L. Parker, M. Gould, J. Rodgers, A. Miller, L. McCleod, and L. Leston.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alberta Environment, 2003, RR0307 ALB ENV; Alberta Environment, 2003, RR035 ALB ENV; [Anonymous], 1988, BIRDERS HDB FIELD GU; Ball JR, 2009, 4 INT PARTN FLIGHT C, P37; Bayne EM, 2008, CONSERV BIOL, V22, P1186, DOI 10.1111/j.1523-1739.2008.00973.x; Bernath-Plaisted JS, 2015, EFFECTS OIL GAS DEV; Bleho BI, 2014, CONSERV BIOL, V28, P724, DOI 10.1111/cobi.12259; BOWMAN GB, 1980, J WILDLIFE MANAGE, V44, P806, DOI 10.2307/3808308; (CAPP) CA of PP, 2013, GAS WELLS COMPL CAN; Cody M.L., 1985, P191; CSA Group, 2011, Z66211 CSA; Dale B. W., 2010, ENERGY DEV WILDLIFE, P95; Davis SK, 1998, WILSON BULL, V110, P262; Davis SK, 2005, CONDOR, V107, P605, DOI 10.1650/0010-5422(2005)107[0605:NSPATI]2.0.CO;2; Davis SK, 2004, AUK, V121, P1130, DOI 10.1642/0004-8038(2004)121[1130:ASIGPE]2.0.CO;2; Davis SK, 2003, WILSON BULL, V115, P119, DOI 10.1676/02-138; Donovan TM, 2001, ECOL APPL, V11, P871; DUNWIDDIE PW, 1991, AM MIDL NAT, V125, P206, DOI 10.2307/2426224; Ellis-Felege SN, 2012, J APPL ECOL, V49, P661, DOI 10.1111/j.1365-2664.2012.02126.x; Ellison KS, 2012, STUD AVIAN BIOL, P149; Fisher RJ, 2010, J WILDLIFE MANAGE, V74, P265, DOI 10.2193/2009-020; Flanders AA, 2006, AUK, V123, P171, DOI 10.1642/0004-8038(2006)123[0171:EOIEGO]2.0.CO;2; Fontaine AL, 2004, J RANGE MANAGE, V57, P238, DOI 10.2307/4003790; Forstmeier W, 2004, OIKOS, V104, P487, DOI 10.1111/j.0030-1299.1999.12698.x; Francis CD, 2009, CURR BIOL, V19, P1415, DOI 10.1016/j.cub.2009.06.052; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Frey SN, 2006, J WILDLIFE MANAGE, V70, P1111, DOI 10.2193/0022-541X(2006)70[1111:HUBMIA]2.0.CO;2; GATES JE, 1978, ECOLOGY, V59, P871, DOI 10.2307/1938540; Gauthier DA, 2003, ENVIRON MONIT ASSESS, V88, P343, DOI 10.1023/A:1025585527169; Gilbert MM, 2011, J WILDLIFE MANAGE, V75, P816, DOI 10.1002/jwmg.123; Hagen CA, 2011, STUD AVIAN BIOL, P63; Hebblewhite Mark, 2011, P71; Herkert JR, 2003, CONSERV BIOL, V17, P587, DOI 10.1046/j.1523-1739.2003.01418.x; HERKERT JR, 1994, ECOL APPL, V4, P461, DOI 10.2307/1941950; Hill DP, 1993, BIRDS N AM ONLINE; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Holechek J. L., 2010, RANGE MANAGEMENT PRI, P456; Holloran MJ, 2010, J WILDLIFE MANAGE, V74, P65, DOI 10.2193/2008-291; Homan RN, 2003, ANIM CONSERV, V6, P11, DOI 10.1017/S13679430030032; Johnson Chris J., 2011, P27; KASPARI M, 1993, OIKOS, V68, P414, DOI 10.2307/3544909; Kerns CK, 2010, J WILDLIFE MANAGE, V74, P257, DOI 10.2193/2008-249; Koper N, 2014, ENVIRON MANAGE, V54, P1131, DOI 10.1007/s00267-014-0344-5; Koper N, 2007, J WILDLIFE MANAGE, V71, P2249, DOI 10.2193/2006-354; Koper N, 2016, ECOL EVOL, V6, P245, DOI 10.1002/ece3.1847; Koper N, 2009, LANDSCAPE ECOL, V24, P1287, DOI 10.1007/s10980-009-9375-3; LACEY JR, 1992, WEED TECHNOL, V6, P599, DOI 10.1017/S0890037X00035867; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; LAWTON JH, 1994, PHILOS T ROY SOC B, V344, P61, DOI 10.1098/rstb.1994.0052; Lloyd JD, 2005, CONDOR, V107, P363, DOI 10.1650/7701; Ludlow SM, 2015, CONDOR, V117, P64, DOI 10.1650/CONDOR-14-79.1; Lusk JS, 2013, RANGELAND ECOL MANAG, V66, P401, DOI 10.2111/REM-D-11-00203.1; Maron M, 2012, BIODIVERS CONSERV, V21, P2509, DOI 10.1007/s10531-012-0314-2; MARTIN TE, 1993, BIOSCIENCE, V43, P523, DOI 10.2307/1311947; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Morosinotto C, 2010, J ANIM ECOL, V79, P327, DOI 10.1111/j.1365-2656.2009.01638.x; Mundry R, 2011, BEHAV ECOL SOCIOBIOL, V65, P57, DOI 10.1007/s00265-010-1040-y; Nasen LC, 2011, J ENVIRON MANAGE, V92, P195, DOI 10.1016/j.jenvman.2010.09.004; Peterjohn BG, 1999, STUD AVIAN BIOL, P27; Pietz PJ, 2000, J WILDLIFE MANAGE, V64, P71, DOI 10.2307/3802976; Pitman JC, 2005, J WILDLIFE MANAGE, V69, P1259, DOI 10.2193/0022-541X(2005)069[1259:LASOLP]2.0.CO;2; Renfrew RB, 2005, AUK, V122, P618, DOI 10.1642/0004-8038(2005)122[0618:EABNGB]2.0.CO;2; Renfrew RB, 2003, AUK, V120, P371, DOI 10.1642/0004-8038(2003)120[0371:GPNPNP]2.0.CO;2; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Rodgers JA, 2017, J WILDLIFE MANAGEMEN; Rogers JA, 2013, EFFECTS SHALLOW GAS; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; SAMSON F, 1994, BIOSCIENCE, V44, P418, DOI 10.2307/1312365; Samson FB, 2004, WILDLIFE SOC B, V32, P6, DOI 10.2193/0091-7648(2004)32[6:GPEPPA]2.0.CO;2; Shaffer TL, 2004, AUK, V121, P526, DOI 10.1642/0004-8038(2004)121[0526:AUATAN]2.0.CO;2; Stahl JT, 2006, ECOL MODEL, V198, P23, DOI 10.1016/j.ecolmodel.2006.04.001; Tate KW, 2003, J RANGE MANAGE, V56, P432, DOI 10.2307/4003833; TAYLOR BL, 1993, CONSERV BIOL, V7, P489, DOI 10.1046/j.1523-1739.1993.07030489.x; VICKERY PD, 1992, OIKOS, V63, P281, DOI 10.2307/3545389; Weidinger K, 2002, J ANIM ECOL, V71, P424, DOI 10.1046/j.1365-2656.2002.00611.x; Wiens J. A., 1969, Ornithological Monographs, VNo. 8, P1; WIENS JA, 1979, OECOLOGIA, V42, P253, DOI 10.1007/BF00346594; Wiggins DA, 2006, BAIRDS SPARROW AMMO	79	5	5	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174243	10.1371/journal.pone.0174243	http://dx.doi.org/10.1371/journal.pone.0174243			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355241	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174600040
J	Zhang, ZG; Lv, GD; Li, B; Wang, JJ; Zhao, Y; Kong, FM; Guo, Y; Li, SS				Zhang, Zhao-Gui; Lv, Guang-de; Li, Bing; Wang, Jia-Jia; Zhao, Yan; Kong, Fan-Mei; Guo, Ying; Li, Si-Shen			Isolation and characterization of the TaSnRK2.10 gene and its association with agronomic traits in wheat (Triticum aestivum L.)	PLOS ONE			English	Article							SNF1-RELATED PROTEIN-KINASES; THOUSAND-GRAIN WEIGHT; PCR-AMPLIFICATION; FUNCTIONAL MARKERS; COMMON WHEAT; YIELD; QTL; STRESS; IDENTIFICATION; SELECTION	Sucrose non-fermenting 1-related protein kinases (SnRKs) comprise a major family of signaling genes in plants and are associated with metabolic regulation, nutrient utilization and stress responses. This gene family has been proposed to be involved in sucrose signaling. In the present study, we cloned three copies of the TaSnRK2.10 gene from bread wheat on chromosomes 4A, 4B and 4D. The coding sequence (CDS) is 1086 bp in length and encodes a protein of 361 amino acids that exhibits functional domains shared with SnRK2s. Based on the haplotypes of TaSnRK2.10-4A (Hap-4A-H and Hap-4A-L), a cleaved amplified polymorphic sequence (CAPS) marker designated TaSnRK2.10-4A-CAPS was developed and mapped between the markers D-1092101 and D-100014232 using a set of recombinant inbred lines (RILs). The TaSnRK2.10-4B alleles (Hap-4B-G and Hap-4B-A) were transformed into allele-specific PCR (AS-PCR) markers TaSnRK2.10-4B-AS1 and TaSnRK2.10-4B-AS2, which were located between the markers D-1281577 and S-1862758. No diversity was found for TaSnRK2.10-4D. An association analysis using a natural population consisting of 128 winter wheat varieties in multiple environments showed that the thousand grain weight (TGW) and spike length (SL) of Hap-4A-H were significantly higher than those of Hap-4A-L, but pant height (PH) was significantly lower.	[Zhang, Zhao-Gui; Lv, Guang-de; Li, Bing; Wang, Jia-Jia; Zhao, Yan; Kong, Fan-Mei; Guo, Ying; Li, Si-Shen] Shandong Agr Univ, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Lv, Guang-de] Taian Acad Agr Sci, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Guo, Y; Li, SS (corresponding author), Shandong Agr Univ, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	guoying729@126.com; ssli@sdau.edu.cn		Kong, Fanmei/0000-0001-5499-7588; Kong, Fanmei/0000-0003-1650-9146	National Natural Science Foundation of China [31271712]; Natural Science Foundation of Shandong Province, China [ZR2010CZ003]; Improved Agricultural Variety Project of Shandong Province, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province, China(Natural Science Foundation of Shandong Province); Improved Agricultural Variety Project of Shandong Province, China	Support was provided by The National Natural Science Foundation of China (Grant No. 31271712), the Natural Science Foundation of Shandong Province, China (Grant No. ZR2010CZ003), and the Improved Agricultural Variety Project of Shandong Province, China.	AGARWAL RK, 1993, NUCLEIC ACIDS RES, V21, P5283, DOI 10.1093/nar/21.22.5283; ANDERBERG RJ, 1992, P NATL ACAD SCI USA, V89, P10183, DOI 10.1073/pnas.89.21.10183; Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; Babatunde B, 2014, PLOS ONE, V9; Bagge M, 2007, CURR OPIN PLANT BIOL, V10, P211, DOI 10.1016/j.pbi.2007.01.009; Barker JHA, 1996, PLANT PHYSIOL, V112, P1141, DOI 10.1104/pp.112.3.1141; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; Bennett D, 2012, THEOR APPL GENET, V125, P255, DOI 10.1007/s00122-012-1831-9; Bonneau J, 2013, THEOR APPL GENET, V126, P747, DOI 10.1007/s00122-012-2015-3; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Coello P, 2012, J EXP BOT, V63, P913, DOI 10.1093/jxb/err320; Coello P, 2011, J EXP BOT, V62, P883, DOI 10.1093/jxb/erq331; Dong LL, 2014, MOL BREEDING, V34, P937, DOI 10.1007/s11032-014-0087-2; Du QZ, 2012, J HERED, V103, P853, DOI 10.1093/jhered/ess061; Frey UH, 2008, NAT PROTOC, V3, P1312, DOI 10.1038/nprot.2008.112; Guo Y, 2013, FIELD CROP RES, V154, P119, DOI 10.1016/j.fcr.2013.07.012; Halford NG, 2003, J EXP BOT, V54, P467, DOI 10.1093/jxb/erg038; Halford NG, 1998, PLANT MOL BIOL, V37, P735, DOI 10.1023/A:1006024231305; Han Y, 2015, PLANT PHYSIOL, V167, P915, DOI 10.1104/pp.114.251314; HARMON AC, 1994, BIOCHEMISTRY-US, V33, P7278, DOI 10.1021/bi00189a032; HARPER JF, 1994, BIOCHEMISTRY-US, V33, P7267, DOI 10.1021/bi00189a031; Hou J, 2014, PLANT PHYSIOL, V164, P1918, DOI 10.1104/pp.113.232454; Huang JF, 1996, BIOCHEMISTRY-US, V35, P13222, DOI 10.1021/bi960498a; Huang XQ, 2003, THEOR APPL GENET, V106, P1379, DOI 10.1007/s00122-002-1179-7; Jiang QY, 2011, FUNCT INTEGR GENOMIC, V11, P49, DOI 10.1007/s10142-010-0188-x; Jiang YM, 2015, THEOR APPL GENET, V128, P131, DOI 10.1007/s00122-014-2417-5; Johnson RR, 2002, PLANT PHYSIOL, V130, P837, DOI 10.1104/pp.001354; Kang J, 2005, J BIOCHEM BIOPH METH, V64, P147, DOI 10.1016/j.jbbm.2005.06.003; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim KN, 2000, PLANT PHYSIOL, V124, P1844, DOI 10.1104/pp.124.4.1844; Kobayashi Y, 2004, PLANT CELL, V16, P1163, DOI 10.1105/tpc.019943; Kulik A, 2011, OMICS, V15, P859, DOI 10.1089/omi.2011.0091; Kumar N, 2007, MOL BREEDING, V19, P163, DOI 10.1007/s11032-006-9056-8; Ma DY, 2012, MOL BREEDING, V29, P43, DOI 10.1007/s11032-010-9524-z; Mao XG, 2010, J EXP BOT, V61, P683, DOI 10.1093/jxb/erp331; McLoughlin F, 2012, PLANT J, V72, P436, DOI 10.1111/j.1365-313X.2012.05089.x; Musso M, 2006, J MOL DIAGN, V8, P544, DOI 10.2353/jmoldx.2006.060058; Qin L, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-107; Quarrie SA, 2005, THEOR APPL GENET, V110, P865, DOI 10.1007/s00122-004-1902-7; Ramya P, 2010, J APPL GENET, V51, P421, DOI 10.1007/BF03208872; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Rustgi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070526; SARKAR G, 1990, NUCLEIC ACIDS RES, V18, P7465, DOI 10.1093/nar/18.24.7465; See D, 2000, BIOTECHNIQUES, V28, P710, DOI 10.2144/00284st07; Simmonds J, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0191-9; Stein N, 2001, PLANT BREEDING, V120, P354, DOI 10.1046/j.1439-0523.2001.00615.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Su JY, 2006, J INTEGR PLANT BIOL, V48, P938, DOI 10.1111/j.1744-7909.2006.00252.x; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Sun XY, 2009, EUPHYTICA, V165, P615, DOI 10.1007/s10681-008-9794-2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan May H, 2013, Methods Mol Biol, V1017, P105, DOI 10.1007/978-1-62703-438-8_8; Tian SJ, 2013, J EXP BOT, V64, P2063, DOI 10.1093/jxb/ert072; Wang DM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147984; Wang YC, 2013, PLANT J, V75, P553, DOI 10.1111/tpj.12232; Wawer I, 2010, BIOCHEM J, V429, P73, DOI 10.1042/BJ20100492; Wu QH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118144; Xu YF, 2014, THEOR APPL GENET, V127, P59, DOI 10.1007/s00122-013-2201-y; Xu ZS, 2009, J INTEGR PLANT BIOL, V51, P58, DOI 10.1111/j.1744-7909.2008.00776.x; Yang ZB, 2012, THEOR APPL GENET, V125, P1057, DOI 10.1007/s00122-012-1895-6; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang DD, 2015, CROP J, V3, P1, DOI 10.1016/j.cj.2014.08.005; Zhang H, 2010, AMINO ACIDS, V1, P1, DOI DOI 10.1109/NLPKE.2010.5587846; Zhang HY, 2011, J EXP BOT, V62, P975, DOI 10.1093/jxb/erq328; Zhang JJ, 2015, NEW PHYTOL, V205, P293, DOI 10.1111/nph.13030; Zhang JJ, 2013, MOL BREEDING, V32, P771, DOI 10.1007/s11032-013-9905-1; Zhang JJ, 2009, NEW PHYTOL, V181, P843, DOI 10.1111/j.1469-8137.2008.02713.x; Zhang L, 2012, NEW PHYTOL, V195, P574, DOI 10.1111/j.1469-8137.2012.04194.x; Zhang YJ, 2014, MOL BREEDING, V34, P1097, DOI 10.1007/s11032-014-0102-7; Zheng J, 2014, J EXP BOT, V65, P5351, DOI 10.1093/jxb/eru306	70	10	12	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174425	10.1371/journal.pone.0174425	http://dx.doi.org/10.1371/journal.pone.0174425			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355304	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174600049
J	Ciller, C; De Zanet, S; Kamnitsas, K; Maeder, P; Glocker, B; Munier, FL; Rueckert, D; Thiran, JP; Cuadra, MB; Sznitman, R				Ciller, Carlos; De Zanet, Sandro; Kamnitsas, Konstantinos; Maeder, Philippe; Glocker, Ben; Munier, Francis L.; Rueckert, Daniel; Thiran, Jean-Philippe; Cuadra, Meritxell Bach; Sznitman, Raphael			Multi-channel MRI segmentation of eye structures and tumors using patient-specific features	PLOS ONE			English	Article							INTRAOCULAR TUMORS; SHAPE MODELS; RETINOBLASTOMA; DIAGNOSIS; THERAPY; BRAIN	Retinoblastoma and uveal melanoma are fast spreading eye tumors usually diagnosed by using 2D Fundus Image Photography (Fundus) and 2D Ultrasound (US). Diagnosis and treatment planning of such diseases often require additional complementary imaging to confirm the tumor extend via 3D Magnetic Resonance Imaging (MRI). In this context, having automatic segmentations to estimate the size and the distribution of the pathological tissue would be advantageous towards tumor characterization. Until now, the alternative has been the manual delineation of eye structures, a rather time consuming and error-prone task, to be conducted in multiple MRI sequences simultaneously. This situation, and the lack of tools for accurate eye MRI analysis, reduces the interest in MRI beyond the qualitative evaluation of the optic nerve invasion and the confirmation of recurrent malignancies below calcified tumors. In this manuscript, we propose a new framework for the automatic segmentation of eye structures and ocular tumors in multi-sequence MRI. Our key contribution is the introduction of a pathological eye model from which Eye Patient-Specific Features (EPSF)can be computed. These features combine intensity and shape information of pathological tissue while embedded in healthy structures of the eye. We assess our work on a dataset of pathological patient eyes by computing the Dice Similarity Coefficient (DSC) of the sclera, the cornea, the vitreous humor, the lens and the tumor. In addition, we quantitatively show the superior performance of our pathological eye model as compared to the segmentation obtained by using a healthy model (over 4% DSC) and demonstrate the relevance of our EPSF, which improve the final segmentation regardless of the classifier employed.	[Ciller, Carlos; Maeder, Philippe; Thiran, Jean-Philippe; Cuadra, Meritxell Bach] Univ Lausanne, CIBM, Radiol Dept, Lausanne, Switzerland; [Ciller, Carlos; Maeder, Philippe; Thiran, Jean-Philippe; Cuadra, Meritxell Bach] Univ Hosp, Lausanne, Switzerland; [Ciller, Carlos; De Zanet, Sandro; Sznitman, Raphael] Univ Bern, ARTORG Ctr, Ophthalm Technol Grp, Bern, Switzerland; [Kamnitsas, Konstantinos; Glocker, Ben; Rueckert, Daniel] Imperial Coll London, Biomed Image Anal Grp, London, England; [Munier, Francis L.] Jules Gonin Eye Hosp, Unit Pediat Ocular Oncol, Lausanne, Switzerland; [Thiran, Jean-Philippe; Cuadra, Meritxell Bach] Ecole Polytech Fed Lausanne, Signal Proc Lab, Lausanne, Switzerland; [Ciller, Carlos] CIBM, CHUV, Rue Bugnon 46, CH-1011 Lausanne, Switzerland	University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; Imperial College London; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Ciller, C (corresponding author), Univ Lausanne, CIBM, Radiol Dept, Lausanne, Switzerland.; Ciller, C (corresponding author), Univ Hosp, Lausanne, Switzerland.; Ciller, C (corresponding author), Univ Bern, ARTORG Ctr, Ophthalm Technol Grp, Bern, Switzerland.; Ciller, C (corresponding author), CIBM, CHUV, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	carlos.cillerruiz@unil.ch		Bach Cuadra, Meritxell/0000-0003-2730-4285	Swiss Cancer League [KFS-2937-02-2012]; Doc.Mobility grant from the Swiss National Science Foundation (SNF) [P1LAP3-161995]; Hasler Stiftung [15041]; Centre d'Imagerie BioMedcale (CIBM) of the University of Lausanne (UNIL); Ecole Polytechnique Federale de Lausanne (EPFL); University of Geneva (UniGe); Centre Hospitalier Universitaire Vaudois (CHUV); Hopitaux Universitaires de Geneve (HUG); University of Bern (UniBe); Leenaards Foundation; Jeantet Foundation	Swiss Cancer League; Doc.Mobility grant from the Swiss National Science Foundation (SNF); Hasler Stiftung; Centre d'Imagerie BioMedcale (CIBM) of the University of Lausanne (UNIL); Ecole Polytechnique Federale de Lausanne (EPFL); University of Geneva (UniGe); Centre Hospitalier Universitaire Vaudois (CHUV); Hopitaux Universitaires de Geneve (HUG); University of Bern (UniBe); Leenaards Foundation; Jeantet Foundation	This work is supported by a grant from the Swiss Cancer League (KFS-2937-02-2012). This work is supported by a Doc.Mobility grant from the Swiss National Science Foundation (SNF) with number P1LAP3-161995. This work is supported by a grant from the Hasler Stiftung (15041 ). This work is also supported by the Centre d'Imagerie BioMedcale (CIBM) of the University of Lausanne (UNIL), the Ecole Polytechnique Federale de Lausanne (EPFL), the University of Geneva (UniGe), the Centre Hospitalier Universitaire Vaudois (CHUV), the Hopitaux Universitaires de Geneve (HUG), the University of Bern (UniBe) and the Leenaards and the Jeantet Foundations.; This work is also supported by the Centre d'Imagerie BioMedicale (CIBM) of the University of Lausanne (UNIL), the Ecole Polytechnique Federale de Lausanne (EPFL), the University of Geneva (UniGe), the Centre Hospitalier Universitaire Vaudois (CHUV), the Hopitaux Universitaires de Geneve (HUG) and the Leenaards and the Jeantet Foundations. This work is also supported by Swiss Cancer League (KFS-2937-02-2012), Hasler Stiftung (15041) and Doc.Mobility (P1LAP3-161995) from the Swiss National Science Foundation (SNF)	Achanta R, 2012, IEEE T PATTERN ANAL, V34, P2274, DOI 10.1109/TPAMI.2012.120; Balmer A, 2006, ONCOGENE, V25, P5341, DOI 10.1038/sj.onc.1209622; Bauer S, 2011, LECT NOTES COMPUT SC, V6893, P354, DOI 10.1007/978-3-642-23626-6_44; Beenakker JWM, 2013, NMR BIOMED, V26, P1864, DOI 10.1002/nbm.3041; Beenakker JWM, 2016, MAGN RESON MATER PHY, V29, P571, DOI 10.1007/s10334-016-0529-4; Beenakker JWM, 2015, INVEST OPHTH VIS SCI, V56, P1033, DOI 10.1167/iovs.14-15161; Ben Salah M, 2013, LECT NOTES COMPUT SC, V8033, P30, DOI 10.1007/978-3-642-41914-0_4; Boykov YY, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P105, DOI 10.1109/ICCV.2001.937505; Ciller C, 2015, INT J RADIAT ONCOL, V92, P794, DOI 10.1016/j.ijrobp.2015.02.056; COOTES TF, 1995, COMPUT VIS IMAGE UND, V61, P38, DOI 10.1006/cviu.1995.1004; de Graaf P, 2012, AM J NEURORADIOL, V33, P110, DOI 10.3174/ajnr.A2729; de Graaf P, 2012, PEDIATR RADIOL, V42, P2, DOI 10.1007/s00247-011-2201-5; de Jong MC, 2015, SURV OPHTHALMOL, V60, P346, DOI 10.1016/j.survophthal.2015.01.002; De Zanet SI, 2015, IEEE T BIO-MED ENG, V62, P532, DOI 10.1109/TBME.2014.2359676; Dobler B, 2002, PHYS MED BIOL, V47, P593, DOI 10.1088/0031-9155/47/4/304; Frangi AF, 2002, IEEE T MED IMAGING, V21, P1151, DOI 10.1109/TMI.2002.804426; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Harati V, 2011, COMPUT BIOL MED, V41, P483, DOI 10.1016/j.compbiomed.2011.04.010; Ioffe S, 2015, ARXIV 1502 03167, V32, P448; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Kohli P, 2007, IEEE T PATTERN ANAL, V29, P2079, DOI 10.1109/TPAMI.2007.1128; Lucchi A, 2012, IEEE T MED IMAGING, V31, P474, DOI 10.1109/TMI.2011.2171705; Makropoulos A, 2014, IEEE T MED IMAGING, V33, P1818, DOI 10.1109/TMI.2014.2322280; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; Munier FL, 2008, CLIN EXP OPHTHALMOL, V36, P78, DOI 10.1111/j.1442-9071.2007.01602.x; Nyul LG, 1999, MAGNET RESON MED, V42, P1072, DOI 10.1002/(SICI)1522-2594(199912)42:6<1072::AID-MRM11>3.0.CO;2-M; Ruegsegger MB, 2012, INT J RADIAT ONCOL, V84, pE541, DOI 10.1016/j.ijrobp.2012.05.040; Srivastava N, 2014, J MACH LEARN RES, V15, P1929	28	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0173900	10.1371/journal.pone.0173900	http://dx.doi.org/10.1371/journal.pone.0173900			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350816	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174400009
J	Martin, EB; Williams, A; Wooliver, C; Heidel, RE; Adams, S; Dunlap, J; Ramirez-Alvarado, M; Blancas-Mejia, LM; Lands, RH; Kennel, SJ; Wall, JS				Martin, Emily B.; Williams, Angela; Wooliver, Craig; Heidel, R. Eric; Adams, Sarah; Dunlap, John; Ramirez-Alvarado, Marina; Blancas-Mejia, Luis M.; Lands, Ronald H.; Kennel, Stephen J.; Wall, Jonathan S.			Differential recruitment efficacy of patient derived amyloidogenic and myeloma light chain proteins by synthetic fibrils-A metric for predicting amyloid propensity	PLOS ONE			English	Article							BENCE-JONES PROTEINS; THERMAL-STABILITY; MULTIPLE-MYELOMA; VARIABLE DOMAINS; PEPTIDE P5; SERUM; ANTIBODIES; DEPOSITS; DISEASE; IMMUNOGLOBULINS	Background Monoclonal free light chain (LC) proteins are present in the circulation of patients with immunoproliferative disorders such as light chain (AL) amyloidosis and multiple myeloma (MM). Light chain-associated amyloid is a complex pathology composed of proteinaceous fibrils and extracellular matrix proteins found in all patients with AL and in-10-30% of patients who presented with MM. Amyloid deposits systemically in multiple organs and tissues leading to dysfunction and ultimately death. The overall survival of patients with amyloidosis is worse than for those with early stage MM. Methods and findings We have developed a sensitive binding assay quantifying the recruitment of full length, patient-derived LC proteins by synthetic amyloid fibrils, as a method for studying their amyloidogenic potential. In a survey of eight urinary LC, both AL and MM-associated proteins were recruited by synthetic amyloid fibrils; however, AL-associated LC bound significantly more efficiently (p < 0.05) than did MM LCs. The LC proteins used in this study were isolated from urine and presumed to represent a surrogate of serum free light chains. Conclusion The binding of LC to synthetic fibrils in this assay accurately differentiated LC with amyloidogenic propensity from MM LC that were not associated with clinical amyloid disease. Notably, the LC from a MM patient who subsequently developed amyloid behaved as an AL-associated protein in the assay, indicating the possibility for identifying MM patients at risk for developing amyloidosis based on the light chain recruitment efficacy. With this information, at risk patients can be monitored more closely for the development of amyloidosis, allowing timely administration of novel, amyloid-directed immunotherapies this approach may improve the prognosis for these patients.	[Martin, Emily B.; Williams, Angela; Wooliver, Craig; Lands, Ronald H.; Kennel, Stephen J.; Wall, Jonathan S.] Univ Tennessee, Med Ctr, Dept Med, Knoxville, TN 37996 USA; [Heidel, R. Eric; Adams, Sarah] Univ Tennessee, Med Ctr, Dept Surg, Knoxville, TN 37920 USA; [Dunlap, John] Univ Tennessee, Microscopy Facil, Knoxville, TN USA; [Ramirez-Alvarado, Marina; Blancas-Mejia, Luis M.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Ramirez-Alvarado, Marina; Blancas-Mejia, Luis M.] Mayo Clin, Immunol, Rochester, MN USA; [Kennel, Stephen J.; Wall, Jonathan S.] Univ Tennessee, Med Ctr, Dept Radiol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Knoxville; Mayo Clinic; Mayo Clinic; University of Tennessee System; University of Tennessee Health Science Center	Wall, JS (corresponding author), Univ Tennessee, Med Ctr, Dept Med, Knoxville, TN 37996 USA.; Wall, JS (corresponding author), Univ Tennessee, Med Ctr, Dept Radiol, Knoxville, TN 37996 USA.	jwall@utmck.edu	Heidel, Robert Eric/GSE-4942-2022	Heidel, Robert Eric/0000-0002-1518-8072; Wall, Jonathan/0000-0002-5516-8578; Ramirez-Alvarado, Marina/0000-0003-2325-6773; Martin, Emily/0000-0003-4993-5782	National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) [R01DK079984]; National Institute of General Medical Sciences (MR-A) [R01GM071514]; University of TN MC, Department of Medicine; Mayo Foundation	National Institute of Diabetes and Digestive Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of General Medical Sciences (MR-A); University of TN MC, Department of Medicine; Mayo Foundation	This work was supported in part by PHS grants R01DK079984 (JSW) from the National Institute of Diabetes and Digestive Kidney Diseases (NIDDK), and R01GM071514 from the National Institute of General Medical Sciences (MR-A) as well as funds from the University of TN MC, Department of Medicine and the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2016, NATURE, V531, P294, DOI 10.1038/531294a; ABE M, 1993, AM J CLIN PATHOL, V100, P67, DOI 10.1093/ajcp/100.1.67; Blancas-Mejia LM, 2016, BIOCHEMISTRY-US, V55, P2967, DOI 10.1021/acs.biochem.6b00090; Blancas-Mejia LM, 2015, BIOPHYS CHEM, V207, P13, DOI 10.1016/j.bpc.2015.07.005; Blancas-Mejia LM, 2014, J MOL BIOL, V426, P347, DOI 10.1016/j.jmb.2013.10.016; Comenzo RL, 2014, J CLIN ONCOL, V32, P2679, DOI 10.1200/JCO.2014.56.2892; del Pozo-Yauner L, 2014, BIOCHEM BIOPH RES CO, V443, P495, DOI 10.1016/j.bbrc.2013.11.123; Dhodapkar MV, 1997, HEMATOL ONCOL CLIN N, V11, P89, DOI 10.1016/S0889-8588(05)70417-2; Dispenzieri A, 2012, BLOOD REV, V26, P137, DOI 10.1016/j.blre.2012.03.001; Dispenzieri A, 2010, LANCET, V375, P1721, DOI 10.1016/S0140-6736(10)60482-5; Dul JL, 2001, J CELL BIOL, V152, P705, DOI 10.1083/jcb.152.4.705; Enqvist S, 2009, J PATHOL, V219, P473, DOI 10.1002/path.2607; EULITZ M, 1991, J IMMUNOL, V146, P3091; FRANGIONE B, 1983, J IMMUNOL, V131, P2490; Gertz MA, 2016, J CLIN ONCOL, V34, P1097, DOI 10.1200/JCO.2015.63.6530; Guan J, 2014, EMBO MOL MED, V6, P1493, DOI 10.15252/emmm.201404190; Helms LR, 1996, J MOL BIOL, V257, P77, DOI 10.1006/jmbi.1996.0148; Hrncic R, 2000, AM J PATHOL, V157, P1239, DOI 10.1016/S0002-9440(10)64639-1; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; Hutchison CA, 2008, CLIN J AM SOC NEPHRO, V3, P1684, DOI 10.2215/CJN.02290508; Jelinek T, 2016, CRIT REV ONCOL HEMAT, V99, P249, DOI 10.1016/j.critrevonc.2016.01.004; Kaplan B, 2001, AMYLOID, V8, P22, DOI 10.3109/13506120108993811; Khurana R, 2003, AMYLOID, V10, P97, DOI 10.3109/13506120309041731; Kim YS, 2002, J BIOL CHEM, V277, P27240, DOI 10.1074/jbc.M202492200; Kim YS, 2000, J BIOL CHEM, V275, P1570, DOI 10.1074/jbc.275.3.1570; Klimtchuk ES, 2010, BIOCHEMISTRY-US, V49, P9848, DOI 10.1021/bi101351c; Langer A., 2015, BLOOD, V126, P188; Lundmark K, 2005, P NATL ACAD SCI USA, V102, P6098, DOI 10.1073/pnas.0501814102; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; Marin-Argany M, 2015, PROTEIN SCI, V24, P1829, DOI 10.1002/pro.2790; Martin DJ, 2010, AMYLOID, V17, P129, DOI 10.3109/13506129.2010.530081; Martin EB, 2016, SCI REP-UK, V6, DOI 10.1038/srep22695; Martin EB, 2013, BIOCHEM BIOPH RES CO, V436, P85, DOI 10.1016/j.bbrc.2013.05.063; McWilliams-Koeppen HP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137716; Merlini G, 2014, EXPERT REV HEMATOL, V7, P143, DOI 10.1586/17474086.2014.858594; Merlini G, 2012, HEMATOL-AM SOC HEMAT, P595, DOI 10.1182/asheducation-2012.1.595; Murphy CL, 2006, METHOD ENZYMOL, V412, P48, DOI 10.1016/S0076-6879(06)12004-2; O'Nuallain B, 2002, P NATL ACAD SCI USA, V99, P1485, DOI 10.1073/pnas.022662599; O'Nuallain B, 2007, BIOCHEMISTRY-US, V46, P1240, DOI 10.1021/bi0616605; PAUL S, 1995, J BIOL CHEM, V270, P15257, DOI 10.1074/jbc.270.25.15257; Poshusta TL, 2013, INT J MOL SCI, V14, P22604, DOI 10.3390/ijms141122604; Rajkumar SV, 2013, AM J HEMATOL, V88, P225, DOI 10.1002/ajh.23390; Ramirez-Alvarado M, 2012, CURR TOP MED CHEM, V12, P2523; Richards DB, 2015, NEW ENGL J MED, V373, P1106, DOI 10.1056/NEJMoa1504942; Rios-Tamayo R, 2015, CANCER EPIDEMIOL, V39, P693, DOI 10.1016/j.canep.2015.08.002; Rocken C, 2006, J PATHOL, V210, P478, DOI 10.1002/path.2076; Sharma N, 2013, CURR OPIN CARDIOL, V28, P242, DOI 10.1097/HCO.0b013e32835dd165; Sikkink LA, 2008, BIOPHYS CHEM, V135, P25, DOI 10.1016/j.bpc.2008.02.019; Solomon A, 1998, P NATL ACAD SCI USA, V95, P9547, DOI 10.1073/pnas.95.16.9547; Solomon A, 1995, AMYLOID, V2, P269, DOI 10.3109/13506129508999010; SOLOMON A, 1982, J CLIN INVEST, V70, P453, DOI 10.1172/JCI110635; SOLOMON A, 1994, J IMMUNOL, V153, P1658; SOLOMON A, 1985, METHOD ENZYMOL, V116, P101; Souillac PO, 2002, J BIOL CHEM, V277, P12657, DOI 10.1074/jbc.M109230200; STEVENS FJ, 1981, J MOL BIOL, V147, P185, DOI 10.1016/0022-2836(81)90086-3; Stevens FJ, 1999, ANTIBODIES, V5, P175; STEVENS PW, 1995, PROTEIN SCI, V4, P421; Tischer A, 2013, PROTEIN SCI, V22, P1049, DOI 10.1002/pro.2294; Tjernberg LO, 2016, J INTERN MED; Usnarska-Zubkiewicz L, 2014, ADV CLIN EXP MED, V23, P531, DOI 10.17219/acem/23169; Vrana JA, 2009, BLOOD, V114, P4957, DOI 10.1182/blood-2009-07-230722; Wall J, 1999, BIOCHEMISTRY-US, V38, P14101, DOI 10.1021/bi991131j; Wall JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052686; Wall JS, 2010, BLOOD, V116, P2241, DOI 10.1182/blood-2010-03-273797; Wall JS, 2004, J MOL RECOGNIT, V17, P323, DOI 10.1002/jmr.681; Wechalekar AD, 2015, LANCET; Weiss BM, 2014, J CLIN ONCOL, V32, P2699, DOI 10.1200/JCO.2013.50.0892; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030	68	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174152	10.1371/journal.pone.0174152	http://dx.doi.org/10.1371/journal.pone.0174152			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350808	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174400018
J	Cohen, N; Shani, O; Raz, Y; Sharon, Y; Hoffman, D; Abramovitz, L; Erez, N				Cohen, N.; Shani, O.; Raz, Y.; Sharon, Y.; Hoffman, D.; Abramovitz, L.; Erez, N.			Fibroblasts drive an immunosuppressive and growth-promoting microenvironment in breast cancer via secretion of Chitinase 3-like 1	ONCOGENE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; INFLAMMATION; CELLS; EXPRESSION; YKL-40; PROGRESSION; METASTASIS; CHI3L1; CHEMOTHERAPY; RESPONSES	Cancer-Associated Fibroblasts (CAFs) are the most prominent stromal cell type in breast tumors. CAFs promote tumor growth and metastasis by multiple mechanisms, including by mediating tumor-promoting inflammation. Immune modulation in the tumor microenvironment plays a central role in determining disease outcome. However, the functional interactions of CAFs with immune cells are largely unknown. Here we report a novel signaling axis between fibroblasts, cancer cells and immune cells in breast tumors that drives an immunosuppressive microenvironment, mediated by CAF-derived Chi3L1. We demonstrate that Chi3L1 is highly upregulated in CAFs isolated from mammary tumors and pulmonary metastases of transgenic mice, and in the stroma of human breast carcinomas. Genetic ablation of Chi3L1 in fibroblasts in vivo attenuated tumor growth, macrophage recruitment and reprogramming to an M2-like phenotype, enhanced tumor infiltration by CD8(+) and CD4(+) T cells and promoted a Th1 phenotype. These results indicate that CAF-derived Chi3L1 promotes tumor growth and shifts the balance of the immune milieu towards type 2 immunity. Taken together, our findings implicate fibroblast-derived Chi3L1 as a novel key player in the complex reciprocal interactions of stromal cells that facilitate tumor progression and metastasis, and suggest that targeting Chi3L1 may be clinically beneficial in breast cancer.	[Cohen, N.; Shani, O.; Raz, Y.; Sharon, Y.; Hoffman, D.; Abramovitz, L.; Erez, N.] Tel Aviv Univ, Sackler Sch Med, Dept Pathol, IL-69978 Tel Aviv, Israel; [Raz, Y.] Tel Aviv Sourasky Med Ctr, Dept Obstet & Gynecol, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Erez, N (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Pathol, IL-69978 Tel Aviv, Israel.	netaerez@post.tau.ac.il	Yana, Yael Raz/S-7100-2019	Abramovitz, Lilach/0000-0001-9961-9986; Erez, Neta/0000-0001-6506-9074	European Research Council under the European Union's Horizon research and innovation programme [637069 MetCAF]; Israel Science Foundation [813/12]; Israel Cancer Association; Israel Cancer Research Fund (Research Career Development Award)	European Research Council under the European Union's Horizon research and innovation programme; Israel Science Foundation(Israel Science Foundation); Israel Cancer Association; Israel Cancer Research Fund (Research Career Development Award)	This research was supported by grants to NE from the European Research Council under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 637069 MetCAF), from the Israel Science Foundation (#813/12), the Israel Cancer Association and The Israel Cancer Research Fund (Research Career Development Award). We would like to thank Dr Yaron Carmi for scientific discussions, Shahar Biechonski and Hila Schwartz for their help with data analysis and helpful discussions, and Elad Yana for graphical assistance. We thank Dr Ariel Munitz for critical reading of the manuscript. This work was performed in partial fulfillment of the requirements for a PhD of Noam Cohen, Sackler School of Medicine, Tel Aviv University.	Ali HR, 2014, ANN ONCOL, V25, P1536, DOI 10.1093/annonc/mdu191; Bigg HF, 2006, J BIOL CHEM, V281, P21082, DOI 10.1074/jbc.M601153200; Borowsky AD, 2005, CLIN EXP METASTAS, V22, P47, DOI 10.1007/s10585-005-2908-5; Campbell MJ, 2011, BREAST CANCER RES TR, V128, P703, DOI 10.1007/s10549-010-1154-y; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Doedens AL, 2010, CANCER RES, V70, P7465, DOI 10.1158/0008-5472.CAN-10-1439; Erez N, 2013, BIOCHEM BIOPH RES CO, V437, P397, DOI 10.1016/j.bbrc.2013.06.089; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Eurich K, 2009, WORLD J GASTROENTERO, V15, P5249, DOI 10.3748/wjg.15.5249; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jensen BV, 2003, CLIN CANCER RES, V9, P4423; Johansen JS, 2003, BREAST CANCER RES TR, V80, P15, DOI 10.1023/A:1024431000710; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Karo-Atar D, 2015, J ASTHMA, V52, P545, DOI 10.3109/02770903.2014.988222; Kawada M, 2012, ONCOGENE, V31, P3111, DOI 10.1038/onc.2011.498; Komohara Y, 2017, J PATHOL, V241, P313, DOI 10.1002/path.4824; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Libreros S, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00392; Libreros S, 2013, IMMUNOL RES, V57, P99, DOI 10.1007/s12026-013-8459-y; Libreros S, 2012, INT J CANCER, V131, P377, DOI 10.1002/ijc.26379; Lin EY, 2007, CANCER RES, V67, P5064, DOI 10.1158/0008-5472.CAN-07-0912; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lotti F, 2013, J EXP MED, V210, P2851, DOI 10.1084/jem.20131195; Ma B, 2015, CANCER RES, V75, P487, DOI 10.1158/0008-5472.CAN-13-3339; Mantovani A, 2007, BREAST, V16, pS27, DOI 10.1016/j.breast.2007.07.013; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Martey CA, 2004, AM J PHYSIOL-LUNG C, V287, pL981, DOI 10.1152/ajplung.00239.2003; Mizrachy-Schwartz S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000628; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Pollard JW, 2008, J LEUKOCYTE BIOL, V84, P623, DOI 10.1189/jlb.1107762; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Schwartz H, 2016, CANCER RES, V76, P4359, DOI 10.1158/0008-5472.CAN-16-0485; Servais C, 2013, J PATHOL, V229, P198, DOI 10.1002/path.4103; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Sharon Y, 2015, CANCER RES, V75, P963, DOI 10.1158/0008-5472.CAN-14-1990; Sharon Y, 2013, JOVE-J VIS EXP, DOI 10.3791/4425; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Walker RA, 2001, BREAST CANCER RES, V3, P143, DOI 10.1186/bcr287; Zhou Y, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007096	53	139	147	4	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 3	2017	36	31					4457	4468		10.1038/onc.2017.65	http://dx.doi.org/10.1038/onc.2017.65			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FC4JL	28368410	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000406806000008
J	Iyer, JK; Koh, CY; Kazimirova, M; Roller, L; Jobichen, C; Swaminathan, K; Mizuguchi, J; Iwanaga, S; Nuttall, PA; Chan, MY; Kini, RM				Iyer, Janaki Krishnamoorthy; Koh, Cho Yeow; Kazimirova, Maria; Roller, Ladislav; Jobichen, Chacko; Swaminathan, Kunchithapadam; Mizuguchi, Jun; Iwanaga, Sadaaki; Nuttall, Patricia A.; Chan, Mark Y.; Kini, R. Manjunatha			Avathrin: a novel thrombin inhibitor derived from a multicopy precursor in the salivary glands of the ixodid tick, Amblyomma variegatum	FASEB JOURNAL			English	Article						direct thrombin inhibitor; exosite-I inhibitor; blood-feeding arthropods; blood-sucking animals; thrombin-inhibitor complex	BRADYKININ-POTENTIATING PEPTIDES; TROPICAL BONT TICK; ORAL ANTICOAGULANTS; HEPARIN; IDENTIFICATION; BIVALIRUDIN; COMPLEXES; HIRUDIN; PROTEIN; VENOM	Tick saliva is a rich source of antihemostatic compounds. We amplified a cDNA from the salivary glands of the tropical bont tick (Amblyomma variegatum) using primers based on the variegin sequence, which we previously identified as a novel thrombin inhibitor from the same tick species. The transcript encodes a precursor protein comprising a signal peptide and 5 repeats of variegin-like sequences that could be processed into multiple short peptides. These peptides share 31 to 34% identity with variegin. Here, we structurally and functionally characterized one of these peptides named "avathrin." Avathrin is a fast, tight binding competitive inhibitor with an affinity of 545 pM for thrombin and is 4 orders of magnitude more selective towards thrombin than to the other serine proteases of the coagulation cascade. The crystal structure of thrombin-avathrin complex at 2.09 A revealed that avathrin interacts with the thrombin active site and exosite-I. Although avathrin is cleaved by thrombin, the C-terminal cleavage product continues to exert prolonged inhibition. Avathrin is more potent than hirulog-1 in a murine carotid artery thrombosis model. Such precursor proteins that could be processed into multiple thrombin inhibiting peptides appear to be widespread among Amblyomminae, providing an enormous library of molecules for development as potent antithrombotics. Iyer, J. K., Koh, C. Y., Kazimirova, M., Roller, L., Jobichen, C., Swaminathan, K., Mizuguchi, J., Iwanaga, S., Nuttall, P. A., Chan, M. Y., Kini, R. M. Avathrin: a novel thrombin inhibitor derived from a multicopy precursor in the salivary glands of the ixodid tick, Amblyomma variegatum.	[Iyer, Janaki Krishnamoorthy; Koh, Cho Yeow; Jobichen, Chacko; Swaminathan, Kunchithapadam; Kini, R. Manjunatha] Natl Univ Singapore, Prot Sci Lab, Dept Biol Sci, Singapore, Singapore; [Chan, Mark Y.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Iyer, Janaki Krishnamoorthy] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Kazimirova, Maria; Roller, Ladislav] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia; [Mizuguchi, Jun; Iwanaga, Sadaaki] Chemoserotherapeut Res Inst, Kumamoto, Japan; [Nuttall, Patricia A.] Univ Oxford, Dept Zool, Oxford, England; [Chan, Mark Y.] Natl Univ Heart Ctr, Dept Cardiol, Singapore, Singapore; [Kini, R. Manjunatha] Singapore Eye Res Inst, Singapore, Singapore	National University of Singapore; National University of Singapore; McMaster University; Slovak Academy of Sciences; University of Oxford; National University of Singapore; National University of Singapore; Singapore National Eye Center	Kini, RM (corresponding author), Natl Univ Singapore, Prot Sci Lab, Dept Biol Sci, Fac Sci, 14,Sci Dr 4, Singapore 117543, Singapore.	dbskinim@nus.edu.sg	Roller, Ladislav/ABB-2988-2021; Chan, Yan Yee Mark/ABE-1929-2021; Jobichen, Chacko/AAR-7637-2020; Jobichen, Chacko/D-1978-2014; Kazimirova, Maria/U-8222-2017; Chan, Rebecca/D-9859-2018; Koh, Cho Yeow/J-4635-2019; Nuttall, Pat/I-6142-2012	Chan, Yan Yee Mark/0000-0003-0389-7450; Jobichen, Chacko/0000-0001-5927-1815; Kazimirova, Maria/0000-0001-6904-8342; Chan, Rebecca/0000-0001-6158-3885; Koh, Cho Yeow/0000-0003-0002-4603; Roller, Ladislav/0000-0002-9824-2096; Nuttall, Pat/0000-0002-0385-8294; Kini, Manjunatha/0000-0002-6100-3251	Ministry of Education [R-154-000-687-112]; National Medical Research Council; Research and Development "Bridging Discovery to Development of a Novel Parenteral Direct Thrombin Inhibitor" Project; European Regional Development Fund Operational Programme [ITMS: 26240220044]; Singapore Ministry of Education	Ministry of Education; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research and Development "Bridging Discovery to Development of a Novel Parenteral Direct Thrombin Inhibitor" Project; European Regional Development Fund Operational Programme; Singapore Ministry of Education(Ministry of Education, Singapore)	This work was funded by the Ministry of Education "New Factor Xa Inhibitors from Tick Saliva: Structure-Function Relationships" Project; Academic Research Fund: Development of Cardiovascular Agents (R-154-000-687-112); and National Medical Research Council, Research and Development "Bridging Discovery to Development of a Novel Parenteral Direct Thrombin Inhibitor" Project; the European Regional Development Fund Operational Programme (ITMS: 26240220044 to L.R.); and by a graduate research fellowship from the Singapore Ministry of Education (to J.K.I.). The authors declare no conflicts of interest.	[Anonymous], GUIDE IDENTIFICATION; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bauer KA, 2013, HEMATOL-AM SOC HEMAT, P464, DOI 10.1182/asheducation-2013.1.464; Berliner L. J., 1992, J CHEM INF MODEL, P118; BERRY CN, 1994, THROMB HAEMOSTASIS, V72, P381; Bode W, 2006, BLOOD CELL MOL DIS, V36, P122, DOI 10.1016/j.bcmd.2005.12.027; BOURDON P, 1991, FEBS LETT, V294, P163, DOI 10.1016/0014-5793(91)80659-Q; Bridge KI, 2014, THROMB HAEMOSTASIS, V112, P901, DOI 10.1160/TH14-02-0184; Campeiro JD, 2015, BIOCHEM PHARMACOL, V96, P202, DOI 10.1016/j.bcp.2015.05.012; Cavender MA, 2014, LANCET, V384, P599, DOI 10.1016/S0140-6736(14)61216-2; CHANG JY, 1986, BIOCHEM J, V240, P797, DOI 10.1042/bj2400797; Chaudhari K, 2014, NAT REV DRUG DISCOV, V13, P571, DOI 10.1038/nrd4365; Chen W, 2015, J THROMB HAEMOST, V13, P248, DOI 10.1111/jth.12797; Copeland R. A., 2000, ENZYMES PRACTICAL IN, V7; Coppens M, 2012, CIRC RES, V111, P920, DOI 10.1161/CIRCRESAHA.112.264903; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Eckly A, 2011, J THROMB HAEMOST, V9, P779, DOI 10.1111/j.1538-7836.2011.04218.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Francischetti IMB, 1999, BIOCHEMISTRY-US, V38, P16678, DOI 10.1021/bi991231p; Gallaher MP, 2012, PUBLIC INVESTMENTS IN ENERGY TECHNOLOGY, P7; Hirsh J, 2001, CIRCULATION, V103, P2994, DOI 10.1161/01.CIR.103.24.2994; Huntington JA, 2014, THROMB HAEMOSTASIS, V111, P583, DOI 10.1160/TH13-10-0811; Jablonka W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133991; KLINE T, 1991, BIOCHEM BIOPH RES CO, V177, P1049, DOI 10.1016/0006-291X(91)90644-M; Koh CY, 2007, J BIOL CHEM, V282, P29101, DOI 10.1074/jbc.M705600200; Koh CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026367; Koh CY, 2009, CHEMBIOCHEM, V10, P2155, DOI 10.1002/cbic.200900371; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Monroe D, 2002, ARTERIOSCL THROM VAS, V22, P1381, DOI 10.1161/01.ATV.0000031340.68494.34; Nene V, 2002, INT J PARASITOL, V32, P1447, DOI 10.1016/S0020-7519(02)00159-5; QIU XY, 1992, BIOCHEMISTRY-US, V31, P11689, DOI 10.1021/bi00162a004; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Ribeiro JMC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-136; Roller L, 2016, PEPTIDES, V80, P72, DOI 10.1016/j.peptides.2016.02.003; RYDEL TJ, 1994, J BIOL CHEM, V269, P22000; SKRZYPCZAKJANKUN E, 1991, J MOL BIOL, V221, P1379; Soares MR, 2005, TOXICON, V46, P31, DOI 10.1016/j.toxicon.2005.03.006; Steg PG, 2013, JAMA-J AM MED ASSOC, V310, P1145, DOI 10.1001/jama.2013.277165; STUBBS MT, 1993, THROMB RES, V69, P1, DOI 10.1016/0049-3848(93)90002-6; Versteeg HH, 2013, PHYSIOL REV, V93, P327, DOI 10.1152/physrev.00016.2011; Warkentin TE, 2004, BEST PRACT RES CL HA, V17, P105, DOI 10.1016/j.beha.2004.02.002; Yeh CH, 2015, ARTERIOSCL THROM VAS, V35, P1056, DOI 10.1161/ATVBAHA.115.303397	44	11	11	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2981	2995		10.1096/fj.201601216R	http://dx.doi.org/10.1096/fj.201601216R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28363953				2022-12-26	WOS:000405931000023
J	Dhavale, DD; Tsai, C; Bagchi, DP; Engel, LA; Sarezky, J; Kotzbauer, PT				Dhavale, Dhruva D.; Tsai, Christina; Bagchi, Devika P.; Engel, Laura A.; Sarezky, Jonathan; Kotzbauer, Paul T.			A sensitive assay reveals structural requirements for alpha-synuclein fibril growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; SPORADIC PARKINSONS-DISEASE; LEWY BODY DEMENTIA; IN-VITRO; E46K MUTATION; AGGREGATION; MUTANT; STRAINS; BINDING; OLIGOMERIZATION	The accumulation of alpha-synuclein (alpha-syn) fibrils in neuronal inclusions is the defining pathological process in Parkinson's disease (PD). A pathogenic role for alpha-syn fibril accumulation is supported by the identification of dominantly inherited alpha-syn (SNCA) gene mutations in rare cases of familial PD. Fibril formation involves a spontaneous nucleation event in which soluble alpha-syn monomers associate to form seeds, followed by fibril growth during which monomeric alpha-syn molecules sequentially associate with existing seeds. To better investigate this process, we developed sensitive assays that use the fluorescein arsenical dye FlAsH (fluorescein arsenical hairpin binder) to detect soluble oligomers and mature fibrils formed from recombinant alpha-syn protein containing an N-terminal bicysteine tag (C2--alpha-syn). Using seed growth by monomer association (SeGMA) assays to measure fibril growth over 3 h in the presence of C2-alpha-syn monomer, we observed that some familial PD-associated alpha-syn mutations (i.e. H50Q and A53T) greatly increased growth rates, whereas others (E46K, A30P, and G51D) decreased growth rates. Experiments with wild-type seeds extended by mutant monomer and vice versa revealed that single-amino acid differences between seed and monomer proteins consistently decreased growth rates. These results demonstrate that alpha-syn monomer association during fibril growth is a highly ordered process that can be disrupted by misalignment of individual amino acids and that only a subset of familial-PD mutations causes fibril accumulation through increased fibril growth rates. The SeGMA assays reported herein can be utilized to further elucidate structural requirements of alpha-syn fibril growth and to identify growth inhibitors as a potential therapeutic approach in PD.	[Kotzbauer, Paul T.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Kotzbauer, PT (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	kotzbauerp@wustl.edu	Dhavale, Dhruva/AAI-3934-2021	Dhavale, Dhruva/0000-0002-0096-1085	Hope Center Alafi Neuroimaging Laboratory; NIH Shared Instrumentation Grant [S10 RR024733]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS097799, K08NS048924] Funding Source: NIH RePORTER	Hope Center Alafi Neuroimaging Laboratory; NIH Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The atomic force microscope used in the study was supported by the Hope Center Alafi Neuroimaging Laboratory and NIH Shared Instrumentation Grant S10 RR024733.	Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Bagchi DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055031; Ballard C, 2006, NEUROLOGY, V67, P1931, DOI 10.1212/01.wnl.0000249130.63615.cc; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Braak H, 2005, NEUROLOGY, V64, P1404, DOI 10.1212/01.WNL.0000158422.41380.82; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Buell AK, 2014, P NATL ACAD SCI USA, V111, P7671, DOI 10.1073/pnas.1315346111; Chu WH, 2015, J MED CHEM, V58, P6002, DOI 10.1021/acs.jmedchem.5b00571; Comellas G, 2011, J MOL BIOL, V411, P881, DOI 10.1016/j.jmb.2011.06.026; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dettmer U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8314; Engel LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012897; Flagmeier P, 2016, P NATL ACAD SCI USA, V113, P10328, DOI 10.1073/pnas.1604645113; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Gath J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090659; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Giasson BI, 1999, J BIOL CHEM, V274, P7619, DOI 10.1074/jbc.274.12.7619; Gidalevitz T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a009704; GOLBE LI, 1990, ANN NEUROL, V27, P276, DOI 10.1002/ana.410270309; Goodman JL, 2009, CHEMBIOCHEM, V10, P1644, DOI 10.1002/cbic.200900207; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; Hurtig HI, 2000, NEUROLOGY, V54, P1916, DOI 10.1212/WNL.54.10.1916; Jellinger KA, 2012, MOVEMENT DISORD, V27, P8, DOI 10.1002/mds.23795; Kamiyoshihara T, 2007, BIOCHEM BIOPH RES CO, V355, P398, DOI 10.1016/j.bbrc.2007.01.162; Khalaf O, 2014, J BIOL CHEM, V289, P21856, DOI 10.1074/jbc.M114.553297; Kotzbauer PT, 2004, EXP NEUROL, V187, P279, DOI 10.1016/j.expneurol.2004.01.007; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Lemkau LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049750; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Lo Bianco C, 2008, J CLIN INVEST, V118, P3087, DOI 10.1172/JCI35781; Luedtke NW, 2007, NAT CHEM BIOL, V3, P779, DOI 10.1038/nchembio.2007.49; Mahul-Mellier AL, 2015, CELL DEATH DIFFER, V22, P2107, DOI 10.1038/cdd.2015.79; Martin BR, 2005, NAT BIOTECHNOL, V23, P1308, DOI 10.1038/nbt1136; Mbefo MK, 2015, J BIOL CHEM, V290, P9412, DOI 10.1074/jbc.M114.610774; Melki R, 2015, J PARKINSON DIS, V5, P217, DOI 10.3233/JPD-150543; Narkiewicz J, 2014, PRION, V8, P19, DOI 10.4161/pri.28125; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; Ono K, 2011, NEUROBIOL DIS, V43, P715, DOI 10.1016/j.nbd.2011.05.025; Peelaerts W, 2016, J NEUROCHEM, V139, P256, DOI 10.1111/jnc.13595; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Putcha P, 2010, J PHARMACOL EXP THER, V332, P849, DOI 10.1124/jpet.109.158436; Recasens A, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00159; Rutherford NJ, 2014, J NEUROCHEM, V131, P859, DOI 10.1111/jnc.12806; Sato H, 2015, MOL NEUROBIOL, V52, P226, DOI 10.1007/s12035-014-8858-7; Scheck RA, 2012, ACS CHEM BIOL, V7, P1367, DOI 10.1021/cb300216f; Seidel K, 2010, ANN NEUROL, V67, P684, DOI 10.1002/ana.21966; Sidhu A, 2016, ACS CHEM NEUROSCI, V7, P719, DOI 10.1021/acschemneuro.5b00322; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tashiro M, 2008, BIOCHEM BIOPH RES CO, V369, P910, DOI 10.1016/j.bbrc.2008.02.127; Tuttle MD, 2016, NAT STRUCT MOL BIOL, V23, P409, DOI 10.1038/nsmb.3194; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	71	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 2	2017	292	22					9034	9050		10.1074/jbc.M116.767053	http://dx.doi.org/10.1074/jbc.M116.767053			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW5IK	28373279	Green Published, hybrid			2022-12-26	WOS:000402538900004
J	Bedggood, P; Metha, A				Bedggood, Phillip; Metha, Andrew			De-warping of images and improved eye tracking for the scanning laser ophthalmoscope	PLOS ONE			English	Article							LIGHT OPHTHALMOSCOPY	A limitation of scanning laser ophthalmoscopy (SLO) is that eye movements during the capture of each frame distort the retinal image. Various sophisticated strategies have been devised to ensure that each acquired frame can be mapped quickly and accurately onto a chosen reference frame, but such methods are blind to distortions in the reference frame itself. Here we explore a method to address this limitation in software, and demonstrate its accuracy. We used high-speed (200 fps), high-resolution (similar to 1 mu m), flood-based imaging of the human retina with adaptive optics to obtain "ground truth" information on the retinal image and motion of the eye. This information was used to simulate SLO video sequences at 20 fps, allowing us to compare various methods for eye-motion recovery and subsequent minimization of intra-frame distortion. We show that a) a single frame can be near-perfectly recovered with perfect knowledge of intra-frame eye motion; b) eye motion at a given time point within a frame can be accurately recovered by tracking the same strip of tissue across many frames, due to the stochastic symmetry of fixational eye movements. This approach is similar to, and easily adapted from, previously suggested strip-registration approaches; c) quality of frame recovery decreases with amplitude of eye movements, however, the proposed method is affected less by this than other state-of-the-art methods and so offers even greater advantages when fixation is poor. The new method could easily be integrated into existing image processing software, and we provide an example implementation written in Matlab.	[Bedggood, Phillip; Metha, Andrew] Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic, Australia	University of Melbourne	Bedggood, P (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic, Australia.	pabedg@unimelb.edu.au	Metha, Andrew/H-2401-2015	Metha, Andrew/0000-0003-2997-4362; Bedggood, Phillip/0000-0001-5144-3694	Australian Research Council (ARC) Discovery Early Career Researcher Award [DE120101931]; ARC Discovery Project Grant [DP0984649]; A.E. Rowden White Foundation; Melbourne Neuroscience Institute	Australian Research Council (ARC) Discovery Early Career Researcher Award(Australian Research Council); ARC Discovery Project Grant(Australian Research Council); A.E. Rowden White Foundation; Melbourne Neuroscience Institute	This work received financial support from an Australian Research Council (ARC) Discovery Early Career Researcher Award (DE120101931), an ARC Discovery Project Grant (DP0984649), a benevolent bequest from the A.E. Rowden White Foundation, and seed-grants from the Melbourne Neuroscience Institute The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work received financial support from an Australian Research Council (ARC) Discovery Early Career Researcher Award (DE120101931), an ARC Discovery Project Grant (DP09846 49), a benevolent bequest from the A.E. Rowden White Foundation, and seed-grants from the Melbourne Neuroscience Institute (MNI @ the University of Melbourne). The problem of distortion in the reference frame, and possible avenues to correct for it, was brought to our attention through insightful conversations with Alfredo Dubra, to whom we are grateful.	Bedggood P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079251; Cooper RF, 2016, TRANSL VIS SCI TECHN, V5, DOI 10.1167/tvst.5.1.10; Dubra A, 2010, INT WORKSH BIOM IM R; Krauskopf J., 1960, J OPTICAL SOC AM; Rossi EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057956; Rucci M, 2015, ANNU REV VIS SCI, V1, P499, DOI 10.1146/annurev-vision-082114-035742; Vienola KV, 2012, BIOMED OPT EXPRESS, V3, P2950, DOI 10.1364/BOE.3.002950; Vogel CR, 2006, OPT EXPRESS, V14, P487, DOI 10.1364/OPEX.14.000487; Yang Q, 2014, BIOMED OPT EXPRESS, V5, P3174, DOI 10.1364/BOE.5.003174	9	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174617	10.1371/journal.pone.0174617	http://dx.doi.org/10.1371/journal.pone.0174617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369065	gold, Green Published			2022-12-26	WOS:000399351000025
J	Fang, SM; Tian, HZ; Li, XC; Jin, D; Li, XJ; Kong, J; Yang, C; Yang, XS; Lu, Y; Luo, Y; Lin, BC; Niu, WD; Liu, TJ				Fang, Shimeng; Tian, Hongzhu; Li, Xiancheng; Jin, Dong; Li, Xiaojie; Kong, Jing; Yang, Chun; Yang, Xuesong; Lu, Yao; Luo, Yong; Lin, Bingcheng; Niu, Weidong; Liu, Tingjiao			Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification	PLOS ONE			English	Article							EXTRACELLULAR VESICLES; MELANOMA EXOSOMES; EPCAM; HER2; EXPRESSION; SYSTEM; TARGET; CELLS	Increasing attention has been attracted by exosomes in blood-based diagnosis because cancer cells release more exosomes in serum than normal cells and these exosomes over-express a certain number of cancer-related biomarkers. However, capture and biomarker analysis of exosomes for clinical application are technically challenging. In this study, we developed a microfluidic chip for immunocapture and quantification of circulating exosomes from small sample volume and applied this device in clinical study. Circulating EpCAM-positive exosomes were measured in 6 cases breast cancer patients and 3 healthy controls to assist diagnosis. A significant increase in the EpCAM-positive exosome level in these patients was detected, compared to healthy controls. Furthermore, we quantified circulating HER2-positive exosomes in 19 cases of breast cancer patients for molecular classification. We demonstrated that the exosomal HER2 expression levels were almost consistent with that in tumor tissues assessed by immunohistochemical staining. The microfluidic chip might provide a new platform to assist breast cancer diagnosis and molecular classification.	[Fang, Shimeng; Tian, Hongzhu; Jin, Dong; Li, Xiaojie; Kong, Jing; Niu, Weidong; Liu, Tingjiao] Dalian Med Univ, Coll Stomatol, Dalian, Peoples R China; [Li, Xiancheng] Dalian Med Univ, Affiliated Hosp 2, Dept Urol, Dalian, Peoples R China; [Yang, Chun] Dalian Med Univ, Affiliated Hosp 1, Dept Nucl Med, Dalian, Peoples R China; [Yang, Xuesong] Dalian Med Univ, Dept Biochem & Mol Biol, Liaoning Prov Core Lab Glycobiol & Glycoengn, Dalian, Peoples R China; [Lu, Yao; Lin, Bingcheng] Chinese Acad Sci, Dalian Inst Chem Phys, Dept Biotechnol, Dalian, Peoples R China; [Luo, Yong; Lin, Bingcheng] Dalian Univ Technol, Dept Chem Engn, State Key Lab Fine Chem, Dalian, Peoples R China	Dalian Medical University; Dalian Medical University; Dalian Medical University; Dalian Medical University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Dalian University of Technology	Niu, WD; Liu, TJ (corresponding author), Dalian Med Univ, Coll Stomatol, Dalian, Peoples R China.	niuweidonghai@139.com; tinghao@dlmedu.edu.cn	Lu, Yao/Y-4983-2019	Lu, Yao/0000-0002-2169-6479	National Natural Science Foundation of China [81571767, 81171538]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81571767) and National Natural Science Foundation of China (81171538).	Alegre E, 2016, CLIN CHIM ACTA, V454, P28, DOI 10.1016/j.cca.2015.12.031; Alix-Panabieres C, 2014, LAB CHIP, V14, P57, DOI 10.1039/c3lc50644d; An TX, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27522; Atay Safinur, 2014, Commun Integr Biol, V7, pe28231, DOI 10.4161/cib.28231; Atay S, 2014, P NATL ACAD SCI USA, V111, P711, DOI 10.1073/pnas.1310501111; Beije N, 2015, CANCER TREAT REV, V41, P144, DOI 10.1016/j.ctrv.2014.12.008; Chambliss AB, 2016, CLIN PROTEOM, V13, DOI 10.1186/s12014-016-9127-8; Chen C, 2010, LAB CHIP, V10, P505, DOI 10.1039/b916199f; Cimino A, 2010, BREAST CANCER RES TR, V123, P701, DOI 10.1007/s10549-009-0671-z; Ciravolo V, 2012, J CELL PHYSIOL, V227, P658, DOI 10.1002/jcp.22773; Couzin J, 2005, SCIENCE, V308, P1862, DOI 10.1126/science.308.5730.1862; Davies RT, 2012, LAB CHIP, V12, P5202, DOI 10.1039/c2lc41006k; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Ghedini GC, 2010, J CELL PHYSIOL, V225, P256, DOI 10.1002/jcp.22257; He M, 2016, JALA-J LAB AUTOM, V21, P599, DOI 10.1177/2211068216651035; He M, 2014, LAB CHIP, V14, P3773, DOI 10.1039/c4lc00662c; Kogure Takayuki, 2013, Genes Cancer, V4, P261, DOI 10.1177/1947601913499020; Kruger S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-44; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Li J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150247; Lin Jin, 2015, ScientificWorldJournal, V2015, P657086, DOI 10.1155/2015/657086; Martowicz A, 2016, HISTOL HISTOPATHOL, V31, P349, DOI 10.14670/HH-11-678; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Momen-Heravi F, 2013, BIOL CHEM, V394, P1253, DOI 10.1515/hsz-2013-0141; Nuciforo P, 2016, MOL ONCOL, V10, P138, DOI 10.1016/j.molonc.2015.09.002; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Rupp AK, 2011, GYNECOL ONCOL, V122, P437, DOI 10.1016/j.ygyno.2011.04.035; Schnell U, 2013, BBA-BIOMEMBRANES, V1828, P1989, DOI 10.1016/j.bbamem.2013.04.018; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Singh Shailender, 2014, LAB CHIP, V14, P9; Sofia Nahavandi SB, 2014, LAB CHIP, V14, P19; Tagliabue E, 2010, EXPERT OPIN BIOL TH, V10, P711, DOI 10.1517/14712591003689972; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang ZX, 2013, LAB CHIP, V13, P2879, DOI 10.1039/c3lc41343h; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Williams C, 2014, CELL RES, V24, P766, DOI 10.1038/cr.2014.44; Wu YT, 2015, ANALYST, V140, P6631, DOI 10.1039/c5an00688k; Yeo B, 2015, BREAST, V24, P751, DOI 10.1016/j.breast.2015.09.008; Zaborowski MP, 2015, BIOSCIENCE, V65, P783, DOI 10.1093/biosci/biv084; Zhang Peng, 2016, LAB CHIP, P9; Zhao YY Zheng, 2016, LAB CHIP, V16, P8	42	139	141	11	139	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0175050	10.1371/journal.pone.0175050	http://dx.doi.org/10.1371/journal.pone.0175050			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369094	Green Published, gold, Green Submitted			2022-12-26	WOS:000399351000071
J	Torii, Y; Kawada, J; Murata, T; Yoshiyama, H; Kimura, H; Ito, Y				Torii, Yuka; Kawada, Jun-ichi; Murata, Takayuki; Yoshiyama, Hironori; Kimura, Hiroshi; Ito, Yoshinori			Epstein-Barr virus infection-induced inflammasome activation in human monocytes	PLOS ONE			English	Article							HOST-DEFENSE; DNA; LATENCY; NLRP3; CELLS	Inflammasomes are cytoplasmic sensors that regulate the activity of caspase-1 and the secretion of interleukin-1 beta (IL-1 beta) or interleukin-18 (IL-18) in response to foreign molecules, including viral pathogens. They are considered to be an important link between the innate and adaptive immune responses. However, the mechanism by which inflammasome activation occurs during primary Epstein-Barr virus (EBV) infection remains unknown. Human B lymphocytes and epithelial cells are major targets of EBV, although it can also infect a variety of other cell types. In this study, we found that EBV could infect primary human monocytes and the monocyte cell line, THP-1, inducing inflammasome activation. We incubated cell-free EBV with THP-1 cells or primary human monocytes, then confirmed EBV infection using confocal microscopy and flow cytometry. Lytic and latent EBV genes were detected by real-time RT-PCR in EBV-infected monocytes. EBV infection of THP-1 cells and primary human monocytes induced caspase-dependent IL-1 beta production, while EBV infection of B-cell or T-cell lines did not induce IL-1 beta production. To identify the sensor molecule responsible for inflammasome activation during EBV infection, we examined the mRNA and the protein levels of NLR family pyrin domain-containing 3 (NLRP3), absent in melanoma 2 (AIM2), and interferon-inducible protein 16 (IFI16). Increased AIM2 levels were observed in EBV-infected THP-1 cells and primary human monocytes, whereas levels of IFI16 and NLRP3 did not show remarkable change. Furthermore, knockdown of AIM2 by small interfering RNA attenuated caspase-1 activation. Taken together, our results suggest that EBV infection of human monocytes induces caspase-1-dependent IL-1 beta production, and that AIM2, acting as an inflammasome, is involved in this response.	[Torii, Yuka; Kawada, Jun-ichi; Ito, Yoshinori] Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi, Japan; [Torii, Yuka; Murata, Takayuki; Kimura, Hiroshi] Nagoya Univ, Grad Sch Med, Dept Virol, Nagoya, Aichi, Japan; [Yoshiyama, Hironori] Shimane Univ, Fac Med, Dept Microbiol, Izumo, Shimane, Japan	Nagoya University; Nagoya University; Shimane University	Kawada, J (corresponding author), Nagoya Univ, Grad Sch Med, Dept Pediat, Nagoya, Aichi, Japan.	kawadaj@med.nagoya-u.ac.jp	Kimura, Hiroshi/I-2246-2012; Kawada, Jun-ichi/I-7322-2014; Murata, Takayuki/I-2621-2013; Torii, Yuka/AAK-6344-2020; Yoshiyama, Hironori/H-5674-2019; Ito, Yoshinori/A-7591-2016; Kawada, Jun-ichi/AGA-5782-2022	Kimura, Hiroshi/0000-0001-8063-5660; Kawada, Jun-ichi/0000-0003-1553-2539; Murata, Takayuki/0000-0001-7228-0839; Yoshiyama, Hironori/0000-0001-7588-278X; Kawada, Jun-ichi/0000-0003-1553-2539	Japan Agency for Medical Research and Development [15ek0109098, 16K19638]; Grants-in-Aid for Scientific Research [15J40217] Funding Source: KAKEN	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for Scientific Research from the Japan Agency for Medical Research and Development to HK (Practical Research Project for Rare/Intractable Diseases, 15ek0109098) and YT (Grant-in-Aid for Young Scientists, 16K19638). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari MA, 2013, CONSTITUTIVE INTERFE; Ansari MA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005019; Ansari MA, 2013, J VIROL, V87, P8606, DOI 10.1128/JVI.00805-13; Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; Baqui AAMA, 1999, J PERIODONTAL RES, V34, P203, DOI 10.1111/j.1600-0765.1999.tb02243.x; Barbaro ADL, 2008, INT IMMUNOL, V20, P1457, DOI 10.1093/intimm/dxn103; Calattini S, 2010, BLOOD, V116, P4546, DOI 10.1182/blood-2010-05-285452; Denes A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.86; Dinarello CA, 2003, J INFECT DIS, V187, pS370, DOI 10.1086/374751; Horan KA, 2013, J IMMUNOL, V190, P2311, DOI 10.4049/jimmunol.1202749; Ito M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002857; Iwata S, 2010, J GEN VIROL, V91, P42, DOI 10.1099/vir.0.013482-0; Johnson KE, 2013, J VIROL, V87, P5005, DOI 10.1128/JVI.00082-13; Komune N, 2011, J VIROL, V85, P13019, DOI 10.1128/JVI.05942-11; Kubota N, 2008, J VIROL METHODS, V147, P26, DOI 10.1016/j.jviromet.2007.08.012; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Martorelli D, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/931952; Maruo S, 2001, J GEN VIROL, V82, P2373, DOI 10.1099/0022-1317-82-10-2373; Masy E, 2002, J VIROL, V76, P6460, DOI 10.1128/JVI.76.13.6460-6472.2002; McAuley JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003392; Michaud F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011908; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Nour AM, 2011, J BIOL CHEM, V286, P17921, DOI 10.1074/jbc.M110.210575; Ogembo JG, 2013, CELL REP, V3, P371, DOI 10.1016/j.celrep.2013.01.023; Park E, 2014, INFECT IMMUN, V82, P112, DOI 10.1128/IAI.00862-13; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Sashihara J, 2009, VIROLOGY, V391, P249, DOI 10.1016/j.virol.2009.06.013; Savard M, 2000, J VIROL, V74, P2612, DOI 10.1128/JVI.74.6.2612-2619.2000; Scherer O, 2015, J IMMUNOL METHODS, V422, P118, DOI 10.1016/j.jim.2015.04.007; Sun CL, 2015, J IMMUNOL, V194, P1819, DOI 10.4049/jimmunol.1402495; TSUCHIYA S, 1982, CANCER RES, V42, P1530; van de Veerdonk FL, 2012, J INFECT DIS, V206, P197, DOI 10.1093/infdis/jis335; van de Veerdonk Frank L, 2011, Trends Immunol, V32, P110, DOI 10.1016/j.it.2011.01.003; Wada K, 2007, J CLIN MICROBIOL, V45, P1426, DOI 10.1128/JCM.01515-06; Zhou Y, 2016, CURR ANAL CHEM, V12, P425, DOI 10.2174/1573411011666150903204210	36	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							0175053	10.1371/journal.pone.0175053	http://dx.doi.org/10.1371/journal.pone.0175053			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369146	Green Published, Green Submitted, gold			2022-12-26	WOS:000399351000072
J	Twigg, MJ; Wright, D; Kirkdale, CL; Desborough, JA; Thornley, T				Twigg, Michael J.; Wright, David; Kirkdale, Charlotte L.; Desborough, James A.; Thornley, Tracey			The UK Pharmacy Care Plan service: Description, recruitment and initial views on a new community pharmacy intervention	PLOS ONE			English	Article							MEDICINES USE REVIEWS; PATIENT-CENTEREDNESS; MEDICATION; PERCEPTIONS; FRAMEWORK; SUPPORT	Introduction The UK government advocates person-centred healthcare which is ideal for supporting patients to make appropriate lifestyle choices and to address non-adherence. The Community Pharmacy Future group, a collaboration between community pharmacy companies and independents in the UK, introduced a person-centred service for patients with multiple long-term conditions in 50 pharmacies in Northern England. Objective Describe the initial findings from the set up and delivery of a novel community pharmacy-based person-centred service. Method Patients over fifty years of age prescribed more than one medicine including at least one for cardiovascular disease or diabetes were enrolled. Medication review and person-centred consultation resulted in agreed health goals and steps towards achieving them. Data were collated and analysed to determine appropriateness of patient recruitment process and quality of outcome data collection. A focus group of seven pharmacists was used to ascertain initial views on the service. Results Within 3 months of service initiation, 683 patients had baseline clinical data recorded, of which 86.9% were overweight or obese, 53.7% had hypertension and 80.8% had high cardiovascular risk. 544 (77.2%) patients set at least one goal during the first consultation with 120 (22.1%) setting multiple goals. A majority of patients identified their goals as improvement in condition, activity or quality of life. Pharmacists could see the potential patient benefit and the extended role opportunities the service provided. Allowing patients to set their own goals occasionally identified gaps to be addressed in pharmacist knowledge. Conclusion Pharmacists successfully recruited a large number of patients who were appropriate for such a service. Patients were willing to identify goals with the pharmacist, the majority of which, if met, may result in improvements in quality of life. While challenges in delivery were acknowledged, allowing patients to identify their own personalised goals was seen as a positive approach to providing patient services.	[Twigg, Michael J.; Wright, David; Desborough, James A.] Univ East Anglia, Sch Pharm, Norwich, Norfolk, England; [Kirkdale, Charlotte L.; Thornley, Tracey] Boots UK, Nottingham, England; [Thornley, Tracey] Univ Nottingham, Sch Pharm, Nottingham, England	University of East Anglia; University of Nottingham	Twigg, MJ (corresponding author), Univ East Anglia, Sch Pharm, Norwich, Norfolk, England.	m.twigg@uea.ac.uk	Desborough, James/ABF-5389-2020	Thornley, Tracey/0000-0002-9276-052X; Twigg, Michael/0000-0003-0910-3850; Desborough, James/0000-0001-5807-1731	Community Pharmacy Future (CPF) group; UEA	Community Pharmacy Future (CPF) group; UEA	The study design and implementation was funded by the Community Pharmacy Future (CPF) group. The CPF group designed and implemented the service and had sight and approved the submission to the journal. The CPF research team (CLK and TT) are both employees receiving salaries from Boots UK, and were part of the evaluation team who were involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The CPF group also paid a consultancy fee to the team at UEA (MT, DW, JD) to provide advice on service design, to support training and to undertake the evaluation for this service. The specific roles of these authors are articulated in the 'author contributions' section.	Barber N, 2004, QUAL SAF HEALTH CARE, V13, P172, DOI 10.1136/qshc.2003.005926; BROWN JB, 1989, CAN FAM PHYSICIAN, V35, P153; Bryant LJM, 2009, RES SOC ADMIN PHARM, V5, P347, DOI 10.1016/j.sapharm.2009.01.002; Campion P, 2002, BRIT MED J, V325, P691, DOI 10.1136/bmj.325.7366.691; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Celino G, 2007, INT J PHARM PRACT, V15, pB20; Centre for Postgraduate Pharmacy Education, 2014, CONS SKILLS PHARM PR; Collins GS, 2012, BMJ, V344; Cramer JA, 2008, INT J CLIN PRACT, V62, P76, DOI 10.1111/j.1742-1241.2007.01630.x; Davey R, 2010, CONTEMP CLIN TRIALS, V31, P345, DOI 10.1016/j.cct.2010.04.002; Department of Health, 2010, EQ EXC LIB NHS; Elvey Rebecca, 2013, Int J Pharm Pract, V21, P322, DOI 10.1111/ijpp.12019; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Harding G, 2010, PHARM WORLD SCI, V32, P381, DOI 10.1007/s11096-010-9381-1; Health and Social Care Information Centre, 2013, NAT DIAB AUD 2011 20; Health and Social Care Information Centre, 2014, QUAL OUTC FRAM QOF 2; Health Foundation, 2014, PERS CTR CAR MAD SIM; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hibbard JH, 2005, HEALTH SERV RES, V40, P1918, DOI 10.1111/j.1475-6773.2005.00438.x; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Krousel-Wood M, 2009, AM J MANAG CARE, V15, P59; Latif A, 2008, PHARM WORLD SCI, V30, P536, DOI 10.1007/s11096-008-9203-x; McDonald R, 2010, SOC SCI MED, V71, P451, DOI 10.1016/j.socscimed.2010.04.021; Mead N, 2002, SOC SCI MED, V55, P283, DOI 10.1016/S0277-9536(01)00171-X; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Morisky DE, 2011, J CLIN EPIDEMIOL, V64, P255, DOI 10.1016/j.jclinepi.2010.09.002; National Collaborating Centre for Primary Care National Institute for Health and Clinical Excellence, 2009, MED ADH INV PAT DEC; National Institute for Health and Clinical Excellence, 2011, HYP CLIN MAN PRIM HY; NICE, 2009, TYP 2 DIAB MAN TYP 2; NICE, 2014, LIP MOD CARD RISK AS; O'Mahony D, 2010, EUR GERIATR MED, V1, P45, DOI 10.1016/j.eurger.2010.01.007; Pharmaceutical Services Negotiating Committee, 2013, PHARMOUTCOMES DEL EV; The King's Fund, 2012, VIS ACT MAK PAT CTR; Twigg MJ, 2015, INT J PHARM PRACT, V23, P407, DOI 10.1111/ijpp.12196; WESTON WW, 1989, CAN FAM PHYSICIAN, V35, P147; Wilcock M., 2007, PHARM J, V279, P501, DOI 10.1211/PJ.2009.10967873; Wright David, 2015, Int J Pharm Pract, V23, P36, DOI 10.1111/ijpp.12165	38	22	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174500	10.1371/journal.pone.0174500	http://dx.doi.org/10.1371/journal.pone.0174500			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2IH	28369064	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000399351000018
J	Inoguchi, N; Mizuno, N; Baba, S; Kumasaka, T; Natarajan, C; Storz, JF; Moriyama, H				Inoguchi, Noriko; Mizuno, Nobuhiro; Baba, Seiki; Kumasaka, Takashi; Natarajan, Chandrasekhar; Storz, Jay F.; Moriyama, Hideaki			Alteration of the alpha(1)beta(2)/alpha(2)beta(1) subunit interface contributes to the increased hemoglobin-oxygen affinity of high-altitude deer mice	PLOS ONE			English	Article							STRUCTURAL-CHANGES; CRYSTAL-STRUCTURES; ADAPTATION; NANOSECOND; PHOTOLYSIS; MUTATIONS; MYOGLOBIN; PATHWAY; BINDING; DEOXY	Background Deer mice (Peromyscus maniculatus) that are native to high altitudes in the Rocky Mountains have evolved hemoglobins with an increased oxygen- binding affinity relative to those of lowland conspecifics. To elucidate the molecular mechanisms responsible for the evolved increase in hemoglobin- oxygen affinity, the crystal structure of the highland hemoglobin variant was solved and compared with the previously reported structure for the lowland variant. Results Highland hemoglobin yielded at least two crystal types, in which the longest axes were 507 and 230 angstrom. Using the smaller unit cell crystal, the structure was solved at 2.2 angstrom resolution. The asymmetric unit contained two tetrameric hemoglobin molecules. Conclusions The analyses revealed that aPro50 in the highland hemoglobin variant promoted a stable interaction between aHis45 and heme that was not seen in the alpha His50 lowland variant. The alpha Pro50 mutation also altered the nature of atomic contacts at the alpha(1)beta(2)/alpha(2)beta(1) intersubunit interfaces. These results demonstrate how affinity- altering changes in intersubunit interactions can be produced by mutations at structurally remote sites.	[Inoguchi, Noriko; Natarajan, Chandrasekhar; Storz, Jay F.; Moriyama, Hideaki] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Mizuno, Nobuhiro; Baba, Seiki; Kumasaka, Takashi] Japan Synchrotron Radiat Res Inst, Prot Crystal Anal Div, Sayo, Japan	University of Nebraska System; University of Nebraska Lincoln; Japan Synchrotron Radiation Research Institute	Moriyama, H (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	hideaki@unl.edu	Natarajan, Chandrasekhar/D-3144-2012; Kumasaka, Takashi/D-7428-2018; Natarajan, Chandrasekar/ABG-5195-2020	Natarajan, Chandrasekhar/0000-0002-4841-0426; Kumasaka, Takashi/0000-0001-9289-1557; baba, seiki/0000-0002-2589-232X	National Institute of Health/National Heart, Lung, and Blood Institute [HL087216]; University of Nebraska; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM111072] Funding Source: NIH RePORTER	National Institute of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Nebraska; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institute of Health/National Heart, Lung, and Blood Institute (HL087216). University of Nebraska.; We thank the staff of the APS beamline 14-BM-C for expert technical assistance. This work was funded by a grant from the National Institute of Health/National Heart, Lung, and Blood Institute (HL087216).	Adachi S, 2003, P NATL ACAD SCI USA, V100, P7039, DOI 10.1073/pnas.1230629100; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aranda R, 2009, PROTEINS, V75, P217, DOI 10.1002/prot.22236; Balakrishnan G, 2004, J MOL BIOL, V340, P857, DOI 10.1016/j.jmb.2004.05.013; BALDWIN J, 1979, J MOL BIOL, V129, P175, DOI 10.1016/0022-2836(79)90277-8; Birukou I, 2011, J BIOL CHEM, V286, P10515, DOI 10.1074/jbc.M110.176271; DICERA E, 1987, BIOCHEMISTRY-US, V26, P4003, DOI 10.1021/bi00387a039; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischer S, 2011, P NATL ACAD SCI USA, V108, P5608, DOI 10.1073/pnas.1011995108; Inoguchi N, 2013, ACTA CRYSTALLOGR F, V69, P393, DOI 10.1107/S1744309113005708; Jensen B, 2016, COMP BIOCHEM PHYS A, V195, P10, DOI 10.1016/j.cbpa.2016.01.018; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Natarajan C, 2015, MOL BIOL EVOL, V32, P978, DOI 10.1093/molbev/msu403; Natarajan C, 2013, SCIENCE, V340, P1324, DOI 10.1126/science.1236862; Natarajan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020176; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pairet B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012389; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; PERUTZ M F, 1960, Brookhaven Symp Biol, V13, P165; PERUTZ MF, 1972, NATURE, V237, P495, DOI 10.1038/237495a0; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; RUBIN MM, 1966, J MOL BIOL, V21, P265, DOI 10.1016/0022-2836(66)90097-0; Shadrina MS, 2012, J AM CHEM SOC, V134, P11177, DOI 10.1021/ja300903c; Srajer V, 1996, SCIENCE, V274, P1726, DOI 10.1126/science.274.5293.1726; Srajer V, 2001, BIOCHEMISTRY-US, V40, P13802, DOI 10.1021/bi010715u; Srajer V, 2008, METHOD ENZYMOL, V437, P379, DOI 10.1016/S0076-6879(07)37019-5; Storz JF, 2008, HIGH ALT MED BIOL, V9, P148, DOI 10.1089/ham.2007.1079; Storz JF, 2016, J EXP BIOL, V219, P3190, DOI 10.1242/jeb.127134; Storz JF, 2010, J EXP BIOL, V213, P4125, DOI 10.1242/jeb.048181; Storz JF, 2010, J EXP BIOL, V213, P2565, DOI 10.1242/jeb.042598; Storz JF, 2009, P NATL ACAD SCI USA, V106, P14450, DOI 10.1073/pnas.0905224106; Viappiani C, 2014, P NATL ACAD SCI USA, V111, P12758, DOI 10.1073/pnas.1413566111; Voet D, 2011, BIOCHEMISTRY-US, pxxv; WISHNER BC, 1975, J MOL BIOL, V98, P179, DOI 10.1016/S0022-2836(75)80108-2; Yokoyama T, 2006, J MOL BIOL, V356, P790, DOI 10.1016/j.jmb.2005.12.018	38	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174921	10.1371/journal.pone.0174921	http://dx.doi.org/10.1371/journal.pone.0174921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362841	Green Submitted, gold, Green Published			2022-12-26	WOS:000399175000050
J	Seo, Y; Ryu, K; Park, J; Jeon, DK; Jo, S; Lee, HK; Namkung, W				Seo, Yohan; Ryu, Kunhi; Park, Jinhong; Jeon, Dong-Kyu; Jo, Sungwoo; Lee, Ho K.; Namkung, Wan			Inhibition of ANO1 by luteolin and its cytotoxicity in human prostate cancer PC-3 cells	PLOS ONE			English	Article							ACTIVATED CHLORIDE CHANNEL; CA2+-ACTIVATED CL-CHANNELS; EXPRESSION; TMEM16A; PROTEIN; PROLIFERATION	Anoctamin 1 (ANO1), a calcium-activated chloride channel, is highly amplified in prostate cancer, the most common form of cancer and leading causes of cancer death in men, and downregulation of ANO1 expression or its functional activity is known to inhibit cell proliferation, migration and invasion in prostate cancer cells. Here, we performed a cell-based screening for the identification of ANO1 inhibitors as potential anticancer therapeutic agents for prostate cancer. Screening of-300 selected bioactive natural products revealed that luteolin is a novel potent inhibitor of ANO1. Electrophysiological studies indicated that luteolin potently inhibited ANO1 chloride channel activity in a dose-dependent manner with an IC50 value of 9.8 mu M and luteolin did not alter intracellular calcium signaling in PC-3 prostate cancer cells. Luteolin inhibited cell proliferation and migration of PC-3 cells expressing high levels of ANO1 more potently than that of ANO1-deficient PC-3 cells. Notably, luteolin not only inhibited ANO1 channel activity, but also strongly decreased protein expression levels of ANO1. Our results suggest that downregulation of ANO1 by luteolin is a potential mechanism for the anticancer effect of luteolin.	[Seo, Yohan; Ryu, Kunhi; Park, Jinhong; Jeon, Dong-Kyu; Jo, Sungwoo; Namkung, Wan] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Incheon, South Korea; [Seo, Yohan; Lee, Ho K.; Namkung, Wan] Yonsei Univ, Dept Integrated OMICS Biomed Sci, WCU Program Grad Sch, Seoul, South Korea	Yonsei University; Yonsei University	Namkung, W (corresponding author), Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Incheon, South Korea.; Namkung, W (corresponding author), Yonsei Univ, Dept Integrated OMICS Biomed Sci, WCU Program Grad Sch, Seoul, South Korea.	wnamkung@yonsei.ac.kr	서, 요한/AAZ-6433-2020	Seo, Yohan/0000-0002-9335-8604; Lee, Ho Kyun/0000-0003-1707-3217	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2015R1D1A1A01057695]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This work was supported by a Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology [NRF-2015R1D1A1A01057695]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bill A, 2014, J BIOL CHEM, V289, P11029, DOI 10.1074/jbc.M114.549188; Blaen PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121010; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Cha JY, 2015, P NATL ACAD SCI USA, V112, P9722, DOI 10.1073/pnas.1423827112; Chiu FL, 2008, PROSTATE, V68, P61, DOI 10.1002/pros.20690; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Cole WC, 2011, J PHYSIOL-LONDON, V589, P4641, DOI 10.1113/jphysiol.2011.218453; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; Fang J, 2007, CARCINOGENESIS, V28, P713, DOI 10.1093/carcin/bgl189; Guan L, 2016, ONCOTARGET; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Liu W, 2012, CANCER LETT, V326, P41, DOI 10.1016/j.canlet.2012.07.015; Markaverich Barry M, 2012, Int J Biomed Sci, V8, P219; Mazzone A, 2012, BIOCHEM BIOPH RES CO, V427, P248, DOI 10.1016/j.bbrc.2012.09.022; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Oh SJ, 2013, MOL PHARMACOL, V84, P726, DOI 10.1124/mol.113.087502; Picollo A, 2015, J MOL BIOL, V427, P94, DOI 10.1016/j.jmb.2014.09.028; Pratheeshkumar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052279; Ruiz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043265; Sakurai MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100124; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Seo Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155771; Seo Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133656; Shang L, 2016, ONCOTARGET, V7, P24374, DOI 10.18632/oncotarget.8223; Shimoi K, 1998, FEBS LETT, V438, P220, DOI 10.1016/S0014-5793(98)01304-0; Shoulars K, 2010, J STEROID BIOCHEM, V118, P41, DOI 10.1016/j.jsbmb.2009.09.016; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhou Q, 2009, MOL CANCER THER, V8, P1684, DOI 10.1158/1535-7163.MCT-09-0191	33	41	45	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174935	10.1371/journal.pone.0174935	http://dx.doi.org/10.1371/journal.pone.0174935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362855	Green Published, Green Submitted, gold			2022-12-26	WOS:000399175000054
J	Ho, KKY; Lee, JW; Durand, G; Majumder, S; Liu, AP				Ho, Kenneth K. Y.; Lee, Jin Woo; Durand, Gregory; Majumder, Sagardip; Liu, Allen P.			Protein aggregation with poly(vinyl) alcohol surfactant reduces double emulsion-encapsulated mammalian cell-free expression	PLOS ONE			English	Article							MEMBRANE-PROTEIN; ARTIFICIAL CELL; GIANT VESICLES; LIPOSOMES; POLYMERSOMES; COMPARTMENTS; TEMPLATES; BIOLOGY; CHIP; FLOW	Development of artificial cell models requires encapsulation of biomolecules within membrane -bound compartments. There have been limited studies of using mammalian cell-free expression (CFE) system as the `cytosor of artificial cells. We exploit glass capillary droplet microfluidics for the encapsulation of mammalian CFE within double emulsion templated vesicles. The complexity of the physicochemical properties of HeLa cell-free lysate poses a challenge compared with encapsulating simple buffer solutions. In particular, we discovered the formation of aggregates in double emulsion templated vesicles encapsulating mammalian HeLa CFE, but not with bacterial CFE. The aggregates did not arise from insolubility of the proteins made from CFE nor due to the interaction of mammalian CFE with the organic solvents in the middle phase of the double emulsions. We found that aggregation is dependent on the concentration of poly(vinyl) alcohol (PVA) surfactant, a critical double emulsion stabilizing surfactant, and the lysate concentration in mammalian CFE. Despite vesicle instability and reduced protein expression, we demonstrate protein expression by encapsulating mammalian CFE system. Using mass spectrometry and Western blot, we identified and verified that actin is one of the proteins inside the mammalian CFE that aggregated with PVA surfactant. Our work establishes a baseline description of mammalian CFE system encapsulated in double emulsion templated vesicles as a platform for building artificial cells.	[Ho, Kenneth K. Y.; Lee, Jin Woo; Majumder, Sagardip; Liu, Allen P.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Durand, Gregory] Univ Montpellier, Inst Biomol Max Mousseron, UMR 5247, CNRS,ENSCM, Avignon, France; [Durand, Gregory] Univ Avignon & Pays Vaucluse, Avignon, France; [Liu, Allen P.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Liu, Allen P.] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; [Liu, Allen P.] Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Montpellier; Avignon Universite; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Liu, AP (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.; Liu, AP (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.; Liu, AP (corresponding author), Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA.; Liu, AP (corresponding author), Univ Michigan, Biophys Program, Ann Arbor, MI 48109 USA.	allenliu@umich.edu		Liu, Allen/0000-0002-0309-7018; Durand, Gregory/0000-0001-6680-2821	NIH Director's New Innovator Award [DP2 HL117748-01]; National Science Foundation [MCB-1612917]; NIH's Microfluidics in Biomedical Sciences Training Program [T32 EB005582]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [DP2HL117748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005582] Funding Source: NIH RePORTER	NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIH's Microfluidics in Biomedical Sciences Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work is supported by the NIH Director's New Innovator Award (DP2 HL117748-01) to A.P.L, National Science Foundation (MCB-1612917) to A.P.L., and NIH's Microfluidics in Biomedical Sciences Training Program (T32 EB005582) to J.W.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abla M, 2015, J COLLOID INTERF SCI, V445, P127, DOI 10.1016/j.jcis.2014.12.066; Arriaga LR, 2014, SMALL, V10, P950, DOI 10.1002/smll.201301904; Arumugam S, 2015, BIOPHYS J, V108, P1104, DOI 10.1016/j.bpj.2014.12.050; Bucher P, 1998, LANGMUIR, V14, P2712, DOI 10.1021/la971318g; Carlson ED, 2012, BIOTECHNOL ADV, V30, P1185, DOI 10.1016/j.biotechadv.2011.09.016; Caschera F, 2016, CHEM COMMUN, V52, P5467, DOI 10.1039/c6cc00223d; Caschera F, 2014, CURR OPIN CHEM BIOL, V22, P85, DOI 10.1016/j.cbpa.2014.09.028; Colletier Jacques-Philippe, 2002, BMC Biotechnol, V2, P9, DOI 10.1186/1472-6750-2-9; Coyne CW, 2014, JOVE-J VIS EXP, DOI 10.3791/51510; Deng NN, 2016, J AM CHEM SOC, V138, P7584, DOI 10.1021/jacs.6b02107; Deshpande S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10447; Ding Yunfeng, 2014, Life-Basel, V4, P1092, DOI 10.3390/life4041092; Durand G, 2014, NEW AMPHIPHILES HAND; Funakoshi K, 2007, J AM CHEM SOC, V129, P12608, DOI 10.1021/ja074029f; Gadok A.K., 2016, J AM CHEM SOC; Hayward RC, 2006, LANGMUIR, V22, P4457, DOI 10.1021/la060094b; Ho KKY, 2015, METHOD CELL BIOL, V128, P303, DOI 10.1016/bs.mcb.2015.01.014; Kim SH, 2011, LAB CHIP, V11, P3162, DOI 10.1039/c1lc20434c; Liu AP, 2008, NAT PHYS, V4, P789, DOI 10.1038/nphys1071; Liu AP, 2009, NAT REV MOL CELL BIO, V10, P644, DOI 10.1038/nrm2746; Matosevic S, 2013, NAT CHEM, V5, P958, DOI [10.1038/nchem.1765, 10.1038/NCHEM.1765]; Mikami S, 2006, PROTEIN EXPRES PURIF, V46, P348, DOI 10.1016/j.pep.2005.09.021; Mikami S, 2008, PROTEIN EXPRES PURIF, V62, P190, DOI 10.1016/j.pep.2008.09.002; Nishimura K, 2012, LANGMUIR, V28, P8426, DOI 10.1021/la3001703; Noireaux V, 2004, P NATL ACAD SCI USA, V101, P17669, DOI 10.1073/pnas.0408236101; Noireaux V, 2011, P NATL ACAD SCI USA, V108, P3473, DOI 10.1073/pnas.1017075108; Nourian Z, 2013, ACS SYNTH BIOL, V2, P186, DOI 10.1021/sb300125z; Park KH, 2007, BIOCHEM J, V403, P183, DOI 10.1042/BJ20061473; Richmond DL, 2011, P NATL ACAD SCI USA, V108, P9431, DOI 10.1073/pnas.1016410108; Ritz S, 2013, BIOCHIMIE, V95, P1909, DOI 10.1016/j.biochi.2013.06.021; Rodnin MV, 2008, BIOPHYS J, V94, P4348, DOI 10.1529/biophysj.107.126235; Sachse R, 2014, FEBS LETT, V588, P2774, DOI 10.1016/j.febslet.2014.06.007; Shum HC, 2008, LANGMUIR, V24, P7651, DOI 10.1021/la801833a; Shum HC, 2011, J AM CHEM SOC, V133, P4420, DOI 10.1021/ja108673h; Thiele J, 2010, SMALL, V6, P1723, DOI 10.1002/smll.201000798; Utada AS, 2005, SCIENCE, V308, P537, DOI 10.1126/science.1109164	37	19	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174689	10.1371/journal.pone.0174689	http://dx.doi.org/10.1371/journal.pone.0174689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358875	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174800072
J	Ligasova, A; Konecny, P; Frydrych, I; Koberna, K				Ligasova, Anna; Konecny, Petr; Frydrych, Ivo; Koberna, Karel			Looking for ugly ducklings: The role of the stability of BrdU-antibody complex and the improved method of the detection of DNA replication	PLOS ONE			English	Article							NUCLEAR-ORGANIZATION; MAMMALIAN-CELLS; CLICK CHEMISTRY; IN-VIVO; EDU; 5-BROMO-2-DEOXYURIDINE; DENATURATION	5-Bromo-2'-deoxyuridine (BrdU) labelling and immunostaining is commonly used for the detection of DNA replication using specific antibodies. Previously, we found that these antibodies significantly differ in their affinity to BrdU. Our present data showed that one of the reasons for the differences in the replication signal is the speed of antibody dissociation. Whereas highly efficient antibodies created stable complexes with BrdU, the low efficiency antibodies were unstable. A substantial loss of the signal occurred within several minutes. The increase of the complex stability can be achieved by i) formaldehyde fixation or a quick reaction with a secondary antibody. These steps allowed the same or even higher signal/background ratio to be reached as in the highly efficient antibodies. Based on our findings, we optimised an approach for the fully enzymatic detection of BrdU enabling the fast detection of replicational activity without a significant effect on the tested proteins or the fluorescence of the fluorescent proteins. The method was successfully applied for image and flow cytometry. The speed of the method is comparable to the approach based on 5-ethynyl-2'-deoxyuridine. Moreover, in the case of short labelling pulses, the optimised method is even more sensitive. The approach is also applicable for the detection of 5-trifluoromethyl-2'-deoxyuridine.	[Ligasova, Anna; Konecny, Petr; Frydrych, Ivo; Koberna, Karel] Palacky Univ, Inst Mol & Translat Med, Fac Med & Dent, Olomouc, Czech Republic; [Konecny, Petr] Univ Cape Town, Div Immunol, Inst Infect Dis & Mol Med, Fac Hlth Sci, Cape Town, South Africa	Palacky University Olomouc; University of Cape Town	Ligasova, A; Koberna, K (corresponding author), Palacky Univ, Inst Mol & Translat Med, Fac Med & Dent, Olomouc, Czech Republic.	anna.ligasova@upol.cz; karel.koberna@upol.cz	Ligasová, Anna/P-5460-2015; KOBERNA, Karel/G-5551-2019	Ligasová, Anna/0000-0002-1564-3768; KOBERNA, Karel/0000-0002-7375-4298; , Ivo/0000-0003-1412-1607	Technology Agency of the Czech Republic [TA03010598, TE02000058]; Ministry of Health of the Czech Republic [AZV 15-31604A]; Ministry of Education, Youth and Sports [L01304, LM2015064]	Technology Agency of the Czech Republic; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the Technology Agency of the Czech Republic [TA03010598 and TE02000058]; the Ministry of Health of the Czech Republic [AZV 15-31604A] and the Ministry of Education, Youth and Sports [L01304 and LM2015064]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGENO M, 1969, BIOPHYS J, V9, P1281, DOI 10.1016/S0006-3495(69)86452-0; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cristofoli WA, 2007, J MED CHEM, V50, P2851, DOI 10.1021/jm0701472; Diermeier-Daucher S, 2009, CYTOM PART A, V75A, P535, DOI 10.1002/cyto.a.20712; Dimitrova DS, 2002, J CELL SCI, V115, P4037, DOI 10.1242/jcs.00087; GONCHOROFF NJ, 1985, CYTOMETRY, V6, P506, DOI 10.1002/cyto.990060604; Hong V, 2010, BIOCONJUGATE CHEM, V21, P1912, DOI 10.1021/bc100272z; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Kitao H, 2016, SCI REP-UK, V6, DOI 10.1038/srep25286; Kohlmeier F, 2013, CHROMOSOME RES, V21, P87, DOI 10.1007/s10577-013-9340-5; Liboska R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051679; Ligasova A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132393; Ligasova A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117459; Ligasova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052584; Ligasova A, 2009, J STRUCT BIOL, V165, P204, DOI 10.1016/j.jsb.2008.11.004; Loschberger A, 2014, BIOTECHNOL J, V9, P693, DOI 10.1002/biot.201400026; Ross HH, 2011, J NEURO-ONCOL, V105, P485, DOI 10.1007/s11060-011-0621-6; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Stanojcic S, 2008, MOL CELL BIOL, V28, P5265, DOI 10.1128/MCB.00181-08; TAKAGI S, 1993, CYTOMETRY, V14, P640, DOI 10.1002/cyto.990140608; Tang XB, 2007, J NEUROSCI, V27, P5837, DOI 10.1523/JNEUROSCI.5048-06.2007	23	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174893	10.1371/journal.pone.0174893	http://dx.doi.org/10.1371/journal.pone.0174893			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358913	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174800099
J	van Tol, N; Rolloos, M; Pinas, JE; Henkel, CV; Augustijn, D; Hooykaas, PJJ; van der Zaal, BJ				van Tol, Niels; Rolloos, Martijn; Pinas, Johan E.; Henkel, Christiaan V.; Augustijn, Dieuwertje; Hooykaas, Paul J. J.; van der Zaal, Bert J.			Enhancement of Arabidopsis growth characteristics using genome interrogation with artificial transcription factors	PLOS ONE			English	Article							PHENOTYPIC ALTERATION; REPRESSION DOMAIN; GENE-EXPRESSION; PLANT-GROWTH; HETEROSIS; IDENTIFICATION; LIBRARIES; THALIANA; PROTEIN; HYBRIDS	The rapidly growing world population has a greatly increasing demand for plant biomass, thus creating a great interest in the development of methods to enhance the growth and biomass accumulation of crop species. In this study, we used zinc finger artificial transcription factor (ZF-ATF)-mediated genome interrogation to manipulate the growth characteristics and biomass of Arabidopsis plants. We describe the construction of two collections of Arabidopsis lines expressing fusions of three zinc fingers (3F) to the transcriptional repressor motif EAR (3F-EAR) or the transcriptional activator VP16 (3F-VP16), and the characterization of their growth characteristics. In total, six different 3F-ATF lines with a consistent increase in rosette surface area (RSA) of up to 55% were isolated. For two lines we demonstrated that 3F-ATF constructs function as dominant in trans acting causative agents for an increase in RSA and biomass, and for five larger plant lines we have investigated 3F-ATF induced transcriptomic changes. Our results indicate that genome interrogation can be used as a powerful tool for the manipulation of plant growth and biomass and that it might supply novel cues for the discovery of genes and pathways involved in these properties.	[van Tol, Niels; Rolloos, Martijn; Pinas, Johan E.; Henkel, Christiaan V.; Hooykaas, Paul J. J.; van der Zaal, Bert J.] Leiden Univ, Fac Sci, Inst Biol Leiden, Leiden, Netherlands; [van Tol, Niels] BioSolar Cells, Wageningen, Netherlands; [Augustijn, Dieuwertje] Leiden Univ, Fac Sci, Leiden Inst Chem, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	van der Zaal, BJ (corresponding author), Leiden Univ, Fac Sci, Inst Biol Leiden, Leiden, Netherlands.	b.j.v.d.zaal@biology.leidennuniv.nl	Hooykaas, Paul JJ/S-4256-2017	Hooykaas, Paul JJ/0000-0002-9736-6927; Augustijn, Dieuwertje/0000-0002-7990-3661; Henkel, Christiaan/0000-0001-9838-8215	research programme of BioSolar Cells [10TBSC23]; Dutch Ministry of Economic Affairs; Consortium for Improving Plant Yield - Dutch Organisation for Scientific Research (NWO); CIPY grant [ETP3.4]	research programme of BioSolar Cells; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Consortium for Improving Plant Yield - Dutch Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); CIPY grant	NT was funded by the research programme of BioSolar Cells (http://www.biosolarcells.nl; grant no. 10TBSC23), which was co-financed by the Dutch Ministry of Economic Affairs. BioSolar Cells provided support in the form of salaries for NT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of NT is articulated in the 'author contributions' section. MR was funded by the Consortium for Improving Plant Yield, funded by the Dutch Organisation for Scientific Research (NWO; http://www.nwo.n1/). A separate CIPY grant for RNA sequencing was received for an Enabling Technology Platform Hotel project (project number ETP3.4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andorf S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049951; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barber J, 2009, CHEM SOC REV, V38, P185, DOI 10.1039/b802262n; Barth S, 2003, HEREDITY, V91, P36, DOI 10.1038/sj.hdy.6800276; Century K, 2008, PLANT PHYSIOL, V147, P20, DOI 10.1104/pp.108.117887; Choe S, 2001, PLANT J, V26, P573, DOI 10.1046/j.1365-313x.2001.01055.x; De Buck S, 2009, PLANT J, V60, P134, DOI 10.1111/j.1365-313X.2009.03942.x; de Pater S, 2009, PLANT BIOTECHNOL J, V7, P821, DOI 10.1111/j.1467-7652.2009.00446.x; Evans JR, 2013, PLANT PHYSIOL, V162, P1780, DOI 10.1104/pp.113.219006; Gonzalez N, 2012, TRENDS PLANT SCI, V17, P332, DOI 10.1016/j.tplants.2012.02.003; Gonzalez N, 2009, CURR OPIN PLANT BIOL, V12, P157, DOI 10.1016/j.pbi.2008.11.003; Groszmann M, 2014, PLANT PHYSIOL, V166, P265, DOI 10.1104/pp.114.243998; Hart T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-778; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Hiratsu K, 2002, FEBS LETT, V514, P351, DOI 10.1016/S0014-5793(02)02435-3; Horvath BM, 2006, EMBO J, V25, P4909, DOI 10.1038/sj.emboj.7601362; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Huseby S, 2013, J EXP BOT, V64, P1039, DOI 10.1093/jxb/ers378; Jahns P, 2012, BBA-BIOENERGETICS, V1817, P182, DOI 10.1016/j.bbabio.2011.04.012; Jia Q, 2013, PLANT BIOTECHNOL J, V11, P1069, DOI 10.1111/pbi.12101; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kopriva S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00163; Kusterer B, 2007, GENETICS, V175, P2009, DOI 10.1534/genetics.106.069005; Lee JY, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn449; Leister D, 1999, PLANT PHYSIOL BIOCH, V37, P671, DOI 10.1016/S0981-9428(00)80097-2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindhout BI, 2006, PLANT J, V48, P475, DOI 10.1111/j.1365-313X.2006.02877.x; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Meyer RC, 2004, PLANT PHYSIOL, V134, P1813, DOI 10.1104/pp.103.033001; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Mitsuda N, 2011, METHODS MOL BIOL, V754, P87, DOI 10.1007/978-1-61779-154-3_5; Ohta M, 2001, PLANT CELL, V13, P1959, DOI 10.1105/tpc.13.8.1959; Park KS, 2005, J BACTERIOL, V187, P5496, DOI 10.1128/JB.187.15.5496-5499.2005; Park KS, 2003, NAT BIOTECHNOL, V21, P1208, DOI 10.1038/nbt868; Peng SB, 2009, PLANT PROD SCI, V12, P3, DOI 10.1626/pps.12.3; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; Segal DJ, 1999, P NATL ACAD SCI USA, V96, P2758, DOI 10.1073/pnas.96.6.2758; Sorin E, 2015, J EXP BOT, V66, P6175, DOI 10.1093/jxb/erv321; Sun Y, 2000, CELL RES, V10, P325, DOI 10.1038/sj.cr.7290059; Tessmer OL, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S6-S17; van Tol N, 2016, PLANT CELL ENV; van Tol N, 2014, PLANT SCI, V225, P58, DOI 10.1016/j.plantsci.2014.05.015; Weijers D, 2001, DEVELOPMENT, V128, P4289; WIEBE K, 2008, STATE FOOD AGR 2008; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206	48	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174236	10.1371/journal.pone.0174236	http://dx.doi.org/10.1371/journal.pone.0174236			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358915	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174800024
J	Wang, CS; Du, XJ; He, SR; Yuan, YJ; Han, PF; Wang, D; Chen, YN; Liu, JP; Tian, BL; Yang, G; Yi, SN; Gao, FB; Zhong, ZH; Li, HX; Cheng, JQ; Lu, YR				Wang, Chengshi; Du, Xiaojiong; He, Sirong; Yuan, Yujia; Han, Pengfei; Wang, Dan; Chen, Younan; Liu, Jingping; Tian, Bole; Yang, Guang; Yi, Shounan; Gao, Fabao; Zhong, Zhihui; Li, Hongxia; Cheng, Jingqiu; Lu, Yanrong			A preclinical evaluation of alternative site for islet allotransplantation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CD4(+) T-CELLS; BONE-MARROW; DENDRITIC CELLS; TISSUE FACTOR; TRANSPLANTATION; REJECTION; BLOOD; LIVER; GAMMA	The bone marrow cavity (BMC) has recently been identified as an alternative site to the liver for islet transplantation. This study aimed to compare the BMC with the liver as an islet allotransplantation site in diabetic monkeys. Diabetes was induced in Rhesus monkeys using streptozocin, and the monkeys were then divided into the following three groups: Groupl (islets transplanted in the liver with immunosuppressant), Group 2 (islets transplanted in the tibial BMC), and Group 3 (islets transplanted in the tibial BMC with immunosuppressant). The C-peptide and blood glucose levels were preoperatively measured. An intravenous glucose tolerance test (IVGTT) was conducted to assess graft function, and complete blood cell counts were performed to assess cell population changes. Cytokine expression was measured using an enzyme-linked immune sorbent assay (ELISA) and MILLIPLEX. Five monkeys in Group 3 exhibited a significantly increased insulin-independent time compared with the other groups (Group 1: 78.2 +/- 19.0 days; Group 2: 58.8 +/- 17.0 days; Group 3: 189.6 +/- 26.2 days) and demonstrated increases in plasma C-peptide 4 months after transplantation. The infusion procedure was not associated with adverse effects. Functional islets in the BMC were observed 225 days after transplantation using the dithizone (DTZ) and insulin/glucagon stains. Our results showed that allogeneic islets transplanted in the BMC of diabetic Rhesus monkeys remained alive and functional for a longer time than those transplanted in the liver. This study was the first successful demonstration of allogeneic islet engraftment in the BMC of non-human primates (NHPs).	[Wang, Chengshi; He, Sirong; Yuan, Yujia; Han, Pengfei; Wang, Dan; Chen, Younan; Liu, Jingping; Cheng, Jingqiu; Lu, Yanrong] Sichuan Univ, Key Lab Transplant Engn & Immunol, Minist Hlth, Regenerat Med Res Ctr,West China Hosp, Chengdu, Peoples R China; [Du, Xiaojiong; Tian, Bole] Sichuan Univ, West China Hosp, Dept Vasc Surg, Chengdu, Peoples R China; [Yang, Guang] Sichuan Univ, West China Hosp, Anim Ctr, Chengdu, Peoples R China; [Yi, Shounan] Westmead Hosp, Westmead Inst Med Res, Ctr Transplant & Renal Res, Westmead, NSW, Australia; [Gao, Fabao] Sichuan Univ, West China Hosp, Dept Radiol, Mol Imaging Ctr, Chengdu, Peoples R China; [Zhong, Zhihui; Li, Hongxia] Natl Ctr Safety Evaluat Tradit Chinese Med, Chengdu, Peoples R China	Sichuan University; Sichuan University; Sichuan University; University of Sydney; Westmead Institute for Medical Research; Sichuan University	Cheng, JQ; Lu, YR (corresponding author), Sichuan Univ, Key Lab Transplant Engn & Immunol, Minist Hlth, Regenerat Med Res Ctr,West China Hosp, Chengdu, Peoples R China.	jqcheng@scu.edu.cn; luyanrong@scu.edu.cn	wang, chengshi/AAX-4864-2021; Liu, Jingping/P-8908-2019	wang, chengshi/0000-0002-0650-4109; 	key Program of the National Natural Science Foundation of China [30930088, 81370824]; National Program for High Technology Research and Development of China [2012AA020702]; National Key Clinical Project; Young Scientists Fund of NSFC [81400676]	key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program for High Technology Research and Development of China(National High Technology Research and Development Program of China); National Key Clinical Project; Young Scientists Fund of NSFC(National Natural Science Foundation of China (NSFC))	This study was supported by the key Program of the National Natural Science Foundation of China (30930088, 81370824), the National Program for High Technology Research and Development of China (No. 2012AA020702), the National Key Clinical Project, and the Young Scientists Fund of NSFC (81400676). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams JR, 1999, J CLIN INVEST, V103, P1243, DOI 10.1172/JCI5857; Al-Jazaeri A, 2005, XENOTRANSPLANTATION, V12, P189, DOI 10.1111/j.1399-3089.2005.00220.x; Andrades P, 2008, DIABETOLOGIA, V51, P1236, DOI 10.1007/s00125-008-1030-z; Ault A, 2003, LANCET, V361, P2054; Ben Nasr M, 2015, ACTA DIABETOL, V52, P917, DOI 10.1007/s00592-015-0735-y; Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907; Berman DM, 2007, TRANSPLANTATION, V84, P308, DOI 10.1097/01.tp.0000275401.80187.1e; Cantarelli E, 2016, TRANSPLANTATION; Cantarelli E, 2009, BLOOD, V114, P4566, DOI 10.1182/blood-2009-03-209973; Christoffersson G, 2010, DIABETES, V59, P2569, DOI 10.2337/db10-0205; Ciceri F, 2010, CELL TRANSPLANT, V19, P1511, DOI 10.3727/096368910X514279; Ding YC, 2009, DIABETES, V58, P1797, DOI 10.2337/db09-0317; Dombrowski F, 2006, CANCER RES, V66, P1833, DOI 10.1158/0008-5472.CAN-05-2787; Fiorina P, 2008, AM J TRANSPLANT, V8, P1990, DOI 10.1111/j.1600-6143.2008.02353.x; Fiorina P, 2003, J AM SOC NEPHROL, V14, P2150, DOI 10.1097/01.ASN.0000077339.20759.A3; Fiorina P, 2011, J IMMUNOL, V186, P121, DOI 10.4049/jimmunol.1000799; Frassoni F, 2008, LANCET ONCOL, V9, P831, DOI 10.1016/S1470-2045(08)70180-3; Frassoni F, 2010, BEST PRACT RES CL HA, V23, P237, DOI 10.1016/j.beha.2010.06.003; Friedman T, 1999, DIABETES, V48, P2340, DOI 10.2337/diabetes.48.12.2340; Goto M, 2008, XENOTRANSPLANTATION, V15, P225, DOI 10.1111/j.1399-3089.2008.00482.x; Jin X, 2010, EXP BIOL MED, V235, P877, DOI 10.1258/ebm.2010.009361; Kleijwegt FS, 2013, EUR J IMMUNOL, V43, P85, DOI 10.1002/eji.201242879; Kover K, 2011, ISLETS, V3, P93, DOI 10.4161/isl.3.3.15567; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Maffi P, 2013, DIABETES, V62, P3523, DOI 10.2337/db13-0465; Salazar-Maya AM, 2008, AQUICHAN, V8, P8; Meier RPH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091268; Moberg L, 2002, LANCET, V360, P2039, DOI 10.1016/S0140-6736(02)12020-4; Movahedi B, 2003, TRANSPL INT, V16, P186, DOI 10.1111/j.1432-2277.2003.tb00284.x; Perez VL, 2011, DIABETOLOGIA, V54, P1121, DOI 10.1007/s00125-011-2091-y; Rafael E, 2008, AM J TRANSPLANT, V8, P458, DOI 10.1111/j.1600-6143.2007.02060.x; Sakata N, 2009, TRANSPLANTATION, V87, P825, DOI 10.1097/TP.0b013e318199c7d2; Salazar-Banuelos A, 2010, BLOOD, V115, P3643, DOI 10.1182/blood-2009-12-256826; Schmidt P, 2004, XENOTRANSPLANTATION, V11, P347, DOI 10.1111/j.1399-3089.2004.00145.x; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Shimoda M, 2010, DIABETOLOGIA, V53, P1669, DOI 10.1007/s00125-010-1745-5; Sotiropoulou PA, 2006, STEM CELLS, V24, P74, DOI 10.1634/stemcells.2004-0359; Svensson J, 2011, CELL TRANSPLANT, V20, P783, DOI 10.3727/096368910X536527; Toso C, 2009, TRANSPLANTATION, V88, P1286, DOI 10.1097/TP.0b013e3181bc06b0; Toyofuku A, 2006, DIABETES, V55, P34, DOI 10.2337/diabetes.55.01.06.db05-0692; Turnquist HR, 2007, J IMMUNOL, V178, P7018, DOI 10.4049/jimmunol.178.11.7018; Wang C, 2015, SYLWAN, V159, P147; Wu H, 2013, MOL THER, V21, P1778, DOI 10.1038/mt.2013.147; Yasunami Y, 2005, J EXP MED, V202, P913, DOI 10.1084/jem.20050448; Yi SN, 2003, J IMMUNOL, V170, P2750, DOI 10.4049/jimmunol.170.5.2750; Yin DP, 2002, TRANSPLANTATION, V74, P1236, DOI 10.1097/00007890-200211150-00007	46	7	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174505	10.1371/journal.pone.0174505	http://dx.doi.org/10.1371/journal.pone.0174505			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358858	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174800046
J	Ma, ZB; Wang, XJ; He, JH; Xia, JC; Li, YF				Ma, Zebiao; Wang, Xiaojing; He, Jiehua; Xia, Jianchuan; Li, Yanfang			Increased expression of protein kinase CK2 alpha correlates with poor patient prognosis in epithelial ovarian cancer	PLOS ONE			English	Article							NF-KAPPA-B; CATALYTIC SUBUNIT; CK2; INHIBITION; PROLIFERATION; PACLITAXEL; CARCINOMA; CISPLATIN; APOPTOSIS; PATTERNS	Epithelial ovarian cancer (EOC) is one of the deadly gynecological malignancies. The function of protein kinase CK2 alpha(CK2 alpha) in EOC is still unknown. Our study aimed to investigate the relationship between the protein expression of CK2 alpha and the tumor progression, the prognosis of human EOC. In this study, we analyzed the expression levels of CK2 alpha through Western blot, using EOC cell lines like A2780, HO8910, COV644, OVCAR3, SKOV3, and the primary normal ovarian surface epithelial (NOSE) cells. Furthermore, OVCAR3 and SKOV3 EOC cells were employed as a cellular model to study the role of CK2 alpha on cell growth, migration, invasion, apoptosis, and cell cycle distribution. In addition, we investigated CK2 alpha protein expression in tumor tissues from patients with EOC by immunohistochemistry and analyzed the association between CK2 alpha expression and clinicopathologic parameters and prognosis of EOC patients. And we found that compared with NOSE cells, CK2 alpha protein expression was increased in A2780, HO8910, OVCAR3, and SKOV3 ovarian cancer cell lines. Decreased CK2 alpha expression suppressed OVCAR3 and SKOV3 cell growth and induced more apoptosis. CK2 alpha knockdown using specific siRNAs inhibited migration and invasion ability of OVCAR3 and SKOV3 cells. In addition, high CK2 alpha protein expression was found in 68.4% (80/117) of EOC patients. Increased CK2 alpha expression of was significantly correlated with FIGO staging and peritoneal cytology. Patients with higher CK2 alpha expression had a significantly poorer overall survival compared with those with lower CK2 alpha expression. Multi-variate Cox regression analysis proved that increased CK2 alpha expression was an independent prognostic marker for EOC. Taken together, our data displayed that CK2 alpha may play a role in tumor aggressive behavior of EOC and could be used as a marker for predicting prognosis of EOC patient. High CK2 alpha expression might predict poor patient survival.	[Ma, Zebiao; He, Jiehua; Xia, Jianchuan; Li, Yanfang] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Ma, Zebiao; Li, Yanfang] Sun Yat Sen Univ, Ctr Canc, Dept Gynecol Oncol, Guangzhou, Guangdong, Peoples R China; [Ma, Zebiao] Shantou Univ, Coll Med, Canc Hosp, Dept Gynecol Oncol, Shantou, Guangdong, Peoples R China; [Wang, Xiaojing] Zhengzhou Univ, Henan Prov Canc Hosp, Affiliated Canc Hosp, Dept Gynecol Oncol, Zhengzhou, Henan, Peoples R China; [He, Jiehua] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Xia, Jianchuan] Sun Yat Sen Univ, Ctr Canc, Dept Biotherapy, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Shantou University; Zhengzhou University; Sun Yat Sen University; Sun Yat Sen University	Xia, JC; Li, YF (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.; Li, YF (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Gynecol Oncol, Guangzhou, Guangdong, Peoples R China.; Xia, JC (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Biotherapy, Guangzhou, Guangdong, Peoples R China.	xiajch@sysucc.org.cn; liyf@sysucc.org.cn	li, yan/GTI-4638-2022; wang, xiao/HGB-7081-2022	wang, xiao/0000-0002-4088-3341				Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Bae JS, 2015, INT J CANCER, V136, P797, DOI 10.1002/ijc.29043; Brown MS, 2010, CLIN CANCER RES, V16, P2295, DOI 10.1158/1078-0432.CCR-09-3200; Chan JK, 2006, OBSTET GYNECOL, V108, P521, DOI 10.1097/01.AOG.0000231680.58221.a7; Chen CL, 2016, ONCOTARGET, V7, P16248, DOI 10.18632/oncotarget.7637; Chiaramonte R, 2015, INT J BIOCHEM CELL B, V66, P134, DOI 10.1016/j.biocel.2015.07.015; Dixit D, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.10; Dominguez I, 2009, CELL MOL LIFE SCI, V66, P1850, DOI 10.1007/s00018-009-9153-z; Giusiano S, 2011, EUR J CANCER, V47, P792, DOI 10.1016/j.ejca.2010.11.028; Griffiths C T, 1975, Natl Cancer Inst Monogr, V42, P101; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; Guerra B, 2008, CURR MED CHEM, V15, P1870, DOI 10.2174/092986708785132933; HAMILTON TC, 1983, CANCER RES, V43, P5379; Hessenauer A, 2011, CELL SIGNAL, V23, P145, DOI 10.1016/j.cellsig.2010.08.014; Jelovac D, 2011, CA-CANCER J CLIN, V61, P183, DOI 10.3322/caac.20113; Katsumata N, 2009, LANCET, V374, P1331, DOI 10.1016/S0140-6736(09)61157-0; Kendall JJ, 2016, ONCOTARGET; Kim JS, 2007, CLIN CANCER RES, V13, P1019, DOI 10.1158/1078-0432.CCR-06-1602; Lan CY, 2009, GYNECOL ONCOL, V114, P42, DOI 10.1016/j.ygyno.2009.03.034; Laramas M, 2007, EUR J CANCER, V43, P928, DOI 10.1016/j.ejca.2006.11.021; Lin KY, 2010, ANN SURG ONCOL, V17, P1695, DOI 10.1245/s10434-010-0911-9; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Martins LR, 2010, BLOOD, V116, P2724, DOI 10.1182/blood-2010-04-277947; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; MORIMOTO H, 1991, J IMMUNOL, V147, P2609; Ortega CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115609; Pathak HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144126; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Prat J, 2012, ANN ONCOL, V23, P111, DOI 10.1093/annonc/mds300; Presneau N, 2003, ONCOGENE, V22, P1568, DOI 10.1038/sj.onc.1206219; Prudent R, 2010, CANCER RES, V70, P9865, DOI 10.1158/0008-5472.CAN-10-0917; Rozanov DV, 2008, CANCER RES, V68, P4086, DOI 10.1158/0008-5472.CAN-07-6458; Shimada K, 2011, BMC UROL, V11, DOI 10.1186/1471-2490-11-8; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Tang AQ, 2015, MOL MED REP, V11, P2221, DOI 10.3892/mmr.2014.2974; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Wong AST, 2001, GYNECOL ONCOL, V82, P305, DOI 10.1006/gyno.2001.6280; Wright JD, 2015, OBSTET GYNECOL, V125, P1345, DOI 10.1097/AOG.0000000000000854; YOUNG RC, 1983, JAMA-J AM MED ASSOC, V250, P3072, DOI 10.1001/jama.250.22.3072; Zhang HX, 2015, ONCOTARGET, V6, P34800, DOI 10.18632/oncotarget.5470; Zhang SL, 2013, J CELL MOL MED, V17, P854, DOI 10.1111/jcmm.12068; Zhang SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038996; Zhang XZ, 2016, PROCEEDINGS 2016 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P2016, DOI 10.1109/ICIT.2016.7475077; Zou JJ, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-97	44	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174037	10.1371/journal.pone.0174037	http://dx.doi.org/10.1371/journal.pone.0174037			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355289	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174600034
J	Iwakura, Y; Wang, R; Inamura, N; Araki, K; Higashiyama, S; Takei, N; Nawa, H				Iwakura, Yuriko; Wang, Ran; Inamura, Naoko; Araki, Kazuaki; Higashiyama, Shigeki; Takei, Nobuyuki; Nawa, Hiroyuki			Glutamate-dependent ectodomain shedding of neuregulin-1 type II precursors in rat forebrain neurons	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; ALPHA-CONVERTING ENZYME; NICOTINIC ACETYLCHOLINE-RECEPTORS; PERIPHERAL NERVOUS-SYSTEM; PROTEIN-KINASE-C; SYNAPTIC PLASTICITY; SIGNALING PATHWAYS; PARKINSONS-DISEASE; PKC ACTIVATION; ADULT-RAT	The neurotrophic factor neuregulin 1 (NRG1) regulates neuronal development, glial differentiation, and excitatory synapse maturation. NRG1 is synthesized as a membrane-anchored precursor and is then liberated by proteolytic processing or exocytosis. Mature NRG1 then binds to its receptors expressed by neighboring neurons or glial cells. However, the molecular mechanisms that govern this process in the nervous system are not defined in detail. Here we prepared neuron-enriched and glia-enriched cultures from embryonic rat neocortex to investigate the role of neurotransmitters that regulate the liberation/release of NRG1 from the membrane of neurons or glial cells. Using a two-site enzyme immunoassay to detect soluble NRG1, we show that, of various neurotransmitters, glutamate was the most potent inducer of NRG1 release in neuron-enriched cultures. NRG1 release in glia-enriched cultures was relatively limited. Furthermore, among glutamate receptor agonists, N-Methyl-DAspartate (NMDA) and kainate (KA), but not AMPA or tACPD, mimicked the effects of glutamate. Similar findings were acquired from analysis of the hippocampus of rats with KAinduced seizures. To evaluate the contribution of members of a disintegrin and metalloproteinase (ADAM) families to NRG1 release, we transfected primary cultures of neurons with cDNA vectors encoding NRG1 types I, II, or III precursors, each tagged with the alkaline phosphatase reporter. Analysis of alkaline phosphatase activity revealed that the NRG1 type II precursor was subjected to tumor necrosis factor-a-converting enzyme (TACE) / a Disintegrin And Metalloproteinase 17 (ADAM17)-dependent ectodomain shedding in a protein kinase C-dependent manner. These results suggest that glutamatergic neurotransmission positively regulates the ectodomain shedding of NRG1 type II precursors and liberates the active NRG1 domain in an activity-dependent manner.	[Iwakura, Yuriko; Wang, Ran; Inamura, Naoko; Araki, Kazuaki; Takei, Nobuyuki; Nawa, Hiroyuki] Niigata Univ, Brain Res Inst, Dept Mol Neurobiol, Niigata, Japan; [Higashiyama, Shigeki] Ehime Univ, Grad Sch Med, Dept Biochem & Mol Genet, Matsuyama, Ehime, Japan	Niigata University; Ehime University	Iwakura, Y (corresponding author), Niigata Univ, Brain Res Inst, Dept Mol Neurobiol, Niigata, Japan.	yuriko@bri.niigata-u.ac.jp			Naito Foundation Grant for Promotion of Niigata University Research Projects [23C054];  [24700375];  [24116010]; Grants-in-Aid for Scientific Research [16K07053] Funding Source: KAKEN	Naito Foundation Grant for Promotion of Niigata University Research Projects; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant-in-Aid for Young Scientists number 24700375 (YI), The Naito Foundation Grant for Promotion of Niigata University Research Projects number 23C054 (YI), and Grant-in-Aid for Scientific Research on Innovative Areas number 24116010 (HN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2011, J NEUROSCI, V31, P5699, DOI 10.1523/JNEUROSCI.3477-10.2011; Aracri P, 2013, SYNAPSE, V67, P338, DOI 10.1002/syn.21655; BENNETT BD, 1994, NEUROSCIENCE, V62, P707, DOI 10.1016/0306-4522(94)90471-5; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BOWERS GN, 1966, CLIN CHEM, V12, P70; Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Calabresi P, 1998, EUR J NEUROSCI, V10, P2887, DOI 10.1111/j.1460-9568.1998.00294.x; Chakravarthy B, 1999, TRENDS NEUROSCI, V22, P12, DOI 10.1016/S0166-2236(98)01288-0; Cho RW, 2008, NEURON, V57, P858, DOI 10.1016/j.neuron.2008.01.010; Conti F, 1996, GLIA; Dang M, 2013, P NATL ACAD SCI USA, V110, P9776, DOI 10.1073/pnas.1307478110; Dethlefsen SM, 1998, J CELL BIOCHEM, V69, P143, DOI 10.1002/(SICI)1097-4644(19980501)69:2<143::AID-JCB5>3.0.CO;2-S; Eilam R, 1998, P NATL ACAD SCI USA, V95, P1888, DOI 10.1073/pnas.95.4.1888; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fleck D, 2016, J BIOL CHEM, V291, P318, DOI 10.1074/jbc.M115.697995; Fleck D, 2013, J NEUROSCI, V33, P7856, DOI 10.1523/JNEUROSCI.3372-12.2013; Gallo V, 2000, TRENDS PHARMACOL SCI, V21, P252, DOI 10.1016/S0165-6147(00)01494-2; Goddard DR, 2001, GLIA, V34, P267, DOI 10.1002/glia.1060; Gomez-Varela D, 2013, J NEUROSCI, V 33, P17062, DOI 10.1523/JNEUROSCI.1482-13.2013; Hama Y, 2015, NEUROSCI LETT, V587, P17, DOI 10.1016/j.neulet.2014.12.024; Hancock ML, 2008, J CELL BIOL, V181, P511, DOI 10.1083/jcb.200710037; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Hiraoka Y, 2008, BIOCHEM BIOPH RES CO, V370, P154, DOI 10.1016/j.bbrc.2008.03.050; Hoey SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078155; Horiuchi K, 2005, DEV BIOL, V283, P459, DOI 10.1016/j.ydbio.2005.05.004; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Iwakura Y, 2005, J NEUROCHEM, V93, P974, DOI 10.1111/j.1471-4159.2005.03073.x; Iwakura Y, 2001, J BIOL CHEM, V276, P40025, DOI 10.1074/jbc.M103125200; Iwakura Y, 2011, J NEUROCHEM, V118, P57, DOI 10.1111/j.1471-4159.2011.07295.x; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kannangara TS, 2015, CEREB CORTEX, V25, P2102, DOI 10.1093/cercor/bhu017; Karkkainen I, 2000, MOL CELL NEUROSCI, V15, P547, DOI 10.1006/mcne.2000.0848; Kato T, 2015, CURR MOL MED, V15, P222, DOI 10.2174/1566524015666150330143300; Kerber G, 2003, J MOL NEUROSCI, V21, P149, DOI 10.1385/JMN:21:2:149; Kornblum HI, 2000, DEV NEUROSCI-BASEL, V22, P16, DOI 10.1159/000017423; Krivosheya D, 2008, J BIOL CHEM, V283, P32944, DOI 10.1074/jbc.M800073200; KUBOTA Y, 1987, BRAIN RES, V406, P147, DOI 10.1016/0006-8993(87)90779-7; Kwan JC, 2009, J MED CHEM, V52, P5732, DOI 10.1021/jm9009394; Le Gall SM, 2003, J BIOL CHEM, V278, P45255, DOI 10.1074/jbc.M307745200; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Liu SJ, 2006, J NEUROSCI, V26, P9332, DOI 10.1523/JNEUROSCI.2929-06.2006; Liu XH, 2011, J NEUROSCI, V31, P8491, DOI 10.1523/JNEUROSCI.5317-10.2011; Liu Y, 2007, J NEUROSCI, V27, P5301, DOI 10.1523/JNEUROSCI.0376-07.2007; Luo XY, 2011, J BIOL CHEM, V286, P23967, DOI 10.1074/jbc.M111.251538; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Mei L, 2014, NEURON, V83, P27, DOI 10.1016/j.neuron.2014.06.007; Merlos-Suarez A, 2001, J BIOL CHEM, V276, P48510, DOI 10.1074/jbc.M103488200; Miller OH, 2014, ELIFE, V3, DOI 10.7554/eLife.03581; Montero JC, 2000, MOL CELL NEUROSCI, V16, P631, DOI 10.1006/mcne.2000.0896; Moss ML, 2007, ANAL BIOCHEM, V366, P144, DOI 10.1016/j.ab.2007.04.043; MURPHY NP, 1994, EUR J NEUROSCI, V6, P854, DOI 10.1111/j.1460-9568.1994.tb00995.x; Nishi E, 2006, J BIOL CHEM, V281, P31164, DOI 10.1074/jbc.M601316200; O'Keeffe GC, 2009, P NATL ACAD SCI USA, V106, P8754, DOI 10.1073/pnas.0803955106; Oh M, 2004, BIOORG MED CHEM LETT, V14, P6071, DOI 10.1016/j.bmcl.2004.09.082; Ohno M, 2009, NAT NEUROSCI, V12, P1506, DOI 10.1038/nn.2438; Ozaki M, 2004, J NEUROCHEM, V91, P176, DOI 10.1111/j.1471-4159.2004.02719.x; Parikh V, 2010, J NEUROSCI, V30, P3518, DOI 10.1523/JNEUROSCI.5712-09.2010; Park JS, 2009, J NEUROSCI, V29, P3206, DOI 10.1523/JNEUROSCI.4514-08.2009; PATNEAU DK, 1994, NEURON, V12, P357, DOI 10.1016/0896-6273(94)90277-1; Raabe TD, 1997, J NEUROCHEM, V69, P1859; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Rossner S, 2005, J NEUROCHEM, V92, P226, DOI 10.1111/j.1471-4159.2004.02857.x; Sato T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127360; SCERRATI M, 1986, DRUG EXP CLIN RES, V12, P671; Schafer B, 2004, J BIOL CHEM, V279, P47929, DOI 10.1074/jbc.M400129200; Schlondorff J, 1999, J CELL SCI, V112, P3603; Seshadri S, 2010, P NATL ACAD SCI USA, V107, P5622, DOI 10.1073/pnas.0909284107; Shibuya M, 2010, J NEURAL TRANSM, V117, P887, DOI 10.1007/s00702-010-0418-3; Shishido Y, 2006, BIOCHEM BIOPH RES CO, V348, P963, DOI 10.1016/j.bbrc.2006.07.129; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Steiner H, 1999, EXP NEUROL, V159, P494, DOI 10.1006/exnr.1999.7163; Steinthorsdottir V, 2004, GENE, V342, P97, DOI 10.1016/j.gene.2004.07.029; Tamura H, 2012, J NEUROSCI, V32, P12657, DOI 10.1523/JNEUROSCI.2542-12.2012; Taylor AR, 2012, NEUROSCI LETT, V531, P131, DOI 10.1016/j.neulet.2012.10.018; Taylor SB, 2013, NEUROSCIENCE, V249, P31, DOI 10.1016/j.neuroscience.2012.09.045; Vullhorst D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8222; Woo RS, 2007, NEURON, V54, P599, DOI 10.1016/j.neuron.2007.04.009; Yang X, 1998, NEURON, V20, P255, DOI 10.1016/S0896-6273(00)80454-7; Yin DM, 2015, MOL PSYCHIATR, V20, P1251, DOI 10.1038/mp.2014.131; Yokozeki T, 2007, GENES CELLS, V12, P329, DOI 10.1111/j.1365-2443.2007.01060.x; Zhong CB, 2008, J NEUROSCI, V28, P9111, DOI 10.1523/JNEUROSCI.0381-08.2008	83	17	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174780	10.1371/journal.pone.0174780	http://dx.doi.org/10.1371/journal.pone.0174780			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350885	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174400076
J	Kim, BW; Kim, SY; Lee, YS; Kim, SM; Chang, HS; Park, CS				Kim, Bup-Woo; Kim, Soo Young; Lee, Yong Sang; Kim, Seok-Mo; Chang, Hang-Seok; Park, Cheong Soo			Parathyroid score can predict the duration of required calcium supplementation after total thyroidectomy	PLOS ONE			English	Article							RISK-FACTORS; HYPOCALCEMIA; HORMONE; HYPOPARATHYROIDISM; AUTOTRANSPLANTATION	Background Postoperative hypoparathyroidism is the most common complication after total thyroidectomy, owing to unintentional injury or decreased blood flow to the parathyroid glands. Prediction of postoperative hypoparathyroidism would be helpful for surgeons to manage postoperative hypocalcemia. In this study, we scored the discoloration of the parathyroid glands using a new parathyroid scoring system and evaluated the correlation between the parathyroid score and duration of required calcium supplementation after total thyroidectomy. Methods A total of 316 patients undergoing total thyroidectomy between November 2009 and April 2010 were enrolled in this retrospective study. Parathyroid scoring was performed by one experienced surgeon. The status of each of the 4 parathyroid glands was classified as normal color (3 points), slightly discolored (2 points), dark discoloration (1 point), or loss of the gland (0 points), resulting in possible total scores of 0-12. Serum parathyroid hormone (PTH), serum calcium, and ionized calcium concentrations were measured at 2 hours, 2 weeks, 3 months, 6 months, and 1 year after surgery. Patients were also divided into three groups based on the duration of required calcium supplementation: no required supplementation (n = 260, 82.3%), required supplementation for < 6 months (n = 38, 12%), and required supplementation for >= 6 months (n = 18, 5.75%). Results Parathyroid scores were positively correlated with ionized PTH concentrations at 2 hours (r = 0.053, p < 0.001), 2 weeks (r = 0.056, p < 0.001), 3 months (r = 0.032, p < 0.001), 6 months (r = 0.072, p < 0.001), and 1 year (r = 0.071, p < 0.001) after thyroidectomy. Parathyroid scores were significantly and inversely associated with the duration of required calcium supplementation (p = 0.001). Conclusions Parathyroid scores at the end of surgery might be helpful for predicting the degree of postoperative hypocalcemia after total thyroidetomy.	[Kim, Bup-Woo; Kim, Soo Young; Lee, Yong Sang; Kim, Seok-Mo; Chang, Hang-Seok; Park, Cheong Soo] Yonsei Univ, Gangnam Severance Hosp, Dept Surg, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System	Chang, HS (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Dept Surg, Coll Med, Seoul, South Korea.	surghsc@yuhs.ac	Kim, Seok-Mo/AAK-5898-2020	Kim, Seok-Mo/0000-0001-8070-0573; Chang, Hang-Seok/0000-0002-5162-103X; Kim, Bup-Woo/0000-0002-1342-9055; Lee, Yong Sang/0000-0002-8234-8718; Kim, Soo Young/0000-0002-8919-3456	faculty research grant of Yonsei University Col lege of Medicine [6-2011-0066]	faculty research grant of Yonsei University Col lege of Medicine	This study was financially supported by the faculty research grant of Yonsei University Col lege of Medicine for 2011 (6-2011-0066),http://medicine.yonsei.ac.kr/. Bup - Woo Kim received this grant.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud B, 2002, J AM COLL SURGEONS, V195, P456, DOI 10.1016/S1072-7515(02)01310-8; Asari R, 2008, ARCH SURG-CHICAGO, V143, P132, DOI 10.1001/archsurg.2007.55; Bilezikian JP, 2011, J BONE MINER RES, V26, P2317, DOI 10.1002/jbmr.483; Cavallaro G, 2015, WORLD J SURG, V39, P1936, DOI 10.1007/s00268-015-3070-0; Chow TL, 2014, AM J OTOLARYNG, V35, P736, DOI 10.1016/j.amjoto.2014.07.006; Erbil Y, 2009, AM J SURG, V197, P439, DOI 10.1016/j.amjsurg.2008.01.032; Gupta S, 2015, INT J SURG, V18, P150, DOI 10.1016/j.ijsu.2015.04.074; Harris VW, 2009, THYROID, V19, P967, DOI 10.1089/thy.2008.0306; Kihara M, 2003, HEAD NECK-J SCI SPEC, V25, p799 ; Lo CY, 2002, ANZ J SURG, V72, P902, DOI 10.1046/j.1445-2197.2002.02580.x; McCullough M, 2013, AM SURGEON, V79, P768; MCHENRY CR, 1994, SURGERY, V116, P641; Pattou F, 1998, WORLD J SURG, V22, P718, DOI 10.1007/s002689900459; PAYNE RB, 1973, BMJ-BRIT MED J, V4, P643, DOI 10.1136/bmj.4.5893.643; Prim MP, 2001, OTOLARYNG HEAD NECK, V124, P111, DOI 10.1067/mhn.2001.112305; Promberger R, 2010, THYROID, V20, P1371, DOI 10.1089/thy.2010.0157; Rubin MR, 2008, EUR J ENDOCRINOL, V159, P469, DOI 10.1530/EJE-08-0169; Rubin MR, 2010, ARQ BRAS ENDOCRINOL, V54, P220, DOI 10.1590/S0004-27302010000200019; Sywak MS, 2007, ANZ J SURG, V77, P667, DOI 10.1111/j.1445-2197.2007.04183.x; Toniato A, 2008, AM J SURG, V196, P285, DOI 10.1016/j.amjsurg.2007.06.036	20	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174088	10.1371/journal.pone.0174088	http://dx.doi.org/10.1371/journal.pone.0174088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350886	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174400014
J	Ramirez-GarciaLuna, JL; Chan, D; Samberg, R; Abou-Rjeili, M; Wong, TH; Li, AL; Feyerabend, TB; Rodewald, HR; Henderson, JE; Martineau, PA				Ramirez-GarciaLuna, Jose Luis; Chan, Daniel; Samberg, Robert; Abou-Rjeili, Mira; Wong, Timothy H.; Li, Ailian; Feyerabend, Thorsten B.; Rodewald, Hans-Reimer; Henderson, Janet E.; Martineau, Paul A.			Defective bone repair in mast cell-deficient cpa3Cre/+mice	PLOS ONE			English	Article							ENDOCHONDRAL OSSIFICATION; GROWTH-FACTOR; IN-VIVO; MICE; PROGENITORS; MODELS; INFLAMMATION; MACROPHAGES; RELEASE; TISSUES	In the adult skeleton, cells of the immune system interact with those of the skeleton during all phases of bone repair to influence the outcome. Mast cells are immune cells best known for their pathologic role in allergy, and may be involved in chronic inflammatory and fibrotic disorders. Potential roles for mast cells in tissue homeostasis, vascularization and repair remain enigmatic. Previous studies in combined mast cell-and Kit-deficient Kit(w-sh/w-sh) mice (Kit(w-sh)) implicated mast cells in bone repair but Kit(w-sh) mice suffer from additional Kit dependent hematopoietic and non-hematopoietic deficiencies that could have confounded the outcome. The goal of the current study was to compare bone repair in normal wild type (W7) and Cpa3(Cre/+) mice, which lack mast cells in the absence of any other hematopoietic or non-hematopoietic deficiencies. Repair of a femoral window defect was characterized using micro CT imaging and histological analyses from the early inflammatory phase, through soft and hard callus formation, and finally the remodeling phase. The data indicate 1) mast cells appear in healing bone of VVT mice but not Cpa3(Cre/+) mice, beginning 14 days after surgery; 2) re-vascularization of repair tissue and deposition of mineralized bone was delayed and dis-organised in Cpa3(Cre/+) mice compared with WTmice; 3) the defects in Cpa3(Cre/+) mice were associated with little change in anabolic activity and biphasic alterations in osteoclast and macrophage activity. The outcome at 56 days postoperative was complete bridging of the defect in most VVT mice and fibrous mal-union in most Cpa3(Cre/+) mice. The results indicate that mast cells promote bone healing, possibly by recruiting vascular endothelial cells during the inflammatory phase and coordinating anabolic and catabolic activity during tissue remodeling. Taken together the data indicate that mast cells have a positive impact on bone repair.	[Ramirez-GarciaLuna, Jose Luis; Chan, Daniel; Samberg, Robert; Abou-Rjeili, Mira; Wong, Timothy H.; Li, Ailian; Henderson, Janet E.; Martineau, Paul A.] McGill Univ, Montreal Gen Hosp, Hlth Ctr, Bone Engn Labs,Res Inst, C10-160,Cedar Ave, Montreal, PQ, Canada; [Ramirez-GarciaLuna, Jose Luis; Henderson, Janet E.] McGill Univ, Fac Med, Expt Surg, Rue Montaigne, Montreal, PQ, Canada; [Chan, Daniel; Wong, Timothy H.] Univ British Columbia, Biotechnol Program, West Mall, Vancouver, BC, Canada; [Abou-Rjeili, Mira; Henderson, Janet E.] McGill Univ, Expt Med, Fac Med, Rue Montaigne, Montreal, PQ, Canada; [Feyerabend, Thorsten B.; Rodewald, Hans-Reimer] German Canc Res Ctr, Div Cellular Immunol, Heidelberg, Germany	McGill University; McGill University; University of British Columbia; McGill University; Helmholtz Association; German Cancer Research Center (DKFZ)	Henderson, JE (corresponding author), McGill Univ, Montreal Gen Hosp, Hlth Ctr, Bone Engn Labs,Res Inst, C10-160,Cedar Ave, Montreal, PQ, Canada.; Henderson, JE (corresponding author), McGill Univ, Fac Med, Expt Surg, Rue Montaigne, Montreal, PQ, Canada.; Henderson, JE (corresponding author), McGill Univ, Expt Med, Fac Med, Rue Montaigne, Montreal, PQ, Canada.	janet.henderson@mcgill.ca	Ramirez-GarciaLuna, Jose/I-6798-2019	Ramirez-GarciaLuna, Jose/0000-0002-3953-9762	Fonds de Recherche Sante Quebec- Reseau de Recherche en Sante Buccodentaire et Osseuse (FRSQ-RSBO); Jo Miller Orthopaedic Fund; Mexican National Council for Science and Technology (CONACYT); Fonds de Recherche Sante Quebec- Reseau de Recherche en Sante Buccodentaire et Osseuse; Fonds de la Recherche en Sante du Quebec [24813]; Deutsche Forschungsgemeinschaft [SFB Transregio 156]	Fonds de Recherche Sante Quebec- Reseau de Recherche en Sante Buccodentaire et Osseuse (FRSQ-RSBO); Jo Miller Orthopaedic Fund; Mexican National Council for Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fonds de Recherche Sante Quebec- Reseau de Recherche en Sante Buccodentaire et Osseuse; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The Bone Engineering Labs are supported in part by the Fonds de Recherche Sante Quebec- Reseau de Recherche en Sante Buccodentaire et Osseuse (FRSQ-RSBO, http://www.rsbo.ca/) and the Jo Miller Orthopaedic Fund. Jose Ramirez-GarciaLuna is a scholar of the Mexican National Council for Science and Technology (CONACYT, http://www.conacyt.gob.mx/), Robert Samberg by a bursary from McGill Faculty of Medicine, Timothy H. Wong by a studentship from Fonds de Recherche Sante Quebec- Reseau de Recherche en Sante Buccodentaire et Osseuse, and Paul A Martineau is a Chercheur boursier clincien Junior 2 of the Fonds de la Recherche en Sante du Quebec (http://www.frqs.gouv.qc.ca/en/, funding reference number 24813). Thorsten B Feyerabend and Hans-Reimer Rodewald were funded by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/, SFB Transregio 156). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354; Antebi B, 2016, BIOENGINEERING, V3, P3390; BANOVAC K, 1995, J ORTHOP TRAUMA, V9, P482, DOI 10.1097/00005131-199509060-00005; Behrends D, 2016, CLIN ORTHOP IN PRESS; Behrends DA, 2014, EUR CELLS MATER, V28, P209, DOI 10.22203/eCM.v028a14; Bisseret D, 2015, SKELETAL RADIOL, V44, P321, DOI 10.1007/s00256-014-1976-5; Blair RJ, 1997, J CLIN INVEST, V99, P2691, DOI 10.1172/JCI119458; Boesiger J, 1998, J EXP MED, V188, P1135, DOI 10.1084/jem.188.6.1135; Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232; Cindik E D, 2000, Technol Health Care, V8, P267; Dahlin JS, 2013, ALLERGY, V68, P1333, DOI 10.1111/all.12223; Dahlin JS, 2015, MOL IMMUNOL, V63, P9, DOI 10.1016/j.molimm.2014.01.018; Einhorn TA, 1999, CLIN ORTHOP RELAT R, pS59, DOI 10.1097/00003086-199910001-00007; Feyerabend TB, 2016, CELL METAB, V24, P1, DOI 10.1016/j.cmet.2016.06.019; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Gao C, 2013, EUR CELLS MATER, V26, P195, DOI 10.22203/eCM.v026a14; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Henderson J., 2011, METHODS BONE BIOL TI; Kunder CA, 2011, BLOOD, V118, P5383, DOI 10.1182/blood-2011-07-358432; Lemos-Azi M, 2016, BMC MUSCULOSKEL DIS, V17, P465; Lorenzo J, 2015, OSTEOIMMUNOLOGY; Michel A, 2013, J IMMUNOL, V190, P5534, DOI 10.4049/jimmunol.1203355; Moon TC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00569; Nigrovic PA, 2008, AM J PATHOL, V173, P1693, DOI 10.2353/ajpath.2008.080407; Pasparakis M, 2014, NAT REV IMMUNOL, V14, P289, DOI 10.1038/nri3646; Pejler G, 2009, TRENDS IMMUNOL, V30, P401, DOI 10.1016/j.it.2009.04.008; Raggatt LJ, 2014, AM J PATHOL, V184, P3192, DOI 10.1016/j.ajpath.2014.08.017; Rodewald H, 2012, IMMUNITY, V37, P13024; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; Schneider LA, 2007, J EXP MED, V204, P2629, DOI 10.1084/jem.20071262; Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661; Simons M, 2005, CIRCULATION, V111, P1556, DOI 10.1161/01.CIR.0000159345.00591.8F; Soldado F, 2012, J PEDIATR ORTHOPED, V32, P308, DOI 10.1097/BPO.0b013e31824b2843; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Valverde-Franco G, 2004, HUM MOL GENET, V13, P271, DOI 10.1093/hmg/ddh034; van Gastel N, 2014, STEM CELLS, V32, P2407, DOI 10.1002/stem.1783; Vortkamp A, 1998, MECH DEVELOP, V71, P65, DOI 10.1016/S0925-4773(97)00203-7	37	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174396	10.1371/journal.pone.0174396	http://dx.doi.org/10.1371/journal.pone.0174396			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350850	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174400034
J	Maman, S; Murray, KR; Mavedzenge, SN; Oluoch, L; Sijenje, F; Agot, K; Thirumurthy, H				Maman, Suzanne; Murray, Katherine R.; Mavedzenge, Sue Napierala; Oluoch, Lennah; Sijenje, Florence; Agot, Kawango; Thirumurthy, Harsha			A qualitative study of secondary distribution of HIV self-test kits by female sex workers in Kenya	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; CARE; TRANSMISSION; CLIENTS; TRIAL	Promoting awareness of serostatus and frequent HIV testing is especially important among high risk populations such as female sex workers (FSW) and their sexual partners. HIV self-testing is an approach that is gaining ground in sub-Saharan Africa as a strategy to increase knowledge of HIV status and promote safer sexual decisions. However, little is known about self-test distribution strategies that are optimal for increasing testing access among hard-toreach and high risk individuals. We conducted a qualitative study with 18 FSW who participated in a larger study that provided them with five oral fluid-based self-tests, training on how to use the tests, and encouragement to offer the self-tests to their sexual partners using their discretion. Women demonstrated agency in the strategies they used to introduce self-tests to their partners and to avoid conflict with partners. They carefully considered with whom to share self-tests, often assessing the possibility for negative reactions from partners as part of their decision making process. When women faced negative reactions from partners, they drew on strategies they had used before to avoid conflict and physical harm from partners, such as not responding to angry partners and forgoing payment to leave angry partners quickly. Some women also used self-tests to make more informed sexual decisions with their partners.	[Maman, Suzanne] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27599 USA; [Murray, Katherine R.] FHI360, Durham, NC USA; [Mavedzenge, Sue Napierala] Res Triangle Int, San Francisco, CA USA; [Oluoch, Lennah; Sijenje, Florence; Agot, Kawango] Impact Res & Dev Org, Kisumu, Kenya; [Thirumurthy, Harsha] Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Maman, S (corresponding author), Univ North Carolina Chapel Hill, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27599 USA.	smaman@unc.edu		Murray, Katherine/0000-0002-5990-0594; Napierala, Sue/0000-0003-1146-8154; Thirumurthy, Harsha/0000-0002-3308-7603	Bill and Melinda Gates Foundation [OPP1069673]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, K01HD061605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH110316] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the Bill and Melinda Gates Foundation (grant no. OPP1069673).; This study was funded by the Bill and Melinda Gates Foundation (grant no. OPP1107923). We thank all study participants for sharing their experience and giving their time. We also thank Immaculate Akello for assistance in implementing the study, Manali Nekkanti for help coding the qualitative data, the research assistants who conducted enrollment and follow-up, as well as staff at the health facility and drop-in center.	Alary M, 2004, AIDS, V18, P945, DOI 10.1097/00002030-200404090-00013; [Anonymous], 2014, 909090 UNAIDS; ATLAS.ti, 2016, SCI SOFTWARE DEV; Balan IC, 2013, AIDS BEHAV; Beyrer C, 2015, LANCET, V385, P287, DOI 10.1016/S0140-6736(14)60933-8; Carballo-Dieguez A, 2012, AIDS BEHAV, V16, P1753, DOI 10.1007/s10461-012-0274-2; Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102; Figueroa C, 2015, AIDS BEHAV, V19, P1949, DOI 10.1007/s10461-015-1097-8; Jakubowski A, 2015, JAIDS J ACQUIRED IMM; Johnson C, 2014, AIDS BEHAV, V18, pS391, DOI 10.1007/s10461-014-0832-x; Kenya National Bureau of Statistics, 2010, KEN DEM HLTH SURV 20; Mavedzenge SN, 2013, CLIN INFECT DIS, V57, P126, DOI 10.1093/cid/cit156; Musheke M, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-220, 10.1186/1472-6963-13-97]; National AIDS and STI Control Programme Ministry of Health, 2015, GUID HIV TEST SERV K; Odek WO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089180; Osoti AO, 2014, AIDS, V28, P95, DOI 10.1097/QAD.0000000000000023; Rosenberg NE, 2015, LANCET HIV, V2, pE483, DOI 10.1016/S2352-3018(15)00182-4; Shand T, 2014, IDS BULL-I DEV STUD, V45, P53, DOI 10.1111/1759-5436.12068; Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; Thirumurthy H, 2016, LANCET HIV, V3, pE266, DOI 10.1016/S2352-3018(16)00041-2; Vandenhoudt HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054953; Voeten HACM, 2002, SEX TRANSM DIS, V29, P444, DOI 10.1097/00007435-200208000-00003; WHO, 2015, CONSOLIDATED GUIDELI; WHO, 2016, GUID HIV SELF TEST P; WHO, 2011, PREV HIV SEX WORK SE	27	39	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174629	10.1371/journal.pone.0174629	http://dx.doi.org/10.1371/journal.pone.0174629			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346527	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174300065
J	Hariri, BM; McMahon, DB; Chen, B; Freund, JR; Mansfield, CJ; Doghramji, LJ; Adappa, ND; Palmer, JN; Kennedy, DW; Reed, DR; Jiang, PH; Lee, RJ				Hariri, Benjamin M.; McMahon, Derek B.; Chen, Bei; Freund, Jenna R.; Mansfield, Corrine J.; Doghramji, Laurel J.; Adappa, Nithin D.; Palmer, James N.; Kennedy, David W.; Reed, Danielle R.; Jiang, Peihua; Lee, Robert J.			Flavones modulate respiratory epithelial innate immunity: Anti-inflammatory effects and activation of the T2R14 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; BITTER TASTE RECEPTORS; CILIARY-BEAT FREQUENCY; SEROUS ACINAR-CELLS; NONPOLYPOID CHRONIC RHINOSINUSITIS; CA2+-STIMULATED FLUID SECRETION; NASAL MUCOCILIARY CLEARANCE; NITRIC-OXIDE PRODUCTION; MUCIN GENE-EXPRESSION; NF-KAPPA-B	Chronic rhinosinusitis has a significant impact on patient quality of life, creates billions of dollars of annual healthcare costs, and accounts for similar to 20% of adult antibiotic prescriptions in the United States. Because of the rise of resistant microorganisms, there is a critical need to better understand how to stimulate and/or enhance innate immune responses as a therapeutic modality to treat respiratory infections. We recently identified bitter taste receptors (taste family type 2 receptors, or T2Rs) as important regulators of sinonasal immune responses and potentially important therapeutic targets. Here, we examined the immunomodulatory potential of flavones, a class of flavonoids previously demonstrated to have antibacterial and anti-inflammatory effects. Some flavones are also T2R agonists. We found that several flavones inhibit Muc5AC and inducible NOS up-regulation as well as cytokine release in primary and cultured airway cells in response to several inflammatory stimuli. This occurs at least partly through inhibition of protein kinase C and receptor tyrosine kinase activity. We also demonstrate that sinonasal ciliated epithelial cells express T2R14, which closely co-localizes (< 7 nm) with the T2R38 isoform. Heterologously expressed T2R14 responds to multiple flavones. These flavones also activate T2R14-driven calcium signals in primary cells that activate nitric oxide production to increase ciliary beating and mucociliary clearance. TAS2R38 polymorphisms encode functional (PAV: proline, alanine, and valine at positions 49, 262, and 296, respectively) or nonfunctional (AVI: alanine, valine, isoleucine at positions 49, 262, and 296, respectively) T2R38. Our data demonstrate that T2R14 in sinonasal cilia is a potential therapeutic target for upper respiratory infections and that flavones may have clinical potential as topical therapeutics, particularly in T2R38 AVI/AVI individuals.	[Hariri, Benjamin M.; McMahon, Derek B.; Chen, Bei; Freund, Jenna R.; Doghramji, Laurel J.; Adappa, Nithin D.; Palmer, James N.; Kennedy, David W.; Lee, Robert J.] Univ Penn, Perelman Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Philadelphia, PA 19104 USA; [Lee, Robert J.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Mansfield, Corrine J.; Reed, Danielle R.; Jiang, Peihua] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Monell Chemical Senses Center	Lee, RJ (corresponding author), Hosp Univ Penn, Dept Otorhinolaryngol Head & Neck Surg, 5th Floor Ste A,3400 Spruce St, Philadelphia, PA 19104 USA.	rjl@mail.med.upenn.edu	Lee, Robert J./L-4397-2017	Lee, Robert J./0000-0001-5826-6686; Freund, Jenna/0000-0001-8264-8318	National Institutes of Health Grants [P30DC011735, S10OD018125]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC011735, R03DC013862] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018125] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Gruenert (University of California at San Francisco) for 16HBE14o - cells and M. Victoria (University of Pennsylvania) for excellent technical assistance. Genotyping of patient samples was supported by National Institutes of Health Grants P30DC011735 and S10OD018125 (to D. R. R.).	Adappa ND, 2016, INT FORUM ALLERGY RH, V6, P783, DOI 10.1002/alr.21803; Adappa ND, 2016, INT FORUM ALLERGY RH, V6, P356, DOI 10.1002/alr.21675; Adappa ND, 2016, INT FORUM ALLERGY RH, V6, P25, DOI 10.1002/alr.21666; Adappa ND, 2014, INT FORUM ALLERGY RH, V4, P3, DOI 10.1002/alr.21253; Adappa ND, 2013, INT FORUM ALLERGY RH, V3, P184, DOI 10.1002/alr.21140; Agullo G, 1997, BIOCHEM PHARMACOL, V53, P1649, DOI 10.1016/S0006-2952(97)82453-7; Aksoy E, 2004, INT J BIOCHEM CELL B, V36, P183, DOI 10.1016/S1357-2725(03)00210-3; Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Atsuta S, 1998, ANN OTO RHINOL LARYN, V107, P47, DOI 10.1177/000348949810700109; Babu KS, 2006, BIOORG MED CHEM LETT, V16, P221, DOI 10.1016/j.bmcl.2005.09.009; Bachmanov AA, 2014, CURR PHARM DESIGN, V20, P2669, DOI 10.2174/13816128113199990566; Bhattacharyya N, 2008, ANN OTO RHINOL LARYN, V117, P448, DOI 10.1177/000348940811700608; Bhattacharyya N, 2012, OTOLARYNG HEAD NECK, V146, P307, DOI 10.1177/0194599811426089; Braverman I, 1998, J OTOLARYNGOL, V27, P145; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Caltagirone S, 2000, INT J CANCER, V87, P595, DOI 10.1002/1097-0215(20000815)87:4&lt;595::AID-IJC21&gt;3.0.CO;2-5; Campa D, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-88; Caramori G, 2009, HISTOPATHOLOGY, V55, P321, DOI 10.1111/j.1365-2559.2009.03377.x; Chen B, 2006, AM J RHINOL, V20, P325, DOI 10.2500/ajr.2006.20.2870; Cherry Donald K, 2002, Adv Data, P1; Cohen NA, 2006, ANN OTO RHINOL LARYN, V115, P20; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Cruickshank SF, 2003, BRIT J PHARMACOL, V140, P1442, DOI 10.1038/sj.bjp.0705571; CUSHMAN M, 1991, J MED CHEM, V34, P798, DOI 10.1021/jm00106a047; Cushnie TPT, 2011, INT J ANTIMICROB AG, V38, P99, DOI 10.1016/j.ijantimicag.2011.02.014; Dao TT, 2003, ARCH PHARM RES, V26, P581, DOI 10.1007/BF02976703; Dejima K, 2006, ARCH OTOLARYNGOL, V132, P1352, DOI 10.1001/archotol.132.12.1352; Denning GM, 1998, INFECT IMMUN, V66, P5777, DOI 10.1128/IAI.66.12.5777-5784.1998; Diaz-Meco MT, 2012, IMMUNOL REV, V246, P154, DOI 10.1111/j.1600-065X.2012.01093.x; Dzaman Karolina, 2016, Otolaryngol Pol, V70, P13, DOI 10.5604/00306657.1209438; Eynott PR, 2003, J PHARMACOL EXP THER, V304, P22, DOI 10.1124/jpet.102.040295; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; Ferre S, 2015, TRENDS PHARMACOL SCI, V36, P145, DOI 10.1016/j.tips.2015.01.002; FERRIOLA PC, 1989, BIOCHEM PHARMACOL, V38, P1617, DOI 10.1016/0006-2952(89)90309-2; Fischer A, 2002, PULM PHARMACOL THER, V15, P73, DOI 10.1006/pupt.2001.0332; Gahbauer S, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00494; Gaida MM, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw004; Gallegos LL, 2011, METHODS MOL BIOL, V756, P295, DOI 10.1007/978-1-61779-160-4_17; Gallo S, 2016, BMC MED GENET, V17, DOI 10.1186/s12881-016-0321-3; Gamet-Payrastre L, 1999, GEN PHARMACOL-VASC S, V32, P279, DOI 10.1016/S0306-3623(98)00220-1; GEAHLEN RL, 1989, J NAT PROD, V52, P982, DOI 10.1021/np50065a011; Godoy JM, 2011, OTOLARYNG HEAD NECK, V145, P673, DOI 10.1177/0194599811407279; Grecco HE, 2011, CHEMPHYSCHEM, V12, P484, DOI 10.1002/cphc.201000795; Greene TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020123; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gudis DA, 2010, OTOLARYNG CLIN N AM, V43, P461, DOI 10.1016/j.otc.2010.02.007; Guo SW, 2001, ANN HUM BIOL, V28, P111; Hariri BM, 2016, AM J RHINOL ALLERGY, V30, P319, DOI 10.2500/ajra.2016.30.4360; Hariri BM, 2016, AM J RHINOL ALLERGY, V30, P261, DOI 10.2500/ajra.2016.30.4331; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X; HAWS C, 1992, AM J PHYSIOL, V263, pL692, DOI 10.1152/ajplung.1992.263.6.L692; Jiang N, 2016, PLANTS-BASEL, V5, DOI 10.3390/plants5020027; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Kennedy JL, 2013, AM J RHINOL ALLERGY, V27, P467, DOI 10.2500/ajra.2013.27.3960; Kim D, 2016, J BIOL CHEM, V291, P17616, DOI 10.1074/jbc.M116.722736; Kim JO, 2012, PHYTOTHER RES, V26, P1784, DOI 10.1002/ptr.4650; Kim KC, 2014, INT J MOL MED, V34, P592, DOI 10.3892/ijmm.2014.1804; Kingdom TT, 2004, AM J OTOLARYNG, V25, P323, DOI 10.1016/j.amjoto.2004.03.003; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Konig P, 2006, LAB INVEST, V86, P853, DOI 10.1038/labinvest.3700443; Kuhn C, 2013, METHOD CELL BIOL, V117, P229, DOI 10.1016/B978-0-12-408143-7.00013-X; Kuhn C, 2010, CHEM SENSES, V35, P395, DOI 10.1093/chemse/bjq027; Kuroda Y., 2016, SCI REP, V80, P2014; Lai YY, 2011, J ALLERGY CLIN IMMUN, V128, P1207, DOI 10.1016/j.jaci.2011.09.001; Lee RJ, 2008, J GEN PHYSIOL, V132, P161, DOI 10.1085/jgp.200810017; Lee RJ, 2007, J PHYSIOL-LONDON, V582, P1099, DOI 10.1113/jphysiol.2007.131995; Lee RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33221; Lee RJ, 2016, SCI AM, V314, P38; Lee RJ, 2015, CELL MOL LIFE SCI, V72, P217, DOI 10.1007/s00018-014-1736-7; Lee RJ, 2015, CURR OPIN ALLERGY CL, V15, P14, DOI 10.1097/ACI.0000000000000120; Lee RJ, 2014, J MOL MED, V92, P1235, DOI 10.1007/s00109-014-1222-6; Lee RJ, 2014, INNATE IMMUN-LONDON, V20, P606, DOI 10.1177/1753425913503386; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Lee RJ, 2013, FASEB J, V27, P5094, DOI 10.1096/fj.13-234476; Lee RJ, 2013, AM J RHINOL ALLERGY, V27, P283, DOI 10.2500/ajra.2013.27.3911; Lee RJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412817; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Lee RJ, 2010, J CLIN INVEST, V120, P3137, DOI 10.1172/JCI42992; Lee RJ, 2010, AM J PHYSIOL-LUNG C, V298, pL210, DOI 10.1152/ajplung.00342.2009; Levit A, 2014, FASEB J, V28, P1181, DOI 10.1096/fj.13-242594; Li F, 2013, MOL HUM REPROD, V19, P349, DOI 10.1093/molehr/gat009; Lipchock SV, 2013, AM J CLIN NUTR, V98, P1136, DOI 10.3945/ajcn.113.066688; Liu IX, 2001, J PHARM PHARMACOL, V53, P129, DOI 10.1211/0022357011775118; Ll Li, 2008, Shengli Xuebao, V60, P743; Lossow K, 2016, J BIOL CHEM, V291, P15358, DOI 10.1074/jbc.M116.718544; Ly Nghi, 2002, Adv Data, P1; Ma LL, 2016, BIOMED PHARMACOTHER, V81, P491, DOI 10.1016/j.biopha.2016.04.006; MAJIMA Y, 1986, CLIN OTOLARYNGOL, V11, P55, DOI 10.1111/j.1365-2273.1986.tb00108.x; Manes RP, 2012, FACIAL PLAST SURG CL, V20, P87, DOI 10.1016/j.fsc.2011.10.010; Maniscalco M, 2007, INFLAMM RES, V56, P58, DOI 10.1007/s00011-006-6111-1; Marcinkiewicz J, 1997, IMMUNOPHARMACOLOGY, V37, P35, DOI 10.1016/S0162-3109(96)00168-3; Marcinkiewicz J, 2013, POL ARCH MED WEWN, V123, P309, DOI 10.20452/pamw.1780; Martens S, 2005, PHYTOCHEMISTRY, V66, P2399, DOI 10.1016/j.phytochem.2005.07.013; Martinez-Anton A, 2006, CLIN EXP ALLERGY, V36, P448, DOI 10.1111/j.1365-2222.2006.02451.x; Maurer S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00369; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Mfuna Endam L, 2014, INT FORUM ALLERGY RH, V4, P200, DOI 10.1002/alr.21275; Mughal EU, 2006, BIOORGAN MED CHEM, V14, P4704, DOI 10.1016/j.bmc.2006.03.031; Nanua S, 2006, AM J RESP CELL MOL, V35, P602, DOI 10.1165/rcmb.2006-0149OC; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; Navarro-Gonzalez JF, 2011, CONTRIB NEPHROL, V170, P113, DOI 10.1159/000325646; Orhan DD, 2010, MICROBIOL RES, V165, P496, DOI 10.1016/j.micres.2009.09.002; Pan MH, 2002, CARCINOGENESIS, V23, P1677, DOI 10.1093/carcin/23.10.1677; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Ray NF, 1999, J ALLERGY CLIN IMMUN, V103, P408, DOI 10.1016/S0091-6749(99)70464-1; Roland WSU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118200; Roland WSU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094451; Roland WSU, 2013, J AGR FOOD CHEM, V61, P10454, DOI 10.1021/jf403387p; Rom DI, 2017, RHINOLOGY, V55, P90, DOI [10.4193/Rhino16.181, 10.4193/Rhin16.181]; Salathe M, 2007, ANNU REV PHYSIOL, V69, P401, DOI 10.1146/annurev.physiol.69.040705.141253; Sato M, 1996, J ETHNOPHARMACOL, V54, P171, DOI 10.1016/S0378-8741(96)01464-X; Sato Y, 2004, INT J ANTIMICROB AG, V24, P226, DOI 10.1016/j.ijantimicag.2004.02.028; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seleem D, 2017, ARCH ORAL BIOL, V76, P76, DOI 10.1016/j.archoralbio.2016.08.030; SESSA WC, 1995, J BIOL CHEM, V270, P17641, DOI 10.1074/jbc.270.30.17641; Settipane RA, 2013, AM J RHINOL ALLERGY, V27, pS11, DOI 10.2500/ajra.2013.27.3925; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Shin HD, 2012, TUBERC RESPIR DIS, V73, P204, DOI 10.4046/trd.2012.73.4.204; Sikder MA, 2014, TUBERC RESPIR DIS, V76, P120, DOI 10.4046/trd.2014.76.3.120; Sikder MA, 2014, PHYTOTHER RES, V28, P62, DOI 10.1002/ptr.4954; Sisson JH, 2003, J MICROSC-OXFORD, V211, P103, DOI 10.1046/j.1365-2818.2003.01209.x; Song JS, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-28; Stevens WW, 2015, J ALLERGY CLIN IMMUN, V136, P1442, DOI 10.1016/j.jaci.2015.10.009; Suh YA, 2015, INT J ONCOL, V46, P1405, DOI 10.3892/ijo.2014.2808; Vaiyapuri S, 2013, ARTERIOSCL THROM VAS, V33, P2740, DOI 10.1161/ATVBAHA.113.301988; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Wiener A, 2012, NUCLEIC ACIDS RES, V40, pD413, DOI 10.1093/nar/gkr755; Woo KJ, 2005, FEBS LETT, V579, P705, DOI 10.1016/j.febslet.2004.12.048; Wu DL, 2008, INT J ANTIMICROB AG, V32, P421, DOI 10.1016/j.ijantimicag.2008.06.010; Yamamoto K, 2013, SEMIN CELL DEV BIOL, V24, P240, DOI 10.1016/j.semcdb.2012.08.005; Yang H, 2014, ONCOTARGET, V5, P8188, DOI 10.18632/oncotarget.2340; Yao J, 2014, IMMUNOLOGY, V143, P241, DOI 10.1111/imm.12305; Yeh CH, 2014, ENVIRON TOXICOL, V29, P1162, DOI 10.1002/tox.21847; Zhang Q, 2006, ARTERIOSCL THROM VAS, V26, P1015, DOI 10.1161/01.ATV.0000216044.49494.c4; Zhang SY, 2011, AM J RHINOL ALLERGY, V25, P307, DOI 10.2500/ajra.2011.25.3643; Zhang XW, 2011, PHARM BIOL, V49, P256, DOI 10.3109/13880209.2010.501803; Zhang Y, 2011, COMPUT MATH METHOD M, V2011, DOI 10.1155/2011/173748; Zhao KQ, 2012, FASEB J, V26, P3178, DOI 10.1096/fj.11-202184	140	63	64	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 19	2017	292	20					8484	8497		10.1074/jbc.M116.771949	http://dx.doi.org/10.1074/jbc.M116.771949			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EV5FT	28373278	Green Published, hybrid			2022-12-26	WOS:000401788600031
J	Lee, SB; Park, SK; Kim, YS				Lee, Sang Beum; Park, Sung Kwon; Kim, Yong Soo			Maltose binding protein-fusion enhances the bioactivity of truncated forms of pig myostatin propeptide produced in E-coli	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; LATENT MYOSTATIN; BETA SUPERFAMILY; GDF-8 PROPEPTIDE; ACTIVATION; EXPRESSION; MICE; IDENTIFICATION; GROWTH; DOMAIN	Myostatin (MSTN) is a potent negative regulator of skeletal muscle growth. MSTN propeptide (MSTNpro) inhibits MSTN binding to its receptor through complex formation with MSTN, implying that MSTNpro can be a useful agent to improve skeletal muscle growth in meat-producing animals. Four different truncated forms of pig MSTNpro containing N-terminal maltose binding protein (MBP) as a fusion partner were expressed in E. coli, and purified by the combination of affinity chromatography and gel filtration. The MSTN-inhibitory capacities of these proteins were examined in an in vitro gene reporter assay. A MBP-fused, truncated MSTNpro containing residues 42-175 (MBP-Pro42-175) exhibited the same MSTN-inhibitory potency as the full sequence MSTNpro. Truncated MSTNpro proteins containing either residues 42-115 (MBP-Pro42-115) or 42-98 (MBP-Pro42-98) also exhibited MSTN-inhibitory capacity even though the potencies were significantly lower than that of full sequence MSTNpro. In pull-down assays, MBP-Pro42-175, MBP-Pro42-115, and MBPPro42- 98 demonstrated their binding to MSTN. MBP was removed from the truncated MSTNpro proteins by incubation with factor Xa to examine the potential role of MBP on MSTN-inhibitory capacity of those proteins. Removal of MBP from MBP-Pro42-175 and MBP-Pro42-98 resulted in 20-fold decrease in MSTN-inhibitory capacity of Pro42-175 and abolition of MSTN-inhibitory capacity of Pro42-98, indicating that MBP as fusion partner enhanced the MSTN-inhibitory capacity of those truncated MSTNpro proteins. In summary, this study shows that MBP is a very useful fusion partner in enhancing MSTN-inhibitory potency of truncated forms of MSTNpro proteins, and MBP-fused pig MSTNpro consisting of amino acid residues 42-175 is sufficient to maintain the full MSTN-inhibitory capacity.	[Lee, Sang Beum] Seoul Natl Univ, Wide River Inst Immunol, Coll Med, Hongcheon, Gangwon Do, South Korea; [Lee, Sang Beum; Kim, Yong Soo] Univ Hawaii Manoa, Dept Human Nutr Food & Anim Sci, Honolulu, HI 96822 USA; [Park, Sung Kwon] Natl Inst Anim Sci, RDA, Suwon, South Korea; [Park, Sung Kwon] Sejong Univ, Dept Food Sci & Biotechnol, Seoul, South Korea	Seoul National University (SNU); University of Hawaii System; University of Hawaii Manoa; National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Sejong University	Kim, YS (corresponding author), Univ Hawaii Manoa, Dept Human Nutr Food & Anim Sci, Honolulu, HI 96822 USA.	ykim@hawaii.edu		Kim, Yong soo/0000-0001-6648-8430	USDA-NIFA grant [2010-34135-21229]; National Institute of Animal Sciences, Korea [PJ009312]	USDA-NIFA grant; National Institute of Animal Sciences, Korea	This project was supported by USDA-NIFA grant 2010-34135-21229 and a grant (PJ009312) from the National Institute of Animal Sciences, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cash JN, 2012, J BIOL CHEM, V287, P1043, DOI 10.1074/jbc.M111.270801; Haq WY, 2013, APPL MICROBIOL BIOT, V97, P8517, DOI 10.1007/s00253-013-5134-0; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Hu SW, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/862591; Jiang MS, 2004, BIOCHEM BIOPH RES CO, V315, P525, DOI 10.1016/j.bbrc.2004.01.085; Kim YS, 2006, POULTRY SCI, V85, P1062, DOI 10.1093/ps/85.6.1062; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SB, 2016, COMP BIOCHEM PHYS B, V194, P65, DOI 10.1016/j.cbpb.2016.01.010; Lee SB, 2015, AMB EXPRESS, V5, DOI 10.1186/s13568-015-0142-3; Lee SB, 2011, PROTEIN J, V30, P52, DOI 10.1007/s10930-010-9301-1; Lee SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001628; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee SJ, 1999, CURR OPIN GENET DEV, V9, P604, DOI 10.1016/S0959-437X(99)00004-0; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Li ZC, 2010, MOL REPROD DEV, V77, P76, DOI 10.1002/mrd.21111; Matsakas A, 2009, NEUROMUSCULAR DISORD, V19, P489, DOI 10.1016/j.nmd.2009.06.367; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Nakashima M, 1999, MECH DEVELOP, V80, P185, DOI 10.1016/S0925-4773(98)00205-6; Ohsawa Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133713; Pirottin D, 2005, P NATL ACAD SCI USA, V102, P6413, DOI 10.1073/pnas.0502426102; Raran-Kurussi S, 2015, PROTEIN EXPRES PURIF, V110, P159, DOI 10.1016/j.pep.2015.03.004; Raran-Kurussi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049589; Rodgers BD, 2008, ENDOCR REV, V29, P513, DOI 10.1210/er.2008-0003; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Takayama K, 2015, J MED CHEM, V58, P1544, DOI 10.1021/jm501170d; Thies RS, 2001, GROWTH FACTORS, V18, P251; Walton KL, 2010, J BIOL CHEM, V285, P17029, DOI 10.1074/jbc.M110.110288; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Yang JZ, 2001, MOL REPROD DEV, V60, P351, DOI 10.1002/mrd.1097; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	30	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174956	10.1371/journal.pone.0174956	http://dx.doi.org/10.1371/journal.pone.0174956			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369115	Green Published, gold, Green Submitted			2022-12-26	WOS:000399351000064
J	Sun, Y; Guo, WW; Wang, F; Zhan, CJ; Yang, YK; Liu, XX; Bai, ZH				Sun, Yang; Guo, Wenwen; Wang, Fen; Zhan, Chunjun; Yang, Yankun; Liu, Xiuxia; Bai, Zhonghu			Transcriptome analysis of Corynebacterium glutamicum in the process of recombinant protein expression in bioreactors	PLOS ONE			English	Article							ESCHERICHIA-COLI; PICHIA-PASTORIS; SECRETION; ACETATE; PATHWAY; GENOME; GROWTH; FLUX; METABOLISM; FRAGMENT	Corynebacterium glutamicum (C. glutamicum) is a favorable host cell for the production of recombinant proteins, such as important enzymes and pharmaceutical proteins, due to its excellent potential advantages. Herein, we sought to systematically explore the influence of recombinant protein expression on the transcription and metabolism of C. glutamicum. Two C. glutamicum strains, the wild-type strain and an engineered strain expressing enhanced green fluorescent protein (EGFP), were cultured in parallel in 5-L bioreactors to study the change in metabolism in the process of EGFP expression. The results revealed that EGFP expression had great effects on the growth and metabolism of C. glutamicum and contributed to metabolism-like anaerobic conditions as follows: glycolysis was enhanced, the TCA cycle was shunted, and Glu, Val, Met, lactate and acetate were accumulated to produce sufficient ATP for EGFP production and transfer. Many differentially expressed genes related to ribosomal protein, transcriptional regulators, and energy metabolism were found to be expressed in the presence of EGFP, laying the foundation for identifying genomic loci to change the flow of the host cell metabolism to improve the ability of expressing foreign proteins in C. glutamicum.	[Sun, Yang; Guo, Wenwen; Wang, Fen; Zhan, Chunjun; Yang, Yankun; Liu, Xiuxia; Bai, Zhonghu] Jiangnan Univ, Natl Engn Lab Cereal Fermentat Technol, Wuxi, Peoples R China; [Sun, Yang; Guo, Wenwen; Wang, Fen; Zhan, Chunjun; Yang, Yankun; Liu, Xiuxia; Bai, Zhonghu] Jiangnan Univ, Sch Biotechnol, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Peoples R China; [Sun, Yang; Guo, Wenwen; Wang, Fen; Zhan, Chunjun; Yang, Yankun; Liu, Xiuxia; Bai, Zhonghu] Jiangnan Univ, Sch Biotechnol, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Liu, XX; Bai, ZH (corresponding author), Jiangnan Univ, Natl Engn Lab Cereal Fermentat Technol, Wuxi, Peoples R China.; Liu, XX; Bai, ZH (corresponding author), Jiangnan Univ, Sch Biotechnol, Key Lab Ind Biotechnol, Minist Educ, Wuxi, Peoples R China.; Liu, XX; Bai, ZH (corresponding author), Jiangnan Univ, Sch Biotechnol, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi, Peoples R China.	liuxiuxia@jiangnan.edu.cn; baizhonghu@jiangnan.edu.cn	Yang, Yankun/AAJ-3032-2020; Bai, Zhihui/O-5303-2019	Yang, Yankun/0000-0003-4815-6832; Bai, Zhihui/0000-0002-3818-527X				Carlson R, 2004, BIOTECHNOL BIOENG, V86, P149, DOI 10.1002/bit.20044; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Date M, 2006, LETT APPL MICROBIOL, V42, P66, DOI 10.1111/j.1472-765X.2005.01802.x; De Anda R, 2006, METAB ENG, V8, P281, DOI 10.1016/j.ymben.2006.01.002; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eiteman MA, 2006, TRENDS BIOTECHNOL, V24, P530, DOI 10.1016/j.tibtech.2006.09.001; ELMANSI EMT, 1989, J GEN MICROBIOL, V135, P2875; Farmer WR, 1997, APPL ENVIRON MICROB, V63, P3205, DOI 10.1128/AEM.63.8.3205-3210.1997; Gaigalat L, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-104; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kikuchi Y, 2003, APPL ENVIRON MICROB, V69, P358, DOI 10.1128/AEM.69.1.358-366.2003; Kim HJ, 2012, APPL MICROBIOL BIOT, V94, P1079, DOI 10.1007/s00253-011-3779-0; KINOSHITA JH, 1957, J BIOL CHEM, V228, P247; Larsson C, 2000, YEAST, V16, P797, DOI 10.1002/1097-0061(20000630)16:9<797::AID-YEA553>3.3.CO;2-X; Lee JY, 2013, BIOTECHNOL LETT, V35, P709, DOI 10.1007/s10529-012-1135-9; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; LIEBL W, 1992, J BACTERIOL, V174, P1854, DOI 10.1128/jb.174.6.1854-1861.1992; Lietzan AD, 2014, ARCH BIOCHEM BIOPHYS, V562, P70, DOI 10.1016/j.abb.2014.08.008; Liu M, 2015, APPL MICROBIOL BIOT, V99, P10367, DOI 10.1007/s00253-015-6955-9; Liu X., 2016, SCI PROGRAM, V2016, P1, DOI DOI 10.1155/2016/6907231; Liu X, 2016, J IND MICROBIOL BIOT; Liu XX, 2016, CRIT REV BIOTECHNOL, V36, P652, DOI 10.3109/07388551.2015.1004519; Matsuda Y, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-56; Meissner D, 2007, APPL MICROBIOL BIOT, V76, P633, DOI 10.1007/s00253-007-0934-8; Melanie Spornraft, 2015, Biomol Detect Quantif, V5, P15, DOI 10.1016/j.bdq.2015.08.001; Nocon J, 2014, METAB ENG, V24, P129, DOI 10.1016/j.ymben.2014.05.011; Oldiges M, 2014, APPL MICROBIOL BIOT, V98, P5859, DOI 10.1007/s00253-014-5782-8; Plassmeier J, 2012, J BIOTECHNOL, V159, P1, DOI 10.1016/j.jbiotec.2011.09.009; Ruth C, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0120-5; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sun Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167156; Tateno T, 2007, APPL MICROBIOL BIOT, V77, P533, DOI 10.1007/s00253-007-1191-6; Teramoto H, 2011, APPL MICROBIOL BIOT, V91, P677, DOI 10.1007/s00253-011-3281-8; Unrean P, 2014, BIOTECHNOL PROGR, V30, P28, DOI 10.1002/btpr.1855; Vijayasankaran N, 2005, APPL MICROBIOL BIOT, V68, P737, DOI 10.1007/s00253-005-1920-7; Watanabe K, 2013, APPL MICROBIOL BIOT, V97, P4917, DOI 10.1007/s00253-012-4586-y; Watanabe K, 2009, MICROBIOL-SGM, V155, P741, DOI 10.1099/mic.0.024075-0; Yim SS, 2014, APPL MICROBIOL BIOT, V98, P273, DOI 10.1007/s00253-013-5315-x; Zhang X, 2014, ACS CHEM BIOL, V9, P1945, DOI 10.1021/cb5004477; Zhang Y, 2012, APPL ENVIRON MICROB, V78, P5831, DOI 10.1128/AEM.01147-12; Zhao ZH, 2016, BIOTECHNOL LETT, V38, P2119, DOI 10.1007/s10529-016-2196-y; Zhou JW, 2009, BIOTECHNOL ADV, V27, P94, DOI 10.1016/j.biotechadv.2008.10.005	42	5	5	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174824	10.1371/journal.pone.0174824	http://dx.doi.org/10.1371/journal.pone.0174824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369109	Green Published, Green Submitted, gold			2022-12-26	WOS:000399351000052
J	Zhao, M; Howard, EW; Guo, ZY; Parris, AB; Yang, XH				Zhao, Ming; Howard, Erin W.; Guo, Zhiying; Parris, Amanda B.; Yang, Xiaohe			p53 pathway determines the cellular response to alcohol-induced DNA damage in MCF-7 breast cancer cells	PLOS ONE			English	Article							INDUCED PHOSPHORYLATION; CIGARETTE-SMOKING; TARGET GENES; IN-VIVO; CONSUMPTION; ETHANOL; ACETALDEHYDE; MUTATIONS; BRCA1; EPIDEMIOLOGY	Alcohol consumption is associated with increased breast cancer risk; however, the underlying mechanisms that contribute to mammary tumor initiation and progression are unclear. Alcohol is known to induce oxidative stress and DNA damage; likewise, p53 is a critical modulator of the DNA repair pathway and ensures genomic integrity. p53 mutations are frequently detected in breast and other tumors. The impact of alcohol on p53 is recognized, yet the role of p53 in alcohol-induced mammary carcinogenesis remains poorly defined. In our study, we measured alcohol-mediated oxidative DNA damage in MCF-7 cells using 8-OHdG and p-H2AX foci formation assays. p53 activity and target gene expression after alcohol exposure were determined using p53 luciferase reporter assay, qPCR, and Western blotting. A mechanistic study delineating the role of p53 in DNA damage response and cell cycle arrest was based on isogenic MCF-7 cells stably transfected with control ( MCF-7/Con) or p53-targeting siRNA (MCF-7/sip53), and MCF-7 cells that were pretreated with Nutlin-3 (Mdm2 inhibitor) to stabilize p53. Alcohol treatment resulted in significant DNA damage in MCF-7 cells, as indicated by increased levels of 8-OHdG and p-H2AX foci number. A p53-dependent signaling cascade was stimulated by alcohol-induced DNA damage. Moderate to high concentrations of alcohol (0.1-0.8% v/v) induced p53 activation, as indicated by increased p53 phosphorylation, reporter gene activity, and p21/Bax gene expression, which led to G0/G1 cell cycle arrest. Importantly, compared to MCF-7/Con cells, alcohol-induced DNA damage was significantly enhanced, while alcohol-induced p21/Bax expression and cell cycle arrest were attenuated in MCF-7/sip53 cells. In contrast, inhibition of p53 degradation via Nutlin-3 reinforced G0/G1 cell cycle arrest in MCF-7 control cells. Our study suggests that functional p53 plays a critical role in cellular responses to alcohol-induced DNA damage, which protects the cells from DNA damage associated with breast cancer risk.	[Zhao, Ming; Howard, Erin W.; Guo, Zhiying; Parris, Amanda B.; Yang, Xiaohe] North Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst BBRI, Dept Biol & Biomed Sci, Kannapolis, NC 27707 USA	University of North Carolina; North Carolina Central University	Yang, XH (corresponding author), North Carolina Cent Univ, Julius L Chambers Biomed Biotechnol Res Inst BBRI, Dept Biol & Biomed Sci, Kannapolis, NC 27707 USA.	xyang@nccu.edu			pilot project of a U54 grant from National Institute on Alcohol Abuse and Alcoholism (NIAAA) [U54 AA019765]; National Institute of Environmental Health Sciences (NIEHS) [R21ES025337]; pilot project of a U54 grant from National Cancer Institute (NCI) [5U54CA156735]; grant from the American Cancer Society (ACS) [RSG-08-138-01-CNE]; University of North Carolina General Administration (UNC) Research Opportunities Initiative (ROI) Award	pilot project of a U54 grant from National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); pilot project of a U54 grant from National Cancer Institute (NCI); grant from the American Cancer Society (ACS); University of North Carolina General Administration (UNC) Research Opportunities Initiative (ROI) Award	This work was supported in part by a pilot project of a U54 grant from National Institute on Alcohol Abuse and Alcoholism (NIAAA; https://www.niaaa.nih.gov/) (U54 AA019765), an National Institute of Environmental Health Sciences (NIEHS; www.niehs.nih.gov/) grant (R21ES025337), a pilot project of a U54 grant from National Cancer Institute (NCI; https://www.cancer.gov/) (5U54CA156735), a grant from the American Cancer Society (ACS; www.cancer.org/) (RSG-08-138-01-CNE), and a University of North Carolina General Administration (UNC; https://www.northcarolina.edu/) Research Opportunities Initiative (ROI) Award to XY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham J, 2011, ALCOHOL CLIN EXP RES, V35, P2113, DOI 10.1111/j.1530-0277.2011.01563.x; Ahrendt SA, 2000, CANCER RES, V60, P3155; Allemani C, 2011, TUMORI, V97, P142, DOI 10.1700/667.7774; Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; Alshammari Fawaz D, 2015, Asian Pac J Cancer Prev, V16, P6845; Badgwell DB, 2004, MOL CARCINOGEN, V39, P127, DOI 10.1002/mc.10170; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Blasiak J, 2000, TOXICOL IN VITRO, V14, P287, DOI 10.1016/S0887-2333(00)00022-9; Brooks PJ, 2013, ALCOHOL CLIN EXP RES, V37, P23, DOI 10.1111/j.1530-0277.2012.01888.x; Brooks PJ, 1997, ALCOHOL CLIN EXP RES, V21, P1073, DOI 10.1111/j.1530-0277.1997.tb04256.x; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Castro GD, 2006, TOXICOLOGY, V219, P208, DOI 10.1016/j.tox.2005.11.019; Cederbaum AI, 2012, CLIN LIVER DIS, V16, P667, DOI 10.1016/j.cld.2012.08.002; Chen WY, 2011, JAMA-J AM MED ASSOC, V306, P1884, DOI 10.1001/jama.2011.1590; Clarke M, 1998, LANCET, V351, P1451; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Coutelle C, 2004, INT J ONCOL, V25, P1127; Deng CX, 2006, NUCLEIC ACIDS RES, V34, P1416, DOI 10.1093/nar/gkl010; Fontemaggi G, 2002, J BIOL CHEM, V277, P43359, DOI 10.1074/jbc.M205573200; Freudenheim JL, 2004, CARCINOGENESIS, V25, P931, DOI 10.1093/carcin/bgh088; Goldschneider D, 2004, J CELL SCI, V117, P293, DOI 10.1242/jcs.00834; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Jiang QQ, 2015, J BIOL CHEM, V290, P17724, DOI 10.1074/jbc.R115.667931; Kim J-Y, 2016, OFFICIAL J KOREAN CA; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuo LJ, 2008, IN VIVO, V22, P305; Kwan ML, 2010, J CLIN ONCOL, V28, P4410, DOI 10.1200/JCO.2010.29.2730; Levenson AS, 1997, CANCER RES, V57, P3071; Li PY, 2015, BIOCHEM BIOPH RES CO, V464, P1267, DOI 10.1016/j.bbrc.2015.07.117; Li R, 2017, J FORENSIC SCI; Maffei F, 2000, MUTAGENESIS, V15, P517, DOI 10.1093/mutage/15.6.517; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; MIYASHITA T, 1995, CELL, V80, P293; Mullan PB, 2006, ONCOGENE, V25, P5854, DOI 10.1038/sj.onc.1209872; Narayanan PD, 2016, J BREAST CANCER, V19, P122, DOI 10.4048/jbc.2016.19.2.122; Neupane SP, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/3758590; Pani G, 2004, BIOCHEM BIOPH RES CO, V325, P97, DOI 10.1016/j.bbrc.2004.09.213; Powles TJ, 2007, JNCI-J NATL CANCER I, V99, P283, DOI 10.1093/jnci/djk050; Ronchetti D, 2004, ARCH OTOLARYNGOL, V130, P303, DOI 10.1001/archotol.130.3.303; Ross DT, 2001, DIS MARKERS, V17, P99, DOI 10.1155/2001/850531; Saeki H, 2000, BRIT J CANCER, V82, P1892, DOI 10.1054/bjoc.1999.1212; Sanchez-Alvarez R, 2013, CELL CYCLE, V12, P289, DOI 10.4161/cc.23109; Seitz HK, 2012, ALCOHOL ALCOHOLISM, V47, P204, DOI 10.1093/alcalc/ags011; Seo YR, 2002, ONCOGENE, V21, P731, DOI 10.1038/sj.onc.1205129; Sharpless NE, 2002, CELL, V110, P9, DOI 10.1016/S0092-8674(02)00818-8; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Tao MH, 2011, ALCOHOL, V45, P689, DOI 10.1016/j.alcohol.2010.11.006; Theruvathu JA, 2005, NUCLEIC ACIDS RES, V33, P3513, DOI 10.1093/nar/gki661; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tophkhane C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043564; WALDMAN T, 1995, CANCER RES, V55, P5187; Xu B, 2014, MUTAT RES-FUND MOL M, V770, P1, DOI 10.1016/j.mrfmmm.2014.08.004; Xu M, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0532-4; Yu HS, 2010, CHEM-BIOL INTERACT, V188, P367, DOI 10.1016/j.cbi.2010.08.005; Zhang QS, 2013, CARCINOGENESIS, V34, P28, DOI 10.1093/carcin/bgs316; Zhao M, 2016, MOL CARCINOGENESIS; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	57	17	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							0175121	10.1371/journal.pone.0175121	http://dx.doi.org/10.1371/journal.pone.0175121			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369097	Green Submitted, Green Published, gold			2022-12-26	WOS:000399351000077
J	Guiton, PS; Sagawa, JM; Fritz, HM; Boothroyd, JC				Guiton, Pascale S.; Sagawa, Janelle M.; Fritz, Heather M.; Boothroyd, John C.			An in vitro model of intestinal infection reveals a developmentally regulated transcriptome of Toxoplasma sporozoites and a NF-kappa B-like signature in infected host cells	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; GENE-EXPRESSION; GONDII OOCYST; VIRULENCE; PROTEIN; SURVIVAL; KINASES; FAMILY; IDENTIFICATION; ANTIGENS	Toxoplasmosis is a zoonotic infection affecting approximately 30% of the world's human population. After sexual reproduction in the definitive feline host, Toxoplasma oocysts, each containing 8 sporozoites, are shed into the environment where they can go on to infect humans and other warm-blooded intermediate hosts. Here, we use an in vitro model to assess host transcriptomic changes that occur in the earliest stages of such infections. We show that infection of rat intestinal epithelial cells with mature sporozoites primarily results in higher expression of genes associated with Tumor Necrosis Factor alpha (TNF alpha) signaling via NF-kappa B. Furthermore, we find that, consistent with their biology, these mature, invaded sporozoites display a transcriptome intermediate between the previously reported day 10 oocysts and that of their tachyzoite counterparts. Thus, this study uncovers novel host and pathogen factors that may be critical for the establishment of a successful intracellular niche following sporozoite-initiated infection.	[Guiton, Pascale S.; Boothroyd, John C.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Sagawa, Janelle M.; Fritz, Heather M.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA	Stanford University; Washington State University	Boothroyd, JC (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	john.boothroyd@stanford.edu		Boothroyd, John C./0000-0001-9719-745X	National Institutes of Health [R01 A1073756, R01 A1021423]; Stanford Immunology Training [T32 A107290]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073756, R01AI021423, T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Immunology Training; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health R01 A1073756 and R01 A1021423 (JCB), and the Postdoctoral fellowship from the Stanford Immunology Training Grant T32 A107290 (PSG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001094; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Bougdour A, 2013, CELL HOST MICROBE; Bougdour A, 2014, CELL MICROBIOL, V16, P334, DOI 10.1111/cmi.12255; Bradley PJ, 2007, CURR OPIN MICROBIOL, V10, P582, DOI 10.1016/j.mib.2007.09.013; Braun L, 2013, J EXP MED, V210, P2071, DOI 10.1084/jem.20130103; Brooks CF, 2010, CELL HOST MICROBE, V7, P62, DOI 10.1016/j.chom.2009.12.002; Carruthers Vern B., 2008, V47, P33; Chen AL, 2015, MBIO, V6, DOI 10.1128/mBio.02357-14; de Valliere C, 2015, INFLAMM BOWEL DIS, V21, P1269, DOI 10.1097/MIB.0000000000000375; Denkers EY, 2004, IMMUNOL REV, V201, P191, DOI 10.1111/j.0105-2896.2004.00180.x; DUBEY JP, 1972, J PROTOZOOL, V19, P155, DOI 10.1111/j.1550-7408.1972.tb03431.x; Dubey JP, 1998, J PARASITOL, V84, P862, DOI 10.2307/3284606; DUBEY JP, 1970, J PARASITOL, V56, P447, DOI 10.2307/3277601; Dubey JP, 1997, J PARASITOL, V83, P870, DOI 10.2307/3284282; Dubey JP, 1998, CLIN MICROBIOL REV, V11, P267, DOI 10.1128/CMR.11.2.267; DUBEY JP, 1970, J EXP MED, V132, P636, DOI 10.1084/jem.132.4.636; Etheridge RD, 2014, CELL HOST MICROBE, V15, P537, DOI 10.1016/j.chom.2014.04.002; Fox BA, 2016, MBIO, V7, DOI 10.1128/mBio.00193-16; Franco M, 2016, MBIO, V7, DOI 10.1128/mBio.02231-15; FRENKEL JK, 1975, AM J TROP MED HYG, V24, P439, DOI 10.4269/ajtmh.1975.24.439; FRENKEL JK, 1973, J PARASITOL, V59, P587, DOI 10.2307/3278803; Fritz H. M., 2012, PLOS ONE, V7; Hakimi MA, 2015, CURR OPIN MICROBIOL, V26, P24, DOI 10.1016/j.mib.2015.04.003; Hill D, 2011, J PARASITOL, V97, P328, DOI 10.1645/GE-2782.1; Hunter CA, 2012, NAT REV MICROBIOL, V10, P766, DOI 10.1038/nrmicro2858; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Jelenska J, 2002, J BIOL CHEM, V277, P23208, DOI 10.1074/jbc.M200455200; Jelenska J, 2001, P NATL ACAD SCI USA, V98, P2723, DOI 10.1073/pnas.051629998; KASPER LH, 1984, J IMMUNOL, V132, P443; KASPER LH, 1985, J CLIN INVEST, V75, P1570, DOI 10.1172/JCI111862; Koyama T, 2000, J VET MED SCI, V62, P1089, DOI 10.1292/jvms.62.1089; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li J, 2013, STAT METHODS MED RES, V22, P519, DOI 10.1177/0962280211428386; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lindsay DS, 2014, TOXOPLASMA GONDII: THE MODEL APICOMPLEXAN - PERSPECTIVES AND METHODS, 2ND EDITION, P193, DOI 10.1016/B978-0-12-396481-6.00006-4; Lindsay DS, 2009, J PARASITOL, V95, P1019, DOI 10.1645/GE-1919.1; Liu Serena, 2016, F1000Res, V5, DOI 10.12688/f1000research.7223.1; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Mazumdar J, 2006, P NATL ACAD SCI USA, V103, P13192, DOI 10.1073/pnas.0603391103; McLeod R, 2014, TOXOPLASMA GONDII: THE MODEL APICOMPLEXAN - PERSPECTIVES AND METHODS, 2ND EDITION, P99, DOI 10.1016/B978-0-12-396481-6.00004-0; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Huynh MH, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00012-16; Nadipuram SM, 2016, MBIO, V7, DOI 10.1128/mBio.00808-16; Pappas G, 2009, INT J PARASITOL, V39, P1385, DOI 10.1016/j.ijpara.2009.04.003; Peixoto L, 2010, CELL HOST MICROBE, V8, P208, DOI 10.1016/j.chom.2010.07.004; Possenti A, 2010, INT J PARASITOL, V40, P1639, DOI 10.1016/j.ijpara.2010.06.009; Poukchanski A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070637; QUARONI A, 1981, J NATL CANCER I, V67, P1353; QUARONI A, 1979, J CELL BIOL, V80, P248, DOI 10.1083/jcb.80.2.248; Radke JB, 2013, P NATL ACAD SCI USA, V110, P6871, DOI 10.1073/pnas.1300059110; Radke JR, 2004, MOL MICROBIOL, V52, P93, DOI 10.1111/j.1365-2958.2003.03967.x; Robben PM, 2004, J IMMUNOL, V172, P3686, DOI 10.4049/jimmunol.172.6.3686; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Samuelson J, 2013, EUKARYOT CELL, V12, P1578, DOI 10.1128/EC.00213-13; Sanz MJ, 2012, EUR J IMMUNOL, V42, P278, DOI 10.1002/eji.201142231; Seto S, 2011, TRAFFIC, V12, P407, DOI 10.1111/j.1600-0854.2011.01165.x; Shastri AJ, 2014, INFECT IMMUN, V82, P2595, DOI 10.1128/IAI.01339-13; SIBLEY LD, 1991, J IMMUNOL, V147, P2340; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Spano S, 2016, CELL HOST MICROBE, V19, P216, DOI 10.1016/j.chom.2016.01.004; Spano S, 2012, SCIENCE, V338, P960, DOI 10.1126/science.1229224; Speer CA, 1999, INT J PARASITOL, V29, P1509, DOI 10.1016/S0020-7519(99)00132-0; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Talevich E, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-117; Tang BL, 2016, MICROBES INFECT; Tilley M, 1997, INFECT IMMUN, V65, P4598, DOI 10.1128/IAI.65.11.4598-4605.1997; Tomita T, 2013, PLOS PATHOG, V9, DOI [10.1371/journal.ppat.1003823, DOI 10.1371/journal.ppat.1003823]; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; Torrey EF, 2013, TRENDS PARASITOL, V29, P380, DOI 10.1016/j.pt.2013.06.001; Tyler JS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001282; VanWormer E, 2013, COMP IMMUNOL MICROB, V36, P217, DOI 10.1016/j.cimid.2012.10.006; Walker R, 2013, J BIOL CHEM, V288, P31127, DOI 10.1074/jbc.M113.486589; Walker R, 2013, MOL MICROBIOL, V87, P641, DOI 10.1111/mmi.12121; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Wu L, 2015, PARASITOL RES, V114, P1099, DOI 10.1007/s00436-014-4281-2	79	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0173018	10.1371/journal.pone.0173018	http://dx.doi.org/10.1371/journal.pone.0173018			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362800	Green Published, Green Submitted, gold			2022-12-26	WOS:000399175000005
J	Cui, ZZ; Lin, M; Nie, SF; Lan, RS				Cui, Zhezhe; Lin, Mei; Nie, Shaofa; Lan, Rushu			Risk factors associated with Tuberculosis (TB) among people living with HIV/AIDS: A pair-matched case-control study in Guangxi, China	PLOS ONE			English	Article							HIV; INFECTION; TOBACCO	Background As one of the poorest provinces in China, Guangxi has a high HIV and TB prevalence, with the annual number of TB/HIV cases reported by health department among the highest in the country. However, studies on the burden of TB-HIV co-infection and risk factors for active TB among HIV-infected persons in Guangxi have rarely been reported. Objective To investigate the risk factors for active TB among people living with HIV/AIDS in Guangxi Zhuang autonomous region, China. Methods A surveillance survey was conducted of 1 019 HIV-infected patients receiving care at three AIDS prevention and control departments between 2013 and 2015. We investigated the cumulative prevalence of TB during 2 years. To analyze risk factors associated with active TB, we conducted a 1:1 pair-matched case-control study of newly reported active TB/HIV co-infected patients. Controls were patients with HIV without active TB, latent TB infection or other lung disease, who were matched with the case group based on sex and age (3 years). Results A total of 1 019 subjects were evaluated. 160 subjects (15.70%) were diagnosed with active TB, including 85 clinically diagnosed cases and 75 confirmed cases. We performed a 1:1 matched case-control study, with 82 TB/HIV patients and 82 people living with HIV/AIDS based on surveillance site, sex and age (3) years. According to multivariate analysis, smoking (OR= 2.996, 0.992-9.053), lower CD 4(+) T-cell count (OR= 3.288, 1.161-9.311), long duration of HIV-infection (OR = 5.946, 2.221-15.915) and non-use of ART (OR = 7.775, 2.618-23.094) were independent risk factors for TB in people living with HIV/AIDS. Conclusion The prevalence of active TB among people living with HIV/AIDS in Guangxi was 173 times higher than general population in Guangxi. It is necessary for government to integrate control planning and resources for the two diseases. Medical and public health workers should strengthen health education for TB/HIV prevention and treatment and promote smoking cessation. Active TB case finding and early initiation of ART is necessary to minimize the burden of disease among patients with HIV, as is IPT and infection control in healthcare facilities.	[Cui, Zhezhe; Lin, Mei; Lan, Rushu] Guangxi Zhuang Autonomous Reg Ctr Dis Prevent & C, Nanning, Guangxi, Peoples R China; [Nie, Shaofa] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Stat, Wuhan, Peoples R China	Huazhong University of Science & Technology	Lin, M (corresponding author), Guangxi Zhuang Autonomous Reg Ctr Dis Prevent & C, Nanning, Guangxi, Peoples R China.	gxlinmei@126.com		Cui, Zhezhe/0000-0003-3415-6970	Guangxi Medical Technology Project for Health Promotion - Guangxi Health department [S201310-04]	Guangxi Medical Technology Project for Health Promotion - Guangxi Health department	Support was provided by Guangxi Medical Technology Project for Health Promotion by the Guangxi Health department (S201310-04) http://www.gxhfpc.gov.cn/gzdt/zwggs/index.html.	Agarwal SK, 2001, J ASSOC PHYSICIAN I, V2001, P799; [Anonymous], MMWR MORB MORTAL WKL; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Bowerman RJ, 2007, INT J TUBERC LUNG D, V11, P470; Chen J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026827, 10.1371/journal.pone.0025286]; Cheng SM, 2011, CHIN J ANTITUBER, V33, P416; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Costagliola D, 2005, CLIN INFECT DIS, V41, P1772, DOI 10.1086/498315; Cui ZZ, 2015, GUANGXI MED J, V37, P364; Cui ZZ, 2015, CHONGQING MED, V37, P364; Engsig FN, 2011, BMC PULM MED, V11, P1; Gao L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010736; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Karmakar S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/239021; Lawn SD, 2001, CLIN MICROBIOL REV, V14, P753, DOI 10.1128/CMR.14.4.753-777.2001; Lee S, 2009, J NANOSCI NANOTECHNO, V9, P7229, DOI 10.1166/jnn.2009.1637; Li T, 2013, CHINESE J ANTITUBERC, V35, P905; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Lin DW, 2014, CHINESE J GEN PRACTI, V12, P1113; LOU D, 2013, CHINESE J HLTH ED, V29, P22; Niorn A, 2004, SE ASIAN J TROP MED, V35; Rachow A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020458; Raghavan S, 2012, TUBERCULOSIS, V92, P18, DOI 10.1016/j.tube.2011.08.004; Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X; Santoro-Lopes G, 2002, CLIN INFECT DIS, V34, P543, DOI 10.1086/338641; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Vendhan G, 2009, INT J EPIDEMIOL, V38, P1018; Vicenzi E, 2000, J LEUKOCYTE BIOL, V68, P405; Wang JM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-292; Wong ML, 2012, J URBAN HEALTH, V89, P1031, DOI 10.1007/s11524-012-9723-5; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2015, GUID START ANT THER; Yang Gong-huan, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P77	33	13	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0173976	10.1371/journal.pone.0173976	http://dx.doi.org/10.1371/journal.pone.0173976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358846	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174800016
J	Decap, D; Reumers, J; Herzeel, C; Costanza, P; Fostier, J				Decap, Dries; Reumers, Joke; Herzeel, Charlotte; Costanza, Pascal; Fostier, Jan			Halvade-RNA: Parallel variant calling from transcriptomic data using MapReduce	PLOS ONE			English	Article							GENOME ANALYSIS; FRAMEWORK	Given the current cost-effectiveness of next-generation sequencing, the amount of DNAseq and RNA-seq data generated is ever increasing. One of the primary objectives of NGS experiments is calling genetic variants. While highly accurate, most variant calling pipelines are not optimized to run efficiently on large data sets. However, as variant calling in genomic data has become common practice, several methods have been proposed to reduce runtime for DNA-seq analysis through the use of parallel computing. Determining the effectively expressed variants from transcriptomics (RNA-seq) data has only recently become possible, and as such does not yet benefit from efficiently parallelized workflows. We introduce Halvade-RNA, a parallel, multi-node RNA-seq variant calling pipeline based on the GATK Best Practices recommendations. Halvade-RNA makes use of the MapReduce programming model to create and manage parallel data streams on which multiple instances of existing tools such as STAR and GATK operate concurrently. Whereas the single-threaded processing of a typical RNA-seq sample requires similar to 28h, Halvade-RNA reduces this runtime to similar to 2h using a small cluster with two 20-core machines. Even on a single, multi-core workstation, Halvade-RNA can significantly reduce runtime compared to using multi-threading, thus providing for a more cost-effective processing of RNA-seq data. Halvade-RNA is written in Java and uses the Hadoop MapReduce 2.0 API. It supports a wide range of distributions of Hadoop, including Cloudera and Amazon EMR.	[Decap, Dries; Fostier, Jan] Univ Ghent, IDLab, Dept Informat Technol, IMEC, Ghent, Belgium; [Reumers, Joke] Janssen Res & Dev, Beerse, Belgium; [Herzeel, Charlotte] IMEC, Leuven, Belgium; [Costanza, Pascal] Intel Corp Belgium, Leuven, Belgium; [Decap, Dries; Reumers, Joke; Herzeel, Charlotte; Costanza, Pascal; Fostier, Jan] ExaSci Life Lab, Leuven, Belgium	Ghent University; IMEC; Johnson & Johnson; Janssen Pharmaceuticals; IMEC; Intel Corporation	Fostier, J (corresponding author), Univ Ghent, IDLab, Dept Informat Technol, IMEC, Ghent, Belgium.; Fostier, J (corresponding author), ExaSci Life Lab, Leuven, Belgium.	jan.fostier@ugent.be	Fostier, Jan/A-8275-2012	Fostier, Jan/0000-0002-9994-8269; Herzeel, Charlotte/0000-0002-9319-9885; Reumers, Joke/0000-0001-5434-6515	Intel; Janssen Pharmaceutica; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT) [130405, 130406]	Intel(Intel Corporation); Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work is funded by Intel, Janssen Pharmaceutica, and by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT): IWT O&O Projects 130405 and 130406. Dries Decap, Charlotte Herzeel and Jan Fostier are employees of imec vzw, Belgium; Pascal Costanza is an employee of Intel Corporation NV/SA, Belgium; Joke Reumers is an employee of Janssen Pharmaceutica NV/SA, Belgium. All authors were also affiliated with ExaScience Life Lab which is a consortium of companies and universities. These companies provided support in the form of salaries for these authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of each author is articulated in the "author contributions" section.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Chiang C, 2015, NAT METHODS, V12, P966, DOI [10.1038/nmeth.3505, 10.1038/NMETH.3505]; Decap D, 2015, BIOINFORMATICS, V31, P2482, DOI 10.1093/bioinformatics/btv179; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Kelly BJ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0577-x; Lam HYK, 2012, NAT BIOTECHNOL, V30, P226, DOI 10.1038/nbt.2134; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Niemenmaa M, 2012, BIOINFORMATICS, V28, P876, DOI 10.1093/bioinformatics/bts054; Nothaft F., 2015, UCBEECS201S6S; Piskol R, 2013, AM J HUM GENET, V93, P641, DOI 10.1016/j.ajhg.2013.08.008; Puckelwartz MJ, 2014, BIOINFORMATICS, V30, P1508, DOI 10.1093/bioinformatics/btu071; Schatz MC, 2009, BIOINFORMATICS, V25, P1363, DOI 10.1093/bioinformatics/btp236; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tange O, 2011, USENIX MAG, V36, P42, DOI [10.5281/zenodo.16303, DOI 10.5281/ZENODO.16303]; Zou Q, 2015, BIOINFORMATICS, V31, P2475, DOI 10.1093/bioinformatics/btv177; Zou Q, 2014, BRIEF BIOINFORM, V15, P637, DOI 10.1093/bib/bbs088	20	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174575	10.1371/journal.pone.0174575	http://dx.doi.org/10.1371/journal.pone.0174575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358893	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174800057
J	Dolan, KL; Pena, J; Allison, SD; Martiny, JBH				Dolan, Kristin L.; Pena, Jeniffer; Allison, Steven D.; Martiny, Jennifer B. H.			Phylogenetic conservation of substrate use specialization in leaf litter bacteria	PLOS ONE			English	Article							ORGANIC-MATTER DECOMPOSITION; MICROBIAL COMMUNITIES; ENVIRONMENTAL-CHANGE; SOIL RESPIRATION; NITROGEN ADDITION; TEMPERATURE; GRASSLAND; DROUGHT; TRAITS; FUNGI	Environmental change will influence the ecosystem processes regulated by microbial communities, including leaf litter decomposition. To assess how microbial communities and their functioning might respond to increases in temperature, we quantified the distribution of traits related to carbon substrate utilization and temperature sensitivity in leaf litter bacteria isolated from a natural grassland ecosystem in Southern California. The isolates varied substantially in their carbon substrate use, as well as their response to temperature change. To better predict the functioning and responses in natural communities, we also examined if the functional and response traits were phylogenetically patterned or correlated with one another. We found that the distribution of functional traits displayed a phylogenetic pattern, but the sensitivity of the traits to changes in temperature did not. We also did not detect any correlations between carbon substrate use and sensitivity to changes in temperature. Together, these results suggest that information about microbial composition may provide insights to predicting ecosystem function under one temperature, but that these relationships may not hold under new temperature conditions.	[Dolan, Kristin L.; Pena, Jeniffer; Allison, Steven D.; Martiny, Jennifer B. H.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Dolan, Kristin L.] Univ Calif San Francisco, Res Dev Off, San Francisco, CA 94143 USA	University of California System; University of California Irvine; University of California System; University of California San Francisco	Dolan, KL (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.; Dolan, KL (corresponding author), Univ Calif San Francisco, Res Dev Off, San Francisco, CA 94143 USA.	kristin.dolan@ucsf.edu	Martiny, Jennifer/AAB-9323-2019; Allison, Steven D./E-2978-2010	Allison, Steven D./0000-0003-4629-7842; Dolan, Kristin/0000-0003-2642-9406; Martiny, Jennifer/0000-0002-2415-1247	National Science Foundation [1126749]; Department of Energy [DE-FG0210ER64995]; Department of Education [P200A120144]	National Science Foundation(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); Department of Education(US Department of Education)	The following funders provided support for this study: the National Science Foundation (1126749), the Department of Energy (DE-FG0210ER64995), and the Department of Education (P200A120144). These grants were received by JBHM, SDA, and KLD respectively. The funders provided financial support only, and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A. A., 2010, EVOLUTION DARWIN 1 1; Allison SD, 2012, ECOL LETT, V15, P1058, DOI 10.1111/j.1461-0248.2012.01807.x; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Allison SD, 2013, ECOLOGY, V94, P714, DOI 10.1890/12-1243.1; Allison SD, 2009, SOIL BIOL BIOCHEM, V41, P293, DOI 10.1016/j.soilbio.2008.10.032; Alster CJ, 2013, SOIL BIOL BIOCHEM, V64, P68, DOI 10.1016/j.soilbio.2013.03.034; Amend AS, 2016, ISME J, V10, P109, DOI 10.1038/ismej.2015.96; Baker NR, 2015, ECOLOGY; Bouskill NJ, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00364; Bradford MA, 2013, FRONTIERS MICROBIOLO, P4; Bradford MA, 2010, GLOBAL CHANGE BIOL, V16, P1576, DOI 10.1111/j.1365-2486.2009.02040.x; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; CEC, 2003, CEC PUBL; Conant RT, 2008, GLOBAL CHANGE BIOL, V14, P868, DOI 10.1111/j.1365-2486.2008.01541.x; Diaz S, 2013, ECOL EVOL, V3, P2958, DOI 10.1002/ece3.601; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Elsas J. D., 2007, MODERN SOIL MICROBIO; Evans SE, 2014, ECOL LETT, V17, P155, DOI 10.1111/ele.12206; Felsenstein J, 2006, PHYLIP PHYLOGENY INF; Fierer N, 2005, ECOLOGY, V86, P320, DOI 10.1890/04-1254; Fierer N, 2014, FRONTIERS MICROBIOLO, P5; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Follows MJ, 2011, ANNU REV MAR SCI, V3, P427, DOI 10.1146/annurev-marine-120709-142848; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Hararuk O, 2014, GLOB CHANG BIOL; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Keiser AD, 2011, BIOGEOSCIENCES, V8, P1477, DOI 10.5194/bg-8-1477-2011; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lavorel S, 2002, FUNCT ECOL, V16, P545, DOI 10.1046/j.1365-2435.2002.00664.x; LeBauer DS, 2010, CAN J FOREST RES, V40, P1076, DOI 10.1139/X10-054; Lennon JT, 2012, ECOLOGY, V93, P1867, DOI 10.1890/11-1745.1; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Martiny AC, 2013, ISME J, V7, P830, DOI 10.1038/ismej.2012.160; Martiny JBH, 2015, SCIENCE, V350, DOI 10.1126/science.aac9323; Matulich KL, 2015, ISME J, V9, P2477, DOI 10.1038/ismej.2015.58; Matulich KL, 2015, ECOLOGY, V96, P154, DOI 10.1890/14-0357.1; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; Mouginot C, 2014, SOIL BIOL BIOCHEM, V76, P278, DOI 10.1016/j.soilbio.2014.05.011; Philippot L, 2010, NAT REV MICROBIOL, V8, P523, DOI 10.1038/nrmicro2367; Potts DL, 2012, J ARID ENVIRON, V81, P59, DOI 10.1016/j.jaridenv.2012.01.007; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; RATKOWSKY DA, 1982, J BACTERIOL, V149, P1; Romani AM, 2006, ECOLOGY, V87, P2559, DOI 10.1890/0012-9658(2006)87[2559:IOBAFO]2.0.CO;2; Scheiter S, 2013, NEW PHYTOL, V198, P957, DOI 10.1111/nph.12210; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Sheik CS, 2011, ISME J, V5, P1692, DOI 10.1038/ismej.2011.32; Srivastava DS, 2012, ECOL LETT, V15, P637, DOI 10.1111/j.1461-0248.2012.01795.x; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Suseela V, 2013, NEW PHYTOL, V200, P122, DOI 10.1111/nph.12376; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Tan J., 2011, ECOLOGY; Todd-Brown KEO, 2012, BIOGEOCHEMISTRY, V109, P19, DOI 10.1007/s10533-011-9635-6; Treseder KK, 2011, ECOL LETT, V14, P933, DOI 10.1111/j.1461-0248.2011.01650.x; VANDAMME P, 1994, INT J SYST BACTERIOL, V44, P827, DOI 10.1099/00207713-44-4-827; Wallenstein MD, 2012, BIOGEOCHEMISTRY, V109, P35, DOI 10.1007/s10533-011-9641-8; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wieder WR, 2013, NAT CLIM CHANGE, V3, P909, DOI [10.1038/nclimate1951, 10.1038/NCLIMATE1951]; Williams NM, 2010, BIOL CONSERV, V143, P2280, DOI 10.1016/j.biocon.2010.03.024; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Yuste JC, 2011, GLOBAL CHANGE BIOL, V17, P1475, DOI 10.1111/j.1365-2486.2010.02300.x; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	68	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174472	10.1371/journal.pone.0174472	http://dx.doi.org/10.1371/journal.pone.0174472			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358894	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174800042
J	Maillot, M; Vieux, F; Delaere, F; Lluch, A; Darmon, N				Maillot, Matthieu; Vieux, Florent; Delaere, Fabien; Lluch, Anne; Darmon, Nicole			Dietary changes needed to reach nutritional adequacy without increasing diet cost according to income: An analysis among French adults	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; ENERGY-DENSITY DIETS; SOCIOECONOMIC INEQUALITIES; NUTRIENT DENSITY; VEGETABLE INTAKE; HEALTH-PROGRAM; MONETARY VALUE; FOOD CHOICES; QUALITY; FRUIT	Objective To explore the dietary changes needed to achieve nutritional adequacy across income levels at constant energy and diet cost. Materials and methods Individual diet modelling was used to design iso-caloric, nutritionally adequate optimised diets for each observed diet in a sample of adult normo-reporters aged >20 years (n = 1,719) from the Individual and National Dietary Survey (INCA2), 2006-2007. Diet cost was estimated from mean national food prices (2006-2007). A first set of free-cost models explored the impact of optimisation on the variation of diet cost. A second set of isocost models explored the dietary changes induced by the optimisation with cost set equal to the observed one. Analyses of dietary changes were conducted by income quintiles, adjusting for energy intake, sociodemographic and socioeconomic variables, and smoking status. Results The cost of observed diets increased with increasing income quintiles. In free-cost models, the optimisation increased diet cost on average (+0.22 1.03 euros/d) and within each income quintile, with no significant difference between quintiles, but with systematic increases for observed costs lower than 3.85 euros/d. In iso-cost models, it was possible to design nutritionally adequate diets whatever the initial observed cost. On average, the optimisation at iso-cost increased fruits and vegetables (+171 g/day), starchy foods (+121 g/d), water and beverages (+91 g/d), and dairy products (+20 g/d), and decreased the other food groups (e.g. mixed dishes and salted snacks), leading to increased total diet weight (+300 g/d). Those changes were mostly similar across income quintiles, but lower-income individuals needed to introduce significantly more fruit and vegetables than higher-income ones. Conclusions In France, the dietary changes needed to reach nutritional adequacy without increasing cost are similar regardless of income, but may be more difficult to implement when the budget for food is lower than 3.85 euros/d.	[Maillot, Matthieu; Vieux, Florent] Fac Med La Timone, MS Nutr, Marseille, France; [Delaere, Fabien; Lluch, Anne] Danone Nutricia Res, Ctr Daniel Carasso, Palaiseau, France; [Darmon, Nicole] Aix Marseille Univ, NORT, INRA, INSERM, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Danone Nutricia; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Darmon, N (corresponding author), Aix Marseille Univ, NORT, INRA, INSERM, Marseille, France.	nicole.darmon@inra.fr			Danone Research	Danone Research(Danone Nutricia)	This work was supported by Danone Research. Fabien Delaere and Anne Lluch are fulltime employees of Danone Research. Danone Research provided support in the form of salaries for authors FD and AL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aggarwal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037533; Andrieu E, 2006, EUR J CLIN NUTR, V60, P434, DOI 10.1038/sj.ejcn.1602331; [Anonymous], 2000, CINDI DIET GUID; [Anonymous], APPORTS NUTR CONSEIL; Becker W., 2004, Scandinavian Journal of Nutrition, V48, P178, DOI 10.1080/1102680410003794; Bernstein AM, 2010, AM J CLIN NUTR, V92, P1197, DOI 10.3945/ajcn.2010.29854; Beydoun MA, 2008, EUR J CLIN NUTR, V62, P303, DOI 10.1038/sj.ejcn.1602700; Beydoun MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140905; Bihan H, 2012, EUR J CLIN NUTR, V66, P369, DOI 10.1038/ejcn.2011.173; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Bocquier A, 2015, PUBLIC HEALTH NUTR, V18, P2952, DOI 10.1017/S1368980014002912; Buron Mael-Luc, 2014, DIVISION CONDITIONS; Buttriss JL, 2014, NUTR BULL, V39, P115, DOI 10.1111/nbu.12076; Cade J, 1999, PUBLIC HEALTH NUTR, V2, P505, DOI 10.1017/S1368980099000683; Carlson A.C., 2007, CNPP19 USDA; Clark AM, 2011, HEART LUNG, V40, P156, DOI 10.1016/j.hrtlng.2010.01.007; Cottrell M, 2007, ASMDA 2005 P; DANTZIG GB, 1990, INTERFACES, V20, P43, DOI 10.1287/inte.20.4.43; Darmon N, 2005, J AM DIET ASSOC, V105, P1881, DOI 10.1016/j.jada.2005.09.005; Darmon N, 2003, APPETITE, V41, P315, DOI 10.1016/S0195-6663(03)00113-2; Darmon N, 2002, J NUTR, V132, P3764, DOI 10.1093/jn/132.12.3764; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Darmon N, 2015, NUTR REV, V73, P643, DOI 10.1093/nutrit/nuv027; Dowler E, 1997, FOOD POLICY, V22, P405, DOI 10.1016/S0306-9192(97)00031-6; Drewnowski A, 2015, BIG DATA-US, V3, P193, DOI 10.1089/big.2015.0014; Dubuisson C, 2010, BRIT J NUTR, V103, P1035, DOI 10.1017/S0007114509992625; EFSA, 2010, EFSA J, V8, P1826, DOI DOI 10.2903/J.EFSA.2010.1826; Engel E., 1857, Z STAT BUREAUS KONIG, V8-9, P28; Estaquio C, 2008, J AM DIET ASSOC, V108, P2021, DOI 10.1016/j.jada.2008.09.011; Etievant P., 2010, COMPORTEMENTS ALIMEN; European Food Safety Authority (EFSA), 2010, EFSA J; Giskes K, 2010, OBES REV, V11, P413, DOI 10.1111/j.1467-789X.2009.00658.x; Hercberg S, 2008, INT J PUBLIC HEALTH, V53, P68, DOI 10.1007/s00038-008-7016-2; Inserm. INSERM, 2014, COLL EXP COLL; James WPT, 1997, BMJ-BRIT MED J, V314, P1545, DOI 10.1136/bmj.314.7093.1545; Joint FAO/WHO Consultation, 1998, WHO TECHN REP SER, V880; Kant AK, 2006, AM J CLIN NUTR, V84, P1215, DOI 10.1093/ajcn/84.5.1215; Kantar Worldpanel, 2014, FRENCH HOUS CONS PAN; Konttinen H, 2013, PUBLIC HEALTH NUTR, V16, P873, DOI 10.1017/S1368980012003540; Leclerc A, 2006, SOC SCI MED, V62, P2035, DOI 10.1016/j.socscimed.2005.08.031; Ledikwe JH, 2006, J AM DIET ASSOC, V106, P1172, DOI 10.1016/j.jada.2006.05.013; Ledikwe JH, 2005, J NUTR, V135, P273, DOI 10.1093/jn/135.2.273; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Maillot M, 2008, J NUTR, V138, P1107, DOI 10.1093/jn/138.6.1107; Maillot M, 2007, J NUTR, V137, P1815, DOI 10.1093/jn/137.7.1815; Maillot M, 2011, AM J CLIN NUTR, V94, P1127, DOI 10.3945/ajcn.111.016501; Maillot M, 2010, PUBLIC HEALTH NUTR, V13, P1178, DOI 10.1017/S1368980009993028; Maillot M, 2010, AM J CLIN NUTR, V91, P421, DOI 10.3945/ajcn.2009.28426; Malon A, 2010, J AM DIET ASSOC, V110, P848, DOI 10.1016/j.jada.2010.03.027; Marmot M, 2012, LANCET, V380, P1011, DOI 10.1016/S0140-6736(12)61228-8; Marty L, 2015, AM J CLIN NUTR, V102, P190, DOI 10.3945/ajcn.114.104380; Menvielle G, 2009, M S-MED SCI, V25, P192, DOI 10.1051/medsci/2009252192; Monsivais P, 2013, JAMA INTERN MED, V173, P1922, DOI 10.1001/jamainternmed.2013.9479; Monsivais P, 2012, J EPIDEMIOL COMMUN H, V66, P530, DOI 10.1136/jech.2010.122333; Monsivais P, 2009, J AM DIET ASSOC, V109, P814, DOI 10.1016/j.jada.2009.02.002; Morris MA, 2014, J EPIDEMIOL COMMUN H, V68, P1043, DOI 10.1136/jech-2014-204039; Mullie P, 2012, EUR J CLIN NUTR, V66, P150, DOI 10.1038/ejcn.2011.138; National Institute of Statistics and Economic Studies (INSEE), 2014, DEF METH; Pechey R, 2013, SOC SCI MED, V92, P22, DOI 10.1016/j.socscimed.2013.05.012; Rehm CD, 2015, PREV MED, V73, P70, DOI 10.1016/j.ypmed.2015.01.019; Rehm CD, 2011, AM J CLIN NUTR, V94, P1333, DOI 10.3945/ajcn.111.015560; Sato PD, 2016, APPETITE, V96, P174, DOI 10.1016/j.appet.2015.09.010; The French Information Center on Food Quality, 2013, FRENCH FOOD COMP TAB; Timmins KA, 2015, PUBLIC HEALTH NUTR, V18, P151, DOI 10.1017/S1368980013002905; Turrell G, 2002, J HUM NUTR DIET, V15, P355, DOI 10.1046/j.1365-277X.2002.00384.x; United States Department of Agriculture (USDA) US Department of Health and Human Services, 2015, DIET GUID AM 2015 20, V8th; Vieux F, 2012, ECOL ECON, V75, P91, DOI 10.1016/j.ecolecon.2012.01.003; Vieux F, 2013, AM J CLIN NUTR, V97, P569, DOI 10.3945/ajcn.112.035105; Vinther JL, 2016, SOC SCI MED, V157, P120, DOI 10.1016/j.socscimed.2016.04.004; Waterlander WE, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-44; WHO, 2007, WHO TECH REP SER, V935, P1; WHO, 2003, WHO TECHN REP SER, V916, P54; Wiig K, 2009, PUBLIC HEALTH NUTR, V12, P1726, DOI 10.1017/S1368980008004102; Wilde PE, 2009, J CONSUM AFF, V43, P274, DOI 10.1111/j.1745-6606.2009.01140.x; World Health Organization (WHO) Regional Office for Europe, 2012, ACT PLAN IMPL EUR ST	75	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174679	10.1371/journal.pone.0174679	http://dx.doi.org/10.1371/journal.pone.0174679			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VI	28358837	gold, Green Submitted, Green Published			2022-12-26	WOS:000399174800070
J	Nagappan, A; Lee, WS; Yun, JW; Lu, JN; Chang, SH; Jeong, JH; Kim, GS; Jung, JM; Hong, SC				Nagappan, Arulkumar; Lee, Won Sup; Yun, Jeong Won; Lu, Jing Nan; Chang, Seong-Hwan; Jeong, Jae-Hoon; Kim, Gon Sup; Jung, Jin-Myung; Hong, Soon Chan			Tetraarsenic hexoxide induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt suppression and p38 MAPK activation in SW620 human colon cancer cells	PLOS ONE			English	Article							ARSENIC TRIOXIDE; POLY(ADP-RIBOSE) POLYMERASE; CYCLE PROGRESSION; DOWN-REGULATION; UP-REGULATION; DEATH; PATHWAY; BCL-2; MODULATION; INDUCTION	Tetraarsenic hexoxide (As4O6) has been used in Korean folk medicines for the treatment of cancer, however its anti-cancer mechanisms remain obscured. Here, this study investigated the anti-cancer effect of As4O6 on SW620 human colon cancer cells. As4O6 has showed a dose-dependent inhibition of SW620 cells proliferation. As4O6 significantly increased the sub-G1 and G2/M phase population, and Annexin V-positive cells in a dose-dependent manner. G2/M arrest was concomitant with augment of p21 and reduction in cyclin B1, cell division cycle 2 (cdc 2) expressions. Nuclear condensation, cleaved nuclei and poly (adenosine diphosphate-ribose) polymerase (PARP) activation were also observed in As(4)O(6)treated SW620 cells. As4O6 induced depolarization of mitochondrial membrane potential (MMP, Delta psi m) but not reactive oxygen species (ROS) generation. Further, As4O6 increased death receptor 5 (DR5), not DR4 and suppressed the B-cell lymphoma-2 (Bcl-2) and Xlinked inhibitor of apoptosis protein (XIAP) family proteins. As4O6 increased the formation of AVOs (lysosomes and autophagolysosomes) and promoted the conversion of microtubuleassociated protein 1A/1B-light chain 3 (LC3)-I to LC3-II in a dose-and time-dependent manner. Interestingly, a specific phosphoinositide 3-kinase (PI3K)/Akt inhibitor (LY294002) augmented the As4O6 induced cell death; whereas p38 mitogen-activated protein kinases (p38 MAPK) inhibitor (SB203580) abrogated the cell death. Thus, the present study provides the first evidence that As4O6 induced G2/M arrest, apoptosis and autophagic cell death through PI3K/Akt and p38 MAPK pathways alteration in SW620 cells.	[Nagappan, Arulkumar; Lee, Won Sup; Yun, Jeong Won; Lu, Jing Nan] Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Inst Hlth Sci, 90 Chilam Dong, Jinju, South Korea; [Chang, Seong-Hwan] Konkuk Univ, Sch Med, Dept Surg, Seoul, South Korea; [Jeong, Jae-Hoon] Korea Inst Radiol & Med Sci, Res Ctr Radiotherapy, Seoul, South Korea; [Kim, Gon Sup] Gyeongsang Natl Univ, Res Inst Life Sci, 900 Gajwadong, Jinju, South Korea; [Kim, Gon Sup] Gyeongsang Natl Univ, Coll Vet Med, 900 Gajwadong, Jinju, South Korea; [Jung, Jin-Myung] Gyeongsang Natl Univ, Sch Med, Dept Neurosurg, Inst Hlth Sci, 90 Chilam Dong, Jinju, South Korea; [Hong, Soon Chan] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Dept Surg, 90 Chilam Dong, Jinju, South Korea; [Lu, Jing Nan] Fifth Hosp Shijiazhuang, Shijiazhuang, Peoples R China	Gyeongsang National University; Konkuk University; Konkuk University Medical Center; Korea Institute of Radiological & Medical Sciences; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University	Lee, WS (corresponding author), Gyeongsang Natl Univ, Sch Med, Dept Internal Med, Inst Hlth Sci, 90 Chilam Dong, Jinju, South Korea.	lwshmo@hanmail.net		Chang, Seong-Hwan/0000-0002-0419-4418; Hong, Soon-Chan/0000-0003-4499-8741	National Research Foundation of Korea (NRF) - Korea government (MEST) [20120002631]; National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea [0820050]	National Research Foundation of Korea (NRF) - Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	The present study was supported by a grant from the National Research Foundation of Korea (NRF) funded by the Korea government (MEST) (no. 20120002631), in part by a grant of the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea (0820050).	Ai ZL, 2006, BIOCHEM BIOPH RES CO, V348, P1075, DOI 10.1016/j.bbrc.2006.07.181; Aksamitiene E, 2012, BIOCHEM SOC T, V40, P139, DOI 10.1042/BST20110609; Aranda A, 2013, TOXICOL IN VITRO, V27, P954, DOI 10.1016/j.tiv.2013.01.016; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Borutaite V, 2010, ENVIRON MOL MUTAGEN, V51, P406, DOI 10.1002/em.20564; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chang HS, 2007, INT J ONCOL, V30, P1129; Chen GQ, 1996, BLOOD, V88, P1052; Chiruvella KK, 2008, FEBS LETT, V582, P4066, DOI 10.1016/j.febslet.2008.11.001; De Castro LFP, 2002, J MOL RECOGNIT, V15, P209, DOI 10.1002/jmr.581; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Freimoser FM, 1999, APPL ENVIRON MICROB, V65, P3727; Gobeil S, 2001, CELL DEATH DIFFER, V8, P588, DOI 10.1038/sj.cdd.4400851; Goussetis DJ, 2010, J BIOL CHEM, V285, P29989, DOI 10.1074/jbc.M109.090530; Han MH, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/201414; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Jeong JW, 2015, PHYTOTHER RES, V29, P1516, DOI 10.1002/ptr.5402; Kang YH, 2004, CANCER RES, V64, P8960, DOI 10.1158/0008-5472.CAN-04-1830; Kanzawa T, 2003, CANCER RES, V63, P2103; Kim JJ, 2010, CELL DEATH DIFFER, V17, P1420, DOI 10.1038/cdd.2010.19; Lee WS, 2015, ONCOL REP, V33, P2940, DOI 10.3892/or.2015.3890; Liu J, 2008, J PHARMACOL EXP THER, V326, P363, DOI 10.1124/jpet.108.139543; Mitsiades CS, 2004, CURR CANCER DRUG TAR, V4, P235, DOI 10.2174/1568009043333032; Miyajima A, 1997, BRIT J CANCER, V76, P206, DOI 10.1038/bjc.1997.363; Munoz-Gomez JA, 2009, AUTOPHAGY, V5, P61, DOI 10.4161/auto.5.1.7272; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Nutt LK, 2005, CANCER BIOL THER, V4, P459; Park JW, 2001, BIOCHEM BIOPH RES CO, V286, P726, DOI 10.1006/bbrc.2001.5416; Qian WB, 2007, LEUKEMIA RES, V31, P329, DOI 10.1016/j.leukres.2006.06.021; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Shah GM, 1996, BIOCHEM BIOPH RES CO, V229, P838, DOI 10.1006/bbrc.1996.1889; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Smith DM, 2010, CELL DEATH DIFFER, V17, P1867, DOI 10.1038/cdd.2010.53; Srivastava S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24049; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Van Cutsem E, 2014, ANN ONCOL, V25, P1, DOI 10.1093/annonc/mdu260; Wang R, 2016, SCI REP-UK, V6, DOI 10.1038/srep27071; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Wong WWL, 2008, IUBMB LIFE, V60, P390, DOI 10.1002/iub.51; Yang YP, 2008, ACTA PHARMACOL SIN, V29, P123, DOI 10.1111/j.1745-7254.2008.00732.x; Zhang XY, 2012, J CELL BIOCHEM, V113, P3528, DOI 10.1002/jcb.24230	44	37	38	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174591	10.1371/journal.pone.0174591	http://dx.doi.org/10.1371/journal.pone.0174591			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355296	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174600068
J	Teodorowicz, M; Perdijk, O; Verhoek, I; Govers, C; Savelkoul, HFJ; Tang, YF; Wichers, H; Broersen, K				Teodorowicz, Malgorzata; Perdijk, Olaf; Verhoek, Iris; Govers, Coen; Savelkoul, Huub F. J.; Tang, Yongfu; Wichers, Harry; Broersen, Kerensa			Optimized Triton X-114 assisted lipopolysaccharide (LPS) removal method reveals the immunomodulatory effect of food proteins	PLOS ONE			English	Article							ENDOTOXIN REMOVAL; PURIFICATION; BINDING; RECOGNITION; PROTOCOL	Scope Investigations into the immunological response of proteins is often masked by lipopolysaccharide (LPS) contamination. We report an optimized Triton X-114 (TX-114) based LPS extraction method for p-lactoglobulin (BLG) and soy protein extract suitable for cell-based immunological assays. Methods and results Optimization of an existing TX-114 based phase LPS extraction method resulted in >99% reduction of LPS levels. However, remaining TX-114 was found to interfere with LPS and protein concentration assays and decreased viability of THP-1 macrophages and HEK-Blue 293 cells. Upon screening a range of TX-114 extraction procedures, TX-114-binding beads were found to most effectively lower TX-114 levels without affecting protein structural properties. LPS-purified proteins showed reduced capacity to activate TLR4 compared to non treated proteins. LPS-purified BLG did not induce secretion of pro-inflammatory cytokines from THP-1 macrophages, as non-treated protein did, showing that LPS contamination masks the immunomodulatory effect of BLG. Both HEK293 cells expressing TLR4 and differentiated THP-1 macrophages were shown as a relevant model to screen the protein preparations for biological effects of LPS contamination. Conclusion The reported TX-114 assisted LPS-removal from protein preparations followed by bead based removal of TX-114 allows evaluation of natively folded protein preparations for their immunological potential in cell-based studies.	[Teodorowicz, Malgorzata; Perdijk, Olaf; Savelkoul, Huub F. J.] Wageningen Univ & Res, Dept Cell Biol & Immunol, Wageningen, Netherlands; [Verhoek, Iris; Broersen, Kerensa] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Fac Sci & Technol, Nanobiophys Grp, Enschede, Netherlands; [Govers, Coen; Tang, Yongfu; Wichers, Harry] Wageningen Univ & Res, Food & Biobased Res, Wageningen, Netherlands	Wageningen University & Research; University of Twente; Wageningen University & Research	Teodorowicz, M (corresponding author), Wageningen Univ & Res, Dept Cell Biol & Immunol, Wageningen, Netherlands.	gosia.teodorowicz@wur.nl	Savelkoul, Huub FJ/F-6026-2012	Wichers, HJ/0000-0002-8030-7090; Perdijk, Olaf/0000-0002-1843-8858	European Seventh Framework Program FP7-PEOPLE-EF [PIEF-GA-2011302295]; European Community's Seventh Framework Programme [FP7]; 'Nutricia Research Foundation' [2012-35]; UTWIST fellowship	European Seventh Framework Program FP7-PEOPLE-EF; European Community's Seventh Framework Programme [FP7]; 'Nutricia Research Foundation'; UTWIST fellowship	Malgorzata Teodorowicz was supported by European Seventh Framework Program FP7-PEOPLE-2011-1EF, grant number PIEF-GA-2011302295. Presented work was a part of the FibeBiotics EU project supported by the European Community's Seventh Framework Programme [FP7/2007-2013]' and 'Nutricia Research Foundation' project number 2012-35. Kerensa Broersen is supported by a UTWIST fellowship.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Anspach FB, 2001, J BIOCHEM BIOPH METH, V49, P665, DOI 10.1016/S0165-022X(01)00228-7; Bastiaan-Net S, 2013, INT IMMUNOPHARMACOL, V15, P167, DOI 10.1016/j.intimp.2012.11.003; Borges PV, PHARM RES; Brix S, 2003, J ALLERGY CLIN IMMUN, V112, P1216, DOI 10.1016/j.jaci.2003.08.047; Buetler TM, 2011, MOL NUTR FOOD RES, V55, P291, DOI 10.1002/mnfr.201000140; Cavallaro AS, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-57; Chaby R, 2004, CELL MOL LIFE SCI, V61, P1697, DOI 10.1007/s00018-004-4020-4; Chanput W, 2010, FOOD FUNCT, V1, P254, DOI 10.1039/c0fo00113a; Cheng HT, 2008, PROTEIN EXPRES PURIF, V61, P65, DOI 10.1016/j.pep.2008.04.007; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Ghiselli R, 2003, SHOCK, V19, P577, DOI 10.1097/01.shk.0000055236.26446.c9; Govers C., 2016, BIOACTIVE CARBOHYDRA, V8, P15, DOI [10.1016/j.bcdf.2016.09.001, DOI 10.1016/J.BCDF.2016.09.001]; Hanora A, 2005, J BIOTECHNOL, V118, P421, DOI 10.1016/j.jbiotec.2005.05.006; HOLLOWAY PW, 1973, ANAL BIOCHEM, V53, P304, DOI 10.1016/0003-2697(73)90436-3; Jensen LB, 2008, J IMMUNOL METHODS, V335, P116, DOI 10.1016/j.jim.2008.02.012; Jurgens G, 2001, EUR J BIOCHEM, V268, P4233, DOI 10.1046/j.1432-1327.2001.02338.x; Kruger D, 1989, DRUGS MADE GERMANY, V32, P64; L'Hocine L, 2006, J FOOD SCI, V71, pC137, DOI 10.1111/j.1365-2621.2006.tb15609.x; Li LP, 1997, BIOTECHNOL LETT, V19, P135, DOI 10.1023/A:1018304128932; Li X, 2016, INFLAMMATION, V39, P96, DOI 10.1007/s10753-015-0227-9; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Lopes AM, 2010, BIOTECHNOL PROGR, V26, P1644, DOI 10.1002/btpr.463; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Ma R, 2012, ANAL BIOCHEM, V424, P124, DOI 10.1016/j.ab.2012.02.015; Maeshima N, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00003; Magalhaes PO, 2007, J PHARM PHARM SCI, V10, P388; Mathias RA, 2011, METHODS, V54, P396, DOI 10.1016/j.ymeth.2011.01.006; Na YJ, 2004, INT IMMUNOPHARMACOL, V4, P1187, DOI 10.1016/j.intimp.2004.05.009; Netea MG, 2002, TRENDS IMMUNOL, V23, P135, DOI 10.1016/S1471-4906(01)02169-X; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Petsch D, 2000, J BIOTECHNOL, V76, P97, DOI 10.1016/S0168-1656(99)00185-6; Puddu P, 2010, BIOMETALS, V23, P387, DOI 10.1007/s10534-010-9307-3; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reichelt P, 2006, PROTEIN EXPRES PURIF, V46, P483, DOI 10.1016/j.pep.2005.09.027; Schadlicha L, 2009, VACCINE, V27, P1511, DOI 10.1016/j.vaccine.2009.01.014; Schwarz H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113840; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Tynan GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037261; van der Spiegel M, 2013, COMPR REV FOOD SCI F, V12, P662, DOI 10.1111/1541-4337.12032; Verhoeckx K, 2016, REGUL TOXICOL PHARM, V79, P118, DOI 10.1016/j.yrtph.2016.03.016; Verhoeckx KCM, 2015, FOOD CHEM TOXICOL, V80, P223, DOI 10.1016/j.fct.2015.03.005; Zimmerman T, 2006, J IMMUNOL METHODS, V314, P67, DOI 10.1016/j.jim.2006.05.012	43	46	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0173778	10.1371/journal.pone.0173778	http://dx.doi.org/10.1371/journal.pone.0173778			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355240	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174600025
J	Verbruggen, SW; Oyen, ML; Phillips, ATM; Nowlan, NC				Verbruggen, Stefaan W.; Oyen, Michelle L.; Phillips, Andrew T. M.; Nowlan, Niamh C.			Function and failure of the fetal membrane: Modelling the mechanics of the chorion and amnion	PLOS ONE			English	Article							PRETERM PREMATURE RUPTURE; LOWER UTERINE POLE; STRUCTURAL CHARACTERISTICS; ALTERED MORPHOLOGY; CERVIX; LABOR; CHORIOAMNION; ULTRASOUND; MYOMETRIUM; PRESSURE	The fetal membrane surrounds the fetus during pregnancy and is a thin tissue composed of two layers, the chorion and the amnion. While rupture of this membrane normally occurs at term, preterm rupture can result in increased risk of fetal mortality and morbidity, as well as danger of infection in the mother. Although structural changes have been observed in the membrane in such cases, the mechanical behaviour of the human fetal membrane in vivo remains poorly understood and is challenging to investigate experimentally. Therefore, the objective of this study was to develop simplified finite element models to investigate the mechanical behaviour and rupture of the fetal membrane, particularly its constituent layers, under various physiological conditions. It was found that modelling the chorion and amnion as a single layer predicts remarkably different behaviour compared with a more anatomically-accurate bilayer, significantly underestimating stress in the amnion and under-predicting the risk of membrane rupture. Additionally, reductions in chorion-amnion interface lubrication and chorion thickness (reported in cases of preterm rupture) both resulted in increased membrane stress. Interestingly, the inclusion of a weak zone in the fetal membrane that has been observed to develop overlying the cervix would likely cause it to fail at term, during labour. Finally, these findings support the theory that the amnion is the dominant structural component of the fetal membrane and is required to maintain its integrity. The results provide a novel insight into the mechanical effect of structural changes in the chorion and amnion, in cases of both normal and preterm rupture.	[Verbruggen, Stefaan W.; Nowlan, Niamh C.] Imperial Coll London, Dept Bioengn, London, England; [Oyen, Michelle L.] Univ Cambridge, Dept Engn, Trumpington St, Cambridge, England; [Phillips, Andrew T. M.] Imperial Coll London, Dept Civil & Environm Engn, Struct Biomech, London, England	Imperial College London; University of Cambridge; Imperial College London	Verbruggen, SW (corresponding author), Imperial Coll London, Dept Bioengn, London, England.	s.verbruggen@imperial.ac.uk	Verbruggen, Stefaan/J-1919-2016; Oyen, Michelle/M-8682-2019	Verbruggen, Stefaan/0000-0002-2321-1367; Phillips, Andrew/0000-0001-6618-0145	Arthritis Research UK [20683]; Versus Arthritis [20683] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)	This research was funded (ATMP & NCN) by Arthritis Research UK (http://www.arthritisresearchuk.org/), grant reference number 20683. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar BS, 2009, P I MECH ENG D-J AUT, V223, P891, DOI 10.1243/09544070JAUTO1072; BOURNE G, 1962, POSTGRAD MED J, V38, P191, DOI 10.1136/pgmj.38.438.193; Bryant-Greenwood GD, 1998, PLACENTA, V19, P1, DOI 10.1016/S0143-4004(98)90092-3; Buerzle W, 2013, BIOMECH MODEL MECHAN, V12, P747, DOI 10.1007/s10237-012-0438-z; Calvin SE, 2007, ANN NY ACAD SCI, V1101, P166, DOI 10.1196/annals.1389.009; Chai M, 2012, PLACENTA, V33, P604, DOI 10.1016/j.placenta.2012.04.014; Chua WK, 2009, EUR J OBSTET GYN R B, V144, pS128, DOI 10.1016/j.ejogrb.2009.02.029; El Khwad M, 2006, J SOC GYNECOL INVEST, V13, P191, DOI 10.1016/j.jsgi.2005.12.010; El Khwad M, 2005, BIOL REPROD, V72, P720, DOI 10.1095/biolreprod.104.033647; Fan R, 2014, J BIOMECH, V47, P2043, DOI 10.1016/j.jbiomech.2014.03.014; FAWTHROP RK, 1994, CELL TISSUE RES, V277, P315, DOI 10.1007/BF00327779; Fernandez M, 2015, COMPUT METHOD BIOMEC, V13, P1; FISK NM, 1990, OBSTET GYNECOL, V76, P210; FISK NM, 1992, BRIT J OBSTET GYNAEC, V99, P18, DOI 10.1111/j.1471-0528.1992.tb14385.x; Fortner KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083338; GIBBS RS, 1982, OBSTET GYNECOL, V60, P671; GILLESPIE EC, 1950, AM J OBSTET GYNECOL, V59, P949; Giorgi M, 2016, WIRES SYST BIOL MED, V8, P485, DOI 10.1002/wsbm.1356; HELMIG R, 1993, EUR J OBSTET GYN R B, V48, P183, DOI 10.1016/0028-2243(93)90086-R; HILLS BA, 1984, AM J OBSTET GYNECOL, V149, P896, DOI 10.1016/0002-9378(84)90612-4; HILLS BA, 1986, OBSTET GYNECOL, V68, P550; House M, 2012, ULTRASONIC IMAGING, V34, P1, DOI 10.1177/016173461203400101; Joyce EM, 2016, PLACENTA, V38, P57, DOI 10.1016/j.placenta.2015.12.011; Joyce EM, 2009, EUR J OBSTET GYN R B, V144, pS121, DOI 10.1016/j.ejogrb.2009.02.014; Kumar D, 2016, PLACENTA, V42, P59, DOI 10.1016/j.placenta.2016.03.015; Lapeer RJ, 2001, J BIOMECH, V34, P1125, DOI 10.1016/S0021-9290(01)00070-7; Lim R, 2015, REPRODUCTION, V149, P189, DOI 10.1530/REP-14-0493; Lim R, 2014, AM J REPROD IMMUNOL, V71, P297, DOI 10.1111/aji.12181; Magann EF, 2007, OBSTET GYNECOL SURV, V62, P795, DOI 10.1097/01.ogx.0000290349.58707.e0; MALAK TM, 1994, BRIT J OBSTET GYNAEC, V101, P375, DOI 10.1111/j.1471-0528.1994.tb11908.x; MANABE Y, 1991, OBSTET GYNECOL, V78, P24; Manoogian SJ, 2008, J BIOMECH, V41, P3436, DOI 10.1016/j.jbiomech.2008.09.020; Maul H, 2004, J Matern Fetal Neonatal Med, V15, P297, DOI 10.1080/14767050410001695301; McLaren J, 1999, HUM REPROD, V14, P237, DOI 10.1093/humrep/14.1.237; McParland PC, 2003, AM J OBSTET GYNECOL, V189, P1481, DOI 10.1067/S0002-9378(03)00585-4; Menon R, 2007, BEST PRACT RES CL OB, V21, P467, DOI 10.1016/j.bpobgyn.2007.01.008; Mercer BM, 2003, OBSTET GYNECOL, V101, P178, DOI 10.1016/S0029-7844(02)02366-9; Ockleford CD, 2013, PLACENTA, V34, P727, DOI 10.1016/j.placenta.2013.06.002; OXLUND H, 1990, EUR J OBSTET GYN R B, V34, P247, DOI 10.1016/0028-2243(90)90078-F; Oyen ML, 2006, AM J OBSTET GYNECOL, V195, P510, DOI 10.1016/j.ajog.2006.02.010; Oyen ML, 2004, J MATER SCI-MATER M, V15, P651, DOI 10.1023/B:JMSM.0000030205.62668.90; Paskaleva AP, 2007, BIOMECHANICS CERVICA; PEARSALL GW, 1978, J BIOMECH, V11, P167, DOI 10.1016/0021-9290(78)90009-X; PLATT JF, 1990, J CLIN ULTRASOUND, V18, P15, DOI 10.1002/jcu.1870180105; SCHOBER EA, 1994, ANN BIOMED ENG, V22, P540, DOI 10.1007/BF02367090; Sokolowski P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011037; Stanescu AD, 2015, ARCH GYNECOL OBSTET, V291, P987, DOI 10.1007/s00404-014-3504-1; Verbruggen SW, 2015, BIOMECH MODEL MECHAN, P1	48	24	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0171588	10.1371/journal.pone.0171588	http://dx.doi.org/10.1371/journal.pone.0171588			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350838	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000399174400002
J	Beldi-Ferchiou, A; Skouri, N; Ben Ali, C; Safre, I; Abdelkefi, A; Ladeb, S; Mrad, K; Ben Othman, T; Ben Ahmed, M				Beldi-Ferchiou, Asma; Skouri, Nour; Ben Ali, Cyrine; Safre, Ines; Abdelkefi, Abderrahman; Ladeb, Saloua; Mrad, Karima; Ben Othman, Tarek; Ben Ahmed, Melika			Abnormal repression of SHP-1, SHP-2 and SOCS-1 transcription sustains the activation of the JAK/STAT3 pathway and the progression of the disease in multiple myeloma	PLOS ONE			English	Article							PERIPHERAL T-CELLS; HEMATOLOGICAL MALIGNANCIES; UNDETERMINED SIGNIFICANCE; MONOCLONAL GAMMOPATHY; STAT3; APOPTOSIS; SURVIVAL; CYTOKINE; PROLIFERATION; INTERLEUKIN-6	Sustained activation of JAK/STAT3 signaling pathway is classically described in Multiple Myeloma (MM). One explanation could be the silencing of the JAK/STAT suppressor genes, through the hypermethylation of SHP-1 and SOCS-1, previously demonstrated in MM cell lines or in whole bone marrow aspirates. The link between such suppressor gene silencing and the degree of bone marrow invasion or the treatment response has not been evaluated in depth. Using real-time RT-PCR, we studied the expression profile of three JAK/STAT suppressor genes: SHP-1, SHP-2 and SOCS-1 in plasma cells freshly isolated from the bone marrows of MM patients and healthy controls. Our data demonstrated an abnormal repression of such genes in malignant plasma cells and revealed a significant correlation between such defects and the sustained activation of the JAK/STAT3 pathway during MM. The repressed expression of SHP-1 and SHP-2 correlated significantly with a high initial degree of bone marrow infiltration but was, unexpectedly, associated with a better response to the induction therapy. Collectively, our data provide new evidences that substantiate the contribution of JAK/STAT suppressor genes in the pathogenesis of MM. They also highlight the possibility that the decreased gene expression of SHP-1 and SHP-2 could be of interest as a new predictive factor of a favorable treatment response, and suggest new potential mechanisms of action of the therapeutic molecules. Whether such defect helps the progression of the disease from monoclonal gammopathy of unknown significance to MM remains, however, to be determined.	[Beldi-Ferchiou, Asma; Skouri, Nour; Ben Ali, Cyrine; Ben Ahmed, Melika] Inst Pasteur Tunis, Lab Clin Immunol, Tunis, Tunisia; [Safre, Ines] Inst Pasteur Tunis, Lab Mol & Cellular Hematol, Tunis, Tunisia; [Safre, Ines; Ladeb, Saloua; Mrad, Karima; Ben Othman, Tarek; Ben Ahmed, Melika] Univ Tunis El Manar, Fac Med Tunis, Tunis, Tunisia; [Abdelkefi, Abderrahman; Ladeb, Saloua; Ben Othman, Tarek] Bone Marrow Transplantat Ctr, Tunis, Tunisia; [Mrad, Karima] Salah Azaiez Inst, Dept Pathol, Tunis, Tunisia; [Beldi-Ferchiou, Asma] Grp Hosp Mondor, AP HP, Dept Biol Hematol & Immunol, Creteil, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); Universite de Tunis-El-Manar; Centre Nationale de Greffe de la Moelle Osseuse; Universite de Tunis-El-Manar; Institut Salah Azaiez; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Ben Ahmed, M (corresponding author), Inst Pasteur Tunis, Lab Clin Immunol, Tunis, Tunisia.; Ben Ahmed, M (corresponding author), Univ Tunis El Manar, Fac Med Tunis, Tunis, Tunisia.	melika.benahmed@pasteur.rns.tn	BELDI-FERCHIOU, ASMA/Q-6617-2018	Ben Ahmed, Melika/0000-0002-3179-1648				Alas S, 2003, CLIN CANCER RES, V9, P316; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Beaurivage C, 2016, CYTOKINE; Bharti AC, 2004, BLOOD, V103, P3175, DOI 10.1182/blood-2003-06-2151; Bharti AC, 2003, J IMMUNOL, V171, P3863, DOI 10.4049/jimmunol.171.7.3863; Blade J, 2010, ANN ONCOL, V21, P313, DOI 10.1093/annonc/mdq363; Bommert K, 2006, EUR J CANCER, V42, P1574, DOI 10.1016/j.ejca.2005.12.026; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Chatterjee M, 2004, BLOOD, V104, P3712, DOI 10.1182/blood-2004-04-1670; Chatterjee M, 2007, BLOOD, V109, P720, DOI 10.1182/blood-2006-05-024372; Chim CS, 2007, J CLIN PATHOL, V60, P104, DOI 10.1136/jcp.2006.036715; Chim CS, 2004, BLOOD, V103, P4630, DOI 10.1182/blood-2003-06-2007; Chung C, 2016, PHARMACOTHERAPY; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Ferrajoli A, 2006, CURR CANCER DRUG TAR, V6, P671, DOI 10.2174/156800906779010227; Friedrich K, 1999, INT IMMUNOL, V11, P1283, DOI 10.1093/intimm/11.8.1283; Galm O, 2003, BLOOD, V101, P2784, DOI 10.1182/blood-2002-06-1735; Hideshima T, 2002, NAT REV CANCER, V2, P927, DOI 10.1038/nrc952; HILBERT DM, 1995, J EXP MED, V182, P243, DOI 10.1084/jem.182.1.243; Huang WL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-309; Kamio M, 2004, ONCOGENE, V23, P3107, DOI 10.1038/sj.onc.1207453; Kim C, 2014, MOL CARCINOGEN, V53, P793, DOI 10.1002/mc.22035; Kim SM, 2014, CANCER LETT, V354, P153, DOI 10.1016/j.canlet.2014.08.002; Klein B, 2003, INT J HEMATOL, V78, P106, DOI 10.1007/BF02983377; KLEIN B, 1995, BLOOD, V85, P863, DOI 10.1182/blood.V85.4.863.bloodjournal854863; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Kyle RA, 2008, BLOOD, V111, P2962, DOI 10.1182/blood-2007-10-078022; Lee C, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/580135; Lee JH, 2014, CANCER LETT, V345, P140, DOI 10.1016/j.canlet.2013.12.008; Li J, 2010, NEOPLASIA, V12, P28, DOI 10.1593/neo.91192; Lin HQ, 2013, EXP CELL RES, V319, P600, DOI 10.1016/j.yexcr.2012.12.006; Mitsiades CS, 2006, EUR J CANCER, V42, P1564, DOI 10.1016/j.ejca.2005.12.025; Morgan GJ, 2012, NAT REV CANCER, V12, P335, DOI 10.1038/nrc3257; Moriggl R, 1999, IMMUNITY, V11, P225, DOI 10.1016/S1074-7613(00)80097-7; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Mughal TI, 2014, LEUKEMIA LYMPHOMA, V55, P1968, DOI 10.3109/10428194.2013.863307; Phromnoi K, 2011, MOL PHARMACOL, V80, P889, DOI 10.1124/mol.111.073676; Rajkumar SV, 2002, CLIN CANCER RES, V8, P2210; Reddy J, 2005, ONCOGENE, V24, P732, DOI 10.1038/sj.onc.1208032; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Seidl S, 2003, LANCET ONCOL, V4, P557, DOI 10.1016/S1470-2045(03)01195-1; Shain KH, 2009, CANCER RES, V69, P1009, DOI 10.1158/0008-5472.CAN-08-2419; Shi L, 2010, ONCOTARGET, V1, P22, DOI 10.18632/oncotarget.105; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Stanganelli C, 2010, ANN HEMATOL, V89, P191, DOI 10.1007/s00277-009-0818-3; Vainchenker W, 2013, ONCOGENE, V32, P2601, DOI 10.1038/onc.2012.347; Valentino L, 2006, BIOCHEM PHARMACOL, V71, P713, DOI 10.1016/j.bcp.2005.12.017; Wu CY, 2003, J CELL BIOCHEM, V90, P1026, DOI 10.1002/jcb.10727; Yamada Osamu, 2013, JAKSTAT, V2, pe25256, DOI 10.4161/jkst.25256; Zhang T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02845; Zhu SC, 2015, ONCOTARGET, V6, P10460, DOI 10.18632/oncotarget.3399	52	26	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174835	10.1371/journal.pone.0174835	http://dx.doi.org/10.1371/journal.pone.0174835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369102	Green Submitted, Green Published, gold			2022-12-26	WOS:000399351000054
J	Politzer-Ahles, S; Xiang, M; Almeida, D				Politzer-Ahles, Stephen; Xiang, Ming; Almeida, Diogo			"Before" and "after": Investigating the relationship between temporal connectives and chronological ordering using event-related potentials	PLOS ONE			English	Article							MEMORY SPAN; MEG	Sentence-initial temporal clauses headed by before, as in "Before the scientist submitted the paper, the journal changed its policy", have been shown to elicit sustained negative-going brain potentials compared to maximally similar clauses headed by after, as in "After the scientist submitted the paper, the journal changed its policy". Such effects may be due to either one of two potential causes: before clauses may be more difficult than after clauses because they cause the two events in the sentence to be mentioned in an order opposite the order in which they actually occurred, or they may be more difficult because they are ambiguous with regard to whether the event described in the clause actually happened. The present study examined the effect of before and after clauses on sentence processing in both sentence-initial contexts, like those above, and in sentence-final contexts ("The journal changed its policy before/after the scientist submitted the paper"), where an order-of-mention account of the sustained negativity predicts a negativity for after relative to before. There was indeed such a reversal, with before eliciting more negative brain potentials than after in sentence-initial clauses but more positive in sentence-final clauses. The results suggest that the sustained negativity indexes processing costs related to comprehending events that were mentioned out of order.	[Politzer-Ahles, Stephen] Univ Oxford, Fac Linguist Philol & Phonet, Oxford, England; [Politzer-Ahles, Stephen] New York Univ Abu Dhabi, NYUAD Inst, Abu Dhabi, U Arab Emirates; [Xiang, Ming] Univ Chicago, Linguist Dept Chicago, Chicago, IL 60637 USA; [Almeida, Diogo] New York Univ Abu Dhabi, Psychol Program, Abu Dhabi, U Arab Emirates	University of Oxford; University of Chicago	Politzer-Ahles, S (corresponding author), Univ Oxford, Fac Linguist Philol & Phonet, Oxford, England.; Politzer-Ahles, S (corresponding author), New York Univ Abu Dhabi, NYUAD Inst, Abu Dhabi, U Arab Emirates.	sjpolit@polyu.edu.hk	Almeida, Diogo/C-2558-2017; Politzer-Ahles, Stephen/N-4421-2014	Almeida, Diogo/0000-0003-4674-8092; Politzer-Ahles, Stephen/0000-0002-5474-7930				Almeida D, 2013, BRAIN LANG, V127, P497, DOI 10.1016/j.bandl.2013.09.013; AMIDON A, 1972, J VERB LEARN VERB BE, V11, P417, DOI 10.1016/S0022-5371(72)80022-7; ANSCOMBE GEM, 1964, PHILOS REV, V73, P3, DOI 10.2307/2183199; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Baggio G., 2004, THESIS; Baggio G, 2015, TOP COGN SCI, V7, P287, DOI 10.1111/tops.12125; Baker CI, 2007, NAT NEUROSCI, V10, P3, DOI 10.1038/nn0107-3; Beaver D., 2003, P SEMANTICS LINGUIST, P37; CLARK EV, 1971, J VERB LEARN VERB BE, V10, P266, DOI 10.1016/S0022-5371(71)80054-3; CLARK HH, 1968, Q J EXP PSYCHOL, V20, P129, DOI 10.1080/14640746808400141; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; Crain S, 1982, PAPERS REPORTS CHILD, V21, P33; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Giannakidou A, 1999, LINGUIST PHILOS, V22, P367, DOI 10.1023/A:1005492130684; GIANNAKIDOU A, 1998, POLARITY SENSITIVITY; Groppe DM, 2011, PSYCHOPHYSIOLOGY, V48, P1711, DOI 10.1111/j.1469-8986.2011.01273.x; Hagoort P, 2003, COGNITIVE BRAIN RES, V16, P38, DOI 10.1016/S0926-6410(02)00208-2; Heinamaki O., 1971, 8 REG M CHIC LING SO, P139; Hindy NC, 2012, J NEUROSCI, V32, P5795, DOI 10.1523/JNEUROSCI.6294-11.2012; HOCKETT CF, 1960, SCI AM, V203, P88, DOI 10.1038/scientificamerican0960-88; Kane MJ, 2004, J EXP PSYCHOL GEN, V133, P189, DOI 10.1037/0096-3445.133.2.189; KING JW, 1995, J COGNITIVE NEUROSCI, V7, P376, DOI 10.1162/jocn.1995.7.3.376; Kukona A, 2014, COGNITION, V133, P25, DOI 10.1016/j.cognition.2014.05.011; MANDLER JM, 1986, LANG COGNITIVE PROC, V1, P309, DOI DOI 10.1080/01690968608404680; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Merchant J., 2015, LINGUIST ANAL, V39, P415; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Munte TF, 1998, NATURE, V395, P71, DOI 10.1038/25731; NATSOPOULOS D, 1986, J PSYCHOLINGUIST RES, V15, P243; Nieuwland MS, 2015, J COGNITIVE NEUROSCI, V27, P2215, DOI 10.1162/jocn_a_00856; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pijnacker J, 2011, J COGNITIVE NEUROSCI, V23, P471, DOI 10.1162/jocn.2009.21360; Vos SH, 2001, PSYCHOPHYSIOLOGY, V38, P41, DOI 10.1111/1469-8986.3810041; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; Xiang M, 2014, 6 ANN M SOC NEUR LAN; Ye Z, 2012, NEUROIMAGE, V59, P3662, DOI 10.1016/j.neuroimage.2011.11.039; Ye Z, 2011, J COGNITIVE NEUROSCI, V23, P3694, DOI 10.1162/jocn_a_00037	38	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0175199	10.1371/journal.pone.0175199	http://dx.doi.org/10.1371/journal.pone.0175199			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ES2IH	28369132	Green Published, Green Submitted, gold			2022-12-26	WOS:000399351000079
J	Rahbari, M; Rahlfs, S; Jortzik, E; Bogeski, I; Becker, K				Rahbari, Mahsa; Rahlfs, Stefan; Jortzik, Esther; Bogeski, Ivan; Becker, Katja			H2O2 dynamics in the malaria parasite Plasmodium falciparum	PLOS ONE			English	Article							MYCOBACTERIOPHAGE BXB1 INTEGRASE; INTRACELLULAR HYDROGEN-PEROXIDE; OXYR TRANSCRIPTION FACTOR; INFECTED ERYTHROCYTES; OXIDATIVE STRESS; CHLOROQUINE RESISTANCE; REACTIVE OXYGEN; ARTEMISININ RESISTANCE; SIGNALING MOLECULES; 2-CYS PEROXIREDOXIN	Hydrogen peroxide is an important antimicrobial agent but is also crucially involved in redox signaling and pathogen-host cell interactions. As a basis for systematically investigating intracellular H2O2 dynamics and regulation in living malaria parasites, we established the genetically encoded fluorescent H2O2 sensors roGFP2-Orp1 and HyPer-3 in Plasmodium falciparum. Both ratiometric redox probes as well as the pH control SypHer were expressed in the cytosol of blood-stage parasites. Both redox sensors showed reproducible sensitivity towards H2O2 in the lower micromolar range in vitro and in the parasites. Due to the pH sensitivity of HyPer-3, we used parasites expressing roGFP2-Orp1 for evaluation of short-, medium-, and long-term effects of antimalarial drugs on H2O2 levels and detoxification in Plasmodium. None of the quinolines or artemisinins tested had detectable direct effects on the H2O2 homeostasis at pharmacologically relevant concentrations. However, pre-treat-ment of the cells with antimalarial drugs or heat shock led to a higher tolerance towards exogenous H2O2. The systematic evaluation and comparison of the two genetically encoded cytosolic H2O2 probes in malaria parasites provides a basis for studying parasite-host cell interactions or drug effects with spatio-temporal resolution while preserving cell integrity.	[Rahbari, Mahsa; Rahlfs, Stefan; Jortzik, Esther; Becker, Katja] Justus Liebig Univ Giessen, Biochem & Mol Biol, Interdisciplinary Res Ctr, Giessen, Hessen, Germany; [Bogeski, Ivan] Georg August Univ Gottingen, Mol Physiol, Inst Cardiovasc Physiol, Univ Med Ctr, Gottingen, Niedersachsen, Germany	Justus Liebig University Giessen; University of Gottingen	Becker, K (corresponding author), Justus Liebig Univ Giessen, Biochem & Mol Biol, Interdisciplinary Res Ctr, Giessen, Hessen, Germany.	katja.becker@uni-giessen.de	Bogeski, Ivan/ABA-2141-2021; Hua, QX/HGE-3640-2022	Bogeski, Ivan/0000-0001-9879-7174; 				Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Adjalley SH, 2010, METHODS MOL BIOL, V634, P87, DOI 10.1007/978-1-60761-652-8_6; Albrecht SC, 2011, CELL METAB, V14, P819, DOI 10.1016/j.cmet.2011.10.010; Antoine T, 2014, J ANTIMICROB CHEMOTH, V69, P1005, DOI 10.1093/jac/dkt486; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; ATAMNA H, 1993, MOL BIOCHEM PARASIT, V61, P231, DOI 10.1016/0166-6851(93)90069-A; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bilan DS, 2013, ACS CHEM BIOL, V8, P535, DOI 10.1021/cb300625g; Bray PG, 2005, MOL MICROBIOL, V56, P323, DOI 10.1111/j.1365-2958.2005.04556.x; Buchholz K, 2008, ANTIMICROB AGENTS CH, V52, P183, DOI 10.1128/AAC.00773-07; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; CHRISTMAN MF, 1989, P NATL ACAD SCI USA, V86, P3484, DOI 10.1073/pnas.86.10.3484; COLLINSON LP, 1992, J GEN MICROBIOL, V138, P329, DOI 10.1099/00221287-138-2-329; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Cox AG, 2009, BIOCHEMISTRY-US, V48, P6495, DOI 10.1021/bi900558g; Crabb BS, 2004, METH MOL B, V270, P263; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; DAVIES JMS, 1995, ARCH BIOCHEM BIOPHYS, V317, P1, DOI 10.1006/abbi.1995.1128; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Ermakova YG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6222; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Fourquet S, 2008, ANTIOXID REDOX SIGN, V10, P1565, DOI 10.1089/ars.2008.2049; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ginsburg H, 1998, BIOCHEM PHARMACOL, V56, P1305, DOI 10.1016/S0006-2952(98)00184-1; Gorka AP, 2013, J MED CHEM, V56, P5231, DOI 10.1021/jm400282d; Gutsche M, 2009, J BIOL CHEM, V284, P31532, DOI 10.1074/jbc.M109.059246; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Hoebe RA, 2007, NAT BIOTECHNOL, V25, P249, DOI 10.1038/nbt1278; Ismail HM, 2016, P NATL ACAD SCI USA, V113, P2080, DOI 10.1073/pnas.1600459113; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Jortzik E, 2012, INT J MED MICROBIOL, V302, P187, DOI 10.1016/j.ijmm.2012.07.007; Kasozi D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003782; Kimura R, 2013, PARASITOL INT, V62, P137, DOI 10.1016/j.parint.2012.11.005; Komaki-Yasuda K, 2003, FEBS LETT, V547, P140, DOI 10.1016/S0014-5793(03)00694-X; Krafts K, 2012, PARASITOL RES, V111, P1, DOI 10.1007/s00436-012-2886-x; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lukyanov KA, 2014, BBA-GEN SUBJECTS, V1840, P745, DOI 10.1016/j.bbagen.2013.05.030; Markvicheva KN, 2011, BIOORGAN MED CHEM, V19, P1079, DOI 10.1016/j.bmc.2010.07.014; Mbengue A, 2015, NATURE, V520, P683, DOI 10.1038/nature14412; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Mohon A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-431; Morgan B, 2011, FREE RADICAL BIO MED, V51, P1943, DOI 10.1016/j.freeradbiomed.2011.08.035; Muller S, 2003, REDOX REP, V8, P251, DOI 10.1179/135100003225002853; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; Neill SJ, 2002, J EXP BOT, V53, P1237, DOI 10.1093/jexbot/53.372.1237; Nkrumah LJ, 2006, NAT METHODS, V3, P615, DOI 10.1038/NMETH904; ORJIH AU, 1994, LANCET, V343, P295, DOI 10.1016/S0140-6736(94)91142-8; Parsonage D, 2010, P NATL ACAD SCI USA, V107, P6240, DOI 10.1073/pnas.0910057107; Patzewitz EM, 2013, ANTIOXID REDOX SIGN, V19, P683, DOI 10.1089/ars.2012.4625; PAUL F, 1981, LANCET, V2, P70; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Rahbari M, 2015, BIOL CHEM, V396, P445, DOI 10.1515/hsz-2014-0279; Rhee SG, 2010, MOL CELLS, V29, P539, DOI 10.1007/s10059-010-0082-3; SIMOES APCF, 1992, ARCH BIOCHEM BIOPHYS, V298, P651, DOI 10.1016/0003-9861(92)90462-6; Smith DA, 2004, MOL BIOL CELL, V15, P4179, DOI 10.1091/mbc.E04-03-0181; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Sturm N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000383; Sturm N, 2009, ANTIMICROB AGENTS CH, V53, P622, DOI 10.1128/AAC.00544-08; Sullivan DJ, 2013, CURR PHARM DESIGN, V19, P282, DOI 10.2174/138161213804070294; Tilley L, 2016, TRENDS PARASITOL, V32, P682, DOI 10.1016/j.pt.2016.05.010; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wainwright M, 2005, TROP MED INT HEALTH, V10, P501, DOI 10.1111/j.1365-3156.2005.01417.x; Wang J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10111; Wang J, 2010, PLOS ONE, V5, pA158, DOI 10.1371/journal.pone.0009582; Wei Q, 2012, NUCLEIC ACIDS RES, V40, P4320, DOI 10.1093/nar/gks017; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; World Health Organization, WORLD MAL REP 2015; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	76	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174837	10.1371/journal.pone.0174837	http://dx.doi.org/10.1371/journal.pone.0174837			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369083	gold, Green Published			2022-12-26	WOS:000399351000055
J	Tu, SJ; Wang, SP; Cheng, FC; Weng, CE; Huang, WT; Chang, WJ; Chen, YJ				Tu, Shu-Ju; Wang, Shun-Ping; Cheng, Fu-Chou; Weng, Chia-En; Huang, Wei-Tzu; Chang, Wei-Jeng; Chen, Ying-Ju			Attenuating trabecular morphology associated with low magnesium diet evaluated using micro computed tomography	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; BONE-MINERAL DENSITY; SURFACE-AREA; CT; VOLUME; SIZE	Objective The literature shows that bone mineral density (BMD) and the geometric architecture of trabecular bone in the femur may be affected by inadequate dietary intake of Mg. In this study, we used microcomputed tomography (micro-CT) to characterize and quantify the impact of a low-Mg diet on femoral trabecular bones in mice. Materials and methods Four-week-old C57BL/6J male mice were randomly assigned to 2 groups and supplied either a normal or low-Mg diet for 8weeks. Samples of plasma and urine were collected for biochemical analysis, and femur tissues were removed for micro-CT imaging. In addition to considering standard parameters, we regarded trabecular bone as a cylindrical rod and used computational algorithms for a technical assessment of the morphological characteristics of the bones. BMD (mg-HA/cm(3)) was obtained using a standard phantom. Results We observed a decline in the total tissue volume, bone volume, percent bone volume, fractal dimension, number of trabecular segments, number of connecting nodes, bone mineral content (mg-HA), and BMD, as well as an increase in the structural model index and surface-area-to-volume ratio in low-Mg mice. Subsequently, we examined the distributions of the trabecular segment length and radius, and a series of specific local maximums were identified. The biochemical analysis revealed a 43% (96%) decrease in Mg and a 40% (71%) decrease in Ca in plasma (urine excretion). Conclusions This technical assessment performed using micro-CT revealed a lower population of femoral trabecular bones and a decrease in BMD at the distal metaphysis in the low-Mg mice. Examining the distributions of the length and radius of trabecular segments showed that the average length and radius of the trabecular segments in low-Mg mice are similar to those in normal mice.	[Tu, Shu-Ju; Weng, Chia-En; Huang, Wei-Tzu] Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Tao Yuan, Taiwan; [Tu, Shu-Ju] Linkuo Chang Gung Mem Hosp, Dept Med Imaging & Intervent, Tao Yuan, Taiwan; [Wang, Shun-Ping] Taichung Vet Gen Hosp, Dept Orthoped, Taichung, Taiwan; [Wang, Shun-Ping] Tunghai Univ, Dept Life Sci, Taichung, Taiwan; [Cheng, Fu-Chou] Taichung Vet Gen Hosp, Stem Cell Ctr, Dept Med Res, Taichung, Taiwan; [Chang, Wei-Jeng] Natl Lab Anim Ctr, Natl Appl Res Labs, Taipei, Taiwan; [Chen, Ying-Ju] Providence Univ, Dept Food & Nutr, Taichung, Taiwan	Chang Gung University; Taichung Veterans General Hospital; Tunghai University; Taichung Veterans General Hospital; National Applied Research Laboratories - Taiwan; Providence University - Taiwan	Chen, YJ (corresponding author), Providence Univ, Dept Food & Nutr, Taichung, Taiwan.	yjchen5@pu.edu.tw		Tu, Shu-Ju/0000-0003-2545-1062				Barbour KE, 2010, J BONE MINER RES, V25, P1017, DOI 10.1002/jbmr.6; Bilezikian J.P., 2008, PRINCIPLES BONE BIOL; BLAKE GM, 1992, MED PHYS, V19, P459, DOI 10.1118/1.596834; BOSKEY AL, 1992, J ORTHOP RES, V10, P774, DOI 10.1002/jor.1100100605; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bushberg JerroldT., 2011, ESSENTIAL PHYS MED I, V3rd ed.; CARPENTER TO, 1992, AM J PHYSIOL, V263, pE107, DOI 10.1152/ajpendo.1992.263.1.E107; Chien CC, 2013, BIOTECHNOL ADV, V31, P396, DOI 10.1016/j.biotechadv.2011.12.001; Creedon A, 1999, BRIT J NUTR, V82, P63, DOI 10.1017/S0007114599001130; Dahl C, 2013, BONE, V57, P84, DOI 10.1016/j.bone.2013.06.017; Deng HW, 2002, J BONE MINER METAB, V20, P358, DOI 10.1007/s007740200052; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Holdsworth DW, 2002, TRENDS BIOTECHNOL, V20, pS34, DOI 10.1016/S0167-7799(02)02004-8; Kalender WA, 2006, PHYS MED BIOL, V51, pR29, DOI 10.1088/0031-9155/51/13/R03; KENNEY MA, 1994, CALCIFIED TISSUE INT, V54, P44, DOI 10.1007/BF00316289; Laskey MA, 1996, NUTRITION, V12, P45, DOI 10.1016/0899-9007(95)00017-8; Lorensen William E., 1987, P ACM SIGGRAPH, P163, DOI [10.1145/37401.37422, DOI 10.1145/37401.37422]; Malluche HH, 2013, NAT REV NEPHROL, V9, P671, DOI 10.1038/nrneph.2013.198; Marxen M, 2004, MED PHYS, V31, P305, DOI 10.1118/1.1637971; Newman TS, 2006, COMPUT GRAPH-UK, V30, P854, DOI 10.1016/j.cag.2006.07.021; Qiu SJ, 2010, J BONE MINER RES, V25, P423, DOI 10.1359/jbmr.091003; Ritman EL, 2011, ANNU REV BIOMED ENG, V13, P531, DOI 10.1146/annurev-bioeng-071910-124717; ROSENBERG G, 1984, AQUAT BOT, V19, P65, DOI 10.1016/0304-3770(84)90008-1; RUBIN GD, 1994, RADIOLOGY, V190, P181, DOI 10.1148/radiology.190.1.8259402; Rude RK, 2004, J NUTR, V134, P79, DOI 10.1093/jn/134.1.79; Ruiz O, 2010, LECT NOTES ENG COMP, P609; Tu SJ, 2006, PHYS MED BIOL, V51, P1283, DOI 10.1088/0031-9155/51/5/017; Vos FM, 2003, RADIOLOGY, V228, P878, DOI 10.1148/radiol.2283020846; Yin Z, 2013, NAT CELL BIOL, V15, P860, DOI 10.1038/ncb2764	30	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174806	10.1371/journal.pone.0174806	http://dx.doi.org/10.1371/journal.pone.0174806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369124	Green Published, Green Submitted, gold			2022-12-26	WOS:000399351000047
J	Zhang, LJ; Cai, WZ; Luo, JY; Zhang, S; Wang, CY; Lv, LM; Zhu, XZ; Wang, L; Cui, JJ				Zhang, Li-Juan; Cai, Wan-Zhi; Luo, Jun-Yu; Zhang, Shuai; Wang, Chun-Yi; Lv, Li-Min; Zhu, Xiang-Zhen; Wang, Li; Cui, Jin-Jie			Phylogeographic patterns of Lygus pratensis (Hemiptera: Miridae): Evidence for weak genetic structure and recent expansion in northwest China	PLOS ONE			English	Article							HAPLOTYPE RECONSTRUCTION; STRONG SUBDIVISION; DNA; MITOCHONDRIAL; DISPERSAL; EVOLUTION; REVEAL; LEPIDOPTERA; POPULATIONS; INFERENCE	Lygus pratensis (L.) is an important cotton pest in China, especially in the northwest region. Nymphs and adults cause serious quality and yield losses. However, the genetic structure and geographic distribution of L. pratensis is not well known. We analyzed genetic diversity, geographical structure, gene flow, and population dynamics of L. pratensis in northwest China using mitochondrial and nuclear sequence datasets to study phylogeographical patterns and demographic history. L. pratensis (n = 286) were collected at sites across an area spanning 2,180,000 km(2), including the Xinjiang and Gansu-Ningxia regions. Populations in the two regions could be distinguished based on mitochondrial criteria but the overall genetic structure was weak. The nuclear dataset revealed a lack of diagnostic genetic structure across sample areas. Phylogenetic analysis indicated a lack of population level monophyly that may have been caused by incomplete lineage sorting. The Mantel test showed a significant correlation between genetic and geographic distances among the populations based on the mtDNA data. However the nuclear dataset did not show significant correlation. A high level of gene flow among populations was indicated by migration analysis; human activities may have also facilitated insect movement. The availability of irrigation water and ample cotton hosts makes the Xinjiang region well suited for L. pratensis reproduction. Bayesian skyline plot analysis, star-shaped network, and neutrality tests all indicated that L. pratensis has experienced recent population expansion. Climatic changes and extensive areas occupied by host plants have led to population expansion of L. pratensis. In conclusion, the present distribution and phylogeographic pattern of L. pratensis was influenced by climate, human activities, and availability of plant hosts.	[Zhang, Li-Juan; Luo, Jun-Yu; Zhang, Shuai; Wang, Chun-Yi; Lv, Li-Min; Zhu, Xiang-Zhen; Wang, Li; Cui, Jin-Jie] CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China; [Cai, Wan-Zhi] China Agr Univ, Dept Entomol, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; China Agricultural University	Cui, JJ (corresponding author), CAAS, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China.	aycuijinjie@163.com		Zhang, Shuai/0000-0003-3646-1522	National Natural Science Foundation of China [31601888]; National Special Transgenic Project of China [2016ZX08011-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Special Transgenic Project of China	This work was supported by the National Natural Science Foundation of China (31601888) and the National Special Transgenic Project of China (2016ZX08011-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Bandelt HJ, 2000, MOL PHYLOGENET EVOL, V16, P8, DOI 10.1006/mpev.2000.0792; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Chiang TY, 2000, GENOME, V43, P1090, DOI 10.1139/gen-43-6-1090; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darwin C.R., 1859, ORIGIN SPECIES MEANS; Dergousoff SJ, 2016, ENTOMOL NEWS, V126, P132, DOI 10.3157/021.126.0209; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drury DW, 2009, J HERED, V100, P732, DOI 10.1093/jhered/esp077; Du MY, 1996, THEOR APPL CLIMATOL, V55, P139, DOI 10.1007/BF00864709; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Eronen L, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-542; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fay JC, 1999, MOL BIOL EVOL, V16, P1003, DOI 10.1093/oxfordjournals.molbev.a026175; Fu YX, 1997, GENETICS, V147, P915; Green AJ, 2006, BIOL LETT-UK, V2, P55, DOI 10.1098/rsbl.2005.0413; Guo XG, 2007, MOL PHYLOGENET EVOL, V45, P643, DOI 10.1016/j.ympev.2007.06.013; He C, 2000, ENTOMOTAXONOMIA, V23, P124; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; HU XW, 2000, STUDIES SPATIAL AGGL, P46; Huang ZS, 2008, MOL ECOL, V17, P1930, DOI 10.1111/j.1365-294X.2008.03730.x; Huang ZS, 2010, MOL ECOL RESOUR, V10, P1066, DOI 10.1111/j.1755-0998.2010.02843.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Johnson C. G., 1949, Proceedings of the Royal Entomological Society of London (A), V24, P128; Kimmel G, 2005, P NATL ACAD SCI USA, V102, P158, DOI 10.1073/pnas.0404730102; Kohyama TI, 2014, MOL ECOL, V23, P421, DOI 10.1111/mec.12597; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu B, 2015, J ASIA-PAC ENTOMOL, V18, P139, DOI 10.1016/j.aspen.2014.12.011; Liu L, 2015, GLOBAL CITY GEOGRAPH, P218; Lu XS, 1984, ALFALFA INTRO CHINA; Lu YH, 2008, BIOL CONTROL MIRIDS, P151; Ma C, 2012, MOL ECOL, V21, P4344, DOI 10.1111/j.1365-294X.2012.05684.x; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Meng XF, 2008, MOL ECOL, V17, P2880, DOI 10.1111/j.1365-294X.2008.03792.x; Morgan K, 2011, MOL ECOL, V20, P4533, DOI 10.1111/j.1365-294X.2011.05268.x; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Orzack SH, 2003, GENETICS, V165, P915; Porretta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044515; SCOTT AJ, 2001, GLOBAL CITY REGIONS, P72; Severini C, 1996, INSECT MOL BIOL, V5, P181, DOI 10.1111/j.1365-2583.1996.tb00052.x; [施雅风 Shi Yafeng], 2003, [第四纪研究, Quaternary Sciences], V23, P152; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas A, 2003, ANN HUM GENET, V67, P608, DOI 10.1046/j.1529-8817.2003.00054.x; Walker M, 2009, J QUATERNARY SCI, V24, P3, DOI 10.1002/jqs.1227; Wan XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025238; Wei SJ, 2015, MOL ECOL, V24, P4094, DOI 10.1111/mec.13300; Wei SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059654; Wright S, 1931, GENETICS, V16, P0097; WRIGHT S, 1978, P580; Wu YJ, 2016, J BIOGEOGR; Xun HZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26755; Yang H, 1990, STUDIES CLIMATIC ENV, P206; YANG MC, 2001, CHINA COTTON, V27, P31; Ye Z, 2014, MOL ECOL, V23, P3080, DOI 10.1111/mec.12797; Zhang AB, 2005, MOL ECOL, V14, P3823, DOI 10.1111/j.1365-294X.2005.02705.x; Zhang LJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14009; Zhang MW, 2010, MOL PHYLOGENET EVOL, V54, P47, DOI 10.1016/j.ympev.2009.10.019; Zhang RY, 2012, MOL PHYLOGENET EVOL, V65, P562, DOI 10.1016/j.ympev.2012.07.011; Zhu Hongbo, 2012, CHIN COTT, V39, P1	68	12	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174712	10.1371/journal.pone.0174712	http://dx.doi.org/10.1371/journal.pone.0174712			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369108	Green Published, gold, Green Submitted			2022-12-26	WOS:000399351000035
J	Letsolo, BT; Jones, RE; Rowson, J; Grimstead, JW; Keith, WN; Jenkins, GJS; Baird, DM				Letsolo, Boitelo T.; Jones, Rhiannon E.; Rowson, Jan; Grimstead, Julia W.; Keith, W. Nicol; Jenkins, Gareth J. S.; Baird, Duncan M.			Extensive telomere erosion is consistent with localised clonal expansions in Barrett's metaplasia	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; HUMAN-CELLS; ESOPHAGEAL ADENOCARCINOMA; CHROMOSOMAL INSTABILITY; IMMORTAL CELLS; INCREASED RISK; PROGRESSION; DYSFUNCTION; FUSION; CANCER	Barrett's oesophagus is a premalignant metaplastic condition that predisposes patients to the development of oesophageal adenocarcinoma. However, only a minor fraction of Barrett's oesophagus patients progress to adenocarcinoma and it is thus essential to determine bio-molecular markers that can predict the progression of this condition. Telomere dysfunction is considered to drive clonal evolution in several tumour types and telomere length analysis provides clinically relevant prognostic and predictive information. The aim of this work was to use high-resolution telomere analysis to examine telomere dynamics in Barrett's oesophagus. Telomere length analysis of XpYp, 17p, 11q and 9p, chromosome arms that contain key cancer related genes that are known to be subjected to copy number changes in Barrett's metaplasia, revealed similar profiles at each chromosome end, indicating that no one specific telomere is likely to suffer preferential telomere erosion. Analysis of patient matched tissues (233 samples from 32 patients) sampled from normal squamous oesophagus, Z-line, and 2 cm intervals within Barrett's metaplasia, plus oesophago-gastric junction, gastric body and antrum, revealed extensive telomere erosion in Barrett's metaplasia to within the length ranges at which telomere fusion is detected in other tumour types. Telomere erosion was not uniform, with distinct zones displaying more extensive erosion and more homogenous telomere length profiles. These data are consistent with an extensive proliferative history of cells within Barrett's metaplasia and are indicative of localised clonal growth. The extent of telomere erosion highlights the potential of telomere dysfunction to drive genome instability and clonal evolution in Barrett's metaplasia.	[Letsolo, Boitelo T.; Jones, Rhiannon E.; Rowson, Jan; Grimstead, Julia W.; Baird, Duncan M.] Cardiff Univ, Sch Med, Div Canc & Genet, Heath Pk, Cardiff, S Glam, Wales; [Keith, W. Nicol] Univ Glasgow, Coll Med Vet & Life Sci, Inst Canc Sci, Glasgow, Lanark, Scotland; [Jenkins, Gareth J. S.] Swansea Univ, Sch Med, GI Canc Grp, Swansea, W Glam, Wales	Cardiff University; University of Glasgow; Swansea University	Baird, DM (corresponding author), Cardiff Univ, Sch Med, Div Canc & Genet, Heath Pk, Cardiff, S Glam, Wales.	bairddm@cardiff.ac.uk	Keith, Nicol/D-3325-2009; Baird, Duncan M/C-9671-2011	Keith, Nicol/0000-0001-7862-3580; Baird, Duncan M/0000-0001-8408-5467; jenkins, gareth/0000-0002-5437-8389	Cancer Research UK [C17199/A6932, C17199/A18246]; WNK laboratory by Cancer Research UK [C2193/A15584]; Cancer Research UK [18246] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); WNK laboratory by Cancer Research UK; Cancer Research UK(Cancer Research UK)	The work of the DMB laboratory was supported by Cancer Research UK httpa/www. cancerresearchuk org (C17199/A6932, C17199/A18246) and in the WNK laboratory by Cancer Research UK grant (C2193/A15584).	Arber N, 1996, CANCER EPIDEM BIOMAR, V5, P457; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Baird DM, 2008, CYTOGENET GENOME RES, V122, P308, DOI 10.1159/000167817; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; Bani-Hani K, 2000, J NATL CANCER I, V92, P1316, DOI 10.1093/jnci/92.16.1316; Barrett MT, 1999, NAT GENET, V22, P106, DOI 10.1038/8816; Britt-Compton B, 2006, HUM MOL GENET, V15, P725, DOI 10.1093/hmg/ddi486; Britt-Compton B, 2012, LEUKEMIA, V26, P826, DOI 10.1038/leu.2011.281; Capper R, 2007, GENE DEV, V21, P2495, DOI 10.1101/gad.439107; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Drewitz DJ, 1997, AM J GASTROENTEROL, V92, P212; Fass R, 2001, GUT, V48, P310, DOI 10.1136/gut.48.3.310; Finley JC, 2006, CANCER EPIDEM BIOMAR, V15, P1451, DOI 10.1158/1055-9965.EPI-05-0837; Flejou JF, 2007, HISTOPATHOLOGY, V50, P3, DOI 10.1111/j.1365-2559.2006.02569.x; Galipeau PC, 2007, PLOS MED, V4, P342, DOI 10.1371/jourmal.pmed.0040067; Galipeau PC, 1996, P NATL ACAD SCI USA, V93, P7081, DOI 10.1073/pnas.93.14.7081; Going JJ, 2004, NEOPLASIA, V6, P85; HAGGITT RC, 1994, HUM PATHOL, V25, P982, DOI 10.1016/0046-8177(94)90057-4; Hardie JJ, 2005, CANCER LETT, V217, P221, DOI 10.1016/j.canlet.2004.06.025; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Jenkins GJS, 2002, BRIT J SURG, V89, P824, DOI 10.1046/j.1365-2168.2002.02107.x; Jones CH, 2012, BRIT J HAEMATOL, V156, P573, DOI 10.1111/j.1365-2141.2011.09022.x; Jones RE, 2014, CELL REP, V8, P1063, DOI 10.1016/j.celrep.2014.07.007; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kolquist KA, 1998, NAT GENET, V19, P182, DOI 10.1038/554; Letsolo BT, 2010, NUCLEIC ACIDS RES, V38, P1841, DOI 10.1093/nar/gkp1183; Liddiard K, 2016, GENOME RES; Lin TT, 2014, BRIT J HAEMATOL, V167, P214, DOI 10.1111/bjh.13023; Lin TT, 2010, BLOOD, V116, P1899, DOI 10.1182/blood-2010-02-272104; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Meeker AK, 2004, CLIN CANCER RES, V10, P3317, DOI 10.1158/1078-0432.CCR-0984-03; MURNANE JP, 1994, EMBO J, V13, P4953, DOI 10.1002/j.1460-2075.1994.tb06822.x; Rabinovitch PS, 2001, AM J GASTROENTEROL, V96, P3071, DOI 10.1111/j.1572-0241.2001.05261.x; Reid BJ, 2001, AM J GASTROENTEROL, V96, P2839; Roger L, 2013, JNCI-J NATL CANCER I, V105, P1202, DOI 10.1093/jnci/djt191; Ross-Innes CS, 2015, NAT GENET, V47, P1038, DOI 10.1038/ng.3357; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Simpson K, 2015, MOL ONCOL, V9, P1186, DOI 10.1016/j.molonc.2015.02.003; Souza RF, 2007, AM J PHYSIOL-GASTR L, V293, pG19, DOI 10.1152/ajpgi.00055.2007; Spechler SJ, 2002, NEW ENGL J MED, V346, P836, DOI 10.1056/NEJMcp012118; Williams L, 2005, BRIT J CANCER, V92, P1759, DOI 10.1038/sj.bjc.6602533; Williams L, 2009, MUTAT RES-FUND MOL M, V669, P104, DOI 10.1016/j.mrfmmm.2009.05.009; Wong DJ, 2001, CANCER RES, V61, P8284; Wright WE, 2001, CURR OPIN GENET DEV, V11, P98, DOI 10.1016/S0959-437X(00)00163-5	45	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174833	10.1371/journal.pone.0174833	http://dx.doi.org/10.1371/journal.pone.0174833			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362812	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000399175000040
J	An, YY; Kim, SH; Kang, BJ				An, Yeong Yi; Kim, Sung Hun; Kang, Bong Joo			Differentiation of malignant and benign breast lesions: Added value of the qualitative analysis of breast lesions on diffusion weighted imaging (DWI) using readout segmented echo-planar imaging at 3.0 T	PLOS ONE			English	Article							CONTRAST-ENHANCED MRI; PROGNOSTIC-FACTORS; TEXTURE ANALYSIS; CANCER-DETECTION; DIAGNOSIS; IMAGES; TUMORS; HETEROGENEITY; MORPHOLOGY; CARCINOMA	Objective To determine the added value of qualitative analysis as an adjunct to quantitative analysis for the discrimination of benign and malignant lesions in patients with breast cancer using diffusion-weighted imaging (DWI) with readout-segmented echo-planar imaging (rs-EPI). Methods A total of 99 patients with 144 lesions were reviewed from our prospectively collected database. DWI data were obtained using rs-EPI acquired at 3.0 T. The diagnostic performances of DWI in the qualitative, quantitative, and combination analyses were compared with that of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). Additionally, the effect of lesion size on the diagnostic performance of the DWI combination analysis was evaluated. Results The strongest indicators of malignancy on DWI were a heterogeneous pattern (P = 0.005) and an apparent diffusion coefficient (ADC) value <1.0 x 10-3 mm2/sec (P = 0.002). The area under the curve (AUC) values for the qualitative analysis, quantitative analysis, and combination analysis on DWI were 0.732 (95% CI, 0.651-0.803), 0.780 (95% CI, 0.7030.846), and 0.826 (95% CI, 0.754-0.885), respectively (P<0.0001). The AUC for the combination analysis on DWI was superior to that for DCE-MRI alone (0.651, P = 0.003) but inferior to that for DCE-MRI plus the ADC value (0.883, P = 0.03). For the DWI combination analysis, the sensitivity was significantly lower in the size <1 cm group than in the size >1 cm group (80% vs. 95.6%, P = 0.034). Conclusions Qualitative analysis of tumor morphology was diagnostically applicable on DWI using rsEPI. This qualitative analysis adds value to quantitative analyses for lesion characterization in patients with breast cancer.	[An, Yeong Yi] Catholic Univ Korea, St Vincents Hosp, Dept Radiol, Coll Med, 93 Jungbu Daero, Suwon, Gyeonggi Do, South Korea; [Kim, Sung Hun; Kang, Bong Joo] Catholic Univ Korea, Seoul St Marys Hosp, Dept Radiol, Coll Med, 222 Banpo Daero, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Kang, BJ (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Radiol, Coll Med, 222 Banpo Daero, Seoul, South Korea.	lionmain@catholic.ac.kr		An, Yeong Yi/0000-0003-0905-8498	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI14C1731]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	Statistical consultation was provided by members of the Department of Biostatistics at the Catholic Research Coordinating Center, which were supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI14C1731).	American College of Radiology, 2013, BREAST IM REP DAT SY; Ballesio L, 2009, EUR J RADIOL, V71, P96, DOI 10.1016/j.ejrad.2008.03.025; Baltzer PAT, 2010, EUR RADIOL, V20, P1101, DOI 10.1007/s00330-009-1654-5; Barentsz MW, 2015, J MAGN RESON IMAGING, V42, P1656, DOI 10.1002/jmri.24929; Bogner W, 2015, RADIOLOGY, V274, P74, DOI 10.1148/radiol.14132340; Bogner W, 2012, RADIOLOGY, V263, P64, DOI 10.1148/radiol.12111494; Chen W, 2007, MAGN RESON MED, V58, P562, DOI 10.1002/mrm.21347; Choi SY, 2012, BRIT J RADIOL, V85, pE474, DOI 10.1259/bjr/79381464; Davnall F, 2012, INSIGHTS IMAGING, V3, P573, DOI 10.1007/s13244-012-0196-6; DeMartini W, 2008, ACAD RADIOL, V15, P408, DOI 10.1016/j.acra.2007.11.006; Fischer U, 1999, RADIOLOGY, V213, P881, DOI 10.1148/radiology.213.3.r99dc01881; Hancu I, 2016, MAGN RESON MED; Holdsworth SJ, 2011, AM J NEURORADIOL, V32, P1274, DOI 10.3174/ajnr.A2481; Jeh SK, 2011, J MAGN RESON IMAGING, V33, P102, DOI 10.1002/jmri.22400; Kang BJ, 2015, J MAGN RESON IMAGING, V41, P616, DOI 10.1002/jmri.24617; Karahaliou A, 2010, BRIT J RADIOL, V83, P296, DOI 10.1259/bjr/50743919; Kim YJ, 2014, KOREAN J RADIOL, V15, P403, DOI 10.3348/kjr.2014.15.4.403; Kul S, 2011, AM J ROENTGENOL, V196, P210, DOI 10.2214/AJR.10.4258; Kuroki-Suzuki Seiko, 2007, Magn Reson Med Sci, V6, P21, DOI 10.2463/mrms.6.21; La Yun B, 2014, KOREAN J RADIOL, V15, P591, DOI 10.3348/kjr.2014.15.5.591; Malich A, 2005, AM J ROENTGENOL, V185, P964, DOI 10.2214/AJR.04.1073; Marini C, 2007, EUR RADIOL, V17, P2646, DOI 10.1007/s00330-007-0621-2; Newell D, 2010, EUR RADIOL, V20, P771, DOI 10.1007/s00330-009-1616-y; Nie K, 2008, ACAD RADIOL, V15, P1513, DOI 10.1016/j.acra.2008.06.005; Orel SG, 2001, RADIOLOGY, V220, P13, DOI 10.1148/radiology.220.1.r01jl3113; Park MJ, 2007, KOREAN J RADIOL, V8, P390, DOI 10.3348/kjr.2007.8.5.390; Partridge SC, 2011, MAGN RESON MED, V65, P1759, DOI 10.1002/mrm.22762; Partridge SC, 2010, AM J ROENTGENOL, V194, P1664, DOI 10.2214/AJR.09.3534; Preim U, 2012, EUR J RADIOL, V81, P1532, DOI 10.1016/j.ejrad.2011.04.045; Teruel JR, 2015, MAGN RESON MED, V74, P1138, DOI 10.1002/mrm.25489; Trimboli RM, 2014, AM J ROENTGENOL, V203, P674, DOI 10.2214/AJR.13.11816; Tsushima Y, 2007, ACAD RADIOL, V14, P643, DOI 10.1016/j.acra.2007.02.006; Wisner DJ, 2014, J MAGN RESON IMAGING, V40, P674, DOI 10.1002/jmri.24416; Woods BJ, 2007, J MAGN RESON IMAGING, V25, P495, DOI 10.1002/jmri.20837; Yabuuchi H, 2011, EUR RADIOL, V21, P11, DOI 10.1007/s00330-010-1890-8; Yabuuchi H, 2008, J MAGN RESON IMAGING, V28, P1157, DOI 10.1002/jmri.21570; Yuen S, 2007, J MAGN RESON IMAGING, V25, P502, DOI 10.1002/jmri.20845	37	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174681	10.1371/journal.pone.0174681	http://dx.doi.org/10.1371/journal.pone.0174681			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358833	gold, Green Submitted, Green Published			2022-12-26	WOS:000399174800071
J	Sheu, SJ; Chen, JL; Bee, YS; Chen, YA; Lin, SH; Shu, CW				Sheu, Shwu-Jiuan; Chen, Jiunn-Liang; Bee, Youn-Shen; Chen, Yi-An; Lin, Shi-Han; Shu, Chih-Wen			Differential autophagic effects of vital dyes in retinal pigment epithelial ARPE-19 and photoreceptor 661W cells	PLOS ONE			English	Article							INTERNAL LIMITING MEMBRANE; BRILLIANT BLUE-G; INDOCYANINE GREEN; OXIDATIVE STRESS; MACULAR HOLE; ACTIVATION; DEATH; RESVERATROL; MECHANISMS; VITRECTOMY	Indocyanine green (ICG) and brilliant blue G (BBG) are commonly used vital dyes to remove internal limiting membrane (ILM) in vitreoretinal surgery. The vital dyes have shown cytotoxic effects in ocular cells. Autophagy is a stress responsive pathway for either protecting cells or promoting cell death. However, the role of autophagy in ocular cells in response to the vital dyes remains unknown. In this study, we found that ICG and BBG reduced cell viability in both human retinal pigment epithelial ARPE-19 and mouse photoreceptor 661W cells. ICG and BBG induced lipidated GFP-LC3-II and LC3-II in ARPE-19 and 661W cells. Combination treatment with the autophagy inhibitor chloroquine indicated that ICG and BBG reduced autophagic flux in ARPE-19 cells, whereas the vital dyes induced autophagic flux in 661W cells. Moreover, genetic and pharmacological ablation of autophagy enhanced vital dyes-induced cytotoxicity in ocular cells. Dietary supplements, including resveratrol, lutein, and CoQ10, induced autophagy and diminished the cytotoxic effects of ICG and BBG in ocular cells. These results suggest that autophagy may protect ARPE-19 and 661W cells from vital dyes-induced damage.	[Sheu, Shwu-Jiuan; Chen, Jiunn-Liang; Bee, Youn-Shen; Chen, Yi-An] Kaohsiung Vet Gen Hosp, Dept Ophthalmol, Kaohsiung, Taiwan; [Sheu, Shwu-Jiuan; Chen, Jiunn-Liang] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Jiunn-Liang] Chung Hwa Univ Med Technol, Dept Optometry, Tainan, Taiwan; [Bee, Youn-Shen] Yuh Ing Jr Coll Hlth Care & Management, Kaohsiung, Taiwan; [Bee, Youn-Shen] Natl Def Med Ctr, Taipei, Taiwan; [Lin, Shi-Han; Shu, Chih-Wen] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan	Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Chung Hua University; National Defense Medical Center; Kaohsiung Veterans General Hospital	Sheu, SJ (corresponding author), Kaohsiung Vet Gen Hosp, Dept Ophthalmol, Kaohsiung, Taiwan.; Sheu, SJ (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Shu, CW (corresponding author), Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan.	sjiuansheu@gmail.com; cwshu@vghks.gov.tw	Shu, Chih-Wen/AAE-9652-2019	Shu, Chih-Wen/0000-0002-7774-0002	Kaohsiung Veterans General Hospital [VGHKS105-094]; Ministry of Science and Technology [MOST1052314-B-075B-005, 102, 105-2311B-075B-001]	Kaohsiung Veterans General Hospital; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by Kaohsiung Veterans General Hospital (VGHKS105-094) and Ministry of Science and Technology (MOST1052314-B-075B-005 to SJS and 102 and 105-2311B-075B-001 to CWS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida FP, 2014, JAMA OPHTHALMOL; Balaiya S, 2011, RETINA-J RET VIT DIS, V31, P1128, DOI 10.1097/IAE.0b013e3181fe543a; Chen K, 2011, J BIOL CHEM, V286, P21993, DOI 10.1074/jbc.M111.225805; Ci Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.506; Deosaran E, 2013, J CELL SCI, V126, P939, DOI 10.1242/jcs.114819; Eng KE, 2010, AUTOPHAGY, V6, P634, DOI 10.4161/auto.6.5.12112; Frost LS, 2014, EXP EYE RES, V124, P56, DOI 10.1016/j.exer.2014.04.010; Grabarska A, 2013, POSTEP HIG MED DOSW, V67, P722; Hohn F, 2014, OPHTHALMOLOGE, V111, P882, DOI 10.1007/s00347-014-3158-1; Jindal A, 2014, NEPAL J OPHTHALMOL, V6, P98, DOI 10.3126/nepjoph.v6i1.10779; Kaarniranta K, 2013, AUTOPHAGY, V9, P973, DOI 10.4161/auto.24546; Kawaguchi T, 2012, CARDIOVASC RES, V96, P456, DOI 10.1093/cvr/cvs282; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kumar V, 2016, SCI REP-UK, V6, DOI 10.1038/srep28142; Kunchithapautham K, 2007, AUTOPHAGY, V3, P433, DOI 10.4161/auto.4294; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Luke M, 2008, GRAEF ARCH CLIN EXP, V246, P817, DOI 10.1007/s00417-007-0761-8; Maia M, 2004, RETINA-J RET VIT DIS, V24, P157, DOI 10.1097/00006982-200402000-00024; Maia M, 2004, RETINA-J RET VIT DIS, V24, P80, DOI 10.1097/00006982-200402000-00012; Maia M, 2009, BRIT J OPHTHALMOL, V93, P1687, DOI 10.1136/bjo.2008.151597; Miranda S, 2012, J CELL PHYSIOL, V227, P2352, DOI 10.1002/jcp.22970; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morales MC, 2010, INVEST OPHTH VIS SCI, V51, P6018, DOI 10.1167/iovs.09-4916; Muta-Takada K, 2009, BIOFACTORS, V35, P435, DOI 10.1002/biof.56; Park D, 2016, SCI REP-UK, V6, DOI 10.1038/srep21772; Park HYL, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.26; Penha FM, 2008, J OCUL PHARMACOL TH, V24, P52, DOI 10.1089/jop.2007.0047; Penha FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064094; Rodrigues EB, 2010, AM J OPHTHALMOL, V149, P265, DOI 10.1016/j.ajo.2009.08.020; Rodrigues EB, 2009, SURV OPHTHALMOL, V54, P576, DOI 10.1016/j.survophthal.2009.04.011; Rodrigues EB, 2009, RETINA-J RET VIT DIS, V29, P497, DOI 10.1097/IAE.0b013e318196b1ad; Sayanagi K, 2007, BRIT J OPHTHALMOL, V91, P939, DOI 10.1136/bjo.2006.108746; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Smiddy W E, 1996, Bull Soc Belge Ophtalmol, V262, P31; Spaide RF, 2002, RETINA-J RET VIT DIS, V22, P637, DOI 10.1097/00006982-200210000-00016; Ungvari Z, 2011, EXERC SPORT SCI REV, V39, P128, DOI 10.1097/JES.0b013e3182141f80; Villeneuve NF, 2010, ANTIOXID REDOX SIGN, V13, P1699, DOI 10.1089/ars.2010.3211; Yoon HS, 1996, AM J OPHTHALMOL, V122, P67, DOI 10.1016/S0002-9394(14)71965-8; Yuen D, 2009, AM J OPHTHALMOL, V147, P251, DOI 10.1016/j.ajo.2008.08.031; Zhu JJ, 2015, TRANSPLANTATION, V99, P48, DOI 10.1097/TP.0000000000000476	41	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174736	10.1371/journal.pone.0174736	http://dx.doi.org/10.1371/journal.pone.0174736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358857	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174800079
J	Al-Maqtari, T; Hong, KU; Vajravelu, BN; Moktar, A; Cao, PX; Moore, JB; Bolli, R				Al-Maqtari, Tareq; Hong, Kyung U.; Vajravelu, Bathri N.; Moktar, Afsoon; Cao, Pengxiao; Moore, Joseph B.; Bolli, Roberto			Transcription factor-induced activation of cardiac gene expression in human c-kit plus cardiac progenitor cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; EPIGENETIC REGULATION; MYOCARDIAL-INFARCTION; HEART DEVELOPMENT; TRANSGENIC MICE; DEFINED FACTORS; FACTORS NKX2-5; MEF2 PROTEINS; DIFFERENTIATION; GATA-4	Although transplantation of c-kit+ cardiac progenitor cells (CPCs) significantly alleviates post-myocardial infarction left ventricular dysfunction, generation of cardiomyocytes by exogenous CPCs in the recipient heart has often been limited. Inducing robust differentiation would be necessary for improving the efficacy of the regenerative cardiac cell therapy. We assessed the hypothesis that differentiation of human c-kit+ CPCs can be enhanced by priming them with cardiac transcription factors (TFs). We introduced five different TFs (Gata4, MEF2C, NKX2.5, TBX5, and BAF60C) into CPCs, either alone or in combination, and then examined the expression of marker genes associated with the major cardiac cell types using quantitative RT-PCR. When introduced individually, Gata4 and TBX5 induced a subset of myocyte markers. Moreover, Gata4 alone significantly induced smooth muscle cell and fibroblast markers. Interestingly, these gene expression changes brought by Gata4 were also accompanied by morphological changes. In contrast, MEF2C and NKX2.5 were largely ineffective in initiating cardiac gene expression in CPCs. Surprisingly, introduction of multiple TFs in different combinations mostly failed to act synergistically. Likewise, addition of BAF60C to Gata4 and/or TBX5 did not further potentiate their effects on cardiac gene expression. Based on our results, it appears that GATA4 is able to potentiate gene expression programs associated with multiple cardiovascular lineages in CPCs, suggesting that GATA4 may be effective in priming CPCs for enhanced differentiation in the setting of stem cell therapy.	[Al-Maqtari, Tareq; Hong, Kyung U.; Vajravelu, Bathri N.; Moktar, Afsoon; Cao, Pengxiao; Moore, Joseph B.; Bolli, Roberto] Univ Louisville, Dept Med, Inst Mol Cardiol, Louisville, KY 40292 USA	University of Louisville	Bolli, R (corresponding author), Univ Louisville, Dept Med, Inst Mol Cardiol, Louisville, KY 40292 USA.	rbolli@louisville.edu	Al-Maqtari, Tareq/AAO-7951-2021; Hong, Kyung Uk/G-7145-2011; Vajravelu, Bathri/K-5504-2019	Hong, Kyung Uk/0000-0001-6700-9470; 	NIH [R01 HL-55757, HL-70897, HL-76794, P01 HL-78825]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by NIH grants R01 HL-55757, HL-70897, HL-76794, and P01 HL-78825. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181; Aries A, 2004, P NATL ACAD SCI USA, V101, P6975, DOI 10.1073/pnas.0401833101; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Bearzi C, 2009, P NATL ACAD SCI USA, V106, P15885, DOI 10.1073/pnas.0907622106; Behfar A, 2010, J AM COLL CARDIOL, V56, P721, DOI 10.1016/j.jacc.2010.03.066; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Brewer AC, 2005, STEM CELLS DEV, V14, P425, DOI 10.1089/scd.2005.14.425; Cai CX, 2012, J BIOL CHEM, V287, P33720, DOI 10.1074/jbc.M112.385542; Chen JX, 2012, CIRC RES, V111, P50, DOI 10.1161/CIRCRESAHA.112.270264; Cheng K, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001260; David R, 2009, CARDIOVASC RES, V84, P263, DOI 10.1093/cvr/cvp211; Dixon JE, 2011, MOL THER, V19, P1695, DOI 10.1038/mt.2011.125; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; Fischer KM, 2009, CIRCULATION, V120, P2077, DOI 10.1161/CIRCULATIONAHA.109.884403; Fransioli J, 2008, STEM CELLS, V26, P1315, DOI 10.1634/stemcells.2007-0751; Gago-Lopez N, 2014, STEM CELL REP, V2, P576, DOI 10.1016/j.stemcr.2014.03.003; Goumans MJ, 2008, STEM CELL RES, V1, P138, DOI 10.1016/j.scr.2008.02.003; Grepin C, 1997, DEVELOPMENT, V124, P2387; Hartung S, 2013, STEM CELLS DEV, V22, P1112, DOI 10.1089/scd.2012.0351; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; He JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027719; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Hong Kyung U, 2014, Curr Treat Options Cardiovasc Med, V16, P324, DOI 10.1007/s11936-014-0324-3; Hong KU, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0346-0; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Juliandi B, 2010, DEV GROWTH DIFFER, V52, P493, DOI 10.1111/j.1440-169X.2010.01175.x; Kasahara H, 1998, CIRC RES, V82, P936, DOI 10.1161/01.RES.82.9.936; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Li Q, 2011, BASIC RES CARDIOL; Li QH, 2011, BASIC RES CARDIOL, V106, P849, DOI 10.1007/s00395-011-0180-1; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lien CL, 1999, DEVELOPMENT, V126, P75; Linhares VLF, 2004, CARDIOVASC RES, V64, P402, DOI 10.1016/j.cardiores.2004.09.021; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; LINTS TJ, 1993, DEVELOPMENT, V119, P969; Lunyak VV, 2008, HUM MOL GENET, V17, pR28, DOI 10.1093/hmg/ddn149; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; MUNRO S, 1984, EMBO J, V3, P3087, DOI 10.1002/j.1460-2075.1984.tb02263.x; Pasumarthi KBS, 2005, CIRC RES, V96, P110, DOI 10.1161/01.RES.0000152326.91223.4F; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Rivkees SA, 1999, J BIOL CHEM, V274, P14204, DOI 10.1074/jbc.274.20.14204; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; Schlesinger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001313; Searcy RD, 1998, DEVELOPMENT, V125, P4461; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Sepulveda JL, 2002, J BIOL CHEM, P277; Skerjanc IS, 1998, J BIOL CHEM, P273; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; Terada R, 2011, CARDIOVASC RES, V91, P289, DOI 10.1093/cvr/cvr037; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; van Vliet P, 2008, NETH HEART J, V16, P163, DOI 10.1007/BF03086138; Vanpoucke G, 2004, NUCLEIC ACIDS RES, V32, P4155, DOI 10.1093/nar/gkh727; Wang DZ, 2001, DEVELOPMENT, V128, P4623; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wu H, 2006, PEDIATR RES, V59, p21R, DOI 10.1203/01.pdr.0000203565.76028.2a	64	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							0174242	10.1371/journal.pone.0174242	http://dx.doi.org/10.1371/journal.pone.0174242			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355297	gold, Green Submitted, Green Published			2022-12-26	WOS:000399174600039
J	Barajas, D; Aponte-Ubillus, JJ; Akeefe, H; Cinek, T; Peltier, J; Gold, D				Barajas, Daniel; Aponte-Ubillus, Juan Jose; Akeefe, Hassibullah; Cinek, Tomas; Peltier, Joseph; Gold, Daniel			Generation of infectious recombinant Adeno-associated virus in Saccharomyces cerevisiae	PLOS ONE			English	Article							GENES AFFECTING REPLICATION; TYPE-2 DNA-REPLICATION; PROTEIN-KINASE; CAPSID PROTEIN; HOST FACTORS; YEAST; IDENTIFICATION; VECTORS; EXPRESSION; PARTICLES	The yeast Saccharomyces cerevisiae has been successfully employed to establish model systems for a number of viruses. Such model systems are powerful tools to study the virus biology and in particular for the identification and characterization of host factors playing a role in the viral infection cycle. Adeno-associated viruses (AAV) are heavily studied due to their use as gene delivery vectors. AAV relies on other helper viruses for successful replication and on host factors for several aspects of the viral life cycle. However the role of host and helper viral factors is only partially known. Production of recombinant AAV (rAAV) vectors for gene delivery applications depends on knowledge of AAV biology and the limited understanding of host and helper viral factors may be precluding efficient production, particularly in heterologous systems. Model systems in simpler eukaryotes like the yeast S. cerevisiae would be useful tools to identify and study the role of host factors in AAV biology. Here we show that expression of AAV2 viral proteins VP1, VP2, VP3, AAP, Rep78, Rep52 and an ITR-flanked DNA in yeast leads to capsid formation, DNA replication and encapsidation, resulting in formation of infectious particles. Many of the AAV characteristics observed in yeast resemble those in other systems, making it a suitable model system. Future findings in the yeast system could be translatable to other AAV host systems and aid in more efficient production of rAAV vectors.	[Barajas, Daniel; Aponte-Ubillus, Juan Jose; Akeefe, Hassibullah; Cinek, Tomas; Peltier, Joseph; Gold, Daniel] BioMarin Pharmaceut Inc, Novato, CA 94949 USA; [Aponte-Ubillus, Juan Jose] Keck Grad Inst, Claremont, CA USA	BioMarin Pharmaceutical Inc.; Claremont Colleges; Keck Graduate Institute	Barajas, D (corresponding author), BioMarin Pharmaceut Inc, Novato, CA 94949 USA.	dbarajas@bmrn.com		Barajas, Daniel/0000-0002-5758-5631; Aponte-Ubillus, Juan Jose/0000-0002-2985-4865	BioMarin Pharmaceutical	BioMarin Pharmaceutical(Johnson & Johnson)	This work was funded by BioMarin Pharmaceutical. The funder provided support in the form of salaries for authors [DB, JJAU, HA, TC, JP, DG], equipment and reagents, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adachi K, 2011, DNA REPAIR HUM HEAL; ALNEMRI ES, 1994, J BIOL CHEM, V269, P30828; Backovic A, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-124; Carter BJ, 2004, MOL THER, V10, P981, DOI 10.1016/j.ymthe.2004.09.011; Cervelli T, 2008, J CELL SCI, V121, P349, DOI 10.1242/jcs.003632; Cervelli T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023474; Chandramouli S, 2013, VACCINE, V31, P3872, DOI 10.1016/j.vaccine.2013.06.062; Daya S, 2008, CLIN MICROBIOL REV, V21, P583, DOI 10.1128/CMR.00008-08; FLOTTE TR, 1995, GENE THER, V2, P29; Galao RP, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-32; Gancarz BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023988; Geoffroy M, 2005, HELPER FUNCTIONS REQ, V4, P265; Girod A, 2002, J GEN VIROL, V83, P973, DOI 10.1099/0022-1317-83-5-973; HOLSCHER C, 1995, J VIROL, V69, P6880; Jiang Y, 2006, J VIROL, V80, P7394, DOI 10.1128/JVI.02686-05; King JA, 2001, EMBO J, V20, P3282, DOI 10.1093/emboj/20.12.3282; Kushner DB, 2003, P NATL ACAD SCI USA, V100, P15764, DOI 10.1073/pnas.2536857100; Matsushita T, 1998, GENE THER, V5, P938, DOI 10.1038/sj.gt.3300680; Nagy PD, 2014, TRENDS MICROBIOL, V22, P309, DOI 10.1016/j.tim.2014.02.003; Nagy PD, 2010, ADV VIRUS RES, V76, P123, DOI 10.1016/S0065-3527(10)76004-8; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Nash K, 2007, J VIROL, V81, P5777, DOI 10.1128/JVI.02651-06; Nash K, 2009, J VIROL, V83, P454, DOI 10.1128/JVI.01939-08; NI TH, 1994, J VIROL, V68, P1128, DOI 10.1128/JVI.68.2.1128-1138.1994; Nicolas A, 2010, J VIROL, V84, P8871, DOI 10.1128/JVI.00725-10; Panavas T, 2005, P NATL ACAD SCI USA, V102, P7326, DOI 10.1073/pnas.0502604102; Qing KY, 2001, J VIROL, V75, P8968, DOI 10.1128/JVI.75.19.8968-8976.2001; Rodriguez-Limas WA, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-33; SASAGAWA T, 1995, VIROLOGY, V206, P126, DOI 10.1016/S0042-6822(95)80027-1; Schwartz RA, 2009, J VIROL, V83, P6269, DOI 10.1128/JVI.00318-09; Sonntag F, 2010, P NATL ACAD SCI USA, V107, P10220, DOI 10.1073/pnas.1001673107; Thakur SS, 2012, PRODUCTION RECOMBINA; Timpe J, 2005, CURR GENE THER, V5, P273, DOI 10.2174/1566523054065011; Urabe M, 2006, J VIROL, V80, P1874, DOI 10.1128/JVI.80.4.1874-1885.2006; Vogel Rebecca, 2013, Open Virol J, V7, P98, DOI 10.2174/1874357901307010098; Wang XS, 1997, J VIROL, V71, P3077, DOI 10.1128/JVI.71.4.3077-3082.1997; Ward P, 2001, J VIROL, V75, P10250, DOI 10.1128/JVI.75.21.10250-10258.2001; Ward P, 1998, J VIROL, V72, P420, DOI 10.1128/JVI.72.1.420-427.1998; Weitzman MD, 2011, METHODS MOL BIOL, V807, P1, DOI 10.1007/978-1-61779-370-7_1; Wright JF, 2014, BIOMEDICINES, V2, P80, DOI 10.3390/biomedicines2010080; Xiao PJ, 2012, THER DELIV, V3, P835, DOI 10.4155/TDE.12.63; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Zeltins A, 2013, MOL BIOTECHNOL, V53, P92, DOI 10.1007/s12033-012-9598-4; Zielonka A, 2012, J GEN VIROL, V93, P2658, DOI 10.1099/vir.0.044917-0	44	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0173010	10.1371/journal.pone.0173010	http://dx.doi.org/10.1371/journal.pone.0173010			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355224	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174600008
J	Chae, S; Desai, S; Crowell, M; Sedgh, G; Singh, S				Chae, Sophia; Desai, Sheila; Crowell, Marjorie; Sedgh, Gilda; Singh, Susheela			Characteristics of women obtaining induced abortions in selected low- and middle-income countries	PLOS ONE			English	Article							RISK-FACTORS; PREVALENCE	Background In 2010-2014, approximately 86% of abortions took place in low- and middle-income countries (LMICs). Although abortion incidence varies minimally across geographical regions, it varies widely by subregion and within countries by subgroups of women. Differential abortion levels stem from variation in the level of unintended pregnancies and in the likelihood that women with unintended pregnancies obtain abortions. Objectives To examine the characteristics of women obtaining induced abortions in LMICs. Methods We use data from official statistics, population-based surveys, and abortion patient surveys to examine variation in the percentage distribution of abortions and abortion rates by age at abortion, marital status, parity, wealth, education, and residence. We analyze data from five countries in Africa, 13 in Asia, eight in Europe, and two in Latin America and the Caribbean (LAC). Results Women across all sociodemographic subgroups obtain abortions. In most countries, women aged 20-29 obtained the highest proportion of abortions, and while adolescents obtained a substantial fraction of abortions, they do not make up a disproportionate share. Region-specific patterns were observed in the distribution of abortions by parity. In many countries, a higher fraction of abortions occurred among women of high socioeconomic status, as measured by wealth status, educational attainment, and urban residence. Due to limited data on marital status, it is unknown whether married or unmarried women make up a larger share of abortions. Conclusions These findings help to identify subgroups of women with disproportionate levels of abortion, and can inform policies and programs to reduce the incidence of unintended pregnancies; and in LMICs that have restrictive abortion laws, these findings can also inform policies to minimize the consequences of unsafe abortion and motivate liberalization of abortion laws. Program planners, policymakers, and advocates can use this information to improve access to safe abortion services, postabortion care, and contraceptive services.	[Chae, Sophia; Desai, Sheila; Crowell, Marjorie; Sedgh, Gilda; Singh, Susheela] Guttmacher Inst, New York, NY 10038 USA		Chae, S (corresponding author), Guttmacher Inst, New York, NY 10038 USA.	schae@guttmacher.org	Chae, Sophia/AAU-8160-2020	Chae, Sophia/0000-0002-9232-4779	Guttmacher Center for Population Research Innovation and Dissemination (NIH grant) [R24 HD074034]	Guttmacher Center for Population Research Innovation and Dissemination (NIH grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors received funding from an anonymous donor. Additional support was provided by the Guttmacher Center for Population Research Innovation and Dissemination (NIH grant R24 HD074034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge data assistance provided by Tamara Fetters and Suzette Audam. The authors also thank Akinrinola Bankole, Aparna Sundaram, Elena Prada, and Anna Popinchalk for their comments on earlier drafts. Additional support was provided by the Guttmacher Center for Population Research Innovation and Dissemination (NIH grant R24 HD074034). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Adjei G, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1572-1; Agrawal S, 2008, DETERMINANTS OF INDU; Bahadur A, 2008, ARCH GYNECOL OBSTET, V278, P329, DOI 10.1007/s00404-008-0574-y; Bankole A, 1999, INT FAM PLAN PERSPEC, V25, P68, DOI 10.2307/2991944; Bankole A, 1998, INT FAM PLAN PERSPEC, V24, P117, DOI 10.2307/3038208; Bankole A, 2010, STUD FAMILY PLANN, V41, P117, DOI 10.1111/j.1728-4465.2010.00232.x; Bernabe-Ortiz A, 2009, CAN MED ASSOC J, V180, P298, DOI 10.1503/cmaj.071399; Biddlecom A., 2007, PROTECTING NEXT GENE; Bowes T, 2006, Curationis, V29, P12; Gao GP, 2015, J OBSTET GYNAECOL RE, V41, P383, DOI 10.1111/jog.12547; Gelaye AA, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-50; Grant MJ, 2010, POPUL DEV REV, V36, P71, DOI 10.1111/j.1728-4457.2010.00318.x; Kalyanwala S, 2012, CULT HEALTH SEX, V14, P241, DOI 10.1080/13691058.2011.619280; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Klutsey EE, 2014, INT J WOMENS HEALTH, V6, P809, DOI 10.2147/IJWH.S62018; Lloyd Cynthia B., 2005, GROWING GLOBAL CHANG; Mahapatra P, 2007, LANCET, V370, P1653, DOI 10.1016/S0140-6736(07)61308-7; Kalb MMY, 2011, STUD FAMILY PLANN, V42, P159, DOI 10.1111/j.1728-4465.2011.00277.x; Paudel P, 2013, J NEPAL MED ASSOC, V52, P432; Rossier C, 2003, STUD FAMILY PLANN, V34, P87, DOI 10.1111/j.1728-4465.2003.00087.x; Rutstein S. O., 2004, DHS WEALTH INDEX; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Sedgh G, 2016, LANCET, V388, P258, DOI 10.1016/S0140-6736(16)30380-4; Singh S, 2016, BJOG-INT J OBSTET GY, V123, P1489, DOI 10.1111/1471-0528.13552; Singh S, 2012, ADDING IT COSTS BENE; SINGH Susheela, 2009, ABORTION WORLDWIDE D; Sundaram A, 2012, STUD FAMILY PLANN, V43, P273, DOI 10.1111/j.1728-4465.2012.00326.x; The World Bank, WORLD BANK COUNTR LE; United Nations Statistics Division, DEM YB 2016; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8; Westoff CF, 2010, DHS COMP REP, V25; Woog V., 2015, ADOLESCENT WOMENS NE	32	35	35	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0172976	10.1371/journal.pone.0172976	http://dx.doi.org/10.1371/journal.pone.0172976			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	ER9VG	28355285	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174600007
J	Chung, YK; Lin, CC				Chung, Yuan-Kai; Lin, Chung-Chi			Heat-induced symmetry breaking in ant (Hymenoptera: Formicidae) escape behavior	PLOS ONE			English	Article							EVACUATION	The collective egress of social insects is important in dangerous situations such as natural disasters or enemy attacks. Some studies have described the phenomenon of symmetry breaking in ants, with two exits induced by a repellent. However, whether symmetry breaking occurs under high temperature conditions, which are a common abiotic stress, remains unknown. In our study, we deposited a group of Polyrhachis dives ants on a heated platform and counted the number of escaping ants with two identical exits. We discovered that ants asymmetrically escaped through two exits when the temperature of the heated platform was >32.75 degrees C. The degree of asymmetry increased linearly with the temperature of the platform. Furthermore, the higher the temperature of heated platform was, the more ants escaped from the heated platform. However, the number of escaping ants decreased for 3 min when the temperature was higher than the critical thermal limit ( 39.46 degrees C), which is the threshold for ants to endure high temperature without a loss of performance. Moreover, the ants tended to form small groups to escape from the thermal stress. A preparatory formation of ant grouping was observed before they reached the exit, indicating that the ants actively clustered rather than accidentally gathered at the exits to escape. We suggest that a combination of individual and grouping ants may help to optimize the likelihood of survival during evacuation.	[Chung, Yuan-Kai] Natl Chung Hsing Univ, Dept Phys, Taichung, Taiwan; [Chung, Yuan-Kai] Aqua Fairy Biotechnol Co Ltd, Taichung, Taiwan; [Lin, Chung-Chi] Natl Changhua Univ Educ, Dept Biol, Changhua, Taiwan	National Chung Hsing University; National Changhua University of Education	Lin, CC (corresponding author), Natl Changhua Univ Educ, Dept Biol, Changhua, Taiwan.	cclin@cc.ncue.edu.tw		Lin, Chung-Chi/0000-0003-4824-4605	Ministry of Science and Technology of Taiwan [NSC102-2511-S-018-012-MY2]; Aqua Fairy Biotechnology Company Limited	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Aqua Fairy Biotechnology Company Limited	This work was supported by grants from the Ministry of Science and Technology of Taiwan (NSC102-2511-S-018-012-MY2 to CCL). The funder of Aqua Fairy Biotechnology Company Limited provided support in the form of salaries for author YKC. Both funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section in manuscript.	Altshuler E, 2005, AM NAT, V166, P643, DOI 10.1086/498139; Boari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081082; Burd M, 2006, PHYSICA A, V372, P124, DOI 10.1016/j.physa.2006.05.004; Caut S, 2013, ECOSCIENCE, V20, P19, DOI 10.2980/20-1-3559; Cerda X, 1998, FUNCT ECOL, V12, P45, DOI 10.1046/j.1365-2435.1998.00160.x; Evison SEF, 2008, BEHAV ECOL SOCIOBIOL, V63, P261, DOI 10.1007/s00265-008-0657-6; Fahy RF, 2012, FIRE MATER, V36, P328, DOI 10.1002/fam.1083; Fourcassie V, 2010, J EXP BIOL, V213, P2357, DOI 10.1242/jeb.031237; Grice A., 2009, FIRE RISK FIRE SAFET; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helbing D, 2002, PEDESTRIAN AND EVACUATION DYNAMICS, P21; Holldobler B., 1990, pi; Hurlbert AH, 2008, ECOL ENTOMOL, V33, P144, DOI 10.1111/j.1365-2311.2007.00962.x; KAY CAR, 1978, PHYSIOL ZOOL, V51, P206, DOI 10.1086/physzool.51.2.30157867; Li G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114517; Pan XS, 2007, AI SOC, V22, P113, DOI 10.1007/s00146-007-0126-1; Parisi DR, 2007, PHYSICA A, V385, P343, DOI 10.1016/j.physa.2007.06.033; Pratt SC, 2002, BEHAV ECOL SOCIOBIOL, V52, P117, DOI 10.1007/s00265-002-0487-x; Sharma KR, 2015, CELL REP, V12, P1261, DOI 10.1016/j.celrep.2015.07.031; Soria SA, 2012, SAFETY SCI, V50, P1584, DOI 10.1016/j.ssci.2012.03.010; Wang SJ, 2016, J INSECT BEHAV, V29, P735, DOI 10.1007/s10905-016-9593-x; Wang SJ, 2016, PHYSICA A, V457, P239, DOI 10.1016/j.physa.2016.03.083; Wang SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131784; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102	24	17	18	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0173642	10.1371/journal.pone.0173642	http://dx.doi.org/10.1371/journal.pone.0173642			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355235	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174600020
J	Badaoui, B; Fougeroux, A; Petit, F; Anselmo, A; Gorni, C; Cucurachi, M; Cersini, A; Granato, A; Cardeti, G; Formato, G; Mutinelli, F; Giuffra, E; Williams, JL; Botti, S				Badaoui, Bouabid; Fougeroux, Andre; Petit, Fabien; Anselmo, Anna; Gorni, Chiara; Cucurachi, Marco; Cersini, Antonella; Granato, Anna; Cardeti, Giusy; Formato, Giovanni; Mutinelli, Franco; Giuffra, Elisabetta; Williams, John L.; Botti, Sara			RNA-sequence analysis of gene expression from honeybees (Apis mellifera) infected with Nosema ceranae	PLOS ONE			English	Article							BEE COLONY LOSSES; INNATE IMMUNITY; NATURAL INFECTION; VARROA-DESTRUCTOR; FEEDING-BEHAVIOR; MANDUCA-SEXTA; MICROSPORIDIA; RESPONSES; GENOME; ARCHITECTURE	Honeybees (Apis mellifera) are constantly subjected to many biotic stressors including parasites. This study examined honeybees infected with Nosema ceranae (N. ceranae). N. = ceranae infection increases the bees energy requirements and may contribute to their decreased survival. RNA-seq was used to investigate gene expression at days 5, 10 and 15 Post Infection (P. I) with N. ceranae. The expression levels of genes, isoforms, alternative transcription start sites (TSS) and differential promoter usage revealed a complex pattern of transcriptional and post-transcriptional gene regulation suggesting that bees use a range of tactics to cope with the stress of N. ceranae infection. N. ceranae infection may cause reduced immune function in the bees by: (i) disturbing the host amino acids metabolism (ii) down-regulating expression of antimicrobial peptides (iii) down-regulation of cuticle coatings and (iv) down-regulation of odorant binding proteins.	[Badaoui, Bouabid; Anselmo, Anna; Gorni, Chiara; Cucurachi, Marco; Giuffra, Elisabetta; Botti, Sara] Integrat Biol Grp, Parco Tecnol Padano CERSA, Lodi, Italy; [Fougeroux, Andre] Syngenta, Guyancourt, France; [Petit, Fabien] RNAGRO, Tours, France; [Cersini, Antonella; Cardeti, Giusy; Formato, Giovanni] Ist Zooprofilatt Sperimentale Lazio & Toscana, Rome, Italy; [Granato, Anna; Mutinelli, Franco] Ist Zooprofilatt Sperimentale Venezie, Padua, Italy; [Williams, John L.] Univ Adelaide, Davies Res Ctr, Roseworthy, SA, Australia; [Badaoui, Bouabid] Mohamed V Univ Rabat, Sci Fac, Rabat, Morocco; [Giuffra, Elisabetta] INRA, Lab Anim Genet & Integrat Biol Team Genet, Jouy En Josas, France	Syngenta; IZS Lazio e Toscana; IZS delle Venezie; University of Adelaide; Mohammed V University in Rabat; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Botti, S (corresponding author), Integrat Biol Grp, Parco Tecnol Padano CERSA, Lodi, Italy.	sara.botti@ptp.it	MUTINELLI, FRANCO/K-7525-2018; Badaoui, Bouabid/AAV-8968-2021; Giuffra, Elisabetta/J-8080-2014; Formato, Giovanni/ABA-6990-2021	MUTINELLI, FRANCO/0000-0003-2903-9390; Formato, Giovanni/0000-0002-1202-5745; Williams, John/0000-0001-5188-7957; Anselmo, Anna/0000-0002-5279-8670; Giuffra, Elisabetta/0000-0001-9568-2056	Eureka-Eurostars Project Application [E!5069 NewBone]; Syngenta	Eureka-Eurostars Project Application; Syngenta(Syngenta)	Funded by Eureka-Eurostars Project Application E!5069 NewBone. Andrea Fougeroux was employed by Syngenta during the course of the study. Syngenta provided support in the form of salary for author AF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; This project was supported by the Eureka-Eurostars Project E!5069 NewBone. The authors would like to thank Maria Cecere for the technical help. The authors declare no competing financial interests.	Alaux C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-496; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Aliferis KA, 2012, J INSECT PHYSIOL, V58, P1349, DOI 10.1016/j.jinsphys.2012.07.010; Amdam GV, 2004, EXP GERONTOL, V39, P767, DOI 10.1016/j.exger.2004.02.010; Amdam GV, 2004, J ECON ENTOMOL, V97, P741, DOI 10.1603/0022-0493(2004)097[0741:APIWHB]2.0.CO;2; Ament SA, 2010, WIRES SYST BIOL MED, V2, P566, DOI 10.1002/wsbm.73; Antunez K, 2009, ENVIRON MICROBIOL, V11, P2284, DOI 10.1111/j.1462-2920.2009.01953.x; Aronstein KA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-391; Asea A, 2003, EXERC IMMUNOL REV, V9, P25; Aufauvre J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091686; Baaten Bas Jg, 2010, Commun Integr Biol, V3, P508, DOI 10.4161/cib.3.6.13495; Bacandritsos N, 2010, J INVERTEBR PATHOL, V105, P335, DOI 10.1016/j.jip.2010.08.004; Badaoui B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091918; Borneck R, 2010, J APICULT RES, V49, P334, DOI 10.3896/IBRA.1.49.4.06; BRANDT CR, 1978, J INVERTEBR PATHOL, V32, P12, DOI 10.1016/0022-2011(78)90169-6; Brown JB, 2014, NATURE, V512, P393, DOI 10.1038/nature12962; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; CASTEELS P, 1989, EMBO J, V8, P2387, DOI 10.1002/j.1460-2075.1989.tb08368.x; CASTEELS P, 1990, EUR J BIOCHEM, V187, P381, DOI 10.1111/j.1432-1033.1990.tb15315.x; CASTEELS P, 1993, J BIOL CHEM, V268, P7044; CASTEELSJOSSON K, 1994, J BIOL CHEM, V269, P28569; Chan QWT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r156; Chan QWT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-387; Chen J, 2015, MOL BIOL EVOL, V32, P2393, DOI 10.1093/molbev/msv120; Chen YP, 2009, J INVERTEBR PATHOL, V101, P204, DOI 10.1016/j.jip.2009.05.012; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Currie RW, 2010, J APICULT RES, V49, P104, DOI 10.3896/IBRA.1.49.1.18; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Dussaubat C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037017; Elsik CG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-86; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Evans JD, 2006, J INVERTEBR PATHOL, V93, P135, DOI 10.1016/j.jip.2006.04.004; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Garcia-Palencia P, 2010, J APICULT RES, V49, P278, DOI 10.3896/IBRA.1.49.3.08; Goncalves RLS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041083; Gorman MJ, 2001, INSECT BIOCHEM MOLEC, V31, P257, DOI 10.1016/S0965-1748(00)00145-4; GRIMSTAD PR, 1980, J MED ENTOMOL, V17, P1, DOI 10.1093/jmedent/17.1.1; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2013, ENV MICROBIOL REP, V5, P17, DOI 10.1111/1758-2229.12024; Higes M, 2009, J APICULT RES, V48, P217, DOI 10.3896/IBRA.1.48.3.12; Holt HL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-799; Huang Zachary, 2012, Terrestrial Arthropod Reviews, V5, P175, DOI 10.1163/187498312X639568; Hwang MS, 2002, NUCLEIC ACIDS RES, V30, P5029, DOI 10.1093/nar/gkf640; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kaneko T, 2005, CELL MICROBIOL, V7, P461, DOI 10.1111/j.1462-5822.2005.00504.x; Kanost MR, 2001, ADV EXP MED BIOL, V484, P319; Kawaji H, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r118; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; Khamis AM, 2015, SCI REP-UK, V5, DOI 10.1038/srep11136; Klaudiny J, 2005, INSECT BIOCHEM MOLEC, V35, P11, DOI 10.1016/j.ibmb.2004.09.007; Krawczak M, 2007, HUM MUTAT, V28, P150, DOI 10.1002/humu.20400; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee KP, 2006, P ROY SOC B-BIOL SCI, V273, P823, DOI 10.1098/rspb.2005.3385; Liu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009482; Malone LA, 1998, J INVERTEBR PATHOL, V71, P169, DOI 10.1006/jipa.1997.4715; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Martin-Hernandez R, 2011, PARASITOL RES, V109, P605, DOI 10.1007/s00436-011-2292-9; Mastrangelo AM, 2012, PLANT SCI, V185, P40, DOI 10.1016/j.plantsci.2011.09.006; Mayack C, 2009, J INVERTEBR PATHOL, V100, P185, DOI 10.1016/j.jip.2008.12.001; McDonnell CM, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-25; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Naug D, 2009, APIDOLOGIE, V40, P595, DOI 10.1051/apido/2009039; Osta MA, 2004, J EXP BIOL, V207, P2551, DOI 10.1242/jeb.01066; Parker R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r81; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; Ponton F, 2013, J INSECT PHYSIOL, V59, P130, DOI 10.1016/j.jinsphys.2012.10.011; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Samaranayake YH, 2001, J CLIN MICROBIOL, V39, P3296, DOI 10.1128/JCM.39.9.3296-3302.2001; Snodgrass RE, 1984, ANATOMY OF THE HONEY; Steiner H, 2004, IMMUNOL REV, V198, P83, DOI 10.1111/j.0105-2896.2004.0120.x; Sun W, 2012, INSECT BIOCHEM MOLEC, V42, P935, DOI 10.1016/j.ibmb.2012.09.006; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Thompson SN, 2008, J COMP PHYSIOL B, V178, P515, DOI 10.1007/s00360-007-0244-6; Topolska G, 2008, J APIC SCI, V52, P95; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van der Zee R, 2010, J APICULT RES, V49, P121, DOI 10.3896/IBRA.1.49.1.25; WANG DI, 1970, J INVERTEBR PATHOL, V15, P202, DOI 10.1016/0022-2011(70)90235-1; Ward KN, 2008, EXP GERONTOL, V43, P530, DOI 10.1016/j.exger.2008.03.012; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Zhang Y, 2010, J INSECT PHYSIOL, V56, P1207, DOI 10.1016/j.jinsphys.2010.03.019; Zou Z, 2006, INSECT MOL BIOL, V15, P603, DOI 10.1111/j.1365-2583.2006.00684.x	84	32	37	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0173438	10.1371/journal.pone.0173438	http://dx.doi.org/10.1371/journal.pone.0173438			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350872	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174400007
J	Ludtmann, MHR; Arber, C; Bartolome, F; de Vicente, M; Preza, E; Carro, E; Houlden, H; Gandhi, S; Wray, S; Abramov, AY				Ludtmann, Marthe H. R.; Arber, Charles; Bartolome, Fernando; de Vicente, Macarena; Preza, Elisavet; Carro, Eva; Houlden, Henry; Gandhi, Sonia; Wray, Selina; Abramov, Andrey Y.			Mutations in valosin-containing protein (VCP) decrease ADP/ATP translocation across the mitochondrial membrane and impair energy metabolism in human neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); ATP; induced pluripotent stem cell (iPS cell) (iPSC); mitochondria; ANT; VCP	ADENINE-NUCLEOTIDE TRANSLOCASE; PLURIPOTENT STEM-CELLS; ATP LEVELS; MICE; BIOENERGETICS; PROGENITORS; MECHANISM; SYNTHASE; NETWORKS; DISEASE	Mutations in the gene encoding valosin-containing protein (VCP) lead to multisystem proteinopathies including frontotemporal dementia. We have previously shown that patient-derived VCP mutant fibroblasts exhibit lower mitochondrial membrane potential, uncoupled respiration, and reduced ATP levels. This study addresses the underlying basis for mitochondrial uncoupling using VCP knockdown neuroblastoma cell lines, induced pluripotent stem cells (iPSCs), and iPSC-derived cortical neurons from patients with pathogenic mutations in VCP. Using fluorescent live cell imaging and respiration analysis we demonstrate a VCP mutation/knockdown-induced dysregulation in the adenine nucleotide translocase, which results in a slower rate of ADP or ATP translocation across the mitochondrial membranes. This deregulation can explain the mitochondrial uncoupling and lower ATP levels in VCP mutation-bearing neurons via reduced ADP availability for ATP synthesis. This study provides evidence for a role of adenine nucleotide translocase in the mechanism underlying altered mitochondrial function in VCP-related degeneration, and this new insight may inform efforts to better understand and manage neurodegenerative disease and other proteinopathies.	[Ludtmann, Marthe H. R.; Arber, Charles; Preza, Elisavet; Wray, Selina; Abramov, Andrey Y.] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Bartolome, Fernando; de Vicente, Macarena; Carro, Eva] Hosp 12 Octubre I 12, Neurodegenerat Disorders Grp, Res Inst, Madrid 28041, Spain; [Houlden, Henry] Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England; [Gandhi, Sonia] UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; [Bartolome, Fernando; de Vicente, Macarena; Carro, Eva] Biomed Res Networking Ctr Neurodegenerat Dis CIBE, Madrid 28041, Spain	University of London; University College London; Hospital Universitario 12 de Octubre; University of London; University College London; University of London; University College London	Abramov, AY (corresponding author), UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England.	a.abramov@ucl.ac.uk	Bartolome, Fernando/D-4618-2011; Abramov, Andrey Y/H-9053-2012; Abramov, Andrey/AAC-6712-2019; Carro, Eva/D-6240-2018; Houlden, Henry J/C-1532-2008; Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020; Wray, Selina/C-3682-2009; Ludtmann, Marthe/A-1446-2013; Arber, Charles/L-9989-2015	Bartolome, Fernando/0000-0001-9322-8933; Abramov, Andrey Y/0000-0002-7646-7235; Abramov, Andrey/0000-0002-7646-7235; Carro, Eva/0000-0002-6504-4579; Houlden, Henry J/0000-0002-2866-7777; Wray, Selina/0000-0003-3062-7050; Ludtmann, Marthe/0000-0003-1051-6425; Arber, Charles/0000-0002-9743-8134; PREZA, ELISAVET/0000-0003-4082-4621	National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC); Wellcome Trust grant; NIHR Queen Square Dementia Biomedical Research Unit UCL/UCLH; MRC [MR/M02492X/1] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL5-Gandhi] Funding Source: researchfish; Medical Research Council [MR/M02492X/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10082] Funding Source: researchfish; Wellcome Trust [100172/Z/12/Z] Funding Source: researchfish; Muscular Dystrophy UK [16GRO-PS36-0055] Funding Source: researchfish	National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC); Wellcome Trust grant(Wellcome Trust); NIHR Queen Square Dementia Biomedical Research Unit UCL/UCLH; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Muscular Dystrophy UK	This work was supported by the National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC), a Wellcome Trust grant, and the NIHR Queen Square Dementia Biomedical Research Unit UCL/UCLH. The authors declare that they have no conflicts of interest with the contents of this article.	Abramov AY, 2010, BBA-GEN SUBJECTS, V1800, P297, DOI 10.1016/j.bbagen.2009.08.002; Angelova PR, 2016, J CELL SCI, V129, P1792, DOI 10.1242/jcs.180737; Bartolome F, 2013, NEURON, V78, P57, DOI 10.1016/j.neuron.2013.02.028; Bobba A, 2013, BBA-BIOENERGETICS, V1827, P848, DOI 10.1016/j.bbabio.2013.04.001; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Brown S, 2011, STEM CELLS, V29, P1176, DOI 10.1002/stem.666; Ding WX, 2012, J BIOL CHEM, V287, P42373, DOI 10.1074/jbc.M112.413674; Edri R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7500; Ganote CE, 2003, J MOL CELL CARDIOL, V35, P749, DOI 10.1016/S0022-2828(03)00114-7; Imamura H, 2009, P NATL ACAD SCI USA, V106, P15651, DOI 10.1073/pnas.0904764106; Johnson AE, 2015, ELIFE, V4, DOI 10.7554/eLife.07366; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Ludtmann MHR, 2016, J NEUROSCI, V36, P10510, DOI 10.1523/JNEUROSCI.1659-16.2016; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Nalbandian A, 2015, MITOCHONDRION, V22, P1, DOI 10.1016/j.mito.2015.02.004; Nalbandian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046308; Nalbandian A, 2013, MUSCLE NERVE, V47, P260, DOI 10.1002/mus.23522; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Papkovskaia TD, 2012, HUM MOL GENET, V21, P4201, DOI 10.1093/hmg/dds244; Plun-Favreau H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.77; Schirris TJJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14533; Shi YC, 2012, NAT PROTOC, V7, P1836, DOI 10.1038/nprot.2012.116; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Sposito T, 2015, HUM MOL GENET, V24, P5260, DOI 10.1093/hmg/ddv246; Vallier L, 2009, STEM CELLS, V27, P2655, DOI 10.1002/stem.199; Vieira HLA, 2000, CELL DEATH DIFFER, V7, P1146, DOI 10.1038/sj.cdd.4400778; Weihl CC, 2007, HUM MOL GENET, V16, P919, DOI 10.1093/hmg/ddm037; WEINBACH EC, 1963, P NATL ACAD SCI USA, V50, P561, DOI 10.1073/pnas.50.3.561; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Wray S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043099; Yin HZ, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.115; Zhivotovsky B, 2009, CELL DEATH DIFFER, V16, P1419, DOI 10.1038/cdd.2009.118	34	19	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8907	8917		10.1074/jbc.M116.762898	http://dx.doi.org/10.1074/jbc.M116.762898			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28360103	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-26	WOS:000402153900043
J	Al-Mrabeh, A; Hollingsworth, KG; Steven, S; Tiniakos, D; Taylor, R				Al-Mrabeh, Ahmad; Hollingsworth, Kieren G.; Steven, Sarah; Tiniakos, Dina; Taylor, Roy			Quantification of intrapancreatic fat in type 2 diabetes by MRI	PLOS ONE			English	Article							BETA-CELL FUNCTION; PANCREATIC TRIACYLGLYCEROL DISTRIBUTION; INSULIN-SECRETION; ECTOPIC FAT; LIVER-DISEASE; WATER MRI; STEATOSIS; INFILTRATION; OBESITY; RESISTANCE	Objectives Accumulation of intrapancreatic fat may be important in type 2 diabetes, but widely varying data have been reported. The standard quantification by MRI in vivo is time consuming and dependent upon a high level of experience. We aimed to develop a new method which would minimise inter-observer variation and to compare this against previously published datasets. Methods A technique of 'biopsying' the image to minimise inclusion of non-parenchymal tissues was developed. Additionally, thresholding was applied to exclude both pancreatic ducts and intrusions of visceral fat, with pixels of fat values of < 1% or >20% being excluded. The new MR image 'biopsy' (MR-opsy) was compared to the standard method by 6 independent observers with wide experience of image analysis but no experience of pancreas imaging. The effect of the new method was examined on datasets from two studies of weight loss in type 2 diabetes. Results At low levels of intrapancreatic fat neither the result nor the inter-observer CV was changed by MR-opsy, thresholding or a combination of the methods. However, at higher levels the conventional method exhibited poor inter-observer agreement (coefficient of variation 26.9%) and the new combined method improved the CV to 4.3% (p<0.03). Using either MR-opsy alone or with thresholding, the new methods indicated a closer relationship between decrease in intrapancreatic fat and fall in blood glucose. Conclusion The inter-observer variation for quantifying intrapancreatic fat was substantially improved by the new method when pancreas fat levels were moderately high. The method will improve comparability of pancreas fat measurement between research groups.	[Al-Mrabeh, Ahmad; Hollingsworth, Kieren G.; Steven, Sarah; Taylor, Roy] Newcastle Univ, Inst Cellular Med, Magnet Resonance Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Tiniakos, Dina] Newcastle Univ, Newcastle Upon Tyne Hosp, Dept Cellular Pathol, Royal Victoria Infirm, Newcastle Upon Tyne, Tyne & Wear, England; [Tiniakos, Dina] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Taylor, R (corresponding author), Newcastle Univ, Inst Cellular Med, Magnet Resonance Ctr, Newcastle Upon Tyne, Tyne & Wear, England.	roy.taylor@ncl.ac.uk	Tiniakos, Dina G/AAA-5708-2020	Taylor, Roy/0000-0001-6273-0170	National Institute of Health Research Newcastle Biomedical Research Centre Grant; Newcastle Hospitals Healthcare Charity grant [JAG/ML/1214]; Novo Nordisk UK Research Foundation Research Fellowship	National Institute of Health Research Newcastle Biomedical Research Centre Grant; Newcastle Hospitals Healthcare Charity grant; Novo Nordisk UK Research Foundation Research Fellowship	The clinical study was funded by a National Institute of Health Research Newcastle Biomedical Research Centre Grant, a Newcastle Hospitals Healthcare Charity grant (JAG/ML/1214) for method development, and a Novo Nordisk UK Research Foundation Research Fellowship (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mrabeh A, 2016, DIABETOLOGIA; Begovatz P, 2015, DIABETOLOGIA, V58, P2679, DOI 10.1007/s00125-015-3770-x; Begovatz P, 2015, DIABETOLOGIA, V58, P1646, DOI 10.1007/s00125-015-3544-5; Buchowski MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047079; Chai J, 2016, EXP THER MED, V11, P476, DOI 10.3892/etm.2015.2925; Cohen M, 2014, OBESITY, V22, P1280, DOI 10.1002/oby.20674; Della Corte C, 2015, CLIN ENDOCRINOL, V83, P656, DOI 10.1111/cen.12862; ELKS ML, 1993, ENDOCRINOLOGY, V133, P208, DOI 10.1210/en.133.1.208; Ferrannini E, 2004, DIABETES, V53, P160, DOI 10.2337/diabetes.53.1.160; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gaborit B, 2015, INT J OBESITY, V39, P480, DOI 10.1038/ijo.2014.126; GLOVER GH, 1991, MAGNET RESON MED, V18, P371, DOI 10.1002/mrm.1910180211; Hallsworth K, 2011, GUT, V60, P1278, DOI 10.1136/gut.2011.242073; Hamilton G, 2011, NMR BIOMED, V24, P784, DOI 10.1002/nbm.1622; Heni M, 2010, DIABETES-METAB RES, V26, P200, DOI 10.1002/dmrr.1073; Hernando D, 2017, MAGN RESON MED, V77, P1516, DOI 10.1002/mrm.26228; Hollingsworth KG, 2015, DIABETOLOGIA, V58, P2676, DOI 10.1007/s00125-015-3718-1; Hu HH, 2010, OBESITY, V18, P841, DOI 10.1038/oby.2009.352; Idilman IS, 2015, ABDOM IMAGING, V40, P1512, DOI 10.1007/s00261-015-0385-0; Isserow JA, 1999, AM J ROENTGENOL, V173, P1263, DOI 10.2214/ajr.173.5.10541101; Kim HJ, 2007, AM J ROENTGENOL, V188, P429, DOI 10.2214/AJR.05.1095; Kim SY, 2014, RADIOLOGY, V271, P104, DOI 10.1148/radiol.13122883; Kovanlikaya A, 2005, PEDIATR RADIOL, V35, P601, DOI 10.1007/s00247-005-1413-y; Kuhn JP, 2015, RADIOLOGY, V276, P129, DOI 10.1148/radiol.15140446; Lalloyer F, 2006, DIABETES, V55, P1605, DOI 10.2337/db06-0016; Le KA, 2011, DIABETES CARE, V34, P485, DOI 10.2337/dc10-0760; LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878; Li J, 2011, PANCREAS, V40, P295, DOI 10.1097/MPA.0b013e318201669f; Lim EL, 2011, DIABETOLOGIA, V54, P2506, DOI 10.1007/s00125-011-2204-7; Lingvay I, 2009, J CLIN ENDOCR METAB, V94, P4070, DOI 10.1210/jc.2009-0584; Liu CY, 2007, MAGN RESON MED, V58, P354, DOI 10.1002/mrm.21301; Livingstone RS, 2014, MAGN RESON MATER PHY, V27, P397, DOI 10.1007/s10334-013-0421-4; Ma J, 2014, CHINESE MED J-PEKING, V127, P3548, DOI 10.3760/cma.j.issn.0366-6999.20141178; Macauley M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126825; Mann LW, 2016, RADIOLOGY, V278, P247, DOI 10.1148/radiol.2015150320; MATSUMOTO S, 1995, RADIOLOGY, V194, P453, DOI 10.1148/radiology.194.2.7824726; Ou HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062561; Pacifico L, 2015, CLIN ENDOCRINOLOGY; Patel NS, 2013, ALIMENT PHARM THER, V37, P630, DOI 10.1111/apt.12237; Patel NS, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/498296; Pezzilli R, 2014, WORLD J DIABETES, V5, P415, DOI 10.4239/wjd.v5.i4.415; Pinnick K, 2010, J CELL BIOCHEM, V109, P683, DOI 10.1002/jcb.22445; Pinnick KE, 2008, OBESITY, V16, P522, DOI 10.1038/oby.2007.110; Reeder SB, 2007, J MAGN RESON IMAGING, V25, P644, DOI 10.1002/jmri.20831; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; Schwenzer NF, 2008, INVEST RADIOL, V43, P330, DOI 10.1097/RLI.0b013e31816a88c6; Sengupta S, 2016, MAGN RESON MED, V76, P183, DOI 10.1002/mrm.25848; Sijens PE, 2010, WORLD J GASTROENTERO, V16, P1993, DOI 10.3748/wjg.v16.i16.1993; Steven S., 2016, DIABETES CARE; Steven S, 2016, DIABETES CARE, V39, P158, DOI 10.2337/dc15-0750; Storgaard H, 2003, METABOLISM, V52, P885, DOI 10.1016/S0026-0495(03)00102-1; Szczepaniak LS, 2012, DIABETES CARE, V35, P2377, DOI 10.2337/dc12-0701; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Targher G, 2012, J ENDOCRINOL INVEST, V35, P748, DOI 10.3275/8011; Tushuizen ME, 2007, DIABETES CARE, V30, P2916, DOI 10.2337/dc07-0326; van der Zijl NJ, 2011, J CLIN ENDOCR METAB, V96, P459, DOI 10.1210/jc.2010-1722; White MG, 2016, DIABETES CARE, V39, P2080, DOI 10.2337/dc16-0619; Wicklow BA, 2015, CAN J DIABETES, V39, P398, DOI 10.1016/j.jcjd.2015.04.001; Wong VWS, 2014, AM J GASTROENTEROL, V109, P589, DOI 10.1038/ajg.2014.1; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	60	48	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0174660	10.1371/journal.pone.0174660	http://dx.doi.org/10.1371/journal.pone.0174660			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369092	gold, Green Published, Green Submitted			2022-12-26	WOS:000399351000030
J	Jin, XL; Chen, XL; Xiao, L; Shi, CH; Chen, L; Yu, B; Yi, ZL; Yoo, JH; Heo, K; Yu, CY; Yamada, T; Sacks, EJ; Peng, JH				Jin, Xiaoli; Chen, Xiaoling; Xiao, Liang; Shi, Chunhai; Chen, Liang; Yu, Bin; Yi, Zili; Yoo, Ji Hye; Heo, Kweon; Yu, Chang Yeon; Yamada, Toshihiko; Sacks, Erik J.; Peng, Junhua			Application of visible and near-infrared spectroscopy to classification of Miscanthus species	PLOS ONE			English	Article							REFLECTANCE SPECTROSCOPY; GEOGRAPHICAL ORIGIN; MATURE TREES; PREDICTION; SEEDLINGS; SOLUBLES; GRAINS; ASSAY	The feasibility of visible and near infrared (NIR) spectroscopy as tool to classify Miscanthus samples was explored in this study. Three types of Miscanthus plants, namely, M. sinensis, M. sacchariflorus and M. fIoridulus, were analyzed using a NIR spectrophotometer. Several classification models based on the NIR spectra data were developed using line discriminated analysis (LDA), partial least squares (PLS), least squares support vector machine regression (LSSVR), radial basis function (RBF) and neural network (NN). The principal component analysis (PCA) presented rough classification with overlapping samples, while the models of Line_LSSVR, RBF_LSSVR and RBF_NN presented almost same calibration and validation results. Due to the higher speed of Line_LSSVR than RBF_ LSSVR and RBF_ NN, we selected the line_LSSVR model as a representative. In our study, the model based on line_LSSVR showed higher accuracy than LDA and PLS models. The total correct classification rates of 87.79 and 96.51% were observed based on LDA and PLS model in the testing set, respectively, while the line_LSSVR showed 99.42% of total correct classification rate. Meanwhile, the lin_LSSVR model in the testing set showed correct classification rate of 100, 100 and 96.77% for M. sinensis, M. sacchariflorus and M. fIoridulus, respectively. The lin_ LSSVR model assigned 99.42% of samples to the right groups, except one M. fIoridulus sample. The results demonstrated that NIR spectra combined with a preliminary morphological classification could be an effective and reliable procedure for the classification of Miscanthus species.	[Jin, Xiaoli; Chen, Xiaoling; Shi, Chunhai] Zhejiang Univ, Dept Agron, Hangzhou, Zhejiang, Peoples R China; [Jin, Xiaoli; Chen, Xiaoling; Shi, Chunhai] Zhejiang Univ, Key Lab Crop Germplasm Resource Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Xiao, Liang; Yi, Zili] Hunan Agr Univ, Hunan Prov Key Lab Germplasm Innovat & Utilizat C, Changsha, Hunan, Peoples R China; [Chen, Liang] Chinese Acad Sci, Wuhan Bot Garden, Wuhan, Hubei, Peoples R China; [Yu, Bin] Wuhan Junxiu Hort Sci & Technol Co Ltd, Wuhan, Hubei, Peoples R China; [Yoo, Ji Hye; Heo, Kweon; Yu, Chang Yeon] Kangwon Natl Univ, Chunchon, Gangwon, South Korea; [Yamada, Toshihiko] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Sapporo, Hokkaido, Japan; [Sacks, Erik J.] Univ Illinois, Dept Crop Sci, Urbana, IL USA; [Peng, Junhua] China Natl Seed Grp Co Ltd, Life Sci & Technol Ctr, Wuhan, Hubei, Peoples R China	Zhejiang University; Zhejiang University; Hunan Agricultural University; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Kangwon National University; Hokkaido University; University of Illinois System; University of Illinois Urbana-Champaign	Jin, XL (corresponding author), Zhejiang Univ, Dept Agron, Hangzhou, Zhejiang, Peoples R China.; Jin, XL (corresponding author), Zhejiang Univ, Key Lab Crop Germplasm Resource Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China.	jinxl@zju.edu.cn	Peng, Junhua/HHZ-2344-2022; Yamada, Toshihiko/A-5111-2012	Peng, Junhua/0000-0002-8428-3137; Yamada, Toshihiko/0000-0002-7845-6556	DOE Office of Science, Office of Biological and Environmental Research (BER) [DE-SC0006634, DE-SC0012379]; Open Foundation of Hunan Provincial Key Laboratory for Germplasm Innovation and Utilization of Crop [15KFXM02]	DOE Office of Science, Office of Biological and Environmental Research (BER)(United States Department of Energy (DOE)); Open Foundation of Hunan Provincial Key Laboratory for Germplasm Innovation and Utilization of Crop	This research was supported by the DOE Office of Science, Office of Biological and Environmental Research (BER) [grant no. DE-SC0006634 and DE-SC0012379], and Open Foundation of Hunan Provincial Key Laboratory for Germplasm Innovation and Utilization of Crop (15KFXM02). Wuhan Junxiu Horticultural Science, Technology Co., Ltd., Life Science and Technology Center, China National Seed Group Co., Ltd., provided support in the form of salaries for authors [BY & JP] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This research was supported by the DOE Office of Science, Office of Biological and Environmental Research (BER) [grant no. DE-SC0006634 and DE-SC0012379], and Open Foundation of Hunan Provincial Key Laboratory for Germplasm Innovation and Utilization of Crop (15KFXM02). We also thank Professor Yi Ren for the advices of classification in Miscanthus species.	Dang-Le AT, 2013, TREES-STRUCT FUNCT, V27, P773, DOI 10.1007/s00468-012-0832-2; Arana I, 2005, J NEAR INFRARED SPEC, V13, P349, DOI 10.1255/jnirs.566; Cavender-Bares J, 2000, OECOLOGIA, V124, P8, DOI 10.1007/PL00008865; Chen LZ, 2012, FOOD CHEM, V135, P338, DOI 10.1016/j.foodchem.2012.02.156; Clark LV, 2016, ANN BOT; Despagne F, 1998, ANALYST, V123, p157R; Eriksen J., 2015, BIORESOURCE TECHNOLO, V198, P124; Fagan CC, 2011, BIORESOURCE TECHNOL, V102, P5200, DOI 10.1016/j.biortech.2011.01.087; Hayes DJM, 2012, BIORESOURCE TECHNOL, V119, P393, DOI 10.1016/j.biortech.2012.05.137; He WM, 2013, J WOOD CHEM TECHNOL, V33, P52, DOI 10.1080/02773813.2012.731463; Huang JF, 2012, BIORESOURCE TECHNOL, V121, P274, DOI 10.1016/j.biortech.2012.06.015; Ishida A, 2005, TREE PHYSIOL, V25, P513, DOI 10.1093/treephys/25.5.513; Lande S, 2010, WOOD SCI TECHNOL, V44, P189, DOI 10.1007/s00226-009-0278-x; Lang C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134521; Li X. L., 2015, SCI REP, V5, P11; Li X, 2013, GENES GENOM, V35, P13, DOI 10.1007/s13258-013-0063-y; Lin C, 2014, FOOD CHEM, V162, P10, DOI 10.1016/j.foodchem.2014.04.056; Mediavilla S, 2009, ECOL RES, V24, P1083, DOI 10.1007/s11284-009-0587-4; Moscetti R, 2015, J SCI FOOD AGR, V95, P2619, DOI 10.1002/jsfa.6992; Payne CE, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0222-2; Pu YQ, 2008, J WOOD CHEM TECHNOL, V28, P122, DOI 10.1080/02773810802125008; Sun BL, 2011, HOLZFORSCHUNG, V65, P689, DOI 10.1515/HF.2011.075; Sun QA, 2010, BOT J LINN SOC, V164, P178, DOI 10.1111/j.1095-8339.2010.01082.x; Vermeulen P, 2015, FOOD CHEM, V189, P19, DOI 10.1016/j.foodchem.2014.09.103; Wu LM, 2015, BIORESOURCE TECHNOL, V177, P118, DOI 10.1016/j.biortech.2014.11.073; Xi Q., 2004, Plant Breeding and Seed Science, V49, P63; Yan J, 2012, GCB BIOENERGY, V4, P49, DOI 10.1111/j.1757-1707.2011.01108.x; Zhao HY, 2013, FOOD CHEM, V138, P1902, DOI 10.1016/j.foodchem.2012.11.037; Zhou XF, 2015, FOOD CHEM, V189, P13, DOI 10.1016/j.foodchem.2014.09.104	29	4	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0171360	10.1371/journal.pone.0171360	http://dx.doi.org/10.1371/journal.pone.0171360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369059	Green Published, Green Submitted, gold			2022-12-26	WOS:000399351000005
J	Zhou, Y; Wang, SR; Zhu, HD; Li, PP; Yang, BT; Ma, JZ				Zhou, Yu; Wang, Sirui; Zhu, Hedan; Li, Pipeng; Yang, Baotian; Ma, Jianzhang			Phylogeny and biogeography of South Chinese brown frogs (Ranidae, Anura)	PLOS ONE			English	Article							TIBETAN PLATEAU; RIBOSOMAL-RNA; CYTOCHROME-B; MITOCHONDRIAL 12S; RANA-CHENSINENSIS; DNA-SEQUENCES; SPECIES GROUP; UPLIFT; EVOLUTION; HISTORY	Few studies have explored the role of Cenozoic tectonic evolution in shaping the patterns and processes of extant animal distributions in and around East Asia. In this study, we selected South Chinese brown frogs as a model to examine the phylogenetic and biogeographical consequences of Miocene tectonic events within South China and its margins. We used mitochondrial and nuclear molecular data to reconstruct phylogenetic interrelationships among Chinese brown frogs using Bayesian and maximum likelihood analyses. The phylogeny results show that there are four main clades of Chinese brown frogs. Excepting the three commonly known Chinese brown frog species groups, R. maoershanensis forms an independent clade nearest to the R. japonica group. Phylogeny and P-distance analyses confirmed R. maoershanensis as a valid species. Among South Chinese brown frogs, there are four subclades associated with four geographical areas: (I) R. maoershanensis; (II) R. japonica; (III) R. chaochiaoensis; and (IV) other species of the R. longicrus species group. Divergence times, estimated using mitochondrial sequences, place the vicariance events among the four subclades in the middle to late Miocene epoch. Our results suggest that (1) South Chinese brown frogs originated due to a vicariance event separating them from the R. chensinensis species group at the time of the Geological movement (similar to 18 million years ago, Ma) in southern Tibet and the Himalayan region; (2) the separation and speciation of R. maoershanensis from the R. japonica group occurred due to the dry climate at approximately 16 Ma; (3) South Chinese brown frogs migrated from South China to Japan at the time (similar to 10.8 Ma) that the global sea-level fell and the East China Sea Shelf Basin was swamp facies, when a land gallery may have formed across the sea to connect the two areas; and (4) R. chaochiaoensis separated from other species of the R. longicrus species group during the uplift of the Tibetan Plateau at approximately 9.5 Ma.	[Zhou, Yu; Wang, Sirui; Zhu, Hedan; Ma, Jianzhang] Northeast Forestry Univ, Coll Wildlife Resources, Harbin, Heilongjiang, Peoples R China; [Zhou, Yu; Ma, Jianzhang] Northeast Forestry Univ, Chinese State Forestry Adm, Feline Res Ctr, Harbin, Peoples R China; [Li, Pipeng; Yang, Baotian] Shenyang Normal Univ, Coll Life Sci, Shenyang, Liaoning, Peoples R China	Northeast Forestry University - China; Northeast Forestry University - China; Shenyang Normal University	Ma, JZ (corresponding author), Northeast Forestry Univ, Coll Wildlife Resources, Harbin, Heilongjiang, Peoples R China.; Ma, JZ (corresponding author), Northeast Forestry Univ, Chinese State Forestry Adm, Feline Res Ctr, Harbin, Peoples R China.; Li, PP; Yang, BT (corresponding author), Shenyang Normal Univ, Coll Life Sci, Shenyang, Liaoning, Peoples R China.	lipipeng@yahoo.com; bt-yang@163.com; jianzhangma@163.com	Zhou, Yu/AAD-1788-2022; Zhou, Yu/K-2889-2015	Zhou, Yu/0000-0003-3079-7703	National Natural Science Fund of China [31372209, L1322010, 30470206, 30870276]; Director Foundation of Experimental Center, Shenyang Normal University [Syzx1104]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Director Foundation of Experimental Center, Shenyang Normal University	This study was financially supported by the National Natural Science Fund of China (Grant Nos. 31372209, L1322010, 30470206, 30870276), the Director Foundation of Experimental Center, Shenyang Normal University (Syzx1104).	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; ARMIJO R, 1986, J GEOPHYS RES-SOLID, V91, P13803, DOI 10.1029/JB091iB14p13803; ARMIJO R, 1989, J GEOPHYS RES-SOLID, V94, P2787, DOI 10.1029/JB094iB03p02787; Beebee TJC, 2005, HEREDITY, V95, P423, DOI 10.1038/sj.hdy.6800736; Bossuyt F, 2006, SYST BIOL, V55, P579, DOI 10.1080/10635150600812551; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Che J, 2007, ZOOL SCI, V24, P71, DOI 10.2108/zsj.24.71; Che J, 2012, MOL ECOL RESOUR, V12, P247, DOI 10.1111/j.1755-0998.2011.03090.x; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; Fei L., 2009, FAUNA SINICA AMPHIBI, V3; Frost D. R., 2016, AMPHIBIANS SPECIES W; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Haq BU, 2005, GEOARABIA, V10, P127; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; Hodges K, 1995, NATURE INT WEEKLY J, V374, P49; Hou FH, 2012, APPL MECH MAT; Jiang HC, 2008, PALAEOGEOGR PALAEOCL, V265, P30, DOI 10.1016/j.palaeo.2008.04.016; Jiang J-p, 2002, J SICHUAN U NATURAL, P85; John CM, 2004, GEOLOGY, V32, P829, DOI 10.1130/G20580.1; Kartavtsev YP, 2006, RUSS J GENET+, V42, P341, DOI 10.1134/S1022795406040016; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025777, 10.1371/journal.pone.0028840, 10.1371/journal.pone.0027198]; Li S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070461; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034013; Ligen C., 1988, OIL GAS GEOLOGY, V9, P100; Lin Ying-Chi, 2013, ScientificWorldJournal, V2013, P736386, DOI 10.1155/2013/736386; [卢海建 Lu Haijian], 2014, [中国地质, Geology of China], V41, P1724; Lu Y.-Y., 2004, SICHUAN J ZOOL, V24, P271; Lu Yu-yan, 2006, Sichuan Journal of Zoology, V25, P267; Lu Yu-Yan, 2007, Acta Zootaxonomica Sinica, V32, P792; Macey JR, 1998, MOL PHYLOGENET EVOL, V9, P80, DOI 10.1006/mpev.1997.0440; Miao YF, 2012, EARTH-SCI REV, V112, P155, DOI 10.1016/j.earscirev.2012.02.003; MOLNAR P, 1993, REV GEOPHYS, V31, P357, DOI 10.1029/93RG02030; Ni N., 2015, MITOCHONDR DNA, V27, P1; Nylander J. A. A., 2004, MRMODELTEST V2; Pauly GB, 2009, HERPETOLOGICA, V65, P115, DOI 10.1655/08-031R1.1; Pay- ton C.E., 1977, AAPG BULL, V26, P83, DOI DOI 10.1306/M26490C6; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rambaut A., 2014, TRACER V1 6; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shen XX, 2013, MOL BIOL EVOL, V30, P2235, DOI 10.1093/molbev/mst122; Shi Y.F., 1998, UPLIFT ENV CHANGES Q; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stuart BL, 2004, MOL PHYLOGENET EVOL, V31, P164, DOI 10.1016/S1055-7903(03)00258-6; Sumida M, 2003, ZOOL SCI, V20, P567, DOI 10.2108/zsj.20.567; Sumida M, 2002, MOL PHYLOGENET EVOL, V25, P293, DOI 10.1016/S1055-7903(02)00243-9; Sumida M, 2000, MOL PHYLOGENET EVOL, V16, P278, DOI 10.1006/mpev.2000.0791; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tanaka-Ueno T, 1999, COPEIA, P187, DOI 10.2307/1447400; Tang ZH, 2011, EARTH PLANET SC LETT, V302, P439, DOI 10.1016/j.epsl.2010.12.042; Taylor M, 2003, TECTONICS, V22; Taylor M, 2009, GEOSPHERE, V5, P199, DOI 10.1130/GES00217.1; Wang G., 1992, ACTA SEDIMENTOLOGICA, V10, P100; Wang PX, 2004, GEOPHYS MONOGR SER, V149, P1, DOI 10.1029/149GM01; Xie F., 2000, CULTUM HERPETOLOGICA, V8, P74; Yan F, 2011, ASIAN HERPETOL RES, V2, P61, DOI 10.3724/SP.J.1245.2011.00061; Yang BT, 2010, ASIAN HERPETOL RES, V1, P97, DOI 10.3724/SP.J.1245.2010.00097; YIN A, 1994, J GEOPHYS RES-SOL EA, V99, P18175, DOI 10.1029/94JB00504; Zhou WW, 2012, MOL ECOL, V21, P960, DOI 10.1111/j.1365-294X.2011.05411.x; Zhou Y, 2015, J HERPETOL, V49, P302, DOI 10.1670/13-111	65	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0175113	10.1371/journal.pone.0175113	http://dx.doi.org/10.1371/journal.pone.0175113			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369142	gold, Green Published, Green Submitted			2022-12-26	WOS:000399351000076
J	Burch, A; Tao-Cheng, JH; Dosemeci, A				Burch, Amelia; Tao-Cheng, Jung-Hwa; Dosemeci, Ayse			A novel synaptic junction preparation for the identification and characterization of cleft proteins	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; POSTSYNAPTIC DENSITY; GLUTAMATE RECEPTORS; RAT-BRAIN; PROTEOMIC ANALYSIS; DENDRITIC SPINES; COMPLEXES; SYNAPSES; NEUROLIGIN-1; LOCALIZATION	Identification of synaptic cleft components has been hampered by the lack of a suitable preparation enriched in synaptic junctions devoid of adjoining peripheral membranes. Prior strategies for the isolation of synaptic junctions, relying on detergents for the removal of peripheral membranes, resulted in substantial loss of membranes lining the cleft. Here, a novel, detergent-free method is described for the preparation of a synaptic junction (SJ) fraction, using phospholipase A(2). Limited digestion of synaptic plasma membrane (SPM) fraction with phospholipase A(2) followed by centrifugation over a sucrose cushion results in selective removal of membranes peripheral to the cleft while junctional membranes remain relatively intact as observed by electron microscopy. Enrichment in synaptic junctional structures and loss of membranes peripheral to the junctional area are further verified by demonstrating enrichment in PSD-95 and loss in mGluR5, respectively. The SJ fraction is enriched in neuroligins and neurexins, in agreement with immuno-electron microscopy data showing their selective localization to the junctional area. Among additional cell adhesion molecules tested, N-cadherin and specific isoforms of the SynCAM and SALM families also show marked enrichment in the SJ fraction, suggesting preferential localization at the synaptic cleft while others show little enrichment or decrease, suggesting that they are not restricted to or concentrated at the synaptic cleft. Treatment of the SJ fraction with glycosidases results in electrophoretic mobility shifts of all cell adhesion molecules tested, indicating glycosylation at the synaptic cleft. Biochemical and ultrastructural data presented indicate that the novel synaptic junction preparation can be used as a predictive tool for the identification and characterization of the components of the synaptic cleft.	[Burch, Amelia; Dosemeci, Ayse] NINDS, Neurobiol Lab, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Tao-Cheng, Jung-Hwa] NINDS, EM Facil, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Burch, A (corresponding author), NINDS, Neurobiol Lab, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	amelburch@gmail.com		Burch, Amelia/0000-0001-8533-4293	Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health, USA; Intramural Research Program of National Institute of Neurological Disorders and Stroke, National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003113] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health, USA; Intramural Research Program of National Institute of Neurological Disorders and Stroke, National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health, USA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to profusely thank Rita Azzam and Virginia Crocker for their EM technical support and Christine A. Winters for hippocampal neuronal cultures. Also, a special thank you to Dr. Thomas Reese for advice and encouragement throughout the study and for a critical reading of the manuscript. Summer intern, Lele Mathis, participated in the initial phase of the project. This research was supported by the Intramural Research Program of National Institute of Neurological Disorders and Stroke, National Institutes of Health.	BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Bouvier D, 2008, J NEUROCHEM, V106, P682, DOI 10.1111/j.1471-4159.2008.05416.x; Budreck EC, 2013, P NATL ACAD SCI USA, V110, P725, DOI 10.1073/pnas.1214718110; Choi Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep26676; COTMAN CW, 1972, J CELL BIOL, V55, P696, DOI 10.1083/jcb.55.3.696; DAVIS GA, 1973, BRAIN RES, V62, P135, DOI 10.1016/0006-8993(73)90624-0; de Arce KP, 2015, NEURON, V88, P1165, DOI 10.1016/j.neuron.2015.11.011; Dosemeci A, 2011, ADV NEUROBIOL, V2, P227, DOI 10.1007/978-1-4419-7197-5_9; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fukaya M, 2000, J COMP NEUROL, V426, P572; Fux CM, 2003, MOL CELL NEUROSCI, V24, P939, DOI 10.1016/j.mcn.2003.07.001; GRAY EG, 1962, J ANAT, V96, P79; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; High Brigit, 2015, Front Synaptic Neurosci, V7, P9, DOI 10.3389/fnsyn.2015.00009; Hunt CA, 1996, J NEUROSCI, V16, P1380; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Loh KH, 2016, CELL, V166, P1295, DOI 10.1016/j.cell.2016.07.041; Lucic V, 2005, STRUCTURE, V13, P423, DOI 10.1016/j.str.2005.02.005; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Missler M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005694; Niederkofler V, 2010, DEVELOPMENT, V137, P427, DOI 10.1242/dev.042515; Peters A., 1991, FINE STRUCTURE NERVO; Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013; Petralia RS, 1998, NEUROPHARMACOLOGY, V37, P1321, DOI 10.1016/S0028-3908(98)00118-X; Robbins EM, 2010, NEURON, V68, P894, DOI 10.1016/j.neuron.2010.11.003; Schuster T, 1998, J NEUROBIOL, V37, P359, DOI 10.1002/(SICI)1097-4695(19981115)37:3<359::AID-NEU2>3.0.CO;2-4; Seabold GK, 2008, J BIOL CHEM, V283, P8395, DOI 10.1074/jbc.M709456200; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tao-Cheng JH, 2014, NEUROSCIENCE, V266, P80, DOI 10.1016/j.neuroscience.2014.01.066; THERIEN HM, 1976, J CELL BIOL, V71, P807, DOI 10.1083/jcb.71.3.807; Tremblay ME, 2007, J COMP NEUROL, V501, P691, DOI 10.1002/cne.21263; Uchigashima M, 2016, P NATL ACAD SCI USA, V113, P4206, DOI 10.1073/pnas.1514074113; Yang Y, 2011, NEUROSCIENCE, V192, P132, DOI 10.1016/j.neuroscience.2011.06.061; Zuber B, 2005, P NATL ACAD SCI USA, V102, P19192, DOI 10.1073/pnas.0509527102	36	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174895	10.1371/journal.pone.0174895	http://dx.doi.org/10.1371/journal.pone.0174895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362857	Green Published, gold, Green Submitted			2022-12-26	WOS:000399175000048
J	Xavier, JC; Trathan, PN; Ceia, FR; Tarling, GA; Adlard, S; Fox, D; Edwards, EWJ; Vieira, RP; Medeiros, R; De Broyer, C; Cherel, Y				Xavier, Jose C.; Trathan, Philip N.; Ceia, Filipe R.; Tarling, Geraint A.; Adlard, Stacey; Fox, Derren; Edwards, Ewan W. J.; Vieira, Rui P.; Medeiros, Renata; De Broyer, Claude; Cherel, Yves			Sexual and individual foraging segregation in Gentoo penguins Pygoscelis papua from the Southern Ocean during an abnormal winter	PLOS ONE			English	Article							STABLE-ISOTOPES; CLIMATE-CHANGE; EUDYPTES-CHRYSOLOPHUS; MACARONI PENGUINS; SCOTIA SEA; PROCELLARIA-AEQUINOCTIALIS; APTENODYTES-PATAGONICUS; INTERANNUAL VARIATION; ROCKHOPPER PENGUINS; DIOMEDEA-EXULANS	Knowledge about sexual segregation and gender-specific, or indeed individual specialization, in marine organisms has improved considerably in the past decade. In this context, we tested the "Intersexual Competition Hypothesis" for penguins by investigating the feeding ecology of Gentoo penguins during their austral winter non-breeding season. We considered this during unusual environmental conditions (i.e. the year 2009 had observations of high sea surface and air temperatures) in comparison with the long term average at Bird Island, South Georgia. Through conventional (i.e. stomach contents) and stable isotopic values from red blood cells, plasma and feathers of both male and female Gentoo penguins, we showed that there were significant differences between sexes, with males feeding mainly on fish (54% by mass) followed by crustaceans (38%) whereas females fed mainly on crustaceans (89% by mass) followed by fish (4%). Themisto gaudichaudii was the most important crustacean prey for males (64% by mass; 82% by number; 53% by frequency of occurrence) and females (63% by mass; 77% by number; 89% by frequency of occurrence), contrasting with all previous studies that found Antarctic krill Euphausia superba were generally the main prey. Stable isotopic data showed that, in terms of habitat use (based on delta C-13), there were significant differences in short-term carbon signatures between males and females (based on plasma and red blood cells), suggesting that both sexes explored different habitats, with females exploring more offshore pelagic waters and males feeding more in coastal benthic waters. Based on delta N-15, males fed on significantly higher trophic level than females (based on plasma and red blood cells), in agreement with our diet results., Thus, Gentoo penguins behave in a similar manner to other non-breeding penguins species (e.g. king, macaroni and rockhopper penguins), albeit at a smaller spatial scale (as they do not disperse as these other penguins do), in that they have a wider habitat and trophic niche during the Antarctic Winter (in comparison to Summer). We also detected individual specialization in feeding/trophic levels for each gender, with certain males feeding mainly on fish and certain females mainly on crustaceans, which may be driven the prevailing environmental conditions that lead individuals to search for alternative prey, and cause sexual diet segregation. Our results provide further information to help improve understanding about sexual segregation and individual specialization of marine organisms, while contributing valuable information on the winter diet for Antarctic monitoring programs and for modelling Antarctic marine food webs.	[Xavier, Jose C.; Ceia, Filipe R.; Vieira, Rui P.] Univ Coimbra, Dept Life Sci, Marine & Environm Sci Ctr, Coimbra, Portugal; [Xavier, Jose C.; Trathan, Philip N.; Tarling, Geraint A.; Adlard, Stacey; Fox, Derren; Edwards, Ewan W. J.] British Antarctic Survey, Nat Environm Res Council, Madingley Rd, Cambridge, England; [Medeiros, Renata] Cardiff Univ, Cardiff Sch Biosci, Sir Martin Evans Bldg, Cardiff, S Glam, Wales; [De Broyer, Claude] Royal Belgian Inst Nat Sci OD Taxon & Phylogeny, Rue Vautier 29, Brussels, Belgium; [Cherel, Yves] Univ La Rochelle, CNRS, UPR 7372, Ctr Etud Biol Chize, Villiers En Bois, France; [Vieira, Rui P.] Univ Southampton, Natl Oceanog Ctr Southampton, Grad Sch, Waterfront Campus,European Way, Southampton, Hants, England	Universidade de Coimbra; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Cardiff University; Royal Belgian Institute of Natural Sciences; Centre National de la Recherche Scientifique (CNRS); La Rochelle Universite; NERC National Oceanography Centre; University of Southampton	Xavier, JC (corresponding author), Univ Coimbra, Dept Life Sci, Marine & Environm Sci Ctr, Coimbra, Portugal.; Xavier, JC (corresponding author), British Antarctic Survey, Nat Environm Res Council, Madingley Rd, Cambridge, England.	jccx@cantab.net	Ceia, Filipe R./A-2196-2012; Vieira, Rui/R-6881-2019; Medeiros, Renata/M-8616-2015; Vieira, Rui Pedro/G-1738-2012	Ceia, Filipe R./0000-0002-5470-5183; Medeiros, Renata/0000-0002-5833-309X; /0000-0002-9621-6660; Vieira, Rui Pedro/0000-0001-8491-2565	Investigator FCT program [IF/00616/2013]; Foundation for Science and Technology (Portugal); European Social Fund (POPH, EU) through a post-doc grant [SFRH/BPD/95372/2013]; Portuguese Science Foundation [SFRH/BD/84030/2012]; FCT [MARE - UID/MAR/04292/2013]; Natural Environment Research Council [bas0100035] Funding Source: researchfish; NERC [bas0100035] Funding Source: UKRI	Investigator FCT program(Portuguese Foundation for Science and Technology); Foundation for Science and Technology (Portugal)(Portuguese Foundation for Science and Technology); European Social Fund (POPH, EU) through a post-doc grant; Portuguese Science Foundation(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work is part of SCAR AnT-ERA, ICED, BAS-CEPH programs. JX is supported by the Investigator FCT program (IF/00616/2013) and FRC is supported by the Foundation for Science and Technology (Portugal) and the European Social Fund (POPH, EU) through a post-doc grant (SFRH/BPD/95372/2013). RPV is currently supported by a doctoral grant from the Portuguese Science Foundation (SFRH/BD/84030/2012). This study benefited from the strategic program of MARE, financed by FCT (MARE - UID/MAR/04292/2013).; Pierre Richard, Richard Phillips, Miguel Guerreiro, Pedro Alvito, Vitor Paiva and Jon Watkins for providing valuable contributions in the laboratory during the planning and execution of the project. David Thompson for reviewing a final version of the manuscript. We also thank Marcella Libertelli for aiding the identification of small otoliths. This work is part of SCAR AnT-ERA, ICED, BAS-CEPH programs. JX is supported by the Investigator FCT program (IF/00616/2013) and FRC is supported by the Foundation for Science and Technology (Portugal) and the European Social Fund (POPH, EU) through a post-doc grant (SFRH/BPD/95372/2013). RPV is currently supported by a doctoral grant from the Portuguese Science Foundation (SFRH/BD/84030/2012). This study benefited from the strategic program of MARE, financed by FCT (MAREUID/MAR/04292/2013).	ADAMS NJ, 1987, J ZOOL, V212, P303, DOI 10.1111/j.1469-7998.1987.tb05992.x; Ainley DG, 1998, POLAR BIOL, V20, P311, DOI 10.1007/s003000050308; Angelier F, 2008, GEN COMP ENDOCR, V156, P134, DOI 10.1016/j.ygcen.2007.12.001; [Anonymous], 1996, GUIDE USE OTOLITHS S; Baduini CL, 2001, FISH OCEANOGR, V10, P117, DOI 10.1046/j.1365-2419.2001.00156.x; Barlow KE, 2002, MAR ECOL PROG SER, V232, P291, DOI 10.3354/meps232291; Baylis AMM, 2015, MAR BIOL, V162, P99, DOI 10.1007/s00227-014-2561-0; Bearhop S, 2006, MAR ECOL PROG SER, V311, P157, DOI 10.3354/meps311157; Berrow SD, 1999, POLAR BIOL, V22, P156, DOI 10.1007/s003000050405; Berrow SD, 1999, ANTARCT SCI, V11, P283, DOI 10.1017/S0954102099000371; Bertellotti M, 2002, WATERBIRDS, V25, P479, DOI 10.1675/1524-4695(2002)025[0479:DSOMPU]2.0.CO;2; Bethge P, 1997, J ZOOL, V242, P483; Bolnick DI, 2004, EVOLUTION, V58, P608, DOI 10.1111/j.0014-3820.2004.tb01683.x; Boltovskoy Demetrio, 1999, P1; Bost C. A., 1994, Marine Ornithology, V22, P237; BOST CA, 1992, J ZOOL, V226, P135, DOI 10.1111/j.1469-7998.1992.tb06132.x; Bost CA, 1990, EVOLUTIONARY ECOLOGY, P85; Brierley A.S., 1999, CCAMLR Science, V6, P47; Brooke MD, 2004, P ROY SOC B-BIOL SCI, V271, pS246, DOI 10.1098/rsbl.2003.0153; Carravieri A, 2013, SCI TOTAL ENVIRON, V454, P141, DOI 10.1016/j.scitotenv.2013.02.060; Ceia FR, 2015, MAR BIOL, V162, P1923, DOI 10.1007/s00227-015-2735-4; Ceia FR, 2014, MAR BIOL, V161, P1861, DOI 10.1007/s00227-014-2468-9; Ceia FR, 2012, MAR BIOL, V159, P1581, DOI 10.1007/s00227-012-1946-1; CHAPPELL MA, 1993, BEHAV ECOL SOCIOBIOL, V33, P173, DOI 10.1007/BF00216598; Cherel Y, 2005, OECOLOGIA, V145, P533, DOI 10.1007/s00442-005-0156-7; Cherel Y, 2005, PHYSIOL BIOCHEM ZOOL, V78, P106, DOI 10.1086/425202; Cherel Y, 2007, J ANIM ECOL, V76, P826, DOI 10.1111/j.1365-2656.2007.01238.x; Cherel Y, 2014, MAR ECOL PROG SER, V505, P267, DOI 10.3354/meps10795; Chiaradia A, 2012, AUSTRAL ECOL, V37, P610, DOI 10.1111/j.1442-9993.2011.02323.x; Cimino MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep18820; Clarke J, 1998, POLAR BIOL, V20, P248, DOI 10.1007/s003000050301; Constable AJ, 2014, GLOBAL CHANGE BIOL, V20, P3004, DOI 10.1111/gcb.12623; Costantini V, 2008, ANIM REPROD SCI, V106, P162, DOI 10.1016/j.anireprosci.2007.12.013; Croxall J, SELECTED SCI PAPERS, P483; Croxall J.P., 1987, P347; Croxall J. P., 1999, Marine Ornithology, V27, P1; CROXALL JP, 1995, J ZOOL, V237, P133, DOI 10.1111/j.1469-7998.1995.tb02752.x; Croxall JP, 2002, SCIENCE, V297, P1510, DOI 10.1126/science.1071987; CROXALL JP, 1988, CONDOR, V90, P157, DOI 10.2307/1368444; Croxall JP, 1999, MAR ECOL PROG SER, V177, P115, DOI 10.3354/meps177115; CROXALL JP, 1988, POLAR BIOL, V9, P9, DOI 10.1007/BF00441760; CROXALL JP, 1980, IBIS, V122, P245, DOI 10.1111/j.1474-919X.1980.tb02665.x; DAVIS RW, 1989, J ANIM ECOL, V58, P59, DOI 10.2307/4986; Dehnhard N, 2011, POLAR BIOL, V34, P1763, DOI 10.1007/s00300-011-1026-x; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Fielding S, 2014, ICES J MAR SCI, V71, P2578, DOI 10.1093/icesjms/fsu104; Fielding S, 2012, DEEP-SEA RES PT II, V59, P173, DOI 10.1016/j.dsr2.2011.08.002; Forcada J, 2009, GLOBAL CHANGE BIOL, V15, P1618, DOI 10.1111/j.1365-2486.2009.01909.x; Forero MG, 2002, MAR ECOL PROG SER, V234, P289, DOI 10.3354/meps234289; GON O, 1990, FISHES SO OCEAN; Gorman KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090081; Gray CM, 2001, ANIM BEHAV, V62, P117, DOI 10.1006/anbe.2001.1717; Green JA, 2005, MAR ECOL PROG SER, V296, P183, DOI 10.3354/meps296183; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Gutt J, 2015, GLOBAL CHANGE BIOL, V21, P1434, DOI 10.1111/gcb.12794; Harris MP, 1996, BIRD STUDY, V43, P220, DOI 10.1080/00063659609461014; Hecht T., 1987, South African Journal of Antarctic Research, V17, P2; Hill S, MULTIPLE INDICATORS; Hill SL, 2012, DEEP-SEA RES PT II, V59, P237, DOI 10.1016/j.dsr2.2011.09.001; HOBSON KA, 1993, AUK, V110, P638, DOI 10.2307/4088430; Hull CL, 2000, CAN J ZOOL, V78, P333, DOI 10.1139/cjz-78-3-333; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Kane J. E., 1966, Discovery Reports, V34, P163; Kato A., 1991, Marine Ornithology, V19, P31; Kennicutt MC, 2014, NATURE, V512, P23, DOI 10.1038/512023a; KING JC, 1994, INT J CLIMATOL, V14, P357, DOI 10.1002/joc.3370140402; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lescroel A, 2004, POLAR BIOL, V27, P206, DOI 10.1007/s00300-003-0571-3; Lewis S, 2002, P ROY SOC B-BIOL SCI, V269, P1687, DOI 10.1098/rspb.2002.2083; Lewis S, 2001, NATURE, V412, P816, DOI 10.1038/35090566; Lockley, 1954, SEA BIRDS; Ludynia K, 2013, ANIM BEHAV, V85, P255, DOI 10.1016/j.anbehav.2012.11.001; Lynch HJ, 2012, ECOLOGY, V93, P1367; Main CE, 2009, POLAR BIOL, V32, P569, DOI 10.1007/s00300-008-0552-7; Mancini PL, 2013, J EXP MAR BIOL ECOL, V449, P186, DOI 10.1016/j.jembe.2013.09.011; Masello JF, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00103.1; MCKENNA JE, 1991, FISH B-NOAA, V89, P643; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; Murphy EJ, 2007, PHILOS T R SOC B, V362, P113, DOI 10.1098/rstb.2006.1957; Murphy EJ, 2012, CURR OPIN ENV SUST, V4, P264, DOI 10.1016/j.cosust.2012.05.005; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Olsson O, 1997, IBIS, V139, P504, DOI 10.1111/j.1474-919X.1997.tb04666.x; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Quillfeldt P, 2004, ANIM BEHAV, V68, P613, DOI 10.1016/j.anbehav.2003.12.002; R Core Team, 2021, R LANGUAGE ENV STAT; Ratcliffe N, 2012, CCAMLR SCI, V19, P75; Reid K, 2001, P ROY SOC B-BIOL SCI, V268, P377, DOI 10.1098/rspb.2000.1371; Renner M, 1998, COLON WATERBIRD, V21, P444, DOI 10.2307/1521659; Rey AR, 2012, EMU, V112, P90, DOI 10.1071/MU11065; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Ropert-Coudert Y, 2003, WATERBIRDS, V26, P403, DOI 10.1675/1524-4695(2003)026[0403:IDSITL]2.0.CO;2; Ropert-Coudert Y, 2015, ECOGRAPHY, V38, P111, DOI 10.1111/ecog.01182; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; Schreiber E.A., 2002, P179; SEDDON PJ, 1990, EMU, V90, P53, DOI 10.1071/MU9900053; Selander R.K., 1972, SEXUAL SELECTION DES, P180, DOI DOI 10.4324/9781315129266-8; Smale M. J., 1995, ICHTHYOLOGICAL MONOG, V1, P1, DOI DOI 10.5962/BHL.TITLE.141860; Stowasser G, 2012, DEEP-SEA RES PT II, V59, P208, DOI 10.1016/j.dsr2.2011.08.004; Tanton JL, 2004, POLAR BIOL, V27, P299, DOI 10.1007/s00300-004-0592-6; Taylor SS, 2002, CAN J ZOOL, V80, P700, DOI 10.1139/Z02-046; Tranquilla LM, 2010, ESTUAR COAST SHELF S, V89, P97, DOI 10.1016/j.ecss.2010.06.003; Trivelpiece W.Z., 1983, Antarctic Journal of the United States, V18, P209; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; VOLKMAN NJ, 1980, CONDOR, V82, P373, DOI 10.2307/1367558; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Watanuki Y, 2003, IBIS, V145, P558, DOI 10.1046/j.1474-919X.2003.00165.x; Wearmouth VJ, 2008, ADV MAR BIOL, V54, P107, DOI 10.1016/S0065-2881(08)00002-3; Whitehouse MJ, 2008, DEEP-SEA RES PT I, V55, P1218, DOI 10.1016/j.dsr.2008.06.002; Wienecke BC, 1997, MAR ECOL PROG SER, V159, P249, DOI 10.3354/meps159249; Williams R., 1990, ANARE RES NOTES; WILLIAMS TD, 1992, J ZOOL, V227, P211, DOI 10.1111/j.1469-7998.1992.tb04818.x; WILLIAMS TD, 1991, IBIS, V133, P3, DOI 10.1111/j.1474-919X.1991.tb04803.x; Williams TD, 1990, WGCEMP9038; Xavier J. C, 2009, CEPHALOPOD BEAK GUID; Xavier J.C., 2015, EXPLORING LAST CONTI, P229, DOI DOI 10.1007/978-3-319-18947-5_12; Xavier JC, 2004, FISH OCEANOGR, V13, P324, DOI 10.1111/j.1365-2419.2004.00298.x; Xavier JC, 2003, IBIS, V145, P593, DOI 10.1046/j.1474-919X.2003.00196.x; Xavier JC, 2015, CIM SER MATH SCI, V2, P389, DOI 10.1007/978-3-319-16121-1_20	120	28	28	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174850	10.1371/journal.pone.0174850	http://dx.doi.org/10.1371/journal.pone.0174850			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362847	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000399175000043
J	Lee, SY; Zhu, JJ; Salzberg, AC; Zhang, B; Liu, DJJ; Muscat, JE; Langan, ST; Connor, JR				Lee, Sang Y.; Zhu, Junjia; Salzberg, Anna C.; Zhang, Bo; Liu, Dajiang J.; Muscat, Joshua E.; Langan, Sara T.; Connor, James R.			Analysis of single nucleotide variants of HFE gene and association to survival in The Cancer Genome Atlas GBM data	PLOS ONE			English	Article							HEREDITARY HEMOCHROMATOSIS; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; H63D MUTATIONS; BREAST-CANCER; POLYMORPHISMS; C282Y; RISK; BETA(2)-MICROGLOBULIN	Human hemochromatosis protein (HFE) is involved in iron metabolism. Two major HFE polymorphisms, H63D and C282Y, have been associated with an increased risk of cancers. Previously, we reported decreased gender effects in overall survival based on H63D or C282Y HFE polymorphisms patients with glioblastoma multiforme (GBM). However, the effect of other single nucleotide variation (SNV) in the HFE gene on the cancer development and progression has not been systematically studied. To expand our finding in a larger sample, and to identify other HFE SNV, we analyzed the frequency of somatic SNV in HFE gene and its relationship to survival in GBM patients using The Cancer Genome Atlas (TCGA) GBM (Caucasian only) database. We found 9 SNVs with increased frequency in blood normal of TCGA GBM patients compared to the 1000Genome. Among 9 SNVs, 7 SNVs were located in the intron and 2 SNVs (i.e., H63D, C282Y) in the exon of HFE gene. The statistical analysis demonstrated that blood normal samples of TCGA GBM have more H63D (p = 0.0002, 95% Confidence interval (CI): 0.2119-0.3223) or C282Y (p = 0.0129, 95% CI: 0.0474-0.1159) HFE polymorphisms than 1000Genome. The Kaplan-Meier survival curve for the 264 GBM samples revealed no difference between wild type (WT) HFE and H63D, and WT HFE and C282Y GBM patients. In addition, there was no difference in the survival of male/female GBM patients based on HFE genotype. There was no correlation between HFE expression and survival. In conclusion, the current results suggest that somatic HFE polymorphisms do not impact GBM patients' survival in the TCGA data set of GBM.	[Lee, Sang Y.; Langan, Sara T.; Connor, James R.] Penn State Univ, Dept Neurosurg, Coll Med, Penn State Hershey Med Ctr, Hershey, PA 17033 USA; [Zhu, Junjia; Muscat, Joshua E.] Penn State Univ, Dept Publ Hlth Sci, Coll Med, Penn State Hershey Med Ctr, Hershey, PA USA; [Salzberg, Anna C.] Penn State Univ, Inst Personalized Med, Penn State Hershey Med Ctr, Coll Med, Hershey, PA USA; [Zhang, Bo] Penn State Univ, Dept Biochem & Mol Biol, Penn State Hershey Med Ctr, Coll Med, Hershey, PA USA; [Liu, Dajiang J.] Penn State Univ, Dept Publ Hlth Sci & Biochem & Mol Biol, Inst Personalized Med, Coll Med,Penn State Hershey Med Ctr, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Lee, SY (corresponding author), Penn State Univ, Dept Neurosurg, Coll Med, Penn State Hershey Med Ctr, Hershey, PA 17033 USA.	SYL3@psu.edu		Liu, Dajiang/0000-0001-6553-858X; Lee, Sang/0000-0003-3911-8316	Department of Neurosurgery at the PennsyIvania state University college of Medicine (SYL); National Institutes of Health [R21DA040177, R01HG008983]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM102057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA040177] Funding Source: NIH RePORTER	Department of Neurosurgery at the PennsyIvania state University college of Medicine (SYL); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Department of Neurosurgery at the PennsyIvania state University college of Medicine (SYL). These studies were supported by R21DA040177 and R01HG008983 (DJL) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparing of the manuscript.	Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Asberg A, 2013, SCAND J GASTROENTERO, V48, P189, DOI 10.3109/00365521.2012.752028; Batschauer AP, 2011, MOL CELL BIOCHEM, V357, P247, DOI 10.1007/s11010-011-0895-1; Boukovalas S, 2015, AM SURGEON, V81, P884; CBTRUS, 2013, CBTRUS STAT REP NPCR; Chen WD, 2013, TUMOR BIOL, V34, P2255, DOI 10.1007/s13277-013-0766-3; di Montemuros FM, 2001, NEUROLOGY, V57, P1342, DOI 10.1212/WNL.57.7.1342; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Feder JN, 1997, J BIOL CHEM, V272, P14025, DOI 10.1074/jbc.272.22.14025; Gannon PO, 2011, INT J CANCER, V128, P2326, DOI 10.1002/ijc.25577; Goswami CP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-970; Hanson EH, 2001, AM J EPIDEMIOL, V154, P193, DOI 10.1093/aje/154.3.193; Heath JL, 2013, NUTRIENTS, V5, P2836, DOI 10.3390/nu5082836; Jin F, 2011, J CANCER RES CLIN, V137, P1095, DOI 10.1007/s00432-010-0970-0; Jin F, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-18; Lee SY, 2007, FASEB J, V21, P564, DOI 10.1096/fj.06-6397com; Lee SY, 2015, J NEURO-ONCOL, V122, P97, DOI 10.1007/s11060-014-1681-1; Lee SY, 2011, INT J CANCER, V129, P2104, DOI 10.1002/ijc.25888; Lv YF, 2016, J CELL MOL MED, V20, P1219, DOI 10.1111/jcmm.12764; Marshall DS, 1999, INT J MOL MED, V4, P389; Osborne NJ, 2010, HEPATOLOGY, V51, P1311, DOI 10.1002/hep.23448; Pirisi M, 2000, CANCER, V89, P297, DOI 10.1002/1097-0142(20000715)89:2<297::AID-CNCR14>3.0.CO;2-N; Ropero P, 2007, REV ESP ENFERM DIG, V99, P376; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Shi Z, 2009, INT J CANCER, V125, P78, DOI 10.1002/ijc.24304; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Waheed A, 1997, P NATL ACAD SCI USA, V94, P12384, DOI 10.1073/pnas.94.23.12384; Zhang Meng, 2015, Asian Pac J Cancer Prev, V16, P4633	29	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174778	10.1371/journal.pone.0174778	http://dx.doi.org/10.1371/journal.pone.0174778			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358914	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174800086
J	Liu, XC; Chen, SX; Liu, JJ; Xu, DZ; Li, W; Zhan, YQ; Li, YF; Chen, YB; Zhou, ZW; Sun, XW				Liu, Xuechao; Chen, Shangxiang; Liu, Jianjun; Xu, Dazhi; Li, Wei; Zhan, Youqing; Li, Yuanfang; Chen, Yingbo; Zhou, Zhiwei; Sun, Xiaowei			Impact of systemic inflammation on gastric cancer outcomes	PLOS ONE			English	Article							REACTIVE PROTEIN/ALBUMIN RATIO; NEUTROPHIL-LYMPHOCYTE RATIO; GLASGOW PROGNOSTIC SCORE; CELL LUNG-CANCER; CURATIVE RESECTION; HEPATOCELLULAR-CARCINOMA; PREDICTS PROGNOSIS; CHEMOTHERAPY; MORTALITY; SURVIVAL	Background The prognostic value of neutrophil-lymphocyte ratio (NLR) and Glasgow Prognostic Score (GPS) has been extensively validated in various cancers. We aimed to examine the usefulness of a combination of NLR and GPS (named CNG) for predicting survival outcomes in patients after curative resection for gastric cancer (GC). Methods We retrospectively analyzed the records of 1056 patients who underwent curative resection as initial treatment for GC from October 2000 to September 2012. The preoperative CNG was calculated as follows: patients with hypoalbuminemia (< 35 g/L), elevated C-reactive protein (> 10 mg/L), and elevated NLR (> 2) were allocated a score of 3; patients with two, one, or no abnormal values were allocated a score of 2, 1, or 0, respectively. Results The NLR and GPS were the only inflammatory variables independently associated with overall survival (OS) in multivariate analysis. When they were replaced by CNG in multivariate analysis, CNG was independently associated with OS (hazard ratio [HR] for CNG 1 [1.367, 95% CI: 1.065-1.755; P= 0.014], CNG 2 [1.887, 95% CI: 1.182-3.011; P= 0.008], and CNG 3 [2.224, 95% CI: 1.238-3.997; P = 0.008]; P = 0.020). In stage-matched analysis, the prognostic significance was still maintained in stage I-Ill (P= 0.002, P= 0.042, and P< 0.001, respectively). In addition, 5-year survival rates ranged from 92% (stage I) to 35% (stage III) and from 65%(CNG 0) to 18%(CNG 3) with tumor-nodes-metastasis (TNM) stage or CNG alone. However, the combination of TNM and CNG stratified 5-year survival rates from 98% (TNM I, CNG 0) to 12% (TNM III, CNG 3). Conclusion The preoperative CNG is a novel predictor of postoperative survival, and the combination of CNG and TNM effectively stratifies outcomes in patients after curative resection for GC.	[Liu, Xuechao; Chen, Shangxiang; Liu, Jianjun; Xu, Dazhi; Li, Wei; Zhan, Youqing; Li, Yuanfang; Chen, Yingbo; Zhou, Zhiwei; Sun, Xiaowei] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Liu, Xuechao; Chen, Shangxiang; Liu, Jianjun; Xu, Dazhi; Li, Wei; Zhan, Youqing; Li, Yuanfang; Chen, Yingbo; Zhou, Zhiwei; Sun, Xiaowei] Sun Yat Sen Univ, Canc Ctr, Dept Gastr & Pancreat Surg, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Sun, XW (corresponding author), Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.; Sun, XW (corresponding author), Sun Yat Sen Univ, Canc Ctr, Dept Gastr & Pancreat Surg, Guangzhou, Guangdong, Peoples R China.	sunxw@sysucc.org.cn	Li, Yuan/GXV-1310-2022					Ahn HS, 2010, CANCER-AM CANCER SOC, V116, P5592, DOI 10.1002/cncr.25550; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Chen WQ, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-016-0137-8; Chen YS, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0058-y; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Forrest LM, 2003, BRIT J CANCER, V89, P1028, DOI 10.1038/sj.bjc.6601242; Hsu JT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001589; Hu B, 2014, CLIN CANCER RES, V20, P6212, DOI 10.1158/1078-0432.CCR-14-0442; Hwang JE, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-489; Ishizuka M, 2014, J SURG ONCOL, V110, P935, DOI 10.1002/jso.23753; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kasymjanova G, 2010, CURR ONCOL, V17, P52; Kinoshita A, 2015, ANN SURG ONCOL, V22, P803, DOI 10.1245/s10434-014-4048-0; Liu XC, 2015, TRANSL ONCOL, V8, P339, DOI 10.1016/j.tranon.2015.06.006; Lorente D, 2015, ANN ONCOL, V26, P750, DOI 10.1093/annonc/mdu587; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Proctor MJ, 2013, CANCER-AM CANCER SOC, V119, P2325, DOI 10.1002/cncr.28018; Proctor MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116206; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Puntoni M, 2008, ANN ONCOLOGY OFFI S7; Rahman R, 2014, WORLD J GASTROENTERO, V20, P4483, DOI 10.3748/wjg.v20.i16.4483; Roxburgh CSD, 2009, ANN SURG, V249, P788, DOI 10.1097/SLA.0b013e3181a3e738; Sasako M, 2008, NEW ENGL J MED, V359, P453, DOI 10.1056/NEJMoa0707035; Shiba H, 2015, WORLD J SURG, V39, P753, DOI 10.1007/s00268-014-2844-0; Wang DH, 2011, J NANOMATER, V2011, DOI 10.1155/2011/518706; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Wisastra R, 2014, CANCERS, V6, P1500, DOI 10.3390/cancers6031500; Yodying H, 2015, ANN SURG ONCOLOGY; Zhang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126496; Zhang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111906	34	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174085	10.1371/journal.pone.0174085	http://dx.doi.org/10.1371/journal.pone.0174085			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358923	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174800020
J	Ribeiro, RS; Passos, CS; Novaes, AS; Maquigussa, E; Gloria, MA; Visona, I; Ykuta, O; Oyama, LM; Boim, MA				Ribeiro, Rosemara S.; Passos, Clevia S.; Novaes, Antonio S.; Maquigussa, Edgar; Gloria, Maria A.; Visona, Iria; Ykuta, Olinda; Oyama, Lila M.; Boim, Mirian A.			Precocious obesity predisposes the development of more severe cisplatin-induced acute kidney injury in young adult mice	PLOS ONE			English	Article							MINERALOCORTICOID RECEPTOR; METABOLIC SYNDROME; DISEASE; ASSOCIATION; OVERWEIGHT; CANCER; RATS	Obesity and its consequences can damage the kidney over time. However, less is known about the impact of developing overweight/obesity during childhood on the kidney in adulthood and the renal impact of a superimposed acute kidney injury (AKI). This study evaluated the effect of obesity induced by a high-fat diet initiated soon after weaning on the adult life of mice and their response to superimposed nephrotoxic effects of cisplatin. C57BL/6 post weaning mice (3 weeks old) were divided into a control group (CT, n = 12) and a high-fat diet group (HF, n = 12). After 9 weeks, animals were further divided into the following groups: CT, CT treated with a single dose of cisplatin (CTCis, 20 mg/kg, i.p.), HF and HF treated with cisplatin (HFCis). The HF group exhibited higher body weight gain compatible with a moderate obesity. Obese mice presented increased visceral adiposity, hyperkalemia, sodium retention, glomerular hyperfiltration and proteinuria, without any significant changes in blood pressure and glycemia. AKI induced by cisplatin was exacerbated in obese animals with a 92% reduction in the GFR versus a 31% decrease in the CTCis group; this sharp decline resulted in severely elevated serum creatinine and urea levels. Acute tubular necrosis induced by cisplatin was worsened in obese mice. The HFCis group exhibited robust systemic and intrarenal inflammation that was significantly higher than that in the CTCis group; the HFCis group also showed a higher degree of renal oxidative stress. In conclusion, the moderate degree of obesity induced shortly after weaning resulted in mild early renal alterations, however, obese young animals were prone to develop a much more severe AKI induced by cisplatin.	[Ribeiro, Rosemara S.; Passos, Clevia S.; Novaes, Antonio S.; Maquigussa, Edgar; Gloria, Maria A.; Ykuta, Olinda; Boim, Mirian A.] Univ Fed Sao Paulo, Dept Med, Div Renal, Sao Paulo, Brazil; [Visona, Iria] Univ Fed Sao Paulo, Dept Pathol, Sao Paulo, Brazil; [Oyama, Lila M.] Univ Fed Sao Paulo, Nutr Physiol, Dept Physiol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Boim, MA (corresponding author), Univ Fed Sao Paulo, Dept Med, Div Renal, Sao Paulo, Brazil.	maboim@unifesp.br	Maquigussa, Edgar/G-7685-2016; Boim, Mirian A/L-6574-2013; Oyama, Lila M/B-7609-2012; Novaes, Antonio da Silva/A-5459-2017	Novaes, Antonio da Silva/0000-0002-8418-2504; Maquigussa, Edgar/0000-0003-1756-1579; A Boim, Mirian/0000-0001-7500-8371	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [470662/2013-1]; Fundagao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) to RSR; Coordenagao de Aperfeigoamento de Pessoal de Nivel superior (CAPES); Fundagao Oswaldo Ramos	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundagao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) to RSR(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenagao de Aperfeigoamento de Pessoal de Nivel superior (CAPES); Fundagao Oswaldo Ramos	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), grant no 470662/2013-1 to MAB, by Fundagao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) to RSR, by Coordenagao de Aperfeigoamento de Pessoal de Nivel superior (CAPES), and by Fundagao Oswaldo Ramos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Camici Marcello, 2012, Front Biosci (Elite Ed), V4, P1058, DOI 10.2741/E441; Caprio M, 2007, FASEB J, V21, P2185, DOI 10.1096/fj.06-7970com; Caprio M, 2011, ENDOCRINOLOGY, V152, P113, DOI 10.1210/en.2010-0674; Correia-Costa L, 2015, PEDIATR RES, V78, P436, DOI 10.1038/pr.2015.130; D'Agati VD, 2016, NAT REV NEPHROL, V12, P453, DOI 10.1038/nrneph.2016.75; Danziger J, 2016, CRIT CARE MED, V44, P328, DOI 10.1097/CCM.0000000000001398; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Felizardo Raphael Jose Ferreira, 2014, World J Nephrol, V3, P50, DOI 10.5527/wjn.v3.i3.50; Fujita T, 2010, HYPERTENSION, V55, P813, DOI 10.1161/HYPERTENSIONAHA.109.149062; Gabbay E, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0137-y; Gelber RP, 2005, AM J KIDNEY DIS, V46, P871, DOI 10.1053/j.ajkd.2005.08.015; Hanigan Marie H, 2003, Cancer Ther, V1, P47; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; Henegar JR, 2001, J AM SOC NEPHROL, V12, P1211, DOI 10.1681/ASN.V1261211; Kurt E, 1999, CLIN NEPHROL, V52, P397; Lebwohl D, 1998, EUR J CANCER, V34, P1522, DOI 10.1016/S0959-8049(98)00224-X; Levin BE, 2002, AM J PHYSIOL-REG I, V282, pR46, DOI 10.1152/ajpregu.2002.282.1.R46; Mammi C, 2016, INT J OBESITY, V40, P964, DOI 10.1038/ijo.2016.13; Mascali A, 2016, INT J IMMUNOPATH PH, V29, P354, DOI 10.1177/0394632016643550; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Mount P, 2015, METABOLITES, V5, P720, DOI 10.3390/metabo5040720; Nagase M, 2006, J AM SOC NEPHROL, V17, P3438, DOI 10.1681/ASN.2006080944; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Okui S, 2012, EUR J PHARMACOL, V685, P149, DOI 10.1016/j.ejphar.2012.04.027; Ozkok A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/967826; Palipoch S, 2013, J TOXICOL PATHOL, V26, P293, DOI 10.1293/tox.26.293; Ramesh G, 2004, KIDNEY INT, V66, pS56, DOI 10.1111/j.1523-1755.2004.09109.x; Redon J, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0555-z; Sahoo Krushnapriya, 2015, J Family Med Prim Care, V4, P187, DOI 10.4103/2249-4863.154628; Santos NAG, 2007, ARCH TOXICOL, V81, P495, DOI 10.1007/s00204-006-0173-2; Shashaty Michael G S, 2014, Ann Am Thorac Soc, V11, P1286, DOI 10.1513/AnnalsATS.201404-159FR; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Szeto HH, 2016, KIDNEY INT; Wang Y, 2008, KIDNEY INT, V73, P19, DOI 10.1038/sj.ki.5002586; Willemse PPM, 2014, ACTA ONCOL, V53, P351, DOI 10.3109/0284186X.2013.819116; Woods SC, 2003, J NUTR, V133, P1081, DOI 10.1093/jn/133.4.1081; Zhang BZ, 2008, J AM SOC NEPHROL, V19, P923, DOI 10.1681/ASN.2007090982; Zhang C, 2010, FREE RADICAL BIO MED, V48, P1109, DOI 10.1016/j.freeradbiomed.2010.01.029	40	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174721	10.1371/journal.pone.0174721	http://dx.doi.org/10.1371/journal.pone.0174721			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358868	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174800078
J	Walsh, DM; McCullough, SD; Yourstone, S; Jones, SW; Cairns, BA; Jones, CD; Jaspers, I; Diaz-Sanchez, D				Walsh, Dana M.; McCullough, Shaun D.; Yourstone, Scott; Jones, Samuel W.; Cairns, Bruce A.; Jones, Corbin D.; Jaspers, Ilona; Diaz-Sanchez, David			Alterations in airway microbiota in patients with PaO2/FiO(2) ratio <= 300 after burn and inhalation injury	PLOS ONE			English	Article							ANAEROBIC-BACTERIA; PNEUMONIA; INFLAMMATION; ANTIBIOTICS; DISEASE	Background Injury to the airways after smoke inhalation is a major mortality risk factor in victims of burn injuries, resulting in a 15-45% increase in patient deaths. Damage to the airways by smoke may induce acute respiratory distress syndrome (ARDS), which is partly characterized by hypoxemia in the airways. While ARDS has been associated with bacterial infection, the impact of hypoxemia on airway microbiota is unknown. Our objective was to identify differences in microbiota within the airways of burn patients who develop hypoxemia early after inhalation injury and those that do not using next-generation sequencing of bacterial 16S rRNA genes. Results DNA was extracted from therapeutic bronchial washings of 48 patients performed within 72 hours of hospitalization for burn and inhalation injury at the North Carolina Jaycee Burn Center. DNA was prepared for sequencing using a novel molecule tagging method and sequenced on the Illumina MiSeq platform. Bacterial species were identified using the MTToolbox pipeline. Patients with hypoxemia, as indicated by a PaO2/FiO(2) ratio < 300, had a 30% increase in abundance of Streptococcaceae and Enterobacteriaceae and 84% increase in Staphylococcaceae as compared to patients with a PaO2/FiO(2) ratio > 300. Wilcoxon rank-sum test identified significant enrichment in abundance of OTUs identified as Prevotella melaninogenica (p = 0.042), Corynebacterium (p = 0.037) and Mogibacterium (p = 0.048). Linear discriminant effect size analysis (LefSe) confirmed significant enrichment of Prevotella melaninognica among patients with a PaO2/FiO(2) ratio < 300 (p<0.05). These results could not be explained by differences in antibiotic treatment. Conclusions The airway microbiota following burn and inhalation injury is altered in patients with a PaO2/ FiO(2) ratio <= 300 early after injury. Enrichment of specific taxa in patients with a PaO2/FiO(2) ratio <= 300 may indicate airway environment and patient changes that favor these microbes. Longitudinal studies are necessary to identify stably colonizing taxa that play roles in hypoxemia and ARDS pathogenesis.	[Walsh, Dana M.; Jaspers, Ilona] Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC 27599 USA; [McCullough, Shaun D.; Diaz-Sanchez, David] US EPA, Natl Hlth & Environm Effects Res Lab, Chapel Hill, NC USA; [Yourstone, Scott; Jones, Corbin D.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Yourstone, Scott; Jones, Corbin D.] Univ N Carolina, Program Bioinformat & Computat Biol, Chapel Hill, NC USA; [Jones, Samuel W.; Cairns, Bruce A.] Univ N Carolina, Dept Surg, Chapel Hill, NC USA; [Jones, Samuel W.; Cairns, Bruce A.] Univ N Carolina, North Carolina Jaycee Burn Ctr, Chapel Hill, NC USA; [Jones, Corbin D.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC USA; [Jones, Corbin D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Jones, Corbin D.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Jaspers, Ilona] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA; [Jaspers, Ilona] Univ N Carolina, Ctr Environm Med Asthma & Lung Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; United States Environmental Protection Agency; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Walsh, DM (corresponding author), Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC 27599 USA.	danamariewalsh87@gmail.com	Jaspers, Ilona/AAZ-5035-2020	McCullough, Shaun/0000-0001-6660-346X	United States Environmental Protection Agency (www.epa.gov) Cooperative "Human Health Effects of Environmental Pollutants" [CR83578501]; National Institutes of Health (www.nih.gov) Toxicology Training [T32 ES007126]; National Institutes of Health North Carolina TraCS Institute [UL1RR02574]; National Institutes of Health UNC Center for Environmental Health and Susceptibility [P3OES010126]; National Institutes of Health [5K08GM109106]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067553, K12GM000678] Funding Source: NIH RePORTER	United States Environmental Protection Agency (www.epa.gov) Cooperative "Human Health Effects of Environmental Pollutants"; National Institutes of Health (www.nih.gov) Toxicology Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health North Carolina TraCS Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health UNC Center for Environmental Health and Susceptibility; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following: I.J. received funding from the United States Environmental Protection Agency (www.epa.gov) Cooperative Agreement CR83578501 "Human Health Effects of Environmental Pollutants," which was used to purchase all necessary supplies and to pay for sequencing and publication of this manuscript; D.M.W.'s stipend came from the National Institutes of Health (www.nih.gov) Toxicology Training grant T32 ES007126; S.W.J. received funding from the National Institutes of Health North Carolina TraCS Institute UL1RR02574, National Institutes of Health UNC Center for Environmental Health and Susceptibility P3OES010126, and National Institutes of Health 5K08GM109106, each of which paid for supplies and personnel to collect the patient samples and establish the repository as detailed in Jones et. al. [12]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu NA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003783; Abt MC, 2013, CURR OPIN MICROBIOL, V16, P4, DOI 10.1016/j.mib.2012.12.002; Agvald-Ohman C, 2003, CLIN MICROBIOL INFEC, V9, P397, DOI 10.1046/j.1469-0691.2003.00551.x; American Burn Association, 2015, NAT BURN REP 2015 RE; Arthur JC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5724; Bastarache JA, 2011, TXB CRITICAL CARE, P388; Brill SE, 2015, THORAX, V70, P930, DOI 10.1136/thoraxjnl-2015-207194; Brusselaers N, 2012, BURNS, V38, P364, DOI 10.1016/j.burns.2011.09.005; Buckingham SC, 2014, FEIGIN CHERRYS TXB P, P1825; Cohen-Poradosu R, 2015, DOUGLAS BENNETTS PRI, p2736 o; Collie D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142097; De Steenhuijsen Piters WAA., 2015, ISME J, V10, P1; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dickson RP, 2013, EXPERT REV RESP MED, V7, P245, DOI [10.1586/ers.13.24, 10.1586/ERS.13.24]; Dickson RP, 2015, AM J PHYSL LUNG CELL; Dickson RP, 2015, ANNU REV PHYSIOL, P1; Dreyfuss D, 2005, CLIN CHEST MED, V26, P105, DOI 10.1016/j.ccm.2004.10.014; Dries DJ, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-31; Edelman DA, 2007, J BURN CARE RES, V28, P241, DOI 10.1097/BCR.0B013E318031D049; El-Helbawy R H, 2011, Ann Burns Fire Disasters, V24, P82; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Field TR, 2010, ANAEROBE, V16, P337, DOI 10.1016/j.anaerobe.2010.04.002; Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598; Haegeman B, 2013, ISME J, V7, P1092, DOI 10.1038/ismej.2013.10; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hale VL, 2017, CANCER EPIDEM BIOMAR, V26, P85, DOI 10.1158/1055-9965.EPI-16-0337; Han MK, 2014, LANCET RESP MED, V2, P548, DOI 10.1016/S2213-2600(14)70069-4; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Jeschke MG, 2017, SABISTON TXB SURG, P505; Jones SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064250; Lai CC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003333; Larsen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031976; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Lin CC, 2012, BURNS, V38, P203, DOI 10.1016/j.burns.2011.08.010; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Marsland BJ, 2013, CHEST, V144, P632, DOI 10.1378/chest.12-2854; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mira-Pascual L, 2015, J GASTROENTEROL, V50, P167, DOI 10.1007/s00535-014-0963-x; Mirkovic B, 2015, AM J RESP CRIT CARE, V192, P1314, DOI 10.1164/rccm.201505-0943OC; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; R Core Team, 2021, R LANGUAGE ENV STAT; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Schultz L, 2013, BURNS, V39, P1355, DOI 10.1016/j.burns.2013.04.009; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; SHIRANI KZ, 1987, ANN SURG, V205, P82, DOI 10.1097/00000658-198701000-00015; Sommer MOA, 2011, CURR OPIN MICROBIOL, V14, P556, DOI 10.1016/j.mib.2011.07.005; Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003; Ulrich M, 2010, RELATIVE CONTRIBUTIO, P978; Yourstone SM, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-284; Zemanick ET, 2015, ANN AM THORAC SOC, V12, P221, DOI 10.1513/AnnalsATS.201407-310OC; Zumla A, 2014, LANCET INFECT DIS, V14, P1123, DOI 10.1016/S1473-3099(14)70827-8	56	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0173848	10.1371/journal.pone.0173848	http://dx.doi.org/10.1371/journal.pone.0173848			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358811	Green Submitted, Green Published, gold			2022-12-26	WOS:000399174800011
J	Huang, GF; Wang, MM; Hu, YY; Lv, SH; Li, CF				Huang, Guofu; Wang, Mianmian; Hu, Yongyou; Lv, Sihao; Li, Changfang			Synthesis, characterization, and debromination reactivity of cellulose-stabilized Pd/Fe nanoparticles for 2,2', 4,4'tretrabromodiphenyl ether	PLOS ONE			English	Article							ZERO-VALENT IRON; NANOSCALE ZEROVALENT IRON; POLYBROMINATED DIPHENYL ETHERS; FE-PD NANOPARTICLES; CARBOXYMETHYL CELLULOSE; BIMETALLIC NANOPARTICLES; DECHLORINATION; DEGRADATION; KINETICS; REMOVAL	In this study, two kinds of cellulose derivatives (polyanionic cellulose (PAC) and hydroxypropylmethyl cellulose (HPMC)) were selected as stabilizers of Pd/Fe nanoparticles (NPs) to investigate their influences on the debromination performances of 2,2', 4,4'-tretrabromodiphenyl ether (BDE47). Field emission scanning electron microscope (FE-SEM) images revealed that the cellulose-stabilized Pd/Fe NPs were smaller and more uniform than the bare-Pd/Fe NPs. X-ray diffractometer (XRD) and X-ray photoelectron spectroscopy (XPS) results suggested that cellulose coatings found on Pd/Fe NPs surfaces featured some anti-oxidation abilities, which followed the order of HPMC < PAC. Sedimentation tests demonstrated that the stabilizing power of PAC for Pd/Fe NPs was higher than that of HPMC. Fourier transfer infrared spectrometer (FTIR) results indicated that PAC molecules were bound to the Pd/Fe NPs surfaces by polar covalent bonds and hydrogen bonds, while HPMC molecules interacted with the nanoparticles by hydrogen bonds. Batch debromination test for BDE47 demonstrated that the catalytic debromination rate with cellulose-stabilized Pd/Fe NPs was higher than that with bare-Pd/Fe NPs during reaction period of 15 min. Overall, this study indicated that both celluloses are beneficial to forming smaller, more regular, stable and antioxidative Pd/Fe NPs, leading to higher debromination reactivity for BDE47 compared with the bare-Pd/Fe NPs. Therefore Pd/Fe NPs can be utilized as a promising remediation technology for the contaminated groundwater and soils.	[Huang, Guofu; Hu, Yongyou; Li, Changfang] South China Univ Technol, Sch Environm & Energy, Key Lab Pollut Control & Ecosyst Restorat Ind Clu, Minist Educ, Guangzhou, Guangdong, Peoples R China; [Huang, Guofu; Hu, Yongyou; Li, Changfang] South China Univ Technol, State Key Lab Pulp & Paper Engn, Guangzhou, Guangdong, Peoples R China; [Wang, Mianmian; Lv, Sihao] Dongguan Univ Technol, Sch Environm & Civil Engn, Dongguan, Peoples R China; [Wang, Mianmian] Dongguan Cleaner Prod Ctr, Dongguan, Peoples R China	South China University of Technology; South China University of Technology; Dongguan University of Technology	Hu, YY (corresponding author), South China Univ Technol, Sch Environm & Energy, Key Lab Pollut Control & Ecosyst Restorat Ind Clu, Minist Educ, Guangzhou, Guangdong, Peoples R China.; Hu, YY (corresponding author), South China Univ Technol, State Key Lab Pulp & Paper Engn, Guangzhou, Guangdong, Peoples R China.	ppyyhu@scut.edu.cn			National Natural Science Fund of China (Foundation of Guangdong Province of China) [U1401235]	National Natural Science Fund of China (Foundation of Guangdong Province of China)	This work was supported by the National Natural Science Fund of China (Foundation of Guangdong Province of China; No. U1401235). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2002, ENVIRON SCI TECHNOL, V36, P4326, DOI 10.1021/es025562s; Ahn SC, 2008, J HAZARD MATER, V156, P17, DOI 10.1016/j.jhazmat.2007.11.104; Bhattachatjee S, 2016, ENVIRON SCI TECHNOL, V50, P1812, DOI 10.1021/acs.est.5b05074; Cao J, 2011, SCI TOTAL ENVIRON, V409, P2336, DOI 10.1016/j.scitotenv.2011.02.045; Cirtiu CM, 2011, COLLOID SURFACE A, V390, P95, DOI 10.1016/j.colsurfa.2011.09.011; Elliott DW, 2001, ENVIRON SCI TECHNOL, V35, P4922, DOI 10.1021/es0108584; Fang M, 2012, NANOTECHNOLOGY, V23, P1262; Fang ZQ, 2011, J HAZARD MATER, V185, P958, DOI 10.1016/j.jhazmat.2010.09.113; He F, 2005, ENVIRON SCI TECHNOL, V39, P3314, DOI 10.1021/es048743y; He F, 2007, ENVIRON SCI TECHNOL, V41, P6216, DOI 10.1021/es0705543; He F, 2007, IND ENG CHEM RES, V46, P29, DOI 10.1021/ie0610896; He F, 2008, APPL CATAL B-ENVIRON, V84, P533, DOI 10.1016/j.apcatb.2008.05.008; Jang Min-Hee, 2014, Environ Health Toxicol, V29, pe2014022, DOI 10.5620/eht.e2014022; Keum YS, 2005, ENVIRON SCI TECHNOL, V39, P2280, DOI 10.1021/es048846g; Li MC, 2016, IND ENG CHEM RES, V55, P133, DOI 10.1021/acs.iecr.5b03510; Li XQ, 2008, IND ENG CHEM RES, V47, P2131, DOI 10.1021/ie061655x; Li X, 2008, CHEMOSPHERE, V73, P1594, DOI 10.1016/j.chemosphere.2008.08.031; Lin YH, 2010, SCI TOTAL ENVIRON, V408, P2260, DOI 10.1016/j.scitotenv.2010.01.039; Lin YH, 2009, COLLOID SURFACE A, V349, P137, DOI 10.1016/j.colsurfa.2009.08.007; Lowry GV, 2004, ENVIRON SCI TECHNOL, V38, P5208, DOI 10.1021/es049835q; Maity D, 2013, CARBOHYD POLYM, V98, P80, DOI 10.1016/j.carbpol.2013.05.020; O'Carroll D, 2013, ADV WATER RESOUR, V51, P104, DOI 10.1016/j.advwatres.2012.02.005; Petersen EJ, 2012, J HAZARD MATER, V243, P73, DOI 10.1016/j.jhazmat.2012.09.070; Phenrat T., 2015, ENVIRON SCI POLLUT R, P1; Phenrat T, 2008, J NANOPART RES, V10, P795, DOI 10.1007/s11051-007-9315-6; Qiu XH, 2011, J HAZARD MATER, V193, P70, DOI 10.1016/j.jhazmat.2011.07.024; Rodriguez-Maroto JM, 2009, CHEMOSPHERE, V74, P804, DOI 10.1016/j.chemosphere.2008.10.020; Sakulchaicharoen N, 2010, J CONTAM HYDROL, V118, P117, DOI 10.1016/j.jconhyd.2010.09.004; Shi LN, 2011, WATER RES, V45, P886, DOI 10.1016/j.watres.2010.09.025; Shimizu A, 2012, J HAZARD MATER, V201, P60, DOI 10.1016/j.jhazmat.2011.11.009; Shokes TE, 1993, ENVIRON SCI TECHNOL, V33, P282; Sun YP, 2007, COLLOID SURFACE A, V308, P60, DOI 10.1016/j.colsurfa.2007.05.029; Sun YK, 2016, WATER RES, V100, P277, DOI 10.1016/j.watres.2016.05.031; Tiwari A, 2016, LUMINESCENCE, V31, P428, DOI 10.1002/bio.2978; Umegaki T, 2009, INT J HYDROGEN ENERG, V34, P3816, DOI 10.1016/j.ijhydene.2009.03.003; Wang XY, 2015, APPL SURF SCI, V345, P57, DOI 10.1016/j.apsusc.2015.03.131; Wang XY, 2013, SCI TOTAL ENVIRON, V449, P157, DOI 10.1016/j.scitotenv.2013.01.008; Xu J, 2008, J PHYS CHEM C, V112, P9133, DOI 10.1021/jp7097262; Yan W, 2012, ENVIRON SCI TECHNOL, V46, P7018, DOI 10.1021/es2039695; Yang P, 2015, MAT RES INNOVATIO S5, V19; Zhang M, 2011, WATER RES, V45, P2401, DOI 10.1016/j.watres.2011.01.028; Zhao X, 2016, WATER RES, V100, P245, DOI 10.1016/j.watres.2016.05.019; Zhou L, 2014, CHEMOSPHERE, V104, P155, DOI 10.1016/j.chemosphere.2013.10.085; Zhuang YA, 2010, ENVIRON SCI TECHNOL, V44, P8236, DOI 10.1021/es101601s	44	9	9	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174589	10.1371/journal.pone.0174589	http://dx.doi.org/10.1371/journal.pone.0174589			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355273	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174600067
J	Lowe, PP; Gyongyosi, B; Satishchandran, A; Iracheta-Vellve, A; Ambade, A; Kodys, K; Catalano, D; Ward, DV; Szabo, G				Lowe, Patrick P.; Gyongyosi, Benedek; Satishchandran, Abhishek; Iracheta-Vellve, Arvin; Ambade, Aditya; Kodys, Karen; Catalano, Donna; Ward, Doyle V.; Szabo, Gyongyi			Alcohol-related changes in the intestinal microbiome influence neutrophil infiltration, inflammation and steatosis in early alcoholic hepatitis in mice	PLOS ONE			English	Article							DANGER SIGNALS; LIVER-DISEASE; CROSS-TALK; URIC-ACID; STEATOHEPATITIS; ACTIVATION; ETHANOL; MICROFLORA; PROTECTS; INJURY	Background Alcohol-induced intestinal dysbiosis disrupts homeostatic gut-liver axis function and is essential in the development of alcoholic liver disease. Here, we investigate changes in enteric microbiome composition in a model of early alcoholic steatohepatitis and dissect the pathogenic role of intestinal microbes in alcohol-induced liver pathology. Materials and methods Wild type mice received a 10-day diet that was either 5% alcohol-containing or an isocaloric control diet plus a single binge. 16S rDNA sequencing defined the bacterial communities in the cecum of alcohol-and pair-fed animals. Some mice were treated with an antibiotic cocktail prior to and throughout alcohol feeding. Liver neutrophils, cytokines and steatosis were evaluated. Results Acute-on-chronic alcohol administration induced shifts in various bacterial phyla in the cecum, including increased Actinobacteria and a reduction in Verrucomicrobia driven entirely by a reduction in the genus Akkermansia. Antibiotic treatment reduced the gut bacterial load and circulating bacterial wall component lipopolysaccharide (LPS). We found that bacterial load suppression prevented alcohol-related increases in the number of myeloperoxidase- (MPO) positive infiltrating neutrophils in the liver. Expression of liver mRNA tumor necrosis factor alpha (Tnfa), C-X-C motif chemokine ligand 1 (Cxcl1) and circulating protein monocyte chemoattractant protein-1 (MCP-1) were also reduced in antibiotic-treated alcohol- fed mice. Alcohol-induced hepatic steatosis measured by Oil-Red O staining was significantly reduced in antibiotic treated mice. Genes regulating lipid production and storage were also altered by alcohol and antibiotic treatment. Interestingly, antibiotic treatment did not protect from alcohol-induced increases in serum aminotransferases (ALT/AST). Conclusions Our data indicate that acute-on-chronic alcohol feeding alters the microflora at multiple taxonomic levels and identifies loss of Akkermansia as an early marker of alcohol-induced gut dysbiosis. We conclude that gut microbes influence liver inflammation, neutrophil infiltration and liver steatosis following alcohol consumption and these data further emphasize the role of the gut-liver axis in early alcoholic liver disease.	[Lowe, Patrick P.; Gyongyosi, Benedek; Satishchandran, Abhishek; Iracheta-Vellve, Arvin; Ambade, Aditya; Kodys, Karen; Catalano, Donna; Szabo, Gyongyi] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Ward, Doyle V.] Univ Massachusetts, Sch Med, Ctr Microbiome Res, Worcester, MA USA; [Ward, Doyle V.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Szabo, G (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.	Gyongyi.Szabo@umassmed.edu	Iracheta-Vellve, Arvin/K-6140-2014	Iracheta-Vellve, Arvin/0000-0002-6635-3904	National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health [5R01AA017729-05, F30AA024680]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA021893, U01AA021907, F30AA024680] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Research reported in this publication was supported by the National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health under award numbers 5R01AA017729-05 (to G.S.) and F30AA024680 (to P.L.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambade A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21340; Bala S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096864; Bertola A, 2013, HEPATOLOGY, V58, P1814, DOI 10.1002/hep.26419; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; BODE JC, 1984, HEPATO-GASTROENTEROL, V31, P30; Bull-Otterson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053028; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carvalho BM, 2012, DIABETOLOGIA, V55, P2823, DOI 10.1007/s00125-012-2648-4; Centers for Disease Control and Prevention, ALC PUBL HLTH ALC RE; Chen P, 2015, ALCOHOL CLIN EXP RES, V39, P2313, DOI 10.1111/acer.12900; Dominguez M, 2009, GASTROENTEROLOGY, V136, P1639, DOI 10.1053/j.gastro.2009.01.056; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Ferrier L, 2006, AM J PATHOL, V168, P1148, DOI 10.2353/ajpath.2006.050617; Geissmann Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054072; Iracheta-Vellve A, 2015, J HEPATOL, V63, P1147, DOI 10.1016/j.jhep.2015.06.013; JACOB AI, 1977, GASTROENTEROLOGY, V72, P1268; Leclercq S, 2014, P NATL ACAD SCI USA, V111, pE4485, DOI 10.1073/pnas.1415174111; Mathews S, 2016, CELL MOL IMMUNOL, V13, P206, DOI 10.1038/cmi.2015.06; Nath B, 2011, HEPATOLOGY, V53, P1526, DOI 10.1002/hep.24256; National Institute on Alcohol AaA, 2014, ALC FACTS STAT 2014; PARES A, 1986, J HEPATOL, V2, P33, DOI 10.1016/S0168-8278(86)80006-X; Petrasek J, 2015, J LEUKOCYTE BIOL, V98, P249, DOI 10.1189/jlb.3AB1214-590R; Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777; Rehm J, 2010, ADDICTION, V105, P817, DOI 10.1111/j.1360-0443.2010.02899.x; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Schnabl B, 2014, GASTROENTEROLOGY, V146, P1513, DOI 10.1053/j.gastro.2014.01.020; Szabo G, 2015, GASTROENTEROLOGY, V148, P30, DOI 10.1053/j.gastro.2014.10.042; Wang LR, 2016, CELL HOST MICROBE, V19, P227, DOI 10.1016/j.chom.2016.01.003	29	65	69	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174544	10.1371/journal.pone.0174544	http://dx.doi.org/10.1371/journal.pone.0174544			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350851	Green Published, gold			2022-12-26	WOS:000399174400055
J	Pan, L; Pasternak, DA; Xu, J; Xu, MM; Lu, ZG; Pasternak, GW; Pan, YX				Pan, Ling; Pasternak, David A.; Xu, Jin; Xu, Mingming; Lu, Zhigang; Pasternak, Gavril W.; Pan, Ying-Xian			Isolation and characterization of alternatively spliced variants of the mouse sigma(1) receptor gene, Sigmar1	PLOS ONE			English	Article							AMINO-ACID-RESIDUES; LIGAND-BINDING; ENDOPLASMIC-RETICULUM; MOLECULAR-CLONING; CELL-LINE; EXPRESSION; SITES; LOCALIZATION; PLASTICITY; RELEASE	The sigma(1) receptor acts as a chaperone at the endoplasmic reticulum, associates with multiple proteins in various cellular systems, and involves in a number of diseases, such as addiction, pain, cancer and psychiatric disorders. The sigma(1) receptor is encoded by the single copy SIGMAR1 gene. The current study identifies five alternatively spliced variants of the mouse sigma(1) receptor gene using a polymerase chain reaction cloning approach. All the splice variants are generated by exon skipping or alternative 3' or 5' splicing, producing the truncated sigma(1) receptor. Similar alternative splicing has been observed in the human SIGMAR1 gene based on the molecular cloning or genome sequence prediction, suggesting conservation of alternative splicing of SIGMAR1 gene. Using quantitative polymerase chain reactions, we demonstrate differential expression of several splice variants in mouse tissues and brain regions. When expressed in HEK293 cells, all the splice variants fail to bind sigma ligands, implicating that each truncated region in these splice variants is important for ligand binding. However, co-immunoprecipitation (Co-IP) study in HEK293 cells co-transfected with tagged constructs reveals that all the splice variants maintain their ability to physically associate with a mu opioid receptor (mMOR-1), providing useful information to correlate the motifs/sequences necessary for their physical association. Furthermore, a competition Co-IP study showed that all the variants can disrupt in a dose-dependent manner the dimerization of the original sigma1 receptor with mMOR-1, suggesting a potential dominant negative function and providing significant insights into their function.	[Pan, Ling; Pasternak, David A.; Xu, Jin; Xu, Mingming; Pasternak, Gavril W.; Pan, Ying-Xian] Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10021 USA; [Pan, Ling; Pasternak, David A.; Xu, Jin; Xu, Mingming; Pasternak, Gavril W.; Pan, Ying-Xian] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA; [Lu, Zhigang] Nanjing Univ Chinese Med, Minist Educ, Key Lab Acupuncture & Med Res, Nanjing, Jiangsu, Peoples R China; [Lu, Zhigang] Nanjing Univ Chinese Med, Clin Med Coll 1, Nanjing, Jiangsu, Peoples R China	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine	Pan, YX (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10021 USA.; Pan, YX (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA.	pany@mskcc.org			National Institutes of Health [DA013997, DA029244, DA06241, DA07242]; National Cancer Institute [CA08748]; PeterF. Mc Manus Charitable Trust; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006241, R21DA029244, R01DA013997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PeterF. Mc Manus Charitable Trust; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health (DA013997 and DA029244 to Y-X.P., DA06241 and DA07242 to G.W.P. and a core grant from the National Cancer Institute to MSKCC (CA08748) and grants from the PeterF. Mc Manus Charitable Trust, Mr. William H. Good win and Mrs.Alice Goodwin and the Commonwealth Foundation for Cancer Research and The Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center.The funders had no role in study design, data collection and analysis,decision to publish, or preparation of the manuscript.	Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Bowen W D, 2000, Pharm Acta Helv, V74, P211; Bowen Wayne D., 1993, Molecular Neuropharmacology, V3, P117; Crottes D, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00175; Ganapathy ME, 1999, J PHARMACOL EXP THER, V289, P251; GUNDLACH AL, 1986, J NEUROSCI, V6, P1757; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P718, DOI 10.1124/jpet.103.051284; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Kekuda R, 1996, BIOCHEM BIOPH RES CO, V229, P553, DOI 10.1006/bbrc.1996.1842; Kim FJ, 2010, MOL PHARMACOL, V77, P695, DOI 10.1124/mol.109.057083; Li X, 2015, SHOCK VIB, V2015, DOI 10.1155/2015/431476; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; Martina M, 2007, J PHYSIOL-LONDON, V578, P143, DOI 10.1113/jphysiol.2006.116178; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Mei JF, 2001, BIOCHEM PHARMACOL, V62, P349, DOI 10.1016/S0006-2952(01)00666-9; Monnet FP, 1996, BRIT J PHARMACOL, V119, P65, DOI 10.1111/j.1476-5381.1996.tb15678.x; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pan YX, 1999, MOL PHARMACOL, V56, P396, DOI 10.1124/mol.56.2.396; Pan YX, 1998, J NEUROCHEM, V70, P2279; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prasad PD, 1998, J NEUROCHEM, V70, P443; QUIRION R, 1992, TRENDS PHARMACOL SCI, V13, P85, DOI 10.1016/0165-6147(92)90030-A; Rousseaux CG, 2016, J RECEPT SIG TRANSD, V36, P327, DOI 10.3109/10799893.2015.1015737; RyanMoro J, 1996, NEUROCHEM RES, V21, P1309, DOI 10.1007/BF02532372; Schmidt HR, 2016, NATURE, V532, P527, DOI 10.1038/nature17391; Seth P, 1997, BIOCHEM BIOPH RES CO, V241, P535, DOI 10.1006/bbrc.1997.7840; Seth P, 2001, BBA-MOL CELL RES, V1540, P59, DOI 10.1016/S0167-4889(01)00117-3; Seth P, 1998, J NEUROCHEM, V70, P922; Shioda N, 2012, J BIOL CHEM, V287, P23318, DOI 10.1074/jbc.M112.349142; Spruce BA, 2004, CANCER RES, V64, P4875, DOI 10.1158/0008-5472.CAN-03-3180; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VILNER BJ, 1995, CANCER RES, V55, P408; WALKER JM, 1990, PHARMACOL REV, V42, P355; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Xu J, 2013, J BIOL CHEM; Yamamoto H, 1999, FEBS LETT, V445, P19, DOI 10.1016/S0014-5793(99)00084-8	38	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174694	10.1371/journal.pone.0174694	http://dx.doi.org/10.1371/journal.pone.0174694			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350844	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174400073
J	Wang, MJ; Cai, SL; Ding, W; Deng, YJ; Zhao, Q				Wang, Maojing; Cai, Shanglang; Ding, Wei; Deng, Yujie; Zhao, Qing			Efficacy and effects on cardiac function of radiofrequency catheter ablation vs. direct current cardioversion of persistent atrial fibrillation with left ventricular systolic dysfunction	PLOS ONE			English	Article							PULMONARY-VEIN ISOLATION; HEART-FAILURE; FOLLOW-UP; RHYTHM CONTROL; SINUS RHYTHM; METAANALYSIS; MANAGEMENT; SAFETY; TRIAL	Objective To evaluate the effect of catheter ablation vs. direct current synchronized cardioversion (DCC) in patients with persistent atrial fibrillation (AF) and left ventricular systolic dysfunction, and to define baseline features of patients that will get more benefit from ablation. Methods From July 2013 to October 2014, 97 consecutive single-center patients with persistent AF and symptomatic heart failure (left ventricular ejection fraction (LVEF) < 50%) underwent DCC followed by amiodarone (n = 40) or circumferential pulmonary vein isolation (PVI; n = 57) according to patient's preference were recruited in the study. Post-ablation recurrence was treated with atrial roof and mitral isthmus lines ablation with or without PVI based on restoration or not of pulmonary vein (PV) potential conduction. Study outcomes were 12-month rate of sustained sinus rhythm (SR) and cardiac function. Baseline characteristics were compared between patients with and without cardiac function improvement post ablation. Results With similarly distributed characteristics at baseline, ablation (mean 1.8 procedures) relative to DCC yielded significantly higher level of 12-month SR maintenance rate (68.42% vs. 35%, P = 0.001); and better LVEF and New York Heart Association class. with significant effect for DCC only in maintained SR cases. Post ablation LVEF increased (> 20% or to over 55%) in 31 (54.39%) patients with worse baseline cardiac function and ventricular rate control. Conclusions Catheter ablation relative to cardioversion of persistent AF with symptomatic heart failure yielded better 12-month SR maintenance and cardiac function. Compared with nonresponders, patients with improved LVEF post-ablation had poorer ventricular rate control and cardiac function at baseline, suggesting a significant component of tachycardia-induced cardiomyopathy in this group.	[Wang, Maojing; Cai, Shanglang; Deng, Yujie; Zhao, Qing] Qingdao Univ, Dept Cardiol, Affiliated Hosp, Qingdao, Peoples R China; [Ding, Wei] Huangdao Dist Peoples Hosp, Dept Ophthalmol, Qingdao, Shandong, Peoples R China	Qingdao University	Zhao, Q (corresponding author), Qingdao Univ, Dept Cardiol, Affiliated Hosp, Qingdao, Peoples R China.	zhaoqingqddx@163.com						Bonanno C, 2010, J CARDIOVASC MED, V11, P408, DOI 10.2459/JCM.0b013e328332e926; Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P32, DOI 10.1161/CIRCEP.109.859116; Chen MS, 2004, J AM COLL CARDIOL, V43, P1004, DOI 10.1016/j.jacc.2003.09.056; Corley SD, 2004, CIRCULATION, V109, P1509, DOI 10.1161/01.CIR.0000121736.16643.11; Dagres N, 2011, J CARD FAIL, V17, P964, DOI 10.1016/j.cardfail.2011.07.009; Daoud EG, 1996, AM J CARDIOL, V78, P1433, DOI 10.1016/S0002-9149(97)89297-1; Hunter RJ, 2014, CIRC-ARRHYTHMIA ELEC, V7, P31, DOI 10.1161/CIRCEP.113.000806; Jais P, 2007, HEART RHYTHM, V4, P803, DOI 10.1016/j.hrthm.2007.01.021; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Jones DG, 2013, J AM COLL CARDIOL, V61, P1894, DOI 10.1016/j.jacc.2013.01.069; Khan MN, 2008, NEW ENGL J MED, V359, P1778, DOI 10.1056/NEJMoa0708234; Knecht S, 2008, EUR HEART J, V29, P2359, DOI 10.1093/eurheartj/ehn302; LINDERER T, 1983, CIRCULATION, V67, P1045, DOI 10.1161/01.CIR.67.5.1045; Lip GYH, 2014, EUR HEART J, V35, P3365, DOI 10.1093/eurheartj/ehu374; MacDonald MR, 2011, HEART, V97, P740, DOI 10.1136/hrt.2010.207340; Mamas MA, 2009, EUR J HEART FAIL, V11, P676, DOI 10.1093/eurjhf/hfp085; Martino E, 2001, ENDOCR REV, V22, P240, DOI 10.1210/er.22.2.240; Nergardh AK, 2007, EUR HEART J, V28, P1351, DOI 10.1093/eurheartj/ehl544; Ouyang FF, 2004, CIRCULATION, V110, P2090, DOI 10.1161/01.CIR.0000144459.37455.EE; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Trulock KM, 2014, J AM COLL CARDIOL, V64, P710, DOI 10.1016/j.jacc.2014.06.1169; VANDENBERG MP, 1993, LANCET, V341, P1667, DOI 10.1016/0140-6736(93)90808-T; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E	25	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174510	10.1371/journal.pone.0174510	http://dx.doi.org/10.1371/journal.pone.0174510			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350861	Green Submitted, gold, Green Published			2022-12-26	WOS:000399174400051
J	Deguchi, S; Katsushima, K; Hatanaka, A; Shinjo, K; Ohka, F; Wakabayashi, T; Zong, H; Natsume, A; Kondo, Y				Deguchi, S.; Katsushima, K.; Hatanaka, A.; Shinjo, K.; Ohka, F.; Wakabayashi, T.; Zong, H.; Natsume, A.; Kondo, Y.			Oncogenic effects of evolutionarily conserved noncoding RNA ECONEXIN on gliomagenesis	ONCOGENE			English	Article							TOPOISOMERASE-II; MOSAIC ANALYSIS; DOUBLE MARKERS; REVEALS; CELL; CANCER; GLIOMA; CERNA; TRANSCRIPTION; PLURIPOTENCY	Accumulating studies have demonstrated the importance of long noncoding RNAs (lncRNAs) during oncogenic transformation. However, because most lncRNAs are currently uncharacterized, the identification of novel oncogenic lncRNAs is difficult. Given that intergenic lncRNA have substantially less sequence conservation patterns than protein-coding genes across species, evolutionary conserved intergenic lncRNAs are likely to be functional. The current study identified a novel intergenic lncRNA, LINC00461 (ECONEXIN) using a combined approach consisting of searching lncRNAs by evolutionary conservation and validating their expression in a glioma mouse model. ECONEXIN was the most highly conserved intergenic lncRNA containing 83.0% homology with the mouse ortholog (C130071C03Rik) for a region over 2500 bp in length within its exon 3. Expressions of ECONEXIN and C130071C03Rik were significantly upregulated in both human and mouse glioma tissues. Moreover, the expression of C130071C03Rik was upregulated even in precancerous conditions and markedly increased during glioma progression. Functional analysis of ECONEXIN in glioma cell lines, U87 and U251, showed it was dominantly located in the cytoplasm and interacted with miR-411-5p via two binding sites within ECONEXIN. Inhibition of ECONEXIN upregulated miR-411-5p together with the downregulation of its target, Topoisomerase 2 alpha (TOP2A), in glioma cell lines, resulting in decreased cell proliferation. Our data demonstrated that ECONEXIN is a potential oncogene that regulates TOP2A by sponging miR-411-5p in glioma. In addition, our investigative approaches to identify conserved lncRNA and their molecular characterization by validation in mouse tumor models may be useful to functionally annotate novel lncRNAs, especially cancer-associated lncRNAs.	[Deguchi, S.; Katsushima, K.; Hatanaka, A.; Shinjo, K.; Kondo, Y.] Nagoya City Univ, Grad Sch Med Sci, Dept Epigenom, Nagoya, Aichi, Japan; [Deguchi, S.; Ohka, F.; Wakabayashi, T.; Natsume, A.] Nagoya Univ, Sch Med, Dept Neurosurg, Nagoya, Aichi, Japan; [Zong, H.] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA	Nagoya City University; Nagoya University; University of Virginia	Kondo, Y (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Epigenom, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	ykondo@med.nagoya-cu.ac.jp	katsushima, keisuke/AAD-5945-2019; katsushima, keisuke/AAV-5204-2020; Natsume, Atsushi/I-7364-2014; Ohka, Fumiharu/A-3420-2016	katsushima, keisuke/0000-0001-7770-432X; Natsume, Atsushi/0000-0002-9113-0470; Zong, Hui/0000-0002-4263-9633; Ohka, Fumiharu/0000-0002-5569-5626	Japan Society for the Promotion of Science [25290048]; Grants-in-Aid for Scientific Research [17K14995] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was performed as research programs of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), Ministry of Education, Culture, Sports, Science and Technology of Japan (YK), of the Project for Cancer Research And Therapeutic Evolution (P-CREATE) from the Japan Agency for Medical Research and development, AMED (YK), of the PRESTO, JST (YK) and of the Grant-in-Aid for Scientific Research, the Japan Society for the Promotion of Science (25290048, YK).	Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Chen T, 2015, ONCOGENE, V34, P4019, DOI 10.1038/onc.2014.332; CLARK PI, 1994, J CLIN ONCOL, V12, P1427, DOI 10.1200/JCO.1994.12.7.1427; Denzler R, 2014, MOL CELL, V54, P766, DOI 10.1016/j.molcel.2014.03.045; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hezroni H, 2015, CELL REP, V11, P1110, DOI 10.1016/j.celrep.2015.04.023; Holmberg J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018454; Ideue T, 2009, RNA, V15, P1578, DOI 10.1261/rna.1657609; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Katsushima K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13616; Ke J, 2015, ONCOTARGET, V6, P21934, DOI 10.18632/oncotarget.4290; Kim SU, 2004, NEUROPATHOLOGY, V24, P159, DOI 10.1111/j.1440-1789.2004.00552.x; Kutter C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002841; Labreche K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8207; Leonard A, 2013, ANTICANCER RES, V33, P3307; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Lin NW, 2014, MOL CELL, V53, P1005, DOI 10.1016/j.molcel.2014.01.021; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Mistry AR, 2005, NEW ENGL J MED, V352, P1529, DOI 10.1056/NEJMoa042715; Mo CF, 2015, STEM CELL RES THER, V6, DOI 10.1186/scrt535; Moran I, 2012, CELL METAB, V16, P435, DOI 10.1016/j.cmet.2012.08.010; Oliver PL, 2015, CEREB CORTEX, V25, P3572, DOI 10.1093/cercor/bhu196; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Quinn JJ, 2016, GENE DEV, V30, P191, DOI 10.1101/gad.272187.115; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Sone M, 2007, J CELL SCI, V120, P2498, DOI 10.1242/jcs.009357; Suzuki H, 2015, NAT GENET, V47, P458, DOI 10.1038/ng.3273; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Ulitsky I, 2016, NAT REV GENET, V17, P601, DOI 10.1038/nrg.2016.85; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wahlestedt C, 2013, NAT REV DRUG DISCOV, V12, P433, DOI 10.1038/nrd4018; Washietl S, 2014, GENOME RES, V24, P616, DOI 10.1101/gr.165035.113; Yang GD, 2014, BBA-GENE REGUL MECH, V1839, P1097, DOI 10.1016/j.bbagrm.2014.08.012; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	44	57	57	0	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 10	2017	36	32					4629	4640		10.1038/onc.2017.88	http://dx.doi.org/10.1038/onc.2017.88			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FD0RK	28368417				2022-12-26	WOS:000407246200010
J	Frieling, JS; Shay, G; Izumi, V; Aherne, ST; Saul, RG; Budzevich, M; Koomen, J; Lynch, CC				Frieling, J. S.; Shay, G.; Izumi, V.; Aherne, S. T.; Saul, R. G.; Budzevich, M.; Koomen, J.; Lynch, C. C.			Matrix metalloproteinase processing of PTHrP yields a selective regulator of osteogenesis, PTHrP(1-17)	ONCOGENE			English	Article							HORMONE-RELATED PROTEIN; STABLE-ISOTOPE STANDARDS; OSTEOBLAST-DERIVED PTHRP; PARATHYROID-HORMONE; PROSTATE-CANCER; BONE METASTASIS; PTH/PTHRP-RECEPTOR; ANTIPEPTIDE ANTIBODIES; SIGNALING PATHWAYS; MASS-SPECTROMETRY	Parathyroid hormone-related protein (PTHrP) is a critical regulator of bone resorption and augments osteolysis in skeletal malignancies. Here we report that the mature PTHrP(1-36) hormone is processed by matrix metalloproteinases to yield a stable product, PTHrP(1-17). PTHrP(1-17) retains the ability to signal through PTH1R to induce calcium flux and ERK phosphorylation but not cyclic AMP production or CREB phosphorylation. Notably, PTHrP(1-17) promotes osteoblast migration and mineralization in vitro, and systemic administration of PTHrP(1-17) augments ectopic bone formation in vivo. Further, in contrast to PTHrP(1-36), PTHrP(1-17) does not affect osteoclast formation/function in vitro or in vivo. Finally, immunoprecipitation-mass spectrometry analyses using PTHrP(1-17)-specific antibodies establish that PTHrP(1-17) is indeed generated by cancer cells. Thus, matrix metalloproteinase-directed processing of PTHrP disables the osteolytic functions of the mature hormone to promote osteogenesis, indicating important roles for this circuit in bone remodelling in normal and disease contexts.	[Frieling, J. S.; Shay, G.; Aherne, S. T.; Lynch, C. C.] H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, SRB-3,12902,Magnolia Dr, Tampa, FL USA; [Izumi, V.; Koomen, J.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL USA; [Saul, R. G.] Leidos Biomed Res, Antibody Characterizat Lab, Frederick, MD USA; [Budzevich, M.] H Lee Moffitt Canc Ctr & Res Inst, Canc Imaging & Metab, Tampa, FL USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); H Lee Moffitt Cancer Center & Research Institute	Lynch, CC (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, SRB-3,12902,Magnolia Dr, Tampa, FL USA.	conor.lynch@moffitt.org		Shay, Gemma/0000-0001-6126-7049; Frieling, Jeremy/0000-0002-2181-1836	State of Florida Bankhead Coley Program [5BC-O1]; Miles for Moffitt Foundation Award; Moffitt Cancer Center Grant [P30-CA076292];  [R01-CA143094]	State of Florida Bankhead Coley Program; Miles for Moffitt Foundation Award; Moffitt Cancer Center Grant; 	This work was supported by R01-CA143094 (CCL), the State of Florida Bankhead Coley Program grant 5BC-O1 (CCL) and by a Miles for Moffitt Foundation Award. This work was also supported in part by the Core Facilities of the Moffitt Cancer Center Grant P30-CA076292. The authors thank Joe Johnson (Moffitt Analytical Microscopy), Robert Sprung (Moffitt Proteomics) and Gordon Whiteley (SAIC-Frederick, NCI-Frederick) for their helpful suggestions and expertise, and Drs John Cleveland and Srikumar Chellappan for critical review of this study.	Amizuka N, 2000, HISTOL HISTOPATHOL, V15, P957, DOI 10.14670/HH-15.957; Anderson NL, 2004, J PROTEOME RES, V3, P235, DOI 10.1021/pr034086h; Azarani A, 1996, J BIOL CHEM, V271, P14931, DOI 10.1074/jbc.271.25.14931; Bilezikian JP, 2015, PARATHYROIDBASIC C, P946; Bonfil RD, 2006, INT J CANCER, V118, P2721, DOI 10.1002/ijc.21645; Cook LM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29384; Cramer SD, 1996, J UROLOGY, V156, P526, DOI 10.1016/S0022-5347(01)65919-6; Croucher PI, 2016, NAT REV CANCER, V16, P373, DOI 10.1038/nrc.2016.44; Cupp ME, 2013, J PHARMACOL EXP THER, V345, P404, DOI 10.1124/jpet.112.199752; Cuthbertson RM, 1999, BBA-PROTEIN STRUCT M, V1432, P64, DOI 10.1016/S0167-4838(99)00078-3; Datta NS, 2007, J BONE MINER RES, V22, P951, DOI 10.1359/JBMR.070328; Esbrit P, 2013, BIOCHEM PHARMACOL, V85, P1417, DOI 10.1016/j.bcp.2013.03.002; Frieling JS, 2015, CANCER CONTROL, V22, P109, DOI 10.1177/107327481502200114; Fukushima H, 2005, J DENT RES, V84, P329, DOI 10.1177/154405910508400407; Gallien S, 2012, MOL CELL PROTEOMICS, V11, P1709, DOI 10.1074/mcp.O112.019802; Garcia-Martin A, 2014, MOL ENDOCRINOL, V28, P925, DOI 10.1210/me.2013-1225; Guise TA, 2002, BONE, V30, P670, DOI 10.1016/S8756-3282(02)00685-3; Guise TA, 1997, CANCER-AM CANCER SOC, V80, P1572, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1572::AID-CNCR7>3.3.CO;2-D; Helfrich M.H., 2003, BONE RES PROTOCOLS; Hodde JP, 2004, J SURG RES, V120, P189, DOI 10.1016/j.jss.2003.10.022; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Ibaragi S, 2010, ANTICANCER RES, V30, P5029; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Katafuchi T, 2015, CELL METAB, V21, P898, DOI 10.1016/j.cmet.2015.05.004; Kawashima-Ohya Y, 1998, ENDOCRINOLOGY, V139, P2120, DOI 10.1210/en.139.4.2120; Krane SM, 2008, BONE, V43, P7, DOI 10.1016/j.bone.2008.03.020; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Luck MD, 1999, MOL ENDOCRINOL, V13, P670, DOI 10.1210/me.13.5.670; Lynch CC, 2005, CANCER CELL, V7, P485, DOI 10.1016/j.ccr.2005.04.013; Lynch CC, 2011, BONE, V48, P44, DOI 10.1016/j.bone.2010.06.007; Ma YFL, 2001, ENDOCRINOLOGY, V142, P4047, DOI 10.1210/en.142.9.4047; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mak IWY, 2013, BONE, V55, P198, DOI 10.1016/j.bone.2013.02.020; Martin TJ, 2016, PHYSIOL REV, V96, P831, DOI 10.1152/physrev.00031.2015; Martin TJ, 2005, J CLIN INVEST, V115, P2322, DOI 10.1172/JCI26239; McCauley LK, 2012, J BONE MINER RES, V27, P1231, DOI 10.1002/jbmr.1617; Miao DS, 2004, ENDOCRINOLOGY, V145, P3554, DOI 10.1210/en.2003-1695; Miao DS, 2005, J CLIN INVEST, V115, P2402, DOI 10.1172/JCI24918; Mohammad Khalid S., 2008, V455, P37, DOI 10.1007/978-1-59745-104-8_3; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; ORLOFF JJ, 1994, ENDOCR REV, V15, P40, DOI 10.1210/er.15.1.40; Park HJ, 2015, J CELL PHYSIOL, V230, P667, DOI 10.1002/jcp.24790; Pettway GJ, 2005, BONE, V36, P959, DOI 10.1016/j.bone.2005.02.015; Pezzato E, 2004, INT J CANCER, V112, P787, DOI 10.1002/ijc.20460; Philbrick W, 2001, PARATHYROIDBASIC C, P881; Philbrick WM, 1996, PHYSIOL REV, V76, P127, DOI 10.1152/physrev.1996.76.1.127; Remily-Wood ER, 2011, PROTEOM CLIN APPL, V5, P383, DOI 10.1002/prca.201000115; Ruchon AF, 2000, J BONE MINER RES, V15, P1266, DOI 10.1359/jbmr.2000.15.7.1266; Schluter KD, 2001, BRIT J PHARMACOL, V132, P427, DOI 10.1038/sj.bjp.0703830; Stewart AF, 1996, BONE, V19, P303, DOI 10.1016/S8756-3282(96)00221-9; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; TAKUWA Y, 1989, AM J PHYSIOL, V257, pE797, DOI 10.1152/ajpendo.1989.257.6.E797; Thiolloy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029862; Valin A, 1997, J CELL PHYSIOL, V170, P209, DOI 10.1002/(SICI)1097-4652(199702)170:2<209::AID-JCP13>3.3.CO;2-Y; Washam CL, 2013, CANCER EPIDEM BIOMAR, V22, P972, DOI 10.1158/1055-9965.EPI-12-1318-T; Winding B, 2002, CLIN CANCER RES, V8, P1932; Wu TT, 1998, INT J CANCER, V77, P887, DOI 10.1002/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z; YATES AJP, 1988, J CLIN INVEST, V81, P932, DOI 10.1172/JCI113406; Yoon H, 2013, BIOL CHEM, V394, P137, DOI 10.1515/hsz-2012-0249; Zhao WG, 1999, J CLIN INVEST, V103, P517, DOI 10.1172/JCI5481	63	6	7	3	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 3	2017	36	31					4498	4507		10.1038/onc.2017.70	http://dx.doi.org/10.1038/onc.2017.70			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FC4JL	28368420	Green Accepted			2022-12-26	WOS:000406806000011
J	Li, ZR; Zhang, J; Mulholland, M; Zhang, WZ				Li, Ziru; Zhang, Jing; Mulholland, Michael; Zhang, Weizhen			mTOR activation protects liver from ischemia/reperfusion-induced injury through NF-kappa B pathway	FASEB JOURNAL			English	Article						hepatic steatosis; IKKI3; nuclear translocation; TSC1	NONALCOHOLIC FATTY LIVER; REPERFUSION INJURY; MAMMALIAN TARGET; MOUSE-LIVER; RAPAMYCIN; ISCHEMIA; COMPLEX; METABOLISM; AUTOPHAGY; DISEASE	Hepatic steatosis renders liver more vulnerable to ischemia/reperfusion injury (IRI), which commonly occurs in transplantation, trauma, and liver resection. The underlying mechanism is not fully characterized. We aimed to clarify the role of mechanistic target of rapamycin (mTOR) signaling in hepatic ischemidreperfusion injury (HIRI) in normal and steatotic liver using Alb-TSC1(-/-) (AT) and Alb-mTOR(-/-) (Am) transgenic mice. Steatotic liver induced by high-fat diet was more vulnerable to IRI. Activation of hepatic mTOR in AT mice decreased lipid accumulation attenuated HIRI as measured by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining, circulating levels of alanine aminotransferase and lactate dehydrogenase, and inflammatory mediators such as monocyte chemoattractant protein 1 (MCP-1), TNF-alpha, and IL-6 and hepatic cleaved caspase 3 in mice fed either a normal chow diet or a high-fat diet. The effects of mTOR activation on hepatic cleaved caspase 3 were reversed by rapamycin, an inhibitor of mTOR signaling. Inhibition of hepatic mTOR in Am mice increased hepatic lipid deposition and HIRI. The increment in hepatic susceptibility to IRI was significantly attenuated by pretreatment with IKKI3 inhibitor. Further, suppression of mTOR facilitated nuclear translocation of NF-KB p65. In conclusion, our study suggests that mTOR activity in hepatocytes decreases hepatic vulnerability to injury through a mechanism dependent on NF-KB proinflammatory cytokine signaling pathway in both normal and steatotic liver. Li, Z., Zhang, J., Mulholland, M., Zhang, W. mTOR activation protects liver from ischemia/ reperfusion-induced injury through NF-KB pathway.	[Li, Ziru; Zhang, Jing; Mulholland, Michael; Zhang, Weizhen] Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA; [Zhang, Weizhen] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing, Peoples R China	University of Michigan System; University of Michigan; Peking University	Mulholland, M (corresponding author), Univ Michigan, Med Ctr, Dept Surg, MSII, 4618B,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.; Zhang, WZ (corresponding author), Univ Michigan, Med Ctr, Dept Physiol & Pathophysiol, MSII, 4618B,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	micham@umich.edu; weizhenz@umich.edu	zhang, weizhen/K-1484-2018	zhang, weizhen/0000-0001-8791-2798; Li, Ziru/0000-0002-2755-9299	National Natural Science Foundation of China [81330010, 81390354]; American Diabetes Association [1-13-BS-225]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK110273-01A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110273] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Diabetes Association(American Diabetes Association); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part, by grants from the National Natural Science Foundation of China (81330010 and 81390354; to J.Z. and W.Z.), the American Diabetes Association (1-13-BS-225; to Z.L.), and the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK110273-01A1; to M.M. and W.Z.). The authors declare no conflicts of interest.	Ai D, 2012, J CLIN INVEST, V122, P1677, DOI 10.1172/JCI61248; Bae EJ, 2012, J BIOL CHEM, V287, P18769, DOI 10.1074/jbc.M112.365544; Busaidy NL, 2012, J CLIN ONCOL, V30, P2919, DOI 10.1200/JCO.2011.39.7356; Chaveroux C, 2013, CELL METAB, V17, P586, DOI 10.1016/j.cmet.2013.03.003; Fouraschen Suomi Mg, 2013, World J Transplant, V3, P36, DOI 10.5500/wjt.v3.i3.36; Gulati P, 2007, BIOCHEM SOC T, V35, P236, DOI 10.1042/BST0350236; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Kang JW, 2014, CELL PHYSIOL BIOCHEM, V33, P23, DOI 10.1159/000356647; Kenerson HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117000; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Luedde T, 2005, J CLIN INVEST, V115, P849, DOI 10.1172/JCI200523493; Palmes D, 2008, VIRCHOWS ARCH, V452, P545, DOI 10.1007/s00428-008-0604-y; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Ringelhan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046469; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Selzner M, 2001, SEMIN LIVER DIS, V21, P105, DOI 10.1055/s-2001-12933; Sheng M, 2015, TRANSPL P, V47, P275, DOI 10.1016/j.transproceed.2015.01.010; Shimada S, 2015, SURG TODAY, V45, P892, DOI 10.1007/s00595-014-1064-4; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wan FY, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000067; Wang YG, 2010, MOL MED REP, V3, P909, DOI 10.3892/mmr.2010.365; Wang YH, 2015, NAT REV MOL CELL BIO, V16, P678, DOI 10.1038/nrm4074; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu G, 2012, DIABETOLOGIA, V55, P1813, DOI 10.1007/s00125-012-2509-1; Zhu J, 2015, TRANSPL P, V47, P1646, DOI 10.1016/j.transproceed.2015.05.013; Zhu JJ, 2015, TRANSPLANTATION, V99, P48, DOI 10.1097/TP.0000000000000476	29	27	29	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3018	3026		10.1096/fj.201601278R	http://dx.doi.org/10.1096/fj.201601278R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28356345	Green Published			2022-12-26	WOS:000405931000026
J	Ricci, E; Ronchetti, S; Pericolini, E; Gabrielli, E; Cari, L; Gentili, M; Roselletti, E; Migliorati, G; Vecchiarelli, A; Riccardi, C				Ricci, Erika; Ronchetti, Simona; Pericolini, Eva; Gabrielli, Elena; Cari, Luigi; Gentili, Marco; Roselletti, Elena; Migliorati, Graziella; Vecchiarelli, Anna; Riccardi, Carlo			Role of the glucocorticoid-induced leucine zipper gene in dexamethasone-induced inhibition of mouse neutrophil migration via control of annexin A1 expression	FASEB JOURNAL			English	Article						inflammation; peritonitis; transcription	NF-KAPPA-B; IN-VIVO; GILZ EXPRESSION; T-LYMPHOCYTES; CELL-SURFACE; INFLAMMATION; PU.1; RECEPTOR; BINDING; PROTEIN	The glucocorticoid-induced leucine zipper (GILZ) gene is a pivotal mediator of the anti-inflammatory effects of glucocorticoids (GCs) that are known to regulate the function of both adaptive and innate immunity cells. Our aim was to investigate the role of GILZ in GC-induced inhibition of neutrophil migration, as this role has not been investigated before. We found that GILZ expression was induced by dexamethasone (DEX), a synthetic GC, in neutrophils, and that it regulated migration of these cells into inflamed tissues under DEX treatment. Of note, inhibition of neutrophil migration was not observed in GILZ-knockout mice with peritonitis that were treated by DEX. This was because DEX was unable to up-regulate annexin Al (Anxal) expression in the absence of GILZ. Furthermore, we showed that GILZ mediates Anxal induction by GCs by transactivating Anxal expression at the promoter level via binding with the transcription factor, PU.1. The present findings shed light on the role of GILZ in the mechanism of induction of Anxal by GCs. As Anxal is an important protein for the resolution of inflammatory response, GILZ may represent a new pharmacologic target for treatment of inflammatory diseases. Ricci, E., Ronchetti, S., Pericolini, E., Gabrielli, E., Cari, L., Gentili, M., Roselletti, E., Migliorati, G., Vecchiarelli, A., Riccardi, C. Role of the glucocorticoid-induced leucine zipper gene in dexamethasone-induced inhibition of mouse neutrophil migration via control of annexin Al expression.	[Ricci, Erika; Ronchetti, Simona; Cari, Luigi; Gentili, Marco; Migliorati, Graziella; Riccardi, Carlo] Univ Perugia, Dept Med, Pharmacol Sect, Ple Lucio Severi 1, I-06132 Perugia, Italy; [Pericolini, Eva; Gabrielli, Elena; Roselletti, Elena; Vecchiarelli, Anna] Univ Perugia, Dept Expt Med, Microbiol Sect, Perugia, Italy; [Pericolini, Eva] Univ Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, Modena, Italy	University of Perugia; University of Perugia; Universita di Modena e Reggio Emilia	Riccardi, C (corresponding author), Univ Perugia, Dept Med, Pharmacol Sect, Ple Lucio Severi 1, I-06132 Perugia, Italy.	carlo.riccardi@unipg.it	Riccardi, Carlo/N-4610-2014; Gentili, Marco/ABA-7786-2021; Pericolini, Eva/AAZ-5848-2021; Cari, Luigi/P-4428-2019; Cari, Luigi/I-8598-2018; Ronchetti, Simona/L-2325-2013	Riccardi, Carlo/0000-0001-9257-3997; Gentili, Marco/0000-0002-2305-4488; Cari, Luigi/0000-0003-0698-3872; Cari, Luigi/0000-0003-0698-3872; Ronchetti, Simona/0000-0002-5639-4243; Pericolini, Eva/0000-0002-5299-8197; MIGLIORATI, Graziella/0000-0002-9475-6399; Roselletti, Elena/0000-0003-3929-7502; Vecchiarelli, Anna/0000-0002-3185-6720	Associazione Italiana per la Ricerca sul Cancro (Milan, Italy) [IG14291]	Associazione Italiana per la Ricerca sul Cancro (Milan, Italy)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Associazione Italiana per la Ricerca sul Cancro (Milan, Italy; Grant IG14291 to C.R.)	Alves JC, 2009, P NATL ACAD SCI USA, V106, P4018, DOI 10.1073/pnas.0900196106; Antonicelli F, 2001, EUR J BIOCHEM, V268, P62, DOI 10.1046/j.1432-1327.2001.01840.x; Ayroldi E, 2015, CELL DEATH DIFFER, V22, P118, DOI 10.1038/cdd.2014.129; Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Ayroldi E, 2014, FASEB J, V28, P5055, DOI 10.1096/fj.14-254755; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Bereshchenko O, 2014, CELL REP, V7, P464, DOI 10.1016/j.celrep.2014.03.004; Bruscoli S, 2015, BLOOD, V126, P1790, DOI 10.1182/blood-2015-03-631580; Bruscoli S, 2012, J BIOL CHEM, V287, P1242, DOI 10.1074/jbc.M111.316372; Cannarile L, 2006, BLOOD, V107, P1039, DOI 10.1182/blood-2005-05-2183; Cari Luigi, 2015, Results Immunol, V5, P37, DOI 10.1016/j.rinim.2015.10.003; Chatterjee BE, 2005, J LEUKOCYTE BIOL, V78, P639, DOI 10.1189/jlb.0405206; CHEN HM, 1995, BLOOD, V85, P2918, DOI 10.1182/blood.V85.10.2918.bloodjournal85102918; Cheng Q, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00169; Cheng Q, 2013, J IMMUNOL, V191, P424, DOI 10.4049/jimmunol.1202662; Cohen N, 2006, BLOOD, V107, P2037, DOI 10.1182/blood-2005-07-2760; CRONSTEIN BN, 1992, P NATL ACAD SCI USA, V89, P9991, DOI 10.1073/pnas.89.21.9991; D'Acunto CW, 2014, CELL SIGNAL, V26, P173, DOI 10.1016/j.cellsig.2013.09.020; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; da Cunha EE, 2012, PULM PHARMACOL THER, V25, P303, DOI 10.1016/j.pupt.2012.04.002; Dalli J, 2008, BLOOD, V112, P2512, DOI 10.1182/blood-2008-02-140533; Damazo AS, 2006, J IMMUNOL, V176, P4410, DOI 10.4049/jimmunol.176.7.4410; de Coupade C, 2003, BRIT J PHARMACOL, V140, P133, DOI 10.1038/sj.bjp.0705413; Delfino DV, 2006, INT IMMUNOPHARMACOL, V6, P1126, DOI 10.1016/j.intimp.2006.02.001; Di Marco B, 2007, NUCLEIC ACIDS RES, V35, P517, DOI 10.1093/nar/gkl1080; Espinasse MA, 2016, J INNATE IMMUN, V8, P81, DOI 10.1159/000439052; Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P638, DOI 10.1016/j.intimp.2013.06.034; Gabrielli E, 2016, VIRULENCE, V7, P819, DOI 10.1080/21505594.2016.1184385; Gastardelo TS, 2009, AM J PATHOL, V174, P177, DOI 10.2353/ajpath.2009.080342; Geering B, 2013, TRENDS IMMUNOL, V34, P398, DOI 10.1016/j.it.2013.04.002; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gimenes AD, 2015, EXP EYE RES, V134, P24, DOI 10.1016/j.exer.2015.03.013; Girol AP, 2013, J IMMUNOL, V190, P5689, DOI 10.4049/jimmunol.1202030; Glowacka E, 2010, ADV MED SCI-POLAND, V55, P254, DOI 10.2478/v10039-010-0037-0; Gunzer M, 2014, BRIT J HAEMATOL, V164, P189, DOI 10.1111/bjh.12608; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; HARRIS JG, 1995, EUR J PHARMACOL, V279, P149, DOI 10.1016/0014-2999(95)00145-B; Hayhoe RPG, 2006, BLOOD, V107, P2123, DOI 10.1182/blood-2005-08-3099; Hoppstadter J, 2015, J IMMUNOL, V194, P6057, DOI 10.4049/jimmunol.1403207; Iseki Y, 2009, LEUKEMIA RES, V33, P1658, DOI 10.1016/j.leukres.2009.04.010; Lecona E, 2008, MOL CELL BIOL, V28, P4665, DOI 10.1128/MCB.00650-07; Leech M, 1998, CLIN EXP IMMUNOL, V112, P383; Maitra S, 2000, MOL CELL BIOL, V20, P1911, DOI 10.1128/MCB.20.6.1911-1922.2000; MANCUSO F, 1995, J IMMUNOL, V155, P377; Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200; Perretti M, 2000, CELL BIOL INT, V24, P163, DOI 10.1006/cbir.1999.0468; Perretti M, 2009, BRIT J PHARMACOL, V158, P936, DOI 10.1111/j.1476-5381.2009.00483.x; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Riccardi C, 2001, ADV EXP MED BIOL, V495, P31; Rocksen D, 2000, CLIN EXP IMMUNOL, V122, P249, DOI 10.1046/j.1365-2249.2000.01373.x; Rogers JH, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3983686; Ronchetti S, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00170; Schramm R, 2004, INFLAMM RES, V53, P644, DOI 10.1007/s00011-004-1307-8; Solomon LA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1303-0; Srinivasan M, 2011, J BIOL CHEM, V286, P44799, DOI 10.1074/jbc.M111.279257; Stopka T, 2005, EMBO J, V24, P3712, DOI 10.1038/sj.emboj.7600834; Sugimoto MA, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8239258; Throm SL, 2003, J LEUKOCYTE BIOL, V74, P111, DOI 10.1189/jlb.0203061; Vago JP, 2015, J IMMUNOL, V194, P4940, DOI 10.4049/jimmunol.1401722; Vago JP, 2012, J LEUKOCYTE BIOL, V92, P249, DOI 10.1189/jlb.0112008; Vicari L, 2006, LEUKEMIA, V20, P2208, DOI 10.1038/sj.leu.2404447; Wang J, 2014, ANN NY ACAD SCI, V1319, P66, DOI 10.1111/nyas.12445; Yang YH, 2009, J IMMUNOL, V183, P1435, DOI 10.4049/jimmunol.0804000; Zhang P, 2000, BLOOD, V96, P2641	66	27	28	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3054	3065		10.1096/fj.201601315R	http://dx.doi.org/10.1096/fj.201601315R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28373208				2022-12-26	WOS:000405931000029
J	Carvalho, LAC; Truzzi, DR; Fallani, TS; Alves, SV; Toledo, JC; Augusto, O; Netto, LES; Meotti, FC				Carvalho, Larissa A. C.; Truzzi, Daniela R.; Fallani, Thamiris S.; Alves, Simone V.; Toledo, Jose Carlos; Augusto, Ohara; Netto, Luis E. S.; Meotti, Flavia C.			Urate hydroperoxide oxidizes human peroxiredoxin 1 and peroxiredoxin 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hydrogen peroxide; inflammation; oxidation-reduction (redox); peroxiredoxin; uric acid; urate hydroperoxide	CYSTEINE SULFINIC ACID; URIC-ACID; 2-CYS PEROXIREDOXIN; HYDROGEN-PEROXIDE; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; ANTIOXIDANT DEFENSE; OXIDASE ACTIVITY; RATE-CONSTANTS; REDUCTION	Urate hydroperoxide is a product of the oxidation of uric acid by inflammatory heme peroxidases. The formation of urate hydroperoxide might be a key event in vascular inflammation, where there is large amount of uric acid and inflammatory peroxidases. Urate hydroperoxide oxidizes glutathione and sulfur-containing amino acids and is expected to react fast toward reactive thiols from peroxiredoxins (Prxs). The kinetics for the oxidation of the cytosolic 2-Cys Prx1 and Prx2 revealed that urate hydroperoxide oxidizes these enzymes at rates comparable with hydrogen peroxide. The second-order rate constants of these reactions were 4.9 x 10(5) and 2.3 x 10(6) m(-1) s(-1) for Prx1 and Prx2, respectively. Kinetic and simulation data suggest that the oxidation of Prx2 by urate hydroperoxide occurs by a three-step mechanism, where the peroxide reversibly associates with the enzyme; then it oxidizes the peroxidatic cysteine, and finally, the rate-limiting disulfide bond is formed. Of relevance, the disulfide bond formation was much slower in Prx2 (k(3) = 0.31 s(-1)) than Prx1 (k(3) = 14.9 s(-1)). In addition, Prx2 was more sensitive than Prx1 to hyperoxidation caused by both urate hydroperoxide and hydrogen peroxide. Urate hydroperoxide oxidized Prx2 from intact erythrocytes to the same extent as hydrogen peroxide. Therefore, Prx1 and Prx2 are likely targets of urate hydroperoxide in cells. Oxidation of Prxs by urate hydroperoxide might affect cell function and be partially responsible for the pro-oxidant and pro-inflammatory effects of uric acid.	[Carvalho, Larissa A. C.; Truzzi, Daniela R.; Fallani, Thamiris S.; Augusto, Ohara; Meotti, Flavia C.] Univ Sao Paulo, Dept Bioquim, Inst Quim IQUSP, BR-05508000 Sao Paulo, SP, Brazil; [Alves, Simone V.; Netto, Luis E. S.] Univ Sao Paulo, Dept Genet & Biol Evolut, Inst Biociencias IB USP, BR-05508000 Sao Paulo, SP, Brazil; [Toledo, Jose Carlos] Univ Sao Paulo, Dept Quim, Fac Filosofia Ciencias & Letras Ribeirao Preto, BR-05508000 Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Meotti, FC (corresponding author), Univ Sao Paulo, Inst Quim IQUSP, Ave Prof Lineu Prestes 748,Bloco 10,Sala 1001, BR-05508000 Sao Paulo, SP, Brazil.	flaviam@iq.usp.br	Netto, Luis/A-3783-2008; Augusto, Ohara/D-3839-2012; Truzzi, Daniela R/B-2540-2014; Meotti, Flavia/AAS-8804-2021; Toledo, Jose C/J-4360-2015; Meotti, Flavia/H-1621-2015	Netto, Luis/0000-0002-4250-9177; Augusto, Ohara/0000-0002-7220-4286; Truzzi, Daniela R/0000-0003-4421-9621; Meotti, Flavia/0000-0002-7217-3352; Toledo Junior, Jose Carlos/0000-0003-0818-0846; Anastacio da Costa Carvalho, Larissa/0000-0001-5720-5910	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; CEPID Redoxoma [2013/07937-8]; Conselho Nacional de Pesquisa Tecnologica (CNPq) [472105/2012-4];  [2011/18106-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CEPID Redoxoma; Conselho Nacional de Pesquisa Tecnologica (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); 	This work was supported in part by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, CEPID Redoxoma 2013/07937-8, Young Researcher 2011/18106-4, and Conselho Nacional de Pesquisa Tecnologica (CNPq) 472105/2012-4.; Recipients of scholarship support from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo.	Alderman MH, 2007, CIRCULATION, V116, P880, DOI 10.1161/CIRCULATIONAHA.107.728600; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; ARUOMA OI, 1989, FEBS LETT, V244, P76, DOI 10.1016/0014-5793(89)81166-4; Baldwin W, 2011, DIABETES, V60, P1258, DOI 10.2337/db10-0916; Bayer SB, 2013, FASEB J, V27, P3315, DOI 10.1096/fj.13-227298; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cox AG, 2009, BIOCHEMISTRY-US, V48, P6495, DOI 10.1021/bi900558g; Cox AG, 2009, BIOCHEM J, V421, P51, DOI 10.1042/BJ20090242; Domazou AS, 2012, FREE RADICAL BIO MED, V52, P1929, DOI 10.1016/j.freeradbiomed.2012.02.045; Engelman R, 2013, J BIOL CHEM, V288, P11312, DOI 10.1074/jbc.M112.433755; Filipe P, 2002, EUR J BIOCHEM, V269, P5474, DOI 10.1046/j.1432-1033.2002.03245.x; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Hanschmann EM, 2010, J BIOL CHEM, V285, P40699, DOI 10.1074/jbc.M110.185827; Haynes AC, 2013, J BIOL CHEM, V288, P29714, DOI 10.1074/jbc.M113.473470; Ihalin R, 2006, ARCH BIOCHEM BIOPHYS, V445, P261, DOI 10.1016/j.abb.2005.07.004; Jarvis RM, 2012, FREE RADICAL BIO MED, V53, P1522, DOI 10.1016/j.freeradbiomed.2012.08.001; Jeong W, 2006, J BIOL CHEM, V281, P14400, DOI 10.1074/jbc.M511082200; Johnson RJ, 2004, NEW ENGL J MED, V350, P1071, DOI 10.1056/NEJMp048015; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Karplus PA, 2015, FREE RADICAL BIO MED, V80, P183, DOI 10.1016/j.freeradbiomed.2014.10.009; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; KITTRIDGE KJ, 1984, FEBS LETT, V170, P162, DOI 10.1016/0014-5793(84)81391-5; Klebanoff S. J, 1991, PEROXIDASES CHEM BIO, V1, P1; Konig J, 2003, J BIOL CHEM, V278, P24409, DOI 10.1074/jbc.M301145200; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Lee WS, 2007, J BIOL CHEM, V282, P22011, DOI 10.1074/jbc.M610330200; Lotufo PA, 2016, ANGIOLOGY, V67, P180, DOI 10.1177/0003319715585037; Low FM, 2008, ANTIOXID REDOX SIGN, V10, P1621, DOI 10.1089/ars.2008.2081; Low FM, 2007, BLOOD, V109, P2611, DOI 10.1182/blood-2006-09-048728; Madrigal-Matute J, 2015, FREE RADICAL BIO MED, V86, P352, DOI 10.1016/j.freeradbiomed.2015.06.001; Manta B, 2009, ARCH BIOCHEM BIOPHYS, V484, P146, DOI 10.1016/j.abb.2008.11.017; Mendes P, 1997, TRENDS BIOCHEM SCI, V22, P361, DOI 10.1016/S0968-0004(97)01103-1; Meotti FC, 2011, J BIOL CHEM, V286, P12901, DOI 10.1074/jbc.M110.172460; Mullen L, 2015, MOL MED, V21, DOI 10.2119/molmed.2015.00033; Nagy P, 2011, J BIOL CHEM, V286, P18048, DOI 10.1074/jbc.M111.232355; Nakagawa T, 2006, KIDNEY INT, V69, P1722, DOI 10.1038/sj.ki.5000391; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Oda M, 2002, MOL BIOL EVOL, V19, P640, DOI 10.1093/oxfordjournals.molbev.a004123; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; Parsonage D, 2015, BIOCHEMISTRY-US, V54, P1567, DOI 10.1021/bi501515w; Patricio ES, 2015, CHEM RES TOXICOL, V28, P1556, DOI 10.1021/acs.chemrestox.5b00132; Perkins A, 2013, BIOCHEMISTRY-US, V52, P8708, DOI 10.1021/bi4011573; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Peskin AV, 2016, J BIOL CHEM, V291, P3053, DOI 10.1074/jbc.M115.692798; Peskin AV, 2013, J BIOL CHEM, V288, P14170, DOI 10.1074/jbc.M113.460881; Rhee SG, 2016, MOL CELLS, V39, P1, DOI 10.14348/molcells.2016.2368; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Salzano S, 2014, P NATL ACAD SCI USA, V111, P12157, DOI 10.1073/pnas.1401712111; Santos CXC, 1999, ARCH BIOCHEM BIOPHYS, V372, P285, DOI 10.1006/abbi.1999.1491; Sautin YY, 2008, NUCLEOS NUCLEOT NUCL, V27, P608, DOI 10.1080/15257770802138558; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; Seidel A, 2014, J BIOL CHEM, V289, P21937, DOI 10.1074/jbc.M113.544957; Seo JH, 2009, J BIOL CHEM, V284, P13455, DOI 10.1074/jbc.M900641200; SIMIC MG, 1989, J AM CHEM SOC, V111, P5778, DOI 10.1021/ja00197a042; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; Tairum CA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33133; Toledo JC, 2011, FREE RADICAL BIO MED, V50, P1032, DOI 10.1016/j.freeradbiomed.2011.02.020; Trujillo M, 2008, METHOD ENZYMOL, V441, P173, DOI 10.1016/S0076-6879(08)01210-X; Trujillo M, 2007, ARCH BIOCHEM BIOPHYS, V467, P95, DOI 10.1016/j.abb.2007.08.008; Winterbourn CC, 2016, MOL CELLS, V39, P26, DOI 10.14348/molcells.2016.2325; Winterbourn CC, 2015, NAT CHEM BIOL, V11, P5, DOI 10.1038/nchembio.1722; Woo HA, 2005, J BIOL CHEM, V280, P3125, DOI 10.1074/jbc.C400496200; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; WOODWARD JJ, 1994, NEUROPHARMACOLOGY, V33, P635, DOI 10.1016/0028-3908(94)90168-6	68	32	33	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 26	2017	292	21					8705	8715		10.1074/jbc.M116.767657	http://dx.doi.org/10.1074/jbc.M116.767657			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EW0BU	28348082	hybrid, Green Published			2022-12-26	WOS:000402153900017
J	Shaw, AN; Mummey, DL				Shaw, Alanna N.; Mummey, Daniel L.			Poa secunda local collections and commercial releases: A genotypic evaluation	PLOS ONE			English	Article							GENETIC DIVERSITY; SEED DISPERSAL; GREAT-BASIN; PLANT; RESTORATION; AFLP; APOMIXIS; TRAITS; POPULATIONS; DIFFERENTIATION	The genetics of native plants influence the success of ecological restoration, yet genetic variability of local seed collections and commercial seed releases remains unclear for most taxa. Poa secunda, a common native grass species in Intermountain West grasslands and a frequent component of restoration seed mixes, is one such species. Here, we evaluate the genetic variation of local Poa secunda collections in the context of wild populations and commercial seed releases. We evaluated AFLP markers for seven Poa secunda collections made over a 4000-hectare area and four commercial releases (High Plains, MT-1, Opportunity, and Sherman). We compare the genetic distance and distribution of genetic variation within and between local collections and commercial releases. The extent and patterns of genetic variation in our local collections indicate subtle site differences with most variation occurring within rather than between collections. Identical genetic matches were usually, but not always, found within 5 m 2 collection sites. Our results suggest that the genetic variation in two Poa secunda releases (High Plains and MT-1) is similar to our local collections. Our results affirm that guidelines for Poa secunda seed collection should follow recommendations for selfing species, by collecting from many sites over large individual sites.	[Shaw, Alanna N.; Mummey, Daniel L.] MPG Ranch, Missoula, MT 59801 USA		Shaw, AN (corresponding author), MPG Ranch, Missoula, MT 59801 USA.	alanna.n.shaw@gmail.com	Shaw, Alanna/J-4385-2019	Shaw, Alanna/0000-0002-6405-5225	MPG Ranch	MPG Ranch	This study was funded by MPG Ranch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Lauren Shreading and Kelly LaFlamme for assistance collecting plant materials. We thank Kristina Hufford for valuable comments and editing. MPG Ranch generously funded this research.	ARNOW LA, 1981, SYST BOT, V6, P412, DOI 10.2307/2418452; Basey AC., 2015, NATIV PLANTS J, V16, P37, DOI [10.3368/npj.16.1.37, DOI 10.3368/NPJ.16.1.37]; Baughman OW, 2016, J ARID ENVIRON, V124, P193, DOI 10.1016/j.jaridenv.2015.08.011; Bengtsson BO, 2003, J EVOLUTION BIOL, V16, P189, DOI 10.1046/j.1420-9101.2003.00523.x; Blignaut M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061704; Broadhurst LM, 2008, EVOL APPL, V1, P587, DOI 10.1111/j.1752-4571.2008.00045.x; Brown A. H. D., 1995, P75; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Carr DE, 2003, PHILOS T R SOC B, V358, P1071, DOI 10.1098/rstb.2003.1295; Catanach A, 2015, SOMATIC GENOME MANIP, P147; Cheplick Gregory P., 1998, P84, DOI 10.1017/CBO9780511525445.005; CLAUSEN J, 1961, EUPHYTICA, V10, P87, DOI 10.1007/BF00037208; Crawford LA, 2012, MOL ECOL, V21, P5911, DOI 10.1111/mec.12069; Duminil J, 2007, AM NAT, V169, P662, DOI 10.1086/513490; Dyer AR, 2016, ECOL RESTOR, V34, P39, DOI 10.3368/er.34.1.39; ELLSTRAND NC, 1987, AM J BOT, V74, P123, DOI 10.2307/2444338; EXCOFFIER L, 1992, GENETICS, V131, P479; Ferdinandez YSN, 2005, CROP SCI, V45, P1064, DOI 10.2135/cropsci2004.0332; Fu YB, 2004, CROP SCI, V44, P2254, DOI 10.2135/cropsci2004.2254; Garnier LKM, 2002, AM J BOT, V89, P1785, DOI 10.3732/ajb.89.11.1785; GILMARTIN AJ, 1986, SYST BOT, V11, P559, DOI 10.2307/2419034; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; Halkett F, 2005, TRENDS ECOL EVOL, V20, P194, DOI 10.1016/j.tree.2005.01.001; Halvorson R., 2011, KALMIOPSIS, V18, P10; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; HARTUNG ME, 1946, AM J BOT, V33, P516, DOI 10.2307/2437587; HEIDEL B, 1982, Northwest Science, V56, P108; Herget ME, ECOLOGICAL RESTORATI; Herget ME, 2015, RESTOR ECOL, V23, P277, DOI 10.1111/rec.12177; Herget ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119889; Hitchcock AS, 1971, MANUAL GRASSES US; Hufford KM, 2003, TRENDS ECOL EVOL, V18, P147, DOI 10.1016/S0169-5347(03)00002-8; Johnson RC, 2015, EVOL APPL, V8, P172, DOI 10.1111/eva.12240; Jones TA, 2015, ELEMENTA-SCI ANTHROP, V3, P1, DOI 10.12952/journal.elementa.000047; Jones TA, 2003, RESTOR ECOL, V11, P281, DOI 10.1046/j.1526-100X.2003.00064.x; Jones TA, 2013, BIOSCIENCE, V63, P211, DOI 10.1525/bio.2013.63.3.9; Kelley AM, 2009, CROP SCI, V49, P1395, DOI 10.2135/cropsci2008.09.0553; KELLOGG EA, 1987, AM J BOT, V74, P1431, DOI 10.2307/2444319; KELLOGG EA, 1985, J ARNOLD ARBORETUM, V66, P201, DOI 10.5962/bhl.part.13182; KELLOGG EA, 1985, J RANGE MANAGE, V38, P516, DOI 10.2307/3899743; Kettenring KM, 2014, J APPL ECOL, V51, P339, DOI 10.1111/1365-2664.12202; Knapp E., 1994, ECOL RESTOR, V12, P40, DOI [10.3368/er.12.1.40, DOI 10.3368/ER.12.1.40]; KOLTUNOW AM, 1995, PLANT PHYSIOL, V108, P1345, DOI 10.1104/pp.108.4.1345; Larson J, 2015, OECOLOGIA, P1; Larson SR, 2001, CROP SCI, V41, P1300, DOI 10.2135/cropsci2001.4141300x; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Leger EA, 2015, NAT AREA J, V35, P54, DOI 10.3375/043.035.0108; Lesica P, 1999, RESTOR ECOL, V7, P42, DOI 10.1046/j.1526-100X.1999.07105.x; LOVELESS MD, 1984, ANNU REV ECOL SYST, V15, P65, DOI 10.1146/annurev.es.15.110184.000433; Majerus M., 2009, PLANT GUIDE SANDBERG; Majerus ME, 2000, RELEASE NOTICE HIGH; Majerus S., 2008, Native Plants Journal, V9, P103, DOI 10.2979/NPJ.2008.9.2.103; MARSHALL DR, 1979, HEREDITY, V42, P159, DOI 10.1038/hdy.1979.20; McKay JK, 2005, RESTOR ECOL, V13, P432, DOI 10.1111/j.1526-100X.2005.00058.x; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; PAMILO P, 1987, GENET RES, V49, P135, DOI 10.1017/S0016672300026938; Patterson JT, 2005, GENOME, V48, P76, DOI 10.1139/G04-102; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; SILANDER JA, 1979, SCIENCE, V203, P658, DOI 10.1126/science.203.4381.658; St Clair JB, 2013, EVOL APPL, V6, P933, DOI 10.1111/eva.12077; Stebbins GL, 1941, AM J BOT, V28, P371, DOI 10.2307/2436813; Svensson BM, 1996, ECOLOGICAL B, P133; United States Department of Agriculture, 2010, SHERM BIG BLUEGR USD, P1; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407	66	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2017	12	4							e0173221	10.1371/journal.pone.0173221	http://dx.doi.org/10.1371/journal.pone.0173221			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES2IH	28369130	Green Published, Green Submitted, gold			2022-12-26	WOS:000399351000008
J	Guinoiseau, T; Moreau, A; Hohnadel, G; Ngo-Giang-Huong, N; Brulard, C; Vourc'h, P; Goudeau, A; Gaudy-Graffin, C				Guinoiseau, Thibault; Moreau, Alain; Hohnadel, Guillaume; Ngo-Giang-Huong, Nicole; Brulard, Celine; Vourc'h, Patrick; Goudeau, Alain; Gaudy-Graffin, Catherine			Deep sequencing is an appropriate tool for the selection of unique Hepatitis C virus (HCV) variants after single genomic amplification	PLOS ONE			English	Article							IN-VIVO	Hepatitis C virus (HCV) evolves rapidly in a single host and circulates as a quasispecies wich is a complex mixture of genetically distinct virus's but closely related namely variants. To identify intra-individual diversity and investigate their functional properties in vitro, it is necessary to define their quasispecies composition and isolate the HCV variants. This is possible using single genome amplification (SGA). This technique, based on serially diluted cDNA to amplify a single cDNA molecule (clonal amplicon), has already been used to determine individual HCV diversity. In these studies, positive PCR reactions from SGA were directly sequenced using Sanger technology. The detection of non-clonal amplicons is necessary for excluding them to facilitate further functional analysis. Here, we compared Next Generation Sequencing (NGS) with De Novo assembly and Sanger sequencing for their ability to distinguish clonal and non-clonal amplicons after SGA on one plasma specimen. All amplicons (n = 42) classified as clonal by NGS were also classified as clonal by Sanger sequencing. No double peaks were seen on electropherograms for non-clonal amplicons with position-specific nucleotide variation below 15% by NGS. Altogether, NGS circumvented many of the difficulties encountered when using Sanger sequencing after SGA and is an appropriate tool to reliability select clonal amplicons for further functional studies.	[Guinoiseau, Thibault; Moreau, Alain; Hohnadel, Guillaume; Goudeau, Alain; Gaudy-Graffin, Catherine] Univ Tours, INSERM U966, Tours, France; [Guinoiseau, Thibault; Moreau, Alain; Hohnadel, Guillaume; Goudeau, Alain; Gaudy-Graffin, Catherine] CHRU Tours, Tours, France; [Ngo-Giang-Huong, Nicole] Chiang Mai Univ, Fac Associated Med Sci, Inst Rech Dev IRD UMI PHPT 174, Chiang Mai, Thailand; [Brulard, Celine; Vourc'h, Patrick] Univ Tours, UMR INSERM U930, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; Chiang Mai University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Guinoiseau, T (corresponding author), Univ Tours, INSERM U966, Tours, France.; Guinoiseau, T (corresponding author), CHRU Tours, Tours, France.	t.guinoiseau@yahoo.fr	Ngo-Giang-Huong, Nicole/G-2860-2017	Ngo-Giang-Huong, Nicole/0000-0001-8950-3234; VOURC'H, Patrick/0000-0001-7960-8139	Region Centre Val de Loire, 'VIROTRANSAC" Grant [00094545, AE 2014-1850]	Region Centre Val de Loire, 'VIROTRANSAC" Grant	This work was supported from the Region Centre Val de Loire, 'VIROTRANSAC" Grant from: convention 2014 00094545 / operation AE 2014-1850 (http://www.regioncentre-valdeloire.fr/accueil/les-services-en-ligne/appels-a-projets/recherche-et-innovation.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Arienzo VD, 2013, J VIROL, V87, P13609; Ascione Antonio, 2007, Dig Liver Dis, V39 Suppl 1, pS4, DOI 10.1016/S1590-8658(07)80003-X; Bartenschlager R, 2000, J GEN VIROL, V81, P1631, DOI 10.1099/0022-1317-81-7-1631; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Di Lillo FA, 2015, ANN HEPATOL, V14, P442, DOI 10.1016/S1665-2681(19)31164-0; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Ferns RB, 2016, VIROLOGY, V492, P213, DOI 10.1016/j.virol.2016.02.003; Lallemant M, 2000, N ENGL J MED, V343; Li H, 2015, J VIROL, V90; Li HJ, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-29; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Ngo-Giang-Huong N, 2010, INT J INFECT DIS, V14, pE602, DOI 10.1016/j.ijid.2009.09.002; OGATA N, 1991, P NATL ACAD SCI USA, V88, P3392, DOI 10.1073/pnas.88.8.3392; Ribeiro RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002881; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; STEINHAUER DA, 1992, GENE, V122, P281, DOI 10.1016/0378-1119(92)90216-C; Stoddard MB, 2015, MBIO, V6, DOI 10.1128/mBio.02518-14; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268	21	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174852	10.1371/journal.pone.0174852	http://dx.doi.org/10.1371/journal.pone.0174852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362878	gold, Green Published, Green Submitted			2022-12-26	WOS:000399175000044
J	Mottola, G; Chatterjee, A; Wu, B; Chen, MA; Conte, MS				Mottola, Giorgio; Chatterjee, Anuran; Wu, Bian; Chen, Mian; Conte, Michael S.			Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (CAMP/PKA) pathway	PLOS ONE			English	Article							PRORESOLVING LIPID MEDIATORS; GROWTH-FACTOR; PROMOTE RESOLUTION; INFLAMMATION; ACTIVATION; PHOSPHORYLATION; PAXILLIN; PKA; EPIDEMIOLOGY; ANGIOPLASTY	Background and objectives Resolvin D1 (RvD1) is a specialized pro-resolving lipid mediator that has been previously shown to attenuate vascular smooth muscle cell (VSMC) migration, a key process in the development of intimal hyperplasia. We sought to investigate the role of the cAMP/PKA pathway in mediating the effects of the aspirin-triggered epimer 17R-RvD1 (AT-RvD1) on VSMC migration. Methods VSMCs were harvested from human saphenous veins. VSMCs were analyzed for intracellular cAMP levels and PKA activity after exposure to AT-RvD1. Platelet-derived growth factor (PDGF)-induced migration and cytoskeletal changes in VSMCs were observed through scratch, Transwell, and cell shape assays in the presence or absence of a PKA inhibitor (Rp-8-Br-cAMP). Further investigation of the pathways involved in AT-RvD1 signaling was performed by measuring Rac1 activity, vasodilator stimulated phosphoprotein (VASP) phosphorylation and paxillin translocation. Finally, we examined the role of RvD1 receptors (GPR32 and ALX/FPR2) in AT-RvD1 induced effects on VSMC migration and PKA activity. Results Treatment with AT-RvD1 induced a significant increase in cAMP levels and PKA activity in VSMCs at 5 minutes and 30 minutes, respectively. AT-RvD1 attenuated PDGF-induced VSMC migration and cytoskeletal rearrangements. These effects were attenuated by the PKA inhibitor Rp-8-Br-cAMP, suggesting cAMP/PKA involvement. Treatment of VSMC with AT-RvD1 inhibited PDGF-stimulated Rac1 activity, increased VASP phosphorylation, and attenuated paxillin localization to focal adhesions; these effects were negated by the addition of Rp-8-Br-cAMP. The effects of AT-RvD1 on VSMC migration and PKA activity were attenuated by blocking ALX/FPR2, suggesting an important role of this G-protein coupled receptor. Conclusions Our results suggest that AT-RvD1 attenuates PDGF-induced VSMC migration via ALX/FPR2 and cAMP/PKA. Interference with Rac1, VASP and paxillin function appear to mediate the downstream effects of AT-RvD1 on VSMC migration.	[Mottola, Giorgio; Chatterjee, Anuran; Wu, Bian; Chen, Mian; Conte, Michael S.] Univ Calif San Francisco, Dept Surg, Div Vasc & Endovasc Surg, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Mottola, G (corresponding author), Univ Calif San Francisco, Dept Surg, Div Vasc & Endovasc Surg, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	Giorgio.Mottola@ucsf.edu	Mottola, Giorgio/AAO-4375-2021	Mottola, Giorgio/0000-0003-0670-8619	National Heart, Lung, and Blood Institute [5R01HL119508]; American Heart Association Scientist Development [13SDG16940069]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119508] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Scientist Development(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute (5R01HL119508) to MSC and the American Heart Association Scientist Development Grant (13SDG16940069) to AC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi D, 2015, FASEB J, V29, P2504, DOI 10.1096/fj.14-265363; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Burdyga A, 2013, BBA-MOL CELL RES, V1833, P2664, DOI 10.1016/j.bbamcr.2013.06.011; Cai YJ, 2015, CIRC RES, V116, P1120, DOI 10.1161/CIRCRESAHA.116.304408; Chateigner-Boutin AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089620; Chung CY, 2000, P NATL ACAD SCI USA, V97, P5225, DOI 10.1073/pnas.97.10.5225; Colas RA, 2014, AM J PHYSIOL-CELL PH, P307; Conte MS, 2006, J VASC SURG, V43, P742, DOI 10.1016/j.jvs.2005.12.058; Criqui MH, 2015, CIRC RES, V116, P1509, DOI 10.1161/CIRCRESAHA.116.303849; DAVIES MG, 1994, BRIT J SURG, V81, P1254, DOI 10.1002/bjs.1800810904; Doanes AM, 1998, BIOCHEM MOL BIOL INT, V45, P279; Elajami TK, 2016, FASEB J, V30, P2792, DOI 10.1096/fj.201500155R; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Fredman G, 2014, P NATL ACAD SCI USA, V111, P14530, DOI 10.1073/pnas.1410851111; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Goncharova EA, 2012, AM J RESP CELL MOL, V46, P48, DOI 10.1165/rcmb.2011-0217OC; Goodney PP, 2009, J VASC SURG, V50, P54, DOI 10.1016/j.jvs.2009.01.035; Goto A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00321; GROTENDORST GR, 1982, J CELL PHYSIOL, V113, P261, DOI 10.1002/jcp.1041130213; Han JW, 2001, J BIOL CHEM, V276, P40903, DOI 10.1074/jbc.M102665200; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; Hirsch AT, 2008, VASC MED, V13, P209, DOI 10.1177/1358863X08089277; Ho KJ, 2010, AM J PATHOL, V177, P2116, DOI 10.2353/ajpath.2010.091082; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Hsieh WC, 2014, BLOOD, V124, P2847, DOI 10.1182/blood-2014-03-564609; Indolfi C, 1997, NAT MED, V3, P775, DOI 10.1038/nm0797-775; Inoue T, 2011, JACC-CARDIOVASC INTE, V4, P1057, DOI 10.1016/j.jcin.2011.05.025; JACKSON CL, 1993, ARTERIOSCLER THROMB, V13, P1218, DOI 10.1161/01.ATV.13.8.1218; JAWIEN A, 1992, J CLIN INVEST, V89, P507, DOI 10.1172/JCI115613; Johnson R, 2006, AM SURGEON, V72, P51; Keinan D, 2013, INT J MOL SCI, V14, P5501, DOI 10.3390/ijms14035501; Krishnamoorthy N, 2015, J IMMUNOL, V194, P863, DOI 10.4049/jimmunol.1402534; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Lee HN, 2013, BIOCHEM PHARMACOL, V86, P759, DOI 10.1016/j.bcp.2013.07.002; Liu Y, 2016, INT J MOL MED, V38, P1235, DOI 10.3892/ijmm.2016.2721; Louis SF, 2010, EXP CLIN CARDIOL, V15, pE75; Mayeenuddin LH, 2006, J BIOL CHEM, V281, P1921, DOI 10.1074/jbc.M506035200; McKean JS, 2015, CARDIOVASC RES, V107, P546, DOI 10.1093/cvr/cvv176; Miyahara T, 2013, FASEB J, V27, P2220, DOI 10.1096/fj.12-225615; MIYATA T, 1991, J SURG RES, V50, P485, DOI 10.1016/0022-4804(91)90029-L; Novo S, 2002, DIABETES OBES METAB, V4, pS1, DOI 10.1046/j.1463-1326.2002.0040s20s1.x; Palmer D, 1998, CIRC RES, V82, P852; Pandiella A, 2013, CLIN CANCER RES, V19, P4564, DOI 10.1158/1078-0432.CCR-12-1662; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Sachs T, 2011, J VASC SURG, V54, P1021, DOI 10.1016/j.jvs.2011.03.281; Schillinger M, 2007, CIRCULATION, V115, P2745, DOI 10.1161/CIRCULATIONAHA.107.688341; Schlegel N, 2008, AM J PHYSIOL-CELL PH, V294, pC178, DOI 10.1152/ajpcell.00273.2007; Schwartz SM, 1997, J CLIN INVEST, V100, pS87; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Sok MCP, 2017, ACTA BIOMATER; Spite M, 2010, CIRC RES, V107, P1170, DOI 10.1161/CIRCRESAHA.110.223883; Staiculescu MC, 2013, CARDIOVASC RES, V98, P428, DOI 10.1093/cvr/cvt034; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; THORGEIRSSON G, 1979, LAB INVEST, V41, P51; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Wang Q, 2014, J IMMUNOL, V192, P3765, DOI 10.4049/jimmunol.1302421; Williams HC, 2010, FASEB J, V24; Wu B., 2016, J VASC SURG; Zhao L, 2014, AM J PHYSIOL-CELL PH, V307, pC1130, DOI 10.1152/ajpcell.00151.2014	61	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2017	12	3							e0174936	10.1371/journal.pone.0174936	http://dx.doi.org/10.1371/journal.pone.0174936			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VK	28362840	Green Published, Green Submitted, gold			2022-12-26	WOS:000399175000055
J	Morriss, SC; Studham, ME; Tylka, GL; MacIntosh, GC				Morriss, Stephanie C.; Studham, Matthew E.; Tylka, Gregory L.; MacIntosh, Gustavo C.			Validation of a hairy roots system to study soybean-soybean aphid interactions	PLOS ONE			English	Article							RESISTANCE GENE; AGROBACTERIUM-RHIZOGENES; PLANT-RESISTANCE; IDENTIFICATION; TRANSFORMATION; MANAGEMENT; INDUCTION; PROTEINS; RUST; ACID	The soybean aphid (Aphis glycines) is one of the main insect pests of soybean (Glycine max) worldwide. Genomics approaches have provided important data on transcriptome changes, both in the insect and in the plant, in response to the plant-aphid interaction. However, the difficulties to transform soybean and to rear soybean aphid on artificial media have hindered our ability to systematically test the function of genes identified by those analyses as mediators of plant resistance to the insect. An efficient approach to produce transgenic soybean material is the production of transformed hairy roots using Agrobacterium rhizogenes; however, soybean aphids colonize leaves or stems and thus this approach has not been utilized. Here, we developed a hairy root system that allowed effective aphid feeding. We show that this system supports aphid performance similar to that observed in leaves. The use of hairy roots to study plant resistance is validated by experiments showing that roots generated from cotyledons of resistant lines carrying the Rag1 or Rag2 resistance genes are also resistant to aphid feeding, while related susceptible lines are not. Our results demonstrate that hairy roots are a good system to study soybean aphid-soybean interactions, providing a quick and effective method that could be used for functional analysis of the resistance response to this insect.	[Morriss, Stephanie C.; Studham, Matthew E.; MacIntosh, Gustavo C.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Tylka, Gregory L.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA	Iowa State University; Iowa State University	MacIntosh, GC (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	gustavo@iastate.edu		MacIntosh, Gustavo/0000-0003-1350-1229	Iowa Soybean Association	Iowa Soybean Association	This research was supported in part by the Iowa Soybean Association and the soybean checkoff through a grant to GLT and GCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt J, 2013, CROP SCI, V53, P1491, DOI 10.2135/cropsci2012.11.0672; Bansal R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-972; Brechenmacher L, 2015, J PROTEOME RES, V14, P4137, DOI 10.1021/acs.jproteome.5b00146; Chiozza MV, 2010, ENVIRON ENTOMOL, V39, P856, DOI 10.1603/EN09338; Cho HJ, 2000, PLANTA, V210, P195, DOI 10.1007/PL00008126; Gunadi A, 2016, PEST MANAG SCI; Hanson A. A., 2016, APHID RESISTANT SOYB; Hanson AA, 2016, CROP SCI, V56, P154, DOI 10.2135/cropsci2015.05.0287; Hesler LS, 2013, ENTOMOL EXP APPL, V147, P201, DOI 10.1111/eea.12073; Hill CB, 2012, EUPHYTICA, V186, P635, DOI 10.1007/s10681-012-0695-z; Hill CB, 2006, CROP SCI, V46, P1601, DOI 10.2135/cropsci2005.11-0421; Hill CB, 2010, J ECON ENTOMOL, V103, P509, DOI 10.1603/EC09179; Jun TH, 2012, THEOR APPL GENET, V124, P13, DOI 10.1007/s00122-011-1682-9; Kaloshian I., 2016, MANAGEMENT INSECT PE, P217, DOI DOI 10.1007/978-3-319-24049-7_9; Kang ST, 2008, CROP SCI, V48, P1744, DOI 10.2135/cropsci2007.12.0672; Kereszt A, 2007, NAT PROTOC, V2, P948, DOI 10.1038/nprot.2007.141; Kim KS, 2008, CROP SCI, V48, P923, DOI 10.2135/cropsci2007.08.0447; Kim KS, 2010, THEOR APPL GENET, V121, P599, DOI 10.1007/s00122-010-1333-6; Kim KS, 2010, THEOR APPL GENET, V120, P1063, DOI 10.1007/s00122-009-1234-8; Lee H, 2013, COMPREHENSIVE SURVEY OF INTERNATIONAL SOYBEAN RESEARCH - GENETICS, PHYSIOLOGY, AGRONOMY AND NITROGEN RELATIONSHIPS, P489, DOI 10.5772/51076; Li Y, 2008, NEW PHYTOL, V179, P185, DOI 10.1111/j.1469-8137.2008.02443.x; Li Y, 2007, MOL BREEDING, V19, P25, DOI 10.1007/s11032-006-9039-9; Liu SM, 2012, NATURE, V492, P256, DOI 10.1038/nature11651; McCarville MT, 2012, J ECON ENTOMOL, V105, P1835, DOI 10.1603/EC12043; McCarville MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086415; McCarville MT, 2012, CROP PROT, V42, P210, DOI 10.1016/j.cropro.2012.05.022; McCarville MT, 2012, AGR ENV; Meyer JDF, 2009, PLANT PHYSIOL, V150, P295, DOI 10.1104/pp.108.134551; Mian MAR, 2008, THEOR APPL GENET, V117, P955, DOI 10.1007/s00122-008-0835-y; Michel AP, 2011, SOYBEAN - MOLECULAR ASPECTS OF BREEDING, P355; Morales AMAP, 2013, FUNCT PLANT BIOL, V40, P1029, DOI 10.1071/FP12296; Niblack T., 2009, PLANT HLTH PROG, V10, P33, DOI [10.1094/PHP-2009-0513-01-RV, DOI 10.1094/PHP-2009-0513-01-RV]; Niblack TL, 2002, J NEMATOL, V34, P279; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Rossi M, 1998, P NATL ACAD SCI USA, V95, P9750, DOI 10.1073/pnas.95.17.9750; SAVKA MA, 1990, PHYTOPATHOLOGY, V80, P503, DOI 10.1094/Phyto-80-503; Selote D, 2010, PLANT PHYSIOL, V153, P1199, DOI 10.1104/pp.110.158147; Studham ME, 2013, MOL PLANT MICROBE IN, V26, P116, DOI 10.1094/MPMI-05-12-0124-FI; Subramanian S, 2005, PLANT PHYSIOL, V137, P1345, DOI 10.1104/pp.104.057257; Taylor CG, 2006, METH MOL B, V343, P155; Veena V, 2007, IN VITRO CELL DEV-PL, V43, P383, DOI 10.1007/s11627-007-9096-8; Whitham Steven A, 2016, Curr Protoc Plant Biol, V1, P263, DOI 10.1002/cppb.20012; Wiarda SL, 2012, J ECON ENTOMOL, V105, P252, DOI 10.1603/EC11020; Zhang CQ, 2012, MOL PLANT MICROBE IN, V25, P1307, DOI 10.1094/MPMI-02-12-0046-R; Zust T, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.206, 10.1038/nplants.2015.206]	45	4	4	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2017	12	3							e0174914	10.1371/journal.pone.0174914	http://dx.doi.org/10.1371/journal.pone.0174914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VI	28358854	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174800103
J	Booth, JK; Page, JE; Bohlmann, J				Booth, Judith K.; Page, Jonathan E.; Bohlmann, Jorg			Terpene synthases from Cannabis sativa	PLOS ONE			English	Article							CHAIN-LENGTH SPECIFICITY; GERANYLGERANYL DIPHOSPHATE; FUNCTIONAL EXPRESSION; GLANDULAR TRICHOMES; SMALL-SUBUNIT; BIOSYNTHESIS; EVOLUTION; GENERATION; PROTEINS; SYNERGY	Cannabis (Cannabis sativa) plants produce and accumulate a terpene-rich resin in glandular trichomes, which are abundant on the surface of the female inflorescence. Bouquets of different monoterpenes and sesquiterpenes are important components of cannabis resin as they define some of the unique organoleptic properties and may also influence medicinal qualities of different cannabis strains and varieties. Transcriptome analysis of trichomes of the cannabis hemp variety `Finola' revealed sequences of all stages of terpene biosynthesis. Nine cannabis terpene synthases (CsTPS) were identified in subfamilies TPS-a and TPS-b. Functional characterization identified mono- and sesqui-TPS, whose products collectively comprise most of the terpenes of `Finola' resin, including major compounds such as P-myrcene, (E)-beta-ocimene, (-)-limonene, (+)-alpha-pinene, beta-caryophyllene, and alpha-humulene. Transcripts associated with terpene biosynthesis are highly expressed in trichomes compared to non-resin producing tissues. Knowledge of the CsTPS gene family may offer opportunities for selection and improvement of terpene profiles of interest in different cannabis strains and varieties.	[Booth, Judith K.; Bohlmann, Jorg] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Page, Jonathan E.] Anandia Labs, Vancouver, BC V6T 1Z4, Canada; [Page, Jonathan E.; Bohlmann, Jorg] Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Bohlmann, J (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada.	bohlmann@msl.ubc.ca			Natural Sciences and Engineering Research Council (NSERC) of Canada; NSERC Graduate Scholarship; NSERC	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported with funds to JB from a Discovery Grant of the Natural Sciences and Engineering Research Council (NSERC) of Canada and an NSERC Graduate Scholarship to JKB. JEP contributed to the study in his academic capacity as an Adjunct Professor in the Department of Botany at the University of British Columbia. JEP is also the CEO and President of Anandia Labs Inc., which is hereby acknowledged. The funder (NSERC) provided financial support in the form of salary through a fellowship for JKB and research materials. Anandia Labs provided in -kind support in the form of plant materials. Anandia Labs did not provide financial support for this project. The funder (NSERC) and Anandia Labs did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Aharoni A, 2004, PLANT CELL, V16, P3110, DOI 10.1105/tpc.104.023895; Aizpurua-Olaizola O, 2016, J NAT PROD, V79, P324, DOI 10.1021/acs.jnatprod.5b00949; Bohlmann J, 1997, J BIOL CHEM, V272, P21784, DOI 10.1074/jbc.272.35.21784; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Burke C, 2002, J BIOL CHEM, V277, P3141, DOI 10.1074/jbc.M105900200; Carretero-Paulet L, 2013, GENE, V524, P40, DOI 10.1016/j.gene.2012.10.071; CHAPPELL J, 1995, PLANT PHYSIOL, V109, P1337, DOI 10.1104/pp.109.4.1337; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Cunillera N, 1996, J BIOL CHEM, V271, P7774, DOI 10.1074/jbc.271.13.7774; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; de Meijer EPM, 2009, EUPHYTICA, V168, P95, DOI 10.1007/s10681-009-9894-7; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; ElSohly M.A., 2007, MARIJUANA CANNABINOI, DOI 10.1007/978-1-59259-947-9; Elzinga S., 2015, NAT PROD CHEM RES, V3, P181, DOI [10.4172/2329-6836.1000181, DOI 10.4172/2329-6836.1000181]; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fellermeier M, 2001, EUR J BIOCHEM, V268, P1596, DOI 10.1046/j.1432-1327.2001.02030.x; Fischedick JT, 2010, PHYTOCHEMISTRY, V71, P2058, DOI 10.1016/j.phytochem.2010.10.001; Gagne SJ, 2012, P NATL ACAD SCI USA, V109, P12811, DOI 10.1073/pnas.1200330109; GERSHENZON J, 1992, ANAL BIOCHEM, V200, P130, DOI 10.1016/0003-2697(92)90288-I; Gertsch J, 2008, P NATL ACAD SCI USA, V105, P9099, DOI 10.1073/pnas.0803601105; Gilmore S, 2003, FORENSIC SCI INT, V131, P65, DOI 10.1016/S0379-0738(02)00397-3; Gunnewich N, 2007, NAT PROD COMMUN, V2, P223; Hazekamp A, 2012, DRUG TEST ANAL, V4, P660, DOI 10.1002/dta.407; Hillig KW, 2004, BIOCHEM SYST ECOL, V32, P875, DOI 10.1016/j.bse.2004.04.004; Kollner TG, 2008, PLANT CELL, V20, P482, DOI 10.1105/tpc.107.051672; Lange BM, 2015, ANNU REV PLANT BIOL, V66, P139, DOI 10.1146/annurev-arplant-043014-114639; Li H.-L., 1973, ECON BOT, V28, P437, DOI [DOI 10.1007/BF02862859, 10.1007/BF02862859]; McDowell ET, 2011, PLANT PHYSIOL, V155, P524, DOI 10.1104/pp.110.167114; O'Maille PE, 2004, ANAL BIOCHEM, V335, P210, DOI 10.1016/j.ab.2004.09.011; Orlova I, 2009, PLANT CELL, V21, P4002, DOI 10.1105/tpc.109.071282; Paetzold H, 2010, MOL PLANT, V3, P904, DOI 10.1093/mp/ssq032; Roach CR, 2014, J BIOL CHEM, V289, P23859, DOI 10.1074/jbc.M114.571703; Ross SA, 1996, J NAT PROD, V59, P49, DOI 10.1021/np960004a; Russo EB, 2011, BRIT J PHARMACOL, V163, P1344, DOI 10.1111/j.1476-5381.2011.01238.x; Russo EB, 2008, J EXP BOT, V59, P4171, DOI 10.1093/jxb/ern260; Sawler J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133292; Small E, 2015, BOT REV, V81, P189, DOI 10.1007/s12229-015-9157-3; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Tholl D, 2015, ADV BIOCHEM ENG BIOT, V148, P63, DOI 10.1007/10_2014_295; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van Bakel H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r102; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wagner H, 2009, PHYTOMEDICINE, V16, P97, DOI 10.1016/j.phymed.2008.12.018; Walter MH, 2002, PLANT J, V31, P243, DOI 10.1046/j.1365-313X.2002.01352.x; Wang GD, 2008, PLANT PHYSIOL, V148, P1254, DOI 10.1104/pp.108.125187; Wang GD, 2009, P NATL ACAD SCI USA, V106, P9914, DOI 10.1073/pnas.0904069106; Weiblen GD, 2015, NEW PHYTOL, V208, P1241, DOI 10.1111/nph.13562	48	128	132	15	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0173911	10.1371/journal.pone.0173911	http://dx.doi.org/10.1371/journal.pone.0173911			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355238	Green Published, gold			2022-12-26	WOS:000399174600030
J	Concha-Velasco, F; Gonzalez-Lagos, E; Seas, C; Bustamante, B				Concha-Velasco, Fatima; Gonzalez-Lagos, Elsa; Seas, Carlos; Bustamante, Beatriz			Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis	PLOS ONE			English	Article							HIGH-DOSE FLUCONAZOLE; EARLY FUNGICIDAL ACTIVITY; AMPHOTERICIN-B; RANDOMIZED-TRIAL; COMBINED COHORT; FUNGAL BURDEN; COMBINATION; AIDS; MORTALITY; FLUCYTOSINE	Introduction The first-line combination therapy for HIV-associated cryptococcal meningitis (CM), a condition of high mortality particularly in the first two weeks of treatment, consists of amphotericin B plus flucytosine (5-FC). Given that 5-FC remains unavailable in many countries, the knowledge of factors influencing mycological clearance in patients treated with second-line therapy could contribute to effective management. Objectives To determine the factors associated with the clearance of Cryptococcus sp. from the cerebrospinal fluid by the second week of effective antifungal therapy (early mycological clearance) in HIV-associated CM. Methods 0Retrospective cohort study based on secondary data corresponding to HIV-associated CM cases hospitalized at a tertiary health care center in Lima, Peru where 5-FC remains unavailable. Risk factors associated with early mycological clearance were analyzed by generalized linear regression models. Results From January 2000 to December 2013, 234 individuals were discharged with a diagnosis of HIV-associated CM; in 215 we retrieved the required data. The inpatient mortality was 20% (43/215), 15 of them in the first two weeks of treatment. In the final model (157 cases), adjusted for age, previous episode of CM, ART use, type of antifungal treatment, raised intracranial pressure, frequency of therapeutic lumbar punctures, baseline fungal burden and treatment period, the factors associated with early mycological clearance were: Amphotericin B deoxycholate plus fluconazole as combination therapy (RR, 1.56; 95% CI, 1.14-2.14); severe baseline intracranial pressure (>= 35 cm H2O) (RR, 0.57; 95% CI, 0.33-0.99); and baseline fungal burden over 4.5 log(10) CFU/mL (RR, 0.61 95% CI: 0.39-0.95). Conclusions In a setting without access to first-line therapy for CM, the combination therapy with amphotericin B deoxycholate plus fluconazole was positively associated with early mycological clearance, while high fungal burden and severe baseline intracranial pressure were negatively associated, and thus related to failure.	[Concha-Velasco, Fatima; Gonzalez-Lagos, Elsa; Seas, Carlos; Bustamante, Beatriz] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Concha-Velasco, Fatima; Gonzalez-Lagos, Elsa; Seas, Carlos] Univ Peruana Cayetano Heredia, Fac Med, Lima, Peru; [Seas, Carlos; Bustamante, Beatriz] Hosp Cayetano Heredia, Dept Enfermedades Infecciosas Trop & Dermatol, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia	Concha-Velasco, F (corresponding author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.; Concha-Velasco, F (corresponding author), Univ Peruana Cayetano Heredia, Fac Med, Lima, Peru.	faliricc@hotmail.com		Seas, Carlos/0000-0001-7067-9141; Bustamante, Beatriz/0000-0002-6826-5211; Concha Velasco, Fatima Rosario/0000-0002-1704-3184	Fogarty International Center at the U.S. National Institute of Health (NIH) through Peru International Clinical, Operational, and Health Services Research and Training Award [1U2RTWO07368-01A1]; Program for Advanced Research Capacities for AIDS in Peru (PARACAS) [D43TW00976301]; NIH [U01A1069923]; Belgian Government through the Framework Agreement; Institute of Tropical Medicine of Antwerp, Belgium; Merck Sharp Dohme Corp; FOGARTY INTERNATIONAL CENTER [D43TW009763] Funding Source: NIH RePORTER	Fogarty International Center at the U.S. National Institute of Health (NIH) through Peru International Clinical, Operational, and Health Services Research and Training Award; Program for Advanced Research Capacities for AIDS in Peru (PARACAS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Belgian Government through the Framework Agreement; Institute of Tropical Medicine of Antwerp, Belgium; Merck Sharp Dohme Corp(Merck & Company); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was partially supported by Fogarty International Center at the U.S. National Institute of Health (NIH) through Peru International Clinical, Operational, and Health Services Research and Training Award (Peru ICOHRTA network for AIDS/TB research) [grant number 1U2RTWO07368-01A1] and Program for Advanced Research Capacities for AIDS in Peru (PARACAS) [grant number D43TW00976301]. The HIV Research Unit at the Institute of Tropical Medicine Alexander von Humboldt in Lima is additionally funded by the NIH-funded Caribbean, Central and South America network for HIV epidemiology (CCASAnet), a member cohort of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) (U01A1069923). Between 2003 and 2010, the HIV Research Unit and the Mycology Laboratory at the Institute of Tropical Medicine were partially funded by the Directorate-General for Development Cooperation of the Belgian Government through the Framework Agreement with the Institute of Tropical Medicine of Antwerp, Belgium. Also, we confirm that, one of the coauthors, Beatriz Bustamante, currently receives funding for research from Merck Sharp & Dohme Corp (Merck Investigators Studies Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bicanic T, 2007, CLIN INFECT DIS, V45, P76, DOI 10.1086/518607; Bicanic T, 2009, CLIN INFECT DIS, V49, P702, DOI 10.1086/604716; Bicanic T, 2009, AIDS, V23, P701, DOI 10.1097/QAD.0b013e32832605fe; Bosshard PP, 2011, MYCOSES, V54, pE539, DOI 10.1111/j.1439-0507.2010.01977.x; Boulware DR, 2014, NEW ENGL J MED, V370, P2487, DOI 10.1056/NEJMoa1312884; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; Campbell JI, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv010; Canessa J, 2011, WORLD J AIDS, V1, P8, DOI DOI 10.4236/WJA.2011.11002; Dammert P, 2008, J INFECTION, V57, P260, DOI 10.1016/j.jinf.2008.06.020; Day JN, 2013, NEW ENGL J MED, V368, P2522, DOI [10.1056/NEJMc1305981, 10.1056/NEJMoa1110404]; DUPONT B, 1992, NEW ENGL J MED, V326, P1568; Graybill JR, 2000, CLIN INFECT DIS, V30, P47, DOI 10.1086/313603; Jarvis JN, 2007, AIDS, V21, P2119, DOI 10.1097/QAD.0b013e3282a4a64d; Jarvis JN, 2014, CLIN INFECT DIS, V58, P736, DOI 10.1093/cid/cit794; Larsen RA, 2004, ANTIMICROB AGENTS CH, V48, P985, DOI 10.1128/AAC.48.3.985-991.2004; Longley N, 2008, CLIN INFECT DIS, V47, P1556, DOI 10.1086/593194; Loyse A, 2013, LANCET INFECT DIS, V13, P629, DOI 10.1016/S1473-3099(13)70078-1; Loyse A, 2012, CLIN INFECT DIS, V54, P121, DOI 10.1093/cid/cir745; Montezuma-Rusca Jairo Mauricio, 2014, Curr Treat Options Infect Dis, V6, P326; Mora DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120297; Morris AJ, 1996, J CLIN MICROBIOL, V34, P1583, DOI 10.1128/JCM.34.6.1583-1585.1996; Nussbaum JC, 2010, CLIN INFECT DIS, V50, P338, DOI 10.1086/649861; Pappas PG, 2009, CLIN INFECT DIS, V48, P1775, DOI 10.1086/599112; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Perfect JR, 2013, CURR MED RES OPIN, V29, P3, DOI 10.1185/03007995.2012.761134; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Robinson PA, 1999, CLIN INFECT DIS, V28, P82, DOI 10.1086/515074; Rolfes MA, 2014, CLIN INFECT DIS, V59, P1607, DOI 10.1093/cid/ciu596; Rothe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067311; vanderHorst CM, 1997, NEW ENGL J MED, V337, P15, DOI 10.1056/NEJM199707033370103; Vidal JE, 2013, BRAZ J INFECT DIS, V17, P353, DOI 10.1016/j.bjid.2012.10.020	31	6	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0174459	10.1371/journal.pone.0174459	http://dx.doi.org/10.1371/journal.pone.0174459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355252	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174600051
J	Schnabl-Feichter, E; Tichy, A; Bockstahler, B				Schnabl-Feichter, Eva; Tichy, Alexander; Bockstahler, Barbara			Coefficients of variation of ground reaction force measurement in cats	PLOS ONE			English	Article							COMPENSATORY LOAD REDISTRIBUTION; LABRADOR RETRIEVERS; GAIT ANALYSIS; DOGS; WALKING; ONYCHECTOMY; WALKWAY; OSTEOARTHRITIS; LAMENESS; INDEXES	Gait analysis has been extensively performed in dogs and horses; however, very little is known about feline biomechanics. It was, therefore, the aim of this study to determine the coefficient of variation (CV) among three ground reaction force (GRF) measurements taken for 15 client-owned European shorthaired cats without a training period and a short acclimatisation time. Gait was measured as each cat walked across a pressure-sensitive walkway, and measurements were made three times over a multi-week period (range: 2 to 17 weeks). The parameters evaluated were peak vertical force (PFz), vertical impulse (IFz), stance phase duration (SPD), step length (SL), paw contact area (PCA) and symmetry index (SI%) of the front and hind limbs. After averaging each of the values from the three measurements, the CV and 95% confidence interval (CI) were calculated for all parameters. PFz showed the lowest CV (similar to 3%), while IFz showed the highest CV (similar to 11%) when normalised to body mass. When the GRFs were normalised to total force, the CV of PFz dropped to similar to 2% and that of IFz dropped to similar to 3%. The CV of SL and PCA were lower (similar to 6% respectively similar to 5%) compared to the CV for SPD (similar to 10%). The SI% for both PFz and IFz were comparable to the values reported in the gait analysis literature for dogs. Results of the current study indicate that gait analysis of cats using pressure-sensitive walkways produces reliable data and is a promising approach for evaluation of lameness. The results also suggest that PFz may be a more reliable parameter than IFz and that normalisation to percent of total force may aid in interpretation of the evaluated data.	[Schnabl-Feichter, Eva] Univ Vet Med, Small Anim Surg, Univ Clin Small Anim, Dept Compan Anim & Horses, Vienna, Austria; [Tichy, Alexander] Univ Vet Med, Dept Biomed Sci Platform Bioinformat & Biostat, Vienna, Austria; [Bockstahler, Barbara] Univ Vet Med, Sect Phys Therapy, Dept Compan Anim & Horses, Univ Clin Small Anim,Small Anim Surg, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Schnabl-Feichter, E (corresponding author), Univ Vet Med, Small Anim Surg, Univ Clin Small Anim, Dept Compan Anim & Horses, Vienna, Austria.	eva.schnabl-feichter@vetmeduni.ac.at	Bockstahler, Barbara/P-3152-2019; Schnabl-Feichter, Eva/AAM-1050-2020	Bockstahler, Barbara/0000-0002-1499-5753; Schnabl-Feichter, Eva/0000-0003-1058-6511				Bockstahler B, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0715-7; Bockstahler BA, 2009, VET J, V180, P202, DOI 10.1016/j.tvjl.2007.12.025; BUDSBERG SC, 1993, AM J VET RES, V54, P1569; Corbee RJ, 2014, VET J, V202, P116, DOI 10.1016/j.tvjl.2014.07.001; Fischer S, 2013, VET J, V197, P746, DOI 10.1016/j.tvjl.2013.04.009; Gillette RL, 2008, VET J, V178, P165, DOI 10.1016/j.tvjl.2008.01.009; Guillot M, 2013, VET J, V196, P360, DOI 10.1016/j.tvjl.2013.01.009; Guillot M, 2012, VET SURG, V41, P328, DOI 10.1111/j.1532-950X.2012.00976.x; Lascelles BDX, 2007, VET REC, V160, P512, DOI 10.1136/vr.160.15.512; Lascelles BDX, 2006, AM J VET RES, V67, P277, DOI 10.2460/ajvr.67.2.277; McLaughlin RM, 2001, VET CLIN N AM-SMALL, V31, P193, DOI 10.1016/S0195-5616(01)50045-5; Nordquist B, 2011, VET COMP ORTHOPAED, V24, P435, DOI 10.3415/VCOT-11-01-0015; Oosterlinck M, 2011, AM J VET RES, V72, P820, DOI 10.2460/ajvr.72.6.820; Robinson DA, 2007, JAVMA-J AM VET MED A, V230, P353, DOI 10.2460/javma.230.3.353; Romans CW, 2005, JAVMA-J AM VET MED A, V227, P89, DOI 10.2460/javma.2005.227.89; Romans CW, 2004, AM J VET RES, V65, P1276, DOI 10.2460/ajvr.2004.65.1276; Schnabl E, 2015, VET J, V206, P83, DOI 10.1016/j.tvjl.2015.05.017; Souza ANA, 2013, VET COMP ORTHOPAED, V26, P6, DOI 10.3415/VCOT-11-07-0100; Stadig SM, 2015, J FELINE MED SURG, V17, P523, DOI 10.1177/1098612X14551588; Strasser T, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0241-4; Verdugo MR, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-129; Voss K, 2011, VET COMP ORTHOPAED, V24, P106, DOI 10.3415/VCOT-10-06-0098	22	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2017	12	3							e0171946	10.1371/journal.pone.0171946	http://dx.doi.org/10.1371/journal.pone.0171946			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VG	28355209	Green Published, gold, Green Submitted			2022-12-26	WOS:000399174600001
J	Marrotte, RR; Bowman, J				Marrotte, Robby R.; Bowman, Jeff			The relationship between least-cost and resistance distance	PLOS ONE			English	Article							FRAGMENTED LANDSCAPE; GENETIC-STRUCTURE; CIRCUIT-THEORY; CONNECTIVITY; HABITAT; MODEL; DISPERSAL; REVEAL; GRAPH; FLOW	Least-cost modelling and circuit theory are common analogs used in ecology and evolution to model gene flow or animal movement across landscapes. Least-cost modelling estimates the least-cost distance, whereas circuit theory estimates resistance distance. The bias added in choosing one method over the other has not been well documented. We designed an experiment to test whether both methods were linearly related. We also tested the sensitivity of these metrics to variation in Euclidean distance, spatial autocorrelation, the number of pixels representing the landscape, and data aggregation. We found that least-cost and resistance distance were not linearly related unless a transformation was applied. Resistance distance was less sensitive to the number of pixels representing a landscape and was also less sensitive than least-cost distance to the Euclidean distance between nodes. Spatial autocorrelation did not affect either method or the relationship between methods. Resistance distance was more sensitive to aggregation in any form compared to least-cost distance. Therefore, the metric used to infer movement or gene flow and the manipulations applied to the data used to calculate these metrics may govern findings.	[Marrotte, Robby R.] Trent Univ, Environm & Life Sci Grad Program, Peterborough, ON, Canada; [Bowman, Jeff] Ontario Minist Nat Resources & Forestry, Wildlife Res & Monitoring Sect, Peterborough, ON, Canada	Trent University; Ministry of Natural Resources & Forestry	Marrotte, RR (corresponding author), Trent Univ, Environm & Life Sci Grad Program, Peterborough, ON, Canada.	robbymarrotte@trentu.ca	Bowman, Jeff/B-4147-2009	Bowman, Jeff/0000-0002-1892-4469	Natural Sciences and Engineering Research Council of Canada Discovery; Natural Sciences and Engineering Research Council of Canada postgraduate scholarship; Ontario Ministry of Natural Resources and Forestry	Natural Sciences and Engineering Research Council of Canada Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada postgraduate scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Ministry of Natural Resources and Forestry	Funding was provided by a Natural Sciences and Engineering Research Council of Canada Discovery grant to JB, a Natural Sciences and Engineering Research Council of Canada postgraduate scholarship to RRM and by the Ontario Ministry of Natural Resources and Forestry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; [Anonymous], 2016, LANDSCAPE ECOLOGY, P1; Arguelles M, 2015, J BIOGEOGR, V42, P778; Beier P, 2009, ECOL APPL, V19, P2067, DOI 10.1890/08-1898.1; Borgman L, 1984, GEOSTATISTICS NAT RE; Chandra AK, 1997, COMPUT COMPLEX, V6, P312; Decout S, 2012, LANDSCAPE ECOL, V27, P267, DOI 10.1007/s10980-011-9694-z; DIETRICH CR, 1993, WATER RESOUR RES, V29, P2861, DOI 10.1029/93WR01070; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Dilts T, 2016, ECOL APPL IN PRESS; Doyle P.G., 1984, RANDOM WALKS ELECT N; Etherington TR, 2013, LANDSCAPE ECOL, V28, P1223, DOI 10.1007/s10980-013-9880-2; Fang JN, 2003, COMMUN NUMER METH EN, V19, P801, DOI 10.1002/cnm.621; Fouss F, 2007, IEEE T KNOWL DATA EN, V19, P355, DOI 10.1109/TKDE.2007.46; Garroway CJ, 2011, MOL ECOL, V20, P3978, DOI 10.1111/j.1365-294X.2011.05243.x; Gebbers R, 2010, GEOSTATISTICAL APPLICATIONS FOR PRECISION AGRICULTURE, P269, DOI 10.1007/978-90-481-9133-8_11; Gimona A, 2012, BIOL CONSERV, V149, P93, DOI 10.1016/j.biocon.2012.01.060; Koen EL, 2012, MOL ECOL RESOUR, V12, P686, DOI 10.1111/j.1755-0998.2012.03123.x; Koen EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011785; Leonard P.B., 2016, METHODS ECOL EVOL; Marrotte RR, 2014, MOL ECOL, V23, P3983, DOI 10.1111/mec.12847; McClure ML, 2016, LANDSCAPE ECOL, P1; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Melles SJ, 2011, PROCEDIA ENV SCI, P240; Pebesma E, 2016, CRAN REFERENCE MANUA; Phillipsen I, 2013, ECOGRAPHY; Pomeroy PP, 2000, J ZOOL, V250, P1; Poor EE, 2012, PLOS ONE, P7; Proctor MF, 2015, J WILDLIFE MANAGE, V79, P544, DOI 10.1002/jwmg.862; R Core Team, 2013, R LANG ENV STAT COMP; Richards-Zawacki C., 2009, DIVERS DISTRIB; Row JR, 2010, MOL ECOL, V19, P5157, DOI 10.1111/j.1365-294X.2010.04872.x; Sacks B, 2016, ECOL EVOL; Schadt S, 2002, ECOL APPL, V12, P1469; Schwartz MK, 2009, ECOLOGY, V90, P3222, DOI 10.1890/08-1287.1; Simon JA, 2014, EVOL APPL, V7, P750, DOI 10.1111/eva.12165; Smit HA, 2007, MOL ECOL, V16, P2680, DOI 10.1111/j.1365-294X.2007.03334.x; Spear SF, 2005, MOL ECOL, V14, P2553, DOI 10.1111/j.1365-294X.2005.02573.x; Stevenson CD, 2013, ECOL EVOL, V3, P2350, DOI 10.1002/ece3.638; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Struebig MJ, 2011, ECOL LETT, V14, P582, DOI 10.1111/j.1461-0248.2011.01623.x; Tobler W. R., 1961, MAP TRANSFORMATIONS; TOBLER WR, 1963, GEOGR REV, V53, P59, DOI 10.2307/212809; van Etten J., 2014, R PACKAGE GDISTANCE, P21; Van Strien MJ, 2012, MOL ECOL, V21, P4010, DOI 10.1111/j.1365-294X.2012.05687.x; Vanreusel W, 2007, BIOL CONSERV, V135, P202, DOI 10.1016/j.biocon.2006.10.035; Wang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105086; Wang IJ, 2009, MOL ECOL, V18, P1365, DOI 10.1111/j.1365-294X.2009.04122.x; Yannic G, 2012, BIOL J LINN SOC, V105, P864, DOI 10.1111/j.1095-8312.2011.01824.x; Zeigler SL, 2011, BIODIVERS CONSERV, V20, P2779, DOI 10.1007/s10531-011-0107-z	52	32	32	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174212	10.1371/journal.pone.0174212	http://dx.doi.org/10.1371/journal.pone.0174212			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350863	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174400020
J	Zanoni, M; Aventurato, IK; Hunter, J; Sucupira, MCA; Diaz, RS				Zanoni, Michelle; Aventurato, Italo Karmann; Hunter, James; Araripe Sucupira, Maria Cecilia; Diaz, Ricardo Sobhie			Uniquely altered transcripts are associated with immune preservation in HIV infection	PLOS ONE			English	Article							LEUKOCYTE PROTEASE INHIBITOR; CD8(+) T-CELLS; GENE-EXPRESSION; PROTEINASE-INHIBITOR; ANTITHROMBIN-III; DENDRITIC CELLS; C-FOS; CHEMOKINE; ACTIVATION; ELASTASE	The mechanisms underlying host HIV control hold much promise in the search for a functional HIV cure. We investigated the host genomic signatures in elite controllers or rapid progressors following recent infection and the correlates of immune reconstitution during combination antiretroviral therapy. We characterized the HIV-specific longitudinal host transcriptional response of peripheral blood mononuclear cells from elite controllers, rapid progressors, immune responders and non-responders using a RT-qPCR array in a cohort of recently HIV-infected Brazilian individuals. The elite controllers expressed unique transcripts early in infection that were closely associated with specialized cross-presentation between XCR1(+) DCs and antigen-specific CD8(+) T cells (XCL1). The natural suppression of HIV was also associated with the highly functional co-expression of cytokines and chemokines (CCL2, TNF and IL-10) concomitant with the maintenance of important antiinflammatory and anticoagulant properties (Antithrombin III). Immune responders exhibited exclusively upregulated mRNAs possibly related to stem cell mobilization before combination antiretroviral therapy (neutrophil elastase). Our longitudinal approach to gene expression permitted us to discover previously unrecognized determinants that contribute to natural or antiretroviral-mediated HIV-1 immune control.	[Zanoni, Michelle; Aventurato, Italo Karmann; Hunter, James; Araripe Sucupira, Maria Cecilia; Diaz, Ricardo Sobhie] Univ Fed Sao Paulo, Dept Med, Retrovirol Lab, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Diaz, RS (corresponding author), Univ Fed Sao Paulo, Dept Med, Retrovirol Lab, Sao Paulo, Brazil.	rsdiaz@catg.com.br	Hunter, James/J-6106-2016; Araripe Sucupira, Maria Cecilia/K-1931-2012	Hunter, James/0000-0001-9524-0629; Araripe Sucupira, Maria Cecilia/0000-0002-1114-5382	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04/15856-9]; Brazil National Council of Technological and Scientific Development (CNPQ)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazil National Council of Technological and Scientific Development (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grant 04/15856-9 (to R.S.D.) and the Brazil National Council of Technological and Scientific Development (CNPQ) Fellowships (to M.Z. and I.K.A.).; The authors are grateful to study participants for their generous contribution to this research. We thank Esper G Kallas, Alda Maria Da-Cruz, Juliana Terzi Maricato, Reinaldo Salomao and Telma Miyuki Oshiro for advice and helpful discussions. We also thank Rodrigo Cortes for assistance with linear regression analysis and Helena Tomiyama and Priscilla Ramos Costa for providing the PBMC samples. We gratefully acknowledge the support of Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grant 04/15856-9 (to R.S.D.) and the Brazil National Council of Technological and Scientific Development (CNPQ) Fellowships (to M.Z. and I.K.A.) in this work.	Sucupira MCA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030292; Ashcroft GS, 2000, NAT MED, V6, P1147, DOI 10.1038/80489; Asmal M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048234; Bachem A, 2010, J EXP MED, V207, P1273, DOI 10.1084/jem.20100348; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; Chen HB, 2012, NAT IMMUNOL, V13, P691, DOI 10.1038/ni.2342; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; FOURET P, 1989, J EXP MED, V169, P833, DOI 10.1084/jem.169.3.833; GAUTHIER F, 1982, BIOCHIM BIOPHYS ACTA, V700, P178, DOI 10.1016/0167-4838(82)90095-4; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Geiben-Lynn R, 2002, J BIOL CHEM, V277, P42352, DOI 10.1074/jbc.M207079200; Guzzo C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003852; Helleberg M, 2012, INFECTION, V40, P627, DOI 10.1007/s15010-012-0293-y; Hersperger AR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000917; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Kallas Esper Georges, 2004, Braz J Infect Dis, V8, P399, DOI 10.1590/S1413-86702004000600003; Klimenkova O, 2014, BLOOD, V123, P1239, DOI 10.1182/blood-2013-06-508887; Lama J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-52; Lei Y, 2012, MICROBES INFECT, V14, P262, DOI 10.1016/j.micinf.2011.10.003; Levesque JP, 2001, BLOOD, V98, P1289, DOI 10.1182/blood.V98.5.1289; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; Marchbank KJ, 2000, J IMMUNOL, V165, P2354, DOI 10.4049/jimmunol.165.5.2354; MCNEELY TB, 1995, J CLIN INVEST, V96, P456, DOI 10.1172/JCI118056; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254; MULLER S, 1995, EUR J IMMUNOL, V25, P1744, DOI 10.1002/eji.1830250638; Oelschlager C, 2002, BLOOD, V99, P4015, DOI 10.1182/blood.V99.11.4015; Opal SM, 2003, CRIT CARE, V7, P23, DOI 10.1186/cc1854; Payne TL, 2014, J VIROL, V88, P9514, DOI 10.1128/JVI.00802-14; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pulendran B, 2010, NAT IMMUNOL, V11, P647, DOI 10.1038/ni.1894; Rajasuriar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020713; Ray N, 2006, INT IMMUNOL, V18, P671, DOI 10.1093/intimm/dxl004; Saitoh H, 2001, AM J PHYSIOL-LUNG C, V280, pL79, DOI 10.1152/ajplung.2001.280.1.L79; Sallenave JM, 1997, J LEUKOCYTE BIOL, V61, P695, DOI 10.1002/jlb.61.6.695; Singh KK, 2009, PEDIATR RES, V65, p55R, DOI 10.1203/PDR.0b013e31819dca03; Taggart CC, 2005, J EXP MED, V202, P1659, DOI 10.1084/jem.20050768; Tarosso LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011436; van Wetering S, 2000, J INVEST MED, V48, P359; Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478; Yamazaki C, 2010, BIOCHEM BIOPH RES CO, V397, P756, DOI 10.1016/j.bbrc.2010.06.029; Yang OO, 2002, J INFECT DIS, V185, P1174, DOI 10.1086/339678; Yoshida R, 2012, BIOCHEM BIOPH RES CO, V423, P247, DOI 10.1016/j.bbrc.2012.05.097	47	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0169868	10.1371/journal.pone.0169868	http://dx.doi.org/10.1371/journal.pone.0169868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350860	Green Published, Green Submitted, gold			2022-12-26	WOS:000399174400001
J	Zou, B; Li, JF; Zhou, Q; Quan, ZX				Zou, Bin; Li, JieFu; Zhou, Quan; Quan, Zhe-Xue			MIPE: A metagenome-based community structure explorer and SSU primer evaluation tool	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; PCR; DIVERSITY; RESOURCE; DATABASE; MISMATCH; GENOMES; DESIGN	An understanding of microbial community structure is an important issue in the field of molecular ecology. The traditional molecular method involves amplification of small subunit ribosomal RNA (SSU rRNA) genes by polymerase chain reaction (PCR). However, PCR-based amplicon approaches are affected by primer bias and chimeras. With the development of high-throughput sequencing technology, unbiased SSU rRNA gene sequences can be mined from shotgun sequencing-based metagenomic or metatranscriptomic datasets to obtain a reflection of the microbial community structure in specific types of environment and to evaluate SSU primers. However, the use of short reads obtained through next-generation sequencing for primer evaluation has not been well resolved. The software MIPE (MIcrobiota metagenome Primer Explorer) was developed to adapt numerous short reads from metagenomes and metatranscriptomes. Using metagenomic or metatranscriptomic datasets as input, MIPE extracts and aligns rRNA to reveal detailed information on microbial composition and evaluate SSU rRNA primers. A mock dataset, a real Metagenomics Rapid Annotation using Subsystem Technology (MG-RAST) test dataset, two PrimerProspector test datasets and a real metatranscriptomic dataset were used to validate MIPE. The software calls Mothur (v1.33.3) and the SILVA database (v119) for the alignment and classification of rRNA genes from a metagenome or metatranscriptome. MIPE can effectively extract shotgun rRNA reads from a metagenome or metatranscriptome and is capable of classifying these sequences and exhibiting sensitivity to different SSU rRNA PCR primers. Therefore, MIPE can be used to guide primer design for specific environmental samples.	[Zou, Bin; Li, JieFu; Zhou, Quan; Quan, Zhe-Xue] Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, Shanghai, Peoples R China; [Li, JieFu] Chinese Acad Sci, CAS MPG Partner Inst Computat Biol PICB, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Quan, ZX (corresponding author), Fudan Univ, Sch Life Sci, Dept Microbiol & Microbial Engn, Shanghai, Peoples R China.	quanzx@fudan.edu.cn	Quan, Zhexue/B-8046-2013	Quan, Zhexue/0000-0002-7561-8572	National Natural Science Foundation of China [31170114]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31170114) http://www.nsfc.gov.cn/.	Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Bengtsson J, 2011, ANTON LEEUW INT J G, V100, P471, DOI 10.1007/s10482-011-9598-6; Biers EJ, 2009, APPL ENVIRON MICROB, V75, P2221, DOI 10.1128/AEM.02118-08; Bru D, 2008, APPL ENVIRON MICROB, V74, P1660, DOI 10.1128/AEM.02403-07; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Goff SA, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00034; Greuter D, 2016, NUCLEIC ACIDS RES, V44, pD586, DOI 10.1093/nar/gkv1232; Gulvik CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050362; Guo JR, 2016, APPL ENVIRON MICROB, V82, P157, DOI 10.1128/AEM.02772-15; Huang Y, 2009, BIOINFORMATICS, V25, P1338, DOI 10.1093/bioinformatics/btp161; Hugerth LW, 2014, APPL ENVIRON MICROB, V80, P5116, DOI 10.1128/AEM.01403-14; Hunter S, 2014, NUCLEIC ACIDS RES, V42, pD600, DOI 10.1093/nar/gkt961; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Li XR, 2014, APPL MICROBIOL BIOT, V98, P3777, DOI 10.1007/s00253-014-5583-0; Mao DP, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-66; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; Mou XZ, 2008, NATURE, V451, P708, DOI 10.1038/nature06513; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Pace NR, 2009, MICROBIOL MOL BIOL R, V73, P565, DOI 10.1128/MMBR.00033-09; Peabody MA, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0788-5; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; Sanschagrin S, 2014, JOVE-J VIS EXP, DOI 10.3791/51709; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Walker AW, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0087-4; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wilke A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004008; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Woese CR, 1998, P NATL ACAD SCI USA, V95, P11043, DOI 10.1073/pnas.95.19.11043; Wu JH, 2009, J MICROBIOL METH, V77, P267, DOI 10.1016/j.mimet.2009.03.001; Yu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038183	42	6	8	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2017	12	3							e0174609	10.1371/journal.pone.0174609	http://dx.doi.org/10.1371/journal.pone.0174609			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VE	28350876	gold, Green Published, Green Submitted			2022-12-26	WOS:000399174400065
J	Lamei, S; Hu, YOO; Olofsson, TC; Andersson, AF; Forsgren, E; Vasquez, A				Lamei, Sepideh; Hu, Yue O. O.; Olofsson, Tobias C.; Andersson, Anders F.; Forsgren, Eva; Vasquez, Alejandra			Improvement of identification methods for honeybee specific Lactic Acid Bacteria; future approaches	PLOS ONE			English	Article							APIS-MELLIFERA; LACTOBACILLUS-KUNKEEI; COMPARATIVE GENOMICS; SP NOV.; STOMACH; DIVERSITY; REVEALS; POLLEN; FLORA; BEES	Honeybees face many parasites and pathogens and consequently rely on a diverse set of individual and group-level defenses to prevent disease. The crop microbiota of Apis mellifera, composed of 13 Lactic Acid Bacterial (LAB) species within the genera Lactobacillus and Bifidobacterium, form a beneficial symbiotic relationship with each other and the honeybee to protect their niche and their host. Possibly playing a vital role in honeybee health, it is important that these honeybee specific Lactic Acid Bacterial (hbs-LAB) symbionts can be correctly identified, isolated and cultured, to further investigate their health promoting properties. We have previously reported successful identification to the strain level by culture-dependent methods and we recently sequenced and annotated the genomes of the 13 hbs-LAB. However, the hitherto applied techniques are unfortunately very time consuming, expensive and not ideal when analyzing a vast quantity of samples. In addition, other researchers have constantly failed to identify the 13 hbs-LAB from honeybee samples by using inadequate media and/or molecular techniques based on 16S rRNA gene sequencing with insufficient discriminatory power. The aim of this study was to develop better and more suitable methods for the identification and cultivation of hbs-LAB. We compared currently used bacterial cultivation media and could for the first time demonstrate a significant variation in the hbs-LAB basic requirements for optimal growth. We also present a new bacterial identification approach based on amplicon sequencing of a region of the 16S rRNA gene using the Illumina platform and an error correction software that can be used to successfully differentiate and rapidly identify the 13 hbs-LAB to the strain level.	[Lamei, Sepideh; Olofsson, Tobias C.; Vasquez, Alejandra] Lund Univ, Dept Lab Med Lund, Sect Med Microbiol, Lund, Sweden; [Lamei, Sepideh; Forsgren, Eva] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden; [Hu, Yue O. O.; Andersson, Anders F.] KTH Royal Inst Technol, Sci Life Lab, Sch Biotechnol, Div Gene Technol, Stockholm, Sweden	Lund University; Swedish University of Agricultural Sciences; Royal Institute of Technology	Vasquez, A (corresponding author), Lund Univ, Dept Lab Med Lund, Sect Med Microbiol, Lund, Sweden.	Alejandra.vasquez@med.lu.se	Andersson, Anders/J-9310-2019; Hu, Yue/AHB-2985-2022	Andersson, Anders/0000-0002-3627-6899; Hu, Yue/0000-0002-2025-2198	Swedish Research Council FORMAS [2012-822, 2013-423]; China Scholarship Council (CSC) [201206950024]	Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); China Scholarship Council (CSC)(China Scholarship Council)	This work was funded by grants from The Swedish Research Council FORMAS (grants: 2012-822 and 2013-423) and Y.O.O.H. was supported by a scholarship from the China Scholarship Council (CSC#201206950024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058425, 10.1371/journal.pone.0083125]; Anderson KE, 2014, MOL ECOL, V23, P5904, DOI 10.1111/mec.12966; Arskold E, 2008, J BACTERIOL, V190, P206, DOI 10.1128/JB.01227-07; Butler E., 2014, INT WOUND J, V2014, P1; Butler E, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-235; Callahan BJ, 2015, NAT METHODS, V13; Audisio MC, 2011, MICROBIOL RES, V166, P1, DOI 10.1016/j.micres.2010.01.003; Coenye T, 2003, FEMS MICROBIOL LETT, V228, P45, DOI 10.1016/S0378-1097(03)00717-1; CONDON C, 1995, J BACTERIOL, V177, P4152, DOI 10.1128/jb.177.14.4152-4156.1995; Corby-Harris V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095056; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Degnan PH, 2012, ISME J, V6, P183, DOI 10.1038/ismej.2011.74; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edwards CG, 1998, J APPL MICROBIOL, V84, P698, DOI 10.1046/j.1365-2672.1998.00399.x; Ellegaard KM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1476-6; Endo A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2339-x; Endo A, 2013, SYST APPL MICROBIOL, V36, P444, DOI 10.1016/j.syapm.2013.06.002; Endo A, 2012, INT J SYST EVOL MICR, V62, P500, DOI 10.1099/ijs.0.031054-0; Engel P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004596; Eren AM, 2015, ISME J, V9, P968, DOI 10.1038/ismej.2014.195; Evans JD, 2004, J ECON ENTOMOL, V97, P752, DOI 10.1603/0022-0493(2004)097[0752:BPIAIR]2.0.CO;2; Forsgren E, 2010, APIDOLOGIE, V41, P99, DOI 10.1051/apido/2009065; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Hu YOO, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016.00679, 10.5589/fmicb.2016.00679]; Kalia A, 1999, ANAL BIOCHEM, V275, P1, DOI 10.1006/abio.1999.4259; Killer J, 2014, INT J SYST EVOL MICR, V64, P152, DOI 10.1099/ijs.0.053033-0; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kwong WK, 2014, GENOME ANNOUNC, V2; Maggi M, 2013, VET MICROBIOL, V167, P474, DOI 10.1016/j.vetmic.2013.07.030; Makarova KS, 2007, J BACTERIOL, V189, P1199, DOI 10.1128/JB.01351-06; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Meixner MD, 2014, J APICULT RES, V53, P215, DOI 10.3896/IBRA.1.53.2.04; Molenaar D, 2005, J BACTERIOL, V187, P6119, DOI 10.1128/JB.187.17.6119-6127.2005; MORISHITA T, 1981, J BACTERIOL, V148, P64, DOI 10.1128/JB.148.1.64-71.1981; Mudronova D, 2011, J APICULT RES, V50, P323, DOI 10.3896/IBRA.1.50.4.11; Neveling DP, 2012, CURR MICROBIOL, V65, P507, DOI 10.1007/s00284-012-0186-4; Nicolson Susan W., 2007, P215, DOI 10.1007/978-1-4020-5937-7_5; O'Sullivan O, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-50; Olofsson TC, 2014, INT WOUND J, P1; Olofsson TC, 2008, CURR MICROBIOL, V57, P356, DOI 10.1007/s00284-008-9202-0; Olofsson TC, 2014, INT J SYST EVOL MICR, V64, P3109, DOI 10.1099/ijs.0.059600-0; Olofsson TC, 2011, APIDOLOGIE, V42, P696, DOI 10.1007/s13592-011-0064-2; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ragout A, 1996, BIOTECHNOL LETT, V18, P1105, DOI 10.1007/BF00129740; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sinclair L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116955; Stanley R. G., 1974, POLLEN BIOL BIOCH MA, P117; Tamarit D, 2015, GENOME BIOL EVOL, V7, P1455, DOI 10.1093/gbe/evv079; Temmerman R, 2004, TRENDS FOOD SCI TECH, V15, P348, DOI 10.1016/j.tifs.2003.12.007; Toft C, 2010, NAT REV GENET, V11, P465, DOI 10.1038/nrg2798; Vasquez A, 2001, LETT APPL MICROBIOL, V32, P215, DOI 10.1046/j.1472-765X.2001.00901.x; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; Vasquez A, 2009, J APICULT RES, V48, P189, DOI 10.3896/IBRA.1.48.3.07; Vasquez A, 2009, APIDOLOGIE, V40, P26, DOI 10.1051/apido:2008063; Vojvodic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072106	57	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2017	12	3							e0174614	10.1371/journal.pone.0174614	http://dx.doi.org/10.1371/journal.pone.0174614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER9VD	28346815	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000399174300061
J	Noto, A; De Vitis, C; Pisanu, ME; Roscilli, G; Ricci, G; Catizone, A; Sorrentino, G; Chianese, G; Taglialatela-Scafati, O; Trisciuoglio, D; Del Bufalo, D; Di Martile, M; Di Napoli, A; Ruco, L; Costantini, S; Jakopin, Z; Budillon, A; Melino, G; Del Sal, G; Ciliberto, G; Mancini, R				Noto, A.; De Vitis, C.; Pisanu, M. E.; Roscilli, G.; Ricci, G.; Catizone, A.; Sorrentino, G.; Chianese, G.; Taglialatela-Scafati, O.; Trisciuoglio, D.; Del Bufalo, D.; Di Martile, M.; Di Napoli, A.; Ruco, L.; Costantini, S.; Jakopin, Z.; Budillon, A.; Melino, G.; Del Sal, G.; Ciliberto, G.; Mancini, R.			Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ	ONCOGENE			English	Article							CELL-DEATH; HEPATOCELLULAR-CARCINOMA; CENTER STAGE; FATTY-ACIDS; TAZ; EXPRESSION; YAP; PROGRESSION; METABOLISM; EXTRACTION	Recent evidences suggest that stearoyl-CoA-desaturase 1 (SCD1), the enzyme involved in monounsaturated fatty acids synthesis, has a role in several cancers. We previously demonstrated that SCD1 is important in lung cancer stem cells survival and propagation. In this article, we first show, using primary cell cultures from human lung adenocarcinoma, that the effectors of the Hippo pathway, Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ), are required for the generation of lung cancer three-dimensional cultures and that SCD1 knock down and pharmacological inhibition both decrease expression, nuclear localization and transcriptional activity of YAP and TAZ. Regulation of YAP/TAZ by SCD1 is at least in part dependent upon beta-catenin pathway activity, as YAP/TAZ downregulation induced by SCD1 blockade can be rescued by the addition of exogenous wnt3a ligand. In addition, SCD1 activation of nuclear YAP/TAZ requires inactivation of the beta-catenin destruction complex. In line with the in vitro findings, immunohistochemistry analysis of lung adenocarcinoma samples showed that expression levels of SCD1 co-vary with those of beta-catenin and YAP/TAZ. Mining available gene expression data sets allowed to observe that high co-expression levels of SCD1, beta-catenin, YAP/TAZ and downstream targets have a strong negative prognostic value in lung adenocarcinoma. Finally, bioinformatics analyses directed to identify which gene combinations had synergistic effects on clinical outcome in lung cancer showed that poor survival is associated with high co-expression of SCD1, beta-catenin and the YAP/ TAZ downstream target birc5. In summary, our data demonstrate for the first time the involvement of SCD1 in the regulation of the Hippo pathway in lung cancer, and point to fatty acids metabolism as a key regulator of lung cancer stem cells.	[Noto, A.; De Vitis, C.; Roscilli, G.; Di Napoli, A.; Ruco, L.; Mancini, R.] Sapienza Univ Rome, St Andrea Hosp, Dept Clin & Mol Med, Rome, Italy; [Pisanu, M. E.; Costantini, S.; Budillon, A.; Ciliberto, G.] Fdn G Pascale, Natl Canc Inst, IRCCS, Naples, Italy; [Ricci, G.] Univ Campania Luigi Vanvitelli, Dept Expt Med, Naples, Italy; [Catizone, A.] Sapienza Univ Rome, Fac Pharm & Med, Dept Anat Histol Forens Med & Orthoped, Sect Histol & Embryol, Rome, Italy; [Sorrentino, G.] Lab Nazl CIB LNCIB, Area Sci Pk, Trieste, Italy; [Chianese, G.; Taglialatela-Scafati, O.] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Trisciuoglio, D.; Del Bufalo, D.; Di Martile, M.] IRCSS Natl Canc Inst Regina Elena, Res Adv Diagnost & Technol Innovat Dept, Preclin Models & New Therapeut Agents Units, Rome, Italy; [Jakopin, Z.] Univ Ljubljana, Fac Pharm, Ljubljana, Slovenia; [Melino, G.] Univ Leicester, Toxicol Unit, Med Res Council, Leicester, Leics, England; [Del Sal, G.] Univ Trieste, Dept Sci Vita, Trieste, Italy; [Ciliberto, G.] IRCSS Natl Canc Inst Regina Elena, Via Elio Chianesi 53, I-00144 Rome, Italy	Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; IRCCS Fondazione Pascale; Universita della Campania Vanvitelli; Sapienza University Rome; University of Naples Federico II; University of Ljubljana; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Leicester; University of Trieste	Ciliberto, G (corresponding author), IRCSS Natl Canc Inst Regina Elena, Via Elio Chianesi 53, I-00144 Rome, Italy.	gennaro.ciliberto@ifo.gov.it	Pisanu, Maria Elena/AAC-9143-2019; Jakopin, Žiga/B-7089-2019; Di Napoli, Arianna/AAB-3210-2022; trisciuoglio, daniela/AAL-4002-2021; Budillon, Alfredo/K-4763-2016; Di Martile, Marta/K-3348-2018; Del Bufalo, Donatella/AAC-1594-2021; Ciliberto, Gennaro/J-4131-2017; De Vitis, Claudia/K-4726-2016; Del Bufalo, Donatella/K-8673-2016; Trisciuoglio, Daniela/H-2131-2016	Jakopin, Žiga/0000-0001-9384-0858; Di Napoli, Arianna/0000-0002-3159-5380; Budillon, Alfredo/0000-0002-6330-6053; Di Martile, Marta/0000-0001-9924-9022; Del Bufalo, Donatella/0000-0002-3148-6096; Ciliberto, Gennaro/0000-0003-2851-8605; De Vitis, Claudia/0000-0001-8899-2347; Del Bufalo, Donatella/0000-0002-3148-6096; pisanu, maria elena/0000-0002-0029-3523; Sorrentino, Giovanni/0000-0001-8628-8778; Costantini, Susan/0000-0002-7538-4657; Trisciuoglio, Daniela/0000-0002-7007-7914	Italian Association for Cancer Research (AIRC) grant [IG17009, IG15216]; Fondo di Ricerca di Ateneo [C26A142LZ8]; POR FESR Lazio; Italian Association for Cancer Research (AIRC) Special Program Molecular Clinical Oncology '5 per mille' [10016]; AIRC IG [17659]; Italian Ministry of Health [RF-2011-02346976]	Italian Association for Cancer Research (AIRC) grant(Fondazione AIRC per la ricerca sul cancro); Fondo di Ricerca di Ateneo; POR FESR Lazio; Italian Association for Cancer Research (AIRC) Special Program Molecular Clinical Oncology '5 per mille'(Fondazione AIRC per la ricerca sul cancro); AIRC IG(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy)	The work was supported by Italian Association for Cancer Research (AIRC) grant IG17009 to RM, and grant IG15216 to GC. Fondo di Ricerca di Ateneo 2014 (C26A142LZ8) and by POR FESR Lazio 2007/2013 to RM. We are grateful to Stefano Piccolo for kindly providing TOP-FLASH reporter plasmid. We acknowledge Claudia Cippittelli for technical support on immunohistochemistry. We acknowledge Italian Association for Cancer Research (AIRC) Special Program Molecular Clinical Oncology '5 per mille' (grant no. 10016), AIRC IG (grant no. 17659) and the Italian Ministry of Health (RF-2011-02346976), to GDS.	Amelio I, 2016, CELL DEATH DIFFER, V23, P912, DOI 10.1038/cdd.2016.12; Antonov AV, 2011, NUCLEIC ACIDS RES, V39, pW323, DOI 10.1093/nar/gkr372; Azzolin L, 2014, CELL, V158, P157, DOI 10.1016/j.cell.2014.06.013; Bartucci M, 2015, ONCOGENE, V34, P681, DOI 10.1038/onc.2014.5; Belkaid A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1452-1; Byagowi S, 2015, CAN J DIABETES, V39, P123, DOI 10.1016/j.jcjd.2014.09.006; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Castro LFC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-132; Chen LiPing, 2016, Journal of Zhejiang A&F University, V33, P1; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Di Agostino S, 2016, EMBO REP, V17, P188, DOI 10.15252/embr.201540488; Hayashi H, 2015, CANCER RES, V75, P4985, DOI 10.1158/0008-5472.CAN-15-0291; Huang GM, 2015, CANCER LETT, V358, P180, DOI 10.1016/j.canlet.2014.12.036; Igal RA, 2010, CARCINOGENESIS, V31, P1509, DOI 10.1093/carcin/bgq131; Lau AN, 2014, EMBO J, V33, P468, DOI 10.1002/embj.201386082; Leger S, 2010, BIOORG MED CHEM LETT, V20, P499, DOI 10.1016/j.bmcl.2009.11.111; LEPAGE G, 1984, J LIPID RES, V25, P1391; Li JJ, 2017, CELL STEM CELL, V20, P303, DOI 10.1016/j.stem.2016.11.004; Mancini R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021320; Mason P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033823; Mauvoisin D, 2013, CANCER SCI, V104, P36, DOI 10.1111/cas.12032; Meacham CE, 2013, NATURE, V501, P328, DOI 10.1038/nature12624; Minville-Walz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014363; Noguchi S, 2014, CLIN CANCER RES, V20, P4660, DOI 10.1158/1078-0432.CCR-13-3328; Noto A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.444; Noto A, 2013, ONCOTARGET, V4, P1253, DOI 10.18632/oncotarget.1141; Ntambi JM, 1999, J LIPID RES, V40, P1549; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Piccolo S, 2013, CLIN CANCER RES, V19, P4925, DOI 10.1158/1078-0432.CCR-12-3172; Potze L, 2016, ONCOGENE, V35, P427, DOI 10.1038/onc.2015.102; Rappa G, 2013, EXP CELL RES, V319, P810, DOI 10.1016/j.yexcr.2013.01.003; Rios-Esteves J, 2014, J BIOL CHEM, V289, P17009, DOI 10.1074/jbc.M114.561209; Rios-Esteves J, 2013, CELL REP, V4, P1072, DOI 10.1016/j.celrep.2013.08.027; Roongta UV, 2011, MOL CANCER RES, V9, P1551, DOI 10.1158/1541-7786.MCR-11-0126; Roscilli G, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0816-x; Santinon G, 2016, TRENDS CELL BIOL, V26, P289, DOI 10.1016/j.tcb.2015.11.004; Scaglia N, 2008, INT J ONCOL, V33, P839, DOI 10.3892/ijo_00000072; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Southam AD, 2015, CANCER RES, V75, P2530, DOI 10.1158/0008-5472.CAN-15-0202; Tirinato L, 2015, STEM CELLS, V33, P35, DOI 10.1002/stem.1837; von Roemeling CA, 2015, J CLIN ENDOCR METAB, V100, pE697, DOI 10.1210/jc.2014-2764; von Roemeling CA, 2013, CLIN CANCER RES, V19, P2368, DOI 10.1158/1078-0432.CCR-12-3249; Wang Y, 2010, CANCER SCI, V101, P1279, DOI 10.1111/j.1349-7006.2010.01511.x; Xie M, 2012, J THORAC ONCOL, V7, P799, DOI 10.1097/JTO.0b013e318248240b; Yeung B, 2016, INT J CANCER, V138, P533, DOI 10.1002/ijc.29457; Zhang K, 2015, BIOCHEMISTRY-US, V54, P6555, DOI 10.1021/acs.biochem.5b01014; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606	48	91	95	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 10	2017	36	32					4573	4584		10.1038/onc.2017.75	http://dx.doi.org/10.1038/onc.2017.75			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FD0RK	28368399				2022-12-26	WOS:000407246200005
